[{"pmid": 38293276, "pmcid": "PMC10826380", "title": "Reclassification of RAS/BRAF allele mutations predicts the survival benefit of triplet chemotherapy in metastatic colorectal cancer", "journal": "Ther Adv Med Oncol", "authors": ["Zhang X", "Ma H", "He Y", "He W", "Chen N", "Li Y", "Zhong W", "Wu G", "Zhou X", "Hua H", "Ye F", "Cai H", "Jiang W"], "date": "2024-01-28T00:00:00Z", "year": 2024, "snippets": [{"_id": "38293276@15076", "snip_text": "The most prevalent KRAS-mutated alleles were KRAS G12D (14.7%), KRAS G12V (10.7%), KRAS G13D (9.8%), KRAS G12C (3.2%), and KRAS A146T (2.0%).", "section": "results", "mentions": ["106|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "83|4|gene|ncbi_gene@3845|KRAS", "69|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "50|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "123|4|gene|ncbi_gene@3845|KRAS", "128|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "45|4|gene|ncbi_gene@3845|KRAS", "88|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "101|4|gene|ncbi_gene@3845|KRAS", "19|4|gene|ncbi_gene@3845|KRAS", "64|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "The most prevalent KRAS-mutated alleles were KRAS G12D (14.7%), KRAS G12V (10.7%), KRAS G13D (9.8%), KRAS G12C (3.2%), and KRAS <m>A146T</m> (2.0%)."}], "citations": {"NLM": "Zhang X, Ma H, He Y, He W, Chen N, Li Y, Zhong W, Wu G, Zhou X, Hua H, Ye F, Cai H, Jiang W. Reclassification of RAS/BRAF allele mutations predicts the survival benefit of triplet chemotherapy in metastatic colorectal cancer Ther Adv Med Oncol. PMID: 38293276", "BibTeX": "@article{38293276, title={Reclassification of RAS/BRAF allele mutations predicts the survival benefit of triplet chemotherapy in metastatic colorectal cancer}, author={Zhang X and Ma H and He Y and He W and Chen N and Li Y and Zhong W and Wu G and Zhou X and Hua H and Ye F and Cai H and Jiang W}, journal={Ther Adv Med Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 38282550, "pmcid": "PMC10812383", "title": "Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity", "journal": "Cancer Res Commun", "authors": ["Shah SM", "Demidova EV", "Ringenbach S", "Faezov B", "Andrake M", "Gandhi A", "Mur P", "Viana-Errasti J", "Xiu J", "Swensen J", "Valle L", "Dunbrack RL Jr", "Hall MJ", "Arora S"], "date": "2024-01-26T00:00:00Z", "year": 2024, "snippets": [{"_id": "38282550@30566", "snip_text": "In contrast, KRAS A146T:overall, a less commonly observed KRAS mutation :was the most frequent KRAS mutation in Groups 2 and 3, and not found in Groups 1 and 4.", "section": "results", "mentions": ["58|4|gene|ncbi_gene@3845|KRAS", "18|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "13|4|gene|ncbi_gene@3845|KRAS", "95|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "In contrast, KRAS A146T:overall, a less commonly observed KRAS mutation :was the most frequent KRAS mutation in Groups 2 and 3, and not found in Groups 1 and 4."}], "citations": {"NLM": "Shah SM, Demidova EV, Ringenbach S, Faezov B, Andrake M, Gandhi A, Mur P, Viana-Errasti J, Xiu J, Swensen J, Valle L, Dunbrack RL Jr, Hall MJ, Arora S. Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity Cancer Res Commun. PMID: 38282550", "BibTeX": "@article{38282550, title={Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity}, author={Shah SM and Demidova EV and Ringenbach S and Faezov B and Andrake M and Gandhi A and Mur P and Viana-Errasti J and Xiu J and Swensen J and Valle L and Dunbrack RL Jr and Hall MJ and Arora S}, journal={Cancer Res Commun}}"}, "is_sup_mat_match": false}, {"pmid": 38982409, "pmcid": "PMC11234528", "title": "Malignant solitary fibrous tumor of the kidney with IGF2 secretion and without hypoglycemia", "journal": "World J Surg Oncol", "authors": ["Zhou L", "Liu Y", "Xu T", "Dong L", "Yang X", "Wang C"], "date": "2024-07-09T00:00:00Z", "year": 2024, "snippets": [{"_id": "38982409@7933", "snip_text": "Considering the rarity of malignant SFT of the kidney, DNA sequencing was performed to explore its molecular features, which revealed a missense mutation in KRAS (exon 4 436G>A A146T) (Fig. 6).", "section": "other", "mentions": ["177|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "157|4|gene|ncbi_gene@3845|KRAS", "36|17|disease|ncbi_mesh@D000075529|SFT of the kidney", "170|6|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|436G>A"], "text_hl": "Considering the rarity of malignant SFT of the kidney, DNA sequencing was performed to explore its molecular features, which revealed a missense mutation in KRAS (exon 4 436G>A <m>A146T</m>) (Fig. 6)."}], "citations": {"NLM": "Zhou L, Liu Y, Xu T, Dong L, Yang X, Wang C. Malignant solitary fibrous tumor of the kidney with IGF2 secretion and without hypoglycemia World J Surg Oncol. PMID: 38982409", "BibTeX": "@article{38982409, title={Malignant solitary fibrous tumor of the kidney with IGF2 secretion and without hypoglycemia}, author={Zhou L and Liu Y and Xu T and Dong L and Yang X and Wang C}, journal={World J Surg Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 38397405, "pmcid": "PMC10887151", "title": "A Challenging Correlation between Tumor Cellularity and Somatic Variant Allele Fraction in Lung and Colorectal Cancers:Specimens of Low Tumor Percentage Should Be Analyzed with Caution", "journal": "Biomolecules", "authors": ["Zarabi SK", "Zhai L", "Cheng YW"], "date": "2024-01-31T00:00:00Z", "year": 2024, "snippets": [{"_id": "38397405@33227", "snip_text": "Gene\tVariant\tNumber\tPercentage\t \tEGFR\tEx19 deletion\t59 \t50.9% \t \tEx19 insertion\t1 \t0.9% \t \tEx20 insertion\t11 \t9.5% \t \tG719A/S\t4 \t3.4% \t \tL858R\t34 \t29.3% \t \tL861Q\t4 \t3.4% \t \tOther (G721A, L747P, R776L)\t3 \t2.6% \t \tKRAS\tG12A/C/D/F/R/S/V\t262 \t87.0% \t \tG13C/D/R/V\t19 \t6.3% \t \tQ61H/K/L\t18 \t6.0% \t \tA146T/V\t2 \t0.7% \t \tBRAF\tG464V\t1 \t3.0% \t \tG466A/V\t5 \t15.2% \t \tG469A/R/V\t9 \t27.3% \t \tN581I/S\t3 \t9.1% \t \tN594G/N\t5 \t15.2% \t \tK601E\t2 \t6.1% \t \tV600E\t8 \t24.2% \t \t", "section": "table", "mentions": ["353|5|variant|litvar@rs1258111302##&&&litvar@#673#|G469A", "137|5|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|L858R", "212|4|gene|ncbi_gene@3845|KRAS", "292|7|variant|litvar@rs121913527##&&&litvar@#3845#|A146T/V", "156|5|variant|litvar@rs121913444##&&&litvar@#1956#&&&litvar@CA176021#rs121913444##|L861Q", "333|7|variant|litvar@rs121913351##&&&litvar@#673#|G466A/V", "375|7|variant|litvar@rs121913370##&&&litvar@#673#|N581I/S", "311|4|gene|ncbi_gene@673|BRAF", "118|7|variant|litvar@rs28929495##&&&litvar@#1956#|G719A/S", "217|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12A/C", "33|4|gene|ncbi_gene@1956|EGFR", "394|7|variant|litvar@rs121913338##&&&litvar@#673#|N594G/N", "271|6|variant|litvar@rs17851045##&&&litvar@#3845#|Q61H/K", "248|6|variant|litvar@rs112445441##&&&litvar@#3845#|G13C/D", "194|5|variant|litvar@rs1275022697##&&&litvar@#1956#|R776L", "187|5|variant|litvar@rs397517096##&&&litvar@#1956#&&&litvar@CA135800#rs397517096##|L747P", "180|5|variant|litvar@rs1407608935##&&&litvar@#1956#|G721A", "316|5|variant|litvar@rs121913348##&&&litvar@#673#&&&litvar@CA135076#rs121913348##|G464V", "414|5|variant|litvar@rs121913364##&&&litvar@#673#&&&litvar@CA123645#rs121913364##|K601E", "431|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E"], "figure_id": "biomolecules-14-00168-t002", "text_hl": "Gene\tVariant\tNumber\tPercentage\t \tEGFR\tEx19 deletion\t59 \t50.9% \t \tEx19 insertion\t1 \t0.9% \t \tEx20 insertion\t11 \t9.5% \t \tG719A/S\t4 \t3.4% \t \tL858R\t34 \t29.3% \t \tL861Q\t4 \t3.4% \t \tOther (G721A, L747P, R776L)\t3 \t2.6% \t \tKRAS\tG12A/C/D/F/R/S/V\t262 \t87.0% \t \tG13C/D/R/V\t19 \t6.3% \t \tQ61H/K/L\t18 \t6.0% \t \t<m>A146T</m>/V\t2 \t0.7% \t \tBRAF\tG464V\t1 \t3.0% \t \tG466A/V\t5 \t15.2% \t \tG469A/R/V\t9 \t27.3% \t \tN581I/S\t3 \t9.1% \t \tN594G/N\t5 \t15.2% \t \tK601E\t2 \t6.1% \t \tV600E\t8 \t24.2% \t \t"}], "citations": {"NLM": "Zarabi SK, Zhai L, Cheng YW. A Challenging Correlation between Tumor Cellularity and Somatic Variant Allele Fraction in Lung and Colorectal Cancers:Specimens of Low Tumor Percentage Should Be Analyzed with Caution Biomolecules. PMID: 38397405", "BibTeX": "@article{38397405, title={A Challenging Correlation between Tumor Cellularity and Somatic Variant Allele Fraction in Lung and Colorectal Cancers:Specimens of Low Tumor Percentage Should Be Analyzed with Caution}, author={Zarabi SK and Zhai L and Cheng YW}, journal={Biomolecules}}"}, "is_sup_mat_match": false}, {"pmid": 39628993, "pmcid": "PMC11612501", "title": "Exploring the molecular profile of localized colon cancer: insights from the AIO Colopredict Plus registry", "journal": "Front Oncol", "authors": ["Ekmekciu I", "Zucha DM", "Christmann J", "Wisser S", "Heuer V", "Sargin B", "Hollerbach S", "Lamberti C", "M\u00fcller L", "Lugnier C", "Verdoodt B", "Denz R", "Terzer T", "Feder I", "Reinacher-Schick A", "Tannapfel A", "Tischoff I"], "date": "2024-11-19T00:00:00Z", "year": 2024, "snippets": [{"_id": "39628993@19457", "snip_text": "In the MSI-H population, mutations such as p.G12D, p.G13D, and p.G12A were more prevalent in males, while p.A146T and p.G12C were more common in females, although the overall numbers were low.", "section": "results", "mentions": ["63|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "43|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "118|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "51|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "106|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "7|5|disease|ncbi_mesh@D053842|MSI-H"], "text_hl": "In the MSI-H population, mutations such as p.G12D, p.G13D, and p.G12A were more prevalent in males, while <m>p.A146T</m> and p.G12C were more common in females, although the overall numbers were low."}], "citations": {"NLM": "Ekmekciu I, Zucha DM, Christmann J, Wisser S, Heuer V, Sargin B, Hollerbach S, Lamberti C, M\u00fcller L, Lugnier C, Verdoodt B, Denz R, Terzer T, Feder I, Reinacher-Schick A, Tannapfel A, Tischoff I. Exploring the molecular profile of localized colon cancer: insights from the AIO Colopredict Plus registry Front Oncol. PMID: 39628993", "BibTeX": "@article{39628993, title={Exploring the molecular profile of localized colon cancer: insights from the AIO Colopredict Plus registry}, author={Ekmekciu I and Zucha DM and Christmann J and Wisser S and Heuer V and Sargin B and Hollerbach S and Lamberti C and M\u00fcller L and Lugnier C and Verdoodt B and Denz R and Terzer T and Feder I and Reinacher-Schick A and Tannapfel A and Tischoff I}, journal={Front Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 38875469, "pmcid": "PMC11179507", "title": "KRAS, NRAS and BRAF Mutational Profile of Colorectal Cancer in a Series of Moroccan Patients", "journal": "Cancer Control", "authors": ["El Zaitouni S", "Laraqui A", "Ghaouti M", "Benzekri A", "Kettani F", "Bajjou T", "Sekhsokh Y", "Benmokhtar S", "Jafari M", "Baba W", "Oukabli M", "El Annaz H", "Abi R", "Tagajdid MR", "El Kochri S", "Lahlou IA", "Ameziane El Hassani R", "Ennibi K"], "date": "2024-01-01T00:00:00Z", "year": 2024, "snippets": [{"_id": "38875469@889", "snip_text": "Concurrent KRAS mutations were identified in 9.5% (11/116); including six in codon 146 (A146P/T/V), three in codon 61 (Q61H/L/R), one in codon 12 (G12 A and Q61H), and one in codon 13 (G13D and Q61 L).", "section": "abstract", "mentions": ["157|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "88|7|variant|litvar@rs121913527##&&&litvar@#3845#|A146P/T", "147|5|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12 A", "11|4|gene|ncbi_gene@3845|KRAS", "185|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "194|5|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61 L", "119|8|variant|litvar@rs17851045##&&&litvar@#3845#|Q61H/L/R"], "text_hl": "Concurrent KRAS mutations were identified in 9.5% (11/116); including six in codon 146 (A146P/T/V), three in codon 61 (Q61H/L/R), one in codon 12 (G12 A and Q61H), and one in codon 13 (G13D and Q61 L)."}], "citations": {"NLM": "El Zaitouni S, Laraqui A, Ghaouti M, Benzekri A, Kettani F, Bajjou T, Sekhsokh Y, Benmokhtar S, Jafari M, Baba W, Oukabli M, El Annaz H, Abi R, Tagajdid MR, El Kochri S, Lahlou IA, Ameziane El Hassani R, Ennibi K. KRAS, NRAS and BRAF Mutational Profile of Colorectal Cancer in a Series of Moroccan Patients Cancer Control. PMID: 38875469", "BibTeX": "@article{38875469, title={KRAS, NRAS and BRAF Mutational Profile of Colorectal Cancer in a Series of Moroccan Patients}, author={El Zaitouni S and Laraqui A and Ghaouti M and Benzekri A and Kettani F and Bajjou T and Sekhsokh Y and Benmokhtar S and Jafari M and Baba W and Oukabli M and El Annaz H and Abi R and Tagajdid MR and El Kochri S and Lahlou IA and Ameziane El Hassani R and Ennibi K}, journal={Cancer Control}}"}, "is_sup_mat_match": false}, {"pmid": 38652382, "pmcid": "PMC11127803", "title": "Isolated Langerhans cell histiocytosis in the stomach of adults: four-case series and literature review", "journal": "J Hematop", "authors": ["Zhao J", "Li Y", "Zhang Y", "Mei X", "Liu W", "Li Y"], "date": "2024-06-01T00:00:00Z", "year": 2024, "snippets": [{"_id": "38652382@4473", "snip_text": "The KRAS gene mutations detected by the kit included exon 2 (G12S, G12D, G12C, G12R, G12V, G12A, G13C, and G13D), exon 3 (Q61L, Q61R, and Q61H), and exon 4 (K117N, A146T, A146V, and A146P).", "section": "methods", "mentions": ["107|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "91|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "164|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "157|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "4|4|gene|ncbi_gene@3845|KRAS", "85|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "128|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "171|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "97|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "122|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "138|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "67|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "61|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "79|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "182|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "73|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C"], "text_hl": "The KRAS gene mutations detected by the kit included exon 2 (G12S, G12D, G12C, G12R, G12V, G12A, G13C, and G13D), exon 3 (Q61L, Q61R, and Q61H), and exon 4 (K117N, <m>A146T</m>, A146V, and A146P)."}], "citations": {"NLM": "Zhao J, Li Y, Zhang Y, Mei X, Liu W, Li Y. Isolated Langerhans cell histiocytosis in the stomach of adults: four-case series and literature review J Hematop. PMID: 38652382", "BibTeX": "@article{38652382, title={Isolated Langerhans cell histiocytosis in the stomach of adults: four-case series and literature review}, author={Zhao J and Li Y and Zhang Y and Mei X and Liu W and Li Y}, journal={J Hematop}}"}, "is_sup_mat_match": false}, {"pmid": 39287844, "pmcid": "PMC11565173", "title": "Cancer in Multilineage Mosaic RASopathies due to Pathogenic Variants in HRAS or KRAS: A Systematic Review and Meta-analysis", "journal": "Clin Cancer Res", "authors": ["Windrich J", "Ney GM", "Rosenberg PS", "Kim J", "Zenker M", "Stewart DR", "Kratz CP"], "date": "2024-11-15T00:00:00Z", "year": 2024, "snippets": [{"_id": "39287844@11425", "snip_text": "Notably, there were several patients with a mosaic KRAS PV predicting a biochemically distinct KRAS p.Ala146Thr substitution, which seems to be selected among patients with certain types of mosaic RASopathies.", "section": "discussion", "mentions": ["159|8|species|ncbi_taxonomy@9606|patients", "100|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "28|8|species|ncbi_taxonomy@9606|patients", "197|11|disease||RASopathies", "95|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "Notably, there were several patients with a mosaic KRAS PV predicting a biochemically distinct KRAS <m>p.Ala146Thr</m> substitution, which seems to be selected among patients with certain types of mosaic RASopathies."}], "citations": {"NLM": "Windrich J, Ney GM, Rosenberg PS, Kim J, Zenker M, Stewart DR, Kratz CP. Cancer in Multilineage Mosaic RASopathies due to Pathogenic Variants in HRAS or KRAS: A Systematic Review and Meta-analysis Clin Cancer Res. PMID: 39287844", "BibTeX": "@article{39287844, title={Cancer in Multilineage Mosaic RASopathies due to Pathogenic Variants in HRAS or KRAS: A Systematic Review and Meta-analysis}, author={Windrich J and Ney GM and Rosenberg PS and Kim J and Zenker M and Stewart DR and Kratz CP}, journal={Clin Cancer Res}}"}, "is_sup_mat_match": false}, {"pmid": 38613907, "pmcid": "PMC11033065", "title": "Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases", "journal": "ESMO Open", "authors": ["Tonello M", "Baratti D", "Sammartino P", "Di Giorgio A", "Robella M", "Sassaroli C", "Framarini M", "Valle M", "Macr\u00ec A", "Graziosi L", "Coccolini F", "Lippolis PV", "Gelmini R", "Deraco M", "Biacchi D", "Aulicino M", "Vaira M", "De Franciscis S", "D'Acapito F", "Carboni F", "Milone E", "Donini A", "Fugazzola P", "Faviana P", "Sorrentino L", "Pizzolato E", "Cenzi C", "Del Bianco P", "Sommariva A"], "date": "2024-04-12T00:00:00Z", "year": 2024, "snippets": [{"_id": "38613907@887", "snip_text": "Two different prognostic groups of KRAS mutation subtypes were identified: KRASMUT1 (G12R, G13A, G13C, G13V, Q61H, K117N, A146V), median OS > 120 months and KRASMUT2 (G12A, G12C, G12D, G12S, G12V, G13D, A59E, A59V, A146T), OS: 31.2 months.", "section": "abstract", "mentions": ["215|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "97|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "91|4|variant|litvar@rs193929331##&&&litvar@#3845#&&&litvar@CA250291#rs193929331##|G13A", "122|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "203|4|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|A59E", "115|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "35|4|gene|ncbi_gene@3845|KRAS", "109|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "173|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "167|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "185|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "179|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "197|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "191|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "103|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "209|4|variant|litvar@rs104886029##&&&litvar@#3845#&&&litvar@CA269881#rs104886029##|A59V", "85|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R"], "text_hl": "Two different prognostic groups of KRAS mutation subtypes were identified: KRASMUT1 (G12R, G13A, G13C, G13V, Q61H, K117N, A146V), median OS > 120 months and KRASMUT2 (G12A, G12C, G12D, G12S, G12V, G13D, A59E, A59V, <m>A146T</m>), OS: 31.2 months."}], "citations": {"NLM": "Tonello M, Baratti D, Sammartino P, Di Giorgio A, Robella M, Sassaroli C, Framarini M, Valle M, Macr\u00ec A, Graziosi L, Coccolini F, Lippolis PV, Gelmini R, Deraco M, Biacchi D, Aulicino M, Vaira M, De Franciscis S, D'Acapito F, Carboni F, Milone E, Donini A, Fugazzola P, Faviana P, Sorrentino L, Pizzolato E, Cenzi C, Del Bianco P, Sommariva A. Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases ESMO Open. PMID: 38613907", "BibTeX": "@article{38613907, title={Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases}, author={Tonello M and Baratti D and Sammartino P and Di Giorgio A and Robella M and Sassaroli C and Framarini M and Valle M and Macr\u00ec A and Graziosi L and Coccolini F and Lippolis PV and Gelmini R and Deraco M and Biacchi D and Aulicino M and Vaira M and De Franciscis S and D'Acapito F and Carboni F and Milone E and Donini A and Fugazzola P and Faviana P and Sorrentino L and Pizzolato E and Cenzi C and Del Bianco P and Sommariva A}, journal={ESMO Open}}"}, "is_sup_mat_match": false}, {"pmid": 38798959, "pmcid": "PMC11128178", "title": "RAS/RAF/MAPK Pathway Mutations as Predictive Biomarkers in Middle Eastern Colorectal Cancer: A Systematic Review", "journal": "Clin Med Insights Oncol", "authors": ["Benmokhtar S", "Laraqui A", "Hilali F", "Bajjou T", "El Zaitouni S", "Jafari M", "Baba W", "Elannaz H", "Lahlou IA", "Hafsa C", "Oukabli M", "Mahfoud T", "Tanz R", "Ichou M", "Ennibi K", "Dakka N", "Sekhsokh Y"], "date": "2024-05-25T00:00:00Z", "year": 2024, "snippets": [{"_id": "38798959@28081", "snip_text": "In exon 4, the most common mutation was K117N (33.3%, 9 of 15), followed by A146T (33%, 5 of 15) and A146V (6.6%, 1 of 15).", "section": "results", "mentions": ["101|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "76|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "40|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N"], "text_hl": "In exon 4, the most common mutation was K117N (33.3%, 9 of 15), followed by <m>A146T</m> (33%, 5 of 15) and A146V (6.6%, 1 of 15)."}], "citations": {"NLM": "Benmokhtar S, Laraqui A, Hilali F, Bajjou T, El Zaitouni S, Jafari M, Baba W, Elannaz H, Lahlou IA, Hafsa C, Oukabli M, Mahfoud T, Tanz R, Ichou M, Ennibi K, Dakka N, Sekhsokh Y. RAS/RAF/MAPK Pathway Mutations as Predictive Biomarkers in Middle Eastern Colorectal Cancer: A Systematic Review Clin Med Insights Oncol. PMID: 38798959", "BibTeX": "@article{38798959, title={RAS/RAF/MAPK Pathway Mutations as Predictive Biomarkers in Middle Eastern Colorectal Cancer: A Systematic Review}, author={Benmokhtar S and Laraqui A and Hilali F and Bajjou T and El Zaitouni S and Jafari M and Baba W and Elannaz H and Lahlou IA and Hafsa C and Oukabli M and Mahfoud T and Tanz R and Ichou M and Ennibi K and Dakka N and Sekhsokh Y}, journal={Clin Med Insights Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 32582557, "pmcid": "PMC7296099", "title": "Clinicopathological Characteristics and Mutation Spectrum of Colorectal Adenocarcinoma With Mucinous Component in a Chinese Cohort: Comparison With Classical Adenocarcinoma.", "journal": "Front Oncol", "authors": ["Chen J", "Zhou L", "Gao J", "Lu T", "Wang J", "Wu H", "Liang Z"], "date": "2020-06-09T00:00:00Z", "year": 2020, "snippets": [{"_id": "32582557@20419", "snip_text": "Forty-eight of the mutations were point mutation (13 of G12D, 10 of G12V, 9 of G13D, 8 of A146T, 2 of Q61R, 1 of A146V, 1 of G12C, 1 of G12S, 1 of Q61H, 1 of A146T and G13D, 1 of T20M and G13D), with only one insertion (G12_G13insA).", "section": "results", "mentions": ["56|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "158|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "113|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "79|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "68|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "179|4|variant|litvar@#3845#p.T20M&&&litvar@#3845#|T20M", "168|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "188|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "90|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "136|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "125|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "147|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "102|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R"], "text_hl": "Forty-eight of the mutations were point mutation (13 of G12D, 10 of G12V, 9 of G13D, 8 of <m>A146T</m>, 2 of Q61R, 1 of A146V, 1 of G12C, 1 of G12S, 1 of Q61H, 1 of <m>A146T</m> and G13D, 1 of T20M and G13D), with only one insertion (G12_G13insA)."}], "citations": {"NLM": "Chen J, Zhou L, Gao J, Lu T, Wang J, Wu H, Liang Z. Clinicopathological Characteristics and Mutation Spectrum of Colorectal Adenocarcinoma With Mucinous Component in a Chinese Cohort: Comparison With Classical Adenocarcinoma. Front Oncol. PMID: 32582557", "BibTeX": "@article{32582557, title={Clinicopathological Characteristics and Mutation Spectrum of Colorectal Adenocarcinoma With Mucinous Component in a Chinese Cohort: Comparison With Classical Adenocarcinoma.}, author={Chen J and Zhou L and Gao J and Lu T and Wang J and Wu H and Liang Z}, journal={Front Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 27335808, "pmcid": "PMC4906127", "title": "Diagnostic RAS mutation analysis by polymerase chain reaction (PCR)", "journal": "Biomol Detect Quantif", "authors": ["Cree IA"], "date": "2016-06-06T00:00:00Z", "year": 2016, "snippets": [{"_id": "27335808@20655", "snip_text": "Exon\tCodon\tExample Mutations\t \t2\t12\tG12C (c.34G > T)\t \t\t\tG12R (c.34G > C)\t \t\t\tG12S (c.34G > A)\t \t\t\tG12A (c.35G > C)\t \t\t\tG12D (c.35G > A)\t \t\t\tG12V (c.35G > T)\t \t\t13\tG13D (c.38G > A)\t \t3\t59\tA59E (c.176C > A)\t \t\t\tA59G (c.176C > G)\t \t\t\tA59T (c.175G > A)\t \t\t61\tQ61K (c.181C > A)\t \t\t\tQ61L (c.182A > T)\t \t\t\tQ61R (c.182A > G)\t \t\t\tQ61H (c.183A > C)\t \t\t\tQ61H (c.183A > T)\t \t4\t117\tK117N (c.351A > C)\t \t\t146\tA146P (c.436G > C)\t \t\t\tA146T (c.436G > A)\t \t\t\tA146V (c.437C > T)\t \t", "section": "table", "mentions": ["232|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "99|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "306|10|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|c.182A > G", "164|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "42|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G > T", "141|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "84|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G > A", "256|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "126|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "210|4|variant|litvar@rs763572530##&&&litvar@#1956#|A59G", "403|10|variant|litvar@rs121913527##&&&litvar@#3845#|c.436G > C", "36|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "344|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "238|10|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|c.175G > A", "449|10|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C > T", "396|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "188|4|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|A59E", "419|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "426|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "284|10|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|c.182A > T", "78|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "442|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "377|10|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|c.351A > C", "216|10|variant|litvar@rs763572530##&&&litvar@#1956#|c.176C > G", "262|10|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA180750#rs121913238##|c.181C > A", "120|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "322|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "370|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "63|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G > C", "194|10|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|c.176C > A", "105|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > C", "147|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "350|10|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|c.183A > T", "57|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "328|10|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA180922#rs17851045##|c.183A > C", "170|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "300|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "278|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L"], "figure_id": "tbl0005", "text_hl": "Exon\tCodon\tExample Mutations\t \t2\t12\tG12C (c.34G > T)\t \t\t\tG12R (c.34G > C)\t \t\t\tG12S (c.34G > A)\t \t\t\tG12A (c.35G > C)\t \t\t\tG12D (c.35G > A)\t \t\t\tG12V (c.35G > T)\t \t\t13\tG13D (c.38G > A)\t \t3\t59\tA59E (c.176C > A)\t \t\t\tA59G (c.176C > G)\t \t\t\tA59T (c.175G > A)\t \t\t61\tQ61K (c.181C > A)\t \t\t\tQ61L (c.182A > T)\t \t\t\tQ61R (c.182A > G)\t \t\t\tQ61H (c.183A > C)\t \t\t\tQ61H (c.183A > T)\t \t4\t117\tK117N (c.351A > C)\t \t\t146\tA146P (c.436G > C)\t \t\t\t<m>A146T</m> (c.436G > A)\t \t\t\tA146V (c.437C > T)\t \t"}], "citations": {"NLM": "Cree IA. Diagnostic RAS mutation analysis by polymerase chain reaction (PCR) Biomol Detect Quantif. PMID: 27335808", "BibTeX": "@article{27335808, title={Diagnostic RAS mutation analysis by polymerase chain reaction (PCR)}, author={Cree IA}, journal={Biomol Detect Quantif}}"}, "is_sup_mat_match": false}, {"pmid": 32810928, "pmcid": "PMC8247027", "title": "Pathogenic postzygotic mosaicism in the tyrosine receptor kinase pathway: potential unidentified human disease hidden away in a few cells.", "journal": "FEBS J", "authors": ["Tiemann-Boege I", "Mair T", "Yasari A", "Zurovec M"], "date": "2021-05-01T00:00:00Z", "year": 2021, "snippets": [{"_id": "32810928@11909", "snip_text": "Syndrome Genes and substitutions Level of mosaicism Affected tissue Time of onset Ref.   Proteus AKT1 (E17K) Level and phenotype of Proteus greatly depend on the timing of the mutation, the affected tissue type, or restriction to certain germ layer. Asymmetrically and irregularly growing tissues mainly in skin, bone, and adipose tissue; increased risk in thrombosis and subsequent pulmonary embolism 6-18 months after birth [31, 64]   PROS; for example, Klippel-Trenaunay PIK3CA (E545K, E454G, H1047R, H1047L) < 1% detected by NGS CLVM (capillary, lymphatic, and venous malformations), skin and tissue with lesions, and buccal cells Phenotype dependent on mutation type and distribution [32, 65]   FD/MAS GNAS (R201H, R201C) Unknown; 'obligatory mosaic' Endoderm, mesoderm, and ectoderm Children and young adults [66]   SWS GNAQ (R183Q) Mutant allele in affected tissues ranged from 1% to 18% Skin specially face, eye, nervous, and neurological anomalies Infants [35]   PPV and extensive dermal melanocytosis GNA11 (R183C, R183S)GNAQ (R183Q, Q209P) Low level of postzygotic mutations; percentage of mosaicism in skin was lowest with 1.5% Dermal melanocytosis (Mongolian blue spots), ocular melanocytosis, vascular birthmarks, and neurological abnormalities Infants [41, 67, 68, 69, 70]   NCM NRAS (Q61R, Q61K) Affected cutaneous and neurological tissues Development in neural crest and neuroectoderm; skin and central nerve system Children [36, 37]   SFMS HRAS (G13R)KRAS (G12D)NRAS (Q61R) Mutation frequency of 52% in head nevus sebaceous, 13% in hyperpigmented lesions, and 24.3% in lip nevus sebaceous tissues Nevus sebaceous, neurological anomalies, eye, skeletal, height, brain, head, genitourinary, cardiovascular, neoplasia From birth onwards [38, 39]   OES KRAS (A146T, A146V, G13D, L19F) RASopathy; frequency < 40% of tissues Skin; epibulbar dermoids and congenital scalp lesions (aplasia cutis congenita; ACC) Children [71, 72]   Encephalocraniocutaneous Lipomatosis (ECCL) FGFR1 (K656E, N546K)KRAS (A146T) Alternate allele fraction of 23-55% in fibroblasts from affected tissues; not detected in saliva or blood Cutaneous, ocular, and CNS; nevus psiloliparus as hallmark of ECCL Children [71, 73, 74]   ", "section": "table", "mentions": ["1037|5|variant|litvar@rs397514698##&&&litvar@#2776#&&&litvar@CA143805#rs397514698##|R183Q", "474|6|gene|ncbi_gene@5290|PIK3CA", "789|8|species|ncbi_taxonomy@9606|Children", "1550|22|disease|ncbi_mesh@C537836|hyperpigmented lesions", "1486|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "539|46|disease|ncbi_mesh@D008209|capillary, lymphatic, and venous malformations", "1458|4|gene|ncbi_gene@3265|HRAS", "832|5|variant|litvar@rs397514698##&&&litvar@#2776#&&&litvar@CA143805#rs397514698##|R183Q", "1162|20|disease|ncbi_mesh@D049328|Mongolian blue spots", "1464|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "2012|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "456|17|disease|ncbi_mesh@D007715|Klippel-Trenaunay", "1433|8|species|ncbi_taxonomy@9606|Children", "1773|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "713|5|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|R201H", "1917|3|disease|ncbi_mesh@D004476|ACC", "2006|4|gene|ncbi_gene@3845|KRAS", "1767|4|gene|ncbi_gene@3845|KRAS", "1011|5|gene|ncbi_gene@2767|GNA11", "972|3|disease|ncbi_mesh@D020752|PPV", "1866|24|disease|ncbi_mesh@D004476|congenital scalp lesions", "700|2|disease|ncbi_mesh@D000795|FD", "1140|20|disease|ncbi_mesh@C535835|Dermal melanocytosis", "437|4|disease|ncbi_mesh@C537340|PROS", "1591|15|disease|ncbi_mesh@D054000|nevus sebaceous", "1300|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "489|5|variant|litvar@rs367955950##&&&litvar@#2260#&&&litvar@CA4718399#rs367955950##|E454G", "1044|5|variant|litvar@rs121913492##&&&litvar@#2776#&&&litvar@CA16602436#rs121913492##|Q209P", "1986|5|gene|ncbi_gene@2260|FGFR1", "1615|15|disease|ncbi_mesh@D054000|Nevus sebaceous", "1922|8|species|ncbi_taxonomy@9606|Children", "1475|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1763|3|disease|ncbi_mesh@C563969|OES", "496|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "2187|4|disease|ncbi_mesh@C535736|ECCL", "957|7|species|ncbi_taxonomy@9606|Infants", "1980|4|disease|ncbi_mesh@C535736|ECCL", "921|35|disease|ncbi_mesh@D009421|nervous, and neurological anomalies", "990|20|disease|ncbi_mesh@C535835|dermal melanocytosis", "1018|5|variant|litvar@rs776549085##&&&litvar@#2260#|R183C", "1793|4|variant|litvar@rs121913538##&&&litvar@#3845#&&&litvar@CA210356#rs121913538##|L19F", "482|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "1031|4|gene|ncbi_gene@2776|GNAQ", "1942|36|disease|ncbi_mesh@C535736|Encephalocraniocutaneous Lipomatosis", "1632|22|disease|ncbi_mesh@D009421|neurological anomalies", "1993|5|variant|litvar@rs869320694##&&&litvar@#2260#&&&litvar@CA358862#rs869320694##|K656E", "1526|15|disease|ncbi_mesh@D054000|nevus sebaceous", "2125|26|disease|ncbi_mesh@D002494|Cutaneous, ocular, and CNS", "357|10|disease|ncbi_mesh@D013927|thrombosis", "1843|18|disease|ncbi_mesh@D003884|epibulbar dermoids", "707|4|gene|ncbi_gene@2778|GNAS", "1705|27|disease|ncbi_mesh@D009369|, cardiovascular, neoplasia", "383|18|disease|ncbi_mesh@D011655|pulmonary embolism", "1294|4|gene|ncbi_gene@4893|NRAS", "1025|5|variant|litvar@rs776549085##&&&litvar@#2260#&&&litvar@CA4718358#rs776549085##|R183S", "826|4|gene|ncbi_gene@2776|GNAQ", "1469|4|gene|ncbi_gene@3845|KRAS", "1892|23|disease|ncbi_mesh@D004476|aplasia cutis congenita", "97|4|gene|ncbi_gene@207|AKT1", "533|4|disease||CLVM", "504|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|H1047L", "2192|8|species|ncbi_taxonomy@9606|Children", "1787|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1259|7|species|ncbi_taxonomy@9606|Infants", "1780|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "1480|4|gene|ncbi_gene@4893|NRAS", "1799|9|disease||RASopathy", "2000|5|variant|litvar@rs779707422##&&&litvar@#2260#&&&litvar@CA357830#rs779707422##|N546K", "1306|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "2153|18|disease|ncbi_mesh@D009506|nevus psiloliparus"], "figure_id": "febs15528-tbl-0001", "text_hl": "Syndrome Genes and substitutions Level of mosaicism Affected tissue Time of onset Ref.   Proteus AKT1 (E17K) Level and phenotype of Proteus greatly depend on the timing of the mutation, the affected tissue type, or restriction to certain germ layer. Asymmetrically and irregularly growing tissues mainly in skin, bone, and adipose tissue; increased risk in thrombosis and subsequent pulmonary embolism 6-18 months after birth [31, 64]   PROS; for example, Klippel-Trenaunay PIK3CA (E545K, E454G, H1047R, H1047L) < 1% detected by NGS CLVM (capillary, lymphatic, and venous malformations), skin and tissue with lesions, and buccal cells Phenotype dependent on mutation type and distribution [32, 65]   FD/MAS GNAS (R201H, R201C) Unknown; 'obligatory mosaic' Endoderm, mesoderm, and ectoderm Children and young adults [66]   SWS GNAQ (R183Q) Mutant allele in affected tissues ranged from 1% to 18% Skin specially face, eye, nervous, and neurological anomalies Infants [35]   PPV and extensive dermal melanocytosis GNA11 (R183C, R183S)GNAQ (R183Q, Q209P) Low level of postzygotic mutations; percentage of mosaicism in skin was lowest with 1.5% Dermal melanocytosis (Mongolian blue spots), ocular melanocytosis, vascular birthmarks, and neurological abnormalities Infants [41, 67, 68, 69, 70]   NCM NRAS (Q61R, Q61K) Affected cutaneous and neurological tissues Development in neural crest and neuroectoderm; skin and central nerve system Children [36, 37]   SFMS HRAS (G13R)KRAS (G12D)NRAS (Q61R) Mutation frequency of 52% in head nevus sebaceous, 13% in hyperpigmented lesions, and 24.3% in lip nevus sebaceous tissues Nevus sebaceous, neurological anomalies, eye, skeletal, height, brain, head, genitourinary, cardiovascular, neoplasia From birth onwards [38, 39]   OES KRAS (<m>A146T</m>, A146V, G13D, L19F) RASopathy; frequency < 40% of tissues Skin; epibulbar dermoids and congenital scalp lesions (aplasia cutis congenita; ACC) Children [71, 72]   Encephalocraniocutaneous Lipomatosis (ECCL) FGFR1 (K656E, N546K)KRAS (<m>A146T</m>) Alternate allele fraction of 23-55% in fibroblasts from affected tissues; not detected in saliva or blood Cutaneous, ocular, and CNS; nevus psiloliparus as hallmark of ECCL Children [71, 73, 74]   "}], "citations": {"NLM": "Tiemann-Boege I, Mair T, Yasari A, Zurovec M. Pathogenic postzygotic mosaicism in the tyrosine receptor kinase pathway: potential unidentified human disease hidden away in a few cells. FEBS J. PMID: 32810928", "BibTeX": "@article{32810928, title={Pathogenic postzygotic mosaicism in the tyrosine receptor kinase pathway: potential unidentified human disease hidden away in a few cells.}, author={Tiemann-Boege I and Mair T and Yasari A and Zurovec M}, journal={FEBS J}}"}, "is_sup_mat_match": false}, {"pmid": 32466784, "pmcid": "PMC7257555", "title": "A novel NGS-based microsatellite instability (MSI) status classifier with 9 loci for colorectal cancer patients.", "journal": "J Transl Med", "authors": ["Zheng K", "Wan H", "Zhang J", "Shan G", "Chai N", "Li D", "Fang N", "Liu L", "Zhang J", "Du R", "Wu Q", "Li X", "Zhang C"], "date": "2020-05-28T00:00:00Z", "year": 2020, "snippets": [{"_id": "32466784@17843", "snip_text": "Gene Hotspot Number of variant cases   Total MSI-H MSS   KRAS p.G12V/S/D/A 16 3 13   p.G13D 7 5 2   p.Q61H 2 0 2   p.A146T 4 3 1   NRAS p.Q61R/H/L 3 0 3   BRAF p.V600E 4 4 0   TCF7L2 p.E384fs 10 10 0   RNF43 p.G659fs 7 7 0   TGFBR2 p.E125fs 6 6 0   QKI p.K132fs 4 4 0   CARD11 p.R555fs 3 3 0   BCORL1 p.S1679fs 3 3 0   JAK3 p.Q39fs 2 2 0   BCOR p.Q1156fs 2 2 0   ", "section": "table", "mentions": ["183|8|variant|litvar@#6934#p.E384fsX&&&litvar@#6934#|p.E384fs", "249|3|gene|ncbi_gene@9444|QKI", "345|9|variant|litvar@#54880#p.Q1156fsX&&&litvar@#54880#|p.Q1156fs", "202|5|gene|ncbi_gene@54894|RNF43", "324|7|variant|litvar@#3718#p.Q39fsX&&&litvar@#3718#|p.Q39fs", "115|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "340|4|gene|ncbi_gene@54880|BCOR", "100|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "62|8|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12V/S", "270|6|gene|ncbi_gene@84433|CARD11", "232|8|variant|litvar@#7048#p.E125fsX&&&litvar@#7048#|p.E125fs", "176|6|gene|ncbi_gene@6934|TCF7L2", "155|4|gene|ncbi_gene@673|BRAF", "136|8|variant|litvar@rs11554290##&&&litvar@#4893#|p.Q61R/H", "131|4|gene|ncbi_gene@4893|NRAS", "85|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "253|8|variant|litvar@rs786203589##&&&litvar@#7157#|p.K132fs", "294|6|gene|ncbi_gene@63035|BCORL1", "71|3|variant|litvar@#3845#|D/A", "160|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "57|4|gene|ncbi_gene@3845|KRAS", "225|6|gene|ncbi_gene@7048|TGFBR2", "301|9|variant|litvar@#63035#p.S1679fsX&&&litvar@#63035#|p.S1679fs", "45|5|disease|ncbi_mesh@D053842|MSI-H", "277|8|variant|litvar@rs63750806##&&&litvar@#4436#|p.R555fs", "319|4|gene|ncbi_gene@3718|JAK3", "208|8|variant|litvar@#54894#p.G659fsX&&&litvar@#54894#|p.G659fs"], "figure_id": "Tab3", "text_hl": "Gene Hotspot Number of variant cases   Total MSI-H MSS   KRAS p.G12V/S/D/A 16 3 13   p.G13D 7 5 2   p.Q61H 2 0 2   <m>p.A146T</m> 4 3 1   NRAS p.Q61R/H/L 3 0 3   BRAF p.V600E 4 4 0   TCF7L2 p.E384fs 10 10 0   RNF43 p.G659fs 7 7 0   TGFBR2 p.E125fs 6 6 0   QKI p.K132fs 4 4 0   CARD11 p.R555fs 3 3 0   BCORL1 p.S1679fs 3 3 0   JAK3 p.Q39fs 2 2 0   BCOR p.Q1156fs 2 2 0   "}], "citations": {"NLM": "Zheng K, Wan H, Zhang J, Shan G, Chai N, Li D, Fang N, Liu L, Zhang J, Du R, Wu Q, Li X, Zhang C. A novel NGS-based microsatellite instability (MSI) status classifier with 9 loci for colorectal cancer patients. J Transl Med. PMID: 32466784", "BibTeX": "@article{32466784, title={A novel NGS-based microsatellite instability (MSI) status classifier with 9 loci for colorectal cancer patients.}, author={Zheng K and Wan H and Zhang J and Shan G and Chai N and Li D and Fang N and Liu L and Zhang J and Du R and Wu Q and Li X and Zhang C}, journal={J Transl Med}}"}, "is_sup_mat_match": false}, {"pmid": 36849965, "pmcid": "PMC9969638", "title": "Mixed small cell neuroendocrine carcinoma and squamous cell carcinoma covered by tubulovillous adenoma in the rectum: a case report and detailed molecular analyses.", "journal": "World J Surg Oncol", "authors": ["He F", "He X", "Cui M", "Wang Y"], "date": "2023-02-27T00:00:00Z", "year": 2023, "snippets": [{"_id": "36849965@6966", "snip_text": "Gene Mutations Abundance (%)   Adenoma NEC SCC   KRAS c.436G>A (p.A146T) 25.5 28.3 31.7   BRCA1 c.4987-2A>G 45.3 34.2 27.7   CDK4 Copy number amplification - CN: 4.6 -   TP53 c.159G>A (p.W53*) 41.6 85.2 79.8   APC c.3964G>T (p.E1322*) 52.3 94.0 78.3   FBXW7 c.217C>T (p.Q73*) 27.6 47.5 37.3   FBXW7 c.372+1G>A 26.4 44.2 32.4   RB1 c.1963dup (p.Y655Lfs*13) - 67.3% 71.2%   RNF43 c.131del (p.Q44Rfs*7) 25.5 52.1 53.6   FLT4 c.1426C>T (p.R476W) 28.9 49.6 52.5   KMT2B c.74G>A (p.R25Q) - - 22.7   MLH3 c.484A>G (p.M162V) 49.4 7.3 14.3   PDGFRB c.886A>T (p.S296C) 22.2 6.2 8.8   PKHD1 c.11006C>T (p.S3669L) 26.3 60.9 53.1   TMB Mutations/Mbases 6.2 8.2 10.3   Low < 10 Low Low High   High >=10      Microsatellite  Stable Stable Stable   ", "section": "table", "mentions": ["474|6|variant|litvar@rs1044896377##&&&litvar@#54894#&&&litvar@CA292015224#rs1044896377##|p.R25Q", "185|6|variant|litvar@#7157#p.53dup&&&litvar@#7157#|p.W53*", "96|11|variant|litvar@rs397509212##&&&litvar@#672#&&&litvar@CA3132#rs397509212##|c.4987-2A>G", "268|6|variant|litvar@#55294#p.73dup&&&litvar@#55294#|p.Q73*", "508|7|variant|litvar@rs188493164##&&&litvar@#27030#&&&litvar@CA7276018#rs188493164##|p.M162V", "388|10|variant|litvar@#54894#p.Q44RfsX7&&&litvar@#54894#|p.Q44Rfs*7", "574|5|gene|ncbi_gene@5314|PKHD1", "592|8|variant|litvar@rs554782195##&&&litvar@#5314#&&&litvar@CA3850973#rs554782195##|p.S3669L", "225|8|variant|litvar@#324#p.E1322*&&&litvar@#324#|p.E1322*", "49|4|gene|ncbi_gene@3845|KRAS", "459|5|gene|ncbi_gene@9757|KMT2B", "372|5|gene|ncbi_gene@54894|RNF43", "550|7|variant|litvar@rs764858967##&&&litvar@#5159#&&&litvar@CA3508167#rs764858967##|p.S296C", "342|12|variant|litvar@rs397508924##&&&litvar@#672#&&&litvar@CA327793#rs397508924##|p.Y655Lfs*13", "175|8|variant|litvar@rs1064794618##&&&litvar@#7157#|c.159G>A", "214|9|variant|litvar@rs764773634##&&&litvar@#9757#&&&litvar@CA9384927#rs764773634##|c.3964G>T", "417|4|gene|ncbi_gene@2324|FLT4", "64|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "258|8|variant|litvar@rs1057520008##&&&litvar@#7157#|c.217C>T", "210|3|gene|ncbi_gene@324|APC", "170|4|gene|ncbi_gene@7157|TP53", "378|8|variant|litvar@#54894#c.131del&&&litvar@#54894#|c.131del", "498|8|variant|litvar@rs188493164##&&&litvar@#27030#&&&litvar@CA7276018#rs188493164##|c.484A>G", "31|15|disease|ncbi_mesh@D002294|Adenoma NEC SCC", "299|10|variant|litvar@#55294#c.372+1G>A&&&litvar@#55294#|c.372+1G>A", "465|7|variant|litvar@rs1407730273##&&&litvar@#5159#|c.74G>A", "54|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "90|5|gene|ncbi_gene@672|BRCA1", "125|4|gene|ncbi_gene@1019|CDK4", "540|8|variant|litvar@rs764858967##&&&litvar@#5159#&&&litvar@CA3508167#rs764858967##|c.886A>T", "422|9|variant|litvar@rs756924526##&&&litvar@#2324#&&&litvar@CA3606728#rs756924526##|c.1426C>T", "433|7|variant|litvar@rs756924526##&&&litvar@#2324#&&&litvar@CA3606728#rs756924526##|p.R476W", "331|9|variant|litvar@rs397508924##&&&litvar@#672#|c.1963dup", "580|10|variant|litvar@rs554782195##&&&litvar@#5314#&&&litvar@CA3850973#rs554782195##|c.11006C>T", "293|5|gene|ncbi_gene@55294|FBXW7", "493|4|gene|ncbi_gene@27030|MLH3", "533|6|gene|ncbi_gene@5159|PDGFRB", "252|5|gene|ncbi_gene@55294|FBXW7", "327|3|gene|ncbi_gene@5925|RB1"], "figure_id": "Tab1", "text_hl": "Gene Mutations Abundance (%)   Adenoma NEC SCC   KRAS c.436G>A (<m>p.A146T</m>) 25.5 28.3 31.7   BRCA1 c.4987-2A>G 45.3 34.2 27.7   CDK4 Copy number amplification - CN: 4.6 -   TP53 c.159G>A (p.W53*) 41.6 85.2 79.8   APC c.3964G>T (p.E1322*) 52.3 94.0 78.3   FBXW7 c.217C>T (p.Q73*) 27.6 47.5 37.3   FBXW7 c.372+1G>A 26.4 44.2 32.4   RB1 c.1963dup (p.Y655Lfs*13) - 67.3% 71.2%   RNF43 c.131del (p.Q44Rfs*7) 25.5 52.1 53.6   FLT4 c.1426C>T (p.R476W) 28.9 49.6 52.5   KMT2B c.74G>A (p.R25Q) - - 22.7   MLH3 c.484A>G (p.M162V) 49.4 7.3 14.3   PDGFRB c.886A>T (p.S296C) 22.2 6.2 8.8   PKHD1 c.11006C>T (p.S3669L) 26.3 60.9 53.1   TMB Mutations/Mbases 6.2 8.2 10.3   Low < 10 Low Low High   High >=10      Microsatellite  Stable Stable Stable   "}], "citations": {"NLM": "He F, He X, Cui M, Wang Y. Mixed small cell neuroendocrine carcinoma and squamous cell carcinoma covered by tubulovillous adenoma in the rectum: a case report and detailed molecular analyses. World J Surg Oncol. PMID: 36849965", "BibTeX": "@article{36849965, title={Mixed small cell neuroendocrine carcinoma and squamous cell carcinoma covered by tubulovillous adenoma in the rectum: a case report and detailed molecular analyses.}, author={He F and He X and Cui M and Wang Y}, journal={World J Surg Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 25943333, "pmcid": "PMC4424481", "title": "Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab.", "journal": "J Transl Med", "authors": ["Giampieri R", "Mandolesi A", "Abouelkhair KM", "Loretelli C", "Del Prete M", "Faloppi L", "Maristella B", "Ibrahim EM", "Scarpelli M", "Cascinu S", "Scartozzi M"], "date": "2015-05-07T00:00:00Z", "year": 2015, "snippets": [{"_id": "25943333@8155", "snip_text": "The variants of codons 12, 13, 59, 61, 117 and 146 of the K-RAS gene (G12D, G12A, G12V, G12S, G12R, G12C, G13D, G13C in exon 2; A59P, A59T, A59S, A59G, A59E, A59V, Q61K, Q61E, Q61R, Q61L, Q61P, Q61H in exon 3; K117Q, K117E, K117T, K117I, K117R, K117N, A146P, A146T, A146S, A146G, A146E, A146V in exon 4) have been analysed via pyrosequencing using the \"Anti-EGFR MoAb response kit (KRAS status) (Diatech Pharmacogenetics.", "section": "methods", "mentions": ["224|5|variant|litvar@#1956#p.K117T&&&litvar@#1956#|K117T", "266|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146S", "164|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "182|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "280|5|variant|litvar@rs1240818498##&&&litvar@#3479#|A146E", "100|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "231|5|variant|litvar@#1956#p.K117I&&&litvar@#1956#|K117I", "128|4|variant|litvar@rs763572530##&&&litvar@#1956#|A59P", "146|4|variant|litvar@rs763572530##&&&litvar@#1956#|A59G", "82|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "140|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA354836#rs121913528##|A59S", "188|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "358|4|gene|ncbi_gene@1956|EGFR", "245|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "76|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "217|5|variant|litvar@#1956#p.K117E&&&litvar@#1956#|K117E", "106|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "152|4|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|A59E", "170|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "273|5|variant|litvar@rs374619740##&&&litvar@#2065#&&&litvar@CA6621966#rs374619740##|A146G", "259|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "382|4|gene|ncbi_gene@3845|KRAS", "287|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "88|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "58|5|gene|ncbi_gene@3845|K-RAS", "158|4|variant|litvar@rs104886029##&&&litvar@#3845#&&&litvar@CA269881#rs104886029##|A59V", "194|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "70|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "134|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "112|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "176|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "210|5|variant|litvar@#1956#p.K117Q&&&litvar@#1956#|K117Q", "94|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "252|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "238|5|variant|litvar@#1956#p.K117R&&&litvar@#1956#|K117R"], "text_hl": "The variants of codons 12, 13, 59, 61, 117 and 146 of the K-RAS gene (G12D, G12A, G12V, G12S, G12R, G12C, G13D, G13C in exon 2; A59P, A59T, A59S, A59G, A59E, A59V, Q61K, Q61E, Q61R, Q61L, Q61P, Q61H in exon 3; K117Q, K117E, K117T, K117I, K117R, K117N, A146P, <m>A146T</m>, A146S, A146G, A146E, A146V in exon 4) have been analysed via pyrosequencing using the \"Anti-EGFR MoAb response kit (KRAS status) (Diatech Pharmacogenetics."}], "citations": {"NLM": "Giampieri R, Mandolesi A, Abouelkhair KM, Loretelli C, Del Prete M, Faloppi L, Maristella B, Ibrahim EM, Scarpelli M, Cascinu S, Scartozzi M. Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab. J Transl Med. PMID: 25943333", "BibTeX": "@article{25943333, title={Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab.}, author={Giampieri R and Mandolesi A and Abouelkhair KM and Loretelli C and Del Prete M and Faloppi L and Maristella B and Ibrahim EM and Scarpelli M and Cascinu S and Scartozzi M}, journal={J Transl Med}}"}, "is_sup_mat_match": false}, {"pmid": 30719547, "pmcid": "PMC6611891", "title": "European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projects.", "journal": "Virchows Arch", "authors": ["Keppens C", "Dufraing K", "van Krieken HJ", "Siebers AG", "Kafatos G", "Lowe K", "Demonty G", "Dequeker EMC"], "date": "2019-07-01T00:00:00Z", "year": 2019, "snippets": [{"_id": "30719547@34659", "snip_text": "Error rates were highest for a case containing the c.436G > A p.(Ala146Thr) variant (15.4%, n = 123) in 2016, and for the c.176C > A p.(Ala59Glu) variant (24.8%, n = 105) in 2017.", "section": "discussion", "mentions": ["51|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "136|8|variant|litvar@rs1291197787##&&&litvar@#2710#|Ala59Glu", "65|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|Ala146Thr", "122|10|variant|litvar@rs1291197787##&&&litvar@#2710#|c.176C > A"], "text_hl": "Error rates were highest for a case containing the c.436G > A p.(<m>Ala146Thr</m>) variant (15.4%, n = 123) in 2016, and for the c.176C > A p.(Ala59Glu) variant (24.8%, n = 105) in 2017."}], "citations": {"NLM": "Keppens C, Dufraing K, van Krieken HJ, Siebers AG, Kafatos G, Lowe K, Demonty G, Dequeker EMC. European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projects. Virchows Arch. PMID: 30719547", "BibTeX": "@article{30719547, title={European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projects.}, author={Keppens C and Dufraing K and van Krieken HJ and Siebers AG and Kafatos G and Lowe K and Demonty G and Dequeker EMC}, journal={Virchows Arch}}"}, "is_sup_mat_match": false}, {"pmid": 31160330, "title": "RAS Mutations Are Not Created Equal.", "journal": "Cancer Discov", "authors": ["Hobbs GA", "Der CJ"], "date": "2019-06-01T00:00:00Z", "year": 2019, "snippets": [{"_id": "31160330@37", "snip_text": "In this issue of Cancer Discovery, Poulin and colleagues apply structural, biochemical, and biological profiling of two mutants of KRAS, one found most frequently in all cancers (G12D) and one found nearly exclusively in colorectal cancer (A146T).", "section": "abstract", "mentions": ["17|6|disease|ncbi_mesh@D009369|Cancer", "179|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "170|7|disease|ncbi_mesh@D009369|cancers", "221|17|disease|ncbi_mesh@D015179|colorectal cancer", "240|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "131|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "In this issue of Cancer Discovery, Poulin and colleagues apply structural, biochemical, and biological profiling of two mutants of KRAS, one found most frequently in all cancers (G12D) and one found nearly exclusively in colorectal cancer (<m>A146T</m>)."}], "citations": {"NLM": "Hobbs GA, Der CJ. RAS Mutations Are Not Created Equal. Cancer Discov. PMID: 31160330", "BibTeX": "@article{31160330, title={RAS Mutations Are Not Created Equal.}, author={Hobbs GA and Der CJ}, journal={Cancer Discov}}"}, "is_sup_mat_match": false}, {"pmid": 33802849, "pmcid": "PMC8002639", "title": "Recent Updates on the Significance of KRAS Mutations in Colorectal Cancer Biology.", "journal": "Cells", "authors": ["L\u00e1szl\u00f3 L", "Kurilla A", "Tak\u00e1cs T", "Kudlik G", "Koprivanacz K", "Buday L", "Vas V"], "date": "2021-03-17T00:00:00Z", "year": 2021, "snippets": [{"_id": "33802849@9230", "snip_text": "The glutamine residue at position 61, the glycine residues at positions at 12 and 13, and the alanine residue at position 146, which form the GDP/GTP pocket, are indicated with colours.", "section": "figure_legend", "mentions": ["4|32|variant|litvar@#4192#|glutamine residue at position 61", "94|31|variant|litvar@rs121913527##&&&litvar@#3845#|alanine residue at position 146", "142|3|chemical|ncbi_mesh@D006153|GDP", "146|3|chemical|ncbi_mesh@D006160|GTP"], "figure_id": "cells-10-00667-f002", "text_hl": "The glutamine residue at position 61, the glycine residues at positions at 12 and 13, and the alanine residue at position 146, which form the GDP/GTP pocket, are indicated with colours."}], "citations": {"NLM": "L\u00e1szl\u00f3 L, Kurilla A, Tak\u00e1cs T, Kudlik G, Koprivanacz K, Buday L, Vas V. Recent Updates on the Significance of KRAS Mutations in Colorectal Cancer Biology. Cells. PMID: 33802849", "BibTeX": "@article{33802849, title={Recent Updates on the Significance of KRAS Mutations in Colorectal Cancer Biology.}, author={L\u00e1szl\u00f3 L and Kurilla A and Tak\u00e1cs T and Kudlik G and Koprivanacz K and Buday L and Vas V}, journal={Cells}}"}, "is_sup_mat_match": false}, {"pmid": 26970110, "title": "Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis.", "journal": "Clin Genet", "authors": ["Boppudi S", "B\u00f6gershausen N", "Hove HB", "Percin EF", "Aslan D", "Dvorsky R", "Kayhan G", "Li Y", "Cursiefen C", "Tantcheva-Poor I", "Toft PB", "Bartsch O", "Lissewski C", "Wieland I", "Jakubiczka S", "Wollnik B", "Ahmadian MR", "Heindl LM", "Zenker M"], "date": "2016-10-01T00:00:00Z", "year": 2016, "snippets": [{"_id": "26970110@812", "snip_text": "In all four cases, Sanger sequencing of the KRAS gene in DNA from lesional tissue detected mutations affecting codon 146 (p.Ala146Val, p.Ala146Thr) at variable levels of mosaicism.", "section": "abstract", "mentions": ["44|4|gene|ncbi_gene@3845|KRAS", "135|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "122|11|variant|litvar@rs1057519725##&&&litvar@#3845#|p.Ala146Val"], "text_hl": "In all four cases, Sanger sequencing of the KRAS gene in DNA from lesional tissue detected mutations affecting codon 146 (p.Ala146Val, <m>p.Ala146Thr</m>) at variable levels of mosaicism."}], "citations": {"NLM": "Boppudi S, B\u00f6gershausen N, Hove HB, Percin EF, Aslan D, Dvorsky R, Kayhan G, Li Y, Cursiefen C, Tantcheva-Poor I, Toft PB, Bartsch O, Lissewski C, Wieland I, Jakubiczka S, Wollnik B, Ahmadian MR, Heindl LM, Zenker M. Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis. Clin Genet. PMID: 26970110", "BibTeX": "@article{26970110, title={Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis.}, author={Boppudi S and B\u00f6gershausen N and Hove HB and Percin EF and Aslan D and Dvorsky R and Kayhan G and Li Y and Cursiefen C and Tantcheva-Poor I and Toft PB and Bartsch O and Lissewski C and Wieland I and Jakubiczka S and Wollnik B and Ahmadian MR and Heindl LM and Zenker M}, journal={Clin Genet}}"}, "is_sup_mat_match": false}, {"pmid": 33469311, "pmcid": "PMC7812042", "title": "Case Report: Myeloid Sarcoma Development During Treatment for B Cell Lymphoblastic Lymphoma in a Boy with KRAS/NRAS Gene Mutations.", "journal": "Onco Targets Ther", "authors": ["Yuan X", "Yu U", "Chen S", "Xu H", "Yi M", "Jiang X", "Song J", "Chen X", "Chen S", "Lin Z", "Li C", "Wen F", "Liu S"], "date": "2021-01-13T00:00:00Z", "year": 2021, "snippets": [{"_id": "33469311@10072", "snip_text": "NGS examinations of the skin and testicular samples showed mutations of both the KRAS (c.436G>A, p.A146T) and NRAS genes (c.35G>A, p.G12D).", "section": "other", "mentions": ["110|4|gene|ncbi_gene@4893|NRAS", "122|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G>A", "81|4|gene|ncbi_gene@3845|KRAS", "97|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "131|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "87|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A"], "text_hl": "NGS examinations of the skin and testicular samples showed mutations of both the KRAS (c.436G>A, <m>p.A146T</m>) and NRAS genes (c.35G>A, p.G12D)."}], "citations": {"NLM": "Yuan X, Yu U, Chen S, Xu H, Yi M, Jiang X, Song J, Chen X, Chen S, Lin Z, Li C, Wen F, Liu S. Case Report: Myeloid Sarcoma Development During Treatment for B Cell Lymphoblastic Lymphoma in a Boy with KRAS/NRAS Gene Mutations. Onco Targets Ther. PMID: 33469311", "BibTeX": "@article{33469311, title={Case Report: Myeloid Sarcoma Development During Treatment for B Cell Lymphoblastic Lymphoma in a Boy with KRAS/NRAS Gene Mutations.}, author={Yuan X and Yu U and Chen S and Xu H and Yi M and Jiang X and Song J and Chen X and Chen S and Lin Z and Li C and Wen F and Liu S}, journal={Onco Targets Ther}}"}, "is_sup_mat_match": false}, {"pmid": 30760858, "pmcid": "PMC8210848", "title": "Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors", "journal": "Mod Pathol", "authors": ["Lasota J", "Kowalik A", "Felisiak-Golabek A", "Zi\u0119ba S", "Waloszczyk P", "Masiuk M", "Wejman J", "Szumilo J", "Miettinen M"], "date": "2019-02-13T00:00:00Z", "year": 2019, "snippets": [{"_id": "30760858@10516", "snip_text": "In one case, p.A146T mutations were identified.", "section": "results", "mentions": ["13|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T"], "text_hl": "In one case, <m>p.A146T</m> mutations were identified."}], "citations": {"NLM": "Lasota J, Kowalik A, Felisiak-Golabek A, Zi\u0119ba S, Waloszczyk P, Masiuk M, Wejman J, Szumilo J, Miettinen M. Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors Mod Pathol. PMID: 30760858", "BibTeX": "@article{30760858, title={Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors}, author={Lasota J and Kowalik A and Felisiak-Golabek A and Zi\u0119ba S and Waloszczyk P and Masiuk M and Wejman J and Szumilo J and Miettinen M}, journal={Mod Pathol}}"}, "is_sup_mat_match": false}, {"pmid": 27020587, "pmcid": "PMC5047012", "title": "KRAS and combined KRAS/TP53 mutations in locally advanced rectal cancer are independently associated with decreased response to neoadjuvant therapy", "journal": "Ann Surg Oncol", "authors": ["Chow OS", "Kuk D", "Keskin M", "Smith JJ", "Camacho N", "Pelossof R", "Chen CT", "Chen Z", "Avila K", "Weiser MR", "Berger MF", "Patil S", "Bergsland E", "Garcia-Aguilar J"], "date": "2016-08-01T00:00:00Z", "year": 2016, "snippets": [{"_id": "27020587@8873", "snip_text": "One patient with a KRAS A146P mutation (exon 4) recognized by MSK-IMPACT was misclassified as wild-type by Sanger Sequencing because only exons 2 and 3 were evaluated.", "section": "results", "mentions": ["4|7|species|ncbi_taxonomy@9606|patient", "24|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "19|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "One patient with a KRAS A146P mutation (exon 4) recognized by MSK-IMPACT was misclassified as wild-type by Sanger Sequencing because only exons 2 and 3 were evaluated."}], "citations": {"NLM": "Chow OS, Kuk D, Keskin M, Smith JJ, Camacho N, Pelossof R, Chen CT, Chen Z, Avila K, Weiser MR, Berger MF, Patil S, Bergsland E, Garcia-Aguilar J. KRAS and combined KRAS/TP53 mutations in locally advanced rectal cancer are independently associated with decreased response to neoadjuvant therapy Ann Surg Oncol. PMID: 27020587", "BibTeX": "@article{27020587, title={KRAS and combined KRAS/TP53 mutations in locally advanced rectal cancer are independently associated with decreased response to neoadjuvant therapy}, author={Chow OS and Kuk D and Keskin M and Smith JJ and Camacho N and Pelossof R and Chen CT and Chen Z and Avila K and Weiser MR and Berger MF and Patil S and Bergsland E and Garcia-Aguilar J}, journal={Ann Surg Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 36142267, "pmcid": "PMC9499649", "title": "Targeted Next-Generation Sequencing-Based Multiple Gene Mutation Profiling of Patients with Rectal Adenocarcinoma Receiving or Not Receiving Neoadjuvant Chemoradiotherapy.", "journal": "Int J Mol Sci", "authors": ["Chang YK", "Tseng HH", "Leung CM", "Lu KC", "Tsai KW"], "date": "2022-09-08T00:00:00Z", "year": 2022, "snippets": [{"_id": "36142267@33011", "snip_text": "Patients No. Genes Protein Change Mutation Type Nucleotide Change Pre-CRT% Post-CRT%   23 APC p.M1383fs Frameshift c.4146_4147insA 38.3 8.1   29 APC p.L1488fs Frameshift c.4461delT 11.7 8.0   18 APC p.E1309 * Stop gained c.3925G > T 16.6 6.6   18 APC p.E1353 * Stop gained c.4057G > T 19.2 6.4   25 BRAF p.V600E Missense c.1799T > A 15.1 11.9   7 FBXW7 p.G459E Missense c.1376G > A 0.0 5.2   29 FBXW7 p.R505C Missense c.1513C > T 12.2 9.6   23 KRAS p.A146T Missense c.436G > A 21.7 5.1   18 SMAD4 p.A118V Missense c.353C > T 0.0 6.1   23 TP53 p.M237I Missense c.711G > A 37.6 6.9   25 TP53 p.R342 * Stop gained c.1024C > T 39.7 22.7   20 TP53 p.R213fs Frameshift c.636dupT 15.6 7.1   29 TP53 p.Q104 * Stop gained c.310C > T 23.6 12.0   18 TP53 p.V173M Missense c.517G > A 26.3 7.2   ", "section": "table", "mentions": ["491|5|gene|ncbi_gene@4089|SMAD4", "444|4|gene|ncbi_gene@3845|KRAS", "321|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T > A", "466|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "687|4|gene|ncbi_gene@7157|TP53", "761|10|variant|litvar@rs876660754##&&&litvar@#7157#&&&litvar@CA10577579#rs876660754##|c.517G > A", "0|8|species|ncbi_taxonomy@9606|Patients", "395|5|gene|ncbi_gene@55294|FBXW7", "611|11|variant|litvar@rs730882029##&&&litvar@#7157#&&&litvar@CA19#rs730882029##|c.1024C > T", "643|8|variant|litvar@rs864309495##&&&litvar@#7157#|p.R213fs", "195|3|gene|ncbi_gene@324|APC", "418|11|variant|litvar@rs149680468##&&&litvar@#55294#&&&litvar@CA16602253#rs149680468##|c.1513C > T", "221|11|variant|litvar@rs1321583762##&&&litvar@#324#|c.3925G > T", "663|9|variant|litvar@rs1131691137##&&&litvar@#324#|c.636dupT", "94|9|variant|litvar@#7157#p.M1383fsX&&&litvar@#7157#|p.M1383fs", "149|9|variant|litvar@rs1114167577##&&&litvar@#324#|p.L1488fs", "449|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "145|3|gene|ncbi_gene@324|APC", "353|7|variant|litvar@rs1246773886##&&&litvar@#79811#|p.G459E", "90|3|gene|ncbi_gene@324|APC", "638|4|gene|ncbi_gene@7157|TP53", "744|7|variant|litvar@rs876660754##&&&litvar@#7157#&&&litvar@CA10577579#rs876660754##|p.V173M", "739|4|gene|ncbi_gene@7157|TP53", "514|10|variant|litvar@rs1064794311##&&&litvar@#7157#|c.353C > T", "560|10|variant|litvar@rs587782664##&&&litvar@#7157#&&&litvar@CA349#rs587782664##|c.711G > A", "273|11|variant|litvar@rs1114167568##&&&litvar@#324#|c.4057G > T", "299|4|gene|ncbi_gene@673|BRAF", "170|10|variant|litvar@#7157#c.4461delT&&&litvar@#7157#|c.4461delT", "247|3|gene|ncbi_gene@324|APC", "538|4|gene|ncbi_gene@7157|TP53", "304|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "347|5|gene|ncbi_gene@55294|FBXW7", "370|11|variant|litvar@rs1228182220##&&&litvar@#3791#|c.1376G > A", "543|7|variant|litvar@rs587782664##&&&litvar@#7157#&&&litvar@CA349#rs587782664##|p.M237I", "713|10|variant|litvar@rs1487238438##&&&litvar@#7157#|c.310C > T", "401|7|variant|litvar@rs149680468##&&&litvar@#55294#&&&litvar@CA16602253#rs149680468##|p.R505C", "497|7|variant|litvar@rs750600586##&&&litvar@#7157#&&&litvar@CA168#rs750600586##|p.A118V", "585|4|gene|ncbi_gene@7157|TP53", "115|15|variant|litvar@#7157#c.4146_4147insA&&&litvar@#7157#|c.4146_4147insA"], "figure_id": "ijms-23-10353-t003", "text_hl": "Patients No. Genes Protein Change Mutation Type Nucleotide Change Pre-CRT% Post-CRT%   23 APC p.M1383fs Frameshift c.4146_4147insA 38.3 8.1   29 APC p.L1488fs Frameshift c.4461delT 11.7 8.0   18 APC p.E1309 * Stop gained c.3925G > T 16.6 6.6   18 APC p.E1353 * Stop gained c.4057G > T 19.2 6.4   25 BRAF p.V600E Missense c.1799T > A 15.1 11.9   7 FBXW7 p.G459E Missense c.1376G > A 0.0 5.2   29 FBXW7 p.R505C Missense c.1513C > T 12.2 9.6   23 KRAS <m>p.A146T</m> Missense c.436G > A 21.7 5.1   18 SMAD4 p.A118V Missense c.353C > T 0.0 6.1   23 TP53 p.M237I Missense c.711G > A 37.6 6.9   25 TP53 p.R342 * Stop gained c.1024C > T 39.7 22.7   20 TP53 p.R213fs Frameshift c.636dupT 15.6 7.1   29 TP53 p.Q104 * Stop gained c.310C > T 23.6 12.0   18 TP53 p.V173M Missense c.517G > A 26.3 7.2   "}], "citations": {"NLM": "Chang YK, Tseng HH, Leung CM, Lu KC, Tsai KW. Targeted Next-Generation Sequencing-Based Multiple Gene Mutation Profiling of Patients with Rectal Adenocarcinoma Receiving or Not Receiving Neoadjuvant Chemoradiotherapy. Int J Mol Sci. PMID: 36142267", "BibTeX": "@article{36142267, title={Targeted Next-Generation Sequencing-Based Multiple Gene Mutation Profiling of Patients with Rectal Adenocarcinoma Receiving or Not Receiving Neoadjuvant Chemoradiotherapy.}, author={Chang YK and Tseng HH and Leung CM and Lu KC and Tsai KW}, journal={Int J Mol Sci}}"}, "is_sup_mat_match": false}, {"pmid": 24859998, "pmcid": "PMC4039802", "title": "KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study.", "journal": "BMJ Open", "authors": ["Negru S", "Papadopoulou E", "Apessos A", "Stanculeanu DL", "Ciuleanu E", "Volovat C", "Croitoru A", "Kakolyris S", "Aravantinos G", "Ziras N", "Athanasiadis E", "Touroutoglou N", "Pavlidis N", "Kalofonos HP", "Nasioulas G"], "date": "2014-05-23T00:00:00Z", "year": 2014, "snippets": [{"_id": "24859998@14984", "snip_text": "Gene Exon Codon Mutations Romanian Greek   KRAS 3 61 c.181C>A (p.Q61K) p.Q61L (c.182A>T 2 2   KRAS 4 146 c.436G>A (p.A146T), c.437C>T (p.A146V) 2 6   NRAS 2 12 c.35G>A (p.G12D), c.34G>T (p.G12C) 7 8   NRAS 3 12 c.181C>A (p.Q61K) 2 2   NRAS 4 146 p.A146V (c.437C>T) 1 0   BRAF 15 600 c.1799T>A (p.V600E) 10 16   ", "section": "table", "mentions": ["271|4|gene|ncbi_gene@673|BRAF", "105|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "235|4|gene|ncbi_gene@4893|NRAS", "115|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "169|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "187|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "211|8|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA180750#rs121913238##|c.181C>A", "53|8|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA180750#rs121913238##|c.181C>A", "150|4|gene|ncbi_gene@4893|NRAS", "246|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "63|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "178|7|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|c.34G>T", "43|4|gene|ncbi_gene@3845|KRAS", "255|8|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C>T", "71|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "94|4|gene|ncbi_gene@3845|KRAS", "79|8|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|c.182A>T", "160|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "201|4|gene|ncbi_gene@4893|NRAS", "135|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "221|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "294|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "283|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "125|8|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C>T"], "figure_id": "BMJOPEN2013004652TB3", "text_hl": "Gene Exon Codon Mutations Romanian Greek   KRAS 3 61 c.181C>A (p.Q61K) p.Q61L (c.182A>T 2 2   KRAS 4 146 c.436G>A (<m>p.A146T</m>), c.437C>T (p.A146V) 2 6   NRAS 2 12 c.35G>A (p.G12D), c.34G>T (p.G12C) 7 8   NRAS 3 12 c.181C>A (p.Q61K) 2 2   NRAS 4 146 p.A146V (c.437C>T) 1 0   BRAF 15 600 c.1799T>A (p.V600E) 10 16   "}], "citations": {"NLM": "Negru S, Papadopoulou E, Apessos A, Stanculeanu DL, Ciuleanu E, Volovat C, Croitoru A, Kakolyris S, Aravantinos G, Ziras N, Athanasiadis E, Touroutoglou N, Pavlidis N, Kalofonos HP, Nasioulas G. KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study. BMJ Open. PMID: 24859998", "BibTeX": "@article{24859998, title={KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study.}, author={Negru S and Papadopoulou E and Apessos A and Stanculeanu DL and Ciuleanu E and Volovat C and Croitoru A and Kakolyris S and Aravantinos G and Ziras N and Athanasiadis E and Touroutoglou N and Pavlidis N and Kalofonos HP and Nasioulas G}, journal={BMJ Open}}"}, "is_sup_mat_match": false}, {"pmid": 27174491, "pmcid": "PMC5240021", "title": "MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia", "journal": "Leukemia", "authors": ["Cant\u00e9-Barrett K", "Spijkers-Hagelstein JA", "Buijs-Gladdines JG", "Uitdehaag JC", "Smits WK", "van der Zwet J", "Buijsman RC", "Zaman GJ", "Pieters R", "Meijerink JP"], "date": "2016-09-01T00:00:00Z", "year": 2016, "snippets": [{"_id": "27174491@39934", "snip_text": "Pt #\tOncogene\tSubtype\tIL7R\tJAK1\tJAK3\tSTAT5B\tN-RAS\tK-RAS\tNF1\tPTEN\tAKT\tNOTCH/ FBXW7\t \t \t \t \tNon-cysteine mutations\t \t \t \t \t \t \t \t \t \t \t1\tMLL\tnd\tV253WN\t:\t:\t:\t:\t:\t \t:\t:\t:\t \t2\t \tETP-ALL\tV253GPSL\t:\t:\t:\t:\t:\t \t:\t:\tPEST\t \t \t \t \tCysteine mutations\t \t \t \t \t \t \t \t \t \t \t3\tTLX3\tnd\tIL241-242CLEG\t:\t:\t:\t:\t:\t \t:\t:\tHD/PEST\t \t4\tTLX3\tTLX\tPILLT240-244RFCPH\t:\t:\t:\tA146T\t:\t \t:\t:\tHD\t \t5\tTLX3\tTLX\tPILLTIS240-246LKC\t:\t:\t:\t:\tA146T\t \t:\t:\t:\t \t6\tTLX3\tTLX\tLLT242-244FHPFNCGP\t:\t:\t:\tG12D\t:\t \t:\t:\tHD\t \t7\tHOXA\tTLX\tL243RLECV\t:\t:\t:\t:\t:\t \t:\t:\tPEST\t \t8\tHOXA\tnd\tLL242-L243FPHQHC\t:\t:\t:\t:\t:\t \t:\t:\tFBXW7\t \t9\tSET-NUP214\tTLX\tLLTIS242-246PQGGC\t:\t:\t:\t:\t:\t \t:\t:\tHD/FBXW7\t \t10\t \tnd\tPIL240-242QSPSC\t:\t:\t:\t:\t:\t \t:\t:\tHD\t \t11\t \tTLX\tLT243-244LMCPT\t:\t:\t:\t:\t:\t \t:\t:\tJM\t \t12\t \tTALLMO\tPILLTIS240-S246LQSC\t:\t:\t:\t:\t:\t \t:\t:\t:\t \t13\tTLX3\tTLX\t:\tE668Q\t:\t:\tnd\tnd\tDel/333dupA\t:\t:\tHD/FBXW7\t \t14\tLYL1/LMO2\tTALLMO\t:\tL624YPILKV\t:\t:\t:\t:\t \t:\t:\tJM/PEST\t \t15\t \tProliferative\t:\tV427M\t:\t:\t:\t:\t \t:\t:\tHD/PEST\t \t16\tCALM-AF10\tnd\t:\tP815S\t:\t:\t:\t:\t \t:\t:\tHD/PEST\t \t17\tRUNX1-AFF3\tETP-ALL\t:\tT901G\tM511I\t:\t:\t:\t \t:\t:\tPEST\t \t18\t \tETP-ALL\t:\tR724H\tM511I\t:\tG12D\t:\t \t:\t:\tPEST\t \t19\t \tETP-ALL\t:\t:\tM511I\t:\tnd\tnd\tDel/-\t:\t:\tPEST\t \t20\tTLX3\tTLX\t:\t:\tM511I\t:\t:\t:\t \t:\t:\tJM\t \t21\tCALM-AF10\tTLX\t:\t:\tR657Q\t:\t:\t:\t \t:\t:\tHD/PEST\t \t22\tTLX3\tTLX\t:\t:\tR657Q\t:\tnd\tnd\t \t:\t:\tND\t \t23\tTLX1\tTLX\t:\t:\t:\tN642H\t:\t:\t \t:\t:\t:\t \t24\tTLX1\tTLX\t:\t:\t:\tN642H\t:\t:\t \tnd\t:\tnd\t \t25\tLMO2\tnd\t:\t:\t:\tN642H\t:\t:\t \t:\t:\tPEST\t \t26\tSIL-TAL1\tTALLMO\t:\t:\t:\tN642H\t:\t:\t \t:\t:\tHD\t \t27\tTLX3\tTLX\t:\t:\t:\t:\tG12D\t:\t \t:\t:\t:\t \t28\tTLX3\tTLX\t:\t:\t:\t:\tG12V\t:\t \t:\t:\tHD\t \t29\tTLX3\tnd\t:\t:\t:\t:\tG12C\t:\t \t:\t:\tHD/FBXW7\t \t30\tTLX3\tnd\t:\t:\t:\t:\tG13V\t:\t \t:\t:\tHD/FBXW7\t \t31\tCALM-AF10\tETP-ALL\t:\t:\t:\tN642H\tG12D\t:\t \t:\t:\t:\t \t32\tSIL-TAL1\tnd\t:\t:\t:\t:\tG13C\t:\t \tMut/Del\t:\t:\t \t33\tNKX2-5\tETP-ALL\t:\t:\t:\t:\tG13D\t:\t \tMut/Mut/Subcl. Del\t:\tHD\t \t34\t \tTALLMO\t:\t:\t:\t:\tG12R\t:\t \t:\t:\tFBXW7\t \t35\tTAL2\tTALLMO\t:\t:\t:\t:\t:\tG12D\t \tno protein\t:\tFBXW7\t \t36\tLMO2\tTALLMO\t:\t:\t:\t:\t:\tG12D\t \t:\t:\t:\t \t37\tTLX3\tTLX\t:\t:\t:\t:\t:\tQ61R\t \t:\t:\tHD/FBXW7\t \t38\tMEF2C\tETP-ALL\t:\t:\t:\t:\t:\tQ61L\t \t:\t:\tHD/PEST\t \t39\tCALM-AF10\tETP-ALL\t:\t:\t:\t:\tnd\tnd\tDel/3734delCinsGGTTTATGGTTT\t:\t:\t:\t \t40\t \tnd\t:\t:\t:\t:\t:\tG12D\t \t:\t:\tHD\t \t41\tTLX3\tTLX\t:\t:\t:\t:\t:\tA146T\t \t:\t:\tPEST\t \t42\tTLX3\tTLX\t:\t:\t:\t:\t:\tA146T\t \t:\t:\tHD\t \t43\tLMO2\tTALLMO\t:\t:\t:\t:\t:\tA146T\t \t:\t:\tHD/FBXW7\t \t44\tSIL-TAL1\tTALLMO\t:\t:\t:\t:\t:\t:\t \tSubcl. Del/:\t:\tHD/PEST\t \t45\tSIL-TAL1\tTALLMO\t:\t:\t:\t:\t:\t:\t \tMut/Mut\t:\t:\t \t46\tSIL-TAL1\tTALLMO\t:\t:\t:\t:\t:\t:\t \tDel/:\t:\tHD\t \t47\tSIL-TAL1\tTALLMO\t:\t:\t:\t:\t:\t:\t \tSubcl. Del/:\t:\t:\t \t48\tSIL-TAL1\tTALLMO\t:\t:\t:\t:\t:\t:\t \tSubcl. Mut/:\t:\t:\t \t49\tSIL-TAL1\tTALLMO\t:\t:\t:\t:\t:\tA146T\t \tDel/Del\t:\t:\t \t50\tSIL-TAL1\tTALLMO\t:\t:\t:\t:\t:\t:\t \tDel/Subcl. Del\t:\t:\t \t51\tSIL-TAL1\tTALLMO\t:\t:\t:\t:\t:\t:\t \tDel/Subcl. Del\t:\t:\t \t52\tSIL-TAL1\tTALLMO\t:\t:\t:\t:\t:\t:\t \tMut/Mut\t:\t:\t \t53\tLMO3\tTALLMO\t:\t:\t:\t:\t:\t:\t \tMut/Mut\t:\t:\t \t54\tLMO2\tTALLMO\t:\t:\t:\t:\t:\t:\t \tMut/Mut\t:\tFBXW7\t \t55\t \tTALLMO\t:\t:\t:\t:\t:\t:\t \tMut/Mut\t:\tHD\t \t56\t \tTALLMO\t:\t:\t:\t:\t:\t:\t \tMut/Mut\t:\t:\t \t57\t \tTALLMO\t:\t:\t:\t:\t:\t:\t \tSubcl. Del/:\t:\t:\t \t58\t \tTALLMO\t:\t:\t:\t:\t:\t:\t \tMut/Subcl. Del\t:\t:\t \t59\t \tTALLMO\t:\t:\t:\t:\t:\t:\t \tMut/Subcl. Del\t:\t:\t \t60\tNKX2:1\tProliferative\t:\t:\t:\t:\t:\t:\t \tMut/:\t:\tHD/FBXW7\t \t61\tTAL1\tProliferative\t:\t:\t:\t:\t:\t:\t \tno protein\t:\tHD\t \t62\tSIL-TAL1\tProliferative\t:\t:\t:\t:\t:\t:\t \tMut/Mut\t:\t:\t \t63\tSIL-TAL1\tProliferative\t:\t:\t:\t:\tnd\t:\t \tMut/Mut\t:\tPEST\t \t64\t \tETP-ALL\t:\t:\t:\t:\t:\tnd\t \tDel/:\t:\tPEST\t \t65\tMYC\tnd\t:\t:\t:\t:\t:\t:\t \tMut/Del\t:\t:\t \t66\tLMO2\tnd\t:\t:\t:\t:\t:\t:\t \tMut/Mut/Subcl. Del\t:\tPEST\t \t67\t \tnd\t:\t:\t:\t:\t:\t:\t \tDel/:\t:\t:\t \t68\t \tnd\t:\t:\t:\t:\t:\t:\t \tMut/Del\t:\t:\t \t69\tTLX1\tProliferative\t:\t:\t:\t:\t:\t:\t \t:\tE17K\t:\t \t70\tTLX3\tProliferative\t:\t:\t:\t:\t:\t:\t \t:\tE17K\tFBXW7\t \t71\tLMO1\tTALLMO\t:\t:\t:\t:\t:\t:\t \t:\tE17K\t:\t \t", "section": "table", "mentions": ["2097|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "2138|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1005|5|variant|litvar@#3716#p.T901G&&&litvar@#3716#|T901G", "1914|5|gene|ncbi_gene@55294|FBXW7", "50|5|gene|ncbi_gene@3845|K-RAS", "2059|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1193|5|variant|litvar@rs758959409##&&&litvar@#3718#|R657Q", "2180|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "817|5|gene|ncbi_gene@55294|FBXW7", "1660|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "1949|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "22|4|gene|ncbi_gene@3575|IL7R", "1051|5|variant|litvar@rs751286635##&&&litvar@#728378#|R724H", "1405|5|variant|litvar@#6777#p.N642H&&&litvar@#6777#|N642H", "1777|5|gene|ncbi_gene@55294|FBXW7", "1318|5|variant|litvar@#6777#p.N642H&&&litvar@#6777#|N642H", "1102|5|variant|litvar@rs752661478##&&&litvar@#3718#&&&litvar@CA9301867#rs752661478##|M511I", "951|5|variant|litvar@rs1477909227##&&&litvar@#3716#|P815S", "27|4|gene|ncbi_gene@3716|JAK1", "1579|5|gene|ncbi_gene@55294|FBXW7", "802|7|variant|litvar@#55294#c.333dupA&&&litvar@#55294#|333dupA", "2746|5|gene|ncbi_gene@55294|FBXW7", "556|5|gene|ncbi_gene@55294|FBXW7", "32|4|gene|ncbi_gene@3718|JAK3", "1446|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "3530|4|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|E17K", "2195|5|gene|ncbi_gene@55294|FBXW7", "782|5|variant|litvar@#55294#p.E668Q&&&litvar@#55294#|E668Q", "1057|5|variant|litvar@rs752661478##&&&litvar@#3718#&&&litvar@CA9301867#rs752661478##|M511I", "60|4|gene|ncbi_gene@5728|PTEN", "1620|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1900|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "1011|5|variant|litvar@rs752661478##&&&litvar@#3718#&&&litvar@CA9301867#rs752661478##|M511I", "1863|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1237|5|variant|litvar@rs758959409##&&&litvar@#3718#|R657Q", "1149|5|variant|litvar@rs752661478##&&&litvar@#3718#&&&litvar@CA9301867#rs752661478##|M511I", "1065|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1483|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "76|5|gene|ncbi_gene@55294|FBXW7", "3439|4|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|E17K", "37|6|gene|ncbi_gene@6777|STAT5B", "451|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1520|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "1614|5|variant|litvar@#6777#p.N642H&&&litvar@#6777#|N642H", "1536|5|gene|ncbi_gene@55294|FBXW7", "3023|5|gene|ncbi_gene@55294|FBXW7", "903|5|variant|litvar@rs1369499617##&&&litvar@#3716#|V427M", "44|5|gene|ncbi_gene@4893|N-RAS", "1764|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "1810|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "3491|5|gene|ncbi_gene@55294|FBXW7", "1709|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1357|5|variant|litvar@#6777#p.N642H&&&litvar@#6777#|N642H", "1830|5|gene|ncbi_gene@55294|FBXW7", "618|5|gene|ncbi_gene@55294|FBXW7", "65|3|gene|ncbi_gene@207|AKT", "1280|5|variant|litvar@#6777#p.N642H&&&litvar@#6777#|N642H", "2487|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1563|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "343|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "3486|4|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|E17K", "399|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "56|3|gene|ncbi_gene@4763|NF1"], "figure_id": "tbl1", "text_hl": "Pt #\tOncogene\tSubtype\tIL7R\tJAK1\tJAK3\tSTAT5B\tN-RAS\tK-RAS\tNF1\tPTEN\tAKT\tNOTCH/ FBXW7\t \t \t \t \tNon-cysteine mutations\t \t \t \t \t \t \t \t \t \t \t1\tMLL\tnd\tV253WN\t:\t:\t:\t:\t:\t \t:\t:\t:\t \t2\t \tETP-ALL\tV253GPSL\t:\t:\t:\t:\t:\t \t:\t:\tPEST\t \t \t \t \tCysteine mutations\t \t \t \t \t \t \t \t \t \t \t3\tTLX3\tnd\tIL241-242CLEG\t:\t:\t:\t:\t:\t \t:\t:\tHD/PEST\t \t4\tTLX3\tTLX\tPILLT240-244RFCPH\t:\t:\t:\t<m>A146T</m>\t:\t \t:\t:\tHD\t \t5\tTLX3\tTLX\tPILLTIS240-246LKC\t:\t:\t:\t:\t<m>A146T</m>\t \t:\t:\t:\t \t6\tTLX3\tTLX\tLLT242-244FHPFNCGP\t:\t:\t:\tG12D\t:\t \t:\t:\tHD\t \t7\tHOXA\tTLX\tL243RLECV\t:\t:\t:\t:\t:\t \t:\t:\tPEST\t \t8\tHOXA\tnd\tLL242-L243FPHQHC\t:\t:\t:\t:\t:\t \t:\t:\tFBXW7\t \t9\tSET-NUP214\tTLX\tLLTIS242-246PQGGC\t:\t:\t:\t:\t:\t \t:\t:\tHD/FBXW7\t \t10\t \tnd\tPIL240-242QSPSC\t:\t:\t:\t:\t:\t \t:\t:\tHD\t \t11\t \tTLX\tLT243-244LMCPT\t:\t:\t:\t:\t:\t \t:\t:\tJM\t \t12\t \tTALLMO\tPILLTIS240-S246LQSC\t:\t:\t:\t:\t:\t \t:\t:\t:\t \t13\tTLX3\tTLX\t:\tE668Q\t:\t:\tnd\tnd\tDel/333dupA\t:\t:\tHD/FBXW7\t \t14\tLYL1/LMO2\tTALLMO\t:\tL624YPILKV\t:\t:\t:\t:\t \t:\t:\tJM/PEST\t \t15\t \tProliferative\t:\tV427M\t:\t:\t:\t:\t \t:\t:\tHD/PEST\t \t16\tCALM-AF10\tnd\t:\tP815S\t:\t:\t:\t:\t \t:\t:\tHD/PEST\t \t17\tRUNX1-AFF3\tETP-ALL\t:\tT901G\tM511I\t:\t:\t:\t \t:\t:\tPEST\t \t18\t \tETP-ALL\t:\tR724H\tM511I\t:\tG12D\t:\t \t:\t:\tPEST\t \t19\t \tETP-ALL\t:\t:\tM511I\t:\tnd\tnd\tDel/-\t:\t:\tPEST\t \t20\tTLX3\tTLX\t:\t:\tM511I\t:\t:\t:\t \t:\t:\tJM\t \t21\tCALM-AF10\tTLX\t:\t:\tR657Q\t:\t:\t:\t \t:\t:\tHD/PEST\t \t22\tTLX3\tTLX\t:\t:\tR657Q\t:\tnd\tnd\t \t:\t:\tND\t \t23\tTLX1\tTLX\t:\t:\t:\tN642H\t:\t:\t \t:\t:\t:\t \t24\tTLX1\tTLX\t:\t:\t:\tN642H\t:\t:\t \tnd\t:\tnd\t \t25\tLMO2\tnd\t:\t:\t:\tN642H\t:\t:\t \t:\t:\tPEST\t \t26\tSIL-TAL1\tTALLMO\t:\t:\t:\tN642H\t:\t:\t \t:\t:\tHD\t \t27\tTLX3\tTLX\t:\t:\t:\t:\tG12D\t:\t \t:\t:\t:\t \t28\tTLX3\tTLX\t:\t:\t:\t:\tG12V\t:\t \t:\t:\tHD\t \t29\tTLX3\tnd\t:\t:\t:\t:\tG12C\t:\t \t:\t:\tHD/FBXW7\t \t30\tTLX3\tnd\t:\t:\t:\t:\tG13V\t:\t \t:\t:\tHD/FBXW7\t \t31\tCALM-AF10\tETP-ALL\t:\t:\t:\tN642H\tG12D\t:\t \t:\t:\t:\t \t32\tSIL-TAL1\tnd\t:\t:\t:\t:\tG13C\t:\t \tMut/Del\t:\t:\t \t33\tNKX2-5\tETP-ALL\t:\t:\t:\t:\tG13D\t:\t \tMut/Mut/Subcl. Del\t:\tHD\t \t34\t \tTALLMO\t:\t:\t:\t:\tG12R\t:\t \t:\t:\tFBXW7\t \t35\tTAL2\tTALLMO\t:\t:\t:\t:\t:\tG12D\t \tno protein\t:\tFBXW7\t \t36\tLMO2\tTALLMO\t:\t:\t:\t:\t:\tG12D\t \t:\t:\t:\t \t37\tTLX3\tTLX\t:\t:\t:\t:\t:\tQ61R\t \t:\t:\tHD/FBXW7\t \t38\tMEF2C\tETP-ALL\t:\t:\t:\t:\t:\tQ61L\t \t:\t:\tHD/PEST\t \t39\tCALM-AF10\tETP-ALL\t:\t:\t:\t:\tnd\tnd\tDel/3734delCinsGGTTTATGGTTT\t:\t:\t:\t \t40\t \tnd\t:\t:\t:\t:\t:\tG12D\t \t:\t:\tHD\t \t41\tTLX3\tTLX\t:\t:\t:\t:\t:\t<m>A146T</m>\t \t:\t:\tPEST\t \t42\tTLX3\tTLX\t:\t:\t:\t:\t:\t<m>A146T</m>\t \t:\t:\tHD\t \t43\tLMO2\tTALLMO\t:\t:\t:\t:\t:\t<m>A146T</m>\t \t:\t:\tHD/FBXW7\t \t44\tSIL-TAL1\tTALLMO\t:\t:\t:\t:\t:\t:\t \tSubcl. Del/:\t:\tHD/PEST\t \t45\tSIL-TAL1\tTALLMO\t:\t:\t:\t:\t:\t:\t \tMut/Mut\t:\t:\t \t46\tSIL-TAL1\tTALLMO\t:\t:\t:\t:\t:\t:\t \tDel/:\t:\tHD\t \t47\tSIL-TAL1\tTALLMO\t:\t:\t:\t:\t:\t:\t \tSubcl. Del/:\t:\t:\t \t48\tSIL-TAL1\tTALLMO\t:\t:\t:\t:\t:\t:\t \tSubcl. Mut/:\t:\t:\t \t49\tSIL-TAL1\tTALLMO\t:\t:\t:\t:\t:\t<m>A146T</m>\t \tDel/Del\t:\t:\t \t50\tSIL-TAL1\tTALLMO\t:\t:\t:\t:\t:\t:\t \tDel/Subcl. Del\t:\t:\t \t51\tSIL-TAL1\tTALLMO\t:\t:\t:\t:\t:\t:\t \tDel/Subcl. Del\t:\t:\t \t52\tSIL-TAL1\tTALLMO\t:\t:\t:\t:\t:\t:\t \tMut/Mut\t:\t:\t \t53\tLMO3\tTALLMO\t:\t:\t:\t:\t:\t:\t \tMut/Mut\t:\t:\t \t54\tLMO2\tTALLMO\t:\t:\t:\t:\t:\t:\t \tMut/Mut\t:\tFBXW7\t \t55\t \tTALLMO\t:\t:\t:\t:\t:\t:\t \tMut/Mut\t:\tHD\t \t56\t \tTALLMO\t:\t:\t:\t:\t:\t:\t \tMut/Mut\t:\t:\t \t57\t \tTALLMO\t:\t:\t:\t:\t:\t:\t \tSubcl. Del/:\t:\t:\t \t58\t \tTALLMO\t:\t:\t:\t:\t:\t:\t \tMut/Subcl. Del\t:\t:\t \t59\t \tTALLMO\t:\t:\t:\t:\t:\t:\t \tMut/Subcl. Del\t:\t:\t \t60\tNKX2:1\tProliferative\t:\t:\t:\t:\t:\t:\t \tMut/:\t:\tHD/FBXW7\t \t61\tTAL1\tProliferative\t:\t:\t:\t:\t:\t:\t \tno protein\t:\tHD\t \t62\tSIL-TAL1\tProliferative\t:\t:\t:\t:\t:\t:\t \tMut/Mut\t:\t:\t \t63\tSIL-TAL1\tProliferative\t:\t:\t:\t:\tnd\t:\t \tMut/Mut\t:\tPEST\t \t64\t \tETP-ALL\t:\t:\t:\t:\t:\tnd\t \tDel/:\t:\tPEST\t \t65\tMYC\tnd\t:\t:\t:\t:\t:\t:\t \tMut/Del\t:\t:\t \t66\tLMO2\tnd\t:\t:\t:\t:\t:\t:\t \tMut/Mut/Subcl. Del\t:\tPEST\t \t67\t \tnd\t:\t:\t:\t:\t:\t:\t \tDel/:\t:\t:\t \t68\t \tnd\t:\t:\t:\t:\t:\t:\t \tMut/Del\t:\t:\t \t69\tTLX1\tProliferative\t:\t:\t:\t:\t:\t:\t \t:\tE17K\t:\t \t70\tTLX3\tProliferative\t:\t:\t:\t:\t:\t:\t \t:\tE17K\tFBXW7\t \t71\tLMO1\tTALLMO\t:\t:\t:\t:\t:\t:\t \t:\tE17K\t:\t \t"}], "citations": {"NLM": "Cant\u00e9-Barrett K, Spijkers-Hagelstein JA, Buijs-Gladdines JG, Uitdehaag JC, Smits WK, van der Zwet J, Buijsman RC, Zaman GJ, Pieters R, Meijerink JP. MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia Leukemia. PMID: 27174491", "BibTeX": "@article{27174491, title={MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia}, author={Cant\u00e9-Barrett K and Spijkers-Hagelstein JA and Buijs-Gladdines JG and Uitdehaag JC and Smits WK and van der Zwet J and Buijsman RC and Zaman GJ and Pieters R and Meijerink JP}, journal={Leukemia}}"}, "is_sup_mat_match": false}, {"pmid": 30621206, "pmcid": "PMC6357143", "title": "Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer.", "journal": "Cancers (Basel)", "authors": ["Raimondi C", "Nicolazzo C", "Belardinilli F", "Loreni F", "Gradilone A", "Mahdavian Y", "Gelibter A", "Giannini G", "Cortesi E", "Gazzaniga P"], "date": "2019-01-04T00:00:00Z", "year": 2019, "snippets": [{"_id": "30621206@5856", "snip_text": "Patient 1 had a primary diagnosis of RAS mutant metastatic rectal cancer (NRAS A146T) and his clinical history has been partially published.", "section": "results", "mentions": ["74|4|gene|ncbi_gene@4893|NRAS", "0|7|species|ncbi_taxonomy@9606|Patient", "59|13|disease|ncbi_mesh@D012004|rectal cancer", "79|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Patient 1 had a primary diagnosis of RAS mutant metastatic rectal cancer (NRAS <m>A146T</m>) and his clinical history has been partially published."}], "citations": {"NLM": "Raimondi C, Nicolazzo C, Belardinilli F, Loreni F, Gradilone A, Mahdavian Y, Gelibter A, Giannini G, Cortesi E, Gazzaniga P. Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer. Cancers (Basel). PMID: 30621206", "BibTeX": "@article{30621206, title={Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer.}, author={Raimondi C and Nicolazzo C and Belardinilli F and Loreni F and Gradilone A and Mahdavian Y and Gelibter A and Giannini G and Cortesi E and Gazzaniga P}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 24224811, "pmcid": "PMC3918454", "title": "Kinetic Mechanisms of Mutation-dependent Harvey Ras Activation and Their Relevance for Development of Costello Syndrome", "journal": "Biochemistry", "authors": ["Wey M", "Lee J", "Jeong SS", "Kim J", "Heo J"], "date": "2013-11-26T00:00:00Z", "year": 2013, "snippets": [{"_id": "24224811@4296", "snip_text": "Symptoms of Costello syndrome also are linked to an unusual HRas NKCD-motif mutant K117R and to the HRas SAK-motif mutants A146T and A146V (Table 1).", "section": "abstract", "mentions": ["12|17|disease|ncbi_mesh@D056685|Costello syndrome", "60|4|gene|ncbi_gene@3265|HRas", "83|5|variant|litvar@rs104894227##&&&litvar@#3265#&&&litvar@CA256490#rs104894227##|K117R", "100|4|gene|ncbi_gene@3265|HRas", "133|5|variant|litvar@rs121917759##&&&litvar@#3265#&&&litvar@CA256494#rs121917759##|A146V", "105|3|gene|ncbi_gene@20873|SAK", "123|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Symptoms of Costello syndrome also are linked to an unusual HRas NKCD-motif mutant K117R and to the HRas SAK-motif mutants <m>A146T</m> and A146V (Table 1)."}], "citations": {"NLM": "Wey M, Lee J, Jeong SS, Kim J, Heo J. Kinetic Mechanisms of Mutation-dependent Harvey Ras Activation and Their Relevance for Development of Costello Syndrome Biochemistry. PMID: 24224811", "BibTeX": "@article{24224811, title={Kinetic Mechanisms of Mutation-dependent Harvey Ras Activation and Their Relevance for Development of Costello Syndrome}, author={Wey M and Lee J and Jeong SS and Kim J and Heo J}, journal={Biochemistry}}"}, "is_sup_mat_match": false}, {"pmid": 29755662, "pmcid": "PMC5945530", "title": "Hotspot KRAS exon 2 mutations in CD166 positive colorectal cancer and colorectal adenoma cells", "journal": "Oncotarget", "authors": ["Wong HL", "Ng LPW", "Koh SP", "Chan LWC", "Wong EYK", "Xue VW", "Tsang HFA", "Chan AKC", "Chiu KY", "Cheuk W", "Wong SCC"], "date": "2018-04-17T00:00:00Z", "year": 2018, "snippets": [{"_id": "29755662@11239", "snip_text": "Types\tGene\tNucleotide change\tAmino acid change\tGenotype\t \tCD166 positive CRC\t \tCarcinoma\tFBXW7\tc.1393C>T\tp.R465C\tMutant\t \tCarcinoma\tTP53\tc.527G>T\tp.C176F\tMutant\t \tCarcinoma\tKRAS\tc.436G>A\tp.A146T\tMutant\t \tCD166 negative CRC\t \tCarcinoma\tTP53\tc.527G>A\tp.C176Y\tMutant\t \tCD166 positive CAD\t \tAdenoma\tAPC\tc.4081_4082delCC\tp.P1361fs*13\tMutant\t \tAdenoma\tAPC\tc.4391_4394delAGAG\tp.E1464fs*8\tMutant\t \tAdenoma\tAPC\tc.4118_4118delC\tp.P1373fs*42\tMutant\t \tAdenoma\tAPC\tc.4216C>T\tp.Q1406*\tMutant\t \tAdenoma\tAPC\tc.3916G>T\tp.E1306*\tMutant\t \tAdenoma\tAPC\tc.3956delC\tp.P1319fs*2\tMutant\t \tAdenoma\tKRAS\tc.436G>A\tp.A146T\tMutant\t \tAdenoma\tKRAS\tc.35G>A\tp.G12D\tMutant\t \tAdenoma\tKRAS\tc.34G>A\tp.G12S\tMutant\t \tAdenoma\tSRC\tc.1591C>T\tp.Q531*\tMutant\t \tAdenoma\tTP53\tc.473G>A\tp.R158H\tMutant\t \tAdenoma\tPIK3CA\tc.1633G>A\tp.E545K\tMutant\t \tCD166 negative CAD\t \tAdenoma\tAPC\tc.4081_4082delCC\tp.P1361fs*13\tMutant\t \t", "section": "table", "mentions": ["691|7|variant|litvar@rs121913314##&&&litvar@#6714#&&&litvar@CA122517#rs121913314##|1591C>T", "685|3|gene|ncbi_gene@6714|SRC", "763|6|gene|ncbi_gene@5290|PIK3CA", "139|6|variant|litvar@rs786202962##&&&litvar@#7157#|527G>T", "266|5|gene|ncbi_gene@214|CD166", "572|4|gene|ncbi_gene@3845|KRAS", "180|6|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|436G>A", "295|3|gene|ncbi_gene@324|APC", "494|7|variant|litvar@#324#g.3916G>T&&&litvar@#324#|3916G>T", "173|4|gene|ncbi_gene@3845|KRAS", "488|3|gene|ncbi_gene@324|APC", "724|4|gene|ncbi_gene@7157|TP53", "350|18|variant|litvar@rs387906235##&&&litvar@#324#|c.4391_4394delAGAG", "346|3|gene|ncbi_gene@324|APC", "731|6|variant|litvar@rs55819519##&&&litvar@#7157#&&&litvar@CA468#rs55819519##|473G>A", "132|4|gene|ncbi_gene@7157|TP53", "588|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "189|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "452|9|variant|litvar@rs587782518##&&&litvar@#324#&&&litvar@CA8967#rs587782518##|c.4216C>T", "448|3|gene|ncbi_gene@324|APC", "830|16|variant|litvar@#324#c.4081_4082delCC&&&litvar@#324#|c.4081_4082delCC", "738|7|variant|litvar@rs55819519##&&&litvar@#7157#&&&litvar@CA468#rs55819519##|p.R158H", "146|7|variant|litvar@rs786202962##&&&litvar@#7157#|p.C176F", "780|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "532|10|variant|litvar@rs1057517558##&&&litvar@#324#|c.3956delC", "105|7|variant|litvar@rs867384286##&&&litvar@#55294#&&&litvar@CA16602851#rs867384286##|p.R465C", "398|3|gene|ncbi_gene@324|APC", "402|15|variant|litvar@#324#c.4118_4118delC&&&litvar@#324#|c.4118_4118delC", "611|4|gene|ncbi_gene@3845|KRAS", "89|5|gene|ncbi_gene@55294|FBXW7", "235|4|gene|ncbi_gene@7157|TP53", "97|7|variant|litvar@rs867384286##&&&litvar@#55294#&&&litvar@CA16602851#rs867384286##|1393C>T", "242|6|variant|litvar@rs786202962##&&&litvar@#7157#&&&litvar@CA254#rs786202962##|527G>A", "204|5|gene|ncbi_gene@214|CD166", "299|16|variant|litvar@#324#c.4081_4082delCC&&&litvar@#324#|c.4081_4082delCC", "648|4|gene|ncbi_gene@3845|KRAS", "624|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "249|7|variant|litvar@rs786202962##&&&litvar@#7157#&&&litvar@CA254#rs786202962##|p.C176Y", "58|5|gene|ncbi_gene@214|CD166", "772|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|1633G>A", "661|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "797|5|gene|ncbi_gene@214|CD166", "655|5|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|34G>A", "826|3|gene|ncbi_gene@324|APC", "528|3|gene|ncbi_gene@324|APC", "618|5|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|35G>A", "579|6|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|436G>A"], "figure_id": "T2", "text_hl": "Types\tGene\tNucleotide change\tAmino acid change\tGenotype\t \tCD166 positive CRC\t \tCarcinoma\tFBXW7\tc.1393C>T\tp.R465C\tMutant\t \tCarcinoma\tTP53\tc.527G>T\tp.C176F\tMutant\t \tCarcinoma\tKRAS\tc.436G>A\t<m>p.A146T</m>\tMutant\t \tCD166 negative CRC\t \tCarcinoma\tTP53\tc.527G>A\tp.C176Y\tMutant\t \tCD166 positive CAD\t \tAdenoma\tAPC\tc.4081_4082delCC\tp.P1361fs*13\tMutant\t \tAdenoma\tAPC\tc.4391_4394delAGAG\tp.E1464fs*8\tMutant\t \tAdenoma\tAPC\tc.4118_4118delC\tp.P1373fs*42\tMutant\t \tAdenoma\tAPC\tc.4216C>T\tp.Q1406*\tMutant\t \tAdenoma\tAPC\tc.3916G>T\tp.E1306*\tMutant\t \tAdenoma\tAPC\tc.3956delC\tp.P1319fs*2\tMutant\t \tAdenoma\tKRAS\tc.436G>A\t<m>p.A146T</m>\tMutant\t \tAdenoma\tKRAS\tc.35G>A\tp.G12D\tMutant\t \tAdenoma\tKRAS\tc.34G>A\tp.G12S\tMutant\t \tAdenoma\tSRC\tc.1591C>T\tp.Q531*\tMutant\t \tAdenoma\tTP53\tc.473G>A\tp.R158H\tMutant\t \tAdenoma\tPIK3CA\tc.1633G>A\tp.E545K\tMutant\t \tCD166 negative CAD\t \tAdenoma\tAPC\tc.4081_4082delCC\tp.P1361fs*13\tMutant\t \t"}], "citations": {"NLM": "Wong HL, Ng LPW, Koh SP, Chan LWC, Wong EYK, Xue VW, Tsang HFA, Chan AKC, Chiu KY, Cheuk W, Wong SCC. Hotspot KRAS exon 2 mutations in CD166 positive colorectal cancer and colorectal adenoma cells Oncotarget. PMID: 29755662", "BibTeX": "@article{29755662, title={Hotspot KRAS exon 2 mutations in CD166 positive colorectal cancer and colorectal adenoma cells}, author={Wong HL and Ng LPW and Koh SP and Chan LWC and Wong EYK and Xue VW and Tsang HFA and Chan AKC and Chiu KY and Cheuk W and Wong SCC}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 36182938, "pmcid": "PMC9526730", "title": "COLONOMICS - integrative omics data of one hundred paired normal-tumoral samples from colon cancer patients.", "journal": "Sci Data", "authors": ["D\u00edez-Villanueva A", "Sanz-Pamplona R", "Sol\u00e9 X", "Cordero D", "Crous-Bou M", "Guin\u00f3 E", "Lopez-Doriga A", "Berenguer A", "Auss\u00f3 S", "Par\u00e9-Brunet L", "Ob\u00f3n-Santacana M", "Moratalla-Navarro F", "Salazar R", "Sanjuan X", "Santos C", "Biondo S", "Diez-Obrero V", "Garcia-Serrano A", "Alonso MH", "Carreras-Torres R", "Closa A", "Moreno V"], "date": "2022-10-01T00:00:00Z", "year": 2022, "snippets": [{"_id": "36182938@24056", "snip_text": "As a validation of the discovery pipeline of SNVs, 6 mutations in KRAS (Q61H, A146T, G12V, G12D, G12S, G13D) and 7 in TP53 (G245D, R248Q, R237H, R273C, R175H, R282W, R213_, G245S) were tested using KASPar genotyping assays in the Fluidigm Biomark platform (dynamic arrays).", "section": "other", "mentions": ["91|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "173|5|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|G245S", "97|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "72|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "103|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "159|5|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|R282W", "131|5|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|R248Q", "124|5|variant|litvar@rs121912656##&&&litvar@#7157#&&&litvar@CA371#rs121912656##|G245D", "66|4|gene|ncbi_gene@3845|KRAS", "145|5|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|R273C", "118|4|gene|ncbi_gene@7157|TP53", "78|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "152|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H", "85|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "138|5|variant|litvar@#7157#p.R237H&&&litvar@#7157#|R237H"], "text_hl": "As a validation of the discovery pipeline of SNVs, 6 mutations in KRAS (Q61H, <m>A146T</m>, G12V, G12D, G12S, G13D) and 7 in TP53 (G245D, R248Q, R237H, R273C, R175H, R282W, R213_, G245S) were tested using KASPar genotyping assays in the Fluidigm Biomark platform (dynamic arrays)."}], "citations": {"NLM": "D\u00edez-Villanueva A, Sanz-Pamplona R, Sol\u00e9 X, Cordero D, Crous-Bou M, Guin\u00f3 E, Lopez-Doriga A, Berenguer A, Auss\u00f3 S, Par\u00e9-Brunet L, Ob\u00f3n-Santacana M, Moratalla-Navarro F, Salazar R, Sanjuan X, Santos C, Biondo S, Diez-Obrero V, Garcia-Serrano A, Alonso MH, Carreras-Torres R, Closa A, Moreno V. COLONOMICS - integrative omics data of one hundred paired normal-tumoral samples from colon cancer patients. Sci Data. PMID: 36182938", "BibTeX": "@article{36182938, title={COLONOMICS - integrative omics data of one hundred paired normal-tumoral samples from colon cancer patients.}, author={D\u00edez-Villanueva A and Sanz-Pamplona R and Sol\u00e9 X and Cordero D and Crous-Bou M and Guin\u00f3 E and Lopez-Doriga A and Berenguer A and Auss\u00f3 S and Par\u00e9-Brunet L and Ob\u00f3n-Santacana M and Moratalla-Navarro F and Salazar R and Sanjuan X and Santos C and Biondo S and Diez-Obrero V and Garcia-Serrano A and Alonso MH and Carreras-Torres R and Closa A and Moreno V}, journal={Sci Data}}"}, "is_sup_mat_match": false}, {"pmid": 33540760, "pmcid": "PMC7867282", "title": "BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK Inhibitor Trametinib in the Treatment of Acute Leukemia.", "journal": "Cancers (Basel)", "authors": ["Seipel K", "Kopp B", "Bacher U", "Pabst T"], "date": "2021-02-02T00:00:00Z", "year": 2021, "snippets": [{"_id": "33540760@37361", "snip_text": "ID AML (FAB) Classification Origin FLT3Gene TP53Gene Other GeneMutations Karyotype   HL-60 M2 de novo wt null NRAS Q61LCDKN2A R80X hypotetraploid   ML-2 M4 T-ALL wt wt MLL-AF6/(t6;11)KRAS A146T t6;11   MOLM-13 M5a, relapse MDS ITD wt MLL-AF9/(t9;11) t9;11   MOLM-16 M0, relapse de novo wt V173MC238S MLL V1368LMTOR T571K hypotetraploid   OCI-AML2 M4 de novo wtA680V wt DNMT3A R635WMLL K1751 * +6, +8, 3q26   OCI-AML3 M4 de novo wt wt DNMT3A R882CNRAS Q61LNPM1 L287fs +1. +5, +8   PL-21 M3 de novo ITDP336L wtP36fs KRAS A146V hypertetraploid   SKM-1 M5, refractory MDS wt R248Q ASXL1, TET2 del9   ", "section": "table", "mentions": ["408|8|disease||OCI-AML3", "168|7|gene|ncbi_gene@4301|MLL-AF6", "500|5|variant|litvar@rs775677376##&&&litvar@#1788#&&&litvar@CA1556119#rs775677376##|P336L", "460|6|variant|litvar@#1788#p.L287fsX&&&litvar@#1788#|L287fs", "188|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "156|5|disease|ncbi_mesh@D054218|T-ALL", "519|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "369|6|gene|ncbi_gene@1788|DNMT3A", "300|3|gene|ncbi_gene@4297|MLL", "110|4|gene|ncbi_gene@4893|NRAS", "183|4|gene|ncbi_gene@3845|KRAS", "223|3|disease|ncbi_mesh@D009190|MDS", "434|6|gene|ncbi_gene@1788|DNMT3A", "202|7|cellline||MOLM-13", "3|3|disease|ncbi_mesh@D015470|AML", "8|3|disease|ncbi_mesh@C535673|FAB", "543|8|cellline||SKM-1 M5", "360|5|variant|litvar@rs372303125##&&&litvar@#2322#&&&litvar@CA6928483#rs372303125##|A680V", "514|4|gene|ncbi_gene@3845|KRAS", "571|5|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|R248Q", "234|7|gene|ncbi_gene@4297|MLL-AF9", "148|4|disease|ncbi_mesh@C537366|ML-2", "85|5|cellline||HL-60", "258|7|cellline||MOLM-16", "564|3|disease|ncbi_mesh@D009190|MDS", "315|5|variant|litvar@#4297#p.T571K&&&litvar@#4297#|T571K", "508|5|variant|litvar@#3845#p.P36fsX&&&litvar@#3845#|P36fs", "44|8|gene|ncbi_gene@7157|TP53Gene", "584|4|gene|ncbi_gene@54790|TET2", "577|5|gene|ncbi_gene@171023|ASXL1", "126|4|variant|litvar@rs778113186##&&&litvar@#4301#&&&litvar@CA4098553#rs778113186##|R80X", "338|8|disease||OCI-AML2"], "figure_id": "cancers-13-00581-t001", "text_hl": "ID AML (FAB) Classification Origin FLT3Gene TP53Gene Other GeneMutations Karyotype   HL-60 M2 de novo wt null NRAS Q61LCDKN2A R80X hypotetraploid   ML-2 M4 T-ALL wt wt MLL-AF6/(t6;11)KRAS <m>A146T</m> t6;11   MOLM-13 M5a, relapse MDS ITD wt MLL-AF9/(t9;11) t9;11   MOLM-16 M0, relapse de novo wt V173MC238S MLL V1368LMTOR T571K hypotetraploid   OCI-AML2 M4 de novo wtA680V wt DNMT3A R635WMLL K1751 * +6, +8, 3q26   OCI-AML3 M4 de novo wt wt DNMT3A R882CNRAS Q61LNPM1 L287fs +1. +5, +8   PL-21 M3 de novo ITDP336L wtP36fs KRAS A146V hypertetraploid   SKM-1 M5, refractory MDS wt R248Q ASXL1, TET2 del9   "}], "citations": {"NLM": "Seipel K, Kopp B, Bacher U, Pabst T. BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK Inhibitor Trametinib in the Treatment of Acute Leukemia. Cancers (Basel). PMID: 33540760", "BibTeX": "@article{33540760, title={BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK Inhibitor Trametinib in the Treatment of Acute Leukemia.}, author={Seipel K and Kopp B and Bacher U and Pabst T}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 27416070, "pmcid": "PMC4945036", "title": "Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations.", "journal": "PLoS One", "authors": ["Zonta E", "Garlan F", "P\u00e9cuchet N", "Perez-Toralla K", "Caen O", "Milbury C", "Didelot A", "Fabre E", "Blons H", "Laurent-Puig P", "Taly V"], "date": "2016-07-14T00:00:00Z", "year": 2016, "snippets": [{"_id": "27416070@22239", "snip_text": "Some castPCR  assays targeting less frequent mutations (p.Q61Q, p.Q61H, p.A146T for KRAS, p.G469A for BRAF and p.Q61R for NRAS, not available with TaqMan  system) were also validated by dPCR in a context of clinical follow-up (data not shown).", "section": "discussion", "mentions": ["102|4|gene|ncbi_gene@673|BRAF", "64|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "72|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "111|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "84|4|gene|ncbi_gene@3845|KRAS", "56|6|variant|litvar@rs373900050##&&&litvar@#7294#|p.Q61Q", "122|4|gene|ncbi_gene@4893|NRAS", "90|7|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|p.G469A"], "text_hl": "Some castPCR  assays targeting less frequent mutations (p.Q61Q, p.Q61H, <m>p.A146T</m> for KRAS, p.G469A for BRAF and p.Q61R for NRAS, not available with TaqMan  system) were also validated by dPCR in a context of clinical follow-up (data not shown)."}], "citations": {"NLM": "Zonta E, Garlan F, P\u00e9cuchet N, Perez-Toralla K, Caen O, Milbury C, Didelot A, Fabre E, Blons H, Laurent-Puig P, Taly V. Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations. PLoS One. PMID: 27416070", "BibTeX": "@article{27416070, title={Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations.}, author={Zonta E and Garlan F and P\u00e9cuchet N and Perez-Toralla K and Caen O and Milbury C and Didelot A and Fabre E and Blons H and Laurent-Puig P and Taly V}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 30575318, "pmcid": "PMC6346227", "title": "Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer.", "journal": "Cancer Med", "authors": ["Osumi H", "Shinozaki E", "Takeda Y", "Wakatsuki T", "Ichimura T", "Saiura A", "Yamaguchi K", "Takahashi S", "Noda T", "Zembutsu H"], "date": "2019-01-01T00:00:00Z", "year": 2019, "snippets": [{"_id": "30575318@9404", "snip_text": "We examined twelve types of RAS exon 2 (G12S, G12C, G12R, G12D, G12V, G12A, G13S, G13C, G13R, G13D, G13V, and G13A), eight types of RAS exon 3 (A59T, A59G, Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H), and four types of RAS exon 4 (K117N, A146T, A146P, and A146V) mutations using Luminex 100/200TM (Luminex) and UniMAG (MBL) system, as previously described.28, 29", "section": "methods", "mentions": ["52|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "70|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "190|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "46|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "110|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13A", "174|4|variant|litvar@#4893#p.Q61P&&&litvar@#4893#|Q61P", "144|4|variant|litvar@#50639#c.59A>T&&&litvar@#50639#|A59T", "64|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "82|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA16602444#rs112445441##|G13C", "315|3|gene|ncbi_gene@50639|MBL", "58|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "252|5|variant|litvar@#50639#p.A146V&&&litvar@#50639#|A146V", "156|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "94|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "76|4|variant|litvar@rs112445441##&&&litvar@#3845#|G13S", "168|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "150|4|variant|litvar@#50639#c.59A>G&&&litvar@#50639#|A59G", "88|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "234|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "227|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "180|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "100|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "215|3|disease||RAS", "241|5|variant|litvar@#50639#p.A146P&&&litvar@#50639#|A146P", "40|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "162|4|variant|litvar@#4893#p.Q61E&&&litvar@#4893#|Q61E"], "text_hl": "We examined twelve types of RAS exon 2 (G12S, G12C, G12R, G12D, G12V, G12A, G13S, G13C, G13R, G13D, G13V, and G13A), eight types of RAS exon 3 (A59T, A59G, Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H), and four types of RAS exon 4 (K117N, <m>A146T</m>, A146P, and A146V) mutations using Luminex 100/200TM (Luminex) and UniMAG (MBL) system, as previously described.28, 29"}], "citations": {"NLM": "Osumi H, Shinozaki E, Takeda Y, Wakatsuki T, Ichimura T, Saiura A, Yamaguchi K, Takahashi S, Noda T, Zembutsu H. Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer. Cancer Med. PMID: 30575318", "BibTeX": "@article{30575318, title={Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer.}, author={Osumi H and Shinozaki E and Takeda Y and Wakatsuki T and Ichimura T and Saiura A and Yamaguchi K and Takahashi S and Noda T and Zembutsu H}, journal={Cancer Med}}"}, "is_sup_mat_match": false}, {"pmid": 33076847, "pmcid": "PMC7574488", "title": "Discovering the molecular differences between right- and left-sided colon cancer using machine learning methods.", "journal": "BMC Cancer", "authors": ["Jiang Y", "Yan X", "Liu K", "Shi Y", "Wang C", "Hu J", "Li Y", "Wu Q", "Xiang M", "Zhao R"], "date": "2020-10-19T00:00:00Z", "year": 2020, "snippets": [{"_id": "33076847@10428", "snip_text": "Mutationa avsnp150b Gene.refGenec weightsd Sample Number in LCC(%)e Sample Number in RCC_(%)f P valueg   chr7_140753336_140753336_A_T rs113488022 BRAF 0.12 2 (1.8) 35 (20.5) 4.72E-15   chr12_25245347_25245347_C_T rs112445441 KRAS 0.09 5 (4.5) 20 (11.7) 4.07E-08   chr5_112839942_112839942_C_T rs121913332 APC 0.09 1 (0.9) 18 (10.5) 2.93E-07   chr12_25245350_25245350_C_G rs121913529 KRAS 0.09 1 (0.9) 6 (3.5) 0.02   chr12_25245350_25245350_C_T rs121913529 KRAS 0.07 8 (7.1) 26 (15.2) 8.74E-11   chr17_7674220_7674220_C_T rs11540652 TP53 0.06 10 (8.9) 2 (1.2) 0.56   chr7_135929761_135929762_AT_A . LUZP6;MTPN 0.06 4 (3.6) 2 (1.2) 0.56   chr3_179234297_179234297_A_G rs121913279 PIK3CA 0.05 5 (4.5) 7 (4.1) 0.01   chr12_25245350_25245350_C_A rs121913529 KRAS 0.04 11 (9.8) 13 (7.6) 3.46E-05   chr3_179218294_179218294_G_A rs121913273 PIK3CA 0.04 4 (3.6) 5 (2.9) 0.04   chr12_25225628_25225628_C_T rs121913527 KRAS 0.03 2 (1.8) 6 (3.5) 0.02   chr5_112780895_112780895_C_T rs587781392 APC 0.03 4 (3.6) 4 (2.3) 0.08   chr5_78039082_78039083_GT_G . AP3B1 0.03 2 (1.8) 10 (5.8) 5.37E-4   chr15_23567535_23567536_CT_C . MKRN3 0.02 1 (0.9) 15 (8.8) 5.29E-06   chr17_7673802_7673802_C_T rs28934576 TP53 0.02 5 (4.5) 6 (3.5) 0.02   chr3_46375665_46375666_TG_T rs939905165 LOC102724297 0.02 0 (0) 15 (8.8) 5.29E-06   chr1_244056271_244056272_GA_G rs972665297 ZBTB18 0.02 2 (1.8) 17 (9.9) 7.77E-07   chr7_1747914_1747915_TA_T . ELFN1 0.02 2 (1.8) 8 (4.7) 3.08E-3   chr12_109581434_109581435_GC_G . MVK 0.02 0 (0) 11 (6.4) 2.16E-4   chr4_105242265_105242266_CT_C . TET2-AS1 0.02 1 (0.9) 8 (4.7) 3.08E-3   chr8_13568071_13568072_CT_C rs1014242184 C8orf48 0.01 1 (0.9) 14 (8.2) 1.36E-05   chr17_58357799_58357800_AC_A rs781215815 RNF43 0.01 0 (0) 17 (9.9) 7.77E-07   chr2_68464196_68464197_AT_A . FBXO48 0.01 0 (0) 9 (5.3) 1.29E-3   chr4_154609909_154609910_GT_G . FGG 0.01 0 (0) 10 (5.8) 5.32E-4   chr17_7675088_7675088_C_T rs28934578 TP53 0.01 10 (8.9) 13 (7.6) 3.46E-05   chr2_147926116_147926117_TA_T rs764719749 ACVR2A 0.01 1 (0.9) 11 (6.4) 2.16E-4   chr5_112838220_112838220_C_T rs121913333 APC 0.01 3 (2.7) 7 (4.1) 7.22E-3   chr13_108232109_108232110_CA_C rs977361714 ABHD13 0.003 1 (0.9) 9 (5.3) 1.29E-3   chr4_44698597_44698598_GA_G . GUF1 0.003 1 (0.9) 11 (6.4) 2.16E-4   chr6_98837428_98837429_CT_C rs898072886 POU3F2 0.003 1 (0.9) 10 (5.8) 5.32E-4   ", "section": "table", "mentions": ["110|23|variant|litvar@#673#c.140753336_140753336A>T&&&litvar@#673#|140753336_140753336_A_T", "821|11|variant|litvar@rs121913273##&&&litvar@#5290#|rs121913273", "2046|23|variant|litvar@#324#c.112838220_112838220C>T&&&litvar@#324#|112838220_112838220_C_T", "371|11|variant|litvar@rs121913529##&&&litvar@#3845#|rs121913529", "642|23|variant|litvar@#5290#c.179234297_179234297A>G&&&litvar@#5290#|179234297_179234297_A_G", "2295|11|variant|litvar@rs898072886##&&&litvar@#5454#|rs898072886", "908|4|gene|ncbi_gene@3845|KRAS", "666|11|variant|litvar@rs121913279##&&&litvar@#5290#|rs121913279", "1703|11|variant|litvar@rs781215815##&&&litvar@#54894#|rs781215815", "1633|7|gene|ncbi_gene@157773|C8orf48", "946|23|variant|litvar@#324#c.112780895_112780895C>T&&&litvar@#324#|112780895_112780895_C_T", "1336|11|variant|litvar@rs972665297##&&&litvar@#10472#|rs972665297", "85|3|disease|ncbi_mesh@D015179|RCC", "833|6|gene|ncbi_gene@5290|PIK3CA", "896|11|variant|litvar@rs121913527##&&&litvar@#3845#|rs121913527", "146|4|gene|ncbi_gene@673|BRAF", "2082|3|gene|ncbi_gene@324|APC", "2307|6|gene|ncbi_gene@5454|POU3F2", "532|4|gene|ncbi_gene@7157|TP53", "678|6|gene|ncbi_gene@5290|PIK3CA", "1680|22|variant|litvar@#54894#|58357799_58357800_AC_A", "1189|4|gene|ncbi_gene@7157|TP53", "1311|24|variant|litvar@#10472#|244056271_244056272_GA_G", "719|21|variant|litvar@#3845#c.25245350_25245350C>A&&&litvar@#3845#|25245350_25245350_C_A", "1348|6|gene|ncbi_gene@10472|ZBTB18", "1910|10|variant|litvar@rs28934578##&&&litvar@#7157#|rs28934578", "191|21|variant|litvar@#3845#c.25245347_25245347C>T&&&litvar@#3845#|25245347_25245347_C_T", "1552|4|gene|ncbi_gene@54790|TET2", "1113|5|gene|ncbi_gene@7681|MKRN3", "456|4|gene|ncbi_gene@3845|KRAS", "1990|11|variant|litvar@rs764719749##&&&litvar@#92#|rs764719749", "1044|5|gene|ncbi_gene@8546|AP3B1", "1416|5|gene|ncbi_gene@392617|ELFN1", "444|11|variant|litvar@rs121913529##&&&litvar@#3845#|rs121913529", "1620|12|variant|litvar@rs1014242184##&&&litvar@#157773#|rs1014242184", "797|23|variant|litvar@#5290#c.179218294_179218294G>A&&&litvar@#5290#|179218294_179218294_G_A", "269|23|variant|litvar@#324#c.112839942_112839942C>T&&&litvar@#324#|112839942_112839942_C_T", "1850|3|gene|ncbi_gene@2266|FGG", "2002|6|gene|ncbi_gene@92|ACVR2A", "383|4|gene|ncbi_gene@3845|KRAS", "1227|22|variant|litvar@#102724297#|46375665_46375666_TG_T", "293|11|variant|litvar@rs121913332##&&&litvar@#324#|rs121913332", "1782|6|gene|ncbi_gene@554251|FBXO48", "521|10|variant|litvar@rs11540652##&&&litvar@#7157#|rs11540652", "1921|4|gene|ncbi_gene@7157|TP53", "1965|24|variant|litvar@#92#|147926116_147926117_TA_T", "2148|11|variant|litvar@rs977361714##&&&litvar@#84945#|rs977361714", "2229|4|gene|ncbi_gene@60558|GUF1", "1178|10|variant|litvar@rs28934576##&&&litvar@#7157#|rs28934576", "2070|11|variant|litvar@rs121913333##&&&litvar@#324#|rs121913333", "874|21|variant|litvar@#3845#c.25225628_25225628C>T&&&litvar@#3845#|25225628_25225628_C_T", "1890|19|variant|litvar@#7157#c.7675088_7675088C>T&&&litvar@#7157#|7675088_7675088_C_T", "305|3|gene|ncbi_gene@324|APC", "970|11|variant|litvar@rs587781392##&&&litvar@#324#|rs587781392", "2160|6|gene|ncbi_gene@84945|ABHD13", "1250|11|variant|litvar@rs939905165##&&&litvar@#102724297#|rs939905165", "753|4|gene|ncbi_gene@3845|KRAS", "1486|3|gene|ncbi_gene@4598|MVK", "134|11|variant|litvar@rs113488022##&&&litvar@#673#|rs113488022", "225|4|gene|ncbi_gene@3845|KRAS", "741|11|variant|litvar@rs121913529##&&&litvar@#3845#|rs121913529", "213|11|variant|litvar@rs112445441##&&&litvar@#3845#|rs112445441", "501|19|variant|litvar@#7157#c.7674220_7674220C>T&&&litvar@#7157#|7674220_7674220_C_T", "1262|12|gene|ncbi_gene@102724297|LOC102724297", "1715|5|gene|ncbi_gene@54894|RNF43", "1158|19|variant|litvar@#7157#c.7673802_7673802C>T&&&litvar@#7157#|7673802_7673802_C_T", "982|3|gene|ncbi_gene@324|APC", "349|21|variant|litvar@#3845#c.25245350_25245350C>G&&&litvar@#3845#|25245350_25245350_C_G", "422|21|variant|litvar@#3845#c.25245350_25245350C>T&&&litvar@#3845#|25245350_25245350_C_T"], "figure_id": "Tab1", "text_hl": "Mutationa avsnp150b Gene.refGenec weightsd Sample Number in LCC(%)e Sample Number in RCC_(%)f P valueg   chr7_140753336_140753336_A_T rs113488022 BRAF 0.12 2 (1.8) 35 (20.5) 4.72E-15   chr12_25245347_25245347_C_T rs112445441 KRAS 0.09 5 (4.5) 20 (11.7) 4.07E-08   chr5_112839942_112839942_C_T rs121913332 APC 0.09 1 (0.9) 18 (10.5) 2.93E-07   chr12_25245350_25245350_C_G rs121913529 KRAS 0.09 1 (0.9) 6 (3.5) 0.02   chr12_25245350_25245350_C_T rs121913529 KRAS 0.07 8 (7.1) 26 (15.2) 8.74E-11   chr17_7674220_7674220_C_T rs11540652 TP53 0.06 10 (8.9) 2 (1.2) 0.56   chr7_135929761_135929762_AT_A . LUZP6;MTPN 0.06 4 (3.6) 2 (1.2) 0.56   chr3_179234297_179234297_A_G rs121913279 PIK3CA 0.05 5 (4.5) 7 (4.1) 0.01   chr12_25245350_25245350_C_A rs121913529 KRAS 0.04 11 (9.8) 13 (7.6) 3.46E-05   chr3_179218294_179218294_G_A rs121913273 PIK3CA 0.04 4 (3.6) 5 (2.9) 0.04   chr12_25225628_25225628_C_T rs121913527 KRAS 0.03 2 (1.8) 6 (3.5) 0.02   chr5_112780895_112780895_C_T rs587781392 APC 0.03 4 (3.6) 4 (2.3) 0.08   chr5_78039082_78039083_GT_G . AP3B1 0.03 2 (1.8) 10 (5.8) 5.37E-4   chr15_23567535_23567536_CT_C . MKRN3 0.02 1 (0.9) 15 (8.8) 5.29E-06   chr17_7673802_7673802_C_T rs28934576 TP53 0.02 5 (4.5) 6 (3.5) 0.02   chr3_46375665_46375666_TG_T rs939905165 LOC102724297 0.02 0 (0) 15 (8.8) 5.29E-06   chr1_244056271_244056272_GA_G rs972665297 ZBTB18 0.02 2 (1.8) 17 (9.9) 7.77E-07   chr7_1747914_1747915_TA_T . ELFN1 0.02 2 (1.8) 8 (4.7) 3.08E-3   chr12_109581434_109581435_GC_G . MVK 0.02 0 (0) 11 (6.4) 2.16E-4   chr4_105242265_105242266_CT_C . TET2-AS1 0.02 1 (0.9) 8 (4.7) 3.08E-3   chr8_13568071_13568072_CT_C rs1014242184 C8orf48 0.01 1 (0.9) 14 (8.2) 1.36E-05   chr17_58357799_58357800_AC_A rs781215815 RNF43 0.01 0 (0) 17 (9.9) 7.77E-07   chr2_68464196_68464197_AT_A . FBXO48 0.01 0 (0) 9 (5.3) 1.29E-3   chr4_154609909_154609910_GT_G . FGG 0.01 0 (0) 10 (5.8) 5.32E-4   chr17_7675088_7675088_C_T rs28934578 TP53 0.01 10 (8.9) 13 (7.6) 3.46E-05   chr2_147926116_147926117_TA_T rs764719749 ACVR2A 0.01 1 (0.9) 11 (6.4) 2.16E-4   chr5_112838220_112838220_C_T rs121913333 APC 0.01 3 (2.7) 7 (4.1) 7.22E-3   chr13_108232109_108232110_CA_C rs977361714 ABHD13 0.003 1 (0.9) 9 (5.3) 1.29E-3   chr4_44698597_44698598_GA_G . GUF1 0.003 1 (0.9) 11 (6.4) 2.16E-4   chr6_98837428_98837429_CT_C rs898072886 POU3F2 0.003 1 (0.9) 10 (5.8) 5.32E-4   "}], "citations": {"NLM": "Jiang Y, Yan X, Liu K, Shi Y, Wang C, Hu J, Li Y, Wu Q, Xiang M, Zhao R. Discovering the molecular differences between right- and left-sided colon cancer using machine learning methods. BMC Cancer. PMID: 33076847", "BibTeX": "@article{33076847, title={Discovering the molecular differences between right- and left-sided colon cancer using machine learning methods.}, author={Jiang Y and Yan X and Liu K and Shi Y and Wang C and Hu J and Li Y and Wu Q and Xiang M and Zhao R}, journal={BMC Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 29643917, "pmcid": "PMC5831938", "title": "Predictive and Prognostic Implications of Mutation Profiling and Microsatellite Instability Status in Patients with Metastatic Colorectal Carcinoma.", "journal": "Gastroenterol Res Pract", "authors": ["Liu J", "Zeng W", "Huang C", "Wang J", "Yang D", "Ma D"], "date": "2018-01-31T00:00:00Z", "year": 2018, "snippets": [{"_id": "29643917@29543", "snip_text": "Genes Codon Mutation Cases (% of 461)   Total cases with RAS mutation   230 (49.9%)   Total cases with KRAS mutation   201 (43.6%)   KRAS 12 p.G12D 74 (16.1%)   12 p.G12V 35 (7.6%)   12 p.G12C 15 (3.3%)   12 p.G12A 6 (1.3%)   12 p.G12R 9 (1.9%)   12 p.G12S 1 (0.2%)   13 p.G13D 31 (6.7%)   59 p.A59T 4 (0.9%)   61 p.Q61H 2 (0.4%)   146 p.A146T 16 (3.5%)   146 p.A146V 3 (0.6%)   Others Others 5 (1.1%)   Total cases with NRAS mutation   13 (2.8%)   NRAS 12 p.G12D 4 (0.9%)   12 p.G12S 2 (0.4%)   18 p.A18T 1 (0.2%)   61 p.Q61L 4 (0.9%)   61 p.Q61R 2 (0.4%)   Total cases with HRAS mutation   1 (0.2%)   HRAS 12 p.G12D 1 (0.2%)   Total cases with BRAF mutation   26 (5.6%)   BRAF 600 V600E 26 (5.6%)   ", "section": "table", "mentions": ["576|4|gene|ncbi_gene@3265|HRAS", "499|6|variant|litvar@rs121913248##&&&litvar@#4893#&&&litvar@CA16602497#rs121913248##|p.A18T", "541|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "293|6|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|p.A59T", "520|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "208|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "336|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "314|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "186|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "421|4|gene|ncbi_gene@4893|NRAS", "646|4|gene|ncbi_gene@673|BRAF", "229|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "478|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "449|4|gene|ncbi_gene@4893|NRAS", "103|4|gene|ncbi_gene@3845|KRAS", "271|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "457|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "250|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "674|4|gene|ncbi_gene@673|BRAF", "360|7|variant|litvar@rs121917759##&&&litvar@#3265#&&&litvar@CA256494#rs121917759##|p.A146V", "611|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "603|4|gene|ncbi_gene@3265|HRAS", "683|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "141|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "133|4|gene|ncbi_gene@3845|KRAS", "164|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V"], "figure_id": "tab1", "text_hl": "Genes Codon Mutation Cases (% of 461)   Total cases with RAS mutation   230 (49.9%)   Total cases with KRAS mutation   201 (43.6%)   KRAS 12 p.G12D 74 (16.1%)   12 p.G12V 35 (7.6%)   12 p.G12C 15 (3.3%)   12 p.G12A 6 (1.3%)   12 p.G12R 9 (1.9%)   12 p.G12S 1 (0.2%)   13 p.G13D 31 (6.7%)   59 p.A59T 4 (0.9%)   61 p.Q61H 2 (0.4%)   146 <m>p.A146T</m> 16 (3.5%)   146 p.A146V 3 (0.6%)   Others Others 5 (1.1%)   Total cases with NRAS mutation   13 (2.8%)   NRAS 12 p.G12D 4 (0.9%)   12 p.G12S 2 (0.4%)   18 p.A18T 1 (0.2%)   61 p.Q61L 4 (0.9%)   61 p.Q61R 2 (0.4%)   Total cases with HRAS mutation   1 (0.2%)   HRAS 12 p.G12D 1 (0.2%)   Total cases with BRAF mutation   26 (5.6%)   BRAF 600 V600E 26 (5.6%)   "}], "citations": {"NLM": "Liu J, Zeng W, Huang C, Wang J, Yang D, Ma D. Predictive and Prognostic Implications of Mutation Profiling and Microsatellite Instability Status in Patients with Metastatic Colorectal Carcinoma. Gastroenterol Res Pract. PMID: 29643917", "BibTeX": "@article{29643917, title={Predictive and Prognostic Implications of Mutation Profiling and Microsatellite Instability Status in Patients with Metastatic Colorectal Carcinoma.}, author={Liu J and Zeng W and Huang C and Wang J and Yang D and Ma D}, journal={Gastroenterol Res Pract}}"}, "is_sup_mat_match": false}, {"pmid": 33785863, "pmcid": "PMC8102188", "title": "Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia.", "journal": "Leukemia", "authors": ["Lundgren S", "Ker\u00e4nen MAI", "Kankainen M", "Huuhtanen J", "Walldin G", "Kerr CM", "Clemente M", "Ebeling F", "Rajala H", "Br\u00fcck O", "L\u00e4hdesm\u00e4ki H", "Hannula S", "Hannunen T", "Ellonen P", "Young NS", "Ogawa S", "Maciejewski JP", "Hellstr\u00f6m-Lindberg E", "Mustjoki S"], "date": "2021-05-01T00:00:00Z", "year": 2021, "snippets": [{"_id": "33785863@25603", "snip_text": "KRAS A146P, JAGN1 T473A, and TNFAIP3 D212fs mutations were predicted to be pathogenic, and same KRAS mutation has been found in several hematologic neoplasms (genomic mutation ID in COSMIC v91: COSV55541748).", "section": "results", "mentions": ["29|7|gene|ncbi_gene@7128|TNFAIP3", "37|6|variant|litvar@#7128#p.D212fsX&&&litvar@#7128#|D212fs", "182|6|cellline||COSMIC", "96|4|gene|ncbi_gene@3845|KRAS", "12|5|gene|ncbi_gene@84522|JAGN1", "0|4|gene|ncbi_gene@3845|KRAS", "18|5|variant|litvar@#84522#c.473T>A&&&litvar@#84522#|T473A", "136|21|disease|ncbi_mesh@D019337|hematologic neoplasms", "5|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P"], "text_hl": "KRAS A146P, JAGN1 T473A, and TNFAIP3 D212fs mutations were predicted to be pathogenic, and same KRAS mutation has been found in several hematologic neoplasms (genomic mutation ID in COSMIC v91: COSV55541748)."}], "citations": {"NLM": "Lundgren S, Ker\u00e4nen MAI, Kankainen M, Huuhtanen J, Walldin G, Kerr CM, Clemente M, Ebeling F, Rajala H, Br\u00fcck O, L\u00e4hdesm\u00e4ki H, Hannula S, Hannunen T, Ellonen P, Young NS, Ogawa S, Maciejewski JP, Hellstr\u00f6m-Lindberg E, Mustjoki S. Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia. Leukemia. PMID: 33785863", "BibTeX": "@article{33785863, title={Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia.}, author={Lundgren S and Ker\u00e4nen MAI and Kankainen M and Huuhtanen J and Walldin G and Kerr CM and Clemente M and Ebeling F and Rajala H and Br\u00fcck O and L\u00e4hdesm\u00e4ki H and Hannula S and Hannunen T and Ellonen P and Young NS and Ogawa S and Maciejewski JP and Hellstr\u00f6m-Lindberg E and Mustjoki S}, journal={Leukemia}}"}, "is_sup_mat_match": false}, {"pmid": 36005935, "pmcid": "PMC9413567", "title": "Colon Cancer Pharmacogenetics: A Narrative Review.", "journal": "Pharmacy (Basel)", "authors": ["Alfaro Alfaro \u00c1E", "Murillo Castillo B", "Cordero Garc\u00eda E", "Tasc\u00f3n J", "Morales AI"], "date": "2022-08-05T00:00:00Z", "year": 2022, "snippets": [{"_id": "36005935@15123", "snip_text": "They are substantially found in codons 12 and 13 of exon 2 (80% are G12D, G12V, G12C, G12A, and G13D) and are consistently lower in codon 61 of exon 3 (5% are Q61H, Q61L, and Q61R) and codon 146 of exon 4 (2% are A146T and A146V).", "section": "other", "mentions": ["213|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "175|4|variant|litvar@rs121913233##&&&litvar@#3265#&&&litvar@CA173968#rs121913233##|Q61R", "159|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "223|5|variant|litvar@rs121917759##&&&litvar@#3265#&&&litvar@CA256494#rs121917759##|A146V", "165|4|variant|litvar@rs121913233##&&&litvar@#3265#&&&litvar@CA16602500#rs121913233##|Q61L", "74|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "96|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "80|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "68|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "86|4|variant|litvar@rs771447288##&&&litvar@#3265#&&&litvar@CA5779330#rs771447288##|G12A"], "text_hl": "They are substantially found in codons 12 and 13 of exon 2 (80% are G12D, G12V, G12C, G12A, and G13D) and are consistently lower in codon 61 of exon 3 (5% are Q61H, Q61L, and Q61R) and codon 146 of exon 4 (2% are <m>A146T</m> and A146V)."}], "citations": {"NLM": "Alfaro Alfaro \u00c1E, Murillo Castillo B, Cordero Garc\u00eda E, Tasc\u00f3n J, Morales AI. Colon Cancer Pharmacogenetics: A Narrative Review. Pharmacy (Basel). PMID: 36005935", "BibTeX": "@article{36005935, title={Colon Cancer Pharmacogenetics: A Narrative Review.}, author={Alfaro Alfaro \u00c1E and Murillo Castillo B and Cordero Garc\u00eda E and Tasc\u00f3n J and Morales AI}, journal={Pharmacy (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 31941061, "pmcid": "PMC7016562", "title": "Molecular Classification of Gastric Cancer among Alaska Native People", "journal": "Cancers (Basel)", "authors": ["Martinson HA", "Mallari D", "Richter C", "Wu TT", "Tiesinga J", "Alberts SR", "Olnes MJ"], "date": "2020-01-13T00:00:00Z", "year": 2020, "snippets": [{"_id": "31941061@42681", "snip_text": "Gene\tTotal Number of Samples n\t82\t295\t \tFunction\tAlaska Native n (%)\tTCGA Nature 2014 n (%)\t \tTP53\t\t\t\t \tR282W\tMissense\t3 (3.7)\t5 (1.7)\t \tR267W\tMissense\t2 (2.4)\t0 (0)\t \tG245S\tMissense\t2 (2.4)\t2 (0.7)\t \tH193R\tMissense\t1 (1.2)\t2 (0.7)\t \tR273H\tMissense\t1 (1.2)\t10 (3.4)\t \tR196*\tNonsense\t1 (1.2)\t3 (1.0)\t \tPIK3CA\t\t\t\t \tE545K\tMissense\t7 (8.5)\t12 (4.1)\t \tH1047R\tMissense\t3 (3.7)\t13 (4.4)\t \tK111N\tMissense\t1 (1.2)\t2 (0.7)\t \tR88Q\tMissense\t1 (1.2)\t4 (1.4)\t \tPTEN\t\t\t\t \tS10N\tMissense\t1 (1.2)\t0 (0)\t \tR130Q\tMissense\t1 (1.2)\t1 (0.3)\t \t1026+2delT\tIF deletion\t1 (1.2)\t0 (0)\t \tQ214*\tTruncating\t1 (1.2)\t0 (0)\t \tKRAS\t\t\t\t \tG12D/A\tMissense\t2 (2.4)\t12 (4.1)\t \tG13D\tMissense\t1 (1.2)\t10 (3.4)\t \tA146T\tMissense\t1 (1.2)\t2 (0.7)\t \tSTK11\t\t\t\t \tF354L\tMissense\t6 (7.3)\t0 (0)\t \tCTNNB1\t\t\t\t \tS37F\tMissense\t2 (2.4)\t2 (0.7)\t \tD32N\tMissense\t1 (1.2)\t1 (0.3)\t \tG34R\tMissense\t1 (1.2)\t2 (0.7)\t \t", "section": "table", "mentions": ["457|4|variant|litvar@rs149636614##&&&litvar@#472#&&&litvar@CA286708#rs149636614##|S10N", "201|5|variant|litvar@rs786201838##&&&litvar@#7157#&&&litvar@CA274#rs786201838##|H193R", "137|5|variant|litvar@rs55832599##&&&litvar@#7157#&&&litvar@CA423#rs55832599##|R267W", "670|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "168|5|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|G245S", "714|5|variant|litvar@rs59912467##&&&litvar@#6794#&&&litvar@CA22247#rs59912467##|F354L", "637|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "234|5|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|R273H", "382|5|variant|litvar@rs1057519934##&&&litvar@#5290#|K111N", "703|5|gene|ncbi_gene@6794|STK11", "487|5|variant|litvar@rs121909229##&&&litvar@#5728#&&&litvar@CA437#rs121909229##|R130Q", "94|4|gene|ncbi_gene@7157|TP53", "415|4|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|R88Q", "104|5|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|R282W", "313|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "520|10|variant|litvar@#3845#c.1026+2delT&&&litvar@#3845#|1026+2delT", "757|4|variant|litvar@rs121913403##&&&litvar@#1499#&&&litvar@CA127279#rs121913403##|S37F", "821|4|variant|litvar@rs121913399##&&&litvar@#1499#&&&litvar@CA16602685#rs121913399##|G34R", "347|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "789|4|variant|litvar@rs28931588##&&&litvar@#1499#&&&litvar@CA16602681#rs28931588##|D32N", "447|4|gene|ncbi_gene@5728|PTEN", "592|4|gene|ncbi_gene@3845|KRAS", "301|6|gene|ncbi_gene@5290|PIK3CA", "745|6|gene|ncbi_gene@1499|CTNNB1", "602|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12D/A"], "figure_id": "cancers-12-00198-t003", "text_hl": "Gene\tTotal Number of Samples n\t82\t295\t \tFunction\tAlaska Native n (%)\tTCGA Nature 2014 n (%)\t \tTP53\t\t\t\t \tR282W\tMissense\t3 (3.7)\t5 (1.7)\t \tR267W\tMissense\t2 (2.4)\t0 (0)\t \tG245S\tMissense\t2 (2.4)\t2 (0.7)\t \tH193R\tMissense\t1 (1.2)\t2 (0.7)\t \tR273H\tMissense\t1 (1.2)\t10 (3.4)\t \tR196*\tNonsense\t1 (1.2)\t3 (1.0)\t \tPIK3CA\t\t\t\t \tE545K\tMissense\t7 (8.5)\t12 (4.1)\t \tH1047R\tMissense\t3 (3.7)\t13 (4.4)\t \tK111N\tMissense\t1 (1.2)\t2 (0.7)\t \tR88Q\tMissense\t1 (1.2)\t4 (1.4)\t \tPTEN\t\t\t\t \tS10N\tMissense\t1 (1.2)\t0 (0)\t \tR130Q\tMissense\t1 (1.2)\t1 (0.3)\t \t1026+2delT\tIF deletion\t1 (1.2)\t0 (0)\t \tQ214*\tTruncating\t1 (1.2)\t0 (0)\t \tKRAS\t\t\t\t \tG12D/A\tMissense\t2 (2.4)\t12 (4.1)\t \tG13D\tMissense\t1 (1.2)\t10 (3.4)\t \t<m>A146T</m>\tMissense\t1 (1.2)\t2 (0.7)\t \tSTK11\t\t\t\t \tF354L\tMissense\t6 (7.3)\t0 (0)\t \tCTNNB1\t\t\t\t \tS37F\tMissense\t2 (2.4)\t2 (0.7)\t \tD32N\tMissense\t1 (1.2)\t1 (0.3)\t \tG34R\tMissense\t1 (1.2)\t2 (0.7)\t \t"}], "citations": {"NLM": "Martinson HA, Mallari D, Richter C, Wu TT, Tiesinga J, Alberts SR, Olnes MJ. Molecular Classification of Gastric Cancer among Alaska Native People Cancers (Basel). PMID: 31941061", "BibTeX": "@article{31941061, title={Molecular Classification of Gastric Cancer among Alaska Native People}, author={Martinson HA and Mallari D and Richter C and Wu TT and Tiesinga J and Alberts SR and Olnes MJ}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 32522977, "pmcid": "PMC7286916", "title": "Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma", "journal": "Oncogenesis", "authors": ["Weidner P", "S\u00f6hn M", "Schroeder T", "Helm L", "Hauber V", "Gutting T", "Betge J", "R\u00f6cken C", "Rohrbacher FN", "Pattabiraman VR", "Bode JW", "Seger R", "Saar D", "Nunes-Alves A", "Wade RC", "Ebert MPA", "Burgermeister E"], "date": "2020-06-10T00:00:00Z", "year": 2020, "snippets": [{"_id": "32522977@17447", "snip_text": "This effect was more pronounced in the PDO lines with the activating KRAS mutations of codon 12 or 13 as compared with KRAS WT PDO lines or the line with the A146T mutation (p = 0.016 high vs.", "section": "results", "mentions": ["119|4|gene|ncbi_gene@3845|KRAS", "158|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "69|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "This effect was more pronounced in the PDO lines with the activating KRAS mutations of codon 12 or 13 as compared with KRAS WT PDO lines or the line with the <m>A146T</m> mutation (p = 0.016 high vs."}], "citations": {"NLM": "Weidner P, S\u00f6hn M, Schroeder T, Helm L, Hauber V, Gutting T, Betge J, R\u00f6cken C, Rohrbacher FN, Pattabiraman VR, Bode JW, Seger R, Saar D, Nunes-Alves A, Wade RC, Ebert MPA, Burgermeister E. Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma Oncogenesis. PMID: 32522977", "BibTeX": "@article{32522977, title={Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma}, author={Weidner P and S\u00f6hn M and Schroeder T and Helm L and Hauber V and Gutting T and Betge J and R\u00f6cken C and Rohrbacher FN and Pattabiraman VR and Bode JW and Seger R and Saar D and Nunes-Alves A and Wade RC and Ebert MPA and Burgermeister E}, journal={Oncogenesis}}"}, "is_sup_mat_match": false}, {"pmid": 35764878, "pmcid": "PMC9437031", "title": "A novel HRAS c.466C>T p.(Phe156Leu) variant in two patients with attenuated features of Costello syndrome.", "journal": "Eur J Hum Genet", "authors": ["Lindsey-Temple S", "Edwards M", "Rickassel V", "Nauth T", "Rosenberger G"], "date": "2022-06-29T00:00:00Z", "year": 2022, "snippets": [{"_id": "35764878@1880", "snip_text": "A more variable, milder or \"attenuated\" phenotype occurs with rarer pathogenic HRAS variants, such as p.Thr58Ile, p.Gly60Asp/Val or p.Ala146Thr/Val/Pro.", "section": "introduction", "mentions": ["79|4|gene|ncbi_gene@3265|HRAS", "114|10|variant|litvar@rs730880460##&&&litvar@#3265#&&&litvar@CA296057#rs730880460##|p.Gly60Asp", "132|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "102|10|variant|litvar@rs121917758##&&&litvar@#3265#&&&litvar@CA341206#rs121917758##|p.Thr58Ile", "144|7|variant|litvar@#3265#|Val/Pro"], "text_hl": "A more variable, milder or \"attenuated\" phenotype occurs with rarer pathogenic HRAS variants, such as p.Thr58Ile, p.Gly60Asp/Val or <m>p.Ala146Thr</m>/Val/Pro."}], "citations": {"NLM": "Lindsey-Temple S, Edwards M, Rickassel V, Nauth T, Rosenberger G. A novel HRAS c.466C>T p.(Phe156Leu) variant in two patients with attenuated features of Costello syndrome. Eur J Hum Genet. PMID: 35764878", "BibTeX": "@article{35764878, title={A novel HRAS c.466C>T p.(Phe156Leu) variant in two patients with attenuated features of Costello syndrome.}, author={Lindsey-Temple S and Edwards M and Rickassel V and Nauth T and Rosenberger G}, journal={Eur J Hum Genet}}"}, "is_sup_mat_match": false}, {"pmid": 24039993, "pmcid": "PMC3767798", "title": "Keratin23 (KRT23) knockdown decreases proliferation and affects the DNA damage response of colon cancer cells.", "journal": "PLoS One", "authors": ["Birkenkamp-Demtr\u00f6der K", "Hahn SA", "Mansilla F", "Thorsen K", "Maghnouj A", "Christensen R", "\u00d8ster B", "\u00d8rntoft TF"], "date": "2013-09-09T00:00:00Z", "year": 2013, "snippets": [{"_id": "24039993@8478", "snip_text": "Colon cancer cell lines in this study were HCT116 (MSI), DLD1 (MSI), SW480 (MSS, p53 mutated), SW948 (MSS, Dukes' type C, grade III, tumorigenic, p53 mutated), LS1034 (MSS, Dukes C, mutations in p53 (G245S), APC (E1309fs*4) and KRAS (A146T).", "section": "methods", "mentions": ["43|6|cellline||HCT116", "81|3|gene|ncbi_gene@7157|p53", "146|3|gene|ncbi_gene@7157|p53", "228|4|gene|ncbi_gene@3845|KRAS", "213|7|variant|litvar@rs121913224##&&&litvar@#324#|E1309fs", "234|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "95|5|cellline||SW948", "57|4|cellline||DLD1", "208|3|gene|ncbi_gene@324|APC", "69|5|cellline||SW480", "200|5|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|G245S", "160|6|cellline||LS1034", "195|3|gene|ncbi_gene@7157|p53", "0|12|disease|ncbi_mesh@D015179|Colon cancer"], "text_hl": "Colon cancer cell lines in this study were HCT116 (MSI), DLD1 (MSI), SW480 (MSS, p53 mutated), SW948 (MSS, Dukes' type C, grade III, tumorigenic, p53 mutated), LS1034 (MSS, Dukes C, mutations in p53 (G245S), APC (E1309fs*4) and KRAS (<m>A146T</m>)."}], "citations": {"NLM": "Birkenkamp-Demtr\u00f6der K, Hahn SA, Mansilla F, Thorsen K, Maghnouj A, Christensen R, \u00d8ster B, \u00d8rntoft TF. Keratin23 (KRT23) knockdown decreases proliferation and affects the DNA damage response of colon cancer cells. PLoS One. PMID: 24039993", "BibTeX": "@article{24039993, title={Keratin23 (KRT23) knockdown decreases proliferation and affects the DNA damage response of colon cancer cells.}, author={Birkenkamp-Demtr\u00f6der K and Hahn SA and Mansilla F and Thorsen K and Maghnouj A and Christensen R and \u00d8ster B and \u00d8rntoft TF}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 24669769, "pmcid": "PMC4024121", "title": "A graph theoretic approach to utilizing protein structure to identify non-random somatic mutations.", "journal": "BMC Bioinformatics", "authors": ["Ryslik GA", "Cheng Y", "Cheung KH", "Modis Y", "Zhao H"], "date": "2014-03-26T00:00:00Z", "year": 2014, "snippets": [{"_id": "24669769@40751", "snip_text": "Specifically, residue 61 mutations are typically found in colorectal and lung cancer  while mutations K117N and A146T are found in colorectal cancer .", "section": "discussion", "mentions": ["131|17|disease|ncbi_mesh@D015179|colorectal cancer", "58|26|disease|ncbi_mesh@D015179|colorectal and lung cancer", "102|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "112|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Specifically, residue 61 mutations are typically found in colorectal and lung cancer  while mutations K117N and <m>A146T</m> are found in colorectal cancer ."}], "citations": {"NLM": "Ryslik GA, Cheng Y, Cheung KH, Modis Y, Zhao H. A graph theoretic approach to utilizing protein structure to identify non-random somatic mutations. BMC Bioinformatics. PMID: 24669769", "BibTeX": "@article{24669769, title={A graph theoretic approach to utilizing protein structure to identify non-random somatic mutations.}, author={Ryslik GA and Cheng Y and Cheung KH and Modis Y and Zhao H}, journal={BMC Bioinformatics}}"}, "is_sup_mat_match": false}, {"pmid": 37578492, "pmcid": "PMC10651289", "title": "Development and validation of a mutation-annotated prognostic score for intrahepatic cholangiocarcinoma after resection: a retrospective cohort study", "journal": "Int J Surg", "authors": ["Wang XY", "Zhu WW", "Lu L", "Li YT", "Zhu Y", "Yang LY", "Sun HT", "Wang CQ", "Lin J", "Huang C", "Yang X", "Fan J", "Jia HL", "Zhang JB", "Yin BB", "Chen JH", "Qin LX"], "date": "2023-11-01T00:00:00Z", "year": 2023, "snippets": [{"_id": "37578492@21622", "snip_text": "We found that all mutation subtypes of TP53 were associated with a poorer OS of ICCs (Fig. 2B), whereas only KRAS G12 mutations (G12V/D/S/C/A), but not KRAS non-G12 mutations (Q61R/L/K/H; G13D/C; A146T), were predictive of a shorter OS (Fig. 2C).", "section": "results", "mentions": ["176|6|variant|litvar@rs121913240##&&&litvar@#3845#|Q61R/L", "114|3|variant|litvar@rs121913529##&&&litvar@#3845#|G12", "39|4|gene|ncbi_gene@7157|TP53", "109|4|gene|ncbi_gene@3845|KRAS", "80|4|disease||ICCs", "161|3|variant|litvar@rs121913529##&&&litvar@#3845#|G12", "188|6|variant|litvar@rs112445441##&&&litvar@#3845#|G13D/C", "129|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "152|4|gene|ncbi_gene@3845|KRAS", "196|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "We found that all mutation subtypes of TP53 were associated with a poorer OS of ICCs (Fig. 2B), whereas only KRAS G12 mutations (G12V/D/S/C/A), but not KRAS non-G12 mutations (Q61R/L/K/H; G13D/C; <m>A146T</m>), were predictive of a shorter OS (Fig. 2C)."}], "citations": {"NLM": "Wang XY, Zhu WW, Lu L, Li YT, Zhu Y, Yang LY, Sun HT, Wang CQ, Lin J, Huang C, Yang X, Fan J, Jia HL, Zhang JB, Yin BB, Chen JH, Qin LX. Development and validation of a mutation-annotated prognostic score for intrahepatic cholangiocarcinoma after resection: a retrospective cohort study Int J Surg. PMID: 37578492", "BibTeX": "@article{37578492, title={Development and validation of a mutation-annotated prognostic score for intrahepatic cholangiocarcinoma after resection: a retrospective cohort study}, author={Wang XY and Zhu WW and Lu L and Li YT and Zhu Y and Yang LY and Sun HT and Wang CQ and Lin J and Huang C and Yang X and Fan J and Jia HL and Zhang JB and Yin BB and Chen JH and Qin LX}, journal={Int J Surg}}"}, "is_sup_mat_match": false}, {"pmid": 29872864, "pmcid": "PMC6224316", "title": "Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors.", "journal": "JAMA Oncol", "authors": ["Ptashkin RN", "Mandelker DL", "Coombs CC", "Bolton K", "Yelskaya Z", "Hyman DM", "Solit DB", "Baselga J", "Arcila ME", "Ladanyi M", "Zhang L", "Levine RL", "Berger MF", "Zehir A"], "date": "2018-11-01T00:00:00Z", "year": 2018, "snippets": [{"_id": "29872864@14398", "snip_text": "Sex/Age at Blood Sampling, y Gene Amino Acid Change VAF Cancer Type Highest OncoKB Levela   Blood Tumor   M/84 BRCA2 Q3156* 0.344 0.118 Melanoma 2B   M/74 IDH2 R140Q 0.405 0.082 Pancreatic 2B   F/72 IDH2 R140Q 0.298 0.063 NSCLC 2B   M/68 IDH2 R140Q 0.162 0.048 NSCLC 2B   M/76 IDH2 R140Q 0.270 0.039 NSCLC 2B   F/59 BRCA1 E1836Q 0.332 0.036 Endometrial 2B   F/74 NRAS G12R 0.442 0.119 NSCLC 3B   F/80 NRAS G12V 0.081 0.037 Uterine sarcoma 3B   F/83 IDH1 R132H 0.077 0.033 Melanoma 3B   F/70 IDH1 R132C 0.048 0.022 Melanoma 3B   M/43 PTEN D24G 0.348 0.174 Colorectal 4   F/50 NF1 R2616* 0.237 0.095 Breast carcinoma 4   M/68 KRAS G60D 0.297 0.094 Prostate 4   M/55 NF1 X1554_splice 0.105 0.049 Melanoma 4   M/79 NF1 F256Lfs* 0.141 0.043 Prostate 4   M/78 KRAS A146P 0.132 0.035 Skin cancer, nonmelanoma 4   F/77 KRAS G12R 0.087 0.041 Colorectal R1   ", "section": "table", "mentions": ["160|5|variant|litvar@rs121913502##&&&litvar@#3418#&&&litvar@CA124277#rs121913502##|R140Q", "472|8|disease|ncbi_mesh@D008545|Melanoma", "811|4|gene|ncbi_gene@3845|KRAS", "56|6|disease|ncbi_mesh@D009369|Cancer", "423|15|disease|ncbi_mesh@D012509|Uterine sarcoma", "322|6|variant|litvar@#672#p.E1836Q&&&litvar@#672#|E1836Q", "243|5|variant|litvar@rs121913502##&&&litvar@#3418#&&&litvar@CA124277#rs121913502##|R140Q", "575|3|gene|ncbi_gene@4763|NF1", "454|5|variant|litvar@rs121913500##&&&litvar@#3417#&&&litvar@CA170874#rs121913500##|R132H", "782|6|disease|ncbi_mesh@D009369|cancer", "816|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "496|5|variant|litvar@rs121913499##&&&litvar@#3417#&&&litvar@CA16602374#rs121913499##|R132C", "514|8|disease|ncbi_mesh@D008545|Melanoma", "155|4|gene|ncbi_gene@3418|IDH2", "693|8|disease|ncbi_mesh@D008545|Melanoma", "178|13|disease|ncbi_mesh@D010195|Pancreatic 2B", "238|4|gene|ncbi_gene@3418|IDH2", "449|4|gene|ncbi_gene@3417|IDH1", "624|4|gene|ncbi_gene@3845|KRAS", "111|5|gene|ncbi_gene@675|BRCA2", "491|4|gene|ncbi_gene@3417|IDH1", "98|5|disease|ncbi_mesh@D009369|Tumor", "555|10|disease|ncbi_mesh@D015179|Colorectal", "341|11|disease|ncbi_mesh@D014591|Endometrial", "664|3|gene|ncbi_gene@4763|NF1", "736|8|disease|ncbi_mesh@D011472|Prostate", "222|8|disease|ncbi_mesh@C536043|NSCLC 2B", "759|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "282|5|variant|litvar@rs121913502##&&&litvar@#3418#&&&litvar@CA124277#rs121913502##|R140Q", "363|4|gene|ncbi_gene@4893|NRAS", "629|4|variant|litvar@rs868324434##&&&litvar@#3418#&&&litvar@CA274623691#rs868324434##|G60D", "204|5|variant|litvar@rs121913502##&&&litvar@#3418#&&&litvar@CA124277#rs121913502##|R140Q", "300|8|disease|ncbi_mesh@C536043|NSCLC 2B", "533|4|gene|ncbi_gene@5728|PTEN", "711|3|gene|ncbi_gene@4763|NF1", "754|4|gene|ncbi_gene@3845|KRAS", "538|4|variant|litvar@rs797044910##&&&litvar@#5728#&&&litvar@CA204760#rs797044910##|D24G", "368|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "136|11|disease|ncbi_mesh@D008545|Melanoma 2B", "598|16|disease|ncbi_mesh@D001943|Breast carcinoma", "277|4|gene|ncbi_gene@3418|IDH2", "406|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "199|4|gene|ncbi_gene@3418|IDH2", "401|4|gene|ncbi_gene@4893|NRAS", "316|5|gene|ncbi_gene@672|BRCA1", "646|8|disease|ncbi_mesh@D011472|Prostate", "833|10|disease|ncbi_mesh@D015179|Colorectal", "261|8|disease|ncbi_mesh@C536043|NSCLC 2B", "385|5|disease||NSCLC"], "figure_id": "T1", "text_hl": "Sex/Age at Blood Sampling, y Gene Amino Acid Change VAF Cancer Type Highest OncoKB Levela   Blood Tumor   M/84 BRCA2 Q3156* 0.344 0.118 Melanoma 2B   M/74 IDH2 R140Q 0.405 0.082 Pancreatic 2B   F/72 IDH2 R140Q 0.298 0.063 NSCLC 2B   M/68 IDH2 R140Q 0.162 0.048 NSCLC 2B   M/76 IDH2 R140Q 0.270 0.039 NSCLC 2B   F/59 BRCA1 E1836Q 0.332 0.036 Endometrial 2B   F/74 NRAS G12R 0.442 0.119 NSCLC 3B   F/80 NRAS G12V 0.081 0.037 Uterine sarcoma 3B   F/83 IDH1 R132H 0.077 0.033 Melanoma 3B   F/70 IDH1 R132C 0.048 0.022 Melanoma 3B   M/43 PTEN D24G 0.348 0.174 Colorectal 4   F/50 NF1 R2616* 0.237 0.095 Breast carcinoma 4   M/68 KRAS G60D 0.297 0.094 Prostate 4   M/55 NF1 X1554_splice 0.105 0.049 Melanoma 4   M/79 NF1 F256Lfs* 0.141 0.043 Prostate 4   M/78 KRAS A146P 0.132 0.035 Skin cancer, nonmelanoma 4   F/77 KRAS G12R 0.087 0.041 Colorectal R1   "}], "citations": {"NLM": "Ptashkin RN, Mandelker DL, Coombs CC, Bolton K, Yelskaya Z, Hyman DM, Solit DB, Baselga J, Arcila ME, Ladanyi M, Zhang L, Levine RL, Berger MF, Zehir A. Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors. JAMA Oncol. PMID: 29872864", "BibTeX": "@article{29872864, title={Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors.}, author={Ptashkin RN and Mandelker DL and Coombs CC and Bolton K and Yelskaya Z and Hyman DM and Solit DB and Baselga J and Arcila ME and Ladanyi M and Zhang L and Levine RL and Berger MF and Zehir A}, journal={JAMA Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 37508780, "pmcid": "PMC10376905", "title": "Extreme Gradient Boosting Tuned with Metaheuristic Algorithms for Predicting Myeloid NGS Onco-Somatic Variant Pathogenicity", "journal": "Bioengineering (Basel)", "authors": ["Pellegrino E", "Camilla C", "Abbou N", "Beaufils N", "Pissier C", "Gabert J", "Nanni-Metellus I", "Ouafik L"], "date": "2023-06-23T00:00:00Z", "year": 2023, "snippets": [{"_id": "37508780@102122", "snip_text": "Genes\tAmino Acid\tCoding\tXGBoost DE\tMLRF\t \tKRAS\tp.Gly12Cys\tc.34G>T\tPathogenic\tNO\t \tKRAS\tp.Gln61Lys\tc.180_181delinsCA\tPathogenic\tYES\t \tKRAS\tp.Ala146Pro\tc.436G>C\tPathogenic\tYES\t \tBRAF\tp.Val600Glu\tc.1799T>A\tLikely pathogenic\tYES\t \tBRAF\tp.Asp594Asn\tc.1780G>A\tLikely pathogenic\tYES\t \tBRAF\tp.Gly469Val\tc.1406G>T\tLikely pathogenic\tYES\t \tEGFR\tp.Glu709Lys\tc.2125G>A\tLikely pathogenic\tYES\t \tEGFR\tp.Thr790Met\tc.2369C>T\tLikely benign\tYES\t \tEGFR\tp.Leu747_Ala750delinsPro\tc.2239_2248delinsC\tPathogenic\tYES\t \tPIK3CA\tp.His1047Arg\tc.3140A>G\tPathogenic\tYES\t \tEGFR\tp.Thr725Met\tc.2174C>T\tLikely benign\tYES\t \t", "section": "table", "mentions": ["87|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Gln61Lys", "540|4|gene|ncbi_gene@1956|EGFR", "385|11|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|p.Thr790Met", "329|4|gene|ncbi_gene@1956|EGFR", "47|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.Gly12Cys", "232|11|variant|litvar@#1956#p.D594N&&&litvar@#1956#|p.Asp594Asn", "42|4|gene|ncbi_gene@3845|KRAS", "380|4|gene|ncbi_gene@1956|EGFR", "138|11|variant|litvar@rs121913527##&&&litvar@#3845#|p.Ala146Pro", "283|11|variant|litvar@#1956#p.G469V&&&litvar@#1956#|p.Gly469Val", "500|12|variant|litvar@#1956#p.H1047R&&&litvar@#1956#|p.His1047Arg", "545|11|variant|litvar@rs767505234##&&&litvar@#1956#&&&litvar@CA4265987#rs767505234##|p.Thr725Met", "427|4|gene|ncbi_gene@1956|EGFR", "82|4|gene|ncbi_gene@3845|KRAS", "432|24|variant|litvar@rs121913229##&&&litvar@#1956#|p.Leu747_Ala750delinsPro", "133|4|gene|ncbi_gene@3845|KRAS", "334|11|variant|litvar@rs727504256##&&&litvar@#1956#&&&litvar@CA180563#rs727504256##|p.Glu709Lys", "181|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.Val600Glu"], "figure_id": "bioengineering-10-00753-t010", "text_hl": "Genes\tAmino Acid\tCoding\tXGBoost DE\tMLRF\t \tKRAS\tp.Gly12Cys\tc.34G>T\tPathogenic\tNO\t \tKRAS\tp.Gln61Lys\tc.180_181delinsCA\tPathogenic\tYES\t \tKRAS\tp.Ala146Pro\tc.436G>C\tPathogenic\tYES\t \tBRAF\tp.Val600Glu\tc.1799T>A\tLikely pathogenic\tYES\t \tBRAF\tp.Asp594Asn\tc.1780G>A\tLikely pathogenic\tYES\t \tBRAF\tp.Gly469Val\tc.1406G>T\tLikely pathogenic\tYES\t \tEGFR\tp.Glu709Lys\tc.2125G>A\tLikely pathogenic\tYES\t \tEGFR\tp.Thr790Met\tc.2369C>T\tLikely benign\tYES\t \tEGFR\tp.Leu747_Ala750delinsPro\tc.2239_2248delinsC\tPathogenic\tYES\t \tPIK3CA\tp.His1047Arg\tc.3140A>G\tPathogenic\tYES\t \tEGFR\tp.Thr725Met\tc.2174C>T\tLikely benign\tYES\t \t"}], "citations": {"NLM": "Pellegrino E, Camilla C, Abbou N, Beaufils N, Pissier C, Gabert J, Nanni-Metellus I, Ouafik L. Extreme Gradient Boosting Tuned with Metaheuristic Algorithms for Predicting Myeloid NGS Onco-Somatic Variant Pathogenicity Bioengineering (Basel). PMID: 37508780", "BibTeX": "@article{37508780, title={Extreme Gradient Boosting Tuned with Metaheuristic Algorithms for Predicting Myeloid NGS Onco-Somatic Variant Pathogenicity}, author={Pellegrino E and Camilla C and Abbou N and Beaufils N and Pissier C and Gabert J and Nanni-Metellus I and Ouafik L}, journal={Bioengineering (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 29844874, "pmcid": "PMC5963609", "title": "Combined assessment of the TNM stage and BRAF mutational status at diagnosis in sporadic colorectal cancer patients.", "journal": "Oncotarget", "authors": ["Sayagu\u00e9s JM", "Del Carmen S", "Del Mar Abad M", "Corchete LA", "Bengoechea O", "Anduaga MF", "Balde\u00f3n MJ", "Cruz JJ", "Alcazar JA", "Angoso M", "Gonz\u00e1lez M", "Garc\u00eda J", "Mu\u00f1oz-Bellvis L", "Orfao A", "Sarasquete ME"], "date": "2018-05-08T00:00:00Z", "year": 2018, "snippets": [{"_id": "29844874@11351", "snip_text": "Gene status N. of cases (%) Exon location Mutation (N. of cases)   KRAS       Wild type 63 (72%)      Mutated 24 (28%)       Exon 2 G12D(7), G12V(5), G12A(4), G12S(1), G13D(2)     Exon 3 Q61H(1), Q61L(1)     Exon 4 A146P(1), A146T(1), K147E(1)   NRAS       Wild type 86 (99%)      Mutated 1 (1%)       Exon 3 Q61K(1)   BRAF       Wild type 81 (93%)      Mutated 6 (7%)       Exon 15 V600E (6)   TP53       Wild type 58 (66%)      Mutated 29 (33%)       Exon 4 L111R (1), G112del (1)     Exon 5 C135F (1), P152AfsTer14 (1), R156H (1), R158C (1), V173L (1), R175H (3), H178PfsTer47 (1), c.376-2A>G splice (1)     Exon 6 Q192* (1), R196* (1), L201GfsTer47 (1), S215R (1).     Exon 7 R248W (2), R248Q (1), C275Y (1), N247I (1), T253PfsTer92 (1)     Exon 8 R282W (3), R273C (1), C277VfsTer68 (1), V272M (1)     Exon 10 S366A (1)   ", "section": "table", "mentions": ["168|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "523|5|variant|litvar@rs371524413##&&&litvar@#7157#&&&litvar@CA216#rs371524413##|R156H", "585|10|variant|litvar@rs786202799##&&&litvar@#7157#&&&litvar@CA146#rs786202799##|c.376-2A>G", "67|4|gene|ncbi_gene@3845|KRAS", "702|5|variant|litvar@rs863224451##&&&litvar@#7157#&&&litvar@CA337141#rs863224451##|C275Y", "141|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "246|4|gene|ncbi_gene@4893|NRAS", "471|7|variant|litvar@#7157#c.112delG&&&litvar@#7157#|G112del", "150|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "159|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "225|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "196|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "187|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "132|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "235|5|variant|litvar@rs387907206##&&&litvar@#3845#&&&litvar@CA279985#rs387907206##|K147E", "680|5|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|R248W", "763|5|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|R273C", "556|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H", "460|5|variant|litvar@rs1057519997##&&&litvar@#7157#|L111R", "713|5|variant|litvar@rs786201762##&&&litvar@#7157#&&&litvar@CA378#rs786201762##|N247I", "534|5|variant|litvar@rs770374782##&&&litvar@#7157#&&&litvar@CA1448#rs770374782##|R158C", "658|5|variant|litvar@rs1057520001##&&&litvar@#7157#|S215R", "395|4|gene|ncbi_gene@7157|TP53", "814|5|variant|litvar@rs17881470##&&&litvar@#7157#&&&litvar@CA36#rs17881470##|S366A", "383|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "792|5|variant|litvar@rs121912657##&&&litvar@#7157#&&&litvar@CA427#rs121912657##|V272M", "691|5|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|R248Q", "309|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "494|5|variant|litvar@rs587781991##&&&litvar@#7157#|C135F", "545|5|variant|litvar@rs876660754##&&&litvar@#7157#|V173L", "215|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "752|5|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|R282W", "319|4|gene|ncbi_gene@673|BRAF"], "figure_id": "T3", "text_hl": "Gene status N. of cases (%) Exon location Mutation (N. of cases)   KRAS       Wild type 63 (72%)      Mutated 24 (28%)       Exon 2 G12D(7), G12V(5), G12A(4), G12S(1), G13D(2)     Exon 3 Q61H(1), Q61L(1)     Exon 4 A146P(1), <m>A146T</m>(1), K147E(1)   NRAS       Wild type 86 (99%)      Mutated 1 (1%)       Exon 3 Q61K(1)   BRAF       Wild type 81 (93%)      Mutated 6 (7%)       Exon 15 V600E (6)   TP53       Wild type 58 (66%)      Mutated 29 (33%)       Exon 4 L111R (1), G112del (1)     Exon 5 C135F (1), P152AfsTer14 (1), R156H (1), R158C (1), V173L (1), R175H (3), H178PfsTer47 (1), c.376-2A>G splice (1)     Exon 6 Q192* (1), R196* (1), L201GfsTer47 (1), S215R (1).     Exon 7 R248W (2), R248Q (1), C275Y (1), N247I (1), T253PfsTer92 (1)     Exon 8 R282W (3), R273C (1), C277VfsTer68 (1), V272M (1)     Exon 10 S366A (1)   "}], "citations": {"NLM": "Sayagu\u00e9s JM, Del Carmen S, Del Mar Abad M, Corchete LA, Bengoechea O, Anduaga MF, Balde\u00f3n MJ, Cruz JJ, Alcazar JA, Angoso M, Gonz\u00e1lez M, Garc\u00eda J, Mu\u00f1oz-Bellvis L, Orfao A, Sarasquete ME. Combined assessment of the TNM stage and BRAF mutational status at diagnosis in sporadic colorectal cancer patients. Oncotarget. PMID: 29844874", "BibTeX": "@article{29844874, title={Combined assessment of the TNM stage and BRAF mutational status at diagnosis in sporadic colorectal cancer patients.}, author={Sayagu\u00e9s JM and Del Carmen S and Del Mar Abad M and Corchete LA and Bengoechea O and Anduaga MF and Balde\u00f3n MJ and Cruz JJ and Alcazar JA and Angoso M and Gonz\u00e1lez M and Garc\u00eda J and Mu\u00f1oz-Bellvis L and Orfao A and Sarasquete ME}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 29254176, "pmcid": "PMC5731886", "title": "Lung cancer mutation testing: a clinical retesting study of agreement between a real-time PCR and a mass spectrometry test.", "journal": "Oncotarget", "authors": ["Shepherd P", "Sheath KL", "Tin ST", "Khwaounjoo P", "Aye PS", "Li A", "Laking GR", "Kingston NJ", "Lewis CA", "Mark Elwood J", "Love DR", "McKeage MJ"], "date": "2017-09-16T00:00:00Z", "year": 2017, "snippets": [{"_id": "29254176@16427", "snip_text": "RT-PCR test MS assay n   NMD KRAS G12C 40   NMD KRAS G12V 28   NMD KRAS G12D 21   NMD KRAS G12A 9   NMD KRAS G13C 5   NMD KRAS Q61H 4   NMD BRAF V600E 3   NMD KRAS G12R 2   NMD KRAS Q61L 2   NMD NRAS Q61R 2   NMD BRAF G469R 1   NMD KRAS A146T 1   NMD KRAS G12C, KRAS G12V 1   NMD KRAS G12S 1   NMD KRAS G13D/N 1   NMD KRAS Q61R 1   NMD NRAS G12D/E, KRAS G12D 1   NMD NRAS G13R 1   NMD NRAS Q61H 1   NMD NRAS Q61L 1   NMD NRAS Q61Q/K 1   ", "section": "table", "mentions": ["177|4|gene|ncbi_gene@3845|KRAS", "232|4|gene|ncbi_gene@3845|KRAS", "72|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "164|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "67|4|gene|ncbi_gene@3845|KRAS", "341|6|variant|litvar@rs121913237##&&&litvar@#4893#|G12D/E", "127|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "182|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "256|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "104|4|gene|ncbi_gene@3845|KRAS", "159|4|gene|ncbi_gene@3845|KRAS", "403|4|gene|ncbi_gene@4893|NRAS", "251|4|gene|ncbi_gene@3845|KRAS", "421|4|gene|ncbi_gene@4893|NRAS", "91|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "109|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "408|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "385|4|gene|ncbi_gene@4893|NRAS", "298|4|gene|ncbi_gene@3845|KRAS", "390|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "285|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "349|4|gene|ncbi_gene@3845|KRAS", "367|4|gene|ncbi_gene@4893|NRAS", "280|4|gene|ncbi_gene@3845|KRAS", "218|5|variant|litvar@rs121913357##&&&litvar@#673#&&&litvar@CA123653#rs121913357##|G469R", "354|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "372|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "262|4|gene|ncbi_gene@3845|KRAS", "336|4|gene|ncbi_gene@4893|NRAS", "426|6|variant|litvar@rs121913254##&&&litvar@#4893#|Q61Q/K", "145|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "267|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "323|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "237|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "318|4|gene|ncbi_gene@3845|KRAS", "29|4|gene|ncbi_gene@3845|KRAS", "303|6|variant|litvar@rs112445441##&&&litvar@#3845#|G13D/N", "48|4|gene|ncbi_gene@3845|KRAS", "122|4|gene|ncbi_gene@3845|KRAS", "34|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "195|4|gene|ncbi_gene@4893|NRAS", "213|4|gene|ncbi_gene@673|BRAF", "53|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "200|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R"], "figure_id": "T6", "text_hl": "RT-PCR test MS assay n   NMD KRAS G12C 40   NMD KRAS G12V 28   NMD KRAS G12D 21   NMD KRAS G12A 9   NMD KRAS G13C 5   NMD KRAS Q61H 4   NMD BRAF V600E 3   NMD KRAS G12R 2   NMD KRAS Q61L 2   NMD NRAS Q61R 2   NMD BRAF G469R 1   NMD KRAS <m>A146T</m> 1   NMD KRAS G12C, KRAS G12V 1   NMD KRAS G12S 1   NMD KRAS G13D/N 1   NMD KRAS Q61R 1   NMD NRAS G12D/E, KRAS G12D 1   NMD NRAS G13R 1   NMD NRAS Q61H 1   NMD NRAS Q61L 1   NMD NRAS Q61Q/K 1   "}], "citations": {"NLM": "Shepherd P, Sheath KL, Tin ST, Khwaounjoo P, Aye PS, Li A, Laking GR, Kingston NJ, Lewis CA, Mark Elwood J, Love DR, McKeage MJ. Lung cancer mutation testing: a clinical retesting study of agreement between a real-time PCR and a mass spectrometry test. Oncotarget. PMID: 29254176", "BibTeX": "@article{29254176, title={Lung cancer mutation testing: a clinical retesting study of agreement between a real-time PCR and a mass spectrometry test.}, author={Shepherd P and Sheath KL and Tin ST and Khwaounjoo P and Aye PS and Li A and Laking GR and Kingston NJ and Lewis CA and Mark Elwood J and Love DR and McKeage MJ}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 29682243, "pmcid": "PMC5903922", "title": "Frequency of NRAS Gene Mutation in Wild Type KRAS and BRAF Colorectal Cancers; a Single Center Study.", "journal": "Middle East J Dig Dis", "authors": ["Momenzadeh H", "Mirzai M", "Jowkar Z", "Geramizadeh B"], "date": "2018-01-01T00:00:00Z", "year": 2018, "snippets": [{"_id": "29682243@11348", "snip_text": "Author Country Year Method Sample size KRAS and BRAF NRAS mutation Most common mutation      Naseri et al. Iran 2016 Real time-sequencing 50 Not Reported 2%    Codon 146 (exon3):(436G > A) Ala to Thr         Payande et al. Iran 2016 Allele specific-sequencing 83 Not Reported 4.3% Not reported   Current Study Iran 2016 PCR-Sequencing 50 Wild type 5.7%    Codon 61181C > A and 182A > T      ", "section": "table", "mentions": ["179|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|436G > A", "362|10|variant|litvar@#4893#g.61181C>A&&&litvar@#4893#|61181C > A", "377|8|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|182A > T", "53|4|gene|ncbi_gene@4893|NRAS", "48|4|gene|ncbi_gene@673|BRAF", "39|4|gene|ncbi_gene@3845|KRAS"], "figure_id": "T2", "text_hl": "Author Country Year Method Sample size KRAS and BRAF NRAS mutation Most common mutation      Naseri et al. Iran 2016 Real time-sequencing 50 Not Reported 2%    Codon 146 (exon3):(436G > A) Ala to Thr         Payande et al. Iran 2016 Allele specific-sequencing 83 Not Reported 4.3% Not reported   Current Study Iran 2016 PCR-Sequencing 50 Wild type 5.7%    Codon 61181C > A and 182A > T      "}], "citations": {"NLM": "Momenzadeh H, Mirzai M, Jowkar Z, Geramizadeh B. Frequency of NRAS Gene Mutation in Wild Type KRAS and BRAF Colorectal Cancers; a Single Center Study. Middle East J Dig Dis. PMID: 29682243", "BibTeX": "@article{29682243, title={Frequency of NRAS Gene Mutation in Wild Type KRAS and BRAF Colorectal Cancers; a Single Center Study.}, author={Momenzadeh H and Mirzai M and Jowkar Z and Geramizadeh B}, journal={Middle East J Dig Dis}}"}, "is_sup_mat_match": false}, {"pmid": 33923563, "pmcid": "PMC8073052", "title": "Assessment of Resistance Mechanisms and Clinical Implications in Patients with KRAS Mutated-Metastatic Breast Cancer and Resistance to CDK4/6 Inhibitors.", "journal": "Cancers (Basel)", "authors": ["Raimondi L", "Raimondi FM", "Pietranera M", "Di Rocco A", "Di Benedetto L", "Miele E", "Lazzeroni R", "Cimino G", "Spinelli GP"], "date": "2021-04-16T00:00:00Z", "year": 2021, "snippets": [{"_id": "33923563@11545", "snip_text": "Forty patients (37.7%) had a detectable KRAS mutation (mutKRAS) in codon G12V, G12D or G13D, and four patients (3.7%) had less common mutKRAS on tumour tissue (i.e.  G12A = 2; A146T = 1; G12R = 1).", "section": "results", "mentions": ["40|4|gene|ncbi_gene@3845|KRAS", "187|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "145|6|disease|ncbi_mesh@D009369|tumour", "166|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "6|8|species|ncbi_taxonomy@9606|patients", "176|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "102|8|species|ncbi_taxonomy@9606|patients"], "text_hl": "Forty patients (37.7%) had a detectable KRAS mutation (mutKRAS) in codon G12V, G12D or G13D, and four patients (3.7%) had less common mutKRAS on tumour tissue (i.e.  G12A = 2; <m>A146T</m> = 1; G12R = 1)."}], "citations": {"NLM": "Raimondi L, Raimondi FM, Pietranera M, Di Rocco A, Di Benedetto L, Miele E, Lazzeroni R, Cimino G, Spinelli GP. Assessment of Resistance Mechanisms and Clinical Implications in Patients with KRAS Mutated-Metastatic Breast Cancer and Resistance to CDK4/6 Inhibitors. Cancers (Basel). PMID: 33923563", "BibTeX": "@article{33923563, title={Assessment of Resistance Mechanisms and Clinical Implications in Patients with KRAS Mutated-Metastatic Breast Cancer and Resistance to CDK4/6 Inhibitors.}, author={Raimondi L and Raimondi FM and Pietranera M and Di Rocco A and Di Benedetto L and Miele E and Lazzeroni R and Cimino G and Spinelli GP}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 33002027, "pmcid": "PMC7529221", "title": "KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer.", "journal": "PLoS One", "authors": ["Jo P", "Bernhardt M", "Nietert M", "K\u00f6nig A", "Azizian A", "Schirmer MA", "Grade M", "Kitz J", "Reuter-Jessen K", "Ghadimi M", "Str\u00f6bel P", "Schildhaus HU", "Gaedcke J"], "date": "2020-10-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "33002027@14411", "snip_text": "In codon 13, 100% of the mutations consisted of c.38G>A (G13D) and in codon 146, 100% were c.436G>A (A146T).", "section": "results", "mentions": ["57|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "91|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "48|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "101|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "In codon 13, 100% of the mutations consisted of c.38G>A (G13D) and in codon 146, 100% were c.436G>A (<m>A146T</m>)."}], "citations": {"NLM": "Jo P, Bernhardt M, Nietert M, K\u00f6nig A, Azizian A, Schirmer MA, Grade M, Kitz J, Reuter-Jessen K, Ghadimi M, Str\u00f6bel P, Schildhaus HU, Gaedcke J. KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer. PLoS One. PMID: 33002027", "BibTeX": "@article{33002027, title={KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer.}, author={Jo P and Bernhardt M and Nietert M and K\u00f6nig A and Azizian A and Schirmer MA and Grade M and Kitz J and Reuter-Jessen K and Ghadimi M and Str\u00f6bel P and Schildhaus HU and Gaedcke J}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 26184520, "pmcid": "PMC7513622", "title": "Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial", "journal": "Lancet Oncol", "authors": ["Tabernero J", "Lenz HJ", "Siena S", "Sobrero A", "Falcone A", "Ychou M", "Humblet Y", "Bouch\u00e9 O", "Mineur L", "Barone C", "Adenis A", "Yoshino T", "Goldberg RM", "Sargent DJ", "Wagner A", "Laurent D", "Teufel M", "Jeffers M", "Grothey A", "Van Cutsem E"], "date": "2015-08-01T00:00:00Z", "year": 2015, "snippets": [{"_id": "26184520@45394", "snip_text": "\tFrequency in COSMIC*\tPlasma DNA BEAMing in CORRECT\t \tKRAS\t\t\t \tG12D\t5783/16 453 (35%)\t116/413 (28%)\t \tG12V\t3677/16 453 (22%)\t72/413 (17%)\t \tG12C\t1334/16 453 (8%)\t35/413 (8%)\t \tG12A\t1039/16 453 (6%)\t36/413 (9%)\t \tG12S\t963/16 453 (6%)\t16/413 (4%)\t \tG12R\t203/16 453 (1%)\t9/413 (2%)\t \tG13D\t3235/16 453 (20%)\t67/413 (16%)\t \tQ61H\t126/16 453 (1%)\t50/413 (12%)\t \tA146T\t93/16 453 (1%)\t12/413 (3%)\t \tPIK3CA\t\t\t \tE542K\t273/1098 (25%)\t27/89 (30%)\t \tE545K\t412/1098 (38%)\t37/89 (42%)\t \tE545G\t36/1098 (3%)\t9/89 (10%)\t \tH1047R\t306/1098 (28%)\t12/89 (13%)\t \tH1047L\t47/1098 (4%)\t3/89 (3%)\t \tH1047Y\t24/1098 (2%)\t1/89 (1%)\t \t", "section": "table", "mentions": ["355|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "436|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "212|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "102|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "281|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "571|6|variant|litvar@rs121913281##&&&litvar@#5290#&&&litvar@CA130471#rs121913281##|H1047Y", "247|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "503|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "390|6|gene|ncbi_gene@5290|PIK3CA", "471|5|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123336#rs121913274##|E545G", "54|4|gene|ncbi_gene@3845|KRAS", "63|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "539|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|H1047L", "176|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "140|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "319|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "401|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K"], "figure_id": "T3", "text_hl": "\tFrequency in COSMIC*\tPlasma DNA BEAMing in CORRECT\t \tKRAS\t\t\t \tG12D\t5783/16 453 (35%)\t116/413 (28%)\t \tG12V\t3677/16 453 (22%)\t72/413 (17%)\t \tG12C\t1334/16 453 (8%)\t35/413 (8%)\t \tG12A\t1039/16 453 (6%)\t36/413 (9%)\t \tG12S\t963/16 453 (6%)\t16/413 (4%)\t \tG12R\t203/16 453 (1%)\t9/413 (2%)\t \tG13D\t3235/16 453 (20%)\t67/413 (16%)\t \tQ61H\t126/16 453 (1%)\t50/413 (12%)\t \t<m>A146T</m>\t93/16 453 (1%)\t12/413 (3%)\t \tPIK3CA\t\t\t \tE542K\t273/1098 (25%)\t27/89 (30%)\t \tE545K\t412/1098 (38%)\t37/89 (42%)\t \tE545G\t36/1098 (3%)\t9/89 (10%)\t \tH1047R\t306/1098 (28%)\t12/89 (13%)\t \tH1047L\t47/1098 (4%)\t3/89 (3%)\t \tH1047Y\t24/1098 (2%)\t1/89 (1%)\t \t"}], "citations": {"NLM": "Tabernero J, Lenz HJ, Siena S, Sobrero A, Falcone A, Ychou M, Humblet Y, Bouch\u00e9 O, Mineur L, Barone C, Adenis A, Yoshino T, Goldberg RM, Sargent DJ, Wagner A, Laurent D, Teufel M, Jeffers M, Grothey A, Van Cutsem E. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial Lancet Oncol. PMID: 26184520", "BibTeX": "@article{26184520, title={Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial}, author={Tabernero J and Lenz HJ and Siena S and Sobrero A and Falcone A and Ychou M and Humblet Y and Bouch\u00e9 O and Mineur L and Barone C and Adenis A and Yoshino T and Goldberg RM and Sargent DJ and Wagner A and Laurent D and Teufel M and Jeffers M and Grothey A and Van Cutsem E}, journal={Lancet Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 24042735, "pmcid": "PMC3816225", "title": "Epigenetic and genetic features of 24 colon cancer cell lines.", "journal": "Oncogenesis", "authors": ["Ahmed D", "Eide PW", "Eilertsen IA", "Danielsen SA", "Ekn\u00e6s M", "Hektoen M", "Lind GE", "Lothe RA"], "date": "2013-09-16T00:00:00Z", "year": 2013, "snippets": [{"_id": "24042735@19992", "snip_text": "Two hyperactivating mutations, BRAFA146T (LS1034) and PIK3CAP449T (HT-29/WiDr) have previously been reported in regions not covered in the present study.", "section": "methods", "mentions": ["35|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "67|5|cellline||HT-29", "60|5|variant|litvar@#7157#p.P449T&&&litvar@#7157#|P449T"], "text_hl": "Two hyperactivating mutations, BRAFA146T (LS1034) and PIK3CAP449T (HT-29/WiDr) have previously been reported in regions not covered in the present study."}], "citations": {"NLM": "Ahmed D, Eide PW, Eilertsen IA, Danielsen SA, Ekn\u00e6s M, Hektoen M, Lind GE, Lothe RA. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis. PMID: 24042735", "BibTeX": "@article{24042735, title={Epigenetic and genetic features of 24 colon cancer cell lines.}, author={Ahmed D and Eide PW and Eilertsen IA and Danielsen SA and Ekn\u00e6s M and Hektoen M and Lind GE and Lothe RA}, journal={Oncogenesis}}"}, "is_sup_mat_match": false}, {"pmid": 21712828, "pmcid": "PMC3142798", "title": "Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumours.", "journal": "Br J Cancer", "authors": ["Weidlich S", "Walsh K", "Crowther D", "Burczynski ME", "Feuerstein G", "Carey FA", "Steele RJ", "Wolf CR", "Miele G", "Smith G"], "date": "2011-07-12T00:00:00Z", "year": 2011, "snippets": [{"_id": "21712828@35971", "snip_text": "      Frequency (%)   Mutation Nucleotide change Amino-acid change Dideoxy sequencing Pyrosequencing   K-Ras 26.4% 32.4%    Codon 12 G34A Gly12Ser 1/102 (1%) 3/102 (2.9%)     G34T Gly12Cys 1/102 (1%) 4/102 (3.9%)     G35T Gly12Val 8/102 (7.8%) 9/102 (8.8%)     G35C Gly12Arg 1/102 (1%) 1/102 (1%)     G35A Gly12Asp 8/102 (7.8%) 8/102 (7.8%)    Codon 13 G38A Gly13Asp 6/102 (5.9%) 6/102 (5.9%)    Codon 61 None detected None detected 0/102 0/102    Codon 146 G436A Ala146Thr 2/102 (1.9%) 2/102 (1.9%)    Codon 14 Ins 41-44 14Gly15 1/102 (1%) 1/102 (1%)    Codon 22 C65A Gln22Lys 1/102 (0.6%) 1/102 (0.6%)               B-Raf 8.8% 11.5%    Codon 600 T1798A Val600Glu 9/102 (8.8%) 12/102 (11.5%)               PIK3CA 8.8% 13.70%    Codon 542 G1624A Glu542Lys 4/102 (3.9%) 4/102 (3.9%)    Codon 545 G1633A Glu545Lys 3/102 (2.9%) 7/102 (6.8%)    Codon 546 A1637C Gln546Pro 1/102 (1%) 1/102 (1%)    Codon 1023 None detected None detected 0/102 0/102    Codon 1047 A3140G His1047Arg 1/102 (1%) 2/102 (1.9%)   ", "section": "table", "mentions": ["795|6|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|G1633A", "266|8|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|Gly12Arg", "301|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G35A", "358|8|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|Gly13Asp", "175|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G34T", "802|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|Glu545Lys", "851|6|variant|litvar@rs397517201##&&&litvar@#5290#|A1637C", "707|6|gene|ncbi_gene@5290|PIK3CA", "858|9|variant|litvar@rs397517201##&&&litvar@#5290#|Gln546Pro", "306|8|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|Gly12Asp", "138|8|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|Gly12Ser", "965|10|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|His1047Arg", "261|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G35C", "103|5|gene|ncbi_gene@3845|K-Ras", "464|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|Ala146Thr", "217|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G35T", "353|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G38A", "618|5|gene|ncbi_gene@673|B-Raf", "739|6|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|G1624A", "564|4|variant|litvar@rs1240033172##&&&litvar@#10178#|C65A", "746|9|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|Glu542Lys", "458|5|variant|litvar@rs755969956##&&&litvar@#5290#&&&litvar@CA2710540#rs755969956##|G436A", "180|8|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|Gly12Cys", "958|6|variant|litvar@#5290#g.3140A>G&&&litvar@#5290#|A3140G", "133|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G34A", "222|8|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|Gly12Val", "648|6|variant|litvar@rs756196759##&&&litvar@#10178#&&&litvar@CA10510241#rs756196759##|T1798A", "655|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|Val600Glu", "569|8|variant|litvar@rs121913236##&&&litvar@#3845#&&&litvar@CA16602771#rs121913236##|Gln22Lys"], "figure_id": "tbl2", "text_hl": "      Frequency (%)   Mutation Nucleotide change Amino-acid change Dideoxy sequencing Pyrosequencing   K-Ras 26.4% 32.4%    Codon 12 G34A Gly12Ser 1/102 (1%) 3/102 (2.9%)     G34T Gly12Cys 1/102 (1%) 4/102 (3.9%)     G35T Gly12Val 8/102 (7.8%) 9/102 (8.8%)     G35C Gly12Arg 1/102 (1%) 1/102 (1%)     G35A Gly12Asp 8/102 (7.8%) 8/102 (7.8%)    Codon 13 G38A Gly13Asp 6/102 (5.9%) 6/102 (5.9%)    Codon 61 None detected None detected 0/102 0/102    Codon 146 G436A <m>Ala146Thr</m> 2/102 (1.9%) 2/102 (1.9%)    Codon 14 Ins 41-44 14Gly15 1/102 (1%) 1/102 (1%)    Codon 22 C65A Gln22Lys 1/102 (0.6%) 1/102 (0.6%)               B-Raf 8.8% 11.5%    Codon 600 T1798A Val600Glu 9/102 (8.8%) 12/102 (11.5%)               PIK3CA 8.8% 13.70%    Codon 542 G1624A Glu542Lys 4/102 (3.9%) 4/102 (3.9%)    Codon 545 G1633A Glu545Lys 3/102 (2.9%) 7/102 (6.8%)    Codon 546 A1637C Gln546Pro 1/102 (1%) 1/102 (1%)    Codon 1023 None detected None detected 0/102 0/102    Codon 1047 A3140G His1047Arg 1/102 (1%) 2/102 (1.9%)   "}], "citations": {"NLM": "Weidlich S, Walsh K, Crowther D, Burczynski ME, Feuerstein G, Carey FA, Steele RJ, Wolf CR, Miele G, Smith G. Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumours. Br J Cancer. PMID: 21712828", "BibTeX": "@article{21712828, title={Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumours.}, author={Weidlich S and Walsh K and Crowther D and Burczynski ME and Feuerstein G and Carey FA and Steele RJ and Wolf CR and Miele G and Smith G}, journal={Br J Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 30519308, "pmcid": "PMC6277612", "title": "Efficacy of CapeOX plus Cetuximab Treatment as a First-Line Therapy for Patients with Extended RAS/BRAF/PIK3CA Wild-Type Advanced or Metastatic Colorectal Cancer.", "journal": "J Cancer", "authors": ["Iwamoto S", "Maeda H", "Hazama S", "Oba K", "Okayama N", "Suehiro Y", "Yamasaki T", "Suzuki N", "Nagano H", "Sakamoto J", "Mishima H", "Nagata N"], "date": "2018-10-18T00:00:00Z", "year": 2018, "snippets": [{"_id": "30519308@24540", "snip_text": "It should be noted that one patient had both A146T and H1047R mutations, and another patient had D594G and H1047R mutations, simultaneously.", "section": "figure_legend", "mentions": ["28|7|species|ncbi_taxonomy@9606|patient", "55|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "45|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "85|7|species|ncbi_taxonomy@9606|patient", "97|5|variant|litvar@rs121913338##&&&litvar@#673#&&&litvar@CA123657#rs121913338##|D594G", "107|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R"], "figure_id": "F1", "text_hl": "It should be noted that one patient had both <m>A146T</m> and H1047R mutations, and another patient had D594G and H1047R mutations, simultaneously."}], "citations": {"NLM": "Iwamoto S, Maeda H, Hazama S, Oba K, Okayama N, Suehiro Y, Yamasaki T, Suzuki N, Nagano H, Sakamoto J, Mishima H, Nagata N. Efficacy of CapeOX plus Cetuximab Treatment as a First-Line Therapy for Patients with Extended RAS/BRAF/PIK3CA Wild-Type Advanced or Metastatic Colorectal Cancer. J Cancer. PMID: 30519308", "BibTeX": "@article{30519308, title={Efficacy of CapeOX plus Cetuximab Treatment as a First-Line Therapy for Patients with Extended RAS/BRAF/PIK3CA Wild-Type Advanced or Metastatic Colorectal Cancer.}, author={Iwamoto S and Maeda H and Hazama S and Oba K and Okayama N and Suehiro Y and Yamasaki T and Suzuki N and Nagano H and Sakamoto J and Mishima H and Nagata N}, journal={J Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 30046162, "pmcid": "PMC6365384", "title": "Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability.", "journal": "Leukemia", "authors": ["Dutta AK", "Fink JL", "Grady JP", "Morgan GJ", "Mullighan CG", "To LB", "Hewett DR", "Zannettino ACW"], "date": "2019-02-01T00:00:00Z", "year": 2019, "snippets": [{"_id": "30046162@21194", "snip_text": "Furthermore, we identified a KRAS mutation (A146P) in subclone 11, whose population proportion size, interestingly, did not change during MM progression.", "section": "results", "mentions": ["29|4|gene|ncbi_gene@3845|KRAS", "138|2|disease|ncbi_mesh@D009101|MM", "44|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P"], "text_hl": "Furthermore, we identified a KRAS mutation (A146P) in subclone 11, whose population proportion size, interestingly, did not change during MM progression."}], "citations": {"NLM": "Dutta AK, Fink JL, Grady JP, Morgan GJ, Mullighan CG, To LB, Hewett DR, Zannettino ACW. Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability. Leukemia. PMID: 30046162", "BibTeX": "@article{30046162, title={Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability.}, author={Dutta AK and Fink JL and Grady JP and Morgan GJ and Mullighan CG and To LB and Hewett DR and Zannettino ACW}, journal={Leukemia}}"}, "is_sup_mat_match": false}, {"pmid": 31175866, "pmcid": "PMC6756950", "title": "Intraductal Papillary Mucinous Neoplasms Arise from Multiple Independent Clones, Each With Distinct Mutations", "journal": "Gastroenterology", "authors": ["Fischer CG", "Beleva Guthrie V", "Braxton AM", "Zheng L", "Wang P", "Song Q", "Griffin JF", "Chianchiano PE", "Hosoda W", "Niknafs N", "Springer S", "Dal Molin M", "Masica D", "Scharpf RB", "Thompson ED", "He J", "Wolfgang CL", "Hruban RH", "Roberts NJ", "Lennon AM", "Jiao Y", "Karchin R", "Wood LD"], "date": "2019-10-01T00:00:00Z", "year": 2019, "snippets": [{"_id": "31175866@47879", "snip_text": " Case\tSex\tAge (at surgery)*\tLocation\tSize (cm)\tPredominant Histological Subtype\tFinal Diagnosis\tTissue Analyzed\t# of regions\t# of samples (LGD,HGD,PDAC)\tMutations Identified\t \tIPC01\tF\t80\tHead\t1.6\tGastric\tIPMN with LGD\tIPMN\t6\t 6\t(6,0,0)\tKRAS(p.G12D, p.G12R, p.G12V, p.GQ60GK), RNF43(p.A169T)\t \tIPC02\tM\t50\tTail\t4.5\tGastric\tIPMN with LGD\tIPMN\t8\t 8\t(8,0,0)\tKRAS(p.G12D, p.G12R, p.G12V), GNAS(p.R201C, p.R201H), RNF43(p.R286W), TP53(p.P72R)\t \tIPC03\tF\t60\tTail\t2.3\tGastric\tIPMN with LGD\tIPMN\t6\t 6\t(6,0,0)\tKRAS(p.G12D, p.G12R, p.G12V), GNAS(p.R201H), CDKN2A(p.R80P)\t \tIPC04\tM\t70\tHead\t4.2\tGastric\tIPMN with LGD\tIPMN\t6\t 6\t(6,0,0)\tKRAS(p.G12R), GNAS(p.R201H)\t \tIPC05\tF\t80\tTail\t2.8\tGastric\tIPMN with LGD\tIPMN\t8\t 8\t(8,0,0)\tKRAS(p.G12V), GNAS(p.R201C)\t \tIPC06\tM\t60\tBody\t3\tGastric\tIPMN with LGD\tIPMN\t9\t 9\t(9,0,0)\tKRAS(p.G12V) GNAS(p.R201C), BRAF(p.N486_P490d el), CTNNB1(p.S45F), TP53(p.L369M)\t \tIPC07\tM\t60\tHead\t5\tGastric\tIPMN with LGD\tIPMN\t11\t 11\t(11,0,0)\tKRAS(p.G12D p.G12V), GNAS(p.R201C), RNF43(p.W15*, p.A115Pfs*43), PIK3CA(p.N1044K)\t \tIPC08\tF\t70\tHead\t3\tGastric\tIPMN with LGD\tIPMN\t8\t 8\t(8,0,0)\tKRAS(p.G12D, p.G12R, p.G12V, p.A146V), GNAS(p.R201C, p.Q227H), RNF43(p.P231L), BRAF(p.N486_P490del), ATM(p.P1526P)\t \tIPC09\tM\t80\tTail\t3\tIntestinal\tIPMN with LGD\tIPMN\t7\t 7\t(7,0,0)\tKRAS(p.G12D, p.G12V), PIK3CA(p.H1047R)\t \tIPC10\tM\t70\tHead\t3\tGastric\tIPMN with LGD\tIPMN\t6\t 6\t(6,0,0)\tKRAS(p.G12D, p.G12V), GNAS(p.R201C, p.R201H), RNF43(p.L418M), STK11(p.P203S)\t \tIPC11\tM\t70\tHead\t5\tPancreatobiliary\tIPMN with HGD\tIPMN\t10\t 13\t(6,7,0)\tKRAS(p.G12V, p.G12S), GNAS(p.R201C, p.R201H, p.Q227E)\t \tIPC12\tF\t90\tHead\t5.5\tIntestinal\tIPMN with HGD\tIPMN\t23\t 25\t(3,22,0)\tKRAS(p.A146V, p.Q61H), GNAS(p.R201C, p.Q227H), RNF43(p.Q6Rfs*9), ATM(p.L2475Yfs*2), TP53(p.P72R)\t \tIPC13\tM\t70\tHead\t6.5\tIntestinal\tIPMN with invasive carcinoma (ductal)\tIPMN and carcinoma\t22\t 25\t(0,20,5)\tKRAS(p.G12D), GNAS(p.R201H)\t \tIPC14\t M\t70\t Head\t2.9\tIntestinal\tIPMN with invasive carcinoma (ductal)\tIPMN\t11\t 12\t(5,7,0)\tKRAS(p.G12R), GNAS(p.R201H), BRAF(p.E26D), ATM(p.L1517F)\t \tIPC15\t M\t70\t Head\t3\tPancreatobiliary\tIPMN with HGD\tIPMN\t8\t 9\t(5,4,0)\tKRAS(p.G12D, p.G12V), GNAS(p.R201C, p.R201S), RNF43(p.E37*)\t \tIPC16\t F\t70\t Tail\t2.4\tIntestinal\tIPMN with HGD\tIPMN\t6\t 10\t(7,3,0)\tKRAS(p.G12D), GNAS(p.R201H), RNF43(p.R49Sfs*3, p.R132*, p.Q152*, p.T76Nfs*13)\t \tIPC17\t M\t80\t Head\t5\tIntestinal\tIPMN with HGD\tIPMN\t18\t 19\t(15,4,0)\tKRAS(p.A146T, p.Q61H), GNAS(p.R201C), RNF43(p.C119Lfs*6), BRAF(p.T241M), CDKN2A(p.H83N)\t \tIPC18\t M\t60\t Head\t4\tPancreatobiliary\tIPMN with HGD\tIPMN\t8\t 9\t(1,8,0)\tKRAS(p.G12V), RNF43(p.A115Pfs*43, p.S216L)\t \tIPC19\t M\t70\t Head\t4\tIntestinal\tIPMN with HGD\tIPMN\t6\t 6\t(0,6,0)\tKRAS(p.G12D), GNAS(p.R201H), RNF43(p.A169T, p.R337*), APC(p.R99W)\t \tIPC20\t M\t70\t Head\t2.7\tIntestinal\tIPMN with invasive carcinoma (ductal)\tIPMN\t24\t 24\t(0,24,0)\tKRAS(p.G13D), GNAS(p.R201C), RNF43(p.I141N, p.I201N), TP53(p.V172D, p.P152L, p.D208A, p.R248Q)\t \t", "section": "table", "mentions": ["625|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "2380|4|gene|ncbi_gene@2778|GNAS", "2682|6|variant|litvar@rs139196838##&&&litvar@#324#&&&litvar@CA7948#rs139196838##|p.R99W", "397|7|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|p.R201H", "1089|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1554|7|variant|litvar@rs137854533##&&&litvar@#2778#|p.Q227E", "511|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "1123|4|gene|ncbi_gene@2778|GNAS", "1137|7|variant|litvar@rs137854533##&&&litvar@#2778#&&&litvar@CA347037#rs137854533##|p.Q227H", "2105|4|gene|ncbi_gene@2778|GNAS", "2119|7|variant|litvar@rs11554273##&&&litvar@#2778#&&&litvar@CA126086#rs11554273##|p.R201S", "2225|4|gene|ncbi_gene@2778|GNAS", "2385|7|variant|litvar@rs11554273##&&&litvar@#2778#&&&litvar@CA126067#rs11554273##|p.R201C", "276|5|gene|ncbi_gene@54894|RNF43", "2678|3|gene|ncbi_gene@324|APC", "1128|7|variant|litvar@rs11554273##&&&litvar@#2778#&&&litvar@CA126067#rs11554273##|p.R201C", "2230|7|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|p.R201H", "1413|7|variant|litvar@rs2526374##&&&litvar@#54894#&&&litvar@CA8673209#rs2526374##|p.L418M", "2267|7|variant|litvar@rs587782705##&&&litvar@#7157#|p.Q152*", "1522|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "1275|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1366|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "2828|7|variant|litvar@rs11554273##&&&litvar@#2778#|p.I201N", "2629|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1168|14|variant|litvar@#673#p.P486,490del&&&litvar@#673#|p.N486_P490del", "849|6|gene|ncbi_gene@1499|CTNNB1", "2819|7|variant|litvar@#54894#p.I141N&&&litvar@#54894#|p.I141N", "634|4|gene|ncbi_gene@2778|GNAS", "2668|7|variant|litvar@#324#p.R337*&&&litvar@#324#|p.R337*", "358|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1163|4|gene|ncbi_gene@673|BRAF", "407|5|gene|ncbi_gene@54894|RNF43", "1388|7|variant|litvar@rs11554273##&&&litvar@#2778#&&&litvar@CA126067#rs11554273##|p.R201C", "1659|7|variant|litvar@rs11554273##&&&litvar@#2778#&&&litvar@CA126067#rs11554273##|p.R201C", "1984|4|gene|ncbi_gene@673|BRAF", "2246|10|variant|litvar@#54894#p.R49SfsX3&&&litvar@#54894#|p.R49Sfs*3", "2852|7|variant|litvar@rs587782705##&&&litvar@#7157#&&&litvar@CA204#rs587782705##|p.P152L", "282|7|variant|litvar@rs779337229##&&&litvar@#54894#&&&litvar@CA292015206#rs779337229##|p.A169T", "2357|4|gene|ncbi_gene@3845|KRAS", "1113|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "2784|4|gene|ncbi_gene@3845|KRAS", "992|12|variant|litvar@#54894#p.A115PfsX43&&&litvar@#54894#|p.A115Pfs*43", "2653|5|gene|ncbi_gene@54894|RNF43", "428|6|variant|litvar@rs1042522##&&&litvar@#7157#&&&litvar@CA72#rs1042522##|p.P72R", "1536|7|variant|litvar@rs11554273##&&&litvar@#2778#&&&litvar@CA126067#rs11554273##|p.R201C", "2362|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "1715|4|gene|ncbi_gene@7157|TP53", "543|6|gene|ncbi_gene@1029|CDKN2A", "2550|7|variant|litvar@rs775028128##&&&litvar@#54894#&&&litvar@CA8673360#rs775028128##|p.S216L", "1989|6|variant|litvar@rs371877084##&&&litvar@#673#&&&litvar@CA135143#rs371877084##|p.E26D", "1645|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "1423|5|gene|ncbi_gene@6794|STK11", "2638|4|gene|ncbi_gene@2778|GNAS", "2536|12|variant|litvar@#54894#p.A115PfsX43&&&litvar@#54894#|p.A115Pfs*43", "241|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1262|4|gene|ncbi_gene@3845|KRAS", "1696|3|gene|ncbi_gene@472|ATM", "2643|7|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|p.R201H", "1955|4|gene|ncbi_gene@3845|KRAS", "826|4|gene|ncbi_gene@673|BRAF", "1284|6|gene|ncbi_gene@5290|PIK3CA", "620|4|gene|ncbi_gene@3845|KRAS", "2516|4|gene|ncbi_gene@3845|KRAS", "533|7|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|p.R201H", "550|6|variant|litvar@rs1057519883##&&&litvar@#1029#|p.R80P", "954|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1960|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "2870|7|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|p.R248Q", "1383|4|gene|ncbi_gene@2778|GNAS", "1097|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "1397|7|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|p.R201H", "519|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1631|4|gene|ncbi_gene@3845|KRAS", "498|4|gene|ncbi_gene@3845|KRAS", "1654|4|gene|ncbi_gene@2778|GNAS", "1668|7|variant|litvar@rs137854533##&&&litvar@#2778#&&&litvar@CA347037#rs137854533##|p.Q227H", "2861|7|variant|litvar@#7157#p.D208A&&&litvar@#7157#|p.D208A", "1185|3|gene|ncbi_gene@472|ATM", "870|7|variant|litvar@#7157#p.L369M&&&litvar@#7157#|p.L369M", "1531|4|gene|ncbi_gene@2778|GNAS", "1636|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "1147|5|gene|ncbi_gene@54894|RNF43", "2129|5|gene|ncbi_gene@54894|RNF43", "2803|7|variant|litvar@rs11554273##&&&litvar@#2778#&&&litvar@CA126067#rs11554273##|p.R201C", "1545|7|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|p.R201H", "2211|4|gene|ncbi_gene@3845|KRAS", "1853|7|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|p.R201H", "1509|4|gene|ncbi_gene@3845|KRAS", "947|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1374|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "710|4|gene|ncbi_gene@3845|KRAS", "1189|8|variant|litvar@rs1800889##&&&litvar@#472#&&&litvar@CA151926#rs1800889##|p.P1526P", "1007|6|gene|ncbi_gene@5290|PIK3CA", "2083|4|gene|ncbi_gene@3845|KRAS", "374|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "856|6|variant|litvar@rs121913409##&&&litvar@#1499#&&&litvar@CA127283#rs121913409##|p.S45F", "1700|12|variant|litvar@#472#p.L2475YfsX2&&&litvar@#472#|p.L2475Yfs*2", "2530|5|gene|ncbi_gene@54894|RNF43", "1969|4|gene|ncbi_gene@2778|GNAS", "1839|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "2789|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "798|4|gene|ncbi_gene@3845|KRAS", "413|7|variant|litvar@rs886926322##&&&litvar@#54894#&&&litvar@CA292013732#rs886926322##|p.R286W", "968|7|variant|litvar@rs11554273##&&&litvar@#2778#&&&litvar@CA126067#rs11554273##|p.R201C", "1105|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "366|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "528|4|gene|ncbi_gene@2778|GNAS", "1974|7|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|p.R201H", "715|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1720|6|variant|litvar@rs1042522##&&&litvar@#7157#&&&litvar@CA72#rs1042522##|p.P72R", "2216|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1084|4|gene|ncbi_gene@3845|KRAS", "803|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1429|7|variant|litvar@rs199809905##&&&litvar@#4089#&&&litvar@CA8965836#rs199809905##|p.P203S", "1153|7|variant|litvar@rs2680701##&&&litvar@#54894#&&&litvar@CA8673319#rs2680701##|p.P231L", "1267|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "2088|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "2659|7|variant|litvar@rs779337229##&&&litvar@#54894#&&&litvar@CA292015206#rs779337229##|p.A169T", "383|4|gene|ncbi_gene@2778|GNAS", "865|4|gene|ncbi_gene@7157|TP53", "2521|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "811|4|gene|ncbi_gene@2778|GNAS", "1848|4|gene|ncbi_gene@2778|GNAS", "249|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "1361|4|gene|ncbi_gene@3845|KRAS", "388|7|variant|litvar@rs11554273##&&&litvar@#2778#&&&litvar@CA126067#rs11554273##|p.R201C", "1014|8|variant|litvar@#5290#p.N1044K&&&litvar@#5290#|p.N1044K", "2798|4|gene|ncbi_gene@2778|GNAS", "2813|5|gene|ncbi_gene@54894|RNF43", "1998|3|gene|ncbi_gene@472|ATM", "2624|4|gene|ncbi_gene@3845|KRAS", "2276|11|variant|litvar@#54894#p.T76NfsX13&&&litvar@#54894#|p.T76Nfs*13", "2240|5|gene|ncbi_gene@54894|RNF43", "984|6|variant|litvar@#54894#p.15dup&&&litvar@#54894#|p.W15*", "2110|7|variant|litvar@rs11554273##&&&litvar@#2778#&&&litvar@CA126067#rs11554273##|p.R201C", "816|7|variant|litvar@rs11554273##&&&litvar@#2778#&&&litvar@CA126067#rs11554273##|p.R201C", "978|5|gene|ncbi_gene@54894|RNF43", "724|4|gene|ncbi_gene@2778|GNAS", "2002|8|variant|litvar@rs754058482##&&&litvar@#472#&&&litvar@CA337222#rs754058482##|p.L1517F", "2430|6|gene|ncbi_gene@1029|CDKN2A", "503|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "729|7|variant|litvar@rs11554273##&&&litvar@#2778#&&&litvar@CA126067#rs11554273##|p.R201C", "353|4|gene|ncbi_gene@3845|KRAS", "963|4|gene|ncbi_gene@2778|GNAS", "2371|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "2258|7|variant|litvar@#54894#p.R132*&&&litvar@#54894#|p.R132*", "1291|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.H1047R", "2096|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "2415|4|gene|ncbi_gene@673|BRAF", "423|4|gene|ncbi_gene@7157|TP53", "1514|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1684|9|variant|litvar@#54894#p.Q6RfsX9&&&litvar@#54894#|p.Q6Rfs*9", "942|4|gene|ncbi_gene@3845|KRAS", "257|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1407|5|gene|ncbi_gene@54894|RNF43", "1678|5|gene|ncbi_gene@54894|RNF43", "2838|4|gene|ncbi_gene@7157|TP53", "2420|7|variant|litvar@rs387906660##&&&litvar@#673#&&&litvar@CA259660#rs387906660##|p.T241M", "2437|6|variant|litvar@rs748144169##&&&litvar@#472#|p.H83N", "639|7|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|p.R201H", "2135|6|variant|litvar@#54894#p.37dup&&&litvar@#54894#|p.E37*", "2395|5|gene|ncbi_gene@54894|RNF43", "2843|7|variant|litvar@rs945979997##&&&litvar@#5728#|p.V172D", "1834|4|gene|ncbi_gene@3845|KRAS", "236|4|gene|ncbi_gene@3845|KRAS"], "figure_id": "T1", "text_hl": " Case\tSex\tAge (at surgery)*\tLocation\tSize (cm)\tPredominant Histological Subtype\tFinal Diagnosis\tTissue Analyzed\t# of regions\t# of samples (LGD,HGD,PDAC)\tMutations Identified\t \tIPC01\tF\t80\tHead\t1.6\tGastric\tIPMN with LGD\tIPMN\t6\t 6\t(6,0,0)\tKRAS(p.G12D, p.G12R, p.G12V, p.GQ60GK), RNF43(p.A169T)\t \tIPC02\tM\t50\tTail\t4.5\tGastric\tIPMN with LGD\tIPMN\t8\t 8\t(8,0,0)\tKRAS(p.G12D, p.G12R, p.G12V), GNAS(p.R201C, p.R201H), RNF43(p.R286W), TP53(p.P72R)\t \tIPC03\tF\t60\tTail\t2.3\tGastric\tIPMN with LGD\tIPMN\t6\t 6\t(6,0,0)\tKRAS(p.G12D, p.G12R, p.G12V), GNAS(p.R201H), CDKN2A(p.R80P)\t \tIPC04\tM\t70\tHead\t4.2\tGastric\tIPMN with LGD\tIPMN\t6\t 6\t(6,0,0)\tKRAS(p.G12R), GNAS(p.R201H)\t \tIPC05\tF\t80\tTail\t2.8\tGastric\tIPMN with LGD\tIPMN\t8\t 8\t(8,0,0)\tKRAS(p.G12V), GNAS(p.R201C)\t \tIPC06\tM\t60\tBody\t3\tGastric\tIPMN with LGD\tIPMN\t9\t 9\t(9,0,0)\tKRAS(p.G12V) GNAS(p.R201C), BRAF(p.N486_P490d el), CTNNB1(p.S45F), TP53(p.L369M)\t \tIPC07\tM\t60\tHead\t5\tGastric\tIPMN with LGD\tIPMN\t11\t 11\t(11,0,0)\tKRAS(p.G12D p.G12V), GNAS(p.R201C), RNF43(p.W15*, p.A115Pfs*43), PIK3CA(p.N1044K)\t \tIPC08\tF\t70\tHead\t3\tGastric\tIPMN with LGD\tIPMN\t8\t 8\t(8,0,0)\tKRAS(p.G12D, p.G12R, p.G12V, p.A146V), GNAS(p.R201C, p.Q227H), RNF43(p.P231L), BRAF(p.N486_P490del), ATM(p.P1526P)\t \tIPC09\tM\t80\tTail\t3\tIntestinal\tIPMN with LGD\tIPMN\t7\t 7\t(7,0,0)\tKRAS(p.G12D, p.G12V), PIK3CA(p.H1047R)\t \tIPC10\tM\t70\tHead\t3\tGastric\tIPMN with LGD\tIPMN\t6\t 6\t(6,0,0)\tKRAS(p.G12D, p.G12V), GNAS(p.R201C, p.R201H), RNF43(p.L418M), STK11(p.P203S)\t \tIPC11\tM\t70\tHead\t5\tPancreatobiliary\tIPMN with HGD\tIPMN\t10\t 13\t(6,7,0)\tKRAS(p.G12V, p.G12S), GNAS(p.R201C, p.R201H, p.Q227E)\t \tIPC12\tF\t90\tHead\t5.5\tIntestinal\tIPMN with HGD\tIPMN\t23\t 25\t(3,22,0)\tKRAS(p.A146V, p.Q61H), GNAS(p.R201C, p.Q227H), RNF43(p.Q6Rfs*9), ATM(p.L2475Yfs*2), TP53(p.P72R)\t \tIPC13\tM\t70\tHead\t6.5\tIntestinal\tIPMN with invasive carcinoma (ductal)\tIPMN and carcinoma\t22\t 25\t(0,20,5)\tKRAS(p.G12D), GNAS(p.R201H)\t \tIPC14\t M\t70\t Head\t2.9\tIntestinal\tIPMN with invasive carcinoma (ductal)\tIPMN\t11\t 12\t(5,7,0)\tKRAS(p.G12R), GNAS(p.R201H), BRAF(p.E26D), ATM(p.L1517F)\t \tIPC15\t M\t70\t Head\t3\tPancreatobiliary\tIPMN with HGD\tIPMN\t8\t 9\t(5,4,0)\tKRAS(p.G12D, p.G12V), GNAS(p.R201C, p.R201S), RNF43(p.E37*)\t \tIPC16\t F\t70\t Tail\t2.4\tIntestinal\tIPMN with HGD\tIPMN\t6\t 10\t(7,3,0)\tKRAS(p.G12D), GNAS(p.R201H), RNF43(p.R49Sfs*3, p.R132*, p.Q152*, p.T76Nfs*13)\t \tIPC17\t M\t80\t Head\t5\tIntestinal\tIPMN with HGD\tIPMN\t18\t 19\t(15,4,0)\tKRAS(<m>p.A146T</m>, p.Q61H), GNAS(p.R201C), RNF43(p.C119Lfs*6), BRAF(p.T241M), CDKN2A(p.H83N)\t \tIPC18\t M\t60\t Head\t4\tPancreatobiliary\tIPMN with HGD\tIPMN\t8\t 9\t(1,8,0)\tKRAS(p.G12V), RNF43(p.A115Pfs*43, p.S216L)\t \tIPC19\t M\t70\t Head\t4\tIntestinal\tIPMN with HGD\tIPMN\t6\t 6\t(0,6,0)\tKRAS(p.G12D), GNAS(p.R201H), RNF43(p.A169T, p.R337*), APC(p.R99W)\t \tIPC20\t M\t70\t Head\t2.7\tIntestinal\tIPMN with invasive carcinoma (ductal)\tIPMN\t24\t 24\t(0,24,0)\tKRAS(p.G13D), GNAS(p.R201C), RNF43(p.I141N, p.I201N), TP53(p.V172D, p.P152L, p.D208A, p.R248Q)\t \t"}], "citations": {"NLM": "Fischer CG, Beleva Guthrie V, Braxton AM, Zheng L, Wang P, Song Q, Griffin JF, Chianchiano PE, Hosoda W, Niknafs N, Springer S, Dal Molin M, Masica D, Scharpf RB, Thompson ED, He J, Wolfgang CL, Hruban RH, Roberts NJ, Lennon AM, Jiao Y, Karchin R, Wood LD. Intraductal Papillary Mucinous Neoplasms Arise from Multiple Independent Clones, Each With Distinct Mutations Gastroenterology. PMID: 31175866", "BibTeX": "@article{31175866, title={Intraductal Papillary Mucinous Neoplasms Arise from Multiple Independent Clones, Each With Distinct Mutations}, author={Fischer CG and Beleva Guthrie V and Braxton AM and Zheng L and Wang P and Song Q and Griffin JF and Chianchiano PE and Hosoda W and Niknafs N and Springer S and Dal Molin M and Masica D and Scharpf RB and Thompson ED and He J and Wolfgang CL and Hruban RH and Roberts NJ and Lennon AM and Jiao Y and Karchin R and Wood LD}, journal={Gastroenterology}}"}, "is_sup_mat_match": false}, {"pmid": 33257690, "pmcid": "PMC7705699", "title": "Molecular subtype-specific responses of colon cancer cells to the SMAC mimetic Birinapant", "journal": "Cell Death Dis", "authors": ["Fichtner M", "Bozkurt E", "Salvucci M", "McCann C", "McAllister KA", "Halang L", "D\u00fcssmann H", "Kinsella S", "Crawford N", "Sessler T", "Longley DB", "Prehn JHM"], "date": "2020-11-30T00:00:00Z", "year": 2020, "snippets": [{"_id": "33257690@20570", "snip_text": "\tMSI/MSS status\tKRAS status\tBRAF status\tPIK3CA status\tPTEN status\tP53 Status\tConsensus molecular subtype\tCRC intrinsic subtype\t \tRKO\tMSI\tWT\tV600E\tH1047R\tPositive\tWT\tCMS1\tCRIS-D\t \tHT-29\tMSS\tWT\tV600E\tP449T\tPositive\tR273H\tCMS1\tCRIS-B\t \tHCT116\tMSI\tG13D\tWT\tH1047R\tPositive\tWT\tCMS1\tCRIS-D\t \tHCT116-p53-/-\tMSI\tG13D\tWT\tH1047R\tPositive\tKO\tCMS1\tCRIS-E\t \tLoVo\tMSI\tG13D\tWT\tWT\tPositive\tWT\tCMS1\tCRIS-B\t \tGP5D\tMSI\tG12D\tWT\tH1047L\tPositive\tWT\tCMS2\tCRIS-C\t \tLIM1215\tMSI\tWT\tWT\tWT\tPositive\tWT\tCMS2\tCRIS-C\t \tLS1034\tMSS\tA146T\tWT\tWT\tPositive\tG245S\tCMS2\tCRIS-D\t \tDLD-1\tMSI\tG13D\tWT\tE545K\tPositive\tS241F\tCMS2\tCRIS-A\t \tSW620\tMSS\tG12V\tWT\tWT\tPositive\tR273H\tCMS2\tCRIS-D\t \tC106\tMSS\tG13C\tWT\tWT\tPositive\tT125M\tCMS2\tCRIS-C\t \tLS174T\tMSI\tG12D\tWT\tH1047R\tPositive\tWT\tCMS3\tCRIS-A\t \tLS513\tMSS\tG12D\tWT\tWT\tPositive\tWT\tCMS3\tCRIS-E\t \tMDST8\tMSS\tWT\tV600K\tWT\tNull\tWT\tCMS4\tCRIS-D\t \t", "section": "table", "mentions": ["803|5|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16602420#rs121913227##|V600K", "16|4|gene|ncbi_gene@3845|KRAS", "498|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "244|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "710|6|variant|litvar@#7157#p.H1047R&&&litvar@#7157#|H1047R", "140|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "549|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "213|5|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|R273H", "252|6|variant|litvar@#7157#p.H1047R&&&litvar@#7157#|H1047R", "702|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "28|4|gene|ncbi_gene@673|BRAF", "753|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "519|5|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|G245S", "602|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "572|5|variant|litvar@rs28934573##&&&litvar@#7157#&&&litvar@CA359#rs28934573##|S241F", "66|3|gene|ncbi_gene@7157|P53", "622|5|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|R273H", "146|6|variant|litvar@#7157#p.H1047R&&&litvar@#7157#|H1047R", "671|5|variant|litvar@rs786201057##&&&litvar@#7157#&&&litvar@CA140#rs786201057##|T125M", "399|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "198|5|variant|litvar@rs1159548462##&&&litvar@#841#|P449T", "651|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "353|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "192|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "292|3|gene|ncbi_gene@7157|p53", "557|5|variant|litvar@#7157#p.E545K&&&litvar@#7157#|E545K", "303|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "407|6|variant|litvar@#7157#p.H1047L&&&litvar@#7157#|H1047L", "311|6|variant|litvar@#7157#p.H1047R&&&litvar@#7157#|H1047R"], "figure_id": "Tab1", "text_hl": "\tMSI/MSS status\tKRAS status\tBRAF status\tPIK3CA status\tPTEN status\tP53 Status\tConsensus molecular subtype\tCRC intrinsic subtype\t \tRKO\tMSI\tWT\tV600E\tH1047R\tPositive\tWT\tCMS1\tCRIS-D\t \tHT-29\tMSS\tWT\tV600E\tP449T\tPositive\tR273H\tCMS1\tCRIS-B\t \tHCT116\tMSI\tG13D\tWT\tH1047R\tPositive\tWT\tCMS1\tCRIS-D\t \tHCT116-p53-/-\tMSI\tG13D\tWT\tH1047R\tPositive\tKO\tCMS1\tCRIS-E\t \tLoVo\tMSI\tG13D\tWT\tWT\tPositive\tWT\tCMS1\tCRIS-B\t \tGP5D\tMSI\tG12D\tWT\tH1047L\tPositive\tWT\tCMS2\tCRIS-C\t \tLIM1215\tMSI\tWT\tWT\tWT\tPositive\tWT\tCMS2\tCRIS-C\t \tLS1034\tMSS\t<m>A146T</m>\tWT\tWT\tPositive\tG245S\tCMS2\tCRIS-D\t \tDLD-1\tMSI\tG13D\tWT\tE545K\tPositive\tS241F\tCMS2\tCRIS-A\t \tSW620\tMSS\tG12V\tWT\tWT\tPositive\tR273H\tCMS2\tCRIS-D\t \tC106\tMSS\tG13C\tWT\tWT\tPositive\tT125M\tCMS2\tCRIS-C\t \tLS174T\tMSI\tG12D\tWT\tH1047R\tPositive\tWT\tCMS3\tCRIS-A\t \tLS513\tMSS\tG12D\tWT\tWT\tPositive\tWT\tCMS3\tCRIS-E\t \tMDST8\tMSS\tWT\tV600K\tWT\tNull\tWT\tCMS4\tCRIS-D\t \t"}], "citations": {"NLM": "Fichtner M, Bozkurt E, Salvucci M, McCann C, McAllister KA, Halang L, D\u00fcssmann H, Kinsella S, Crawford N, Sessler T, Longley DB, Prehn JHM. Molecular subtype-specific responses of colon cancer cells to the SMAC mimetic Birinapant Cell Death Dis. PMID: 33257690", "BibTeX": "@article{33257690, title={Molecular subtype-specific responses of colon cancer cells to the SMAC mimetic Birinapant}, author={Fichtner M and Bozkurt E and Salvucci M and McCann C and McAllister KA and Halang L and D\u00fcssmann H and Kinsella S and Crawford N and Sessler T and Longley DB and Prehn JHM}, journal={Cell Death Dis}}"}, "is_sup_mat_match": false}, {"pmid": 31553708, "pmcid": "PMC6765160", "title": "KRAS, NRAS, BRAF, HER2 and microsatellite instability in metastatic colorectal cancer - practical implications for the clinician.", "journal": "Radiol Oncol", "authors": ["Afr\u0103s\u00e2nie VA", "Marinca MV", "Alexa-Stratulat T", "Gafton B", "P\u0103duraru M", "Adavidoaiei AM", "Miron L", "Rusu C"], "date": "2019-09-24T00:00:00Z", "year": 2019, "snippets": [{"_id": "31553708@6429", "snip_text": "In exon 2, mutations are common in codons 12: G12D, G12V and G12C; in exon 3, the affected codons are Q61H and Q61R, while in exon 4 the codons involved are A146T and A146V.", "section": "methods", "mentions": ["167|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "52|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "157|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "61|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "111|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "102|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "46|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D"], "text_hl": "In exon 2, mutations are common in codons 12: G12D, G12V and G12C; in exon 3, the affected codons are Q61H and Q61R, while in exon 4 the codons involved are <m>A146T</m> and A146V."}], "citations": {"NLM": "Afr\u0103s\u00e2nie VA, Marinca MV, Alexa-Stratulat T, Gafton B, P\u0103duraru M, Adavidoaiei AM, Miron L, Rusu C. KRAS, NRAS, BRAF, HER2 and microsatellite instability in metastatic colorectal cancer - practical implications for the clinician. Radiol Oncol. PMID: 31553708", "BibTeX": "@article{31553708, title={KRAS, NRAS, BRAF, HER2 and microsatellite instability in metastatic colorectal cancer - practical implications for the clinician.}, author={Afr\u0103s\u00e2nie VA and Marinca MV and Alexa-Stratulat T and Gafton B and P\u0103duraru M and Adavidoaiei AM and Miron L and Rusu C}, journal={Radiol Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 27236105, "pmcid": "PMC4992636", "title": "RASopathy Gene Mutations in Melanoma", "journal": "J Invest Dermatol", "authors": ["Halaban R", "Krauthammer M"], "date": "2016-09-01T00:00:00Z", "year": 2016, "snippets": [{"_id": "27236105@11155", "snip_text": "Likewise, we identified two cases of NF1-mutant melanomas, one with KRASA146T and the other with KRASQ22K, suggesting a similar situation.", "section": "other", "mentions": ["68|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T", "37|3|gene|ncbi_gene@4763|NF1", "48|9|disease|ncbi_mesh@D008545|melanomas"], "text_hl": "Likewise, we identified two cases of NF1-mutant melanomas, one with KRASA146T and the other with KRASQ22K, suggesting a similar situation."}], "citations": {"NLM": "Halaban R, Krauthammer M. RASopathy Gene Mutations in Melanoma J Invest Dermatol. PMID: 27236105", "BibTeX": "@article{27236105, title={RASopathy Gene Mutations in Melanoma}, author={Halaban R and Krauthammer M}, journal={J Invest Dermatol}}"}, "is_sup_mat_match": false}, {"pmid": 33534128, "pmcid": "PMC8213564", "title": "Digoxin treatment reactivates in vivo radioactive iodide uptake and correlates with favorable clinical outcome in non-medullary thyroid cancer.", "journal": "Cell Oncol (Dordr)", "authors": ["Crezee T", "Tesselaar MH", "Nagarajah J", "Corver WE", "Morreau J", "Pritchard C", "Kimura S", "Kuiper JG", "van Engen-van Grunsven I", "Smit JWA", "Netea-Maier RT", "Plantinga TS"], "date": "2021-02-03T00:00:00Z", "year": 2021, "snippets": [{"_id": "33534128@29880", "snip_text": "Digoxin-treated NMTC patients  Matched NMTC patients not treated with digoxin   Pt M/F Age at diagnosis TNM staging at diagnosis a Histology Mutation status Digoxin dose(mg daily) Duration of digoxin treatment before and after NMTC diagnosis Other medication Pt M/F Age at diagnosis TNMstaging at diagnosis* Histology Mutation status Other medication   1 M 88 years T2N1bM0 PTC BRAF V600E, TERT C250T 0.0625 5 weeks before, 4 years after Furosemide 1-1 M 82 years T1bN1bM0 PTC BRAF V600E, TERT C228T -   2 M 79 years T2N0M1 PTC BRAF V600E, TERT C250T 0.125 14 weeks before, 2 months after Bisoprolol 2-1 M 76 years T2N1bM1 PTC BRAF V600E, TERT C228T -   3 F 88 years T3N1bM0 PTC BRAF V600E, TERT C228T 0.125 5 years + 2 months before, 2 years + 7 months after Furosemide, Bisoprolol 3-1 F 84 years T3N1bM0 PTC BRAF V600E, TERT C228T Metoprolol            3-2 F 84 years T3N1bM0 PTC BRAF V600E, TERT C228T Irbesartan   4 F 76 years T3N1aM1 PTC BRAF V600E, TERT WT 0.0625- 0.125 5 weeks before, 2 years + 7 months after Metoprolol, Perindopril, HCTZ 4-1 F 80 years T3N1bM1 PTC BRAF V600E, TERT WT -   5 F 69 years T1aN1aM0 PTC BRAF V600E, TERT WT 0.125 4 weeks before, 3 months after Atenolol 5-1 F 69 years T1bN1aM0 PTC BRAF V600E, TERT WT -   6 F 80 years T3N1aM0 FVPTC PIK3CA H1047R, TERT C250T 0.125- 0.25 7 years + 5 months before, 1 year + 7 months after Furosemide, Bisoprolol, Lisinopril 6-1 F 76 years T3N1aM1 FVPTC NRAS Q61R, TERT C228T -   7 F 78 years T3N1bM0 FTC (PD) TERT WT 0.25 1 year + 8 months before, 8 years after Losartan 7-1 F 81 years T4aN0M0 FTC (PD) KRAS A146T, TERT WT -   8 F 77 years T3N1aM1 FTC (WD) KRAS Q61R, TERT C228T 0.25 2 months before, 2 months after - 8-1 F 82 years T3N0M1 FTC (WD) NRAS Q61R, TERT C228T HCTZ   9 F 81 years T3N1aM0 HCC NRAS Q61R, TERT C228T 0.25 5 years + 7 months before, 6 months after Furosemide,Candesartan 9-1 F 74 years T3N1bM0 HCC TERT C228T Insulin   10 F 77 years T2N1bM0 HCC PRMT5/PPARG, TERT WT 0.25 6 years + 7 months before, 2 months after - 10-1/11-1 M 72 years T3N1bM0 HCC TERT WT Furosemide, Perindopril, HCTZ, Valsartan, Insulin   11 M 79 years T3N1aM0 HCC TERT WT 0.125- 0.25 10 years + 6 months before, 5 months after Enalapril   ", "section": "table", "mentions": ["1735|5|variant|litvar@rs375878504##&&&litvar@#3265#&&&litvar@CA5779225#rs375878504##|C228T", "16|4|disease|ncbi_mesh@C536914|NMTC", "1719|4|gene|ncbi_gene@4893|NRAS", "899|5|variant|litvar@rs375878504##&&&litvar@#3265#&&&litvar@CA5779225#rs375878504##|C228T", "1784|4|gene|ncbi_gene@7015|TERT", "760|10|chemical|ncbi_mesh@D005665|Furosemide", "1643|5|variant|litvar@rs375878504##&&&litvar@#3265#&&&litvar@CA5779225#rs375878504##|C228T", "1888|3|disease|ncbi_mesh@C536913|HCC", "627|4|gene|ncbi_gene@673|BRAF", "1769|3|disease|ncbi_mesh@C536913|HCC", "1618|3|disease||FTC", "1290|5|variant|litvar@rs757630933##&&&litvar@#4914#&&&litvar@CA1167343#rs757630933##|C250T", "374|3|gene|ncbi_gene@5979|PTC", "1638|4|gene|ncbi_gene@7015|TERT", "939|3|gene|ncbi_gene@5979|PTC", "1710|3|disease||FTC", "827|5|variant|litvar@rs375878504##&&&litvar@#3265#&&&litvar@CA5779225#rs375878504##|C228T", "1018|10|chemical|ncbi_mesh@D008790|Metoprolol", "1614|3|species|ncbi_taxonomy@408139|aM1", "2042|4|gene|ncbi_gene@7015|TERT", "1897|5|variant|litvar@rs375878504##&&&litvar@#3265#&&&litvar@CA5779225#rs375878504##|C228T", "1080|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1475|2|disease|ncbi_mesh@D010300|PD", "623|3|gene|ncbi_gene@19713|PTC", "528|4|gene|ncbi_gene@109880|BRAF", "882|4|gene|ncbi_gene@673|BRAF", "0|7|chemical|ncbi_mesh@D004077|Digoxin", "955|4|gene|ncbi_gene@7015|TERT", "1270|6|gene|ncbi_gene@5290|PIK3CA", "2075|4|chemical|ncbi_mesh@D006852|HCTZ", "1215|3|gene|ncbi_gene@5979|PTC", "1479|4|gene|ncbi_gene@7015|TERT", "2124|3|disease|ncbi_mesh@C536913|HCC", "157|7|chemical|ncbi_mesh@D004077|Digoxin", "1413|3|species|ncbi_taxonomy@408139|aM1", "1428|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "1623|2|disease|ncbi_mesh@D006527|WD", "1439|5|variant|litvar@rs375878504##&&&litvar@#3265#&&&litvar@CA5779225#rs375878504##|C228T", "1715|2|disease|ncbi_mesh@D006527|WD", "1892|4|gene|ncbi_gene@7015|TERT", "1585|4|gene|ncbi_gene@7015|TERT", "1383|10|chemical|ncbi_mesh@D017706|Lisinopril", "70|7|chemical|ncbi_mesh@D004077|digoxin", "1434|4|gene|ncbi_gene@7015|TERT", "1741|4|chemical|ncbi_mesh@D006852|HCTZ", "1773|4|gene|ncbi_gene@4893|NRAS", "1789|5|variant|litvar@rs375878504##&&&litvar@#3265#&&&litvar@CA5779225#rs375878504##|C228T", "696|5|variant|litvar@rs375878504##&&&litvar@#3265#&&&litvar@CA5779225#rs375878504##|C228T", "675|3|gene|ncbi_gene@5979|PTC", "545|5|variant|litvar@rs757630933##&&&litvar@#4914#&&&litvar@CA1167343#rs757630933##|C250T", "39|4|disease|ncbi_mesh@C536914|NMTC", "1703|6|disease||T3N0M1", "378|4|gene|ncbi_gene@673|BRAF", "227|4|disease|ncbi_mesh@C536914|NMTC", "943|4|gene|ncbi_gene@673|BRAF", "833|10|chemical|ncbi_mesh@D008790|Metoprolol", "2128|4|gene|ncbi_gene@7015|TERT", "438|10|chemical|ncbi_mesh@D005665|Furosemide", "691|4|gene|ncbi_gene@7015|TERT", "1532|8|chemical|ncbi_mesh@D019808|Losartan", "1277|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "540|4|gene|ncbi_gene@21752|TERT", "878|3|gene|ncbi_gene@5979|PTC", "482|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1632|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "1071|3|gene|ncbi_gene@5979|PTC", "2050|10|chemical|ncbi_mesh@D005665|Furosemide", "1137|4|gene|ncbi_gene@7015|TERT", "1724|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "1219|4|gene|ncbi_gene@673|BRAF", "1371|10|chemical|ncbi_mesh@D017298|Bisoprolol", "1470|3|disease||FTC", "1573|4|gene|ncbi_gene@3845|KRAS", "684|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "395|5|variant|litvar@rs757630933##&&&litvar@#4914#&&&litvar@CA1167343#rs757630933##|C250T", "533|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "894|4|gene|ncbi_gene@7015|TERT", "477|4|gene|ncbi_gene@673|BRAF", "887|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1087|4|gene|ncbi_gene@7015|TERT", "1730|4|gene|ncbi_gene@7015|TERT", "1130|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "192|7|chemical|ncbi_mesh@D004077|digoxin", "1935|3|disease|ncbi_mesh@C536913|HCC", "1285|4|gene|ncbi_gene@7015|TERT", "644|5|variant|litvar@rs375878504##&&&litvar@#3265#&&&litvar@CA5779225#rs375878504##|C228T", "679|4|gene|ncbi_gene@673|BRAF", "806|3|gene|ncbi_gene@5979|PTC", "390|4|gene|ncbi_gene@7015|TERT", "1564|3|disease||FTC", "1125|4|gene|ncbi_gene@673|BRAF", "104|3|gene|ncbi_gene@10178|TNM", "1423|4|gene|ncbi_gene@4893|NRAS", "1359|10|chemical|ncbi_mesh@D005665|Furosemide", "935|3|species|ncbi_taxonomy@408139|aM1", "822|4|gene|ncbi_gene@7015|TERT", "815|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "383|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1043|4|chemical|ncbi_mesh@D006852|HCTZ", "1075|4|gene|ncbi_gene@673|BRAF", "948|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1952|4|gene|ncbi_gene@7015|TERT", "1231|4|gene|ncbi_gene@7015|TERT", "772|10|chemical|ncbi_mesh@D017298|Bisoprolol", "44|8|species|ncbi_taxonomy@9606|patients", "2038|3|disease|ncbi_mesh@C536913|HCC", "639|4|gene|ncbi_gene@7015|TERT", "494|5|variant|litvar@rs375878504##&&&litvar@#3265#&&&litvar@CA5779225#rs375878504##|C228T", "21|8|species|ncbi_taxonomy@9606|patients", "632|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "473|3|gene|ncbi_gene@19713|PTC", "1853|11|chemical|ncbi_mesh@C081643|Candesartan", "1569|2|disease|ncbi_mesh@D010300|PD", "1224|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "524|3|gene|ncbi_gene@5979|PTC", "1578|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1778|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "589|10|chemical|ncbi_mesh@D017298|Bisoprolol", "1842|10|chemical|ncbi_mesh@D005665|Furosemide", "1627|4|gene|ncbi_gene@3845|KRAS", "1121|3|gene|ncbi_gene@5979|PTC", "489|4|gene|ncbi_gene@7015|TERT", "810|4|gene|ncbi_gene@673|BRAF"], "figure_id": "Tab1", "text_hl": "Digoxin-treated NMTC patients  Matched NMTC patients not treated with digoxin   Pt M/F Age at diagnosis TNM staging at diagnosis a Histology Mutation status Digoxin dose(mg daily) Duration of digoxin treatment before and after NMTC diagnosis Other medication Pt M/F Age at diagnosis TNMstaging at diagnosis* Histology Mutation status Other medication   1 M 88 years T2N1bM0 PTC BRAF V600E, TERT C250T 0.0625 5 weeks before, 4 years after Furosemide 1-1 M 82 years T1bN1bM0 PTC BRAF V600E, TERT C228T -   2 M 79 years T2N0M1 PTC BRAF V600E, TERT C250T 0.125 14 weeks before, 2 months after Bisoprolol 2-1 M 76 years T2N1bM1 PTC BRAF V600E, TERT C228T -   3 F 88 years T3N1bM0 PTC BRAF V600E, TERT C228T 0.125 5 years + 2 months before, 2 years + 7 months after Furosemide, Bisoprolol 3-1 F 84 years T3N1bM0 PTC BRAF V600E, TERT C228T Metoprolol            3-2 F 84 years T3N1bM0 PTC BRAF V600E, TERT C228T Irbesartan   4 F 76 years T3N1aM1 PTC BRAF V600E, TERT WT 0.0625- 0.125 5 weeks before, 2 years + 7 months after Metoprolol, Perindopril, HCTZ 4-1 F 80 years T3N1bM1 PTC BRAF V600E, TERT WT -   5 F 69 years T1aN1aM0 PTC BRAF V600E, TERT WT 0.125 4 weeks before, 3 months after Atenolol 5-1 F 69 years T1bN1aM0 PTC BRAF V600E, TERT WT -   6 F 80 years T3N1aM0 FVPTC PIK3CA H1047R, TERT C250T 0.125- 0.25 7 years + 5 months before, 1 year + 7 months after Furosemide, Bisoprolol, Lisinopril 6-1 F 76 years T3N1aM1 FVPTC NRAS Q61R, TERT C228T -   7 F 78 years T3N1bM0 FTC (PD) TERT WT 0.25 1 year + 8 months before, 8 years after Losartan 7-1 F 81 years T4aN0M0 FTC (PD) KRAS <m>A146T</m>, TERT WT -   8 F 77 years T3N1aM1 FTC (WD) KRAS Q61R, TERT C228T 0.25 2 months before, 2 months after - 8-1 F 82 years T3N0M1 FTC (WD) NRAS Q61R, TERT C228T HCTZ   9 F 81 years T3N1aM0 HCC NRAS Q61R, TERT C228T 0.25 5 years + 7 months before, 6 months after Furosemide,Candesartan 9-1 F 74 years T3N1bM0 HCC TERT C228T Insulin   10 F 77 years T2N1bM0 HCC PRMT5/PPARG, TERT WT 0.25 6 years + 7 months before, 2 months after - 10-1/11-1 M 72 years T3N1bM0 HCC TERT WT Furosemide, Perindopril, HCTZ, Valsartan, Insulin   11 M 79 years T3N1aM0 HCC TERT WT 0.125- 0.25 10 years + 6 months before, 5 months after Enalapril   "}], "citations": {"NLM": "Crezee T, Tesselaar MH, Nagarajah J, Corver WE, Morreau J, Pritchard C, Kimura S, Kuiper JG, van Engen-van Grunsven I, Smit JWA, Netea-Maier RT, Plantinga TS. Digoxin treatment reactivates in vivo radioactive iodide uptake and correlates with favorable clinical outcome in non-medullary thyroid cancer. Cell Oncol (Dordr). PMID: 33534128", "BibTeX": "@article{33534128, title={Digoxin treatment reactivates in vivo radioactive iodide uptake and correlates with favorable clinical outcome in non-medullary thyroid cancer.}, author={Crezee T and Tesselaar MH and Nagarajah J and Corver WE and Morreau J and Pritchard C and Kimura S and Kuiper JG and van Engen-van Grunsven I and Smit JWA and Netea-Maier RT and Plantinga TS}, journal={Cell Oncol (Dordr)}}"}, "is_sup_mat_match": false}, {"pmid": 29352306, "pmcid": "PMC5774843", "title": "Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR.", "journal": "PLoS One", "authors": ["Peraldo-Neia C", "Cavalloni G", "Fenocchio E", "Cagnazzo C", "Gammaitoni L", "Cereda S", "Nasti G", "Satolli MA", "Aprile G", "Reni M", "Avallone A", "Spadi R", "Venesio T", "Martin V", "Doglioni C", "Frattini M", "Aglietta M", "Leone F"], "date": "2018-01-19T00:00:00Z", "year": 2018, "snippets": [{"_id": "29352306@8800", "snip_text": "In our previous work we described 3 patients with BRAF V600E mutations, 2 with NRAS mutations (A146S and Q61R), and 2 with PIK3CA E545K mutations.", "section": "results", "mentions": ["79|4|gene|ncbi_gene@4893|NRAS", "105|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "36|8|species|ncbi_taxonomy@9606|patients", "123|6|gene|ncbi_gene@5290|PIK3CA", "130|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "50|4|gene|ncbi_gene@673|BRAF", "55|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "95|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146S"], "text_hl": "In our previous work we described 3 patients with BRAF V600E mutations, 2 with NRAS mutations (A146S and Q61R), and 2 with PIK3CA E545K mutations."}], "citations": {"NLM": "Peraldo-Neia C, Cavalloni G, Fenocchio E, Cagnazzo C, Gammaitoni L, Cereda S, Nasti G, Satolli MA, Aprile G, Reni M, Avallone A, Spadi R, Venesio T, Martin V, Doglioni C, Frattini M, Aglietta M, Leone F. Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR. PLoS One. PMID: 29352306", "BibTeX": "@article{29352306, title={Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR.}, author={Peraldo-Neia C and Cavalloni G and Fenocchio E and Cagnazzo C and Gammaitoni L and Cereda S and Nasti G and Satolli MA and Aprile G and Reni M and Avallone A and Spadi R and Venesio T and Martin V and Doglioni C and Frattini M and Aglietta M and Leone F}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 37700806, "pmcid": "PMC10494558", "title": "Targeting KRAS in pancreatic adenocarcinoma: Progress in demystifying the holy grail", "journal": "World J Clin Oncol", "authors": ["Elhariri A", "Alhaj A", "Ahn D", "Sonbol MB", "Bekaii-Saab T", "Wu C", "Rutenberg MS", "Stauffer J", "Starr J", "Majeed U", "Jones J", "Borad M", "Babiker H"], "date": "2023-08-24T00:00:00Z", "year": 2023, "snippets": [{"_id": "37700806@2400", "snip_text": "Others are A11T, A146T, A18V, G12A, G12I, G12L, G12S, G13C, G13D, G13H, G13P, G13R, L23V, Q61H, Q61K, Q61R.", "section": "figure_legend", "mentions": ["42|4|variant|litvar@rs121913530##&&&litvar@#3845#|G12L", "90|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "60|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "102|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "72|4|variant|litvar@rs112445441##&&&litvar@#3845#|G13P", "84|4|variant|litvar@#3845#p.L23V&&&litvar@#3845#|L23V", "54|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "24|4|variant|litvar@#3845#p.A18V&&&litvar@#3845#|A18V", "96|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "17|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "11|4|variant|litvar@#3845#c.11A>T&&&litvar@#3845#|A11T", "66|4|variant|litvar@rs112445441##&&&litvar@#3845#|G13H", "36|4|variant|litvar@rs121913530##&&&litvar@#3845#|G12I", "30|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "78|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "48|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S"], "figure_id": "F1", "text_hl": "Others are A11T, <m>A146T</m>, A18V, G12A, G12I, G12L, G12S, G13C, G13D, G13H, G13P, G13R, L23V, Q61H, Q61K, Q61R."}], "citations": {"NLM": "Elhariri A, Alhaj A, Ahn D, Sonbol MB, Bekaii-Saab T, Wu C, Rutenberg MS, Stauffer J, Starr J, Majeed U, Jones J, Borad M, Babiker H. Targeting KRAS in pancreatic adenocarcinoma: Progress in demystifying the holy grail World J Clin Oncol. PMID: 37700806", "BibTeX": "@article{37700806, title={Targeting KRAS in pancreatic adenocarcinoma: Progress in demystifying the holy grail}, author={Elhariri A and Alhaj A and Ahn D and Sonbol MB and Bekaii-Saab T and Wu C and Rutenberg MS and Stauffer J and Starr J and Majeed U and Jones J and Borad M and Babiker H}, journal={World J Clin Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 36900260, "pmcid": "PMC10001009", "title": "Predictive and Prognostic Value of Oncogene Mutations and Microsatellite Instability in Locally-Advanced Rectal Cancer Treated with Neoadjuvant Radiation-Based Therapy: A Systematic Review and Meta-Analysis", "journal": "Cancers (Basel)", "authors": ["De Mattia E", "Polesel J", "Mezzalira S", "Palazzari E", "Pollesel S", "Toffoli G", "Cecchin E"], "date": "2023-02-25T00:00:00Z", "year": 2023, "snippets": [{"_id": "36900260@17014", "snip_text": "Of note, El Otmani et al., in a subgroup analysis according to the specific codon mutations of KRAS, showed a significant association between mutations detected at codon 146 (i.e.  A146T and A146V) and the presence of both recurrence and distant metastases (p = 0.019).", "section": "results", "mentions": ["95|4|gene|ncbi_gene@3845|KRAS", "246|10|disease|ncbi_mesh@D009362|metastases", "181|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "191|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V"], "text_hl": "Of note, El Otmani et al., in a subgroup analysis according to the specific codon mutations of KRAS, showed a significant association between mutations detected at codon 146 (i.e.  <m>A146T</m> and A146V) and the presence of both recurrence and distant metastases (p = 0.019)."}], "citations": {"NLM": "De Mattia E, Polesel J, Mezzalira S, Palazzari E, Pollesel S, Toffoli G, Cecchin E. Predictive and Prognostic Value of Oncogene Mutations and Microsatellite Instability in Locally-Advanced Rectal Cancer Treated with Neoadjuvant Radiation-Based Therapy: A Systematic Review and Meta-Analysis Cancers (Basel). PMID: 36900260", "BibTeX": "@article{36900260, title={Predictive and Prognostic Value of Oncogene Mutations and Microsatellite Instability in Locally-Advanced Rectal Cancer Treated with Neoadjuvant Radiation-Based Therapy: A Systematic Review and Meta-Analysis}, author={De Mattia E and Polesel J and Mezzalira S and Palazzari E and Pollesel S and Toffoli G and Cecchin E}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 33328217, "pmcid": "PMC7611341", "title": "MNK Inhibition Sensitizes KRAS-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression.", "journal": "Cancer Discov", "authors": ["Knight JRP", "Alexandrou C", "Skalka GL", "Vlahov N", "Pennel K", "Officer L", "Teodosio A", "Kanellos G", "Gay DM", "May-Wilson S", "Smith EM", "Najumudeen AK", "Gilroy K", "Ridgway RA", "Flanagan DJ", "Smith RCL", "McDonald L", "MacKay C", "Cheasty A", "McArthur K", "Stanway E", "Leach JDG", "Jackstadt R", "Waldron JA", "Campbell AD", "Vlachogiannis G", "Valeri N", "Haigis KM", "Sonenberg N", "Proud CG", "Jones NP", "Swarbrick ME", "McKinnon HJ", "Faller WJ", "Le Quesne J", "Edwards J", "Willis AE", "Bushell M", "Sansom OJ"], "date": "2020-12-16T00:00:00Z", "year": 2020, "snippets": [{"_id": "33328217@9244", "snip_text": "In colorectal cancer KRASA146T can drive anti-EGFR resistance, but correlates with better survival than KRASG12D, and is less potent in cooperating with Apc loss in mouse models.", "section": "results", "mentions": ["3|17|disease|ncbi_mesh@D015179|colorectal cancer", "46|4|gene|ncbi_gene@13649|EGFR", "165|5|species|ncbi_taxonomy@10090|mouse", "21|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T", "153|3|gene|ncbi_gene@11789|Apc"], "text_hl": "In colorectal cancer KRASA146T can drive anti-EGFR resistance, but correlates with better survival than KRASG12D, and is less potent in cooperating with Apc loss in mouse models."}], "citations": {"NLM": "Knight JRP, Alexandrou C, Skalka GL, Vlahov N, Pennel K, Officer L, Teodosio A, Kanellos G, Gay DM, May-Wilson S, Smith EM, Najumudeen AK, Gilroy K, Ridgway RA, Flanagan DJ, Smith RCL, McDonald L, MacKay C, Cheasty A, McArthur K, Stanway E, Leach JDG, Jackstadt R, Waldron JA, Campbell AD, Vlachogiannis G, Valeri N, Haigis KM, Sonenberg N, Proud CG, Jones NP, Swarbrick ME, McKinnon HJ, Faller WJ, Le Quesne J, Edwards J, Willis AE, Bushell M, Sansom OJ. MNK Inhibition Sensitizes KRAS-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression. Cancer Discov. PMID: 33328217", "BibTeX": "@article{33328217, title={MNK Inhibition Sensitizes KRAS-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression.}, author={Knight JRP and Alexandrou C and Skalka GL and Vlahov N and Pennel K and Officer L and Teodosio A and Kanellos G and Gay DM and May-Wilson S and Smith EM and Najumudeen AK and Gilroy K and Ridgway RA and Flanagan DJ and Smith RCL and McDonald L and MacKay C and Cheasty A and McArthur K and Stanway E and Leach JDG and Jackstadt R and Waldron JA and Campbell AD and Vlachogiannis G and Valeri N and Haigis KM and Sonenberg N and Proud CG and Jones NP and Swarbrick ME and McKinnon HJ and Faller WJ and Le Quesne J and Edwards J and Willis AE and Bushell M and Sansom OJ}, journal={Cancer Discov}}"}, "is_sup_mat_match": false}, {"pmid": 37555357, "pmcid": "PMC10556276", "title": " DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell-rich histological mimics", "journal": "J Pathol Clin Res", "authors": ["Guimar\u00e3es LM", "Baumhoer D", "Andrei V", "Friedel D", "Koelsche C", "Gomez RS", "von Deimling A", "Gomes CC"], "date": "2023-11-01T00:00:00Z", "year": 2023, "snippets": [{"_id": "37555357@24584", "snip_text": "KRAS mutations (including the hot-spots p.G12A/D/V and p.G13D, and other variants p.K117N, p.A146P/T/V, p.Q61R/L, and p.A11Q) were reported in 64% of NOF of bone.", "section": "discussion", "mentions": ["55|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "118|6|variant|litvar@#3845#p.A11Q&&&litvar@#3845#|p.A11Q", "82|7|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.K117N", "91|7|variant|litvar@rs121913527##&&&litvar@#3845#|p.A146P", "40|8|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12A/D", "0|4|gene|ncbi_gene@3845|KRAS", "104|6|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|p.Q61R", "150|11|disease|ncbi_mesh@D018214|NOF of bone"], "text_hl": "KRAS mutations (including the hot-spots p.G12A/D/V and p.G13D, and other variants p.K117N, p.A146P/T/V, p.Q61R/L, and p.A11Q) were reported in 64% of NOF of bone."}], "citations": {"NLM": "Guimar\u00e3es LM, Baumhoer D, Andrei V, Friedel D, Koelsche C, Gomez RS, von Deimling A, Gomes CC.  DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell-rich histological mimics J Pathol Clin Res. PMID: 37555357", "BibTeX": "@article{37555357, title={ DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell-rich histological mimics}, author={Guimar\u00e3es LM and Baumhoer D and Andrei V and Friedel D and Koelsche C and Gomez RS and von Deimling A and Gomes CC}, journal={J Pathol Clin Res}}"}, "is_sup_mat_match": false}, {"pmid": 37559590, "pmcid": "PMC10407719", "title": "Gastric metastasis from nodular malignant melanoma of the auricle with multigene aberrations: A rare case report and literature review", "journal": "Oncol Lett", "authors": ["Yuan YC", "Li Y", "Pan Y", "Gao B"], "date": "2023-07-13T00:00:00Z", "year": 2023, "snippets": [{"_id": "37559590@6365", "snip_text": "ARMS-PCR revealed the BRAF V600E mutation (Fig. 3), and no common NRAS (G12D, G12S, G13D, G13R, G12C, G12V, G12A, G13V, A59D, Q61R, Q61K, Q61L, Q61H, K117N, and A146T) mutations were found.", "section": "other", "mentions": ["27|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "108|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "102|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "120|4|variant|litvar@#4893#p.A59D&&&litvar@#4893#|A59D", "22|4|gene|ncbi_gene@673|BRAF", "161|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "72|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "114|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "132|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "84|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "150|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "144|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "126|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "66|4|gene|ncbi_gene@4893|NRAS", "78|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "96|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "90|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "138|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L"], "text_hl": "ARMS-PCR revealed the BRAF V600E mutation (Fig. 3), and no common NRAS (G12D, G12S, G13D, G13R, G12C, G12V, G12A, G13V, A59D, Q61R, Q61K, Q61L, Q61H, K117N, and <m>A146T</m>) mutations were found."}], "citations": {"NLM": "Yuan YC, Li Y, Pan Y, Gao B. Gastric metastasis from nodular malignant melanoma of the auricle with multigene aberrations: A rare case report and literature review Oncol Lett. PMID: 37559590", "BibTeX": "@article{37559590, title={Gastric metastasis from nodular malignant melanoma of the auricle with multigene aberrations: A rare case report and literature review}, author={Yuan YC and Li Y and Pan Y and Gao B}, journal={Oncol Lett}}"}, "is_sup_mat_match": false}, {"pmid": 29725370, "pmcid": "PMC5920233", "title": "Upregulation of c-mesenchymal epithelial transition expression and RAS mutations are associated with late lung metastasis and poor prognosis in colorectal carcinoma.", "journal": "Exp Ther Med", "authors": ["Liu J", "Zeng W", "Huang C", "Wang J", "Xu L", "Ma D"], "date": "2018-05-01T00:00:00Z", "year": 2018, "snippets": [{"_id": "29725370@12339", "snip_text": "Mapping correlations between molecular biomarkers demonstrated that 4 patients carried concurrent KRAS and NRAS mutations (combinations were p.G12D/p.G12D, p.G12D/p.A18T and p.A146T/p.Q61L), and in another 4 patients, KRAS and BRAF mutations (combinations were all p.G12D/p.V600E) were concomitantly observed.", "section": "results", "mentions": ["163|6|variant|litvar@rs121913248##&&&litvar@#4893#&&&litvar@CA16602497#rs121913248##|p.A18T", "174|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "182|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "70|8|species|ncbi_taxonomy@9606|patients", "265|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "208|8|species|ncbi_taxonomy@9606|patients", "156|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "148|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "272|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "141|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "98|4|gene|ncbi_gene@3845|KRAS", "218|4|gene|ncbi_gene@3845|KRAS", "227|4|gene|ncbi_gene@673|BRAF", "107|4|gene|ncbi_gene@4893|NRAS"], "text_hl": "Mapping correlations between molecular biomarkers demonstrated that 4 patients carried concurrent KRAS and NRAS mutations (combinations were p.G12D/p.G12D, p.G12D/p.A18T and <m>p.A146T</m>/p.Q61L), and in another 4 patients, KRAS and BRAF mutations (combinations were all p.G12D/p.V600E) were concomitantly observed."}], "citations": {"NLM": "Liu J, Zeng W, Huang C, Wang J, Xu L, Ma D. Upregulation of c-mesenchymal epithelial transition expression and RAS mutations are associated with late lung metastasis and poor prognosis in colorectal carcinoma. Exp Ther Med. PMID: 29725370", "BibTeX": "@article{29725370, title={Upregulation of c-mesenchymal epithelial transition expression and RAS mutations are associated with late lung metastasis and poor prognosis in colorectal carcinoma.}, author={Liu J and Zeng W and Huang C and Wang J and Xu L and Ma D}, journal={Exp Ther Med}}"}, "is_sup_mat_match": false}, {"pmid": 33672345, "pmcid": "PMC7927050", "title": "Germline and Somatic Whole-Exome Sequencing Identifies New Candidate Genes Involved in Familial Predisposition to Serrated Polyposis Syndrome.", "journal": "Cancers (Basel)", "authors": ["Soares de Lima Y", "Arnau-Collell C", "D\u00edaz-Gay M", "Bonjoch L", "Franch-Exp\u00f3sito S", "Mu\u00f1oz J", "Moreira L", "Oca\u00f1a T", "Cuatrecasas M", "Herrera-Pariente C", "Carballal S", "Moreno L", "D\u00edaz de Bustamante A", "Castells A", "Bujanda L", "Cubiella J", "Rodr\u00edguez-Alcalde D", "Balaguer F", "Castellv\u00ed-Bel S"], "date": "2021-02-23T00:00:00Z", "year": 2021, "snippets": [{"_id": "33672345@15438", "snip_text": "On the other hand, only one KRAS (A146T) variant of unknown significance (VUS) was identified in the somatic profile of one patient in family SPS.14 (Supplementary Table S4).", "section": "results", "mentions": ["124|7|species|ncbi_taxonomy@9606|patient", "28|4|gene|ncbi_gene@3845|KRAS", "34|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "142|6|disease|ncbi_mesh@D044483|SPS.14"], "text_hl": "On the other hand, only one KRAS (<m>A146T</m>) variant of unknown significance (VUS) was identified in the somatic profile of one patient in family SPS.14 (Supplementary Table S4)."}], "citations": {"NLM": "Soares de Lima Y, Arnau-Collell C, D\u00edaz-Gay M, Bonjoch L, Franch-Exp\u00f3sito S, Mu\u00f1oz J, Moreira L, Oca\u00f1a T, Cuatrecasas M, Herrera-Pariente C, Carballal S, Moreno L, D\u00edaz de Bustamante A, Castells A, Bujanda L, Cubiella J, Rodr\u00edguez-Alcalde D, Balaguer F, Castellv\u00ed-Bel S. Germline and Somatic Whole-Exome Sequencing Identifies New Candidate Genes Involved in Familial Predisposition to Serrated Polyposis Syndrome. Cancers (Basel). PMID: 33672345", "BibTeX": "@article{33672345, title={Germline and Somatic Whole-Exome Sequencing Identifies New Candidate Genes Involved in Familial Predisposition to Serrated Polyposis Syndrome.}, author={Soares de Lima Y and Arnau-Collell C and D\u00edaz-Gay M and Bonjoch L and Franch-Exp\u00f3sito S and Mu\u00f1oz J and Moreira L and Oca\u00f1a T and Cuatrecasas M and Herrera-Pariente C and Carballal S and Moreno L and D\u00edaz de Bustamante A and Castells A and Bujanda L and Cubiella J and Rodr\u00edguez-Alcalde D and Balaguer F and Castellv\u00ed-Bel S}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 26619011, "pmcid": "PMC4744099", "title": "Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.", "journal": "Nat Biotechnol", "authors": ["Chang MT", "Asthana S", "Gao SP", "Lee BH", "Chapman JS", "Kandoth C", "Gao J", "Socci ND", "Solit DB", "Olshen AB", "Schultz N", "Taylor BS"], "date": "2016-02-01T00:00:00Z", "year": 2016, "snippets": [{"_id": "26619011@25382", "snip_text": "Whereas activating KRAS A146T mutations arise predominantly in colorectal carcinomas (Supplementary Table 2), RAC1 A159V mutations are most common in head and neck cancers and were not present in any melanomas, despite the frequency of RAC1 P29S in this cancer type.", "section": "results", "mentions": ["200|9|disease|ncbi_mesh@D008545|melanomas", "254|6|disease|ncbi_mesh@D009369|cancer", "19|4|gene|ncbi_gene@3845|KRAS", "63|21|disease|ncbi_mesh@D015179|colorectal carcinomas", "236|4|gene|ncbi_gene@5879|RAC1", "110|4|gene|ncbi_gene@5879|RAC1", "150|21|disease|ncbi_mesh@D006258|head and neck cancers", "115|5|variant|litvar@rs753094370##&&&litvar@#4609#&&&litvar@CA4875290#rs753094370##|A159V", "24|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "241|4|variant|litvar@rs1057519874##&&&litvar@#5879#|P29S"], "text_hl": "Whereas activating KRAS <m>A146T</m> mutations arise predominantly in colorectal carcinomas (Supplementary Table 2), RAC1 A159V mutations are most common in head and neck cancers and were not present in any melanomas, despite the frequency of RAC1 P29S in this cancer type."}], "citations": {"NLM": "Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C, Gao J, Socci ND, Solit DB, Olshen AB, Schultz N, Taylor BS. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Nat Biotechnol. PMID: 26619011", "BibTeX": "@article{26619011, title={Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.}, author={Chang MT and Asthana S and Gao SP and Lee BH and Chapman JS and Kandoth C and Gao J and Socci ND and Solit DB and Olshen AB and Schultz N and Taylor BS}, journal={Nat Biotechnol}}"}, "is_sup_mat_match": false}, {"pmid": 25120700, "pmcid": "PMC4114707", "title": "Mutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinoma.", "journal": "Oncol Lett", "authors": ["Hou W", "Liu J", "Chen P", "Wang H", "Ye BC", "Qiang F"], "date": "2014-09-01T00:00:00Z", "year": 2014, "snippets": [{"_id": "25120700@17765", "snip_text": "Gene Mutation Forward primer sequence (5' to 3') Reverse primer sequence (5' to 3')   KRAS G12C, G12D, G13S, G13D, L19F, Q22K CTTAAGCGTCGATGGAGGAG CCCTGACATACTCCCAAGGA    A59T, Q61E, Q61R, Q61H GGTGCTTAGTGGCCATTTGT CCTAGGTTTCAATCCCAGCA    A146T TTGTGGACAGGTTTTGAAAGA AGAAACCAAAGCCAAAAGCA   NRAS G12S, G12V, G13R, G13V, A18T GCCCAAGGACTGTTGAAAAA CCGACAAGTGAGAGACAGGA    Q61K, Q61R, Q61H GGCAGAAATGGGCTTGAATA AGGTTAATATCCGCAAATGAC   HRAS G12S, G12V, G13R, G13D GTGGGTTTGCCCTTCAGAT TGGTGGATGTCCTCAAAAGA    Q61K, Q61R, Q61H TGGCTGTGTGAACTCCCC GTCAGTGAGTGCTGCTCCC   BRAF G464V, G466V, G469A, V471F CACTTGGTAGACGGGACTCG AGTTTATTGATGCGAACAGTGA    D594G, L597V, V600E AACTCTTCATAATGCTTGCTCTGA AGCCTCAATTCTTACCATCCA   PIK3CA R38G, Q75E, R108H GCCTAATCAAGTCAAACTATGGAA AAGCTTTATGGTTATTTGCATTTT    G118D ATGTTTGCTGCCTTTGCTCT ATAAGCAGTCCCTGCCTTCA    C378R TAAGGGGATTGTGGGCCTAT AATGGGGTCTTGCTTTGTTG    C420R CTCATGCTTGCTTTGGTTCA TTGGCATGCTCTTCAATCAC    P539R, E542K, E545K, E545G, Q546K GATTGGTTCTTTCCTGTCTCTG CCACAAATATCAATTTACAACCATTG    T1025A, M1043T, M1043I, H1047Y, H1047R, H1047L CATTTGCTCCAAACTGACCA CACCCCAAGCATTTTTCTTC   PIK3R1 G376R CAGACGGGACCTTTTTGGTA AACAAAATAGCTGACATGGAAACA    K459E, D464H GGCTTCTCTGACCCATTAACC CCCCACCTCATTCGTAAAAA    L570P GGAAGAGAAGCCACGCTTTA CCCAACCACTCGTTCAACTT   PTEN R130G, R130Q CCGTATAGCGTAAATTCCCAGA TCTCAGATCCAGGAAGAGGAA   R233X TGCTTGAGATCAAGATTGCAG GCCATAAGGCCTTTTCCTTC    ", "section": "table", "mentions": ["448|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "177|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA16602362#rs121913254##|Q61E", "587|5|variant|litvar@rs121913376##&&&litvar@#673#&&&litvar@CA281968#rs121913376##|V471F", "940|5|variant|litvar@rs121913285##&&&litvar@#5290#&&&litvar@CA16602696#rs121913285##|P539R", "1043|6|variant|litvar@rs121913283##&&&litvar@#5290#&&&litvar@CA183868#rs121913283##|M1043I", "1294|5|variant|litvar@rs121909224##&&&litvar@#5728#&&&litvar@CA16602437#rs121909224##|R130G", "301|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1239|5|variant|litvar@#5728#p.L570P&&&litvar@#5728#|L570P", "968|5|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123338#rs121913286##|Q546K", "647|5|variant|litvar@rs121913369##&&&litvar@#673#&&&litvar@CA123651#rs121913369##|L597V", "239|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "375|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "1354|5|variant|litvar@rs121909219##&&&litvar@#5728#&&&litvar@CA549#rs121909219##|R233X", "1067|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|H1047L", "1125|5|variant|litvar@rs1057519757##&&&litvar@#5295#|G376R", "1180|5|variant|litvar@#5295#p.K459E&&&litvar@#5295#|K459E", "709|6|gene|ncbi_gene@5290|PIK3CA", "91|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "109|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1289|4|gene|ncbi_gene@5728|PTEN", "183|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "431|4|gene|ncbi_gene@3265|HRAS", "1035|6|variant|litvar@rs1057519937##&&&litvar@#5290#|M1043T", "716|4|variant|litvar@rs749415085##&&&litvar@#5290#|R38G", "307|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "1118|6|gene|ncbi_gene@5295|PIK3R1", "381|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "436|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "454|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "509|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "566|5|variant|litvar@rs121913348##&&&litvar@#673#&&&litvar@CA135076#rs121913348##|G464V", "640|5|variant|litvar@rs121913338##&&&litvar@#673#&&&litvar@CA123657#rs121913338##|D594G", "947|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "1059|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "1301|5|variant|litvar@rs121909229##&&&litvar@#5728#&&&litvar@CA437#rs121909229##|R130Q", "97|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "580|5|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|G469A", "515|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "290|4|gene|ncbi_gene@4893|NRAS", "787|5|variant|litvar@rs587777790##&&&litvar@#5290#&&&litvar@CA170883#rs587777790##|G118D", "115|4|variant|litvar@rs745476335##&&&litvar@#673#&&&litvar@CA4517047#rs745476335##|L19F", "189|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "654|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "961|5|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123336#rs121913274##|E545G", "728|5|variant|litvar@rs886042002##&&&litvar@#5290#&&&litvar@CA10602871#rs886042002##|R108H", "313|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "561|4|gene|ncbi_gene@673|BRAF", "1027|6|variant|litvar@rs397517202##&&&litvar@#5290#&&&litvar@CA136374#rs397517202##|T1025A", "1187|5|variant|litvar@rs121913348##&&&litvar@#673#|D464H", "838|5|variant|litvar@#5290#p.C378R&&&litvar@#5290#|C378R", "171|4|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|A59T", "954|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "295|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "103|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA16602674#rs121434595##|G13S", "722|4|variant|litvar@rs1285162474##&&&litvar@#174#|Q75E", "369|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "442|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "889|5|variant|litvar@rs121913272##&&&litvar@#5290#&&&litvar@CA180900#rs121913272##|C420R", "1051|6|variant|litvar@rs121913281##&&&litvar@#5290#&&&litvar@CA130471#rs121913281##|H1047Y", "121|4|variant|litvar@rs121917757##&&&litvar@#3265#&&&litvar@CA122553#rs121917757##|Q22K", "573|5|variant|litvar@rs121913351##&&&litvar@#673#&&&litvar@CA123647#rs121913351##|G466V", "503|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "319|4|variant|litvar@rs121913248##&&&litvar@#4893#&&&litvar@CA16602497#rs121913248##|A18T"], "figure_id": "tI-ol-08-03-1249", "text_hl": "Gene Mutation Forward primer sequence (5' to 3') Reverse primer sequence (5' to 3')   KRAS G12C, G12D, G13S, G13D, L19F, Q22K CTTAAGCGTCGATGGAGGAG CCCTGACATACTCCCAAGGA    A59T, Q61E, Q61R, Q61H GGTGCTTAGTGGCCATTTGT CCTAGGTTTCAATCCCAGCA    <m>A146T</m> TTGTGGACAGGTTTTGAAAGA AGAAACCAAAGCCAAAAGCA   NRAS G12S, G12V, G13R, G13V, A18T GCCCAAGGACTGTTGAAAAA CCGACAAGTGAGAGACAGGA    Q61K, Q61R, Q61H GGCAGAAATGGGCTTGAATA AGGTTAATATCCGCAAATGAC   HRAS G12S, G12V, G13R, G13D GTGGGTTTGCCCTTCAGAT TGGTGGATGTCCTCAAAAGA    Q61K, Q61R, Q61H TGGCTGTGTGAACTCCCC GTCAGTGAGTGCTGCTCCC   BRAF G464V, G466V, G469A, V471F CACTTGGTAGACGGGACTCG AGTTTATTGATGCGAACAGTGA    D594G, L597V, V600E AACTCTTCATAATGCTTGCTCTGA AGCCTCAATTCTTACCATCCA   PIK3CA R38G, Q75E, R108H GCCTAATCAAGTCAAACTATGGAA AAGCTTTATGGTTATTTGCATTTT    G118D ATGTTTGCTGCCTTTGCTCT ATAAGCAGTCCCTGCCTTCA    C378R TAAGGGGATTGTGGGCCTAT AATGGGGTCTTGCTTTGTTG    C420R CTCATGCTTGCTTTGGTTCA TTGGCATGCTCTTCAATCAC    P539R, E542K, E545K, E545G, Q546K GATTGGTTCTTTCCTGTCTCTG CCACAAATATCAATTTACAACCATTG    T1025A, M1043T, M1043I, H1047Y, H1047R, H1047L CATTTGCTCCAAACTGACCA CACCCCAAGCATTTTTCTTC   PIK3R1 G376R CAGACGGGACCTTTTTGGTA AACAAAATAGCTGACATGGAAACA    K459E, D464H GGCTTCTCTGACCCATTAACC CCCCACCTCATTCGTAAAAA    L570P GGAAGAGAAGCCACGCTTTA CCCAACCACTCGTTCAACTT   PTEN R130G, R130Q CCGTATAGCGTAAATTCCCAGA TCTCAGATCCAGGAAGAGGAA   R233X TGCTTGAGATCAAGATTGCAG GCCATAAGGCCTTTTCCTTC    "}], "citations": {"NLM": "Hou W, Liu J, Chen P, Wang H, Ye BC, Qiang F. Mutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinoma. Oncol Lett. PMID: 25120700", "BibTeX": "@article{25120700, title={Mutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinoma.}, author={Hou W and Liu J and Chen P and Wang H and Ye BC and Qiang F}, journal={Oncol Lett}}"}, "is_sup_mat_match": false}, {"pmid": 31035693, "pmcid": "PMC6562944", "title": "Molecular and Morphological Profiling of Lung Cancer: A Foundation for \"Next-Generation\" Pathologists and Oncologists", "journal": "Cancers (Basel)", "authors": ["Kashima J", "Kitadai R", "Okuma Y"], "date": "2019-04-29T00:00:00Z", "year": 2019, "snippets": [{"_id": "31035693@24659", "snip_text": "Other acquired resistance after using osimertinib consists of uncommon EGFR mutations, HER amplification (2%), HER2 mutation (1%), SPTBN1-ALK (1%), MET amplification (15%), BRAF mutation V600E (3%), KRAS mutations (G12D/C, A146T, 3%) and PI3KCA mutations (7%).", "section": "methods", "mentions": ["71|4|gene|ncbi_gene@1950|EGFR", "199|4|gene|ncbi_gene@3845|KRAS", "38|11|chemical|ncbi_mesh@C000596361|osimertinib", "173|4|gene|ncbi_gene@673|BRAF", "223|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "148|3|gene|ncbi_gene@79811|MET", "138|3|gene|ncbi_gene@238|ALK", "187|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "111|4|gene|ncbi_gene@2064|HER2", "215|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12D/C", "131|6|gene|ncbi_gene@6711|SPTBN1"], "text_hl": "Other acquired resistance after using osimertinib consists of uncommon EGFR mutations, HER amplification (2%), HER2 mutation (1%), SPTBN1-ALK (1%), MET amplification (15%), BRAF mutation V600E (3%), KRAS mutations (G12D/C, <m>A146T</m>, 3%) and PI3KCA mutations (7%)."}], "citations": {"NLM": "Kashima J, Kitadai R, Okuma Y. Molecular and Morphological Profiling of Lung Cancer: A Foundation for \"Next-Generation\" Pathologists and Oncologists Cancers (Basel). PMID: 31035693", "BibTeX": "@article{31035693, title={Molecular and Morphological Profiling of Lung Cancer: A Foundation for \"Next-Generation\" Pathologists and Oncologists}, author={Kashima J and Kitadai R and Okuma Y}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 35536216, "pmcid": "PMC9256797", "title": "Delineating the RAS Conformational Landscape.", "journal": "Cancer Res", "authors": ["Parker MI", "Meyer JE", "Golemis EA", "Dunbrack RL"], "date": "2022-05-10T00:00:00Z", "year": 2022, "snippets": [{"_id": "35536216@14096", "snip_text": "Of note, a non-canonical, GDP-bound SW1 conformation called \"beta'\" or \"Mg-Free\" has been recently observed in WT as well as V14I and A146T mutated RAS structures, but it is uncertain if this conformation is biologically common.", "section": "results", "mentions": ["125|4|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|V14I", "134|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "72|2|chemical|ncbi_mesh@D008274|Mg", "26|3|chemical|ncbi_mesh@D006153|GDP"], "text_hl": "Of note, a non-canonical, GDP-bound SW1 conformation called \"beta'\" or \"Mg-Free\" has been recently observed in WT as well as V14I and <m>A146T</m> mutated RAS structures, but it is uncertain if this conformation is biologically common."}], "citations": {"NLM": "Parker MI, Meyer JE, Golemis EA, Dunbrack RL. Delineating the RAS Conformational Landscape. Cancer Res. PMID: 35536216", "BibTeX": "@article{35536216, title={Delineating the RAS Conformational Landscape.}, author={Parker MI and Meyer JE and Golemis EA and Dunbrack RL}, journal={Cancer Res}}"}, "is_sup_mat_match": false}, {"pmid": 33572269, "pmcid": "PMC7915563", "title": "Cell Line Models for Acquired Resistance to First-Line Osimertinib in Lung Cancers-Applications and Limitations.", "journal": "Cells", "authors": ["Ohara S", "Suda K", "Mitsudomi T"], "date": "2021-02-09T00:00:00Z", "year": 2021, "snippets": [{"_id": "33572269@17538", "snip_text": "Furthermore, a recent study reported that PIK3CA mutations (E453K, E545K, H1047R; 7%), BRAF V600E mutations (3%), and KRAS mutations (G12D/C, A146T; 3%) were detected in specimens from patients who developed AR to first-line osimertinib.", "section": "other", "mentions": ["134|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "74|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "92|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "142|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "225|11|chemical|ncbi_mesh@C000596361|osimertinib", "208|2|disease|ncbi_mesh@D063730|AR", "87|4|gene|ncbi_gene@673|BRAF", "67|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "185|8|species|ncbi_taxonomy@9606|patients", "60|5|variant|litvar@rs1057519925##&&&litvar@#5290#|E453K", "42|6|gene|ncbi_gene@5290|PIK3CA", "118|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "Furthermore, a recent study reported that PIK3CA mutations (E453K, E545K, H1047R; 7%), BRAF V600E mutations (3%), and KRAS mutations (G12D/C, <m>A146T</m>; 3%) were detected in specimens from patients who developed AR to first-line osimertinib."}], "citations": {"NLM": "Ohara S, Suda K, Mitsudomi T. Cell Line Models for Acquired Resistance to First-Line Osimertinib in Lung Cancers-Applications and Limitations. Cells. PMID: 33572269", "BibTeX": "@article{33572269, title={Cell Line Models for Acquired Resistance to First-Line Osimertinib in Lung Cancers-Applications and Limitations.}, author={Ohara S and Suda K and Mitsudomi T}, journal={Cells}}"}, "is_sup_mat_match": false}, {"pmid": 26989027, "pmcid": "PMC5008360", "title": "Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients", "journal": "Oncotarget", "authors": ["Hsu HC", "Thiam TK", "Lu YJ", "Yeh CY", "Tsai WS", "You JF", "Hung HY", "Tsai CN", "Hsu A", "Chen HC", "Chen SJ", "Yang TS"], "date": "2016-04-19T00:00:00Z", "year": 2016, "snippets": [{"_id": "26989027@13855", "snip_text": "For example, two Q61L (exon 3), one Q61H (exon 3), and one A146T (exon 4) KRAS mutations were detected in the non-responders.", "section": "results", "mentions": ["36|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "17|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "59|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "74|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "For example, two Q61L (exon 3), one Q61H (exon 3), and one <m>A146T</m> (exon 4) KRAS mutations were detected in the non-responders."}], "citations": {"NLM": "Hsu HC, Thiam TK, Lu YJ, Yeh CY, Tsai WS, You JF, Hung HY, Tsai CN, Hsu A, Chen HC, Chen SJ, Yang TS. Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients Oncotarget. PMID: 26989027", "BibTeX": "@article{26989027, title={Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients}, author={Hsu HC and Thiam TK and Lu YJ and Yeh CY and Tsai WS and You JF and Hung HY and Tsai CN and Hsu A and Chen HC and Chen SJ and Yang TS}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 29093617, "pmcid": "PMC5656456", "title": "Detection of KRAS G12D in colorectal cancer stool by droplet digital PCR.", "journal": "World J Gastroenterol", "authors": ["Olmedillas-L\u00f3pez S", "L\u00e9vano-Linares DC", "Alexandre CLA", "Vega-Clemente L", "S\u00e1nchez EL", "Villagrasa A", "Ru\u00edz-Tovar J", "Garc\u00eda-Arranz M", "Garc\u00eda-Olmo D"], "date": "2017-10-21T00:00:00Z", "year": 2017, "snippets": [{"_id": "29093617@12070", "snip_text": " KRAS wild-type KRAS mutations   Codon 12 Codon 13 Others   G12D G12V G12R G12S G13D G13R A146V A146T A59T Q61R Q61H Q61L   Right colon 17 2 0 1 0 3 1 1 1 0 1 1 0   Left colon 19 6 5 0 0 1 0 1 1 1 0 0 0   Rectum 2 2 0 0 1 1 0 0 0 0 0 1 1     10 5 1 1 5 1 2 2 1 1 2 1   Total 38 (54.29%) 32 (45.71%)   ", "section": "table", "mentions": ["96|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "16|4|gene|ncbi_gene@3845|KRAS", "70|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "65|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1|4|gene|ncbi_gene@3845|KRAS", "80|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "112|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "102|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "75|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "85|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "60|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "117|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "90|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "107|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R"], "figure_id": "T2", "text_hl": " KRAS wild-type KRAS mutations   Codon 12 Codon 13 Others   G12D G12V G12R G12S G13D G13R A146V <m>A146T</m> A59T Q61R Q61H Q61L   Right colon 17 2 0 1 0 3 1 1 1 0 1 1 0   Left colon 19 6 5 0 0 1 0 1 1 1 0 0 0   Rectum 2 2 0 0 1 1 0 0 0 0 0 1 1     10 5 1 1 5 1 2 2 1 1 2 1   Total 38 (54.29%) 32 (45.71%)   "}], "citations": {"NLM": "Olmedillas-L\u00f3pez S, L\u00e9vano-Linares DC, Alexandre CLA, Vega-Clemente L, S\u00e1nchez EL, Villagrasa A, Ru\u00edz-Tovar J, Garc\u00eda-Arranz M, Garc\u00eda-Olmo D. Detection of KRAS G12D in colorectal cancer stool by droplet digital PCR. World J Gastroenterol. PMID: 29093617", "BibTeX": "@article{29093617, title={Detection of KRAS G12D in colorectal cancer stool by droplet digital PCR.}, author={Olmedillas-L\u00f3pez S and L\u00e9vano-Linares DC and Alexandre CLA and Vega-Clemente L and S\u00e1nchez EL and Villagrasa A and Ru\u00edz-Tovar J and Garc\u00eda-Arranz M and Garc\u00eda-Olmo D}, journal={World J Gastroenterol}}"}, "is_sup_mat_match": false}, {"pmid": 30445769, "pmcid": "PMC6262543", "title": "Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy.", "journal": "Cells", "authors": ["Nagano T", "Tachihara M", "Nishimura Y"], "date": "2018-11-15T00:00:00Z", "year": 2018, "snippets": [{"_id": "30445769@16928", "snip_text": "Recently, analysis of circulating tumor DNA revealed the emergence of distinct KRAS activating mutations (G12A, Q61H, and A146T) in three of 43 EGFR-mutant NSCLC patients with acquired activating mutations.", "section": "other", "mentions": ["122|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "144|4|gene|ncbi_gene@1956|EGFR", "112|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "156|5|disease|ncbi_mesh@D002289|NSCLC", "34|5|disease|ncbi_mesh@D009369|tumor", "79|4|gene|ncbi_gene@24525|KRAS", "162|8|species|ncbi_taxonomy@9606|patients", "106|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A"], "text_hl": "Recently, analysis of circulating tumor DNA revealed the emergence of distinct KRAS activating mutations (G12A, Q61H, and <m>A146T</m>) in three of 43 EGFR-mutant NSCLC patients with acquired activating mutations."}], "citations": {"NLM": "Nagano T, Tachihara M, Nishimura Y. Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy. Cells. PMID: 30445769", "BibTeX": "@article{30445769, title={Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy.}, author={Nagano T and Tachihara M and Nishimura Y}, journal={Cells}}"}, "is_sup_mat_match": false}, {"pmid": 30677207, "pmcid": "PMC6594036", "title": "Comprehensive molecular and clinicopathological analysis of vascular malformations: A study of 319 cases.", "journal": "Genes Chromosomes Cancer", "authors": ["Ten Broek RW", "Eijkelenboom A", "van der Vleuten CJM", "Kamping EJ", "Kets M", "Verhoeven BH", "Gr\u00fcnberg K", "Schultze Kool LJ", "Tops BBJ", "Ligtenberg MJL", "Flucke U"], "date": "2019-08-01T00:00:00Z", "year": 2019, "snippets": [{"_id": "30677207@9638", "snip_text": "Gene Identified variant(s) Variant allele frequency (%) Age/sex Site Clinical features Histology   Prospective panel   GNA11 c.627G > C (p.Gln209His) 9 64/m Hand Unknown Veno-capillary malformation   GNA11 c.547C > T (p.Arg183Cys) 5 61/m Upper eyelid Congenital port wine stain; progressive hypertrophy Veno-capillary malformation   GNA11 c.626A > T (p.Gln209Leu) 3 72/m Acetabulum Unknown Veno-capillary malformation   GNAQ c.548G > A (p.Arg183Gln) 8 67/f Skin neck Residue after venous malformation Veno-capillary malformation   GNAQ c.627A > C (p.Gln209His) 4 57/f Arm Atypical lesion; spectrum non-involuted congenital hemangioma (NICH)/ venous malformation Veno-capillary malformation   GNAQ c.548G > A (p.Arg183Gln) 8 81/f Lower lip Port wine stain in Sturge Weber Syndrome Combined vascular malformation   GNAQ c.627A > C (p.Gln209His) 18 64/f Epidural Epidural mass Veno-capillary malformation   GNAQ c.548G > A (p.Arg183Gln) 8 43/f Upper lip Port wine stain with firm hypertrophy; KTS spectrum Venous malformation   GNAQ c.626A > T (p.Gln209Leu) 21 15/m Skin clavicle Non congenital vascular high flow lesion Veno-capillary malformation   AKT-1 c.49G > A (p.Glu17Lys) 8 5/m Saphenous vein Congenital port wine stain of one leg with firm overgrowth; mild phenotype of Proteus. Venous malformation   KRAS c.35_38delinsCTCA (p.Gly12_Gly13delinsAlaHis) 32 56/f Flank Vascularized tumor Veno-capillary malformation   KRAS c.64C > A (p.Gln22Lys) 22 32/m Cheek KTS-spectrum with lymphedema and port-wine stain leg and multiple vascular lesions left side face Veno-capillary malformation   KRAS c.35G > C (p.Gly12Ala) 18 32/m Cheek Lipoma with vascular lesion Venous malformation   KRAS c.436G > A (p.Ala146Thr) 17 45/f Arm KTS spectrum with venolymphatic lesion and port wine stain Venous malformation   KRAS c.37G > T (p.Gly13Cys) 2 8/f Lower jaw Unknown Veno-capillary malformation   KRAS c.35G > A (p.Gly12Asp) 9 70/f Subcutis buttock Unknown Veno-capillary malformation   NRAS c.182A > G (p.Gln61Arg) 14 12/m Thoracal skin Multiple eruptive pyogenic granuloma Capillary malformation   IDH1 c.394C > T (p.Arg132Cys) 2 12/f Upper arm muscle Venous malformation or non-involuted congenital hemangioma Veno-capillary malformation   IDH1 c.394C > T (p.Arg132Cys) 14 38/f Foot Unknown SCH   IDH1 c.394C > T (p.Arg132Cys) 10 15/m Soft tissue foot Unknown SCH   PIK3CA; GNAQ c.3140A > G (p.His1047Arg); c.627A > C (p.Gln209His) 26; 26 53/m Skull/dura Vascular proliferation with Masson-like features Veno-capillary malformation   PIK3CA; GNA11 c.3140A > G (p.His1047Arg); c.627G > C (p.Gln209His) 17; 17 57/m Skin pericumbilical Unknown Veno-capillary malformation   PIK3CA; GNA11 c.1633G > A (p.Glu545Lys); c.627G > T (p.Gln209His) 7; 6 45/m Skin nose Venous malformation Veno-capillary malformation   PIK3CA; IDH1 c.3140A > G (p.His1047Arg); c.394C > T (p.Arg132Cys) 12; 9 5/f Scapula Venolymphatic malformation, atypical by ultrasound SCH   Retrospective panel   TEK c.2690A > G (p.Tyr897Cys) 3 11/f Jaw Venous malformation Venous malformation   TEK c.2740C > T (p.Leu914Phe) 5 20/f Labia minora Venous malformation Venous malformation   TEK c.2740C > T (p.Leu914Phe) 11 15/m Soft tissue leg Venous malformation Veno-capillary malformation   TEK c.2740C > T (p.Leu914Phe) 9 67/f Upper lip Venous lake Combined malformation (extensive lymphatic component)   TEK c.2690A > G (p.Tyr897Cys) 4 80/f Subcutis Unknown Combined malformation (extensive lymphatic component)   TEK c.2690A > G (p.Tyr897Cys) 4 9/f Groin Venous malformation, also anemia. d.d. Blue rubber bleb nevus. Combined malformation (extensive lymphatic component)   TEK c.2740C > T (p.Leu914Phe) 8 33/m Lower arm Venous malformation Venous malformation   TEK c.2740C > T (p.Leu914Phe) 5 17/f Leg Unknown Veno-capillary malformation   TEK c.2740C > T (p.Leu914Phe) 5 10/m Lip Venous malformation Veno-capillary malformation   TEK c.2740C > T (p.Leu914Phe) 9 15/m Soft tissue arm Unknown Veno-capillary malformation   TEK c.2689 T > C (p.Tyr897His) 12 2/m Arm Localized atypical tumor by ultra sound. d.d. vascular malformation Veno-capillary malformation   GNAQ c.548G > A (p.Arg183Gln) 7 56/f Face Port wine stain with hypertrophy Venous malformation   KRAS c.34G > T (p.Gly12Cys) 6 76/m Lower leg Arteriovenous malformation (AVM) with ulceration AVM   KRAS c.34G > T (p.Gly12Cys) 6 68/f Finger AVM AVM   KRAS c.35G > T (p.Gly12Val) 3 17/f Brain Unknown Venous malformation   GNA11 c.626A > T (p.Gln209Leu) 9 45/m Skin ear canal Unknown Veno-capillary malformation   PIK3CA; GNAQ c.1624G > A (p.Gln542Lys); c.627A > C (p.Gln209His) 15; 13 27/m Skin High flow lesion, d.d. AVM Veno-capillary malformation   PIK3CA; IDH1 c.1624G > A (p.Gln542Lys); c.394C > T (p.Arg132Cys) 24; 20 21/m Subcutis leg Atypical vascular lesion SCH   ", "section": "table", "mentions": ["4617|11|disease|ncbi_mesh@D054318|flow lesion", "1391|27|disease|omim@163000|Veno-capillary malformation", "4669|6|gene|ncbi_gene@5290|PIK3CA", "662|27|disease|omim@163000|Veno-capillary malformation", "1063|4|disease|ncbi_mesh@D012871|Skin", "1481|10|disease|ncbi_mesh@D008209|lymphedema", "1995|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Gln61Arg", "4368|4|gene|ncbi_gene@3845|KRAS", "1209|15|disease|ncbi_mesh@D019339|port wine stain", "3193|19|disease|ncbi_mesh@C563977|Venous malformation", "692|4|gene|ncbi_gene@2776|GNAQ", "3801|11|variant|litvar@rs781070018##&&&litvar@#2064#&&&litvar@CA8534380#rs781070018##|c.2740C > T", "4332|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.Gly12Cys", "1307|4|gene|ncbi_gene@3845|KRAS", "4500|27|disease|omim@163000|Veno-capillary malformation", "2239|10|variant|litvar@rs121913499##&&&litvar@#3417#&&&litvar@CA16602374#rs121913499##|c.394C > T", "1822|10|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|p.Gly13Cys", "3485|11|variant|litvar@rs80338909##&&&litvar@#7010#&&&litvar@CA259741#rs80338909##|p.Tyr897Cys", "4161|15|disease|ncbi_mesh@D019339|Port wine stain", "1661|19|disease|ncbi_mesh@C563977|Venous malformation", "2877|7|disease|ncbi_mesh@C535802|Scapula", "1811|9|variant|litvar@rs104894228##&&&litvar@#3265#&&&litvar@CA295247#rs104894228##|c.37G > T", "548|11|variant|litvar@rs1057519742##&&&litvar@#2767#|p.Gln209His", "2108|11|variant|litvar@rs121913499##&&&litvar@#3417#&&&litvar@CA16602374#rs121913499##|p.Arg132Cys", "2718|11|variant|litvar@rs1057519742##&&&litvar@#2767#|p.Gln209His", "3858|27|disease|omim@163000|Veno-capillary malformation", "1596|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > C", "2555|12|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.His1047Arg", "3247|11|variant|litvar@rs781070018##&&&litvar@#2064#&&&litvar@CA8534380#rs781070018##|c.2740C > T", "2673|5|gene|ncbi_gene@2767|GNA11", "3139|3|gene|ncbi_gene@7010|TEK", "3362|11|variant|litvar@rs80338909##&&&litvar@#7010#&&&litvar@CA259741#rs80338909##|c.2690A > G", "3834|23|disease|ncbi_mesh@D008047|Lip Venous malformation", "2401|10|variant|litvar@rs1227526639##&&&litvar@#3418#|c.627A > C", "1858|27|disease|omim@163000|Veno-capillary malformation", "4316|4|gene|ncbi_gene@3845|KRAS", "2692|11|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.Glu545Lys", "3064|11|variant|litvar@rs781070018##&&&litvar@#2064#|p.Leu914Phe", "1496|15|disease|ncbi_mesh@D019339|port-wine stain", "2968|11|variant|litvar@rs80338909##&&&litvar@#7010#&&&litvar@CA259741#rs80338909##|c.2690A > G", "921|11|variant|litvar@rs397514698##&&&litvar@#2776#&&&litvar@CA143805#rs397514698##|p.Arg183Gln", "1529|16|disease|ncbi_mesh@D014652|vascular lesions", "1806|4|gene|ncbi_gene@3845|KRAS", "3213|27|disease|omim@163000|Veno-capillary malformation", "4530|6|gene|ncbi_gene@5290|PIK3CA", "635|4|disease||NICH", "1888|4|gene|ncbi_gene@3845|KRAS", "2827|12|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.His1047Arg", "1030|10|variant|litvar@rs1057519742##&&&litvar@#2767#|c.626A > T", "2854|11|variant|litvar@rs121913499##&&&litvar@#3417#&&&litvar@CA16602374#rs121913499##|p.Arg132Cys", "420|4|gene|ncbi_gene@2776|GNAQ", "1768|15|disease|ncbi_mesh@D019339|port wine stain", "303|27|disease|omim@163000|Veno-capillary malformation", "1743|20|disease|ncbi_mesh@D009059|venolymphatic lesion", "1312|17|variant|litvar@#3845#c.35_38delinsCTCA&&&litvar@#3845#|c.35_38delinsCTCA", "1148|3|gene|ncbi_gene@207|AKT", "1846|3|disease|ncbi_mesh@D007571|jaw", "2542|11|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A > G", "4124|10|variant|litvar@rs767439253##&&&litvar@#5290#&&&litvar@CA2710555#rs767439253##|c.548G > A", "4358|7|disease|ncbi_mesh@D002538|AVM AVM", "457|4|disease|ncbi_mesh@D012871|Skin", "1561|27|disease|omim@163000|Veno-capillary malformation", "2706|10|variant|litvar@rs1227526639##&&&litvar@#3418#|c.627G > T", "1591|4|gene|ncbi_gene@3845|KRAS", "1042|11|variant|litvar@rs121913492##&&&litvar@#2776#&&&litvar@CA16602434#rs121913492##|p.Gln209Leu", "1645|15|disease|ncbi_mesh@D014652|vascular lesion", "536|10|variant|litvar@rs1227526639##&&&litvar@#3418#|c.627A > C", "2096|10|variant|litvar@rs121913499##&&&litvar@#3417#&&&litvar@CA16602374#rs121913499##|c.394C > T", "4136|11|variant|litvar@rs397514698##&&&litvar@#2776#&&&litvar@CA143805#rs397514698##|p.Arg183Gln", "4321|9|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|c.34G > T", "4403|33|disease|ncbi_mesh@D020520|Brain Unknown Venous malformation", "481|19|disease|ncbi_mesh@C563977|venous malformation", "1683|4|gene|ncbi_gene@3845|KRAS", "3510|19|disease|ncbi_mesh@C563977|Venous malformation", "3949|27|disease|omim@163000|Veno-capillary malformation", "2814|11|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A > G", "206|10|variant|litvar@rs757031960##&&&litvar@#3417#&&&litvar@CA2078964#rs757031960##|c.547C > T", "2665|6|gene|ncbi_gene@5290|PIK3CA", "4768|19|disease|ncbi_mesh@D002277|vascular lesion SCH", "568|19|disease|ncbi_mesh@C566258|Arm Atypical lesion", "4031|14|disease|ncbi_mesh@D009369|atypical tumor", "4709|10|variant|litvar@rs121913499##&&&litvar@#3417#&&&litvar@CA16602374#rs121913499##|c.394C > T", "3375|11|variant|litvar@rs80338909##&&&litvar@#7010#&&&litvar@CA259741#rs80338909##|p.Tyr897Cys", "2607|4|disease|ncbi_mesh@D012871|Skin", "3629|3|gene|ncbi_gene@7010|TEK", "598|35|disease|ncbi_mesh@D003865|non-involuted congenital hemangioma", "3358|3|gene|ncbi_gene@7010|TEK", "3646|11|variant|litvar@rs781070018##&&&litvar@#2064#|p.Leu914Phe", "3472|11|variant|litvar@rs80338909##&&&litvar@#7010#&&&litvar@CA259741#rs80338909##|c.2690A > G", "909|10|variant|litvar@rs767439253##&&&litvar@#5290#&&&litvar@CA2710555#rs767439253##|c.548G > A", "1607|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.Gly12Ala", "1721|7|disease|ncbi_mesh@D007715|Arm KTS", "3047|3|gene|ncbi_gene@7010|TEK", "218|11|variant|litvar@rs397514698##|p.Arg183Cys", "2536|5|gene|ncbi_gene@2767|GNA11", "2582|11|variant|litvar@rs1057519742##&&&litvar@#2767#|p.Gln209His", "2842|10|variant|litvar@rs121913499##&&&litvar@#3417#&&&litvar@CA16602374#rs121913499##|c.394C > T", "4721|11|variant|litvar@rs121913499##&&&litvar@#3417#&&&litvar@CA16602374#rs121913499##|p.Arg132Cys", "3156|11|variant|litvar@rs781070018##&&&litvar@#2064#|p.Leu914Phe", "371|18|disease|ncbi_mesh@D009382|Acetabulum Unknown", "4310|3|disease|ncbi_mesh@D002538|AVM", "1003|19|disease|ncbi_mesh@C563977|Venous malformation", "3797|3|gene|ncbi_gene@7010|TEK", "830|11|variant|litvar@rs1057519742##&&&litvar@#2767#|p.Gln209His", "3755|39|disease|omim@163000|Leg Unknown Veno-capillary malformation", "1421|4|gene|ncbi_gene@3845|KRAS", "2635|27|disease|omim@163000|Veno-capillary malformation", "4695|11|variant|litvar@#2776#p.Q542K&&&litvar@#2776#|p.Gln542Lys", "977|11|disease|ncbi_mesh@D006984|hypertrophy", "4607|4|disease|ncbi_mesh@D012871|Skin", "2373|11|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A > G", "2498|27|disease|omim@163000|Veno-capillary malformation", "3892|11|variant|litvar@rs781070018##&&&litvar@#2064#&&&litvar@CA8534380#rs781070018##|c.2740C > T", "1106|11|disease|ncbi_mesh@D054318|flow lesion", "4457|11|variant|litvar@rs121913492##&&&litvar@#2776#&&&litvar@CA16602434#rs121913492##|p.Gln209Leu", "4538|4|gene|ncbi_gene@2776|GNAQ", "1688|10|variant|litvar@rs1409475654##&&&litvar@#9630#|c.436G > A", "339|10|variant|litvar@rs1057519742##&&&litvar@#2767#|c.626A > T", "437|11|variant|litvar@rs397514698##&&&litvar@#2776#&&&litvar@CA143805#rs397514698##|p.Arg183Gln", "3243|3|gene|ncbi_gene@7010|TEK", "697|10|variant|litvar@rs767439253##&&&litvar@#5290#&&&litvar@CA2710555#rs767439253##|c.548G > A", "2024|4|disease|ncbi_mesh@D012871|skin", "2570|10|variant|litvar@rs182693596##&&&litvar@#3417#&&&litvar@CA2078950#rs182693596##|c.627G > C", "4373|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA261525#rs121913237##|c.35G > T", "2368|4|gene|ncbi_gene@2776|GNAQ", "1426|9|variant|litvar@rs121917757##&&&litvar@#3265#&&&litvar@CA122553#rs121917757##|c.64C > A", "4232|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.Gly12Cys", "1276|7|disease|ncbi_mesh@D016715|Proteus", "2964|3|gene|ncbi_gene@7010|TEK", "4261|26|disease|ncbi_mesh@D001165|Arteriovenous malformation", "1983|10|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|c.182A > G", "2386|12|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.His1047Arg", "3001|3|disease|ncbi_mesh@D007571|Jaw", "709|11|variant|litvar@rs397514698##&&&litvar@#2776#&&&litvar@CA143805#rs397514698##|p.Arg183Gln", "2771|27|disease|omim@163000|Veno-capillary malformation", "1437|10|variant|litvar@rs121913236##&&&litvar@#3845#&&&litvar@CA16602771#rs121913236##|p.Gln22Lys", "2296|10|variant|litvar@rs121913499##&&&litvar@#3417#&&&litvar@CA16602374#rs121913499##|c.394C > T", "4089|27|disease|omim@163000|Veno-capillary malformation", "200|5|gene|ncbi_gene@2767|GNA11", "818|10|variant|litvar@rs1227526639##&&&litvar@#3418#|c.627A > C", "3979|3|gene|ncbi_gene@7010|TEK", "333|5|gene|ncbi_gene@2767|GNA11", "2981|11|variant|litvar@rs80338909##&&&litvar@#7010#&&&litvar@CA259741#rs80338909##|p.Tyr897Cys", "1025|4|gene|ncbi_gene@2776|GNAQ", "789|21|disease|ncbi_mesh@D054079|vascular malformation", "2679|11|variant|litvar@rs937591117##&&&litvar@CA21616309#rs937591117##|c.1633G > A", "4119|4|gene|ncbi_gene@2776|GNAQ", "1366|5|disease|ncbi_mesh@D021501|Flank", "3143|11|variant|litvar@rs781070018##&&&litvar@#2064#&&&litvar@CA8534380#rs781070018##|c.2740C > T", "947|19|disease|ncbi_mesh@D019339|lip Port wine stain", "4477|4|disease|ncbi_mesh@D012871|Skin", "2145|19|disease|ncbi_mesh@C563977|Venous malformation", "4445|10|variant|litvar@rs1057519742##&&&litvar@#2767#|c.626A > T", "2308|11|variant|litvar@rs121913499##&&&litvar@#3417#&&&litvar@CA16602374#rs121913499##|p.Arg132Cys", "3722|11|variant|litvar@rs781070018##&&&litvar@#2064#&&&litvar@CA8534380#rs781070018##|c.2740C > T", "170|27|disease|omim@163000|Veno-capillary malformation", "119|5|gene|ncbi_gene@2767|GNA11", "2360|6|gene|ncbi_gene@5290|PIK3CA", "4067|21|disease|ncbi_mesh@D054079|vascular malformation", "4543|11|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|c.1624G > A", "501|27|disease|omim@163000|Veno-capillary malformation", "758|21|disease|ncbi_mesh@D013341|Sturge Weber Syndrome", "3814|11|variant|litvar@rs781070018##&&&litvar@#2064#|p.Leu914Phe", "137|11|variant|litvar@rs1057519742##&&&litvar@#2767#|p.Gln209His", "425|10|variant|litvar@rs767439253##&&&litvar@#5290#&&&litvar@CA2710555#rs767439253##|c.548G > A", "3905|11|variant|litvar@rs781070018##&&&litvar@#2064#|p.Leu914Phe", "4570|10|variant|litvar@rs1227526639##&&&litvar@#3418#|c.627A > C", "1784|19|disease|ncbi_mesh@C563977|Venous malformation", "2801|6|gene|ncbi_gene@5290|PIK3CA", "3997|11|variant|litvar@rs80338909##&&&litvar@#7010#|p.Tyr897His", "262|15|disease|ncbi_mesh@D019339|port wine stain", "1893|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "1154|9|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|c.49G > A", "531|4|gene|ncbi_gene@2776|GNAQ", "4682|11|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|c.1624G > A", "2171|60|disease|omim@163000|-involuted congenital hemangioma Veno-capillary malformation", "1948|27|disease|omim@163000|Veno-capillary malformation", "4439|5|gene|ncbi_gene@2767|GNA11", "1457|9|disease|ncbi_mesh@D007715|Cheek KTS", "3468|3|gene|ncbi_gene@7010|TEK", "1627|12|disease|ncbi_mesh@C536084|Cheek Lipoma", "874|27|disease|omim@163000|Veno-capillary malformation", "4289|3|disease|ncbi_mesh@D002538|AVM", "4582|11|variant|litvar@rs1057519742##&&&litvar@#2767#|p.Gln209His", "1904|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.Gly12Asp", "1978|4|gene|ncbi_gene@4893|NRAS", "1165|10|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|p.Glu17Lys", "2741|29|disease|ncbi_mesh@D009668|Skin nose Venous malformation", "3260|11|variant|litvar@rs781070018##&&&litvar@#2064#|p.Leu914Phe", "4221|9|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|c.34G > T", "642|19|disease|ncbi_mesh@C563977|venous malformation", "1285|19|disease|ncbi_mesh@C563977|Venous malformation", "3990|5|variant|litvar@#7010#|T > C", "904|4|gene|ncbi_gene@2776|GNAQ", "2528|6|gene|ncbi_gene@5290|PIK3CA", "4635|31|disease|ncbi_mesh@D002538|AVM Veno-capillary malformation", "3554|17|disease|ncbi_mesh@C536240|rubber bleb nevus", "1118|27|disease|omim@163000|Veno-capillary malformation", "813|4|gene|ncbi_gene@2776|GNAQ", "2251|11|variant|litvar@rs121913499##&&&litvar@#3417#&&&litvar@CA16602374#rs121913499##|p.Arg132Cys", "4482|17|disease|ncbi_mesh@D004427|ear canal Unknown", "291|11|disease|ncbi_mesh@D006984|hypertrophy", "3290|6|disease|ncbi_mesh@D014647|Venous", "2066|22|disease|omim@163000|Capillary malformation", "1700|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "351|11|variant|litvar@rs121913492##&&&litvar@#2776#&&&litvar@CA16602434#rs121913492##|p.Gln209Leu", "735|19|disease|ncbi_mesh@D019339|lip Port wine stain", "4384|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.Gly12Val", "3005|39|disease|ncbi_mesh@C563977|Venous malformation Venous malformation", "1372|18|disease|ncbi_mesh@D009369|Vascularized tumor", "2047|18|disease|ncbi_mesh@D017789|pyogenic granuloma", "3633|11|variant|litvar@rs781070018##&&&litvar@#2064#&&&litvar@CA8534380#rs781070018##|c.2740C > T", "3097|39|disease|ncbi_mesh@C563977|Venous malformation Venous malformation", "4182|31|disease|ncbi_mesh@D006984|hypertrophy Venous malformation", "3718|3|gene|ncbi_gene@7010|TEK", "125|10|variant|litvar@rs182693596##&&&litvar@#3417#&&&litvar@CA2078950#rs182693596##|c.627G > C", "2885|26|disease|ncbi_mesh@C564254|Venolymphatic malformation", "3676|39|disease|ncbi_mesh@C563977|Venous malformation Venous malformation", "3735|11|variant|litvar@rs781070018##&&&litvar@#2064#|p.Leu914Phe", "3888|3|gene|ncbi_gene@7010|TEK", "3051|11|variant|litvar@rs781070018##&&&litvar@#2064#&&&litvar@CA8534380#rs781070018##|c.2740C > T", "4556|11|variant|litvar@#2776#p.Q542K&&&litvar@#2776#|p.Gln542Lys", "390|27|disease|omim@163000|Veno-capillary malformation", "2413|11|variant|litvar@rs1057519742##&&&litvar@#2767#|p.Gln209His", "157|12|disease|ncbi_mesh@D009382|Hand Unknown", "4216|4|gene|ncbi_gene@3845|KRAS"], "figure_id": "gcc22739-tbl-0001", "text_hl": "Gene Identified variant(s) Variant allele frequency (%) Age/sex Site Clinical features Histology   Prospective panel   GNA11 c.627G > C (p.Gln209His) 9 64/m Hand Unknown Veno-capillary malformation   GNA11 c.547C > T (p.Arg183Cys) 5 61/m Upper eyelid Congenital port wine stain; progressive hypertrophy Veno-capillary malformation   GNA11 c.626A > T (p.Gln209Leu) 3 72/m Acetabulum Unknown Veno-capillary malformation   GNAQ c.548G > A (p.Arg183Gln) 8 67/f Skin neck Residue after venous malformation Veno-capillary malformation   GNAQ c.627A > C (p.Gln209His) 4 57/f Arm Atypical lesion; spectrum non-involuted congenital hemangioma (NICH)/ venous malformation Veno-capillary malformation   GNAQ c.548G > A (p.Arg183Gln) 8 81/f Lower lip Port wine stain in Sturge Weber Syndrome Combined vascular malformation   GNAQ c.627A > C (p.Gln209His) 18 64/f Epidural Epidural mass Veno-capillary malformation   GNAQ c.548G > A (p.Arg183Gln) 8 43/f Upper lip Port wine stain with firm hypertrophy; KTS spectrum Venous malformation   GNAQ c.626A > T (p.Gln209Leu) 21 15/m Skin clavicle Non congenital vascular high flow lesion Veno-capillary malformation   AKT-1 c.49G > A (p.Glu17Lys) 8 5/m Saphenous vein Congenital port wine stain of one leg with firm overgrowth; mild phenotype of Proteus. Venous malformation   KRAS c.35_38delinsCTCA (p.Gly12_Gly13delinsAlaHis) 32 56/f Flank Vascularized tumor Veno-capillary malformation   KRAS c.64C > A (p.Gln22Lys) 22 32/m Cheek KTS-spectrum with lymphedema and port-wine stain leg and multiple vascular lesions left side face Veno-capillary malformation   KRAS c.35G > C (p.Gly12Ala) 18 32/m Cheek Lipoma with vascular lesion Venous malformation   KRAS c.436G > A (<m>p.Ala146Thr</m>) 17 45/f Arm KTS spectrum with venolymphatic lesion and port wine stain Venous malformation   KRAS c.37G > T (p.Gly13Cys) 2 8/f Lower jaw Unknown Veno-capillary malformation   KRAS c.35G > A (p.Gly12Asp) 9 70/f Subcutis buttock Unknown Veno-capillary malformation   NRAS c.182A > G (p.Gln61Arg) 14 12/m Thoracal skin Multiple eruptive pyogenic granuloma Capillary malformation   IDH1 c.394C > T (p.Arg132Cys) 2 12/f Upper arm muscle Venous malformation or non-involuted congenital hemangioma Veno-capillary malformation   IDH1 c.394C > T (p.Arg132Cys) 14 38/f Foot Unknown SCH   IDH1 c.394C > T (p.Arg132Cys) 10 15/m Soft tissue foot Unknown SCH   PIK3CA; GNAQ c.3140A > G (p.His1047Arg); c.627A > C (p.Gln209His) 26; 26 53/m Skull/dura Vascular proliferation with Masson-like features Veno-capillary malformation   PIK3CA; GNA11 c.3140A > G (p.His1047Arg); c.627G > C (p.Gln209His) 17; 17 57/m Skin pericumbilical Unknown Veno-capillary malformation   PIK3CA; GNA11 c.1633G > A (p.Glu545Lys); c.627G > T (p.Gln209His) 7; 6 45/m Skin nose Venous malformation Veno-capillary malformation   PIK3CA; IDH1 c.3140A > G (p.His1047Arg); c.394C > T (p.Arg132Cys) 12; 9 5/f Scapula Venolymphatic malformation, atypical by ultrasound SCH   Retrospective panel   TEK c.2690A > G (p.Tyr897Cys) 3 11/f Jaw Venous malformation Venous malformation   TEK c.2740C > T (p.Leu914Phe) 5 20/f Labia minora Venous malformation Venous malformation   TEK c.2740C > T (p.Leu914Phe) 11 15/m Soft tissue leg Venous malformation Veno-capillary malformation   TEK c.2740C > T (p.Leu914Phe) 9 67/f Upper lip Venous lake Combined malformation (extensive lymphatic component)   TEK c.2690A > G (p.Tyr897Cys) 4 80/f Subcutis Unknown Combined malformation (extensive lymphatic component)   TEK c.2690A > G (p.Tyr897Cys) 4 9/f Groin Venous malformation, also anemia. d.d. Blue rubber bleb nevus. Combined malformation (extensive lymphatic component)   TEK c.2740C > T (p.Leu914Phe) 8 33/m Lower arm Venous malformation Venous malformation   TEK c.2740C > T (p.Leu914Phe) 5 17/f Leg Unknown Veno-capillary malformation   TEK c.2740C > T (p.Leu914Phe) 5 10/m Lip Venous malformation Veno-capillary malformation   TEK c.2740C > T (p.Leu914Phe) 9 15/m Soft tissue arm Unknown Veno-capillary malformation   TEK c.2689 T > C (p.Tyr897His) 12 2/m Arm Localized atypical tumor by ultra sound. d.d. vascular malformation Veno-capillary malformation   GNAQ c.548G > A (p.Arg183Gln) 7 56/f Face Port wine stain with hypertrophy Venous malformation   KRAS c.34G > T (p.Gly12Cys) 6 76/m Lower leg Arteriovenous malformation (AVM) with ulceration AVM   KRAS c.34G > T (p.Gly12Cys) 6 68/f Finger AVM AVM   KRAS c.35G > T (p.Gly12Val) 3 17/f Brain Unknown Venous malformation   GNA11 c.626A > T (p.Gln209Leu) 9 45/m Skin ear canal Unknown Veno-capillary malformation   PIK3CA; GNAQ c.1624G > A (p.Gln542Lys); c.627A > C (p.Gln209His) 15; 13 27/m Skin High flow lesion, d.d. AVM Veno-capillary malformation   PIK3CA; IDH1 c.1624G > A (p.Gln542Lys); c.394C > T (p.Arg132Cys) 24; 20 21/m Subcutis leg Atypical vascular lesion SCH   "}], "citations": {"NLM": "Ten Broek RW, Eijkelenboom A, van der Vleuten CJM, Kamping EJ, Kets M, Verhoeven BH, Gr\u00fcnberg K, Schultze Kool LJ, Tops BBJ, Ligtenberg MJL, Flucke U. Comprehensive molecular and clinicopathological analysis of vascular malformations: A study of 319 cases. Genes Chromosomes Cancer. PMID: 30677207", "BibTeX": "@article{30677207, title={Comprehensive molecular and clinicopathological analysis of vascular malformations: A study of 319 cases.}, author={Ten Broek RW and Eijkelenboom A and van der Vleuten CJM and Kamping EJ and Kets M and Verhoeven BH and Gr\u00fcnberg K and Schultze Kool LJ and Tops BBJ and Ligtenberg MJL and Flucke U}, journal={Genes Chromosomes Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 34307463, "pmcid": "PMC8295990", "title": "Divergent Mechanisms Activating RAS and Small GTPases Through Post-translational Modification.", "journal": "Front Mol Biosci", "authors": ["Osaka N", "Hirota Y", "Ito D", "Ikeda Y", "Kamata R", "Fujii Y", "Chirasani VR", "Campbell SL", "Takeuchi K", "Senda T", "Sasaki AT"], "date": "2021-07-08T00:00:00Z", "year": 2021, "snippets": [{"_id": "34307463@11013", "snip_text": "The improvements in sequencing technology in the 2000s have uncovered additional point mutations in the G4 (e.g.  K117N) and G5 (e.g.  A146T) motifs that promote RAS activation.", "section": "other", "mentions": ["135|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "114|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N"], "text_hl": "The improvements in sequencing technology in the 2000s have uncovered additional point mutations in the G4 (e.g.  K117N) and G5 (e.g.  <m>A146T</m>) motifs that promote RAS activation."}], "citations": {"NLM": "Osaka N, Hirota Y, Ito D, Ikeda Y, Kamata R, Fujii Y, Chirasani VR, Campbell SL, Takeuchi K, Senda T, Sasaki AT. Divergent Mechanisms Activating RAS and Small GTPases Through Post-translational Modification. Front Mol Biosci. PMID: 34307463", "BibTeX": "@article{34307463, title={Divergent Mechanisms Activating RAS and Small GTPases Through Post-translational Modification.}, author={Osaka N and Hirota Y and Ito D and Ikeda Y and Kamata R and Fujii Y and Chirasani VR and Campbell SL and Takeuchi K and Senda T and Sasaki AT}, journal={Front Mol Biosci}}"}, "is_sup_mat_match": false}, {"pmid": 32428030, "pmcid": "PMC7237001", "title": "NADPH oxidase 1 is highly expressed in human large and small bowel cancers.", "journal": "PLoS One", "authors": ["Lu J", "Jiang G", "Wu Y", "Antony S", "Meitzler JL", "Juhasz A", "Liu H", "Roy K", "Makhlouf H", "Chuaqui R", "Butcher D", "Konat\u00e9 MM", "Doroshow JH"], "date": "2020-05-19T00:00:00Z", "year": 2020, "snippets": [{"_id": "32428030@49530", "snip_text": "Status ATCC cell line RAS mutation NOX1/beta-actin x 106 Origin Corroboration in literature    SW403 KRAS G12V 120303 Colorectal adenocarcinoma    SW480 KRAS G12V 47 Colorectal adenocarcinoma    SW620 KRAS G12V 3 Colorectal adenocarcinoma    LS174T KRAS G12D 96065 Colorectal adenocarcinoma    LS123 KRAS G12S 144 Colorectal adenocarcinoma    SW837 KRAS G12C 95 Colorectal adenocarcinoma    DLD-1 KRAS G13D 8546 Colorectal adenocarcinoma    HCT-8 KRAS G13D 6748 Colorectal adenocarcinoma    T84 KRAS G13D 1157 Colorectal carcinoma    LoVo KRAS G13D 219 Colorectal adenocarcinoma    HCT-15 KRAS G13D 198 Colorectal adenocarcinoma    HCT-116 KRAS G13D 118 Colorectal carcinoma    SW948 KRAS Q61L 1437 Colorectal adenocarcinoma    HRAS mutant CRC SW1116 HRAS G161R 494 Colorectal adenocarcinoma KRAS G12A    SW48 HRAS G161R 7 Colorectal adenocarcinoma KRAS WT    RAS WT CRC HT-29 RAS WT 33697 Colorectal adenocarcinoma    WiDr RAS WT 33513 Colorectal adenocarcinoma    Caco-2 RAS WT 16975 Colorectal adenocarcinoma    COLO 201 RAS WT 10 Colorectal adenocarcinoma    COLO 205 RAS WT 931 Colorectal adenocarcinoma    COLO 320HSR RAS WT 21 Colorectal adenocarcinoma    COLO 320DM RAS WT 40 Colorectal adenocarcinoma    LS1034 RAS WT 45194 Colorectal carcinoma KRAS A146T    SW1417 RAS WT 22 Colorectal adenocarcinoma    RKO RAS WT 4 Colon carcinoma    RKO-E6 RAS WT 1 Derived from RKO; disrupted p53 function    p53R RAS WT 1 Derived from RKO    RAS WT normal colon CCD-18Co RAS WT 85 Normal colon fibroblast    ", "section": "table", "mentions": ["539|4|gene|ncbi_gene@3845|KRAS", "305|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "797|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "147|5|cellline||SW480", "1063|4|species|ncbi_taxonomy@307630|COLO", "397|4|gene|ncbi_gene@3845|KRAS", "35|4|gene|ncbi_gene@27035|NOX1", "751|4|gene|ncbi_gene@3265|HRAS", "632|7|cellline||HCT-116", "1333|9|disease|ncbi_mesh@D009369|carcinoma", "40|10|gene|ncbi_gene@728378|beta-actin", "495|4|gene|ncbi_gene@3845|KRAS", "206|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "849|4|gene|ncbi_gene@3845|KRAS", "412|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "201|4|gene|ncbi_gene@3845|KRAS", "766|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "986|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "1285|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "684|4|gene|ncbi_gene@3845|KRAS", "1254|4|gene|ncbi_gene@3845|KRAS", "106|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "354|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "1015|4|species|ncbi_taxonomy@307630|COLO", "1112|4|species|ncbi_taxonomy@307630|COLO", "665|9|disease|ncbi_mesh@D009369|carcinoma", "1134|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "166|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "937|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "254|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1163|4|species|ncbi_taxonomy@307630|COLO", "640|4|gene|ncbi_gene@3845|KRAS", "153|4|gene|ncbi_gene@3845|KRAS", "95|5|cellline||SW403", "756|5|variant|litvar@rs750721065##&&&litvar@#3265#|G161R", "823|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "1034|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "589|4|gene|ncbi_gene@3845|KRAS", "300|4|gene|ncbi_gene@3845|KRAS", "792|4|gene|ncbi_gene@3845|KRAS", "553|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "603|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "314|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "402|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "213|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "966|6|cellline||Caco-2", "462|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "118|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "265|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "521|9|disease|ncbi_mesh@D009369|carcinoma", "500|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "101|4|gene|ncbi_gene@3845|KRAS", "1083|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "349|4|gene|ncbi_gene@3845|KRAS", "362|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "1259|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1184|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "195|5|cellline||SW620", "890|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "815|5|variant|litvar@rs750721065##&&&litvar@#3265#|G161R", "689|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "249|4|gene|ncbi_gene@3845|KRAS", "586|2|cellline||15", "678|5|cellline||SW948", "594|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "699|25|disease|ncbi_mesh@D003110|Colorectal adenocarcinoma", "1244|9|disease|ncbi_mesh@D009369|carcinoma", "452|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "645|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "447|4|gene|ncbi_gene@3845|KRAS", "158|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "728|4|gene|ncbi_gene@3265|HRAS", "544|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "810|4|gene|ncbi_gene@3265|HRAS"], "figure_id": "pone.0233208.t002", "text_hl": "Status ATCC cell line RAS mutation NOX1/beta-actin x 106 Origin Corroboration in literature    SW403 KRAS G12V 120303 Colorectal adenocarcinoma    SW480 KRAS G12V 47 Colorectal adenocarcinoma    SW620 KRAS G12V 3 Colorectal adenocarcinoma    LS174T KRAS G12D 96065 Colorectal adenocarcinoma    LS123 KRAS G12S 144 Colorectal adenocarcinoma    SW837 KRAS G12C 95 Colorectal adenocarcinoma    DLD-1 KRAS G13D 8546 Colorectal adenocarcinoma    HCT-8 KRAS G13D 6748 Colorectal adenocarcinoma    T84 KRAS G13D 1157 Colorectal carcinoma    LoVo KRAS G13D 219 Colorectal adenocarcinoma    HCT-15 KRAS G13D 198 Colorectal adenocarcinoma    HCT-116 KRAS G13D 118 Colorectal carcinoma    SW948 KRAS Q61L 1437 Colorectal adenocarcinoma    HRAS mutant CRC SW1116 HRAS G161R 494 Colorectal adenocarcinoma KRAS G12A    SW48 HRAS G161R 7 Colorectal adenocarcinoma KRAS WT    RAS WT CRC HT-29 RAS WT 33697 Colorectal adenocarcinoma    WiDr RAS WT 33513 Colorectal adenocarcinoma    Caco-2 RAS WT 16975 Colorectal adenocarcinoma    COLO 201 RAS WT 10 Colorectal adenocarcinoma    COLO 205 RAS WT 931 Colorectal adenocarcinoma    COLO 320HSR RAS WT 21 Colorectal adenocarcinoma    COLO 320DM RAS WT 40 Colorectal adenocarcinoma    LS1034 RAS WT 45194 Colorectal carcinoma KRAS A146T    SW1417 RAS WT 22 Colorectal adenocarcinoma    RKO RAS WT 4 Colon carcinoma    RKO-E6 RAS WT 1 Derived from RKO; disrupted p53 function    p53R RAS WT 1 Derived from RKO    RAS WT normal colon CCD-18Co RAS WT 85 Normal colon fibroblast    "}], "citations": {"NLM": "Lu J, Jiang G, Wu Y, Antony S, Meitzler JL, Juhasz A, Liu H, Roy K, Makhlouf H, Chuaqui R, Butcher D, Konat\u00e9 MM, Doroshow JH. NADPH oxidase 1 is highly expressed in human large and small bowel cancers. PLoS One. PMID: 32428030", "BibTeX": "@article{32428030, title={NADPH oxidase 1 is highly expressed in human large and small bowel cancers.}, author={Lu J and Jiang G and Wu Y and Antony S and Meitzler JL and Juhasz A and Liu H and Roy K and Makhlouf H and Chuaqui R and Butcher D and Konat\u00e9 MM and Doroshow JH}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 35359599, "pmcid": "PMC8962378", "title": "KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese Patients.", "journal": "Front Mol Biosci", "authors": ["Wang S", "Li Q", "Ma P", "Fang Y", "Yu Y", "Jiang N", "Miao H", "Tang Q", "Yang Y", "Xing S", "Chen R", "Yi X", "Li N"], "date": "2022-03-11T00:00:00Z", "year": 2022, "snippets": [{"_id": "35359599@11443", "snip_text": "Mutation Mutated No. Mutated rate (%)   G12D 89 29.2   G12V 75 24.6   G13D 33 10.8   G12C 23 7.5   G12A 15 4.9   Q61H 15 4.9   G12R 14 4.6   A146T 8 2.6   G13C 6 2.0   G12S 5 1.6   Q61L 5 1.6   Q22K 3 1.0   A146V 3 1.0   G12F 2 0.7   Q61R 2 0.7   E63K 2 0.7   L19F 1 0.3   D33E 1 0.3   A59G 1 0.3   T74P 1 0.3   K117R 1 0.3   Total 305 100.0   ", "section": "table", "mentions": ["168|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "234|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "99|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "299|4|variant|litvar@#3845#p.T74P&&&litvar@#3845#|T74P", "221|4|variant|litvar@rs121913529##&&&litvar@#3845#|G12F", "260|4|variant|litvar@rs121913538##&&&litvar@#3845#&&&litvar@CA210356#rs121913538##|L19F", "127|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "312|5|variant|litvar@rs587782329##&&&litvar@#7157#&&&litvar@CA391#rs587782329##|K117R", "40|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "113|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "207|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "155|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "194|4|variant|litvar@rs121913236##&&&litvar@#3845#&&&litvar@CA16602771#rs121913236##|Q22K", "181|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "247|4|variant|litvar@rs1195801490##&&&litvar@#79811#|E63K", "141|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "70|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "286|4|variant|litvar@rs559848002##&&&litvar@#1029#&&&litvar@CA5012207#rs559848002##|A59G", "55|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "273|4|variant|litvar@rs1064795989##&&&litvar@#1029#|D33E", "85|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C"], "figure_id": "T2", "text_hl": "Mutation Mutated No. Mutated rate (%)   G12D 89 29.2   G12V 75 24.6   G13D 33 10.8   G12C 23 7.5   G12A 15 4.9   Q61H 15 4.9   G12R 14 4.6   <m>A146T</m> 8 2.6   G13C 6 2.0   G12S 5 1.6   Q61L 5 1.6   Q22K 3 1.0   A146V 3 1.0   G12F 2 0.7   Q61R 2 0.7   E63K 2 0.7   L19F 1 0.3   D33E 1 0.3   A59G 1 0.3   T74P 1 0.3   K117R 1 0.3   Total 305 100.0   "}], "citations": {"NLM": "Wang S, Li Q, Ma P, Fang Y, Yu Y, Jiang N, Miao H, Tang Q, Yang Y, Xing S, Chen R, Yi X, Li N. KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese Patients. Front Mol Biosci. PMID: 35359599", "BibTeX": "@article{35359599, title={KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese Patients.}, author={Wang S and Li Q and Ma P and Fang Y and Yu Y and Jiang N and Miao H and Tang Q and Yang Y and Xing S and Chen R and Yi X and Li N}, journal={Front Mol Biosci}}"}, "is_sup_mat_match": false}, {"pmid": 34063325, "pmcid": "PMC8147632", "title": "NRAS Mutations May Be Involved in the Pathogenesis of Cutaneous Rosai Dorfman Disease: A Pilot Study.", "journal": "Biology (Basel)", "authors": ["Wu KJ", "Li SH", "Liao JB", "Chiou CC", "Wu CS", "Chen CC"], "date": "2021-05-02T00:00:00Z", "year": 2021, "snippets": [{"_id": "34063325@1358", "snip_text": "NRAS mutation was detected in 4 of 7 cases (4/7; 51.7%), and NRAS A146T was the most common mutant point (n = 4/7), followed by NRAS G13S (n = 2/7).", "section": "abstract", "mentions": ["133|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA16602674#rs121434595##|G13S", "128|4|gene|ncbi_gene@4893|NRAS", "61|4|gene|ncbi_gene@4893|NRAS", "0|4|gene|ncbi_gene@4893|NRAS", "66|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "NRAS mutation was detected in 4 of 7 cases (4/7; 51.7%), and NRAS <m>A146T</m> was the most common mutant point (n = 4/7), followed by NRAS G13S (n = 2/7)."}], "citations": {"NLM": "Wu KJ, Li SH, Liao JB, Chiou CC, Wu CS, Chen CC. NRAS Mutations May Be Involved in the Pathogenesis of Cutaneous Rosai Dorfman Disease: A Pilot Study. Biology (Basel). PMID: 34063325", "BibTeX": "@article{34063325, title={NRAS Mutations May Be Involved in the Pathogenesis of Cutaneous Rosai Dorfman Disease: A Pilot Study.}, author={Wu KJ and Li SH and Liao JB and Chiou CC and Wu CS and Chen CC}, journal={Biology (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 30412858, "pmcid": "PMC6226617", "title": "Clinical Validation of Newly Developed Multiplex Kit Using Luminex xMAP Technology for Detecting Simultaneous RAS and BRAF Mutations in Colorectal Cancer: Results of the RASKET-B Study.", "journal": "Neoplasia", "authors": ["Taniguchi H", "Okamoto W", "Muro K", "Akagi K", "Hara H", "Nishina T", "Kajiwara T", "Denda T", "Hironaka S", "Kudo T", "Satoh T", "Yamanaka T", "Abe Y", "Fukushima Y", "Yoshino T"], "date": "2018-12-01T00:00:00Z", "year": 2018, "snippets": [{"_id": "30412858@10195", "snip_text": "Thus, using the RASKET-B KIT, we simultaneously examined 12 types of RAS exon 2 (G12S, G12C, G12R, G12D, G12 V, G12A, G13S, G13C, G13R, G13D, G13V, and G13A), 8 types of RAS exon 3 (A59T, A59G, Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H), 4 types of RAS exon 4 (K117N, A146T, A146P, and A146V) mutations, and BRAF exon 15 (V600E).", "section": "methods", "mentions": ["130|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "194|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "25|3|gene|ncbi_gene@3815|KIT", "228|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "93|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "212|4|variant|litvar@rs557317141##&&&litvar@#3815#&&&litvar@CA2923183#rs557317141##|Q61P", "142|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "112|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "87|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "305|4|gene|ncbi_gene@673|BRAF", "272|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "118|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA16602445#rs121913535##|G13S", "265|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "283|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "258|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "81|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "206|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "188|4|variant|litvar@rs781085650##&&&litvar@#673#&&&litvar@CA4517046#rs781085650##|A59G", "319|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "200|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "218|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "105|5|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12 V", "124|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA16602444#rs112445441##|G13C", "99|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "182|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "152|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13A", "136|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D"], "text_hl": "Thus, using the RASKET-B KIT, we simultaneously examined 12 types of RAS exon 2 (G12S, G12C, G12R, G12D, G12 V, G12A, G13S, G13C, G13R, G13D, G13V, and G13A), 8 types of RAS exon 3 (A59T, A59G, Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H), 4 types of RAS exon 4 (K117N, <m>A146T</m>, A146P, and A146V) mutations, and BRAF exon 15 (V600E)."}], "citations": {"NLM": "Taniguchi H, Okamoto W, Muro K, Akagi K, Hara H, Nishina T, Kajiwara T, Denda T, Hironaka S, Kudo T, Satoh T, Yamanaka T, Abe Y, Fukushima Y, Yoshino T. Clinical Validation of Newly Developed Multiplex Kit Using Luminex xMAP Technology for Detecting Simultaneous RAS and BRAF Mutations in Colorectal Cancer: Results of the RASKET-B Study. Neoplasia. PMID: 30412858", "BibTeX": "@article{30412858, title={Clinical Validation of Newly Developed Multiplex Kit Using Luminex xMAP Technology for Detecting Simultaneous RAS and BRAF Mutations in Colorectal Cancer: Results of the RASKET-B Study.}, author={Taniguchi H and Okamoto W and Muro K and Akagi K and Hara H and Nishina T and Kajiwara T and Denda T and Hironaka S and Kudo T and Satoh T and Yamanaka T and Abe Y and Fukushima Y and Yoshino T}, journal={Neoplasia}}"}, "is_sup_mat_match": false}, {"pmid": 34055366, "pmcid": "PMC8143655", "title": "Synchronous pituitary and pineal gland lesions presenting with panhypopituitarism in a patient with widespread colorectal cancer: a case report.", "journal": "Oxf Med Case Reports", "authors": ["Struja T", "Capraro J"], "date": "2021-05-24T00:00:00Z", "year": 2021, "snippets": [{"_id": "34055366@2392", "snip_text": "The tumour was found to have mutations in PIK3CA (exon 21, c.3140AQ > G; p.(His1047Arg)) and KRAS (exon 4, c.436G > A; p.(Ala146Thr)).", "section": "other", "mentions": ["73|14|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.(His1047Arg)", "42|6|gene|ncbi_gene@5290|PIK3CA", "4|6|disease|ncbi_mesh@D009369|tumour", "119|13|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.(Ala146Thr)", "107|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "93|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "The tumour was found to have mutations in PIK3CA (exon 21, c.3140AQ > G; p.(His1047Arg)) and KRAS (exon 4, c.436G > A; p.(<m>Ala146Thr</m>))."}], "citations": {"NLM": "Struja T, Capraro J. Synchronous pituitary and pineal gland lesions presenting with panhypopituitarism in a patient with widespread colorectal cancer: a case report. Oxf Med Case Reports. PMID: 34055366", "BibTeX": "@article{34055366, title={Synchronous pituitary and pineal gland lesions presenting with panhypopituitarism in a patient with widespread colorectal cancer: a case report.}, author={Struja T and Capraro J}, journal={Oxf Med Case Reports}}"}, "is_sup_mat_match": false}, {"pmid": 35474548, "pmcid": "PMC9209352", "title": "Performance of Idylla  RAS-BRAF mutation test for formalin-fixed paraffin-embedded tissues of colorectal cancer", "journal": "Int J Clin Oncol", "authors": ["Makutani Y", "Sakai K", "Yamada M", "Wada T", "Chikugo T", "Satou T", "Iwasa Y", "Yamamoto H", "de Velasco MA", "Nishio K", "Kawamura J"], "date": "2022-04-26T00:00:00Z", "year": 2022, "snippets": [{"_id": "35474548@8020", "snip_text": "Gene\tCodon (exon)\tAmino acid change\tCoding region change\t \tKRAS mutation detection\tCodon 12 (exon 2)\tG12C\tc.34G>T\t \tG12R\tc.34G>C\t \tG12S\tc.34G>A\t \tG12A\tc.35G>C\t \tG12D\tc.35G>A\t \tG12V\tc.35G>T\t \tCodon 13 (exon 2)\tG13D\tc.38G>A\t \tCodon 59 (exon 3)\tA59E\tc.176C>A\t \tA59G\tc.176C>G\t \tA59T\tc.175G>A\t \tCodon 61 (exon 3)\tQ61H\tc.183A>C; c.183A>T\t \tQ61K\tc.181C>A; c.180_181delinsAA\t \tQ61L\tc.182A>T\t \tQ61R\tc.182A>G\t \tCodon 117 (exon 4)\tK117N\tc.351A>C; c.351A>T\t \tCodon 146 (exon 4)\tA146P\tc.436G>C\t \tA146T\tc.436G>A\t \tA146V\tc.437C>T\t \tNRAS mutation detection\tCodon 12 (exon 2)\tG12C\tc.34G>T\t \tG12D\tc.35G>A\t \tG12A\tc.35G>C\t \tG12V\tc.35G>T\t \tCodon 13 (exon 2)\tG13D\tc.38G>A\t \tG13V\tc.38G>T\t \tG13R\tc.37G>C\t \tCodon 59 (exon 3)\tA59T\tc.175G>A\t \tCodon 61 (exon 3)\tQ61K\tc.181C>A\t \tQ61L\tc.182A>T\t \tQ61R\tc.182A>G\t \tQ61H\tc.183A>C\t \tCodon 117 (exon 4)\tK117N\tc.351G>C; c.351G>T\t \tCodon 146 (exon 4)\tA146T\tc.436G>A\t \tBRAF mutation detection\tCodon 600 (exon15)\tV600E\tc.1799T>A\t \t", "section": "table", "mentions": ["281|6|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|175G>A", "604|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "474|6|variant|litvar@rs121913527##&&&litvar@#3845#|436G>C", "341|6|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA180750#rs121913238##|181C>A", "817|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "349|17|variant|litvar@#4893#c.180_181delinsAA&&&litvar@#4893#|c.180_181delinsAA", "216|5|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|38G>A", "392|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|182A>G", "138|5|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|34G>A", "637|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "741|6|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA180750#rs121913238##|181C>A", "773|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|182A>G", "923|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "146|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "483|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "931|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|1799T>A", "315|6|variant|litvar@rs121913255##&&&litvar@#4893#|183A>C", "508|6|variant|litvar@rs1057519725##&&&litvar@#3845#|437C>T", "323|8|variant|litvar@rs121913255##&&&litvar@#4893#&&&litvar@CA16042285#rs121913255##|c.183A>T", "574|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "161|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "265|6|variant|litvar@rs763572530##&&&litvar@#1956#|176C>G", "420|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "833|8|variant|litvar@rs1268659696##&&&litvar@#207#|c.351G>T", "168|5|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|35G>A", "466|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "782|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "116|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "581|5|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|35G>A", "369|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "667|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "700|4|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|A59T", "750|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "589|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "131|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "674|5|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|37G>C", "209|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "596|5|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|35G>C", "428|6|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|351A>C", "249|6|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|176C>A", "500|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "517|4|gene|ncbi_gene@4893|NRAS", "436|8|variant|litvar@rs770248150##&&&litvar@#3845#|c.351A>T", "863|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "880|4|gene|ncbi_gene@673|BRAF", "242|4|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|A59E", "274|4|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|A59T", "611|5|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA261525#rs121913237##|35G>T", "766|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "334|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "559|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "385|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "59|4|gene|ncbi_gene@3845|KRAS", "644|5|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|38G>A", "734|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "101|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "566|5|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|34G>T", "825|6|variant|litvar@rs767291079##&&&litvar@#22882#&&&litvar@CA4862148#rs767291079##|351G>C", "153|5|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|35G>C", "652|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "308|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "871|6|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|436G>A", "659|5|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|38G>T", "707|6|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|175G>A", "491|6|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|436G>A", "757|6|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|182A>T", "258|4|variant|litvar@rs763572530##&&&litvar@#1956#|A59G", "108|5|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|34G>T", "789|6|variant|litvar@rs121913255##&&&litvar@#4893#|183A>C", "376|6|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|182A>T", "176|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "123|5|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|34G>C", "183|5|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA261525#rs121913237##|35G>T"], "figure_id": "Tab1", "text_hl": "Gene\tCodon (exon)\tAmino acid change\tCoding region change\t \tKRAS mutation detection\tCodon 12 (exon 2)\tG12C\tc.34G>T\t \tG12R\tc.34G>C\t \tG12S\tc.34G>A\t \tG12A\tc.35G>C\t \tG12D\tc.35G>A\t \tG12V\tc.35G>T\t \tCodon 13 (exon 2)\tG13D\tc.38G>A\t \tCodon 59 (exon 3)\tA59E\tc.176C>A\t \tA59G\tc.176C>G\t \tA59T\tc.175G>A\t \tCodon 61 (exon 3)\tQ61H\tc.183A>C; c.183A>T\t \tQ61K\tc.181C>A; c.180_181delinsAA\t \tQ61L\tc.182A>T\t \tQ61R\tc.182A>G\t \tCodon 117 (exon 4)\tK117N\tc.351A>C; c.351A>T\t \tCodon 146 (exon 4)\tA146P\tc.436G>C\t \t<m>A146T</m>\tc.436G>A\t \tA146V\tc.437C>T\t \tNRAS mutation detection\tCodon 12 (exon 2)\tG12C\tc.34G>T\t \tG12D\tc.35G>A\t \tG12A\tc.35G>C\t \tG12V\tc.35G>T\t \tCodon 13 (exon 2)\tG13D\tc.38G>A\t \tG13V\tc.38G>T\t \tG13R\tc.37G>C\t \tCodon 59 (exon 3)\tA59T\tc.175G>A\t \tCodon 61 (exon 3)\tQ61K\tc.181C>A\t \tQ61L\tc.182A>T\t \tQ61R\tc.182A>G\t \tQ61H\tc.183A>C\t \tCodon 117 (exon 4)\tK117N\tc.351G>C; c.351G>T\t \tCodon 146 (exon 4)\t<m>A146T</m>\tc.436G>A\t \tBRAF mutation detection\tCodon 600 (exon15)\tV600E\tc.1799T>A\t \t"}], "citations": {"NLM": "Makutani Y, Sakai K, Yamada M, Wada T, Chikugo T, Satou T, Iwasa Y, Yamamoto H, de Velasco MA, Nishio K, Kawamura J. Performance of Idylla  RAS-BRAF mutation test for formalin-fixed paraffin-embedded tissues of colorectal cancer Int J Clin Oncol. PMID: 35474548", "BibTeX": "@article{35474548, title={Performance of Idylla  RAS-BRAF mutation test for formalin-fixed paraffin-embedded tissues of colorectal cancer}, author={Makutani Y and Sakai K and Yamada M and Wada T and Chikugo T and Satou T and Iwasa Y and Yamamoto H and de Velasco MA and Nishio K and Kawamura J}, journal={Int J Clin Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 33753749, "pmcid": "PMC7985210", "title": "The origins and genetic interactions of KRAS mutations are allele- and tissue-specific.", "journal": "Nat Commun", "authors": ["Cook JH", "Melloni GEM", "Gulhan DC", "Park PJ", "Haigis KM"], "date": "2021-03-22T00:00:00Z", "year": 2021, "snippets": [{"_id": "33753749@8472", "snip_text": "COAD had a unique enrichment of G13D and A146T alleles, while PAAD was distinct in its high frequency of G12R mutations.", "section": "results", "mentions": ["62|4|disease|ncbi_mesh@D010190|PAAD", "0|4|disease|ncbi_mesh@D003110|COAD", "32|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "41|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "105|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R"], "text_hl": "COAD had a unique enrichment of G13D and <m>A146T</m> alleles, while PAAD was distinct in its high frequency of G12R mutations."}], "citations": {"NLM": "Cook JH, Melloni GEM, Gulhan DC, Park PJ, Haigis KM. The origins and genetic interactions of KRAS mutations are allele- and tissue-specific. Nat Commun. PMID: 33753749", "BibTeX": "@article{33753749, title={The origins and genetic interactions of KRAS mutations are allele- and tissue-specific.}, author={Cook JH and Melloni GEM and Gulhan DC and Park PJ and Haigis KM}, journal={Nat Commun}}"}, "is_sup_mat_match": false}, {"pmid": 37435524, "pmcid": "PMC10332309", "title": "Leishmania donovani visceral leishmaniasis diagnosed by metagenomics next-generation sequencing in an infant with acute lymphoblastic leukemia: a case report", "journal": "Front Public Health", "authors": ["Chang L", "Che G", "Yang Q", "Lai S", "Teng J", "Duan J", "Liu T", "Liu F"], "date": "2023-06-22T00:00:00Z", "year": 2023, "snippets": [{"_id": "37435524@4193", "snip_text": "Based on the above testing, the boy was diagnosed with B-cell acute lymphoblastic leukemia (B-ALL, L2, ETV6-PEX5 fusion gene positive, KRAS A146V and KRAS A146T mutation, IKZF1-8 heterozygous deletion, 45, XY, der (7; 12) (q10; q10)(5)/46, XY (15).", "section": "other", "mentions": ["135|4|gene|ncbi_gene@3845|KRAS", "150|4|gene|ncbi_gene@3845|KRAS", "140|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "108|4|gene|ncbi_gene@5830|PEX5", "103|4|gene|ncbi_gene@2120|ETV6", "155|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Based on the above testing, the boy was diagnosed with B-cell acute lymphoblastic leukemia (B-ALL, L2, ETV6-PEX5 fusion gene positive, KRAS A146V and KRAS <m>A146T</m> mutation, IKZF1-8 heterozygous deletion, 45, XY, der (7; 12) (q10; q10)(5)/46, XY (15)."}], "citations": {"NLM": "Chang L, Che G, Yang Q, Lai S, Teng J, Duan J, Liu T, Liu F. Leishmania donovani visceral leishmaniasis diagnosed by metagenomics next-generation sequencing in an infant with acute lymphoblastic leukemia: a case report Front Public Health. PMID: 37435524", "BibTeX": "@article{37435524, title={Leishmania donovani visceral leishmaniasis diagnosed by metagenomics next-generation sequencing in an infant with acute lymphoblastic leukemia: a case report}, author={Chang L and Che G and Yang Q and Lai S and Teng J and Duan J and Liu T and Liu F}, journal={Front Public Health}}"}, "is_sup_mat_match": false}, {"pmid": 33769165, "pmcid": "PMC8298276", "title": "Drugging multiple same-allele driver mutations in cancer", "journal": "Expert Opin Drug Discov", "authors": ["Nussinov R", "Zhang M", "Maloney R", "Jang H"], "date": "2021-03-26T00:00:00Z", "year": 2021, "snippets": [{"_id": "33769165@10834", "snip_text": "The case of K-RasG12D versus K-RasA146T provides an example.", "section": "other", "mentions": ["12|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|K-RasG12D", "29|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|K-RasA146T"], "text_hl": "The case of K-RasG12D versus K-RasA146T provides an example."}], "citations": {"NLM": "Nussinov R, Zhang M, Maloney R, Jang H. Drugging multiple same-allele driver mutations in cancer Expert Opin Drug Discov. PMID: 33769165", "BibTeX": "@article{33769165, title={Drugging multiple same-allele driver mutations in cancer}, author={Nussinov R and Zhang M and Maloney R and Jang H}, journal={Expert Opin Drug Discov}}"}, "is_sup_mat_match": false}, {"pmid": 37264205, "pmcid": "PMC11184491", "title": "Genomic profiling informs diagnoses and treatment in vascular anomalies", "journal": "Nat Med", "authors": ["Li D", "Sheppard SE", "March ME", "Battig MR", "Surrey LF", "Srinivasan AS", "Matsuoka LS", "Tian L", "Wang F", "Seiler C", "Dayneka J", "Borst AJ", "Matos MC", "Paulissen SM", "Krishnamurthy G", "Nriagu B", "Sikder T", "Casey M", "Williams L", "Rangu S", "O'Connor N", "Thomas A", "Pinto E", "Hou C", "Nguyen K", "Pellegrino da Silva R", "Chehimi SN", "Kao C", "Biroc L", "Britt AD", "Queenan M", "Reid JR", "Napoli JA", "Low DM", "Vatsky S", "Treat J", "Smith CL", "Cahill AM", "Snyder KM", "Adams DM", "Dori Y", "Hakonarson H"], "date": "2023-06-01T00:00:00Z", "year": 2023, "snippets": [{"_id": "37264205@19103", "snip_text": "Comparably, expression of KRAS-A146T in zebrafish resulted in thoracic duct dilatation and tissue expansion (Extended Data Fig. 1e-g).", "section": "results", "mentions": ["31|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "26|4|gene|ncbi_gene@445289|KRAS", "40|9|species|ncbi_taxonomy@7955|zebrafish"], "text_hl": "Comparably, expression of KRAS-<m>A146T</m> in zebrafish resulted in thoracic duct dilatation and tissue expansion (Extended Data Fig. 1e-g)."}], "citations": {"NLM": "Li D, Sheppard SE, March ME, Battig MR, Surrey LF, Srinivasan AS, Matsuoka LS, Tian L, Wang F, Seiler C, Dayneka J, Borst AJ, Matos MC, Paulissen SM, Krishnamurthy G, Nriagu B, Sikder T, Casey M, Williams L, Rangu S, O'Connor N, Thomas A, Pinto E, Hou C, Nguyen K, Pellegrino da Silva R, Chehimi SN, Kao C, Biroc L, Britt AD, Queenan M, Reid JR, Napoli JA, Low DM, Vatsky S, Treat J, Smith CL, Cahill AM, Snyder KM, Adams DM, Dori Y, Hakonarson H. Genomic profiling informs diagnoses and treatment in vascular anomalies Nat Med. PMID: 37264205", "BibTeX": "@article{37264205, title={Genomic profiling informs diagnoses and treatment in vascular anomalies}, author={Li D and Sheppard SE and March ME and Battig MR and Surrey LF and Srinivasan AS and Matsuoka LS and Tian L and Wang F and Seiler C and Dayneka J and Borst AJ and Matos MC and Paulissen SM and Krishnamurthy G and Nriagu B and Sikder T and Casey M and Williams L and Rangu S and O'Connor N and Thomas A and Pinto E and Hou C and Nguyen K and Pellegrino da Silva R and Chehimi SN and Kao C and Biroc L and Britt AD and Queenan M and Reid JR and Napoli JA and Low DM and Vatsky S and Treat J and Smith CL and Cahill AM and Snyder KM and Adams DM and Dori Y and Hakonarson H}, journal={Nat Med}}"}, "is_sup_mat_match": false}, {"pmid": 27555788, "pmcid": "PMC4968864", "title": "Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy.", "journal": "Onco Targets Ther", "authors": ["Nemecek R", "Berkovcova J", "Radova L", "Kazda T", "Mlcochova J", "Vychytilova-Faltejskova P", "Slaby O", "Svoboda M"], "date": "2016-07-28T00:00:00Z", "year": 2016, "snippets": [{"_id": "27555788@14027", "snip_text": "In particular, we found the following variations in KRAS alterations: G12V, G12C, A146T, V8I, and D57Y.", "section": "results", "mentions": ["70|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "52|4|gene|ncbi_gene@3845|KRAS", "98|4|variant|litvar@#3845#p.D57Y&&&litvar@#3845#|D57Y", "82|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "76|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C"], "text_hl": "In particular, we found the following variations in KRAS alterations: G12V, G12C, <m>A146T</m>, V8I, and D57Y."}], "citations": {"NLM": "Nemecek R, Berkovcova J, Radova L, Kazda T, Mlcochova J, Vychytilova-Faltejskova P, Slaby O, Svoboda M. Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy. Onco Targets Ther. PMID: 27555788", "BibTeX": "@article{27555788, title={Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy.}, author={Nemecek R and Berkovcova J and Radova L and Kazda T and Mlcochova J and Vychytilova-Faltejskova P and Slaby O and Svoboda M}, journal={Onco Targets Ther}}"}, "is_sup_mat_match": false}, {"pmid": 32782529, "pmcid": "PMC7400335", "title": "Effect of KRAS and NRAS mutations on the prognosis of patients with synchronous metastatic colorectal cancer presenting with liver-only and lung-only metastases.", "journal": "Oncol Lett", "authors": ["Chuang SC", "Huang CW", "Chen YT", "Ma CJ", "Tsai HL", "Chang TK", "Su WC", "Hsu WH", "Kuo CH", "Wang JY"], "date": "2020-09-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "32782529@15775", "snip_text": "KRAS exon 2 mutations were detected in 39.4% (56/142) of patients, with both LiM and LuM-only CRC, which included 24 (42.9%) patients with G12D, 8 (14.3%) patients with G12V, 7 (12.5%) patients with A146T, 6 (10.7%) with G13D, 3 (5.4%) patients with G12C, 3 (5.4%) patients with codon 61, 2 (3.6%) patients with G12A, 1 (1.8%) patients with G13R, 1 (1.8%) patient with G12S and 1 (1.8%) patient with G12D, G13D mutations.", "section": "results", "mentions": ["312|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "327|8|species|ncbi_taxonomy@9606|patients", "250|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "369|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "0|4|gene|ncbi_gene@3845|KRAS", "155|8|species|ncbi_taxonomy@9606|patients", "236|8|species|ncbi_taxonomy@9606|patients", "57|8|species|ncbi_taxonomy@9606|patients", "406|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "77|3|disease||LiM", "400|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "185|8|species|ncbi_taxonomy@9606|patients", "298|8|species|ncbi_taxonomy@9606|patients", "356|7|species|ncbi_taxonomy@9606|patient", "341|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "221|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "94|3|disease|ncbi_mesh@D015179|CRC", "169|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "265|8|species|ncbi_taxonomy@9606|patients", "387|7|species|ncbi_taxonomy@9606|patient", "139|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "85|3|disease||LuM", "199|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "125|8|species|ncbi_taxonomy@9606|patients"], "text_hl": "KRAS exon 2 mutations were detected in 39.4% (56/142) of patients, with both LiM and LuM-only CRC, which included 24 (42.9%) patients with G12D, 8 (14.3%) patients with G12V, 7 (12.5%) patients with <m>A146T</m>, 6 (10.7%) with G13D, 3 (5.4%) patients with G12C, 3 (5.4%) patients with codon 61, 2 (3.6%) patients with G12A, 1 (1.8%) patients with G13R, 1 (1.8%) patient with G12S and 1 (1.8%) patient with G12D, G13D mutations."}], "citations": {"NLM": "Chuang SC, Huang CW, Chen YT, Ma CJ, Tsai HL, Chang TK, Su WC, Hsu WH, Kuo CH, Wang JY. Effect of KRAS and NRAS mutations on the prognosis of patients with synchronous metastatic colorectal cancer presenting with liver-only and lung-only metastases. Oncol Lett. PMID: 32782529", "BibTeX": "@article{32782529, title={Effect of KRAS and NRAS mutations on the prognosis of patients with synchronous metastatic colorectal cancer presenting with liver-only and lung-only metastases.}, author={Chuang SC and Huang CW and Chen YT and Ma CJ and Tsai HL and Chang TK and Su WC and Hsu WH and Kuo CH and Wang JY}, journal={Oncol Lett}}"}, "is_sup_mat_match": false}, {"pmid": 37675274, "pmcid": "PMC10477963", "title": "Targeted therapies in non-small cell lung cancer: present and future", "journal": "Fac Rev", "authors": ["McLaughlin J", "Berkman J", "Nana-Sinkam P"], "date": "2023-09-04T00:00:00Z", "year": 2023, "snippets": [{"_id": "37675274@16620", "snip_text": "Most were commonly found to occur at the drug-binding site; however, there were amino acids located outside of the drug-binding pocket that impeded GTP hydrolysis (G13D and Q16R) or facilitated GDP to GTP nucleotide exchange (G13D, A59S, and A146P).", "section": "other", "mentions": ["201|3|chemical|ncbi_mesh@D006160|GTP", "226|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "164|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "232|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA354836#rs121913528##|A59S", "242|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "194|3|chemical|ncbi_mesh@D006153|GDP", "173|4|variant|litvar@#3845#p.Q16R&&&litvar@#3845#|Q16R", "148|3|chemical|ncbi_mesh@D006160|GTP"], "text_hl": "Most were commonly found to occur at the drug-binding site; however, there were amino acids located outside of the drug-binding pocket that impeded GTP hydrolysis (G13D and Q16R) or facilitated GDP to GTP nucleotide exchange (G13D, A59S, and A146P)."}], "citations": {"NLM": "McLaughlin J, Berkman J, Nana-Sinkam P. Targeted therapies in non-small cell lung cancer: present and future Fac Rev. PMID: 37675274", "BibTeX": "@article{37675274, title={Targeted therapies in non-small cell lung cancer: present and future}, author={McLaughlin J and Berkman J and Nana-Sinkam P}, journal={Fac Rev}}"}, "is_sup_mat_match": false}, {"pmid": 27444064, "pmcid": "PMC5739515", "title": "Pancreatic cancer biology and genetics from an evolutionary perspective", "journal": "Nat Rev Cancer", "authors": ["Makohon-Moore A", "Iacobuzio-Donahue CA"], "date": "2016-09-01T00:00:00Z", "year": 2016, "snippets": [{"_id": "27444064@30885", "snip_text": "One explanation for this paradox is that the spectrum of KRAS germline mutations differs with respect to the codons affected and thus they do not lead to KRAS hyperactivity to the same extent as oncogenic mutations, for example, G12S, K117R and A146T mutations, in patients with Costello syndrome compared with G12D mutations in those with pancreatic cancers.", "section": "other", "mentions": ["154|4|gene|ncbi_gene@3845|KRAS", "245|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "57|4|gene|ncbi_gene@3845|KRAS", "265|8|species|ncbi_taxonomy@9606|patients", "235|5|variant|litvar@rs587782329##&&&litvar@#7157#&&&litvar@CA391#rs587782329##|K117R", "229|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "340|18|disease|ncbi_mesh@D010190|pancreatic cancers", "279|17|disease|ncbi_mesh@D056685|Costello syndrome", "311|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D"], "text_hl": "One explanation for this paradox is that the spectrum of KRAS germline mutations differs with respect to the codons affected and thus they do not lead to KRAS hyperactivity to the same extent as oncogenic mutations, for example, G12S, K117R and <m>A146T</m> mutations, in patients with Costello syndrome compared with G12D mutations in those with pancreatic cancers."}], "citations": {"NLM": "Makohon-Moore A, Iacobuzio-Donahue CA. Pancreatic cancer biology and genetics from an evolutionary perspective Nat Rev Cancer. PMID: 27444064", "BibTeX": "@article{27444064, title={Pancreatic cancer biology and genetics from an evolutionary perspective}, author={Makohon-Moore A and Iacobuzio-Donahue CA}, journal={Nat Rev Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 34995318, "pmcid": "PMC8740967", "title": "Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load.", "journal": "PLoS One", "authors": ["Rye MS", "Garrett KL", "Holt RA", "Platell CF", "McCoy MJ"], "date": "2022-01-07T00:00:00Z", "year": 2022, "snippets": [{"_id": "34995318@19341", "snip_text": "b Includes A146T, G12A, G12C, G12D, G12R, G12S, G12V, G13D and G13R.", "section": "table", "mentions": ["36|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "11|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "54|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "63|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13R", "48|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "18|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "24|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "42|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "30|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D"], "figure_id": "pone.0262416.t001", "text_hl": "b Includes <m>A146T</m>, G12A, G12C, G12D, G12R, G12S, G12V, G13D and G13R."}], "citations": {"NLM": "Rye MS, Garrett KL, Holt RA, Platell CF, McCoy MJ. Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load. PLoS One. PMID: 34995318", "BibTeX": "@article{34995318, title={Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load.}, author={Rye MS and Garrett KL and Holt RA and Platell CF and McCoy MJ}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 28350094, "pmcid": "PMC5403533", "title": "Routine genetic testing of lung cancer specimens derived from surgery, bronchoscopy and fluid aspiration by next generation sequencing.", "journal": "Int J Oncol", "authors": ["Yamamoto G", "Kikuchi M", "Kobayashi S", "Arai Y", "Fujiyoshi K", "Wakatsuki T", "Kakuta M", "Yamane Y", "Iijima Y", "Mizutani H", "Nakajima Y", "Sudo J", "Kinoshita H", "Kurimoto F", "Akiyama H", "Uramoto H", "Sakai H", "Akagi Y", "Akagi K"], "date": "2017-05-01T00:00:00Z", "year": 2017, "snippets": [{"_id": "28350094@11563", "snip_text": "Only one case harbored mutation in exon 4 (A146T).", "section": "results", "mentions": ["43|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Only one case harbored mutation in exon 4 (<m>A146T</m>)."}], "citations": {"NLM": "Yamamoto G, Kikuchi M, Kobayashi S, Arai Y, Fujiyoshi K, Wakatsuki T, Kakuta M, Yamane Y, Iijima Y, Mizutani H, Nakajima Y, Sudo J, Kinoshita H, Kurimoto F, Akiyama H, Uramoto H, Sakai H, Akagi Y, Akagi K. Routine genetic testing of lung cancer specimens derived from surgery, bronchoscopy and fluid aspiration by next generation sequencing. Int J Oncol. PMID: 28350094", "BibTeX": "@article{28350094, title={Routine genetic testing of lung cancer specimens derived from surgery, bronchoscopy and fluid aspiration by next generation sequencing.}, author={Yamamoto G and Kikuchi M and Kobayashi S and Arai Y and Fujiyoshi K and Wakatsuki T and Kakuta M and Yamane Y and Iijima Y and Mizutani H and Nakajima Y and Sudo J and Kinoshita H and Kurimoto F and Akiyama H and Uramoto H and Sakai H and Akagi Y and Akagi K}, journal={Int J Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 29255376, "pmcid": "PMC5723122", "title": "Cis-oriented solvent-front EGFR G796S mutation in tissue and ctDNA in a patient progressing on osimertinib: a case report and review of the literature.", "journal": "Lung Cancer (Auckl)", "authors": ["Klempner SJ", "Mehta P", "Schrock AB", "Ali SM", "Ou SI"], "date": "2017-12-06T00:00:00Z", "year": 2017, "snippets": [{"_id": "29255376@12359", "snip_text": "Genomic alteration Tissue MAF ctDNA MAF Additional genomic information   EGFR L858R 50.52% 12.8% N/A   EGFR T790M 37.14% 11.2% N/A   EGFR G796S 38.69% 11.6% N/A   EGFR amplification N/A ND 16 copies predicted   TP53 R273H 25.8% 3.0% N/A   TP53 V31I 62.24% ND N/A   BCOR V1456fs*12 5.75% N/A N/A   ERRFI1 L96fs*26 8.66% N/A N/A   LZTR1 Y136* 49.75% N/A N/A   MYC amplification N/A ND 7 copies predicted   BRAF amplification N/A ND 10 copies predicted   KEL amplification N/A N/A 10 copies predicted   CDK2NA loss N/A N/A N/A   CDKN2B loss N/A N/A N/A   KRAS A146S ND 1.2% N/A   Variants of unknown significance   AR S176R Detected N/A N/A   CARD11 amplification Detected N/A N/A   EZH2 amplification Detected N/A N/A   FLCN F188I Detected N/A N/A   IKZF1 S364W Detected N/A N/A   IKZF1 amplification Detected N/A N/A   INHBA amplification Detected N/A N/A   INPP4B amplification Detected N/A N/A   KMT2C amplification Detected N/A N/A   MLL2 Q3745_H3746insQ Detected N/A N/A   MSH2 L530I Detected N/A N/A   PMS2 amplification Detected N/A N/A   RAC1 amplification Detected N/A N/A   SPTA1 R1387H Detected N/A N/A   TET2 Q321del Detected N/A N/A   BRCA2 A2351P ND Detected N/A   ERBB2 R487G ND Detected N/A   TSC1 A84T Detected N/A N/A   Microsatellite stable Detected N/A N/A   ", "section": "table", "mentions": ["163|4|gene|ncbi_gene@1956|EGFR", "615|5|variant|litvar@rs1057520001##&&&litvar@#7157#|S176R", "1114|4|gene|ncbi_gene@54790|TET2", "78|5|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|L858R", "640|6|gene|ncbi_gene@84433|CARD11", "216|5|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|R273H", "265|4|gene|ncbi_gene@54880|BCOR", "452|3|gene|ncbi_gene@3792|KEL", "138|5|variant|litvar@rs754426793##&&&litvar@#1956#&&&litvar@CA4266064#rs754426793##|G796S", "1119|7|variant|litvar@rs587778704##&&&litvar@#54790#|Q321del", "270|7|variant|litvar@#54880#p.V1456fsX&&&litvar@#54880#|V1456fs", "73|4|gene|ncbi_gene@1956|EGFR", "754|5|variant|litvar@#2146#p.S364W&&&litvar@#2146#|S364W", "304|5|variant|litvar@#54206#p.L96fsX&&&litvar@#54206#|L96fs", "211|4|gene|ncbi_gene@7157|TP53", "557|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146S", "133|4|gene|ncbi_gene@1956|EGFR", "526|6|gene|ncbi_gene@1030|CDKN2B", "1212|4|variant|litvar@rs118203357##&&&litvar@#7248#&&&litvar@CA6597#rs118203357##|A84T", "239|4|gene|ncbi_gene@7157|TP53", "297|6|gene|ncbi_gene@54206|ERRFI1", "244|4|variant|litvar@rs201753350##&&&litvar@#7157#&&&litvar@CA357868#rs201753350##|V31I", "1207|4|gene|ncbi_gene@7248|TSC1", "404|4|gene|ncbi_gene@673|BRAF", "1177|5|gene|ncbi_gene@2064|ERBB2", "552|4|gene|ncbi_gene@3845|KRAS", "680|4|gene|ncbi_gene@2146|EZH2", "723|5|variant|litvar@#2146#p.F188I&&&litvar@#2146#|F188I", "1006|4|gene|ncbi_gene@5395|PMS2", "1183|5|variant|litvar@rs904614425##&&&litvar@#4916#|R487G", "108|5|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|T790M", "358|3|gene|ncbi_gene@4609|MYC", "500|6|gene|ncbi_gene@1017|CDK2NA", "1088|6|variant|litvar@rs368282292##&&&litvar@#6708#&&&litvar@CA1182815#rs368282292##|R1387H", "1152|6|variant|litvar@rs80358930##&&&litvar@#675#&&&litvar@CA24802#rs80358930##|A2351P", "1146|5|gene|ncbi_gene@675|BRCA2", "103|4|gene|ncbi_gene@1956|EGFR", "981|5|variant|litvar@#5395#p.L530I&&&litvar@#5395#|L530I", "1082|5|gene|ncbi_gene@6708|SPTA1", "1044|4|gene|ncbi_gene@5879|RAC1"], "figure_id": "ts1-lctt-8-241", "text_hl": "Genomic alteration Tissue MAF ctDNA MAF Additional genomic information   EGFR L858R 50.52% 12.8% N/A   EGFR T790M 37.14% 11.2% N/A   EGFR G796S 38.69% 11.6% N/A   EGFR amplification N/A ND 16 copies predicted   TP53 R273H 25.8% 3.0% N/A   TP53 V31I 62.24% ND N/A   BCOR V1456fs*12 5.75% N/A N/A   ERRFI1 L96fs*26 8.66% N/A N/A   LZTR1 Y136* 49.75% N/A N/A   MYC amplification N/A ND 7 copies predicted   BRAF amplification N/A ND 10 copies predicted   KEL amplification N/A N/A 10 copies predicted   CDK2NA loss N/A N/A N/A   CDKN2B loss N/A N/A N/A   KRAS A146S ND 1.2% N/A   Variants of unknown significance   AR S176R Detected N/A N/A   CARD11 amplification Detected N/A N/A   EZH2 amplification Detected N/A N/A   FLCN F188I Detected N/A N/A   IKZF1 S364W Detected N/A N/A   IKZF1 amplification Detected N/A N/A   INHBA amplification Detected N/A N/A   INPP4B amplification Detected N/A N/A   KMT2C amplification Detected N/A N/A   MLL2 Q3745_H3746insQ Detected N/A N/A   MSH2 L530I Detected N/A N/A   PMS2 amplification Detected N/A N/A   RAC1 amplification Detected N/A N/A   SPTA1 R1387H Detected N/A N/A   TET2 Q321del Detected N/A N/A   BRCA2 A2351P ND Detected N/A   ERBB2 R487G ND Detected N/A   TSC1 A84T Detected N/A N/A   Microsatellite stable Detected N/A N/A   "}], "citations": {"NLM": "Klempner SJ, Mehta P, Schrock AB, Ali SM, Ou SI. Cis-oriented solvent-front EGFR G796S mutation in tissue and ctDNA in a patient progressing on osimertinib: a case report and review of the literature. Lung Cancer (Auckl). PMID: 29255376", "BibTeX": "@article{29255376, title={Cis-oriented solvent-front EGFR G796S mutation in tissue and ctDNA in a patient progressing on osimertinib: a case report and review of the literature.}, author={Klempner SJ and Mehta P and Schrock AB and Ali SM and Ou SI}, journal={Lung Cancer (Auckl)}}"}, "is_sup_mat_match": false}, {"pmid": 35913398, "pmcid": "PMC9478530", "title": "Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6.", "journal": "Cancer Res", "authors": ["Sorokin AV", "Kanikarla Marie P", "Bitner L", "Syed M", "Woods M", "Manyam G", "Kwong LN", "Johnson B", "Morris VK", "Jones P", "Menter DG", "Lee MS", "Kopetz S"], "date": "2022-08-01T00:00:00Z", "year": 2022, "snippets": [{"_id": "35913398@11711", "snip_text": "On the basis of this finding, we evaluated typical RAS models that include a mixture of exon 2 KRASG12/13 (n = 6) P-loop domain mutated PDX models, extended RAS models that include NRASQ61 switch II domain mutated tumors (n = 2) along with KRASA146T nucleotide exchange promoting domain mutated tumors (n = 3; refs.", "section": "results", "mentions": ["240|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T", "214|6|disease|ncbi_mesh@D009369|tumors", "295|6|disease|ncbi_mesh@D009369|tumors"], "text_hl": "On the basis of this finding, we evaluated typical RAS models that include a mixture of exon 2 KRASG12/13 (n = 6) P-loop domain mutated PDX models, extended RAS models that include NRASQ61 switch II domain mutated tumors (n = 2) along with KRASA146T nucleotide exchange promoting domain mutated tumors (n = 3; refs."}], "citations": {"NLM": "Sorokin AV, Kanikarla Marie P, Bitner L, Syed M, Woods M, Manyam G, Kwong LN, Johnson B, Morris VK, Jones P, Menter DG, Lee MS, Kopetz S. Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6. Cancer Res. PMID: 35913398", "BibTeX": "@article{35913398, title={Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6.}, author={Sorokin AV and Kanikarla Marie P and Bitner L and Syed M and Woods M and Manyam G and Kwong LN and Johnson B and Morris VK and Jones P and Menter DG and Lee MS and Kopetz S}, journal={Cancer Res}}"}, "is_sup_mat_match": false}, {"pmid": 30686769, "pmcid": "PMC6398439", "title": "Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases", "journal": "Cancer Cell", "authors": ["Connor AA", "Denroche RE", "Jang GH", "Lemire M", "Zhang A", "Chan-Seng-Yue M", "Wilson G", "Grant RC", "Merico D", "Lungu I", "Bartlett JMS", "Chadwick D", "Liang SB", "Eagles J", "Mbabaali F", "Miller JK", "Krzyzanowski P", "Armstrong H", "Luo X", "Jorgensen LGT", "Romero JM", "Bavi P", "Fischer SE", "Serra S", "Hafezi-Bakhtiari S", "Caglar D", "Roehrl MHA", "Cleary S", "Hollingsworth MA", "Petersen GM", "Thayer S", "Law CHL", "Nanji S", "Golan T", "Smith AL", "Borgida A", "Dodd A", "Hedley D", "Wouters BG", "O'Kane GM", "Wilson JM", "Zogopoulos G", "Notta F", "Knox JJ", "Gallinger S"], "date": "2019-02-11T00:00:00Z", "year": 2019, "snippets": [{"_id": "30686769@6328", "snip_text": "One additional NRAS variant (p.A146T) may also be activating.", "section": "results", "mentions": ["15|4|gene|ncbi_gene@4893|NRAS", "29|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T"], "text_hl": "One additional NRAS variant (<m>p.A146T</m>) may also be activating."}], "citations": {"NLM": "Connor AA, Denroche RE, Jang GH, Lemire M, Zhang A, Chan-Seng-Yue M, Wilson G, Grant RC, Merico D, Lungu I, Bartlett JMS, Chadwick D, Liang SB, Eagles J, Mbabaali F, Miller JK, Krzyzanowski P, Armstrong H, Luo X, Jorgensen LGT, Romero JM, Bavi P, Fischer SE, Serra S, Hafezi-Bakhtiari S, Caglar D, Roehrl MHA, Cleary S, Hollingsworth MA, Petersen GM, Thayer S, Law CHL, Nanji S, Golan T, Smith AL, Borgida A, Dodd A, Hedley D, Wouters BG, O'Kane GM, Wilson JM, Zogopoulos G, Notta F, Knox JJ, Gallinger S. Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases Cancer Cell. PMID: 30686769", "BibTeX": "@article{30686769, title={Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases}, author={Connor AA and Denroche RE and Jang GH and Lemire M and Zhang A and Chan-Seng-Yue M and Wilson G and Grant RC and Merico D and Lungu I and Bartlett JMS and Chadwick D and Liang SB and Eagles J and Mbabaali F and Miller JK and Krzyzanowski P and Armstrong H and Luo X and Jorgensen LGT and Romero JM and Bavi P and Fischer SE and Serra S and Hafezi-Bakhtiari S and Caglar D and Roehrl MHA and Cleary S and Hollingsworth MA and Petersen GM and Thayer S and Law CHL and Nanji S and Golan T and Smith AL and Borgida A and Dodd A and Hedley D and Wouters BG and O'Kane GM and Wilson JM and Zogopoulos G and Notta F and Knox JJ and Gallinger S}, journal={Cancer Cell}}"}, "is_sup_mat_match": false}, {"pmid": 32220889, "pmcid": "PMC7334063", "title": "Constitutive activation of RAS/MAPK pathway cooperates with trisomy 21 and is therapeutically exploitable in Down syndrome B-cell Leukemia", "journal": "Clin Cancer Res", "authors": ["Laurent AP", "Siret A", "Ignacimouttou C", "Panchal K", "Diop M", "Jenni S", "Tsai YC", "Roos-Weil D", "Aid Z", "Prade N", "Lagarde S", "Plassard D", "Pierron G", "Daudigeos E", "Lecluse Y", "Droin N", "Bornhauser BC", "Cheung LC", "Crispino JD", "Gaudry M", "Bernard OA", "Macintyre E", "Barin Bonnigal C", "Kotecha RS", "Geoerger B", "Ballerini P", "Bourquin JP", "Delabesse E", "Mercher T", "Malinge S"], "date": "2020-07-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "32220889@23917", "snip_text": "Next, we assessed the efficacy of Trametinib on the survival of two B-ALL+21 models carrying RAS activating mutations: iAMP01 (NRASG12V) and HeH09 (KRASA146T).", "section": "results", "mentions": ["34|10|chemical|ncbi_mesh@C560077|Trametinib", "119|6|cellline||iAMP01", "68|5|disease|ncbi_mesh@D015456|B-ALL", "148|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T", "131|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V"], "text_hl": "Next, we assessed the efficacy of Trametinib on the survival of two B-ALL+21 models carrying RAS activating mutations: iAMP01 (NRASG12V) and HeH09 (KRASA146T)."}], "citations": {"NLM": "Laurent AP, Siret A, Ignacimouttou C, Panchal K, Diop M, Jenni S, Tsai YC, Roos-Weil D, Aid Z, Prade N, Lagarde S, Plassard D, Pierron G, Daudigeos E, Lecluse Y, Droin N, Bornhauser BC, Cheung LC, Crispino JD, Gaudry M, Bernard OA, Macintyre E, Barin Bonnigal C, Kotecha RS, Geoerger B, Ballerini P, Bourquin JP, Delabesse E, Mercher T, Malinge S. Constitutive activation of RAS/MAPK pathway cooperates with trisomy 21 and is therapeutically exploitable in Down syndrome B-cell Leukemia Clin Cancer Res. PMID: 32220889", "BibTeX": "@article{32220889, title={Constitutive activation of RAS/MAPK pathway cooperates with trisomy 21 and is therapeutically exploitable in Down syndrome B-cell Leukemia}, author={Laurent AP and Siret A and Ignacimouttou C and Panchal K and Diop M and Jenni S and Tsai YC and Roos-Weil D and Aid Z and Prade N and Lagarde S and Plassard D and Pierron G and Daudigeos E and Lecluse Y and Droin N and Bornhauser BC and Cheung LC and Crispino JD and Gaudry M and Bernard OA and Macintyre E and Barin Bonnigal C and Kotecha RS and Geoerger B and Ballerini P and Bourquin JP and Delabesse E and Mercher T and Malinge S}, journal={Clin Cancer Res}}"}, "is_sup_mat_match": false}, {"pmid": 31692488, "pmcid": "PMC6708395", "title": "Comprehensive assessment of HER2 alteration in a colorectal cancer cohort: from next-generation sequencing to clinical significance.", "journal": "Cancer Manag Res", "authors": ["Yeh YM", "Lee CH", "Chen SH", "Lee CT", "Chen YL", "Lin BW", "Lin SC", "Chan RH", "Lee JC", "Shen MR", "Lin PC"], "date": "2019-08-20T00:00:00Z", "year": 2019, "snippets": [{"_id": "31692488@10246", "snip_text": "Notes: *Including 2 A146T, 2 Q61H, 2 G12C, 2 G12S, 1 D132N, 1 Q61L, 1 G15D, 1 G12W and 1 G13C mutation; +Including 1 N345I, 1 N345K, 1 G363R, 1 C420R, 1 E542K, 1 E545D, 1 E689K and 1 E726K mutation.", "section": "table", "mentions": ["144|5|variant|litvar@rs121913272##&&&litvar@#5290#&&&litvar@CA180900#rs121913272##|C420R", "153|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "53|5|variant|litvar@#5290#p.D132N&&&litvar@#5290#|D132N", "37|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "117|5|variant|litvar@rs1057519938##&&&litvar@#5290#|N345I", "62|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "78|4|variant|litvar@rs121913530##&&&litvar@#3845#|G12W", "45|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "29|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "70|4|variant|litvar@#5290#p.G15D&&&litvar@#5290#|G15D", "89|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13C", "162|5|variant|litvar@rs121913275##&&&litvar@#5290#&&&litvar@CA210104#rs121913275##|E545D", "171|5|variant|litvar@rs121913420##&&&litvar@#1956#&&&litvar@CA16602539#rs121913420##|E689K", "20|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "135|5|variant|litvar@rs745751553##&&&litvar@#7157#&&&litvar@CA33#rs745751553##|G363R", "126|5|variant|litvar@rs121913284##&&&litvar@#5290#&&&litvar@CA16602517#rs121913284##|N345K", "183|5|variant|litvar@rs867262025##&&&litvar@#5290#&&&litvar@CA16602910#rs867262025##|E726K"], "figure_id": "T0001", "text_hl": "Notes: *Including 2 <m>A146T</m>, 2 Q61H, 2 G12C, 2 G12S, 1 D132N, 1 Q61L, 1 G15D, 1 G12W and 1 G13C mutation; +Including 1 N345I, 1 N345K, 1 G363R, 1 C420R, 1 E542K, 1 E545D, 1 E689K and 1 E726K mutation."}], "citations": {"NLM": "Yeh YM, Lee CH, Chen SH, Lee CT, Chen YL, Lin BW, Lin SC, Chan RH, Lee JC, Shen MR, Lin PC. Comprehensive assessment of HER2 alteration in a colorectal cancer cohort: from next-generation sequencing to clinical significance. Cancer Manag Res. PMID: 31692488", "BibTeX": "@article{31692488, title={Comprehensive assessment of HER2 alteration in a colorectal cancer cohort: from next-generation sequencing to clinical significance.}, author={Yeh YM and Lee CH and Chen SH and Lee CT and Chen YL and Lin BW and Lin SC and Chan RH and Lee JC and Shen MR and Lin PC}, journal={Cancer Manag Res}}"}, "is_sup_mat_match": false}, {"pmid": 24832158, "pmcid": "PMC4134735", "title": "DETECTION OF THE BRAF V600E MUTATION IN COLON CARCINOMA - CRITICAL EVALUATION OF THE IMUNOHISTOCHEMICAL APPROACH", "journal": "Am J Surg Pathol", "authors": ["Lasota J", "Kowalik A", "Wasag B", "Wang ZF", "Felisiak-Golabek A", "Coates T", "Kopczynski J", "Gozdz S", "Miettinen M"], "date": "2014-09-01T00:00:00Z", "year": 2014, "snippets": [{"_id": "24832158@14778", "snip_text": "Five mutations were found in codon 146 including four c.436G>A, and one c.437C>T.", "section": "results", "mentions": ["72|8|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C>T", "54|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A"], "text_hl": "Five mutations were found in codon 146 including four c.436G>A, and one c.437C>T."}], "citations": {"NLM": "Lasota J, Kowalik A, Wasag B, Wang ZF, Felisiak-Golabek A, Coates T, Kopczynski J, Gozdz S, Miettinen M. DETECTION OF THE BRAF V600E MUTATION IN COLON CARCINOMA - CRITICAL EVALUATION OF THE IMUNOHISTOCHEMICAL APPROACH Am J Surg Pathol. PMID: 24832158", "BibTeX": "@article{24832158, title={DETECTION OF THE BRAF V600E MUTATION IN COLON CARCINOMA - CRITICAL EVALUATION OF THE IMUNOHISTOCHEMICAL APPROACH}, author={Lasota J and Kowalik A and Wasag B and Wang ZF and Felisiak-Golabek A and Coates T and Kopczynski J and Gozdz S and Miettinen M}, journal={Am J Surg Pathol}}"}, "is_sup_mat_match": false}, {"pmid": 37842094, "pmcid": "PMC10571159", "title": "Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function", "journal": "Front Cell Dev Biol", "authors": ["Fernandes LM", "Tresemer J", "Zhang J", "Rios JJ", "Scallan JP", "Dellinger MT"], "date": "2023-09-25T00:00:00Z", "year": 2023, "snippets": [{"_id": "37842094@3050", "snip_text": "To date, five different activating KRAS mutations (p.G12V, p.G12D, p.G13D, p.Q61R, and p.A146T) have been identified in patients.", "section": "introduction", "mentions": ["59|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "51|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "120|8|species|ncbi_taxonomy@9606|patients", "67|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "87|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "35|4|gene|ncbi_gene@16653|KRAS", "75|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R"], "text_hl": "To date, five different activating KRAS mutations (p.G12V, p.G12D, p.G13D, p.Q61R, and <m>p.A146T</m>) have been identified in patients."}], "citations": {"NLM": "Fernandes LM, Tresemer J, Zhang J, Rios JJ, Scallan JP, Dellinger MT. Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function Front Cell Dev Biol. PMID: 37842094", "BibTeX": "@article{37842094, title={Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function}, author={Fernandes LM and Tresemer J and Zhang J and Rios JJ and Scallan JP and Dellinger MT}, journal={Front Cell Dev Biol}}"}, "is_sup_mat_match": false}, {"pmid": 33521700, "pmcid": "PMC7817862", "title": "The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)", "journal": "Cell Rep Med", "authors": ["Salgia R", "Pharaon R", "Mambetsariev I", "Nam A", "Sattler M"], "date": "2021-01-19T00:00:00Z", "year": 2021, "snippets": [{"_id": "33521700@7242", "snip_text": "More recent work suggests that another potential mechanism of oncogenic KRAS activation (A146T mutant and possibly also V14I and G12D) involves the acceleration of intrinsic and guanine nucleotide exchange factor-induced nucleotide exchange.", "section": "introduction", "mentions": ["72|4|gene|ncbi_gene@3845|KRAS", "89|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "178|34|gene|ncbi_gene@6654|guanine nucleotide exchange factor", "129|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "120|4|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|V14I"], "text_hl": "More recent work suggests that another potential mechanism of oncogenic KRAS activation (<m>A146T</m> mutant and possibly also V14I and G12D) involves the acceleration of intrinsic and guanine nucleotide exchange factor-induced nucleotide exchange."}], "citations": {"NLM": "Salgia R, Pharaon R, Mambetsariev I, Nam A, Sattler M. The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) Cell Rep Med. PMID: 33521700", "BibTeX": "@article{33521700, title={The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)}, author={Salgia R and Pharaon R and Mambetsariev I and Nam A and Sattler M}, journal={Cell Rep Med}}"}, "is_sup_mat_match": false}, {"pmid": 32336014, "pmcid": "PMC7400788", "title": "RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K-RAS mutant tumors", "journal": "Mol Oncol", "authors": ["Yuan X", "Tang Z", "Du R", "Yao Z", "Cheung SH", "Zhang X", "Wei J", "Zhao Y", "Du Y", "Liu Y", "Hu X", "Gong W", "Liu Y", "Gao Y", "Huang Z", "Cao Z", "Wei M", "Zhou C", "Wang L", "Rosen N", "Smith PD", "Luo L"], "date": "2020-08-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "32336014@29027", "snip_text": "Cell line\tRAS mutation\tEOHSA\tMaximum EC50 shift for selumetinib\t \tP-value*\tPercentagea\t \tNSCLC:\t \tCalu-6\tK-RASQ61K\t< 0.0001\t0.45\t> 100-fold  \t \tA549\tK-RASG12S\t< 0.0001\t0.16\t77-fold  \t \tNCI-H2122\tK-RASG12C\t< 0.0001\t0.30\t17-fold  \t \tNCI-H23\tK-RASG12C\t< 0.0001\t0.25\t19-fold  \t \tSW1573\tK-RASG12C\t< 0.0001\t0.20\t> 100-fold  \t \tNCI-H358\tK-RASG12C\t< 0.0001\t0.33\t9-fold  \t \tNCI-H1299\tN-RASQ61K\t< 0.0001\t0.41\t4-fold  \t \tCalu-1\tK-RASG12C\t0.0669\t0.00\t9-fold  \t \tSK-LU-1\tK-RASG12D\t< 0.0001\t0.14\tNo shift\t \tCRC:\t \tLS174T\tK-RASG12D\t0.0048\t0.11\t18-fold  \t \tLoVo\tK-RASG13D\t< 0.0001\t0.22\t30-fold  \t \tT84\tK-RASG13D\t0.0001\t0.06\t19-fold  \t \tDLD-1\tK-RASG13D\t< 0.0001\t0.20\t> 100-fold  \t \tHCC2998\tK-RASA146T\t< 0.0001\t0.23\t34-fold  \t \tHCT8\tK-RASG13D\t0.0082\t0.05\t9-fold  \t \tSW480\tK-RASG12V\t0.9983\t0.00\tNo shift\t \t", "section": "table", "mentions": ["325|4|variant|litvar@#3845#|H358", "369|5|variant|litvar@#3845#|H1299", "673|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|K-RASA146T", "458|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|K-RASG12D", "582|3|variant|litvar@#3845#|T84", "235|3|variant|litvar@#3845#|H23", "507|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|K-RASG12D", "189|5|variant|litvar@#3845#|H2122"], "figure_id": "mol212698-tbl-0002", "text_hl": "Cell line\tRAS mutation\tEOHSA\tMaximum EC50 shift for selumetinib\t \tP-value*\tPercentagea\t \tNSCLC:\t \tCalu-6\tK-RASQ61K\t< 0.0001\t0.45\t> 100-fold  \t \tA549\tK-RASG12S\t< 0.0001\t0.16\t77-fold  \t \tNCI-H2122\tK-RASG12C\t< 0.0001\t0.30\t17-fold  \t \tNCI-H23\tK-RASG12C\t< 0.0001\t0.25\t19-fold  \t \tSW1573\tK-RASG12C\t< 0.0001\t0.20\t> 100-fold  \t \tNCI-H358\tK-RASG12C\t< 0.0001\t0.33\t9-fold  \t \tNCI-H1299\tN-RASQ61K\t< 0.0001\t0.41\t4-fold  \t \tCalu-1\tK-RASG12C\t0.0669\t0.00\t9-fold  \t \tSK-LU-1\tK-RASG12D\t< 0.0001\t0.14\tNo shift\t \tCRC:\t \tLS174T\tK-RASG12D\t0.0048\t0.11\t18-fold  \t \tLoVo\tK-RASG13D\t< 0.0001\t0.22\t30-fold  \t \tT84\tK-RASG13D\t0.0001\t0.06\t19-fold  \t \tDLD-1\tK-RASG13D\t< 0.0001\t0.20\t> 100-fold  \t \tHCC2998\tK-RASA146T\t< 0.0001\t0.23\t34-fold  \t \tHCT8\tK-RASG13D\t0.0082\t0.05\t9-fold  \t \tSW480\tK-RASG12V\t0.9983\t0.00\tNo shift\t \t"}], "citations": {"NLM": "Yuan X, Tang Z, Du R, Yao Z, Cheung SH, Zhang X, Wei J, Zhao Y, Du Y, Liu Y, Hu X, Gong W, Liu Y, Gao Y, Huang Z, Cao Z, Wei M, Zhou C, Wang L, Rosen N, Smith PD, Luo L. RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K-RAS mutant tumors Mol Oncol. PMID: 32336014", "BibTeX": "@article{32336014, title={RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K-RAS mutant tumors}, author={Yuan X and Tang Z and Du R and Yao Z and Cheung SH and Zhang X and Wei J and Zhao Y and Du Y and Liu Y and Hu X and Gong W and Liu Y and Gao Y and Huang Z and Cao Z and Wei M and Zhou C and Wang L and Rosen N and Smith PD and Luo L}, journal={Mol Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 24897499, "pmcid": "PMC4045804", "title": "Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation.", "journal": "PLoS One", "authors": ["Takano S", "Fukasawa M", "Maekawa S", "Kadokura M", "Miura M", "Shindo H", "Takahashi E", "Sato T", "Enomoto N"], "date": "2014-06-04T00:00:00Z", "year": 2014, "snippets": [{"_id": "24897499@19658", "snip_text": "Case Age Sex  Diagnosis  GNAS   KRAS          Mutation VF (%) Coverage Mutation VF (%) Coverage    1 62 M   WT   G12D 23.0 634    2 73 M   WT   G12R 16.4 691    3 68 M   WT   G12D 12.2 809    4 63 F   WT   G12V 6.9 800    5 62 F   WT   G12V 8.8 2567    6 77 M   WT   G12D 11.8 1441    7 51 F   WT   G12D 12.0 1731    8 72 M   WT   G12D 14.5 689    9 77 F   WT   G12V 20.3 723    10 65 F   WT   G12D 20.5 985    11 67 M   WT   G12V 34.8 863    12 60 M   WT   A146T 1.21 990     13 53 M  without IPMN WT   G12D 19.24 2355     14 67 M   WT   G12D 16.13 595     15 78 M   WT   G12D 1.87 268     6 73 F   WT   G12R 28.22 1244     17 57 F   WT   G12R 55.63 6899     18 52 M   WT   G12V 13.59 2126     19 72 F   WT   G12V 4.92 488     20 71 F   WT   G12V 32.44 4263     21 61 M PDAC  WT   G12V 30.55 4458     22 78 M   WT   Q61H 23.27 1985     23 78 F   WT   WT       24 80 F   WT   WT       25 71 F   WT   WT      26 67 M   WT   WT      27 82 F   R201C 5.5 2321 G12D 6.5 1364    28 78 M   R201H 13.8 4075 G12D 13.2 2058     29 72 M   R201H 5.7 2440 G12D 14.4 2145    30 69 M  with IPMN R201C 1.0 2235 WT       31 80 M  (PDAC concomitant R201H 5.8 925 WT      32 73 M  with IPMN) WT   G12V 25.4 688     33 78 F   WT   G12V 6.5 851     34 73 M   WT   G12V 1.9 1134     35 63 F   WT   G12D 11.3 1185    36 79 F   WT   G12D 14.9 2563     37 72 M   R201C 10.4 501 G12V 10.5 467    38 79 M   R201C 11.8 2154 G12D 16.2 1292     39 79 F  PDAC derived from WT   Q61H 10.5 873    40 80 F  IPMN WT   G12D 16.9 2330     41 69 M   WT   WT      42 37 M   WT   WT      43 81 M   R201H 46.6 1302 Q61H 48.0 1628    44 69 M   R201C 49.6 1215 G12D 42.9 815    45 78 F IPMN without PDAC WT   G12V 39.3 751    46 62 M   R201H 39.4 1089 G12V 38.3 650    47 67 M   R201H 16.1 1051 G12D 16.2 1183    48 76 M   WT   G12D 7.0 512    ", "section": "table", "mentions": ["539|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1028|5|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|R201H", "25|4|gene|ncbi_gene@2778|GNAS", "941|5|chemical||R201C", "999|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "494|4|disease|ncbi_mesh@D000077779|IPMN", "1602|5|chemical||R201C", "1114|4|disease|ncbi_mesh@D021441|PDAC", "1178|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "113|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1656|4|disease|ncbi_mesh@D021441|PDAC", "1752|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "573|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "394|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "710|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "983|5|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|R201H", "605|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "1353|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1243|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "504|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "206|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1211|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "362|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "426|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "771|4|disease|ncbi_mesh@D021441|PDAC", "1736|5|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|R201H", "32|4|gene|ncbi_gene@3845|KRAS", "1473|4|disease|ncbi_mesh@D000077779|IPMN", "1785|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "743|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1080|5|chemical||R201C", "1666|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1643|4|disease|ncbi_mesh@D000077779|IPMN", "1131|5|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|R201H", "1276|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "817|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "1396|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "675|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "331|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1574|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "299|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1338|5|chemical||R201C", "1483|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "175|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1043|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1309|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1075|4|disease|ncbi_mesh@D000077779|IPMN", "1558|5|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|R201H", "1447|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "1424|4|disease|ncbi_mesh@D021441|PDAC", "267|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "782|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1167|4|disease|ncbi_mesh@D000077779|IPMN", "1709|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "640|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "144|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "956|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "458|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "236|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1618|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1693|5|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|R201H"], "figure_id": "pone-0098718-t004", "text_hl": "Case Age Sex  Diagnosis  GNAS   KRAS          Mutation VF (%) Coverage Mutation VF (%) Coverage    1 62 M   WT   G12D 23.0 634    2 73 M   WT   G12R 16.4 691    3 68 M   WT   G12D 12.2 809    4 63 F   WT   G12V 6.9 800    5 62 F   WT   G12V 8.8 2567    6 77 M   WT   G12D 11.8 1441    7 51 F   WT   G12D 12.0 1731    8 72 M   WT   G12D 14.5 689    9 77 F   WT   G12V 20.3 723    10 65 F   WT   G12D 20.5 985    11 67 M   WT   G12V 34.8 863    12 60 M   WT   <m>A146T</m> 1.21 990     13 53 M  without IPMN WT   G12D 19.24 2355     14 67 M   WT   G12D 16.13 595     15 78 M   WT   G12D 1.87 268     6 73 F   WT   G12R 28.22 1244     17 57 F   WT   G12R 55.63 6899     18 52 M   WT   G12V 13.59 2126     19 72 F   WT   G12V 4.92 488     20 71 F   WT   G12V 32.44 4263     21 61 M PDAC  WT   G12V 30.55 4458     22 78 M   WT   Q61H 23.27 1985     23 78 F   WT   WT       24 80 F   WT   WT       25 71 F   WT   WT      26 67 M   WT   WT      27 82 F   R201C 5.5 2321 G12D 6.5 1364    28 78 M   R201H 13.8 4075 G12D 13.2 2058     29 72 M   R201H 5.7 2440 G12D 14.4 2145    30 69 M  with IPMN R201C 1.0 2235 WT       31 80 M  (PDAC concomitant R201H 5.8 925 WT      32 73 M  with IPMN) WT   G12V 25.4 688     33 78 F   WT   G12V 6.5 851     34 73 M   WT   G12V 1.9 1134     35 63 F   WT   G12D 11.3 1185    36 79 F   WT   G12D 14.9 2563     37 72 M   R201C 10.4 501 G12V 10.5 467    38 79 M   R201C 11.8 2154 G12D 16.2 1292     39 79 F  PDAC derived from WT   Q61H 10.5 873    40 80 F  IPMN WT   G12D 16.9 2330     41 69 M   WT   WT      42 37 M   WT   WT      43 81 M   R201H 46.6 1302 Q61H 48.0 1628    44 69 M   R201C 49.6 1215 G12D 42.9 815    45 78 F IPMN without PDAC WT   G12V 39.3 751    46 62 M   R201H 39.4 1089 G12V 38.3 650    47 67 M   R201H 16.1 1051 G12D 16.2 1183    48 76 M   WT   G12D 7.0 512    "}], "citations": {"NLM": "Takano S, Fukasawa M, Maekawa S, Kadokura M, Miura M, Shindo H, Takahashi E, Sato T, Enomoto N. Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation. PLoS One. PMID: 24897499", "BibTeX": "@article{24897499, title={Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation.}, author={Takano S and Fukasawa M and Maekawa S and Kadokura M and Miura M and Shindo H and Takahashi E and Sato T and Enomoto N}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 30814910, "pmcid": "PMC6376795", "title": "ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma.", "journal": "Cancer Cell Int", "authors": ["Liu Y", "Wang X", "Deng L", "Ping L", "Shi Y", "Zheng W", "Lin N", "Wang X", "Tu M", "Xie Y", "Liu W", "Ying Z", "Zhang C", "Pan Z", "Wang X", "Ding N", "Song Y", "Zhu J"], "date": "2019-02-14T00:00:00Z", "year": 2019, "snippets": [{"_id": "30814910@24726", "snip_text": "Gene Amino acid change Mutation type Domain Frequency (%)   RHOA G17V Missense GTP binding 41.7   ZAP70 K333R, A601V, R175H, A76E, A475T Missense SH2, protein kinase 41.7   CARD11 A704V, E373Q, S904I, A701V Missense PDZ 33.3   CD28 D124E, T195P, R198H Missense Extracellular, cytoplasmic 25   FYN T15M, D390G, A412V Missense SH2, protein kinase 25   LCK R168Q, A305T, A349T, Q504H Missense SH2, protein kinase 33.3   PIK3CA W824C, K1063R, Q859E, L94P Missense  41.7   ITK A397D, A525T Missense Protein kinase 16.7   KRAS G13C, A146S Missense GTP binding 16.7   PIK3R1 A48V, K567E, A682V Missense SH3, SH2 25   VAV1 C7Y, L325P Missense  16.7   AKT1 A409V Missense Protein kinase 8.3   ", "section": "table", "mentions": ["521|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "561|6|gene|ncbi_gene@5295|PIK3R1", "201|5|variant|litvar@#940#p.A701V&&&litvar@#940#|A701V", "350|3|gene|ncbi_gene@3932|LCK", "574|5|variant|litvar@rs757015607##&&&litvar@#7535#&&&litvar@CA1790538#rs757015607##|K567E", "239|5|variant|litvar@#940#p.T195P&&&litvar@#940#|T195P", "303|5|variant|litvar@#2534#p.D390G&&&litvar@#2534#|D390G", "297|4|variant|litvar@rs140762956##&&&litvar@#2534#&&&litvar@CA144884550#rs140762956##|T15M", "354|5|variant|litvar@#3932#p.R168Q&&&litvar@#3932#|R168Q", "620|5|variant|litvar@rs781227475##&&&litvar@#3932#&&&litvar@CA741289#rs781227475##|L325P", "648|5|variant|litvar@rs780970275##&&&litvar@#7535#&&&litvar@CA1790398#rs780970275##|A409V", "368|5|variant|litvar@rs776445077##&&&litvar@#940#&&&litvar@CA2066913#rs776445077##|A349T", "568|4|variant|litvar@rs200276601##&&&litvar@#5295#&&&litvar@CA3290258#rs200276601##|A48V", "111|5|variant|litvar@rs1222194883##&&&litvar@#7535#|A601V", "194|5|variant|litvar@#84433#p.S904I&&&litvar@#84433#|S904I", "98|5|gene|ncbi_gene@7535|ZAP70", "180|5|variant|litvar@#84433#p.A704V&&&litvar@#84433#|A704V", "60|4|gene|ncbi_gene@387|RHOA", "173|6|gene|ncbi_gene@84433|CARD11", "424|5|variant|litvar@#5290#p.W824C&&&litvar@#5290#|W824C", "479|5|variant|litvar@rs753217800##&&&litvar@#3702#&&&litvar@CA3533141#rs753217800##|A525T", "643|4|gene|ncbi_gene@207|AKT1", "65|4|variant|litvar@#387#p.G17V&&&litvar@#387#|G17V", "131|5|variant|litvar@rs199994054##&&&litvar@#7535#&&&litvar@CA52564165#rs199994054##|A475T", "293|3|gene|ncbi_gene@2534|FYN", "310|5|variant|litvar@rs866782954##&&&litvar@#5295#&&&litvar@CA119909286#rs866782954##|A412V", "446|4|variant|litvar@#3702#p.L94P&&&litvar@#3702#|L94P", "431|6|variant|litvar@#5290#p.K1063R&&&litvar@#5290#|K1063R", "232|5|variant|litvar@rs1412636143##&&&litvar@#940#|D124E", "472|5|variant|litvar@#3702#p.A397D&&&litvar@#3702#|A397D", "417|6|gene|ncbi_gene@5290|PIK3CA", "361|5|variant|litvar@#3932#c.305A>T&&&litvar@#3932#|A305T", "125|4|variant|litvar@#7535#p.A76E&&&litvar@#7535#|A76E", "581|5|variant|litvar@rs866782954##&&&litvar@#5295#&&&litvar@CA119909286#rs866782954##|A682V", "246|5|variant|litvar@rs199647272##&&&litvar@#940#&&&litvar@CA2066991#rs199647272##|R198H", "615|3|variant|litvar@#207#p.C7Y&&&litvar@#207#|C7Y", "527|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146S", "375|5|variant|litvar@#3932#p.Q504H&&&litvar@#3932#|Q504H", "439|5|variant|litvar@#5290#p.Q859E&&&litvar@#5290#|Q859E", "118|5|variant|litvar@rs55964305##&&&litvar@#7535#|R175H", "104|5|variant|litvar@#7535#p.K333R&&&litvar@#7535#|K333R", "187|5|variant|litvar@#84433#p.E373Q&&&litvar@#84433#|E373Q", "468|3|gene|ncbi_gene@3702|ITK", "516|4|gene|ncbi_gene@3845|KRAS", "227|4|gene|ncbi_gene@940|CD28", "542|3|chemical|ncbi_mesh@D006160|GTP", "79|3|chemical|ncbi_mesh@D006160|GTP"], "figure_id": "Tab2", "text_hl": "Gene Amino acid change Mutation type Domain Frequency (%)   RHOA G17V Missense GTP binding 41.7   ZAP70 K333R, A601V, R175H, A76E, A475T Missense SH2, protein kinase 41.7   CARD11 A704V, E373Q, S904I, A701V Missense PDZ 33.3   CD28 D124E, T195P, R198H Missense Extracellular, cytoplasmic 25   FYN T15M, D390G, A412V Missense SH2, protein kinase 25   LCK R168Q, A305T, A349T, Q504H Missense SH2, protein kinase 33.3   PIK3CA W824C, K1063R, Q859E, L94P Missense  41.7   ITK A397D, A525T Missense Protein kinase 16.7   KRAS G13C, A146S Missense GTP binding 16.7   PIK3R1 A48V, K567E, A682V Missense SH3, SH2 25   VAV1 C7Y, L325P Missense  16.7   AKT1 A409V Missense Protein kinase 8.3   "}], "citations": {"NLM": "Liu Y, Wang X, Deng L, Ping L, Shi Y, Zheng W, Lin N, Wang X, Tu M, Xie Y, Liu W, Ying Z, Zhang C, Pan Z, Wang X, Ding N, Song Y, Zhu J. ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma. Cancer Cell Int. PMID: 30814910", "BibTeX": "@article{30814910, title={ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma.}, author={Liu Y and Wang X and Deng L and Ping L and Shi Y and Zheng W and Lin N and Wang X and Tu M and Xie Y and Liu W and Ying Z and Zhang C and Pan Z and Wang X and Ding N and Song Y and Zhu J}, journal={Cancer Cell Int}}"}, "is_sup_mat_match": false}, {"pmid": 32929562, "pmcid": "PMC7897192", "title": "Current methods in translational cancer research.", "journal": "Cancer Metastasis Rev", "authors": ["Lee MW", "Miljanic M", "Triplett T", "Ramirez C", "Aung KL", "Eckhardt SG", "Capasso A"], "date": "2021-03-01T00:00:00Z", "year": 2021, "snippets": [{"_id": "32929562@20083", "snip_text": "The third patient, on the other hand, had a mutated KRAS (A146T) and two truncating APC mutations.", "section": "other", "mentions": ["10|7|species|ncbi_taxonomy@9606|patient", "52|4|gene|ncbi_gene@3845|KRAS", "84|3|gene|ncbi_gene@324|APC", "58|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "The third patient, on the other hand, had a mutated KRAS (<m>A146T</m>) and two truncating APC mutations."}], "citations": {"NLM": "Lee MW, Miljanic M, Triplett T, Ramirez C, Aung KL, Eckhardt SG, Capasso A. Current methods in translational cancer research. Cancer Metastasis Rev. PMID: 32929562", "BibTeX": "@article{32929562, title={Current methods in translational cancer research.}, author={Lee MW and Miljanic M and Triplett T and Ramirez C and Aung KL and Eckhardt SG and Capasso A}, journal={Cancer Metastasis Rev}}"}, "is_sup_mat_match": false}, {"pmid": 29069792, "pmcid": "PMC5641135", "title": "Acquired somatic TP53 or PIK3CA mutations are potential predictors of when polyps evolve into colorectal cancer.", "journal": "Oncotarget", "authors": ["Chang PY", "Chen JS", "Chang SC", "Wang MC", "Chang NC", "Wen YH", "Tsai WS", "Liu WH", "Liu HL", "Lu JJ"], "date": "2017-08-21T00:00:00Z", "year": 2017, "snippets": [{"_id": "29069792@11040", "snip_text": "Gene name (RefSeq ID) Nucleotide Change Amino Acid Change Variant effect Patient no   TP53 (NM_000546) c.C321A COSM45040_p.Y107* stopgain 1   c.A641G COSM43687_p.H214R nonsynonymous missense 1   c.A659G COSM10758_p.Y220C nonsynonymous missense 1   c.A701G COSM10725_p.Y234C nonsynonymous missense 1   c.G731A COSM10883_p.G244D nonsynonymous missense 1   c.G733A COSM6932_p.G245S nonsynonymous missense 1   KRAS (NM_033360) c.G34A COSM517_p.G12S nonsynonymous missense 1   c.G34T COSM516_p.G12C nonsynonymous missense 1   c.G35A COSM521_p.G12D nonsynonymous missense 5   c.G35T COSM520_p.G12V nonsynonymous missense 3   c.G38A COSM532_p.G13D nonsynonymous missense 4   c.A183C COSM554_p.Q61H nonsynonymous missense 2   c.G436A COSM19404_p.A146T nonsynonymous missense 1   APC (NM_000038) c.C2626T COSM18852_p.R876* stopgain 2   c.C3340T COSM13125_p.R1114* stopgain 1   c.C3367T COSM1432255_p.Q1123* stopgain 1   c.G3856T COSM18772_p.E1286* stopgain 2   c.C3871T COSM19072_p.Q1291* stopgain 2   c.C3880T COSM18960_p.Q1294* stopgain 1   c.3894_3895delTG COSM18980 p.S1298fs frameshift 1   c.C3907T COSM13728_p.Q1303* stopgain 1   c.G3916T COSM18760_p.E1306* stopgain 2   c.C4031G p.S1344* stopgain 1   c.G4033T COSM18759_p.E1345* stopgain 1   c.4060delT COSM292626_p.S1355fs*60 frameshift 1   c.C4067G COSM18779_p.S1356* stopgain 1   c.G4120T COSM19085_p.E1374* stopgain 1   c.C4285T COSM18836_p.Q1429* stopgain 1   c.C4348T COSM13127_p.R1450* stopgain 4   c.4385_4388delAGAG COSM1432412_p.E1464fs*8 frameshift 1   c.4498delT p.F1500fs frameshift 1   c.G4660T COSM33818_p.E1554* stopgain 1   SMAD4 (NM_005359) c.G1082A COSM14122_p.R361H nonsynonymous missense 1   FBXW7 (NM_018315) c.C1153T COSM170725_p.R385C nonsynonymous missense 1   c.G1196A COSM94297_p.R399Q nonsynonymous missense 1   c.G1196T COSM99619_p.R399L nonsynonymous missense 1   c.C1273T COSM74637_p.R425C nonsynonymous missense 1   c.C1505T COSM295016_p.S502L nonsynonymous missense 1   BRAF (NM_004333) c.T1799A COSM476_p.V600E nonsynonymous missense 1   GNAS (NM_001077489) c.C556T p.R186C nonsynonymous missense 2   ", "section": "table", "mentions": ["570|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.G35T", "1679|8|variant|litvar@rs867384286##&&&litvar@#55294#&&&litvar@CA16602851#rs867384286##|c.C1153T", "1372|8|variant|litvar@rs74535574##&&&litvar@#324#&&&litvar@CA16030720#rs74535574##|c.C4285T", "668|7|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA180922#rs17851045##|c.A183C", "1061|9|variant|litvar@rs863225353##&&&litvar@#324#|p.S1298fs", "806|7|variant|litvar@#324#p.R876*&&&litvar@#324#|p.R876*", "301|7|variant|litvar@rs985033810##&&&litvar@#7157#&&&litvar@CA287488006#rs985033810##|c.G731A", "1331|8|variant|litvar@#4089#c.4120G>T&&&litvar@#4089#|c.G4120T", "1807|7|variant|litvar@rs866987936##&&&litvar@#55294#|p.R399L", "868|8|variant|litvar@rs587782518##&&&litvar@#324#&&&litvar@CA8967#rs587782518##|c.C3367T", "1350|8|variant|litvar@#4089#p.E1374*&&&litvar@#4089#|p.E1374*", "160|7|variant|litvar@rs1057519992##&&&litvar@#7157#|p.H214R", "521|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.G35A", "371|7|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|p.G245S", "993|8|variant|litvar@#324#c.3880C>T&&&litvar@#324#|c.C3880T", "1548|8|variant|litvar@rs749782426##&&&litvar@#324#|c.G4660T", "248|7|variant|litvar@rs587780073##&&&litvar@#7157#&&&litvar@CA337#rs587780073##|c.A701G", "354|7|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|c.G733A", "619|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.G38A", "1012|8|variant|litvar@#324#p.Q1294*&&&litvar@#324#|p.Q1294*", "1567|8|variant|litvar@#4089#p.E1554*&&&litvar@#4089#|p.E1554*", "1168|8|variant|litvar@rs1114167578##&&&litvar@#324#|c.C4031G", "1788|8|variant|litvar@rs866987936##&&&litvar@#55294#|c.G1196T", "1626|7|variant|litvar@rs377767347##&&&litvar@#4089#&&&litvar@CA128097#rs377767347##|p.R361H", "1177|8|variant|litvar@#324#p.S1344*&&&litvar@#324#|p.S1344*", "1699|7|variant|litvar@rs867384286##&&&litvar@#55294#&&&litvar@CA16602851#rs867384286##|p.R385C", "971|8|variant|litvar@#324#p.Q1291*&&&litvar@#324#|p.Q1291*", "472|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.G34T", "2048|7|variant|litvar@rs11554273##&&&litvar@#2778#&&&litvar@CA126067#rs11554273##|p.R186C", "1485|11|variant|litvar@rs387906234##&&&litvar@#324#|p.E1464fs*8", "1086|8|variant|litvar@rs74535574##&&&litvar@#324#&&&litvar@CA16030720#rs74535574##|c.C3907T", "1105|8|variant|litvar@#324#p.Q1303*&&&litvar@#324#|p.Q1303*", "889|8|variant|litvar@#324#p.Q1123*&&&litvar@#324#|p.Q1123*", "1034|16|variant|litvar@#324#c.3894_3895delTG&&&litvar@#324#|c.3894_3895delTG", "684|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "1968|8|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.T1799A", "1985|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "121|7|variant|litvar@#7157#p.Y107*&&&litvar@#7157#|p.Y107*", "2040|7|variant|litvar@rs11554273##&&&litvar@#2778#&&&litvar@CA126067#rs11554273##|c.C556T", "1512|10|variant|litvar@#4089#c.4498delT&&&litvar@#4089#|c.4498delT", "487|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "718|7|variant|litvar@rs763181290##&&&litvar@#324#&&&litvar@CA38866#rs763181290##|c.G436A", "319|7|variant|litvar@rs985033810##&&&litvar@#7157#|p.G244D", "213|7|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|p.Y220C", "1861|7|variant|litvar@rs149680468##&&&litvar@#55294#&&&litvar@CA16602253#rs149680468##|p.R425C", "1916|7|variant|litvar@rs760384475##&&&litvar@#324#|p.S502L", "1661|5|gene|ncbi_gene@55294|FBXW7", "423|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.G34A", "634|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "86|4|gene|ncbi_gene@7157|TP53", "1432|8|variant|litvar@#4089#p.R1450*&&&litvar@#4089#|p.R1450*", "1896|8|variant|litvar@rs760384475##&&&litvar@#324#&&&litvar@CA29849#rs760384475##|c.C1505T", "1607|8|variant|litvar@rs377767347##&&&litvar@#4089#&&&litvar@CA128097#rs377767347##|c.G1082A", "1391|8|variant|litvar@#4089#p.Q1429*&&&litvar@#4089#|p.Q1429*", "438|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "1290|8|variant|litvar@#4089#c.4067C>G&&&litvar@#4089#|c.C4067G", "585|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1589|5|gene|ncbi_gene@4089|SMAD4", "73|7|species|ncbi_taxonomy@9606|Patient", "1309|8|variant|litvar@#4089#p.S1356*&&&litvar@#4089#|p.S1356*", "827|8|variant|litvar@rs121913331##&&&litvar@#324#&&&litvar@CA10582306#rs121913331##|c.C3340T", "1199|8|variant|litvar@rs1211642532##&&&litvar@#324#|c.G4033T", "1753|7|variant|litvar@rs866987936##&&&litvar@#55294#&&&litvar@CA16602856#rs866987936##|p.R399Q", "266|7|variant|litvar@rs587780073##&&&litvar@#7157#&&&litvar@CA337#rs587780073##|p.Y234C", "846|8|variant|litvar@#324#p.R1114*&&&litvar@#324#|p.R1114*", "1218|8|variant|litvar@#4089#p.E1345*&&&litvar@#4089#|p.E1345*", "536|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "142|7|variant|litvar@rs1057519992##&&&litvar@#7157#|c.A641G", "1951|4|gene|ncbi_gene@673|BRAF", "787|8|variant|litvar@rs121913333##&&&litvar@#324#&&&litvar@CA338207#rs121913333##|c.C2626T", "1454|18|variant|litvar@#4089#c.4385_4388delAGAG&&&litvar@#4089#|c.4385_4388delAGAG", "1842|8|variant|litvar@rs149680468##&&&litvar@#55294#&&&litvar@CA16602253#rs149680468##|c.C1273T", "2020|4|gene|ncbi_gene@2778|GNAS", "1240|10|variant|litvar@#4089#c.4060delT&&&litvar@#4089#|c.4060delT", "952|8|variant|litvar@rs1420195332##&&&litvar@#324#|c.C3871T", "1523|9|variant|litvar@#2778#p.F1500fsX&&&litvar@#2778#|p.F1500fs", "771|3|gene|ncbi_gene@324|APC", "1127|8|variant|litvar@rs121913462##&&&litvar@#324#&&&litvar@CA16029925#rs121913462##|c.G3916T", "911|8|variant|litvar@rs1211642532##&&&litvar@#324#|c.G3856T", "1262|12|variant|litvar@#4089#p.S1355fsX60&&&litvar@#4089#|p.S1355fs*60", "406|4|gene|ncbi_gene@3845|KRAS", "736|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "1146|8|variant|litvar@#324#p.E1306*&&&litvar@#324#|p.E1306*", "930|8|variant|litvar@#324#p.E1286*&&&litvar@#324#|p.E1286*", "103|7|variant|litvar@rs770776262##&&&litvar@#7157#|c.C321A", "1734|8|variant|litvar@rs866987936##&&&litvar@#55294#&&&litvar@CA16602856#rs866987936##|c.G1196A", "195|7|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|c.A659G", "1413|8|variant|litvar@rs121913332##&&&litvar@#324#&&&litvar@CA9465#rs121913332##|c.C4348T"], "figure_id": "T3", "text_hl": "Gene name (RefSeq ID) Nucleotide Change Amino Acid Change Variant effect Patient no   TP53 (NM_000546) c.C321A COSM45040_p.Y107* stopgain 1   c.A641G COSM43687_p.H214R nonsynonymous missense 1   c.A659G COSM10758_p.Y220C nonsynonymous missense 1   c.A701G COSM10725_p.Y234C nonsynonymous missense 1   c.G731A COSM10883_p.G244D nonsynonymous missense 1   c.G733A COSM6932_p.G245S nonsynonymous missense 1   KRAS (NM_033360) c.G34A COSM517_p.G12S nonsynonymous missense 1   c.G34T COSM516_p.G12C nonsynonymous missense 1   c.G35A COSM521_p.G12D nonsynonymous missense 5   c.G35T COSM520_p.G12V nonsynonymous missense 3   c.G38A COSM532_p.G13D nonsynonymous missense 4   c.A183C COSM554_p.Q61H nonsynonymous missense 2   c.G436A COSM19404_p.A146T nonsynonymous missense 1   APC (NM_000038) c.C2626T COSM18852_p.R876* stopgain 2   c.C3340T COSM13125_p.R1114* stopgain 1   c.C3367T COSM1432255_p.Q1123* stopgain 1   c.G3856T COSM18772_p.E1286* stopgain 2   c.C3871T COSM19072_p.Q1291* stopgain 2   c.C3880T COSM18960_p.Q1294* stopgain 1   c.3894_3895delTG COSM18980 p.S1298fs frameshift 1   c.C3907T COSM13728_p.Q1303* stopgain 1   c.G3916T COSM18760_p.E1306* stopgain 2   c.C4031G p.S1344* stopgain 1   c.G4033T COSM18759_p.E1345* stopgain 1   c.4060delT COSM292626_p.S1355fs*60 frameshift 1   c.C4067G COSM18779_p.S1356* stopgain 1   c.G4120T COSM19085_p.E1374* stopgain 1   c.C4285T COSM18836_p.Q1429* stopgain 1   c.C4348T COSM13127_p.R1450* stopgain 4   c.4385_4388delAGAG COSM1432412_p.E1464fs*8 frameshift 1   c.4498delT p.F1500fs frameshift 1   c.G4660T COSM33818_p.E1554* stopgain 1   SMAD4 (NM_005359) c.G1082A COSM14122_p.R361H nonsynonymous missense 1   FBXW7 (NM_018315) c.C1153T COSM170725_p.R385C nonsynonymous missense 1   c.G1196A COSM94297_p.R399Q nonsynonymous missense 1   c.G1196T COSM99619_p.R399L nonsynonymous missense 1   c.C1273T COSM74637_p.R425C nonsynonymous missense 1   c.C1505T COSM295016_p.S502L nonsynonymous missense 1   BRAF (NM_004333) c.T1799A COSM476_p.V600E nonsynonymous missense 1   GNAS (NM_001077489) c.C556T p.R186C nonsynonymous missense 2   "}], "citations": {"NLM": "Chang PY, Chen JS, Chang SC, Wang MC, Chang NC, Wen YH, Tsai WS, Liu WH, Liu HL, Lu JJ. Acquired somatic TP53 or PIK3CA mutations are potential predictors of when polyps evolve into colorectal cancer. Oncotarget. PMID: 29069792", "BibTeX": "@article{29069792, title={Acquired somatic TP53 or PIK3CA mutations are potential predictors of when polyps evolve into colorectal cancer.}, author={Chang PY and Chen JS and Chang SC and Wang MC and Chang NC and Wen YH and Tsai WS and Liu WH and Liu HL and Lu JJ}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 33497604, "pmcid": "PMC8178163", "title": "Structure of an inactive conformation of GTP-bound RhoA GTPase", "journal": "Structure", "authors": ["Lin Y", "Lu S", "Zhang J", "Zheng Y"], "date": "2021-01-12T00:00:00Z", "year": 2021, "snippets": [{"_id": "33497604@31863", "snip_text": "Similarly, A146T in K-Ras leads to a conformation characterized by a destabilized Switch I, rapid nucleotide exchange, and increased rate of deuterium exchange in Switch I. There seems to be an association between protein dynamics in the Switch regions and conformational equilibrium between states, and increased flexibility often leads to a higher state 1 population in Ras.", "section": "discussion", "mentions": ["98|10|chemical|ncbi_mesh@D009711|nucleotide", "141|9|chemical|ncbi_mesh@D003903|deuterium", "11|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Similarly, <m>A146T</m> in K-Ras leads to a conformation characterized by a destabilized Switch I, rapid nucleotide exchange, and increased rate of deuterium exchange in Switch I. There seems to be an association between protein dynamics in the Switch regions and conformational equilibrium between states, and increased flexibility often leads to a higher state 1 population in Ras."}], "citations": {"NLM": "Lin Y, Lu S, Zhang J, Zheng Y. Structure of an inactive conformation of GTP-bound RhoA GTPase Structure. PMID: 33497604", "BibTeX": "@article{33497604, title={Structure of an inactive conformation of GTP-bound RhoA GTPase}, author={Lin Y and Lu S and Zhang J and Zheng Y}, journal={Structure}}"}, "is_sup_mat_match": false}, {"pmid": 33209599, "pmcid": "PMC7653137", "title": "KRAS G12C mutations in Asia: a landscape analysis of 11,951 Chinese tumor samples.", "journal": "Transl Lung Cancer Res", "authors": ["Loong HH", "Du N", "Cheng C", "Lin H", "Guo J", "Lin G", "Li M", "Jiang T", "Shi Z", "Cui Y", "Jin X", "Yao J", "Xing Y", "Yao M", "Wang K", "Mok TSK", "Liu L"], "date": "2020-10-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "33209599@31951", "snip_text": "KRAS aberration Proportions (607 KRAS aberrations in 591 samples)   G12C 218 (35.9%)   G12V 108 (17.8%)   G12D 99 (16.3%)   Amplification 57 (9.4%)   G12A 37 (6.1%)   Q61H 18 (3.0%)   G13C 15 (2.5%)   G13D 13 (2.1%)   G12S 7(1.2%)   A146T 5 (0.8%)   Q61L 4 (0.7%)   G12R 3 (0.5%)   Q22K 3 (0.5%)   G13V 2 (0.3%)   Q61R 2 (0.3%)   G12F 2 (0.3%)   A146V 2 (0.3%)   K117N 2 (0.3%)   R164Q 1 (0.2%)   V8E 1 (0.2%)   L19F 1 (0.2%)   G60V 1 (0.2%)   P34A 1 (0.2%)   T50I 1 (0.2%)   A59G 1 (0.2%)   F156L 1 (0.2%)   E31K 1 (0.2%)   D119H 1 (0.2%)   ", "section": "table", "mentions": ["250|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|Q61L", "106|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "0|4|gene|ncbi_gene@3845|KRAS", "346|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "444|4|variant|litvar@rs371311801##&&&litvar@#7050#|P34A", "525|5|variant|litvar@rs200988301##&&&litvar@#55294#&&&litvar@CA108595455#rs200988301##|D119H", "184|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "150|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "33|4|gene|ncbi_gene@3845|KRAS", "363|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "428|4|variant|litvar@rs727503108##&&&litvar@#3845#&&&litvar@CA176493#rs727503108##|G60V", "412|4|variant|litvar@rs121913538##&&&litvar@#3845#&&&litvar@CA210356#rs121913538##|L19F", "68|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "476|4|variant|litvar@rs201258988##&&&litvar@#3417#&&&litvar@CA2079108#rs201258988##|A59G", "460|4|variant|litvar@rs1407509439##&&&litvar@#3845#|T50I", "167|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "201|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "218|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "282|4|variant|litvar@rs121913236##&&&litvar@#3845#&&&litvar@CA16602771#rs121913236##|Q22K", "266|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "330|4|variant|litvar@rs121913529##&&&litvar@#3845#|G12F", "233|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "298|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "314|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|Q61R", "492|5|variant|litvar@rs104894362##&&&litvar@#3845#&&&litvar@CA279964#rs104894362##|F156L", "509|4|variant|litvar@rs763184444##&&&litvar@#324#&&&litvar@CA33035#rs763184444##|E31K", "380|5|variant|litvar@rs372793780##&&&litvar@#3845#&&&litvar@CA135580#rs372793780##|R164Q", "87|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V"], "figure_id": "tS.2", "text_hl": "KRAS aberration Proportions (607 KRAS aberrations in 591 samples)   G12C 218 (35.9%)   G12V 108 (17.8%)   G12D 99 (16.3%)   Amplification 57 (9.4%)   G12A 37 (6.1%)   Q61H 18 (3.0%)   G13C 15 (2.5%)   G13D 13 (2.1%)   G12S 7(1.2%)   <m>A146T</m> 5 (0.8%)   Q61L 4 (0.7%)   G12R 3 (0.5%)   Q22K 3 (0.5%)   G13V 2 (0.3%)   Q61R 2 (0.3%)   G12F 2 (0.3%)   A146V 2 (0.3%)   K117N 2 (0.3%)   R164Q 1 (0.2%)   V8E 1 (0.2%)   L19F 1 (0.2%)   G60V 1 (0.2%)   P34A 1 (0.2%)   T50I 1 (0.2%)   A59G 1 (0.2%)   F156L 1 (0.2%)   E31K 1 (0.2%)   D119H 1 (0.2%)   "}], "citations": {"NLM": "Loong HH, Du N, Cheng C, Lin H, Guo J, Lin G, Li M, Jiang T, Shi Z, Cui Y, Jin X, Yao J, Xing Y, Yao M, Wang K, Mok TSK, Liu L. KRAS G12C mutations in Asia: a landscape analysis of 11,951 Chinese tumor samples. Transl Lung Cancer Res. PMID: 33209599", "BibTeX": "@article{33209599, title={KRAS G12C mutations in Asia: a landscape analysis of 11,951 Chinese tumor samples.}, author={Loong HH and Du N and Cheng C and Lin H and Guo J and Lin G and Li M and Jiang T and Shi Z and Cui Y and Jin X and Yao J and Xing Y and Yao M and Wang K and Mok TSK and Liu L}, journal={Transl Lung Cancer Res}}"}, "is_sup_mat_match": false}, {"pmid": 35267450, "pmcid": "PMC8909869", "title": "The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy.", "journal": "Cancers (Basel)", "authors": ["Canale M", "Andrikou K", "Priano I", "Cravero P", "Pasini L", "Urbini M", "Delmonte A", "Crin\u00f2 L", "Bronte G", "Ulivi P"], "date": "2022-02-23T00:00:00Z", "year": 2022, "snippets": [{"_id": "35267450@24664", "snip_text": "In the FLAURA study, mutations of KRAS, like G12D and A146T, were described in the cfDNA of 3% of cases; in the study conducted by Schoenfeld on tumor tissue, KRAS mutation G12A was recorded in one case (4%).", "section": "other", "mentions": ["145|5|disease|ncbi_mesh@D009369|tumor", "34|4|gene|ncbi_gene@3845|KRAS", "173|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "54|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "159|4|gene|ncbi_gene@3845|KRAS", "45|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "7|6|gene|ncbi_gene@6790|FLAURA"], "text_hl": "In the FLAURA study, mutations of KRAS, like G12D and <m>A146T</m>, were described in the cfDNA of 3% of cases; in the study conducted by Schoenfeld on tumor tissue, KRAS mutation G12A was recorded in one case (4%)."}], "citations": {"NLM": "Canale M, Andrikou K, Priano I, Cravero P, Pasini L, Urbini M, Delmonte A, Crin\u00f2 L, Bronte G, Ulivi P. The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy. Cancers (Basel). PMID: 35267450", "BibTeX": "@article{35267450, title={The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy.}, author={Canale M and Andrikou K and Priano I and Cravero P and Pasini L and Urbini M and Delmonte A and Crin\u00f2 L and Bronte G and Ulivi P}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 34557754, "pmcid": "PMC8454558", "title": "Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors.", "journal": "Innovation (N Y)", "authors": ["Du X", "Yang B", "An Q", "Assaraf YG", "Cao X", "Xia J"], "date": "2021-04-03T00:00:00Z", "year": 2021, "snippets": [{"_id": "34557754@40193", "snip_text": "Several alterations, such as NRAS mutations (G12V, G12R, Q61K, and E63K), KRAS mutations (G12S, G12A, Q61H, G12D, G13D, and A146T), BRAF mutations (G469A and V600E), MEK1 mutations, deletion of neurofibromin 1 (NF1), a GTPase-activating protein which negatively regulates the RAS/MAPK pathway, and gene amplification of v-crk sarcoma virus CT10 oncogene homolog-like (CRKL), provoke the sustained activation of RAS/RAF/MEK/ERK signaling pathway.", "section": "other", "mentions": ["419|3|gene|ncbi_gene@17242|MEK", "90|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "74|4|gene|ncbi_gene@16653|KRAS", "67|4|variant|litvar@rs139429793##&&&litvar@#1956#&&&litvar@CA4265432#rs139429793##|E63K", "124|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "108|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "194|15|gene|ncbi_gene@18015|neurofibromin 1", "415|3|gene|ncbi_gene@387609|RAF", "158|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "102|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "166|4|gene|ncbi_gene@26395|MEK1", "368|4|gene|ncbi_gene@12929|CRKL", "219|25|gene|ncbi_gene@218397|GTPase-activating protein", "211|3|gene|ncbi_gene@18015|NF1", "132|4|gene|ncbi_gene@109880|BRAF", "114|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "45|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "148|5|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|G469A", "29|4|gene|ncbi_gene@18176|NRAS", "57|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "96|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "51|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "423|3|gene|ncbi_gene@26413|ERK"], "text_hl": "Several alterations, such as NRAS mutations (G12V, G12R, Q61K, and E63K), KRAS mutations (G12S, G12A, Q61H, G12D, G13D, and <m>A146T</m>), BRAF mutations (G469A and V600E), MEK1 mutations, deletion of neurofibromin 1 (NF1), a GTPase-activating protein which negatively regulates the RAS/MAPK pathway, and gene amplification of v-crk sarcoma virus CT10 oncogene homolog-like (CRKL), provoke the sustained activation of RAS/RAF/MEK/ERK signaling pathway."}], "citations": {"NLM": "Du X, Yang B, An Q, Assaraf YG, Cao X, Xia J. Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors. Innovation (N Y). PMID: 34557754", "BibTeX": "@article{34557754, title={Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors.}, author={Du X and Yang B and An Q and Assaraf YG and Cao X and Xia J}, journal={Innovation (N Y)}}"}, "is_sup_mat_match": false}, {"pmid": 24192036, "pmcid": "PMC3814616", "title": "BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling.", "journal": "Elife", "authors": ["Vin H", "Ojeda SS", "Ching G", "Leung ML", "Chitsazzadeh V", "Dwyer DW", "Adelmann CH", "Restrepo M", "Richards KN", "Stewart LR", "Du L", "Ferguson SB", "Chakravarti D", "Ehrenreiter K", "Baccarini M", "Ruggieri R", "Curry JL", "Kim KB", "Ciurea AM", "Duvic M", "Prieto VG", "Ullrich SE", "Dalby KN", "Flores ER", "Tsai KY"], "date": "2013-11-05T00:00:00Z", "year": 2013, "snippets": [{"_id": "24192036@9040", "snip_text": "ALK_F1174LIV_T3520CAG ALK_F1245C_T3734G   ALK_F1245VI_T3733GA BRAF_G464EVA_G1391ATC   BRAF_G466R_G1396CA BRAF_K601E_A1801G   BRAF_V600EAG_T1799ACG_F CTNNB1_S45APT_T133GCA   CTNNB1_T41APS_A121GCS EGFR_Y813C_A2438G   GNAS_R201SC_C601AT KRAS_G12SRC_G34ACT   KRAS_Q61EKX_C181GAT MET_H1112_A3335GT   MET_Y1248HD_T3742CG PIK3CA_A1046V_C3137T   PIK3CA_C420R_T1258C PIK3CA_E110K_G328A   PIK3CA_E418K_G1252A PIK3CA_F909L_C2727G   PIK3CA_H1047RL_A3140 GT PIK3CA_H701P_A2102C   PIK3CA_N345K_T1035A PIK3CA_Q060K_C178A   PIK3CA_R088Q_G263A PIK3CA_S405F_C1214T   TNK2_R99Q_G296A BRAF_G466EVA_G1397ATC   BRAF_V600LM_G1798 TA CTNNB1_S37APT_T109GCA   CTNNB1_S45CFY_C134GTA EGFR_G719_G2155TA   EGFR_L858R_T2573G EGFR_T790M_C2369T   EPHA3_K761N_G2283 FGFR2_S252W_C755G   FOXL2_C134W_C402G KIT_K642E_A1924G   KIT_R634W_C1900T KIT_V560D_T1679A   KIT_V825A_T2474C KIT_Y553N_T1657A   KRAS_G12DAV_G35ACT MET_N375S_A1124G   NRAS_G12SRC_G34ACT PIK3CA_E453K_G1357A   PIK3CA_E545AGV_A1634CGT PIK3CA_H1047RL_A3140 GT..1.   PIK3CA_K111N_G333C PIK3CA_M1043V_A3127G   PIK3CA_P539R_C1616G BRAF_E586K_G1756A   BRAF_G469EVA_G1406ATC CTNNB1_S33APT_T97GCA   CTNNB1_S37CFY_C110GTA EGFR_L861_T2582AG   EGFR_T854I_C2561T FGFR2_N549KK_T1647GA   FRAP_R2505P_G7514C FRAP_S2215Y_C6644T   IDH2_R172MK_G515 TA JAK2_V617F_G1849T   KIT_L576P_T1727C KIT_N566D_A1696 G   KRAS_A146PT_G436CA NRAS_G12DAV_G35ACT   KRAS_Q61HHE_A183CTG KRAS_G13SRC_G37ACT   NRAS_G13DAV_G38ACT NRAS_Q61HHQ_A183TCG   PDGFRA_N659Y_A1975T PDGFRA_V561D_T1682A   PIK3CA_E545KQ_G1633AC PIK3CA_H1047Y_C3139T   PIK3CA_Q546EK_C1636 GA PIK3CA_Y1021HN_T3061CA   RET_M918T_T2753C AKT1_G173R_G517C   AKT2_E17K_G49A BRAF_G469R_G1405CA   BRAF_L597R_T1790G BRAF_V600_G1800   CTNNB1_G34EVA_G101ATC EGFR_S720P_T2158C   GNA11_Q209LP_A626 TC IDH1_R132CGS_C394TGA   IDH2_R140LQ_G419 TA IDH2_R140W_C418T   IDH2_R172S_G516T KIT_D816HNY_G2446CAT   KIT_V559ADG_T1676CAG KRAS_G10R_G28A   KRAS_Q61LPR_A182TCG MET_H1112Y_C3334T   MET_M1268T_T3803C MET_T1010I_C3029T   NRAS_A146T_G436A NRAS_Q61EKX_C181GAT   PDGFRA_D842V_A2525T PDGFRA_D842_G2524TA   PDGFRA_N659K_C1977A PIK3CA_E542KQ_G1624AC   PIK3CA_G1049R_G3145C PIK3CA_M1043I_G3129ATC   PIK3R1_D560Y_G1678T PRKAG2_N488I_A1463T   AKT2_G175R_G523C AKT3_G171R_G511A   ALK_F1174L_C3522AG ALK_I1171N_T3512A   ALK_R1275QL_G3824AT BRAF_D594GV_A1781 GT   CTNNB1_D32HNY_G94CAT FBWX7_R465C_C1393T   FBWX7_R479QL_G1436AT FBWX7_R505HLP_G1514ATC   FGFR3_G370C_G1108T GNAQ_Q209H_A627T   IDH2_R140W_C419T IDH2_R172GW_A514 GT   KIT_N822KNK_T2466GCA KRAS_G13DAV_G38ACT   PDPK1_D527E_C1581G PIK3CA_E542VG_A1625TG   PIK3CA_E545D_G1635CT PIK3CA_T1025SA_A3073TG   PIK3CA_Y1021C_A3062G PIK3R1_N564K_C1693AG   PRKAG1_R70Q_G209A AKT1_E17K_G49A   AKT1_K179M_A536T BRAF_V600EAG_T1799ACG_R   CDK4_R24C_C70T CDK4_R24H_G71A   CTNNB1_D32AGT_A95CGV FBWX7_R465HL_G1394AT   FGFR3_G697C_G2089T FGFR3_K650MT_A1949 TC   FGFR3_R248C_C742T FGFR3_S371C_A1111T   FGFR3_Y373C_A1118G GNAS_R201H_G602A   IDH1_R132HL_G395AT KIT_N822YHD_A2464TCG   MET_R988C_C2962T MET_Y1253D_T3757 G   NRAS_G13SRC_G37ACT NRAS_Q61RPL_A182GCT   PIK3CA_Q546LPR_A1637TCG TNK2_E346K_G1036A   PIK3CA_H1047RL_A3140 GT ALK_F1245C_T3734G   ", "section": "table", "mentions": ["1521|6|variant|litvar@rs1169935336##&&&litvar@#208#|C3139T", "2865|6|variant|litvar@#2261#p.A1111T&&&litvar@#2261#|A1111T", "1920|6|variant|litvar@rs926525536##&&&litvar@#1499#|C3334T", "2208|5|variant|litvar@rs1287829901##&&&litvar@#2263#|G511A", "2197|4|gene|ncbi_gene@10000|AKT3", "2721|4|variant|litvar@rs748200070##&&&litvar@#10188#&&&litvar@CA2776712#rs748200070##|R24C", "351|6|variant|litvar@#5290#p.T1258C&&&litvar@#5290#|T1258C", "2954|3|gene|ncbi_gene@79811|MET", "2392|5|variant|litvar@rs121913479##&&&litvar@#2261#&&&litvar@CA129946#rs121913479##|G370C", "3101|3|gene|ncbi_gene@238|ALK", "26|6|variant|litvar@rs863225283##&&&litvar@#238#&&&litvar@CA279597#rs863225283##|F1245C", "2463|3|gene|ncbi_gene@3815|KIT", "1089|8|variant|litvar@#1499#p.G1406I&&&litvar@#1499#|G1406ATC", "1772|4|gene|ncbi_gene@3418|IDH2", "173|6|gene|ncbi_gene@1499|CTNNB1", "480|6|variant|litvar@rs781049167##&&&litvar@#9344#|T1035A", "406|5|variant|litvar@rs867182279##&&&litvar@#1956#&&&litvar@CA158940652#rs867182279##|F909L", "816|6|variant|litvar@#3815#p.T1679A&&&litvar@#3815#|T1679A", "1340|4|gene|ncbi_gene@4893|NRAS", "1244|4|gene|ncbi_gene@3418|IDH2", "2569|6|gene|ncbi_gene@5290|PIK3CA", "3057|4|gene|ncbi_gene@10188|TNK2", "1588|6|variant|litvar@#208#p.T2753C&&&litvar@#208#|T2753C", "206|6|variant|litvar@#2778#p.A2438G&&&litvar@#2778#|A2438G", "1909|3|gene|ncbi_gene@79811|MET", "358|6|gene|ncbi_gene@5290|PIK3CA", "1163|4|gene|ncbi_gene@1956|EGFR", "2555|5|variant|litvar@rs121913275##&&&litvar@#5290#&&&litvar@CA210104#rs121913275##|E545D", "1816|5|variant|litvar@rs1057519736##&&&litvar@#3418#|R172S", "720|5|variant|litvar@rs561021424##&&&litvar@#23043#|K761N", "487|6|gene|ncbi_gene@5290|PIK3CA", "1402|4|gene|ncbi_gene@4893|NRAS", "1450|5|variant|litvar@rs1057519700##&&&litvar@#5156#|N659Y", "1606|5|variant|litvar@#208#p.G517C&&&litvar@#208#|G517C", "634|6|gene|ncbi_gene@1499|CTNNB1", "2048|6|gene|ncbi_gene@5156|PDGFRA", "1650|4|gene|ncbi_gene@673|BRAF", "2185|5|variant|litvar@rs183250272##&&&litvar@#2263#&&&litvar@CA5720992#rs183250272##|G175R", "549|4|gene|ncbi_gene@10188|TNK2", "295|3|gene|ncbi_gene@79811|MET", "842|3|gene|ncbi_gene@3815|KIT", "1067|6|variant|litvar@#673#p.G1756A&&&litvar@#673#|G1756A", "1872|4|gene|ncbi_gene@3845|KRAS", "1321|4|gene|ncbi_gene@3845|KRAS", "1553|6|gene|ncbi_gene@5290|PIK3CA", "2429|5|variant|litvar@rs267606870##&&&litvar@#3418#&&&litvar@CA16602464#rs267606870##|R140W", "624|7|variant|litvar@rs387906676##&&&litvar@#2263#&&&litvar@CA128691#rs387906676##|T109GCA", "1624|4|variant|litvar@rs757542528##&&&litvar@#4170#&&&litvar@CA1079281#rs757542528##|G49A", "911|6|variant|litvar@#5290#p.G34T&&&litvar@#5290#|G34ACT", "1996|7|variant|litvar@#79811#p.C181D&&&litvar@#79811#|C181GAT", "22|3|gene|ncbi_gene@238|ALK", "1181|5|gene|ncbi_gene@2263|FGFR2", "2650|5|variant|litvar@rs1394591088##&&&litvar@#10188#|G209A", "852|6|variant|litvar@#3845#p.T1657A&&&litvar@#3845#|T1657A", "2964|6|variant|litvar@#79811#p.C2962T&&&litvar@#79811#|C2962T", "2019|6|variant|litvar@#5156#p.A2525T&&&litvar@#5156#|A2525T", "2898|5|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|R201H", "1797|5|variant|litvar@rs267606870##&&&litvar@#3418#&&&litvar@CA16602464#rs267606870##|R140W", "2484|4|gene|ncbi_gene@3845|KRAS", "940|6|gene|ncbi_gene@5290|PIK3CA", "2798|5|variant|litvar@rs121913480##&&&litvar@#2261#&&&litvar@CA16602701#rs121913480##|G697C", "125|4|gene|ncbi_gene@673|BRAF", "2912|4|gene|ncbi_gene@3417|IDH1", "2835|5|gene|ncbi_gene@2261|FGFR3", "2684|5|variant|litvar@rs1387287647##&&&litvar@#2778#|A536T", "918|6|gene|ncbi_gene@5290|PIK3CA", "2975|6|variant|litvar@#79811#p.Y1253D&&&litvar@#79811#|Y1253D", "62|4|gene|ncbi_gene@673|BRAF", "1421|4|gene|ncbi_gene@4893|NRAS", "110|5|variant|litvar@rs121913364##&&&litvar@#673#&&&litvar@CA123645#rs121913364##|K601E", "578|8|variant|litvar@#673#p.G1397I&&&litvar@#673#|G1397ATC", "1978|5|variant|litvar@rs752863627##&&&litvar@#79811#|G436A", "1811|4|gene|ncbi_gene@3418|IDH2", "1443|6|gene|ncbi_gene@5156|PDGFRA", "2255|3|gene|ncbi_gene@238|ALK", "3068|6|variant|litvar@rs547820632##&&&litvar@#4217#|G1036A", "1686|6|gene|ncbi_gene@1499|CTNNB1", "1863|8|variant|litvar@#3845#p.T1676Q&&&litvar@#3845#|T1676CAG", "3004|6|variant|litvar@#4893#p.G37T&&&litvar@#4893#|G37ACT", "386|5|variant|litvar@rs397517199##&&&litvar@#5290#&&&litvar@CA136365#rs397517199##|E418K", "2517|6|variant|litvar@#5290#p.C1581G&&&litvar@#5290#|C1581G", "1476|6|variant|litvar@#5290#p.T1682A&&&litvar@#5290#|T1682A", "2931|3|gene|ncbi_gene@3815|KIT", "899|4|gene|ncbi_gene@4893|NRAS", "1719|6|variant|litvar@#1956#p.T2158C&&&litvar@#1956#|T2158C", "738|5|variant|litvar@rs79184941##&&&litvar@#2263#&&&litvar@CA122985#rs79184941##|S252W", "246|6|variant|litvar@#5290#p.G34T&&&litvar@#5290#|G34ACT", "534|5|variant|litvar@rs764343376##&&&litvar@#11184#|S405F", "1284|3|gene|ncbi_gene@3815|KIT", "527|6|gene|ncbi_gene@5290|PIK3CA", "1749|4|gene|ncbi_gene@3417|IDH1", "1882|4|variant|litvar@rs767024079##&&&litvar@#10188#|G28A", "338|6|gene|ncbi_gene@5290|PIK3CA", "1036|6|gene|ncbi_gene@5290|PIK3CA", "1143|4|gene|ncbi_gene@1956|EGFR", "452|5|variant|litvar@rs121913282##&&&litvar@#5290#&&&litvar@CA16602519#rs121913282##|H701P", "1661|6|variant|litvar@#673#p.T1790G&&&litvar@#673#|T1790G", "2853|5|gene|ncbi_gene@2261|FGFR3", "789|3|gene|ncbi_gene@3815|KIT", "2524|6|gene|ncbi_gene@5290|PIK3CA", "2325|5|variant|litvar@rs542338613##&&&litvar@#11184#|R465C", "1668|4|gene|ncbi_gene@673|BRAF", "2904|5|variant|litvar@#3417#p.G602A&&&litvar@#3417#|G602A", "1582|5|variant|litvar@rs781609053##&&&litvar@#1956#&&&litvar@CA4266204#rs781609053##|M918T", "195|4|gene|ncbi_gene@1956|EGFR", "2202|5|variant|litvar@rs1402272180##&&&litvar@#10000#|G171R", "589|4|gene|ncbi_gene@673|BRAF", "1933|6|variant|litvar@#79811#p.M1268T&&&litvar@#79811#|M1268T", "1700|7|variant|litvar@#1956#p.G101I&&&litvar@#1956#|G101ATC", "2971|3|gene|ncbi_gene@79811|MET", "1967|4|gene|ncbi_gene@4893|NRAS", "1361|4|gene|ncbi_gene@3845|KRAS", "3023|7|variant|litvar@rs1489246318##&&&litvar@#3717#|A182GCT", "2398|6|variant|litvar@#2261#p.G1108T&&&litvar@#2261#|G1108T", "955|8|variant|litvar@#5290#p.A1634R&&&litvar@#5290#|A1634CGT", "2410|5|variant|litvar@rs1394591088##&&&litvar@#10188#|Q209H", "2026|6|gene|ncbi_gene@5156|PDGFRA", "515|5|variant|litvar@#5290#p.R088Q&&&litvar@#5290#|R088Q", "1228|6|variant|litvar@#3418#p.S2215Y&&&litvar@#3418#|S2215Y", "379|6|gene|ncbi_gene@5290|PIK3CA", "656|4|gene|ncbi_gene@1956|EGFR", "1940|6|variant|litvar@rs112490195##&&&litvar@#3418#|T3803C", "2151|6|variant|litvar@#51422#p.G1678T&&&litvar@#51422#|G1678T", "770|3|gene|ncbi_gene@3815|KIT", "3011|4|gene|ncbi_gene@4893|NRAS", "825|3|gene|ncbi_gene@3815|KIT", "1007|5|variant|litvar@#5290#p.G333C&&&litvar@#5290#|G333C", "412|6|variant|litvar@#5290#p.C2727G&&&litvar@#5290#|C2727G", "467|6|gene|ncbi_gene@5290|PIK3CA", "2886|6|variant|litvar@#2778#p.A1118G&&&litvar@#2778#|A1118G", "2092|6|gene|ncbi_gene@5290|PIK3CA", "648|7|variant|litvar@#1956#p.C134V&&&litvar@#1956#|C134GTA", "2804|6|variant|litvar@#2261#p.G2089T&&&litvar@#2261#|G2089T", "2893|4|gene|ncbi_gene@2778|GNAS", "774|5|variant|litvar@rs121913512##&&&litvar@#3815#&&&litvar@CA123547#rs121913512##|K642E", "275|3|gene|ncbi_gene@79811|MET", "884|5|variant|litvar@rs112797533##&&&litvar@#9175#&&&litvar@CA89561431#rs112797533##|N375S", "267|7|variant|litvar@#79811#p.C181D&&&litvar@#79811#|C181GAT", "445|6|gene|ncbi_gene@5290|PIK3CA", "1294|6|variant|litvar@#3815#p.T1727C&&&litvar@#3815#|T1727C", "829|5|variant|litvar@rs121913524##&&&litvar@#3815#&&&litvar@CA16602706#rs121913524##|V825A", "1235|6|variant|litvar@rs1448375861##&&&litvar@#3265#|C6644T", "2006|6|gene|ncbi_gene@5156|PDGFRA", "2594|6|gene|ncbi_gene@5290|PIK3CA", "1951|6|variant|litvar@#79811#p.T1010I&&&litvar@#79811#|T1010I", "1889|4|gene|ncbi_gene@3845|KRAS", "91|5|variant|litvar@rs121913353##&&&litvar@#673#&&&litvar@CA168090546#rs121913353##|G466R", "1264|10|variant|litvar@#3717#p.V61F&&&litvar@#3717#|JAK2_V617F", "1121|6|gene|ncbi_gene@1499|CTNNB1", "2055|5|variant|litvar@rs1057519700##&&&litvar@#5156#|N659K", "2158|6|gene|ncbi_gene@51422|PRKAG2", "1792|4|gene|ncbi_gene@3418|IDH2", "371|5|variant|litvar@rs397516813##&&&litvar@#5894#&&&litvar@CA134687#rs397516813##|G328A", "2661|4|variant|litvar@rs387906659##&&&litvar@#208#&&&litvar@CA128662#rs387906659##|E17K", "1929|3|gene|ncbi_gene@79811|MET", "1456|6|variant|litvar@#5156#p.A1975T&&&litvar@#5156#|A1975T", "2099|6|variant|litvar@rs121913277##&&&litvar@#5290#&&&litvar@CA16602520#rs121913277##|G1049R", "1634|5|variant|litvar@rs121913357##&&&litvar@#673#&&&litvar@CA123653#rs121913357##|G469R", "873|6|variant|litvar@#79811#p.G35T&&&litvar@#79811#|G35ACT", "744|5|variant|litvar@#2263#p.C755G&&&litvar@#2263#|C755G", "1209|6|variant|litvar@#2263#p.R2505P&&&litvar@#2263#|R2505P", "3048|8|variant|litvar@#10188#p.A1637S&&&litvar@#10188#|A1637TCG", "2992|4|gene|ncbi_gene@4893|NRAS", "1393|6|variant|litvar@#4893#p.G37T&&&litvar@#4893#|G37ACT", "345|5|variant|litvar@rs121913272##&&&litvar@#5290#&&&litvar@CA180900#rs121913272##|C420R", "1043|5|variant|litvar@rs121913285##&&&litvar@#5290#&&&litvar@CA16602696#rs121913285##|P539R", "105|4|gene|ncbi_gene@673|BRAF", "508|6|gene|ncbi_gene@5290|PIK3CA", "540|6|variant|litvar@#10188#p.C1214T&&&litvar@#10188#|C1214T", "994|6|gene|ncbi_gene@5290|PIK3CA", "1275|6|variant|litvar@#3815#p.G1849T&&&litvar@#3815#|G1849T", "234|4|gene|ncbi_gene@3845|KRAS", "925|5|variant|litvar@rs1057519925##&&&litvar@#5290#|E453K", "2106|6|variant|litvar@rs1429139604##&&&litvar@#1432#|G3145C", "1463|6|gene|ncbi_gene@5156|PDGFRA", "2678|5|variant|litvar@#673#p.K179M&&&litvar@#673#|K179M", "75|8|variant|litvar@#673#p.G1391I&&&litvar@#673#|G1391ATC", "1708|4|gene|ncbi_gene@1956|EGFR", "1168|5|variant|litvar@#1956#p.T854I&&&litvar@#1956#|T854I", "3033|6|gene|ncbi_gene@5290|PIK3CA", "1216|6|variant|litvar@rs1458160409##&&&litvar@#5594#|G7514C", "2690|4|gene|ncbi_gene@673|BRAF", "2375|8|variant|litvar@#2261#p.G1514I&&&litvar@#2261#|G1514ATC", "2216|3|gene|ncbi_gene@238|ALK", "1027|6|variant|litvar@rs1405102859##&&&litvar@#2261#|A3127G", "1135|7|variant|litvar@rs1450615133##&&&litvar@#79811#|C110GTA", "1984|4|gene|ncbi_gene@4893|NRAS", "1947|3|gene|ncbi_gene@79811|MET", "1851|3|gene|ncbi_gene@3815|KIT", "559|5|variant|litvar@rs1291834042##&&&litvar@#2263#|G296A", "13|8|variant|litvar@#238#p.T3520Q&&&litvar@#238#|T3520CAG", "1822|5|variant|litvar@#3815#p.G516T&&&litvar@#3815#|G516T", "2859|5|variant|litvar@rs121913484##&&&litvar@#2261#&&&litvar@CA341399#rs121913484##|S371C", "42|3|gene|ncbi_gene@238|ALK", "322|6|variant|litvar@rs1219554154##&&&litvar@#238#|A1046V", "500|5|variant|litvar@#5290#p.C178A&&&litvar@#5290#|C178A", "116|6|variant|litvar@#673#p.A1801G&&&litvar@#673#|A1801G", "1530|6|gene|ncbi_gene@5290|PIK3CA", "1098|6|gene|ncbi_gene@1499|CTNNB1", "86|4|gene|ncbi_gene@673|BRAF", "1301|3|gene|ncbi_gene@3815|KIT", "138|8|variant|litvar@#1499#p.T1799T&&&litvar@#1499#|T1799ACG", "149|6|gene|ncbi_gene@1499|CTNNB1", "215|4|gene|ncbi_gene@2778|GNAS", "2666|4|variant|litvar@rs757542528##&&&litvar@#4170#&&&litvar@CA1079281#rs757542528##|G49A", "474|5|variant|litvar@rs121913284##&&&litvar@#5290#&&&litvar@CA16602517#rs121913284##|N345K", "2298|6|gene|ncbi_gene@1499|CTNNB1", "2475|8|variant|litvar@#3845#p.T2466A&&&litvar@#3845#|T2466GCA", "2726|4|variant|litvar@rs774372457##&&&litvar@#51422#&&&litvar@CA58756#rs774372457##|C70T", "1305|5|variant|litvar@rs1057519705##&&&litvar@#3815#|N566D", "806|3|gene|ncbi_gene@3815|KIT", "2191|5|variant|litvar@rs1269157146##&&&litvar@#5894#|G523C", "2601|6|variant|litvar@rs121913288##&&&litvar@#5290#&&&litvar@CA16602699#rs121913288##|Y1021C", "1958|6|variant|litvar@rs1310674057##&&&litvar@#5290#|C3029T", "681|5|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|L858R", "2424|4|gene|ncbi_gene@3418|IDH2", "1013|6|gene|ncbi_gene@5290|PIK3CA", "329|6|variant|litvar@rs1477195834##&&&litvar@#598#|C3137T", "2748|6|gene|ncbi_gene@1499|CTNNB1", "2331|6|variant|litvar@#1499#p.C1393T&&&litvar@#1499#|C1393T", "2958|5|variant|litvar@#79811#p.R988C&&&litvar@#79811#|R988C", "810|5|variant|litvar@rs121913521##&&&litvar@#3815#&&&litvar@CA16602396#rs121913521##|V560D", "2435|5|variant|litvar@#3418#p.C419T&&&litvar@#3418#|C419T", "2235|3|gene|ncbi_gene@238|ALK", "2645|4|variant|litvar@rs774372457##&&&litvar@#51422#&&&litvar@CA58756#rs774372457##|R70Q", "2138|6|gene|ncbi_gene@5295|PIK3R1", "1600|5|variant|litvar@rs751516579##&&&litvar@#10188#&&&litvar@CA2776892#rs751516579##|G173R", "2165|5|variant|litvar@rs121908989##&&&litvar@#51422#&&&litvar@CA13797#rs121908989##|N488I", "799|6|variant|litvar@#3815#p.C1900T&&&litvar@#3815#|C1900T", "610|6|gene|ncbi_gene@1499|CTNNB1", "1076|4|gene|ncbi_gene@673|BRAF", "2171|6|variant|litvar@#208#p.A1463T&&&litvar@#208#|A1463T", "861|4|gene|ncbi_gene@3845|KRAS", "2608|6|variant|litvar@#5295#g.3062A>G&&&litvar@#5295#|A3062G", "2841|5|variant|litvar@rs121913482##&&&litvar@#2261#&&&litvar@CA126378#rs121913482##|R248C", "1020|6|variant|litvar@rs1057519936##&&&litvar@#5290#|M1043V", "1840|8|variant|litvar@#3815#p.G2446H&&&litvar@#3815#|G2446CAT", "163|7|variant|litvar@rs752739736##&&&litvar@#949#|T133GCA", "1828|3|gene|ncbi_gene@3815|KIT", "2874|5|gene|ncbi_gene@2261|FGFR3", "392|6|variant|litvar@#5290#p.G1252A&&&litvar@#5290#|G1252A", "554|4|variant|litvar@rs113498671##&&&litvar@#10188#&&&litvar@CA2776901#rs113498671##|R99Q", "2113|6|gene|ncbi_gene@5290|PIK3CA", "3062|5|variant|litvar@rs970946035##&&&litvar@#10188#&&&litvar@CA90765886#rs970946035##|E346K", "758|5|variant|litvar@#1956#p.C134W&&&litvar@#1956#|C134W", "1001|5|variant|litvar@rs1057519934##&&&litvar@#5290#|K111N", "1877|4|variant|litvar@rs267606870##&&&litvar@#3418#&&&litvar@CA124281#rs267606870##|G10R", "1049|6|variant|litvar@#673#p.C1616G&&&litvar@#673#|C1616G", "1061|5|variant|litvar@rs121913340##&&&litvar@#673#&&&litvar@CA135092#rs121913340##|E586K", "699|5|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|T790M", "1381|4|gene|ncbi_gene@3845|KRAS", "315|6|gene|ncbi_gene@5290|PIK3CA", "2180|4|gene|ncbi_gene@208|AKT2", "1352|6|variant|litvar@#79811#p.G35T&&&litvar@#79811#|G35ACT", "1762|7|variant|litvar@#3418#p.C394X&&&litvar@#3418#|C394TGA", "2943|8|variant|litvar@#79811#p.A2464S&&&litvar@#79811#|A2464TCG", "846|5|variant|litvar@rs1057519704##&&&litvar@#3815#|Y553N", "2622|5|variant|litvar@rs773686816##&&&litvar@#5295#|N564K", "2615|6|gene|ncbi_gene@5295|PIK3R1", "880|3|gene|ncbi_gene@79811|MET", "2416|5|variant|litvar@rs1360371977##&&&litvar@#11183#|A627T", "1629|4|gene|ncbi_gene@673|BRAF", "2736|4|variant|litvar@rs781775119##&&&litvar@#10188#&&&litvar@CA2776711#rs781775119##|R24H", "705|6|variant|litvar@#1956#p.C2369T&&&litvar@#1956#|C2369T", "732|5|gene|ncbi_gene@2263|FGFR2", "2741|4|variant|litvar@rs199963585##&&&litvar@#51422#&&&litvar@CA56510#rs199963585##|G71A", "458|6|variant|litvar@#5290#p.A2102C&&&litvar@#5290#|A2102C", "565|4|gene|ncbi_gene@673|BRAF", "2239|6|variant|litvar@rs1057519698##&&&litvar@#238#|I1171N", "2811|5|gene|ncbi_gene@2261|FGFR3", "1655|5|variant|litvar@rs121913366##&&&litvar@#673#&&&litvar@CA123649#rs121913366##|L597R", "399|6|gene|ncbi_gene@5290|PIK3CA", "2120|6|variant|litvar@rs121913283##&&&litvar@#5290#&&&litvar@CA183868#rs121913283##|M1043I", "200|5|variant|litvar@rs766217118##&&&litvar@#2263#&&&litvar@CA5720446#rs766217118##|Y813C", "676|4|gene|ncbi_gene@1956|EGFR", "2013|5|variant|litvar@rs121908585##&&&litvar@#5156#&&&litvar@CA123194#rs121908585##|D842V", "2061|6|variant|litvar@#5290#p.C1977A&&&litvar@#5290#|C1977A", "890|6|variant|litvar@#4893#p.A1124G&&&litvar@#4893#|A1124G", "2386|5|gene|ncbi_gene@2261|FGFR3", "1414|6|variant|litvar@#4893#p.G38T&&&litvar@#4893#|G38ACT", "1803|5|variant|litvar@rs397517199##&&&litvar@CA136365#rs397517199##|C418T", "1112|6|variant|litvar@rs372430349##&&&litvar@#2263#&&&litvar@CA5721181#rs372430349##|T97GCA", "2703|8|variant|litvar@#1499#p.T1799T&&&litvar@#1499#|T1799ACG", "2548|6|gene|ncbi_gene@5290|PIK3CA", "2275|4|gene|ncbi_gene@673|BRAF", "33|6|variant|litvar@rs775699235##&&&litvar@#1499#|T3734G", "2246|6|variant|litvar@#238#g.3512T>A&&&litvar@#238#|T3512A", "1507|6|gene|ncbi_gene@5290|PIK3CA", "255|4|gene|ncbi_gene@3845|KRAS", "2511|5|variant|litvar@rs759906958##&&&litvar@#2263#&&&litvar@CA5720726#rs759906958##|D527E", "1713|5|variant|litvar@rs1373597201##&&&litvar@#10188#|S720P", "2068|6|gene|ncbi_gene@5290|PIK3CA", "3105|6|variant|litvar@rs863225283##&&&litvar@#238#&&&litvar@CA279597#rs863225283##|F1245C", "2441|4|gene|ncbi_gene@3418|IDH2", "1485|6|gene|ncbi_gene@5290|PIK3CA", "2220|6|variant|litvar@rs863225281##&&&litvar@#238#&&&litvar@CA279616#rs863225281##|F1174L", "2792|5|gene|ncbi_gene@2261|FGFR3", "2847|5|variant|litvar@#2261#p.C742T&&&litvar@#2261#|C742T", "687|6|variant|litvar@#1956#p.T2573G&&&litvar@#1956#|T2573G", "2312|6|variant|litvar@#1499#p.G94H&&&litvar@#1499#|G94CAT", "1470|5|variant|litvar@rs121908586##&&&litvar@#5156#&&&litvar@CA123203#rs121908586##|V561D", "2127|8|variant|litvar@#5295#p.G3129I&&&litvar@#5295#|G3129ATC", "2145|5|variant|litvar@rs1057519839##&&&litvar@#5295#|D560Y", "1056|4|gene|ncbi_gene@673|BRAF", "694|4|gene|ncbi_gene@1956|EGFR", "2880|5|variant|litvar@rs121913485##&&&litvar@#2261#&&&litvar@CA341413#rs121913485##|Y373C", "1514|6|variant|litvar@rs121913281##&&&litvar@#5290#&&&litvar@CA130471#rs121913281##|H1047Y", "365|5|variant|litvar@rs1450615133##&&&litvar@#79811#|E110K", "2496|6|variant|litvar@#4893#p.G38T&&&litvar@#4893#|G38ACT", "1901|7|variant|litvar@rs1489246318##&&&litvar@#3717#|A182TCG", "521|5|variant|litvar@rs776041038##&&&litvar@#3417#|G263A", "931|6|variant|litvar@#5290#p.G1357A&&&litvar@#5290#|G1357A", "1913|6|variant|litvar@#79811#p.H1112Y&&&litvar@#79811#|H1112Y", "835|6|variant|litvar@#3815#p.T2474C&&&litvar@#3815#|T2474C", "780|6|variant|litvar@#3815#p.A1924G&&&litvar@#3815#|A1924G", "764|5|variant|litvar@#3815#p.C402G&&&litvar@#3815#|C402G", "1174|6|variant|litvar@#2263#p.C2561T&&&litvar@#2263#|C2561T", "1373|7|variant|litvar@rs781002756##&&&litvar@#6416#|A183CTG", "1972|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1433|7|variant|litvar@rs781002756##&&&litvar@#6416#|A183TCG", "1288|5|variant|litvar@rs121913513##&&&litvar@#3815#&&&litvar@CA16602401#rs121913513##|L576P", "3112|6|variant|litvar@rs775699235##&&&litvar@#1499#|T3734G", "494|5|variant|litvar@#5290#p.Q060K&&&litvar@#5290#|Q060K", "0|3|gene|ncbi_gene@238|ALK", "793|5|variant|litvar@rs144369407##&&&litvar@#3815#&&&litvar@CA2923610#rs144369407##|R634W", "1614|4|gene|ncbi_gene@208|AKT2"], "figure_id": "tbl1", "text_hl": "ALK_F1174LIV_T3520CAG ALK_F1245C_T3734G   ALK_F1245VI_T3733GA BRAF_G464EVA_G1391ATC   BRAF_G466R_G1396CA BRAF_K601E_A1801G   BRAF_V600EAG_T1799ACG_F CTNNB1_S45APT_T133GCA   CTNNB1_T41APS_A121GCS EGFR_Y813C_A2438G   GNAS_R201SC_C601AT KRAS_G12SRC_G34ACT   KRAS_Q61EKX_C181GAT MET_H1112_A3335GT   MET_Y1248HD_T3742CG PIK3CA_A1046V_C3137T   PIK3CA_C420R_T1258C PIK3CA_E110K_G328A   PIK3CA_E418K_G1252A PIK3CA_F909L_C2727G   PIK3CA_H1047RL_A3140 GT PIK3CA_H701P_A2102C   PIK3CA_N345K_T1035A PIK3CA_Q060K_C178A   PIK3CA_R088Q_G263A PIK3CA_S405F_C1214T   TNK2_R99Q_G296A BRAF_G466EVA_G1397ATC   BRAF_V600LM_G1798 TA CTNNB1_S37APT_T109GCA   CTNNB1_S45CFY_C134GTA EGFR_G719_G2155TA   EGFR_L858R_T2573G EGFR_T790M_C2369T   EPHA3_K761N_G2283 FGFR2_S252W_C755G   FOXL2_C134W_C402G KIT_K642E_A1924G   KIT_R634W_C1900T KIT_V560D_T1679A   KIT_V825A_T2474C KIT_Y553N_T1657A   KRAS_G12DAV_G35ACT MET_N375S_A1124G   NRAS_G12SRC_G34ACT PIK3CA_E453K_G1357A   PIK3CA_E545AGV_A1634CGT PIK3CA_H1047RL_A3140 GT..1.   PIK3CA_K111N_G333C PIK3CA_M1043V_A3127G   PIK3CA_P539R_C1616G BRAF_E586K_G1756A   BRAF_G469EVA_G1406ATC CTNNB1_S33APT_T97GCA   CTNNB1_S37CFY_C110GTA EGFR_L861_T2582AG   EGFR_T854I_C2561T FGFR2_N549KK_T1647GA   FRAP_R2505P_G7514C FRAP_S2215Y_C6644T   IDH2_R172MK_G515 TA JAK2_V617F_G1849T   KIT_L576P_T1727C KIT_N566D_A1696 G   KRAS_A146PT_G436CA NRAS_G12DAV_G35ACT   KRAS_Q61HHE_A183CTG KRAS_G13SRC_G37ACT   NRAS_G13DAV_G38ACT NRAS_Q61HHQ_A183TCG   PDGFRA_N659Y_A1975T PDGFRA_V561D_T1682A   PIK3CA_E545KQ_G1633AC PIK3CA_H1047Y_C3139T   PIK3CA_Q546EK_C1636 GA PIK3CA_Y1021HN_T3061CA   RET_M918T_T2753C AKT1_G173R_G517C   AKT2_E17K_G49A BRAF_G469R_G1405CA   BRAF_L597R_T1790G BRAF_V600_G1800   CTNNB1_G34EVA_G101ATC EGFR_S720P_T2158C   GNA11_Q209LP_A626 TC IDH1_R132CGS_C394TGA   IDH2_R140LQ_G419 TA IDH2_R140W_C418T   IDH2_R172S_G516T KIT_D816HNY_G2446CAT   KIT_V559ADG_T1676CAG KRAS_G10R_G28A   KRAS_Q61LPR_A182TCG MET_H1112Y_C3334T   MET_M1268T_T3803C MET_T1010I_C3029T   NRAS_A146T_G436A NRAS_Q61EKX_C181GAT   PDGFRA_D842V_A2525T PDGFRA_D842_G2524TA   PDGFRA_N659K_C1977A PIK3CA_E542KQ_G1624AC   PIK3CA_G1049R_G3145C PIK3CA_M1043I_G3129ATC   PIK3R1_D560Y_G1678T PRKAG2_N488I_A1463T   AKT2_G175R_G523C AKT3_G171R_G511A   ALK_F1174L_C3522AG ALK_I1171N_T3512A   ALK_R1275QL_G3824AT BRAF_D594GV_A1781 GT   CTNNB1_D32HNY_G94CAT FBWX7_R465C_C1393T   FBWX7_R479QL_G1436AT FBWX7_R505HLP_G1514ATC   FGFR3_G370C_G1108T GNAQ_Q209H_A627T   IDH2_R140W_C419T IDH2_R172GW_A514 GT   KIT_N822KNK_T2466GCA KRAS_G13DAV_G38ACT   PDPK1_D527E_C1581G PIK3CA_E542VG_A1625TG   PIK3CA_E545D_G1635CT PIK3CA_T1025SA_A3073TG   PIK3CA_Y1021C_A3062G PIK3R1_N564K_C1693AG   PRKAG1_R70Q_G209A AKT1_E17K_G49A   AKT1_K179M_A536T BRAF_V600EAG_T1799ACG_R   CDK4_R24C_C70T CDK4_R24H_G71A   CTNNB1_D32AGT_A95CGV FBWX7_R465HL_G1394AT   FGFR3_G697C_G2089T FGFR3_K650MT_A1949 TC   FGFR3_R248C_C742T FGFR3_S371C_A1111T   FGFR3_Y373C_A1118G GNAS_R201H_G602A   IDH1_R132HL_G395AT KIT_N822YHD_A2464TCG   MET_R988C_C2962T MET_Y1253D_T3757 G   NRAS_G13SRC_G37ACT NRAS_Q61RPL_A182GCT   PIK3CA_Q546LPR_A1637TCG TNK2_E346K_G1036A   PIK3CA_H1047RL_A3140 GT ALK_F1245C_T3734G   "}], "citations": {"NLM": "Vin H, Ojeda SS, Ching G, Leung ML, Chitsazzadeh V, Dwyer DW, Adelmann CH, Restrepo M, Richards KN, Stewart LR, Du L, Ferguson SB, Chakravarti D, Ehrenreiter K, Baccarini M, Ruggieri R, Curry JL, Kim KB, Ciurea AM, Duvic M, Prieto VG, Ullrich SE, Dalby KN, Flores ER, Tsai KY. BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling. Elife. PMID: 24192036", "BibTeX": "@article{24192036, title={BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling.}, author={Vin H and Ojeda SS and Ching G and Leung ML and Chitsazzadeh V and Dwyer DW and Adelmann CH and Restrepo M and Richards KN and Stewart LR and Du L and Ferguson SB and Chakravarti D and Ehrenreiter K and Baccarini M and Ruggieri R and Curry JL and Kim KB and Ciurea AM and Duvic M and Prieto VG and Ullrich SE and Dalby KN and Flores ER and Tsai KY}, journal={Elife}}"}, "is_sup_mat_match": false}, {"pmid": 34638411, "pmcid": "PMC8507869", "title": "Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring.", "journal": "Cancers (Basel)", "authors": ["Reita D", "Pabst L", "Pencreach E", "Gu\u00e9rin E", "Dano L", "Rimelen V", "Voegeli AC", "Vallat L", "Mascaux C", "Beau-Faller M"], "date": "2021-09-30T00:00:00Z", "year": 2021, "snippets": [{"_id": "34638411@55160", "snip_text": "KRAS mutations, such as G12D/C or A146T (3%), were described in FLAURA.", "section": "other", "mentions": ["24|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12D/C", "0|4|gene|ncbi_gene@3845|KRAS", "64|6|gene|ncbi_gene@6790|FLAURA", "34|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "KRAS mutations, such as G12D/C or A146T (3%), were described in FLAURA."}], "citations": {"NLM": "Reita D, Pabst L, Pencreach E, Gu\u00e9rin E, Dano L, Rimelen V, Voegeli AC, Vallat L, Mascaux C, Beau-Faller M. Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring. Cancers (Basel). PMID: 34638411", "BibTeX": "@article{34638411, title={Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring.}, author={Reita D and Pabst L and Pencreach E and Gu\u00e9rin E and Dano L and Rimelen V and Voegeli AC and Vallat L and Mascaux C and Beau-Faller M}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 32723567, "pmcid": "PMC7393484", "title": "Biology, Pathology, and Therapeutic Targeting of RAS", "journal": "Adv Cancer Res", "authors": ["Rhett JM", "Khan I", "O'Bryan JP"], "date": "2020-01-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "32723567@88946", "snip_text": "A number of RAS mutants (Q61L, G13D, and A146T) possess high intrinsic nucleotide dissociation rates suggesting that they spontaneously release GTP and reside in a nucleotide-free state more frequently than wild type RAS or other RAS mutants.", "section": "other", "mentions": ["25|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "164|10|chemical|ncbi_mesh@D009711|nucleotide", "71|10|chemical|ncbi_mesh@D009711|nucleotide", "31|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "144|3|gene|ncbi_gene@92170|GTP", "41|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "A number of RAS mutants (Q61L, G13D, and A146T) possess high intrinsic nucleotide dissociation rates suggesting that they spontaneously release GTP and reside in a nucleotide-free state more frequently than wild type RAS or other RAS mutants."}], "citations": {"NLM": "Rhett JM, Khan I, O'Bryan JP. Biology, Pathology, and Therapeutic Targeting of RAS Adv Cancer Res. PMID: 32723567", "BibTeX": "@article{32723567, title={Biology, Pathology, and Therapeutic Targeting of RAS}, author={Rhett JM and Khan I and O'Bryan JP}, journal={Adv Cancer Res}}"}, "is_sup_mat_match": false}, {"pmid": 35840984, "pmcid": "PMC9287895", "title": "Emerging strategies to overcome resistance to third-generation EGFR inhibitors.", "journal": "J Hematol Oncol", "authors": ["Shi K", "Wang G", "Pei J", "Zhang J", "Wang J", "Ouyang L", "Wang Y", "Li W"], "date": "2022-07-15T00:00:00Z", "year": 2022, "snippets": [{"_id": "35840984@22158", "snip_text": "The common K-RAS mutations include G12S, G12D, G12A, Q61H, and A146T.", "section": "other", "mentions": ["47|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "63|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "11|5|gene|ncbi_gene@3845|K-RAS", "53|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "35|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "41|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D"], "text_hl": "The common K-RAS mutations include G12S, G12D, G12A, Q61H, and <m>A146T</m>."}], "citations": {"NLM": "Shi K, Wang G, Pei J, Zhang J, Wang J, Ouyang L, Wang Y, Li W. Emerging strategies to overcome resistance to third-generation EGFR inhibitors. J Hematol Oncol. PMID: 35840984", "BibTeX": "@article{35840984, title={Emerging strategies to overcome resistance to third-generation EGFR inhibitors.}, author={Shi K and Wang G and Pei J and Zhang J and Wang J and Ouyang L and Wang Y and Li W}, journal={J Hematol Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 28404952, "pmcid": "PMC5522202", "title": "High-throughput detection of clinically targetable alterations using next-generation sequencing", "journal": "Oncotarget", "authors": ["Vendrell JA", "Grand D", "Rouquette I", "Costes V", "Icher S", "Selves J", "Larrieux M", "Barbe A", "Brousset P", "Solassol J"], "date": "2017-06-20T00:00:00Z", "year": 2017, "snippets": [{"_id": "28404952@14094", "snip_text": "Gene\tNucleotide change\tAmino Acid change\tVAF (Laboratory 1)\tVAF (Laboratory 2)\tMean inter-laboratories\tExpectedVAF (%)b\t \tMeana\tSD\tCV(%)\tMeana\tSD\tCV(%)\tMeana\tSD\tCV(%)\t \tBRAF\tc.1798G>A\tp.Val600Met\t3.88\t0.45\t11.55\t4.10\t0.37\t9.09\t4.01\t0.37\t9.16\t4.0\t \tEGFR\tc.2235_2249delGGA ATTAAGAGAAGC\tp.Glu746_Ala750del\t4.13\t0.70\t16.98\t4.01\t0.23\t5.69\t4.06\t0.39\t9.64\t4.2\t \tMET\tc.3757T>G\tp.Tyr1253Asp\t4.25\t0.48\t11.30\t4.56\t0.33\t7.28\t4.44\t0.38\t8.45\t4.0\t \tKRAS\tc.436G>A\tp.Ala146Thr\t4.43\t0.17\t3.89\t5.41\t0.10\t1.78\t5.02\t0.55\t10.86\t5.0\t \tKRAS\tc.34G>A\tp.Gly12Ser\t4.78\t0.48\t9.97\t5.26\t0.34\t6.44\t5.07\t0.43\t8.46\t5.0\t \tNRAS\tc.183A>T\tp.Gln61His\t4.42\t0.92\t20.84\t5.17\t0.85\t16.47\t4.87\t0.86\t17.70\t5.0\t \tPIK3CA\tc.1624G>A\tp.Glu542Lys\t5.07\t1.09\t21.50\t6.13\t0.13\t2.12\t5.71\t0.80\t14.05\t5.0\t \tBRAF\tc.1799T>A\tp.Val600Glu\t7.57\t0.39\t5.17\t7.13\t0.17\t2.42\t7.30\t0.33\t4.56\t8.0\t \tEGFR\tc.2155G>A\tp.Gly719Ser\t16.40\t0.44\t2.70\t15.75\t0.42\t2.68\t16.01\t0.51\t3.22\t16.7\t \tMET\tc.710delT\tp.Leu238TyrfsTer25\t20.33\t0.29\t1.41\t19.74\t0.39\t1.98\t19.97\t0.45\t2.26\t20.0\t \tKRAS\tc.38G>A\tp.Gly13Asp\t25.13\t4.14\t16.49\t26.24\t0.12\t0.46\t25.80\t2.16\t8.38\t25.0\t \tPIK3CA\tc.3140A>G\tp.His1047Arg\t29.09\t0.63\t2.17\t28.45\t0.41\t1.43\t28.71\t0.55\t1.93\t30.0\t \t", "section": "table", "mentions": ["748|4|gene|ncbi_gene@673|BRAF", "908|3|gene|ncbi_gene@79811|MET", "434|4|gene|ncbi_gene@3845|KRAS", "517|7|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA180753#rs121913250##|c.34G>A", "1001|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "914|7|variant|litvar@#79811#c.710delT&&&litvar@#79811#|710delT", "174|9|variant|litvar@rs121913378##&&&litvar@#673#&&&litvar@CA135101#rs121913378##|c.1798G>A", "359|9|variant|litvar@rs1057519824##&&&litvar@#4233#|c.3757T>G", "592|8|variant|litvar@rs121913255##&&&litvar@#4893#&&&litvar@CA16042285#rs121913255##|c.183A>T", "169|4|gene|ncbi_gene@673|BRAF", "1076|6|gene|ncbi_gene@5290|PIK3CA", "1083|9|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A>G", "355|3|gene|ncbi_gene@79811|MET", "253|17|variant|litvar@#1956#p.G2235_2249del&&&litvar@#1956#|c.2235_2249delGGA", "439|8|variant|litvar@rs1330628617##&&&litvar@#2066#|c.436G>A", "284|18|variant|litvar@#1956#p.E,A746,750del&&&litvar@#1956#|p.Glu746_Ala750del", "996|4|gene|ncbi_gene@3845|KRAS", "666|6|gene|ncbi_gene@5290|PIK3CA", "753|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "673|9|variant|litvar@rs535202189##&&&litvar@#2066#&&&litvar@CA2088066#rs535202189##|c.1624G>A", "587|4|gene|ncbi_gene@4893|NRAS", "512|4|gene|ncbi_gene@3845|KRAS", "831|9|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126722#rs28929495##|c.2155G>A", "826|4|gene|ncbi_gene@1956|EGFR", "248|4|gene|ncbi_gene@1956|EGFR"], "figure_id": "T2", "text_hl": "Gene\tNucleotide change\tAmino Acid change\tVAF (Laboratory 1)\tVAF (Laboratory 2)\tMean inter-laboratories\tExpectedVAF (%)b\t \tMeana\tSD\tCV(%)\tMeana\tSD\tCV(%)\tMeana\tSD\tCV(%)\t \tBRAF\tc.1798G>A\tp.Val600Met\t3.88\t0.45\t11.55\t4.10\t0.37\t9.09\t4.01\t0.37\t9.16\t4.0\t \tEGFR\tc.2235_2249delGGA ATTAAGAGAAGC\tp.Glu746_Ala750del\t4.13\t0.70\t16.98\t4.01\t0.23\t5.69\t4.06\t0.39\t9.64\t4.2\t \tMET\tc.3757T>G\tp.Tyr1253Asp\t4.25\t0.48\t11.30\t4.56\t0.33\t7.28\t4.44\t0.38\t8.45\t4.0\t \tKRAS\tc.436G>A\t<m>p.Ala146Thr</m>\t4.43\t0.17\t3.89\t5.41\t0.10\t1.78\t5.02\t0.55\t10.86\t5.0\t \tKRAS\tc.34G>A\tp.Gly12Ser\t4.78\t0.48\t9.97\t5.26\t0.34\t6.44\t5.07\t0.43\t8.46\t5.0\t \tNRAS\tc.183A>T\tp.Gln61His\t4.42\t0.92\t20.84\t5.17\t0.85\t16.47\t4.87\t0.86\t17.70\t5.0\t \tPIK3CA\tc.1624G>A\tp.Glu542Lys\t5.07\t1.09\t21.50\t6.13\t0.13\t2.12\t5.71\t0.80\t14.05\t5.0\t \tBRAF\tc.1799T>A\tp.Val600Glu\t7.57\t0.39\t5.17\t7.13\t0.17\t2.42\t7.30\t0.33\t4.56\t8.0\t \tEGFR\tc.2155G>A\tp.Gly719Ser\t16.40\t0.44\t2.70\t15.75\t0.42\t2.68\t16.01\t0.51\t3.22\t16.7\t \tMET\tc.710delT\tp.Leu238TyrfsTer25\t20.33\t0.29\t1.41\t19.74\t0.39\t1.98\t19.97\t0.45\t2.26\t20.0\t \tKRAS\tc.38G>A\tp.Gly13Asp\t25.13\t4.14\t16.49\t26.24\t0.12\t0.46\t25.80\t2.16\t8.38\t25.0\t \tPIK3CA\tc.3140A>G\tp.His1047Arg\t29.09\t0.63\t2.17\t28.45\t0.41\t1.43\t28.71\t0.55\t1.93\t30.0\t \t"}], "citations": {"NLM": "Vendrell JA, Grand D, Rouquette I, Costes V, Icher S, Selves J, Larrieux M, Barbe A, Brousset P, Solassol J. High-throughput detection of clinically targetable alterations using next-generation sequencing Oncotarget. PMID: 28404952", "BibTeX": "@article{28404952, title={High-throughput detection of clinically targetable alterations using next-generation sequencing}, author={Vendrell JA and Grand D and Rouquette I and Costes V and Icher S and Selves J and Larrieux M and Barbe A and Brousset P and Solassol J}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 35562977, "pmcid": "PMC9105346", "title": "Preparation of Duplex Sequencing Libraries for Archival Paraffin-Embedded Tissue Samples Using Single-Strand-Specific Nuclease P1.", "journal": "Int J Mol Sci", "authors": ["Mitiushkina NV", "Yanus GA", "Kuligina ES", "Laidus TA", "Romanko AA", "Kholmatov MM", "Ivantsov AO", "Aleksakhina SN", "Imyanitov EN"], "date": "2022-04-21T00:00:00Z", "year": 2022, "snippets": [{"_id": "35562977@40944", "snip_text": "Label Sex Age Main Genotyping Result Mutations in KRAS, NRAS or BRAF Genes   MSI#1 female 35 MSI No   MSI#2 female 71 MSI BRAF V600E   MSI#3 female 45 MSI No   MSI#4 female 78 MSI KRAS Q61K   MUTYH#1 female 48 MUTYH Y179C (ClinVar VCV000005293.37, pathogenic), G396D (ClinVar VCV000005294, pathogenic) KRAS G12C   MUTYH#2 female 59 MUTYH Y179C (ClinVar VCV000005293.37, pathogenic), G396D (ClinVar VCV000005294, pathogenic) KRAS G12C   MUTYH#3 male 39 MUTYH R245H (ClinVar VCV000140877.19, pathogenic), G396D (ClinVar VCV000005294, pathogenic) KRAS G12C   POLD1#1 male 42 POLD1 A516V (dbSNP rs752755096, rare SNP, significance unknown) BRAF V600E   POLD1#2 female 51 POLD1 V538I (ClinVar VCV001025450.1, uncertain significance) BRAF V600E   POLE#1 male 33 POLE S297F (somatic mutation, COSMIC COSM937330, FATHMM prediction: pathogenic) KRAS A146T   WT#1 male 68  KRAS G13D   WT#2 male 67  No   WT#3 male 68  No   WT#4 female 66  KRAS G12V   WT#5 female 72  KRAS G12V   WT#6 female 40  No   WT#7 male 69  No   ", "section": "table", "mentions": ["667|5|gene|ncbi_gene@5424|POLD1", "314|5|gene|ncbi_gene@4595|MUTYH", "578|5|variant|litvar@rs752755096##&&&litvar@#5424#|A516V", "875|4|species|ncbi_taxonomy@2710861|WT#2", "868|4|variant|litvar@#5424#p.G13D&&&litvar@#5424#|G13D", "436|5|gene|ncbi_gene@4595|MUTYH", "549|4|variant|litvar@#5424#c.12G>C&&&litvar@#5424#|G12C", "452|5|gene|ncbi_gene@4595|MUTYH", "383|5|variant|litvar@rs36053993##&&&litvar@#4595#&&&litvar@CA11561#rs36053993##|G396D", "673|5|variant|litvar@#5424#p.V538I&&&litvar@#5424#|V538I", "503|5|variant|litvar@rs36053993##&&&litvar@#4595#&&&litvar@CA11561#rs36053993##|G396D", "216|5|variant|litvar@rs34612342##&&&litvar@#4595#&&&litvar@CA11761#rs34612342##|Y179C", "572|5|gene|ncbi_gene@5424|POLD1", "185|4|variant|litvar@#5424#p.Q61K&&&litvar@#5424#|Q61K", "733|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "641|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "841|5|variant|litvar@#5424#c.146A>T&&&litvar@#5424#|A146T", "127|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "761|5|variant|litvar@#5424#p.S297F&&&litvar@#5424#|S297F", "338|5|variant|litvar@rs34612342##&&&litvar@#4595#&&&litvar@CA11761#rs34612342##|Y179C", "556|5|gene|ncbi_gene@5424|POLD1", "591|11|variant|litvar@rs752755096##&&&litvar@#5424#|rs752755096", "458|5|variant|litvar@rs140342925##&&&litvar@#4595#&&&litvar@CA14226#rs140342925##|R245H", "307|4|variant|litvar@#5424#c.12G>C&&&litvar@#5424#|G12C", "210|5|gene|ncbi_gene@4595|MUTYH", "934|4|variant|litvar@#5424#p.G12V&&&litvar@#5424#|G12V", "429|4|variant|litvar@#5424#c.12G>C&&&litvar@#5424#|G12C", "332|5|gene|ncbi_gene@4595|MUTYH", "261|5|variant|litvar@rs36053993##&&&litvar@#4595#&&&litvar@CA11561#rs36053993##|G396D", "192|5|gene|ncbi_gene@4595|MUTYH", "962|4|variant|litvar@#5424#p.G12V&&&litvar@#5424#|G12V"], "figure_id": "ijms-23-04586-t001", "text_hl": "Label Sex Age Main Genotyping Result Mutations in KRAS, NRAS or BRAF Genes   MSI#1 female 35 MSI No   MSI#2 female 71 MSI BRAF V600E   MSI#3 female 45 MSI No   MSI#4 female 78 MSI KRAS Q61K   MUTYH#1 female 48 MUTYH Y179C (ClinVar VCV000005293.37, pathogenic), G396D (ClinVar VCV000005294, pathogenic) KRAS G12C   MUTYH#2 female 59 MUTYH Y179C (ClinVar VCV000005293.37, pathogenic), G396D (ClinVar VCV000005294, pathogenic) KRAS G12C   MUTYH#3 male 39 MUTYH R245H (ClinVar VCV000140877.19, pathogenic), G396D (ClinVar VCV000005294, pathogenic) KRAS G12C   POLD1#1 male 42 POLD1 A516V (dbSNP rs752755096, rare SNP, significance unknown) BRAF V600E   POLD1#2 female 51 POLD1 V538I (ClinVar VCV001025450.1, uncertain significance) BRAF V600E   POLE#1 male 33 POLE S297F (somatic mutation, COSMIC COSM937330, FATHMM prediction: pathogenic) KRAS <m>A146T</m>   WT#1 male 68  KRAS G13D   WT#2 male 67  No   WT#3 male 68  No   WT#4 female 66  KRAS G12V   WT#5 female 72  KRAS G12V   WT#6 female 40  No   WT#7 male 69  No   "}], "citations": {"NLM": "Mitiushkina NV, Yanus GA, Kuligina ES, Laidus TA, Romanko AA, Kholmatov MM, Ivantsov AO, Aleksakhina SN, Imyanitov EN. Preparation of Duplex Sequencing Libraries for Archival Paraffin-Embedded Tissue Samples Using Single-Strand-Specific Nuclease P1. Int J Mol Sci. PMID: 35562977", "BibTeX": "@article{35562977, title={Preparation of Duplex Sequencing Libraries for Archival Paraffin-Embedded Tissue Samples Using Single-Strand-Specific Nuclease P1.}, author={Mitiushkina NV and Yanus GA and Kuligina ES and Laidus TA and Romanko AA and Kholmatov MM and Ivantsov AO and Aleksakhina SN and Imyanitov EN}, journal={Int J Mol Sci}}"}, "is_sup_mat_match": false}, {"pmid": 23085539, "pmcid": "PMC3717945", "title": "Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.", "journal": "Oncotarget", "authors": ["McCubrey JA", "Steelman LS", "Chappell WH", "Abrams SL", "Franklin RA", "Montalto G", "Cervello M", "Libra M", "Candido S", "Malaponte G", "Mazzarino MC", "Fagone P", "Nicoletti F", "B\u00e4secke J", "Mijatovic S", "Maksimovic-Ivanic D", "Milella M", "Tafuri A", "Chiarini F", "Evangelisti C", "Cocco L", "Martelli AM"], "date": "2012-10-01T00:00:00Z", "year": 2012, "snippets": [{"_id": "23085539@27730", "snip_text": "The in frame deletions of MEK occurred at MEK1 K59del, the NRAS mutations occurred at NRAS Q61K and A146T in the presence and absence of the MEK1 P387S mutation in the A375 BRAF V600E line and NRAS Q61K in the YUSIT1 BRAF V600K line.", "section": "introduction", "mentions": ["91|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "59|4|gene|ncbi_gene@4893|NRAS", "100|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "86|4|gene|ncbi_gene@4893|NRAS", "146|5|variant|litvar@rs111034213##&&&litvar@#672#|P387S", "26|3|gene|ncbi_gene@5609|MEK", "178|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "222|5|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16602420#rs121913227##|V600K", "168|4|cellline||A375", "47|6|variant|litvar@rs869025339##&&&litvar@#5604#|K59del", "193|4|gene|ncbi_gene@4893|NRAS", "42|4|gene|ncbi_gene@5604|MEK1", "210|6|cellline||YUSIT1", "173|4|gene|ncbi_gene@673|BRAF", "141|4|gene|ncbi_gene@5604|MEK1", "198|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "217|4|gene|ncbi_gene@673|BRAF"], "text_hl": "The in frame deletions of MEK occurred at MEK1 K59del, the NRAS mutations occurred at NRAS Q61K and <m>A146T</m> in the presence and absence of the MEK1 P387S mutation in the A375 BRAF V600E line and NRAS Q61K in the YUSIT1 BRAF V600K line."}], "citations": {"NLM": "McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Franklin RA, Montalto G, Cervello M, Libra M, Candido S, Malaponte G, Mazzarino MC, Fagone P, Nicoletti F, B\u00e4secke J, Mijatovic S, Maksimovic-Ivanic D, Milella M, Tafuri A, Chiarini F, Evangelisti C, Cocco L, Martelli AM. Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. Oncotarget. PMID: 23085539", "BibTeX": "@article{23085539, title={Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.}, author={McCubrey JA and Steelman LS and Chappell WH and Abrams SL and Franklin RA and Montalto G and Cervello M and Libra M and Candido S and Malaponte G and Mazzarino MC and Fagone P and Nicoletti F and B\u00e4secke J and Mijatovic S and Maksimovic-Ivanic D and Milella M and Tafuri A and Chiarini F and Evangelisti C and Cocco L and Martelli AM}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 33060766, "pmcid": "PMC7567075", "title": "Evaluation of the RAS signaling network in response to MEK inhibition using organoids derived from a familial adenomatous polyposis patient.", "journal": "Sci Rep", "authors": ["Osumi H", "Muroi A", "Sakahara M", "Kawachi H", "Okamoto T", "Natsume Y", "Yamanaka H", "Takano H", "Kusama D", "Shinozaki E", "Ooki A", "Yamaguchi K", "Ueno M", "Takeuchi K", "Noda T", "Nagayama S", "Koshikawa N", "Yao R"], "date": "2020-10-15T00:00:00Z", "year": 2020, "snippets": [{"_id": "33060766@10481", "snip_text": "HCT70-5P, -9P and -10T1 harbored the KRAS mutations A146T, G12C and G13D, respectively.", "section": "results", "mentions": ["10|3|cellline||-9P", "37|4|gene|ncbi_gene@3845|KRAS", "52|5|variant|litvar@rs763181290##&&&litvar@#324#&&&litvar@CA38866#rs763181290##|A146T", "59|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "0|8|cellline||HCT70-5P", "68|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "18|5|cellline||-10T1"], "text_hl": "HCT70-5P, -9P and -10T1 harbored the KRAS mutations <m>A146T</m>, G12C and G13D, respectively."}], "citations": {"NLM": "Osumi H, Muroi A, Sakahara M, Kawachi H, Okamoto T, Natsume Y, Yamanaka H, Takano H, Kusama D, Shinozaki E, Ooki A, Yamaguchi K, Ueno M, Takeuchi K, Noda T, Nagayama S, Koshikawa N, Yao R. Evaluation of the RAS signaling network in response to MEK inhibition using organoids derived from a familial adenomatous polyposis patient. Sci Rep. PMID: 33060766", "BibTeX": "@article{33060766, title={Evaluation of the RAS signaling network in response to MEK inhibition using organoids derived from a familial adenomatous polyposis patient.}, author={Osumi H and Muroi A and Sakahara M and Kawachi H and Okamoto T and Natsume Y and Yamanaka H and Takano H and Kusama D and Shinozaki E and Ooki A and Yamaguchi K and Ueno M and Takeuchi K and Noda T and Nagayama S and Koshikawa N and Yao R}, journal={Sci Rep}}"}, "is_sup_mat_match": false}, {"pmid": 32776177, "pmcid": "PMC7810640", "title": "Clinical responses to PD-1 inhibition and their molecular characterization in six patients with mismatch repair-deficient metastatic cancer of the digestive system", "journal": "J Cancer Res Clin Oncol", "authors": ["Hirsch D", "Gaiser T", "Merx K", "Weingaertner S", "Forster M", "Hendricks A", "Woenckhaus M", "Schubert T", "Hofheinz RD", "Gencer D"], "date": "2021-01-01T00:00:00Z", "year": 2021, "snippets": [{"_id": "32776177@13398", "snip_text": "Patient ID\tP1\tP2\tP3\tP4\tP5\tP6\t \tAge at diagnosis (years)\t58\t48\t48\t52\t49\t35\t \tGender\tMale\tFemale\tMale\tFemale\tMale\tMale\t \tECOG performance status\t1\t0\t0\t1\t0\t0\t \tPrimary tumor location\tColon (cecum)\tColon (transverse)\tColon (cecum)\tPortal vein/bile duct/liver\tDuodenum\tColon (ascending)\t \tTumor histology\tUndifferentiated adenocarcinoma with signet ring cell component\tIntestinal-type adenocarcinoma with mucinous component\tMucinous adenocarcinoma\tCholangio-carcinoma\tMucinous adenocarcinoma\tMucinous adenocarcinoma\t \tHistologic differentiation\tPoor\tModerate\tPoor\tPoor\tPoor\tModerate\t \tUICC stage at diagnosis\tIV\tIIIB\tIIIB\tIIIA\tIV\tIIIC\t \tMetastatic sites\tPeritoneum, abdominal lymph nodes\tLiver, abdominal lymph nodes\tRectum\tBone, muscle\tDuodenum, lung, abdominal lymph nodes\tLiver, abdominal lymph nodes\t \tMedian time sinceinitial diagnosis (months)\t21\t5\t23\t47\t3\t20\t \tPrevious primary tumor resection\tYes\tYes\tYes\tYes\tNo\tYes\t \tNumber of prior systemic treatments\t2\t1\t1\t1\t1\t1\t \tPrior therapies received (ctx regimens/agents)\t5-FU/FA + Bevacizumab (palliative 1st line)FOLFIRI + Bevacizumab (palliative 2nd line)\tCapecitabine (adjuvant)\tFOLFOX (adjuvant)\tGemcitabine + Cisplatin (palliative 1st line)\tFOLFOXIRI (neoadjuvant)\tFOLFOX + Bevacizumab (additive)\t \tPrior radiotherapy\tNo\tNo\tNo\tYes\tNo\tNo\t \tPrevious malignancies\tN/A\tN/A\tN/A\tEndometrial carcinoma\tN/A\tN/A\t \tLynch syndrome\tYes\tYes\tYes\tYes\tNo\tNo\t \tMMR status (IHC)\tMMR-deficient\tMMR-deficient\tMMR-deficient\tMMR-deficient\tMMR-deficient\tNot done\t \tMMR protein expression (IHC)\tMLH1 + , MSH2 -, MSH6 -, PMS2 +\tMLH1 -, MSH2 + , MSH6 + , PMS2 -\tMLH1 + , MSH2 -, MSH6 -, PMS2 + \tMLH1 -, MSH2 + , MSH6 + , PMS2 -\tMLH1 -, MSH2 + , MSH6 + , PMS2 -\tN/A\t \tMSI status (PCR)\tMSI-high\tNot done\tNot done\tMSI-high\tNot done\tMSI-high\t \tBRAF mutation status\tWild-type\tWild-type\tNot done\tNot done\tNot done\tWild-type\t \tKRAS mutation status\tp.A146T\tp.G13D\tNot done\tNot done\tNot done\tWild-type\t \tNRAS mutation status\tWild-type\tWild-type\tNot done\tNot done\tNot done\tWild-type\t \tPD-L1 expression at baseline\tNot done\t < 1%\tNot done\tNot done\tNot done\tNot done\t \t", "section": "table", "mentions": ["1572|4|gene|ncbi_gene@17688|MSH6", "0|7|species|ncbi_taxonomy@9606|Patient", "1671|4|gene|ncbi_gene@17688|MSH6", "2001|5|gene|ncbi_gene@29126|PD-L1", "1555|4|gene|ncbi_gene@17350|MLH1", "1605|4|gene|ncbi_gene@17688|MSH6", "1662|4|gene|ncbi_gene@17685|MSH2", "1647|4|gene|ncbi_gene@18861|PMS2", "1532|4|gene|ncbi_gene@17685|MSH2", "1523|4|gene|ncbi_gene@17350|MLH1", "1869|5|variant|litvar@rs63750335##&&&litvar@#4436#&&&litvar@CA18373#rs63750335##|A146T", "1588|4|gene|ncbi_gene@17350|MLH1", "1597|4|gene|ncbi_gene@17685|MSH2", "1548|4|gene|ncbi_gene@18861|PMS2", "1638|4|gene|ncbi_gene@17688|MSH6", "1581|4|gene|ncbi_gene@18861|PMS2", "1654|4|gene|ncbi_gene@17350|MLH1", "1613|4|gene|ncbi_gene@18861|PMS2", "1680|4|gene|ncbi_gene@18861|PMS2", "1875|6|variant|litvar@rs1305890535##&&&litvar@#5395#|p.G13D", "1563|4|gene|ncbi_gene@17685|MSH2", "1629|4|gene|ncbi_gene@17685|MSH2", "1540|4|gene|ncbi_gene@17688|MSH6", "1621|4|gene|ncbi_gene@17350|MLH1"], "figure_id": "Tab1", "text_hl": "Patient ID\tP1\tP2\tP3\tP4\tP5\tP6\t \tAge at diagnosis (years)\t58\t48\t48\t52\t49\t35\t \tGender\tMale\tFemale\tMale\tFemale\tMale\tMale\t \tECOG performance status\t1\t0\t0\t1\t0\t0\t \tPrimary tumor location\tColon (cecum)\tColon (transverse)\tColon (cecum)\tPortal vein/bile duct/liver\tDuodenum\tColon (ascending)\t \tTumor histology\tUndifferentiated adenocarcinoma with signet ring cell component\tIntestinal-type adenocarcinoma with mucinous component\tMucinous adenocarcinoma\tCholangio-carcinoma\tMucinous adenocarcinoma\tMucinous adenocarcinoma\t \tHistologic differentiation\tPoor\tModerate\tPoor\tPoor\tPoor\tModerate\t \tUICC stage at diagnosis\tIV\tIIIB\tIIIB\tIIIA\tIV\tIIIC\t \tMetastatic sites\tPeritoneum, abdominal lymph nodes\tLiver, abdominal lymph nodes\tRectum\tBone, muscle\tDuodenum, lung, abdominal lymph nodes\tLiver, abdominal lymph nodes\t \tMedian time sinceinitial diagnosis (months)\t21\t5\t23\t47\t3\t20\t \tPrevious primary tumor resection\tYes\tYes\tYes\tYes\tNo\tYes\t \tNumber of prior systemic treatments\t2\t1\t1\t1\t1\t1\t \tPrior therapies received (ctx regimens/agents)\t5-FU/FA + Bevacizumab (palliative 1st line)FOLFIRI + Bevacizumab (palliative 2nd line)\tCapecitabine (adjuvant)\tFOLFOX (adjuvant)\tGemcitabine + Cisplatin (palliative 1st line)\tFOLFOXIRI (neoadjuvant)\tFOLFOX + Bevacizumab (additive)\t \tPrior radiotherapy\tNo\tNo\tNo\tYes\tNo\tNo\t \tPrevious malignancies\tN/A\tN/A\tN/A\tEndometrial carcinoma\tN/A\tN/A\t \tLynch syndrome\tYes\tYes\tYes\tYes\tNo\tNo\t \tMMR status (IHC)\tMMR-deficient\tMMR-deficient\tMMR-deficient\tMMR-deficient\tMMR-deficient\tNot done\t \tMMR protein expression (IHC)\tMLH1 + , MSH2 -, MSH6 -, PMS2 +\tMLH1 -, MSH2 + , MSH6 + , PMS2 -\tMLH1 + , MSH2 -, MSH6 -, PMS2 + \tMLH1 -, MSH2 + , MSH6 + , PMS2 -\tMLH1 -, MSH2 + , MSH6 + , PMS2 -\tN/A\t \tMSI status (PCR)\tMSI-high\tNot done\tNot done\tMSI-high\tNot done\tMSI-high\t \tBRAF mutation status\tWild-type\tWild-type\tNot done\tNot done\tNot done\tWild-type\t \tKRAS mutation status\t<m>p.A146T</m>\tp.G13D\tNot done\tNot done\tNot done\tWild-type\t \tNRAS mutation status\tWild-type\tWild-type\tNot done\tNot done\tNot done\tWild-type\t \tPD-L1 expression at baseline\tNot done\t < 1%\tNot done\tNot done\tNot done\tNot done\t \t"}], "citations": {"NLM": "Hirsch D, Gaiser T, Merx K, Weingaertner S, Forster M, Hendricks A, Woenckhaus M, Schubert T, Hofheinz RD, Gencer D. Clinical responses to PD-1 inhibition and their molecular characterization in six patients with mismatch repair-deficient metastatic cancer of the digestive system J Cancer Res Clin Oncol. PMID: 32776177", "BibTeX": "@article{32776177, title={Clinical responses to PD-1 inhibition and their molecular characterization in six patients with mismatch repair-deficient metastatic cancer of the digestive system}, author={Hirsch D and Gaiser T and Merx K and Weingaertner S and Forster M and Hendricks A and Woenckhaus M and Schubert T and Hofheinz RD and Gencer D}, journal={J Cancer Res Clin Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 33254149, "pmcid": "PMC7834984", "title": "KRAS mutations are negatively correlated with immunity in colon cancer.", "journal": "Aging (Albany NY)", "authors": ["Fu X", "Wang X", "Duanmu J", "Li T", "Jiang Q"], "date": "2020-11-26T00:00:00Z", "year": 2020, "snippets": [{"_id": "33254149@7578", "snip_text": "We also performed survival analysis of four types of KRAS mutations whose mutation frequency were higher than 10/399: rs112445441 (p = 0.339), rs121913527 (p = 0.359), rs121913529 (p < 0.001), and rs121913530 (p = 0.003) (Figure 2A-2D).", "section": "results", "mentions": ["53|4|gene|ncbi_gene@3845|KRAS", "168|11|variant|litvar@rs121913529##&&&litvar@#3845#|rs121913529", "143|11|variant|litvar@rs121913527##&&&litvar@#3845#|rs121913527", "118|11|variant|litvar@rs112445441##&&&litvar@#3845#|rs112445441", "197|11|variant|litvar@rs121913530##&&&litvar@#3845#|rs121913530"], "text_hl": "We also performed survival analysis of four types of KRAS mutations whose mutation frequency were higher than 10/399: rs112445441 (p = 0.339), rs121913527 (p = 0.359), rs121913529 (p < 0.001), and rs121913530 (p = 0.003) (Figure 2A-2D)."}], "citations": {"NLM": "Fu X, Wang X, Duanmu J, Li T, Jiang Q. KRAS mutations are negatively correlated with immunity in colon cancer. Aging (Albany NY). PMID: 33254149", "BibTeX": "@article{33254149, title={KRAS mutations are negatively correlated with immunity in colon cancer.}, author={Fu X and Wang X and Duanmu J and Li T and Jiang Q}, journal={Aging (Albany NY)}}"}, "is_sup_mat_match": false}, {"pmid": 19913317, "pmcid": "PMC7373270", "title": "KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy", "journal": "Radiother Oncol", "authors": ["Gaedcke J", "Grade M", "Jung K", "Schirmer M", "Jo P", "Obermeyer C", "Wolff HA", "Herrmann MK", "Beissbarth T", "Becker H", "Ried T", "Ghadimi M"], "date": "2010-01-01T00:00:00Z", "year": 2010, "snippets": [{"_id": "19913317@25753", "snip_text": "Codon\tNumber\tNucleotide exchange\tAmino acid\t \t12 (n = 29)\t1\t34G>A\tGly12Ser\t \t\t1\t34G>T\tGly12Cys\t \t\t1\t34G>T + 36T>G\tGly12Trp\t \t\t15\t35G>A\tGly12Asp\t \t\t3\t35G>C\tGly12Ala\t \t\t8\t35G>T\tGly12Val\t \t13 (n = 10)\t10\t38G>A\tGly13Asp\t \t61 (n = 3)\t2\t182A>T\tGln61Leu\t \t\t1\t182A>G\tGln61Arg\t \t146 (n = 3)\t2\t436G>A\tAla146Thr\t \t\t1\t436G>C\tAla146Pro\t \t", "section": "table", "mentions": ["80|5|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|34G>T", "201|5|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|38G>A", "66|8|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|Gly12Ser", "60|5|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|34G>A", "252|6|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|182A>G", "149|5|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|35G>C", "207|8|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|Gly13Asp", "108|5|variant|litvar@#3845#c.36T>G&&&litvar@#3845#|36T>G", "284|6|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|436G>A", "175|8|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|Gly12Val", "86|8|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|Gly12Cys", "169|5|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|35G>T", "306|6|variant|litvar@rs121913527##&&&litvar@#3845#|436G>C", "100|5|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|34G>T", "114|8|variant|litvar@rs121913530##&&&litvar@#3845#|Gly12Trp", "155|8|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|Gly12Ala", "231|6|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|182A>T"], "figure_id": "T2", "text_hl": "Codon\tNumber\tNucleotide exchange\tAmino acid\t \t12 (n = 29)\t1\t34G>A\tGly12Ser\t \t\t1\t34G>T\tGly12Cys\t \t\t1\t34G>T + 36T>G\tGly12Trp\t \t\t15\t35G>A\tGly12Asp\t \t\t3\t35G>C\tGly12Ala\t \t\t8\t35G>T\tGly12Val\t \t13 (n = 10)\t10\t38G>A\tGly13Asp\t \t61 (n = 3)\t2\t182A>T\tGln61Leu\t \t\t1\t182A>G\tGln61Arg\t \t146 (n = 3)\t2\t436G>A\t<m>Ala146Thr</m>\t \t\t1\t436G>C\tAla146Pro\t \t"}], "citations": {"NLM": "Gaedcke J, Grade M, Jung K, Schirmer M, Jo P, Obermeyer C, Wolff HA, Herrmann MK, Beissbarth T, Becker H, Ried T, Ghadimi M. KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy Radiother Oncol. PMID: 19913317", "BibTeX": "@article{19913317, title={KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy}, author={Gaedcke J and Grade M and Jung K and Schirmer M and Jo P and Obermeyer C and Wolff HA and Herrmann MK and Beissbarth T and Becker H and Ried T and Ghadimi M}, journal={Radiother Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 32906677, "pmcid": "PMC7563652", "title": "Latest Development in Multiple Myeloma.", "journal": "Cancers (Basel)", "authors": ["Imai Y"], "date": "2020-09-07T00:00:00Z", "year": 2020, "snippets": [{"_id": "32906677@1289", "snip_text": "No KRAS mutations, including KRASp.G12A and exon-4 mutations KRASp.A146T and KRASp.A146V, were correlated with patient survival.", "section": "other", "mentions": ["81|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "33|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "65|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "111|7|species|ncbi_taxonomy@9606|patient", "3|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "No KRAS mutations, including KRASp.G12A and exon-4 mutations KRASp.A146T and KRASp.A146V, were correlated with patient survival."}], "citations": {"NLM": "Imai Y. Latest Development in Multiple Myeloma. Cancers (Basel). PMID: 32906677", "BibTeX": "@article{32906677, title={Latest Development in Multiple Myeloma.}, author={Imai Y}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 32814491, "pmcid": "PMC7444156", "title": "NF1 germline mutation in a Chinese family with colon cancer.", "journal": "J Int Med Res", "authors": ["Lou H", "Zhai C", "Gong L", "Pan H", "Pan H", "Zhang Y", "Yang M", "Hu Z"], "date": "2020-08-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "32814491@3788", "snip_text": "A germline mutation of NF1 L581Ffs*6 (VAF [variant allele frequency]: 24%) and somatic mutations of KRAS A146P (VAF: 10%), NRAS Q61K (VAF: 12%), TP53 R175H (VAF: 13%), and CD274 (PD-L1) T290M (VAF: 11%) were detected.", "section": "other", "mentions": ["27|7|variant|litvar@rs762735676##&&&litvar@#4763#|L581Ffs", "23|3|gene|ncbi_gene@4763|NF1", "134|3|disease||VAF", "38|3|disease||VAF", "105|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "172|5|gene|ncbi_gene@29126|CD274", "157|3|disease||VAF", "145|4|gene|ncbi_gene@7157|TP53", "186|5|variant|litvar@rs369350813##&&&litvar@#29126#&&&litvar@CA4973795#rs369350813##|T290M", "179|5|gene|ncbi_gene@29126|PD-L1", "123|4|gene|ncbi_gene@4893|NRAS", "100|4|gene|ncbi_gene@3845|KRAS", "128|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "112|3|disease||VAF", "193|3|disease||VAF", "150|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H"], "text_hl": "A germline mutation of NF1 L581Ffs*6 (VAF [variant allele frequency]: 24%) and somatic mutations of KRAS A146P (VAF: 10%), NRAS Q61K (VAF: 12%), TP53 R175H (VAF: 13%), and CD274 (PD-L1) T290M (VAF: 11%) were detected."}], "citations": {"NLM": "Lou H, Zhai C, Gong L, Pan H, Pan H, Zhang Y, Yang M, Hu Z. NF1 germline mutation in a Chinese family with colon cancer. J Int Med Res. PMID: 32814491", "BibTeX": "@article{32814491, title={NF1 germline mutation in a Chinese family with colon cancer.}, author={Lou H and Zhai C and Gong L and Pan H and Pan H and Zhang Y and Yang M and Hu Z}, journal={J Int Med Res}}"}, "is_sup_mat_match": false}, {"pmid": 30478296, "pmcid": "PMC6255900", "title": "Iron removal enhances vitamin C-induced apoptosis and growth inhibition of K-562 leukemic cells", "journal": "Sci Rep", "authors": ["Tsuma-Kaneko M", "Sawanobori M", "Kawakami S", "Uno T", "Nakamura Y", "Onizuka M", "Ando K", "Kawada H"], "date": "2018-11-26T00:00:00Z", "year": 2018, "snippets": [{"_id": "30478296@24449", "snip_text": "A total of 24 mutations of KRAS codon12 (G12S, G12C, G12R, G12D, G12V, G12A), codon 13 (G13S, G13C, G13R, G13D, G13V, and G13A), codon59 (A59T and A59G), codon 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H), codon117 (K117N), and codon 146 (A146T, A146P, and A146V) were analyzed by the PCR-rSSO method using the Luminex assay kit (MBL, Aichi, Japan).", "section": "methods", "mentions": ["170|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "27|4|gene|ncbi_gene@3845|KRAS", "188|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "147|4|variant|litvar@rs781085650##&&&litvar@#673#&&&litvar@CA4517046#rs781085650##|A59G", "94|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "215|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "53|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "245|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "238|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "122|4|variant|litvar@rs193929331##&&&litvar@#3845#&&&litvar@CA250291#rs193929331##|G13A", "106|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "138|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "198|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "182|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "47|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "88|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA16602445#rs121913535##|G13S", "65|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "59|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "100|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "164|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "176|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "71|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "256|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "112|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "41|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S"], "text_hl": "A total of 24 mutations of KRAS codon12 (G12S, G12C, G12R, G12D, G12V, G12A), codon 13 (G13S, G13C, G13R, G13D, G13V, and G13A), codon59 (A59T and A59G), codon 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H), codon117 (K117N), and codon 146 (<m>A146T</m>, A146P, and A146V) were analyzed by the PCR-rSSO method using the Luminex assay kit (MBL, Aichi, Japan)."}], "citations": {"NLM": "Tsuma-Kaneko M, Sawanobori M, Kawakami S, Uno T, Nakamura Y, Onizuka M, Ando K, Kawada H. Iron removal enhances vitamin C-induced apoptosis and growth inhibition of K-562 leukemic cells Sci Rep. PMID: 30478296", "BibTeX": "@article{30478296, title={Iron removal enhances vitamin C-induced apoptosis and growth inhibition of K-562 leukemic cells}, author={Tsuma-Kaneko M and Sawanobori M and Kawakami S and Uno T and Nakamura Y and Onizuka M and Ando K and Kawada H}, journal={Sci Rep}}"}, "is_sup_mat_match": false}, {"pmid": 28532404, "pmcid": "PMC5441096", "title": "Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform.", "journal": "BMC Cancer", "authors": ["Darwanto A", "Hein AM", "Strauss S", "Kong Y", "Sheridan A", "Richards D", "Lader E", "Ngowe M", "Pelletier T", "Adams D", "Ricker A", "Patel N", "K\u00fchne A", "Hughes S", "Shiffman D", "Zimmermann D", "Te Kaat K", "Rothmann T"], "date": "2017-05-22T00:00:00Z", "year": 2017, "snippets": [{"_id": "28532404@15987", "snip_text": "Sample no. KRAS AA change KRAS variant allele fraction (%)   Therascreen PCR/Pyro GeneReadera MiSeqa   1 G12D + 21 7   2 G12D + 39 12   3 A59T 19 15 14   4 G13D + 41 15   5 G12D + 45 11   6 Q61H 14 9 13   7 A146P 41 40 32   8 Q61H 36 35 26   9 Q61H 32 22 35   10 K117 N 24 34 39   11 G13D + 47 15   12 G12C + 32 10   13 G13D + 39 10   14 Q61H 26 21 23   ", "section": "table", "mentions": ["190|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "26|4|gene|ncbi_gene@3845|KRAS", "244|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "138|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "121|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "105|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "173|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "302|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "320|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "11|4|gene|ncbi_gene@3845|KRAS", "156|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "207|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "284|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "226|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "338|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H"], "figure_id": "Tab4", "text_hl": "Sample no. KRAS AA change KRAS variant allele fraction (%)   Therascreen PCR/Pyro GeneReadera MiSeqa   1 G12D + 21 7   2 G12D + 39 12   3 A59T 19 15 14   4 G13D + 41 15   5 G12D + 45 11   6 Q61H 14 9 13   7 A146P 41 40 32   8 Q61H 36 35 26   9 Q61H 32 22 35   10 K117 N 24 34 39   11 G13D + 47 15   12 G12C + 32 10   13 G13D + 39 10   14 Q61H 26 21 23   "}], "citations": {"NLM": "Darwanto A, Hein AM, Strauss S, Kong Y, Sheridan A, Richards D, Lader E, Ngowe M, Pelletier T, Adams D, Ricker A, Patel N, K\u00fchne A, Hughes S, Shiffman D, Zimmermann D, Te Kaat K, Rothmann T. Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform. BMC Cancer. PMID: 28532404", "BibTeX": "@article{28532404, title={Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform.}, author={Darwanto A and Hein AM and Strauss S and Kong Y and Sheridan A and Richards D and Lader E and Ngowe M and Pelletier T and Adams D and Ricker A and Patel N and K\u00fchne A and Hughes S and Shiffman D and Zimmermann D and Te Kaat K and Rothmann T}, journal={BMC Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 22722830, "pmcid": "PMC3927413", "title": "Emergence of KRAS mutations and acquired resistance to anti EGFR therapy in colorectal cancer", "journal": "Nature", "authors": ["Misale S", "Yaeger R", "Hobor S", "Scala E", "Janakiraman M", "Liska D", "Valtorta E", "Schiavo R", "Buscarino M", "Siravegna G", "Bencardino K", "Cercek A", "Chen CT", "Veronese S", "Zanon C", "Sartore-Bianchi A", "Gambacorta M", "Gallicchio M", "Vakiani E", "Boscaro V", "Medico E", "Weiser M", "Siena S", "Di Nicolantonio F", "Solit D", "Bardelli A"], "date": "2012-06-28T00:00:00Z", "year": 2012, "snippets": [{"_id": "22722830@5500", "snip_text": "MS genotyping identified a KRAS A146T mutation following four passages in increasing concentrations of cetuximab (20 nM and higher, Fig.S5b).", "section": "abstract", "mentions": ["103|9|chemical|ncbi_mesh@D000068818|cetuximab", "27|4|gene|ncbi_gene@3845|KRAS", "32|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "MS genotyping identified a KRAS <m>A146T</m> mutation following four passages in increasing concentrations of cetuximab (20 nM and higher, Fig.S5b)."}], "citations": {"NLM": "Misale S, Yaeger R, Hobor S, Scala E, Janakiraman M, Liska D, Valtorta E, Schiavo R, Buscarino M, Siravegna G, Bencardino K, Cercek A, Chen CT, Veronese S, Zanon C, Sartore-Bianchi A, Gambacorta M, Gallicchio M, Vakiani E, Boscaro V, Medico E, Weiser M, Siena S, Di Nicolantonio F, Solit D, Bardelli A. Emergence of KRAS mutations and acquired resistance to anti EGFR therapy in colorectal cancer Nature. PMID: 22722830", "BibTeX": "@article{22722830, title={Emergence of KRAS mutations and acquired resistance to anti EGFR therapy in colorectal cancer}, author={Misale S and Yaeger R and Hobor S and Scala E and Janakiraman M and Liska D and Valtorta E and Schiavo R and Buscarino M and Siravegna G and Bencardino K and Cercek A and Chen CT and Veronese S and Zanon C and Sartore-Bianchi A and Gambacorta M and Gallicchio M and Vakiani E and Boscaro V and Medico E and Weiser M and Siena S and Di Nicolantonio F and Solit D and Bardelli A}, journal={Nature}}"}, "is_sup_mat_match": false}, {"pmid": 36358690, "pmcid": "PMC9654168", "title": "Rosai-Dorfman Disease between Proliferation and Neoplasia.", "journal": "Cancers (Basel)", "authors": ["Elbaz Younes I", "Sokol L", "Zhang L"], "date": "2022-10-27T00:00:00Z", "year": 2022, "snippets": [{"_id": "36358690@25616", "snip_text": "A study of Wu et al. showed NRAS (A146T) mutation was the most common among point mutants, followed by NRAS G13S, suggesting that the mutations may play a role in pathogenesis of cutaneous RDD.", "section": "other", "mentions": ["103|4|gene|ncbi_gene@4893|NRAS", "34|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "108|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA16602674#rs121434595##|G13S", "28|4|gene|ncbi_gene@4893|NRAS", "179|13|disease|ncbi_mesh@D015618|cutaneous RDD"], "text_hl": "A study of Wu et al. showed NRAS (<m>A146T</m>) mutation was the most common among point mutants, followed by NRAS G13S, suggesting that the mutations may play a role in pathogenesis of cutaneous RDD."}], "citations": {"NLM": "Elbaz Younes I, Sokol L, Zhang L. Rosai-Dorfman Disease between Proliferation and Neoplasia. Cancers (Basel). PMID: 36358690", "BibTeX": "@article{36358690, title={Rosai-Dorfman Disease between Proliferation and Neoplasia.}, author={Elbaz Younes I and Sokol L and Zhang L}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 36599679, "pmcid": "PMC9951350", "title": "Mutant KRAS Drives Immune Evasion by Sensitizing Cytotoxic T-Cells to Activation-Induced Cell Death in Colorectal Cancer", "journal": "Adv Sci (Weinh)", "authors": ["Liu H", "Liang Z", "Cheng S", "Huang L", "Li W", "Zhou C", "Zheng X", "Li S", "Zeng Z", "Kang L"], "date": "2023-01-04T00:00:00Z", "year": 2023, "snippets": [{"_id": "36599679@4808", "snip_text": "D) Statistics of CD8+ T-cells within the tumor tissues in 76 CRC patients of KRAS mutations (Left panel, Others include KRAS G12C (n = 4), G12R (n = 2), G12S (n = 6), G13C (n = 1), K117N (n = 1), A146T (n = 2), and Q61H (n = 2) mutations), and in 25 CRC patients of dMMR (Middle panel, Others include KRAS G12V (n = 1), K117N (n = 1), A146T (n = 2), and Q61H (n = 2) mutations), and in 51 CRC patients of pMMR (Right panel, Others include KRAS G12C (n = 4), G12R (n = 2), G12S (n = 6), and G13C (n = 1) mutations).", "section": "figure_legend", "mentions": ["301|4|gene|ncbi_gene@3845|KRAS", "254|8|species|ncbi_taxonomy@9606|patients", "439|4|gene|ncbi_gene@3845|KRAS", "181|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "335|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "125|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "354|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "120|4|gene|ncbi_gene@3845|KRAS", "306|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "444|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "139|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "77|4|gene|ncbi_gene@3845|KRAS", "196|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "215|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "472|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "167|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "458|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "393|8|species|ncbi_taxonomy@9606|patients", "490|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "153|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "65|8|species|ncbi_taxonomy@9606|patients", "320|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "17|3|gene|ncbi_gene@925|CD8"], "figure_id": "advs5018-fig-0001", "text_hl": "D) Statistics of CD8+ T-cells within the tumor tissues in 76 CRC patients of KRAS mutations (Left panel, Others include KRAS G12C (n = 4), G12R (n = 2), G12S (n = 6), G13C (n = 1), K117N (n = 1), <m>A146T</m> (n = 2), and Q61H (n = 2) mutations), and in 25 CRC patients of dMMR (Middle panel, Others include KRAS G12V (n = 1), K117N (n = 1), <m>A146T</m> (n = 2), and Q61H (n = 2) mutations), and in 51 CRC patients of pMMR (Right panel, Others include KRAS G12C (n = 4), G12R (n = 2), G12S (n = 6), and G13C (n = 1) mutations)."}], "citations": {"NLM": "Liu H, Liang Z, Cheng S, Huang L, Li W, Zhou C, Zheng X, Li S, Zeng Z, Kang L. Mutant KRAS Drives Immune Evasion by Sensitizing Cytotoxic T-Cells to Activation-Induced Cell Death in Colorectal Cancer Adv Sci (Weinh). PMID: 36599679", "BibTeX": "@article{36599679, title={Mutant KRAS Drives Immune Evasion by Sensitizing Cytotoxic T-Cells to Activation-Induced Cell Death in Colorectal Cancer}, author={Liu H and Liang Z and Cheng S and Huang L and Li W and Zhou C and Zheng X and Li S and Zeng Z and Kang L}, journal={Adv Sci (Weinh)}}"}, "is_sup_mat_match": false}, {"pmid": 37751775, "pmcid": "PMC10665783", "title": "Clinical characteristics of patients with KRAS mutation detected by liquid biopsy", "journal": "Thorac Cancer", "authors": ["Amino Y", "Low SK", "Ninomiya H", "Kiritani A", "Miyadera K", "Kakuto S", "Akita T", "Tsugitomi R", "Ariyasu R", "Uchibori K", "Kitazono S", "Yanagitani N", "Nishio M"], "date": "2023-11-01T00:00:00Z", "year": 2023, "snippets": [{"_id": "37751775@11264", "snip_text": "\tKRAS mutation detected in liquid and tissue samples\tKRAS mutation detected only in liquid samples\tKRAS mutation detected only in tissue samples\t \t\t(N = 21)\t(N = 10)\t(N = 7)\t \tKRAS mutation, N (%)\t \tG12V\t7\t(33.3)\t1\t(10)\t3\t(42.9)\t \tG12A\t4\t(19.0)\t1\t(10)\t1\t(14.3)\t \tG12D\t3\t(14.3)\t2\t(20)\t2\t(28.6)\t \tG12C\t3\t(14.3)\t1\t(10)\t1\t(14.3)\t \tQ61H\t3\t(14.3)\t1\t(10)\t0\t\t \tG12S\t0\t\t2\t(20)\t0\t\t \tG13D\t1\t(4.8)\t0\t\t0\t\t \tA146T\t0\t\t1\t(10)\t0\t\t \tAmplification\t0\t\t1\t(10)\t0\t\t \t", "section": "table", "mentions": ["99|4|gene|ncbi_gene@3845|KRAS", "295|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "1|4|gene|ncbi_gene@3845|KRAS", "199|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "263|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "353|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "373|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "176|4|gene|ncbi_gene@3845|KRAS", "394|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "327|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "231|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "53|4|gene|ncbi_gene@3845|KRAS"], "figure_id": "tca15123-tbl-0003", "text_hl": "\tKRAS mutation detected in liquid and tissue samples\tKRAS mutation detected only in liquid samples\tKRAS mutation detected only in tissue samples\t \t\t(N = 21)\t(N = 10)\t(N = 7)\t \tKRAS mutation, N (%)\t \tG12V\t7\t(33.3)\t1\t(10)\t3\t(42.9)\t \tG12A\t4\t(19.0)\t1\t(10)\t1\t(14.3)\t \tG12D\t3\t(14.3)\t2\t(20)\t2\t(28.6)\t \tG12C\t3\t(14.3)\t1\t(10)\t1\t(14.3)\t \tQ61H\t3\t(14.3)\t1\t(10)\t0\t\t \tG12S\t0\t\t2\t(20)\t0\t\t \tG13D\t1\t(4.8)\t0\t\t0\t\t \t<m>A146T</m>\t0\t\t1\t(10)\t0\t\t \tAmplification\t0\t\t1\t(10)\t0\t\t \t"}], "citations": {"NLM": "Amino Y, Low SK, Ninomiya H, Kiritani A, Miyadera K, Kakuto S, Akita T, Tsugitomi R, Ariyasu R, Uchibori K, Kitazono S, Yanagitani N, Nishio M. Clinical characteristics of patients with KRAS mutation detected by liquid biopsy Thorac Cancer. PMID: 37751775", "BibTeX": "@article{37751775, title={Clinical characteristics of patients with KRAS mutation detected by liquid biopsy}, author={Amino Y and Low SK and Ninomiya H and Kiritani A and Miyadera K and Kakuto S and Akita T and Tsugitomi R and Ariyasu R and Uchibori K and Kitazono S and Yanagitani N and Nishio M}, journal={Thorac Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 28201998, "pmcid": "PMC5312443", "title": "Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples.", "journal": "BMC Cancer", "authors": ["Weyn C", "Van Raemdonck S", "Dendooven R", "Maes V", "Zwaenepoel K", "Lambin S", "Pauwels P"], "date": "2017-02-16T00:00:00Z", "year": 2017, "snippets": [{"_id": "28201998@4686", "snip_text": "The Idylla  KRAS Mutation Test (Biocartis, Mechelen, Belgium) is CE-IVD labeled and allows characterization of 21 hot-spot KRAS mutations in exons 2, 3 and 4, namely G12D, G12A, G12C, G13D, G12V, G12S, G12R, A59T/E/G, Q61H, Q61K, Q61R/L, K117N and A146P/T/V.", "section": "introduction", "mentions": ["248|7|variant|litvar@rs121913527##&&&litvar@#3845#|A146P/T", "12|4|gene|ncbi_gene@3845|KRAS", "166|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "184|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "208|6|variant|litvar@rs121913528##&&&litvar@#3845#|A59T/E", "178|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "196|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "123|4|gene|ncbi_gene@3845|KRAS", "4|6|chemical||Idylla", "190|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "224|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "218|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "202|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "172|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "230|6|variant|litvar@rs121913240##&&&litvar@#3845#|Q61R/L", "238|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N"], "text_hl": "The Idylla  KRAS Mutation Test (Biocartis, Mechelen, Belgium) is CE-IVD labeled and allows characterization of 21 hot-spot KRAS mutations in exons 2, 3 and 4, namely G12D, G12A, G12C, G13D, G12V, G12S, G12R, A59T/E/G, Q61H, Q61K, Q61R/L, K117N and A146P/T/V."}], "citations": {"NLM": "Weyn C, Van Raemdonck S, Dendooven R, Maes V, Zwaenepoel K, Lambin S, Pauwels P. Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples. BMC Cancer. PMID: 28201998", "BibTeX": "@article{28201998, title={Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples.}, author={Weyn C and Van Raemdonck S and Dendooven R and Maes V and Zwaenepoel K and Lambin S and Pauwels P}, journal={BMC Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 29762787, "pmcid": "PMC6030971", "title": "LitVar: a semantic search engine for linking genomic variant data in PubMed and PMC.", "journal": "Nucleic Acids Res", "authors": ["Allot A", "Peng Y", "Wei CH", "Lee K", "Phan L", "Lu Z"], "date": "2018-05-14T00:00:00Z", "year": 2018, "snippets": [{"_id": "29762787@527", "snip_text": "In addition, the same genetic variant can be mentioned in publications with various names (e.g. 'A146T' versus 'c.436G>A' versus 'rs121913527').", "section": "abstract", "mentions": ["97|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "112|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "130|11|variant|litvar@rs121913527##&&&litvar@#3845#|rs121913527"], "text_hl": "In addition, the same genetic variant can be mentioned in publications with various names (e.g. '<m>A146T</m>' versus 'c.436G>A' versus 'rs121913527')."}], "citations": {"NLM": "Allot A, Peng Y, Wei CH, Lee K, Phan L, Lu Z. LitVar: a semantic search engine for linking genomic variant data in PubMed and PMC. Nucleic Acids Res. PMID: 29762787", "BibTeX": "@article{29762787, title={LitVar: a semantic search engine for linking genomic variant data in PubMed and PMC.}, author={Allot A and Peng Y and Wei CH and Lee K and Phan L and Lu Z}, journal={Nucleic Acids Res}}"}, "is_sup_mat_match": false}, {"pmid": 38456804, "pmcid": "PMC11061612", "title": "Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations", "journal": "Cancer Discov", "authors": ["Bashi AC", "Coker EA", "Bulusu KC", "Jaaks P", "Crafter C", "Lightfoot H", "Milo M", "McCarten K", "Jenkins DF", "van der Meer D", "Lynch JT", "Barthorpe S", "Andersen CL", "Barry ST", "Beck A", "Cidado J", "Gordon JA", "Hall C", "Hall J", "Mali I", "Mironenko T", "Mongeon K", "Morris J", "Richardson L", "Smith PD", "Tavana O", "Tolley C", "Thomas F", "Willis BS", "Yang W", "O'Connor MJ", "McDermott U", "Critchlow SE", "Drew L", "Fawell SE", "Mettetal JT", "Garnett MJ"], "date": "2024-05-01T00:00:00Z", "year": 2024, "snippets": [{"_id": "38456804@32139", "snip_text": "These cell lines predominantly harbored alterations in MAPK pathway family members including OCI-AML5 (SOS1N2337Y, NF1K1385R), ML-2 (KRASA146T), HL-60 (NRASQ61L), and Nomo-1 (KRASG13D).", "section": "results", "mentions": ["167|6|gene|ncbi_gene@23420|Nomo-1", "156|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "145|5|cellline||HL-60", "127|4|cellline||ML-2", "133|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T", "93|8|cellline||OCI-AML5"], "text_hl": "These cell lines predominantly harbored alterations in MAPK pathway family members including OCI-AML5 (SOS1N2337Y, NF1K1385R), ML-2 (KRASA146T), HL-60 (NRASQ61L), and Nomo-1 (KRASG13D)."}], "citations": {"NLM": "Bashi AC, Coker EA, Bulusu KC, Jaaks P, Crafter C, Lightfoot H, Milo M, McCarten K, Jenkins DF, van der Meer D, Lynch JT, Barthorpe S, Andersen CL, Barry ST, Beck A, Cidado J, Gordon JA, Hall C, Hall J, Mali I, Mironenko T, Mongeon K, Morris J, Richardson L, Smith PD, Tavana O, Tolley C, Thomas F, Willis BS, Yang W, O'Connor MJ, McDermott U, Critchlow SE, Drew L, Fawell SE, Mettetal JT, Garnett MJ. Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations Cancer Discov. PMID: 38456804", "BibTeX": "@article{38456804, title={Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations}, author={Bashi AC and Coker EA and Bulusu KC and Jaaks P and Crafter C and Lightfoot H and Milo M and McCarten K and Jenkins DF and van der Meer D and Lynch JT and Barthorpe S and Andersen CL and Barry ST and Beck A and Cidado J and Gordon JA and Hall C and Hall J and Mali I and Mironenko T and Mongeon K and Morris J and Richardson L and Smith PD and Tavana O and Tolley C and Thomas F and Willis BS and Yang W and O'Connor MJ and McDermott U and Critchlow SE and Drew L and Fawell SE and Mettetal JT and Garnett MJ}, journal={Cancer Discov}}"}, "is_sup_mat_match": false}, {"pmid": 38586204, "pmcid": "PMC10996017", "title": "Simultaneous blastic plasmacytoid dendritic cell neoplasm and myelofibrosis: A case report", "journal": "Oncol Lett", "authors": ["Luo F", "Li B", "Li J", "Li Y"], "date": "2024-03-22T00:00:00Z", "year": 2024, "snippets": [{"_id": "38586204@46664", "snip_text": "Mutant gene\tChromosome\tMutation location, exon\tNucleotide alteration\tAmino acid alteration\tdbSNP reference no.\tMutation frequency\tSequencing depth, X\t \tDIS3\t13q22.1\t17\tc.2339G>C\tp.R780T\t-\t0.166\t1,661\t \tNRAS\t1p13.2\t4\tc.436G>A\tp.A146T\t-\t0.045\t1,474\t \tNRAS\t1p13.2\t2\tc.35G>A\tp.G12D\trs121913237\t0.017\t2,051\t \tNRAS\t1p13.2\t2\tc.34G>A\tp.G12S\trs121913250\t0.035\t2,044\t \tTET2\t4q24\t3\tc.2245C>T\tp.Q749*\t-\t0.011\t1,881\t \tTET2\t4q24\t5\tc.3578G>A\tp.C1193Y\t-\t0.580\t1,573\t \tTET2\t4q24\t11\tc.4794T>G\tp.Y1598*\t-\t0.182\t1,994\t \tCSMD1\t8p23.2\t14\tc.2012G>A\tp.R671H\trs376413480\t0.137\t1,576\t \tTET2\t4q24\t9\tc.4160A>G\tp.N1387S\t-\t0.039\t1,272\t \tBCORL1\tXq26.1\t4\tc.469G>A\tp.A157T\trs147775035\t0.998\t996\t \tPDGFRA\t4q12\t15\tc.2153G>A\tp.R718Q\trs367722824\t0.667\t1,443\t \t", "section": "table", "mentions": ["625|6|variant|litvar@rs147775035##&&&litvar@#63035#&&&litvar@CA10514126#rs147775035##|469G>A", "465|9|variant|litvar@#54790#c.4794T>G&&&litvar@#54790#|c.4794T>G", "697|11|variant|litvar@rs367722824##&&&litvar@#5156#|rs367722824", "500|5|gene|ncbi_gene@64478|CSMD1", "427|8|variant|litvar@#54790#p.C1193Y&&&litvar@#54790#|p.C1193Y", "526|7|variant|litvar@rs376413480##&&&litvar@#64478#|p.R671H", "178|7|variant|litvar@#22894#p.R780T&&&litvar@#22894#|p.R780T", "218|6|variant|litvar@rs139849066##&&&litvar@#22894#&&&litvar@CA252141184#rs139849066##|436G>A", "634|5|variant|litvar@rs147775035##&&&litvar@#63035#&&&litvar@CA10514126#rs147775035##|A157T", "202|4|gene|ncbi_gene@4893|NRAS", "518|7|variant|litvar@rs376413480##&&&litvar@#64478#|2012G>A", "534|11|variant|litvar@rs376413480##&&&litvar@#64478#|rs376413480", "560|4|gene|ncbi_gene@54790|TET2", "574|7|variant|litvar@rs1052160399##&&&litvar@#81608#|4160A>G", "664|6|gene|ncbi_gene@5156|PDGFRA", "582|8|variant|litvar@rs1422916349##&&&litvar@#54790#|p.N1387S", "640|11|variant|litvar@rs147775035##&&&litvar@#63035#|rs147775035", "152|4|gene|ncbi_gene@22894|DIS3", "227|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "170|7|variant|litvar@#22894#c.2339G>C&&&litvar@#22894#|2339G>C", "373|7|variant|litvar@rs558231202##&&&litvar@#4893#&&&litvar@CA29048847#rs558231202##|2245C>T", "689|7|variant|litvar@rs367722824##&&&litvar@#5156#&&&litvar@CA2922757#rs367722824##|p.R718Q", "249|4|gene|ncbi_gene@4893|NRAS", "278|11|variant|litvar@rs121913237##&&&litvar@#4893#|rs121913237", "304|4|gene|ncbi_gene@4893|NRAS", "405|4|gene|ncbi_gene@54790|TET2", "419|7|variant|litvar@rs560807863##&&&litvar@#64478#|3578G>A", "333|11|variant|litvar@rs121913250##&&&litvar@#4893#|rs121913250", "359|4|gene|ncbi_gene@54790|TET2", "271|6|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA130425#rs121913237##|p.G12D", "681|7|variant|litvar@rs367722824##&&&litvar@#5156#&&&litvar@CA2922757#rs367722824##|2153G>A", "265|5|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|35G>A", "320|5|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA180753#rs121913250##|34G>A", "452|4|gene|ncbi_gene@54790|TET2", "326|6|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA180753#rs121913250##|p.G12S", "607|6|gene|ncbi_gene@63035|BCORL1"], "figure_id": "tII-ol-27-5-14354", "text_hl": "Mutant gene\tChromosome\tMutation location, exon\tNucleotide alteration\tAmino acid alteration\tdbSNP reference no.\tMutation frequency\tSequencing depth, X\t \tDIS3\t13q22.1\t17\tc.2339G>C\tp.R780T\t-\t0.166\t1,661\t \tNRAS\t1p13.2\t4\tc.436G>A\t<m>p.A146T</m>\t-\t0.045\t1,474\t \tNRAS\t1p13.2\t2\tc.35G>A\tp.G12D\trs121913237\t0.017\t2,051\t \tNRAS\t1p13.2\t2\tc.34G>A\tp.G12S\trs121913250\t0.035\t2,044\t \tTET2\t4q24\t3\tc.2245C>T\tp.Q749*\t-\t0.011\t1,881\t \tTET2\t4q24\t5\tc.3578G>A\tp.C1193Y\t-\t0.580\t1,573\t \tTET2\t4q24\t11\tc.4794T>G\tp.Y1598*\t-\t0.182\t1,994\t \tCSMD1\t8p23.2\t14\tc.2012G>A\tp.R671H\trs376413480\t0.137\t1,576\t \tTET2\t4q24\t9\tc.4160A>G\tp.N1387S\t-\t0.039\t1,272\t \tBCORL1\tXq26.1\t4\tc.469G>A\tp.A157T\trs147775035\t0.998\t996\t \tPDGFRA\t4q12\t15\tc.2153G>A\tp.R718Q\trs367722824\t0.667\t1,443\t \t"}], "citations": {"NLM": "Luo F, Li B, Li J, Li Y. Simultaneous blastic plasmacytoid dendritic cell neoplasm and myelofibrosis: A case report Oncol Lett. PMID: 38586204", "BibTeX": "@article{38586204, title={Simultaneous blastic plasmacytoid dendritic cell neoplasm and myelofibrosis: A case report}, author={Luo F and Li B and Li J and Li Y}, journal={Oncol Lett}}"}, "is_sup_mat_match": false}, {"pmid": 24885062, "pmcid": "PMC4051153", "title": "Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.", "journal": "Mol Cancer", "authors": ["Imamura Y", "Lochhead P", "Yamauchi M", "Kuchiba A", "Qian ZR", "Liao X", "Nishihara R", "Jung S", "Wu K", "Nosho K", "Wang YE", "Peng S", "Bass AJ", "Haigis KM", "Meyerhardt JA", "Chan AT", "Fuchs CS", "Ogino S"], "date": "2014-05-31T00:00:00Z", "year": 2014, "snippets": [{"_id": "24885062@5931", "snip_text": "Codon Nucleotide change Amino acid change Codon change No. of cases Proportion among 1267 cases   Any Any Any Any 505 40%   12 Any Any Any 344 27%   13 Any Any Any 115 9.1%   61 Any Any Any 19 1.5%   146 Any Any Any 40 3.2%   Mutations identified in only one of codons 12, 13, 61 and 146       12 c.34G>A p.G12S GGT>AGT 12 1.0%   12 c.34G>C p.G12R GGT>CGT 7 0.6%   12 c.34G>T p.G12C GGT>TGT 43 3.4%   12 c.35G>A p.G12D GGT>GAT 157 12%   12 c.35G>C p.G12A GGT>GCT 20 1.6%   12 c.35G>T p.G12V GGT>GTT 93 7.3%   12 c.35_36delinsCA p.G12A GGT>GCA 1 0.1%   13 c.37G>C p.G13R GGC>CGC 1 0.1%   13 c.37G>T p.G13C GGC>TGC 2 0.2%   13 c.38G>A p.G13D GGC>GAC 103 8.1%   13 c.38G>T p.G13V GGC>GTC 2 0.2%   61 c.182A>G p.Q61R CAA>CGA 2 0.2%   61 c.182A>T p.Q61L CAA>CTA 4 0.3%   61 c.183A>C p.Q61H CAA>CAC 7 0.6%   60, 61 c.180_181delinsAA p.Q61K GGT + CAA>GGA + AAA 4 0.3%   146 c.436G>A p.A146T GCA>ACA 21 1.7%   146 c.436G>C p.A146P GCA>CCA 3 0.2%   146 c.437C>T p.A146V GCA>GTA 11 0.9%   Mutations identified in two or more of codons 12, 13, 61 and 146       12, 13 c.35G>A, c.38G>A p.G12D, p.G13D GGT>GAT, GGC>GAC 4 0.3%   12, 13 c.35G>T, c.37G>T p.G12V, p.G13C GGT>GTT, GGC>TGC 1 0.1%   12, c.35G>T, p.G12V, GGT>GTT, GGT + CAA>GGA + AAA 1 0.1%   60, 61 c.180_181delinsAA p.Q61K   12, 146 c.34G>C, c.436G>A p.G12R, p.A146T GGT>CGT, GCA>ACA 1 0.1%   12, 146 c.34G>T, c.436G>A p.G12C, p.A146T GGT>TGT, GCA>ACA 1 0.1%   12, 146 c.34G>T, c.437C>T p.G12C, p.A146V GGT>TGT, GCA>GTA 1 0.1%   12, 146 c.35G>T, c.436G>A p.G12V, p.A146T GGT>GTT, GCA>ACA 1 0.1%   13, 146 c.38G>A, c.436G>A p.G13D, p.A146T GGC>GAC, GCA>ACA 1 0.1%   12, 13, 61 c.35G>A, c.38G>A, c.183A>T p.G12D, p.G13D, p.Q61H GGT>GAT, GGC>GAC, CAA>CAT 1 0.1%   ", "section": "table", "mentions": ["1485|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "1324|7|variant|litvar@#3845#|GCA>ACA", "867|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "884|7|variant|litvar@#3845#|GCA>ACA", "341|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "1659|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "333|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>C", "1596|7|variant|litvar@#3845#|GCA>ACA", "297|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G>A", "1633|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "1216|7|variant|litvar@#3845#|CAA>GGA", "484|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1683|7|variant|litvar@#3845#|GGC>GAC", "605|7|variant|litvar@#3845#|GGC>TGC", "1587|7|variant|litvar@#3845#|GGC>GAC", "448|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "305|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "876|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "1503|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1519|7|variant|litvar@#3845#|GGT>GTT", "1624|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "491|7|variant|litvar@#3845#|GGT>GTT", "1528|7|variant|litvar@#3845#|GCA>ACA", "1184|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "312|7|variant|litvar@#3845#|GGT>AGT", "1349|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>T", "809|17|variant|litvar@#3845#c.180_181delinsAA&&&litvar@#3845#|c.180_181delinsAA", "404|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "1246|17|variant|litvar@#3845#c.180_181delinsAA&&&litvar@#3845#|c.180_181delinsAA", "1367|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "1451|7|variant|litvar@#3845#|GGT>TGT", "662|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|c.38G>T", "1579|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "840|7|variant|litvar@#3845#|CAA>GGA", "1066|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "923|7|variant|litvar@#3845#|GCA>CCA", "455|7|variant|litvar@#3845#|GGT>GCT", "633|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "706|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "570|7|variant|litvar@#3845#|GGC>CGC", "670|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|p.G13V", "419|7|variant|litvar@#3845#|GGT>GAT", "733|8|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|c.182A>T", "1057|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "1642|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|c.183A>T", "1426|8|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C>T", "1443|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "1089|7|variant|litvar@#3845#|GGT>GAT", "1299|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "528|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "1154|7|variant|litvar@#3845#|GGT>GTT", "1131|7|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA135570#rs121913535##|c.37G>T", "915|7|variant|litvar@rs121913527##&&&litvar@#3845#|p.A146P", "1358|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "1553|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "590|7|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA135570#rs121913535##|c.37G>T", "1667|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "1571|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "1122|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "1692|7|variant|litvar@#3845#|CAA>CAT", "1139|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "598|6|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|p.G13C", "827|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "677|7|variant|litvar@#3845#|GGC>GTC", "383|7|variant|litvar@#3845#|GGT>TGT", "1417|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>T", "1201|7|variant|litvar@#3845#|GGT>GTT", "535|7|variant|litvar@#3845#|GGT>GCA", "778|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "348|7|variant|litvar@#3845#|GGT>CGT", "476|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "1264|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "1674|7|variant|litvar@#3845#|GGT>GAT", "1290|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "1307|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "440|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>C", "512|15|variant|litvar@#3845#c.35_36delinsCA&&&litvar@#3845#|c.35_36delinsCA", "555|7|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|c.37G>C", "742|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "1562|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "1651|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1435|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "785|7|variant|litvar@#3845#|CAA>CAC", "906|8|variant|litvar@rs121913527##&&&litvar@#3845#|c.436G>C", "1460|7|variant|litvar@#3845#|GCA>GTA", "563|6|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|p.G13R", "412|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "749|7|variant|litvar@#3845#|CAA>CTA", "1281|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>C", "1082|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "1074|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "625|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "1147|6|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|p.G13C", "368|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>T", "1494|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "1511|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "1383|7|variant|litvar@#3845#|GGT>TGT", "1392|7|variant|litvar@#3845#|GCA>ACA", "1193|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1098|7|variant|litvar@#3845#|GGC>GAC", "1163|7|variant|litvar@#3845#|GGC>TGC", "376|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "713|7|variant|litvar@#3845#|CAA>CGA", "640|7|variant|litvar@#3845#|GGC>GAC", "769|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA180922#rs17851045##|c.183A>C", "1375|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "944|8|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C>T", "961|7|variant|litvar@#3845#|GCA>GTA", "1315|7|variant|litvar@#3845#|GGT>CGT", "953|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "697|8|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|c.182A>G"], "figure_id": "T1", "text_hl": "Codon Nucleotide change Amino acid change Codon change No. of cases Proportion among 1267 cases   Any Any Any Any 505 40%   12 Any Any Any 344 27%   13 Any Any Any 115 9.1%   61 Any Any Any 19 1.5%   146 Any Any Any 40 3.2%   Mutations identified in only one of codons 12, 13, 61 and 146       12 c.34G>A p.G12S GGT>AGT 12 1.0%   12 c.34G>C p.G12R GGT>CGT 7 0.6%   12 c.34G>T p.G12C GGT>TGT 43 3.4%   12 c.35G>A p.G12D GGT>GAT 157 12%   12 c.35G>C p.G12A GGT>GCT 20 1.6%   12 c.35G>T p.G12V GGT>GTT 93 7.3%   12 c.35_36delinsCA p.G12A GGT>GCA 1 0.1%   13 c.37G>C p.G13R GGC>CGC 1 0.1%   13 c.37G>T p.G13C GGC>TGC 2 0.2%   13 c.38G>A p.G13D GGC>GAC 103 8.1%   13 c.38G>T p.G13V GGC>GTC 2 0.2%   61 c.182A>G p.Q61R CAA>CGA 2 0.2%   61 c.182A>T p.Q61L CAA>CTA 4 0.3%   61 c.183A>C p.Q61H CAA>CAC 7 0.6%   60, 61 c.180_181delinsAA p.Q61K GGT + CAA>GGA + AAA 4 0.3%   146 c.436G>A <m>p.A146T</m> GCA>ACA 21 1.7%   146 c.436G>C p.A146P GCA>CCA 3 0.2%   146 c.437C>T p.A146V GCA>GTA 11 0.9%   Mutations identified in two or more of codons 12, 13, 61 and 146       12, 13 c.35G>A, c.38G>A p.G12D, p.G13D GGT>GAT, GGC>GAC 4 0.3%   12, 13 c.35G>T, c.37G>T p.G12V, p.G13C GGT>GTT, GGC>TGC 1 0.1%   12, c.35G>T, p.G12V, GGT>GTT, GGT + CAA>GGA + AAA 1 0.1%   60, 61 c.180_181delinsAA p.Q61K   12, 146 c.34G>C, c.436G>A p.G12R, <m>p.A146T</m> GGT>CGT, GCA>ACA 1 0.1%   12, 146 c.34G>T, c.436G>A p.G12C, <m>p.A146T</m> GGT>TGT, GCA>ACA 1 0.1%   12, 146 c.34G>T, c.437C>T p.G12C, p.A146V GGT>TGT, GCA>GTA 1 0.1%   12, 146 c.35G>T, c.436G>A p.G12V, <m>p.A146T</m> GGT>GTT, GCA>ACA 1 0.1%   13, 146 c.38G>A, c.436G>A p.G13D, <m>p.A146T</m> GGC>GAC, GCA>ACA 1 0.1%   12, 13, 61 c.35G>A, c.38G>A, c.183A>T p.G12D, p.G13D, p.Q61H GGT>GAT, GGC>GAC, CAA>CAT 1 0.1%   "}], "citations": {"NLM": "Imamura Y, Lochhead P, Yamauchi M, Kuchiba A, Qian ZR, Liao X, Nishihara R, Jung S, Wu K, Nosho K, Wang YE, Peng S, Bass AJ, Haigis KM, Meyerhardt JA, Chan AT, Fuchs CS, Ogino S. Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review. Mol Cancer. PMID: 24885062", "BibTeX": "@article{24885062, title={Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.}, author={Imamura Y and Lochhead P and Yamauchi M and Kuchiba A and Qian ZR and Liao X and Nishihara R and Jung S and Wu K and Nosho K and Wang YE and Peng S and Bass AJ and Haigis KM and Meyerhardt JA and Chan AT and Fuchs CS and Ogino S}, journal={Mol Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 35312176, "pmcid": "PMC9385586", "title": "Relationship between perioperative oncological evaluation and recurrence using circulating tumor DNA with KRAS mutation in patients with colorectal cancer.", "journal": "Cancer Med", "authors": ["Hayashi T", "Yoshida Y", "Yamada T", "Tanaka K", "Shimaoka H", "Kajitani R", "Munechika T", "Nagano H", "Matsumoto Y", "Komono A", "Sakamoto R", "Aisu N", "Yoshimatsu G", "Yoshimura F", "Hasegawa S"], "date": "2022-03-21T00:00:00Z", "year": 2022, "snippets": [{"_id": "35312176@539", "snip_text": "METHODS: Among 304 cases of colorectal cancer surgery, ctDNA was sampled from the perioperative blood of 84 patients with CRC with KRAS mutation (exon 4 p.A146T, exon 4 p.A146V, exon 2 p.G12A, exon 2 p.G12C, exon 2 p.G12D, exon 2 p.G12S, exon 2 p.G12V, exon 2 p.G13D, exon 3 p.Q61H) and analyzed using the digital polymerase chain reaction system.", "section": "abstract", "mentions": ["200|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "245|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "122|3|disease|ncbi_mesh@D015179|CRC", "108|8|species|ncbi_taxonomy@9606|patients", "260|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "28|17|disease|ncbi_mesh@D015179|colorectal cancer", "185|6|variant|litvar@##p.G12A|p.G12A", "169|7|variant|litvar@##p.A146V|p.A146V", "275|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "153|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "230|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "215|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D"], "text_hl": "METHODS: Among 304 cases of colorectal cancer surgery, ctDNA was sampled from the perioperative blood of 84 patients with CRC with KRAS mutation (exon 4 <m>p.A146T</m>, exon 4 p.A146V, exon 2 p.G12A, exon 2 p.G12C, exon 2 p.G12D, exon 2 p.G12S, exon 2 p.G12V, exon 2 p.G13D, exon 3 p.Q61H) and analyzed using the digital polymerase chain reaction system."}], "citations": {"NLM": "Hayashi T, Yoshida Y, Yamada T, Tanaka K, Shimaoka H, Kajitani R, Munechika T, Nagano H, Matsumoto Y, Komono A, Sakamoto R, Aisu N, Yoshimatsu G, Yoshimura F, Hasegawa S. Relationship between perioperative oncological evaluation and recurrence using circulating tumor DNA with KRAS mutation in patients with colorectal cancer. Cancer Med. PMID: 35312176", "BibTeX": "@article{35312176, title={Relationship between perioperative oncological evaluation and recurrence using circulating tumor DNA with KRAS mutation in patients with colorectal cancer.}, author={Hayashi T and Yoshida Y and Yamada T and Tanaka K and Shimaoka H and Kajitani R and Munechika T and Nagano H and Matsumoto Y and Komono A and Sakamoto R and Aisu N and Yoshimatsu G and Yoshimura F and Hasegawa S}, journal={Cancer Med}}"}, "is_sup_mat_match": false}, {"pmid": 30588011, "pmcid": "PMC6294057", "title": "c.1439delA frameshift deletion mutation in familial adenomatous polyposis.", "journal": "Onco Targets Ther", "authors": ["Ma DJ", "Wang BS", "Yue JB", "Li ZJ", "Sun YL"], "date": "2018-12-11T00:00:00Z", "year": 2018, "snippets": [{"_id": "30588011@16139", "snip_text": "Test items Exons/codons Type of mutation Test results      KRAS/NRAS/BRAF joint mutation detection KRAS Exon-2 G12S, G12D Wild type   KRAS Exon-2 G12C, G12R, G12V, G12A, G13C Mutant   KRAS Exon-2 G13D Wild type   KRAS Exon-3 Q61L, Q61R, Q61H Wild type   KRAS Exon-4 K117N, A146T, A146V, A146P Wild type   NRAS Exon-2 G12D, G12S Wild type   NRAS Exon-2 G13D Wild type   NRAS Exon-2 G13R, G12C, G12V, G12A, G13V Wild type   NRAS Exon-3 Q61R, Q61K, Q61L, Q61H Wild type   NRAS Exon-4 A146T Wild type   BRAF Exon-15 V600E Wild type   ", "section": "table", "mentions": ["305|4|gene|ncbi_gene@4893|NRAS", "434|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|Q61R", "99|4|gene|ncbi_gene@3845|KRAS", "266|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "164|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "237|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "393|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "280|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "352|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "499|4|gene|ncbi_gene@673|BRAF", "196|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "399|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "440|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "64|4|gene|ncbi_gene@4893|NRAS", "146|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "59|4|gene|ncbi_gene@3845|KRAS", "381|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "422|4|gene|ncbi_gene@4893|NRAS", "69|4|gene|ncbi_gene@673|BRAF", "152|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "170|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "225|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|Q61L", "273|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "340|4|gene|ncbi_gene@4893|NRAS", "469|4|gene|ncbi_gene@4893|NRAS", "317|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "446|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|Q61L", "111|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "184|4|gene|ncbi_gene@3845|KRAS", "287|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "231|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|Q61R", "512|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "158|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "323|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "387|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "405|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "254|4|gene|ncbi_gene@3845|KRAS", "134|4|gene|ncbi_gene@3845|KRAS", "369|4|gene|ncbi_gene@4893|NRAS", "481|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "452|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "213|4|gene|ncbi_gene@3845|KRAS", "117|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D"], "figure_id": "t1-ott-11-8987", "text_hl": "Test items Exons/codons Type of mutation Test results      KRAS/NRAS/BRAF joint mutation detection KRAS Exon-2 G12S, G12D Wild type   KRAS Exon-2 G12C, G12R, G12V, G12A, G13C Mutant   KRAS Exon-2 G13D Wild type   KRAS Exon-3 Q61L, Q61R, Q61H Wild type   KRAS Exon-4 K117N, <m>A146T</m>, A146V, A146P Wild type   NRAS Exon-2 G12D, G12S Wild type   NRAS Exon-2 G13D Wild type   NRAS Exon-2 G13R, G12C, G12V, G12A, G13V Wild type   NRAS Exon-3 Q61R, Q61K, Q61L, Q61H Wild type   NRAS Exon-4 <m>A146T</m> Wild type   BRAF Exon-15 V600E Wild type   "}], "citations": {"NLM": "Ma DJ, Wang BS, Yue JB, Li ZJ, Sun YL. c.1439delA frameshift deletion mutation in familial adenomatous polyposis. Onco Targets Ther. PMID: 30588011", "BibTeX": "@article{30588011, title={c.1439delA frameshift deletion mutation in familial adenomatous polyposis.}, author={Ma DJ and Wang BS and Yue JB and Li ZJ and Sun YL}, journal={Onco Targets Ther}}"}, "is_sup_mat_match": false}, {"pmid": 25790293, "pmcid": "PMC4377644", "title": "Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia.", "journal": "Nat Commun", "authors": ["Ma X", "Edmonson M", "Yergeau D", "Muzny DM", "Hampton OA", "Rusch M", "Song G", "Easton J", "Harvey RC", "Wheeler DA", "Ma J", "Doddapaneni H", "Vadodaria B", "Wu G", "Nagahawatte P", "Carroll WL", "Chen IM", "Gastier-Foster JM", "Relling MV", "Smith MA", "Devidas M", "Guidry Auvil JM", "Downing JR", "Loh ML", "Willman CL", "Gerhard DS", "Mullighan CG", "Hunger SP", "Zhang J"], "date": "2015-03-19T00:00:00Z", "year": 2015, "snippets": [{"_id": "25790293@8619", "snip_text": "For example, PAPJIB had subclonal mutations of KRAS p.Ala146Thr, NRAS p.Gly13Asp and PTPN11 p.Ser502Pro with MAFs of 0.021, 0.025 and 0.233, respectively, at diagnosis, and persistence of only the NRAS p.Gly13Asp mutation with MAF increased 10-fold to 0.234 at relapse.", "section": "results", "mentions": ["65|4|gene|ncbi_gene@4893|NRAS", "52|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "197|4|gene|ncbi_gene@4893|NRAS", "85|6|gene|ncbi_gene@5781|PTPN11", "202|10|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.Gly13Asp", "70|10|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.Gly13Asp", "92|11|variant|litvar@#5781#p.S502P&&&litvar@#5781#|p.Ser502Pro", "47|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "For example, PAPJIB had subclonal mutations of KRAS <m>p.Ala146Thr</m>, NRAS p.Gly13Asp and PTPN11 p.Ser502Pro with MAFs of 0.021, 0.025 and 0.233, respectively, at diagnosis, and persistence of only the NRAS p.Gly13Asp mutation with MAF increased 10-fold to 0.234 at relapse."}], "citations": {"NLM": "Ma X, Edmonson M, Yergeau D, Muzny DM, Hampton OA, Rusch M, Song G, Easton J, Harvey RC, Wheeler DA, Ma J, Doddapaneni H, Vadodaria B, Wu G, Nagahawatte P, Carroll WL, Chen IM, Gastier-Foster JM, Relling MV, Smith MA, Devidas M, Guidry Auvil JM, Downing JR, Loh ML, Willman CL, Gerhard DS, Mullighan CG, Hunger SP, Zhang J. Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. Nat Commun. PMID: 25790293", "BibTeX": "@article{25790293, title={Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia.}, author={Ma X and Edmonson M and Yergeau D and Muzny DM and Hampton OA and Rusch M and Song G and Easton J and Harvey RC and Wheeler DA and Ma J and Doddapaneni H and Vadodaria B and Wu G and Nagahawatte P and Carroll WL and Chen IM and Gastier-Foster JM and Relling MV and Smith MA and Devidas M and Guidry Auvil JM and Downing JR and Loh ML and Willman CL and Gerhard DS and Mullighan CG and Hunger SP and Zhang J}, journal={Nat Commun}}"}, "is_sup_mat_match": false}, {"pmid": 34094546, "pmcid": "PMC8165703", "title": "Drug sensitivity profile of minor KRAS mutations in colorectal cancer using mix culture assay: The effect of AMG-510, a novel KRAS G12C selective inhibitor, on colon cancer cells is markedly enhanced by the combined inhibition of MEK and BCL-XL.", "journal": "Mol Clin Oncol", "authors": ["Kitazawa M", "Miyagawa Y", "Koyama M", "Nakamura S", "Hondo N", "Miyazaki S", "Muranaka F", "Tokumaru S", "Yamamoto Y", "Ehara T", "Kuroiwa M", "Tanaka H", "Komatsu D", "Takeoka M", "Soejima Y"], "date": "2021-07-01T00:00:00Z", "year": 2021, "snippets": [{"_id": "34094546@727", "snip_text": "The current study focused on minor KRAS mutations (G12A, G12C, G12S, Q61H and A146T) and evaluated whether these were resistant to anti-EGFR antibodies using a mix culture assay.", "section": "abstract", "mentions": ["51|4|variant|litvar@#1956#c.12G>A&&&litvar@#1956#|G12A", "57|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "78|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "136|4|gene|ncbi_gene@1956|EGFR", "63|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "69|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H"], "text_hl": "The current study focused on minor KRAS mutations (G12A, G12C, G12S, Q61H and <m>A146T</m>) and evaluated whether these were resistant to anti-EGFR antibodies using a mix culture assay."}], "citations": {"NLM": "Kitazawa M, Miyagawa Y, Koyama M, Nakamura S, Hondo N, Miyazaki S, Muranaka F, Tokumaru S, Yamamoto Y, Ehara T, Kuroiwa M, Tanaka H, Komatsu D, Takeoka M, Soejima Y. Drug sensitivity profile of minor KRAS mutations in colorectal cancer using mix culture assay: The effect of AMG-510, a novel KRAS G12C selective inhibitor, on colon cancer cells is markedly enhanced by the combined inhibition of MEK and BCL-XL. Mol Clin Oncol. PMID: 34094546", "BibTeX": "@article{34094546, title={Drug sensitivity profile of minor KRAS mutations in colorectal cancer using mix culture assay: The effect of AMG-510, a novel KRAS G12C selective inhibitor, on colon cancer cells is markedly enhanced by the combined inhibition of MEK and BCL-XL.}, author={Kitazawa M and Miyagawa Y and Koyama M and Nakamura S and Hondo N and Miyazaki S and Muranaka F and Tokumaru S and Yamamoto Y and Ehara T and Kuroiwa M and Tanaka H and Komatsu D and Takeoka M and Soejima Y}, journal={Mol Clin Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 30481508, "pmcid": "PMC6467705", "title": "Clinical validation of coexisting driver mutations in colorectal cancers", "journal": "Hum Pathol", "authors": ["Zheng G", "Tseng LH", "Haley L", "Ibrahim J", "Bynum J", "Xian R", "Gocke CD", "Eshleman JR", "Lin MT"], "date": "2019-04-01T00:00:00Z", "year": 2019, "snippets": [{"_id": "30481508@12529", "snip_text": "Coexisting KRAS p.A146T and NRAS p.Q61R mutations were detected in CRC0125.", "section": "results", "mentions": ["33|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "11|4|gene|ncbi_gene@3845|KRAS", "28|4|gene|ncbi_gene@4893|NRAS", "16|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T"], "text_hl": "Coexisting KRAS <m>p.A146T</m> and NRAS p.Q61R mutations were detected in CRC0125."}], "citations": {"NLM": "Zheng G, Tseng LH, Haley L, Ibrahim J, Bynum J, Xian R, Gocke CD, Eshleman JR, Lin MT. Clinical validation of coexisting driver mutations in colorectal cancers Hum Pathol. PMID: 30481508", "BibTeX": "@article{30481508, title={Clinical validation of coexisting driver mutations in colorectal cancers}, author={Zheng G and Tseng LH and Haley L and Ibrahim J and Bynum J and Xian R and Gocke CD and Eshleman JR and Lin MT}, journal={Hum Pathol}}"}, "is_sup_mat_match": false}, {"pmid": 34393517, "pmcid": "PMC8357621", "title": "Bead-Based Isolation of Circulating Tumor DNA from Pancreatic Cancer Patients Enables High Fidelity Next Generation Sequencing.", "journal": "Cancer Manag Res", "authors": ["Balendran-Braun S", "Kieler M", "Liebmann-Reindl S", "Unseld M", "Bianconi D", "W Prager G", "Streubel B"], "date": "2021-08-07T00:00:00Z", "year": 2021, "snippets": [{"_id": "34393517@19039", "snip_text": "Patient # Sample Gene Symbol Amino Acid Change Variant Frequency (%) Detection Threshold Controls Codon Change Therapy Response ctDNA Dynamics versus CT Results   1 1st sample KRAS p.G12D 4.43 0.053 c.35G>A PD Unexpected (decrease of VAF in PD)     SMAD4 p.Y131D 1.84 0.008 c.392A>G     2nd sample KRAS p.G12D 2.01 0.053 c.35G>A      SMAD4 p.Y131D 0.00 0.008 c.392A>G    2 1st sample PIK3CA p.Q546L 4.40 0.000 c. 1637A>T PR Consistent     KRAS p.G12V 6.96 0.000 c.35G>T       TP53 p.R273H 1.91 0.050 c.818G>A       SMAD4 p.Q256* 0.00 0.061 c.766C>T      2nd sample PIK3CA p.Q546L 0.00 0.000 c. 1637A>T       KRAS p.G12V 0.00 0.000 c.35G>T       TP53 p.R273H 0.00 0.050 c.818G>A       SMAD4 p.Q256* 0.56 0.061 c.766C>T     3 1st sample PIK3CA p.G1007V 0.25 0.104 c.3020G>T SD Unexpected (increase of VAF and new variant in follow-up sample in SD)     EGFR p.Q791H 0.22 0.023 c.2373G>T      PDGFRA p.L839P 0.00 0.034 c.2516T>C     2nd sample PIK3CA p.G1007V 1.58 0.104 c.3020G>T      EGFR p.Q791H 1.50 0.023 c.2373G>T      PDGFRA p.L839P 1.25 0.034 c.2516T>C    4 1st sample KRAS p.G12R 1.37 0.015 c.34G>C PD unexpected (decrease of VAF in PD)     TP53 p.D208V 1.82 0.000 c.623_624delACinsTT     2nd sample KRAS p.G12R 0.19 0.015 c.34G>C      TP53 p.D208V 0.33 0.000 c.623_624delACinsTT    5 1st sample MET p.G1201V 2.06 0.212 c.3602G>T PD Consistent     SMAD4 p.R496H 0.00 0.035 c.1487G>A      2nd sample MET p.G1201V 0.00 0.212 c.3602G>T       SMAD4 p.R496H 0.43 0.035 c.1487G>A     6 1st sample SMAD4 p.R445* 0.17 0.062 c.1333C>T PD Consistent     CDKN2A p.Y129C 0.23 0.029 c.385A>G      2nd sample SMAD4 p.R445* 0.24 0.062 c.1333C>T       CDKN2A p.Y129C 0.48 0.029 c.385A>G     7 1st sample KRAS p.G12D 4.54 0.053 c.35G>A PR Consistent     TP53 p.P152T 1.66 0.000 c.454C>A       KRAS p.A146T 0.19 0.049 c.437C>T      2nd sample KRAS p.G12D 0.09 0.053 c.35G>A       TP53 p.P152T 0.00 0.000 c.454C>A       KRAS p.A146T 0.15 0.049 c.437C>T     8 1st sample KRAS p.G12V 0.79 0.000 c.35G>T SD Consistent    2nd sample KRAS p.G12V 0.17 0.000 c.35G>T     9 1st sample /     PR /    2nd sample /         10 1st sample KRAS p.G12V 0.87 0.000 c.35G>T PR Unexpected (stable VAF in PR)    2nd sample KRAS p.G12V 0.43 0.000 c.35G>T    11 1st sample KRAS p.G12D 0.41 0.053 c.35G>A PD Unexpected (decrease of VAF in PD)    2nd sample KRAS p.G12D 0.12 0.053 c.35G>A    12 1st sample KRAS p.A146T 0.24 0.049 c.437C>T SD Unexpected (mutation disappeared during therapy in stable disease)    2nd sample KRAS p.A146T 0.00 0.049 c.437C>T    13 1st sample KRAS p.Q61R 21.73 0.037 c.182A>G PD Unexpected (decrease of VAF in PD)     TP53 p.F212SfsTer3 16.58 0.000 c.635_636delTT     2nd sample KRAS p.Q61R 8.04 0.037 c.182A>G      TP53 p.F212SfsTer3 2.90 0.000 c.635_636delTT    14 1st sample KRAS p.G12R 15.18 0.015 c.34G>C SD Consistent     TP53 p.G245V 16.74 0.000 c.734G>T      2nd sample KRAS p.G12R 0.87 0.015 c.34G>C       TP53 p.G245V 1.67 0.000 c.734G>T     15 1st sample KRAS p.A134S 0.00 0.000 c.400G>T PD Consistent     TP53 p.Y126D 1.41 0.009 c.376T>G      2nd sample KRAS p.A134S 1.47 0.000 c.400G>T       TP53 p.Y126D 0.36 0.009 c.376T>G     16 1st sample KRAS p.G12D 2.79 0.053 c.35G>A PD Unexpected (decrease of VAF in PD)     TP53 p.R282W 1.32 0.090 c.844C>T     2nd sample KRAS p.G12D 1.83 0.053 c.35G>A      TP53 p.R282W 1.10 0.090 c.844C>T    17 1st sample KRAS p.G12R 0.85 0.015 c.34G>C SD Unexpected (mutations disappeared during therapy in stable disease)     CDKN2A p.Y129C 0.40 0.029 c.385A>G     2nd sample KRAS p.G12R 0.00 0.015 c.34G>C      CDKN2A p.Y129C 0.00 0.029 c.385A>G    18 1st sample /     PD /    2nd sample /         19 1st sample /     SD /    2nd sample /         20 1st sample /     SD /    2nd sample /         21 1st sample KRAS p.G12D 0.46 0.053 c.35G>A PD Unexpected (decrease of VAF in PD)     SMAD4 p.R135* 0.64 0.073 c.403C>T     2nd sample KRAS p.G12D 0.08 0.053 c.35G>A      SMAD4 p.R135* 0.00 0.073 c.403C>T    ", "section": "table", "mentions": ["2195|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1006|9|variant|litvar@rs1413493019##&&&litvar@#1956#|c.2373G>T", "2677|6|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|p.Q61R", "500|8|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|c.818G>A", "462|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "572|7|variant|litvar@rs397517201##&&&litvar@#5290#|p.Q546L", "2959|4|gene|ncbi_gene@3845|KRAS", "3064|7|variant|litvar@rs372599739##&&&litvar@#1029#|p.A134S", "2913|7|variant|litvar@rs121912656##&&&litvar@#7157#&&&litvar@CA1743#rs121912656##|p.G245V", "207|2|disease|ncbi_mesh@D010300|PD", "439|4|gene|ncbi_gene@3845|KRAS", "2321|4|gene|ncbi_gene@3845|KRAS", "2603|2|disease|ncbi_mesh@D010300|PD", "1872|7|variant|litvar@rs1204379654##&&&litvar@#7157#|p.P152T", "476|4|gene|ncbi_gene@7157|TP53", "3275|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "3469|7|variant|litvar@rs774058987##&&&litvar@#7157#|p.Y129C", "1549|6|gene|ncbi_gene@1029|CDKN2A", "2795|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>C", "1575|8|variant|litvar@rs774058987##&&&litvar@#7157#&&&litvar@CA8354945#rs774058987##|c.385A>G", "249|5|gene|ncbi_gene@4089|SMAD4", "3214|2|disease|ncbi_mesh@D010300|PD", "298|4|gene|ncbi_gene@3845|KRAS", "1641|6|gene|ncbi_gene@1029|CDKN2A", "3930|8|variant|litvar@rs377767326##&&&litvar@#4089#&&&litvar@CA259169#rs377767326##|c.403C>T", "3892|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "1305|8|variant|litvar@#79811#p.G1201V&&&litvar@#79811#|p.G1201V", "384|6|gene|ncbi_gene@5290|PIK3CA", "1210|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "2015|4|gene|ncbi_gene@3845|KRAS", "987|7|variant|litvar@rs1413493019##&&&litvar@#1956#|p.Q791H", "0|7|species|ncbi_taxonomy@9606|Patient", "1104|2|disease|ncbi_mesh@D010300|PD", "1835|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1531|2|disease|ncbi_mesh@D010300|PD", "1956|4|gene|ncbi_gene@3845|KRAS", "3330|8|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|c.844C>T", "2776|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "2112|4|gene|ncbi_gene@3845|KRAS", "850|4|gene|ncbi_gene@1956|EGFR", "241|2|disease|ncbi_mesh@D010300|PD", "2642|14|variant|litvar@rs1131691030##&&&litvar@#7157#|c.635_636delTT", "1502|7|variant|litvar@#4089#p.R445*&&&litvar@#4089#|p.R445*", "540|8|variant|litvar@rs1131691006##&&&litvar@#7157#|c.766C>T", "3306|4|gene|ncbi_gene@7157|TP53", "3805|3|chemical||VAF", "3548|6|gene|ncbi_gene@1029|CDKN2A", "3059|4|gene|ncbi_gene@3845|KRAS", "3574|8|variant|litvar@rs774058987##&&&litvar@#7157#&&&litvar@CA8354945#rs774058987##|c.385A>G", "3845|8|variant|litvar@rs377767326##&&&litvar@#4089#&&&litvar@CA259169#rs377767326##|c.403C>T", "594|7|variant|litvar@rs397517201##&&&litvar@#5290#|1637A>T", "1469|9|variant|litvar@rs876660045##&&&litvar@#4089#&&&litvar@CA10580989#rs876660045##|c.1487G>A", "3311|7|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|p.R282W", "1353|5|gene|ncbi_gene@4089|SMAD4", "3154|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "2560|8|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|c.182A>G", "608|4|gene|ncbi_gene@3845|KRAS", "1228|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>C", "1766|8|variant|litvar@rs1204379654##&&&litvar@#7157#|c.454C>A", "650|7|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|p.R273H", "2821|4|gene|ncbi_gene@7157|TP53", "3270|4|gene|ncbi_gene@3845|KRAS", "3488|8|variant|litvar@rs774058987##&&&litvar@#7157#&&&litvar@CA8354945#rs774058987##|c.385A>G", "2486|4|gene|ncbi_gene@3845|KRAS", "3361|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "181|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1378|9|variant|litvar@rs876660045##&&&litvar@#4089#&&&litvar@CA10580989#rs876660045##|c.1487G>A", "2344|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "631|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "2826|7|variant|litvar@rs121912656##&&&litvar@#7157#&&&litvar@CA1743#rs121912656##|p.G245V", "1301|3|gene|ncbi_gene@79811|MET", "1265|19|variant|litvar@#3845#c.623_624delinsAC,TT&&&litvar@#3845#|c.623_624delACinsTT", "915|9|variant|litvar@rs151064287##&&&litvar@#1956#&&&litvar@CA4266144#rs151064287##|c.2516T>C", "684|5|gene|ncbi_gene@4089|SMAD4", "2491|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "2846|8|variant|litvar@rs121912656##&&&litvar@#7157#&&&litvar@CA1743#rs121912656##|c.734G>T", "2695|8|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|c.182A>G", "1450|7|variant|litvar@rs876660045##&&&litvar@#4089#&&&litvar@CA10580989#rs876660045##|p.R496H", "1805|8|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C>T", "2536|4|gene|ncbi_gene@3845|KRAS", "1606|7|variant|litvar@#4089#p.R445*&&&litvar@#4089#|p.R445*", "1716|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "1028|7|variant|litvar@rs151064287##&&&litvar@#1956#|p.L839P", "2876|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "1325|9|variant|litvar@#79811#c.3602G>T&&&litvar@#79811#|c.3602G>T", "2541|6|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|p.Q61R", "1781|4|gene|ncbi_gene@3845|KRAS", "359|8|variant|litvar@rs55819519##&&&litvar@#7157#&&&litvar@CA468#rs55819519##|c.392A>G", "3227|7|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|p.R282W", "3149|4|gene|ncbi_gene@3845|KRAS", "3535|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>C", "3103|7|variant|litvar@rs886039483##&&&litvar@#7157#&&&litvar@CA10588672#rs886039483##|p.Y126D", "1359|7|variant|litvar@rs876660045##&&&litvar@#4089#&&&litvar@CA10580989#rs876660045##|p.R496H", "1930|8|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C>T", "1786|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "2326|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "2213|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "2374|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "1404|3|gene|ncbi_gene@79811|MET", "896|7|variant|litvar@rs151064287##&&&litvar@#1956#|p.L839P", "690|7|variant|litvar@#4089#p.Q256*&&&litvar@#4089#|p.Q256*", "940|6|gene|ncbi_gene@5290|PIK3CA", "1906|4|gene|ncbi_gene@3845|KRAS", "1600|5|gene|ncbi_gene@4089|SMAD4", "3747|4|gene|ncbi_gene@3845|KRAS", "1408|8|variant|litvar@#79811#p.G1201V&&&litvar@#79811#|p.G1201V", "669|8|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|c.818G>A", "3379|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>C", "199|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "234|3|chemical||VAF", "303|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "3293|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "176|4|gene|ncbi_gene@3845|KRAS", "1911|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "274|8|variant|litvar@rs55819519##&&&litvar@#7157#&&&litvar@CA468#rs55819519##|c.392A>G", "2739|14|variant|litvar@rs1131691030##&&&litvar@#7157#|c.635_636delTT", "645|4|gene|ncbi_gene@7157|TP53", "1625|9|variant|litvar@rs377767360##&&&litvar@#4089#&&&litvar@CA189448#rs377767360##|c.1333C>T", "2020|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1047|9|variant|litvar@rs151064287##&&&litvar@#1956#&&&litvar@CA4266144#rs151064287##|c.2516T>C", "1138|2|disease|ncbi_mesh@D010300|PD", "1205|4|gene|ncbi_gene@3845|KRAS", "1742|4|gene|ncbi_gene@7157|TP53", "3905|5|gene|ncbi_gene@4089|SMAD4", "2932|8|variant|litvar@rs121912656##&&&litvar@#7157#&&&litvar@CA1743#rs121912656##|c.734G>T", "1496|5|gene|ncbi_gene@4089|SMAD4", "1961|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "2894|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>C", "2117|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "2510|8|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C>T", "334|5|gene|ncbi_gene@4089|SMAD4", "2238|4|gene|ncbi_gene@3845|KRAS", "1891|8|variant|litvar@rs1204379654##&&&litvar@#7157#|c.454C>A", "1853|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "3034|8|variant|litvar@rs886039483##&&&litvar@#7157#&&&litvar@CA10588672#rs886039483##|c.376T>G", "255|7|variant|litvar@#4089#p.Y131D&&&litvar@#4089#|p.Y131D", "481|7|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|p.R273H", "874|9|variant|litvar@rs1413493019##&&&litvar@#1956#|c.2373G>T", "3462|6|gene|ncbi_gene@1029|CDKN2A", "2611|4|gene|ncbi_gene@7157|TP53", "3778|2|disease|ncbi_mesh@D010300|PD", "1151|7|variant|litvar@rs1464727668##&&&litvar@#7157#|p.D208V", "3246|8|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|c.844C>T", "1867|4|gene|ncbi_gene@7157|TP53", "3010|4|gene|ncbi_gene@7157|TP53", "1073|4|gene|ncbi_gene@3845|KRAS", "3869|4|gene|ncbi_gene@3845|KRAS", "1693|4|gene|ncbi_gene@3845|KRAS", "3122|8|variant|litvar@rs886039483##&&&litvar@#7157#&&&litvar@CA10588672#rs886039483##|c.376T>G", "321|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "2596|3|chemical||VAF", "3222|4|gene|ncbi_gene@7157|TP53", "413|7|variant|litvar@rs397517201##&&&litvar@#5290#|1637A>T", "613|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "3015|7|variant|litvar@rs886039483##&&&litvar@#7157#&&&litvar@CA10588672#rs886039483##|p.Y126D", "3820|5|gene|ncbi_gene@4089|SMAD4", "889|6|gene|ncbi_gene@5156|PDGFRA", "3098|4|gene|ncbi_gene@7157|TP53", "2135|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "3911|7|variant|litvar@#4089#p.R135*&&&litvar@#4089#|p.R135*", "2369|4|gene|ncbi_gene@3845|KRAS", "3172|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "947|8|variant|litvar@#5290#p.G1007V&&&litvar@#5290#|p.G1007V", "3207|3|chemical||VAF", "982|4|gene|ncbi_gene@1956|EGFR", "3812|2|disease|ncbi_mesh@D010300|PD", "2190|4|gene|ncbi_gene@3845|KRAS", "2672|4|gene|ncbi_gene@3845|KRAS", "2709|4|gene|ncbi_gene@7157|TP53", "1241|4|gene|ncbi_gene@7157|TP53", "3874|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "2992|2|disease|ncbi_mesh@D010300|PD", "565|6|gene|ncbi_gene@5290|PIK3CA", "1246|7|variant|litvar@rs1464727668##&&&litvar@#7157#|p.D208V", "3826|7|variant|litvar@#4089#p.R135*&&&litvar@#4089#|p.R135*", "735|6|gene|ncbi_gene@5290|PIK3CA", "1428|9|variant|litvar@#79811#c.3602G>T&&&litvar@#79811#|c.3602G>T", "1335|2|disease|ncbi_mesh@D010300|PD", "1747|7|variant|litvar@rs1204379654##&&&litvar@#7157#|p.P152T", "2261|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "1521|9|variant|litvar@rs377767360##&&&litvar@#4089#&&&litvar@CA189448#rs377767360##|c.1333C>T", "1131|3|chemical||VAF", "1830|4|gene|ncbi_gene@3845|KRAS", "1146|4|gene|ncbi_gene@7157|TP53", "2771|4|gene|ncbi_gene@3845|KRAS", "2964|7|variant|litvar@rs372599739##&&&litvar@#1029#|p.A134S", "3752|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1021|6|gene|ncbi_gene@5156|PDGFRA", "515|5|gene|ncbi_gene@4089|SMAD4", "1096|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>C", "1667|8|variant|litvar@rs774058987##&&&litvar@#7157#&&&litvar@CA8354945#rs774058987##|c.385A>G", "1170|19|variant|litvar@#3845#c.623_624delinsAC,TT&&&litvar@#3845#|c.623_624delACinsTT", "444|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "967|9|variant|litvar@#5290#c.3020G>T&&&litvar@#5290#|c.3020G>T", "1556|7|variant|litvar@rs774058987##&&&litvar@#7157#|p.Y129C", "2038|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "2393|8|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C>T", "2908|4|gene|ncbi_gene@7157|TP53", "340|7|variant|litvar@#4089#p.Y131D&&&litvar@#4089#|p.Y131D", "2243|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1648|7|variant|litvar@rs774058987##&&&litvar@#7157#|p.Y129C", "709|8|variant|litvar@rs1131691006##&&&litvar@#7157#|c.766C>T", "1979|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "3356|4|gene|ncbi_gene@3845|KRAS", "3606|2|disease|ncbi_mesh@D010300|PD", "391|7|variant|litvar@rs397517201##&&&litvar@#5290#|p.Q546L", "3512|4|gene|ncbi_gene@3845|KRAS", "1078|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "855|7|variant|litvar@rs1413493019##&&&litvar@#1956#|p.Q791H", "1698|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "742|8|variant|litvar@#5290#p.G1007V&&&litvar@#5290#|p.G1007V", "799|3|chemical||VAF", "1444|5|gene|ncbi_gene@4089|SMAD4", "3083|8|variant|litvar@rs876660754##&&&litvar@#7157#|c.400G>T", "2569|2|disease|ncbi_mesh@D010300|PD", "762|9|variant|litvar@#5290#c.3020G>T&&&litvar@#5290#|c.3020G>T", "3770|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "2871|4|gene|ncbi_gene@3845|KRAS", "2983|8|variant|litvar@rs876660754##&&&litvar@#7157#|c.400G>T", "3555|7|variant|litvar@rs774058987##&&&litvar@#7157#|p.Y129C", "3517|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "521|7|variant|litvar@#4089#p.Q256*&&&litvar@#4089#|p.Q256*", "3180|2|disease|ncbi_mesh@D010300|PD"], "figure_id": "t0002", "text_hl": "Patient # Sample Gene Symbol Amino Acid Change Variant Frequency (%) Detection Threshold Controls Codon Change Therapy Response ctDNA Dynamics versus CT Results   1 1st sample KRAS p.G12D 4.43 0.053 c.35G>A PD Unexpected (decrease of VAF in PD)     SMAD4 p.Y131D 1.84 0.008 c.392A>G     2nd sample KRAS p.G12D 2.01 0.053 c.35G>A      SMAD4 p.Y131D 0.00 0.008 c.392A>G    2 1st sample PIK3CA p.Q546L 4.40 0.000 c. 1637A>T PR Consistent     KRAS p.G12V 6.96 0.000 c.35G>T       TP53 p.R273H 1.91 0.050 c.818G>A       SMAD4 p.Q256* 0.00 0.061 c.766C>T      2nd sample PIK3CA p.Q546L 0.00 0.000 c. 1637A>T       KRAS p.G12V 0.00 0.000 c.35G>T       TP53 p.R273H 0.00 0.050 c.818G>A       SMAD4 p.Q256* 0.56 0.061 c.766C>T     3 1st sample PIK3CA p.G1007V 0.25 0.104 c.3020G>T SD Unexpected (increase of VAF and new variant in follow-up sample in SD)     EGFR p.Q791H 0.22 0.023 c.2373G>T      PDGFRA p.L839P 0.00 0.034 c.2516T>C     2nd sample PIK3CA p.G1007V 1.58 0.104 c.3020G>T      EGFR p.Q791H 1.50 0.023 c.2373G>T      PDGFRA p.L839P 1.25 0.034 c.2516T>C    4 1st sample KRAS p.G12R 1.37 0.015 c.34G>C PD unexpected (decrease of VAF in PD)     TP53 p.D208V 1.82 0.000 c.623_624delACinsTT     2nd sample KRAS p.G12R 0.19 0.015 c.34G>C      TP53 p.D208V 0.33 0.000 c.623_624delACinsTT    5 1st sample MET p.G1201V 2.06 0.212 c.3602G>T PD Consistent     SMAD4 p.R496H 0.00 0.035 c.1487G>A      2nd sample MET p.G1201V 0.00 0.212 c.3602G>T       SMAD4 p.R496H 0.43 0.035 c.1487G>A     6 1st sample SMAD4 p.R445* 0.17 0.062 c.1333C>T PD Consistent     CDKN2A p.Y129C 0.23 0.029 c.385A>G      2nd sample SMAD4 p.R445* 0.24 0.062 c.1333C>T       CDKN2A p.Y129C 0.48 0.029 c.385A>G     7 1st sample KRAS p.G12D 4.54 0.053 c.35G>A PR Consistent     TP53 p.P152T 1.66 0.000 c.454C>A       KRAS <m>p.A146T</m> 0.19 0.049 c.437C>T      2nd sample KRAS p.G12D 0.09 0.053 c.35G>A       TP53 p.P152T 0.00 0.000 c.454C>A       KRAS <m>p.A146T</m> 0.15 0.049 c.437C>T     8 1st sample KRAS p.G12V 0.79 0.000 c.35G>T SD Consistent    2nd sample KRAS p.G12V 0.17 0.000 c.35G>T     9 1st sample /     PR /    2nd sample /         10 1st sample KRAS p.G12V 0.87 0.000 c.35G>T PR Unexpected (stable VAF in PR)    2nd sample KRAS p.G12V 0.43 0.000 c.35G>T    11 1st sample KRAS p.G12D 0.41 0.053 c.35G>A PD Unexpected (decrease of VAF in PD)    2nd sample KRAS p.G12D 0.12 0.053 c.35G>A    12 1st sample KRAS <m>p.A146T</m> 0.24 0.049 c.437C>T SD Unexpected (mutation disappeared during therapy in stable disease)    2nd sample KRAS <m>p.A146T</m> 0.00 0.049 c.437C>T    13 1st sample KRAS p.Q61R 21.73 0.037 c.182A>G PD Unexpected (decrease of VAF in PD)     TP53 p.F212SfsTer3 16.58 0.000 c.635_636delTT     2nd sample KRAS p.Q61R 8.04 0.037 c.182A>G      TP53 p.F212SfsTer3 2.90 0.000 c.635_636delTT    14 1st sample KRAS p.G12R 15.18 0.015 c.34G>C SD Consistent     TP53 p.G245V 16.74 0.000 c.734G>T      2nd sample KRAS p.G12R 0.87 0.015 c.34G>C       TP53 p.G245V 1.67 0.000 c.734G>T     15 1st sample KRAS p.A134S 0.00 0.000 c.400G>T PD Consistent     TP53 p.Y126D 1.41 0.009 c.376T>G      2nd sample KRAS p.A134S 1.47 0.000 c.400G>T       TP53 p.Y126D 0.36 0.009 c.376T>G     16 1st sample KRAS p.G12D 2.79 0.053 c.35G>A PD Unexpected (decrease of VAF in PD)     TP53 p.R282W 1.32 0.090 c.844C>T     2nd sample KRAS p.G12D 1.83 0.053 c.35G>A      TP53 p.R282W 1.10 0.090 c.844C>T    17 1st sample KRAS p.G12R 0.85 0.015 c.34G>C SD Unexpected (mutations disappeared during therapy in stable disease)     CDKN2A p.Y129C 0.40 0.029 c.385A>G     2nd sample KRAS p.G12R 0.00 0.015 c.34G>C      CDKN2A p.Y129C 0.00 0.029 c.385A>G    18 1st sample /     PD /    2nd sample /         19 1st sample /     SD /    2nd sample /         20 1st sample /     SD /    2nd sample /         21 1st sample KRAS p.G12D 0.46 0.053 c.35G>A PD Unexpected (decrease of VAF in PD)     SMAD4 p.R135* 0.64 0.073 c.403C>T     2nd sample KRAS p.G12D 0.08 0.053 c.35G>A      SMAD4 p.R135* 0.00 0.073 c.403C>T    "}], "citations": {"NLM": "Balendran-Braun S, Kieler M, Liebmann-Reindl S, Unseld M, Bianconi D, W Prager G, Streubel B. Bead-Based Isolation of Circulating Tumor DNA from Pancreatic Cancer Patients Enables High Fidelity Next Generation Sequencing. Cancer Manag Res. PMID: 34393517", "BibTeX": "@article{34393517, title={Bead-Based Isolation of Circulating Tumor DNA from Pancreatic Cancer Patients Enables High Fidelity Next Generation Sequencing.}, author={Balendran-Braun S and Kieler M and Liebmann-Reindl S and Unseld M and Bianconi D and W Prager G and Streubel B}, journal={Cancer Manag Res}}"}, "is_sup_mat_match": false}, {"pmid": 35624529, "pmcid": "PMC9441000", "title": "High prevalence of unusual KRAS, NRAS, and BRAF mutations in POLE-hypermutated colorectal cancers.", "journal": "Mol Oncol", "authors": ["Favre L", "Cohen J", "Calderaro J", "P\u00e9criaux A", "Nguyen CT", "Bourgoin R", "Larnaudie L", "Dupuy A", "Ollier M", "Lechapt E", "Sloma I", "Tournigand C", "Rousseau B", "Pujals A"], "date": "2022-09-01T00:00:00Z", "year": 2022, "snippets": [{"_id": "35624529@15104", "snip_text": "But unlike classical CRC, POLE-mutated tumors were strongly associated with unusual mutations, which exhibit rare prevalence in these genes: 65% harbored noncodon 12 KRAS mutations (G13D; V14I; D57N; E98*; K117N; A146T; K147T/E or K170Q); 20% harbored noncodon 12 NRAS mutation (Q61R; E132K; R167*); 40% harbored a non-V600E BRAF mutation (F294L; Y633C; L312P; S602Y; Q356K; R354*; S102Y; L567V; R389C; F247L); 55% harbored a PIK3CA mutation.", "section": "results", "mentions": ["426|6|gene|ncbi_gene@5290|PIK3CA", "325|4|gene|ncbi_gene@673|BRAF", "389|5|variant|litvar@rs864622673##&&&litvar@#4292#&&&litvar@CA350026#rs864622673##|L567V", "285|5|variant|litvar@rs1456325880##&&&litvar@#4893#|E132K", "340|5|variant|litvar@#673#p.F294L&&&litvar@#673#|F294L", "279|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "39|6|disease|ncbi_mesh@D009369|tumors", "368|5|variant|litvar@#673#p.Q356K&&&litvar@#673#|Q356K", "361|5|variant|litvar@#673#p.S602Y&&&litvar@#673#|S602Y", "354|5|variant|litvar@rs63751202##&&&litvar@#4292#&&&litvar@CA339456#rs63751202##|L312P", "292|5|variant|litvar@#4893#p.R167*&&&litvar@#4893#|R167*", "403|5|variant|litvar@rs397516903##&&&litvar@#673#&&&litvar@CA295904#rs397516903##|F247L", "21|3|disease|ncbi_mesh@D015179|CRC", "396|5|variant|litvar@rs397507472##&&&litvar@#673#&&&litvar@CA281962#rs397507472##|R389C", "220|7|variant|litvar@rs387907206##&&&litvar@#3845#|K147T/E", "382|5|variant|litvar@#5290#p.S102Y&&&litvar@#5290#|S102Y", "206|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "375|5|variant|litvar@#673#p.R354*&&&litvar@#673#|R354*", "264|4|gene|ncbi_gene@4893|NRAS", "231|5|variant|litvar@#4893#p.K170Q&&&litvar@#4893#|K170Q", "26|4|gene|ncbi_gene@18973|POLE", "188|4|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|V14I", "319|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "213|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "166|4|gene|ncbi_gene@3845|KRAS", "182|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "347|5|variant|litvar@#673#p.Y633C&&&litvar@#673#|Y633C", "194|4|variant|litvar@rs1465850103##&&&litvar@#4893#|D57N"], "text_hl": "But unlike classical CRC, POLE-mutated tumors were strongly associated with unusual mutations, which exhibit rare prevalence in these genes: 65% harbored noncodon 12 KRAS mutations (G13D; V14I; D57N; E98*; K117N; <m>A146T</m>; K147T/E or K170Q); 20% harbored noncodon 12 NRAS mutation (Q61R; E132K; R167*); 40% harbored a non-V600E BRAF mutation (F294L; Y633C; L312P; S602Y; Q356K; R354*; S102Y; L567V; R389C; F247L); 55% harbored a PIK3CA mutation."}], "citations": {"NLM": "Favre L, Cohen J, Calderaro J, P\u00e9criaux A, Nguyen CT, Bourgoin R, Larnaudie L, Dupuy A, Ollier M, Lechapt E, Sloma I, Tournigand C, Rousseau B, Pujals A. High prevalence of unusual KRAS, NRAS, and BRAF mutations in POLE-hypermutated colorectal cancers. Mol Oncol. PMID: 35624529", "BibTeX": "@article{35624529, title={High prevalence of unusual KRAS, NRAS, and BRAF mutations in POLE-hypermutated colorectal cancers.}, author={Favre L and Cohen J and Calderaro J and P\u00e9criaux A and Nguyen CT and Bourgoin R and Larnaudie L and Dupuy A and Ollier M and Lechapt E and Sloma I and Tournigand C and Rousseau B and Pujals A}, journal={Mol Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 32415199, "pmcid": "PMC7229219", "title": "Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing.", "journal": "Sci Rep", "authors": ["Vessies DCL", "Greuter MJE", "van Rooijen KL", "Linders TC", "Lanfermeijer M", "Ramkisoensing KL", "Meijer GA", "Koopman M", "Coup\u00e9 VMH", "Vink GR", "Fijneman RJA", "van den Broek D"], "date": "2020-05-15T00:00:00Z", "year": 2020, "snippets": [{"_id": "32415199@15764", "snip_text": "Tissue KRAS resulta Months between tissue biopsy and blood collection total cfDNA analysed (ng)b Reported mutant copies (mAF)c ddPCR Idylla COBAS z480 BEAMing   KRAS p.G12_G12insAG Unknown 23.7 9 (0.12%) ntd nt nt KRAS p.G12X   KRAS p.G12V Unknown 23.0 1167 (15.4%) KRAS p.G12X/G13X KRAS p.G12V KRAS p.G12X KRAS p.G12X   KRAS p.A146T 9 17.3 106 (1.7%) nt KRAS p.A146T KRAS p.146x KRAS p.A146T   KRAS p.G12D 0 94.4 39 (0.13%) KRAS p.G12X/G13X KRAS p.G12D KRAS p.G12X KRAS p.G12X   KRAS p.G13D Unknown 8.1  nd nde KRAS p.G13D nd nd   KRAS p.G12V Unknown 167.0 4656 (8.5%) KRAS p.G12X/G13X KRAS p.G12V KRAS p.G12X KRAS p.G12X   KRAS p.G12C 5 10.1  nd nd nd nd nd   KRAS p.G12D 9 13.7  nd nd nd nd nd   KRAS p.G12D 20 8.2  nd nd KRAS p.G12D nd nd   KRAS p.G13D 22 10.2  nd nd nd nd nd   KRAS amplification Unknown 4.2  nd nt nt nt nt   Overall sensitivity (%)    38%f 67% 44% 50%   ", "section": "table", "mentions": ["466|4|gene|ncbi_gene@3845|KRAS", "214|4|gene|ncbi_gene@3845|KRAS", "228|4|gene|ncbi_gene@3845|KRAS", "283|4|gene|ncbi_gene@3845|KRAS", "630|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "783|4|gene|ncbi_gene@3845|KRAS", "480|4|gene|ncbi_gene@3845|KRAS", "575|6|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12X", "704|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "667|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "750|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "300|6|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12X", "380|4|gene|ncbi_gene@3845|KRAS", "447|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "582|4|variant|litvar@rs112445441##&&&litvar@#3845#|G13X", "385|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "616|6|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12X", "266|4|gene|ncbi_gene@3845|KRAS", "166|14|variant|litvar@#3845#p.AG12ins&&&litvar@#3845#|p.G12_G12insAG", "321|4|gene|ncbi_gene@3845|KRAS", "307|4|gene|ncbi_gene@3845|KRAS", "517|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "219|6|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12X", "454|4|gene|ncbi_gene@3845|KRAS", "532|4|gene|ncbi_gene@3845|KRAS", "587|4|gene|ncbi_gene@3845|KRAS", "604|6|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12X", "725|4|gene|ncbi_gene@3845|KRAS", "471|6|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12X", "233|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "395|4|gene|ncbi_gene@3845|KRAS", "161|4|gene|ncbi_gene@3845|KRAS", "611|4|gene|ncbi_gene@3845|KRAS", "485|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "662|4|gene|ncbi_gene@3845|KRAS", "437|4|variant|litvar@rs112445441##&&&litvar@#3845#|G13X", "430|6|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12X", "625|4|gene|ncbi_gene@3845|KRAS", "326|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "288|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "745|4|gene|ncbi_gene@3845|KRAS", "368|4|gene|ncbi_gene@3845|KRAS", "570|4|gene|ncbi_gene@3845|KRAS", "699|4|gene|ncbi_gene@3845|KRAS", "295|4|gene|ncbi_gene@3845|KRAS", "271|6|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12X", "442|4|gene|ncbi_gene@3845|KRAS", "537|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "312|6|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12X", "592|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "355|4|gene|ncbi_gene@3845|KRAS", "360|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "459|6|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12X", "730|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "599|4|gene|ncbi_gene@3845|KRAS", "512|4|gene|ncbi_gene@3845|KRAS", "278|4|variant|litvar@rs112445441##&&&litvar@#3845#|G13X", "7|4|gene|ncbi_gene@3845|KRAS", "425|4|gene|ncbi_gene@3845|KRAS", "400|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D"], "figure_id": "Tab2", "text_hl": "Tissue KRAS resulta Months between tissue biopsy and blood collection total cfDNA analysed (ng)b Reported mutant copies (mAF)c ddPCR Idylla COBAS z480 BEAMing   KRAS p.G12_G12insAG Unknown 23.7 9 (0.12%) ntd nt nt KRAS p.G12X   KRAS p.G12V Unknown 23.0 1167 (15.4%) KRAS p.G12X/G13X KRAS p.G12V KRAS p.G12X KRAS p.G12X   KRAS <m>p.A146T</m> 9 17.3 106 (1.7%) nt KRAS <m>p.A146T</m> KRAS p.146x KRAS <m>p.A146T</m>   KRAS p.G12D 0 94.4 39 (0.13%) KRAS p.G12X/G13X KRAS p.G12D KRAS p.G12X KRAS p.G12X   KRAS p.G13D Unknown 8.1  nd nde KRAS p.G13D nd nd   KRAS p.G12V Unknown 167.0 4656 (8.5%) KRAS p.G12X/G13X KRAS p.G12V KRAS p.G12X KRAS p.G12X   KRAS p.G12C 5 10.1  nd nd nd nd nd   KRAS p.G12D 9 13.7  nd nd nd nd nd   KRAS p.G12D 20 8.2  nd nd KRAS p.G12D nd nd   KRAS p.G13D 22 10.2  nd nd nd nd nd   KRAS amplification Unknown 4.2  nd nt nt nt nt   Overall sensitivity (%)    38%f 67% 44% 50%   "}], "citations": {"NLM": "Vessies DCL, Greuter MJE, van Rooijen KL, Linders TC, Lanfermeijer M, Ramkisoensing KL, Meijer GA, Koopman M, Coup\u00e9 VMH, Vink GR, Fijneman RJA, van den Broek D. Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing. Sci Rep. PMID: 32415199", "BibTeX": "@article{32415199, title={Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing.}, author={Vessies DCL and Greuter MJE and van Rooijen KL and Linders TC and Lanfermeijer M and Ramkisoensing KL and Meijer GA and Koopman M and Coup\u00e9 VMH and Vink GR and Fijneman RJA and van den Broek D}, journal={Sci Rep}}"}, "is_sup_mat_match": false}, {"pmid": 32300895, "pmcid": "PMC7162829", "title": "Metabolic characterization of colorectal cancer cells harbouring different KRAS mutations in codon 12, 13, 61 and 146 using human SW48 isogenic cell lines.", "journal": "Metabolomics", "authors": ["Varshavi D", "Varshavi D", "McCarthy N", "Veselkov K", "Keun HC", "Everett JR"], "date": "2020-04-16T00:00:00Z", "year": 2020, "snippets": [{"_id": "32300895@858", "snip_text": "METHODS: We applied an NMR-based metabonomics approach to compare the metabolic profiles of the intracellular extracts and the extracellular media from isogenic human SW48 CRC cell lines with different KRAS mutations in codons 12 (G12D, G12A, G12C, G12S, G12R, G12V), 13 (G13D), 61 (Q61H) and 146 (A146T) with their wild-type counterpart.", "section": "abstract", "mentions": ["237|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "243|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "249|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "272|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "261|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "283|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "161|5|species|ncbi_taxonomy@9606|human", "255|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "167|4|cellline||SW48", "298|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "231|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "202|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "METHODS: We applied an NMR-based metabonomics approach to compare the metabolic profiles of the intracellular extracts and the extracellular media from isogenic human SW48 CRC cell lines with different KRAS mutations in codons 12 (G12D, G12A, G12C, G12S, G12R, G12V), 13 (G13D), 61 (Q61H) and 146 (<m>A146T</m>) with their wild-type counterpart."}], "citations": {"NLM": "Varshavi D, Varshavi D, McCarthy N, Veselkov K, Keun HC, Everett JR. Metabolic characterization of colorectal cancer cells harbouring different KRAS mutations in codon 12, 13, 61 and 146 using human SW48 isogenic cell lines. Metabolomics. PMID: 32300895", "BibTeX": "@article{32300895, title={Metabolic characterization of colorectal cancer cells harbouring different KRAS mutations in codon 12, 13, 61 and 146 using human SW48 isogenic cell lines.}, author={Varshavi D and Varshavi D and McCarthy N and Veselkov K and Keun HC and Everett JR}, journal={Metabolomics}}"}, "is_sup_mat_match": false}, {"pmid": 29854313, "pmcid": "PMC5978263", "title": "Simultaneous identification of clinically relevant single nucleotide variants, copy number alterations and gene fusions in solid tumors by targeted next-generation sequencing", "journal": "Oncotarget", "authors": ["Oliveira DM", "Mirante T", "Mignogna C", "Scrima M", "Migliozzi S", "Rocco G", "Franco R", "Corcione F", "Viglietto G", "Malanga D", "Rizzuto A"], "date": "2018-04-27T00:00:00Z", "year": 2018, "snippets": [{"_id": "29854313@8445", "snip_text": "Patient\tSNV\tAlleleFrequency\tValidation (Sequencing)\tCNA\tValidation (RT-PCR)\tFusion\t \tCC1\tBRAF-V600E\t32%\tSanger\t\t\t\t \tCC2\tMTOR-T1977KKRAS-G12D\t7,5%16%\t\t\t\t\t \tCC3\t\t\t\t\t\t\t \tCC4\tKRAS-A146T\t8%\t\tFGFR1 (5)\tYes\t\t \tCC5\tKRAS-G12C\t14%\t\t\t\t\t \tCC6\tPIK3CA-E542KKRAS-G12V\t30%49%\tSangerSanger\t\t\t\t \tCC7\tPIK3CA-H1047RBRAF-V600E\t23%22.5%\tSanger\t\t\t\t \tCC8\tPIK3CA-G1049CBRAF-V600E\t20%19%\tSangerSanger\t\t\t\t \tCC9\t\t\t\t\t\t\t \tCC10\t\t\t\t\t\t\t \tCC11\tKRAS-A146T\t44.5%\t\t\t\t\t \tCC12\tNRAS-G61K\t25%\t\t\t\t\t \tCC13\t\t\tNGS Panel**\t\t\t\t \tCC14\t\t\t\t\t\t\t \tCC15\t\t\t\t\t\t\t \tCC16\tPIK3CA-H1047YBRAF-V600E\t16.5%9%\t\t\t\t\t \tCC17\tKRAS-G12SPIK3CA-E542K\t37.5%39%\t\t\t\t\t \tCC18\tKRAS-G12V\t37.5%\t\t\t\t\t \tCC19\tKRAS-A146T\t57%\t\t\t\t\t \tCC20\t\t\t\t\t\t\t \tCC21\t\t\tNGS Panel\t\t\t\t \tCC22\t\t\t\t\t\t\t \tCC23\t\t\t\t\t\t\t \tCC24\tKRAS-G12VPIK3CA-E545K\t31%39%\t\t\t\t\t \tCC25\tKRAS-G13D\t15%\t\t\t\t\t \tCC26\tKRAS-G12AERBB3-G332K\t15%5.5%\t\t\t\t\t \tCC27\t\t\t\t\t\t\t \tCC28\tKRAS-G12SEGFR-G719DNRAS-G61K\t33%10%38%\tSanger\t\t\t\t \tCC29\tKRAS-G13DPIK3CA-E545K\t31%36%\t\t\t\t\t \tCC30\tRET-A883VKRAS-G12DAKT1-E17K\t9%37%11%\t\t\t\t\t \tCC31\tKRAS-G13DKRAS-A146T\t10%38%\t\t\t\t\t \t", "section": "table", "mentions": ["443|4|variant|litvar@#4893#p.G61K&&&litvar@#4893#|G61K", "349|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "949|4|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|E17K", "282|6|gene|ncbi_gene@5290|PIK3CA", "830|4|gene|ncbi_gene@3845|KRAS", "752|4|gene|ncbi_gene@3845|KRAS", "940|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "988|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "886|4|gene|ncbi_gene@3845|KRAS", "630|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "415|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "207|4|gene|ncbi_gene@3845|KRAS", "176|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "300|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "854|4|variant|litvar@#4893#p.G61K&&&litvar@#4893#|G61K", "926|3|gene|ncbi_gene@5979|RET", "186|5|gene|ncbi_gene@2260|FGFR1", "212|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "712|4|gene|ncbi_gene@3845|KRAS", "974|4|gene|ncbi_gene@3845|KRAS", "598|4|gene|ncbi_gene@3845|KRAS", "94|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "120|4|gene|ncbi_gene@2475|MTOR", "513|6|gene|ncbi_gene@5290|PIK3CA", "625|4|gene|ncbi_gene@3845|KRAS", "728|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "792|5|variant|litvar@rs869320694##&&&litvar@#2260#|G332K", "979|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "572|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "556|4|gene|ncbi_gene@3845|KRAS", "410|4|gene|ncbi_gene@3845|KRAS", "717|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "902|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "171|4|gene|ncbi_gene@3845|KRAS", "777|4|gene|ncbi_gene@3845|KRAS", "531|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "603|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "331|6|gene|ncbi_gene@5290|PIK3CA", "438|4|gene|ncbi_gene@4893|NRAS", "231|6|gene|ncbi_gene@5290|PIK3CA"], "figure_id": "T3", "text_hl": "Patient\tSNV\tAlleleFrequency\tValidation (Sequencing)\tCNA\tValidation (RT-PCR)\tFusion\t \tCC1\tBRAF-V600E\t32%\tSanger\t\t\t\t \tCC2\tMTOR-T1977KKRAS-G12D\t7,5%16%\t\t\t\t\t \tCC3\t\t\t\t\t\t\t \tCC4\tKRAS-<m>A146T</m>\t8%\t\tFGFR1 (5)\tYes\t\t \tCC5\tKRAS-G12C\t14%\t\t\t\t\t \tCC6\tPIK3CA-E542KKRAS-G12V\t30%49%\tSangerSanger\t\t\t\t \tCC7\tPIK3CA-H1047RBRAF-V600E\t23%22.5%\tSanger\t\t\t\t \tCC8\tPIK3CA-G1049CBRAF-V600E\t20%19%\tSangerSanger\t\t\t\t \tCC9\t\t\t\t\t\t\t \tCC10\t\t\t\t\t\t\t \tCC11\tKRAS-<m>A146T</m>\t44.5%\t\t\t\t\t \tCC12\tNRAS-G61K\t25%\t\t\t\t\t \tCC13\t\t\tNGS Panel**\t\t\t\t \tCC14\t\t\t\t\t\t\t \tCC15\t\t\t\t\t\t\t \tCC16\tPIK3CA-H1047YBRAF-V600E\t16.5%9%\t\t\t\t\t \tCC17\tKRAS-G12SPIK3CA-E542K\t37.5%39%\t\t\t\t\t \tCC18\tKRAS-G12V\t37.5%\t\t\t\t\t \tCC19\tKRAS-<m>A146T</m>\t57%\t\t\t\t\t \tCC20\t\t\t\t\t\t\t \tCC21\t\t\tNGS Panel\t\t\t\t \tCC22\t\t\t\t\t\t\t \tCC23\t\t\t\t\t\t\t \tCC24\tKRAS-G12VPIK3CA-E545K\t31%39%\t\t\t\t\t \tCC25\tKRAS-G13D\t15%\t\t\t\t\t \tCC26\tKRAS-G12AERBB3-G332K\t15%5.5%\t\t\t\t\t \tCC27\t\t\t\t\t\t\t \tCC28\tKRAS-G12SEGFR-G719DNRAS-G61K\t33%10%38%\tSanger\t\t\t\t \tCC29\tKRAS-G13DPIK3CA-E545K\t31%36%\t\t\t\t\t \tCC30\tRET-A883VKRAS-G12DAKT1-E17K\t9%37%11%\t\t\t\t\t \tCC31\tKRAS-G13DKRAS-<m>A146T</m>\t10%38%\t\t\t\t\t \t"}], "citations": {"NLM": "Oliveira DM, Mirante T, Mignogna C, Scrima M, Migliozzi S, Rocco G, Franco R, Corcione F, Viglietto G, Malanga D, Rizzuto A. Simultaneous identification of clinically relevant single nucleotide variants, copy number alterations and gene fusions in solid tumors by targeted next-generation sequencing Oncotarget. PMID: 29854313", "BibTeX": "@article{29854313, title={Simultaneous identification of clinically relevant single nucleotide variants, copy number alterations and gene fusions in solid tumors by targeted next-generation sequencing}, author={Oliveira DM and Mirante T and Mignogna C and Scrima M and Migliozzi S and Rocco G and Franco R and Corcione F and Viglietto G and Malanga D and Rizzuto A}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 32815783, "title": "Mediastinal Germ Cell Tumor and Acute Megakaryoblastic Leukemia With Co-occurring KRAS Mutation and Complex Cytogenetics.", "journal": "Pediatr Dev Pathol", "authors": ["Amra N", "Zarate LV", "Punia JN", "Mahajan P", "Stevens AM", "Roy A", "Curry CV", "Cortes-Santiago N", "Fisher KE"], "date": "2020-11-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "32815783@700", "snip_text": "Next-generation sequencing revealed identical KRAS Proto-Oncogene, GTPase (KRAS) p.Ala146Thr, TP53 p.Leu257Pro, and PTEN p.Leu181Pro missense mutations at similar variant allele frequencies in both the NSGCT and AMKL samples.", "section": "abstract", "mentions": ["81|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "202|5|disease|ncbi_mesh@C537844|NSGCT", "46|4|gene|ncbi_gene@3845|KRAS", "116|4|gene|ncbi_gene@5728|PTEN", "121|11|variant|litvar@#5728#p.L181P&&&litvar@#5728#|p.Leu181Pro", "94|4|gene|ncbi_gene@7157|TP53", "212|4|disease|ncbi_mesh@D007947|AMKL", "75|4|gene|ncbi_gene@3845|KRAS", "99|11|variant|litvar@rs28934577##&&&litvar@#7157#|p.Leu257Pro"], "text_hl": "Next-generation sequencing revealed identical KRAS Proto-Oncogene, GTPase (KRAS) <m>p.Ala146Thr</m>, TP53 p.Leu257Pro, and PTEN p.Leu181Pro missense mutations at similar variant allele frequencies in both the NSGCT and AMKL samples."}], "citations": {"NLM": "Amra N, Zarate LV, Punia JN, Mahajan P, Stevens AM, Roy A, Curry CV, Cortes-Santiago N, Fisher KE. Mediastinal Germ Cell Tumor and Acute Megakaryoblastic Leukemia With Co-occurring KRAS Mutation and Complex Cytogenetics. Pediatr Dev Pathol. PMID: 32815783", "BibTeX": "@article{32815783, title={Mediastinal Germ Cell Tumor and Acute Megakaryoblastic Leukemia With Co-occurring KRAS Mutation and Complex Cytogenetics.}, author={Amra N and Zarate LV and Punia JN and Mahajan P and Stevens AM and Roy A and Curry CV and Cortes-Santiago N and Fisher KE}, journal={Pediatr Dev Pathol}}"}, "is_sup_mat_match": false}, {"pmid": 25065594, "pmcid": "PMC4836617", "title": "Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey", "journal": "Oncogene", "authors": ["Park JT", "Johnson N", "Liu S", "Levesque M", "Wang YJ", "Ho H", "Huso D", "Maitra A", "Parsons MJ", "Prescott JD", "Leach SD"], "date": "2015-05-21T00:00:00Z", "year": 2015, "snippets": [{"_id": "25065594@751", "snip_text": "This system allowed us to rapidly compare the ability of 12 different KRAS mutations (G12A, G12C, G12D, G12F, G12R, G12S, G12V, G13C, G13D, Q61L, Q61R, and A146T) to drive pancreatic tumorigenesis in vivo.", "section": "abstract", "mentions": ["110|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "98|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "146|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "156|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "70|4|gene|ncbi_gene@3845|KRAS", "116|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "134|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "122|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "92|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "128|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "86|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "140|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "104|4|variant|litvar@rs121913529##&&&litvar@#3845#|G12F"], "text_hl": "This system allowed us to rapidly compare the ability of 12 different KRAS mutations (G12A, G12C, G12D, G12F, G12R, G12S, G12V, G13C, G13D, Q61L, Q61R, and <m>A146T</m>) to drive pancreatic tumorigenesis in vivo."}], "citations": {"NLM": "Park JT, Johnson N, Liu S, Levesque M, Wang YJ, Ho H, Huso D, Maitra A, Parsons MJ, Prescott JD, Leach SD. Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey Oncogene. PMID: 25065594", "BibTeX": "@article{25065594, title={Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey}, author={Park JT and Johnson N and Liu S and Levesque M and Wang YJ and Ho H and Huso D and Maitra A and Parsons MJ and Prescott JD and Leach SD}, journal={Oncogene}}"}, "is_sup_mat_match": false}, {"pmid": 26137573, "pmcid": "PMC4486202", "title": "Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study.", "journal": "EBioMedicine", "authors": ["Yoshino T", "Muro K", "Yamaguchi K", "Nishina T", "Denda T", "Kudo T", "Okamoto W", "Taniguchi H", "Akagi K", "Kajiwara T", "Hironaka S", "Satoh T"], "date": "2015-02-14T00:00:00Z", "year": 2015, "snippets": [{"_id": "26137573@10945", "snip_text": "Thus, using RASKET KIT, we examined twelve types of RAS exon 2 (G12S, G12C, G12R, G12D, G12V, G12A, G13S, G13C, G13R, G13D, G13V, and G13A), eight types of RAS exon 3 (A59T, A59G, Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H), and four types of RAS exon 4 (K117N, A146T, A146P, and A146V) mutations, simultaneously (Table S2).", "section": "methods", "mentions": ["214|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "134|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13A", "198|4|variant|litvar@rs557317141##&&&litvar@#3815#&&&litvar@CA2923183#rs557317141##|Q61P", "118|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "192|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "88|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "258|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "124|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "100|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA16602445#rs121913535##|G13S", "276|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "251|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "70|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "112|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "265|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "82|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "64|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "19|3|gene|ncbi_gene@3815|KIT", "204|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "76|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "174|4|variant|litvar@rs763572530##&&&litvar@#1956#|A59G", "94|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "168|4|variant|litvar@rs747004948##&&&litvar@#3815#&&&litvar@CA2923181#rs747004948##|A59T", "186|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "106|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "180|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K"], "text_hl": "Thus, using RASKET KIT, we examined twelve types of RAS exon 2 (G12S, G12C, G12R, G12D, G12V, G12A, G13S, G13C, G13R, G13D, G13V, and G13A), eight types of RAS exon 3 (A59T, A59G, Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H), and four types of RAS exon 4 (K117N, <m>A146T</m>, A146P, and A146V) mutations, simultaneously (Table S2)."}], "citations": {"NLM": "Yoshino T, Muro K, Yamaguchi K, Nishina T, Denda T, Kudo T, Okamoto W, Taniguchi H, Akagi K, Kajiwara T, Hironaka S, Satoh T. Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study. EBioMedicine. PMID: 26137573", "BibTeX": "@article{26137573, title={Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study.}, author={Yoshino T and Muro K and Yamaguchi K and Nishina T and Denda T and Kudo T and Okamoto W and Taniguchi H and Akagi K and Kajiwara T and Hironaka S and Satoh T}, journal={EBioMedicine}}"}, "is_sup_mat_match": false}, {"pmid": 24006859, "pmcid": "PMC3844320", "title": "Simultaneous identification of 36 mutations in KRAS codons 61and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kit", "journal": "BMC Cancer", "authors": ["Bando H", "Yoshino T", "Shinozaki E", "Nishina T", "Yamazaki K", "Yamaguchi K", "Yuki S", "Kajiura S", "Fujii S", "Yamanaka T", "Tsuchihara K", "Ohtsu A"], "date": "2013-09-03T00:00:00Z", "year": 2013, "snippets": [{"_id": "24006859@7694", "snip_text": "A total of 36 mutations of KRAS codon 61 (Q61K, Q61E, Q61L, Q61P, Q61R, Q61H), KRAS codon 146 (A146T, A146S, A146P, A146E, A146V, A146G), BRAF codon 600 (V600E), NRAS codon 12 (G12S, G12C, G12R, G12D, G12V, G12A), codon 13 (G13S, G13C, G13R, G13D, G13V, G13A), codon 61 (Q61K, Q61E, Q61L, Q61P, Q61R, Q61H), PIK3CA exon 9 codon 542 (E542K), codon 545 (E545K), codon 546 (E546K), and exon 20 codon 1047 (H1047R, H1047L) were analyzed using Luminex (xMAP) technology (GENOSEARCH Mu-PACK, MBL, Japan).", "section": "methods", "mentions": ["177|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "371|5|variant|litvar@#5290#p.E546K&&&litvar@#5290#|E546K", "72|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "283|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "301|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "242|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "411|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|H1047L", "27|4|gene|ncbi_gene@3845|KRAS", "183|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "224|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA16602674#rs121434595##|G13S", "54|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "102|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146S", "201|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "289|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "116|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146E", "60|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "207|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "271|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "248|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "130|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146G", "138|4|gene|ncbi_gene@673|BRAF", "403|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "189|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "230|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13C", "79|4|gene|ncbi_gene@3845|KRAS", "154|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "162|4|gene|ncbi_gene@4893|NRAS", "42|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "333|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "277|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "254|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602364#rs121434596##|G13A", "295|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "352|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "95|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "48|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "66|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "195|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "308|6|gene|ncbi_gene@5290|PIK3CA", "236|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "123|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "109|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P"], "text_hl": "A total of 36 mutations of KRAS codon 61 (Q61K, Q61E, Q61L, Q61P, Q61R, Q61H), KRAS codon 146 (<m>A146T</m>, A146S, A146P, A146E, A146V, A146G), BRAF codon 600 (V600E), NRAS codon 12 (G12S, G12C, G12R, G12D, G12V, G12A), codon 13 (G13S, G13C, G13R, G13D, G13V, G13A), codon 61 (Q61K, Q61E, Q61L, Q61P, Q61R, Q61H), PIK3CA exon 9 codon 542 (E542K), codon 545 (E545K), codon 546 (E546K), and exon 20 codon 1047 (H1047R, H1047L) were analyzed using Luminex (xMAP) technology (GENOSEARCH Mu-PACK, MBL, Japan)."}], "citations": {"NLM": "Bando H, Yoshino T, Shinozaki E, Nishina T, Yamazaki K, Yamaguchi K, Yuki S, Kajiura S, Fujii S, Yamanaka T, Tsuchihara K, Ohtsu A. Simultaneous identification of 36 mutations in KRAS codons 61and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kit BMC Cancer. PMID: 24006859", "BibTeX": "@article{24006859, title={Simultaneous identification of 36 mutations in KRAS codons 61and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kit}, author={Bando H and Yoshino T and Shinozaki E and Nishina T and Yamazaki K and Yamaguchi K and Yuki S and Kajiura S and Fujii S and Yamanaka T and Tsuchihara K and Ohtsu A}, journal={BMC Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 31572061, "pmcid": "PMC6757372", "title": "Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases.", "journal": "Cancer Cell Int", "authors": ["Fassan M", "Vianello L", "Sacchi D", "Fanelli GN", "Munari G", "Scarpa M", "Cappellesso R", "Loupakis F", "Lanza C", "Salmaso R", "Mescoli C", "Valeri N", "Agostini M", "D'Angelo E", "Lonardi S", "Pucciarelli S", "Veronese N", "Luchini C", "Rugge M"], "date": "2019-09-24T00:00:00Z", "year": 2019, "snippets": [{"_id": "31572061@549", "snip_text": "b Representative Sequenom MassArray output profiles for KRAS c.436G> A (p.A146T), PIK3CA c.1634A>C (p.E545A), BRAF c1799T>A (p.V600E) and NRAS c.35G>A (p.G12D) mutations.", "section": "figure_legend", "mentions": ["110|4|gene|ncbi_gene@673|BRAF", "82|6|gene|ncbi_gene@5290|PIK3CA", "138|4|gene|ncbi_gene@4893|NRAS", "89|9|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123342#rs121913274##|c.1634A>C", "115|8|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c1799T>A", "152|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "125|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "143|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G>A", "61|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G> A", "100|7|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123342#rs121913274##|p.E545A", "56|4|gene|ncbi_gene@3845|KRAS", "72|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T"], "figure_id": "Fig2", "text_hl": "b Representative Sequenom MassArray output profiles for KRAS c.436G> A (<m>p.A146T</m>), PIK3CA c.1634A>C (p.E545A), BRAF c1799T>A (p.V600E) and NRAS c.35G>A (p.G12D) mutations."}], "citations": {"NLM": "Fassan M, Vianello L, Sacchi D, Fanelli GN, Munari G, Scarpa M, Cappellesso R, Loupakis F, Lanza C, Salmaso R, Mescoli C, Valeri N, Agostini M, D'Angelo E, Lonardi S, Pucciarelli S, Veronese N, Luchini C, Rugge M. Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases. Cancer Cell Int. PMID: 31572061", "BibTeX": "@article{31572061, title={Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases.}, author={Fassan M and Vianello L and Sacchi D and Fanelli GN and Munari G and Scarpa M and Cappellesso R and Loupakis F and Lanza C and Salmaso R and Mescoli C and Valeri N and Agostini M and D'Angelo E and Lonardi S and Pucciarelli S and Veronese N and Luchini C and Rugge M}, journal={Cancer Cell Int}}"}, "is_sup_mat_match": false}, {"pmid": 27900004, "pmcid": "PMC5103950", "title": "Role of specific DNA mutations in the peripheral blood of colorectal cancer patients for the assessment of tumor stage and residual disease following tumor resection", "journal": "Oncol Lett", "authors": ["Norcic G", "Jelenc F", "Cerkovnik P", "Stegel V", "Novakovic S"], "date": "2016-11-01T00:00:00Z", "year": 2016, "snippets": [{"_id": "27900004@27187", "snip_text": "Gene\tExon\tNt change\taa change\t \tKRAS\t2\tc.34G>C\tp.Gly12Arg\t \t\t\tc.34G>T\tp.Gly12Cys\t \t\t\tc.34G>A\tp.Gly12Ser\t \t\t\tc.35G>T\tp.Gly12Val\t \t\t\tc.35G>C\tp.Gly12Ala\t \t\t\tc.35G>A\tp.Gly12Asp\t \t\t\tc.38G>A\tp.Gly13Asp\t \t\t3\tc.182A>G\tp.Gln61Arg\t \t\t\tc.183A>C\tp.Gln61His\t \t\t\tc.183A>T\tp.Gln61His\t \t\t\tc.182A>T\tp.Gln61Leu\t \t\t4\tc.351A>C\t  p.Lys117Asn\t \t\t\tc.351A>T\t  p.Lys117Asn\t \t\t\tc.350A>G\t  p.Lys117Arg\t \t\t\tc.349A>G\t  p.Lys117Glu\t \t\t\tc.436G>A\t  p.Ala146Thr\t \t\t\tc.436G>C\t  p.Ala146Pro\t \t\t\tc.437C>T\t  p.Ala146Val\t \tBRAF\t15\tc.1799T>A\t  p.Val600Glu\t \t", "section": "table", "mentions": ["201|8|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|c.182A>G", "273|8|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|c.182A>T", "417|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "177|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "298|8|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|c.351A>C", "108|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "154|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "390|11|variant|litvar@rs755475967##&&&litvar@#673#|p.Lys117Glu", "225|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA180922#rs17851045##|c.183A>C", "379|8|variant|litvar@rs755475967##&&&litvar@#673#&&&litvar@CA4516982#rs755475967##|c.349A>G", "485|4|gene|ncbi_gene@673|BRAF", "505|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.Val600Glu", "363|11|variant|litvar@rs755475967##&&&litvar@#673#|p.Lys117Arg", "444|11|variant|litvar@rs121913527##&&&litvar@#3845#|p.Ala146Pro", "493|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "471|11|variant|litvar@rs1057519725##&&&litvar@#3845#|p.Ala146Val", "336|11|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.Lys117Asn", "39|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>C", "352|8|variant|litvar@rs755475967##&&&litvar@#673#&&&litvar@CA4516982#rs755475967##|c.350A>G", "32|4|gene|ncbi_gene@3845|KRAS", "433|8|variant|litvar@rs121913527##&&&litvar@#3845#|c.436G>C", "249|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|c.183A>T", "460|8|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C>T", "131|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>C", "325|8|variant|litvar@rs770248150##&&&litvar@#3845#|c.351A>T", "85|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G>A", "309|11|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.Lys117Asn", "406|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "62|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>T"], "figure_id": "tI-ol-0-0-5078", "text_hl": "Gene\tExon\tNt change\taa change\t \tKRAS\t2\tc.34G>C\tp.Gly12Arg\t \t\t\tc.34G>T\tp.Gly12Cys\t \t\t\tc.34G>A\tp.Gly12Ser\t \t\t\tc.35G>T\tp.Gly12Val\t \t\t\tc.35G>C\tp.Gly12Ala\t \t\t\tc.35G>A\tp.Gly12Asp\t \t\t\tc.38G>A\tp.Gly13Asp\t \t\t3\tc.182A>G\tp.Gln61Arg\t \t\t\tc.183A>C\tp.Gln61His\t \t\t\tc.183A>T\tp.Gln61His\t \t\t\tc.182A>T\tp.Gln61Leu\t \t\t4\tc.351A>C\t  p.Lys117Asn\t \t\t\tc.351A>T\t  p.Lys117Asn\t \t\t\tc.350A>G\t  p.Lys117Arg\t \t\t\tc.349A>G\t  p.Lys117Glu\t \t\t\tc.436G>A\t  <m>p.Ala146Thr</m>\t \t\t\tc.436G>C\t  p.Ala146Pro\t \t\t\tc.437C>T\t  p.Ala146Val\t \tBRAF\t15\tc.1799T>A\t  p.Val600Glu\t \t"}], "citations": {"NLM": "Norcic G, Jelenc F, Cerkovnik P, Stegel V, Novakovic S. Role of specific DNA mutations in the peripheral blood of colorectal cancer patients for the assessment of tumor stage and residual disease following tumor resection Oncol Lett. PMID: 27900004", "BibTeX": "@article{27900004, title={Role of specific DNA mutations in the peripheral blood of colorectal cancer patients for the assessment of tumor stage and residual disease following tumor resection}, author={Norcic G and Jelenc F and Cerkovnik P and Stegel V and Novakovic S}, journal={Oncol Lett}}"}, "is_sup_mat_match": false}, {"pmid": 33042833, "pmcid": "PMC7517330", "title": "Targeting the Mutational Landscape of Bystander Cells: Drug-Promoted Blood Cancer From High-Prevalence Pre-neoplasias in Patients on BRAF Inhibitors.", "journal": "Front Oncol", "authors": ["Simnica D", "Ittrich H", "Bockemeyer C", "Stein A", "Binder M"], "date": "2020-09-11T00:00:00Z", "year": 2020, "snippets": [{"_id": "33042833@10450", "snip_text": "This analysis showed that two of eleven (18%) MBL cases harbored activating RAS mutations (HRAS G13S and KRAS A146T).", "section": "results", "mentions": ["96|4|variant|litvar@rs104894228##&&&litvar@#3265#&&&litvar@CA16602769#rs104894228##|G13S", "105|4|gene|ncbi_gene@3845|KRAS", "91|4|gene|ncbi_gene@3265|HRAS", "110|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "46|3|disease|ncbi_mesh@D015448|MBL"], "text_hl": "This analysis showed that two of eleven (18%) MBL cases harbored activating RAS mutations (HRAS G13S and KRAS <m>A146T</m>)."}], "citations": {"NLM": "Simnica D, Ittrich H, Bockemeyer C, Stein A, Binder M. Targeting the Mutational Landscape of Bystander Cells: Drug-Promoted Blood Cancer From High-Prevalence Pre-neoplasias in Patients on BRAF Inhibitors. Front Oncol. PMID: 33042833", "BibTeX": "@article{33042833, title={Targeting the Mutational Landscape of Bystander Cells: Drug-Promoted Blood Cancer From High-Prevalence Pre-neoplasias in Patients on BRAF Inhibitors.}, author={Simnica D and Ittrich H and Bockemeyer C and Stein A and Binder M}, journal={Front Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 30562355, "pmcid": "PMC6298683", "title": "Analysis of KRAS, NRAS and BRAF mutational profile by combination of in-tube hybridization and universal tag-microarray in tumor tissue and plasma of colorectal cancer patients.", "journal": "PLoS One", "authors": ["Damin F", "Galbiati S", "Soriani N", "Burgio V", "Ronzoni M", "Ferrari M", "Chiari M"], "date": "2018-12-18T00:00:00Z", "year": 2018, "snippets": [{"_id": "30562355@7864", "snip_text": "To prove the assay specificity of all the 22 mutations analyzed that is KRAS codon 12 (G12A, G12C, G12D, G12R, G12S, G12V), 13 (G13D), 61 (Q61H - A>C and A>T-, Q61K, Q61L, Q61R) and 146 (A146T), NRAS codon 12 (G12A, G12C, G12D, G12S, G12V) and 13 (G13D, G13R, G13V) and BRAF codon 15 (V600E), we used the heterozygous reference standards by Diatech Pharmacogenetics with the exception of the mutations KRAS Q61R, Q61H (A>T), Q61K, A146T and NRAS G12A, G12C, G12S, G12V, G13R and G13V where the references were not available.", "section": "methods", "mentions": ["402|4|gene|ncbi_gene@3845|KRAS", "419|3|variant|litvar@#3845#|A>T", "99|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "72|4|gene|ncbi_gene@3845|KRAS", "228|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "285|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "260|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "407|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "458|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "210|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "270|4|gene|ncbi_gene@673|BRAF", "160|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "128|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "154|3|variant|litvar@#3845#|A>T", "105|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "413|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "87|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "216|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "248|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "441|4|gene|ncbi_gene@4893|NRAS", "234|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "446|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "93|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "111|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "166|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "464|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "146|3|variant|litvar@#4893#|A>C", "139|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "470|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "254|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "479|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "222|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "187|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "195|4|gene|ncbi_gene@4893|NRAS", "452|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "172|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "431|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "117|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "425|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K"], "text_hl": "To prove the assay specificity of all the 22 mutations analyzed that is KRAS codon 12 (G12A, G12C, G12D, G12R, G12S, G12V), 13 (G13D), 61 (Q61H - A>C and A>T-, Q61K, Q61L, Q61R) and 146 (<m>A146T</m>), NRAS codon 12 (G12A, G12C, G12D, G12S, G12V) and 13 (G13D, G13R, G13V) and BRAF codon 15 (V600E), we used the heterozygous reference standards by Diatech Pharmacogenetics with the exception of the mutations KRAS Q61R, Q61H (A>T), Q61K, <m>A146T</m> and NRAS G12A, G12C, G12S, G12V, G13R and G13V where the references were not available."}], "citations": {"NLM": "Damin F, Galbiati S, Soriani N, Burgio V, Ronzoni M, Ferrari M, Chiari M. Analysis of KRAS, NRAS and BRAF mutational profile by combination of in-tube hybridization and universal tag-microarray in tumor tissue and plasma of colorectal cancer patients. PLoS One. PMID: 30562355", "BibTeX": "@article{30562355, title={Analysis of KRAS, NRAS and BRAF mutational profile by combination of in-tube hybridization and universal tag-microarray in tumor tissue and plasma of colorectal cancer patients.}, author={Damin F and Galbiati S and Soriani N and Burgio V and Ronzoni M and Ferrari M and Chiari M}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 27167191, "pmcid": "PMC5129956", "title": "Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models.", "journal": "Oncotarget", "authors": ["Lee MS", "Helms TL", "Feng N", "Gay J", "Chang QE", "Tian F", "Wu JY", "Toniatti C", "Heffernan TP", "Powis G", "Kwong LN", "Kopetz S"], "date": "2016-06-28T00:00:00Z", "year": 2016, "snippets": [{"_id": "27167191@17638", "snip_text": "(D), Xenografts implanted with patient-derived CRC cells harboring KRAS A146T mutation were treated with vehicle control daily, palbociclib 100 mg/kg daily, trametinib 3 mg/kg every 2 days, or palbociclib 100 mg/kg daily + trametinib 3 mg/kg every 2 days, and tumor volume was measured twice per week.", "section": "figure_legend", "mentions": ["193|11|chemical|ncbi_mesh@C500026|palbociclib", "260|5|disease|ncbi_mesh@D009369|tumor", "47|3|disease|ncbi_mesh@D015179|CRC", "223|10|chemical|ncbi_mesh@C560077|trametinib", "157|10|chemical|ncbi_mesh@C560077|trametinib", "72|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "67|4|gene|ncbi_gene@3845|KRAS", "128|11|chemical|ncbi_mesh@C500026|palbociclib", "31|7|species|ncbi_taxonomy@9606|patient"], "figure_id": "F5", "text_hl": "(D), Xenografts implanted with patient-derived CRC cells harboring KRAS <m>A146T</m> mutation were treated with vehicle control daily, palbociclib 100 mg/kg daily, trametinib 3 mg/kg every 2 days, or palbociclib 100 mg/kg daily + trametinib 3 mg/kg every 2 days, and tumor volume was measured twice per week."}], "citations": {"NLM": "Lee MS, Helms TL, Feng N, Gay J, Chang QE, Tian F, Wu JY, Toniatti C, Heffernan TP, Powis G, Kwong LN, Kopetz S. Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models. Oncotarget. PMID: 27167191", "BibTeX": "@article{27167191, title={Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models.}, author={Lee MS and Helms TL and Feng N and Gay J and Chang QE and Tian F and Wu JY and Toniatti C and Heffernan TP and Powis G and Kwong LN and Kopetz S}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 34162980, "pmcid": "PMC8222375", "title": "A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial.", "journal": "NPJ Precis Oncol", "authors": ["Petak I", "Kamal M", "Dirner A", "Bieche I", "Doczi R", "Mariani O", "Filotas P", "Salomon A", "Vodicska B", "Servois V", "Varkondi E", "Gentien D", "Tihanyi D", "Tresca P", "Lakatos D", "Servant N", "Deri J", "du Rusquec P", "Hegedus C", "Bello Roufai D", "Schwab R", "Dupain C", "Valyi-Nagy IT", "Le Tourneau C"], "date": "2021-06-23T00:00:00Z", "year": 2021, "snippets": [{"_id": "34162980@20286", "snip_text": "Patient ID Example 1 Example 2 Example 3 Example 4 Example 5   Tumor type Colorectal cancer Lung cancer Colorectal cancer Lung cancer Breast cancer   Molecular profile KRAS-G12V, TP53-A159V; PTEN loss TP53-P278R, FLT3-M665T; INPP4B, STK11 loss; RICTOR amplification APC-E1295del; PTEN, STK11, INPP4B loss AR, ER expression; TP53-G266E; PTEN, STK11, INPP4B loss ER, PR expression; PIK3CA-E545K, KRAS-A146T; PTEN loss   Molecular alteration-MTA pairing used in SHIVA01 PTEN loss-everolimus FLT3 mutation-sorafenib PTEN loss-everolimus AR expression-abiraterone PIK3CA mutation and PTEN loss-everolimus   AEL score of the MTA used -1291.37 191.61 266.93 315.04 4165   Response to MTA Progressive disease Stable disease Stable disease Stable disease Partial response   All targets (n) 25 16 9 22 25    Positive 20 15 6 19 20    Negative 5 1 3 3 6   All associated drugs (n) 271 226 200 269 287    Registered-positive 75 88 81 91 76    Registered-negative 33 10 17 17 31    Clinical development-positive 109 123 82 140 128    Clinical development-negative 54 5 20 21 65   All evidence used (n) 1894 1778 1138 1716 1165    Frequency-based 466 547 539 409 265    Function-based 871 689 491 769 765    Other 557 542 108 538 135   All connections (n) 2886 2498 1362 2450 1888    Clinical evidence-based 998 724 629 829 907    Preclinical evidence-based 1322 1142 178 1128 643    In silico evidence-based 25 27 3 21 11    Frequency-based 541 605 552 472 327   ", "section": "table", "mentions": ["168|4|gene|ncbi_gene@3845|KRAS", "324|4|gene|ncbi_gene@7157|TP53", "245|6|gene|ncbi_gene@253260|RICTOR", "173|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "191|4|gene|ncbi_gene@5728|PTEN", "502|9|chemical|ncbi_mesh@D000077157|sorafenib", "394|4|gene|ncbi_gene@3845|KRAS", "467|4|gene|ncbi_gene@5728|PTEN", "522|10|chemical|ncbi_mesh@D000068338|everolimus", "92|11|disease|ncbi_mesh@D008175|Lung cancer", "74|17|disease|ncbi_mesh@D015179|Colorectal cancer", "206|5|variant|litvar@rs876659802##&&&litvar@#7157#|P278R", "477|10|chemical|ncbi_mesh@D000068338|everolimus", "184|5|variant|litvar@rs1218758923##&&&litvar@#1025#|A159V", "201|4|gene|ncbi_gene@7157|TP53", "266|4|gene|ncbi_gene@324|APC-", "387|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "677|3|chemical||MTA", "547|11|chemical|ncbi_mesh@C089740|abiraterone", "286|5|gene|ncbi_gene@6794|STK11", "309|2|gene|ncbi_gene@2069|ER", "439|3|chemical||MTA", "280|4|gene|ncbi_gene@5728|PTEN", "0|7|species|ncbi_taxonomy@9606|Patient", "619|3|chemical||MTA", "179|4|gene|ncbi_gene@7157|TP53", "218|5|variant|litvar@#2322#p.M665T&&&litvar@#2322#|M665T", "579|4|gene|ncbi_gene@5728|PTEN", "122|11|disease|ncbi_mesh@D008175|Lung cancer", "365|2|gene|ncbi_gene@5241|PR", "342|5|gene|ncbi_gene@6794|STK11", "380|6|gene|ncbi_gene@5290|PIK3CA", "293|6|gene|ncbi_gene@8821|INPP4B", "336|4|gene|ncbi_gene@5728|PTEN", "559|6|gene|ncbi_gene@5290|PIK3CA", "361|2|gene|ncbi_gene@2069|ER", "406|4|gene|ncbi_gene@5728|PTEN", "349|6|gene|ncbi_gene@8821|INPP4B", "488|4|gene|ncbi_gene@2322|FLT3", "134|13|disease|ncbi_mesh@D001943|Breast cancer", "329|5|variant|litvar@rs193920774##&&&litvar@#7157#&&&litvar@CA421#rs193920774##|G266E", "225|6|gene|ncbi_gene@8821|INPP4B", "233|5|gene|ncbi_gene@6794|STK11", "589|10|chemical|ncbi_mesh@D000068338|everolimus", "104|17|disease|ncbi_mesh@D015179|Colorectal cancer", "213|4|gene|ncbi_gene@2322|FLT3", "512|4|gene|ncbi_gene@5728|PTEN", "399|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "270|8|variant|litvar@#5728#p.E1295del&&&litvar@#5728#|E1295del"], "figure_id": "Tab1", "text_hl": "Patient ID Example 1 Example 2 Example 3 Example 4 Example 5   Tumor type Colorectal cancer Lung cancer Colorectal cancer Lung cancer Breast cancer   Molecular profile KRAS-G12V, TP53-A159V; PTEN loss TP53-P278R, FLT3-M665T; INPP4B, STK11 loss; RICTOR amplification APC-E1295del; PTEN, STK11, INPP4B loss AR, ER expression; TP53-G266E; PTEN, STK11, INPP4B loss ER, PR expression; PIK3CA-E545K, KRAS-<m>A146T</m>; PTEN loss   Molecular alteration-MTA pairing used in SHIVA01 PTEN loss-everolimus FLT3 mutation-sorafenib PTEN loss-everolimus AR expression-abiraterone PIK3CA mutation and PTEN loss-everolimus   AEL score of the MTA used -1291.37 191.61 266.93 315.04 4165   Response to MTA Progressive disease Stable disease Stable disease Stable disease Partial response   All targets (n) 25 16 9 22 25    Positive 20 15 6 19 20    Negative 5 1 3 3 6   All associated drugs (n) 271 226 200 269 287    Registered-positive 75 88 81 91 76    Registered-negative 33 10 17 17 31    Clinical development-positive 109 123 82 140 128    Clinical development-negative 54 5 20 21 65   All evidence used (n) 1894 1778 1138 1716 1165    Frequency-based 466 547 539 409 265    Function-based 871 689 491 769 765    Other 557 542 108 538 135   All connections (n) 2886 2498 1362 2450 1888    Clinical evidence-based 998 724 629 829 907    Preclinical evidence-based 1322 1142 178 1128 643    In silico evidence-based 25 27 3 21 11    Frequency-based 541 605 552 472 327   "}], "citations": {"NLM": "Petak I, Kamal M, Dirner A, Bieche I, Doczi R, Mariani O, Filotas P, Salomon A, Vodicska B, Servois V, Varkondi E, Gentien D, Tihanyi D, Tresca P, Lakatos D, Servant N, Deri J, du Rusquec P, Hegedus C, Bello Roufai D, Schwab R, Dupain C, Valyi-Nagy IT, Le Tourneau C. A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial. NPJ Precis Oncol. PMID: 34162980", "BibTeX": "@article{34162980, title={A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial.}, author={Petak I and Kamal M and Dirner A and Bieche I and Doczi R and Mariani O and Filotas P and Salomon A and Vodicska B and Servois V and Varkondi E and Gentien D and Tihanyi D and Tresca P and Lakatos D and Servant N and Deri J and du Rusquec P and Hegedus C and Bello Roufai D and Schwab R and Dupain C and Valyi-Nagy IT and Le Tourneau C}, journal={NPJ Precis Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 31341022, "title": "Structural basis of the atypical activation mechanism of KRASV14I.", "journal": "J Biol Chem", "authors": ["Bera AK", "Lu J", "Wales TE", "Gondi S", "Gurbani D", "Nelson A", "Engen JR", "Westover KD"], "date": "2019-09-20T00:00:00Z", "year": 2019, "snippets": [{"_id": "31341022@752", "snip_text": "Hydrogen-deuterium exchange MS analysis confirmed that this conformation occurs in solution, but also disclosed a difference in kinetics when compared with KRASA146T, another RAS mutant that displays a nearly identical conformation in previously reported crystal structures.", "section": "abstract", "mentions": ["9|9|chemical|ncbi_mesh@D003903|deuterium", "0|8|chemical|ncbi_mesh@D006859|Hydrogen", "156|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T"], "text_hl": "Hydrogen-deuterium exchange MS analysis confirmed that this conformation occurs in solution, but also disclosed a difference in kinetics when compared with KRASA146T, another RAS mutant that displays a nearly identical conformation in previously reported crystal structures."}], "citations": {"NLM": "Bera AK, Lu J, Wales TE, Gondi S, Gurbani D, Nelson A, Engen JR, Westover KD. Structural basis of the atypical activation mechanism of KRASV14I. J Biol Chem. PMID: 31341022", "BibTeX": "@article{31341022, title={Structural basis of the atypical activation mechanism of KRASV14I.}, author={Bera AK and Lu J and Wales TE and Gondi S and Gurbani D and Nelson A and Engen JR and Westover KD}, journal={J Biol Chem}}"}, "is_sup_mat_match": false}, {"pmid": 25412182, "pmcid": "PMC4239073", "title": "Novel KRAS gene mutations in sporadic colorectal cancer.", "journal": "PLoS One", "authors": ["Naser WM", "Shawarby MA", "Al-Tamimi DM", "Seth A", "Al-Quorain A", "Nemer AM", "Albagha OM"], "date": "2014-11-20T00:00:00Z", "year": 2014, "snippets": [{"_id": "25412182@8586", "snip_text": "Sequencing was applied to detect KRAS exon 4 mutations as kits for detection of A146T - which is the exon 4 mutation reported to be commonly involved in colorectal cancer - were not commercially available.", "section": "methods", "mentions": ["80|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "153|17|disease|ncbi_mesh@D015179|colorectal cancer", "33|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "Sequencing was applied to detect KRAS exon 4 mutations as kits for detection of <m>A146T</m> - which is the exon 4 mutation reported to be commonly involved in colorectal cancer - were not commercially available."}], "citations": {"NLM": "Naser WM, Shawarby MA, Al-Tamimi DM, Seth A, Al-Quorain A, Nemer AM, Albagha OM. Novel KRAS gene mutations in sporadic colorectal cancer. PLoS One. PMID: 25412182", "BibTeX": "@article{25412182, title={Novel KRAS gene mutations in sporadic colorectal cancer.}, author={Naser WM and Shawarby MA and Al-Tamimi DM and Seth A and Al-Quorain A and Nemer AM and Albagha OM}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 28178681, "pmcid": "PMC5522060", "title": "Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experience.", "journal": "Oncotarget", "authors": ["Gong J", "Cho M", "Sy M", "Salgia R", "Fakih M"], "date": "2017-06-27T00:00:00Z", "year": 2017, "snippets": [{"_id": "28178681@5249", "snip_text": "Characteristic (n = 138) Frequency (%)   Age (at initial diagnosis) Median (range)    56 (27-88)   Sex     Male 82 (59.4%)    Female 56 (40.6%)   Ethnicity     White 85 (61.6%)    Asian 29 (21.0%)    Black 7 (5.1%)    Other 3 (2.2%)    Unknown 14 (10.1%)   Primary disease site     Sigmoid colon 46 (33.3%)    Rectal 27 (19.6%)    Cecum 21 (15.2%)    Rectosigmoid 13 (9.4%)    Colon NOS 31 (22.5%)   Stage (at diagnosis)     II 5 (3.6%)    III 16 (11.6%)    IV 117 (84.8%)   Relapsed disease     Yes 52 (37.7%)    No 86 (62.3%)   KRAS alterations 68 (49.3%)    G12D 23 (16.7%)    G13D 10 (7.2%)    G12V 8 (5.8%)    G12S 7 (5.1%)    G12C 6 (4.3%)    A146T 3 (2.2%)    G12A 2 (1.4%)    Amplification 2 (1.4%)    Q61H 1 (0.7%)    Q61K 1 (0.7%)    Q61L 1 (0.7%)    K117N 1 (0.7%)    R68S 1 (0.7%)    A146V 1 (0.7%)    A146V^sub 1 (0.7%)   BRAF alterations 9 (6.5%)    V600E 5 (3.6%)    D594G 1 (0.7%)    G466V 1 (0.7%)    G469E 1 (0.7%)    L597R 1 (0.7%)   NRAS alterations     Q61K 2 (1.4%)    Amplification 1 (0.7%)   ARAF mutation     S214F 1 (0.7%)   RAF1 mutation     S257L 1 (0.7%)   ERBB2 alterations     Amplification 7 (5.1%)   MET alterations     Amplification 3 (2.2%)   AKT1/AKT2 mutations     AKT1 3 (2.2%)    AKT2 1 (0.7%)   Total number of clinically significant alterations Median (range) 5 (1-25)   MSI     MSS 121 (87.7%)    MSI-L 0 (0.0%)    MSI-H 2 (1.4%)    Unknown/not reported 15 (10.9%)   ", "section": "table", "mentions": ["530|4|gene|ncbi_gene@3845|KRAS", "1069|5|variant|litvar@rs80338796##&&&litvar@#5894#&&&litvar@CA235334#rs80338796##|S257L", "1183|4|gene|ncbi_gene@208|AKT2", "632|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "936|5|variant|litvar@rs121913366##&&&litvar@#673#&&&litvar@CA123649#rs121913366##|L597R", "1178|4|gene|ncbi_gene@207|AKT1", "882|5|variant|litvar@rs121913338##&&&litvar@#673#&&&litvar@CA123657#rs121913338##|D594G", "1219|4|gene|ncbi_gene@208|AKT2", "779|4|variant|litvar@#673#p.R68S&&&litvar@#673#|R68S", "290|5|disease|ncbi_mesh@D003108|colon", "900|5|variant|litvar@rs121913351##&&&litvar@#673#&&&litvar@CA123647#rs121913351##|G466V", "918|5|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|G469E", "710|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "1202|4|gene|ncbi_gene@207|AKT1", "835|4|gene|ncbi_gene@673|BRAF", "1320|3|disease|ncbi_mesh@D053842|MSS", "864|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "615|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "1034|5|variant|litvar@rs1057519786##&&&litvar@#369#|S214F", "1051|4|gene|ncbi_gene@5894|RAF1", "744|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "649|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1133|3|gene|ncbi_gene@79811|MET", "796|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "1312|3|gene|ncbi_gene@5928|MSI", "814|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "974|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "598|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "561|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1086|5|gene|ncbi_gene@2064|ERBB2", "1016|4|gene|ncbi_gene@369|ARAF", "1339|5|disease|ncbi_mesh@D007926|MSI-L", "1357|5|disease|ncbi_mesh@D000848|MSI-H", "761|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "667|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "377|9|disease|ncbi_mesh@D003108|Colon NOS", "580|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "727|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "953|4|gene|ncbi_gene@4893|NRAS"], "figure_id": "T1", "text_hl": "Characteristic (n = 138) Frequency (%)   Age (at initial diagnosis) Median (range)    56 (27-88)   Sex     Male 82 (59.4%)    Female 56 (40.6%)   Ethnicity     White 85 (61.6%)    Asian 29 (21.0%)    Black 7 (5.1%)    Other 3 (2.2%)    Unknown 14 (10.1%)   Primary disease site     Sigmoid colon 46 (33.3%)    Rectal 27 (19.6%)    Cecum 21 (15.2%)    Rectosigmoid 13 (9.4%)    Colon NOS 31 (22.5%)   Stage (at diagnosis)     II 5 (3.6%)    III 16 (11.6%)    IV 117 (84.8%)   Relapsed disease     Yes 52 (37.7%)    No 86 (62.3%)   KRAS alterations 68 (49.3%)    G12D 23 (16.7%)    G13D 10 (7.2%)    G12V 8 (5.8%)    G12S 7 (5.1%)    G12C 6 (4.3%)    <m>A146T</m> 3 (2.2%)    G12A 2 (1.4%)    Amplification 2 (1.4%)    Q61H 1 (0.7%)    Q61K 1 (0.7%)    Q61L 1 (0.7%)    K117N 1 (0.7%)    R68S 1 (0.7%)    A146V 1 (0.7%)    A146V^sub 1 (0.7%)   BRAF alterations 9 (6.5%)    V600E 5 (3.6%)    D594G 1 (0.7%)    G466V 1 (0.7%)    G469E 1 (0.7%)    L597R 1 (0.7%)   NRAS alterations     Q61K 2 (1.4%)    Amplification 1 (0.7%)   ARAF mutation     S214F 1 (0.7%)   RAF1 mutation     S257L 1 (0.7%)   ERBB2 alterations     Amplification 7 (5.1%)   MET alterations     Amplification 3 (2.2%)   AKT1/AKT2 mutations     AKT1 3 (2.2%)    AKT2 1 (0.7%)   Total number of clinically significant alterations Median (range) 5 (1-25)   MSI     MSS 121 (87.7%)    MSI-L 0 (0.0%)    MSI-H 2 (1.4%)    Unknown/not reported 15 (10.9%)   "}], "citations": {"NLM": "Gong J, Cho M, Sy M, Salgia R, Fakih M. Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experience. Oncotarget. PMID: 28178681", "BibTeX": "@article{28178681, title={Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experience.}, author={Gong J and Cho M and Sy M and Salgia R and Fakih M}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 36184073, "title": "Identification of novel genetic and epigenetic regulators of different tissue types of cervical cancer.", "journal": "J Obstet Gynaecol Res", "authors": ["Chandra S", "Sarkar S", "Mandal P"], "date": "2022-10-02T00:00:00Z", "year": 2022, "snippets": [{"_id": "36184073@781", "snip_text": "In these pathways, missense mutation especially S310F in the ERBB2 gene as well as G12D and A146T in the KRAS gene were significantly associated with adenocarcinoma cases.", "section": "abstract", "mentions": ["150|14|disease|ncbi_mesh@D000230|adenocarcinoma", "48|5|variant|litvar@rs1057519816##&&&litvar@#2064#|S310F", "92|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "105|4|gene|ncbi_gene@3845|KRAS", "83|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "61|5|gene|ncbi_gene@2064|ERBB2"], "text_hl": "In these pathways, missense mutation especially S310F in the ERBB2 gene as well as G12D and <m>A146T</m> in the KRAS gene were significantly associated with adenocarcinoma cases."}], "citations": {"NLM": "Chandra S, Sarkar S, Mandal P. Identification of novel genetic and epigenetic regulators of different tissue types of cervical cancer. J Obstet Gynaecol Res. PMID: 36184073", "BibTeX": "@article{36184073, title={Identification of novel genetic and epigenetic regulators of different tissue types of cervical cancer.}, author={Chandra S and Sarkar S and Mandal P}, journal={J Obstet Gynaecol Res}}"}, "is_sup_mat_match": false}, {"pmid": 30834291, "pmcid": "PMC6395096", "title": "Clinicopathological features and endoscopic characteristics of inverted sessile serrated adenomas/polyps.", "journal": "Endosc Int Open", "authors": ["Takashima K", "Oono Y", "Kojima M", "Ikematsu H", "Akimoto T", "Yano T"], "date": "2019-03-01T00:00:00Z", "year": 2019, "snippets": [{"_id": "30834291@8065", "snip_text": "Thirty-six mutations in KRAS codon 61 (Q61K, Q61E, Q61 L, Q61P, Q61 R, and Q61H); KRAS codon 146 (A146 T, A146S, A146P, A146E, A146V, and A146G); BRAF codon 600 (V600E); NRAS codon 12 (G12S, G12C, G12 R, G12 D, G12V, and G12A); NRAS codon 13 (G13S, G13C, G13 R, G13 D, G13V, and G13A); NRAS codon 61 (Q61K, Q61E, Q61 L, Q61P, Q61 R, and Q61H); PIK3CA exon 9 codon 542 (E542K); PIK3CA exon 9 codon 545 (E545K); PIK3CA exon 9 codon 546 (E546K); and PIK3CA exon 20 codon 1047 (H1047 R and H1047 L) were analyzed using Luminex technology (GENOSEARCH Mu-PACK; MBL) .", "section": "methods", "mentions": ["64|5|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61 R", "410|6|gene|ncbi_gene@5290|PIK3CA", "138|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146G", "228|4|gene|ncbi_gene@4893|NRAS", "98|6|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146 T", "269|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "326|5|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61 R", "45|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "191|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "447|6|gene|ncbi_gene@5290|PIK3CA", "320|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "279|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602364#rs121434596##|G13A", "146|4|gene|ncbi_gene@673|BRAF", "313|5|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61 L", "106|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146S", "51|5|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61 L", "162|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "486|7|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|H1047 L", "262|5|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13 D", "120|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146E", "243|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA16602674#rs121434595##|G13S", "82|4|gene|ncbi_gene@3845|KRAS", "307|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "211|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "204|5|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12 D", "221|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "369|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "555|3|gene|ncbi_gene@50639|MBL", "170|4|gene|ncbi_gene@4893|NRAS", "255|5|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13 R", "249|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13C", "24|4|gene|ncbi_gene@3845|KRAS", "344|6|gene|ncbi_gene@5290|PIK3CA", "474|7|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047 R", "402|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "113|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "185|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "75|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "286|4|gene|ncbi_gene@4893|NRAS", "127|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "337|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "39|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "377|6|gene|ncbi_gene@5290|PIK3CA", "58|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "435|5|variant|litvar@#5290#p.E546K&&&litvar@#5290#|E546K", "301|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "197|5|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12 R"], "text_hl": "Thirty-six mutations in KRAS codon 61 (Q61K, Q61E, Q61 L, Q61P, Q61 R, and Q61H); KRAS codon 146 (A146 T, A146S, A146P, A146E, A146V, and A146G); BRAF codon 600 (V600E); NRAS codon 12 (G12S, G12C, G12 R, G12 D, G12V, and G12A); NRAS codon 13 (G13S, G13C, G13 R, G13 D, G13V, and G13A); NRAS codon 61 (Q61K, Q61E, Q61 L, Q61P, Q61 R, and Q61H); PIK3CA exon 9 codon 542 (E542K); PIK3CA exon 9 codon 545 (E545K); PIK3CA exon 9 codon 546 (E546K); and PIK3CA exon 20 codon 1047 (H1047 R and H1047 L) were analyzed using Luminex technology (GENOSEARCH Mu-PACK; MBL) ."}], "citations": {"NLM": "Takashima K, Oono Y, Kojima M, Ikematsu H, Akimoto T, Yano T. Clinicopathological features and endoscopic characteristics of inverted sessile serrated adenomas/polyps. Endosc Int Open. PMID: 30834291", "BibTeX": "@article{30834291, title={Clinicopathological features and endoscopic characteristics of inverted sessile serrated adenomas/polyps.}, author={Takashima K and Oono Y and Kojima M and Ikematsu H and Akimoto T and Yano T}, journal={Endosc Int Open}}"}, "is_sup_mat_match": false}, {"pmid": 37627135, "pmcid": "PMC10452999", "title": "Brown Tumour in Chronic Kidney Disease: Revisiting an Old Disease with a New Perspective", "journal": "Cancers (Basel)", "authors": ["Santoso D", "Thaha M", "Empitu MA", "Kadariswantiningsih IN", "Suryantoro SD", "Haryati MR", "Hertanto DM", "Pramudya D", "Bintoro SUY", "Nasronudin N", "Alsagaff MY", "Susilo H", "Wungu CDK", "Budhiparama NC", "Hogendoorn PCW"], "date": "2023-08-15T00:00:00Z", "year": 2023, "snippets": [{"_id": "37627135@18553", "snip_text": "The most prevalent KRAS activating mutations found were related to p.A146P/T/V, p.G12D/V, p.G13C/D, p.K117R, and p.Q22K, affecting BT development in both the axial and peripheral areas (Figure 5B,C).", "section": "other", "mentions": ["67|7|variant|litvar@rs121913527##&&&litvar@#3845#|p.A146P", "92|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "80|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "19|4|gene|ncbi_gene@3845|KRAS", "100|7|variant|litvar@#3845#p.K117R&&&litvar@#3845#|p.K117R", "113|6|variant|litvar@rs121913236##&&&litvar@#3845#&&&litvar@CA16602771#rs121913236##|p.Q22K"], "text_hl": "The most prevalent KRAS activating mutations found were related to p.A146P/T/V, p.G12D/V, p.G13C/D, p.K117R, and p.Q22K, affecting BT development in both the axial and peripheral areas (Figure 5B,C)."}], "citations": {"NLM": "Santoso D, Thaha M, Empitu MA, Kadariswantiningsih IN, Suryantoro SD, Haryati MR, Hertanto DM, Pramudya D, Bintoro SUY, Nasronudin N, Alsagaff MY, Susilo H, Wungu CDK, Budhiparama NC, Hogendoorn PCW. Brown Tumour in Chronic Kidney Disease: Revisiting an Old Disease with a New Perspective Cancers (Basel). PMID: 37627135", "BibTeX": "@article{37627135, title={Brown Tumour in Chronic Kidney Disease: Revisiting an Old Disease with a New Perspective}, author={Santoso D and Thaha M and Empitu MA and Kadariswantiningsih IN and Suryantoro SD and Haryati MR and Hertanto DM and Pramudya D and Bintoro SUY and Nasronudin N and Alsagaff MY and Susilo H and Wungu CDK and Budhiparama NC and Hogendoorn PCW}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 37188188, "pmcid": "PMC10176449", "title": "PD-1 inhibitor combined with radiotherapy and GM-CSF in MSS/pMMR metastatic colon cancer: a case report", "journal": "Front Oncol", "authors": ["Yang J", "Xing P", "Kong Y", "Xu M", "Zhang L"], "date": "2023-04-28T00:00:00Z", "year": 2023, "snippets": [{"_id": "37188188@3728", "snip_text": "Genetic testing of tumor tissue revealed that missense mutation A146T was found in exon 4 of the KRAS gene.", "section": "other", "mentions": ["97|4|gene|ncbi_gene@3845|KRAS", "64|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Genetic testing of tumor tissue revealed that missense mutation <m>A146T</m> was found in exon 4 of the KRAS gene."}], "citations": {"NLM": "Yang J, Xing P, Kong Y, Xu M, Zhang L. PD-1 inhibitor combined with radiotherapy and GM-CSF in MSS/pMMR metastatic colon cancer: a case report Front Oncol. PMID: 37188188", "BibTeX": "@article{37188188, title={PD-1 inhibitor combined with radiotherapy and GM-CSF in MSS/pMMR metastatic colon cancer: a case report}, author={Yang J and Xing P and Kong Y and Xu M and Zhang L}, journal={Front Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 35158933, "pmcid": "PMC8833570", "title": "KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders.", "journal": "Cancers (Basel)", "authors": ["Vendramini E", "Bomben R", "Pozzo F", "Bittolo T", "Tissino E", "Gattei V", "Zucchetto A"], "date": "2022-01-28T00:00:00Z", "year": 2022, "snippets": [{"_id": "35158933@20627", "snip_text": "Of interest, a rare BL variant characterized by a precursor B cell immunophenotype, called precursor B cell phenotype Burkitt leukemia (preBLL), was shown to present with frequent (50%) KRAS (G13D, A146T) and NRAS (G13D/R) aberrations.", "section": "other", "mentions": ["136|6|disease||preBLL", "186|4|gene|ncbi_gene@3845|KRAS", "198|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "215|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "118|16|disease|ncbi_mesh@D002051|Burkitt leukemia", "20|2|disease|ncbi_mesh@D002051|BL", "209|4|gene|ncbi_gene@4893|NRAS"], "text_hl": "Of interest, a rare BL variant characterized by a precursor B cell immunophenotype, called precursor B cell phenotype Burkitt leukemia (preBLL), was shown to present with frequent (50%) KRAS (G13D, <m>A146T</m>) and NRAS (G13D/R) aberrations."}], "citations": {"NLM": "Vendramini E, Bomben R, Pozzo F, Bittolo T, Tissino E, Gattei V, Zucchetto A. KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders. Cancers (Basel). PMID: 35158933", "BibTeX": "@article{35158933, title={KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders.}, author={Vendramini E and Bomben R and Pozzo F and Bittolo T and Tissino E and Gattei V and Zucchetto A}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 31127692, "pmcid": "PMC6639182", "title": "Molecular characterization of colorectal cancer using whole-exome sequencing in a Taiwanese population.", "journal": "Cancer Med", "authors": ["Chang YS", "Lee CC", "Ke TW", "Chang CM", "Chao DS", "Huang HY", "Chang JG"], "date": "2019-07-01T00:00:00Z", "year": 2019, "snippets": [{"_id": "31127692@10322", "snip_text": "Beyond the well-established point mutations in codons 12 and 13 of exon 2 of KRAS, we identified mutations in codon 117 of exon 4 (K117N, 11.11%) and codon 146 of exon 4 (A146T, 11.11%).", "section": "results", "mentions": ["77|4|gene|ncbi_gene@3845|KRAS", "171|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "131|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N"], "text_hl": "Beyond the well-established point mutations in codons 12 and 13 of exon 2 of KRAS, we identified mutations in codon 117 of exon 4 (K117N, 11.11%) and codon 146 of exon 4 (<m>A146T</m>, 11.11%)."}], "citations": {"NLM": "Chang YS, Lee CC, Ke TW, Chang CM, Chao DS, Huang HY, Chang JG. Molecular characterization of colorectal cancer using whole-exome sequencing in a Taiwanese population. Cancer Med. PMID: 31127692", "BibTeX": "@article{31127692, title={Molecular characterization of colorectal cancer using whole-exome sequencing in a Taiwanese population.}, author={Chang YS and Lee CC and Ke TW and Chang CM and Chao DS and Huang HY and Chang JG}, journal={Cancer Med}}"}, "is_sup_mat_match": false}, {"pmid": 34953682, "pmcid": "PMC8810687", "title": "Anticancer drug resistance: an update and perspective", "journal": "Drug Resist Updat", "authors": ["Nussinov R", "Tsai CJ", "Jang H"], "date": "2021-12-16T00:00:00Z", "year": 2021, "snippets": [{"_id": "34953682@19979", "snip_text": "KRas A146T mutation occurs in certain cancers but not in PDAC, and A146T is associated with better overall survival than G12 mutations of KRas.", "section": "other", "mentions": ["57|4|disease|ncbi_mesh@D021441|PDAC", "5|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "67|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "138|4|gene|ncbi_gene@3845|KRas", "121|3|variant|litvar@rs121913529##&&&litvar@#3845#|G12", "0|4|gene|ncbi_gene@3845|KRas", "38|7|disease|ncbi_mesh@D009369|cancers"], "text_hl": "KRas <m>A146T</m> mutation occurs in certain cancers but not in PDAC, and <m>A146T</m> is associated with better overall survival than G12 mutations of KRas."}], "citations": {"NLM": "Nussinov R, Tsai CJ, Jang H. Anticancer drug resistance: an update and perspective Drug Resist Updat. PMID: 34953682", "BibTeX": "@article{34953682, title={Anticancer drug resistance: an update and perspective}, author={Nussinov R and Tsai CJ and Jang H}, journal={Drug Resist Updat}}"}, "is_sup_mat_match": false}, {"pmid": 36930789, "pmcid": "PMC10098058", "title": "  KRAS ,  NRAS ,  BRAF, and  PIK3CA  mutation rates, clinicopathological association, and their prognostic value in Iranian colorectal cancer patients", "journal": "J Clin Lab Anal", "authors": ["Mirzapoor Abbasabadi Z", "Hamedi Asl D", "Rahmani B", "Shahbadori R", "Karami S", "Peymani A", "Taghizadeh S", "Samiee Rad F"], "date": "2023-03-17T00:00:00Z", "year": 2023, "snippets": [{"_id": "36930789@12681", "snip_text": "Other mutations included G12C, G12S, G12A, G12R, Q61H, and A146T.", "section": "results", "mentions": ["49|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "37|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "43|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "25|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "31|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "59|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Other mutations included G12C, G12S, G12A, G12R, Q61H, and <m>A146T</m>."}], "citations": {"NLM": "Mirzapoor Abbasabadi Z, Hamedi Asl D, Rahmani B, Shahbadori R, Karami S, Peymani A, Taghizadeh S, Samiee Rad F.   KRAS ,  NRAS ,  BRAF, and  PIK3CA  mutation rates, clinicopathological association, and their prognostic value in Iranian colorectal cancer patients J Clin Lab Anal. PMID: 36930789", "BibTeX": "@article{36930789, title={  KRAS ,  NRAS ,  BRAF, and  PIK3CA  mutation rates, clinicopathological association, and their prognostic value in Iranian colorectal cancer patients}, author={Mirzapoor Abbasabadi Z and Hamedi Asl D and Rahmani B and Shahbadori R and Karami S and Peymani A and Taghizadeh S and Samiee Rad F}, journal={J Clin Lab Anal}}"}, "is_sup_mat_match": false}, {"pmid": 33848152, "pmcid": "PMC8154616", "title": "Mechanistic Differences of Activation of Rac1P29S and Rac1A159V.", "journal": "J Phys Chem B", "authors": ["Senyuz S", "Jang H", "Nussinov R", "Keskin O", "Gursoy A"], "date": "2021-04-22T00:00:00Z", "year": 2021, "snippets": [{"_id": "33848152@40211", "snip_text": "A recent structural study on GDP-bound K-RasA146T shows that K-RasA146T adopts an open Switch I conformation and a large conformational change in ss2-ss3 strands.", "section": "discussion", "mentions": ["39|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|K-RasA146T", "29|3|chemical|ncbi_mesh@D006153|GDP", "61|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|K-RasA146T"], "text_hl": "A recent structural study on GDP-bound K-RasA146T shows that K-RasA146T adopts an open Switch I conformation and a large conformational change in ss2-ss3 strands."}], "citations": {"NLM": "Senyuz S, Jang H, Nussinov R, Keskin O, Gursoy A. Mechanistic Differences of Activation of Rac1P29S and Rac1A159V. J Phys Chem B. PMID: 33848152", "BibTeX": "@article{33848152, title={Mechanistic Differences of Activation of Rac1P29S and Rac1A159V.}, author={Senyuz S and Jang H and Nussinov R and Keskin O and Gursoy A}, journal={J Phys Chem B}}"}, "is_sup_mat_match": false}, {"pmid": 34597339, "pmcid": "PMC8486135", "title": "Multisite verification of the accuracy of a multi-gene next generation sequencing panel for detection of mutations and copy number alterations in solid tumours.", "journal": "PLoS One", "authors": ["Bartlett J", "Amemiya Y", "Arts H", "Bayani J", "Eng B", "Grafodatskaya D", "Kamel Reid S", "Lariviere M", "Lo B", "McClure R", "Mittal V", "Sadikovic B", "Sadis S", "Seth A", "Smith J", "Zhang X", "Feilotter H"], "date": "2021-10-01T00:00:00Z", "year": 2021, "snippets": [{"_id": "34597339@21441", "snip_text": "    PARTICIPATING LABS    GENE AA Change Expected (%) A B C D E F G   DNA Std #1 BRAF V600E 11 12 12 11 12 ND 11 11   KIT D816V 10 10 10 11 10 ND 10 9   EGFR E746_A750del 2 NC NC NC NC ND NC NC   EGFR L858R 3 4 NC NC NC ND NC NC   EGFR T790M 1 NC NC NC NC ND NC NC   EGFR G719S 25 25 23 26 26 ND 23 26   KRAS G13D 15 13 14 16 17 ND 15 16   KRAS G12D 6 8 7 7 8 ND 6 6   NRAS Q61K 13 11 11 12 13 ND 9 11   PIK3CA H1047R 18 18 18 18 20 ND 23 19   PIK3CA E545K 9 9 9 8 8 ND 8 7   DNA Std #2 EGFR L861Q 5 4 5 4 5 5 6 4   EGFR E746_A750del 5 5 6 4 4 6 4 4   EGFR L858R 5 5 6 5 8 7 5 6   EGFR T790M 5 6 7 6 5 6 5 6   EGFR G719S 5 5 5 4 5 5 5 6   DNA Std #3 KRAS G12D 5 5 5 4 4 4 4  6   KRAS G13D 5 5 5  5 5 5 5 4   KRAS Q61H 5 4 5 5 5 5 5 5   KRAS A146T 5 5 5 6 7 6 4 5   NRAS G12V 5 6 5 5 4 5 4 5   NRAS Q61K 5 6 6 4 6 6 5 4   ", "section": "table", "mentions": ["650|4|gene|ncbi_gene@3845|KRAS", "201|5|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|L858R", "81|4|gene|ncbi_gene@673|BRAF", "581|4|gene|ncbi_gene@1956|EGFR", "765|4|gene|ncbi_gene@4893|NRAS", "615|5|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126722#rs28929495##|G719S", "655|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "770|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "411|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "196|4|gene|ncbi_gene@1956|EGFR", "793|4|gene|ncbi_gene@4893|NRAS", "158|12|variant|litvar@#1956#p.A746,750del&&&litvar@#1956#|E746_A750del", "521|12|variant|litvar@#1956#p.A746,750del&&&litvar@#1956#|E746_A750del", "451|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "444|6|gene|ncbi_gene@5290|PIK3CA", "492|5|variant|litvar@rs121913444##&&&litvar@#1956#&&&litvar@CA176021#rs121913444##|L861Q", "679|4|gene|ncbi_gene@3845|KRAS", "798|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "557|5|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|L858R", "272|5|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126722#rs28929495##|G719S", "118|3|gene|ncbi_gene@3815|KIT", "610|4|gene|ncbi_gene@1956|EGFR", "684|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "122|5|variant|litvar@rs121913507##&&&litvar@#3815#&&&litvar@CA123513#rs121913507##|D816V", "340|4|gene|ncbi_gene@3845|KRAS", "741|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "236|5|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|T790M", "487|4|gene|ncbi_gene@1956|EGFR", "552|4|gene|ncbi_gene@1956|EGFR", "231|4|gene|ncbi_gene@1956|EGFR", "304|4|gene|ncbi_gene@3845|KRAS", "586|5|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|T790M", "345|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "708|4|gene|ncbi_gene@3845|KRAS", "267|4|gene|ncbi_gene@1956|EGFR", "309|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "736|4|gene|ncbi_gene@3845|KRAS", "86|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "713|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "369|4|gene|ncbi_gene@4893|NRAS", "153|4|gene|ncbi_gene@1956|EGFR", "516|4|gene|ncbi_gene@1956|EGFR", "404|6|gene|ncbi_gene@5290|PIK3CA", "374|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K"], "figure_id": "pone.0258188.t012", "text_hl": "    PARTICIPATING LABS    GENE AA Change Expected (%) A B C D E F G   DNA Std #1 BRAF V600E 11 12 12 11 12 ND 11 11   KIT D816V 10 10 10 11 10 ND 10 9   EGFR E746_A750del 2 NC NC NC NC ND NC NC   EGFR L858R 3 4 NC NC NC ND NC NC   EGFR T790M 1 NC NC NC NC ND NC NC   EGFR G719S 25 25 23 26 26 ND 23 26   KRAS G13D 15 13 14 16 17 ND 15 16   KRAS G12D 6 8 7 7 8 ND 6 6   NRAS Q61K 13 11 11 12 13 ND 9 11   PIK3CA H1047R 18 18 18 18 20 ND 23 19   PIK3CA E545K 9 9 9 8 8 ND 8 7   DNA Std #2 EGFR L861Q 5 4 5 4 5 5 6 4   EGFR E746_A750del 5 5 6 4 4 6 4 4   EGFR L858R 5 5 6 5 8 7 5 6   EGFR T790M 5 6 7 6 5 6 5 6   EGFR G719S 5 5 5 4 5 5 5 6   DNA Std #3 KRAS G12D 5 5 5 4 4 4 4  6   KRAS G13D 5 5 5  5 5 5 5 4   KRAS Q61H 5 4 5 5 5 5 5 5   KRAS <m>A146T</m> 5 5 5 6 7 6 4 5   NRAS G12V 5 6 5 5 4 5 4 5   NRAS Q61K 5 6 6 4 6 6 5 4   "}], "citations": {"NLM": "Bartlett J, Amemiya Y, Arts H, Bayani J, Eng B, Grafodatskaya D, Kamel Reid S, Lariviere M, Lo B, McClure R, Mittal V, Sadikovic B, Sadis S, Seth A, Smith J, Zhang X, Feilotter H. Multisite verification of the accuracy of a multi-gene next generation sequencing panel for detection of mutations and copy number alterations in solid tumours. PLoS One. PMID: 34597339", "BibTeX": "@article{34597339, title={Multisite verification of the accuracy of a multi-gene next generation sequencing panel for detection of mutations and copy number alterations in solid tumours.}, author={Bartlett J and Amemiya Y and Arts H and Bayani J and Eng B and Grafodatskaya D and Kamel Reid S and Lariviere M and Lo B and McClure R and Mittal V and Sadikovic B and Sadis S and Seth A and Smith J and Zhang X and Feilotter H}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 28328955, "pmcid": "PMC5362218", "title": "Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA.", "journal": "PLoS One", "authors": ["Berger AW", "Schwerdel D", "Welz H", "Marienfeld R", "Schmidt SA", "Kleger A", "Ettrich TJ", "Seufferlein T"], "date": "2017-03-22T00:00:00Z", "year": 2017, "snippets": [{"_id": "28328955@12390", "snip_text": "Isolated cfDNA was amplified using ddPCR  Supermix for Probes (Bio-Rad , Hercules, California, USA) and the respective PrimePCR  ddPCR  Mutation Assay for KRAS p.A146T, KRAS p.A59T, KRAS p.Q61H, KRAS p.Q61L and the ddPCR  KRAS Screening Multiplex Kit (Bio-Rad , Hercules, California, USA) which covers the 7 most frequent KRAS mutations in colorectal cancer (KRAS p.G12A/G12C/G12D/G12R/G12S/G12V/G13D).", "section": "methods", "mentions": ["386|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "187|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "364|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "182|4|gene|ncbi_gene@3845|KRAS", "174|6|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|p.A59T", "391|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "322|4|gene|ncbi_gene@3845|KRAS", "169|4|gene|ncbi_gene@3845|KRAS", "155|4|gene|ncbi_gene@3845|KRAS", "396|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "340|17|disease|ncbi_mesh@D015179|colorectal cancer", "222|4|gene|ncbi_gene@3845|KRAS", "359|4|gene|ncbi_gene@3845|KRAS", "200|6|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|p.Q61L", "160|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "195|4|gene|ncbi_gene@3845|KRAS", "371|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "381|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "376|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D"], "text_hl": "Isolated cfDNA was amplified using ddPCR  Supermix for Probes (Bio-Rad , Hercules, California, USA) and the respective PrimePCR  ddPCR  Mutation Assay for KRAS <m>p.A146T</m>, KRAS p.A59T, KRAS p.Q61H, KRAS p.Q61L and the ddPCR  KRAS Screening Multiplex Kit (Bio-Rad , Hercules, California, USA) which covers the 7 most frequent KRAS mutations in colorectal cancer (KRAS p.G12A/G12C/G12D/G12R/G12S/G12V/G13D)."}], "citations": {"NLM": "Berger AW, Schwerdel D, Welz H, Marienfeld R, Schmidt SA, Kleger A, Ettrich TJ, Seufferlein T. Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA. PLoS One. PMID: 28328955", "BibTeX": "@article{28328955, title={Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA.}, author={Berger AW and Schwerdel D and Welz H and Marienfeld R and Schmidt SA and Kleger A and Ettrich TJ and Seufferlein T}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 33854968, "pmcid": "PMC8039443", "title": "KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer", "journal": "Front Oncol", "authors": ["Ottaiano A", "Nasti G", "Santorsola M", "Altieri V", "Di Fruscio G", "Circelli L", "Luce A", "Cossu AM", "Scognamiglio G", "Perri F", "Correra M", "Belli A", "Delrio P", "Botti G", "Caraglia M"], "date": "2021-03-29T00:00:00Z", "year": 2021, "snippets": [{"_id": "33854968@13894", "snip_text": "KRAS status in primary tumor\tTotal\tAge\tGender\tGrading\tSide of primary tumor\tpT*\tLymph nodes involvement (pN)*\t \t<65\t>=65\tM\tF\tG1/G2\tG3\tLeft\tRight\tT1/T2\tT3\tT4\t0\t1-3\t>3\t \tp.G12D\t63\t7\t12\t11\t8\t5\t14\t8\t11\t3\t9\t7\t2\t5\t12\t \tp.G13D\t5\t4\t3\t6\t1\t8\t4\t5\t1\t7\t1\t1\t7\t1\t \tp.G12V\t3\t4\t3\t4\t1\t6\t2\t5\t1\t5\t1\t0\t5\t2\t \tp.G12A\t3\t3\t3\t3\t1\t5\t2\t4\t1\t4\t1\t0\t3\t3\t \tp.G12C\t4\t2\t3\t3\t0\t6\t1\t5\t2\t3\t1\t1\t3\t2\t \tp.A146T\t3\t2\t3\t2\t1\t4\t2\t3\t0\t3\t2\t0\t2\t3\t \tp.G12S\t1\t3\t2\t2\t0\t4\t0\t4\t1\t2\t1\t1\t3\t0\t \tp.A146V\t1\t1\t1\t1\t0\t2\t0\t2\t1\t1\t0\t0\t2\t0\t \tp.G13R\t0\t2\t0\t2\t0\t2\t1\t1\t2\t0\t0\t1\t0\t1\t \tp.G13C\t0\t1\t1\t0\t1\t0\t1\t0\t0\t1\t1\t0\t1\t1\t \tp.K117N\t1\t0\t0\t1\t0\t1\t0\t1\t0\t0\t1\t1\t0\t0\t \tp.G12F\t1\t0\t1\t0\t0\t1\t1\t0\t1\t0\t0\t1\t0\t0\t \tWild-type\t51\t18\t23\t20\t21\t9\t32\t28\t23\t11\t21\t9\t15\t19\t17\t \t", "section": "table", "mentions": ["361|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "0|4|gene|ncbi_gene@3845|KRAS", "474|6|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|p.G13R", "511|6|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|p.G13C", "399|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "15|7|disease|ncbi_mesh@D010538|primary", "548|7|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.K117N", "213|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "287|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "168|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "250|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "586|6|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12F", "436|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "324|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "62|7|disease|ncbi_mesh@D010538|primary"], "figure_id": "T1", "text_hl": "KRAS status in primary tumor\tTotal\tAge\tGender\tGrading\tSide of primary tumor\tpT*\tLymph nodes involvement (pN)*\t \t<65\t>=65\tM\tF\tG1/G2\tG3\tLeft\tRight\tT1/T2\tT3\tT4\t0\t1-3\t>3\t \tp.G12D\t63\t7\t12\t11\t8\t5\t14\t8\t11\t3\t9\t7\t2\t5\t12\t \tp.G13D\t5\t4\t3\t6\t1\t8\t4\t5\t1\t7\t1\t1\t7\t1\t \tp.G12V\t3\t4\t3\t4\t1\t6\t2\t5\t1\t5\t1\t0\t5\t2\t \tp.G12A\t3\t3\t3\t3\t1\t5\t2\t4\t1\t4\t1\t0\t3\t3\t \tp.G12C\t4\t2\t3\t3\t0\t6\t1\t5\t2\t3\t1\t1\t3\t2\t \t<m>p.A146T</m>\t3\t2\t3\t2\t1\t4\t2\t3\t0\t3\t2\t0\t2\t3\t \tp.G12S\t1\t3\t2\t2\t0\t4\t0\t4\t1\t2\t1\t1\t3\t0\t \tp.A146V\t1\t1\t1\t1\t0\t2\t0\t2\t1\t1\t0\t0\t2\t0\t \tp.G13R\t0\t2\t0\t2\t0\t2\t1\t1\t2\t0\t0\t1\t0\t1\t \tp.G13C\t0\t1\t1\t0\t1\t0\t1\t0\t0\t1\t1\t0\t1\t1\t \tp.K117N\t1\t0\t0\t1\t0\t1\t0\t1\t0\t0\t1\t1\t0\t0\t \tp.G12F\t1\t0\t1\t0\t0\t1\t1\t0\t1\t0\t0\t1\t0\t0\t \tWild-type\t51\t18\t23\t20\t21\t9\t32\t28\t23\t11\t21\t9\t15\t19\t17\t \t"}], "citations": {"NLM": "Ottaiano A, Nasti G, Santorsola M, Altieri V, Di Fruscio G, Circelli L, Luce A, Cossu AM, Scognamiglio G, Perri F, Correra M, Belli A, Delrio P, Botti G, Caraglia M. KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer Front Oncol. PMID: 33854968", "BibTeX": "@article{33854968, title={KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer}, author={Ottaiano A and Nasti G and Santorsola M and Altieri V and Di Fruscio G and Circelli L and Luce A and Cossu AM and Scognamiglio G and Perri F and Correra M and Belli A and Delrio P and Botti G and Caraglia M}, journal={Front Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 39433569, "pmcid": "PMC11493959", "title": "Cancer treatment monitoring using cell-free DNA fragmentomes", "journal": "Nat Commun", "authors": ["van 't Erve I", "Alipanahi B", "Lumbard K", "Skidmore ZL", "Rinaldi L", "Millberg LK", "Carey J", "Chesnick B", "Cristiano S", "Portwood C", "Wu T", "Peters E", "Bolhuis K", "Punt CJA", "Tom J", "Bach PB", "Dracopoli NC", "Meijer GA", "Scharpf RB", "Velculescu VE", "Fijneman RJA", "Leal A"], "date": "2024-10-21T00:00:00Z", "year": 2024, "snippets": [{"_id": "39433569@37569", "snip_text": "The ddPCR  KRAS G12/G13 (#1863506), ddPCR  KRAS Q61 (#12001626), ddPCR  KRAS A146T (#10049550), ddPCRTM BRAF V600 (#12001037), NRAS G12/G13 (#12001627), and NRAS Q61 (#12001006) Screening Kits were purchased from Bio-Rad and used according to the manufacturer's instruction, using 9 microL of sample, 11 microL of ddPCR supermix for probes (no dUTP), 1 microL of the multiplex assay and 1 microL of nuclease-free water.", "section": "methods", "mentions": ["72|4|gene|ncbi_gene@3845|KRAS", "127|4|gene|ncbi_gene@4893|NRAS", "43|4|gene|ncbi_gene@3845|KRAS", "11|4|gene|ncbi_gene@3845|KRAS", "77|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "344|4|chemical|ncbi_mesh@C027078|dUTP", "413|5|chemical|ncbi_mesh@D014867|water", "157|4|gene|ncbi_gene@4893|NRAS", "104|4|gene|ncbi_gene@673|BRAF"], "text_hl": "The ddPCR  KRAS G12/G13 (#1863506), ddPCR  KRAS Q61 (#12001626), ddPCR  KRAS <m>A146T</m> (#10049550), ddPCRTM BRAF V600 (#12001037), NRAS G12/G13 (#12001627), and NRAS Q61 (#12001006) Screening Kits were purchased from Bio-Rad and used according to the manufacturer's instruction, using 9 microL of sample, 11 microL of ddPCR supermix for probes (no dUTP), 1 microL of the multiplex assay and 1 microL of nuclease-free water."}], "citations": {"NLM": "van 't Erve I, Alipanahi B, Lumbard K, Skidmore ZL, Rinaldi L, Millberg LK, Carey J, Chesnick B, Cristiano S, Portwood C, Wu T, Peters E, Bolhuis K, Punt CJA, Tom J, Bach PB, Dracopoli NC, Meijer GA, Scharpf RB, Velculescu VE, Fijneman RJA, Leal A. Cancer treatment monitoring using cell-free DNA fragmentomes Nat Commun. PMID: 39433569", "BibTeX": "@article{39433569, title={Cancer treatment monitoring using cell-free DNA fragmentomes}, author={van 't Erve I and Alipanahi B and Lumbard K and Skidmore ZL and Rinaldi L and Millberg LK and Carey J and Chesnick B and Cristiano S and Portwood C and Wu T and Peters E and Bolhuis K and Punt CJA and Tom J and Bach PB and Dracopoli NC and Meijer GA and Scharpf RB and Velculescu VE and Fijneman RJA and Leal A}, journal={Nat Commun}}"}, "is_sup_mat_match": false}, {"pmid": 37153900, "pmcid": "PMC10160916", "title": "Alisertib exerts KRAS allele-specific anticancer effects on colorectal cancer cell lines", "journal": "Exp Ther Med", "authors": ["Ren B", "Geng Y", "Chen S", "Gao Z", "Zheng K", "Yang Y", "Luo Q", "Feng J", "Luo Z", "Ju Y", "Huang Z"], "date": "2023-04-11T00:00:00Z", "year": 2023, "snippets": [{"_id": "37153900@349", "snip_text": "The viability of Caco-2KRAS wild-type, Colo-678KRAS G12D, SK-CO-1KRAS G12V, HCT116KRAS G13D, CCCL-18KRAS A146T and HT29BRAF V600E cells was examined by Cell Titer-Glo assay, and that of stable cell lines was monitored by IncuCyte.", "section": "abstract", "mentions": ["124|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "52|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "87|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "105|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "70|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V"], "text_hl": "The viability of Caco-2KRAS wild-type, Colo-678KRAS G12D, SK-CO-1KRAS G12V, HCT116KRAS G13D, CCCL-18KRAS <m>A146T</m> and HT29BRAF V600E cells was examined by Cell Titer-Glo assay, and that of stable cell lines was monitored by IncuCyte."}], "citations": {"NLM": "Ren B, Geng Y, Chen S, Gao Z, Zheng K, Yang Y, Luo Q, Feng J, Luo Z, Ju Y, Huang Z. Alisertib exerts KRAS allele-specific anticancer effects on colorectal cancer cell lines Exp Ther Med. PMID: 37153900", "BibTeX": "@article{37153900, title={Alisertib exerts KRAS allele-specific anticancer effects on colorectal cancer cell lines}, author={Ren B and Geng Y and Chen S and Gao Z and Zheng K and Yang Y and Luo Q and Feng J and Luo Z and Ju Y and Huang Z}, journal={Exp Ther Med}}"}, "is_sup_mat_match": false}, {"pmid": 30448735, "pmcid": "PMC6240710", "title": "A Pilot Prospective Study of Refractory Solid Tumor Patients for NGS-Based Targeted Anticancer Therapy.", "journal": "Transl Oncol", "authors": ["Seol YM", "Kwon CH", "Lee SJ", "Lee SJ", "Choi Y", "Choi YJ", "Kim H", "Park DY"], "date": "2018-11-15T00:00:00Z", "year": 2018, "snippets": [{"_id": "30448735@7712", "snip_text": "A KRAS A146 mutation was engineered into the pLenti-C-mGFP-P2A-puro vector using the QuickChange II Site-Directed Mutagenesis Kit (Agilent Technologies, CA, USA) according to the manufacturer's instructions.", "section": "methods", "mentions": ["126|3|gene|ncbi_gene@3815|Kit", "7|4|variant|litvar@rs121913527##&&&litvar@#3845#|A146", "2|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "A KRAS A146 mutation was engineered into the pLenti-C-mGFP-P2A-puro vector using the QuickChange II Site-Directed Mutagenesis Kit (Agilent Technologies, CA, USA) according to the manufacturer's instructions."}], "citations": {"NLM": "Seol YM, Kwon CH, Lee SJ, Lee SJ, Choi Y, Choi YJ, Kim H, Park DY. A Pilot Prospective Study of Refractory Solid Tumor Patients for NGS-Based Targeted Anticancer Therapy. Transl Oncol. PMID: 30448735", "BibTeX": "@article{30448735, title={A Pilot Prospective Study of Refractory Solid Tumor Patients for NGS-Based Targeted Anticancer Therapy.}, author={Seol YM and Kwon CH and Lee SJ and Lee SJ and Choi Y and Choi YJ and Kim H and Park DY}, journal={Transl Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 31344983, "pmcid": "PMC6721623", "title": "Microarray Approach Combined with ddPCR: An Useful Pipeline for the Detection and Quantification of Circulating Tumour dna Mutations.", "journal": "Cells", "authors": ["Galbiati S", "Damin F", "Ferraro L", "Soriani N", "Burgio V", "Ronzoni M", "Gianni L", "Ferrari M", "Chiari M"], "date": "2019-07-24T00:00:00Z", "year": 2019, "snippets": [{"_id": "31344983@10254", "snip_text": "The 5'-end amino-modified oligonucleotides (capture probes), corresponding to thirteen KRAS mutations (G12A, G12C, G12D, G12R, G12S, G12V, G13D, Q61H(A>C), Q61H (A>T), Q61K, Q61L, Q61R and A146T), eight NRAS mutations (G12A, G12C, G12D, G12S, G12V, G13D, G13R and G13V), BRAF mutation (V600E), wild-type sequences (for sequences see Reference) and a control oligonucleotide (COCU8), used as reference spots (Metabion International AG, Steinkirchen, Germany), were dissolved in the printing buffer (150 mM sodium phosphate pH 8.5, 0.01% Sucrose monolaurate) at a concentration of 10 microM and spotted on coated silicon chips by a piezoelectric spotter, SciFLEX ARRAYER S5 (Scienion, Berlin, Germany).", "section": "methods", "mentions": ["168|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "225|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "505|16|chemical|ncbi_mesh@C018279|sodium phosphate", "145|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "162|3|variant|litvar@#4893#|A>T", "611|7|chemical|ncbi_mesh@D012825|silicon", "219|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "115|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "127|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "237|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "255|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "231|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "249|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "203|4|gene|ncbi_gene@4893|NRAS", "139|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "536|19|chemical|ncbi_mesh@C018152|Sucrose monolaurate", "189|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "180|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "109|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "174|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "103|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "358|15|chemical|ncbi_mesh@D009841|oligonucleotide", "264|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "121|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "243|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "156|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "286|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "87|4|gene|ncbi_gene@3845|KRAS", "150|3|variant|litvar@#4893#|A>C", "133|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "271|4|gene|ncbi_gene@673|BRAF"], "text_hl": "The 5'-end amino-modified oligonucleotides (capture probes), corresponding to thirteen KRAS mutations (G12A, G12C, G12D, G12R, G12S, G12V, G13D, Q61H(A>C), Q61H (A>T), Q61K, Q61L, Q61R and <m>A146T</m>), eight NRAS mutations (G12A, G12C, G12D, G12S, G12V, G13D, G13R and G13V), BRAF mutation (V600E), wild-type sequences (for sequences see Reference) and a control oligonucleotide (COCU8), used as reference spots (Metabion International AG, Steinkirchen, Germany), were dissolved in the printing buffer (150 mM sodium phosphate pH 8.5, 0.01% Sucrose monolaurate) at a concentration of 10 microM and spotted on coated silicon chips by a piezoelectric spotter, SciFLEX ARRAYER S5 (Scienion, Berlin, Germany)."}], "citations": {"NLM": "Galbiati S, Damin F, Ferraro L, Soriani N, Burgio V, Ronzoni M, Gianni L, Ferrari M, Chiari M. Microarray Approach Combined with ddPCR: An Useful Pipeline for the Detection and Quantification of Circulating Tumour dna Mutations. Cells. PMID: 31344983", "BibTeX": "@article{31344983, title={Microarray Approach Combined with ddPCR: An Useful Pipeline for the Detection and Quantification of Circulating Tumour dna Mutations.}, author={Galbiati S and Damin F and Ferraro L and Soriani N and Burgio V and Ronzoni M and Gianni L and Ferrari M and Chiari M}, journal={Cells}}"}, "is_sup_mat_match": false}, {"pmid": 38929714, "pmcid": "PMC11204468", "title": "Exploring New Drug Repurposing Opportunities for MEK Inhibitors in RASopathies: A Comprehensive Review of Safety, Efficacy, and Future Perspectives of Trametinib and Selumetinib", "journal": "Life (Basel)", "authors": ["Gazzin A", "Fornari F", "Cardaropoli S", "Carli D", "Tartaglia M", "Ferrero GB", "Mussa A"], "date": "2024-06-06T00:00:00Z", "year": 2024, "snippets": [{"_id": "38929714@44633", "section": "table", "mentions": ["192|8|variant|litvar@rs869025189##&&&litvar@#6016#&&&litvar@CA353872#rs869025189##|c.104G>C", "5067|8|variant|litvar@rs730881014##&&&litvar@#6016#&&&litvar@CA297161#rs730881014##|c.246T>G", "6384|17|disease|ncbi_mesh@D002915|chylous effusions", "7357|23|disease|ncbi_mesh@D017443|Eczematous skin lesions", "1256|7|disease|ncbi_mesh@D003763|leakage", "1849|8|variant|litvar@rs80338796##&&&litvar@#5894#&&&litvar@CA235334#rs80338796##|c.770C>T", "912|4|gene|ncbi_gene@6654|SOS1", "1844|4|gene|ncbi_gene@5894|RAF1", "1966|3|disease|ncbi_mesh@D002312|HCM", "6126|4|gene|ncbi_gene@3845|KRAS", "7026|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.Gly12Asp", "2797|3|disease|ncbi_mesh@D002312|HCM", "3992|7|disease|ncbi_mesh@D001201|ascites", "300|3|gene|ncbi_gene@4879|BNP", "4982|3|disease|ncbi_mesh@D002312|HCM", "2106|4|gene|ncbi_gene@3845|KRAS", "805|12|disease||hypokaliemia", "187|4|gene|ncbi_gene@6016|RIT1", "6131|10|variant|litvar@rs121913527##&&&litvar@#3845#|c.436G > T", "3627|8|variant|litvar@rs730881014##&&&litvar@#6016#&&&litvar@CA297161#rs730881014##|c.246T>G", "4900|3|disease|ncbi_mesh@D002312|HCM", "1165|7|gene|ncbi_gene@213|albumin", "2111|10|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Gln61His", "4805|4|gene|ncbi_gene@6016|RIT1", "3292|11|variant|litvar@rs397517154##&&&litvar@#6654#&&&litvar@CA261728#rs397517154##|p.Arg552Thr", "419|8|variant|litvar@rs730881014##&&&litvar@#6016#&&&litvar@CA297161#rs730881014##|c.246T>G", "660|4|gene|ncbi_gene@369|ARAF", "3860|4|gene|ncbi_gene@6654|SOS1", "4307|17|disease|ncbi_mesh@D002915|Chylous effusions", "6271|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A>G", "3277|4|gene|ncbi_gene@6654|SOS1", "319|36|disease|ncbi_mesh@D006349|Valvular and subvalvular obstruction", "2882|4|gene|ncbi_gene@5894|RAF1", "4642|11|variant|litvar@rs397507549##&&&litvar@#5781#&&&litvar@CA273420#rs397507549##|p.Gln510Glu", "2964|3|disease|ncbi_mesh@D002312|HCM", "6114|4|gene|ncbi_gene@3845|KRAS", "4277|3|disease|ncbi_mesh@D002312|HCM", "917|9|variant|litvar@rs397517159##&&&litvar@#6654#&&&litvar@CA261734#rs397517159##|c.2536G>A", "5481|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A > G", "4329|7|disease|ncbi_mesh@D001201|ascites", "513|3|disease|ncbi_mesh@D002312|HCM", "2700|10|variant|litvar@rs672601334##&&&litvar@#6016#&&&litvar@CA144537#rs672601334##|p.Ala57Gly", "6759|11|variant|litvar@rs121913341##&&&litvar@#673#&&&litvar@CA295915#rs121913341##|p.Phe595Leu", "2437|9|variant|litvar@rs1159930961##&&&litvar@#2050#|c.2173G>A", "271|3|disease|ncbi_mesh@D002312|HCM", "4191|6|gene|ncbi_gene@5781|PTPN11", "5281|20|disease|ncbi_mesh@D010490|pericardial effusion", "1611|24|disease|ncbi_mesh@D008171|restrictive lung disease", "3865|9|variant|litvar@rs727504295##&&&litvar@#6654#&&&litvar@CA273441#rs727504295##|c.1322G>A", "5955|10|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.Gly13Asp", "3282|9|variant|litvar@rs397517154##&&&litvar@#6654#&&&litvar@CA261728#rs397517154##|c.1655G>C", "7225|12|disease|ncbi_mesh@D012871|skin lesions", "429|10|variant|litvar@rs730881014##&&&litvar@#6016#&&&litvar@CA297161#rs730881014##|p.Phe82Leu", "1346|3|gene|ncbi_gene@867|CBL", "7438|4|gene|ncbi_gene@4893|NRAS", "7021|4|gene|ncbi_gene@3845|KRAS", "4403|3|disease|ncbi_mesh@D002312|HCM", "6281|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Gln61Arg", "665|8|variant|litvar@rs746557535##&&&litvar@#2475#&&&litvar@CA590908#rs746557535##|c.640T>C", "3719|3|disease|ncbi_mesh@D002312|HCM", "674|11|variant|litvar@rs746557535##&&&litvar@#2475#|p.Ser214Pro", "1352|7|variant|litvar@#867#c.2322T>G&&&litvar@#867#|2322T>G", "5405|22|disease|ncbi_mesh@D018798|Iron deficiency anemia", "2887|8|variant|litvar@rs80338796##&&&litvar@#5894#&&&litvar@CA235334#rs80338796##|c.770C>T", "2834|3|disease|ncbi_mesh@D002312|HCM", "927|11|variant|litvar@rs397517159##&&&litvar@#6654#&&&litvar@CA261734#rs397517159##|p.Glu846Lys", "1689|17|disease|ncbi_mesh@D010996|pleural effusions", "2896|11|variant|litvar@rs80338796##&&&litvar@#5894#&&&litvar@CA235334#rs80338796##|p.Ser257Leu", "5493|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Gln61Arg", "547|36|disease|ncbi_mesh@D006349|valvular and subvalvular obstruction", "6142|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "2447|11|variant|litvar@rs1159930961##&&&litvar@#2050#|p.Ala725Thr", "1711|28|disease|ncbi_mesh@D011654|pulmonary interstitial edema", "201|10|variant|litvar@rs869025189##&&&litvar@#6016#&&&litvar@CA353872#rs869025189##|p.Ser35Thr", "5076|10|variant|litvar@rs730881014##&&&litvar@#6016#&&&litvar@CA297161#rs730881014##|p.Phe82Leu", "2691|8|variant|litvar@rs672601334##&&&litvar@#6016#&&&litvar@CA144537#rs672601334##|c.170C>G", "5062|4|gene|ncbi_gene@6016|RIT1", "5722|12|disease|ncbi_mesh@D012871|skin lesions", "3875|11|variant|litvar@rs727504295##&&&litvar@#6654#&&&litvar@CA273441#rs727504295##|p.Cys441Tyr", "2014|3|disease|ncbi_mesh@D002312|HCM", "5476|4|gene|ncbi_gene@4893|NRAS", "3622|4|gene|ncbi_gene@6016|RIT1", "499|3|disease|ncbi_mesh@D002312|HCM", "6266|4|gene|ncbi_gene@4893|NRAS", "594|17|disease|ncbi_mesh@D002915|Chylous effusions", "2686|4|gene|ncbi_gene@6016|RIT1", "4198|8|variant|litvar@rs121918463##&&&litvar@#5781#&&&litvar@CA204408#rs121918463##|c.854T>C", "7443|8|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Gln61Lys", "2046|9|chemical|ncbi_mesh@D004110|diltiazem", "3636|10|variant|litvar@rs730881014##&&&litvar@#6016#&&&litvar@CA297161#rs730881014##|p.Phe82Leu", "1225|15|disease|ncbi_mesh@D011654|Pulmonary edema", "4207|11|variant|litvar@rs121918463##&&&litvar@#5781#&&&litvar@CA204408#rs121918463##|p.Phe285Ser", "4574|20|disease|ncbi_mesh@D002318|sudden cardiac event", "414|4|gene|ncbi_gene@6016|RIT1", "285|3|disease|ncbi_mesh@D002312|HCM", "4622|6|gene|ncbi_gene@5781|PTPN11", "5950|4|gene|ncbi_gene@3845|KRAS", "2431|5|gene|ncbi_gene@2050|EPHB4", "528|3|gene|ncbi_gene@4879|BNP", "2031|10|chemical|ncbi_mesh@D000638|Amiodarone", "787|13|disease||Hyponatriemia", "5441|4|chemical|ncbi_mesh@D007501|iron", "1858|11|variant|litvar@rs80338796##&&&litvar@#5894#&&&litvar@CA235334#rs80338796##|p.Ser257Leu", "6754|4|gene|ncbi_gene@673|BRAF", "3806|3|gene|ncbi_gene@4879|BNP", "5253|7|disease|ncbi_mesh@D001201|ascites"], "figure_id": "life-14-00731-t001", "snip_text": "First Author and Year of Publication\tClinical Diagnosis\tGenotype\tAge \tDrug\tDose\tFirstImprovement\tChief Indication\tObservation Period\tTherapeutic Effect\tExitus\tAE\t \tAndelfinger, 2019 \t NS\tRIT1:c.104G>C p.Ser35Thr, Heterozygous\t14 weeks\tTrametinib\t0.020 mg/kg/day\t3 months\tHCM\t17 months\tHCM and NT-pro-BNP normalization. Valvular and subvalvular obstruction improved. Growth improvement.\t-\t-\t \tAndelfinger, 2019 \tNS\tRIT1:c.246T>G, p.Phe82Leu, Heterozygous\t13 weeks\tTrametinib\t0.027 mg/kg/day\t3 months\tHCM\t17 months\tHCM and NT-pro-BNP normalization, valvular and subvalvular obstruction improved. Chylous effusions ceased. Growth improvement.\t-\t-\t \tLi, 2019 \tGLA\tARAF:c.640T>C p.Ser214Pro, Heterozygous\t13 years\tTrametinib\t1 mg/day\t2 months\tCCLA\t1 year\tPulmonary function test improvement. Hyponatriemia and hypokaliemia resolution. Lymphatic remodeling with restructuring of lymphatic system.\t-\t-\t \tDori, 2020 \tNS\tSOS1:c.2536G>A p.Glu846Lys, Heterozygous\t5 years\tTrametinib\t0.010 mg/kg/day escalated to 0.02 mg/kg/day\t-\tBleeding retroperitoneal and duodenal lymphangiectasia, chylothorax.\t-\tSymptom resolution. Improvement in chest radiograph signs. Normalization of albumin and hemoglobin levels without need for transfusion. Pulmonary edema and intestinal leakage reduction. Complete normalization of the duodenal mucosa.\t-\t-\t \tFoster, 2020 \tKLA\tCBL:c.2322T>G p.Tyr774*, VAF 4% frequency (pleural effusion fluid)\t18 years\tTrametinib\t0.010 mg/kg/day in 28 day cycles, than daily\t1 week\tKLA with severe bilateral pulmonary interstitial and mediastinal perfusion\t12 months\tSubjectively improved symptoms. Improved restrictive lung disease. D-dimer value normalization. Complete resolution of pleural effusions and pulmonary interstitial edema.\t-\tGrade 1 acneiform rash, brief eosinophilia, and brief hematuria and proteinuria.\t \tMeisner, 2021 \tNS\tRAF1:c.770C>T p.Ser257Leu, Heterozygous\t20 weeks\tTrametinib\t0.025 mg/kg/day de-escalated to 0.01875 mg/kg/day\t2 days\tMAT, HCM, and chylothorax\t-\tMAT episodes resolution. HCM improvement. Amiodarone and diltiazem weaning.\t-\tSevere diarrhea.\t \tChang, 2021 \tCM-AVM\tKRAS p.Gln61His, low allele frequency consistent with mosaic origin (nasal epithelium)\t15 years\tTrametinib\tuptitration to 1.5 mg/day\t-\tHigh-flow facial AVM with epistaxis\t-\tClinical improvement and decreased epistaxis and need for RBC transfusion.\t-\tAcneiform eruptions and intermittent paronychia.\t \tNicholson, 2022 \tCM-AVM\tEPHB4:c.2173G>A p.Ala725Thr (unspecified sample)\t16 years\tTrametinib\t2 mg/day in 13 cycles of 28 days de escalated to 0.5 mg/day\t-\tCardiac compromise in CM-AVM\t-\tShunting improvement.\t-\tAcneiform eruptions, paronychia, air lightning.\t \tLeegaard, 2022 \tNS\tRIT1:c.170C>G p.Ala57Gly, Heterozygous\t6 months\tTrametinib\t0.025 mg/kg/day escalated to 0.04 mg/kg/day\t1 month\tHCM\t21 months\tComplete regression of HCM\t-\tDry skin and skin rash.\t \tMussa, 2022 \tNS\tRAF1:c.770C>T p.Ser257Leu, Heterozygous\t47 days\tTrametinib\t0.022 mg/kg/day\t4 days\tHCM\t57 days\tWeaning from mechanical ventilation, inotrope demand reduction, NT-proBNP values reduction, Ross score improvement, echocardiographic improvement with septal thickness reduction.\tRefractory congestive heart failure due to pulmonary hypertension and pulmonary artery dilatation.\t-\t \tLioncino, 2022 \tNS\tSOS1:c.1655G>C p.Arg552Thr, Heterozygous\t9 weeks\tTrametinib\t0.020 mg/kg/day\t4 days\tMAT and pleural effusion\t4 months\tPleural effusion resolution, incessant MAT episodes resolution with anti-arrhythmic withdrawn, improvement in respiratory parameters with ventilation weaning, significant reduction in consolidation areas.\t-\t-\t \tNakano, 2022 \tNS\tRIT1:c.246T>G p.Phe82Leu, Heterozygous\t4 years\tTrametinib\t0.025 mg/kg/day\t1 month\tChylotorax and HCM\t2 years(administration time 1 year)\tChylotorax reduction, slight decline in NT-pro-BNP value. Growth improvement.\t-\t-\t \tNakano, 2022 \tNS\tSOS1:c.1322G>A p.Cys441Tyr, Heterozygous\t3 months\tTrametinib\t0.026 mg/kg/day de-escalated to 0.013 mg/kg/day\t1 month\tChilotorax and ascites\t2 y (administration time 1 year)\tChylotorax reduction, ventilation weaning, gradual improvement in pulmonary valve stenosis. Growth improvement.\t-\tGrade 2 skin irritation.\t \tNakano, 2022 \tNS\tPTPN11:c.854T>C p.Phe285Ser, Heterozygous\t4 months\tTrametinib\t0.023 mg/kg/day\t1 month\tHCM and chylotorax\tfew months\tChylous effusions and ascites improvement. Cardiac function stabilization, NT-proBNP reduction, HCM partial improvement, slight improvement in the pulmonary valve gradient. Mechanical ventilation weaning.\tYes. Acute cardiorespiratory event. The suspected cause was a sudden cardiac event.\t-\t \tChakraborty, 2022 \tNS\tPTPN11(unspecified) p.Gln510Glu \t15 years\tSelumetinib\t6.7 mg/m2 twice a day\t-\tRefractory pulmonary and gastrointestinal bleeding\t1 year\tBleeding resolution.\t-\t-\t \tHribernik, 2022 \tNS\tRIT1 variant (unspecified), Heterozygous\t3 years\tTrametinib\t0.032 mg/kg/day \t-\tChylothorax and HCM\t8 months(Administration time 3 months)\tReduction in chest drainage frequency. HCM improvement.\t-\tSevere eczema and increased stoma output.\t \tGordon, 2022 \tNS\tRIT1:c.246T>G p.Phe82Leu, Heterozygous\t22 years\tTrametinib\t1 mg/day escalated to 2 mg/day\t3 months\tCCLA\t28 months\tDramatic and sustained clinical improvement. He showed a total resolution of ascites within 3 months and pericardial effusion resolve 18 months into treatment\t-\tMild nausea, gastritis, constipation, and eczema of the lower legs. Iron deficiency anemia requiring an iron infusion.\t \tCarli, 2022 \tCSHS\tNRAS:c.182A > G, p.Gln61Arg, VAF 29% (epidermal nevus)\t4 years\tTrametinib\t0.032 mg/kg/day de-escalated to 0.025 mg/kg/day\t11 days\tHypophosphatemic rickets and chylotorax\t-\tNormalization of serum phosphate and renal reabsorption., catch-up growth skin lesions, X-ray and densitometry bone mineralization improvement.\t-\tHungry bone syndrome, asymptomatic hyperkaliemia and mild asymptomatic creatinine phosphokinase (CPK) elevation.\t \tSheppard, 2023 \tOculoectodermal syndrome\tKRAS p.Gly13Asp, VAF 10.3-38.8% (hyperpigmented skin, periosteum, muscle, and humerus samples)\t-\tTrametinib\t0.025 mg/kg/day\t-\tCCLA\t-\t-\t-\t-\t \tSheppard, 2023 \tMosaic KRAS-opathy\tKRAS:c.436G > T p.Ala146Thr, VAF at 3.3-3.4% (scrotal tissue)\t-\tTrametinib\t0.005 mg/kg/day\t-\tCCLA\t-\t-\t-\tRhabdomyolysis\t \tChowers, 2023 \tKLA\tNRAS:c.182A>G, p.Gln61Arg, VAF 0.2% (unspecified sample)\t9 years\tTrametinib\t0.025 mg/kg/day\t-\tPericardial and pleural chylous effusions\t11 months\tSymptoms and signs improvement, increased Lansky performance test, increased body weight, improvement in lung function tests, radiological improvement, wean off nocturnal oxygen supplementation, platelets count normalization and D-dimer decrease, weaning of steroid therapy.\t-\tMild facial acneiform rash and hair loss.\t \tD'onofrio, 2023 \tCFC\tBRAF p.Phe595Leu, Heterozygous\t7 years\tTrametinib\t0.025 mg/kg/day\t3 months\tDrug-resistant, recurrent tonic-colonic seizures\t6 months\tDramatic reduction in electroencephalographic anomalies, marked clinical improvement.\t-\t-\t \tD'onofrio, 2023 \tSchimmelpenning syndrome\tKRAS p.Gly12Asp, postzygotic somatic (skin)\t26 months\tTrametinib\t0.025 mg/kg/day escalated to 0.0375 mg/kg/day de-escalated to 0.025 mg/kg/day\t-\tRight focal motor seizures\t22 months\tSeizure frequency and skin lesions dimension reduction.\t-\tSuspected drug induced inflammatory colitis and hypovolemic shock during viral gastroenteritis. Eczematous skin lesions.\t \tCopland, 2023 \tCongenital melanocytic naevus syndrome\tNRAS Gln61Lys (skin)\t13 months\tTrametinib\t0.032 mg/kg/die\t28 days\tFocal seizures\t1 year\tTransient seizure activity resolution, antiepileptic weaning, progression of motor skills, reduction in nevus pigmentation intensity. Progression of symptoms after 10 weeks of therapy.\t-\t-\t \t", "text_hl": "First Author and Year of Publication\tClinical Diagnosis\tGenotype\tAge \tDrug\tDose\tFirstImprovement\tChief Indication\tObservation Period\tTherapeutic Effect\tExitus\tAE\t \tAndelfinger, 2019 \t NS\tRIT1:c.104G>C p.Ser35Thr, Heterozygous\t14 weeks\tTrametinib\t0.020 mg/kg/day\t3 months\tHCM\t17 months\tHCM and NT-pro-BNP normalization. Valvular and subvalvular obstruction improved. Growth improvement.\t-\t-\t \tAndelfinger, 2019 \tNS\tRIT1:c.246T>G, p.Phe82Leu, Heterozygous\t13 weeks\tTrametinib\t0.027 mg/kg/day\t3 months\tHCM\t17 months\tHCM and NT-pro-BNP normalization, valvular and subvalvular obstruction improved. Chylous effusions ceased. Growth improvement.\t-\t-\t \tLi, 2019 \tGLA\tARAF:c.640T>C p.Ser214Pro, Heterozygous\t13 years\tTrametinib\t1 mg/day\t2 months\tCCLA\t1 year\tPulmonary function test improvement. Hyponatriemia and hypokaliemia resolution. Lymphatic remodeling with restructuring of lymphatic system.\t-\t-\t \tDori, 2020 \tNS\tSOS1:c.2536G>A p.Glu846Lys, Heterozygous\t5 years\tTrametinib\t0.010 mg/kg/day escalated to 0.02 mg/kg/day\t-\tBleeding retroperitoneal and duodenal lymphangiectasia, chylothorax.\t-\tSymptom resolution. Improvement in chest radiograph signs. Normalization of albumin and hemoglobin levels without need for transfusion. Pulmonary edema and intestinal leakage reduction. Complete normalization of the duodenal mucosa.\t-\t-\t \tFoster, 2020 \tKLA\tCBL:c.2322T>G p.Tyr774*, VAF 4% frequency (pleural effusion fluid)\t18 years\tTrametinib\t0.010 mg/kg/day in 28 day cycles, than daily\t1 week\tKLA with severe bilateral pulmonary interstitial and mediastinal perfusion\t12 months\tSubjectively improved symptoms. Improved restrictive lung disease. D-dimer value normalization. Complete resolution of pleural effusions and pulmonary interstitial edema.\t-\tGrade 1 acneiform rash, brief eosinophilia, and brief hematuria and proteinuria.\t \tMeisner, 2021 \tNS\tRAF1:c.770C>T p.Ser257Leu, Heterozygous\t20 weeks\tTrametinib\t0.025 mg/kg/day de-escalated to 0.01875 mg/kg/day\t2 days\tMAT, HCM, and chylothorax\t-\tMAT episodes resolution. HCM improvement. Amiodarone and diltiazem weaning.\t-\tSevere diarrhea.\t \tChang, 2021 \tCM-AVM\tKRAS p.Gln61His, low allele frequency consistent with mosaic origin (nasal epithelium)\t15 years\tTrametinib\tuptitration to 1.5 mg/day\t-\tHigh-flow facial AVM with epistaxis\t-\tClinical improvement and decreased epistaxis and need for RBC transfusion.\t-\tAcneiform eruptions and intermittent paronychia.\t \tNicholson, 2022 \tCM-AVM\tEPHB4:c.2173G>A p.Ala725Thr (unspecified sample)\t16 years\tTrametinib\t2 mg/day in 13 cycles of 28 days de escalated to 0.5 mg/day\t-\tCardiac compromise in CM-AVM\t-\tShunting improvement.\t-\tAcneiform eruptions, paronychia, air lightning.\t \tLeegaard, 2022 \tNS\tRIT1:c.170C>G p.Ala57Gly, Heterozygous\t6 months\tTrametinib\t0.025 mg/kg/day escalated to 0.04 mg/kg/day\t1 month\tHCM\t21 months\tComplete regression of HCM\t-\tDry skin and skin rash.\t \tMussa, 2022 \tNS\tRAF1:c.770C>T p.Ser257Leu, Heterozygous\t47 days\tTrametinib\t0.022 mg/kg/day\t4 days\tHCM\t57 days\tWeaning from mechanical ventilation, inotrope demand reduction, NT-proBNP values reduction, Ross score improvement, echocardiographic improvement with septal thickness reduction.\tRefractory congestive heart failure due to pulmonary hypertension and pulmonary artery dilatation.\t-\t \tLioncino, 2022 \tNS\tSOS1:c.1655G>C p.Arg552Thr, Heterozygous\t9 weeks\tTrametinib\t0.020 mg/kg/day\t4 days\tMAT and pleural effusion\t4 months\tPleural effusion resolution, incessant MAT episodes resolution with anti-arrhythmic withdrawn, improvement in respiratory parameters with ventilation weaning, significant reduction in consolidation areas.\t-\t-\t \tNakano, 2022 \tNS\tRIT1:c.246T>G p.Phe82Leu, Heterozygous\t4 years\tTrametinib\t0.025 mg/kg/day\t1 month\tChylotorax and HCM\t2 years(administration time 1 year)\tChylotorax reduction, slight decline in NT-pro-BNP value. Growth improvement.\t-\t-\t \tNakano, 2022 \tNS\tSOS1:c.1322G>A p.Cys441Tyr, Heterozygous\t3 months\tTrametinib\t0.026 mg/kg/day de-escalated to 0.013 mg/kg/day\t1 month\tChilotorax and ascites\t2 y (administration time 1 year)\tChylotorax reduction, ventilation weaning, gradual improvement in pulmonary valve stenosis. Growth improvement.\t-\tGrade 2 skin irritation.\t \tNakano, 2022 \tNS\tPTPN11:c.854T>C p.Phe285Ser, Heterozygous\t4 months\tTrametinib\t0.023 mg/kg/day\t1 month\tHCM and chylotorax\tfew months\tChylous effusions and ascites improvement. Cardiac function stabilization, NT-proBNP reduction, HCM partial improvement, slight improvement in the pulmonary valve gradient. Mechanical ventilation weaning.\tYes. Acute cardiorespiratory event. The suspected cause was a sudden cardiac event.\t-\t \tChakraborty, 2022 \tNS\tPTPN11(unspecified) p.Gln510Glu \t15 years\tSelumetinib\t6.7 mg/m2 twice a day\t-\tRefractory pulmonary and gastrointestinal bleeding\t1 year\tBleeding resolution.\t-\t-\t \tHribernik, 2022 \tNS\tRIT1 variant (unspecified), Heterozygous\t3 years\tTrametinib\t0.032 mg/kg/day \t-\tChylothorax and HCM\t8 months(Administration time 3 months)\tReduction in chest drainage frequency. HCM improvement.\t-\tSevere eczema and increased stoma output.\t \tGordon, 2022 \tNS\tRIT1:c.246T>G p.Phe82Leu, Heterozygous\t22 years\tTrametinib\t1 mg/day escalated to 2 mg/day\t3 months\tCCLA\t28 months\tDramatic and sustained clinical improvement. He showed a total resolution of ascites within 3 months and pericardial effusion resolve 18 months into treatment\t-\tMild nausea, gastritis, constipation, and eczema of the lower legs. Iron deficiency anemia requiring an iron infusion.\t \tCarli, 2022 \tCSHS\tNRAS:c.182A > G, p.Gln61Arg, VAF 29% (epidermal nevus)\t4 years\tTrametinib\t0.032 mg/kg/day de-escalated to 0.025 mg/kg/day\t11 days\tHypophosphatemic rickets and chylotorax\t-\tNormalization of serum phosphate and renal reabsorption., catch-up growth skin lesions, X-ray and densitometry bone mineralization improvement.\t-\tHungry bone syndrome, asymptomatic hyperkaliemia and mild asymptomatic creatinine phosphokinase (CPK) elevation.\t \tSheppard, 2023 \tOculoectodermal syndrome\tKRAS p.Gly13Asp, VAF 10.3-38.8% (hyperpigmented skin, periosteum, muscle, and humerus samples)\t-\tTrametinib\t0.025 mg/kg/day\t-\tCCLA\t-\t-\t-\t-\t \tSheppard, 2023 \tMosaic KRAS-opathy\tKRAS:c.436G > T <m>p.Ala146Thr</m>, VAF at 3.3-3.4% (scrotal tissue)\t-\tTrametinib\t0.005 mg/kg/day\t-\tCCLA\t-\t-\t-\tRhabdomyolysis\t \tChowers, 2023 \tKLA\tNRAS:c.182A>G, p.Gln61Arg, VAF 0.2% (unspecified sample)\t9 years\tTrametinib\t0.025 mg/kg/day\t-\tPericardial and pleural chylous effusions\t11 months\tSymptoms and signs improvement, increased Lansky performance test, increased body weight, improvement in lung function tests, radiological improvement, wean off nocturnal oxygen supplementation, platelets count normalization and D-dimer decrease, weaning of steroid therapy.\t-\tMild facial acneiform rash and hair loss.\t \tD'onofrio, 2023 \tCFC\tBRAF p.Phe595Leu, Heterozygous\t7 years\tTrametinib\t0.025 mg/kg/day\t3 months\tDrug-resistant, recurrent tonic-colonic seizures\t6 months\tDramatic reduction in electroencephalographic anomalies, marked clinical improvement.\t-\t-\t \tD'onofrio, 2023 \tSchimmelpenning syndrome\tKRAS p.Gly12Asp, postzygotic somatic (skin)\t26 months\tTrametinib\t0.025 mg/kg/day escalated to 0.0375 mg/kg/day de-escalated to 0.025 mg/kg/day\t-\tRight focal motor seizures\t22 months\tSeizure frequency and skin lesions dimension reduction.\t-\tSuspected drug induced inflammatory colitis and hypovolemic shock during viral gastroenteritis. Eczematous skin lesions.\t \tCopland, 2023 \tCongenital melanocytic naevus syndrome\tNRAS Gln61Lys (skin)\t13 months\tTrametinib\t0.032 mg/kg/die\t28 days\tFocal seizures\t1 year\tTransient seizure activity resolution, antiepileptic weaning, progression of motor skills, reduction in nevus pigmentation intensity. Progression of symptoms after 10 weeks of therapy.\t-\t-\t \t"}], "citations": {"NLM": "Gazzin A, Fornari F, Cardaropoli S, Carli D, Tartaglia M, Ferrero GB, Mussa A. Exploring New Drug Repurposing Opportunities for MEK Inhibitors in RASopathies: A Comprehensive Review of Safety, Efficacy, and Future Perspectives of Trametinib and Selumetinib Life (Basel). PMID: 38929714", "BibTeX": "@article{38929714, title={Exploring New Drug Repurposing Opportunities for MEK Inhibitors in RASopathies: A Comprehensive Review of Safety, Efficacy, and Future Perspectives of Trametinib and Selumetinib}, author={Gazzin A and Fornari F and Cardaropoli S and Carli D and Tartaglia M and Ferrero GB and Mussa A}, journal={Life (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 33562158, "pmcid": "PMC7915475", "title": "Small EVs-Associated DNA as Complementary Biomarker to Circulating Tumor DNA in Plasma of Metastatic Colorectal Cancer Patients", "journal": "Pharmaceuticals (Basel)", "authors": ["Galbiati S", "Damin F", "Brambilla D", "Ferraro L", "Soriani N", "Ferretti AM", "Burgio V", "Ronzoni M", "Vago R", "Sola L", "Chiari M"], "date": "2021-02-06T00:00:00Z", "year": 2021, "snippets": [{"_id": "33562158@7817", "snip_text": "Figure 1 shows microarray fluorescence images and ddPCR graphical results on three patient plasma samples with KRAS G12C (patient n. 7), KRAS A146T (patient n. 13), and KRAS G13D (patient n. 14) mutations.", "section": "results", "mentions": ["83|7|species|ncbi_taxonomy@9606|patient", "174|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "180|7|species|ncbi_taxonomy@9606|patient", "137|4|gene|ncbi_gene@3845|KRAS", "122|7|species|ncbi_taxonomy@9606|patient", "111|4|gene|ncbi_gene@3845|KRAS", "149|7|species|ncbi_taxonomy@9606|patient", "169|4|gene|ncbi_gene@3845|KRAS", "142|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "116|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C"], "text_hl": "Figure 1 shows microarray fluorescence images and ddPCR graphical results on three patient plasma samples with KRAS G12C (patient n. 7), KRAS <m>A146T</m> (patient n. 13), and KRAS G13D (patient n. 14) mutations."}], "citations": {"NLM": "Galbiati S, Damin F, Brambilla D, Ferraro L, Soriani N, Ferretti AM, Burgio V, Ronzoni M, Vago R, Sola L, Chiari M. Small EVs-Associated DNA as Complementary Biomarker to Circulating Tumor DNA in Plasma of Metastatic Colorectal Cancer Patients Pharmaceuticals (Basel). PMID: 33562158", "BibTeX": "@article{33562158, title={Small EVs-Associated DNA as Complementary Biomarker to Circulating Tumor DNA in Plasma of Metastatic Colorectal Cancer Patients}, author={Galbiati S and Damin F and Brambilla D and Ferraro L and Soriani N and Ferretti AM and Burgio V and Ronzoni M and Vago R and Sola L and Chiari M}, journal={Pharmaceuticals (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 38504345, "pmcid": "PMC10953092", "title": "Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques", "journal": "J Transl Med", "authors": ["Deycmar S", "Johnson BJ", "Ray K", "Schaaf GW", "Ryan DP", "Cullin C", "Dozier BL", "Ferguson B", "Bimber BN", "Olson JD", "Caudell DL", "Whitlow CT", "Solingapuram Sai KK", "Romero EC", "Villinger FJ", "Burgos AG", "Ainsworth HC", "Miller LD", "Hawkins GA", "Chou JW", "Gomes B", "Hettich M", "Ceppi M", "Charo J", "Cline JM"], "date": "2024-03-19T00:00:00Z", "year": 2024, "snippets": [{"_id": "38504345@35525", "snip_text": "ID\tTMB[mut/Mbp]\tSomatic\tGermline\t \tAPC\tAMER1\tKRAS\tBRAF\tTP53\tARID1A\tALK\tMLH1\tMSH2\tMSH6\tPMS2\tMLH1\tMSH2\tMSH6\tPMS2\t \tCRC_1\t40.71\tTMB high\t\tp.F173L_fs\tp.Q61R\t\t\tp.P1328R_fs p.H2020N\t\t\t\t\t\t\t\t\t\t \tCRC_2\t42.66\tTMB high\t\tp.R630L\tp.G12D\t\t\tp.A282V p.G859E\tp.R28S\t\t\t\tp.E745K\t\t\t\t\t \tCRC_3\t50.36\tTMB high\t\t\t\t\tp.M73W_fs\tp.Q423K p.S748N\tp.G902R\t\t\t\t\t\t\t\t\t \tCRC_4\t19.71\tTMB high\tp.A2120T\tp.Q978*\tp.G12S p.G13D\tp.R356Q\t\t\t\tp.S404Y\t\t\t\t\t\t\t\t \tCRC_5\t23.72\tTMB high\t\t\t\t\t\t\tp.G875R\t\t\t\t\tp.R516W\t\t\t\t \tCRC_6\t31.03\tTMB high\tp.R2759H\t\t\tp.P399L_fs\tp.R175H\t\t\tp.R497G_fs\t\t\tp.T680M\t\t\t\t\t \tCRC_7\t13.38\tTMB high\tp.R1450*\t\tp.A59T\t\t\tp.A273P_fs\t\t\t\t\t\t\t\t\t\t \tCRC_8\t15.52\tTMB high\tp.G721* p.T1556N_fs\t\tp.G12D\t\t\tp.G771S p.P1569L_fs\t\t\t\t\t\t\t\t\t\t \tCRC_9\t41.38\tTMB high\t\tp.A36V p.K238N p.K260N_fs p.A622P_fs\tp.G13D p.R68W\tp.P399L_fs\tp.M73W_fs p.A119V p.R175H p.R337H\tp.F2142S_fs\t\t\t\t\t\t\t\t\t\t \tCRC_10\t47.47\tTMB high\tp.L204I p.R2721H\tp.F173L_fs\tp.G12D p.A146T\tp.P399L_fs\tp.P142L\tp.L2240F p.A2238S\tp.Q500R\t\t\t\t\t\t\t\t\t \tCRC_11\t19.74\tTMB high\t\t\tp.A146T\t\t\t\t\t\t\t\t\t\t\t\t\t \tCRC_12\t32.17\tTMB high\tp.A1296T p.A1755V p.N1792M_fs\tp.F173L_fs\tp.G12D\t\t\tp.R1278* p.D1851T_fs\t\t\t\t\t\t\t\t\t\t \tCRC_13\t25.85\tTMB high\tp.N627L_fs\tp.F173L_fs\t\tp.R667Q\tp.M73W_fs\t\t\t\t\t\t\t\t\t\t\t \tCRC_14\t30.98\tTMB high\tp.Y796C p.R1687Q\t\t\t\tp.R273*\tp.P1569L_fs\t\t\t\t\t\t\t\t\t\t \tCRC_15\t17.66\tTMB high\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t \tCRC_16\t22.98\tTMB high\t\t\t\t\t\tp.P1408Q_fs\t\t\t\t\t\t\t\t\t\t \t\tO 29.71\t\t8/16\t7/16\t9/16\t5/16\t6/16\t10/16\t4/16\t2/16\t0/16\t0/16\t2/16\t1/16\t0/16\t0/16\t0/16\t \t", "section": "table", "mentions": ["209|7|variant|litvar@#5395#p.R630L&&&litvar@#5395#|p.R630L", "764|7|variant|litvar@rs267607875##&&&litvar@#4292#&&&litvar@CA7611#rs267607875##|p.P399L", "81|4|gene|ncbi_gene@2956|MSH6", "301|7|variant|litvar@rs878853708##&&&litvar@#2956#&&&litvar@CA10582053#rs878853708##|p.Q423K", "638|8|variant|litvar@#5395#p.T1556N&&&litvar@#5395#|p.T1556N", "976|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "908|7|variant|litvar@#5395#p.P142L&&&litvar@#5395#|p.P142L", "891|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1207|8|variant|litvar@#5395#p.R1687Q&&&litvar@#5395#|p.R1687Q", "291|6|variant|litvar@#5395#p.M73W&&&litvar@#5395#|p.M73W", "1038|8|variant|litvar@#5395#p.N1792M&&&litvar@#5395#|p.N1792M", "91|4|gene|ncbi_gene@698782|MLH1", "793|7|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|p.R175H", "720|7|variant|litvar@rs755878786##&&&litvar@#2956#&&&litvar@CA73549#rs755878786##|p.K238N", "55|4|gene|ncbi_gene@7157|TP53", "1020|8|variant|litvar@#5395#p.A1296T&&&litvar@#5395#|p.A1296T", "1147|7|variant|litvar@rs1060503143##&&&litvar@#5395#|p.R667Q", "660|7|variant|litvar@#5395#p.G771S&&&litvar@#5395#|p.G771S", "50|4|gene|ncbi_gene@673|BRAF", "67|3|gene|ncbi_gene@238|ALK", "1155|6|variant|litvar@#5395#p.M73W&&&litvar@#5395#|p.M73W", "488|8|variant|litvar@#5395#p.R2759H&&&litvar@#5395#|p.R2759H", "39|5|gene|ncbi_gene@139285|AMER1", "106|4|gene|ncbi_gene@5395|PMS2", "380|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "1135|7|variant|litvar@#5395#p.F173L&&&litvar@#5395#|p.F173L", "630|7|variant|litvar@rs63750722##&&&litvar@#4436#|p.G721*", "358|6|variant|litvar@rs1209752228##&&&litvar@#5395#|A2120T", "882|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "76|4|gene|ncbi_gene@4436|MSH2", "897|7|variant|litvar@rs267607875##&&&litvar@#4292#&&&litvar@CA7611#rs267607875##|p.P399L", "862|8|variant|litvar@#5395#p.R2721H&&&litvar@#5395#|p.R2721H", "373|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "801|7|variant|litvar@rs121912664##&&&litvar@#7157#&&&litvar@CA13#rs121912664##|p.R337H", "568|8|variant|litvar@#5395#p.R1450*&&&litvar@#5395#|p.R1450*", "1316|11|variant|litvar@#5395#p.P1408Q,FS&&&litvar@#5395#|p.P1408Q_fs", "728|7|variant|litvar@#5395#p.K260N&&&litvar@#5395#|p.K260N", "71|4|gene|ncbi_gene@698782|MLH1", "1061|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "713|6|variant|litvar@rs61756469##&&&litvar@#2956#&&&litvar@CA7963#rs61756469##|p.A36V", "86|4|gene|ncbi_gene@5395|PMS2", "1050|7|variant|litvar@#5395#p.F173L&&&litvar@#5395#|p.F173L", "499|7|variant|litvar@rs267607875##&&&litvar@#4292#&&&litvar@CA7611#rs267607875##|p.P399L", "750|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "871|7|variant|litvar@#5395#p.F173L&&&litvar@#5395#|p.F173L", "1029|8|variant|litvar@#5395#p.A1755V&&&litvar@#5395#|p.A1755V", "1079|11|variant|litvar@#5395#p.D1851T,FS&&&litvar@#5395#|p.D1851T_fs", "45|4|gene|ncbi_gene@3845|KRAS", "96|4|gene|ncbi_gene@4436|MSH2", "35|3|gene|ncbi_gene@324|APC", "101|4|gene|ncbi_gene@2956|MSH6", "454|7|variant|litvar@#4292#p.R516W&&&litvar@#4292#|p.R516W", "809|8|variant|litvar@#5395#p.F2142S&&&litvar@#5395#|p.F2142S", "785|7|variant|litvar@#5395#p.A119V&&&litvar@#5395#|p.A119V", "1227|11|variant|litvar@#5395#p.P1569L,FS&&&litvar@#5395#|p.P1569L_fs", "1124|7|variant|litvar@#5395#p.N627L&&&litvar@#5395#|p.N627L", "167|8|variant|litvar@#5395#p.H2020N&&&litvar@#5395#|p.H2020N", "739|7|variant|litvar@rs63750280##&&&litvar@#4436#&&&litvar@CA19474#rs63750280##|p.A622P", "234|7|variant|litvar@#5395#p.G859E&&&litvar@#5395#|p.G859E", "533|7|variant|litvar@#5395#p.T680M&&&litvar@#5395#|p.T680M", "317|7|variant|litvar@rs759589138##&&&litvar@#4436#|p.G902R", "925|8|variant|litvar@#5395#p.A2238S&&&litvar@#5395#|p.A2238S", "854|7|variant|litvar@#5395#p.L204I&&&litvar@#5395#|p.L204I", "775|9|variant|litvar@#5395#p.M73W,FS&&&litvar@#5395#|p.M73W_fs", "510|7|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|p.R175H", "757|6|variant|litvar@rs2287499##&&&litvar@#7157#|p.R68W", "916|8|variant|litvar@#5395#p.L2240F&&&litvar@#5395#|p.L2240F", "651|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "146|6|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|p.Q61R", "1199|7|variant|litvar@rs876660564##&&&litvar@#2956#&&&litvar@CA10578139#rs876660564##|p.Y796C", "60|6|gene|ncbi_gene@8289|ARID1A", "309|7|variant|litvar@rs786204073##&&&litvar@#4436#&&&litvar@CA20537#rs786204073##|p.S748N", "520|7|variant|litvar@rs200830026##&&&litvar@#4292#&&&litvar@CA29007#rs200830026##|p.R497G", "442|7|variant|litvar@rs775407589##&&&litvar@#2956#&&&litvar@CA69819#rs775407589##|p.G875R", "135|7|variant|litvar@#5395#p.F173L&&&litvar@#5395#|p.F173L", "934|7|variant|litvar@#5395#p.Q500R&&&litvar@#5395#|p.Q500R", "155|8|variant|litvar@#5395#p.P1328R&&&litvar@#5395#|p.P1328R"], "figure_id": "Tab2", "text_hl": "ID\tTMB[mut/Mbp]\tSomatic\tGermline\t \tAPC\tAMER1\tKRAS\tBRAF\tTP53\tARID1A\tALK\tMLH1\tMSH2\tMSH6\tPMS2\tMLH1\tMSH2\tMSH6\tPMS2\t \tCRC_1\t40.71\tTMB high\t\tp.F173L_fs\tp.Q61R\t\t\tp.P1328R_fs p.H2020N\t\t\t\t\t\t\t\t\t\t \tCRC_2\t42.66\tTMB high\t\tp.R630L\tp.G12D\t\t\tp.A282V p.G859E\tp.R28S\t\t\t\tp.E745K\t\t\t\t\t \tCRC_3\t50.36\tTMB high\t\t\t\t\tp.M73W_fs\tp.Q423K p.S748N\tp.G902R\t\t\t\t\t\t\t\t\t \tCRC_4\t19.71\tTMB high\tp.A2120T\tp.Q978*\tp.G12S p.G13D\tp.R356Q\t\t\t\tp.S404Y\t\t\t\t\t\t\t\t \tCRC_5\t23.72\tTMB high\t\t\t\t\t\t\tp.G875R\t\t\t\t\tp.R516W\t\t\t\t \tCRC_6\t31.03\tTMB high\tp.R2759H\t\t\tp.P399L_fs\tp.R175H\t\t\tp.R497G_fs\t\t\tp.T680M\t\t\t\t\t \tCRC_7\t13.38\tTMB high\tp.R1450*\t\tp.A59T\t\t\tp.A273P_fs\t\t\t\t\t\t\t\t\t\t \tCRC_8\t15.52\tTMB high\tp.G721* p.T1556N_fs\t\tp.G12D\t\t\tp.G771S p.P1569L_fs\t\t\t\t\t\t\t\t\t\t \tCRC_9\t41.38\tTMB high\t\tp.A36V p.K238N p.K260N_fs p.A622P_fs\tp.G13D p.R68W\tp.P399L_fs\tp.M73W_fs p.A119V p.R175H p.R337H\tp.F2142S_fs\t\t\t\t\t\t\t\t\t\t \tCRC_10\t47.47\tTMB high\tp.L204I p.R2721H\tp.F173L_fs\tp.G12D <m>p.A146T</m>\tp.P399L_fs\tp.P142L\tp.L2240F p.A2238S\tp.Q500R\t\t\t\t\t\t\t\t\t \tCRC_11\t19.74\tTMB high\t\t\t<m>p.A146T</m>\t\t\t\t\t\t\t\t\t\t\t\t\t \tCRC_12\t32.17\tTMB high\tp.A1296T p.A1755V p.N1792M_fs\tp.F173L_fs\tp.G12D\t\t\tp.R1278* p.D1851T_fs\t\t\t\t\t\t\t\t\t\t \tCRC_13\t25.85\tTMB high\tp.N627L_fs\tp.F173L_fs\t\tp.R667Q\tp.M73W_fs\t\t\t\t\t\t\t\t\t\t\t \tCRC_14\t30.98\tTMB high\tp.Y796C p.R1687Q\t\t\t\tp.R273*\tp.P1569L_fs\t\t\t\t\t\t\t\t\t\t \tCRC_15\t17.66\tTMB high\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t \tCRC_16\t22.98\tTMB high\t\t\t\t\t\tp.P1408Q_fs\t\t\t\t\t\t\t\t\t\t \t\tO 29.71\t\t8/16\t7/16\t9/16\t5/16\t6/16\t10/16\t4/16\t2/16\t0/16\t0/16\t2/16\t1/16\t0/16\t0/16\t0/16\t \t"}], "citations": {"NLM": "Deycmar S, Johnson BJ, Ray K, Schaaf GW, Ryan DP, Cullin C, Dozier BL, Ferguson B, Bimber BN, Olson JD, Caudell DL, Whitlow CT, Solingapuram Sai KK, Romero EC, Villinger FJ, Burgos AG, Ainsworth HC, Miller LD, Hawkins GA, Chou JW, Gomes B, Hettich M, Ceppi M, Charo J, Cline JM. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques J Transl Med. PMID: 38504345", "BibTeX": "@article{38504345, title={Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques}, author={Deycmar S and Johnson BJ and Ray K and Schaaf GW and Ryan DP and Cullin C and Dozier BL and Ferguson B and Bimber BN and Olson JD and Caudell DL and Whitlow CT and Solingapuram Sai KK and Romero EC and Villinger FJ and Burgos AG and Ainsworth HC and Miller LD and Hawkins GA and Chou JW and Gomes B and Hettich M and Ceppi M and Charo J and Cline JM}, journal={J Transl Med}}"}, "is_sup_mat_match": false}, {"pmid": 38623252, "pmcid": "PMC11016705", "title": "Correlation between NGS panel-based mutation results and clinical information in colorectal cancer patients", "journal": "Heliyon", "authors": ["Cheng B", "Xu L", "Zhang Y", "Yang H", "Liu S", "Ding S", "Zhao H", "Sui Y", "Wang C", "Quan L", "Liu J", "Liu Y", "Wang H", "Zheng Z", "Wu X", "Guo J", "Wen Z", "Zhang R", "Wang F", "Liu H", "Sun S"], "date": "2024-04-05T00:00:00Z", "year": 2024, "snippets": [{"_id": "38623252@24504", "snip_text": "In a sporadic study among young CRC patients, Abedalrhman Alkhateeb et al. found KRAS (G12V, G12D, A146T) and APC genes were pathogenic mutations.", "section": "discussion", "mentions": ["99|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "93|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "110|3|gene|ncbi_gene@324|APC", "81|4|gene|ncbi_gene@3845|KRAS", "32|3|disease|ncbi_mesh@D015179|CRC", "36|8|species|ncbi_taxonomy@9606|patients", "87|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V"], "text_hl": "In a sporadic study among young CRC patients, Abedalrhman Alkhateeb et al. found KRAS (G12V, G12D, <m>A146T</m>) and APC genes were pathogenic mutations."}], "citations": {"NLM": "Cheng B, Xu L, Zhang Y, Yang H, Liu S, Ding S, Zhao H, Sui Y, Wang C, Quan L, Liu J, Liu Y, Wang H, Zheng Z, Wu X, Guo J, Wen Z, Zhang R, Wang F, Liu H, Sun S. Correlation between NGS panel-based mutation results and clinical information in colorectal cancer patients Heliyon. PMID: 38623252", "BibTeX": "@article{38623252, title={Correlation between NGS panel-based mutation results and clinical information in colorectal cancer patients}, author={Cheng B and Xu L and Zhang Y and Yang H and Liu S and Ding S and Zhao H and Sui Y and Wang C and Quan L and Liu J and Liu Y and Wang H and Zheng Z and Wu X and Guo J and Wen Z and Zhang R and Wang F and Liu H and Sun S}, journal={Heliyon}}"}, "is_sup_mat_match": false}, {"pmid": 39390564, "pmcid": "PMC11465924", "title": "Mutational analysis differentiating sporadic carcinomas from colitis-associated colorectal carcinomas", "journal": "Cell Commun Signal", "authors": ["Dregelies T", "Haumaier F", "Sterlacci W", "Backert S", "Vieth M"], "date": "2024-10-10T00:00:00Z", "year": 2024, "snippets": [{"_id": "39390564@19988", "snip_text": "G12V (27.3%) and A146T (9.1%) were detected at the same rates in CAC and sCRC.", "section": "results", "mentions": ["17|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "73|4|disease|ncbi_mesh@D015179|sCRC", "0|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "65|3|disease|ncbi_mesh@D000083023|CAC"], "text_hl": "G12V (27.3%) and <m>A146T</m> (9.1%) were detected at the same rates in CAC and sCRC."}], "citations": {"NLM": "Dregelies T, Haumaier F, Sterlacci W, Backert S, Vieth M. Mutational analysis differentiating sporadic carcinomas from colitis-associated colorectal carcinomas Cell Commun Signal. PMID: 39390564", "BibTeX": "@article{39390564, title={Mutational analysis differentiating sporadic carcinomas from colitis-associated colorectal carcinomas}, author={Dregelies T and Haumaier F and Sterlacci W and Backert S and Vieth M}, journal={Cell Commun Signal}}"}, "is_sup_mat_match": false}, {"pmid": 26226847, "pmcid": "PMC4618462", "title": "Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers", "journal": "Mod Pathol", "authors": ["Haley L", "Tseng LH", "Zheng G", "Dudley J", "Anderson DA", "Azad NS", "Gocke CD", "Eshleman JR", "Lin MT"], "date": "2015-10-01T00:00:00Z", "year": 2015, "snippets": [{"_id": "26226847@11310", "snip_text": "One specimen showed 19% KRAS p.A146T (c.436G4 A), 34% PIK3CA p.V344M (c.1030G4 A), and 43% PIK3CA p.H1047R (c.3140A4 G) mutations and the other a 37% KRAS p.G12C (c.34G4 T) mutation.", "section": "results", "mentions": ["163|8|variant|litvar@#3845#c.34,4G>T&&&litvar@#3845#|c.34G4 T", "61|7|variant|litvar@rs1057519942##&&&litvar@#5290#|p.V344M", "29|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "98|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.H1047R", "91|6|gene|ncbi_gene@5290|PIK3CA", "155|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "38|9|variant|litvar@#4893#c.436,4G>A&&&litvar@#4893#|c.436G4 A", "54|6|gene|ncbi_gene@5290|PIK3CA", "150|4|gene|ncbi_gene@3845|KRAS", "24|4|gene|ncbi_gene@3845|KRAS", "70|10|variant|litvar@rs549712047##&&&litvar@#5894#|c.1030G4 A", "108|10|variant|litvar@#5290#c.3140,4A>G&&&litvar@#5290#|c.3140A4 G"], "text_hl": "One specimen showed 19% KRAS <m>p.A146T</m> (c.436G4 A), 34% PIK3CA p.V344M (c.1030G4 A), and 43% PIK3CA p.H1047R (c.3140A4 G) mutations and the other a 37% KRAS p.G12C (c.34G4 T) mutation."}], "citations": {"NLM": "Haley L, Tseng LH, Zheng G, Dudley J, Anderson DA, Azad NS, Gocke CD, Eshleman JR, Lin MT. Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers Mod Pathol. PMID: 26226847", "BibTeX": "@article{26226847, title={Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers}, author={Haley L and Tseng LH and Zheng G and Dudley J and Anderson DA and Azad NS and Gocke CD and Eshleman JR and Lin MT}, journal={Mod Pathol}}"}, "is_sup_mat_match": false}, {"pmid": 34804441, "pmcid": "PMC8577557", "title": "Gastrointestinal Myeloid Sarcoma a Case Presentation and Review of the Literature.", "journal": "Mediterr J Hematol Infect Dis", "authors": ["Kheirkhah P", "Avila-Rodriguez AM", "Radzik B", "Murga-Zamalloa C"], "date": "2021-11-01T00:00:00Z", "year": 2021, "snippets": [{"_id": "34804441@1942", "snip_text": "Molecular testing demonstrated mutations in SRF2, TET2, and KRAS genes (SRSF2 P95H, TET2 F1901Lfs*4, TET2 S585*, KRAS A146T).", "section": "other", "mentions": ["50|4|gene|ncbi_gene@54790|TET2", "113|4|gene|ncbi_gene@3845|KRAS", "118|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "72|5|gene|ncbi_gene@6427|SRSF2", "78|4|variant|litvar@rs751713049##&&&litvar@#6427#&&&litvar@CA8790422#rs751713049##|P95H", "60|4|gene|ncbi_gene@3845|KRAS", "101|4|gene|ncbi_gene@54790|TET2", "84|4|gene|ncbi_gene@54790|TET2"], "text_hl": "Molecular testing demonstrated mutations in SRF2, TET2, and KRAS genes (SRSF2 P95H, TET2 F1901Lfs*4, TET2 S585*, KRAS <m>A146T</m>)."}], "citations": {"NLM": "Kheirkhah P, Avila-Rodriguez AM, Radzik B, Murga-Zamalloa C. Gastrointestinal Myeloid Sarcoma a Case Presentation and Review of the Literature. Mediterr J Hematol Infect Dis. PMID: 34804441", "BibTeX": "@article{34804441, title={Gastrointestinal Myeloid Sarcoma a Case Presentation and Review of the Literature.}, author={Kheirkhah P and Avila-Rodriguez AM and Radzik B and Murga-Zamalloa C}, journal={Mediterr J Hematol Infect Dis}}"}, "is_sup_mat_match": false}, {"pmid": 35687294, "pmcid": "PMC9588466", "title": "Rare presentation of multiple thromboses in Erdheim-Chester disease: a case-based review.", "journal": "Int J Hematol", "authors": ["Liu Y", "Huang C", "Meng X", "Fang X", "Xie X", "Wang C", "Wang M"], "date": "2022-06-10T00:00:00Z", "year": 2022, "snippets": [{"_id": "35687294@10343", "snip_text": "The patient was also negative for the combined detection of the following KRAS/NRAS gene mutations: KRAS exon 2 mutations G12S/G12D and G12C/G12R/G12V/G12A/G13D; KRAS exon 3 mutations A59T/Q61K and Q61L/Q61R/Q61H; KRAS exon 4 mutation K117N/A146T/A146V/A146P; NRAS exon 2 mutations G12S/G12D, G12C G12V/G12A G13R/G13V and G13D; NRAS exon 3 mutation Q61K/Q61L/Q61R/Q61H; and NRAS exon 4 mutation A146T; and for the following five PIK3CA mutations: H1047R, H1047L, E542K, E545K, and E545D.", "section": "other", "mentions": ["122|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "395|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "260|4|gene|ncbi_gene@4893|NRAS", "253|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "100|4|gene|ncbi_gene@3845|KRAS", "429|6|gene|ncbi_gene@5290|PIK3CA", "447|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "141|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "214|4|gene|ncbi_gene@3845|KRAS", "146|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "235|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "298|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "156|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "293|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "303|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "151|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "4|7|species|ncbi_taxonomy@9606|patient", "308|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "74|4|gene|ncbi_gene@3845|KRAS", "349|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "470|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "198|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "184|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "241|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "313|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "322|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "354|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "203|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "189|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "359|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "79|4|gene|ncbi_gene@4893|NRAS", "208|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "282|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "162|4|gene|ncbi_gene@3845|KRAS", "364|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "374|4|gene|ncbi_gene@4893|NRAS", "287|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "455|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|H1047L", "481|5|variant|litvar@rs121913275##&&&litvar@#5290#&&&litvar@CA210104#rs121913275##|E545D", "328|4|gene|ncbi_gene@4893|NRAS", "463|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "247|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "127|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "136|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C"], "text_hl": "The patient was also negative for the combined detection of the following KRAS/NRAS gene mutations: KRAS exon 2 mutations G12S/G12D and G12C/G12R/G12V/G12A/G13D; KRAS exon 3 mutations A59T/Q61K and Q61L/Q61R/Q61H; KRAS exon 4 mutation K117N/<m>A146T</m>/A146V/A146P; NRAS exon 2 mutations G12S/G12D, G12C G12V/G12A G13R/G13V and G13D; NRAS exon 3 mutation Q61K/Q61L/Q61R/Q61H; and NRAS exon 4 mutation <m>A146T</m>; and for the following five PIK3CA mutations: H1047R, H1047L, E542K, E545K, and E545D."}], "citations": {"NLM": "Liu Y, Huang C, Meng X, Fang X, Xie X, Wang C, Wang M. Rare presentation of multiple thromboses in Erdheim-Chester disease: a case-based review. Int J Hematol. PMID: 35687294", "BibTeX": "@article{35687294, title={Rare presentation of multiple thromboses in Erdheim-Chester disease: a case-based review.}, author={Liu Y and Huang C and Meng X and Fang X and Xie X and Wang C and Wang M}, journal={Int J Hematol}}"}, "is_sup_mat_match": false}, {"pmid": 34239564, "pmcid": "PMC8233098", "title": "Pretreatment 18F-FDG PET/CT Imaging Predicts the KRAS/NRAS/BRAF Gene Mutational Status in Colorectal Cancer.", "journal": "J Oncol", "authors": ["He P", "Zou Y", "Qiu J", "Yang T", "Peng L", "Zhang X"], "date": "2021-06-18T00:00:00Z", "year": 2021, "snippets": [{"_id": "34239564@9178", "snip_text": "The mutation information of exon 2 of KRAS mutations includes Gly12Ser, Gly12Asp, Gly12Ala, Gly12Cys, Gly12Arg, Gly12Val, Gly13Asp, and Gly13Asp; exon 3 includes Ala59Thr, Gln61Lys, Gln61Leu, Gln61Arg, and Gln61His; and exon 4 includes Lys117Asn, Ala146Thr, Ala146Val, and Ala146Pro.", "section": "methods", "mentions": ["136|8|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|Gly13Asp", "72|8|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|Gly12Asp", "182|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Gln61Leu", "102|8|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|Gly12Arg", "192|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Gln61Arg", "112|8|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|Gly12Val", "162|8|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|Ala59Thr", "82|8|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|Gly12Ala", "206|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Gln61His", "62|8|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|Gly12Ser", "172|8|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Gln61Lys", "247|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|Ala146Thr", "258|9|variant|litvar@rs1057519725##&&&litvar@#3845#|Ala146Val", "122|8|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|Gly13Asp", "38|4|gene|ncbi_gene@3845|KRAS", "92|8|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|Gly12Cys", "236|9|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|Lys117Asn", "273|9|variant|litvar@rs121913527##&&&litvar@#3845#|Ala146Pro"], "text_hl": "The mutation information of exon 2 of KRAS mutations includes Gly12Ser, Gly12Asp, Gly12Ala, Gly12Cys, Gly12Arg, Gly12Val, Gly13Asp, and Gly13Asp; exon 3 includes Ala59Thr, Gln61Lys, Gln61Leu, Gln61Arg, and Gln61His; and exon 4 includes Lys117Asn, <m>Ala146Thr</m>, Ala146Val, and Ala146Pro."}], "citations": {"NLM": "He P, Zou Y, Qiu J, Yang T, Peng L, Zhang X. Pretreatment 18F-FDG PET/CT Imaging Predicts the KRAS/NRAS/BRAF Gene Mutational Status in Colorectal Cancer. J Oncol. PMID: 34239564", "BibTeX": "@article{34239564, title={Pretreatment 18F-FDG PET/CT Imaging Predicts the KRAS/NRAS/BRAF Gene Mutational Status in Colorectal Cancer.}, author={He P and Zou Y and Qiu J and Yang T and Peng L and Zhang X}, journal={J Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 28958387, "pmcid": "PMC5824632", "title": "KRAS Alleles: The Devil Is In The Detail", "journal": "Trends Cancer", "authors": ["Haigis KM"], "date": "2017-10-01T00:00:00Z", "year": 2017, "snippets": [{"_id": "28958387@3876", "snip_text": "Interestingly, when looking across the entire spectrum of cancers, mutations at codons 146 (A146T or A146V) and 117 (K117N or K117R) are nearly selective for CRC relative to other cancer types (Box 1).", "section": "other", "mentions": ["101|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "158|3|disease|ncbi_mesh@D015179|CRC", "126|5|variant|litvar@rs104894227##&&&litvar@#3265#&&&litvar@CA256490#rs104894227##|K117R", "58|7|disease|ncbi_mesh@D009369|cancers", "92|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "180|6|disease|ncbi_mesh@D009369|cancer", "117|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N"], "text_hl": "Interestingly, when looking across the entire spectrum of cancers, mutations at codons 146 (<m>A146T</m> or A146V) and 117 (K117N or K117R) are nearly selective for CRC relative to other cancer types (Box 1)."}], "citations": {"NLM": "Haigis KM. KRAS Alleles: The Devil Is In The Detail Trends Cancer. PMID: 28958387", "BibTeX": "@article{28958387, title={KRAS Alleles: The Devil Is In The Detail}, author={Haigis KM}, journal={Trends Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 37007070, "pmcid": "PMC10060882", "title": "Somatic mutation detection and KRAS amplification in testicular germ cell tumors", "journal": "Front Oncol", "authors": ["Cabral ERM", "Pacanhella MF", "Lengert AVH", "Dos Reis MB", "Leal LF", "de Lima MA", "da Silva ALV", "Pinto IA", "Reis RM", "Pinto MT", "C\u00e1rcano FM"], "date": "2023-03-16T00:00:00Z", "year": 2023, "snippets": [{"_id": "37007070@22876", "snip_text": "The A146T variant was identified in non-seminoma case (staging III and intermediate risk) (Figures 3A-D; Table S2).", "section": "results", "mentions": ["4|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "The <m>A146T</m> variant was identified in non-seminoma case (staging III and intermediate risk) (Figures 3A-D; Table S2)."}], "citations": {"NLM": "Cabral ERM, Pacanhella MF, Lengert AVH, Dos Reis MB, Leal LF, de Lima MA, da Silva ALV, Pinto IA, Reis RM, Pinto MT, C\u00e1rcano FM. Somatic mutation detection and KRAS amplification in testicular germ cell tumors Front Oncol. PMID: 37007070", "BibTeX": "@article{37007070, title={Somatic mutation detection and KRAS amplification in testicular germ cell tumors}, author={Cabral ERM and Pacanhella MF and Lengert AVH and Dos Reis MB and Leal LF and de Lima MA and da Silva ALV and Pinto IA and Reis RM and Pinto MT and C\u00e1rcano FM}, journal={Front Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 35096426, "pmcid": "PMC8799359", "title": "Prognostic Impact of Tumor Budding on Moroccan Colon Cancer Patients", "journal": "Int J Surg Oncol", "authors": ["El Agy F", "El Bardai S", "Bouguenouch L", "Lahmidani N", "El Abkari M", "Benjelloun EB", "Ousadden A", "Mazaz K", "ImaneToughrai", "Ibrahimi SA", "Benbrahim Z", "Chbani L"], "date": "2022-01-21T00:00:00Z", "year": 2022, "snippets": [{"_id": "35096426@14750", "snip_text": "Among KRAS variants, G12D was the most frequent (11/31, 35.5%), followed by G13D (8/31, 25.8%), G12C (4/31, 12.9%), A146T (3/31, 9.7%), G12V (2/31, 6.5%), G12R (1/31, 3.2%), G12A (1/31, 3.2%), and G13V (1/31, 3.2%).", "section": "results", "mentions": ["76|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "116|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "197|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "174|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "96|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "155|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "136|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "6|4|gene|ncbi_gene@3845|KRAS", "21|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D"], "text_hl": "Among KRAS variants, G12D was the most frequent (11/31, 35.5%), followed by G13D (8/31, 25.8%), G12C (4/31, 12.9%), <m>A146T</m> (3/31, 9.7%), G12V (2/31, 6.5%), G12R (1/31, 3.2%), G12A (1/31, 3.2%), and G13V (1/31, 3.2%)."}], "citations": {"NLM": "El Agy F, El Bardai S, Bouguenouch L, Lahmidani N, El Abkari M, Benjelloun EB, Ousadden A, Mazaz K, ImaneToughrai, Ibrahimi SA, Benbrahim Z, Chbani L. Prognostic Impact of Tumor Budding on Moroccan Colon Cancer Patients Int J Surg Oncol. PMID: 35096426", "BibTeX": "@article{35096426, title={Prognostic Impact of Tumor Budding on Moroccan Colon Cancer Patients}, author={El Agy F and El Bardai S and Bouguenouch L and Lahmidani N and El Abkari M and Benjelloun EB and Ousadden A and Mazaz K and ImaneToughrai and Ibrahimi SA and Benbrahim Z and Chbani L}, journal={Int J Surg Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 34575870, "pmcid": "PMC8468737", "title": "Building Personalized Cancer Therapeutics through Multi-Omics Assays and Bacteriophage-Eukaryotic Cell Interactions", "journal": "Int J Mol Sci", "authors": ["Wang Q"], "date": "2021-09-08T00:00:00Z", "year": 2021, "snippets": [{"_id": "34575870@40043", "snip_text": "DNA Change\tType\tConsequences\tPercentage in Cancer Patients\t \tchr7:g.140753336A>T\tSubstitution\tMissense BRAF V600E\t4.93%\t \tchr2:g.208248388C>T\tSubstitution\tMissense IDH1 R132H\t3.15%\t \tchr12:g.25245350C>T\tSubstitution\tMissense KRAS G12D\t2.61%\t \tchr3:g.179218303G>A\tSubstitution\tMissense PIK3CA E545K\t2.34%\t \tchr3:g.179234297A>G\tSubstitution\tMissense PIK3CA H1047R\t2.22%\t \tchr12:g.25245350C>A\tSubstitution\tMissense KRAS G12V\t2.06%\t \tchr3:g.179218294G>A\tSubstitution\tMissense PIK3CA E542K\t1.50%\t \tchr17:g.7675088C>T\tSubstitution\tMissense TP53 R175H\t1.49%\t \tchr1:g.114713908T>C\tSubstitution\tMissense NRAS Q61R\t1.44%\t \tchr17:g.7674220C>T\tSubstitution\tMissense TP53 R248Q\t1.16%\t \tchr17:g.7673803G>A\tSubstitution\tMissense TP53 R273C\t1.13%\t \tchr1:g.114713909G>T\tSubstitution\tMissense NRAS Q61K\t0.97%\t \tchr12:g.25245351C>A\tSubstitution\tMissense KRAS G12C\t0.97%\t \tchr12:g.25245347C>T\tSubstitution\tMissense KRAS G13D\t0.95%\t \tchr1:g.6197725delT\tDeletion\tFrameshift RPL22 K15Rfs*5\t0.93%\t \tchr17:g.7673802C>T\tSubstitution\tMissense TP53 R273H\t0.91%\t \tchr17:g.7674221G>A\tSubstitution\tMissense TP53 R248W\t0.89%\t \tchr17:g.58357800delC\tDeletion\tFrameshift RNF43 G659Vfs*41\t0.89%\t \tchr17:g.7673776G>A\tSubstitution\tMissense TP53 R282W\t0.83%\t \tchr17:g.7674894G>A\tSubstitution\tStop Gained TP53 R213*\t0.72%\t \tchr6:g.167003333delT\tDeletion\tIntron FGFR1OP\t0.69%\t \tchr12:g.25227341T>G\tSubstitution\tMissense KRAS Q61H\t0.66%\t \tchr17:g.7674872T>C\tSubstitution\tMissense TP53 Y220C\t0.65%\t \tchr10:g.87965537delT\tDeletion\t3 Prime UTR PTEN\t0.64%\t \tchr3:g.179199088G>A\tSubstitution\tMissense PIK3CA R88Q\t0.62%\t \tchr1:g.64841314delT\tDeletion\tFrameshift JAK1 K860Nfs*16\t0.57%\t \tchr12:g.25245351C>G\tSubstitution\tMissense KRAS G12R\t0.54%\t \tchr17:g.7674945G>A\tSubstitution\tStop Gained TP53 R196*\t0.53%\t \tchr17:g.20204950delA\tDeletion\tFrameshift SPECC1 N303Tfs*63\t0.50%\t \tchr2:g.208248389G>A\tSubstitution\tMissense IDH1 R132C\t0.49%\t \tchr10:g.87933148G>A\tSubstitution\tMissense PTEN R130Q\t0.47%\t \tchr14:g.104780214C>T\tSubstitution\tMissense AKT1 E17K\t0.47%\t \tchr9:g.21971121G>A\tSubstitution\tStop Gained CDKN2A R80*\t0.45%\t \tchr12:g.25245350C>G\tSubstitution\tMissense KRAS G12A\t0.45%\t \tchr17:g.7674230C>T\tSubstitution\tMissense TP53 G245S\t0.42%\t \tchr10:g.87933147C>G\tSubstitution\tMissense PTEN R130G\t0.41%\t \tchr5:g.112839942C>T\tSubstitution\tStop Gained APC R1450*\t0.41%\t \tchr17:g.7675076T>C\tSubstitution\tMissense TP53 H179R\t0.41%\t \tchr5:g.159099589delT\tDeletion\t5 Prime UTR EBF1\t0.39%\t \tchr10:g.87957915C>T\tSubstitution\tStop Gained PTEN R233*\t0.37%\t \tchr3:g.179234297A>T\tSubstitution\tMissense PIK3CA H1047L\t0.34%\t \tchr4:g.152328233G>A\tSubstitution\tMissense FBXW7 R465C\t0.33%\t \tchr7:g.140753337C>T\tSubstitution\tMissense BRAF V600M\t0.33%\t \tchr8:g.102277121delT\tDeletion\tFrameshift UBR5 E2121Kfs*28\t0.33%\t \tchr17:g.7670685G>A\tSubstitution\tStop Gained TP53 R342*\t0.33%\t \tchr16:g.67611435_67611436insA\tInsertion\tFrameshift CTCF T204Nfs*26\t0.33%\t \tchr14:g.55684263delA\tDeletion\t3 Prime UTR KTN1\t0.32%\t \tchr12:g.25245351C>T\tSubstitution\tMissense KRAS G12S\t0.32%\t \tchr17:g.7673704G>A\tSubstitution\tStop Gained TP53 R306*\t0.32%\t \tchr4:g.1801841C>G\tSubstitution\tMissense FGFR3 S249C\t0.32%\t \tchr3:g.179203765T>A\tSubstitution\tMissense PIK3CA N345K\t0.31%\t \tchr17:g.7674953T>C\tSubstitution\tMissense TP53 H193R\t0.30%\t \tchr17:g.7675143C>A\tSubstitution\tMissense TP53 V157F\t0.30%\t \tchrX:g.77508202delA\tDeletion\t3 Prime UTR ATRX\t0.30%\t \tchr7:g.55191822T>G\tSubstitution\tMissense EGFR L858R\t0.30%\t \tchr17:g.39711955C>T\tSubstitution\tMissense ERBB2 S310F\t0.30%\t \tchr1:g.114716124C>G\tSubstitution\tMissense NRAS G13R\t0.30%\t \tchr19:g.3118944A>T\tSubstitution\tMissense GNA11 Q209L\t0.30%\t \tchr1:g.26779440delG\tDeletion\tFrameshift ARID1A D1850Tfs*33\t0.29%\t \tchr1:g.26779863C>T\tSubstitution\tStop Gained ARID1A R1989*\t0.29%\t \tchr5:g.112840254_112840255insA\tInsertion\tFrameshift APC T1556Nfs*3\t0.29%\t \tchr19:g.52212718C>G\tSubstitution\tMissense PPP2R1A P179R\t0.28%\t \tchr2:g.222201320delT\tDeletion\tIntron PAX3\t0.28%\t \tchrX:g.40062191T>C\tSubstitution\tMissense BCOR N1459S\t0.28%\t \tchr1:g.114716126C>T\tSubstitution\tMissense NRAS G12D\t0.27%\t \tchr4:g.152328232C>T\tSubstitution\tMissense FBXW7 R465H\t0.27%\t \tchr10:g.87933147C>T\tSubstitution\tStop Gained PTEN R130*\t0.26%\t \tchr17:g.7675994C>A\tSubstitution\tSplice Region TP53 T125T\t0.26%\t \tchr3:g.179221146G>A\tSubstitution\tMissense PIK3CA E726K\t0.26%\t \tchr17:g.7675124T>C\tSubstitution\tMissense TP53 Y163C\t0.26%\t \tchr5:g.158698822delA\tDeletion\t3 Prime UTR EBF1\t0.26%\t \tchr12:g.132676598G>C\tSubstitution\tMissense POLE P286R\t0.26%\t \tchr1:g.114713908T>A\tSubstitution\tMissense NRAS Q61L\t0.26%\t \tchr12:g.4301917delT\tDeletion\t3 Prime UTR CCND2\t0.25%\t \tchr12:g.49040709delG\tDeletion\tFrameshift KMT2D P2354Lfs*30\t0.25%\t \tchr10:g.87958013delA\tDeletion\tFrameshift PTEN K267Rfs*9\t0.25%\t \tchr10:g.87961042delTACT\tDeletion\tFrameshift PTEN T319*\t0.24%\t \tchr14:g.65076348delA\tDeletion\t3 Prime UTR MAX\t0.24%\t \tchr9:g.77794572T>G\tSubstitution\tMissense GNAQ Q209P\t0.24%\t \tchr11:g.533874T>C\tSubstitution\tMissense HRAS Q61R\t0.24%\t \tchr3:g.179199690G>A\tSubstitution\tMissense PIK3CA G118D\t0.24%\t \tchr13:g.39343745delT\tDeletion\t3 Prime UTR LHFP\t0.24%\t \tchr17:g.7673802C>A\tSubstitution\tMissense TP53 R273L\t0.24%\t \tchr17:g.7675085C>A\tSubstitution\tMissense TP53 C176F\t0.23%\t \tchr10:g.121520163G>C\tSubstitution\tMissense FGFR2 S252W\t0.23%\t \tchr9:g.21971187G>A\tSubstitution\tStop Gained CDKN2A R58*\t0.23%\t \tchr7:g.91973771delA\tDeletion\tFrameshift AKAP9 K39Rfs*17\t0.23%\t \tchr2:g.60458275delT\tDeletion\t3 Prime UTR BCL11A\t0.23%\t \tchr4:g.152326137G>C\tSubstitution\tMissense FBXW7 R505G\t0.23%\t \tchr12:g.25225628C>T\tSubstitution\tMissense KRAS A146T\t0.23%\t \tchr17:g.7674947A>G\tSubstitution\tMissense TP53 I195T\t0.23%\t \tchr5:g.112838220C>T\tSubstitution\tStop Gained APC R876*\t0.22%\t \tchr17:g.7674957G>A\tSubstitution\tStop Gained TP53 Q192*\t0.22%\t \tchr4:g.105240988delT\tDeletion\tIntron TET2\t0.22%\t \tchr17:g.7674216C>A\tSubstitution\tMissense TP53 R249S\t0.22%\t \tchr3:g.181713439delA\tDeletion\t3 Prime UTR SOX2\t0.22%\t \tchr3:g.41224622C>T\tSubstitution\tMissense CTNNB1 S37F\t0.22%\t \tchr17:g.7673767C>T\tSubstitution\tMissense TP53 E285K\t0.22%\t \tchr5:g.112838934C>T\tSubstitution\tStop Gained APC R1114*\t0.22%\t \tchr17:g.7675085C>T\tSubstitution\tMissense TP53 C176Y\t0.22%\t \t\t\tTotal\t58.23%\t \t", "section": "table", "mentions": ["5636|14|variant|litvar@#3105#g.112838220C>T&&&litvar@#3105#|g.112838220C>T", "738|14|variant|litvar@#3105#g.114713909G>T&&&litvar@#3105#|g.114713909G>T", "5397|14|variant|litvar@#3105#g.60458275delT&&&litvar@#3105#|g.60458275delT", "1101|14|variant|litvar@#3105#g.58357800delC&&&litvar@#3105#|g.58357800delC", "4351|5|variant|litvar@rs148924904##&&&litvar@#7157#&&&litvar@CA240#rs148924904##|Y163C", "4529|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|Q61L", "600|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|Q61R", "2630|14|variant|litvar@rs121913378##&&&litvar@#673#&&&litvar@CA135101#rs121913378##|g.140753337C>T", "5127|5|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA1530#rs28934576##|R273L", "5333|14|variant|litvar@#3105#g.91973771delA&&&litvar@#3105#|g.91973771delA", "1227|12|variant|litvar@rs397516436##&&&litvar@#7157#&&&litvar@CA301#rs397516436##|g.7674894G>A", "5970|4|variant|litvar@rs199474358##&&&litvar@#3105#&&&litvar@CA136019050#rs199474358##|S37F", "3822|13|variant|litvar@#3105#g.52212718C>G&&&litvar@#3105#|g.52212718C>G", "5453|14|variant|litvar@#3105#g.152326137G>C&&&litvar@#3105#|g.152326137G>C", "248|14|variant|litvar@#3105#g.179218303G>A&&&litvar@#3105#|g.179218303G>A", "5087|12|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA1530#rs28934576##|g.7673802C>A", "2992|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "4346|4|gene|ncbi_gene@7157|TP53", "417|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "3197|12|variant|litvar@rs786201838##&&&litvar@#7157#&&&litvar@CA274#rs786201838##|g.7674953T>C", "3866|5|variant|litvar@rs1057519991##&&&litvar@#7157#|P179R", "2441|13|variant|litvar@#3105#g.87957915C>T&&&litvar@#3105#|g.87957915C>T", "4548|13|variant|litvar@#3105#g.4301917delT&&&litvar@#3105#|g.4301917delT", "4968|14|variant|litvar@#3105#g.179199690G>A&&&litvar@#3105#|g.179199690G>A", "1443|5|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|Y220C", "4223|4|gene|ncbi_gene@7157|TP53", "5848|4|gene|ncbi_gene@7157|TP53", "1021|5|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|R273H", "66|14|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|g.140753336A>T", "499|12|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|g.7675088C>T", "4670|14|variant|litvar@#3105#g.87958013delA&&&litvar@#3105#|g.87958013delA", "2366|5|variant|litvar@rs1057519991##&&&litvar@#7157#|H179R", "230|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "4734|17|variant|litvar@#3105#g.87961042delTACT&&&litvar@#3105#|g.87961042delTACT", "1438|4|gene|ncbi_gene@7157|TP53", "1644|13|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|g.25245351C>G", "2016|13|variant|litvar@#3105#g.21971121G>A&&&litvar@#3105#|g.21971121G>A", "2242|5|variant|litvar@#3105#p.R130G&&&litvar@#3105#|R130G", "3473|5|variant|litvar@#3105#p.S310F&&&litvar@#3105#|S310F", "4056|14|variant|litvar@#3105#g.152328232C>T&&&litvar@#3105#|g.152328232C>T", "6048|14|variant|litvar@#3105#g.112838934C>T&&&litvar@#3105#|g.112838934C>T", "1875|5|variant|litvar@rs41543413##&&&litvar@#3105#|R132C", "719|5|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|R273C", "5557|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "2361|4|gene|ncbi_gene@7157|TP53", "558|14|variant|litvar@#3105#g.114713908T>C&&&litvar@#3105#|g.114713908T>C", "3011|12|variant|litvar@rs121913344##&&&litvar@#7157#&&&litvar@CA495#rs121913344##|g.7673704G>A", "1936|5|variant|litvar@#3105#p.R130Q&&&litvar@#3105#|R130Q", "311|14|variant|litvar@#3105#g.179234297A>G&&&litvar@#3105#|g.179234297A>G", "2081|13|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|g.25245350C>G", "5012|5|variant|litvar@#3105#p.G118D&&&litvar@#3105#|G118D", "3431|13|variant|litvar@#3105#g.39711955C>T&&&litvar@#3105#|g.39711955C>T", "2691|15|variant|litvar@#3105#g.102277121delT&&&litvar@#3105#|g.102277121delT", "3594|5|variant|litvar@#3105#p.Q209L&&&litvar@#3105#|Q209L", "1343|13|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA180922#rs17851045##|g.25227341T>G", "2896|14|variant|litvar@#3105#g.55684263delA&&&litvar@#3105#|g.55684263delA", "3976|6|variant|litvar@#3105#p.N1459S&&&litvar@#3105#|N1459S", "4183|12|variant|litvar@rs55863639##&&&litvar@#7157#&&&litvar@CA10575452#rs55863639##|g.7675994C>A", "1207|5|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|R282W", "3885|15|variant|litvar@#3105#g.222201320delT&&&litvar@#3105#|g.222201320delT", "5872|15|variant|litvar@#3105#g.181713439delA&&&litvar@#3105#|g.181713439delA", "1142|7|variant|litvar@#3105#p.G659VfsX&&&litvar@#3105#|G659Vfs", "355|6|variant|litvar@#3105#p.H1047R&&&litvar@#3105#|H1047R", "3680|13|variant|litvar@#3105#g.26779863C>T&&&litvar@#3105#|g.26779863C>T", "3411|5|variant|litvar@#3105#p.L858R&&&litvar@#3105#|L858R", "5187|5|variant|litvar@rs786202962##&&&litvar@#7157#|C176F", "4038|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2672|5|variant|litvar@rs121913378##&&&litvar@#673#&&&litvar@CA135101#rs121913378##|V600M", "5516|13|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|g.25225628C>T", "3073|12|variant|litvar@#3105#g.1801841C>G&&&litvar@#3105#|g.1801841C>G", "1895|13|variant|litvar@#3105#g.87933148G>A&&&litvar@#3105#|g.87933148G>A", "3297|5|variant|litvar@rs121912654##&&&litvar@#7157#&&&litvar@CA222#rs121912654##|V157F", "799|13|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|g.25245351C>A", "5032|14|variant|litvar@#3105#g.39343745delT&&&litvar@#3105#|g.39343745delT", "1685|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "3257|12|variant|litvar@rs121912654##&&&litvar@#7157#&&&litvar@CA222#rs121912654##|g.7675143C>A", "5182|4|gene|ncbi_gene@7157|TP53", "2667|4|gene|ncbi_gene@673|BRAF", "5496|5|variant|litvar@#3105#p.R505G&&&litvar@#3105#|R505G", "4426|14|variant|litvar@#3105#g.132676598G>C&&&litvar@#3105#|g.132676598G>C", "1517|14|variant|litvar@#3105#g.179199088G>A&&&litvar@#3105#|g.179199088G>A", "5269|13|variant|litvar@#3105#g.21971187G>A&&&litvar@#3105#|g.21971187G>A", "1561|4|variant|litvar@#3105#p.R88Q&&&litvar@#3105#|R88Q", "3114|5|variant|litvar@rs28934571##&&&litvar@#7157#|S249C", "918|13|variant|litvar@#3105#g.6197725delT&&&litvar@#3105#|g.6197725delT", "1081|5|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|R248W", "2176|4|gene|ncbi_gene@7157|TP53", "189|13|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|g.25245350C>T", "659|5|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|R248Q", "4487|14|variant|litvar@#3105#g.114713908T>A&&&litvar@#3105#|g.114713908T>A", "4891|5|variant|litvar@#3105#p.Q209P&&&litvar@#3105#|Q209P", "859|13|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|g.25245347C>T", "3316|14|variant|litvar@#3105#g.77508202delA&&&litvar@#3105#|g.77508202delA", "6113|12|variant|litvar@rs786202962##&&&litvar@#7157#&&&litvar@CA254#rs786202962##|g.7675085C>T", "108|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1016|4|gene|ncbi_gene@7157|TP53", "3370|13|variant|litvar@#3105#g.55191822T>G&&&litvar@#3105#|g.55191822T>G", "3996|14|variant|litvar@#3105#g.114716126C>T&&&litvar@#3105#|g.114716126C>T", "5989|12|variant|litvar@rs112431538##&&&litvar@#7157#&&&litvar@CA16620615#rs112431538##|g.7673767C>T", "1076|4|gene|ncbi_gene@7157|TP53", "3746|25|variant|litvar@#3105#g.112840254_112840255insA&&&litvar@#3105#|g.112840254_112840255insA", "169|5|variant|litvar@rs41561719##&&&litvar@#3105#&&&litvar@CA3693309#rs41561719##|R132H", "1384|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "1463|14|variant|litvar@#3105#g.87965537delT&&&litvar@#3105#|g.87965537delT", "5617|5|variant|litvar@rs760043106##&&&litvar@#7157#&&&litvar@CA2232#rs760043106##|I195T", "1742|4|gene|ncbi_gene@7157|TP53", "4311|12|variant|litvar@rs148924904##&&&litvar@#7157#&&&litvar@CA240#rs148924904##|g.7675124T>C", "2201|13|variant|litvar@#3105#g.87933147C>G&&&litvar@#3105#|g.87933147C>G", "5612|4|gene|ncbi_gene@7157|TP53", "4850|13|variant|litvar@#3105#g.77794572T>G&&&litvar@#3105#|g.77794572T>G", "2732|8|variant|litvar@#3105#p.E2121KfsX&&&litvar@#3105#|E2121Kfs", "4099|5|variant|litvar@rs377592515##&&&litvar@#9825#|R465H", "3177|5|variant|litvar@#3105#p.N345K&&&litvar@#3105#|N345K", "4797|14|variant|litvar@#3105#g.65076348delA&&&litvar@#3105#|g.65076348delA", "5762|15|variant|litvar@#3105#g.105240988delT&&&litvar@#3105#|g.105240988delT", "1956|14|variant|litvar@#3105#g.104780214C>T&&&litvar@#3105#|g.104780214C>T", "5122|4|gene|ncbi_gene@7157|TP53", "1579|14|variant|litvar@#3105#g.64841314delT&&&litvar@#3105#|g.64841314delT", "5813|12|variant|litvar@rs28934571##&&&litvar@#7157#&&&litvar@CA392#rs28934571##|g.7674216C>A", "3534|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13R", "2951|13|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|g.25245351C>T", "479|5|variant|litvar@#3105#p.E542K&&&litvar@#3105#|E542K", "3237|5|variant|litvar@rs786201838##&&&litvar@#7157#&&&litvar@CA274#rs786201838##|H193R", "4247|14|variant|litvar@#3105#g.179221146G>A&&&litvar@#3105#|g.179221146G>A", "900|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "2796|4|gene|ncbi_gene@7157|TP53", "2385|15|variant|litvar@#3105#g.159099589delT&&&litvar@#3105#|g.159099589delT", "6029|5|variant|litvar@rs112431538##&&&litvar@#7157#&&&litvar@CA16620615#rs112431538##|E285K", "3292|4|gene|ncbi_gene@7157|TP53", "1289|15|variant|litvar@#3105#g.167003333delT&&&litvar@#3105#|g.167003333delT", "2504|14|variant|litvar@#3105#g.179234297A>T&&&litvar@#3105#|g.179234297A>T", "5927|13|variant|litvar@#3105#g.41224622C>T&&&litvar@#3105#|g.41224622C>T", "3935|13|variant|litvar@#3105#g.40062191T>C&&&litvar@#3105#|g.40062191T>C", "539|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H", "5738|4|gene|ncbi_gene@7157|TP53", "4710|7|variant|litvar@#3105#p.K267RfsX&&&litvar@#3105#|K267Rfs", "6153|5|variant|litvar@rs786202962##&&&litvar@#7157#&&&litvar@CA254#rs786202962##|C176Y", "292|5|variant|litvar@#3105#p.E545K&&&litvar@#3105#|E545K", "103|4|gene|ncbi_gene@673|BRAF", "2261|14|variant|litvar@#3105#g.112839942C>T&&&litvar@#3105#|g.112839942C>T", "3492|14|variant|litvar@#3105#g.114716124C>G&&&litvar@#3105#|g.114716124C>G", "2122|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "4119|13|variant|litvar@#3105#g.87933147C>T&&&litvar@#3105#|g.87933147C>T", "4950|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|Q61R", "6148|4|gene|ncbi_gene@7157|TP53", "654|4|gene|ncbi_gene@7157|TP53", "5577|12|variant|litvar@rs760043106##&&&litvar@#7157#&&&litvar@CA2232#rs760043106##|g.7674947A>G", "2871|7|variant|litvar@#3105#p.T204NfsX&&&litvar@#3105#|T204Nfs", "714|4|gene|ncbi_gene@7157|TP53", "4291|5|variant|litvar@#3105#p.E726K&&&litvar@#3105#|E726K", "2548|6|variant|litvar@#3105#p.H1047L&&&litvar@#3105#|H1047L", "1167|12|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|g.7673776G>A", "1265|4|gene|ncbi_gene@7157|TP53", "1704|12|variant|litvar@rs397516435##&&&litvar@#7157#&&&litvar@CA282#rs397516435##|g.7674945G>A", "4911|11|variant|litvar@#3105#g.533874T>C&&&litvar@#3105#|g.533874T>C", "5147|12|variant|litvar@rs786202962##&&&litvar@#7157#|g.7675085C>A", "3613|14|variant|litvar@#3105#g.26779440delG&&&litvar@#3105#|g.26779440delG", "1767|14|variant|litvar@#3105#g.20204950delA&&&litvar@#3105#|g.20204950delA", "4228|5|variant|litvar@rs55863639##&&&litvar@#7157#&&&litvar@CA144#rs55863639##|T125T", "2181|5|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|G245S", "5853|5|variant|litvar@rs28934571##&&&litvar@#7157#&&&litvar@CA392#rs28934571##|R249S", "1619|7|variant|litvar@#3105#p.K860NfsX&&&litvar@#3105#|K860Nfs", "1202|4|gene|ncbi_gene@7157|TP53", "2141|12|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|g.7674230C>T", "780|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA180750#rs121913238##|Q61K", "958|6|variant|litvar@#3105#p.K15RfsX&&&litvar@#3105#|K15Rfs", "1403|12|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|g.7674872T>C", "1041|12|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|g.7674221G>A", "376|13|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|g.25245350C>A", "981|12|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|g.7673802C>T", "619|12|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|g.7674220C>T", "1809|7|variant|litvar@#3105#p.N303,FST&&&litvar@#3105#|N303Tfs", "4468|5|variant|litvar@#3105#p.P286R&&&litvar@#3105#|P286R", "5207|14|variant|litvar@#3105#g.121520163G>C&&&litvar@#3105#|g.121520163G>C", "840|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "1833|14|variant|litvar@#3105#g.208248389G>A&&&litvar@#3105#|g.208248389G>A", "2758|12|variant|litvar@rs730882029##&&&litvar@#7157#&&&litvar@CA19#rs730882029##|g.7670685G>A", "2326|12|variant|litvar@rs1057519991##&&&litvar@#7157#|g.7675076T>C", "2568|14|variant|litvar@#3105#g.152328233G>A&&&litvar@#3105#|g.152328233G>A", "5374|6|variant|litvar@#3105#p.K39RfsX&&&litvar@#3105#|K39Rfs", "3133|14|variant|litvar@#3105#g.179203765T>A&&&litvar@#3105#|g.179203765T>A", "3232|4|gene|ncbi_gene@7157|TP53", "3049|4|gene|ncbi_gene@7157|TP53", "534|4|gene|ncbi_gene@7157|TP53", "2821|23|variant|litvar@#3105#g.67611435_67611436insA&&&litvar@#3105#|g.67611435_67611436insA", "679|12|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|g.7673803G>A", "5700|12|variant|litvar@rs866380588##&&&litvar@#7157#&&&litvar@CA16615700#rs866380588##|g.7674957G>A", "6024|4|gene|ncbi_gene@7157|TP53", "2611|5|variant|litvar@rs576182546##&&&litvar@#9825#|R465C", "127|14|variant|litvar@#3105#g.208248388C>T&&&litvar@#3105#|g.208248388C>T", "4370|15|variant|litvar@#3105#g.158698822delA&&&litvar@#3105#|g.158698822delA", "4603|14|variant|litvar@#3105#g.49040709delG&&&litvar@#3105#|g.49040709delG", "435|14|variant|litvar@#3105#g.179218294G>A&&&litvar@#3105#|g.179218294G>A", "5250|5|variant|litvar@#3105#p.S252W&&&litvar@#3105#|S252W", "3553|12|variant|litvar@#3105#g.3118944A>T&&&litvar@#3105#|g.3118944A>T"], "figure_id": "ijms-22-09712-t001", "text_hl": "DNA Change\tType\tConsequences\tPercentage in Cancer Patients\t \tchr7:g.140753336A>T\tSubstitution\tMissense BRAF V600E\t4.93%\t \tchr2:g.208248388C>T\tSubstitution\tMissense IDH1 R132H\t3.15%\t \tchr12:g.25245350C>T\tSubstitution\tMissense KRAS G12D\t2.61%\t \tchr3:g.179218303G>A\tSubstitution\tMissense PIK3CA E545K\t2.34%\t \tchr3:g.179234297A>G\tSubstitution\tMissense PIK3CA H1047R\t2.22%\t \tchr12:g.25245350C>A\tSubstitution\tMissense KRAS G12V\t2.06%\t \tchr3:g.179218294G>A\tSubstitution\tMissense PIK3CA E542K\t1.50%\t \tchr17:g.7675088C>T\tSubstitution\tMissense TP53 R175H\t1.49%\t \tchr1:g.114713908T>C\tSubstitution\tMissense NRAS Q61R\t1.44%\t \tchr17:g.7674220C>T\tSubstitution\tMissense TP53 R248Q\t1.16%\t \tchr17:g.7673803G>A\tSubstitution\tMissense TP53 R273C\t1.13%\t \tchr1:g.114713909G>T\tSubstitution\tMissense NRAS Q61K\t0.97%\t \tchr12:g.25245351C>A\tSubstitution\tMissense KRAS G12C\t0.97%\t \tchr12:g.25245347C>T\tSubstitution\tMissense KRAS G13D\t0.95%\t \tchr1:g.6197725delT\tDeletion\tFrameshift RPL22 K15Rfs*5\t0.93%\t \tchr17:g.7673802C>T\tSubstitution\tMissense TP53 R273H\t0.91%\t \tchr17:g.7674221G>A\tSubstitution\tMissense TP53 R248W\t0.89%\t \tchr17:g.58357800delC\tDeletion\tFrameshift RNF43 G659Vfs*41\t0.89%\t \tchr17:g.7673776G>A\tSubstitution\tMissense TP53 R282W\t0.83%\t \tchr17:g.7674894G>A\tSubstitution\tStop Gained TP53 R213*\t0.72%\t \tchr6:g.167003333delT\tDeletion\tIntron FGFR1OP\t0.69%\t \tchr12:g.25227341T>G\tSubstitution\tMissense KRAS Q61H\t0.66%\t \tchr17:g.7674872T>C\tSubstitution\tMissense TP53 Y220C\t0.65%\t \tchr10:g.87965537delT\tDeletion\t3 Prime UTR PTEN\t0.64%\t \tchr3:g.179199088G>A\tSubstitution\tMissense PIK3CA R88Q\t0.62%\t \tchr1:g.64841314delT\tDeletion\tFrameshift JAK1 K860Nfs*16\t0.57%\t \tchr12:g.25245351C>G\tSubstitution\tMissense KRAS G12R\t0.54%\t \tchr17:g.7674945G>A\tSubstitution\tStop Gained TP53 R196*\t0.53%\t \tchr17:g.20204950delA\tDeletion\tFrameshift SPECC1 N303Tfs*63\t0.50%\t \tchr2:g.208248389G>A\tSubstitution\tMissense IDH1 R132C\t0.49%\t \tchr10:g.87933148G>A\tSubstitution\tMissense PTEN R130Q\t0.47%\t \tchr14:g.104780214C>T\tSubstitution\tMissense AKT1 E17K\t0.47%\t \tchr9:g.21971121G>A\tSubstitution\tStop Gained CDKN2A R80*\t0.45%\t \tchr12:g.25245350C>G\tSubstitution\tMissense KRAS G12A\t0.45%\t \tchr17:g.7674230C>T\tSubstitution\tMissense TP53 G245S\t0.42%\t \tchr10:g.87933147C>G\tSubstitution\tMissense PTEN R130G\t0.41%\t \tchr5:g.112839942C>T\tSubstitution\tStop Gained APC R1450*\t0.41%\t \tchr17:g.7675076T>C\tSubstitution\tMissense TP53 H179R\t0.41%\t \tchr5:g.159099589delT\tDeletion\t5 Prime UTR EBF1\t0.39%\t \tchr10:g.87957915C>T\tSubstitution\tStop Gained PTEN R233*\t0.37%\t \tchr3:g.179234297A>T\tSubstitution\tMissense PIK3CA H1047L\t0.34%\t \tchr4:g.152328233G>A\tSubstitution\tMissense FBXW7 R465C\t0.33%\t \tchr7:g.140753337C>T\tSubstitution\tMissense BRAF V600M\t0.33%\t \tchr8:g.102277121delT\tDeletion\tFrameshift UBR5 E2121Kfs*28\t0.33%\t \tchr17:g.7670685G>A\tSubstitution\tStop Gained TP53 R342*\t0.33%\t \tchr16:g.67611435_67611436insA\tInsertion\tFrameshift CTCF T204Nfs*26\t0.33%\t \tchr14:g.55684263delA\tDeletion\t3 Prime UTR KTN1\t0.32%\t \tchr12:g.25245351C>T\tSubstitution\tMissense KRAS G12S\t0.32%\t \tchr17:g.7673704G>A\tSubstitution\tStop Gained TP53 R306*\t0.32%\t \tchr4:g.1801841C>G\tSubstitution\tMissense FGFR3 S249C\t0.32%\t \tchr3:g.179203765T>A\tSubstitution\tMissense PIK3CA N345K\t0.31%\t \tchr17:g.7674953T>C\tSubstitution\tMissense TP53 H193R\t0.30%\t \tchr17:g.7675143C>A\tSubstitution\tMissense TP53 V157F\t0.30%\t \tchrX:g.77508202delA\tDeletion\t3 Prime UTR ATRX\t0.30%\t \tchr7:g.55191822T>G\tSubstitution\tMissense EGFR L858R\t0.30%\t \tchr17:g.39711955C>T\tSubstitution\tMissense ERBB2 S310F\t0.30%\t \tchr1:g.114716124C>G\tSubstitution\tMissense NRAS G13R\t0.30%\t \tchr19:g.3118944A>T\tSubstitution\tMissense GNA11 Q209L\t0.30%\t \tchr1:g.26779440delG\tDeletion\tFrameshift ARID1A D1850Tfs*33\t0.29%\t \tchr1:g.26779863C>T\tSubstitution\tStop Gained ARID1A R1989*\t0.29%\t \tchr5:g.112840254_112840255insA\tInsertion\tFrameshift APC T1556Nfs*3\t0.29%\t \tchr19:g.52212718C>G\tSubstitution\tMissense PPP2R1A P179R\t0.28%\t \tchr2:g.222201320delT\tDeletion\tIntron PAX3\t0.28%\t \tchrX:g.40062191T>C\tSubstitution\tMissense BCOR N1459S\t0.28%\t \tchr1:g.114716126C>T\tSubstitution\tMissense NRAS G12D\t0.27%\t \tchr4:g.152328232C>T\tSubstitution\tMissense FBXW7 R465H\t0.27%\t \tchr10:g.87933147C>T\tSubstitution\tStop Gained PTEN R130*\t0.26%\t \tchr17:g.7675994C>A\tSubstitution\tSplice Region TP53 T125T\t0.26%\t \tchr3:g.179221146G>A\tSubstitution\tMissense PIK3CA E726K\t0.26%\t \tchr17:g.7675124T>C\tSubstitution\tMissense TP53 Y163C\t0.26%\t \tchr5:g.158698822delA\tDeletion\t3 Prime UTR EBF1\t0.26%\t \tchr12:g.132676598G>C\tSubstitution\tMissense POLE P286R\t0.26%\t \tchr1:g.114713908T>A\tSubstitution\tMissense NRAS Q61L\t0.26%\t \tchr12:g.4301917delT\tDeletion\t3 Prime UTR CCND2\t0.25%\t \tchr12:g.49040709delG\tDeletion\tFrameshift KMT2D P2354Lfs*30\t0.25%\t \tchr10:g.87958013delA\tDeletion\tFrameshift PTEN K267Rfs*9\t0.25%\t \tchr10:g.87961042delTACT\tDeletion\tFrameshift PTEN T319*\t0.24%\t \tchr14:g.65076348delA\tDeletion\t3 Prime UTR MAX\t0.24%\t \tchr9:g.77794572T>G\tSubstitution\tMissense GNAQ Q209P\t0.24%\t \tchr11:g.533874T>C\tSubstitution\tMissense HRAS Q61R\t0.24%\t \tchr3:g.179199690G>A\tSubstitution\tMissense PIK3CA G118D\t0.24%\t \tchr13:g.39343745delT\tDeletion\t3 Prime UTR LHFP\t0.24%\t \tchr17:g.7673802C>A\tSubstitution\tMissense TP53 R273L\t0.24%\t \tchr17:g.7675085C>A\tSubstitution\tMissense TP53 C176F\t0.23%\t \tchr10:g.121520163G>C\tSubstitution\tMissense FGFR2 S252W\t0.23%\t \tchr9:g.21971187G>A\tSubstitution\tStop Gained CDKN2A R58*\t0.23%\t \tchr7:g.91973771delA\tDeletion\tFrameshift AKAP9 K39Rfs*17\t0.23%\t \tchr2:g.60458275delT\tDeletion\t3 Prime UTR BCL11A\t0.23%\t \tchr4:g.152326137G>C\tSubstitution\tMissense FBXW7 R505G\t0.23%\t \tchr12:g.25225628C>T\tSubstitution\tMissense KRAS <m>A146T</m>\t0.23%\t \tchr17:g.7674947A>G\tSubstitution\tMissense TP53 I195T\t0.23%\t \tchr5:g.112838220C>T\tSubstitution\tStop Gained APC R876*\t0.22%\t \tchr17:g.7674957G>A\tSubstitution\tStop Gained TP53 Q192*\t0.22%\t \tchr4:g.105240988delT\tDeletion\tIntron TET2\t0.22%\t \tchr17:g.7674216C>A\tSubstitution\tMissense TP53 R249S\t0.22%\t \tchr3:g.181713439delA\tDeletion\t3 Prime UTR SOX2\t0.22%\t \tchr3:g.41224622C>T\tSubstitution\tMissense CTNNB1 S37F\t0.22%\t \tchr17:g.7673767C>T\tSubstitution\tMissense TP53 E285K\t0.22%\t \tchr5:g.112838934C>T\tSubstitution\tStop Gained APC R1114*\t0.22%\t \tchr17:g.7675085C>T\tSubstitution\tMissense TP53 C176Y\t0.22%\t \t\t\tTotal\t58.23%\t \t"}], "citations": {"NLM": "Wang Q. Building Personalized Cancer Therapeutics through Multi-Omics Assays and Bacteriophage-Eukaryotic Cell Interactions Int J Mol Sci. PMID: 34575870", "BibTeX": "@article{34575870, title={Building Personalized Cancer Therapeutics through Multi-Omics Assays and Bacteriophage-Eukaryotic Cell Interactions}, author={Wang Q}, journal={Int J Mol Sci}}"}, "is_sup_mat_match": false}, {"pmid": 36213638, "pmcid": "PMC9532577", "title": "Clinical profile in KMT2A-SEPT6-positive acute myeloid leukemia: Does it often co-occur with NRAS mutations?", "journal": "Front Med (Lausanne)", "authors": ["Chen F", "Yang Y", "Fu S"], "date": "2022-09-21T00:00:00Z", "year": 2022, "snippets": [{"_id": "36213638@5932", "snip_text": "Items\tCase 1\tCase 2\tCase 3\tCase 4\t \tSex\tMale\tMale\tMale\tMale\t \tAge\t57 years\t9 years\t16 months\t0 month\t \tPhysical examination\tPerianal abscess\tLower limbs pain, sternal tenderness, and tonsil hypertrophy\tScattered petechiae on the neck, cervical lymphadenopathy and sternal tenderness (+)\tScattered petechiae and ecchymoses\t \tHepatomegaly/splenomegaly\tNo/No\tYes/Yes\tYes/Yes\tYes/Yes\t \tCNS involvement\tNo\tYes\tNo\tNo\t \tWBC/Hb/PLT (x 109/L/g/L/ x 109/L)\t12.3/79.0/105.0\t3.0/93.0/245.0\t123.8/41.0/39.0\t112.0/90.0/9.0\t \tSerum LDH (U/L)\tNA\t966\t2,080\tNA\t \tD-Dimer [mug/L(DDU)]\t13117.0\t3149.0\t2469.0\t620.0\t \tBlood blasts (%)\t69.0\t2.0\t52.0\t17.0\t \tBone marrow blasts (%)\t92.0\t27.5\t56.0\t20.4\t \tMorphological diagnosis\tAML-M5\tAML-M2\tAML-M4\tAML-M5\t \tImmunophenotype\tThe leukemic cells expressed HLA-DR, CD117, CD33, CD13, CD38, CD15, CD64, and CD4\tThe leukemic cells expressed HLA-DR, CD33, CD38, CD15, CD64, and CD4\tThe leukemic cells expressed HLA-DR, CD33, CD13, CD38, CD15, and CD64\tThe leukemic cells expressed HLA-DR, CD33, CD38, CD15, and CD64\t \tKaryotype\t46, Y, t(X;11)(q24;q23)[4]/46,XY[6]\t45,Y,del(X)(q21),der(11)t(X;11)(q24;q23),-20,add(q13)[3]\t46, Y, t(X;11)(q24;q23), del(7)(q21q31)[13]/46,XY[2]\t46,Y,ins(X;11)(q23;q24q12)[10]\t \tGene mutations\tNRAS: NM_002524:exon2:c.G35T:p.G12V, VAF = 0.04, Missense; ASXL1: NM_015338:exon12:c.2464dupA:p.D821fs, VAF = 0.36, Frameshift\tNRAS: NM_002524:exon2:c.G35T:p.G12V, VAF = 0.03, Missense\tNRAS:NM_002524:exon4:c.G436A:p.A146T, VAF = 0.44, Missense\tNegative\t \tTreatment protocol\tIA regimen (resistance); then changed to decitabine combined with half-dose CAG regimen (once) + high dose cytarabine\tMAE regimen + intrathecal chemotherapy + BMT\tHA regimen\tNo chemotherapy\t \tCR\tYes\tYes\tYes\tNA\t \tRelapse\tYes\tYes\tYes\tNA\t \tFollow-up (months)\t18\t43\t36\t0.5\t \tOutcome\tAlive\tAlive\tDied\tDied\t \t", "section": "table", "mentions": ["811|4|gene|ncbi_gene@2526|CD15", "880|4|gene|ncbi_gene@2526|CD15", "1299|5|gene|ncbi_gene@171023|ASXL1", "949|4|gene|ncbi_gene@952|CD38", "1013|4|gene|ncbi_gene@952|CD38", "1367|4|gene|ncbi_gene@4893|NRAS", "1454|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "793|4|gene|ncbi_gene@945|CD33", "786|5|gene|ncbi_gene@3815|CD117", "1269|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1446|7|variant|litvar@rs782605513##&&&litvar@#4297#&&&litvar@CA6303294#rs782605513##|c.G436A", "886|4|gene|ncbi_gene@2209|CD64", "799|4|gene|ncbi_gene@290|CD13", "817|4|gene|ncbi_gene@2209|CD64", "955|4|gene|ncbi_gene@2526|CD15", "1019|4|gene|ncbi_gene@2526|CD15", "1391|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA261525#rs121913237##|G35T", "1029|4|gene|ncbi_gene@2209|CD64", "868|4|gene|ncbi_gene@945|CD33", "1463|3|disease||VAF", "1240|4|gene|ncbi_gene@4893|NRAS", "1344|3|disease||VAF", "1404|3|disease||VAF", "937|4|gene|ncbi_gene@945|CD33", "965|4|gene|ncbi_gene@2209|CD64", "1334|8|variant|litvar@#171023#p.D821fsX&&&litvar@#171023#|p.D821fs", "874|4|gene|ncbi_gene@952|CD38", "1323|10|variant|litvar@#171023#c.2464dupA&&&litvar@#171023#|c.2464dupA", "1396|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1264|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA261525#rs121913237##|G35T", "805|4|gene|ncbi_gene@952|CD38", "943|4|gene|ncbi_gene@290|CD13", "1007|4|gene|ncbi_gene@945|CD33", "1425|4|gene|ncbi_gene@4893|NRAS", "1277|3|disease||VAF"], "figure_id": "T1", "text_hl": "Items\tCase 1\tCase 2\tCase 3\tCase 4\t \tSex\tMale\tMale\tMale\tMale\t \tAge\t57 years\t9 years\t16 months\t0 month\t \tPhysical examination\tPerianal abscess\tLower limbs pain, sternal tenderness, and tonsil hypertrophy\tScattered petechiae on the neck, cervical lymphadenopathy and sternal tenderness (+)\tScattered petechiae and ecchymoses\t \tHepatomegaly/splenomegaly\tNo/No\tYes/Yes\tYes/Yes\tYes/Yes\t \tCNS involvement\tNo\tYes\tNo\tNo\t \tWBC/Hb/PLT (x 109/L/g/L/ x 109/L)\t12.3/79.0/105.0\t3.0/93.0/245.0\t123.8/41.0/39.0\t112.0/90.0/9.0\t \tSerum LDH (U/L)\tNA\t966\t2,080\tNA\t \tD-Dimer [mug/L(DDU)]\t13117.0\t3149.0\t2469.0\t620.0\t \tBlood blasts (%)\t69.0\t2.0\t52.0\t17.0\t \tBone marrow blasts (%)\t92.0\t27.5\t56.0\t20.4\t \tMorphological diagnosis\tAML-M5\tAML-M2\tAML-M4\tAML-M5\t \tImmunophenotype\tThe leukemic cells expressed HLA-DR, CD117, CD33, CD13, CD38, CD15, CD64, and CD4\tThe leukemic cells expressed HLA-DR, CD33, CD38, CD15, CD64, and CD4\tThe leukemic cells expressed HLA-DR, CD33, CD13, CD38, CD15, and CD64\tThe leukemic cells expressed HLA-DR, CD33, CD38, CD15, and CD64\t \tKaryotype\t46, Y, t(X;11)(q24;q23)[4]/46,XY[6]\t45,Y,del(X)(q21),der(11)t(X;11)(q24;q23),-20,add(q13)[3]\t46, Y, t(X;11)(q24;q23), del(7)(q21q31)[13]/46,XY[2]\t46,Y,ins(X;11)(q23;q24q12)[10]\t \tGene mutations\tNRAS: NM_002524:exon2:c.G35T:p.G12V, VAF = 0.04, Missense; ASXL1: NM_015338:exon12:c.2464dupA:p.D821fs, VAF = 0.36, Frameshift\tNRAS: NM_002524:exon2:c.G35T:p.G12V, VAF = 0.03, Missense\tNRAS:NM_002524:exon4:c.G436A:p.A146T, VAF = 0.44, Missense\tNegative\t \tTreatment protocol\tIA regimen (resistance); then changed to decitabine combined with half-dose CAG regimen (once) + high dose cytarabine\tMAE regimen + intrathecal chemotherapy + BMT\tHA regimen\tNo chemotherapy\t \tCR\tYes\tYes\tYes\tNA\t \tRelapse\tYes\tYes\tYes\tNA\t \tFollow-up (months)\t18\t43\t36\t0.5\t \tOutcome\tAlive\tAlive\tDied\tDied\t \t"}], "citations": {"NLM": "Chen F, Yang Y, Fu S. Clinical profile in KMT2A-SEPT6-positive acute myeloid leukemia: Does it often co-occur with NRAS mutations? Front Med (Lausanne). PMID: 36213638", "BibTeX": "@article{36213638, title={Clinical profile in KMT2A-SEPT6-positive acute myeloid leukemia: Does it often co-occur with NRAS mutations?}, author={Chen F and Yang Y and Fu S}, journal={Front Med (Lausanne)}}"}, "is_sup_mat_match": false}, {"pmid": 37343204, "pmcid": "PMC10309506", "title": "Clinical Validation of Plasma-Based Genotyping for RAS and BRAF V600E Mutation in Metastatic Colorectal Cancer: SCRUM-Japan GOZILA Substudy", "journal": "JCO Precis Oncol", "authors": ["Aoki Y", "Nakamura Y", "Denda T", "Ohta T", "Esaki T", "Shiozawa M", "Yamaguchi K", "Yamazaki K", "Sunakawa Y", "Kato T", "Okano N", "Taniguchi H", "Sato T", "Oki E", "Nishina T", "Komatsu Y", "Matsuhashi N", "Goto M", "Yasui H", "Ohtsubo K", "Moriwaki T", "Takahashi N", "Horita Y", "Boku S", "Wakabayashi M", "Ikeno T", "Mitani R", "Yuasa M", "Yoshino T"], "date": "2023-06-01T00:00:00Z", "year": 2023, "snippets": [{"_id": "37343204@7487", "snip_text": "RASKET-B detects 53 mutations, including those in codon 12 (G12S, G12C, G12R, G12D, G12V, and G12A), codon 13 (G13S, G13C, G13R, G13D, G13V, and G13A), codon 59 (A59T and A59G), codon 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H), codon 117 (K117N), and codon 146 (A146T, A146P, and A146V) in both KRAS and NRAS as well as BRAF V600E.", "section": "methods", "mentions": ["321|4|gene|ncbi_gene@673|BRAF", "296|4|gene|ncbi_gene@3845|KRAS", "281|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "305|4|gene|ncbi_gene@4893|NRAS", "206|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "145|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13A", "188|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "117|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "240|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "111|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA16602445#rs121913535##|G13S", "200|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "270|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "129|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "194|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "212|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "60|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "123|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "171|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59G", "263|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "326|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "72|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "162|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "84|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "66|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "222|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "78|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "135|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "94|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A"], "text_hl": "RASKET-B detects 53 mutations, including those in codon 12 (G12S, G12C, G12R, G12D, G12V, and G12A), codon 13 (G13S, G13C, G13R, G13D, G13V, and G13A), codon 59 (A59T and A59G), codon 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H), codon 117 (K117N), and codon 146 (<m>A146T</m>, A146P, and A146V) in both KRAS and NRAS as well as BRAF V600E."}], "citations": {"NLM": "Aoki Y, Nakamura Y, Denda T, Ohta T, Esaki T, Shiozawa M, Yamaguchi K, Yamazaki K, Sunakawa Y, Kato T, Okano N, Taniguchi H, Sato T, Oki E, Nishina T, Komatsu Y, Matsuhashi N, Goto M, Yasui H, Ohtsubo K, Moriwaki T, Takahashi N, Horita Y, Boku S, Wakabayashi M, Ikeno T, Mitani R, Yuasa M, Yoshino T. Clinical Validation of Plasma-Based Genotyping for RAS and BRAF V600E Mutation in Metastatic Colorectal Cancer: SCRUM-Japan GOZILA Substudy JCO Precis Oncol. PMID: 37343204", "BibTeX": "@article{37343204, title={Clinical Validation of Plasma-Based Genotyping for RAS and BRAF V600E Mutation in Metastatic Colorectal Cancer: SCRUM-Japan GOZILA Substudy}, author={Aoki Y and Nakamura Y and Denda T and Ohta T and Esaki T and Shiozawa M and Yamaguchi K and Yamazaki K and Sunakawa Y and Kato T and Okano N and Taniguchi H and Sato T and Oki E and Nishina T and Komatsu Y and Matsuhashi N and Goto M and Yasui H and Ohtsubo K and Moriwaki T and Takahashi N and Horita Y and Boku S and Wakabayashi M and Ikeno T and Mitani R and Yuasa M and Yoshino T}, journal={JCO Precis Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 28514312, "pmcid": "PMC5440149", "title": "Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients.", "journal": "Medicine (Baltimore)", "authors": ["Zick A", "Peretz T", "Lotem M", "Hubert A", "Katz D", "Temper M", "Rottenberg Y", "Uziely B", "Nechushtan H", "Meirovitz A", "Sonnenblick A", "Sapir E", "Edelman D", "Goldberg Y", "Lossos A", "Rosenberg S", "Fried I", "Finklstein R", "Pikarsky E", "Goldshmidt H"], "date": "2017-05-01T00:00:00Z", "year": 2017, "snippets": [{"_id": "28514312@7914", "snip_text": "A KRAS G12D positive case was reclassified as KRAS wild type, a KRAS negative case was reclassified as KRAS A146T positive, and a BRAF V600E negative case was reclassified as BRAF V600E positive.", "section": "results", "mentions": ["7|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "46|4|gene|ncbi_gene@3845|KRAS", "130|4|gene|ncbi_gene@673|BRAF", "103|4|gene|ncbi_gene@3845|KRAS", "108|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "135|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "180|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "64|4|gene|ncbi_gene@3845|KRAS", "175|4|gene|ncbi_gene@673|BRAF", "2|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "A KRAS G12D positive case was reclassified as KRAS wild type, a KRAS negative case was reclassified as KRAS <m>A146T</m> positive, and a BRAF V600E negative case was reclassified as BRAF V600E positive."}], "citations": {"NLM": "Zick A, Peretz T, Lotem M, Hubert A, Katz D, Temper M, Rottenberg Y, Uziely B, Nechushtan H, Meirovitz A, Sonnenblick A, Sapir E, Edelman D, Goldberg Y, Lossos A, Rosenberg S, Fried I, Finklstein R, Pikarsky E, Goldshmidt H. Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients. Medicine (Baltimore). PMID: 28514312", "BibTeX": "@article{28514312, title={Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients.}, author={Zick A and Peretz T and Lotem M and Hubert A and Katz D and Temper M and Rottenberg Y and Uziely B and Nechushtan H and Meirovitz A and Sonnenblick A and Sapir E and Edelman D and Goldberg Y and Lossos A and Rosenberg S and Fried I and Finklstein R and Pikarsky E and Goldshmidt H}, journal={Medicine (Baltimore)}}"}, "is_sup_mat_match": false}, {"pmid": 30041673, "pmcid": "PMC6056937", "title": "Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer.", "journal": "J Exp Clin Cancer Res", "authors": ["Sun Y", "Peng W", "He W", "Luo M", "Chang G", "Shen J", "Zhao X", "Hu Y"], "date": "2018-07-24T00:00:00Z", "year": 2018, "snippets": [{"_id": "30041673@17525", "snip_text": "We found that the level of transgelin-2 was significantly higher in KRAS G12 mutant pancreatic cancer cell lines than in wild-type or other types of KRAS (G13D, Q61R, I171M, A146T, etc.)", "section": "results", "mentions": ["161|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|Q61R", "68|4|gene|ncbi_gene@3845|KRAS", "84|17|disease|ncbi_mesh@D010190|pancreatic cancer", "155|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "167|5|variant|litvar@rs766231905##&&&litvar@#3845#|I171M", "27|12|gene|ncbi_gene@8407|transgelin-2", "149|4|gene|ncbi_gene@3845|KRAS", "174|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "We found that the level of transgelin-2 was significantly higher in KRAS G12 mutant pancreatic cancer cell lines than in wild-type or other types of KRAS (G13D, Q61R, I171M, <m>A146T</m>, etc.)"}], "citations": {"NLM": "Sun Y, Peng W, He W, Luo M, Chang G, Shen J, Zhao X, Hu Y. Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer. J Exp Clin Cancer Res. PMID: 30041673", "BibTeX": "@article{30041673, title={Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer.}, author={Sun Y and Peng W and He W and Luo M and Chang G and Shen J and Zhao X and Hu Y}, journal={J Exp Clin Cancer Res}}"}, "is_sup_mat_match": false}, {"pmid": 29522538, "pmcid": "PMC5871010", "title": "Exome-wide somatic mutation characterization of small bowel adenocarcinoma.", "journal": "PLoS Genet", "authors": ["H\u00e4nninen UA", "Katainen R", "Tanskanen T", "Plaketti RM", "Laine R", "Hamberg J", "Ristim\u00e4ki A", "Pukkala E", "Taipale M", "Mecklin JP", "Forsstr\u00f6m LM", "Pitk\u00e4nen E", "Palin K", "V\u00e4lim\u00e4ki N", "M\u00e4kinen N", "Aaltonen LA"], "date": "2018-03-09T00:00:00Z", "year": 2018, "snippets": [{"_id": "29522538@13970", "snip_text": "Regarding atypical hotspot mutations, however, we identified four out of 11 BRAF mutants where BRAF and KRAS mutations co-occurred: KRASA146T+BRAFD594A (SIA121), KRASG12R+BRAFG469A (SIA228), KRASG12D+BRAFQ257X (SIA214), and KRASG12D+BRAFA404fs (SIA53).", "section": "results", "mentions": ["104|4|gene|ncbi_gene@3845|KRAS", "146|5|variant|litvar@rs121913338##&&&litvar@#673#|D594A", "95|4|gene|ncbi_gene@673|BRAF", "171|9|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|BRAFG469A", "76|4|gene|ncbi_gene@673|BRAF", "132|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T", "204|5|variant|litvar@#673#p.Q257X&&&litvar@#673#|Q257X"], "text_hl": "Regarding atypical hotspot mutations, however, we identified four out of 11 BRAF mutants where BRAF and KRAS mutations co-occurred: KRASA146T+BRAFD594A (SIA121), KRASG12R+BRAFG469A (SIA228), KRASG12D+BRAFQ257X (SIA214), and KRASG12D+BRAFA404fs (SIA53)."}], "citations": {"NLM": "H\u00e4nninen UA, Katainen R, Tanskanen T, Plaketti RM, Laine R, Hamberg J, Ristim\u00e4ki A, Pukkala E, Taipale M, Mecklin JP, Forsstr\u00f6m LM, Pitk\u00e4nen E, Palin K, V\u00e4lim\u00e4ki N, M\u00e4kinen N, Aaltonen LA. Exome-wide somatic mutation characterization of small bowel adenocarcinoma. PLoS Genet. PMID: 29522538", "BibTeX": "@article{29522538, title={Exome-wide somatic mutation characterization of small bowel adenocarcinoma.}, author={H\u00e4nninen UA and Katainen R and Tanskanen T and Plaketti RM and Laine R and Hamberg J and Ristim\u00e4ki A and Pukkala E and Taipale M and Mecklin JP and Forsstr\u00f6m LM and Pitk\u00e4nen E and Palin K and V\u00e4lim\u00e4ki N and M\u00e4kinen N and Aaltonen LA}, journal={PLoS Genet}}"}, "is_sup_mat_match": false}, {"pmid": 30416987, "pmcid": "PMC6212577", "title": "Mutation Status and Immunohistochemical Correlation of KRAS, NRAS, and BRAF in 260 Chinese Colorectal and Gastric Cancers.", "journal": "Front Oncol", "authors": ["Yang Q", "Huo S", "Sui Y", "Du Z", "Zhao H", "Liu Y", "Li W", "Wan X", "Liu T", "Zhang G"], "date": "2018-10-26T00:00:00Z", "year": 2018, "snippets": [{"_id": "30416987@15127", "snip_text": "Gene Exon Codon Mutation name Amino acid Nucleotide COSMIC ID Case, n(%)          Colon cancer Rectal cancer Gastric cancer Total   KRAS 2 12 12CYS G12C GGT>TGT 516 1 (2.6) 3 (5.7) 0 (0) 4 (4.4)      12SER G12S GGT>AGT 517 3 (7.9) 3 (5.7) 0 (0) 6 (6.6)      12ARG G12R GGT>CGT 518 1 (2.6) 1 (1.9) 0 (0) 2 (2.2)      12VAL G12V GGT>GTT 520 8 (21.1) 13 (24.5) 0 (0) 21 (23.1)      12ASP G12D GGT>GAT 521 13 (34.2) 23 (43.4) 0 (0) 36 (39.6)      12ALA G12A GGT>GCT 522 2 (5.3) 1 (1.9) 0 (0) 3 (3.3)     13 13ASP G13D GGC>GAC 532 10 (26.3) 9 (17.0) 0 (0) 19 (20.9)   NRAS 2 12 G12-Mu G12D GGT>GAT 564 0 (0) 3 (50.0) 0 (0) 3 (42.9)     13 G13-Mu G13R G13D G13V GGT>CGT GGT>GAT GGT>GTT 569 573 574 0 (0) 2 (33.3) 0 (0) 2 (28.6)    3 59 A59-Mu A59D GCT>GAT 253327 0 (0) 0 (0) 0 (0) 0 (0)     61 Q61-Mu Q61R CAA>CGA 584 1 (100.0) 1 (1.67) 0 (0) 2 (28.6)    4 117 K117-Mu K117N K117N AAG>AAC AAG>AAT / / 0 (0) 0 (0) 0 (0) 0 (0)     146 A146-Mu A146T GCC>ACC 1237325 0 (0) 0 (0) 0 (0) 0 (0)   BRAF 15 600 600Glu V600E CTC>GAG 476 3 (100.0) 1 (100.0) 1 (100.0) 5 (100.0)   ", "section": "table", "mentions": ["737|4|variant|litvar@#4893#p.A59D&&&litvar@#4893#|A59D", "875|7|variant|litvar@#673#|AAG>AAC", "742|7|variant|litvar@#4893#|GCT>GAT", "1008|7|variant|litvar@#673#|CTC>GAG", "664|7|variant|litvar@#4893#|GGT>GAT", "269|7|variant|litvar@#4893#|GGT>CGT", "863|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "142|5|variant|litvar@rs121913529##&&&litvar@#3845#|12CYS", "641|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "563|4|gene|ncbi_gene@4893|NRAS", "646|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "132|4|gene|ncbi_gene@3845|KRAS", "449|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "206|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "651|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "258|5|variant|litvar@rs121913529##&&&litvar@#3845#|12ARG", "385|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "30|21|chemical||Amino acid Nucleotide", "941|7|variant|litvar@#673#|GCC>ACC", "211|7|variant|litvar@#3845#|GGT>AGT", "509|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "390|7|variant|litvar@#4893#|GGT>GAT", "454|7|variant|litvar@#4893#|GGT>GCT", "656|7|variant|litvar@#4893#|GGT>CGT", "514|7|variant|litvar@#4893#|GGC>GAC", "1002|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "995|6|variant|litvar@rs113488022##&&&litvar@#673#|600Glu", "869|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "148|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "983|4|gene|ncbi_gene@673|BRAF", "503|5|variant|litvar@rs121434596##&&&litvar@#4893#|13ASP", "322|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "327|7|variant|litvar@#4893#|GGT>GTT", "795|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "200|5|variant|litvar@rs121913529##&&&litvar@#3845#|12SER", "379|5|variant|litvar@rs121913529##&&&litvar@#3845#|12ASP", "82|12|disease|ncbi_mesh@D015179|Colon cancer", "443|5|variant|litvar@rs121913529##&&&litvar@#3845#|12ALA", "800|7|variant|litvar@#673#|CAA>CGA", "883|7|variant|litvar@#673#|AAG>AAT", "264|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "153|7|variant|litvar@#3845#|GGT>TGT", "316|5|variant|litvar@rs121913529##&&&litvar@#3845#|12VAL", "580|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "935|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "672|7|variant|litvar@#4893#|GGT>GTT", "102|6|disease|ncbi_mesh@D009369|cancer", "585|7|variant|litvar@#4893#|GGT>GAT", "109|14|disease|ncbi_mesh@D013274|Gastric cancer"], "figure_id": "T3", "text_hl": "Gene Exon Codon Mutation name Amino acid Nucleotide COSMIC ID Case, n(%)          Colon cancer Rectal cancer Gastric cancer Total   KRAS 2 12 12CYS G12C GGT>TGT 516 1 (2.6) 3 (5.7) 0 (0) 4 (4.4)      12SER G12S GGT>AGT 517 3 (7.9) 3 (5.7) 0 (0) 6 (6.6)      12ARG G12R GGT>CGT 518 1 (2.6) 1 (1.9) 0 (0) 2 (2.2)      12VAL G12V GGT>GTT 520 8 (21.1) 13 (24.5) 0 (0) 21 (23.1)      12ASP G12D GGT>GAT 521 13 (34.2) 23 (43.4) 0 (0) 36 (39.6)      12ALA G12A GGT>GCT 522 2 (5.3) 1 (1.9) 0 (0) 3 (3.3)     13 13ASP G13D GGC>GAC 532 10 (26.3) 9 (17.0) 0 (0) 19 (20.9)   NRAS 2 12 G12-Mu G12D GGT>GAT 564 0 (0) 3 (50.0) 0 (0) 3 (42.9)     13 G13-Mu G13R G13D G13V GGT>CGT GGT>GAT GGT>GTT 569 573 574 0 (0) 2 (33.3) 0 (0) 2 (28.6)    3 59 A59-Mu A59D GCT>GAT 253327 0 (0) 0 (0) 0 (0) 0 (0)     61 Q61-Mu Q61R CAA>CGA 584 1 (100.0) 1 (1.67) 0 (0) 2 (28.6)    4 117 K117-Mu K117N K117N AAG>AAC AAG>AAT / / 0 (0) 0 (0) 0 (0) 0 (0)     146 A146-Mu <m>A146T</m> GCC>ACC 1237325 0 (0) 0 (0) 0 (0) 0 (0)   BRAF 15 600 600Glu V600E CTC>GAG 476 3 (100.0) 1 (100.0) 1 (100.0) 5 (100.0)   "}], "citations": {"NLM": "Yang Q, Huo S, Sui Y, Du Z, Zhao H, Liu Y, Li W, Wan X, Liu T, Zhang G. Mutation Status and Immunohistochemical Correlation of KRAS, NRAS, and BRAF in 260 Chinese Colorectal and Gastric Cancers. Front Oncol. PMID: 30416987", "BibTeX": "@article{30416987, title={Mutation Status and Immunohistochemical Correlation of KRAS, NRAS, and BRAF in 260 Chinese Colorectal and Gastric Cancers.}, author={Yang Q and Huo S and Sui Y and Du Z and Zhao H and Liu Y and Li W and Wan X and Liu T and Zhang G}, journal={Front Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 26299805, "pmcid": "PMC4673229", "title": "Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance.", "journal": "Oncotarget", "authors": ["Morkel M", "Riemer P", "Bl\u00e4ker H", "Sers C"], "date": "2015-08-28T00:00:00Z", "year": 2015, "snippets": [{"_id": "26299805@3114", "snip_text": "These affect hotspots in codons 12 and 13 (80% of all KRAS mutations, of these are G12D > G12V > G13D > G12C > G12A), codon 61 (4% of all KRAS mutations, of these are Q61H > Q61L > Q61R) and 146 (1-2% of all KRAS mutations, mostly A146T and A146V).", "section": "introduction", "mentions": ["104|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "241|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "97|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "174|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "90|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "138|4|gene|ncbi_gene@3845|KRAS", "167|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "83|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "54|4|gene|ncbi_gene@3845|KRAS", "208|4|gene|ncbi_gene@3845|KRAS", "181|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "231|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "111|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A"], "text_hl": "These affect hotspots in codons 12 and 13 (80% of all KRAS mutations, of these are G12D > G12V > G13D > G12C > G12A), codon 61 (4% of all KRAS mutations, of these are Q61H > Q61L > Q61R) and 146 (1-2% of all KRAS mutations, mostly <m>A146T</m> and A146V)."}], "citations": {"NLM": "Morkel M, Riemer P, Bl\u00e4ker H, Sers C. Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance. Oncotarget. PMID: 26299805", "BibTeX": "@article{26299805, title={Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance.}, author={Morkel M and Riemer P and Bl\u00e4ker H and Sers C}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 33065029, "pmcid": "PMC7669705", "title": "Targeting KRAS G12C: from inhibitory mechanism to modulation of antitumor effect in patients", "journal": "Cell", "authors": ["Kim D", "Xue JY", "Lito P"], "date": "2020-11-12T00:00:00Z", "year": 2020, "snippets": [{"_id": "33065029@3926", "snip_text": "Less common variants, such as Q61H/L/R/K, interfere with the coordination of the water molecule involved in hydrolysis, whereas A146T enhances the propensity for nucleotide-exchange.", "section": "other", "mentions": ["30|6|variant|litvar@rs17851045##&&&litvar@#3845#|Q61H/L", "128|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "81|5|chemical|ncbi_mesh@D014867|water"], "text_hl": "Less common variants, such as Q61H/L/R/K, interfere with the coordination of the water molecule involved in hydrolysis, whereas <m>A146T</m> enhances the propensity for nucleotide-exchange."}], "citations": {"NLM": "Kim D, Xue JY, Lito P. Targeting KRAS G12C: from inhibitory mechanism to modulation of antitumor effect in patients Cell. PMID: 33065029", "BibTeX": "@article{33065029, title={Targeting KRAS G12C: from inhibitory mechanism to modulation of antitumor effect in patients}, author={Kim D and Xue JY and Lito P}, journal={Cell}}"}, "is_sup_mat_match": false}, {"pmid": 27740967, "pmcid": "PMC5106330", "title": "KRAS Mutation is a Significant Prognostic Factor in Early Stage Lung Adenocarcinoma", "journal": "Am J Surg Pathol", "authors": ["Kadota K", "Sima CS", "Arcila ME", "Hedvat C", "Kris MG", "Jones DR", "Adusumilli PS", "Travis WD"], "date": "2016-12-01T00:00:00Z", "year": 2016, "snippets": [{"_id": "27740967@44591", "snip_text": "Driver mutation\tTotal (%)\tType\tN (%)\t \tKRAS\t129 (27)\tG12C\t57 (44)\t \t\t\tG12V\t22 (17)\t \t\t\tG12D\t15 (12)\t \t\t\tG12A\t14 (11)\t \t\t\tG12F\t2 (2)\t \t\t\tG12R\t1 (1)\t \t\t\tG12S\t1 (1)\t \t\t\tG13C\t8 (6)\t \t\t\tG13D\t1 (1)\t \t\t\tQ61H\t4 (3)\t \t\t\tQ61L\t2 (2)\t \t\t\tQ61R\t1 (1)\t \t\t\tA146T\t1 (1)\t \tEGFR\t86 (18)\tL858R\t42 (49)\t \t\t\tExon 19 del.\t39 (45)\t \t\t\tL861Q\t2 (2)\t \t\t\tS768I\t2 (2)\t \t\t\tG719A\t1 (1)\t \tBRAF\t8 (2)\tV600E\t6 (75)\t \t\t\tD594G\t2 (25)\t \tPIK3CA*\t8 (2)\tE542K\t4 (50)\t \t\t\tC420K\t1 (13)\t \t\t\tE545K\t1 (13)\t \t\t\tH1047R\t1 (13)\t \t\t\tR88Q\t1 (13)\t \tNRAS\t4 (1)\tQ61L\t2 (50)\t \t\t\tQ61K\t1 (25)\t \t\t\tG31R\t1 (25)\t \tAKT1\t1 (0.2)\tE17K\t1 (100)\t \t", "section": "table", "mentions": ["540|4|variant|litvar@#207#p.G31R&&&litvar@#207#|G31R", "508|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "255|4|gene|ncbi_gene@1956|EGFR", "104|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "554|4|gene|ncbi_gene@207|AKT1", "357|4|gene|ncbi_gene@673|BRAF", "196|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "368|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "151|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "327|5|variant|litvar@rs121913465##&&&litvar@#1956#&&&litvar@CA135840#rs121913465##|S768I", "567|4|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|E17K", "211|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "268|5|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|L858R", "414|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "87|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "400|6|gene|ncbi_gene@5290|PIK3CA", "465|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "524|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "166|4|variant|litvar@rs774487133##&&&litvar@#1956#&&&litvar@CA4265099#rs774487133##|G13C", "448|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "241|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "226|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "483|4|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|R88Q", "181|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "311|5|variant|litvar@rs121913444##&&&litvar@#1956#&&&litvar@CA176021#rs121913444##|L861Q", "70|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "497|4|gene|ncbi_gene@4893|NRAS", "39|4|gene|ncbi_gene@3845|KRAS", "121|4|variant|litvar@rs121913529##&&&litvar@#3845#|G12F", "431|5|variant|litvar@#5290#p.C420K&&&litvar@#5290#|C420K", "343|5|variant|litvar@rs121913428##&&&litvar@#1956#&&&litvar@CA135775#rs121913428##|G719A", "53|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "136|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "385|5|variant|litvar@rs121913338##&&&litvar@#673#&&&litvar@CA123657#rs121913338##|D594G"], "figure_id": "T2", "text_hl": "Driver mutation\tTotal (%)\tType\tN (%)\t \tKRAS\t129 (27)\tG12C\t57 (44)\t \t\t\tG12V\t22 (17)\t \t\t\tG12D\t15 (12)\t \t\t\tG12A\t14 (11)\t \t\t\tG12F\t2 (2)\t \t\t\tG12R\t1 (1)\t \t\t\tG12S\t1 (1)\t \t\t\tG13C\t8 (6)\t \t\t\tG13D\t1 (1)\t \t\t\tQ61H\t4 (3)\t \t\t\tQ61L\t2 (2)\t \t\t\tQ61R\t1 (1)\t \t\t\t<m>A146T</m>\t1 (1)\t \tEGFR\t86 (18)\tL858R\t42 (49)\t \t\t\tExon 19 del.\t39 (45)\t \t\t\tL861Q\t2 (2)\t \t\t\tS768I\t2 (2)\t \t\t\tG719A\t1 (1)\t \tBRAF\t8 (2)\tV600E\t6 (75)\t \t\t\tD594G\t2 (25)\t \tPIK3CA*\t8 (2)\tE542K\t4 (50)\t \t\t\tC420K\t1 (13)\t \t\t\tE545K\t1 (13)\t \t\t\tH1047R\t1 (13)\t \t\t\tR88Q\t1 (13)\t \tNRAS\t4 (1)\tQ61L\t2 (50)\t \t\t\tQ61K\t1 (25)\t \t\t\tG31R\t1 (25)\t \tAKT1\t1 (0.2)\tE17K\t1 (100)\t \t"}], "citations": {"NLM": "Kadota K, Sima CS, Arcila ME, Hedvat C, Kris MG, Jones DR, Adusumilli PS, Travis WD. KRAS Mutation is a Significant Prognostic Factor in Early Stage Lung Adenocarcinoma Am J Surg Pathol. PMID: 27740967", "BibTeX": "@article{27740967, title={KRAS Mutation is a Significant Prognostic Factor in Early Stage Lung Adenocarcinoma}, author={Kadota K and Sima CS and Arcila ME and Hedvat C and Kris MG and Jones DR and Adusumilli PS and Travis WD}, journal={Am J Surg Pathol}}"}, "is_sup_mat_match": false}, {"pmid": 29141224, "pmcid": "PMC5709812", "title": "Genetic and genomic characterization of 462 melanoma patient-derived xenografts, tumor biopsies and cell lines", "journal": "Cell Rep", "authors": ["Garman B", "Anastopoulos IN", "Krepler C", "Brafford P", "Sproesser K", "Jiang Y", "Wubbenhorst B", "Amaravadi R", "Bennett J", "Beqiri M", "Elder D", "Flaherty KT", "Frederick DT", "Gangadhar TC", "Guarino M", "Hoon D", "Karakousis G", "Liu Q", "Mitra N", "Petrelli NJ", "Schuchter L", "Shannan B", "Shields CL", "Wargo J", "Wenz B", "Wilson MA", "Xiao M", "Xu W", "Xu X", "Yin X", "Zhang NR", "Davies MA", "Herlyn M", "Nathanson KL"], "date": "2017-11-14T00:00:00Z", "year": 2017, "snippets": [{"_id": "29141224@22350", "snip_text": "Discordant deleterious mutations in KRAS (p.A146T, p.K117N), PTEN and TACC1 were found in two biopsies taken on the same day but different locations in patient progressing on pembrolizumab/dabrafenib (WM4420).", "section": "results", "mentions": ["189|10|chemical|ncbi_mesh@C561627|dabrafenib", "152|7|species|ncbi_taxonomy@9606|patient", "175|13|chemical|ncbi_mesh@C582435|pembrolizumab", "201|6|chemical||WM4420", "36|4|gene|ncbi_gene@3845|KRAS", "42|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "70|5|gene|ncbi_gene@6867|TACC1", "51|7|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.K117N", "61|4|gene|ncbi_gene@5728|PTEN"], "text_hl": "Discordant deleterious mutations in KRAS (<m>p.A146T</m>, p.K117N), PTEN and TACC1 were found in two biopsies taken on the same day but different locations in patient progressing on pembrolizumab/dabrafenib (WM4420)."}], "citations": {"NLM": "Garman B, Anastopoulos IN, Krepler C, Brafford P, Sproesser K, Jiang Y, Wubbenhorst B, Amaravadi R, Bennett J, Beqiri M, Elder D, Flaherty KT, Frederick DT, Gangadhar TC, Guarino M, Hoon D, Karakousis G, Liu Q, Mitra N, Petrelli NJ, Schuchter L, Shannan B, Shields CL, Wargo J, Wenz B, Wilson MA, Xiao M, Xu W, Xu X, Yin X, Zhang NR, Davies MA, Herlyn M, Nathanson KL. Genetic and genomic characterization of 462 melanoma patient-derived xenografts, tumor biopsies and cell lines Cell Rep. PMID: 29141224", "BibTeX": "@article{29141224, title={Genetic and genomic characterization of 462 melanoma patient-derived xenografts, tumor biopsies and cell lines}, author={Garman B and Anastopoulos IN and Krepler C and Brafford P and Sproesser K and Jiang Y and Wubbenhorst B and Amaravadi R and Bennett J and Beqiri M and Elder D and Flaherty KT and Frederick DT and Gangadhar TC and Guarino M and Hoon D and Karakousis G and Liu Q and Mitra N and Petrelli NJ and Schuchter L and Shannan B and Shields CL and Wargo J and Wenz B and Wilson MA and Xiao M and Xu W and Xu X and Yin X and Zhang NR and Davies MA and Herlyn M and Nathanson KL}, journal={Cell Rep}}"}, "is_sup_mat_match": false}, {"pmid": 29642462, "pmcid": "PMC5923365", "title": "New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update", "journal": "Cancers (Basel)", "authors": ["Monta\u00f1o A", "Forero-Castro M", "Marchena-Mendoza D", "Benito R", "Hern\u00e1ndez-Rivas JM"], "date": "2018-04-07T00:00:00Z", "year": 2018, "snippets": [{"_id": "29642462@18142", "snip_text": "Besides the well-known hotspot mutations at codons 12, 13, and 61 (i.e.  NRAS G13D, KRAS, and G12D/G13D), novel mutational sites have also been identified in ALL patients by using NGS methods (e.g.  KRAS: V14I, V14L, K117N and A146T/P).", "section": "other", "mentions": ["94|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "78|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "84|4|gene|ncbi_gene@3845|KRAS", "217|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "99|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "162|8|species|ncbi_taxonomy@9606|patients", "227|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "199|4|gene|ncbi_gene@3845|KRAS", "73|4|gene|ncbi_gene@4893|NRAS", "205|4|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|V14I", "211|4|variant|litvar@rs1452624461##&&&litvar@#5900#|V14L"], "text_hl": "Besides the well-known hotspot mutations at codons 12, 13, and 61 (i.e.  NRAS G13D, KRAS, and G12D/G13D), novel mutational sites have also been identified in ALL patients by using NGS methods (e.g.  KRAS: V14I, V14L, K117N and <m>A146T</m>/P)."}], "citations": {"NLM": "Monta\u00f1o A, Forero-Castro M, Marchena-Mendoza D, Benito R, Hern\u00e1ndez-Rivas JM. New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update Cancers (Basel). PMID: 29642462", "BibTeX": "@article{29642462, title={New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update}, author={Monta\u00f1o A and Forero-Castro M and Marchena-Mendoza D and Benito R and Hern\u00e1ndez-Rivas JM}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 31427573, "pmcid": "PMC6700103", "title": "Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients.", "journal": "Nat Commun", "authors": ["Serebriiskii IG", "Connelly C", "Frampton G", "Newberg J", "Cooke M", "Miller V", "Ali S", "Ross JS", "Handorf E", "Arora S", "Lieu C", "Golemis EA", "Meyer JE"], "date": "2019-08-19T00:00:00Z", "year": 2019, "snippets": [{"_id": "31427573@32121", "snip_text": "Among specific missense substitutions, G12D and G12V showed strong copy number dependence, but not G12A, C, or S; A146T showed a stronger copy number effect than the less common A146V (Fig. 5g).", "section": "results", "mentions": ["39|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "48|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "114|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "99|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "178|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V"], "text_hl": "Among specific missense substitutions, G12D and G12V showed strong copy number dependence, but not G12A, C, or S; <m>A146T</m> showed a stronger copy number effect than the less common A146V (Fig. 5g)."}], "citations": {"NLM": "Serebriiskii IG, Connelly C, Frampton G, Newberg J, Cooke M, Miller V, Ali S, Ross JS, Handorf E, Arora S, Lieu C, Golemis EA, Meyer JE. Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients. Nat Commun. PMID: 31427573", "BibTeX": "@article{31427573, title={Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients.}, author={Serebriiskii IG and Connelly C and Frampton G and Newberg J and Cooke M and Miller V and Ali S and Ross JS and Handorf E and Arora S and Lieu C and Golemis EA and Meyer JE}, journal={Nat Commun}}"}, "is_sup_mat_match": false}, {"pmid": 20807768, "pmcid": "PMC2966122", "title": "Mutational tuning of galectin-3 specificity and biological function.", "journal": "J Biol Chem", "authors": ["Salomonsson E", "Carlsson MC", "Osla V", "Hendus-Altenburger R", "Kahl-Knutson B", "Oberg CT", "Sundin A", "Nilsson R", "Nordberg-Karlsson E", "Nilsson UJ", "Karlsson A", "Rini JM", "Leffler H"], "date": "2010-11-05T00:00:00Z", "year": 2010, "snippets": [{"_id": "20807768@42107", "snip_text": "With regard to the binding of other saccharides, the loss of interaction with Arg-144 (Fig. 4, b and c) may have been compensated for by the presence of Thr instead of Ala-146.", "section": "discussion", "mentions": ["153|22|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|Thr instead of Ala-146", "36|11|chemical|ncbi_mesh@D002241|saccharides", "78|3|chemical|ncbi_mesh@D001120|Arg"], "text_hl": "With regard to the binding of other saccharides, the loss of interaction with Arg-144 (Fig. 4, b and c) may have been compensated for by the presence of Thr instead of Ala-146."}], "citations": {"NLM": "Salomonsson E, Carlsson MC, Osla V, Hendus-Altenburger R, Kahl-Knutson B, Oberg CT, Sundin A, Nilsson R, Nordberg-Karlsson E, Nilsson UJ, Karlsson A, Rini JM, Leffler H. Mutational tuning of galectin-3 specificity and biological function. J Biol Chem. PMID: 20807768", "BibTeX": "@article{20807768, title={Mutational tuning of galectin-3 specificity and biological function.}, author={Salomonsson E and Carlsson MC and Osla V and Hendus-Altenburger R and Kahl-Knutson B and Oberg CT and Sundin A and Nilsson R and Nordberg-Karlsson E and Nilsson UJ and Karlsson A and Rini JM and Leffler H}, journal={J Biol Chem}}"}, "is_sup_mat_match": false}, {"pmid": 35459861, "pmcid": "PMC9033806", "title": "A stop-gain mutation in GXYLT1 promotes metastasis of colorectal cancer via the MAPK pathway.", "journal": "Cell Death Dis", "authors": ["Peng L", "Zhao M", "Liu T", "Chen J", "Gao P", "Chen L", "Xing P", "Wang Z", "Di J", "Xu Q", "Qu H", "Jiang B", "Su X"], "date": "2022-04-22T00:00:00Z", "year": 2022, "snippets": [], "citations": {"NLM": "Peng L, Zhao M, Liu T, Chen J, Gao P, Chen L, Xing P, Wang Z, Di J, Xu Q, Qu H, Jiang B, Su X. A stop-gain mutation in GXYLT1 promotes metastasis of colorectal cancer via the MAPK pathway. Cell Death Dis. PMID: 35459861", "BibTeX": "@article{35459861, title={A stop-gain mutation in GXYLT1 promotes metastasis of colorectal cancer via the MAPK pathway.}, author={Peng L and Zhao M and Liu T and Chen J and Gao P and Chen L and Xing P and Wang Z and Di J and Xu Q and Qu H and Jiang B and Su X}, journal={Cell Death Dis}}"}, "is_sup_mat_match": true}, {"pmid": 25637035, "pmcid": "PMC4318366", "title": "Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium.", "journal": "BMC Cancer", "authors": ["Tops BB", "Normanno N", "Kurth H", "Amato E", "Mafficini A", "Rieber N", "Le Corre D", "Rachiglio AM", "Reiman A", "Sheils O", "Noppen C", "Lacroix L", "Cree IA", "Scarpa A", "Ligtenberg MJ", "Laurent-Puig P"], "date": "2015-01-31T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Tops BB, Normanno N, Kurth H, Amato E, Mafficini A, Rieber N, Le Corre D, Rachiglio AM, Reiman A, Sheils O, Noppen C, Lacroix L, Cree IA, Scarpa A, Ligtenberg MJ, Laurent-Puig P. Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium. BMC Cancer. PMID: 25637035", "BibTeX": "@article{25637035, title={Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium.}, author={Tops BB and Normanno N and Kurth H and Amato E and Mafficini A and Rieber N and Le Corre D and Rachiglio AM and Reiman A and Sheils O and Noppen C and Lacroix L and Cree IA and Scarpa A and Ligtenberg MJ and Laurent-Puig P}, journal={BMC Cancer}}"}, "is_sup_mat_match": true}, {"pmid": 28385781, "pmcid": "PMC5566041", "title": "Monitoring multiple myeloma by quantification of recurrent mutations in serum.", "journal": "Haematologica", "authors": ["Rustad EH", "Coward E", "Skyt\u00f8en ER", "Misund K", "Holien T", "Standal T", "B\u00f8rset M", "Beisvag V", "Myklebost O", "Meza-Zepeda LA", "Dai HY", "Sundan A", "Waage A"], "date": "2017-07-01T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Rustad EH, Coward E, Skyt\u00f8en ER, Misund K, Holien T, Standal T, B\u00f8rset M, Beisvag V, Myklebost O, Meza-Zepeda LA, Dai HY, Sundan A, Waage A. Monitoring multiple myeloma by quantification of recurrent mutations in serum. Haematologica. PMID: 28385781", "BibTeX": "@article{28385781, title={Monitoring multiple myeloma by quantification of recurrent mutations in serum.}, author={Rustad EH and Coward E and Skyt\u00f8en ER and Misund K and Holien T and Standal T and B\u00f8rset M and Beisvag V and Myklebost O and Meza-Zepeda LA and Dai HY and Sundan A and Waage A}, journal={Haematologica}}"}, "is_sup_mat_match": true}, {"pmid": 23819521, "pmcid": "PMC3665581", "title": "Assessment of computational methods for predicting the effects of missense mutations in human cancers.", "journal": "BMC Genomics", "authors": ["Gnad F", "Baucom A", "Mukhyala K", "Manning G", "Zhang Z"], "date": "2013-01-01T00:00:00Z", "year": 2013, "snippets": [], "citations": {"NLM": "Gnad F, Baucom A, Mukhyala K, Manning G, Zhang Z. Assessment of computational methods for predicting the effects of missense mutations in human cancers. BMC Genomics. PMID: 23819521", "BibTeX": "@article{23819521, title={Assessment of computational methods for predicting the effects of missense mutations in human cancers.}, author={Gnad F and Baucom A and Mukhyala K and Manning G and Zhang Z}, journal={BMC Genomics}}"}, "is_sup_mat_match": true}, {"pmid": 30981987, "pmcid": "PMC6817693", "title": "Resectable lung lesions malignancy assessment and cancer detection by ultra-deep sequencing of targeted gene mutations in plasma cell-free DNA.", "journal": "J Med Genet", "authors": ["Peng M", "Xie Y", "Li X", "Qian Y", "Tu X", "Yao X", "Cheng F", "Xu F", "Kong D", "He B", "Liu C", "Cao F", "Yang H", "Yu F", "Xu C", "Tian G"], "date": "2019-10-01T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Peng M, Xie Y, Li X, Qian Y, Tu X, Yao X, Cheng F, Xu F, Kong D, He B, Liu C, Cao F, Yang H, Yu F, Xu C, Tian G. Resectable lung lesions malignancy assessment and cancer detection by ultra-deep sequencing of targeted gene mutations in plasma cell-free DNA. J Med Genet. PMID: 30981987", "BibTeX": "@article{30981987, title={Resectable lung lesions malignancy assessment and cancer detection by ultra-deep sequencing of targeted gene mutations in plasma cell-free DNA.}, author={Peng M and Xie Y and Li X and Qian Y and Tu X and Yao X and Cheng F and Xu F and Kong D and He B and Liu C and Cao F and Yang H and Yu F and Xu C and Tian G}, journal={J Med Genet}}"}, "is_sup_mat_match": true}, {"pmid": 30019318, "pmcid": "PMC6153611", "title": "Clinical validation of the next-generation sequencing-based Extended RAS Panel assay using metastatic colorectal cancer patient samples from the phase 3 PRIME study.", "journal": "J Cancer Res Clin Oncol", "authors": ["Udar N", "Lofton-Day C", "Dong J", "Vavrek D", "Jung AS", "Meier K", "Iyer A", "Slaughter R", "Gutekunst K", "Bach BA", "Peeters M", "Douillard JY"], "date": "2018-10-01T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Udar N, Lofton-Day C, Dong J, Vavrek D, Jung AS, Meier K, Iyer A, Slaughter R, Gutekunst K, Bach BA, Peeters M, Douillard JY. Clinical validation of the next-generation sequencing-based Extended RAS Panel assay using metastatic colorectal cancer patient samples from the phase 3 PRIME study. J Cancer Res Clin Oncol. PMID: 30019318", "BibTeX": "@article{30019318, title={Clinical validation of the next-generation sequencing-based Extended RAS Panel assay using metastatic colorectal cancer patient samples from the phase 3 PRIME study.}, author={Udar N and Lofton-Day C and Dong J and Vavrek D and Jung AS and Meier K and Iyer A and Slaughter R and Gutekunst K and Bach BA and Peeters M and Douillard JY}, journal={J Cancer Res Clin Oncol}}"}, "is_sup_mat_match": true}, {"pmid": 27997540, "pmcid": "PMC5172551", "title": "IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.", "journal": "PLoS Med", "authors": ["Li Y", "Buijs-Gladdines JG", "Cant\u00e9-Barrett K", "Stubbs AP", "Vroegindeweij EM", "Smits WK", "van Marion R", "Dinjens WN", "Horstmann M", "Kuiper RP", "Buijsman RC", "Zaman GJ", "van der Spek PJ", "Pieters R", "Meijerink JP"], "date": "2016-12-20T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Li Y, Buijs-Gladdines JG, Cant\u00e9-Barrett K, Stubbs AP, Vroegindeweij EM, Smits WK, van Marion R, Dinjens WN, Horstmann M, Kuiper RP, Buijsman RC, Zaman GJ, van der Spek PJ, Pieters R, Meijerink JP. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study. PLoS Med. PMID: 27997540", "BibTeX": "@article{27997540, title={IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.}, author={Li Y and Buijs-Gladdines JG and Cant\u00e9-Barrett K and Stubbs AP and Vroegindeweij EM and Smits WK and van Marion R and Dinjens WN and Horstmann M and Kuiper RP and Buijsman RC and Zaman GJ and van der Spek PJ and Pieters R and Meijerink JP}, journal={PLoS Med}}"}, "is_sup_mat_match": true}, {"pmid": 36915628, "pmcid": "PMC10006853", "title": "The EGFR C797S Mutation Confers Resistance to a Novel EGFR Inhibitor CLN-081 to EGFR Exon 20 Insertion Mutations", "journal": "JTO Clin Res Rep", "authors": ["Kagawa Y", "Hayashida T", "Liu J", "Mori S", "Izumi H", "Kumagai S", "Udagawa H", "Hattori N", "Goto K", "Kobayashi SS"], "date": "2023-01-24T00:00:00Z", "year": 2023, "snippets": [], "citations": {"NLM": "Kagawa Y, Hayashida T, Liu J, Mori S, Izumi H, Kumagai S, Udagawa H, Hattori N, Goto K, Kobayashi SS. The EGFR C797S Mutation Confers Resistance to a Novel EGFR Inhibitor CLN-081 to EGFR Exon 20 Insertion Mutations JTO Clin Res Rep. PMID: 36915628", "BibTeX": "@article{36915628, title={The EGFR C797S Mutation Confers Resistance to a Novel EGFR Inhibitor CLN-081 to EGFR Exon 20 Insertion Mutations}, author={Kagawa Y and Hayashida T and Liu J and Mori S and Izumi H and Kumagai S and Udagawa H and Hattori N and Goto K and Kobayashi SS}, journal={JTO Clin Res Rep}}"}, "is_sup_mat_match": true}, {"pmid": 35140362, "pmcid": "PMC9061295", "title": "Acquired somatic variants in inherited myeloid malignancies", "journal": "Leukemia", "authors": ["Armes H", "Rio-Machin A", "Krizs\u00e1n S", "B\u00f6d\u00f6r C", "Kaya F", "Bewicke-Copley F", "Alnajar J", "Walne A", "P\u00e9terffy B", "Tummala H", "Rouault-Pierre K", "Dokal I", "Vulliamy T", "Fitzgibbon J"], "date": "2022-05-01T00:00:00Z", "year": 2022, "snippets": [], "citations": {"NLM": "Armes H, Rio-Machin A, Krizs\u00e1n S, B\u00f6d\u00f6r C, Kaya F, Bewicke-Copley F, Alnajar J, Walne A, P\u00e9terffy B, Tummala H, Rouault-Pierre K, Dokal I, Vulliamy T, Fitzgibbon J. Acquired somatic variants in inherited myeloid malignancies Leukemia. PMID: 35140362", "BibTeX": "@article{35140362, title={Acquired somatic variants in inherited myeloid malignancies}, author={Armes H and Rio-Machin A and Krizs\u00e1n S and B\u00f6d\u00f6r C and Kaya F and Bewicke-Copley F and Alnajar J and Walne A and P\u00e9terffy B and Tummala H and Rouault-Pierre K and Dokal I and Vulliamy T and Fitzgibbon J}, journal={Leukemia}}"}, "is_sup_mat_match": true}, {"pmid": 31602787, "pmcid": "PMC6885423", "title": "Detection of EGFR gene mutation status from pleural effusions and other body fluid specimens in patients with lung adenocarcinoma", "journal": "Thorac Cancer", "authors": ["Zhang P", "Wu X", "Tang M", "Nie X", "Li L"], "date": "2019-12-01T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Zhang P, Wu X, Tang M, Nie X, Li L. Detection of EGFR gene mutation status from pleural effusions and other body fluid specimens in patients with lung adenocarcinoma Thorac Cancer. PMID: 31602787", "BibTeX": "@article{31602787, title={Detection of EGFR gene mutation status from pleural effusions and other body fluid specimens in patients with lung adenocarcinoma}, author={Zhang P and Wu X and Tang M and Nie X and Li L}, journal={Thorac Cancer}}"}, "is_sup_mat_match": true}, {"pmid": 28566428, "pmcid": "PMC5919217", "title": "Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers", "journal": "Sci Transl Med", "authors": ["Sun C", "Fang Y", "Yin J", "Chen J", "Ju Z", "Zhang D", "Chen X", "Vellano CP", "Jeong KJ", "Ng PK", "Eterovic AKB", "Bhola NH", "Lu Y", "Westin SN", "Grandis JR", "Lin SY", "Scott KL", "Peng G", "Brugge J", "Mills GB"], "date": "2017-05-31T00:00:00Z", "year": 2017, "snippets": [{"_id": "28566428@17559", "snip_text": "However, deep NGS sequencing as well as Sanger sequencing of individual PARPi-resistant clones from A2780CP_R demonstrated the presence of KRASA146T, KRASA59T and MAP2K1A283T in 19, 11 and 6% of cells respectively but not in A2780CP parental cells.", "section": "results", "mentions": ["139|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T", "100|9|cellline||A2780CP_R", "225|7|cellline||A2780CP", "72|5|chemical||PARPi"], "text_hl": "However, deep NGS sequencing as well as Sanger sequencing of individual PARPi-resistant clones from A2780CP_R demonstrated the presence of KRASA146T, KRASA59T and MAP2K1A283T in 19, 11 and 6% of cells respectively but not in A2780CP parental cells."}], "citations": {"NLM": "Sun C, Fang Y, Yin J, Chen J, Ju Z, Zhang D, Chen X, Vellano CP, Jeong KJ, Ng PK, Eterovic AKB, Bhola NH, Lu Y, Westin SN, Grandis JR, Lin SY, Scott KL, Peng G, Brugge J, Mills GB. Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers Sci Transl Med. PMID: 28566428", "BibTeX": "@article{28566428, title={Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers}, author={Sun C and Fang Y and Yin J and Chen J and Ju Z and Zhang D and Chen X and Vellano CP and Jeong KJ and Ng PK and Eterovic AKB and Bhola NH and Lu Y and Westin SN and Grandis JR and Lin SY and Scott KL and Peng G and Brugge J and Mills GB}, journal={Sci Transl Med}}"}, "is_sup_mat_match": false}, {"pmid": 30562681, "pmcid": "PMC6297189", "title": "Advantage of Next-Generation Sequencing in Dynamic Monitoring of Circulating Tumor DNA over Droplet Digital PCR in Cetuximab Treated Colorectal Cancer Patients.", "journal": "Transl Oncol", "authors": ["Zhang H", "Liu R", "Yan C", "Liu L", "Tong Z", "Jiang W", "Yao M", "Fang W", "Chen Z"], "date": "2019-03-01T00:00:00Z", "year": 2019, "snippets": [{"_id": "30562681@11891", "snip_text": "Only hotspots of KRAS (G12A/C/D/R/S/V, G13D, Q61H/K/L/R, A146T, K117 N), EGFR (R451C, S492R, S464 L, K467 T, I491M), NRAS (G12A/C/D/R/S/V, G13D, Q61R), MEK1 (K57 N) and BRAF (V600E) are available for ddPCR detection.", "section": "results", "mentions": ["109|5|variant|litvar@#4893#p.I491M&&&litvar@#4893#|I491M", "117|4|gene|ncbi_gene@4893|NRAS", "86|5|variant|litvar@rs1057519860##&&&litvar@#1956#|S492R", "39|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "79|5|variant|litvar@rs377567759##&&&litvar@#1956#&&&litvar@CA158917074#rs377567759##|R451C", "123|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12A/C", "93|6|variant|litvar@rs1240855741##&&&litvar@#1956#|S464 L", "158|5|variant|litvar@rs869025608##&&&litvar@#5604#&&&litvar@CA356995#rs869025608##|K57 N", "45|6|variant|litvar@rs17851045##&&&litvar@#3845#|Q61H/K", "152|4|gene|ncbi_gene@5604|MEK1", "145|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "17|4|gene|ncbi_gene@3845|KRAS", "57|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "139|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "101|6|variant|litvar@#4893#p.K467T&&&litvar@#4893#|K467 T", "175|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "23|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12A/C", "169|4|gene|ncbi_gene@673|BRAF", "64|6|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117 N", "73|4|gene|ncbi_gene@1956|EGFR"], "text_hl": "Only hotspots of KRAS (G12A/C/D/R/S/V, G13D, Q61H/K/L/R, <m>A146T</m>, K117 N), EGFR (R451C, S492R, S464 L, K467 T, I491M), NRAS (G12A/C/D/R/S/V, G13D, Q61R), MEK1 (K57 N) and BRAF (V600E) are available for ddPCR detection."}], "citations": {"NLM": "Zhang H, Liu R, Yan C, Liu L, Tong Z, Jiang W, Yao M, Fang W, Chen Z. Advantage of Next-Generation Sequencing in Dynamic Monitoring of Circulating Tumor DNA over Droplet Digital PCR in Cetuximab Treated Colorectal Cancer Patients. Transl Oncol. PMID: 30562681", "BibTeX": "@article{30562681, title={Advantage of Next-Generation Sequencing in Dynamic Monitoring of Circulating Tumor DNA over Droplet Digital PCR in Cetuximab Treated Colorectal Cancer Patients.}, author={Zhang H and Liu R and Yan C and Liu L and Tong Z and Jiang W and Yao M and Fang W and Chen Z}, journal={Transl Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 34335949, "pmcid": "PMC8317521", "title": "Prognostic Value of KRAS Exon 3 and Exon 4 Mutations in Colorectal Cancer Patients.", "journal": "J Cancer", "authors": ["Guo T", "Wu Y", "Huang D", "Jin Y", "Sheng W", "Cai S", "Zhou X", "Zhu X", "Liu F", "Xu Y"], "date": "2021-07-03T00:00:00Z", "year": 2021, "snippets": [{"_id": "34335949@19832", "snip_text": "Mutations Codons Amino acid alteration Number of patients   Wild type   927   KRAS exon 2 mutation Codon 12 p.G12D 174     p.G12V 121     p.G12S 36     p.G12C 26     p.G12A 15     p.G12R 8     Other amino acid alteration 7     Unknown amino acid alteration 153    Codon 13 P.G13D 184     p.G13R 3     p.G13C 1     p.G13V 1    Unknown codon  51   KRAS exon 3 mutation Codon 61 p.Q61H 8     p.Q61L 7     p.Q61R 5     p.Q61K 2    Codon 59 p.A59T 2    Unknown codon  10   KRAS exon 4 mutation Codon 146 p.A146T 44     p.A146V 4     p.A146N 1    Codon 117 p.K117D 5     p.K117N 3     p.K117R 1    Codon 131 p.Q131fs 1    Unknown codon  16   ", "section": "table", "mentions": ["468|4|gene|ncbi_gene@3845|KRAS", "123|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "579|7|variant|litvar@#3845#p.K117R&&&litvar@#3845#|p.K117R", "180|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "389|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "565|7|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.K117N", "551|7|variant|litvar@#3845#p.K117D&&&litvar@#3845#|p.K117D", "288|6|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|p.G13R", "415|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "314|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|p.G13V", "499|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "436|6|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|p.A59T", "376|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "402|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "346|4|gene|ncbi_gene@3845|KRAS", "275|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "152|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "602|8|variant|litvar@#3845#p.Q131fsX&&&litvar@#3845#|p.Q131fs", "49|8|species|ncbi_taxonomy@9606|patients", "138|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "108|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "78|4|gene|ncbi_gene@3845|KRAS", "301|6|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|p.G13C", "528|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146N", "166|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "514|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V"], "figure_id": "T1", "text_hl": "Mutations Codons Amino acid alteration Number of patients   Wild type   927   KRAS exon 2 mutation Codon 12 p.G12D 174     p.G12V 121     p.G12S 36     p.G12C 26     p.G12A 15     p.G12R 8     Other amino acid alteration 7     Unknown amino acid alteration 153    Codon 13 P.G13D 184     p.G13R 3     p.G13C 1     p.G13V 1    Unknown codon  51   KRAS exon 3 mutation Codon 61 p.Q61H 8     p.Q61L 7     p.Q61R 5     p.Q61K 2    Codon 59 p.A59T 2    Unknown codon  10   KRAS exon 4 mutation Codon 146 <m>p.A146T</m> 44     p.A146V 4     p.A146N 1    Codon 117 p.K117D 5     p.K117N 3     p.K117R 1    Codon 131 p.Q131fs 1    Unknown codon  16   "}], "citations": {"NLM": "Guo T, Wu Y, Huang D, Jin Y, Sheng W, Cai S, Zhou X, Zhu X, Liu F, Xu Y. Prognostic Value of KRAS Exon 3 and Exon 4 Mutations in Colorectal Cancer Patients. J Cancer. PMID: 34335949", "BibTeX": "@article{34335949, title={Prognostic Value of KRAS Exon 3 and Exon 4 Mutations in Colorectal Cancer Patients.}, author={Guo T and Wu Y and Huang D and Jin Y and Sheng W and Cai S and Zhou X and Zhu X and Liu F and Xu Y}, journal={J Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 32962309, "pmcid": "PMC7555209", "title": "PD-L1 Expression on Circulating Tumour Cells May Be Predictive of Response to Regorafenib in Patients Diagnosed with Chemorefractory Metastatic Colorectal Cancer", "journal": "Int J Mol Sci", "authors": ["Raimondi L", "Raimondi FM", "Di Benedetto L", "Cimino G", "Spinelli GP"], "date": "2020-09-20T00:00:00Z", "year": 2020, "snippets": [{"_id": "32962309@6206", "snip_text": "Less common KRAS mutations were found in three patients (i.e.  G12A in two patients and A146T in another one); in one patient, two mutations were found (i.e.  G12D/G12V).", "section": "results", "mentions": ["47|8|species|ncbi_taxonomy@9606|patients", "63|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "159|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "118|7|species|ncbi_taxonomy@9606|patient", "75|8|species|ncbi_taxonomy@9606|patients", "164|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "88|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "12|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "Less common KRAS mutations were found in three patients (i.e.  G12A in two patients and <m>A146T</m> in another one); in one patient, two mutations were found (i.e.  G12D/G12V)."}], "citations": {"NLM": "Raimondi L, Raimondi FM, Di Benedetto L, Cimino G, Spinelli GP. PD-L1 Expression on Circulating Tumour Cells May Be Predictive of Response to Regorafenib in Patients Diagnosed with Chemorefractory Metastatic Colorectal Cancer Int J Mol Sci. PMID: 32962309", "BibTeX": "@article{32962309, title={PD-L1 Expression on Circulating Tumour Cells May Be Predictive of Response to Regorafenib in Patients Diagnosed with Chemorefractory Metastatic Colorectal Cancer}, author={Raimondi L and Raimondi FM and Di Benedetto L and Cimino G and Spinelli GP}, journal={Int J Mol Sci}}"}, "is_sup_mat_match": false}, {"pmid": 37509241, "pmcid": "PMC10377118", "title": "KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies", "journal": "Cancers (Basel)", "authors": ["Ottaiano A", "Sabbatino F", "Perri F", "Cascella M", "Sirica R", "Patrone R", "Capuozzo M", "Savarese G", "Ianniello M", "Petrillo N", "Circelli L", "Granata V", "Berretta M", "Santorsola M", "Nasti G"], "date": "2023-07-12T00:00:00Z", "year": 2023, "snippets": [{"_id": "37509241@4710", "snip_text": "Fourteen patients with rarer variants were excluded from the analysis to prevent potential prognostic interferences that could not be adequately explained due to limited and fragmented numbers (4 p.A146T, 2 p.A146V, 2 p.G13R, 2 p.K117N, 2 p.G13C, 1 p.G12_G13insG, 1 p.G12F).", "section": "other", "mentions": ["266|6|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12F", "218|6|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|p.G13R", "207|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "249|13|variant|litvar@#3845#p.G12,13ins&&&litvar@#3845#|p.G12_G13insG", "9|8|species|ncbi_taxonomy@9606|patients", "239|6|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|p.G13C", "228|7|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.K117N", "196|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T"], "text_hl": "Fourteen patients with rarer variants were excluded from the analysis to prevent potential prognostic interferences that could not be adequately explained due to limited and fragmented numbers (4 <m>p.A146T</m>, 2 p.A146V, 2 p.G13R, 2 p.K117N, 2 p.G13C, 1 p.G12_G13insG, 1 p.G12F)."}], "citations": {"NLM": "Ottaiano A, Sabbatino F, Perri F, Cascella M, Sirica R, Patrone R, Capuozzo M, Savarese G, Ianniello M, Petrillo N, Circelli L, Granata V, Berretta M, Santorsola M, Nasti G. KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies Cancers (Basel). PMID: 37509241", "BibTeX": "@article{37509241, title={KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies}, author={Ottaiano A and Sabbatino F and Perri F and Cascella M and Sirica R and Patrone R and Capuozzo M and Savarese G and Ianniello M and Petrillo N and Circelli L and Granata V and Berretta M and Santorsola M and Nasti G}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 34201893, "pmcid": "PMC8268977", "title": "From Genetics to Histomolecular Characterization: An Insight into Colorectal Carcinogenesis in Lynch Syndrome.", "journal": "Int J Mol Sci", "authors": ["Lepore Signorile M", "Disciglio V", "Di Carlo G", "Pisani A", "Simone C", "Ingravallo G"], "date": "2021-06-23T00:00:00Z", "year": 2021, "snippets": [{"_id": "34201893@11620", "snip_text": "Furthermore, almost all KRAS mutations appearing before MMR deficiency in LS patients are alterations involving specific sequences, such as KRAS G12V and KRAS A146T.", "section": "introduction", "mentions": ["74|2|disease|ncbi_mesh@D003123|LS", "56|14|disease|ncbi_mesh@C536928|MMR deficiency", "24|4|gene|ncbi_gene@3845|KRAS", "145|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "140|4|gene|ncbi_gene@3845|KRAS", "77|8|species|ncbi_taxonomy@9606|patients", "159|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "154|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "Furthermore, almost all KRAS mutations appearing before MMR deficiency in LS patients are alterations involving specific sequences, such as KRAS G12V and KRAS <m>A146T</m>."}], "citations": {"NLM": "Lepore Signorile M, Disciglio V, Di Carlo G, Pisani A, Simone C, Ingravallo G. From Genetics to Histomolecular Characterization: An Insight into Colorectal Carcinogenesis in Lynch Syndrome. Int J Mol Sci. PMID: 34201893", "BibTeX": "@article{34201893, title={From Genetics to Histomolecular Characterization: An Insight into Colorectal Carcinogenesis in Lynch Syndrome.}, author={Lepore Signorile M and Disciglio V and Di Carlo G and Pisani A and Simone C and Ingravallo G}, journal={Int J Mol Sci}}"}, "is_sup_mat_match": false}, {"pmid": 35071006, "pmcid": "PMC8777220", "title": "Prognostic Impact of An Integrative Landscape of Clinical, Immune, and Molecular Features in Non-Metastatic Rectal Cancer", "journal": "Front Oncol", "authors": ["Iseas S", "Sendoya JM", "Robbio J", "Coraglio M", "Kujaruk M", "Mikolaitis V", "Rizzolo M", "Cabanne A", "Ruiz G", "Salanova R", "Gualdrini U", "M\u00e9ndez G", "Antelo M", "Carballido M", "Rotondaro C", "Viglino J", "Eleta M", "Di Sibio A", "Podhajcer OL", "Roca E", "Llera AS", "Golubicki M", "Abba MC"], "date": "2022-01-07T00:00:00Z", "year": 2022, "snippets": [{"_id": "35071006@32112", "snip_text": "Tumors harboring KRAS alterations were characterized by the predominant presence of the A146T, G12D/A/V/S activating mutations followed by G13D, T74P, and G115E AA substitutions ( Figure 4C ).", "section": "discussion", "mentions": ["139|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "17|4|gene|ncbi_gene@3845|KRAS", "145|4|variant|litvar@#3845#p.T74P&&&litvar@#3845#|T74P", "95|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12D/A", "88|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "155|5|variant|litvar@rs754672457##&&&litvar@#1045#|G115E"], "text_hl": "Tumors harboring KRAS alterations were characterized by the predominant presence of the <m>A146T</m>, G12D/A/V/S activating mutations followed by G13D, T74P, and G115E AA substitutions ( Figure 4C )."}], "citations": {"NLM": "Iseas S, Sendoya JM, Robbio J, Coraglio M, Kujaruk M, Mikolaitis V, Rizzolo M, Cabanne A, Ruiz G, Salanova R, Gualdrini U, M\u00e9ndez G, Antelo M, Carballido M, Rotondaro C, Viglino J, Eleta M, Di Sibio A, Podhajcer OL, Roca E, Llera AS, Golubicki M, Abba MC. Prognostic Impact of An Integrative Landscape of Clinical, Immune, and Molecular Features in Non-Metastatic Rectal Cancer Front Oncol. PMID: 35071006", "BibTeX": "@article{35071006, title={Prognostic Impact of An Integrative Landscape of Clinical, Immune, and Molecular Features in Non-Metastatic Rectal Cancer}, author={Iseas S and Sendoya JM and Robbio J and Coraglio M and Kujaruk M and Mikolaitis V and Rizzolo M and Cabanne A and Ruiz G and Salanova R and Gualdrini U and M\u00e9ndez G and Antelo M and Carballido M and Rotondaro C and Viglino J and Eleta M and Di Sibio A and Podhajcer OL and Roca E and Llera AS and Golubicki M and Abba MC}, journal={Front Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 25004944, "pmcid": "PMC4743643", "title": "Comparison of KRAS mutation analysis of colorectal cancer samples by standard testing and next-generation sequencing", "journal": "J Clin Pathol", "authors": ["Kothari N", "Schell MJ", "Teer JK", "Yeatman T", "Shibata D", "Kim R"], "date": "2014-09-01T00:00:00Z", "year": 2014, "snippets": [{"_id": "25004944@22844", "snip_text": "Sample\tStandard testing\tNGS\tExplanation\t \t1\tG12A mutant\tWild type (WT)\t1/147 reads show mutation\t \t2\tG12D mutant\tWT\tLow tumour fraction\t \t3\tG12A mutant\tQ61K mutant\t\t \t4\tWT\tQ61K mutant\t\t \t5\tWT\tQ61K mutant\t\t \t6\tWT\tQ61H mutant\t\t \t7\tWT\tA146T mutant\t\t \t8\tWT\tA146V mutant\t\t \t", "section": "table", "mentions": ["152|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "212|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "192|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "44|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "172|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "232|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "101|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "140|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "253|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V"], "figure_id": "T3", "text_hl": "Sample\tStandard testing\tNGS\tExplanation\t \t1\tG12A mutant\tWild type (WT)\t1/147 reads show mutation\t \t2\tG12D mutant\tWT\tLow tumour fraction\t \t3\tG12A mutant\tQ61K mutant\t\t \t4\tWT\tQ61K mutant\t\t \t5\tWT\tQ61K mutant\t\t \t6\tWT\tQ61H mutant\t\t \t7\tWT\t<m>A146T</m> mutant\t\t \t8\tWT\tA146V mutant\t\t \t"}], "citations": {"NLM": "Kothari N, Schell MJ, Teer JK, Yeatman T, Shibata D, Kim R. Comparison of KRAS mutation analysis of colorectal cancer samples by standard testing and next-generation sequencing J Clin Pathol. PMID: 25004944", "BibTeX": "@article{25004944, title={Comparison of KRAS mutation analysis of colorectal cancer samples by standard testing and next-generation sequencing}, author={Kothari N and Schell MJ and Teer JK and Yeatman T and Shibata D and Kim R}, journal={J Clin Pathol}}"}, "is_sup_mat_match": false}, {"pmid": 33440168, "pmcid": "PMC7897307", "title": "Inhibition of Nonfunctional Ras", "journal": "Cell Chem Biol", "authors": ["Nussinov R", "Jang H", "Gursoy A", "Keskin O", "Gaponenko V"], "date": "2021-02-18T00:00:00Z", "year": 2021, "snippets": [{"_id": "33440168@7686", "snip_text": "Weaker driver mutations can be associated with promoting a high rate of intrinsic and guanine nucleotide exchange factor-induced nucleotide exchange, as in the case of A146T K-Ras4B mutant.", "section": "other", "mentions": ["86|27|chemical||guanine nucleotide exchange", "168|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "174|7|gene|ncbi_gene@3845|K-Ras4B"], "text_hl": "Weaker driver mutations can be associated with promoting a high rate of intrinsic and guanine nucleotide exchange factor-induced nucleotide exchange, as in the case of <m>A146T</m> K-Ras4B mutant."}], "citations": {"NLM": "Nussinov R, Jang H, Gursoy A, Keskin O, Gaponenko V. Inhibition of Nonfunctional Ras Cell Chem Biol. PMID: 33440168", "BibTeX": "@article{33440168, title={Inhibition of Nonfunctional Ras}, author={Nussinov R and Jang H and Gursoy A and Keskin O and Gaponenko V}, journal={Cell Chem Biol}}"}, "is_sup_mat_match": false}, {"pmid": 33111480, "pmcid": "PMC8342588", "title": "Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations.", "journal": "Oncologist", "authors": ["Koopman B", "Groen HJM", "Ligtenberg MJL", "Gr\u00fcnberg K", "Monkhorst K", "de Langen AJ", "Boelens MC", "Paats MS", "von der Th\u00fcsen JH", "Dinjens WNM", "Solleveld N", "van Wezel T", "Gelderblom H", "Hendriks LE", "Speel EM", "Theunissen TE", "Kroeze LI", "Mehra N", "Piet B", "van der Wekken AJ", "Ter Elst A", "Timens W", "Willems SM", "Meijers RWJ", "de Leng WWJ", "van Lindert ASR", "Radonic T", "Hashemi SMS", "Heideman DAM", "Schuuring E", "van Kempen LC"], "date": "2020-10-28T00:00:00Z", "year": 2020, "snippets": [{"_id": "33111480@19712", "snip_text": "Case ID Cancer type Setting Mutational profile Answers received Recommendations Next actionable targetb Agreementc   1A NSCLC Resistance to osimertinib EGFR p.(L747_A750delinsP)BRAF p.(V600E) n = 8 BRAF/MEK inhibition (dabrafenib + trametinib) and osimertinib, in combination or sequential treatment (n = 6)Switch to chemotherapy; if that is not an option, BRAF/MEK inhibition (dabrafenib + trametinib) (n = 1)Switch to chemotherapy (n = 1) BRAF/MEK (n = 7)No target (n = 1) 87.5%   1B CRC Primary stage IV diagnosis KRAS p.(L19F) n = 5 Do NOT treat with anti-EGFR antibodies (n = 3)No contraindication for anti-EGFR antibodies in current guidelines (n = 2) No target (n = 3)EGFR (n = 2) 60%   2A Melanoma Exhaustion of standard treatment options BRAF p.(G464E)NRAS p.(Q61K)CDKN2A p.(R80*) n = 4 First exhaust treatment options with immunotherapy, then treat with palbociclib within the DRUP trial (if biallelic CDKN2A inactivation is proven) (n = 2)Treat with palbociclib within the DRUP trial (if biallelic CDKN2A inactivation is proven) (n = 1)MEK inhibition in compassionate use (n = 1) CDK4/6 (n = 3)MEK (n = 1) 75%   2B NSCLC Primary stage IV diagnosis EGFR p.(G719A)ERBB2 p.(S310F) n = 8 Treat with agent that may inhibit both mutations, such as afatinib (n = 5)Switch to chemotherapy; treat with afatinib at progression (n = 1)Treat with erlotinib; relevance of ERBB2 mutation is unknown (n = 1)ERBB2 mutation may induce resistance; consider lapatinib (ERBB2 inhibitor) (n = 1) EGFR/ERBB2 (n = 6)EGFR (n = 1)ERBB2 (n = 1) 75%   3A NSCLC Resistance to osimertinib EGFR p.(E746_A750del)TP53 p.(P278R)TRIM24-BRAF fusion gene n = 8 EGFR inhibitor (osimertinib) combined with a MEK inhibitor (trametinib), preferentially within a clinical trial (if available) (n = 6)Consider treatment with MEK inhibitor (n = 1)No other options than chemotherapy. Pan-RAF inhibitor such as sorafenib may be beneficial, but no options for trials (n = 1) MEK (n = 7)RAF (n = 1) 87.5%   3B Colorectal cancer Exhaustion of standard treatment options MET p.(R988C)TP53 p.(R158H)TP53 p.(R196*)ERBB2 amplification n = 4 Anti-ERBB2 antibodies (trastuzumab + pertuzumab) within the DRUP trial (n = 4) ERBB2 (n = 4) 100%   4A GIST Primary stage IV diagnosis BRAF p.(V600E) n = 4 BRAF/MEK inhibition (dabrafenib + trametinib or vemurafenib + cobimetinib) within the DRUP trial (n = 4) BRAF/MEK (n = 4) 100%   4B NSCLC Primary stage IV diagnosis KRAS p.(A146T)BRAF p.(G469A)CDKN2A p.(H83Y)TERT promoter: C228T n = 8 Depending on PD-L1, immunotherapy or chemotherapy combined with immunotherapy (n = 7)dNo targets available. Additional diagnostics for revision of diagnosis because of unexpected combination of mutations (n = 1) No targets (n = 7)RAF or MEK (n = 1)d 87.5%   5A NSCLC Resistance to osimertinib EGFR p.(E746_A750del)TP53 p.(F328Ifs*18)MET amplificationEGFR amplification n = 8 Continue osimertinib; combine with MET inhibitor (n = 4)MET inhibitor or chemotherapy combined with immunotherapy (n = 1)Continue osimertinib; combine with anti-EGFR antibodies (necitumumab) (n = 1)Chemotherapy combined with immunotherapy; treat with combination of MET inhibitor and EGFR inhibitor at progression (n = 1)Chemotherapy; treat with MET inhibitor at progression (n = 1) MET (n = 7)EGFR (n = 1) 87.5%   5B NSCLC Resistance to alectinib ALK fusion geneALK p.(G1202R) n = 8 Lorlatinib (or brigatinib within an available trial) (n = 7)Brigatinib within an available trial or chemotherapy; lorlatinib at progression (n = 1) ALK (n = 8) 100%   Total: n = 65 Average: 86%   ", "section": "table", "mentions": ["177|4|gene|ncbi_gene@673|BRAF", "2435|4|gene|ncbi_gene@673|BRAF", "1681|3|gene|ncbi_gene@5609|MEK", "2074|5|gene|ncbi_gene@2064|ERBB2", "2137|10|chemical|ncbi_mesh@C485206|pertuzumab", "2728|3|gene|ncbi_gene@5609|MEK", "761|4|gene|ncbi_gene@4893|NRAS", "1253|8|chemical|ncbi_mesh@D000077716|afatinib", "1974|17|disease|ncbi_mesh@D015179|Colorectal cancer", "1486|4|gene|ncbi_gene@1956|EGFR", "1504|4|gene|ncbi_gene@1956|EGFR", "2304|11|chemical|ncbi_mesh@D000077484|vemurafenib", "3350|10|chemical|ncbi_mesh@C000590786|Lorlatinib", "1304|8|chemical|ncbi_mesh@D000077716|afatinib", "2366|3|gene|ncbi_gene@5609|MEK", "2318|11|chemical|ncbi_mesh@C574276|cobimetinib", "2440|9|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|p.(G469A)", "781|8|variant|litvar@#1029#p.R80fsX)&&&litvar@#1029#|p.(R80*)", "2235|4|gene|ncbi_gene@673|BRAF", "2426|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.(A146T)", "774|6|gene|ncbi_gene@1029|CDKN2A", "1940|3|gene|ncbi_gene@5609|MEK", "912|6|gene|ncbi_gene@1029|CDKN2A", "1539|5|disease|ncbi_mesh@D002289|NSCLC", "2922|3|gene|ncbi_gene@79811|MET", "1461|5|gene|ncbi_gene@2064|ERBB2", "182|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.(V600E)", "1516|5|gene|ncbi_gene@2064|ERBB2", "3284|5|disease|ncbi_mesh@D002289|NSCLC", "2875|11|chemical|ncbi_mesh@C000596361|osimertinib", "1851|4|gene|ncbi_gene@51816|Pan-", "198|4|gene|ncbi_gene@673|BRAF", "486|3|disease|ncbi_mesh@D015179|CRC", "2037|9|variant|litvar@#79811#p.R988C&&&litvar@#79811#|p.(R988C)", "2123|11|chemical|ncbi_mesh@D000068878|trastuzumab", "2504|5|gene|ncbi_gene@29126|PD-L1", "2721|3|gene|ncbi_gene@22882|RAF", "1597|9|variant|litvar@rs876659802##&&&litvar@#7157#|p.(P278R)", "2033|3|gene|ncbi_gene@79811|MET", "3333|10|variant|litvar@rs1057519783##&&&litvar@#238#|p.(G1202R)", "362|3|gene|ncbi_gene@5609|MEK", "2051|9|variant|litvar@rs55819519##&&&litvar@#7157#&&&litvar@CA468#rs55819519##|p.(R158H)", "1559|11|chemical|ncbi_mesh@C000596361|osimertinib", "1951|3|gene|ncbi_gene@22882|RAF", "2361|4|gene|ncbi_gene@673|BRAF", "1855|3|gene|ncbi_gene@22882|RAF", "2105|5|gene|ncbi_gene@2064|ERBB2", "2240|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.(V600E)", "1159|4|gene|ncbi_gene@1956|EGFR", "2824|3|gene|ncbi_gene@79811|MET", "2784|4|gene|ncbi_gene@1956|EGFR", "1636|4|gene|ncbi_gene@1956|EGFR", "1491|5|gene|ncbi_gene@2064|ERBB2", "3027|4|gene|ncbi_gene@1956|EGFR", "1652|11|chemical|ncbi_mesh@C000596361|osimertinib", "203|3|gene|ncbi_gene@5609|MEK", "2772|11|chemical|ncbi_mesh@C000596361|osimertinib", "517|4|gene|ncbi_gene@3845|KRAS", "219|10|chemical|ncbi_mesh@C561627|dabrafenib", "3464|10|chemical|ncbi_mesh@C000590786|lorlatinib", "2789|16|variant|litvar@#1956#p.A,)746,750del&&&litvar@#1956#|p.(E746_A750del)", "747|4|gene|ncbi_gene@673|BRAF", "3132|3|gene|ncbi_gene@79811|MET", "248|11|chemical|ncbi_mesh@C000596361|osimertinib", "2060|4|gene|ncbi_gene@7157|TP53", "357|4|gene|ncbi_gene@673|BRAF", "1592|4|gene|ncbi_gene@7157|TP53", "2464|4|gene|ncbi_gene@7015|TERT", "2479|5|variant|litvar@rs200486300##&&&litvar@#2064#|C228T", "2456|8|variant|litvar@rs121913385##&&&litvar@#1029#&&&litvar@CA16602753#rs121913385##|p.(H83Y)", "2046|4|gene|ncbi_gene@7157|TP53", "2449|6|gene|ncbi_gene@1029|CDKN2A", "120|5|disease|ncbi_mesh@D002289|NSCLC", "2388|5|disease|ncbi_mesh@D002289|NSCLC", "1164|9|variant|litvar@rs121913428##&&&litvar@#1956#&&&litvar@CA135775#rs121913428##|p.(G719A)", "2261|3|gene|ncbi_gene@5609|MEK", "2810|14|variant|litvar@#7157#p.F328IfsX18&&&litvar@#7157#|p.(F328Ifs*18)", "3044|11|chemical|ncbi_mesh@C527969|necitumumab", "2203|4|disease|ncbi_mesh@D046152|GIST", "1126|5|disease|ncbi_mesh@D002289|NSCLC", "1105|3|gene|ncbi_gene@5609|MEK", "3410|10|chemical|ncbi_mesh@C000598580|Brigatinib", "2277|10|chemical|ncbi_mesh@C561627|dabrafenib", "560|4|gene|ncbi_gene@1956|EGFR", "675|4|gene|ncbi_gene@1956|EGFR", "441|4|gene|ncbi_gene@673|BRAF", "152|4|gene|ncbi_gene@1956|EGFR", "2805|4|gene|ncbi_gene@7157|TP53", "1794|3|gene|ncbi_gene@5609|MEK", "1571|4|gene|ncbi_gene@1956|EGFR", "3304|9|chemical|ncbi_mesh@C582670|alectinib", "1009|6|gene|ncbi_gene@1029|CDKN2A", "1370|5|gene|ncbi_gene@2064|ERBB2", "1450|9|chemical|ncbi_mesh@D000077341|lapatinib", "1179|9|variant|litvar@rs1057519816##&&&litvar@#2064#|p.(S310F)", "1877|9|chemical|ncbi_mesh@D000077157|sorafenib", "3365|10|chemical|ncbi_mesh@C000598580|brigatinib", "140|11|chemical|ncbi_mesh@C000596361|osimertinib", "752|9|variant|litvar@rs121913348##&&&litvar@#673#&&&litvar@CA250636#rs121913348##|p.(G464E)", "3212|3|gene|ncbi_gene@79811|MET", "3150|4|gene|ncbi_gene@1956|EGFR", "2065|9|variant|litvar@#7157#p.R196*&&&litvar@#7157#|p.(R196*)", "1173|5|gene|ncbi_gene@2064|ERBB2", "1606|6|gene|ncbi_gene@8805|TRIM24", "3260|4|gene|ncbi_gene@1956|EGFR", "612|4|gene|ncbi_gene@1956|EGFR", "3249|3|gene|ncbi_gene@79811|MET", "3314|3|gene|ncbi_gene@238|ALK", "1576|16|variant|litvar@#1956#p.A,)746,750del&&&litvar@#1956#|p.(E746_A750del)", "2752|5|disease|ncbi_mesh@D002289|NSCLC", "1403|5|gene|ncbi_gene@2064|ERBB2", "1613|4|gene|ncbi_gene@673|BRAF", "2256|4|gene|ncbi_gene@673|BRAF", "2901|3|gene|ncbi_gene@79811|MET", "2179|5|gene|ncbi_gene@2064|ERBB2", "2996|11|chemical|ncbi_mesh@C000596361|osimertinib", "378|10|chemical|ncbi_mesh@C561627|dabrafenib", "1047|3|gene|ncbi_gene@5609|MEK", "522|8|variant|litvar@rs121913538##&&&litvar@#3845#&&&litvar@CA210356#rs121913538##|p.(L19F)", "766|8|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.(Q61K)", "2421|4|gene|ncbi_gene@3845|KRAS", "3498|3|gene|ncbi_gene@238|ALK", "446|3|gene|ncbi_gene@5609|MEK", "1346|9|chemical|ncbi_mesh@D000069347|erlotinib", "697|8|disease|ncbi_mesh@D008545|Melanoma"], "figure_id": "onco13580-tbl-0002", "text_hl": "Case ID Cancer type Setting Mutational profile Answers received Recommendations Next actionable targetb Agreementc   1A NSCLC Resistance to osimertinib EGFR p.(L747_A750delinsP)BRAF p.(V600E) n = 8 BRAF/MEK inhibition (dabrafenib + trametinib) and osimertinib, in combination or sequential treatment (n = 6)Switch to chemotherapy; if that is not an option, BRAF/MEK inhibition (dabrafenib + trametinib) (n = 1)Switch to chemotherapy (n = 1) BRAF/MEK (n = 7)No target (n = 1) 87.5%   1B CRC Primary stage IV diagnosis KRAS p.(L19F) n = 5 Do NOT treat with anti-EGFR antibodies (n = 3)No contraindication for anti-EGFR antibodies in current guidelines (n = 2) No target (n = 3)EGFR (n = 2) 60%   2A Melanoma Exhaustion of standard treatment options BRAF p.(G464E)NRAS p.(Q61K)CDKN2A p.(R80*) n = 4 First exhaust treatment options with immunotherapy, then treat with palbociclib within the DRUP trial (if biallelic CDKN2A inactivation is proven) (n = 2)Treat with palbociclib within the DRUP trial (if biallelic CDKN2A inactivation is proven) (n = 1)MEK inhibition in compassionate use (n = 1) CDK4/6 (n = 3)MEK (n = 1) 75%   2B NSCLC Primary stage IV diagnosis EGFR p.(G719A)ERBB2 p.(S310F) n = 8 Treat with agent that may inhibit both mutations, such as afatinib (n = 5)Switch to chemotherapy; treat with afatinib at progression (n = 1)Treat with erlotinib; relevance of ERBB2 mutation is unknown (n = 1)ERBB2 mutation may induce resistance; consider lapatinib (ERBB2 inhibitor) (n = 1) EGFR/ERBB2 (n = 6)EGFR (n = 1)ERBB2 (n = 1) 75%   3A NSCLC Resistance to osimertinib EGFR p.(E746_A750del)TP53 p.(P278R)TRIM24-BRAF fusion gene n = 8 EGFR inhibitor (osimertinib) combined with a MEK inhibitor (trametinib), preferentially within a clinical trial (if available) (n = 6)Consider treatment with MEK inhibitor (n = 1)No other options than chemotherapy. Pan-RAF inhibitor such as sorafenib may be beneficial, but no options for trials (n = 1) MEK (n = 7)RAF (n = 1) 87.5%   3B Colorectal cancer Exhaustion of standard treatment options MET p.(R988C)TP53 p.(R158H)TP53 p.(R196*)ERBB2 amplification n = 4 Anti-ERBB2 antibodies (trastuzumab + pertuzumab) within the DRUP trial (n = 4) ERBB2 (n = 4) 100%   4A GIST Primary stage IV diagnosis BRAF p.(V600E) n = 4 BRAF/MEK inhibition (dabrafenib + trametinib or vemurafenib + cobimetinib) within the DRUP trial (n = 4) BRAF/MEK (n = 4) 100%   4B NSCLC Primary stage IV diagnosis KRAS p.(<m>A146T</m>)BRAF p.(G469A)CDKN2A p.(H83Y)TERT promoter: C228T n = 8 Depending on PD-L1, immunotherapy or chemotherapy combined with immunotherapy (n = 7)dNo targets available. Additional diagnostics for revision of diagnosis because of unexpected combination of mutations (n = 1) No targets (n = 7)RAF or MEK (n = 1)d 87.5%   5A NSCLC Resistance to osimertinib EGFR p.(E746_A750del)TP53 p.(F328Ifs*18)MET amplificationEGFR amplification n = 8 Continue osimertinib; combine with MET inhibitor (n = 4)MET inhibitor or chemotherapy combined with immunotherapy (n = 1)Continue osimertinib; combine with anti-EGFR antibodies (necitumumab) (n = 1)Chemotherapy combined with immunotherapy; treat with combination of MET inhibitor and EGFR inhibitor at progression (n = 1)Chemotherapy; treat with MET inhibitor at progression (n = 1) MET (n = 7)EGFR (n = 1) 87.5%   5B NSCLC Resistance to alectinib ALK fusion geneALK p.(G1202R) n = 8 Lorlatinib (or brigatinib within an available trial) (n = 7)Brigatinib within an available trial or chemotherapy; lorlatinib at progression (n = 1) ALK (n = 8) 100%   Total: n = 65 Average: 86%   "}], "citations": {"NLM": "Koopman B, Groen HJM, Ligtenberg MJL, Gr\u00fcnberg K, Monkhorst K, de Langen AJ, Boelens MC, Paats MS, von der Th\u00fcsen JH, Dinjens WNM, Solleveld N, van Wezel T, Gelderblom H, Hendriks LE, Speel EM, Theunissen TE, Kroeze LI, Mehra N, Piet B, van der Wekken AJ, Ter Elst A, Timens W, Willems SM, Meijers RWJ, de Leng WWJ, van Lindert ASR, Radonic T, Hashemi SMS, Heideman DAM, Schuuring E, van Kempen LC. Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations. Oncologist. PMID: 33111480", "BibTeX": "@article{33111480, title={Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations.}, author={Koopman B and Groen HJM and Ligtenberg MJL and Gr\u00fcnberg K and Monkhorst K and de Langen AJ and Boelens MC and Paats MS and von der Th\u00fcsen JH and Dinjens WNM and Solleveld N and van Wezel T and Gelderblom H and Hendriks LE and Speel EM and Theunissen TE and Kroeze LI and Mehra N and Piet B and van der Wekken AJ and Ter Elst A and Timens W and Willems SM and Meijers RWJ and de Leng WWJ and van Lindert ASR and Radonic T and Hashemi SMS and Heideman DAM and Schuuring E and van Kempen LC}, journal={Oncologist}}"}, "is_sup_mat_match": false}, {"pmid": 35486650, "pmcid": "PMC9053827", "title": "Analytical and clinical validation of an amplicon-based next generation sequencing assay for ultrasensitive detection of circulating tumor DNA.", "journal": "PLoS One", "authors": ["Poh J", "Ngeow KC", "Pek M", "Tan KH", "Lim JS", "Chen H", "Ong CK", "Lim JQ", "Lim ST", "Lim CM", "Goh BC", "Choudhury Y"], "date": "2022-04-29T00:00:00Z", "year": 2022, "snippets": [], "citations": {"NLM": "Poh J, Ngeow KC, Pek M, Tan KH, Lim JS, Chen H, Ong CK, Lim JQ, Lim ST, Lim CM, Goh BC, Choudhury Y. Analytical and clinical validation of an amplicon-based next generation sequencing assay for ultrasensitive detection of circulating tumor DNA. PLoS One. PMID: 35486650", "BibTeX": "@article{35486650, title={Analytical and clinical validation of an amplicon-based next generation sequencing assay for ultrasensitive detection of circulating tumor DNA.}, author={Poh J and Ngeow KC and Pek M and Tan KH and Lim JS and Chen H and Ong CK and Lim JQ and Lim ST and Lim CM and Goh BC and Choudhury Y}, journal={PLoS One}}"}, "is_sup_mat_match": true}, {"pmid": 26527317, "pmcid": "PMC4791262", "title": "Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer.", "journal": "Oncotarget", "authors": ["Lee JY", "Park K", "Lim SH", "Kim HS", "Yoo KH", "Jung KS", "Song HN", "Hong M", "Do IG", "Ahn T", "Lee SK", "Bae SY", "Kim SW", "Lee JE", "Nam SJ", "Kim DH", "Jung HH", "Kim JY", "Ahn JS", "Im YH", "Park YH"], "date": "2015-12-22T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Lee JY, Park K, Lim SH, Kim HS, Yoo KH, Jung KS, Song HN, Hong M, Do IG, Ahn T, Lee SK, Bae SY, Kim SW, Lee JE, Nam SJ, Kim DH, Jung HH, Kim JY, Ahn JS, Im YH, Park YH. Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer. Oncotarget. PMID: 26527317", "BibTeX": "@article{26527317, title={Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer.}, author={Lee JY and Park K and Lim SH and Kim HS and Yoo KH and Jung KS and Song HN and Hong M and Do IG and Ahn T and Lee SK and Bae SY and Kim SW and Lee JE and Nam SJ and Kim DH and Jung HH and Kim JY and Ahn JS and Im YH and Park YH}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 21727090, "pmcid": "PMC3177186", "title": "Predicting the functional impact of protein mutations: application to cancer genomics.", "journal": "Nucleic Acids Res", "authors": ["Reva B", "Antipin Y", "Sander C"], "date": "2011-09-01T00:00:00Z", "year": 2011, "snippets": [], "citations": {"NLM": "Reva B, Antipin Y, Sander C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. PMID: 21727090", "BibTeX": "@article{21727090, title={Predicting the functional impact of protein mutations: application to cancer genomics.}, author={Reva B and Antipin Y and Sander C}, journal={Nucleic Acids Res}}"}, "is_sup_mat_match": true}, {"pmid": 27650546, "pmcid": "PMC5342018", "title": "CoGAPS matrix factorization algorithm identifies transcriptional changes in AP-2alpha target genes in feedback from therapeutic inhibition of the EGFR network.", "journal": "Oncotarget", "authors": ["Fertig EJ", "Ozawa H", "Thakar M", "Howard JD", "Kagohara LT", "Krigsfeld G", "Ranaweera RS", "Hughes RM", "Perez J", "Jones S", "Favorov AV", "Carey J", "Stein-O'Brien G", "Gaykalova DA", "Ochs MF", "Chung CH"], "date": "2016-11-08T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Fertig EJ, Ozawa H, Thakar M, Howard JD, Kagohara LT, Krigsfeld G, Ranaweera RS, Hughes RM, Perez J, Jones S, Favorov AV, Carey J, Stein-O'Brien G, Gaykalova DA, Ochs MF, Chung CH. CoGAPS matrix factorization algorithm identifies transcriptional changes in AP-2alpha target genes in feedback from therapeutic inhibition of the EGFR network. Oncotarget. PMID: 27650546", "BibTeX": "@article{27650546, title={CoGAPS matrix factorization algorithm identifies transcriptional changes in AP-2alpha target genes in feedback from therapeutic inhibition of the EGFR network.}, author={Fertig EJ and Ozawa H and Thakar M and Howard JD and Kagohara LT and Krigsfeld G and Ranaweera RS and Hughes RM and Perez J and Jones S and Favorov AV and Carey J and Stein-O'Brien G and Gaykalova DA and Ochs MF and Chung CH}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 35761395, "pmcid": "PMC9238170", "title": "Somatic targeted mutation profiling of colorectal cancer precursor lesions.", "journal": "BMC Med Genomics", "authors": ["Dos Santos W", "Dos Reis MB", "Porto J", "de Carvalho AC", "Matsushita M", "Oliveira G", "Syrj\u00e4nen K", "Reis RM", "Guimar\u00e3es DP"], "date": "2022-06-28T00:00:00Z", "year": 2022, "snippets": [], "citations": {"NLM": "Dos Santos W, Dos Reis MB, Porto J, de Carvalho AC, Matsushita M, Oliveira G, Syrj\u00e4nen K, Reis RM, Guimar\u00e3es DP. Somatic targeted mutation profiling of colorectal cancer precursor lesions. BMC Med Genomics. PMID: 35761395", "BibTeX": "@article{35761395, title={Somatic targeted mutation profiling of colorectal cancer precursor lesions.}, author={Dos Santos W and Dos Reis MB and Porto J and de Carvalho AC and Matsushita M and Oliveira G and Syrj\u00e4nen K and Reis RM and Guimar\u00e3es DP}, journal={BMC Med Genomics}}"}, "is_sup_mat_match": true}, {"pmid": 24836576, "pmcid": "PMC4048335", "title": "Whole-exome sequencing and clinical interpretation of FFPE tumor samples to guide precision cancer medicine", "journal": "Nat Med", "authors": ["Van Allen EM", "Wagle N", "Stojanov P", "Perrin DL", "Cibulskis K", "Marlow S", "Jane-Valbuena J", "Friedrich DC", "Kryukov G", "Carter SL", "McKenna A", "Sivachenko A", "Rosenberg M", "Kiezun A", "Voet D", "Lawrence M", "Lichtenstein LT", "Gentry JG", "Huang FW", "Fostel J", "Farlow D", "Barbie D", "Gandhi L", "Lander ES", "Gray SW", "Joffe S", "Janne P", "Garber J", "MacConaill L", "Lindeman N", "Rollins B", "Kantoff P", "Fisher SA", "Gabriel S", "Getz G", "Garraway LA"], "date": "2014-06-01T00:00:00Z", "year": 2014, "snippets": [], "citations": {"NLM": "Van Allen EM, Wagle N, Stojanov P, Perrin DL, Cibulskis K, Marlow S, Jane-Valbuena J, Friedrich DC, Kryukov G, Carter SL, McKenna A, Sivachenko A, Rosenberg M, Kiezun A, Voet D, Lawrence M, Lichtenstein LT, Gentry JG, Huang FW, Fostel J, Farlow D, Barbie D, Gandhi L, Lander ES, Gray SW, Joffe S, Janne P, Garber J, MacConaill L, Lindeman N, Rollins B, Kantoff P, Fisher SA, Gabriel S, Getz G, Garraway LA. Whole-exome sequencing and clinical interpretation of FFPE tumor samples to guide precision cancer medicine Nat Med. PMID: 24836576", "BibTeX": "@article{24836576, title={Whole-exome sequencing and clinical interpretation of FFPE tumor samples to guide precision cancer medicine}, author={Van Allen EM and Wagle N and Stojanov P and Perrin DL and Cibulskis K and Marlow S and Jane-Valbuena J and Friedrich DC and Kryukov G and Carter SL and McKenna A and Sivachenko A and Rosenberg M and Kiezun A and Voet D and Lawrence M and Lichtenstein LT and Gentry JG and Huang FW and Fostel J and Farlow D and Barbie D and Gandhi L and Lander ES and Gray SW and Joffe S and Janne P and Garber J and MacConaill L and Lindeman N and Rollins B and Kantoff P and Fisher SA and Gabriel S and Getz G and Garraway LA}, journal={Nat Med}}"}, "is_sup_mat_match": true}, {"pmid": 27929064, "pmcid": "PMC5155160", "title": "Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer.", "journal": "Nat Commun", "authors": ["Van Emburgh BO", "Arena S", "Siravegna G", "Lazzari L", "Crisafulli G", "Corti G", "Mussolin B", "Baldi F", "Buscarino M", "Bartolini A", "Valtorta E", "Vidal J", "Bellosillo B", "Germano G", "Pietrantonio F", "Ponzetti A", "Albanell J", "Siena S", "Sartore-Bianchi A", "Di Nicolantonio F", "Montagut C", "Bardelli A"], "date": "2016-12-08T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Van Emburgh BO, Arena S, Siravegna G, Lazzari L, Crisafulli G, Corti G, Mussolin B, Baldi F, Buscarino M, Bartolini A, Valtorta E, Vidal J, Bellosillo B, Germano G, Pietrantonio F, Ponzetti A, Albanell J, Siena S, Sartore-Bianchi A, Di Nicolantonio F, Montagut C, Bardelli A. Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer. Nat Commun. PMID: 27929064", "BibTeX": "@article{27929064, title={Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer.}, author={Van Emburgh BO and Arena S and Siravegna G and Lazzari L and Crisafulli G and Corti G and Mussolin B and Baldi F and Buscarino M and Bartolini A and Valtorta E and Vidal J and Bellosillo B and Germano G and Pietrantonio F and Ponzetti A and Albanell J and Siena S and Sartore-Bianchi A and Di Nicolantonio F and Montagut C and Bardelli A}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 29245897, "pmcid": "PMC5725088", "title": "Comparative analysis of primary versus relapse/refractory DLBCL identifies shifts in mutation spectrum.", "journal": "Oncotarget", "authors": ["Greenawalt DM", "Liang WS", "Saif S", "Johnson J", "Todorov P", "Dulak A", "Enriquez D", "Halperin R", "Ahmed A", "Saveliev V", "Carpten J", "Craig D", "Barrett JC", "Dougherty B", "Zinda M", "Fawell S", "Dry JR", "Byth K"], "date": "2017-06-15T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Greenawalt DM, Liang WS, Saif S, Johnson J, Todorov P, Dulak A, Enriquez D, Halperin R, Ahmed A, Saveliev V, Carpten J, Craig D, Barrett JC, Dougherty B, Zinda M, Fawell S, Dry JR, Byth K. Comparative analysis of primary versus relapse/refractory DLBCL identifies shifts in mutation spectrum. Oncotarget. PMID: 29245897", "BibTeX": "@article{29245897, title={Comparative analysis of primary versus relapse/refractory DLBCL identifies shifts in mutation spectrum.}, author={Greenawalt DM and Liang WS and Saif S and Johnson J and Todorov P and Dulak A and Enriquez D and Halperin R and Ahmed A and Saveliev V and Carpten J and Craig D and Barrett JC and Dougherty B and Zinda M and Fawell S and Dry JR and Byth K}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 35347147, "pmcid": "PMC8960760", "title": "Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification.", "journal": "Nat Commun", "authors": ["Liu T", "Rao J", "Hu W", "Cui B", "Cai J", "Liu Y", "Sun H", "Chen X", "Tang Y", "Chen J", "Wang X", "Wang H", "Qian W", "Mao B", "Guo S", "Wang R", "Liu Y", "Shen S"], "date": "2022-03-28T00:00:00Z", "year": 2022, "snippets": [], "citations": {"NLM": "Liu T, Rao J, Hu W, Cui B, Cai J, Liu Y, Sun H, Chen X, Tang Y, Chen J, Wang X, Wang H, Qian W, Mao B, Guo S, Wang R, Liu Y, Shen S. Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification. Nat Commun. PMID: 35347147", "BibTeX": "@article{35347147, title={Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification.}, author={Liu T and Rao J and Hu W and Cui B and Cai J and Liu Y and Sun H and Chen X and Tang Y and Chen J and Wang X and Wang H and Qian W and Mao B and Guo S and Wang R and Liu Y and Shen S}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 27824051, "pmcid": "PMC5105166", "title": "Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.", "journal": "Nat Commun", "authors": ["Gu Z", "Churchman M", "Roberts K", "Li Y", "Liu Y", "Harvey RC", "McCastlain K", "Reshmi SC", "Payne-Turner D", "Iacobucci I", "Shao Y", "Chen IM", "Valentine M", "Pei D", "Mungall KL", "Mungall AJ", "Ma Y", "Moore R", "Marra M", "Stonerock E", "Gastier-Foster JM", "Devidas M", "Dai Y", "Wood B", "Borowitz M", "Larsen EE", "Maloney K", "Mattano LA Jr", "Angiolillo A", "Salzer WL", "Burke MJ", "Gianni F", "Spinelli O", "Radich JP", "Minden MD", "Moorman AV", "Patel B", "Fielding AK", "Rowe JM", "Luger SM", "Bhatia R", "Aldoss I", "Forman SJ", "Kohlschmidt J", "Mr\u00f3zek K", "Marcucci G", "Bloomfield CD", "Stock W", "Kornblau S", "Kantarjian HM", "Konopleva M", "Paietta E", "Willman CL", "Loh ML", "Hunger SP", "Mullighan CG"], "date": "2016-11-08T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Gu Z, Churchman M, Roberts K, Li Y, Liu Y, Harvey RC, McCastlain K, Reshmi SC, Payne-Turner D, Iacobucci I, Shao Y, Chen IM, Valentine M, Pei D, Mungall KL, Mungall AJ, Ma Y, Moore R, Marra M, Stonerock E, Gastier-Foster JM, Devidas M, Dai Y, Wood B, Borowitz M, Larsen EE, Maloney K, Mattano LA Jr, Angiolillo A, Salzer WL, Burke MJ, Gianni F, Spinelli O, Radich JP, Minden MD, Moorman AV, Patel B, Fielding AK, Rowe JM, Luger SM, Bhatia R, Aldoss I, Forman SJ, Kohlschmidt J, Mr\u00f3zek K, Marcucci G, Bloomfield CD, Stock W, Kornblau S, Kantarjian HM, Konopleva M, Paietta E, Willman CL, Loh ML, Hunger SP, Mullighan CG. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia. Nat Commun. PMID: 27824051", "BibTeX": "@article{27824051, title={Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.}, author={Gu Z and Churchman M and Roberts K and Li Y and Liu Y and Harvey RC and McCastlain K and Reshmi SC and Payne-Turner D and Iacobucci I and Shao Y and Chen IM and Valentine M and Pei D and Mungall KL and Mungall AJ and Ma Y and Moore R and Marra M and Stonerock E and Gastier-Foster JM and Devidas M and Dai Y and Wood B and Borowitz M and Larsen EE and Maloney K and Mattano LA Jr and Angiolillo A and Salzer WL and Burke MJ and Gianni F and Spinelli O and Radich JP and Minden MD and Moorman AV and Patel B and Fielding AK and Rowe JM and Luger SM and Bhatia R and Aldoss I and Forman SJ and Kohlschmidt J and Mr\u00f3zek K and Marcucci G and Bloomfield CD and Stock W and Kornblau S and Kantarjian HM and Konopleva M and Paietta E and Willman CL and Loh ML and Hunger SP and Mullighan CG}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 29085667, "pmcid": "PMC5653930", "title": "Histopathological and genotypic characterization of metastatic colorectal carcinoma with PD-L1 (CD274)-expression: Possible roles of tumour micro environmental factors for CD274 expression.", "journal": "J Pathol Clin Res", "authors": ["Inaguma S", "Lasota J", "Felisiak-Golabek A", "Kowalik A", "Wang Z", "Zieba S", "Kalisz J", "Ikeda H", "Miettinen M"], "date": "2017-10-07T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Inaguma S, Lasota J, Felisiak-Golabek A, Kowalik A, Wang Z, Zieba S, Kalisz J, Ikeda H, Miettinen M. Histopathological and genotypic characterization of metastatic colorectal carcinoma with PD-L1 (CD274)-expression: Possible roles of tumour micro environmental factors for CD274 expression. J Pathol Clin Res. PMID: 29085667", "BibTeX": "@article{29085667, title={Histopathological and genotypic characterization of metastatic colorectal carcinoma with PD-L1 (CD274)-expression: Possible roles of tumour micro environmental factors for CD274 expression.}, author={Inaguma S and Lasota J and Felisiak-Golabek A and Kowalik A and Wang Z and Zieba S and Kalisz J and Ikeda H and Miettinen M}, journal={J Pathol Clin Res}}"}, "is_sup_mat_match": true}, {"pmid": 29937994, "pmcid": "PMC6007951", "title": "The landscape of somatic mutation in sporadic Chinese colorectal cancer.", "journal": "Oncotarget", "authors": ["Liu Z", "Yang C", "Li X", "Luo W", "Roy B", "Xiong T", "Zhang X", "Yang H", "Wang J", "Ye Z", "Chen Y", "Song J", "Ma S", "Zhou Y", "Yang M", "Fang X", "Du J"], "date": "2018-06-08T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Liu Z, Yang C, Li X, Luo W, Roy B, Xiong T, Zhang X, Yang H, Wang J, Ye Z, Chen Y, Song J, Ma S, Zhou Y, Yang M, Fang X, Du J. The landscape of somatic mutation in sporadic Chinese colorectal cancer. Oncotarget. PMID: 29937994", "BibTeX": "@article{29937994, title={The landscape of somatic mutation in sporadic Chinese colorectal cancer.}, author={Liu Z and Yang C and Li X and Luo W and Roy B and Xiong T and Zhang X and Yang H and Wang J and Ye Z and Chen Y and Song J and Ma S and Zhou Y and Yang M and Fang X and Du J}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 36578946, "pmcid": "PMC9792166", "title": "Tumor genomic profiling and personalized tracking of circulating tumor DNA in Vietnamese colorectal cancer patients.", "journal": "Front Oncol", "authors": ["Nguyen HT", "Nguyen TV", "Nguyen Hoang VA", "Tran DH", "Le Trinh NA", "Le MT", "Nguyen Tran TA", "Pham TH", "Dinh TC", "Nguyen TS", "Nguyen The KC", "Mai H", "Chu MT", "Pham DH", "Nguyen XC", "Ngo Ha TM", "Nguyen DS", "Nguyen DQ", "Lu YT", "Do Thi TT", "Truong DK", "Nguyen QT", "Nguyen HN", "Giang H", "Tu LN"], "date": "2022-12-12T00:00:00Z", "year": 2022, "snippets": [], "citations": {"NLM": "Nguyen HT, Nguyen TV, Nguyen Hoang VA, Tran DH, Le Trinh NA, Le MT, Nguyen Tran TA, Pham TH, Dinh TC, Nguyen TS, Nguyen The KC, Mai H, Chu MT, Pham DH, Nguyen XC, Ngo Ha TM, Nguyen DS, Nguyen DQ, Lu YT, Do Thi TT, Truong DK, Nguyen QT, Nguyen HN, Giang H, Tu LN. Tumor genomic profiling and personalized tracking of circulating tumor DNA in Vietnamese colorectal cancer patients. Front Oncol. PMID: 36578946", "BibTeX": "@article{36578946, title={Tumor genomic profiling and personalized tracking of circulating tumor DNA in Vietnamese colorectal cancer patients.}, author={Nguyen HT and Nguyen TV and Nguyen Hoang VA and Tran DH and Le Trinh NA and Le MT and Nguyen Tran TA and Pham TH and Dinh TC and Nguyen TS and Nguyen The KC and Mai H and Chu MT and Pham DH and Nguyen XC and Ngo Ha TM and Nguyen DS and Nguyen DQ and Lu YT and Do Thi TT and Truong DK and Nguyen QT and Nguyen HN and Giang H and Tu LN}, journal={Front Oncol}}"}, "is_sup_mat_match": true}, {"pmid": 30730996, "pmcid": "PMC6366887", "title": "Clinicopathological characterization of SMAD4-mutated intestinal adenocarcinomas: A case-control study", "journal": "PLoS One", "authors": ["Liao X", "Hao Y", "Zhang X", "Ward S", "Houldsworth J", "Polydorides AD", "Harpaz N"], "date": "2019-02-07T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Liao X, Hao Y, Zhang X, Ward S, Houldsworth J, Polydorides AD, Harpaz N. Clinicopathological characterization of SMAD4-mutated intestinal adenocarcinomas: A case-control study PLoS One. PMID: 30730996", "BibTeX": "@article{30730996, title={Clinicopathological characterization of SMAD4-mutated intestinal adenocarcinomas: A case-control study}, author={Liao X and Hao Y and Zhang X and Ward S and Houldsworth J and Polydorides AD and Harpaz N}, journal={PLoS One}}"}, "is_sup_mat_match": true}, {"pmid": 26466571, "pmcid": "PMC4815041", "title": "Mutations driving CLL and their evolution in progression and relapse", "journal": "Nature", "authors": ["Landau DA", "Tausch E", "Taylor-Weiner AN", "Stewart C", "Reiter JG", "Bahlo J", "Kluth S", "Bozic I", "Lawrence M", "B\u00f6ttcher S", "Carter SL", "Cibulskis K", "Mertens D", "Sougnez CL", "Rosenberg M", "Hess JM", "Edelmann J", "Kless S", "Kneba M", "Ritgen M", "Fink A", "Fischer K", "Gabriel S", "Lander ES", "Nowak MA", "D\u00f6hner H", "Hallek M", "Neuberg D", "Getz G", "Stilgenbauer S", "Wu CJ"], "date": "2015-10-22T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Landau DA, Tausch E, Taylor-Weiner AN, Stewart C, Reiter JG, Bahlo J, Kluth S, Bozic I, Lawrence M, B\u00f6ttcher S, Carter SL, Cibulskis K, Mertens D, Sougnez CL, Rosenberg M, Hess JM, Edelmann J, Kless S, Kneba M, Ritgen M, Fink A, Fischer K, Gabriel S, Lander ES, Nowak MA, D\u00f6hner H, Hallek M, Neuberg D, Getz G, Stilgenbauer S, Wu CJ. Mutations driving CLL and their evolution in progression and relapse Nature. PMID: 26466571", "BibTeX": "@article{26466571, title={Mutations driving CLL and their evolution in progression and relapse}, author={Landau DA and Tausch E and Taylor-Weiner AN and Stewart C and Reiter JG and Bahlo J and Kluth S and Bozic I and Lawrence M and B\u00f6ttcher S and Carter SL and Cibulskis K and Mertens D and Sougnez CL and Rosenberg M and Hess JM and Edelmann J and Kless S and Kneba M and Ritgen M and Fink A and Fischer K and Gabriel S and Lander ES and Nowak MA and D\u00f6hner H and Hallek M and Neuberg D and Getz G and Stilgenbauer S and Wu CJ}, journal={Nature}}"}, "is_sup_mat_match": true}, {"pmid": 30202008, "pmcid": "PMC6131244", "title": "Contribution of allelic imbalance to colorectal cancer.", "journal": "Nat Commun", "authors": ["Palin K", "Pitk\u00e4nen E", "Turunen M", "Sahu B", "Pihlajamaa P", "Kivioja T", "Kaasinen E", "V\u00e4lim\u00e4ki N", "H\u00e4nninen UA", "Cajuso T", "Aavikko M", "Tuupanen S", "Kilpivaara O", "van den Berg L", "Kondelin J", "Tanskanen T", "Katainen R", "Grau M", "Rauanheimo H", "Plaketti RM", "Taira A", "Sulo P", "Hartonen T", "Dave K", "Schmierer B", "Botla S", "Sokolova M", "V\u00e4h\u00e4rautio A", "Gladysz K", "Ongen H", "Dermitzakis E", "Bramsen JB", "\u00d8rntoft TF", "Andersen CL", "Ristim\u00e4ki A", "Lepist\u00f6 A", "Renkonen-Sinisalo L", "Mecklin JP", "Taipale J", "Aaltonen LA"], "date": "2018-09-10T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Palin K, Pitk\u00e4nen E, Turunen M, Sahu B, Pihlajamaa P, Kivioja T, Kaasinen E, V\u00e4lim\u00e4ki N, H\u00e4nninen UA, Cajuso T, Aavikko M, Tuupanen S, Kilpivaara O, van den Berg L, Kondelin J, Tanskanen T, Katainen R, Grau M, Rauanheimo H, Plaketti RM, Taira A, Sulo P, Hartonen T, Dave K, Schmierer B, Botla S, Sokolova M, V\u00e4h\u00e4rautio A, Gladysz K, Ongen H, Dermitzakis E, Bramsen JB, \u00d8rntoft TF, Andersen CL, Ristim\u00e4ki A, Lepist\u00f6 A, Renkonen-Sinisalo L, Mecklin JP, Taipale J, Aaltonen LA. Contribution of allelic imbalance to colorectal cancer. Nat Commun. PMID: 30202008", "BibTeX": "@article{30202008, title={Contribution of allelic imbalance to colorectal cancer.}, author={Palin K and Pitk\u00e4nen E and Turunen M and Sahu B and Pihlajamaa P and Kivioja T and Kaasinen E and V\u00e4lim\u00e4ki N and H\u00e4nninen UA and Cajuso T and Aavikko M and Tuupanen S and Kilpivaara O and van den Berg L and Kondelin J and Tanskanen T and Katainen R and Grau M and Rauanheimo H and Plaketti RM and Taira A and Sulo P and Hartonen T and Dave K and Schmierer B and Botla S and Sokolova M and V\u00e4h\u00e4rautio A and Gladysz K and Ongen H and Dermitzakis E and Bramsen JB and \u00d8rntoft TF and Andersen CL and Ristim\u00e4ki A and Lepist\u00f6 A and Renkonen-Sinisalo L and Mecklin JP and Taipale J and Aaltonen LA}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 32728112, "pmcid": "PMC7391693", "title": "Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients.", "journal": "Sci Rep", "authors": ["Lauber C", "Correia N", "Trumpp A", "Rieger MA", "Dolnik A", "Bullinger L", "Roeder I", "Seifert M"], "date": "2020-07-29T00:00:00Z", "year": 2020, "snippets": [], "citations": {"NLM": "Lauber C, Correia N, Trumpp A, Rieger MA, Dolnik A, Bullinger L, Roeder I, Seifert M. Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients. Sci Rep. PMID: 32728112", "BibTeX": "@article{32728112, title={Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients.}, author={Lauber C and Correia N and Trumpp A and Rieger MA and Dolnik A and Bullinger L and Roeder I and Seifert M}, journal={Sci Rep}}"}, "is_sup_mat_match": true}, {"pmid": 35768438, "pmcid": "PMC9243087", "title": "The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma.", "journal": "Nat Commun", "authors": ["Vo JN", "Wu YM", "Mishler J", "Hall S", "Mannan R", "Wang L", "Ning Y", "Zhou J", "Hopkins AC", "Estill JC", "Chan WKB", "Yesil J", "Cao X", "Rao A", "Tsodikov A", "Talpaz M", "Cole CE", "Ye JC", "Multiple Myeloma Research Consortium.", "Bergsagel PL", "Auclair D", "Cho HJ", "Robinson DR", "Chinnaiyan AM"], "date": "2022-06-29T00:00:00Z", "year": 2022, "snippets": [], "citations": {"NLM": "Vo JN, Wu YM, Mishler J, Hall S, Mannan R, Wang L, Ning Y, Zhou J, Hopkins AC, Estill JC, Chan WKB, Yesil J, Cao X, Rao A, Tsodikov A, Talpaz M, Cole CE, Ye JC, Multiple Myeloma Research Consortium., Bergsagel PL, Auclair D, Cho HJ, Robinson DR, Chinnaiyan AM. The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma. Nat Commun. PMID: 35768438", "BibTeX": "@article{35768438, title={The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma.}, author={Vo JN and Wu YM and Mishler J and Hall S and Mannan R and Wang L and Ning Y and Zhou J and Hopkins AC and Estill JC and Chan WKB and Yesil J and Cao X and Rao A and Tsodikov A and Talpaz M and Cole CE and Ye JC and Multiple Myeloma Research Consortium. and Bergsagel PL and Auclair D and Cho HJ and Robinson DR and Chinnaiyan AM}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 28068936, "pmcid": "PMC5223326", "title": "Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients.", "journal": "BMC Cancer", "authors": ["Nakayama I", "Shinozaki E", "Matsushima T", "Wakatsuki T", "Ogura M", "Ichimura T", "Ozaka M", "Takahari D", "Suenaga M", "Chin K", "Mizunuma N", "Yamaguchi K"], "date": "2017-01-09T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Nakayama I, Shinozaki E, Matsushima T, Wakatsuki T, Ogura M, Ichimura T, Ozaka M, Takahari D, Suenaga M, Chin K, Mizunuma N, Yamaguchi K. Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients. BMC Cancer. PMID: 28068936", "BibTeX": "@article{28068936, title={Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients.}, author={Nakayama I and Shinozaki E and Matsushima T and Wakatsuki T and Ogura M and Ichimura T and Ozaka M and Takahari D and Suenaga M and Chin K and Mizunuma N and Yamaguchi K}, journal={BMC Cancer}}"}, "is_sup_mat_match": true}, {"pmid": 29617658, "pmcid": "PMC5918694", "title": "Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas.", "journal": "Cell Rep", "authors": ["Way GP", "Sanchez-Vega F", "La K", "Armenia J", "Chatila WK", "Luna A", "Sander C", "Cherniack AD", "Mina M", "Ciriello G", "Schultz N", "Cancer Genome Atlas Research Network.", "Sanchez Y", "Greene CS"], "date": "2018-04-03T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Way GP, Sanchez-Vega F, La K, Armenia J, Chatila WK, Luna A, Sander C, Cherniack AD, Mina M, Ciriello G, Schultz N, Cancer Genome Atlas Research Network., Sanchez Y, Greene CS. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas. Cell Rep. PMID: 29617658", "BibTeX": "@article{29617658, title={Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas.}, author={Way GP and Sanchez-Vega F and La K and Armenia J and Chatila WK and Luna A and Sander C and Cherniack AD and Mina M and Ciriello G and Schultz N and Cancer Genome Atlas Research Network. and Sanchez Y and Greene CS}, journal={Cell Rep}}"}, "is_sup_mat_match": true}, {"pmid": 28161563, "pmcid": "PMC5293722", "title": "Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors.", "journal": "Neoplasia", "authors": ["Paasinen-Sohns A", "Koelzer VH", "Frank A", "Schafroth J", "Gisler A", "Sachs M", "Graber A", "Rothschild SI", "Wicki A", "Cathomas G", "Mertz KD"], "date": "2017-03-01T00:00:00Z", "year": 2017, "snippets": [{"_id": "28161563@42539", "snip_text": "Patient Diagnosis OFA Result Validation Method   1 NSCLC (squamous) BRAF p. G469VFGFR1 amplification Pyrosequencing, CLPv2-   2 NSCLC (adeno) KRAS p. G12CKRAS p. A59G CLPv2*   3 CRC KRAS p. G13CPIK3CA p. H1047R CLPv2*   4 Melanoma NRAS p. A146T Pyrosequencing   5 NSCLC (pleo) KRAS p. G12A CLPv2   8 NSCLC (adeno), primaryNSCLC (sarcoma), primaryNSCLC (sarcoma), metastasisSCLC, primary EGFR p. L858REGFR p. L858RFGFR1 amplificationMYC amplificationEGFR p. L858R,FGFR1 amplification,MYC amplification- PyrosequencingPyrosequencing--Pyrosequencing--Pyrosequencing   10 NSCLC (adeno) - Pyrosequencing    11 Breast cancer PIK3CA p. N345K HER2 IHC, HER2 SISH   13 Breast cancer PIK3CA p. E545K HER2 IHC, HER2 SISH   17 NSCLC (adeno) BRAF p. V600E Pyrosequencing   19 NSCLC (adeno) KRAS p. G12DEGFR amplificationEGFRvIIIMET exon 14 mutation ---MET IHC   23 CRC KRAS p. Q61KCCND1 amplificationMYC amplification -CCND1 IHCMYC IHC   25 NSCLC (adeno) 1NSCLC (adeno) 2 CD74 - ROS1 fusionCD74 - ROS1 fusion ROS1 IHCROS1 IHC   27 CRC BRAF p. V600EMYC amplification -MYC IHC   29 CRC PIK3CA p. R93QMAP2K1 (MEK) p. K57TMET exon 14 mutation --MET IHC   30 Pancreatic cancer KRAS p. G12DMET exon 14 mutation -MET IHC   32 NSCLC (adeno) EML4 - ALK fusion ALK IHC   35 CRC KRAS p. A146T Pyrosequencing   39 Melanoma BRAF amplificationCDK4 amplification -CDK4 IHC   40 NSCLC (adeno) CD74 - ROS1 fusion ROS1 IHC   43 Thyroid carcinoma (anaplastic) NRAS p. Q61KMET exon 14 mutation -MET IHC   44 Thyroid carcinoma (papillary), primaryThyroid carcinoma (papillary), metastasis BRAF p. V600EBRAF p. V600E PyrosequencingPyrosequencing   45 NSCLC (adeno) EGFR amplificationMET amplification -MET IHC   48 CRC KRAS p. G12V Pyrosequencing   50 NSCLC (NOS) MET amplification MET IHC   51 Erdheim Chester disease 1Erdheim Chester disease 2 BRAF p. V600EBRAF p. V600E PyrosequencingPyrosequencing   ", "section": "table", "mentions": ["483|3|gene|ncbi_gene@4609|MYC", "950|5|disease||adeno", "51|5|disease|ncbi_mesh@D002289|NSCLC", "1555|4|gene|ncbi_gene@673|BRAF", "1811|4|gene|ncbi_gene@673|BRAF", "1071|6|gene|ncbi_gene@5290|PIK3CA", "1067|3|disease|ncbi_mesh@D015179|CRC", "1371|4|gene|ncbi_gene@6098|ROS1", "239|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1227|3|gene|ncbi_gene@238|ALK", "1263|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1684|4|gene|ncbi_gene@3845|KRAS", "928|5|disease|ncbi_mesh@D002289|NSCLC", "363|14|disease||metastasisSCLC", "729|4|gene|ncbi_gene@673|BRAF", "1717|5|disease|ncbi_mesh@D002289|NSCLC", "1251|3|disease|ncbi_mesh@D015179|CRC", "353|7|disease|ncbi_mesh@D012509|sarcoma", "1054|3|gene|ncbi_gene@4609|MYC", "1213|5|disease||adeno", "959|4|gene|ncbi_gene@972|CD74", "1747|3|gene|ncbi_gene@79811|MET", "660|13|disease|ncbi_mesh@D001943|Breast cancer", "575|5|disease||adeno", "315|12|disease||primaryNSCLC", "1724|3|disease||NOS", "142|4|gene|ncbi_gene@3845|KRAS", "285|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "135|5|disease||adeno", "1784|24|disease|ncbi_mesh@D031249|1Erdheim Chester disease", "222|8|disease|ncbi_mesh@D008545|Melanoma", "906|5|gene|ncbi_gene@595|CCND1", "852|3|disease|ncbi_mesh@D015179|CRC", "722|5|disease||adeno", "0|7|species|ncbi_taxonomy@9606|Patient", "1238|3|gene|ncbi_gene@238|ALK", "178|3|disease|ncbi_mesh@D015179|CRC", "300|5|disease|ncbi_mesh@D002289|NSCLC", "1397|17|disease|ncbi_mesh@D013964|Thyroid carcinoma", "619|6|gene|ncbi_gene@5290|PIK3CA", "1336|4|gene|ncbi_gene@1019|CDK4", "1018|3|disease|ncbi_mesh@D015179|CRC", "1428|4|gene|ncbi_gene@4893|NRAS", "457|5|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|L858R", "162|4|variant|litvar@rs781085650##&&&litvar@#673#&&&litvar@CA4517046#rs781085650##|A59G", "277|4|gene|ncbi_gene@3845|KRAS", "387|4|gene|ncbi_gene@1956|EGFR", "1193|3|gene|ncbi_gene@79811|MET", "1357|5|disease||adeno", "635|4|gene|ncbi_gene@2064|HER2", "700|4|gene|ncbi_gene@2064|HER2", "1255|4|gene|ncbi_gene@3845|KRAS", "715|5|disease|ncbi_mesh@D002289|NSCLC", "966|4|gene|ncbi_gene@6098|ROS1", "1159|4|gene|ncbi_gene@3845|KRAS", "1544|10|disease|ncbi_mesh@D009362|metastasis", "1289|8|disease|ncbi_mesh@D008545|Melanoma", "463|5|gene|ncbi_gene@2260|FGFR1", "307|5|disease||adeno", "128|5|disease|ncbi_mesh@D002289|NSCLC", "1022|4|gene|ncbi_gene@673|BRAF", "182|4|gene|ncbi_gene@3845|KRAS", "329|7|disease|ncbi_mesh@D012509|sarcoma", "1350|5|disease|ncbi_mesh@D002289|NSCLC", "1832|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "629|5|variant|litvar@rs121913284##&&&litvar@#5290#&&&litvar@CA16602517#rs121913284##|N345K", "684|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "1616|5|disease|ncbi_mesh@D002289|NSCLC", "68|4|gene|ncbi_gene@673|BRAF", "204|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "1298|4|gene|ncbi_gene@673|BRAF", "605|13|disease|ncbi_mesh@D001943|Breast cancer", "1532|10|disease|ncbi_mesh@D002291|papillary)", "763|5|disease|ncbi_mesh@D002289|NSCLC", "996|4|gene|ncbi_gene@6098|ROS1", "1462|3|gene|ncbi_gene@79811|MET", "1506|26|disease|ncbi_mesh@D009369|primaryThyroid carcinoma (", "1576|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1819|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "264|5|disease|ncbi_mesh@D002289|NSCLC", "1729|3|gene|ncbi_gene@79811|MET", "1475|29|disease|ncbi_mesh@D000077273|Thyroid carcinoma (papillary)", "839|3|gene|ncbi_gene@79811|MET", "1128|3|gene|ncbi_gene@79811|MET", "339|12|disease||primaryNSCLC", "1760|23|disease|ncbi_mesh@D031249|Erdheim Chester disease", "1364|4|gene|ncbi_gene@972|CD74", "231|4|gene|ncbi_gene@4893|NRAS", "1680|3|disease|ncbi_mesh@D015179|CRC", "674|6|gene|ncbi_gene@5290|PIK3CA", "1623|5|disease||adeno", "690|4|gene|ncbi_gene@2064|HER2", "1383|4|gene|ncbi_gene@6098|ROS1", "984|4|gene|ncbi_gene@6098|ROS1", "568|5|disease|ncbi_mesh@D002289|NSCLC", "777|4|gene|ncbi_gene@3845|KRAS", "770|5|disease||adeno", "1206|5|disease|ncbi_mesh@D002289|NSCLC", "935|5|disease||adeno", "645|4|gene|ncbi_gene@2064|HER2", "1667|3|gene|ncbi_gene@79811|MET", "856|4|gene|ncbi_gene@3845|KRAS", "1692|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V"], "figure_id": "t0015", "text_hl": "Patient Diagnosis OFA Result Validation Method   1 NSCLC (squamous) BRAF p. G469VFGFR1 amplification Pyrosequencing, CLPv2-   2 NSCLC (adeno) KRAS p. G12CKRAS p. A59G CLPv2*   3 CRC KRAS p. G13CPIK3CA p. H1047R CLPv2*   4 Melanoma NRAS p. <m>A146T</m> Pyrosequencing   5 NSCLC (pleo) KRAS p. G12A CLPv2   8 NSCLC (adeno), primaryNSCLC (sarcoma), primaryNSCLC (sarcoma), metastasisSCLC, primary EGFR p. L858REGFR p. L858RFGFR1 amplificationMYC amplificationEGFR p. L858R,FGFR1 amplification,MYC amplification- PyrosequencingPyrosequencing--Pyrosequencing--Pyrosequencing   10 NSCLC (adeno) - Pyrosequencing    11 Breast cancer PIK3CA p. N345K HER2 IHC, HER2 SISH   13 Breast cancer PIK3CA p. E545K HER2 IHC, HER2 SISH   17 NSCLC (adeno) BRAF p. V600E Pyrosequencing   19 NSCLC (adeno) KRAS p. G12DEGFR amplificationEGFRvIIIMET exon 14 mutation ---MET IHC   23 CRC KRAS p. Q61KCCND1 amplificationMYC amplification -CCND1 IHCMYC IHC   25 NSCLC (adeno) 1NSCLC (adeno) 2 CD74 - ROS1 fusionCD74 - ROS1 fusion ROS1 IHCROS1 IHC   27 CRC BRAF p. V600EMYC amplification -MYC IHC   29 CRC PIK3CA p. R93QMAP2K1 (MEK) p. K57TMET exon 14 mutation --MET IHC   30 Pancreatic cancer KRAS p. G12DMET exon 14 mutation -MET IHC   32 NSCLC (adeno) EML4 - ALK fusion ALK IHC   35 CRC KRAS p. <m>A146T</m> Pyrosequencing   39 Melanoma BRAF amplificationCDK4 amplification -CDK4 IHC   40 NSCLC (adeno) CD74 - ROS1 fusion ROS1 IHC   43 Thyroid carcinoma (anaplastic) NRAS p. Q61KMET exon 14 mutation -MET IHC   44 Thyroid carcinoma (papillary), primaryThyroid carcinoma (papillary), metastasis BRAF p. V600EBRAF p. V600E PyrosequencingPyrosequencing   45 NSCLC (adeno) EGFR amplificationMET amplification -MET IHC   48 CRC KRAS p. G12V Pyrosequencing   50 NSCLC (NOS) MET amplification MET IHC   51 Erdheim Chester disease 1Erdheim Chester disease 2 BRAF p. V600EBRAF p. V600E PyrosequencingPyrosequencing   "}], "citations": {"NLM": "Paasinen-Sohns A, Koelzer VH, Frank A, Schafroth J, Gisler A, Sachs M, Graber A, Rothschild SI, Wicki A, Cathomas G, Mertz KD. Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors. Neoplasia. PMID: 28161563", "BibTeX": "@article{28161563, title={Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors.}, author={Paasinen-Sohns A and Koelzer VH and Frank A and Schafroth J and Gisler A and Sachs M and Graber A and Rothschild SI and Wicki A and Cathomas G and Mertz KD}, journal={Neoplasia}}"}, "is_sup_mat_match": false}, {"pmid": 30814645, "pmcid": "PMC6393680", "title": "Prognostic impact of ATM mutations in patients with metastatic colorectal cancer.", "journal": "Sci Rep", "authors": ["Randon G", "Fuc\u00e0 G", "Rossini D", "Raimondi A", "Pagani F", "Perrone F", "Tamborini E", "Busico A", "Peverelli G", "Morano F", "Niger M", "Antista M", "Corallo S", "Saggio S", "Borelli B", "Zucchelli G", "Milione M", "Pruneri G", "Di Bartolomeo M", "Falcone A", "de Braud F", "Cremolini C", "Pietrantonio F"], "date": "2019-02-27T00:00:00Z", "year": 2019, "snippets": [{"_id": "30814645@8620", "snip_text": "ID MSI status ATM TP53 KRAS NRAS BRAF APC   Mutation HS Mutation HS Mutation HS Mutation HS Mutation HS Mutation HS   1 MSI K610T 60 R248Q 70 G12V 70 : : : : E1464VfsTer8 44   2 NA E1325Stop 94 R175C 180 : : : : : : : :   3 MSS D2870H 52 : : G12S 114 : : : : R1450Stop 106   4 MSS R3047Stop 88 : : G12D 58 : : : : R1450Stop 46   5 MSI R337C 32 : : G13D 36 : : : : I1307K 156   6 MSS P3050L 254 P278S 173 Q61H 120 : : : : : :   7 MSI P604S 132 R196Stop 194 G12V 140 : : : : E1286Stop 198   8 MSS R337C 30 I254S 200 G12V 140 : : : : R1450Stop 64   9 MSS A1309T 136 S215R 192 : : : : : : S1346Stop 72   10 MSS V410A 230 : : : : : : : : : :   11 MSS R337H 34 : : : : : : :  I1311MfsTer10 200   12 NA R2443Q 184 R273C 290 : : : : : : E1353FfsTer20 284   13 MSS R337C 114 : : A146T 212 : : : : T1438HfsTer35 106   14 MSS E1704D 240 : : : : : : : : E1379Stop 710   15 MSS Q2729H 128 : : A146T 104 : : : : T1556NfsTer3 76   16 MSS V410A 200 : : : : : : : : E1309DfsTer4 158   17 MSS R337H 46 R249G 42 G12V 46 : : : : : :   18 MSS P604S 194 R273H 306 : : : : : : Q12894Stop 320   19 MSS R2691H 52 C238Y 122 : : : : : : E1317Q 158   20 MSS R337C 50 : : G12V 96 : : : : H1349QfsTer4 166   21 MSS S333F 40 G266E 760 : : : : : : : :   22 MSS L1939V 44 R282W 268 : : : : : : : :   23 MSS V410A 142 I251S 98 : : : : : : E1547Stop 86   24 MSS V410A 314 Y205H 207 : : : : : : : :   25 MSS R337H 108 R175H 196 G13D 190 : : : : : :   26 MSS S333F 290 R273C 140 : : : : : : : :   27 MSS S1691R 204 R175H 113 : : : : : : : :   28 MSS splice site 184_185 + K1992T 212 + 102 V73fs*50 90 : : : : V600E 350 : :   29 MSI F1928fs*9 206 R27H + R17H 340 : : : : V600E 468 : :   30 MSS F858L 300 V274F 66 : : : : : : : :   31 MSS R337H 20 : : A146T 140 : : : : : :   32 MSS R2912G 116 R2912G 400 : : G12S 120 : : : :   33 MSS G2695V 46 G245S 60 : : : : : : R1450Stop 50   34 MSS V410A 132 R273C 108 G12V : : : : : R1450Stop 62   35 MSS F858L 146 R282W 202 : : : : : : Q1291Stop 84   ", "section": "table", "mentions": ["1126|3|gene|ncbi_gene@64374|MSS", "548|3|gene|ncbi_gene@64374|MSS", "707|5|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|R273C", "919|3|gene|ncbi_gene@64374|MSS", "124|5|variant|litvar@#324#p.K610T&&&litvar@#324#|K610T", "1239|5|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|R282W", "1755|6|variant|litvar@rs376676328##&&&litvar@#472#&&&litvar@CA157198#rs376676328##|R2912G", "1666|5|variant|litvar@rs1057520005##&&&litvar@#7157#|V274F", "1323|3|gene|ncbi_gene@64374|MSS", "1088|5|variant|litvar@rs730882005##&&&litvar@#7157#&&&litvar@CA351#rs730882005##|C238Y", "1859|5|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|R273C", "1535|6|variant|litvar@rs150757822##&&&litvar@#472#&&&litvar@CA286913#rs150757822##|K1992T", "1552|5|variant|litvar@rs730882018##&&&litvar@#7157#|V73fs", "348|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1185|5|variant|litvar@rs28904919##&&&litvar@#472#&&&litvar@CA157204#rs28904919##|S333F", "607|5|variant|litvar@rs1390189763##&&&litvar@#324#|V410A", "1337|5|variant|litvar@rs1057520008##&&&litvar@#7157#|Y205H", "1194|5|variant|litvar@rs193920774##&&&litvar@#7157#&&&litvar@CA421#rs193920774##|G266E", "923|5|variant|litvar@rs1390189763##&&&litvar@#324#|V410A", "383|6|variant|litvar@rs778267979##&&&litvar@#472#&&&litvar@CA6266522#rs778267979##|P3050L", "811|3|gene|ncbi_gene@64374|MSS", "194|5|variant|litvar@rs138729528##&&&litvar@#7157#&&&litvar@CA2442#rs138729528##|R175C", "298|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1906|5|variant|litvar@rs1800056##&&&litvar@#472#&&&litvar@CA157086#rs1800056##|F858L", "696|6|variant|litvar@rs587782310##&&&litvar@#472#&&&litvar@CA167770#rs587782310##|R2443Q", "142|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "984|5|variant|litvar@rs587782082##&&&litvar@#7157#|R249G", "23|4|gene|ncbi_gene@3845|KRAS", "433|5|variant|litvar@rs2227922##&&&litvar@#472#&&&litvar@CA157068#rs2227922##|P604S", "1616|4|variant|litvar@rs1242444722##&&&litvar@#472#|R17H", "1143|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "404|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "975|5|variant|litvar@rs121912664##&&&litvar@#7157#&&&litvar@CA13#rs121912664##|R337H", "1225|3|gene|ncbi_gene@64374|MSS", "1652|3|gene|ncbi_gene@64374|MSS", "1074|3|gene|ncbi_gene@64374|MSS", "53|2|chemical||HS", "1572|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1018|3|gene|ncbi_gene@64374|MSS", "456|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "752|3|gene|ncbi_gene@64374|MSS", "224|3|gene|ncbi_gene@64374|MSS", "1110|6|variant|litvar@rs1801166##&&&litvar@#324#&&&litvar@CA8815#rs1801166##|E1317Q", "1392|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "77|2|chemical||HS", "880|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1274|5|variant|litvar@rs1390189763##&&&litvar@#324#|V410A", "14|3|gene|ncbi_gene@472|ATM", "1284|5|variant|litvar@rs730882027##&&&litvar@#7157#&&&litvar@CA396#rs730882027##|I251S", "563|5|variant|litvar@rs1057520001##&&&litvar@#7157#|S215R", "756|5|variant|litvar@rs587782529##&&&litvar@#7157#&&&litvar@CA10#rs587782529##|R337C", "394|5|variant|litvar@rs17849781##&&&litvar@#7157#|P278S", "1609|4|variant|litvar@rs201852130##&&&litvar@#55294#|R27H", "1595|7|variant|litvar@#64374#p.F1928fsX&&&litvar@#64374#|F1928fs", "552|6|variant|litvar@rs149711770##&&&litvar@#472#&&&litvar@CA242620#rs149711770##|A1309T", "335|5|variant|litvar@rs587782529##&&&litvar@#7157#&&&litvar@CA10#rs587782529##|R337C", "1372|5|variant|litvar@rs121912664##&&&litvar@#7157#&&&litvar@CA13#rs121912664##|R337H", "1849|5|variant|litvar@rs1390189763##&&&litvar@#324#|V410A", "1770|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "101|2|chemical||HS", "133|5|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|R248Q", "364|6|variant|litvar@rs1801155##&&&litvar@#324#&&&litvar@CA8761#rs1801155##|I1307K", "1032|5|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|R273H", "1796|6|variant|litvar@#64374#p.G2695V&&&litvar@#64374#|G2695V", "277|3|gene|ncbi_gene@64374|MSS", "1902|3|gene|ncbi_gene@64374|MSS", "38|3|gene|ncbi_gene@324|APC", "1181|3|gene|ncbi_gene@64374|MSS", "65|2|chemical||HS", "242|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "603|3|gene|ncbi_gene@64374|MSS", "1478|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H", "1327|5|variant|litvar@rs1390189763##&&&litvar@#324#|V410A", "1382|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H", "861|3|gene|ncbi_gene@64374|MSS", "1432|5|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|R273C", "815|6|variant|litvar@#64374#p.E1704D&&&litvar@#64374#|E1704D", "1713|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "865|6|variant|litvar@rs200160084##&&&litvar@#324#&&&litvar@CA16039366#rs200160084##|Q2729H", "971|3|gene|ncbi_gene@64374|MSS", "1130|5|variant|litvar@rs587782529##&&&litvar@#7157#&&&litvar@CA10#rs587782529##|R337C", "1467|6|variant|litvar@rs1800059##&&&litvar@#472#&&&litvar@CA157131#rs1800059##|S1691R", "1792|3|gene|ncbi_gene@64374|MSS", "1696|3|gene|ncbi_gene@64374|MSS", "379|3|gene|ncbi_gene@64374|MSS", "18|4|gene|ncbi_gene@7157|TP53", "228|6|variant|litvar@#64374#p.D2870H&&&litvar@#64374#|D2870H", "1509|3|gene|ncbi_gene@64374|MSS", "89|2|chemical||HS", "1806|5|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|G245S", "1229|6|variant|litvar@#64374#p.L1939V&&&litvar@#64374#|L1939V", "1270|3|gene|ncbi_gene@64374|MSS", "514|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1463|3|gene|ncbi_gene@64374|MSS", "1916|5|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|R282W", "1700|5|variant|litvar@rs121912664##&&&litvar@#7157#&&&litvar@CA13#rs121912664##|R337H", "28|4|gene|ncbi_gene@4893|NRAS", "1869|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "33|4|gene|ncbi_gene@673|BRAF", "642|3|gene|ncbi_gene@64374|MSS", "1744|6|variant|litvar@rs376676328##&&&litvar@#472#&&&litvar@CA157198#rs376676328##|R2912G", "491|3|gene|ncbi_gene@64374|MSS", "1078|6|variant|litvar@rs876658385##&&&litvar@#472#&&&litvar@CA10579281#rs876658385##|R2691H", "1022|5|variant|litvar@rs2227922##&&&litvar@#472#&&&litvar@CA157068#rs2227922##|P604S", "1418|3|gene|ncbi_gene@64374|MSS", "1845|3|gene|ncbi_gene@64374|MSS", "993|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "113|2|chemical||HS", "770|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1656|5|variant|litvar@rs1800056##&&&litvar@#472#&&&litvar@CA157086#rs1800056##|F858L", "1422|5|variant|litvar@rs28904919##&&&litvar@#472#&&&litvar@CA157204#rs28904919##|S333F", "1368|3|gene|ncbi_gene@64374|MSS", "1633|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1740|3|gene|ncbi_gene@64374|MSS", "646|5|variant|litvar@rs121912664##&&&litvar@#7157#&&&litvar@CA13#rs121912664##|R337H", "495|5|variant|litvar@rs587782529##&&&litvar@#7157#&&&litvar@CA10#rs587782529##|R337C", "504|5|variant|litvar@rs1330865474##&&&litvar@#7157#|I254S"], "figure_id": "Tab2", "text_hl": "ID MSI status ATM TP53 KRAS NRAS BRAF APC   Mutation HS Mutation HS Mutation HS Mutation HS Mutation HS Mutation HS   1 MSI K610T 60 R248Q 70 G12V 70 : : : : E1464VfsTer8 44   2 NA E1325Stop 94 R175C 180 : : : : : : : :   3 MSS D2870H 52 : : G12S 114 : : : : R1450Stop 106   4 MSS R3047Stop 88 : : G12D 58 : : : : R1450Stop 46   5 MSI R337C 32 : : G13D 36 : : : : I1307K 156   6 MSS P3050L 254 P278S 173 Q61H 120 : : : : : :   7 MSI P604S 132 R196Stop 194 G12V 140 : : : : E1286Stop 198   8 MSS R337C 30 I254S 200 G12V 140 : : : : R1450Stop 64   9 MSS A1309T 136 S215R 192 : : : : : : S1346Stop 72   10 MSS V410A 230 : : : : : : : : : :   11 MSS R337H 34 : : : : : : :  I1311MfsTer10 200   12 NA R2443Q 184 R273C 290 : : : : : : E1353FfsTer20 284   13 MSS R337C 114 : : <m>A146T</m> 212 : : : : T1438HfsTer35 106   14 MSS E1704D 240 : : : : : : : : E1379Stop 710   15 MSS Q2729H 128 : : <m>A146T</m> 104 : : : : T1556NfsTer3 76   16 MSS V410A 200 : : : : : : : : E1309DfsTer4 158   17 MSS R337H 46 R249G 42 G12V 46 : : : : : :   18 MSS P604S 194 R273H 306 : : : : : : Q12894Stop 320   19 MSS R2691H 52 C238Y 122 : : : : : : E1317Q 158   20 MSS R337C 50 : : G12V 96 : : : : H1349QfsTer4 166   21 MSS S333F 40 G266E 760 : : : : : : : :   22 MSS L1939V 44 R282W 268 : : : : : : : :   23 MSS V410A 142 I251S 98 : : : : : : E1547Stop 86   24 MSS V410A 314 Y205H 207 : : : : : : : :   25 MSS R337H 108 R175H 196 G13D 190 : : : : : :   26 MSS S333F 290 R273C 140 : : : : : : : :   27 MSS S1691R 204 R175H 113 : : : : : : : :   28 MSS splice site 184_185 + K1992T 212 + 102 V73fs*50 90 : : : : V600E 350 : :   29 MSI F1928fs*9 206 R27H + R17H 340 : : : : V600E 468 : :   30 MSS F858L 300 V274F 66 : : : : : : : :   31 MSS R337H 20 : : <m>A146T</m> 140 : : : : : :   32 MSS R2912G 116 R2912G 400 : : G12S 120 : : : :   33 MSS G2695V 46 G245S 60 : : : : : : R1450Stop 50   34 MSS V410A 132 R273C 108 G12V : : : : : R1450Stop 62   35 MSS F858L 146 R282W 202 : : : : : : Q1291Stop 84   "}], "citations": {"NLM": "Randon G, Fuc\u00e0 G, Rossini D, Raimondi A, Pagani F, Perrone F, Tamborini E, Busico A, Peverelli G, Morano F, Niger M, Antista M, Corallo S, Saggio S, Borelli B, Zucchelli G, Milione M, Pruneri G, Di Bartolomeo M, Falcone A, de Braud F, Cremolini C, Pietrantonio F. Prognostic impact of ATM mutations in patients with metastatic colorectal cancer. Sci Rep. PMID: 30814645", "BibTeX": "@article{30814645, title={Prognostic impact of ATM mutations in patients with metastatic colorectal cancer.}, author={Randon G and Fuc\u00e0 G and Rossini D and Raimondi A and Pagani F and Perrone F and Tamborini E and Busico A and Peverelli G and Morano F and Niger M and Antista M and Corallo S and Saggio S and Borelli B and Zucchelli G and Milione M and Pruneri G and Di Bartolomeo M and Falcone A and de Braud F and Cremolini C and Pietrantonio F}, journal={Sci Rep}}"}, "is_sup_mat_match": false}, {"pmid": 32892548, "pmcid": "PMC7991861", "title": "Clinicopathological characteristics and mutational profile of KRAS and NRAS in Tunisian patients with sporadic colorectal cancer", "journal": "Turk J Med Sci", "authors": ["Ounissi D", "Weslati M", "Boughriba R", "Hazgui M", "Bouraoui S"], "date": "2020-09-06T00:00:00Z", "year": 2020, "snippets": [{"_id": "32892548@7606", "snip_text": "Gene Exon Codon Mutation Base change Cosmic ID    2 12 G12C 34G>T 516    G12S 34G>A 517    G12R 34G>C 518   KRAS G12V 35G>T 520    G12D 35G>A 521    G12A 35G>C 522    13 G13D 38G>A 532   NRAS 2 12 G12C 34G>T 562   G12S 34G>A 563   G12D 35G>A 564   G12A 35G>C 565   G12V 35G>T 566   13 G13R 37G>C 569   G13D 38G>A 573   G13V 38G>T 574   3 59 A59D 176C>A 253327   61 Q61K 181C>A 580   Q61L 182A>T 583   Q61R 182A>G 584   Q61H 183A>C 586   4 117 K117N 351G>C _   K117N 351G>T _   146 A146T 436G>A 27174   ", "section": "table", "mentions": ["96|5|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|34G>C", "307|5|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|38G>A", "202|5|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|34G>T", "60|5|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|34G>T", "108|4|gene|ncbi_gene@3845|KRAS", "78|5|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|34G>A", "113|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "302|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "406|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|182A>G", "424|6|variant|litvar@rs121913255##&&&litvar@#4893#|183A>C", "346|6|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|176C>A", "290|5|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|37G>C", "265|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "487|6|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|436G>A", "131|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "197|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "91|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "253|5|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|35G>C", "175|5|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|38G>A", "73|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "55|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "466|6|variant|litvar@rs28934571##&&&litvar@#7157#&&&litvar@CA392#rs28934571##|351G>T", "370|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|181C>A", "460|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "388|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|182A>T", "285|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "248|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "170|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "236|5|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|35G>A", "231|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "154|5|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|35G>C", "136|5|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|35G>A", "449|6|variant|litvar@rs28934571##&&&litvar@#7157#|351G>C", "419|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "324|5|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|38G>T", "341|4|variant|litvar@rs763572530##&&&litvar@#1956#|A59D", "443|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "219|5|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|34G>A", "118|5|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|35G>T", "481|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "401|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "365|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "149|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "383|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "270|5|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|35G>T", "214|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "319|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V"], "figure_id": "T1", "text_hl": "Gene Exon Codon Mutation Base change Cosmic ID    2 12 G12C 34G>T 516    G12S 34G>A 517    G12R 34G>C 518   KRAS G12V 35G>T 520    G12D 35G>A 521    G12A 35G>C 522    13 G13D 38G>A 532   NRAS 2 12 G12C 34G>T 562   G12S 34G>A 563   G12D 35G>A 564   G12A 35G>C 565   G12V 35G>T 566   13 G13R 37G>C 569   G13D 38G>A 573   G13V 38G>T 574   3 59 A59D 176C>A 253327   61 Q61K 181C>A 580   Q61L 182A>T 583   Q61R 182A>G 584   Q61H 183A>C 586   4 117 K117N 351G>C _   K117N 351G>T _   146 <m>A146T</m> 436G>A 27174   "}], "citations": {"NLM": "Ounissi D, Weslati M, Boughriba R, Hazgui M, Bouraoui S. Clinicopathological characteristics and mutational profile of KRAS and NRAS in Tunisian patients with sporadic colorectal cancer Turk J Med Sci. PMID: 32892548", "BibTeX": "@article{32892548, title={Clinicopathological characteristics and mutational profile of KRAS and NRAS in Tunisian patients with sporadic colorectal cancer}, author={Ounissi D and Weslati M and Boughriba R and Hazgui M and Bouraoui S}, journal={Turk J Med Sci}}"}, "is_sup_mat_match": false}, {"pmid": 26435479, "pmcid": "PMC4741554", "title": "Rapid targeted somatic mutation analysis of solid tumors in routine clinical diagnostics.", "journal": "Oncotarget", "authors": ["Magliacane G", "Grassini G", "Bartocci P", "Francaviglia I", "Dal Cin E", "Barbieri G", "Arrigoni G", "Pecciarini L", "Doglioni C", "Cangi MG"], "date": "2015-10-13T00:00:00Z", "year": 2015, "snippets": [{"_id": "26435479@14623", "snip_text": "Amino acid DNA Cancer type   Lung Colorectal Melanoma Others   KRAS  108 197 0 57    p.G12A c.35G > C 10 9 - 1    p.G12C c.34G > T 35 12 - 1    p.G12C c.33_34TG > CT - 2 - -    p.G12D c.35G > A 24 65 - 21    p.G12F c.34_35GG > TT 3 1 - -    p.G12H c.34_35GG > CA - - - 1    p.G12R c.34G > C 1 1 - 5    p.G12S c.34G > A 3 9 - -    p.G12V c.35G > T 18 42 0 23    p.G13C c.37G > T 2 2 - 1    p.G13D c.38G > A 1 24 - -    p.G13R c.37G > C 1 - - -    p.G13V c.38G > T 1 1 - -    p.A59T c.175G > A - 1 - 1    p.Q61H c.183A > C 5 6 - 3    p.Q61L c.182A > T 1 1 - -    p.Q61P c.182A > C - 1 - -    p.Q61K c.180_181TC > AA 1 2 - -    p.Q61R c.182A > G 2 - - -    p.K117R c.350 > G - 1 - -    p.K117N c.351G > C - 3 - -    p.A146P c.436G > C - 3 - -    p.A146T c.436G > A - 10 - -    p.A146V c.437C > T - 1 - -   NRAS  0 14 14 0    p.G12A c.35G > C - - 1 -    p.G12C c.34G > T - 1 - -    p.G12D c.35G > A - 6 - -    p.G13R c.37G > C - - 1 -    p.G13V c.38G > T - 1 - -    p.Q61H c.183A > C - 1 - -    p.Q61K c.181C > A - 3 4 -    p.Q61L c.182A > T - 1 4 -    p.Q61R c.182A > G - 1 4 -   BRAF  5 22 30 1    p.V600E c.1799T > A 5 22 23 1    p.V600E2 c.1799_1800TG > AA - - 1 -    p.V600K c.1798_1799GT > AA - - 5 -    p.K601E c.1801A > G - - 1 -   EGFR  41 0 0 0    p. E709-T710del insA c.2126_2128delAAA 1 - - -    p. E746-A750del c.2232_2249 > AAA 14 - - -    p. E746-T751del insA c.2237_2251del15 1 - - -    p. E746-T751del insVA c.2237_2251 > TGG 1 - - -    p.delL747-A750insP c.2238_2248 > GC 1 - - -    p. E747-A751del c.2240_2254del15 1 - - -    p. L747-S752del insS c.2240_2257del18 1 - - -    p.G719C c.2155G > T 1 - - -    p.T790M c.2369C > T 2 - - -    p.L858R c.2573T > G 14 - - -    p.L861Q c.2582T > A 3 - - -    p.L861R c.2582T > G 1 - - -   PIK3CA  7 58 1 50    p.E542K c.1624G > A 2 10 1 8    p.E545A c.1634A > C - 1 - -    p.E545G c.1634A > G - 1 - 1    p.E545D c.1635G > T - 1 - -    p.E545K c.1633G > A 3 21 - 10    p.E545Q c.1633G > C - 2 - -    p.Q546K c.1636C > A - 1 - 2    p.Q546E c.1636C > G - - - 1    p.Q546P c.1637A > C - 1 - -    p.Q546R c.1637A > G - 4 - -    p.M1043I c.3129G > A - 1 - -    p.H1047L c.3140A > T - 3 - 6    p.H1047R c.3140A > G 2 11 - 22    p.G1049R c.3145G > C - 1 - -   ", "section": "table", "mentions": ["625|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "215|14|variant|litvar@#3845#c.34_35GG>TT&&&litvar@#3845#|c.34_35GG > TT", "474|6|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|p.A59T", "2017|7|variant|litvar@rs397517201##&&&litvar@#5290#|p.Q546P", "878|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1986|7|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123331#rs121913286##|p.Q546E", "1715|7|variant|litvar@rs121913444##&&&litvar@#1956#&&&litvar@CA135940#rs121913444##|p.L861R", "1868|11|variant|litvar@rs121913275##&&&litvar@#5290#&&&litvar@CA210104#rs121913275##|c.1635G > T", "144|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "248|14|variant|litvar@#3845#c.34_35GG>CA&&&litvar@#3845#|c.34_35GG > CA", "934|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|p.G13V", "85|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "1652|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "177|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "425|9|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|c.37G > C", "829|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > C", "1955|7|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123338#rs121913286##|p.Q546K", "1806|11|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123342#rs121913274##|c.1634A > C", "114|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "1056|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A > G", "1104|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T > A", "1353|12|variant|litvar@#1956#p.T746,751del&&&litvar@#1956#|E746-T751del", "1774|11|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|c.1624G > A", "913|9|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|c.37G > C", "885|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "782|10|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C > T", "1562|16|variant|litvar@rs121913438##&&&litvar@#1956#|c.2240_2257del18", "1275|17|variant|litvar@#1956#p.K2126_2128del&&&litvar@#1956#|c.2126_2128delAAA", "92|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > C", "1168|7|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16602420#rs121913227##|p.V600K", "1899|11|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G > A", "446|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|p.G13V", "2143|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.H1047R", "34|19|disease|ncbi_mesh@D008545|Colorectal Melanoma", "184|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "850|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "2152|11|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A > G", "2056|11|variant|litvar@rs397517201##&&&litvar@#5290#&&&litvar@CA136371#rs397517201##|c.1637A > G", "281|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G > C", "691|10|variant|litvar@rs767291079##&&&litvar@#22882#&&&litvar@CA4862148#rs767291079##|c.351G > C", "396|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "751|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "774|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "1513|16|variant|litvar@#5290#c.2240_2254del15&&&litvar@#5290#|c.2240_2254del15", "1932|11|variant|litvar@rs104886003##&&&litvar@#5290#|c.1633G > C", "208|6|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12F", "632|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A > G", "906|6|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|p.G13R", "683|7|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.K117N", "481|10|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|c.175G > A", "337|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "121|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G > T", "1544|12|variant|litvar@#5290#c.747,752delL,S&&&litvar@#5290#|L747-S752del", "568|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA10602732#rs11554290##|c.182A > C", "803|4|gene|ncbi_gene@4893|NRAS", "241|6|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12H", "1027|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|c.182A > T", "1598|11|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126719#rs28929495##|c.2155G > T", "361|6|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|p.G13C", "2025|11|variant|litvar@rs397517201##&&&litvar@#5290#|c.1637A > C", "743|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "302|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "1837|11|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123336#rs121913274##|c.1634A > G", "721|10|variant|litvar@rs121913527##&&&litvar@#3845#|c.436G > C", "274|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "389|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "1994|11|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123331#rs121913286##|c.1636C > G", "969|10|variant|litvar@rs121913255##&&&litvar@#4893#|c.183A > C", "1692|11|variant|litvar@rs121913444##&&&litvar@#1956#&&&litvar@CA176021#rs121913444##|c.2582T > A", "1450|18|variant|litvar@#1956#p.A,P747,750ins&&&litvar@#1956#|p.delL747-A750insP", "330|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1138|18|variant|litvar@#673#c.1799_1800TG>AA&&&litvar@#673#|c.1799_1800TG > AA", "29|4|disease|ncbi_mesh@D008171|Lung", "1660|11|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|c.2573T > G", "713|7|variant|litvar@rs121913527##&&&litvar@#3845#|p.A146P", "418|6|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|p.G13R", "998|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C > A", "822|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "1963|11|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123338#rs121913286##|c.1636C > A", "654|7|variant|litvar@#4893#p.K117R&&&litvar@#4893#|p.K117R", "1020|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "2111|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|p.H1047L", "368|9|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA135570#rs121913535##|c.37G > T", "2120|11|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|c.3140A > T", "1745|6|gene|ncbi_gene@5290|PIK3CA", "539|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|c.182A > T", "309|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G > A", "1629|11|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|c.2369C > T", "2079|8|variant|litvar@rs121913283##&&&litvar@#5290#&&&litvar@CA183868#rs121913283##|p.M1043I", "1077|4|gene|ncbi_gene@673|BRAF", "2088|11|variant|litvar@rs779392990##&&&litvar@#1956#&&&litvar@CA4266338#rs779392990##|c.3129G > A", "1206|7|variant|litvar@rs121913364##&&&litvar@#673#&&&litvar@CA123645#rs121913364##|p.K601E", "590|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "1049|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "1402|12|variant|litvar@#1956#p.T746,751del&&&litvar@#1956#|E746-T751del", "63|4|gene|ncbi_gene@3845|KRAS", "2177|8|variant|litvar@rs121913277##&&&litvar@#5290#&&&litvar@CA16602520#rs121913277##|p.G1049R", "2186|11|variant|litvar@rs121913277##&&&litvar@#5290#&&&litvar@CA16602520#rs121913277##|c.3145G > C", "1723|11|variant|litvar@rs121913444##&&&litvar@#1956#&&&litvar@CA135940#rs121913444##|c.2582T > G", "1500|12|variant|litvar@#5290#p.A747,751del&&&litvar@#5290#|E747-A751del", "597|16|variant|litvar@#4893#c.180_181TC>AA&&&litvar@#4893#|c.180_181TC > AA", "1860|7|variant|litvar@rs121913275##&&&litvar@#5290#&&&litvar@CA210104#rs121913275##|p.E545D", "510|10|variant|litvar@rs121913255##&&&litvar@#4893#|c.183A > C", "2048|7|variant|litvar@rs397517201##&&&litvar@#5290#&&&litvar@CA136371#rs397517201##|p.Q546R", "1307|12|variant|litvar@#1956#p.A746,750del&&&litvar@#1956#|E746-A750del", "532|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "1236|4|gene|ncbi_gene@1956|EGFR", "561|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA10602732#rs11554290##|p.Q61P", "1176|18|variant|litvar@#673#c.1798_1799GT>AA&&&litvar@#673#|c.1798_1799GT > AA", "151|14|variant|litvar@#3845#c.33_34TG>CT&&&litvar@#3845#|c.33_34TG > CT", "1798|7|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123342#rs121913274##|p.E545A", "1371|16|variant|litvar@#1956#c.2237_2251del15&&&litvar@#1956#|c.2237_2251del15", "503|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "1684|7|variant|litvar@rs121913444##&&&litvar@#1956#&&&litvar@CA176021#rs121913444##|p.L861Q", "962|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "1766|7|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.E542K", "453|9|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|c.38G > T", "1891|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "857|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G > T", "1129|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "1621|7|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|p.T790M", "1924|7|variant|litvar@rs104886003##&&&litvar@#5290#|p.E545Q", "991|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "1214|11|variant|litvar@rs104886013##&&&litvar@#1956#&&&litvar@CA269859#rs104886013##|c.1801A > G", "941|9|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|c.38G > T", "1257|12|variant|litvar@#1956#p.T709,710del&&&litvar@#1956#|E709-T710del", "1590|7|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126719#rs28929495##|p.G719C", "11|10|disease|ncbi_mesh@D009369|DNA Cancer", "1829|7|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123336#rs121913274##|p.E545G"], "figure_id": "T2", "text_hl": "Amino acid DNA Cancer type   Lung Colorectal Melanoma Others   KRAS  108 197 0 57    p.G12A c.35G > C 10 9 - 1    p.G12C c.34G > T 35 12 - 1    p.G12C c.33_34TG > CT - 2 - -    p.G12D c.35G > A 24 65 - 21    p.G12F c.34_35GG > TT 3 1 - -    p.G12H c.34_35GG > CA - - - 1    p.G12R c.34G > C 1 1 - 5    p.G12S c.34G > A 3 9 - -    p.G12V c.35G > T 18 42 0 23    p.G13C c.37G > T 2 2 - 1    p.G13D c.38G > A 1 24 - -    p.G13R c.37G > C 1 - - -    p.G13V c.38G > T 1 1 - -    p.A59T c.175G > A - 1 - 1    p.Q61H c.183A > C 5 6 - 3    p.Q61L c.182A > T 1 1 - -    p.Q61P c.182A > C - 1 - -    p.Q61K c.180_181TC > AA 1 2 - -    p.Q61R c.182A > G 2 - - -    p.K117R c.350 > G - 1 - -    p.K117N c.351G > C - 3 - -    p.A146P c.436G > C - 3 - -    <m>p.A146T</m> c.436G > A - 10 - -    p.A146V c.437C > T - 1 - -   NRAS  0 14 14 0    p.G12A c.35G > C - - 1 -    p.G12C c.34G > T - 1 - -    p.G12D c.35G > A - 6 - -    p.G13R c.37G > C - - 1 -    p.G13V c.38G > T - 1 - -    p.Q61H c.183A > C - 1 - -    p.Q61K c.181C > A - 3 4 -    p.Q61L c.182A > T - 1 4 -    p.Q61R c.182A > G - 1 4 -   BRAF  5 22 30 1    p.V600E c.1799T > A 5 22 23 1    p.V600E2 c.1799_1800TG > AA - - 1 -    p.V600K c.1798_1799GT > AA - - 5 -    p.K601E c.1801A > G - - 1 -   EGFR  41 0 0 0    p. E709-T710del insA c.2126_2128delAAA 1 - - -    p. E746-A750del c.2232_2249 > AAA 14 - - -    p. E746-T751del insA c.2237_2251del15 1 - - -    p. E746-T751del insVA c.2237_2251 > TGG 1 - - -    p.delL747-A750insP c.2238_2248 > GC 1 - - -    p. E747-A751del c.2240_2254del15 1 - - -    p. L747-S752del insS c.2240_2257del18 1 - - -    p.G719C c.2155G > T 1 - - -    p.T790M c.2369C > T 2 - - -    p.L858R c.2573T > G 14 - - -    p.L861Q c.2582T > A 3 - - -    p.L861R c.2582T > G 1 - - -   PIK3CA  7 58 1 50    p.E542K c.1624G > A 2 10 1 8    p.E545A c.1634A > C - 1 - -    p.E545G c.1634A > G - 1 - 1    p.E545D c.1635G > T - 1 - -    p.E545K c.1633G > A 3 21 - 10    p.E545Q c.1633G > C - 2 - -    p.Q546K c.1636C > A - 1 - 2    p.Q546E c.1636C > G - - - 1    p.Q546P c.1637A > C - 1 - -    p.Q546R c.1637A > G - 4 - -    p.M1043I c.3129G > A - 1 - -    p.H1047L c.3140A > T - 3 - 6    p.H1047R c.3140A > G 2 11 - 22    p.G1049R c.3145G > C - 1 - -   "}], "citations": {"NLM": "Magliacane G, Grassini G, Bartocci P, Francaviglia I, Dal Cin E, Barbieri G, Arrigoni G, Pecciarini L, Doglioni C, Cangi MG. Rapid targeted somatic mutation analysis of solid tumors in routine clinical diagnostics. Oncotarget. PMID: 26435479", "BibTeX": "@article{26435479, title={Rapid targeted somatic mutation analysis of solid tumors in routine clinical diagnostics.}, author={Magliacane G and Grassini G and Bartocci P and Francaviglia I and Dal Cin E and Barbieri G and Arrigoni G and Pecciarini L and Doglioni C and Cangi MG}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 28259994, "pmcid": "PMC5360420", "title": "Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer.", "journal": "Int J Mol Med", "authors": ["Bai S", "Feng Q", "Pan XY", "Zou H", "Chen HB", "Wang P", "Zhou XL", "Hong YL", "Song SL", "Yang JL"], "date": "2017-04-01T00:00:00Z", "year": 2017, "snippets": [{"_id": "28259994@28578", "snip_text": "Patients K-ras H-ras N-ras   Expression Exon Mutation Expression Mutation Expression Exon Mutation   201503220 + Exon 4 c.436G>A p.A146T - - - Exon 2 c.81T>C   201503213 + - - - - - Exon 2 c.81T>C   201503102 + - - - - - - -   201502928 + Exon 4 c.436G>A p.A146T + - - - -   201502903 + - - + - - Exon 2 c.81T>C   201502056 + Exon 2 c.35G>A p.G12D + - - - -   201501338 + - - + - - Exon 2 c.81T>C   201501304 + - - + - - - -   201500934 + - - + - - Exon 2 c.81T>C   201500667 + - - + - - - -   201412412 + Exon 2 c.38G>A p.G13D + - - - -   201410010 + - - + - - - -   201409737 + Exon 2 c.38G>A p.G13D + - - - -   201408315 + Exon 2 c.35G>C p.G12A + - - Exon 2 c.81T>C   201407762 + - - + - - - -   201406231 + Exon 4 c.436G>A p.A146T          Exon 5 c.526>T p.E176Stop - - - - -   201405694 + - - + - - Exon 2 c.81T>C   201405647 + Exon 2 c.35G>A p.G12D + - - Exon 2 c.81T>C   201503581 + - - + - - - -   201503452 + - - - - - - -   201502977 + Exon 5 c.467T>C p.F156S + - - - -   201502204 + - - + - - - -   201501593 + Exon 2 c.35G>T p.G12V + - - Exon 2 c.81T>C   201501337 + - - + - - - -   201501079 + - - + - - - -   201407828 + Exon 2 c.38G>A p.G13D + - - - -   201407425 + - - + - - Exon 2 c.81T>C   201407236 + Exon 2 c.35G>A p.G12D + - - - -   201405983 + Exon 2 c.38G>A p.G13D + - - Exon 2 c.81T>C   201405149 + - - + - - - -   201404719 + - - + - - - -   201404718 + Exon 2 c.38G>A p.G13D + - - Exon 2 c.81T>C   201404238 + - - + - - - -   201401791 + - - + - - - -   201401610 + - - + - - Exon 2 c.81T>C   ", "section": "table", "mentions": ["962|7|variant|litvar@rs1416532705##&&&litvar@#2064#|p.F156S", "811|7|variant|litvar@rs12628##&&&litvar@#3265#&&&litvar@CA135996#rs12628##|c.81T>C", "341|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "333|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "150|7|variant|litvar@rs12628##&&&litvar@#3265#&&&litvar@CA135996#rs12628##|c.81T>C", "255|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "9|5|gene|ncbi_gene@3845|K-ras", "1509|7|variant|litvar@rs12628##&&&litvar@#3265#&&&litvar@CA135996#rs12628##|c.81T>C", "0|8|species|ncbi_taxonomy@9606|Patients", "1142|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "1150|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "389|7|variant|litvar@rs12628##&&&litvar@#3265#&&&litvar@CA135996#rs12628##|c.81T>C", "513|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "521|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "587|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "15|5|gene|ncbi_gene@3265|H-ras", "120|8|variant|litvar@rs104894231##&&&litvar@#3265#&&&litvar@CA256492#rs104894231##|c.436G>A", "595|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "633|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G>C", "661|7|variant|litvar@rs12628##&&&litvar@#3265#&&&litvar@CA135996#rs12628##|c.81T>C", "1386|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "641|6|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|p.G12A", "1414|7|variant|litvar@rs12628##&&&litvar@#3265#&&&litvar@CA135996#rs12628##|c.81T>C", "1198|7|variant|litvar@rs12628##&&&litvar@#3265#&&&litvar@CA135996#rs12628##|c.81T>C", "129|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "1029|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA261525#rs121913237##|c.35G>T", "868|7|variant|litvar@rs12628##&&&litvar@#3265#&&&litvar@CA135996#rs12628##|c.81T>C", "1394|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "718|8|variant|litvar@rs104894231##&&&litvar@#3265#&&&litvar@CA256492#rs104894231##|c.436G>A", "840|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "848|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "189|7|variant|litvar@rs12628##&&&litvar@#3265#&&&litvar@CA135996#rs12628##|c.81T>C", "953|8|variant|litvar@rs1416532705##&&&litvar@#2064#|c.467T>C", "456|7|variant|litvar@rs12628##&&&litvar@#3265#&&&litvar@CA135996#rs12628##|c.81T>C", "304|7|variant|litvar@rs12628##&&&litvar@#3265#&&&litvar@CA135996#rs12628##|c.81T>C", "1037|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "21|5|gene|ncbi_gene@4893|N-ras", "1057|7|variant|litvar@rs12628##&&&litvar@#3265#&&&litvar@CA135996#rs12628##|c.81T>C", "1273|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "246|8|variant|litvar@rs104894231##&&&litvar@#3265#&&&litvar@CA256492#rs104894231##|c.436G>A", "1227|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "1235|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1301|7|variant|litvar@rs12628##&&&litvar@#3265#&&&litvar@CA135996#rs12628##|c.81T>C", "1281|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "727|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T"], "figure_id": "tIII-ijmm-39-04-0861", "text_hl": "Patients K-ras H-ras N-ras   Expression Exon Mutation Expression Mutation Expression Exon Mutation   201503220 + Exon 4 c.436G>A <m>p.A146T</m> - - - Exon 2 c.81T>C   201503213 + - - - - - Exon 2 c.81T>C   201503102 + - - - - - - -   201502928 + Exon 4 c.436G>A <m>p.A146T</m> + - - - -   201502903 + - - + - - Exon 2 c.81T>C   201502056 + Exon 2 c.35G>A p.G12D + - - - -   201501338 + - - + - - Exon 2 c.81T>C   201501304 + - - + - - - -   201500934 + - - + - - Exon 2 c.81T>C   201500667 + - - + - - - -   201412412 + Exon 2 c.38G>A p.G13D + - - - -   201410010 + - - + - - - -   201409737 + Exon 2 c.38G>A p.G13D + - - - -   201408315 + Exon 2 c.35G>C p.G12A + - - Exon 2 c.81T>C   201407762 + - - + - - - -   201406231 + Exon 4 c.436G>A <m>p.A146T</m>          Exon 5 c.526>T p.E176Stop - - - - -   201405694 + - - + - - Exon 2 c.81T>C   201405647 + Exon 2 c.35G>A p.G12D + - - Exon 2 c.81T>C   201503581 + - - + - - - -   201503452 + - - - - - - -   201502977 + Exon 5 c.467T>C p.F156S + - - - -   201502204 + - - + - - - -   201501593 + Exon 2 c.35G>T p.G12V + - - Exon 2 c.81T>C   201501337 + - - + - - - -   201501079 + - - + - - - -   201407828 + Exon 2 c.38G>A p.G13D + - - - -   201407425 + - - + - - Exon 2 c.81T>C   201407236 + Exon 2 c.35G>A p.G12D + - - - -   201405983 + Exon 2 c.38G>A p.G13D + - - Exon 2 c.81T>C   201405149 + - - + - - - -   201404719 + - - + - - - -   201404718 + Exon 2 c.38G>A p.G13D + - - Exon 2 c.81T>C   201404238 + - - + - - - -   201401791 + - - + - - - -   201401610 + - - + - - Exon 2 c.81T>C   "}], "citations": {"NLM": "Bai S, Feng Q, Pan XY, Zou H, Chen HB, Wang P, Zhou XL, Hong YL, Song SL, Yang JL. Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer. Int J Mol Med. PMID: 28259994", "BibTeX": "@article{28259994, title={Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer.}, author={Bai S and Feng Q and Pan XY and Zou H and Chen HB and Wang P and Zhou XL and Hong YL and Song SL and Yang JL}, journal={Int J Mol Med}}"}, "is_sup_mat_match": false}, {"pmid": 27446446, "pmcid": "PMC4950545", "title": "Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma.", "journal": "Oncol Lett", "authors": ["Palomba G", "Cossu A", "Paliogiannis P", "Pazzola A", "Baldino G", "Scartozzi M", "Ionta MT", "Ortu S", "Capelli F", "Lanzillo A", "Sedda T", "Sanna G", "Barca M", "Virdis L", "Budroni M", "Palmieri G"], "date": "2016-08-01T00:00:00Z", "year": 2016, "snippets": [{"_id": "27446446@25215", "snip_text": "Amino acid mutation DNA mutation No. cases   Mutations in uncommon codons       p.G12_G13insAG c.35_36insAGCTGG 1     p.E49K c.145G>A 1     p.A59E c.176C>A 1     p.K117N c.351A>T 1     p.A146T c.436G>A 3   Coexistent multiple mutations       p.G12D+p.Q61H c.35_36GT>AC + c.183A>C 1     p.G12D+p.Q61L c.35_36GT>AC + c.182A>T 1     p.G13V+p.Q61H c.38G>T + c.183A>C 1   ", "section": "table", "mentions": ["193|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "256|12|variant|litvar@#3845#c.35_36GT>AC&&&litvar@#3845#|c.35_36GT>AC", "249|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "80|14|variant|litvar@#3845#p.AG13ins&&&litvar@#3845#|p.G12_G13insAG", "242|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "147|8|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|c.176C>A", "293|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "286|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "271|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA180922#rs17851045##|c.183A>C", "337|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "185|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "170|8|variant|litvar@rs770248150##&&&litvar@#3845#|c.351A>T", "330|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|p.G13V", "95|16|variant|litvar@#3845#c.35_36insAGCTGG&&&litvar@#3845#|c.35_36insAGCTGG", "354|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA180922#rs17851045##|c.183A>C", "162|7|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.K117N", "300|12|variant|litvar@#3845#c.35_36GT>AC&&&litvar@#3845#|c.35_36GT>AC", "315|8|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|c.182A>T", "140|6|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|p.A59E", "344|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|c.38G>T", "118|6|variant|litvar@rs746572499##&&&litvar@#4893#&&&litvar@CA1020756#rs746572499##|p.E49K", "125|8|variant|litvar@rs746572499##&&&litvar@#4893#&&&litvar@CA1020756#rs746572499##|c.145G>A"], "figure_id": "tII-ol-0-0-4798", "text_hl": "Amino acid mutation DNA mutation No. cases   Mutations in uncommon codons       p.G12_G13insAG c.35_36insAGCTGG 1     p.E49K c.145G>A 1     p.A59E c.176C>A 1     p.K117N c.351A>T 1     <m>p.A146T</m> c.436G>A 3   Coexistent multiple mutations       p.G12D+p.Q61H c.35_36GT>AC + c.183A>C 1     p.G12D+p.Q61L c.35_36GT>AC + c.182A>T 1     p.G13V+p.Q61H c.38G>T + c.183A>C 1   "}], "citations": {"NLM": "Palomba G, Cossu A, Paliogiannis P, Pazzola A, Baldino G, Scartozzi M, Ionta MT, Ortu S, Capelli F, Lanzillo A, Sedda T, Sanna G, Barca M, Virdis L, Budroni M, Palmieri G. Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma. Oncol Lett. PMID: 27446446", "BibTeX": "@article{27446446, title={Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma.}, author={Palomba G and Cossu A and Paliogiannis P and Pazzola A and Baldino G and Scartozzi M and Ionta MT and Ortu S and Capelli F and Lanzillo A and Sedda T and Sanna G and Barca M and Virdis L and Budroni M and Palmieri G}, journal={Oncol Lett}}"}, "is_sup_mat_match": false}, {"pmid": 32164600, "pmcid": "PMC7068927", "title": "Genetic mutational analysis of pediatric acute lymphoblastic leukemia from a single center in China using exon sequencing", "journal": "BMC Cancer", "authors": ["Zhang H", "Wang H", "Qian X", "Gao S", "Xia J", "Liu J", "Cheng Y", "Man J", "Zhai X"], "date": "2020-03-12T00:00:00Z", "year": 2020, "snippets": [{"_id": "32164600@15368", "snip_text": "The well-known hotspot mutations in the Ras genes included G12C/D/S/V (KRAS = 4; NRAS = 5), G13D/S/V (KRAS = 2; NRAS = 3), Q61K/H (KRAS = 1; NRAS = 1) and other mutational sites, such as A146T/P (KRAS = 3) and K117N (KRAS = 1).", "section": "results", "mentions": ["187|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "210|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "92|6|variant|litvar@rs112445441##&&&litvar@#3845#|G13D/S", "123|6|variant|litvar@rs17851045##&&&litvar@#3845#|Q61K/H", "71|4|gene|ncbi_gene@3845|KRAS", "131|4|gene|ncbi_gene@3845|KRAS", "196|4|gene|ncbi_gene@3845|KRAS", "112|4|gene|ncbi_gene@4893|NRAS", "59|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12C/D", "102|4|gene|ncbi_gene@3845|KRAS", "141|4|gene|ncbi_gene@4893|NRAS", "81|4|gene|ncbi_gene@4893|NRAS", "217|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "The well-known hotspot mutations in the Ras genes included G12C/D/S/V (KRAS = 4; NRAS = 5), G13D/S/V (KRAS = 2; NRAS = 3), Q61K/H (KRAS = 1; NRAS = 1) and other mutational sites, such as <m>A146T</m>/P (KRAS = 3) and K117N (KRAS = 1)."}], "citations": {"NLM": "Zhang H, Wang H, Qian X, Gao S, Xia J, Liu J, Cheng Y, Man J, Zhai X. Genetic mutational analysis of pediatric acute lymphoblastic leukemia from a single center in China using exon sequencing BMC Cancer. PMID: 32164600", "BibTeX": "@article{32164600, title={Genetic mutational analysis of pediatric acute lymphoblastic leukemia from a single center in China using exon sequencing}, author={Zhang H and Wang H and Qian X and Gao S and Xia J and Liu J and Cheng Y and Man J and Zhai X}, journal={BMC Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 31819776, "pmcid": "PMC6896405", "title": "High hnRNP AB expression is associated with poor prognosis in patients with colorectal cancer", "journal": "Oncol Lett", "authors": ["Zhou JM", "Jiang H", "Yuan T", "Zhou GX", "Li XB", "Wen KM"], "date": "2019-12-01T00:00:00Z", "year": 2019, "snippets": [{"_id": "31819776@19246", "snip_text": "Roda et al demonstrated that hnRNP A1 acetylation was induced in KRAS A146T allele CRC HCT116 cells following epidermal growth factor (EGF) treatment, whereas the levels of acetyl-hnRNP A1 did not change following EGF treatment in KRAS G13D-unresponsive HCT116 cells, suggesting that hnRNP A1 acetylation, which changes according to KRAS mutational status, is involved in the carcinogenic pathway in CRC.", "section": "discussion", "mentions": ["29|8|gene|ncbi_gene@3178|hnRNP A1", "231|4|gene|ncbi_gene@3845|KRAS", "135|3|gene|ncbi_gene@1950|EGF", "110|23|gene|ncbi_gene@1950|epidermal growth factor", "284|8|gene|ncbi_gene@3178|hnRNP A1", "333|4|gene|ncbi_gene@3845|KRAS", "236|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "65|4|gene|ncbi_gene@3845|KRAS", "214|3|gene|ncbi_gene@1950|EGF", "180|8|gene|ncbi_gene@3178|hnRNP A1", "70|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Roda et al demonstrated that hnRNP A1 acetylation was induced in KRAS <m>A146T</m> allele CRC HCT116 cells following epidermal growth factor (EGF) treatment, whereas the levels of acetyl-hnRNP A1 did not change following EGF treatment in KRAS G13D-unresponsive HCT116 cells, suggesting that hnRNP A1 acetylation, which changes according to KRAS mutational status, is involved in the carcinogenic pathway in CRC."}], "citations": {"NLM": "Zhou JM, Jiang H, Yuan T, Zhou GX, Li XB, Wen KM. High hnRNP AB expression is associated with poor prognosis in patients with colorectal cancer Oncol Lett. PMID: 31819776", "BibTeX": "@article{31819776, title={High hnRNP AB expression is associated with poor prognosis in patients with colorectal cancer}, author={Zhou JM and Jiang H and Yuan T and Zhou GX and Li XB and Wen KM}, journal={Oncol Lett}}"}, "is_sup_mat_match": false}, {"pmid": 25743686, "pmcid": "PMC4655812", "title": "Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M3P)", "journal": "Ann Hematol", "authors": ["Kort\u00fcm KM", "Langer C", "Monge J", "Bruins L", "Zhu YX", "Shi CX", "Jedlowski P", "Egan JB", "Ojha J", "Bullinger L", "Kull M", "Ahmann G", "Rasche L", "Knop S", "Fonseca R", "Einsele H", "Stewart AK", "Braggio E"], "date": "2015-07-01T00:00:00Z", "year": 2015, "snippets": [{"_id": "25743686@8800", "snip_text": "Probable parallel evolution in the RAS/MAPK pathway was observed in two patients with one patient presenting two mutations in one gene (KRAS, p.Tyr64Asn, p.Ala146Thr) and one patient harboring mutations in different genes of the pathway (KRAS and BRAF).", "section": "results", "mentions": ["136|4|gene|ncbi_gene@3845|KRAS", "175|7|species|ncbi_taxonomy@9606|patient", "238|4|gene|ncbi_gene@3845|KRAS", "247|4|gene|ncbi_gene@673|BRAF", "142|10|variant|litvar@#3845#p.Y64N&&&litvar@#3845#|p.Tyr64Asn", "72|8|species|ncbi_taxonomy@9606|patients", "154|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "90|7|species|ncbi_taxonomy@9606|patient"], "text_hl": "Probable parallel evolution in the RAS/MAPK pathway was observed in two patients with one patient presenting two mutations in one gene (KRAS, p.Tyr64Asn, <m>p.Ala146Thr</m>) and one patient harboring mutations in different genes of the pathway (KRAS and BRAF)."}], "citations": {"NLM": "Kort\u00fcm KM, Langer C, Monge J, Bruins L, Zhu YX, Shi CX, Jedlowski P, Egan JB, Ojha J, Bullinger L, Kull M, Ahmann G, Rasche L, Knop S, Fonseca R, Einsele H, Stewart AK, Braggio E. Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M3P) Ann Hematol. PMID: 25743686", "BibTeX": "@article{25743686, title={Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M3P)}, author={Kort\u00fcm KM and Langer C and Monge J and Bruins L and Zhu YX and Shi CX and Jedlowski P and Egan JB and Ojha J and Bullinger L and Kull M and Ahmann G and Rasche L and Knop S and Fonseca R and Einsele H and Stewart AK and Braggio E}, journal={Ann Hematol}}"}, "is_sup_mat_match": false}, {"pmid": 29362371, "pmcid": "PMC5780472", "title": "KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer.", "journal": "Sci Rep", "authors": ["Sclafani F", "Chau I", "Cunningham D", "Hahne JC", "Vlachogiannis G", "Eltahir Z", "Lampis A", "Braconi C", "Kalaitzaki E", "De Castro DG", "Wotherspoon A", "Capdevila J", "Glimelius B", "Tarazona N", "Begum R", "Lote H", "Hulkki Wilson S", "Mentrasti G", "Brown G", "Tait D", "Oates J", "Valeri N"], "date": "2018-01-23T00:00:00Z", "year": 2018, "snippets": [{"_id": "29362371@14660", "snip_text": "Less common KRAS mutations were found in 10 additional patients (i.e.  G12C = 3, G12S = 3, G12A = 2, A146T = 2) (11%).", "section": "results", "mentions": ["12|4|gene|ncbi_gene@3845|KRAS", "71|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "101|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "91|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "55|8|species|ncbi_taxonomy@9606|patients", "81|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S"], "text_hl": "Less common KRAS mutations were found in 10 additional patients (i.e.  G12C = 3, G12S = 3, G12A = 2, <m>A146T</m> = 2) (11%)."}], "citations": {"NLM": "Sclafani F, Chau I, Cunningham D, Hahne JC, Vlachogiannis G, Eltahir Z, Lampis A, Braconi C, Kalaitzaki E, De Castro DG, Wotherspoon A, Capdevila J, Glimelius B, Tarazona N, Begum R, Lote H, Hulkki Wilson S, Mentrasti G, Brown G, Tait D, Oates J, Valeri N. KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer. Sci Rep. PMID: 29362371", "BibTeX": "@article{29362371, title={KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer.}, author={Sclafani F and Chau I and Cunningham D and Hahne JC and Vlachogiannis G and Eltahir Z and Lampis A and Braconi C and Kalaitzaki E and De Castro DG and Wotherspoon A and Capdevila J and Glimelius B and Tarazona N and Begum R and Lote H and Hulkki Wilson S and Mentrasti G and Brown G and Tait D and Oates J and Valeri N}, journal={Sci Rep}}"}, "is_sup_mat_match": false}, {"pmid": 30934598, "pmcid": "PMC6468462", "title": "A Simple and Highly Specific MassARRAY-Based Stool DNA Assay to Prioritize Follow-up Decisions in Fecal Immunochemical Test-Positive Individuals.", "journal": "Cancers (Basel)", "authors": ["Chang PY", "Chen CC", "Chiang JM", "Chang SC", "Wang MC", "Chen JS", "Tsai WS", "You JF", "Lu JJ"], "date": "2019-03-25T00:00:00Z", "year": 2019, "snippets": [{"_id": "30934598@11167", "snip_text": "In total, 10 variants were detected in stool samples (p.R876*, p.R1114* and p.R1450* in APC; p.G12A, p.G12D, p.G12V, p.G13D and p.A146T in KRAS; p.R175H in TP53; p.E545K in PIK3CA).The mutation detection rate was independent of the lesion location (Figure 4C), but it was found to be affected by lesion size (Figure 4D).", "section": "results", "mentions": ["173|6|gene|ncbi_gene@5290|PIK3CA", "63|8|variant|litvar@#324#p.R1114*&&&litvar@#324#|p.R1114*", "93|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "54|7|variant|litvar@#324#p.R876*&&&litvar@#324#|p.R876*", "128|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "109|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "139|4|gene|ncbi_gene@3845|KRAS", "162|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "76|15|variant|litvar@rs587782678##&&&litvar@#324#|p.R1450* in APC", "145|7|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|p.R175H", "156|4|gene|ncbi_gene@7157|TP53", "117|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "101|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D"], "text_hl": "In total, 10 variants were detected in stool samples (p.R876*, p.R1114* and p.R1450* in APC; p.G12A, p.G12D, p.G12V, p.G13D and <m>p.A146T</m> in KRAS; p.R175H in TP53; p.E545K in PIK3CA).The mutation detection rate was independent of the lesion location (Figure 4C), but it was found to be affected by lesion size (Figure 4D)."}], "citations": {"NLM": "Chang PY, Chen CC, Chiang JM, Chang SC, Wang MC, Chen JS, Tsai WS, You JF, Lu JJ. A Simple and Highly Specific MassARRAY-Based Stool DNA Assay to Prioritize Follow-up Decisions in Fecal Immunochemical Test-Positive Individuals. Cancers (Basel). PMID: 30934598", "BibTeX": "@article{30934598, title={A Simple and Highly Specific MassARRAY-Based Stool DNA Assay to Prioritize Follow-up Decisions in Fecal Immunochemical Test-Positive Individuals.}, author={Chang PY and Chen CC and Chiang JM and Chang SC and Wang MC and Chen JS and Tsai WS and You JF and Lu JJ}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 26691448, "pmcid": "PMC4687048", "title": "Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases.", "journal": "Sci Rep", "authors": ["Zhang J", "Zheng J", "Yang Y", "Lu J", "Gao J", "Lu T", "Sun J", "Jiang H", "Zhu Y", "Zheng Y", "Liang Z", "Liu T"], "date": "2015-12-22T00:00:00Z", "year": 2015, "snippets": [{"_id": "26691448@32012", "snip_text": "Gene Exon Codon Mutation Numbers of mutations (% of 1, 110)   KRAS 2 12, 13 G12S, G12D, G12C, G12R, G12V, G12A, G13C, G13D, 443 (40.0)   KRAS 3 61 Q61L, Q61R, Q61H 16 (1.4)   KRAS 4 117, 146 K117N, A146T, A146V, A146P 45 (4.1)   NRAS 2 12, 13 G12D, G12S, G13R, G12C, G12V, G12A, G13V, 24 (2.2)   NRAS 3 61 Q61R, Q61K, Q61L, Q61H 19 (1.7)   NRAS 4 146 A146T 0 (0)   BRAF 15 600 V600E, V600K, V600R, V600D 34 (3.1)   PIK3CA 20 1047 H1047R, H1047L 39 (3.5)   ", "section": "table", "mentions": ["306|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "324|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "118|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "255|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "159|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "377|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "415|6|gene|ncbi_gene@5290|PIK3CA", "261|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "100|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "438|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|H1047L", "212|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "62|6|gene|ncbi_gene@3845|KRAS 2", "198|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "279|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "391|5|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16021333#rs121913227##|V600R", "243|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "82|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "147|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "76|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "312|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "106|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "430|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "175|4|gene|ncbi_gene@3845|KRAS", "351|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "249|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "88|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "267|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "398|5|variant|litvar@rs121913377##&&&litvar@#673#&&&litvar@CA16602419#rs121913377##|V600D", "318|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "191|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "153|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "384|5|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16602420#rs121913227##|V600K", "273|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "112|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "205|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "94|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "365|4|gene|ncbi_gene@673|BRAF"], "figure_id": "t1", "text_hl": "Gene Exon Codon Mutation Numbers of mutations (% of 1, 110)   KRAS 2 12, 13 G12S, G12D, G12C, G12R, G12V, G12A, G13C, G13D, 443 (40.0)   KRAS 3 61 Q61L, Q61R, Q61H 16 (1.4)   KRAS 4 117, 146 K117N, <m>A146T</m>, A146V, A146P 45 (4.1)   NRAS 2 12, 13 G12D, G12S, G13R, G12C, G12V, G12A, G13V, 24 (2.2)   NRAS 3 61 Q61R, Q61K, Q61L, Q61H 19 (1.7)   NRAS 4 146 <m>A146T</m> 0 (0)   BRAF 15 600 V600E, V600K, V600R, V600D 34 (3.1)   PIK3CA 20 1047 H1047R, H1047L 39 (3.5)   "}], "citations": {"NLM": "Zhang J, Zheng J, Yang Y, Lu J, Gao J, Lu T, Sun J, Jiang H, Zhu Y, Zheng Y, Liang Z, Liu T. Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases. Sci Rep. PMID: 26691448", "BibTeX": "@article{26691448, title={Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases.}, author={Zhang J and Zheng J and Yang Y and Lu J and Gao J and Lu T and Sun J and Jiang H and Zhu Y and Zheng Y and Liang Z and Liu T}, journal={Sci Rep}}"}, "is_sup_mat_match": false}, {"pmid": 37326340, "pmcid": "PMC10281467", "title": "Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancer", "journal": "Cancer Biol Ther", "authors": ["Lee CL", "Cremona M", "Farrelly A", "Workman JA", "Kennedy S", "Aslam R", "Carr A", "Madden S", "O'Neill B", "Hennessy BT", "Toomey S"], "date": "2023-12-31T00:00:00Z", "year": 2023, "snippets": [{"_id": "37326340@6803", "snip_text": "Cell Line\tMutational Status\tIC50Palbociclib\tIC50PD0325901\tIC50Gedatolisib\tPalbociclib + PD0325901Doses\tPalbociclib + GedatolisibDoses\t \tCaco-2(ATCC HTB-37)\tWild-Type\t>15 microM\t4.0 microM\t1200 nM\t5 microM +5 microM\t5 microM +1 microM\t \tDLD-1(ATCC CCL-221)\tKRAS G13DPIK3CA E545K\t>15 microM\t13 microM\t183 nM\t2 microM +5 microM\t2 microM +200 nM\t \tLS411N(ATCC CRL-2159)\tBRAF V600E\t0.8 microM\t0.001 microM\t76 nM\t2 microM +5 microM\t2 microM +200 nM\t \tLS1034(ATCC CRL-2158)\tKRAS A146T\t>15 microM\t0.013 microM\t7200 nM\t3 microM +500 nM\t3 microM +400 nM\t \tSNUC4(KCLB 0000C4)\tPIK3CA E545G\t1.7 microM\t0.014 microM\t400 nM\t3 microM +25 nM\t3 microM +400 nM\t \t", "section": "table", "mentions": ["371|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "366|4|gene|ncbi_gene@673|BRAF", "256|4|gene|ncbi_gene@3845|KRAS", "565|6|gene|ncbi_gene@5290|PIK3CA", "472|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "572|5|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123336#rs121913274##|E545G", "272|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "467|4|gene|ncbi_gene@3845|KRAS"], "figure_id": "t0001", "text_hl": "Cell Line\tMutational Status\tIC50Palbociclib\tIC50PD0325901\tIC50Gedatolisib\tPalbociclib + PD0325901Doses\tPalbociclib + GedatolisibDoses\t \tCaco-2(ATCC HTB-37)\tWild-Type\t>15 microM\t4.0 microM\t1200 nM\t5 microM +5 microM\t5 microM +1 microM\t \tDLD-1(ATCC CCL-221)\tKRAS G13DPIK3CA E545K\t>15 microM\t13 microM\t183 nM\t2 microM +5 microM\t2 microM +200 nM\t \tLS411N(ATCC CRL-2159)\tBRAF V600E\t0.8 microM\t0.001 microM\t76 nM\t2 microM +5 microM\t2 microM +200 nM\t \tLS1034(ATCC CRL-2158)\tKRAS <m>A146T</m>\t>15 microM\t0.013 microM\t7200 nM\t3 microM +500 nM\t3 microM +400 nM\t \tSNUC4(KCLB 0000C4)\tPIK3CA E545G\t1.7 microM\t0.014 microM\t400 nM\t3 microM +25 nM\t3 microM +400 nM\t \t"}], "citations": {"NLM": "Lee CL, Cremona M, Farrelly A, Workman JA, Kennedy S, Aslam R, Carr A, Madden S, O'Neill B, Hennessy BT, Toomey S. Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancer Cancer Biol Ther. PMID: 37326340", "BibTeX": "@article{37326340, title={Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancer}, author={Lee CL and Cremona M and Farrelly A and Workman JA and Kennedy S and Aslam R and Carr A and Madden S and O'Neill B and Hennessy BT and Toomey S}, journal={Cancer Biol Ther}}"}, "is_sup_mat_match": false}, {"pmid": 34976316, "pmcid": "PMC8688876", "title": "Enhanced interpretation of 935 hotspot and non-hotspot RAS variants using evidence-based structural bioinformatics.", "journal": "Comput Struct Biotechnol J", "authors": ["Tripathi S", "Dsouza NR", "Mathison AJ", "Leverence E", "Urrutia R", "Zimmermann MT"], "date": "2021-12-11T00:00:00Z", "year": 2021, "snippets": [{"_id": "34976316@16725", "snip_text": "C4 identifies similarities among A146T/V and G13V/D but differences among non-hotspot variants A146T/V and hotspot variants G12A/R/S as well as Q61L/P/H.", "section": "results", "mentions": ["45|6|variant|litvar@rs112445441##&&&litvar@#3845#|G13V/D", "33|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "124|8|variant|litvar@rs121913529##&&&litvar@#3845#|G12A/R/S", "144|6|variant|litvar@rs121913240##&&&litvar@#3845#|Q61L/P", "95|7|variant|litvar@rs121913527##&&&litvar@#3845#|A146T/V"], "text_hl": "C4 identifies similarities among <m>A146T</m>/V and G13V/D but differences among non-hotspot variants <m>A146T</m>/V and hotspot variants G12A/R/S as well as Q61L/P/H."}], "citations": {"NLM": "Tripathi S, Dsouza NR, Mathison AJ, Leverence E, Urrutia R, Zimmermann MT. Enhanced interpretation of 935 hotspot and non-hotspot RAS variants using evidence-based structural bioinformatics. Comput Struct Biotechnol J. PMID: 34976316", "BibTeX": "@article{34976316, title={Enhanced interpretation of 935 hotspot and non-hotspot RAS variants using evidence-based structural bioinformatics.}, author={Tripathi S and Dsouza NR and Mathison AJ and Leverence E and Urrutia R and Zimmermann MT}, journal={Comput Struct Biotechnol J}}"}, "is_sup_mat_match": false}, {"pmid": 34248561, "pmcid": "PMC8255711", "title": "Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer.", "journal": "Case Rep Oncol", "authors": ["Gorshein E", "Matsuda K", "Riedlinger G", "Sokol L", "Rodriguez-Rodriguez L", "Eladoumikdachi F", "Grandhi M", "Ganesan S", "Toppmeyer DL", "Potdevin L", "Toomey K", "Hirshfield KM", "Chan N"], "date": "2021-06-18T00:00:00Z", "year": 2021, "snippets": [{"_id": "34248561@5560", "snip_text": "This revealed the presence of the following genomic alterations: AKT1 E17K; KRAS A146T; NUP93 E14K; and TP53 loss, R213.", "section": "other", "mentions": ["104|4|gene|ncbi_gene@7157|TP53", "88|5|gene|ncbi_gene@9688|NUP93", "94|4|variant|litvar@rs528073782##&&&litvar@#9688#&&&litvar@CA281482204#rs528073782##|E14K", "81|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "76|4|gene|ncbi_gene@3845|KRAS", "65|9|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|AKT1 E17K"], "text_hl": "This revealed the presence of the following genomic alterations: AKT1 E17K; KRAS <m>A146T</m>; NUP93 E14K; and TP53 loss, R213."}], "citations": {"NLM": "Gorshein E, Matsuda K, Riedlinger G, Sokol L, Rodriguez-Rodriguez L, Eladoumikdachi F, Grandhi M, Ganesan S, Toppmeyer DL, Potdevin L, Toomey K, Hirshfield KM, Chan N. Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer. Case Rep Oncol. PMID: 34248561", "BibTeX": "@article{34248561, title={Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer.}, author={Gorshein E and Matsuda K and Riedlinger G and Sokol L and Rodriguez-Rodriguez L and Eladoumikdachi F and Grandhi M and Ganesan S and Toppmeyer DL and Potdevin L and Toomey K and Hirshfield KM and Chan N}, journal={Case Rep Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 35046094, "pmcid": "PMC8983508", "title": "A Structure is Worth a Thousand Words: New Insights for RAS and RAF Regulation.", "journal": "Cancer Discov", "authors": ["Simanshu DK", "Morrison DK"], "date": "2022-04-01T00:00:00Z", "year": 2022, "snippets": [{"_id": "35046094@12965", "snip_text": "The A146T mutation is the fourth most common KRAS alteration (Fig. 1), and it is frequently observed in colorectal and hematopoietic cancers.", "section": "other", "mentions": ["4|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "45|4|gene|ncbi_gene@3845|KRAS", "104|36|disease|ncbi_mesh@D015179|colorectal and hematopoietic cancers"], "text_hl": "The <m>A146T</m> mutation is the fourth most common KRAS alteration (Fig. 1), and it is frequently observed in colorectal and hematopoietic cancers."}], "citations": {"NLM": "Simanshu DK, Morrison DK. A Structure is Worth a Thousand Words: New Insights for RAS and RAF Regulation. Cancer Discov. PMID: 35046094", "BibTeX": "@article{35046094, title={A Structure is Worth a Thousand Words: New Insights for RAS and RAF Regulation.}, author={Simanshu DK and Morrison DK}, journal={Cancer Discov}}"}, "is_sup_mat_match": false}, {"pmid": 29666387, "pmcid": "PMC5904111", "title": "Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients.", "journal": "Sci Rep", "authors": ["Guo F", "Gong H", "Zhao H", "Chen J", "Zhang Y", "Zhang L", "Shi X", "Zhang A", "Jin H", "Zhang J", "He Y"], "date": "2018-04-17T00:00:00Z", "year": 2018, "snippets": [{"_id": "29666387@16263", "snip_text": "In exon 4, the most common mutation was 436G>A (A146T), followed by 351A>T (K117N), 437C>T (A146V), 350A>G (K117R), 436G>C (A146P) and 441G>T (K147N).", "section": "results", "mentions": ["92|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "76|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "40|6|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|436G>A", "48|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "100|6|variant|litvar@rs758945260##&&&litvar@#1956#&&&litvar@CA4265234#rs758945260##|350A>G", "108|5|variant|litvar@rs104894227##&&&litvar@#3265#&&&litvar@CA256490#rs104894227##|K117R", "84|6|variant|litvar@rs1057519725##&&&litvar@#3845#|437C>T", "135|6|variant|litvar@#673#c.441G>T&&&litvar@#673#|441G>T", "68|6|variant|litvar@rs770248150##&&&litvar@#3845#|351A>T", "116|6|variant|litvar@rs121913527##&&&litvar@#3845#|436G>C", "124|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "143|5|variant|litvar@#673#p.K147N&&&litvar@#673#|K147N"], "text_hl": "In exon 4, the most common mutation was 436G>A (<m>A146T</m>), followed by 351A>T (K117N), 437C>T (A146V), 350A>G (K117R), 436G>C (A146P) and 441G>T (K147N)."}], "citations": {"NLM": "Guo F, Gong H, Zhao H, Chen J, Zhang Y, Zhang L, Shi X, Zhang A, Jin H, Zhang J, He Y. Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients. Sci Rep. PMID: 29666387", "BibTeX": "@article{29666387, title={Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients.}, author={Guo F and Gong H and Zhao H and Chen J and Zhang Y and Zhang L and Shi X and Zhang A and Jin H and Zhang J and He Y}, journal={Sci Rep}}"}, "is_sup_mat_match": false}, {"pmid": 31876604, "pmcid": "PMC9281533", "title": "Analysis of Intestinal Metaplasia Without Dysplasia in the Urinary Bladder Reveal Only Rare Mutations Associated With Colorectal Adenocarcinoma", "journal": "Appl Immunohistochem Mol Morphol", "authors": ["Amin A", "Murati-Amador B", "Lombardo KA", "Jackson CL", "Grada Z", "Palsgrove DN", "Matoso A"], "date": "2020-11-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "31876604@8120", "snip_text": "Most common KRAS mutations were at p.G12D (3 cases, 50%), with the rest of the cases showing mutation in p.G12S, p.G13D, and p.A146T (1 case each).", "section": "results", "mentions": ["125|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "113|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "35|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "105|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "12|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "Most common KRAS mutations were at p.G12D (3 cases, 50%), with the rest of the cases showing mutation in p.G12S, p.G13D, and <m>p.A146T</m> (1 case each)."}], "citations": {"NLM": "Amin A, Murati-Amador B, Lombardo KA, Jackson CL, Grada Z, Palsgrove DN, Matoso A. Analysis of Intestinal Metaplasia Without Dysplasia in the Urinary Bladder Reveal Only Rare Mutations Associated With Colorectal Adenocarcinoma Appl Immunohistochem Mol Morphol. PMID: 31876604", "BibTeX": "@article{31876604, title={Analysis of Intestinal Metaplasia Without Dysplasia in the Urinary Bladder Reveal Only Rare Mutations Associated With Colorectal Adenocarcinoma}, author={Amin A and Murati-Amador B and Lombardo KA and Jackson CL and Grada Z and Palsgrove DN and Matoso A}, journal={Appl Immunohistochem Mol Morphol}}"}, "is_sup_mat_match": false}, {"pmid": 26819545, "pmcid": "PMC4721683", "title": "Correlation between Gene Variants, Signaling Pathways, and Efficacy of Chemotherapy Drugs against Colon Cancers", "journal": "Cancer Inform", "authors": ["Tripathi S", "Belkacemi L", "Cheung MS", "Bose RN"], "date": "2016-01-20T00:00:00Z", "year": 2016, "snippets": [{"_id": "26819545@13436", "snip_text": "Moreover, neither oxaliplatin nor 5-FU activity is correlated with the variant A146T of KRAS from HCC_2998 (indicated by X in Tables 1 and 2).", "section": "results", "mentions": ["18|11|chemical|ncbi_mesh@D000077150|oxaliplatin", "88|4|gene|ncbi_gene@3845|KRAS", "34|4|chemical|ncbi_mesh@D005472|5-FU", "79|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Moreover, neither oxaliplatin nor 5-FU activity is correlated with the variant <m>A146T</m> of KRAS from HCC_2998 (indicated by X in Tables 1 and 2)."}], "citations": {"NLM": "Tripathi S, Belkacemi L, Cheung MS, Bose RN. Correlation between Gene Variants, Signaling Pathways, and Efficacy of Chemotherapy Drugs against Colon Cancers Cancer Inform. PMID: 26819545", "BibTeX": "@article{26819545, title={Correlation between Gene Variants, Signaling Pathways, and Efficacy of Chemotherapy Drugs against Colon Cancers}, author={Tripathi S and Belkacemi L and Cheung MS and Bose RN}, journal={Cancer Inform}}"}, "is_sup_mat_match": false}, {"pmid": 23263490, "pmcid": "PMC3785128", "title": "Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas", "journal": "Nat Genet", "authors": ["Palles C", "Cazier JB", "Howarth KM", "Domingo E", "Jones AM", "Broderick P", "Kemp Z", "Spain SL", "Guarino E", "Salguero I", "Sherborne A", "Chubb D", "Carvajal-Carmona LG", "Ma Y", "Kaur K", "Dobbins S", "Barclay E", "Gorman M", "Martin L", "Kovac MB", "Humphray S", "CORGI Consortium.", "WGS500 Consortium.", "Lucassen A", "Holmes CC", "Bentley D", "Donnelly P", "Taylor J", "Petridis C", "Roylance R", "Sawyer EJ", "Kerr DJ", "Clark S", "Grimes J", "Kearsey SE", "Thomas HJ", "McVean G", "Houlston RS", "Tomlinson I"], "date": "2013-02-01T00:00:00Z", "year": 2013, "snippets": [{"_id": "23263490@47456", "snip_text": "Family\tPatient\tSomatic mutations\t \t2702\t1\tAPC Q1338X (C>T); FBXW7 R465C (C>T)\t \t2702\t2\tNone found\t \t2702\t3\tAPC R1114X (C>T), Q1338X (C>T); KRAS G12D (G>A), A146T (A>C)\t \tA\t1\tNone found\t \tI\t1\tAPC Q1338X (C>T); KRAS A146T (A>C); FBXW7 R479Q (G>A)\t \tI\t2\tAPC Q1338X (C>T); KRAS G12D (G>A) x 3\t \tF\t1\tNone found\t \tK\t1\tAPC R1114X (C>T)\t \tC\t1\tNone found\t \tH\t1\tNone found\t \t", "section": "table", "mentions": ["203|3|variant|litvar@#3845#|C>T", "42|3|gene|ncbi_gene@324|APC", "240|3|variant|litvar@#673#|G>A", "107|3|gene|ncbi_gene@324|APC", "125|6|variant|litvar@rs121913327##&&&litvar@#324#&&&litvar@CA8865#rs121913327##|Q1338X", "60|5|gene|ncbi_gene@55294|FBXW7", "269|4|gene|ncbi_gene@3845|KRAS", "156|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "263|3|variant|litvar@#3845#|C>T", "274|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "195|6|variant|litvar@rs121913327##&&&litvar@#324#&&&litvar@CA8865#rs121913327##|Q1338X", "324|3|variant|litvar@#3845#|C>T", "163|3|variant|litvar@#55294#|A>C", "150|3|variant|litvar@#673#|G>A", "255|6|variant|litvar@rs121913327##&&&litvar@#324#&&&litvar@CA8865#rs121913327##|Q1338X", "191|3|gene|ncbi_gene@324|APC", "251|3|gene|ncbi_gene@324|APC", "227|5|gene|ncbi_gene@55294|FBXW7", "66|5|variant|litvar@rs867384286##&&&litvar@#55294#&&&litvar@CA16602851#rs867384286##|R465C", "316|6|variant|litvar@rs121913331##&&&litvar@#324#&&&litvar@CA10582306#rs121913331##|R1114X", "54|3|variant|litvar@#3845#|C>T", "119|3|variant|litvar@#3845#|C>T", "214|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "73|3|variant|litvar@#3845#|C>T", "139|4|gene|ncbi_gene@3845|KRAS", "133|3|variant|litvar@#3845#|C>T", "312|3|gene|ncbi_gene@324|APC", "46|6|variant|litvar@rs121913327##&&&litvar@#324#&&&litvar@CA8865#rs121913327##|Q1338X", "144|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "280|3|variant|litvar@#673#|G>A", "233|5|variant|litvar@rs866987936##&&&litvar@#55294#&&&litvar@CA16602856#rs866987936##|R479Q", "221|3|variant|litvar@#55294#|A>C", "111|6|variant|litvar@rs121913331##&&&litvar@#324#&&&litvar@CA10582306#rs121913331##|R1114X", "209|4|gene|ncbi_gene@3845|KRAS"], "figure_id": "T1", "text_hl": "Family\tPatient\tSomatic mutations\t \t2702\t1\tAPC Q1338X (C>T); FBXW7 R465C (C>T)\t \t2702\t2\tNone found\t \t2702\t3\tAPC R1114X (C>T), Q1338X (C>T); KRAS G12D (G>A), <m>A146T</m> (A>C)\t \tA\t1\tNone found\t \tI\t1\tAPC Q1338X (C>T); KRAS <m>A146T</m> (A>C); FBXW7 R479Q (G>A)\t \tI\t2\tAPC Q1338X (C>T); KRAS G12D (G>A) x 3\t \tF\t1\tNone found\t \tK\t1\tAPC R1114X (C>T)\t \tC\t1\tNone found\t \tH\t1\tNone found\t \t"}], "citations": {"NLM": "Palles C, Cazier JB, Howarth KM, Domingo E, Jones AM, Broderick P, Kemp Z, Spain SL, Guarino E, Salguero I, Sherborne A, Chubb D, Carvajal-Carmona LG, Ma Y, Kaur K, Dobbins S, Barclay E, Gorman M, Martin L, Kovac MB, Humphray S, CORGI Consortium., WGS500 Consortium., Lucassen A, Holmes CC, Bentley D, Donnelly P, Taylor J, Petridis C, Roylance R, Sawyer EJ, Kerr DJ, Clark S, Grimes J, Kearsey SE, Thomas HJ, McVean G, Houlston RS, Tomlinson I. Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas Nat Genet. PMID: 23263490", "BibTeX": "@article{23263490, title={Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas}, author={Palles C and Cazier JB and Howarth KM and Domingo E and Jones AM and Broderick P and Kemp Z and Spain SL and Guarino E and Salguero I and Sherborne A and Chubb D and Carvajal-Carmona LG and Ma Y and Kaur K and Dobbins S and Barclay E and Gorman M and Martin L and Kovac MB and Humphray S and CORGI Consortium. and WGS500 Consortium. and Lucassen A and Holmes CC and Bentley D and Donnelly P and Taylor J and Petridis C and Roylance R and Sawyer EJ and Kerr DJ and Clark S and Grimes J and Kearsey SE and Thomas HJ and McVean G and Houlston RS and Tomlinson I}, journal={Nat Genet}}"}, "is_sup_mat_match": false}, {"pmid": 27302369, "pmcid": "PMC4912618", "title": "A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC.", "journal": "Nat Commun", "authors": ["Schell MJ", "Yang M", "Teer JK", "Lo FY", "Madan A", "Coppola D", "Monteiro AN", "Nebozhyn MV", "Yue B", "Loboda A", "Bien-Willner GA", "Greenawalt DM", "Yeatman TJ"], "date": "2016-06-15T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Schell MJ, Yang M, Teer JK, Lo FY, Madan A, Coppola D, Monteiro AN, Nebozhyn MV, Yue B, Loboda A, Bien-Willner GA, Greenawalt DM, Yeatman TJ. A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC. Nat Commun. PMID: 27302369", "BibTeX": "@article{27302369, title={A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC.}, author={Schell MJ and Yang M and Teer JK and Lo FY and Madan A and Coppola D and Monteiro AN and Nebozhyn MV and Yue B and Loboda A and Bien-Willner GA and Greenawalt DM and Yeatman TJ}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 29896883, "pmcid": "PMC6068346", "title": "Macrophage migration inhibitory factor promotes resistance to MEK blockade in KRAS mutant colorectal cancer cells.", "journal": "Mol Oncol", "authors": ["Cheon SK", "Kim HP", "Park YL", "Jang JE", "Lim Y", "Song SH", "Han SW", "Kim TY"], "date": "2018-08-01T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Cheon SK, Kim HP, Park YL, Jang JE, Lim Y, Song SH, Han SW, Kim TY. Macrophage migration inhibitory factor promotes resistance to MEK blockade in KRAS mutant colorectal cancer cells. Mol Oncol. PMID: 29896883", "BibTeX": "@article{29896883, title={Macrophage migration inhibitory factor promotes resistance to MEK blockade in KRAS mutant colorectal cancer cells.}, author={Cheon SK and Kim HP and Park YL and Jang JE and Lim Y and Song SH and Han SW and Kim TY}, journal={Mol Oncol}}"}, "is_sup_mat_match": true}, {"pmid": 31775766, "pmcid": "PMC6882202", "title": "Identification and ranking of recurrent neo-epitopes in cancer.", "journal": "BMC Med Genomics", "authors": ["Blanc E", "Holtgrewe M", "Dhamodaran A", "Messerschmidt C", "Willimsky G", "Blankenstein T", "Beule D"], "date": "2019-11-27T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Blanc E, Holtgrewe M, Dhamodaran A, Messerschmidt C, Willimsky G, Blankenstein T, Beule D. Identification and ranking of recurrent neo-epitopes in cancer. BMC Med Genomics. PMID: 31775766", "BibTeX": "@article{31775766, title={Identification and ranking of recurrent neo-epitopes in cancer.}, author={Blanc E and Holtgrewe M and Dhamodaran A and Messerschmidt C and Willimsky G and Blankenstein T and Beule D}, journal={BMC Med Genomics}}"}, "is_sup_mat_match": true}, {"pmid": 26460303, "pmcid": "PMC4669589", "title": "Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer", "journal": "J Clin Oncol", "authors": ["Kopetz S", "Desai J", "Chan E", "Hecht JR", "O'Dwyer PJ", "Maru D", "Morris V", "Janku F", "Dasari A", "Chung W", "Issa JP", "Gibbs P", "James B", "Powis G", "Nolop KB", "Bhattacharya S", "Saltz L"], "date": "2015-12-01T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Kopetz S, Desai J, Chan E, Hecht JR, O'Dwyer PJ, Maru D, Morris V, Janku F, Dasari A, Chung W, Issa JP, Gibbs P, James B, Powis G, Nolop KB, Bhattacharya S, Saltz L. Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer J Clin Oncol. PMID: 26460303", "BibTeX": "@article{26460303, title={Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer}, author={Kopetz S and Desai J and Chan E and Hecht JR and O'Dwyer PJ and Maru D and Morris V and Janku F and Dasari A and Chung W and Issa JP and Gibbs P and James B and Powis G and Nolop KB and Bhattacharya S and Saltz L}, journal={J Clin Oncol}}"}, "is_sup_mat_match": true}, {"pmid": 32012149, "pmcid": "PMC7018097", "title": "Mutational processes of distinct POLE exonuclease domain mutants drive an enrichment of a specific TP53 mutation in colorectal cancer", "journal": "PLoS Genet", "authors": ["Fang H", "Barbour JA", "Poulos RC", "Katainen R", "Aaltonen LA", "Wong JWH"], "date": "2020-02-03T00:00:00Z", "year": 2020, "snippets": [], "citations": {"NLM": "Fang H, Barbour JA, Poulos RC, Katainen R, Aaltonen LA, Wong JWH. Mutational processes of distinct POLE exonuclease domain mutants drive an enrichment of a specific TP53 mutation in colorectal cancer PLoS Genet. PMID: 32012149", "BibTeX": "@article{32012149, title={Mutational processes of distinct POLE exonuclease domain mutants drive an enrichment of a specific TP53 mutation in colorectal cancer}, author={Fang H and Barbour JA and Poulos RC and Katainen R and Aaltonen LA and Wong JWH}, journal={PLoS Genet}}"}, "is_sup_mat_match": true}, {"pmid": 29899868, "pmcid": "PMC5995178", "title": "Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling.", "journal": "Oncotarget", "authors": ["Tarlock K", "Zhong S", "He Y", "Ries R", "Severson E", "Bailey M", "Morley S", "Balasubramanian S", "Erlich R", "Lipson D", "Otto GA", "Vergillo JA", "Kolb EA", "Ross JS", "Mughal T", "Stephens PJ", "Miller V", "Meshinchi S", "He J"], "date": "2018-05-29T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Tarlock K, Zhong S, He Y, Ries R, Severson E, Bailey M, Morley S, Balasubramanian S, Erlich R, Lipson D, Otto GA, Vergillo JA, Kolb EA, Ross JS, Mughal T, Stephens PJ, Miller V, Meshinchi S, He J. Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling. Oncotarget. PMID: 29899868", "BibTeX": "@article{29899868, title={Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling.}, author={Tarlock K and Zhong S and He Y and Ries R and Severson E and Bailey M and Morley S and Balasubramanian S and Erlich R and Lipson D and Otto GA and Vergillo JA and Kolb EA and Ross JS and Mughal T and Stephens PJ and Miller V and Meshinchi S and He J}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 29674704, "pmcid": "PMC5908790", "title": "MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancers.", "journal": "Oncogenesis", "authors": ["Wyce A", "Matteo JJ", "Foley SW", "Felitsky DJ", "Rajapurkar SR", "Zhang XP", "Musso MC", "Korenchuk S", "Karpinich NO", "Keenan KM", "Stern M", "Mathew LK", "McHugh CF", "McCabe MT", "Tummino PJ", "Kruger RG", "Carpenter C", "Barbash O"], "date": "2018-04-20T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Wyce A, Matteo JJ, Foley SW, Felitsky DJ, Rajapurkar SR, Zhang XP, Musso MC, Korenchuk S, Karpinich NO, Keenan KM, Stern M, Mathew LK, McHugh CF, McCabe MT, Tummino PJ, Kruger RG, Carpenter C, Barbash O. MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancers. Oncogenesis. PMID: 29674704", "BibTeX": "@article{29674704, title={MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancers.}, author={Wyce A and Matteo JJ and Foley SW and Felitsky DJ and Rajapurkar SR and Zhang XP and Musso MC and Korenchuk S and Karpinich NO and Keenan KM and Stern M and Mathew LK and McHugh CF and McCabe MT and Tummino PJ and Kruger RG and Carpenter C and Barbash O}, journal={Oncogenesis}}"}, "is_sup_mat_match": true}, {"pmid": 29515765, "pmcid": "PMC5839396", "title": "Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.", "journal": "Oncotarget", "authors": ["Montalban-Bravo G", "Takahashi K", "Patel K", "Wang F", "Xingzhi S", "Nogueras GM", "Huang X", "Pierola AA", "Jabbour E", "Colla S", "Ga\u00f1an-Gomez I", "Borthakur G", "Daver N", "Estrov Z", "Kadia T", "Pemmaraju N", "Ravandi F", "Bueso-Ramos C", "Chamseddine A", "Konopleva M", "Zhang J", "Kantarjian H", "Futreal A", "Garcia-Manero G"], "date": "2018-01-03T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Montalban-Bravo G, Takahashi K, Patel K, Wang F, Xingzhi S, Nogueras GM, Huang X, Pierola AA, Jabbour E, Colla S, Ga\u00f1an-Gomez I, Borthakur G, Daver N, Estrov Z, Kadia T, Pemmaraju N, Ravandi F, Bueso-Ramos C, Chamseddine A, Konopleva M, Zhang J, Kantarjian H, Futreal A, Garcia-Manero G. Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. Oncotarget. PMID: 29515765", "BibTeX": "@article{29515765, title={Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.}, author={Montalban-Bravo G and Takahashi K and Patel K and Wang F and Xingzhi S and Nogueras GM and Huang X and Pierola AA and Jabbour E and Colla S and Ga\u00f1an-Gomez I and Borthakur G and Daver N and Estrov Z and Kadia T and Pemmaraju N and Ravandi F and Bueso-Ramos C and Chamseddine A and Konopleva M and Zhang J and Kantarjian H and Futreal A and Garcia-Manero G}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 27149842, "pmcid": "PMC4850357", "title": "Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma.", "journal": "Cell Rep", "authors": ["Giannakis M", "Mu XJ", "Shukla SA", "Qian ZR", "Cohen O", "Nishihara R", "Bahl S", "Cao Y", "Amin-Mansour A", "Yamauchi M", "Sukawa Y", "Stewart C", "Rosenberg M", "Mima K", "Inamura K", "Nosho K", "Nowak JA", "Lawrence MS", "Giovannucci EL", "Chan AT", "Ng K", "Meyerhardt JA", "Van Allen EM", "Getz G", "Gabriel SB", "Lander ES", "Wu CJ", "Fuchs CS", "Ogino S", "Garraway LA"], "date": "2016-04-26T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Giannakis M, Mu XJ, Shukla SA, Qian ZR, Cohen O, Nishihara R, Bahl S, Cao Y, Amin-Mansour A, Yamauchi M, Sukawa Y, Stewart C, Rosenberg M, Mima K, Inamura K, Nosho K, Nowak JA, Lawrence MS, Giovannucci EL, Chan AT, Ng K, Meyerhardt JA, Van Allen EM, Getz G, Gabriel SB, Lander ES, Wu CJ, Fuchs CS, Ogino S, Garraway LA. Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma. Cell Rep. PMID: 27149842", "BibTeX": "@article{27149842, title={Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma.}, author={Giannakis M and Mu XJ and Shukla SA and Qian ZR and Cohen O and Nishihara R and Bahl S and Cao Y and Amin-Mansour A and Yamauchi M and Sukawa Y and Stewart C and Rosenberg M and Mima K and Inamura K and Nosho K and Nowak JA and Lawrence MS and Giovannucci EL and Chan AT and Ng K and Meyerhardt JA and Van Allen EM and Getz G and Gabriel SB and Lander ES and Wu CJ and Fuchs CS and Ogino S and Garraway LA}, journal={Cell Rep}}"}, "is_sup_mat_match": true}, {"pmid": 29895949, "pmcid": "PMC5997733", "title": "Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies.", "journal": "Nat Commun", "authors": ["Russo M", "Lamba S", "Lorenzato A", "Sogari A", "Corti G", "Rospo G", "Mussolin B", "Montone M", "Lazzari L", "Arena S", "Oddo D", "Linnebacher M", "Sartore-Bianchi A", "Pietrantonio F", "Siena S", "Di Nicolantonio F", "Bardelli A"], "date": "2018-06-12T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Russo M, Lamba S, Lorenzato A, Sogari A, Corti G, Rospo G, Mussolin B, Montone M, Lazzari L, Arena S, Oddo D, Linnebacher M, Sartore-Bianchi A, Pietrantonio F, Siena S, Di Nicolantonio F, Bardelli A. Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies. Nat Commun. PMID: 29895949", "BibTeX": "@article{29895949, title={Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies.}, author={Russo M and Lamba S and Lorenzato A and Sogari A and Corti G and Rospo G and Mussolin B and Montone M and Lazzari L and Arena S and Oddo D and Linnebacher M and Sartore-Bianchi A and Pietrantonio F and Siena S and Di Nicolantonio F and Bardelli A}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 29707525, "pmcid": "PMC5863340", "title": "RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients.", "journal": "Can J Gastroenterol Hepatol", "authors": ["Yao J", "Zang W", "Ge Y", "Weygant N", "Yu P", "Li L", "Rao G", "Jiang Z", "Yan R", "He L", "Yu Y", "Jin M", "Cheng G", "An G"], "date": "2018-03-07T00:00:00Z", "year": 2018, "snippets": [{"_id": "29707525@27993", "snip_text": " Gene  Mutation Tissue Plasma   Synchronous group Metachronous group Total Synchronous group Metachronous group Total   KRAS G12A, G12C, G12D, G12V, G13D, G13S 26.32%(5/19) 45.24%(19/42) 39.34%(24/61) 35.42%(17/48) 14.29%(4/28) 27.63%(21/76)   KRAS Q61H, Q61K 5.26%(1/19) 0%(0/42) 1.64%(1/61) 0%(0/48) 10.71%(3/28) 3.95%(3/76)   KRAS A146T 0%(0/19) 0%(0/42) 0%(0/61) 0%(0/48) 3.57%(1/28) 1.32%(1/76)   NRAS G12V, G12D 5.88%(1/17) 0%(0/39) 1.79%(1/56) 2.08%(1/48) 0%(0/28) 1.32%(1/76)   NRAS Q61R, Q61K 0%(0/17) 7.69%(3/39) 5.36%(3/56) 2.08%(1/48) 0%(0/28) 1.32%(1/76)   BRAF Y472F, P403fs 0%(0/18) 0%(0/40) 0%(0/58) 2.08%(1/48) 3.57%(1/28) 2.63%(2/76)   HRAS G12D / / / 2.08%(1/48) 0%(0/28) 1.32%(1/76)   HRAS P167fs / / / 2.08%(1/48) 3.57%(1/28) 2.63%(2/76)   ", "section": "table", "mentions": ["402|4|gene|ncbi_gene@4893|NRAS", "659|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "244|4|gene|ncbi_gene@3845|KRAS", "710|6|variant|litvar@#3265#p.P167fsX&&&litvar@#3265#|P167fs", "149|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "705|4|gene|ncbi_gene@3265|HRAS", "407|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "255|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "582|6|variant|litvar@#673#p.P403fsX&&&litvar@#673#|P403fs", "120|4|gene|ncbi_gene@3845|KRAS", "329|4|gene|ncbi_gene@3845|KRAS", "249|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "570|4|gene|ncbi_gene@673|BRAF", "155|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA16602445#rs121913535##|G13S", "486|4|gene|ncbi_gene@4893|NRAS", "125|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "497|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "137|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "491|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "654|4|gene|ncbi_gene@3265|HRAS", "575|5|variant|litvar@#673#p.Y472F&&&litvar@#673#|Y472F", "131|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "413|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "334|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "143|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V"], "figure_id": "tab2", "text_hl": " Gene  Mutation Tissue Plasma   Synchronous group Metachronous group Total Synchronous group Metachronous group Total   KRAS G12A, G12C, G12D, G12V, G13D, G13S 26.32%(5/19) 45.24%(19/42) 39.34%(24/61) 35.42%(17/48) 14.29%(4/28) 27.63%(21/76)   KRAS Q61H, Q61K 5.26%(1/19) 0%(0/42) 1.64%(1/61) 0%(0/48) 10.71%(3/28) 3.95%(3/76)   KRAS <m>A146T</m> 0%(0/19) 0%(0/42) 0%(0/61) 0%(0/48) 3.57%(1/28) 1.32%(1/76)   NRAS G12V, G12D 5.88%(1/17) 0%(0/39) 1.79%(1/56) 2.08%(1/48) 0%(0/28) 1.32%(1/76)   NRAS Q61R, Q61K 0%(0/17) 7.69%(3/39) 5.36%(3/56) 2.08%(1/48) 0%(0/28) 1.32%(1/76)   BRAF Y472F, P403fs 0%(0/18) 0%(0/40) 0%(0/58) 2.08%(1/48) 3.57%(1/28) 2.63%(2/76)   HRAS G12D / / / 2.08%(1/48) 0%(0/28) 1.32%(1/76)   HRAS P167fs / / / 2.08%(1/48) 3.57%(1/28) 2.63%(2/76)   "}], "citations": {"NLM": "Yao J, Zang W, Ge Y, Weygant N, Yu P, Li L, Rao G, Jiang Z, Yan R, He L, Yu Y, Jin M, Cheng G, An G. RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients. Can J Gastroenterol Hepatol. PMID: 29707525", "BibTeX": "@article{29707525, title={RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients.}, author={Yao J and Zang W and Ge Y and Weygant N and Yu P and Li L and Rao G and Jiang Z and Yan R and He L and Yu Y and Jin M and Cheng G and An G}, journal={Can J Gastroenterol Hepatol}}"}, "is_sup_mat_match": false}, {"pmid": 33147938, "pmcid": "PMC8634184", "title": "Multiclonal complexity of pediatric acute lymphoblastic leukemia and the prognostic relevance of subclonal mutations", "journal": "Haematologica", "authors": ["Anti\u0107 \u017d", "Yu J", "Van Reijmersdal SV", "Van Dijk A", "Dekker L", "Segerink WH", "Sonneveld E", "Fiocco M", "Pieters R", "Hoogerbrugge PM", "Van Leeuwen FN", "Van Kessel AG", "Waanders E", "Kuiper RP"], "date": "2020-11-05T00:00:00Z", "year": 2020, "snippets": [{"_id": "33147938@14720", "snip_text": "This finding indicates that some RAS hotspot mutations (e.g.  KRAS G12D, G13D, A146T) may result in a stronger expansion potential compared to others (e.g.  KRAS A146V, NRAS G12D, G13D), and further illustrates the complex heterogeneity of RAS hotspot mutations in their potential to drive clonal expansion.", "section": "results", "mentions": ["174|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "62|4|gene|ncbi_gene@3845|KRAS", "73|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "180|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "157|4|gene|ncbi_gene@3845|KRAS", "162|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "79|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "169|4|gene|ncbi_gene@4893|NRAS", "67|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D"], "text_hl": "This finding indicates that some RAS hotspot mutations (e.g.  KRAS G12D, G13D, <m>A146T</m>) may result in a stronger expansion potential compared to others (e.g.  KRAS A146V, NRAS G12D, G13D), and further illustrates the complex heterogeneity of RAS hotspot mutations in their potential to drive clonal expansion."}], "citations": {"NLM": "Anti\u0107 \u017d, Yu J, Van Reijmersdal SV, Van Dijk A, Dekker L, Segerink WH, Sonneveld E, Fiocco M, Pieters R, Hoogerbrugge PM, Van Leeuwen FN, Van Kessel AG, Waanders E, Kuiper RP. Multiclonal complexity of pediatric acute lymphoblastic leukemia and the prognostic relevance of subclonal mutations Haematologica. PMID: 33147938", "BibTeX": "@article{33147938, title={Multiclonal complexity of pediatric acute lymphoblastic leukemia and the prognostic relevance of subclonal mutations}, author={Anti\u0107 \u017d and Yu J and Van Reijmersdal SV and Van Dijk A and Dekker L and Segerink WH and Sonneveld E and Fiocco M and Pieters R and Hoogerbrugge PM and Van Leeuwen FN and Van Kessel AG and Waanders E and Kuiper RP}, journal={Haematologica}}"}, "is_sup_mat_match": false}, {"pmid": 30385747, "pmcid": "PMC6212533", "title": "TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw", "journal": "Nat Commun", "authors": ["Gomes CC", "Gayden T", "Bajic A", "Harraz OF", "Pratt J", "Nikbakht H", "Bareke E", "Diniz MG", "Castro WH", "St-Onge P", "Sinnett D", "Han H", "Rivera B", "Mikael LG", "De Jay N", "Kleinman CL", "Valera ET", "Bassenden AV", "Berghuis AM", "Majewski J", "Nelson MT", "Gomez RS", "Jabado N"], "date": "2018-11-01T00:00:00Z", "year": 2018, "snippets": [{"_id": "30385747@14650", "snip_text": "KRAS mutations occurred mainly at known hotspots (p.G12D/A, p.G13D, p.A146V, p.A146P) and in five cases at rare alleles leading to p.V14L, p.L19F, or p.G10E (Supplementary Figs.", "section": "results", "mentions": ["77|7|variant|litvar@rs121913527##&&&litvar@#3845#|p.A146P", "139|6|variant|litvar@rs121913538##&&&litvar@#3845#&&&litvar@CA210356#rs121913538##|p.L19F", "131|6|variant|litvar@rs375812644##&&&litvar@#4609#&&&litvar@CA4875222#rs375812644##|p.V14L", "60|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "50|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "150|6|variant|litvar@#3845#p.G10E&&&litvar@#3845#|p.G10E", "68|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "0|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "KRAS mutations occurred mainly at known hotspots (p.G12D/A, p.G13D, p.A146V, p.A146P) and in five cases at rare alleles leading to p.V14L, p.L19F, or p.G10E (Supplementary Figs."}], "citations": {"NLM": "Gomes CC, Gayden T, Bajic A, Harraz OF, Pratt J, Nikbakht H, Bareke E, Diniz MG, Castro WH, St-Onge P, Sinnett D, Han H, Rivera B, Mikael LG, De Jay N, Kleinman CL, Valera ET, Bassenden AV, Berghuis AM, Majewski J, Nelson MT, Gomez RS, Jabado N. TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw Nat Commun. PMID: 30385747", "BibTeX": "@article{30385747, title={TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw}, author={Gomes CC and Gayden T and Bajic A and Harraz OF and Pratt J and Nikbakht H and Bareke E and Diniz MG and Castro WH and St-Onge P and Sinnett D and Han H and Rivera B and Mikael LG and De Jay N and Kleinman CL and Valera ET and Bassenden AV and Berghuis AM and Majewski J and Nelson MT and Gomez RS and Jabado N}, journal={Nat Commun}}"}, "is_sup_mat_match": false}, {"pmid": 32708575, "pmcid": "PMC7409181", "title": "Study of Ras Mutations' Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis.", "journal": "Cancers (Basel)", "authors": ["Ottaiano A", "Normanno N", "Facchini S", "Cassata A", "Nappi A", "Romano C", "Silvestro L", "De Stefano A", "Rachiglio AM", "Roma C", "Maiello MR", "Scala S", "Delrio P", "Tatangelo F", "Di Mauro A", "Botti G", "Avallone A", "Nasti G"], "date": "2020-07-16T00:00:00Z", "year": 2020, "snippets": [{"_id": "32708575@30079", "snip_text": "Gene Mutation(Proteic Change) Age  Gender  Grading  Side of Primary Tumor  pT *  Lymph Node Involvement (pN) *    <65 >=65 p M F p G1/G2 G3 p Left Right p T1/T2 T3 T4 p 0 1-3 >3 p   KRAS                         p.G12D 22 35  27 30  10 47  26 31  12 30 10  1 6 45     p.G12V 17 21  20 18  6 32  14 24  11 15 9  1 9 25     p.G13D 15 20  18 17  4 31  12 23  7 16 6  0 5 24     p.G12A 6 8  11 3  4 10  4 10  2 5 4  1 3 7     p.G12C 5 8  5 8  3 10  2 11  4 5 3  0 2 10     p.G12S 5 7 0.99 4 8 0.22 2 10 0.78 3 9 0.33 2 5 3 0.94 0 1 9 0.59    p.A146T 2 6  5 3  4 4  4 4  1 2 3  2 1 3     p.A146V 1 2  2 1  0 3  1 2  1 1 0  1 0 1     p.K117N 2 1  0 3  0 3  0 3  0 1 2  0 1 2     p.G13C 0 3  3 0  1 2  1 2  0 1 1  0 0 2     p.G13R 1 1  0 2  1 1  1 1  2 0 0  1 0 1     p.G12_G13insG 0 1  1 0  0 1  0 1  0 1 0  0 0 1     p.G12F 0 1  1 0  0 1  1 0  0 1 0  0 0 1     p.G13D; pG12D 1 0  1 0  0 1  1 0  1 0 0  0 0 1     p.A59E 0 1  1 0  0 1  0 1  0 1 0  1 0 0    NRAS                         p.G12C 2 2  3 1  1 3  1 3  0 3 0  0 1 2     p.Q61H 1 3  2 2  1 3  0 4  0 3 0  0 0 3     p.G12R 1 1  2 0  0 2  0 2  1 0 1  0 0 2     p.Q61E 0 1  0 1  0 1  1 0  0 1 0  0 0 1     p.Q61L 0 1  1 0  0 1  0 1  0 1 0  1 0 0     p.Q61R 0 1  0 1  1 0  0 0  0 1 0  0 0 1     p.V14I 1 0  0 1  0 1  1 1  0 0 1  0 0 1    ", "section": "table", "mentions": ["537|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "267|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "421|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "158|2|variant|litvar@#3845#|T2", "855|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "182|4|gene|ncbi_gene@3845|KRAS", "1154|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "760|13|variant|litvar@#4893#p.G12,13ins&&&litvar@#4893#|p.G12_G13insG", "627|7|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.K117N", "906|6|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|p.A59E", "949|4|gene|ncbi_gene@4893|NRAS", "321|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "1110|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA16602362#rs121913254##|p.Q61E", "716|6|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|p.G13R", "582|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "211|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "374|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "672|6|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|p.G13C", "1242|6|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|p.V14I", "978|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "811|6|variant|litvar@rs121913530##&&&litvar@#3845#|p.G12F", "1022|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "1198|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "134|2|variant|litvar@#3845#|G2", "468|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "68|5|disease|ncbi_mesh@D009369|Tumor", "1066|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R"], "figure_id": "cancers-12-01919-t001", "text_hl": "Gene Mutation(Proteic Change) Age  Gender  Grading  Side of Primary Tumor  pT *  Lymph Node Involvement (pN) *    <65 >=65 p M F p G1/G2 G3 p Left Right p T1/T2 T3 T4 p 0 1-3 >3 p   KRAS                         p.G12D 22 35  27 30  10 47  26 31  12 30 10  1 6 45     p.G12V 17 21  20 18  6 32  14 24  11 15 9  1 9 25     p.G13D 15 20  18 17  4 31  12 23  7 16 6  0 5 24     p.G12A 6 8  11 3  4 10  4 10  2 5 4  1 3 7     p.G12C 5 8  5 8  3 10  2 11  4 5 3  0 2 10     p.G12S 5 7 0.99 4 8 0.22 2 10 0.78 3 9 0.33 2 5 3 0.94 0 1 9 0.59    <m>p.A146T</m> 2 6  5 3  4 4  4 4  1 2 3  2 1 3     p.A146V 1 2  2 1  0 3  1 2  1 1 0  1 0 1     p.K117N 2 1  0 3  0 3  0 3  0 1 2  0 1 2     p.G13C 0 3  3 0  1 2  1 2  0 1 1  0 0 2     p.G13R 1 1  0 2  1 1  1 1  2 0 0  1 0 1     p.G12_G13insG 0 1  1 0  0 1  0 1  0 1 0  0 0 1     p.G12F 0 1  1 0  0 1  1 0  0 1 0  0 0 1     p.G13D; pG12D 1 0  1 0  0 1  1 0  1 0 0  0 0 1     p.A59E 0 1  1 0  0 1  0 1  0 1 0  1 0 0    NRAS                         p.G12C 2 2  3 1  1 3  1 3  0 3 0  0 1 2     p.Q61H 1 3  2 2  1 3  0 4  0 3 0  0 0 3     p.G12R 1 1  2 0  0 2  0 2  1 0 1  0 0 2     p.Q61E 0 1  0 1  0 1  1 0  0 1 0  0 0 1     p.Q61L 0 1  1 0  0 1  0 1  0 1 0  1 0 0     p.Q61R 0 1  0 1  1 0  0 0  0 1 0  0 0 1     p.V14I 1 0  0 1  0 1  1 1  0 0 1  0 0 1    "}], "citations": {"NLM": "Ottaiano A, Normanno N, Facchini S, Cassata A, Nappi A, Romano C, Silvestro L, De Stefano A, Rachiglio AM, Roma C, Maiello MR, Scala S, Delrio P, Tatangelo F, Di Mauro A, Botti G, Avallone A, Nasti G. Study of Ras Mutations' Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis. Cancers (Basel). PMID: 32708575", "BibTeX": "@article{32708575, title={Study of Ras Mutations' Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis.}, author={Ottaiano A and Normanno N and Facchini S and Cassata A and Nappi A and Romano C and Silvestro L and De Stefano A and Rachiglio AM and Roma C and Maiello MR and Scala S and Delrio P and Tatangelo F and Di Mauro A and Botti G and Avallone A and Nasti G}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 36470426, "pmcid": "PMC9808003", "title": "Mapping the KRAS proteoform landscape in colorectal cancer identifies truncated KRAS4B that decreases MAPK signaling.", "journal": "J Biol Chem", "authors": ["Adams LM", "DeHart CJ", "Drown BS", "Anderson LC", "Bocik W", "Boja ES", "Hiltke TM", "Hendrickson CL", "Rodriguez H", "Caldwell M", "Vafabakhsh R", "Kelleher NL"], "date": "2023-01-01T00:00:00Z", "year": 2023, "snippets": [{"_id": "36470426@16046", "snip_text": "KRAS4BGeranyl/Me was only observed in three of the tumors, two of which contained A146T mutations and one which contained a G13D mutation (Fig. 2 and Table S1).", "section": "results", "mentions": ["124|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "82|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "51|6|disease|ncbi_mesh@D009369|tumors"], "text_hl": "KRAS4BGeranyl/Me was only observed in three of the tumors, two of which contained <m>A146T</m> mutations and one which contained a G13D mutation (Fig. 2 and Table S1)."}], "citations": {"NLM": "Adams LM, DeHart CJ, Drown BS, Anderson LC, Bocik W, Boja ES, Hiltke TM, Hendrickson CL, Rodriguez H, Caldwell M, Vafabakhsh R, Kelleher NL. Mapping the KRAS proteoform landscape in colorectal cancer identifies truncated KRAS4B that decreases MAPK signaling. J Biol Chem. PMID: 36470426", "BibTeX": "@article{36470426, title={Mapping the KRAS proteoform landscape in colorectal cancer identifies truncated KRAS4B that decreases MAPK signaling.}, author={Adams LM and DeHart CJ and Drown BS and Anderson LC and Bocik W and Boja ES and Hiltke TM and Hendrickson CL and Rodriguez H and Caldwell M and Vafabakhsh R and Kelleher NL}, journal={J Biol Chem}}"}, "is_sup_mat_match": false}, {"pmid": 29296181, "pmcid": "PMC5746083", "title": "Correlation between MEK signature and Ras gene alteration in advanced gastric cancer.", "journal": "Oncotarget", "authors": ["Ahn S", "Brant R", "Sharpe A", "Dry JR", "Hodgson DR", "Kilgour E", "Kim K", "Kim ST", "Park SH", "Kang WK", "Kim KM", "Lee J"], "date": "2017-05-23T00:00:00Z", "year": 2017, "snippets": [{"_id": "29296181@5472", "snip_text": "Detected KRAS mutations were as follows; G12C (n = 2), G12D (n = 9), G12V (n = 1), A146P (n = 1), A146T (n = 1), F156L (n = 1), Q61H (n = 1), and Q61R (n = 1).", "section": "results", "mentions": ["113|5|variant|litvar@rs104894362##&&&litvar@#3845#&&&litvar@CA279964#rs104894362##|F156L", "98|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "69|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "83|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "146|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|Q61R", "55|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "9|4|gene|ncbi_gene@3845|KRAS", "128|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "41|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C"], "text_hl": "Detected KRAS mutations were as follows; G12C (n = 2), G12D (n = 9), G12V (n = 1), A146P (n = 1), <m>A146T</m> (n = 1), F156L (n = 1), Q61H (n = 1), and Q61R (n = 1)."}], "citations": {"NLM": "Ahn S, Brant R, Sharpe A, Dry JR, Hodgson DR, Kilgour E, Kim K, Kim ST, Park SH, Kang WK, Kim KM, Lee J. Correlation between MEK signature and Ras gene alteration in advanced gastric cancer. Oncotarget. PMID: 29296181", "BibTeX": "@article{29296181, title={Correlation between MEK signature and Ras gene alteration in advanced gastric cancer.}, author={Ahn S and Brant R and Sharpe A and Dry JR and Hodgson DR and Kilgour E and Kim K and Kim ST and Park SH and Kang WK and Kim KM and Lee J}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 37977001, "pmcid": "PMC10774958", "title": "Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer", "journal": "ESMO Open", "authors": ["Doleschal B", "Taghizadeh H", "Lentner T", "Riedl JM", "Granitzer J", "Morariu D", "Decker J", "Aichberger KJ", "Webersinke G", "Kirchweger P", "Petzer A", "Rumpold H"], "date": "2023-12-01T00:00:00Z", "year": 2023, "snippets": [{"_id": "37977001@13187", "snip_text": "Among the other RAS mutations, nine were NRAS mutations, eight were KRAS exon 2 codon 13-altered tumor and eight had very rare KRAS mutations (A146T, Q61L or K117N).", "section": "results", "mentions": ["150|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "68|4|gene|ncbi_gene@3845|KRAS", "127|4|gene|ncbi_gene@3845|KRAS", "97|5|disease|ncbi_mesh@D009369|tumor", "143|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "41|4|gene|ncbi_gene@4893|NRAS", "158|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N"], "text_hl": "Among the other RAS mutations, nine were NRAS mutations, eight were KRAS exon 2 codon 13-altered tumor and eight had very rare KRAS mutations (<m>A146T</m>, Q61L or K117N)."}], "citations": {"NLM": "Doleschal B, Taghizadeh H, Lentner T, Riedl JM, Granitzer J, Morariu D, Decker J, Aichberger KJ, Webersinke G, Kirchweger P, Petzer A, Rumpold H. Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer ESMO Open. PMID: 37977001", "BibTeX": "@article{37977001, title={Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer}, author={Doleschal B and Taghizadeh H and Lentner T and Riedl JM and Granitzer J and Morariu D and Decker J and Aichberger KJ and Webersinke G and Kirchweger P and Petzer A and Rumpold H}, journal={ESMO Open}}"}, "is_sup_mat_match": false}, {"pmid": 31117243, "pmcid": "PMC6572712", "title": "Computational Screening and Analysis of Lung Cancer Related Non-Synonymous Single Nucleotide Polymorphisms on the Human Kirsten Rat Sarcoma Gene.", "journal": "Molecules", "authors": ["Wang Q", "Mehmood A", "Wang H", "Xu Q", "Xiong Y", "Wei DQ"], "date": "2019-05-21T00:00:00Z", "year": 2019, "snippets": [{"_id": "31117243@40741", "snip_text": "rs ID Variant SIFT SNAP2 PROVEAN   Prediction Score Prediction Score Prediction Score   rs17851045 Q61H intolerant 0 effect 94 Deleterious -4.556   rs104886028 M72I tolerated 0.25 effect 7 Deleterious -3.376   rs104886029 A59V intolerant 0 effect 38 Deleterious -3.839   rs104894359 G60S intolerant 0 effect 73 Deleterious -5.817   rs104894359 G60R intolerant 0 effect 99 Deleterious -7.758   rs104894361 K5N intolerant 0 effect 90 Deleterious -3.836   rs104894362 F156L intolerant 0 effect 65 Deleterious -5.310   rs104894364 T58I intolerant 0 effect 97 Deleterious -5.823   rs104894365 V14I intolerant 0 effect 96 Neutral -0.819   rs104894366 P34R intolerant 0 effect 96 Deleterious -7.598   rs104894367 V152G intolerant 0 effect 75 Deleterious -5.873   rs112445441 G13D intolerant 0 effect 98 Deleterious -5.403   rs121913236 Q22K intolerant 0 effect 55 Deleterious -3.313   rs121913238 Q61K intolerant 0.01 effect 69 Deleterious -3.588   rs121913239 Q61E intolerant 0.01 effect 58 Deleterious -2.772   rs121913240 Q61P intolerant 0.01 effect 63 Deleterious -5.602   rs121913241 Q61R intolerant 0.01 effect 63 Deleterious -3.455   rs121913242 Q61L intolerant 0.01 effect 93 Deleterious -6.507   rs121913527 A146P intolerant 0 effect 82 Deleterious -4.513   rs121913528 A59T intolerant 0.01 effect 40 Deleterious -3.727   rs121913528 A59S intolerant 0 effect 35 Deleterious -2.701   rs121913529 G12D intolerant 0 effect 99 Deleterious -5.373   rs121913531 G12A intolerant 0 effect 96 Deleterious -4.621   rs121913534 G12V intolerant 0 effect 98 Deleterious -7.113   rs121913530 G12S intolerant 0 effect 97 Deleterious -4.443   rs121913532 G12R intolerant 0.04 effect 99 Deleterious -6.183   rs121913533 G12C intolerant 0 effect 94 Deleterious -7.161   rs121913535 G13C intolerant 0 effect 92 Deleterious -7.619   rs121913538 L19F intolerant 0 effect 54 Deleterious -3.373   rs193929331 K5E intolerant 0 effect 83 Deleterious -3.154   rs200970347 G179S tolerated 0.06 neutral -36 Neutral -1.374   rs201170656 M189L tolerated 1 neutral -67 Neutral -0.162   rs202247812 N116S intolerant 0 effect 81 Deleterious -4.564   rs372793780 R164Q intolerant 0.02 effect 53 Deleterious -2.610   rs387907205 Y71H intolerant 0 effect 75 Deleterious -4.454   rs387907205 Y71D intolerant 0 effect 86 Deleterious -9.374   rs387907206 K147E intolerant 0 effect 83 Deleterious -3.624   rs397517041 V152F intolerant 0 effect 65 Deleterious -4.424   rs397517042 F156I intolerant 0 effect 62 Deleterious -5.312   rs397517042 F156V intolerant 0 effect 64 Deleterious -6.196   rs397517476 Y166N tolerated 0.28 effect 18 Deleterious -3.387   rs397517476 Y166H tolerated 0.49 effect 4 Neutral -1.392   rs727503106 R97K tolerated 0.29 effect 53 Neutral -2.130   rs727503108 G60V intolerant 0 effect 77 Deleterious -8.727   rs727503110 Q22R intolerant 0 effect 20 Deleterious -3.324   rs727503110 Q22L intolerant 0 effect 49 Deleterious -5.834   rs727504662 M72L intolerant 0.01 effect 46 Deleterious -2.549   rs730880470 T50S tolerated 0.51 neutral -44 Deleterious -3.144   rs730880471 D119N intolerant 0 effect 83 Deleterious -4.566   rs730880472 L23R intolerant 0 effect 77 Deleterious -4.925   rs730880473 A130V intolerant 0.03 effect 17 Neutral -2.446   rs770248150 K117N intolerant 0 effect 86 Deleterious -4.558   rs794727277 N26Y intolerant 0.01 effect 51 Deleterious -5.455   rs794727720 Y157C intolerant 0.02 effect 3 Deleterious -6.787   rs1057517885 I171T tolerated 0.59 neutral -20 Neutral 0.121   rs1057519725 A146V intolerant 0 effect 53 Deleterious -3.625   rs1135401776 K147R intolerant 0.01 effect 18 Deleterious -2.718   rs138669124 F141L intolerant 0.01 effect 65 Deleterious -4.534   rs368557003 Q165R tolerated 0.85 neutral -56 Neutral -0.013   rs373500216 A134G intolerant 0.04 effect 53 Deleterious -3.378   rs374681135 P178S tolerated 0.77 neutral -29 Neutral -0.199   rs529925358 I183V tolerated 0.47 effect 5 Neutral 0.071   rs539423712 V160A tolerated 0.05 effect 28 Deleterious -3.533   rs542902732 M1I intolerant 0.01 neutral -13 Neutral -2.480   rs575569675 T124S tolerated 0.65 neutral -41 Neutral -0.801   rs746609817 K128R tolerated 0.27 effect 11 Neutral -0.496   rs749177256 T158I tolerated 0.14 effect 5 Deleterious -4.132   rs754870563 G138E intolerant 0.02 effect 41 Deleterious -5.915   rs755177746 A155G tolerated 0.08 effect 53 Deleterious -3.310   rs755877953 V160M intolerant 0 effect 20 Deleterious -2.648   rs755967833 I188V intolerant 0.5 effect 26 Neutral -0.257   rs756890312 G77A intolerant 0.01 effect 58 Deleterious -5.942   rs757674707 V160I intolerant 0.04 effect 19 Neutral -0.885   rs757816355 S136N tolerated 0.3 neutral -26 Neutral -1.842   rs766231905 I171M tolerated 0.12 neutral -26 Neutral 0.484   rs770020203 T74A tolerated 0.13 effect 21 Deleterious -4.434   rs771629239 E174K tolerated 0.58 neutral -47 Neutral -0.392   rs772985440 S172C intolerant 0.02 effect 16 Deleterious -2.706   rs775836436 V112I tolerated 0.47 neutral -14 Neutral -0.580   rs778702415 G138R tolerated 0.07 effect 20 Deleterious -5.963   rs779951033 I187V tolerated 1 neutral -69 Neutral 0.083   rs780974222 G75A intolerant 0.02 effect 34 Deleterious -5.938   rs781634879 T127R tolerated 0.63 effect 3 Deleterious -2.928   rs868857258 L79P intolerant 0 effect 76 Deleterious -6.881   rs904755552 I46M intolerant 0 effect 20 Deleterious -2.794   rs953088090 K88E tolerated 0.24 effect 47 Deleterious -2.537   rs989151052 D154G intolerant 0 effect 57 Deleterious -4.537   rs1024789250 K182E tolerated 0.23 effect 35 Neutral -1.118   rs1191739287 K170E tolerated 0.83 effect 2 Neutral -0.754   rs1199162369 R68C intolerant 0 effect 68 Deleterious -7.900   rs1265970615 T158P tolerated 0.23 effect 53 Deleterious -3.632   rs1296330213 L6I tolerated 0.09 neutral -53 Neutral -1.566   rs1296330213 L6V tolerated 0.06 effect 3 Neutral -2.337   rs1307793966 R164G intolerant 0.01 effect 72 Deleterious -4.743   rs1308177469 M189I tolerated 0.24 effect 11 Neutral -0.817   rs1309399018 H95N tolerated 0.5 effect 2 Neutral 0.028   rs1340281106 N86H intolerant 0.04 effect 64 Deleterious -3.195   rs1344202459 I142T tolerated 0.1 effect 26 Deleterious -3.283   rs1363431968 D126H intolerant 0.03 effect 59 Deleterious -3.361   rs1407509439 T50I tolerated 0.15 neutral -20 Deleterious -3.410   rs1434157586 R123W tolerated 0.08 effect 52 Deleterious -6.229   rs1437657227 D92H intolerant 0 effect 37 Deleterious -4.092   rs1463850736 A130T intolerant 0 effect 32 Deleterious -2.556   rs1463850736 A130P intolerant 0.01 effect 51 Deleterious -3.248   rs1463850736 A130S intolerant 0.01 effect 24 Neutral -1.591   rs1470495974 I163V tolerated 0.24 neutral -22 Neutral -0.817   ", "section": "table", "mentions": ["633|11|variant|litvar@rs104894366##&&&litvar@#3845#|rs104894366", "5803|3|variant|litvar@rs1296330213##&&&litvar@#3845#|L6V", "1641|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "4745|4|variant|litvar@rs770020203##&&&litvar@#3845#&&&litvar@CA6486909#rs770020203##|T74A", "5494|5|variant|litvar@rs1024789250##|K182E", "3613|11|variant|litvar@rs138669124##&&&litvar@#3845#|rs138669124", "817|11|variant|litvar@rs121913236##&&&litvar@#3845#|rs121913236", "2257|4|variant|litvar@rs387907205##&&&litvar@#3845#&&&litvar@CA10576919#rs387907205##|Y71D", "6097|12|variant|litvar@rs1344202459##&&&litvar@#3845#|rs1344202459", "515|11|variant|litvar@rs104894364##&&&litvar@#3845#|rs104894364", "1070|11|variant|litvar@rs121913240##|rs121913241", "1458|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "5049|11|variant|litvar@rs779951033##&&&litvar@#3845#|rs779951033", "5555|5|variant|litvar@rs1191739287##&&&litvar@#3845#|K170E", "148|11|variant|litvar@rs104886028##&&&litvar@#3845#|rs104886028", "1766|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "465|5|variant|litvar@rs104894362##&&&litvar@#3845#&&&litvar@CA279964#rs104894362##|F156L", "5431|5|variant|litvar@rs989151052##|D154G", "1519|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1006|11|variant|litvar@rs121913240##&&&litvar@#3845#|rs121913240", "332|11|variant|litvar@rs104894359##&&&litvar@#3845#|rs104894359", "1827|4|variant|litvar@rs121913538##&&&litvar@#3845#&&&litvar@CA210356#rs121913538##|L19F", "2809|4|variant|litvar@rs727503110##&&&litvar@#3845#&&&litvar@CA235299#rs727503110##|Q22R", "3435|5|variant|litvar@rs1057517885##&&&litvar@#3845#|I171T", "6371|4|variant|litvar@rs1437657227##&&&litvar@#3845#|D92H", "6227|12|variant|litvar@rs1407509439##&&&litvar@#3845#|rs1407509439", "6420|12|variant|litvar@rs1463850736##&&&litvar@#3845#|rs1463850736", "1336|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA354836#rs121913528##|A59S", "3122|4|variant|litvar@rs730880472##&&&litvar@#3845#&&&litvar@CA296092#rs730880472##|L23R", "576|11|variant|litvar@rs104894365##&&&litvar@#3845#|rs104894365", "4923|11|variant|litvar@rs775836436##&&&litvar@#3845#|rs775836436", "3306|4|variant|litvar@rs794727277##&&&litvar@#3845#&&&litvar@CA241569#rs794727277##|N26Y", "5742|3|variant|litvar@rs1296330213##&&&litvar@#3845#|L6I", "453|11|variant|litvar@rs104894362##&&&litvar@#3845#|rs104894362", "2119|11|variant|litvar@rs372793780##&&&litvar@#3845#|rs372793780", "5419|11|variant|litvar@rs989151052##|rs989151052", "393|11|variant|litvar@rs104894361##&&&litvar@#3845#|rs104894361", "5061|5|variant|litvar@rs779951033##&&&litvar@#3845#|I187V", "5295|11|variant|litvar@rs904755552##&&&litvar@#3845#|rs904755552", "756|11|variant|litvar@rs112445441##&&&litvar@#3845#|rs112445441", "2196|4|variant|litvar@rs387907205##&&&litvar@#3845#&&&litvar@CA279983#rs387907205##|Y71H", "6293|12|variant|litvar@rs1434157586##&&&litvar@#3845#|rs1434157586", "6358|12|variant|litvar@rs1437657227##&&&litvar@#3845#|rs1437657227", "3740|11|variant|litvar@rs373500216##&&&litvar@#3845#|rs373500216", "5861|5|variant|litvar@rs1307793966##&&&litvar@#3845#|R164G", "2931|4|variant|litvar@rs727504662##&&&litvar@#3845#&&&litvar@CA273592#rs727504662##|M72L", "706|5|variant|litvar@rs104894367##&&&litvar@#3845#&&&litvar@CA256482#rs104894367##|V152G", "829|4|variant|litvar@rs121913236##&&&litvar@#3845#&&&litvar@CA16602771#rs121913236##|Q22K", "2010|5|variant|litvar@rs201170656##&&&litvar@#3845#|M189L", "3690|5|variant|litvar@rs368557003##&&&litvar@#3845#|Q165R", "405|3|variant|litvar@rs104894361##&&&litvar@#3845#&&&litvar@CA16042877#rs104894361##|K5N", "3989|11|variant|litvar@rs542902732##&&&litvar@#3845#|rs542902732", "271|11|variant|litvar@rs104894359##&&&litvar@#3845#|rs104894359", "2748|4|variant|litvar@rs727503108##&&&litvar@#3845#&&&litvar@CA176493#rs727503108##|G60V", "6483|12|variant|litvar@rs1463850736##&&&litvar@#3845#|rs1463850736", "1134|11|variant|litvar@rs121913240##|rs121913242", "6174|5|variant|litvar@rs1363431968##&&&litvar@#3845#|D126H", "954|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "160|4|variant|litvar@rs104886028##&&&litvar@#3845#&&&litvar@CA156305#rs104886028##|M72I", "2689|4|variant|litvar@rs727503106##&&&litvar@#3845#&&&litvar@CA176487#rs727503106##|R97K", "5677|5|variant|litvar@rs1265970615##&&&litvar@#3845#|T158P", "5246|4|variant|litvar@rs868857258##&&&litvar@#3845#&&&litvar@CA234220946#rs868857258##|L79P", "5927|5|variant|litvar@rs1308177469##&&&litvar@#3845#|M189I", "3422|12|variant|litvar@rs1057517885##&&&litvar@#3845#|rs1057517885", "5183|5|variant|litvar@rs781634879##&&&litvar@#3845#&&&litvar@CA6486886#rs781634879##|T127R", "2131|5|variant|litvar@rs372793780##&&&litvar@#3845#&&&litvar@CA135580#rs372793780##|R164Q", "6110|5|variant|litvar@rs1344202459##&&&litvar@#3845#|I142T", "1998|11|variant|litvar@rs201170656##&&&litvar@#3845#|rs201170656", "4498|4|variant|litvar@rs756890312##&&&litvar@#3845#&&&litvar@CA6486906#rs756890312##|G77A", "3678|11|variant|litvar@rs368557003##&&&litvar@#3845#|rs368557003", "3752|5|variant|litvar@rs373500216##&&&litvar@#3845#|A134G", "4050|11|variant|litvar@rs575569675##&&&litvar@#3845#|rs575569675", "4124|5|variant|litvar@rs746609817##&&&litvar@#3845#&&&litvar@CA6486884#rs746609817##|K128R", "2306|11|variant|litvar@rs387907206##&&&litvar@#3845#|rs387907206", "6549|12|variant|litvar@rs1463850736##&&&litvar@#3845#|rs1463850736", "3547|12|variant|litvar@rs1135401776##&&&litvar@#3845#|rs1135401776", "1260|11|variant|litvar@rs121913528##&&&litvar@#3845#|rs121913528", "5119|4|variant|litvar@rs780974222##&&&litvar@#3845#&&&litvar@CA6486907#rs780974222##|G75A", "3867|11|variant|litvar@rs529925358##&&&litvar@#3845#|rs529925358", "5307|4|variant|litvar@rs904755552##&&&litvar@#3845#&&&litvar@CA234221237#rs904755552##|I46M", "768|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1568|11|variant|litvar@rs121913530##&&&litvar@#3845#|rs121913530", "1210|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "222|4|variant|litvar@rs104886029##&&&litvar@#3845#&&&litvar@CA269881#rs104886029##|A59V", "2069|5|variant|litvar@rs202247812##&&&litvar@#3845#&&&litvar@CA270751#rs202247812##|N116S", "5615|4|variant|litvar@rs1199162369##&&&litvar@#3845#|R68C", "1876|11|variant|litvar@rs193929331##&&&litvar@#3845#|rs193929331", "3817|5|variant|litvar@rs374681135##&&&litvar@#3845#|P178S", "2858|11|variant|litvar@rs727503110##&&&litvar@#3845#|rs727503110", "3484|12|variant|litvar@rs1057519725##&&&litvar@#3845#|rs1057519725", "3937|5|variant|litvar@rs539423712##&&&litvar@#3845#|V160A", "5848|12|variant|litvar@rs1307793966##&&&litvar@#3845#|rs1307793966", "1936|11|variant|litvar@rs200970347##&&&litvar@#3845#|rs200970347", "5368|4|variant|litvar@rs953088090##&&&litvar@CA234220903#rs953088090##|K88E", "3625|5|variant|litvar@rs138669124##&&&litvar@#3845#&&&litvar@CA6486879#rs138669124##|F141L", "645|4|variant|litvar@rs104894366##&&&litvar@#3845#&&&litvar@CA280040#rs104894366##|P34R", "2983|11|variant|litvar@rs730880470##&&&litvar@#3845#|rs730880470", "1385|11|variant|litvar@rs121913529##&&&litvar@#3845#|rs121913529", "6032|12|variant|litvar@rs1340281106##&&&litvar@#3845#|rs1340281106", "1693|11|variant|litvar@rs121913532##|rs121913533", "4112|11|variant|litvar@rs746609817##&&&litvar@#3845#|rs746609817", "99|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "2566|5|variant|litvar@rs397517476##&&&litvar@#3845#|Y166N", "1446|11|variant|litvar@rs121913529##|rs121913531", "4172|11|variant|litvar@rs749177256##&&&litvar@#3845#|rs749177256", "4062|5|variant|litvar@rs575569675##&&&litvar@#3845#&&&litvar@CA6486887#rs575569675##|T124S", "527|4|variant|litvar@rs104894364##&&&litvar@#3845#&&&litvar@CA256480#rs104894364##|T58I", "2442|5|variant|litvar@rs397517042##&&&litvar@#3845#&&&litvar@CA273160#rs397517042##|F156I", "1629|11|variant|litvar@rs121913530##|rs121913532", "1888|3|variant|litvar@rs193929331##&&&litvar@#3845#&&&litvar@CA250291#rs193929331##|K5E", "2736|11|variant|litvar@rs727503108##&&&litvar@#3845#|rs727503108", "4733|11|variant|litvar@rs770020203##&&&litvar@#3845#|rs770020203", "5914|12|variant|litvar@rs1308177469##&&&litvar@#3845#|rs1308177469", "2318|5|variant|litvar@rs387907206##&&&litvar@#3845#&&&litvar@CA279985#rs387907206##|K147E", "1198|11|variant|litvar@rs121913527##&&&litvar@#3845#|rs121913527", "2057|11|variant|litvar@rs202247812##&&&litvar@#3845#|rs202247812", "5602|12|variant|litvar@rs1199162369##&&&litvar@#3845#|rs1199162369", "1018|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "2245|11|variant|litvar@rs387907205##&&&litvar@#3845#|rs387907205", "5790|12|variant|litvar@rs1296330213##&&&litvar@#3845#|rs1296330213", "3879|5|variant|litvar@rs529925358##&&&litvar@#3845#|I183V", "344|4|variant|litvar@rs104894359##&&&litvar@#3845#&&&litvar@CA273416#rs104894359##|G60R", "3925|11|variant|litvar@rs539423712##&&&litvar@#3845#|rs539423712", "4550|11|variant|litvar@rs757674707##&&&litvar@#3845#|rs757674707", "1754|11|variant|litvar@rs121913535##&&&litvar@#3845#|rs121913535", "6045|4|variant|litvar@rs1340281106##&&&litvar@#3845#|N86H", "4247|5|variant|litvar@rs754870563##&&&litvar@#3845#&&&litvar@CA6486880#rs754870563##|G138E", "1948|5|variant|litvar@rs200970347##&&&litvar@#3845#|G179S", "4312|5|variant|litvar@rs755177746##&&&litvar@#3845#|A155G", "890|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA180750#rs121913238##|Q61K", "1507|11|variant|litvar@rs121913529##|rs121913534", "4486|11|variant|litvar@rs756890312##&&&litvar@#3845#|rs756890312", "4426|11|variant|litvar@rs755967833##&&&litvar@#3845#|rs755967833", "4858|11|variant|litvar@rs772985440##&&&litvar@#3845#|rs772985440", "4001|3|variant|litvar@rs542902732##&&&litvar@#3845#|M1I", "2554|11|variant|litvar@rs397517476##&&&litvar@#3845#|rs397517476", "588|4|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|V14I", "1815|11|variant|litvar@rs121913538##&&&litvar@#3845#|rs121913538", "3183|5|variant|litvar@rs730880473##&&&litvar@#3845#&&&litvar@CA296095#rs730880473##|A130V", "2797|11|variant|litvar@rs727503110##&&&litvar@#3845#|rs727503110", "4808|5|variant|litvar@rs771629239##&&&litvar@#3845#|E174K", "4376|5|variant|litvar@rs755877953##&&&litvar@#3845#|V160M", "2430|11|variant|litvar@rs397517042##&&&litvar@#3845#|rs397517042", "6433|5|variant|litvar@rs1463850736##&&&litvar@#3845#|A130T", "2504|5|variant|litvar@rs397517042##&&&litvar@#3845#&&&litvar@CA261709#rs397517042##|F156V", "4184|5|variant|litvar@rs749177256##&&&litvar@#3845#|T158I", "88|10|variant|litvar@rs17851045##&&&litvar@#3845#|rs17851045", "1324|11|variant|litvar@rs121913528##&&&litvar@#3845#|rs121913528", "4684|5|variant|litvar@rs766231905##&&&litvar@#3845#|I171M", "2380|5|variant|litvar@rs397517041##&&&litvar@#3845#&&&litvar@CA261705#rs397517041##|V152F", "5664|12|variant|litvar@rs1265970615##&&&litvar@#3845#|rs1265970615", "3060|5|variant|litvar@rs730880471##&&&litvar@#3845#&&&litvar@CA296084#rs730880471##|D119N", "3294|11|variant|litvar@rs794727277##&&&litvar@#3845#|rs794727277", "4235|11|variant|litvar@rs754870563##&&&litvar@#3845#|rs754870563", "4300|11|variant|litvar@rs755177746##&&&litvar@#3845#|rs755177746", "5481|12|variant|litvar@rs1024789250##|rs1024789250", "4672|11|variant|litvar@rs766231905##&&&litvar@#3845#|rs766231905", "3244|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "6240|4|variant|litvar@rs1407509439##&&&litvar@#3845#|T50I", "6306|5|variant|litvar@rs1434157586##&&&litvar@#3845#|R123W", "4562|5|variant|litvar@rs757674707##&&&litvar@#3845#&&&litvar@CA234206964#rs757674707##|V160I", "3171|11|variant|litvar@rs730880473##&&&litvar@#3845#|rs730880473", "2184|11|variant|litvar@rs387907205##&&&litvar@#3845#|rs387907205", "6161|12|variant|litvar@rs1363431968##&&&litvar@#3845#|rs1363431968", "5729|12|variant|litvar@rs1296330213##&&&litvar@#3845#|rs1296330213", "4796|11|variant|litvar@rs771629239##&&&litvar@#3845#|rs771629239", "283|4|variant|litvar@rs104894359##&&&litvar@#3845#&&&litvar@CA256484#rs104894359##|G60S", "2630|5|variant|litvar@rs397517476##&&&litvar@#3845#|Y166H", "4870|5|variant|litvar@rs772985440##&&&litvar@#3845#|S172C", "4438|5|variant|litvar@rs755967833##&&&litvar@#3845#|I188V", "5988|4|variant|litvar@rs1309399018##&&&litvar@#3845#|H95N", "2492|11|variant|litvar@rs397517042##&&&litvar@#3845#|rs397517042", "2919|11|variant|litvar@rs727504662##&&&litvar@#3845#|rs727504662", "1146|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|Q61L", "3805|11|variant|litvar@rs374681135##&&&litvar@#3845#|rs374681135", "2368|11|variant|litvar@rs397517041##&&&litvar@#3845#|rs397517041", "6611|12|variant|litvar@rs1470495974##&&&litvar@#3845#|rs1470495974", "6624|5|variant|litvar@rs1470495974##&&&litvar@#3845#|I163V", "4985|11|variant|litvar@rs778702415##&&&litvar@#3845#|rs778702415", "3048|11|variant|litvar@rs730880471##&&&litvar@#3845#|rs730880471", "1082|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|Q61R", "694|11|variant|litvar@rs104894367##&&&litvar@#3845#|rs104894367", "5542|12|variant|litvar@rs1191739287##&&&litvar@#3845#|rs1191739287", "4935|5|variant|litvar@rs775836436##&&&litvar@#3845#&&&litvar@CA6486889#rs775836436##|V112I", "942|11|variant|litvar@rs121913238##|rs121913239", "3370|5|variant|litvar@rs794727720##&&&litvar@#3845#&&&litvar@CA246093#rs794727720##|Y157C", "4623|5|variant|litvar@rs757816355##&&&litvar@#3845#&&&litvar@CA6486883#rs757816355##|S136N", "2677|11|variant|litvar@rs727503106##&&&litvar@#3845#|rs727503106", "3232|11|variant|litvar@rs770248150##&&&litvar@#3845#|rs770248150", "878|11|variant|litvar@rs121913238##&&&litvar@#3845#|rs121913238", "5234|11|variant|litvar@rs868857258##&&&litvar@#3845#|rs868857258", "6496|5|variant|litvar@rs1463850736##&&&litvar@#3845#|A130P", "2618|11|variant|litvar@rs397517476##&&&litvar@#3845#|rs397517476", "1272|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "1580|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "6562|5|variant|litvar@rs1463850736##&&&litvar@#3845#|A130S", "5171|11|variant|litvar@rs781634879##&&&litvar@#3845#|rs781634879", "3560|5|variant|litvar@rs1135401776##&&&litvar@#3845#|K147R", "5975|12|variant|litvar@rs1309399018##&&&litvar@#3845#|rs1309399018", "2870|4|variant|litvar@rs727503110##&&&litvar@#3845#&&&litvar@CA296089#rs727503110##|Q22L", "3110|11|variant|litvar@rs730880472##&&&litvar@#3845#|rs730880472", "5107|11|variant|litvar@rs780974222##&&&litvar@#3845#|rs780974222", "2995|4|variant|litvar@rs730880470##&&&litvar@#3845#&&&litvar@CA296081#rs730880470##|T50S", "1397|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "4997|5|variant|litvar@rs778702415##&&&litvar@#3845#&&&litvar@CA6486881#rs778702415##|G138R", "3358|11|variant|litvar@rs794727720##&&&litvar@#3845#|rs794727720", "4611|11|variant|litvar@rs757816355##&&&litvar@#3845#|rs757816355", "210|11|variant|litvar@rs104886029##&&&litvar@#3845#|rs104886029", "1705|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "3497|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "4364|11|variant|litvar@rs755877953##&&&litvar@#3845#|rs755877953", "5356|11|variant|litvar@rs953088090##|rs953088090"], "figure_id": "molecules-24-01951-t001", "text_hl": "rs ID Variant SIFT SNAP2 PROVEAN   Prediction Score Prediction Score Prediction Score   rs17851045 Q61H intolerant 0 effect 94 Deleterious -4.556   rs104886028 M72I tolerated 0.25 effect 7 Deleterious -3.376   rs104886029 A59V intolerant 0 effect 38 Deleterious -3.839   rs104894359 G60S intolerant 0 effect 73 Deleterious -5.817   rs104894359 G60R intolerant 0 effect 99 Deleterious -7.758   rs104894361 K5N intolerant 0 effect 90 Deleterious -3.836   rs104894362 F156L intolerant 0 effect 65 Deleterious -5.310   rs104894364 T58I intolerant 0 effect 97 Deleterious -5.823   rs104894365 V14I intolerant 0 effect 96 Neutral -0.819   rs104894366 P34R intolerant 0 effect 96 Deleterious -7.598   rs104894367 V152G intolerant 0 effect 75 Deleterious -5.873   rs112445441 G13D intolerant 0 effect 98 Deleterious -5.403   rs121913236 Q22K intolerant 0 effect 55 Deleterious -3.313   rs121913238 Q61K intolerant 0.01 effect 69 Deleterious -3.588   rs121913239 Q61E intolerant 0.01 effect 58 Deleterious -2.772   rs121913240 Q61P intolerant 0.01 effect 63 Deleterious -5.602   rs121913241 Q61R intolerant 0.01 effect 63 Deleterious -3.455   rs121913242 Q61L intolerant 0.01 effect 93 Deleterious -6.507   rs121913527 A146P intolerant 0 effect 82 Deleterious -4.513   rs121913528 A59T intolerant 0.01 effect 40 Deleterious -3.727   rs121913528 A59S intolerant 0 effect 35 Deleterious -2.701   rs121913529 G12D intolerant 0 effect 99 Deleterious -5.373   rs121913531 G12A intolerant 0 effect 96 Deleterious -4.621   rs121913534 G12V intolerant 0 effect 98 Deleterious -7.113   rs121913530 G12S intolerant 0 effect 97 Deleterious -4.443   rs121913532 G12R intolerant 0.04 effect 99 Deleterious -6.183   rs121913533 G12C intolerant 0 effect 94 Deleterious -7.161   rs121913535 G13C intolerant 0 effect 92 Deleterious -7.619   rs121913538 L19F intolerant 0 effect 54 Deleterious -3.373   rs193929331 K5E intolerant 0 effect 83 Deleterious -3.154   rs200970347 G179S tolerated 0.06 neutral -36 Neutral -1.374   rs201170656 M189L tolerated 1 neutral -67 Neutral -0.162   rs202247812 N116S intolerant 0 effect 81 Deleterious -4.564   rs372793780 R164Q intolerant 0.02 effect 53 Deleterious -2.610   rs387907205 Y71H intolerant 0 effect 75 Deleterious -4.454   rs387907205 Y71D intolerant 0 effect 86 Deleterious -9.374   rs387907206 K147E intolerant 0 effect 83 Deleterious -3.624   rs397517041 V152F intolerant 0 effect 65 Deleterious -4.424   rs397517042 F156I intolerant 0 effect 62 Deleterious -5.312   rs397517042 F156V intolerant 0 effect 64 Deleterious -6.196   rs397517476 Y166N tolerated 0.28 effect 18 Deleterious -3.387   rs397517476 Y166H tolerated 0.49 effect 4 Neutral -1.392   rs727503106 R97K tolerated 0.29 effect 53 Neutral -2.130   rs727503108 G60V intolerant 0 effect 77 Deleterious -8.727   rs727503110 Q22R intolerant 0 effect 20 Deleterious -3.324   rs727503110 Q22L intolerant 0 effect 49 Deleterious -5.834   rs727504662 M72L intolerant 0.01 effect 46 Deleterious -2.549   rs730880470 T50S tolerated 0.51 neutral -44 Deleterious -3.144   rs730880471 D119N intolerant 0 effect 83 Deleterious -4.566   rs730880472 L23R intolerant 0 effect 77 Deleterious -4.925   rs730880473 A130V intolerant 0.03 effect 17 Neutral -2.446   rs770248150 K117N intolerant 0 effect 86 Deleterious -4.558   rs794727277 N26Y intolerant 0.01 effect 51 Deleterious -5.455   rs794727720 Y157C intolerant 0.02 effect 3 Deleterious -6.787   rs1057517885 I171T tolerated 0.59 neutral -20 Neutral 0.121   rs1057519725 A146V intolerant 0 effect 53 Deleterious -3.625   rs1135401776 K147R intolerant 0.01 effect 18 Deleterious -2.718   rs138669124 F141L intolerant 0.01 effect 65 Deleterious -4.534   rs368557003 Q165R tolerated 0.85 neutral -56 Neutral -0.013   rs373500216 A134G intolerant 0.04 effect 53 Deleterious -3.378   rs374681135 P178S tolerated 0.77 neutral -29 Neutral -0.199   rs529925358 I183V tolerated 0.47 effect 5 Neutral 0.071   rs539423712 V160A tolerated 0.05 effect 28 Deleterious -3.533   rs542902732 M1I intolerant 0.01 neutral -13 Neutral -2.480   rs575569675 T124S tolerated 0.65 neutral -41 Neutral -0.801   rs746609817 K128R tolerated 0.27 effect 11 Neutral -0.496   rs749177256 T158I tolerated 0.14 effect 5 Deleterious -4.132   rs754870563 G138E intolerant 0.02 effect 41 Deleterious -5.915   rs755177746 A155G tolerated 0.08 effect 53 Deleterious -3.310   rs755877953 V160M intolerant 0 effect 20 Deleterious -2.648   rs755967833 I188V intolerant 0.5 effect 26 Neutral -0.257   rs756890312 G77A intolerant 0.01 effect 58 Deleterious -5.942   rs757674707 V160I intolerant 0.04 effect 19 Neutral -0.885   rs757816355 S136N tolerated 0.3 neutral -26 Neutral -1.842   rs766231905 I171M tolerated 0.12 neutral -26 Neutral 0.484   rs770020203 T74A tolerated 0.13 effect 21 Deleterious -4.434   rs771629239 E174K tolerated 0.58 neutral -47 Neutral -0.392   rs772985440 S172C intolerant 0.02 effect 16 Deleterious -2.706   rs775836436 V112I tolerated 0.47 neutral -14 Neutral -0.580   rs778702415 G138R tolerated 0.07 effect 20 Deleterious -5.963   rs779951033 I187V tolerated 1 neutral -69 Neutral 0.083   rs780974222 G75A intolerant 0.02 effect 34 Deleterious -5.938   rs781634879 T127R tolerated 0.63 effect 3 Deleterious -2.928   rs868857258 L79P intolerant 0 effect 76 Deleterious -6.881   rs904755552 I46M intolerant 0 effect 20 Deleterious -2.794   rs953088090 K88E tolerated 0.24 effect 47 Deleterious -2.537   rs989151052 D154G intolerant 0 effect 57 Deleterious -4.537   rs1024789250 K182E tolerated 0.23 effect 35 Neutral -1.118   rs1191739287 K170E tolerated 0.83 effect 2 Neutral -0.754   rs1199162369 R68C intolerant 0 effect 68 Deleterious -7.900   rs1265970615 T158P tolerated 0.23 effect 53 Deleterious -3.632   rs1296330213 L6I tolerated 0.09 neutral -53 Neutral -1.566   rs1296330213 L6V tolerated 0.06 effect 3 Neutral -2.337   rs1307793966 R164G intolerant 0.01 effect 72 Deleterious -4.743   rs1308177469 M189I tolerated 0.24 effect 11 Neutral -0.817   rs1309399018 H95N tolerated 0.5 effect 2 Neutral 0.028   rs1340281106 N86H intolerant 0.04 effect 64 Deleterious -3.195   rs1344202459 I142T tolerated 0.1 effect 26 Deleterious -3.283   rs1363431968 D126H intolerant 0.03 effect 59 Deleterious -3.361   rs1407509439 T50I tolerated 0.15 neutral -20 Deleterious -3.410   rs1434157586 R123W tolerated 0.08 effect 52 Deleterious -6.229   rs1437657227 D92H intolerant 0 effect 37 Deleterious -4.092   rs1463850736 A130T intolerant 0 effect 32 Deleterious -2.556   rs1463850736 A130P intolerant 0.01 effect 51 Deleterious -3.248   rs1463850736 A130S intolerant 0.01 effect 24 Neutral -1.591   rs1470495974 I163V tolerated 0.24 neutral -22 Neutral -0.817   "}], "citations": {"NLM": "Wang Q, Mehmood A, Wang H, Xu Q, Xiong Y, Wei DQ. Computational Screening and Analysis of Lung Cancer Related Non-Synonymous Single Nucleotide Polymorphisms on the Human Kirsten Rat Sarcoma Gene. Molecules. PMID: 31117243", "BibTeX": "@article{31117243, title={Computational Screening and Analysis of Lung Cancer Related Non-Synonymous Single Nucleotide Polymorphisms on the Human Kirsten Rat Sarcoma Gene.}, author={Wang Q and Mehmood A and Wang H and Xu Q and Xiong Y and Wei DQ}, journal={Molecules}}"}, "is_sup_mat_match": false}, {"pmid": 25894969, "pmcid": "PMC4404337", "title": "Dissecting Genomic Aberrations in Myeloproliferative Neoplasms by Multiplex-PCR and Next Generation Sequencing.", "journal": "PLoS One", "authors": ["Kirschner MM", "Schemionek M", "Schubert C", "Chatain N", "Sontag S", "Isfort S", "Ortiz-Br\u00fcchle N", "Schmitt K", "Kr\u00fcger L", "Zerres K", "Zenke M", "Br\u00fcmmendorf TH", "Koschmieder S"], "date": "2015-04-20T00:00:00Z", "year": 2015, "snippets": [{"_id": "25894969@23747", "snip_text": "This c.436G>A mutation (32%) was located in exon 4 of the KRAS gene and results in an A146T amino acid exchange.", "section": "results", "mentions": ["86|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "5|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "58|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "This c.436G>A mutation (32%) was located in exon 4 of the KRAS gene and results in an <m>A146T</m> amino acid exchange."}], "citations": {"NLM": "Kirschner MM, Schemionek M, Schubert C, Chatain N, Sontag S, Isfort S, Ortiz-Br\u00fcchle N, Schmitt K, Kr\u00fcger L, Zerres K, Zenke M, Br\u00fcmmendorf TH, Koschmieder S. Dissecting Genomic Aberrations in Myeloproliferative Neoplasms by Multiplex-PCR and Next Generation Sequencing. PLoS One. PMID: 25894969", "BibTeX": "@article{25894969, title={Dissecting Genomic Aberrations in Myeloproliferative Neoplasms by Multiplex-PCR and Next Generation Sequencing.}, author={Kirschner MM and Schemionek M and Schubert C and Chatain N and Sontag S and Isfort S and Ortiz-Br\u00fcchle N and Schmitt K and Kr\u00fcger L and Zerres K and Zenke M and Br\u00fcmmendorf TH and Koschmieder S}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 37503313, "pmcid": "PMC10368968", "title": "Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer", "journal": "Front Oncol", "authors": ["Fang Q", "Wan X", "D'Aiello A", "Sun H", "Gu W", "Li Y", "Zhou C", "Xie B", "Deng Q", "Cheng H", "Zhou S"], "date": "2023-07-12T00:00:00Z", "year": 2023, "snippets": [{"_id": "37503313@9676", "section": "table", "mentions": ["659|4|gene|ncbi_gene@1956|EGFR", "1503|4|gene|ncbi_gene@1956|EGFR", "3266|4|gene|ncbi_gene@1956|EGFR", "2977|4|gene|ncbi_gene@1956|EGFR", "3725|4|gene|ncbi_gene@1956|EGFR", "265|4|gene|ncbi_gene@1956|EGFR", "3071|8|variant|litvar@#1956#p.E1761G&&&litvar@#1956#|p.E1761G", "1977|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "3593|4|gene|ncbi_gene@1956|EGFR", "3161|4|gene|ncbi_gene@1956|EGFR", "1700|6|variant|litvar@#1956#|p.R342", "463|4|gene|ncbi_gene@1956|EGFR", "2932|4|gene|ncbi_gene@1956|EGFR", "2496|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "1188|4|gene|ncbi_gene@1956|EGFR", "1840|7|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.E542K", "1537|4|gene|ncbi_gene@1956|EGFR", "257|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "3433|4|gene|ncbi_gene@1956|EGFR", "863|4|gene|ncbi_gene@1956|EGFR", "3332|4|gene|ncbi_gene@1956|EGFR", "3759|4|gene|ncbi_gene@1956|EGFR", "3557|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "1799|7|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.E542K", "3108|4|gene|ncbi_gene@1956|EGFR", "2892|4|gene|ncbi_gene@1956|EGFR", "672|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "3544|4|gene|ncbi_gene@1956|EGFR", "992|4|gene|ncbi_gene@1956|EGFR", "1901|4|gene|ncbi_gene@1956|EGFR", "868|16|variant|litvar@#1956#p.A,AQRG767delins&&&litvar@#1956#|p.A767delinsAQRG", "841|4|gene|ncbi_gene@1956|EGFR", "3324|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "455|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "3196|4|gene|ncbi_gene@1956|EGFR", "4637|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "3793|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "3145|4|gene|ncbi_gene@1956|EGFR", "2783|4|gene|ncbi_gene@1956|EGFR", "3049|7|variant|litvar@rs368440413##&&&litvar@#2475#|p.R188H", "846|16|variant|litvar@#1956#p.A,AQRG767delins&&&litvar@#1956#|p.A767delinsAQRG", "1773|4|gene|ncbi_gene@1956|EGFR", "2723|4|gene|ncbi_gene@1956|EGFR", "2062|4|gene|ncbi_gene@1956|EGFR", "3476|4|gene|ncbi_gene@1956|EGFR", "442|4|gene|ncbi_gene@1956|EGFR", "2425|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "2104|4|gene|ncbi_gene@1956|EGFR", "1599|4|gene|ncbi_gene@1956|EGFR", "2990|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "2164|4|gene|ncbi_gene@1956|EGFR", "1264|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "3417|4|gene|ncbi_gene@1956|EGFR", "2412|4|gene|ncbi_gene@1956|EGFR", "2517|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "2206|4|gene|ncbi_gene@1956|EGFR", "2311|4|gene|ncbi_gene@1956|EGFR", "1251|4|gene|ncbi_gene@1956|EGFR", "3381|4|gene|ncbi_gene@1956|EGFR", "3029|8|variant|litvar@#1956#p.I4381L&&&litvar@#1956#|p.I4381L", "2371|4|gene|ncbi_gene@1956|EGFR", "911|4|gene|ncbi_gene@1956|EGFR", "1426|4|gene|ncbi_gene@1956|EGFR", "2739|4|gene|ncbi_gene@1956|EGFR", "1945|4|gene|ncbi_gene@1956|EGFR", "2555|4|gene|ncbi_gene@1956|EGFR", "3680|4|gene|ncbi_gene@1956|EGFR", "2620|4|gene|ncbi_gene@1956|EGFR", "756|4|gene|ncbi_gene@1956|EGFR", "3345|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "1394|4|gene|ncbi_gene@1956|EGFR", "476|7|variant|litvar@#1956#p.T854A&&&litvar@#1956#|p.T854A", "3772|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "1523|7|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|p.R273C", "2046|4|gene|ncbi_gene@1956|EGFR", "2666|4|gene|ncbi_gene@1956|EGFR", "2483|4|gene|ncbi_gene@1956|EGFR", "546|4|gene|ncbi_gene@1956|EGFR", "651|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "2010|4|gene|ncbi_gene@1956|EGFR", "2148|4|gene|ncbi_gene@1956|EGFR", "638|4|gene|ncbi_gene@1956|EGFR", "331|4|gene|ncbi_gene@1956|EGFR", "4613|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "740|4|gene|ncbi_gene@1956|EGFR", "2355|4|gene|ncbi_gene@1956|EGFR", "2270|4|gene|ncbi_gene@1956|EGFR", "813|4|gene|ncbi_gene@1956|EGFR", "1639|4|gene|ncbi_gene@1956|EGFR", "2832|4|gene|ncbi_gene@1956|EGFR", "3489|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "2254|4|gene|ncbi_gene@1956|EGFR", "1965|4|gene|ncbi_gene@1956|EGFR", "1332|4|gene|ncbi_gene@1956|EGFR", "1814|4|gene|ncbi_gene@1956|EGFR", "1557|7|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|p.R273C", "3223|4|gene|ncbi_gene@1956|EGFR", "1745|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "3664|4|gene|ncbi_gene@1956|EGFR", "2604|4|gene|ncbi_gene@1956|EGFR", "3279|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "245|4|gene|ncbi_gene@1956|EGFR", "1819|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "277|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "1732|4|gene|ncbi_gene@1956|EGFR", "1957|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "3311|4|gene|ncbi_gene@1956|EGFR", "1085|4|gene|ncbi_gene@1956|EGFR", "3536|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "1673|4|gene|ncbi_gene@1956|EGFR", "1778|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "3780|4|gene|ncbi_gene@1956|EGFR", "2848|4|gene|ncbi_gene@1956|EGFR", "2504|4|gene|ncbi_gene@1956|EGFR", "3740|5|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|L858R", "3523|4|gene|ncbi_gene@1956|EGFR"], "figure_id": "T3", "snip_text": "\tNo.\tGender\tAge\tpTNM\tSurgical tissue\tPostoperative adjuvant therapy\tSite(s) of recurrence\tRecurrence specimen\tCurrent treatment\t \tTissue\tBlood\t \tWild type Mutant\t1\tFemale\t61\tIIB\tWild type\tChemotherapy\tBilateral lungMediastinal lymph node Pleura\tEGFR exon21 p.L858R\tEGFR exon21 p.L858R\tGefitinib\t \t2\tMale\t53\tIA\tWild type\tNone\tBone\t\tEGFR exon21 L858R\tGefitinib\t \t3\tFemale\t53\tIIA\tWild type\tChemotherapy\tBilateral lungMediastinal lymph nodeBrain\tEGFR exon 21 p.L858R\tEGFR exon 21 p.T854A\tGefitinib\t \t4\tMale\t52\tIIIA\tWild type\tChemoradiotherapy\tBrain\t\tEGFR exon19 del\tGefitinib\t \t5\tFemale\t70\tIIIA\tWild type\tChemoradiotherapy\tBoneBilateral lung\tEGFR exon 21 p.L858R\tEGFR exon 21 p.L858R\tGefitinib\t \t6\tMale\t43\tIB\tWild type\tChemotherapy\tPleuralLung\tEGFR exon19 del\tEGFR exon19 del\tIcotinib\t \tMutant Wild type\t7\tMale\t70\tIA\tEGFR exon19 del\tNone\tPleura\tEGFR p.A767delinsAQRG\tEGFR p.A767delinsAQRG\tGefitinb\t \t8\tFemale\t48\tIA\tEGFR exon19 del\tNone\tBilateral lung\tWild type\tWild type\tIcotinib\t \t9\tMale\t58\tIIB\tEGFR exon19 del\tChemotherapy\tBilateral lung\tWild type\tWild type\tGefitinib\t \t10\tFemale\t54\tIIA\tEGFR exon19 del\tChemoradiotherapy\tMediastinal lymph node\tWild type\tWild type\tGefitinib\t \t11\tMale\t56\tIA\tEGFR exon19 del\tNone\tBone\t\tWild type\tGefitinbi\t \t12\tMale\t50\tIA\tEGFR exon 21 p.L858R\tNone\tPleura\tWild type\tWild type\tGefitinbi\t \t13\tMale\t67\tIIIA\tEGFR exon19 del\tChemoradiotherapy\tBrain\t\tWild type\tIcotinib\t \tEGFR Co-Mutation\t14\tMale\t56\tIIA\tEGFR exon19 del\tChemotherapy\tMediastinal lymph nodeBilateral LungLiverSpleen\tEGFR exon19 delTP53 p.R273C exon8\tEGFR exon19 delTP53 p.R273C exon8\tGefitinib\t \t15\tFemale\t53\tIA\tEGFR exon19 del\tNone\tBilateral lungBone\tEGFR exon19 delTP53 exon10 p.R342\tEGFR exon19 delTP53 exon10 p.R342\tIcotinib\t \t16\tMale\t54\tIB\tEGFR exon 21 p.L858R\tChemotherapy\tPleura\tEGFR p.L858R exon21PIK3CA p.E542K exon10\tEGFR p.L858R exon21PIK3CA p.E542K exon10\tGefitinib\t \tMutation consistent\t17\tMale\t79\tIB\tEGFR exon19 del\tChemotherapy\tBilateral lung\tEGFR exon21 p.L858R\tEGFR exon21 p.L858R\tIcotinib\t \t18\tMale\t55\tIA\tEGFR exon19 del\tNone\tBilateral lung\tEGFR exon19 del\tEGFR exon19 del\tGefitinib\t \t19\tMale\t59\tIA\tEGFR exon19 del\tNone\tMediastinal lymph node\tEGFR exon19 del\tEGFR exon19 del\tGefitinib\t \t20\tMale\t63\tIB\tEGFR exon19 del\tChemotherapy\tBoneBilateral lung\tEGFR exon19 del\tEGFR exon19 del\tIctonitb\t \t21\tMale\t60\tIB\tEGFR exon19 del\tChemotherapy\tBilateral lung\tEGFR exon19 del\tEGFR exon19 del\tIcotinib\t \t22\tMale\t72\tIB\tEGFR exon 21 p.L858R\tChemotherapy\tMediastinal lymph nodeBilateral lung\tEGFR exon 21 p.L858R\tEGFR exon 21 p.L858R\tGefitinib\t \t23\tFemale\t50\tIIIA\tEGFR exon19 del\tChemoradiothearpy\tBilateral lung\tEGFR exon19 del\tEGFR exon19 del\tGefitinib\t \t24\tFemale\t58\tIIIA\tEGFR exon19 del\tChemoradiotherapy\tMediastinal lymph node\tEGFR exon19 del\tEGFR exon19 del\tErlotinib\t \t25\tMale\t46\tIIIA\tEGFR exon19 del\tChemoradiotherapy\tBilateral lung\tEGFR exon19 del\tEGFR exon19 del\tGefitinib\t \t26\tMale\t49\tIIIA\tEGFR exon19 del\tChemoradiothearpy\tBone\t\tEGFR exon19 del\tGefinitib\t \t27\tFemale\t62\tIIA\tEGFR exon 21 p.L858R\tChemotherapy\tBone\t\tAPOB exon29 p.I4381L,ARAF exon7 p.R188H, SPTA1 exon37 p.E1761G\tGefitinib\t \t28\tFemale\t59\tIB\tEGFR exon19 del\tChemotherapy\tPleural\tEGFR exon19 del\tEGFR exon19 del\t\t \t29\tFemale\t60\tIA\tEGFR exon19 del\tNone\tBone\t\tEGFR exon19 del\tIcotinib\t \t30\tFemale\t55\tIA\tEGFR exon 21 p.L858R\tNone\tBoneBilateral lung\tEGFR exon 21 p.L858R\tEGFR exon 21 p.L858R\tGefitinib\t \t31\tFemale\t61\tIA\tEGFR exon19 del\tNone\tBilateral lung\tEGFR exon19 del\tEGFR exon19 del\tIcotinib\t \t32\tMale\t62\tIIIA\tEGFR exon 21 p.L858R\tChemoradiotherapy\tPleural\tEGFR exon 21 p.L858R\tEGFR exon 21 p.L858R\tErlotinbi\t \t33\tMale\t56\tIIIA\tEGFR exon19 del\tChemoradiotherapy\tMediastinal lymph nodeBilateral lung\tEGFR exon19 del\tEGFR exon19 del\tIcotinib\t \t34\tFemale\t60\tIIIA\tEGFR exon 21 p.L858R\t\tPleuralBone\tEGFR exon 21 p.L858R\tEGFR exon 21 p.L858R\tGefitinib\t \tWild type consistent\t35\tMale\t55\tIIA\tWild type\tChemoradiotherapy\tBoneLiver\tWild type\tWild type\tChemotherapy\t \t36\tMale\t55\tIIIA\tWild type\tChemoradiotherapy\tBilateral lung\tWild type\tWild type\tChemotherapy\t \t37\tMale\t44\tIIIA\tWild type\tChemoradiotherapy\tBrain\t\tWild type\tChemotherapy\t \t38\tMale\t57\tIB\tWild type\tChemotherapy\tBrain\t\tWild type\tChemotherapy\t \t39\tMale\t64\tIB\tWild type\tChemotherapy\tBilateral lungMediastinal lymph node\tWild type\tWild type\tChemotherapy\t \t40\tFemale\t60\tIB\tWild type\tChemothearpy\tBilateral lungMediastinal lymph node\tWild type\tWild type\tChemotherapy\t \t41\tMale\t66\tIIA\tWild type\tChemotherapy\tBilateral lungMediastinal lymph node\tWild type\tWild type\tChemotherapy\t \t42\tMale\t66\tIIA\tWild type\tChemotherapy\tBone\t\tWild type\tChemotherapy\t \t43\tMale\t74\tIA\tWild type\tNone\tPleural\tWild type, NRAS p.A146T\tWild type, NRAS p.A146T\tChemotherapy\t \t44\tMale\t60\tIB\tWild type\tChemothearpy\tBrain\t\tWild type\tChemotherapy\t \t45\tFemale\t54\tIA\tWild type\tNone\tBrain\t\tWild type\tChemotherapy\t \t", "text_hl": "\tNo.\tGender\tAge\tpTNM\tSurgical tissue\tPostoperative adjuvant therapy\tSite(s) of recurrence\tRecurrence specimen\tCurrent treatment\t \tTissue\tBlood\t \tWild type Mutant\t1\tFemale\t61\tIIB\tWild type\tChemotherapy\tBilateral lungMediastinal lymph node Pleura\tEGFR exon21 p.L858R\tEGFR exon21 p.L858R\tGefitinib\t \t2\tMale\t53\tIA\tWild type\tNone\tBone\t\tEGFR exon21 L858R\tGefitinib\t \t3\tFemale\t53\tIIA\tWild type\tChemotherapy\tBilateral lungMediastinal lymph nodeBrain\tEGFR exon 21 p.L858R\tEGFR exon 21 p.T854A\tGefitinib\t \t4\tMale\t52\tIIIA\tWild type\tChemoradiotherapy\tBrain\t\tEGFR exon19 del\tGefitinib\t \t5\tFemale\t70\tIIIA\tWild type\tChemoradiotherapy\tBoneBilateral lung\tEGFR exon 21 p.L858R\tEGFR exon 21 p.L858R\tGefitinib\t \t6\tMale\t43\tIB\tWild type\tChemotherapy\tPleuralLung\tEGFR exon19 del\tEGFR exon19 del\tIcotinib\t \tMutant Wild type\t7\tMale\t70\tIA\tEGFR exon19 del\tNone\tPleura\tEGFR p.A767delinsAQRG\tEGFR p.A767delinsAQRG\tGefitinb\t \t8\tFemale\t48\tIA\tEGFR exon19 del\tNone\tBilateral lung\tWild type\tWild type\tIcotinib\t \t9\tMale\t58\tIIB\tEGFR exon19 del\tChemotherapy\tBilateral lung\tWild type\tWild type\tGefitinib\t \t10\tFemale\t54\tIIA\tEGFR exon19 del\tChemoradiotherapy\tMediastinal lymph node\tWild type\tWild type\tGefitinib\t \t11\tMale\t56\tIA\tEGFR exon19 del\tNone\tBone\t\tWild type\tGefitinbi\t \t12\tMale\t50\tIA\tEGFR exon 21 p.L858R\tNone\tPleura\tWild type\tWild type\tGefitinbi\t \t13\tMale\t67\tIIIA\tEGFR exon19 del\tChemoradiotherapy\tBrain\t\tWild type\tIcotinib\t \tEGFR Co-Mutation\t14\tMale\t56\tIIA\tEGFR exon19 del\tChemotherapy\tMediastinal lymph nodeBilateral LungLiverSpleen\tEGFR exon19 delTP53 p.R273C exon8\tEGFR exon19 delTP53 p.R273C exon8\tGefitinib\t \t15\tFemale\t53\tIA\tEGFR exon19 del\tNone\tBilateral lungBone\tEGFR exon19 delTP53 exon10 p.R342\tEGFR exon19 delTP53 exon10 p.R342\tIcotinib\t \t16\tMale\t54\tIB\tEGFR exon 21 p.L858R\tChemotherapy\tPleura\tEGFR p.L858R exon21PIK3CA p.E542K exon10\tEGFR p.L858R exon21PIK3CA p.E542K exon10\tGefitinib\t \tMutation consistent\t17\tMale\t79\tIB\tEGFR exon19 del\tChemotherapy\tBilateral lung\tEGFR exon21 p.L858R\tEGFR exon21 p.L858R\tIcotinib\t \t18\tMale\t55\tIA\tEGFR exon19 del\tNone\tBilateral lung\tEGFR exon19 del\tEGFR exon19 del\tGefitinib\t \t19\tMale\t59\tIA\tEGFR exon19 del\tNone\tMediastinal lymph node\tEGFR exon19 del\tEGFR exon19 del\tGefitinib\t \t20\tMale\t63\tIB\tEGFR exon19 del\tChemotherapy\tBoneBilateral lung\tEGFR exon19 del\tEGFR exon19 del\tIctonitb\t \t21\tMale\t60\tIB\tEGFR exon19 del\tChemotherapy\tBilateral lung\tEGFR exon19 del\tEGFR exon19 del\tIcotinib\t \t22\tMale\t72\tIB\tEGFR exon 21 p.L858R\tChemotherapy\tMediastinal lymph nodeBilateral lung\tEGFR exon 21 p.L858R\tEGFR exon 21 p.L858R\tGefitinib\t \t23\tFemale\t50\tIIIA\tEGFR exon19 del\tChemoradiothearpy\tBilateral lung\tEGFR exon19 del\tEGFR exon19 del\tGefitinib\t \t24\tFemale\t58\tIIIA\tEGFR exon19 del\tChemoradiotherapy\tMediastinal lymph node\tEGFR exon19 del\tEGFR exon19 del\tErlotinib\t \t25\tMale\t46\tIIIA\tEGFR exon19 del\tChemoradiotherapy\tBilateral lung\tEGFR exon19 del\tEGFR exon19 del\tGefitinib\t \t26\tMale\t49\tIIIA\tEGFR exon19 del\tChemoradiothearpy\tBone\t\tEGFR exon19 del\tGefinitib\t \t27\tFemale\t62\tIIA\tEGFR exon 21 p.L858R\tChemotherapy\tBone\t\tAPOB exon29 p.I4381L,ARAF exon7 p.R188H, SPTA1 exon37 p.E1761G\tGefitinib\t \t28\tFemale\t59\tIB\tEGFR exon19 del\tChemotherapy\tPleural\tEGFR exon19 del\tEGFR exon19 del\t\t \t29\tFemale\t60\tIA\tEGFR exon19 del\tNone\tBone\t\tEGFR exon19 del\tIcotinib\t \t30\tFemale\t55\tIA\tEGFR exon 21 p.L858R\tNone\tBoneBilateral lung\tEGFR exon 21 p.L858R\tEGFR exon 21 p.L858R\tGefitinib\t \t31\tFemale\t61\tIA\tEGFR exon19 del\tNone\tBilateral lung\tEGFR exon19 del\tEGFR exon19 del\tIcotinib\t \t32\tMale\t62\tIIIA\tEGFR exon 21 p.L858R\tChemoradiotherapy\tPleural\tEGFR exon 21 p.L858R\tEGFR exon 21 p.L858R\tErlotinbi\t \t33\tMale\t56\tIIIA\tEGFR exon19 del\tChemoradiotherapy\tMediastinal lymph nodeBilateral lung\tEGFR exon19 del\tEGFR exon19 del\tIcotinib\t \t34\tFemale\t60\tIIIA\tEGFR exon 21 p.L858R\t\tPleuralBone\tEGFR exon 21 p.L858R\tEGFR exon 21 p.L858R\tGefitinib\t \tWild type consistent\t35\tMale\t55\tIIA\tWild type\tChemoradiotherapy\tBoneLiver\tWild type\tWild type\tChemotherapy\t \t36\tMale\t55\tIIIA\tWild type\tChemoradiotherapy\tBilateral lung\tWild type\tWild type\tChemotherapy\t \t37\tMale\t44\tIIIA\tWild type\tChemoradiotherapy\tBrain\t\tWild type\tChemotherapy\t \t38\tMale\t57\tIB\tWild type\tChemotherapy\tBrain\t\tWild type\tChemotherapy\t \t39\tMale\t64\tIB\tWild type\tChemotherapy\tBilateral lungMediastinal lymph node\tWild type\tWild type\tChemotherapy\t \t40\tFemale\t60\tIB\tWild type\tChemothearpy\tBilateral lungMediastinal lymph node\tWild type\tWild type\tChemotherapy\t \t41\tMale\t66\tIIA\tWild type\tChemotherapy\tBilateral lungMediastinal lymph node\tWild type\tWild type\tChemotherapy\t \t42\tMale\t66\tIIA\tWild type\tChemotherapy\tBone\t\tWild type\tChemotherapy\t \t43\tMale\t74\tIA\tWild type\tNone\tPleural\tWild type, NRAS <m>p.A146T</m>\tWild type, NRAS <m>p.A146T</m>\tChemotherapy\t \t44\tMale\t60\tIB\tWild type\tChemothearpy\tBrain\t\tWild type\tChemotherapy\t \t45\tFemale\t54\tIA\tWild type\tNone\tBrain\t\tWild type\tChemotherapy\t \t"}], "citations": {"NLM": "Fang Q, Wan X, D'Aiello A, Sun H, Gu W, Li Y, Zhou C, Xie B, Deng Q, Cheng H, Zhou S. Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer Front Oncol. PMID: 37503313", "BibTeX": "@article{37503313, title={Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer}, author={Fang Q and Wan X and D'Aiello A and Sun H and Gu W and Li Y and Zhou C and Xie B and Deng Q and Cheng H and Zhou S}, journal={Front Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 29963224, "pmcid": "PMC6021240", "title": "Comprehensive identification of long noncoding RNAs in colorectal cancer.", "journal": "Oncotarget", "authors": ["James de Bony E", "Bizet M", "Van Grembergen O", "Hassabi B", "Calonne E", "Putmans P", "Bontempi G", "Fuks F"], "date": "2018-06-12T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "James de Bony E, Bizet M, Van Grembergen O, Hassabi B, Calonne E, Putmans P, Bontempi G, Fuks F. Comprehensive identification of long noncoding RNAs in colorectal cancer. Oncotarget. PMID: 29963224", "BibTeX": "@article{29963224, title={Comprehensive identification of long noncoding RNAs in colorectal cancer.}, author={James de Bony E and Bizet M and Van Grembergen O and Hassabi B and Calonne E and Putmans P and Bontempi G and Fuks F}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 28926605, "pmcid": "PMC5604939", "title": "Assessment of common somatic mutations of EGFR, KRAS, BRAF, NRAS in pulmonary non-small cell carcinoma using iPLEX  HS, a new highly sensitive assay for the MassARRAY  System.", "journal": "PLoS One", "authors": ["Sutton BC", "Birse RT", "Maggert K", "Ray T", "Hobbs J", "Ezenekwe A", "Kazmierczak J", "Mosko M", "Kish J", "Bullock A", "Shi Z", "Stack MS", "Irwin D"], "date": "2017-09-19T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Sutton BC, Birse RT, Maggert K, Ray T, Hobbs J, Ezenekwe A, Kazmierczak J, Mosko M, Kish J, Bullock A, Shi Z, Stack MS, Irwin D. Assessment of common somatic mutations of EGFR, KRAS, BRAF, NRAS in pulmonary non-small cell carcinoma using iPLEX  HS, a new highly sensitive assay for the MassARRAY  System. PLoS One. PMID: 28926605", "BibTeX": "@article{28926605, title={Assessment of common somatic mutations of EGFR, KRAS, BRAF, NRAS in pulmonary non-small cell carcinoma using iPLEX  HS, a new highly sensitive assay for the MassARRAY  System.}, author={Sutton BC and Birse RT and Maggert K and Ray T and Hobbs J and Ezenekwe A and Kazmierczak J and Mosko M and Kish J and Bullock A and Shi Z and Stack MS and Irwin D}, journal={PLoS One}}"}, "is_sup_mat_match": true}, {"pmid": 26325103, "pmcid": "PMC4578093", "title": "KRAS, NRAS, BRAF mutation comparison of endoscopic and surgically removed primary CRC paired samples: is endoscopy biopsy material adequate for molecular evaluation?", "journal": "Br J Cancer", "authors": ["Saridaki Z", "Saegart X", "De Vriendt V", "Hatzidaki D", "Palmans S", "De Smedt L", "De Hertogh G", "Tejpar S"], "date": "2015-09-15T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Saridaki Z, Saegart X, De Vriendt V, Hatzidaki D, Palmans S, De Smedt L, De Hertogh G, Tejpar S. KRAS, NRAS, BRAF mutation comparison of endoscopic and surgically removed primary CRC paired samples: is endoscopy biopsy material adequate for molecular evaluation? Br J Cancer. PMID: 26325103", "BibTeX": "@article{26325103, title={KRAS, NRAS, BRAF mutation comparison of endoscopic and surgically removed primary CRC paired samples: is endoscopy biopsy material adequate for molecular evaluation?}, author={Saridaki Z and Saegart X and De Vriendt V and Hatzidaki D and Palmans S and De Smedt L and De Hertogh G and Tejpar S}, journal={Br J Cancer}}"}, "is_sup_mat_match": true}, {"pmid": 27737711, "pmcid": "PMC5064898", "title": "Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study", "journal": "J Transl Med", "authors": ["Palomba G", "Doneddu V", "Cossu A", "Paliogiannis P", "Manca A", "Casula M", "Colombino M", "Lanzillo A", "Defraia E", "Pazzola A", "Sanna G", "Putzu C", "Ortu S", "Scartozzi M", "Ionta MT", "Baldino G", "Sarobba G", "Capelli F", "Sedda T", "Virdis L", "Barca M", "Gramignano G", "Budroni M", "Tanda F", "Palmieri G"], "date": "2016-10-13T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Palomba G, Doneddu V, Cossu A, Paliogiannis P, Manca A, Casula M, Colombino M, Lanzillo A, Defraia E, Pazzola A, Sanna G, Putzu C, Ortu S, Scartozzi M, Ionta MT, Baldino G, Sarobba G, Capelli F, Sedda T, Virdis L, Barca M, Gramignano G, Budroni M, Tanda F, Palmieri G. Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study J Transl Med. PMID: 27737711", "BibTeX": "@article{27737711, title={Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study}, author={Palomba G and Doneddu V and Cossu A and Paliogiannis P and Manca A and Casula M and Colombino M and Lanzillo A and Defraia E and Pazzola A and Sanna G and Putzu C and Ortu S and Scartozzi M and Ionta MT and Baldino G and Sarobba G and Capelli F and Sedda T and Virdis L and Barca M and Gramignano G and Budroni M and Tanda F and Palmieri G}, journal={J Transl Med}}"}, "is_sup_mat_match": true}, {"pmid": 36945587, "pmcid": "PMC10029038", "title": "Relapse timing is associated with distinct evolutionary dynamics in DLBCL", "journal": "medRxiv", "authors": ["Hilton LK", "Ngu HS", "Collinge B", "Dreval K", "Ben-Neriah S", "Rushton CK", "Wong JCH", "Cruz M", "Roth A", "Boyle M", "Meissner B", "Slack GW", "Farinha P", "Craig JW", "Gerrie AS", "Freeman CL", "Villa D", "Crump M", "Shepherd L", "Hay AE", "Kuruvilla J", "Savage KJ", "Kridel R", "Karsan A", "Marra MA", "Sehn LH", "Steidl C", "Morin RD", "Scott DW"], "date": "2023-03-08T00:00:00Z", "year": 2023, "snippets": [], "citations": {"NLM": "Hilton LK, Ngu HS, Collinge B, Dreval K, Ben-Neriah S, Rushton CK, Wong JCH, Cruz M, Roth A, Boyle M, Meissner B, Slack GW, Farinha P, Craig JW, Gerrie AS, Freeman CL, Villa D, Crump M, Shepherd L, Hay AE, Kuruvilla J, Savage KJ, Kridel R, Karsan A, Marra MA, Sehn LH, Steidl C, Morin RD, Scott DW. Relapse timing is associated with distinct evolutionary dynamics in DLBCL medRxiv. PMID: 36945587", "BibTeX": "@article{36945587, title={Relapse timing is associated with distinct evolutionary dynamics in DLBCL}, author={Hilton LK and Ngu HS and Collinge B and Dreval K and Ben-Neriah S and Rushton CK and Wong JCH and Cruz M and Roth A and Boyle M and Meissner B and Slack GW and Farinha P and Craig JW and Gerrie AS and Freeman CL and Villa D and Crump M and Shepherd L and Hay AE and Kuruvilla J and Savage KJ and Kridel R and Karsan A and Marra MA and Sehn LH and Steidl C and Morin RD and Scott DW}, journal={medRxiv}}"}, "is_sup_mat_match": true}, {"pmid": 37004022, "pmcid": "PMC10063947", "title": "Plasma ctDNA increases tissue NGS-based detection of therapeutically targetable mutations in lung cancers", "journal": "BMC Cancer", "authors": ["Xie J", "Yao W", "Chen L", "Zhu W", "Liu Q", "Geng G", "Fang J", "Zhao Y", "Xiao L", "Huang Z", "Zhao J"], "date": "2023-03-31T00:00:00Z", "year": 2023, "snippets": [], "citations": {"NLM": "Xie J, Yao W, Chen L, Zhu W, Liu Q, Geng G, Fang J, Zhao Y, Xiao L, Huang Z, Zhao J. Plasma ctDNA increases tissue NGS-based detection of therapeutically targetable mutations in lung cancers BMC Cancer. PMID: 37004022", "BibTeX": "@article{37004022, title={Plasma ctDNA increases tissue NGS-based detection of therapeutically targetable mutations in lung cancers}, author={Xie J and Yao W and Chen L and Zhu W and Liu Q and Geng G and Fang J and Zhao Y and Xiao L and Huang Z and Zhao J}, journal={BMC Cancer}}"}, "is_sup_mat_match": true}, {"pmid": 30341394, "pmcid": "PMC6365378", "title": "Targeting MEK in vemurafenib-resistant hairy cell leukemia", "journal": "Leukemia", "authors": ["Caeser R", "Collord G", "Yao WQ", "Chen Z", "Vassiliou GS", "Beer PA", "Du MQ", "Scott MA", "Follows GA", "Hodson DJ"], "date": "2019-02-01T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Caeser R, Collord G, Yao WQ, Chen Z, Vassiliou GS, Beer PA, Du MQ, Scott MA, Follows GA, Hodson DJ. Targeting MEK in vemurafenib-resistant hairy cell leukemia Leukemia. PMID: 30341394", "BibTeX": "@article{30341394, title={Targeting MEK in vemurafenib-resistant hairy cell leukemia}, author={Caeser R and Collord G and Yao WQ and Chen Z and Vassiliou GS and Beer PA and Du MQ and Scott MA and Follows GA and Hodson DJ}, journal={Leukemia}}"}, "is_sup_mat_match": true}, {"pmid": 28664935, "pmcid": "PMC5837474", "title": "Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease", "journal": "Mod Pathol", "authors": ["Garces S", "Medeiros LJ", "Patel KP", "Li S", "Pina-Oviedo S", "Li J", "Garces JC", "Khoury JD", "Yin CC"], "date": "2017-10-01T00:00:00Z", "year": 2017, "snippets": [{"_id": "28664935@13633", "snip_text": "Among the KRAS-mutated cases, 2 cases had mutations in exon 2 (c.35G>A p.G12D and c.64C>A p.Q22K), and 2 had mutations in exon 4 (c.351A>T p.K117N and c.436G>A p.A146T).", "section": "results", "mentions": ["153|6|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|436G>A", "139|7|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.K117N", "162|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "71|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "10|4|gene|ncbi_gene@3845|KRAS", "84|5|variant|litvar@rs121913236##&&&litvar@#3845#&&&litvar@CA16602771#rs121913236##|64C>A", "132|6|variant|litvar@rs770248150##&&&litvar@#3845#|351A>T", "65|5|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|35G>A", "90|6|variant|litvar@rs121913236##&&&litvar@#3845#&&&litvar@CA16602771#rs121913236##|p.Q22K"], "text_hl": "Among the KRAS-mutated cases, 2 cases had mutations in exon 2 (c.35G>A p.G12D and c.64C>A p.Q22K), and 2 had mutations in exon 4 (c.351A>T p.K117N and c.436G>A <m>p.A146T</m>)."}], "citations": {"NLM": "Garces S, Medeiros LJ, Patel KP, Li S, Pina-Oviedo S, Li J, Garces JC, Khoury JD, Yin CC. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease Mod Pathol. PMID: 28664935", "BibTeX": "@article{28664935, title={Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease}, author={Garces S and Medeiros LJ and Patel KP and Li S and Pina-Oviedo S and Li J and Garces JC and Khoury JD and Yin CC}, journal={Mod Pathol}}"}, "is_sup_mat_match": false}, {"pmid": 38025833, "pmcid": "PMC10646763", "title": "Association of KRAS, NRAS, BRAF and PIK3CA gene mutations with clinicopathological features, prognosis and ring finger protein 215 expression in patients with colorectal cancer", "journal": "Biomed Rep", "authors": ["Wu JB", "Li XJ", "Liu H", "Liu YJ", "Liu XP"], "date": "2023-10-31T00:00:00Z", "year": 2023, "snippets": [{"_id": "38025833@26443", "snip_text": "The rate of mutation in codons 12 and 13 in exon 2 was 4.4% (8/182), that in codon Q61 of exon 3 was 1.1% (2/182), and that in codon A146T of exon 4 was 0.5% (1/182), which was consistent with the findings of a previous study.", "section": "discussion", "mentions": ["83|3|variant|litvar@rs121913240##&&&litvar@#3845#|Q61", "133|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "The rate of mutation in codons 12 and 13 in exon 2 was 4.4% (8/182), that in codon Q61 of exon 3 was 1.1% (2/182), and that in codon <m>A146T</m> of exon 4 was 0.5% (1/182), which was consistent with the findings of a previous study."}], "citations": {"NLM": "Wu JB, Li XJ, Liu H, Liu YJ, Liu XP. Association of KRAS, NRAS, BRAF and PIK3CA gene mutations with clinicopathological features, prognosis and ring finger protein 215 expression in patients with colorectal cancer Biomed Rep. PMID: 38025833", "BibTeX": "@article{38025833, title={Association of KRAS, NRAS, BRAF and PIK3CA gene mutations with clinicopathological features, prognosis and ring finger protein 215 expression in patients with colorectal cancer}, author={Wu JB and Li XJ and Liu H and Liu YJ and Liu XP}, journal={Biomed Rep}}"}, "is_sup_mat_match": false}, {"pmid": 26220423, "pmcid": "PMC4518505", "title": "Detection of KRAS, NRAS and BRAF by mass spectrometry - a sensitive, reliable, fast and cost-effective technique.", "journal": "Diagn Pathol", "authors": ["Kriegsmann M", "Arens N", "Endris V", "Weichert W", "Kriegsmann J"], "date": "2015-07-30T00:00:00Z", "year": 2015, "snippets": [{"_id": "26220423@9950", "snip_text": "KRAS: G12C, G12D, G12V, G12A, G12S, G12R, G13D,G13V, G13A, G13S, Q61H, Q61E, Q61K, Q61R, Q61P, Q61L, K117N, A146T   NRAS: G12C, G12D, G12V, G12A, G12S, G12R, G13D,G13V, G13A, Q61H, Q61E, Q61K, K117N, A146T   BRAF: V600E, V600K,V600R, V600L   ", "section": "table", "mentions": ["163|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "193|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "12|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "77|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "101|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "95|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "169|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13A", "234|5|variant|litvar@rs121913378##&&&litvar@#673#&&&litvar@CA135104#rs121913378##|V600L", "187|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "36|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "221|5|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16602420#rs121913227##|V600K", "128|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "146|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "59|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA16602674#rs121434595##|G13S", "18|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "140|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "152|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "0|4|gene|ncbi_gene@3845|KRAS", "227|5|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16021333#rs121913227##|V600R", "65|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "83|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "47|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "175|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "214|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "6|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "24|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "200|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "42|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "108|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "116|4|gene|ncbi_gene@4893|NRAS", "181|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA16602362#rs121913254##|Q61E", "71|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA16602362#rs121913254##|Q61E", "134|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "208|4|gene|ncbi_gene@673|BRAF", "89|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA10602732#rs11554290##|Q61P", "122|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "158|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "53|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13A", "30|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S"], "figure_id": "Tab1", "text_hl": "KRAS: G12C, G12D, G12V, G12A, G12S, G12R, G13D,G13V, G13A, G13S, Q61H, Q61E, Q61K, Q61R, Q61P, Q61L, K117N, <m>A146T</m>   NRAS: G12C, G12D, G12V, G12A, G12S, G12R, G13D,G13V, G13A, Q61H, Q61E, Q61K, K117N, <m>A146T</m>   BRAF: V600E, V600K,V600R, V600L   "}], "citations": {"NLM": "Kriegsmann M, Arens N, Endris V, Weichert W, Kriegsmann J. Detection of KRAS, NRAS and BRAF by mass spectrometry - a sensitive, reliable, fast and cost-effective technique. Diagn Pathol. PMID: 26220423", "BibTeX": "@article{26220423, title={Detection of KRAS, NRAS and BRAF by mass spectrometry - a sensitive, reliable, fast and cost-effective technique.}, author={Kriegsmann M and Arens N and Endris V and Weichert W and Kriegsmann J}, journal={Diagn Pathol}}"}, "is_sup_mat_match": false}, {"pmid": 25944693, "pmcid": "PMC4558179", "title": "RAS testing in metastatic colorectal cancer: excellent reproducibility amongst 17 Dutch pathology centers.", "journal": "Oncotarget", "authors": ["Boleij A", "Tops BB", "Rombout PD", "Dequeker EM", "Ligtenberg MJ", "van Krieken JH", "Dutch RAS EQA Initiative."], "date": "2015-06-20T00:00:00Z", "year": 2015, "snippets": [{"_id": "25944693@9655", "snip_text": "This concerned mutations in KRAS exon 4 (c.436G>A; p.Ala146Thr), NRAS exon 2 (c.35G>A; p.Gly12Asp), NRAS exon 3 (c.181C>A; p.Gln61Lys) and seven mutations in BRAF (c.1799T>A; p.Val600GLu) that the participating laboratory had not tested for [Table 2].", "section": "results", "mentions": ["87|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.Gly12Asp", "100|4|gene|ncbi_gene@4893|NRAS", "51|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "41|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "123|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Gln61Lys", "65|4|gene|ncbi_gene@4893|NRAS", "28|4|gene|ncbi_gene@3845|KRAS", "177|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|Val600GLu", "158|4|gene|ncbi_gene@673|BRAF", "164|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "78|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G>A", "113|8|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C>A"], "text_hl": "This concerned mutations in KRAS exon 4 (c.436G>A; <m>p.Ala146Thr</m>), NRAS exon 2 (c.35G>A; p.Gly12Asp), NRAS exon 3 (c.181C>A; p.Gln61Lys) and seven mutations in BRAF (c.1799T>A; p.Val600GLu) that the participating laboratory had not tested for [Table 2]."}], "citations": {"NLM": "Boleij A, Tops BB, Rombout PD, Dequeker EM, Ligtenberg MJ, van Krieken JH, Dutch RAS EQA Initiative.. RAS testing in metastatic colorectal cancer: excellent reproducibility amongst 17 Dutch pathology centers. Oncotarget. PMID: 25944693", "BibTeX": "@article{25944693, title={RAS testing in metastatic colorectal cancer: excellent reproducibility amongst 17 Dutch pathology centers.}, author={Boleij A and Tops BB and Rombout PD and Dequeker EM and Ligtenberg MJ and van Krieken JH and Dutch RAS EQA Initiative.}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 35139380, "pmcid": "PMC8936000", "title": "Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants.", "journal": "Cell Rep", "authors": ["Khan I", "Koide A", "Zuberi M", "Ketavarapu G", "Denbaum E", "Teng KW", "Rhett JM", "Spencer-Smith R", "Hobbs GA", "Camp ER", "Koide S", "O'Bryan JP"], "date": "2022-02-08T00:00:00Z", "year": 2022, "snippets": [{"_id": "35139380@5060", "snip_text": "These findings are also consistent with the observation that certain RAS mutants, e.g.  G12D, G13D, Q61L, and A146T, exhibit elevated spontaneous nucleotide release rates.", "section": "introduction", "mentions": ["100|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "88|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "110|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "94|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D"], "text_hl": "These findings are also consistent with the observation that certain RAS mutants, e.g.  G12D, G13D, Q61L, and <m>A146T</m>, exhibit elevated spontaneous nucleotide release rates."}], "citations": {"NLM": "Khan I, Koide A, Zuberi M, Ketavarapu G, Denbaum E, Teng KW, Rhett JM, Spencer-Smith R, Hobbs GA, Camp ER, Koide S, O'Bryan JP. Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants. Cell Rep. PMID: 35139380", "BibTeX": "@article{35139380, title={Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants.}, author={Khan I and Koide A and Zuberi M and Ketavarapu G and Denbaum E and Teng KW and Rhett JM and Spencer-Smith R and Hobbs GA and Camp ER and Koide S and O'Bryan JP}, journal={Cell Rep}}"}, "is_sup_mat_match": false}, {"pmid": 30018674, "pmcid": "PMC6029483", "title": "Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer.", "journal": "Dis Markers", "authors": ["Reggiani Bonetti L", "Barresi V", "Maiorana A", "Manfredini S", "Caprera C", "Bettelli S"], "date": "2018-06-19T00:00:00Z", "year": 2018, "snippets": [{"_id": "30018674@8323", "snip_text": "Among those, 22 (78%) had a single KRAS mutation (G13D in 7 cases, G12D in 6 cases, G12V in 5 cases, G12C in 1 case, G12F in 1 case, A146T in 1, and Q61H in 1), while 6 showed multiple mutations.", "section": "results", "mentions": ["50|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "84|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "101|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "117|4|variant|litvar@rs121913530##&&&litvar@#3845#|G12F", "149|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "35|4|gene|ncbi_gene@3845|KRAS", "67|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "133|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Among those, 22 (78%) had a single KRAS mutation (G13D in 7 cases, G12D in 6 cases, G12V in 5 cases, G12C in 1 case, G12F in 1 case, <m>A146T</m> in 1, and Q61H in 1), while 6 showed multiple mutations."}], "citations": {"NLM": "Reggiani Bonetti L, Barresi V, Maiorana A, Manfredini S, Caprera C, Bettelli S. Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer. Dis Markers. PMID: 30018674", "BibTeX": "@article{30018674, title={Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer.}, author={Reggiani Bonetti L and Barresi V and Maiorana A and Manfredini S and Caprera C and Bettelli S}, journal={Dis Markers}}"}, "is_sup_mat_match": false}, {"pmid": 37576960, "pmcid": "PMC10422880", "title": "Abnormalities of pubertal development and gonadal function in Noonan syndrome", "journal": "Front Endocrinol (Lausanne)", "authors": ["Patti G", "Scaglione M", "Maiorano NG", "Rosti G", "Divizia MT", "Camia T", "De Rose EL", "Zucconi A", "Casalini E", "Napoli F", "Di Iorgi N", "Maghnie M"], "date": "2023-07-28T00:00:00Z", "year": 2023, "snippets": [{"_id": "37576960@23686", "snip_text": "Case\tGene\tMutation\tGender\tAge(y*)\tPubertyonset (y*)\tDosable LH (y*)\tDosable E or T (y*)\tAge at final height (y)\tPubertal stage at last examination\tLast examinationheight (SD)\tDelta Target (SD)\tMenarche(y)\tCryptorchidism\tVT at last examination(ml)\t \t1\tSOS1\tc.322G>A, p.Glu108Lys\tF\t20,4\t14,6\t14,7\t14,1\t18,2\t5\t-0,3\t0,9\t17,0\t\t\t \t2\tKRAS\tc.436G>T, p.Ala146Ser\tF\t17,6\t9,9\t9,9\t9,9\t16,2\t5\t-3,4\t-2,1\t13\t\t\t \t3\tBRAF\tc.770A>G, p.Gln257Arg\tF\t16,1\t10,5\t10,1\t10,1\t15,4\t4\t-3,4\t-2,8\t\t\t\t \t4\tSHOC2\tc.4A>G, p.Ser2Gly\tM\t23,5\t14,2\t14,2\t14,2\t19,6\t5\t-3,7\t-2,5\t\tNo\t20\t \t5\tKRAS\tc.101C>G, p.Pro34Arg\tF\t11,5\t8,9\t8,4\t9,5\t\t2\t-4\t-4\t\t\t\t \t6\tPTPN11\tc.923A>G, p.Ans308Ser\tM\t14,4\t12,1\t11,7\t11,7\t\t2\t-0,7\t-0,4\t\tYes\t5\t \t7\tPTPN11\tc.1403C>T, p.Thr468Met\tM\t17,5\t14,3\t14,3\t14,3\t\t4\t-1,5\t-0,1\t\tNo\t12\t \t8\tPTPN11\tc.236A>G, p.Gln79Arg\tF\t15\t10,5\t9,2\t11,5\t16,6\t5\t-1,8\t-2,1\t12,5\t\t\t \t9\tBRAF\tc.681G>C, p.Val276Leu\tF\t20,1\t16,0\t13,5\t18,5\t\t4\t-0,6\t0,4\t18\t\t\t \t10\tPTPN11\tc.228 G>C, p.Glu76Asp\tM\t21,9\t12,6\t10,5\t12,6\t20,5\t5\t-2,2\t-0,1\t\tNo\t25\t \t11\tPTPN11\tc.922A>G, p.Asn308Asp\tM\t20,0\t13,3\t13,4\t13,4\t17,3\t5\t-2,4\t-1\t\tYes\t20\t \t12\tPTPN11\tc.236 A>G, p.Gln79Arg\tF\t17,7\t14,1\t12,7\t13,1\t\t4\t-1\t-1,3\t\t\t\t \t13\tSHOC2\tc.4A>G, p.Ser2Gly\tM\t15,2\t14,1\t14,2\t14,2\t\t3\t-3,2\t-2,8\t\tNo\t12\t \t14\tPTPN11\tc.188A>G, p.Tyr63Cys\tM\t13,0\t12,9\t12,9\t12,9\t\t2\t-1,5\t-0,8\t\tNo\t8\t \t15\tKRAS\tc.40 G>A, p.Val14Ile\tM\t14,5\t12,7\t8,5\t12,0\t\t2\t-2,3\t-3,9\t\tNo\t6\t \t16\tKRAS\tc.40G>Ap.Val14lle\tF\t29,8\t13,8\t\t\t17\t5\t-2,8\t\t16\t\t\t \t", "section": "table", "mentions": ["1204|6|gene|ncbi_gene@5781|PTPN11", "1278|4|gene|ncbi_gene@3845|KRAS", "266|11|variant|litvar@rs397517164##&&&litvar@#6654#&&&litvar@CA261739#rs397517164##|p.Glu108Lys", "984|6|gene|ncbi_gene@5781|PTPN11", "991|8|variant|litvar@rs28933386##&&&litvar@#5781#&&&litvar@CA220158#rs28933386##|c.922A>G", "1293|10|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|p.Val14Ile", "1081|10|variant|litvar@rs121918466##&&&litvar@#5781#&&&litvar@CA235322#rs121918466##|p.Gln79Arg", "251|4|gene|ncbi_gene@6654|SOS1", "404|8|variant|litvar@rs180177035##&&&litvar@#673#&&&litvar@CA222583#rs180177035##|c.770A>G", "551|8|variant|litvar@rs104894366##&&&litvar@#3845#&&&litvar@CA280040#rs104894366##|c.101C>G", "399|4|gene|ncbi_gene@673|BRAF", "1001|11|variant|litvar@rs28933386##&&&litvar@#5781#&&&litvar@CA220158#rs28933386##|p.Asn308Asp", "775|10|variant|litvar@rs121918466##&&&litvar@#5781#&&&litvar@CA235322#rs121918466##|p.Gln79Arg", "1139|6|variant|litvar@rs267607048##&&&litvar@#8036#&&&litvar@CA118524#rs267607048##|c.4A>G", "922|10|variant|litvar@rs397507514##&&&litvar@#5781#&&&litvar@CA261580#rs397507514##|p.Glu76Asp", "682|6|gene|ncbi_gene@5781|PTPN11", "546|4|gene|ncbi_gene@3845|KRAS", "1221|10|variant|litvar@rs121918459##&&&litvar@#5781#&&&litvar@CA220146#rs121918459##|p.Tyr63Cys", "1063|6|gene|ncbi_gene@5781|PTPN11", "332|8|variant|litvar@rs121913527##&&&litvar@#3845#|c.436G>T", "414|11|variant|litvar@rs180177035##&&&litvar@#673#&&&litvar@CA222583#rs180177035##|p.Gln257Arg", "1349|4|gene|ncbi_gene@3845|KRAS", "917|3|variant|litvar@#5781#|G>C", "1358|3|variant|litvar@#3845#|G>A", "700|11|variant|litvar@rs121918457##&&&litvar@#5781#&&&litvar@CA220134#rs121918457##|p.Thr468Met", "1216|3|variant|litvar@#5781#|A>G", "486|9|variant|litvar@rs267607048##&&&litvar@#8036#&&&litvar@CA118524#rs267607048##|p.Ser2Gly", "327|4|gene|ncbi_gene@3845|KRAS", "342|11|variant|litvar@rs121913527##&&&litvar@#3845#|p.Ala146Ser", "1147|9|variant|litvar@rs267607048##&&&litvar@#8036#&&&litvar@CA118524#rs267607048##|p.Ser2Gly", "561|10|variant|litvar@rs104894366##&&&litvar@#3845#&&&litvar@CA280040#rs104894366##|p.Pro34Arg", "765|8|variant|litvar@rs121918466##&&&litvar@#5781#&&&litvar@CA235322#rs121918466##|c.236A>G", "838|8|variant|litvar@#673#c.681G>C&&&litvar@#673#|c.681G>C", "904|6|gene|ncbi_gene@5781|PTPN11", "256|8|variant|litvar@rs397517164##&&&litvar@#6654#&&&litvar@CA261739#rs397517164##|c.322G>A", "1133|5|gene|ncbi_gene@8036|SHOC2", "614|8|variant|litvar@rs121918455##&&&litvar@#5781#&&&litvar@CA235328#rs121918455##|c.923A>G", "758|6|gene|ncbi_gene@5781|PTPN11", "478|6|variant|litvar@rs267607048##&&&litvar@#8036#&&&litvar@CA118524#rs267607048##|c.4A>G", "607|6|gene|ncbi_gene@5781|PTPN11", "833|4|gene|ncbi_gene@673|BRAF", "472|5|gene|ncbi_gene@8036|SHOC2", "689|9|variant|litvar@rs121918457##&&&litvar@#5781#&&&litvar@CA220134#rs121918457##|c.1403C>T", "848|11|variant|litvar@rs1057518105##&&&litvar@#673#|p.Val276Leu"], "figure_id": "T2", "text_hl": "Case\tGene\tMutation\tGender\tAge(y*)\tPubertyonset (y*)\tDosable LH (y*)\tDosable E or T (y*)\tAge at final height (y)\tPubertal stage at last examination\tLast examinationheight (SD)\tDelta Target (SD)\tMenarche(y)\tCryptorchidism\tVT at last examination(ml)\t \t1\tSOS1\tc.322G>A, p.Glu108Lys\tF\t20,4\t14,6\t14,7\t14,1\t18,2\t5\t-0,3\t0,9\t17,0\t\t\t \t2\tKRAS\tc.436G>T, p.Ala146Ser\tF\t17,6\t9,9\t9,9\t9,9\t16,2\t5\t-3,4\t-2,1\t13\t\t\t \t3\tBRAF\tc.770A>G, p.Gln257Arg\tF\t16,1\t10,5\t10,1\t10,1\t15,4\t4\t-3,4\t-2,8\t\t\t\t \t4\tSHOC2\tc.4A>G, p.Ser2Gly\tM\t23,5\t14,2\t14,2\t14,2\t19,6\t5\t-3,7\t-2,5\t\tNo\t20\t \t5\tKRAS\tc.101C>G, p.Pro34Arg\tF\t11,5\t8,9\t8,4\t9,5\t\t2\t-4\t-4\t\t\t\t \t6\tPTPN11\tc.923A>G, p.Ans308Ser\tM\t14,4\t12,1\t11,7\t11,7\t\t2\t-0,7\t-0,4\t\tYes\t5\t \t7\tPTPN11\tc.1403C>T, p.Thr468Met\tM\t17,5\t14,3\t14,3\t14,3\t\t4\t-1,5\t-0,1\t\tNo\t12\t \t8\tPTPN11\tc.236A>G, p.Gln79Arg\tF\t15\t10,5\t9,2\t11,5\t16,6\t5\t-1,8\t-2,1\t12,5\t\t\t \t9\tBRAF\tc.681G>C, p.Val276Leu\tF\t20,1\t16,0\t13,5\t18,5\t\t4\t-0,6\t0,4\t18\t\t\t \t10\tPTPN11\tc.228 G>C, p.Glu76Asp\tM\t21,9\t12,6\t10,5\t12,6\t20,5\t5\t-2,2\t-0,1\t\tNo\t25\t \t11\tPTPN11\tc.922A>G, p.Asn308Asp\tM\t20,0\t13,3\t13,4\t13,4\t17,3\t5\t-2,4\t-1\t\tYes\t20\t \t12\tPTPN11\tc.236 A>G, p.Gln79Arg\tF\t17,7\t14,1\t12,7\t13,1\t\t4\t-1\t-1,3\t\t\t\t \t13\tSHOC2\tc.4A>G, p.Ser2Gly\tM\t15,2\t14,1\t14,2\t14,2\t\t3\t-3,2\t-2,8\t\tNo\t12\t \t14\tPTPN11\tc.188A>G, p.Tyr63Cys\tM\t13,0\t12,9\t12,9\t12,9\t\t2\t-1,5\t-0,8\t\tNo\t8\t \t15\tKRAS\tc.40 G>A, p.Val14Ile\tM\t14,5\t12,7\t8,5\t12,0\t\t2\t-2,3\t-3,9\t\tNo\t6\t \t16\tKRAS\tc.40G>Ap.Val14lle\tF\t29,8\t13,8\t\t\t17\t5\t-2,8\t\t16\t\t\t \t"}], "citations": {"NLM": "Patti G, Scaglione M, Maiorano NG, Rosti G, Divizia MT, Camia T, De Rose EL, Zucconi A, Casalini E, Napoli F, Di Iorgi N, Maghnie M. Abnormalities of pubertal development and gonadal function in Noonan syndrome Front Endocrinol (Lausanne). PMID: 37576960", "BibTeX": "@article{37576960, title={Abnormalities of pubertal development and gonadal function in Noonan syndrome}, author={Patti G and Scaglione M and Maiorano NG and Rosti G and Divizia MT and Camia T and De Rose EL and Zucconi A and Casalini E and Napoli F and Di Iorgi N and Maghnie M}, journal={Front Endocrinol (Lausanne)}}"}, "is_sup_mat_match": false}, {"pmid": 24944587, "pmcid": "PMC4062050", "title": "Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin.", "journal": "Genome Med", "authors": ["Alakus H", "Babicky ML", "Ghosh P", "Yost S", "Jepsen K", "Dai Y", "Arias A", "Samuels ML", "Mose ES", "Schwab RB", "Peterson MR", "Lowy AM", "Frazer KA", "Harismendy O"], "date": "2014-05-29T00:00:00Z", "year": 2014, "snippets": [{"_id": "24944587@13254", "snip_text": "KRAS was mutated in all nine low-grade MCP samples, with three different missense alterations: G12V (N = 7), G12D (N = 1), and A146T (N = 1).", "section": "discussion", "mentions": ["109|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "39|3|disease|ncbi_mesh@D002277|MCP", "127|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "95|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "0|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "KRAS was mutated in all nine low-grade MCP samples, with three different missense alterations: G12V (N = 7), G12D (N = 1), and <m>A146T</m> (N = 1)."}], "citations": {"NLM": "Alakus H, Babicky ML, Ghosh P, Yost S, Jepsen K, Dai Y, Arias A, Samuels ML, Mose ES, Schwab RB, Peterson MR, Lowy AM, Frazer KA, Harismendy O. Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin. Genome Med. PMID: 24944587", "BibTeX": "@article{24944587, title={Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin.}, author={Alakus H and Babicky ML and Ghosh P and Yost S and Jepsen K and Dai Y and Arias A and Samuels ML and Mose ES and Schwab RB and Peterson MR and Lowy AM and Frazer KA and Harismendy O}, journal={Genome Med}}"}, "is_sup_mat_match": false}, {"pmid": 29228562, "pmcid": "PMC5722514", "title": "Clinical mutational profiling of 1006 lung cancers by next generation sequencing", "journal": "Oncotarget", "authors": ["Illei PB", "Belchis D", "Tseng LH", "Nguyen D", "De Marchi F", "Haley L", "Riel S", "Beierl K", "Zheng G", "Brahmer JR", "Askin FB", "Gocke CD", "Eshleman JR", "Forde PM", "Lin MT"], "date": "2017-05-20T00:00:00Z", "year": 2017, "snippets": [{"_id": "29228562@20457", "snip_text": "mut 1 (VAF%)\tmut 2 (VAF%)\tBRAF kinase activity\t \tKRAS p.Q61H (12%)\tBRAF p.G464V (9.5%)\tactivateda\t \tKRAS p.G12D (19%)\tBRAF p.G466E (3.3%)\tImpaired \t \tKRAS p.A146T (30%)\tBRAF p.G466V (35%)\tImpaired \t \tKRAS p.G12D (19%)\tBRAF p.G466V (14%)\tImpaired \t \tKRAS p.G12V (14%)\tBRAF p.D594G (2.6%)\tImpaired \t \tKRAS p.Q61H (24%)b\tBRAF p.D594N (5.7%)b\tImpaired \t \tKRAS p.G12V (16%) b\tBRAF p.T440I (13%)b\tunknown\t \tKRAS p.G12C (14%)\tBRAF p.G466L (12%)\tunknown\t \tKRAS p.G12R (12%)b\tBRAF p.G469R (11%)b\tunknown\t \tKRAS p.G13D (25%)b\tBRAF p.G469V (20%)b\tunknown\t \tKRAS p. A146T (11%)\tBRAF p.K601N (11%)\tunknown\t \t", "section": "table", "mentions": ["448|4|gene|ncbi_gene@3845|KRAS", "72|7|variant|litvar@rs121913348##&&&litvar@#673#&&&litvar@CA135076#rs121913348##|p.G464V", "26|4|gene|ncbi_gene@673|BRAF", "67|4|gene|ncbi_gene@673|BRAF", "254|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "118|4|gene|ncbi_gene@673|BRAF", "502|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "150|4|gene|ncbi_gene@3845|KRAS", "406|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "169|4|gene|ncbi_gene@673|BRAF", "200|4|gene|ncbi_gene@3845|KRAS", "49|4|gene|ncbi_gene@3845|KRAS", "467|4|gene|ncbi_gene@673|BRAF", "155|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "100|4|gene|ncbi_gene@3845|KRAS", "123|7|variant|litvar@rs121913351##&&&litvar@#673#&&&litvar@CA16602535#rs121913351##|p.G466E", "356|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "472|7|variant|litvar@rs121913357##&&&litvar@#673#&&&litvar@CA123653#rs121913357##|p.G469R", "174|7|variant|litvar@rs121913351##&&&litvar@#673#&&&litvar@CA123647#rs121913351##|p.G466V", "546|4|gene|ncbi_gene@3845|KRAS", "371|4|gene|ncbi_gene@673|BRAF", "453|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "376|7|variant|litvar@#673#p.T440I&&&litvar@#673#|p.T440I", "299|4|gene|ncbi_gene@3845|KRAS", "205|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "54|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "249|4|gene|ncbi_gene@3845|KRAS", "105|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "267|4|gene|ncbi_gene@673|BRAF", "323|7|variant|litvar@rs397516896##&&&litvar@#673#&&&litvar@CA135095#rs397516896##|p.D594N", "419|4|gene|ncbi_gene@673|BRAF", "566|4|gene|ncbi_gene@673|BRAF", "318|4|gene|ncbi_gene@673|BRAF", "497|4|gene|ncbi_gene@3845|KRAS", "554|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "218|4|gene|ncbi_gene@673|BRAF", "272|7|variant|litvar@rs121913338##&&&litvar@#673#&&&litvar@CA123657#rs121913338##|p.D594G", "401|4|gene|ncbi_gene@3845|KRAS", "424|7|variant|litvar@rs121913351##&&&litvar@#673#|p.G466L", "571|7|variant|litvar@rs121913365##&&&litvar@#673#&&&litvar@CA16602734#rs121913365##|p.K601N", "516|4|gene|ncbi_gene@673|BRAF", "351|4|gene|ncbi_gene@3845|KRAS", "521|7|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA135085#rs121913355##|p.G469V", "223|7|variant|litvar@rs121913351##&&&litvar@#673#&&&litvar@CA123647#rs121913351##|p.G466V", "304|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H"], "figure_id": "T5", "text_hl": "mut 1 (VAF%)\tmut 2 (VAF%)\tBRAF kinase activity\t \tKRAS p.Q61H (12%)\tBRAF p.G464V (9.5%)\tactivateda\t \tKRAS p.G12D (19%)\tBRAF p.G466E (3.3%)\tImpaired \t \tKRAS <m>p.A146T</m> (30%)\tBRAF p.G466V (35%)\tImpaired \t \tKRAS p.G12D (19%)\tBRAF p.G466V (14%)\tImpaired \t \tKRAS p.G12V (14%)\tBRAF p.D594G (2.6%)\tImpaired \t \tKRAS p.Q61H (24%)b\tBRAF p.D594N (5.7%)b\tImpaired \t \tKRAS p.G12V (16%) b\tBRAF p.T440I (13%)b\tunknown\t \tKRAS p.G12C (14%)\tBRAF p.G466L (12%)\tunknown\t \tKRAS p.G12R (12%)b\tBRAF p.G469R (11%)b\tunknown\t \tKRAS p.G13D (25%)b\tBRAF p.G469V (20%)b\tunknown\t \tKRAS p. <m>A146T</m> (11%)\tBRAF p.K601N (11%)\tunknown\t \t"}], "citations": {"NLM": "Illei PB, Belchis D, Tseng LH, Nguyen D, De Marchi F, Haley L, Riel S, Beierl K, Zheng G, Brahmer JR, Askin FB, Gocke CD, Eshleman JR, Forde PM, Lin MT. Clinical mutational profiling of 1006 lung cancers by next generation sequencing Oncotarget. PMID: 29228562", "BibTeX": "@article{29228562, title={Clinical mutational profiling of 1006 lung cancers by next generation sequencing}, author={Illei PB and Belchis D and Tseng LH and Nguyen D and De Marchi F and Haley L and Riel S and Beierl K and Zheng G and Brahmer JR and Askin FB and Gocke CD and Eshleman JR and Forde PM and Lin MT}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 32062493, "pmcid": "PMC7448574", "title": "KRAS as a druggable target in NSCLC: Rising like a phoenix after decades of development failures", "journal": "Cancer Treat Rev", "authors": ["Friedlaender A", "Drilon A", "Weiss GJ", "Banna GL", "Addeo A"], "date": "2020-04-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "32062493@4955", "snip_text": "For example, while KRAS G12, G13, and Q61 substitutions impair GTP hydrolysis, others mutations such as KRAS A146T (the most prevalent substitution in gastrointestinal malignancies) maintain hydrolysis similar to wild-type KRAS.", "section": "other", "mentions": ["151|29|disease|ncbi_mesh@D005770|gastrointestinal malignancies", "104|4|gene|ncbi_gene@3845|KRAS", "24|3|variant|litvar@rs121913530##&&&litvar@#3845#|G12", "223|4|gene|ncbi_gene@3845|KRAS", "109|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "63|3|chemical|ncbi_mesh@D006160|GTP", "19|4|gene|ncbi_gene@3845|KRAS", "29|3|variant|litvar@rs112445441##&&&litvar@#3845#|G13"], "text_hl": "For example, while KRAS G12, G13, and Q61 substitutions impair GTP hydrolysis, others mutations such as KRAS <m>A146T</m> (the most prevalent substitution in gastrointestinal malignancies) maintain hydrolysis similar to wild-type KRAS."}], "citations": {"NLM": "Friedlaender A, Drilon A, Weiss GJ, Banna GL, Addeo A. KRAS as a druggable target in NSCLC: Rising like a phoenix after decades of development failures Cancer Treat Rev. PMID: 32062493", "BibTeX": "@article{32062493, title={KRAS as a druggable target in NSCLC: Rising like a phoenix after decades of development failures}, author={Friedlaender A and Drilon A and Weiss GJ and Banna GL and Addeo A}, journal={Cancer Treat Rev}}"}, "is_sup_mat_match": false}, {"pmid": 31477768, "pmcid": "PMC6718424", "title": "Optimisation of robust singleplex and multiplex droplet digital PCR assays for high confidence mutation detection in circulating tumour DNA.", "journal": "Sci Rep", "authors": ["Rowlands V", "Rutkowski AJ", "Meuser E", "Carr TH", "Harrington EA", "Barrett JC"], "date": "2019-09-02T00:00:00Z", "year": 2019, "snippets": [{"_id": "31477768@25922", "snip_text": "(a) KRAS multiplex #1 covering G12A, G12C, G12D, G12V and G13C mutations, (b) KRAS multiplex #2 covering G12R, Q61H A > C, Q61H A > T, Q61L and Q61R mutations, and (c) KRAS multiplex #3 covering G12F, G12S, G13D and A146T mutations.", "section": "figure_legend", "mentions": ["105|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "123|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "43|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "83|9|species|ncbi_taxonomy@1819610|multiplex", "116|5|variant|litvar@#3845#|A > C", "135|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|Q61L", "37|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "195|4|variant|litvar@rs121913529##&&&litvar@#3845#|G12F", "58|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "173|9|species|ncbi_taxonomy@1819610|multiplex", "78|4|gene|ncbi_gene@3845|KRAS", "168|4|gene|ncbi_gene@3845|KRAS", "111|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "207|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "128|5|variant|litvar@#3845#|A > T", "201|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "49|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "4|4|gene|ncbi_gene@3845|KRAS", "9|9|species|ncbi_taxonomy@1819610|multiplex", "31|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "216|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "144|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|Q61R"], "figure_id": "Fig9", "text_hl": "(a) KRAS multiplex #1 covering G12A, G12C, G12D, G12V and G13C mutations, (b) KRAS multiplex #2 covering G12R, Q61H A > C, Q61H A > T, Q61L and Q61R mutations, and (c) KRAS multiplex #3 covering G12F, G12S, G13D and <m>A146T</m> mutations."}], "citations": {"NLM": "Rowlands V, Rutkowski AJ, Meuser E, Carr TH, Harrington EA, Barrett JC. Optimisation of robust singleplex and multiplex droplet digital PCR assays for high confidence mutation detection in circulating tumour DNA. Sci Rep. PMID: 31477768", "BibTeX": "@article{31477768, title={Optimisation of robust singleplex and multiplex droplet digital PCR assays for high confidence mutation detection in circulating tumour DNA.}, author={Rowlands V and Rutkowski AJ and Meuser E and Carr TH and Harrington EA and Barrett JC}, journal={Sci Rep}}"}, "is_sup_mat_match": false}, {"pmid": 28489509, "pmcid": "PMC5501365", "title": "AKT Inhibition in Solid Tumors With AKT1 Mutations", "journal": "J Clin Oncol", "authors": ["Hyman DM", "Smyth LM", "Donoghue MTA", "Westin SN", "Bedard PL", "Dean EJ", "Bando H", "El-Khoueiry AB", "P\u00e9rez-Fidalgo JA", "Mita A", "Schellens JHM", "Chang MT", "Reichel JB", "Bouvier N", "Selcuklu SD", "Soumerai TE", "Torrisi J", "Erinjeri JP", "Ambrose H", "Barrett JC", "Dougherty B", "Foxley A", "Lindemann JPO", "McEwen R", "Pass M", "Schiavon G", "Berger MF", "Chandarlapaty S", "Solit DB", "Banerji U", "Baselga J", "Taylor BS"], "date": "2017-07-10T00:00:00Z", "year": 2017, "snippets": [{"_id": "28489509@15320", "snip_text": "In a patient with nonresponding colorectal cancer, a subclonal KRAS A146T hotspot mutation not detected by local tumor profiling was identified in pretreatment cfDNA, a mutation that preclinically is associated with resistance to AZD5363.", "section": "results", "mentions": ["113|5|disease|ncbi_mesh@D009369|tumor", "68|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "32|17|disease|ncbi_mesh@D015179|colorectal cancer", "230|7|chemical|ncbi_mesh@C575618|AZD5363", "5|7|species|ncbi_taxonomy@9606|patient", "63|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "In a patient with nonresponding colorectal cancer, a subclonal KRAS <m>A146T</m> hotspot mutation not detected by local tumor profiling was identified in pretreatment cfDNA, a mutation that preclinically is associated with resistance to AZD5363."}], "citations": {"NLM": "Hyman DM, Smyth LM, Donoghue MTA, Westin SN, Bedard PL, Dean EJ, Bando H, El-Khoueiry AB, P\u00e9rez-Fidalgo JA, Mita A, Schellens JHM, Chang MT, Reichel JB, Bouvier N, Selcuklu SD, Soumerai TE, Torrisi J, Erinjeri JP, Ambrose H, Barrett JC, Dougherty B, Foxley A, Lindemann JPO, McEwen R, Pass M, Schiavon G, Berger MF, Chandarlapaty S, Solit DB, Banerji U, Baselga J, Taylor BS. AKT Inhibition in Solid Tumors With AKT1 Mutations J Clin Oncol. PMID: 28489509", "BibTeX": "@article{28489509, title={AKT Inhibition in Solid Tumors With AKT1 Mutations}, author={Hyman DM and Smyth LM and Donoghue MTA and Westin SN and Bedard PL and Dean EJ and Bando H and El-Khoueiry AB and P\u00e9rez-Fidalgo JA and Mita A and Schellens JHM and Chang MT and Reichel JB and Bouvier N and Selcuklu SD and Soumerai TE and Torrisi J and Erinjeri JP and Ambrose H and Barrett JC and Dougherty B and Foxley A and Lindemann JPO and McEwen R and Pass M and Schiavon G and Berger MF and Chandarlapaty S and Solit DB and Banerji U and Baselga J and Taylor BS}, journal={J Clin Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 37082097, "pmcid": "PMC10112385", "title": "Treatment outcomes of mucosal melanoma of head and neck: Efficacy of immune checkpoint inhibitors for advanced disease", "journal": "Front Surg", "authors": ["Ohshima S", "Ueki Y", "Yokoyama Y", "Takahashi T", "Shodo R", "Yamazaki K", "Okabe R", "Matsuyama H", "Togashi T", "Takatsuka S", "Takenouchi T", "Horii A"], "date": "2022-12-26T00:00:00Z", "year": 2022, "snippets": [{"_id": "37082097@9805", "snip_text": "We evaluated two types of BRAF exon 15 mutations (V600 E and V600K), 12 types of NRAS exon 2 (G12, G12C, G12R, G12D, G12V, G12A, G13S, G13C, G13R, G13D, G13V, and G13A), nine types of NRAS exon 3 (A59T, A59G, Q61K, Q61E, Q61L, Q61P, Q61R, Q61Ht, and Q61Hc), and five types of NRAS exon 4 (K117Nc, K117Nt, A146T, A146P, and A146V).", "section": "methods", "mentions": ["111|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "105|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "153|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "203|4|variant|litvar@rs781085650##&&&litvar@#673#&&&litvar@CA4517046#rs781085650##|A59G", "123|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "94|3|variant|litvar@rs121913237##&&&litvar@#4893#|G12", "197|4|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|A59T", "215|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA16602362#rs121913254##|Q61E", "117|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "135|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13C", "163|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602364#rs121434596##|G13A", "209|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "227|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA10602732#rs11554290##|Q61P", "147|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "129|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA16602674#rs121434595##|G13S", "323|5|variant|litvar@#4893#p.A146V&&&litvar@#4893#|A146V", "276|4|gene|ncbi_gene@4893|NRAS", "99|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "61|5|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16602420#rs121913227##|V600K", "221|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "141|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "233|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "81|4|gene|ncbi_gene@4893|NRAS", "312|5|variant|litvar@#4893#p.A146P&&&litvar@#4893#|A146P", "184|4|gene|ncbi_gene@4893|NRAS", "305|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "26|4|gene|ncbi_gene@673|BRAF", "50|6|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600 E"], "text_hl": "We evaluated two types of BRAF exon 15 mutations (V600 E and V600K), 12 types of NRAS exon 2 (G12, G12C, G12R, G12D, G12V, G12A, G13S, G13C, G13R, G13D, G13V, and G13A), nine types of NRAS exon 3 (A59T, A59G, Q61K, Q61E, Q61L, Q61P, Q61R, Q61Ht, and Q61Hc), and five types of NRAS exon 4 (K117Nc, K117Nt, <m>A146T</m>, A146P, and A146V)."}], "citations": {"NLM": "Ohshima S, Ueki Y, Yokoyama Y, Takahashi T, Shodo R, Yamazaki K, Okabe R, Matsuyama H, Togashi T, Takatsuka S, Takenouchi T, Horii A. Treatment outcomes of mucosal melanoma of head and neck: Efficacy of immune checkpoint inhibitors for advanced disease Front Surg. PMID: 37082097", "BibTeX": "@article{37082097, title={Treatment outcomes of mucosal melanoma of head and neck: Efficacy of immune checkpoint inhibitors for advanced disease}, author={Ohshima S and Ueki Y and Yokoyama Y and Takahashi T and Shodo R and Yamazaki K and Okabe R and Matsuyama H and Togashi T and Takatsuka S and Takenouchi T and Horii A}, journal={Front Surg}}"}, "is_sup_mat_match": false}, {"pmid": 32854257, "pmcid": "PMC7564483", "title": "A Distinctive microRNA (miRNA) Signature in the Blood of Colorectal Cancer (CRC) Patients at Surgery.", "journal": "Cancers (Basel)", "authors": ["Gasparello J", "Papi C", "Allegretti M", "Giordani E", "Carboni F", "Zazza S", "Pescarmona E", "Romania P", "Giacomini P", "Scapoli C", "Gambari R", "Finotti A"], "date": "2020-08-25T00:00:00Z", "year": 2020, "snippets": [{"_id": "32854257@14793", "snip_text": "To this end, we divided our patient population in two groups: the former bearing KRAS-WT tumors (n = 11), and the latter carrying the p.G12D (n = 5), p.G12V (n = 3), p.G13D (n = 3), p.G12A (n = 2), p.G60D (n = 1), p.A146T (n = 1) and p.G12R (n = 1) KRAS mutations (see Table S2).", "section": "results", "mentions": ["28|7|species|ncbi_taxonomy@9606|patient", "198|6|variant|litvar@#3845#p.G60D&&&litvar@#3845#|p.G60D", "182|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "89|6|disease|ncbi_mesh@D009369|tumors", "166|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "234|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "150|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "134|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "214|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "249|4|gene|ncbi_gene@3845|KRAS", "275|2|cellline||S2", "81|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "To this end, we divided our patient population in two groups: the former bearing KRAS-WT tumors (n = 11), and the latter carrying the p.G12D (n = 5), p.G12V (n = 3), p.G13D (n = 3), p.G12A (n = 2), p.G60D (n = 1), <m>p.A146T</m> (n = 1) and p.G12R (n = 1) KRAS mutations (see Table S2)."}], "citations": {"NLM": "Gasparello J, Papi C, Allegretti M, Giordani E, Carboni F, Zazza S, Pescarmona E, Romania P, Giacomini P, Scapoli C, Gambari R, Finotti A. A Distinctive microRNA (miRNA) Signature in the Blood of Colorectal Cancer (CRC) Patients at Surgery. Cancers (Basel). PMID: 32854257", "BibTeX": "@article{32854257, title={A Distinctive microRNA (miRNA) Signature in the Blood of Colorectal Cancer (CRC) Patients at Surgery.}, author={Gasparello J and Papi C and Allegretti M and Giordani E and Carboni F and Zazza S and Pescarmona E and Romania P and Giacomini P and Scapoli C and Gambari R and Finotti A}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 27121720, "pmcid": "PMC5266405", "title": "Use of a High-Throughput Genotyping Platform (OncoMap) for RAS Mutational Analysis to Predict Cetuximab Efficacy in Patients with Metastatic Colorectal Cancer.", "journal": "Cancer Res Treat", "authors": ["Kim D", "Hong YS", "Kim JE", "Kim KP", "Lee JL", "Chun SM", "Kim J", "Jang SJ", "Kim TW"], "date": "2017-01-01T00:00:00Z", "year": 2017, "snippets": [{"_id": "27121720@21097", "snip_text": "Mutation  No.   KRAS (n=46)      Exon 2 (25/227, 11.0%) G12C 2    G12D 10    G12R 1    G12S 2    G12V 4    G13D 5    G13S 1    Exon 3 (9/227, 4.0%) Q61H 7    Q61L 1    Q61R 1    Exon 4 (12/227, 5.3%) A146T 7    A146V 2    K117N 3   NRAS (n=11)      Exon 2 (6/227, 2.6%) G12A 1    G12D 3    G12V 1    G13V 1    Exon 3 (5/227, 2.2%) Q61H 1    Q61K 2    Q61R 2   ", "section": "table", "mentions": ["168|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "16|4|gene|ncbi_gene@3845|KRAS", "232|4|gene|ncbi_gene@4893|NRAS", "331|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "97|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "290|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "211|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "148|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "77|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "200|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "56|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "158|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "341|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "107|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "270|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "66|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "300|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "222|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "87|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "351|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "117|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA16602445#rs121913535##|G13S", "280|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D"], "figure_id": "t2-crt-2016-069", "text_hl": "Mutation  No.   KRAS (n=46)      Exon 2 (25/227, 11.0%) G12C 2    G12D 10    G12R 1    G12S 2    G12V 4    G13D 5    G13S 1    Exon 3 (9/227, 4.0%) Q61H 7    Q61L 1    Q61R 1    Exon 4 (12/227, 5.3%) <m>A146T</m> 7    A146V 2    K117N 3   NRAS (n=11)      Exon 2 (6/227, 2.6%) G12A 1    G12D 3    G12V 1    G13V 1    Exon 3 (5/227, 2.2%) Q61H 1    Q61K 2    Q61R 2   "}], "citations": {"NLM": "Kim D, Hong YS, Kim JE, Kim KP, Lee JL, Chun SM, Kim J, Jang SJ, Kim TW. Use of a High-Throughput Genotyping Platform (OncoMap) for RAS Mutational Analysis to Predict Cetuximab Efficacy in Patients with Metastatic Colorectal Cancer. Cancer Res Treat. PMID: 27121720", "BibTeX": "@article{27121720, title={Use of a High-Throughput Genotyping Platform (OncoMap) for RAS Mutational Analysis to Predict Cetuximab Efficacy in Patients with Metastatic Colorectal Cancer.}, author={Kim D and Hong YS and Kim JE and Kim KP and Lee JL and Chun SM and Kim J and Jang SJ and Kim TW}, journal={Cancer Res Treat}}"}, "is_sup_mat_match": false}, {"pmid": 34161704, "pmcid": "PMC8864540", "title": "Acquired Resistance to KRASG12C Inhibition in Cancer", "journal": "N Engl J Med", "authors": ["Awad MM", "Liu S", "Rybkin II", "Arbour KC", "Dilly J", "Zhu VW", "Johnson ML", "Heist RS", "Patil T", "Riely GJ", "Jacobson JO", "Yang X", "Persky NS", "Root DE", "Lowder KE", "Feng H", "Zhang SS", "Haigis KM", "Hung YP", "Sholl LM", "Wolpin BM", "Wiese J", "Christiansen J", "Lee J", "Schrock AB", "Lim LP", "Garg K", "Li M", "Engstrom LD", "Waters L", "Lawson JD", "Olson P", "Lito P", "Ou SI", "Christensen JG", "J\u00e4nne PA", "Aguirre AJ"], "date": "2021-06-24T00:00:00Z", "year": 2021, "snippets": [{"_id": "34161704@18056", "snip_text": "For both adagrasib and sotorasib, drug-resistance mutations at residues outside of the drug-binding pocket and known to be involved in enhanced nucleotide exchange, including G13D, A59S, K117N, and A146P, conferred more modest resistance than the G12R and Y96C drug-binding mutations.", "section": "results", "mentions": ["198|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "256|4|variant|litvar@rs587781991##&&&litvar@#7157#&&&litvar@CA160#rs587781991##|Y96C", "181|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA354836#rs121913528##|A59S", "23|9|chemical|ncbi_mesh@C000706028|sotorasib", "9|9|chemical|ncbi_mesh@C000718190|adagrasib", "187|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "175|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "247|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R"], "text_hl": "For both adagrasib and sotorasib, drug-resistance mutations at residues outside of the drug-binding pocket and known to be involved in enhanced nucleotide exchange, including G13D, A59S, K117N, and A146P, conferred more modest resistance than the G12R and Y96C drug-binding mutations."}], "citations": {"NLM": "Awad MM, Liu S, Rybkin II, Arbour KC, Dilly J, Zhu VW, Johnson ML, Heist RS, Patil T, Riely GJ, Jacobson JO, Yang X, Persky NS, Root DE, Lowder KE, Feng H, Zhang SS, Haigis KM, Hung YP, Sholl LM, Wolpin BM, Wiese J, Christiansen J, Lee J, Schrock AB, Lim LP, Garg K, Li M, Engstrom LD, Waters L, Lawson JD, Olson P, Lito P, Ou SI, Christensen JG, J\u00e4nne PA, Aguirre AJ. Acquired Resistance to KRASG12C Inhibition in Cancer N Engl J Med. PMID: 34161704", "BibTeX": "@article{34161704, title={Acquired Resistance to KRASG12C Inhibition in Cancer}, author={Awad MM and Liu S and Rybkin II and Arbour KC and Dilly J and Zhu VW and Johnson ML and Heist RS and Patil T and Riely GJ and Jacobson JO and Yang X and Persky NS and Root DE and Lowder KE and Feng H and Zhang SS and Haigis KM and Hung YP and Sholl LM and Wolpin BM and Wiese J and Christiansen J and Lee J and Schrock AB and Lim LP and Garg K and Li M and Engstrom LD and Waters L and Lawson JD and Olson P and Lito P and Ou SI and Christensen JG and J\u00e4nne PA and Aguirre AJ}, journal={N Engl J Med}}"}, "is_sup_mat_match": false}, {"pmid": 33096795, "pmcid": "PMC7589866", "title": "Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer.", "journal": "Cancers (Basel)", "authors": ["Ottaiano A", "Caraglia M", "Di Mauro A", "Botti G", "Lombardi A", "Galon J", "Luce A", "D'Amore L", "Perri F", "Santorsola M", "Hermitte F", "Savarese G", "Tatangelo F", "Granata V", "Izzo F", "Belli A", "Scala S", "Delrio P", "Circelli L", "Nasti G"], "date": "2020-10-21T00:00:00Z", "year": 2020, "snippets": [{"_id": "33096795@39646", "snip_text": "Groups Patient PT Mutated Genes MT Mutated Genes   Group A PAT1 APC (p.R554TER), TP53 (p.R273H, p.P72R*), BRCA2 (p.Y1655TER). APC (p.R554TER), TP53 (p.P72R, p.R273H), BRCA2 (p.Y1655TER).   PAT2 APC (p.1450TER), TP53 (p.K382TER, p.P72R), KRAS (p.A146T), SMAD4 (p.R361H). APC (p.1450TER), TP53 (p.K382TER, p.P72R).   PAT3 APC (p.S587TER), TP53 (p.V197E, p.V173A, p.P72R), KRAS (p.G13D), KRAS (p.G12D). APC (p.S587TER), TP53 (p.V197E, p.V173A, p.P72R), KRAS (p.G13D).   Group B PAT4 APC (p.Q236TER), TP53 (p.C135F, p.P72R). APC (p.Q236TER), TP53 (p.C135F, p.P72R), KRAS (p.G12C), PIK3CA (p.E545K).   PAT5 APC (p.R876TER, p.M1413TER), TP53 (p.R273H, p.P72R), NRAS (p.Q61K) APC (p.R876TER, p.M1413TER), TP53 (p.R273H, p.P72R), NRAS (p.Q61K), PIK3CA (p.M1043I), SMAD4 (p.Q256TER).   PAT6 APC (p.H298TER, p.K581TER), TP53 (p.P72R). APC (p.H298TER, p.K581TER), TP53 (p.P72R), PIK3CA (p.R88Q), BRAF (p.P403L).   ", "section": "table", "mentions": ["859|6|variant|litvar@rs1042522##&&&litvar@#7157#&&&litvar@CA72#rs1042522##|p.P72R", "763|9|variant|litvar@rs1321296538##&&&litvar@#285641#|p.Q256TER", "194|3|gene|ncbi_gene@324|APC", "315|4|gene|ncbi_gene@285641|PAT3", "81|4|gene|ncbi_gene@7157|TP53", "370|4|gene|ncbi_gene@3845|KRAS", "607|9|variant|litvar@rs121913333##&&&litvar@#324#&&&litvar@CA338207#rs121913333##|p.R876TER", "405|9|variant|litvar@rs137854570##&&&litvar@#324#&&&litvar@CA7219#rs137854570##|p.S587TER", "655|4|gene|ncbi_gene@4893|NRAS", "553|6|variant|litvar@rs1042522##&&&litvar@#7157#&&&litvar@CA72#rs1042522##|p.P72R", "618|10|variant|litvar@#7157#p.M1413X&&&litvar@#7157#|p.M1413TER", "853|4|gene|ncbi_gene@7157|TP53", "113|10|variant|litvar@rs80358721##&&&litvar@#675#&&&litvar@CA21070#rs80358721##|p.Y1655TER", "253|5|gene|ncbi_gene@4089|SMAD4", "728|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "417|4|gene|ncbi_gene@7157|TP53", "737|6|gene|ncbi_gene@5290|PIK3CA", "174|10|variant|litvar@rs80358721##&&&litvar@#675#&&&litvar@CA21070#rs80358721##|p.Y1655TER", "669|3|gene|ncbi_gene@324|APC", "816|6|variant|litvar@rs1042522##&&&litvar@#7157#&&&litvar@CA72#rs1042522##|p.P72R", "480|3|gene|ncbi_gene@324|APC", "432|7|variant|litvar@rs1057519747##&&&litvar@#7157#|p.V173A", "577|6|gene|ncbi_gene@5290|PIK3CA", "167|5|gene|ncbi_gene@675|BRCA2", "450|4|gene|ncbi_gene@3845|KRAS", "891|7|variant|litvar@rs759869837##&&&litvar@#3791#|p.P403L", "485|9|variant|litvar@rs770877994##&&&litvar@#3002#|p.Q236TER", "646|6|variant|litvar@rs1042522##&&&litvar@#7157#&&&litvar@CA72#rs1042522##|p.P72R", "157|7|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|p.R273H", "698|4|gene|ncbi_gene@7157|TP53", "270|3|gene|ncbi_gene@324|APC", "568|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "423|7|variant|litvar@#7157#p.V197E&&&litvar@#7157#|p.V197E", "293|9|variant|litvar@rs139170496##&&&litvar@#4437#|p.K382TER", "876|6|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|p.R88Q", "685|10|variant|litvar@#7157#p.M1413X&&&litvar@#7157#|p.M1413TER", "497|4|gene|ncbi_gene@7157|TP53", "562|4|gene|ncbi_gene@3845|KRAS", "756|5|gene|ncbi_gene@4089|SMAD4", "631|4|gene|ncbi_gene@7157|TP53", "287|4|gene|ncbi_gene@7157|TP53", "391|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "585|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "456|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "7|7|species|ncbi_taxonomy@9606|Patient", "475|4|gene|ncbi_gene@120103|PAT4", "544|7|variant|litvar@rs587781991##&&&litvar@#7157#|p.C135F", "602|3|gene|ncbi_gene@324|APC", "260|7|variant|litvar@rs377767347##&&&litvar@#4089#&&&litvar@CA128097#rs377767347##|p.R361H", "782|3|gene|ncbi_gene@324|APC", "810|4|gene|ncbi_gene@7157|TP53", "237|4|gene|ncbi_gene@3845|KRAS", "126|3|gene|ncbi_gene@324|APC", "352|7|variant|litvar@rs1057519747##&&&litvar@#7157#|p.V173A", "713|6|variant|litvar@rs1042522##&&&litvar@#7157#&&&litvar@CA72#rs1042522##|p.P72R", "217|9|variant|litvar@rs139170496##&&&litvar@#4437#|p.K382TER", "787|9|variant|litvar@#324#p.H298X&&&litvar@#324#|p.H298TER", "106|5|gene|ncbi_gene@675|BRCA2", "131|9|variant|litvar@rs137854573##&&&litvar@#324#&&&litvar@CA5424#rs137854573##|p.R554TER", "637|7|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|p.R273H", "149|6|variant|litvar@rs1042522##&&&litvar@#7157#&&&litvar@CA72#rs1042522##|p.P72R", "343|7|variant|litvar@#7157#p.V197E&&&litvar@#7157#|p.V197E", "521|3|gene|ncbi_gene@324|APC", "745|8|variant|litvar@rs121913283##&&&litvar@#5290#&&&litvar@CA183868#rs121913283##|p.M1043I", "512|6|variant|litvar@rs1042522##&&&litvar@#7157#&&&litvar@CA72#rs1042522##|p.P72R", "96|7|variant|litvar@rs1131691014##&&&litvar@#7157#&&&litvar@CA645369692#rs1131691014##|p.P72R*", "385|4|gene|ncbi_gene@3845|KRAS", "59|4|gene|ncbi_gene@10513|PAT1", "361|6|variant|litvar@rs1042522##&&&litvar@#7157#&&&litvar@CA72#rs1042522##|p.P72R", "885|4|gene|ncbi_gene@673|BRAF", "228|6|variant|litvar@rs1042522##&&&litvar@#7157#&&&litvar@CA72#rs1042522##|p.P72R", "211|4|gene|ncbi_gene@7157|TP53", "526|9|variant|litvar@rs770877994##&&&litvar@#3002#|p.Q236TER", "243|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "143|4|gene|ncbi_gene@7157|TP53", "87|7|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|p.R273H", "825|3|gene|ncbi_gene@324|APC", "320|3|gene|ncbi_gene@324|APC", "189|4|gene|ncbi_gene@153201|PAT2", "830|9|variant|litvar@#324#p.H298X&&&litvar@#324#|p.H298TER", "325|9|variant|litvar@rs137854570##&&&litvar@#324#&&&litvar@CA7219#rs137854570##|p.S587TER", "538|4|gene|ncbi_gene@7157|TP53", "674|9|variant|litvar@rs121913333##&&&litvar@#324#&&&litvar@CA338207#rs121913333##|p.R876TER", "841|9|variant|litvar@rs397508905##&&&litvar@#672#&&&litvar@CA1139#rs397508905##|p.K581TER", "64|3|gene|ncbi_gene@324|APC", "661|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "798|9|variant|litvar@rs397508905##&&&litvar@#672#&&&litvar@CA1139#rs397508905##|p.K581TER", "704|7|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|p.R273H", "722|4|gene|ncbi_gene@4893|NRAS", "69|9|variant|litvar@rs137854573##&&&litvar@#324#&&&litvar@CA5424#rs137854573##|p.R554TER", "376|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "337|4|gene|ncbi_gene@7157|TP53", "441|6|variant|litvar@rs1042522##&&&litvar@#7157#&&&litvar@CA72#rs1042522##|p.P72R", "868|6|gene|ncbi_gene@5290|PIK3CA", "503|7|variant|litvar@rs587781991##&&&litvar@#7157#|p.C135F", "400|3|gene|ncbi_gene@324|APC", "304|6|variant|litvar@rs1042522##&&&litvar@#7157#&&&litvar@CA72#rs1042522##|p.P72R"], "figure_id": "cancers-12-03073-t003", "text_hl": "Groups Patient PT Mutated Genes MT Mutated Genes   Group A PAT1 APC (p.R554TER), TP53 (p.R273H, p.P72R*), BRCA2 (p.Y1655TER). APC (p.R554TER), TP53 (p.P72R, p.R273H), BRCA2 (p.Y1655TER).   PAT2 APC (p.1450TER), TP53 (p.K382TER, p.P72R), KRAS (<m>p.A146T</m>), SMAD4 (p.R361H). APC (p.1450TER), TP53 (p.K382TER, p.P72R).   PAT3 APC (p.S587TER), TP53 (p.V197E, p.V173A, p.P72R), KRAS (p.G13D), KRAS (p.G12D). APC (p.S587TER), TP53 (p.V197E, p.V173A, p.P72R), KRAS (p.G13D).   Group B PAT4 APC (p.Q236TER), TP53 (p.C135F, p.P72R). APC (p.Q236TER), TP53 (p.C135F, p.P72R), KRAS (p.G12C), PIK3CA (p.E545K).   PAT5 APC (p.R876TER, p.M1413TER), TP53 (p.R273H, p.P72R), NRAS (p.Q61K) APC (p.R876TER, p.M1413TER), TP53 (p.R273H, p.P72R), NRAS (p.Q61K), PIK3CA (p.M1043I), SMAD4 (p.Q256TER).   PAT6 APC (p.H298TER, p.K581TER), TP53 (p.P72R). APC (p.H298TER, p.K581TER), TP53 (p.P72R), PIK3CA (p.R88Q), BRAF (p.P403L).   "}], "citations": {"NLM": "Ottaiano A, Caraglia M, Di Mauro A, Botti G, Lombardi A, Galon J, Luce A, D'Amore L, Perri F, Santorsola M, Hermitte F, Savarese G, Tatangelo F, Granata V, Izzo F, Belli A, Scala S, Delrio P, Circelli L, Nasti G. Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer. Cancers (Basel). PMID: 33096795", "BibTeX": "@article{33096795, title={Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer.}, author={Ottaiano A and Caraglia M and Di Mauro A and Botti G and Lombardi A and Galon J and Luce A and D'Amore L and Perri F and Santorsola M and Hermitte F and Savarese G and Tatangelo F and Granata V and Izzo F and Belli A and Scala S and Delrio P and Circelli L and Nasti G}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 35328221, "pmcid": "PMC8946871", "title": "Detection of NTRK Fusions and TRK Expression and Performance of pan-TRK Immunohistochemistry in Routine Diagnostics: Results from a Nationwide Community-Based Cohort", "journal": "Diagnostics (Basel)", "authors": ["Koopman B", "Kuijpers CCHJ", "Groen HJM", "Timens W", "Schuuring E", "Willems SM", "van Kempen LC"], "date": "2022-03-09T00:00:00Z", "year": 2022, "snippets": [{"_id": "35328221@21043", "snip_text": "One EGFR p.(L858R)-mutant patient harbored the novel PRG4-NTRK1 fusion (TRK expression was not tested), and one a KRAS p.(A146T)-mutant patient harbored a CD74-NTRK1 fusion, with TRK expression.", "section": "discussion", "mentions": ["4|4|gene|ncbi_gene@1956|EGFR", "136|7|species|ncbi_taxonomy@9606|patient", "155|4|gene|ncbi_gene@972|CD74", "26|7|species|ncbi_taxonomy@9606|patient", "9|9|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.(L858R)", "160|5|gene|ncbi_gene@4914|NTRK1", "72|3|gene|ncbi_gene@7170|TRK", "119|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.(A146T)", "53|4|gene|ncbi_gene@10216|PRG4", "114|4|gene|ncbi_gene@3845|KRAS", "179|3|gene|ncbi_gene@7170|TRK", "58|5|gene|ncbi_gene@4914|NTRK1"], "text_hl": "One EGFR p.(L858R)-mutant patient harbored the novel PRG4-NTRK1 fusion (TRK expression was not tested), and one a KRAS p.(<m>A146T</m>)-mutant patient harbored a CD74-NTRK1 fusion, with TRK expression."}], "citations": {"NLM": "Koopman B, Kuijpers CCHJ, Groen HJM, Timens W, Schuuring E, Willems SM, van Kempen LC. Detection of NTRK Fusions and TRK Expression and Performance of pan-TRK Immunohistochemistry in Routine Diagnostics: Results from a Nationwide Community-Based Cohort Diagnostics (Basel). PMID: 35328221", "BibTeX": "@article{35328221, title={Detection of NTRK Fusions and TRK Expression and Performance of pan-TRK Immunohistochemistry in Routine Diagnostics: Results from a Nationwide Community-Based Cohort}, author={Koopman B and Kuijpers CCHJ and Groen HJM and Timens W and Schuuring E and Willems SM and van Kempen LC}, journal={Diagnostics (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 25714871, "pmcid": "PMC4978128", "title": "AKT1 E17K in Colorectal Carcinoma Is Associated with BRAF V600E but Not MSI-H Status: A Clinicopathologic Comparison to PIK3CA Helical and Kinase Domain Mutants", "journal": "Mol Cancer Res", "authors": ["Hechtman JF", "Sadowska J", "Huse JT", "Borsu L", "Yaeger R", "Shia J", "Vakiani E", "Ladanyi M", "Arcila ME"], "date": "2015-06-01T00:00:00Z", "year": 2015, "snippets": [{"_id": "25714871@9758", "snip_text": "The other two cases were moderately differentiated, one with a BRAF V600E mutation and the other with a KRAS A146T mutation.", "section": "results", "mentions": ["63|4|gene|ncbi_gene@673|BRAF", "109|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "104|4|gene|ncbi_gene@3845|KRAS", "68|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E"], "text_hl": "The other two cases were moderately differentiated, one with a BRAF V600E mutation and the other with a KRAS <m>A146T</m> mutation."}], "citations": {"NLM": "Hechtman JF, Sadowska J, Huse JT, Borsu L, Yaeger R, Shia J, Vakiani E, Ladanyi M, Arcila ME. AKT1 E17K in Colorectal Carcinoma Is Associated with BRAF V600E but Not MSI-H Status: A Clinicopathologic Comparison to PIK3CA Helical and Kinase Domain Mutants Mol Cancer Res. PMID: 25714871", "BibTeX": "@article{25714871, title={AKT1 E17K in Colorectal Carcinoma Is Associated with BRAF V600E but Not MSI-H Status: A Clinicopathologic Comparison to PIK3CA Helical and Kinase Domain Mutants}, author={Hechtman JF and Sadowska J and Huse JT and Borsu L and Yaeger R and Shia J and Vakiani E and Ladanyi M and Arcila ME}, journal={Mol Cancer Res}}"}, "is_sup_mat_match": false}, {"pmid": 31085763, "pmcid": "PMC6673655", "title": "KRAS G12V Mutation in Acquired Resistance to Combined BRAF and MEK Inhibition in Papillary Thyroid Cancer", "journal": "J Natl Compr Canc Netw", "authors": ["Owen DH", "Konda B", "Sipos J", "Liu T", "Webb A", "Ringel MD", "Timmers CD", "Shah MH"], "date": "2019-05-01T00:00:00Z", "year": 2019, "snippets": [{"_id": "31085763@13185", "snip_text": "A second preclinical study of colorectal cancer found acquired KRAS mutations in exons 2 and 4 (G12D, G13D, and A146T/V) to combination therapies with BRAF and EGFR inhibition or combination BRAF, EGFR, and PI3K-a inhibitors, while the same authors reported the emergence of an acquired mutation in KRAS G12C in a patient with colorectal cancer treated with combination BRAF and MEK inhibition in a clinical trial.", "section": "discussion", "mentions": ["63|4|gene|ncbi_gene@3845|KRAS", "102|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "299|4|gene|ncbi_gene@3845|KRAS", "370|4|gene|ncbi_gene@673|BRAF", "96|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "160|4|gene|ncbi_gene@1956|EGFR", "30|17|disease|ncbi_mesh@D015179|colorectal cancer", "379|3|gene|ncbi_gene@5609|MEK", "191|4|gene|ncbi_gene@673|BRAF", "197|4|gene|ncbi_gene@1956|EGFR", "304|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "151|4|gene|ncbi_gene@673|BRAF", "327|17|disease|ncbi_mesh@D015179|colorectal cancer", "314|7|species|ncbi_taxonomy@9606|patient", "112|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "A second preclinical study of colorectal cancer found acquired KRAS mutations in exons 2 and 4 (G12D, G13D, and <m>A146T</m>/V) to combination therapies with BRAF and EGFR inhibition or combination BRAF, EGFR, and PI3K-a inhibitors, while the same authors reported the emergence of an acquired mutation in KRAS G12C in a patient with colorectal cancer treated with combination BRAF and MEK inhibition in a clinical trial."}], "citations": {"NLM": "Owen DH, Konda B, Sipos J, Liu T, Webb A, Ringel MD, Timmers CD, Shah MH. KRAS G12V Mutation in Acquired Resistance to Combined BRAF and MEK Inhibition in Papillary Thyroid Cancer J Natl Compr Canc Netw. PMID: 31085763", "BibTeX": "@article{31085763, title={KRAS G12V Mutation in Acquired Resistance to Combined BRAF and MEK Inhibition in Papillary Thyroid Cancer}, author={Owen DH and Konda B and Sipos J and Liu T and Webb A and Ringel MD and Timmers CD and Shah MH}, journal={J Natl Compr Canc Netw}}"}, "is_sup_mat_match": false}, {"pmid": 24956168, "pmcid": "PMC4067351", "title": "Panel based MALDI-TOF tumour profiling is a sensitive method for detecting mutations in clinical non small cell lung cancer tumour.", "journal": "PLoS One", "authors": ["Sherwood JL", "M\u00fcller S", "Orr MC", "Ratcliffe MJ", "Walker J"], "date": "2014-06-23T00:00:00Z", "year": 2014, "snippets": [{"_id": "24956168@8739", "snip_text": "Gene Targeted Variantsa   BRAF V600E/K/L   CDNK2A R58*, E61*, E69*,R80*, H83Y, D84Y, P114L, W110*   CTNNB1 S33F/C/Y, S37F/C/Y   EGFR E746_A750DEL-2235-2249, E746_A750DEL-2236-2250, G719A/D/C/S, L858R/M, T790M   ERBB2 D769H, G776V, H878Y, L755S, G776V, H878Y, L755S, V777L, V842I   FGFR K650E/M, R248C, S249C   HRAS G12C/R/S/V/A/D, G13C/R/S, Q61L/R/P/K/E   KRAS G12C/R/S/V/A/D, G13C/S/A/D, Q61E/H/L/R/P, A146A/P/V   STK11 Q37*, Q170*, F354L, D194Y/N,   MET Y1248C, Y1253D   NRAS G12G12C/R/S/V/A/D, G13C/S/A/D, Q61E/H/L/R/P   TP53 R175H/L, R213*, Y220C/S, G245S/C/R, R248W/G, R249S, R273C/L/H, R282W/R   PIK3CA K111E/N/R, E542*/K/Q, E545A/G/D/K/Q, Q546*/H/R/P/L, H1047L/R/Q/Y   PTEN R130G/R/L/P/Q, R166fs*17, R173C/P/H, R233*, R335*   ", "section": "table", "mentions": ["224|5|variant|litvar@rs144434331##&&&litvar@#2064#&&&litvar@CA176042#rs144434331##|G776V", "26|4|gene|ncbi_gene@673|BRAF", "211|5|gene|ncbi_gene@2064|ERBB2", "266|5|variant|litvar@rs121913471##&&&litvar@#2064#&&&litvar@CA135387#rs121913471##|V777L", "341|6|variant|litvar@rs121913240##&&&litvar@#3845#|Q61L/R", "574|5|variant|litvar@rs28934571##&&&litvar@#7157#&&&litvar@CA392#rs28934571##|R249S", "631|7|variant|litvar@rs121913274##&&&litvar@#5290#|E545A/G", "497|6|variant|litvar@rs121913535##&&&litvar@#3845#|G13C/S", "609|7|variant|litvar@rs1057519934##&&&litvar@#5290#|K111E/N", "31|7|variant|litvar@rs113488022##&&&litvar@#673#|V600E/K", "452|3|gene|ncbi_gene@79811|MET", "565|5|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|R248W", "696|9|variant|litvar@#5728#p.R166fsX17&&&litvar@#5728#|R166fs*17", "331|8|variant|litvar@rs121913535##&&&litvar@#3845#|G13C/R/S", "403|7|variant|litvar@rs121913527##&&&litvar@#3845#|A146A/P", "117|6|variant|litvar@rs121913403##&&&litvar@#1499#|S37F/C", "231|5|variant|litvar@#2064#p.H878Y&&&litvar@#2064#|H878Y", "73|4|variant|litvar@#1499#p.H83Y&&&litvar@#1499#|H83Y", "128|4|gene|ncbi_gene@1956|EGFR", "194|5|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|L858R", "529|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H", "361|6|variant|litvar@rs104894229##&&&litvar@#3265#|G12C/R", "707|7|variant|litvar@rs121913293##&&&litvar@#5728#|R173C/P", "203|5|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|T790M", "107|8|variant|litvar@rs121913400##&&&litvar@#1499#|S33F/C/Y", "581|9|variant|litvar@rs28934576##&&&litvar@#7157#|R273C/L/H", "286|5|variant|litvar@rs78311289##&&&litvar@#2261#&&&litvar@CA126376#rs78311289##|K650E", "415|5|gene|ncbi_gene@6794|STK11", "245|5|variant|litvar@rs144434331##&&&litvar@#2064#&&&litvar@CA176042#rs144434331##|G776V", "592|7|variant|litvar@rs28934574##&&&litvar@#7157#|R282W/R", "602|6|gene|ncbi_gene@5290|PIK3CA", "295|5|variant|litvar@rs121913482##&&&litvar@#2261#&&&litvar@CA126378#rs121913482##|R248C", "441|7|variant|litvar@rs121913315##&&&litvar@#6794#|D194Y/N", "473|4|gene|ncbi_gene@4893|NRAS", "554|9|variant|litvar@rs28934575##&&&litvar@#7157#|G245S/C/R", "217|5|variant|litvar@rs121913468##&&&litvar@#2064#&&&litvar@CA16602465#rs121913468##|D769H", "481|6|variant|litvar@rs104894229##&&&litvar@#3265#|G12C/R", "138|7|variant|litvar@#1956#c.750delA&&&litvar@#1956#|A750DEL", "273|5|variant|litvar@rs1057519738##&&&litvar@#2064#|V842I", "524|4|gene|ncbi_gene@7157|TP53", "681|11|variant|litvar@rs121909229##&&&litvar@#5728#|R130G/R/L/P", "259|5|variant|litvar@rs121913470##&&&litvar@#2064#&&&litvar@CA16602502#rs121913470##|L755S", "389|6|variant|litvar@rs17851045##&&&litvar@#3845#|Q61E/H", "100|6|gene|ncbi_gene@1499|CTNNB1", "85|5|variant|litvar@rs1408700990##&&&litvar@#3845#|P114L", "79|4|variant|litvar@#1499#p.D84Y&&&litvar@#1499#|D84Y", "434|5|variant|litvar@rs59912467##&&&litvar@#6794#&&&litvar@CA22247#rs59912467##|F354L", "162|7|variant|litvar@#1956#c.750delA&&&litvar@#1956#|A750DEL", "676|4|gene|ncbi_gene@5728|PTEN", "509|6|variant|litvar@rs17851045##&&&litvar@#3845#|Q61E/H", "302|5|variant|litvar@rs121913483##&&&litvar@#2261#&&&litvar@CA126380#rs121913483##|S249C", "181|7|variant|litvar@rs121913428##&&&litvar@#1956#|G719A/D", "661|12|variant|litvar@rs121913279##&&&litvar@#5290#|H1047L/R/Q/Y", "545|5|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|Y220C", "377|6|variant|litvar@rs121913535##&&&litvar@#3845#|G13C/S", "189|3|variant|litvar@#2064#|C/S", "310|4|gene|ncbi_gene@3265|HRAS", "356|4|gene|ncbi_gene@3845|KRAS", "252|5|variant|litvar@#2064#p.H878Y&&&litvar@#2064#|H878Y", "464|6|variant|litvar@#4893#p.Y1253D&&&litvar@#4893#|Y1253D", "238|5|variant|litvar@rs121913470##&&&litvar@#2064#&&&litvar@CA16602502#rs121913470##|L755S", "456|6|variant|litvar@rs771116500##&&&litvar@#2064#&&&litvar@CA8534615#rs771116500##|Y1248C"], "figure_id": "pone-0100566-t001", "text_hl": "Gene Targeted Variantsa   BRAF V600E/K/L   CDNK2A R58*, E61*, E69*,R80*, H83Y, D84Y, P114L, W110*   CTNNB1 S33F/C/Y, S37F/C/Y   EGFR E746_A750DEL-2235-2249, E746_A750DEL-2236-2250, G719A/D/C/S, L858R/M, T790M   ERBB2 D769H, G776V, H878Y, L755S, G776V, H878Y, L755S, V777L, V842I   FGFR K650E/M, R248C, S249C   HRAS G12C/R/S/V/A/D, G13C/R/S, Q61L/R/P/K/E   KRAS G12C/R/S/V/A/D, G13C/S/A/D, Q61E/H/L/R/P, A146A/P/V   STK11 Q37*, Q170*, F354L, D194Y/N,   MET Y1248C, Y1253D   NRAS G12G12C/R/S/V/A/D, G13C/S/A/D, Q61E/H/L/R/P   TP53 R175H/L, R213*, Y220C/S, G245S/C/R, R248W/G, R249S, R273C/L/H, R282W/R   PIK3CA K111E/N/R, E542*/K/Q, E545A/G/D/K/Q, Q546*/H/R/P/L, H1047L/R/Q/Y   PTEN R130G/R/L/P/Q, R166fs*17, R173C/P/H, R233*, R335*   "}], "citations": {"NLM": "Sherwood JL, M\u00fcller S, Orr MC, Ratcliffe MJ, Walker J. Panel based MALDI-TOF tumour profiling is a sensitive method for detecting mutations in clinical non small cell lung cancer tumour. PLoS One. PMID: 24956168", "BibTeX": "@article{24956168, title={Panel based MALDI-TOF tumour profiling is a sensitive method for detecting mutations in clinical non small cell lung cancer tumour.}, author={Sherwood JL and M\u00fcller S and Orr MC and Ratcliffe MJ and Walker J}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 19924296, "pmcid": "PMC2774511", "title": "Profiling critical cancer gene mutations in clinical tumor samples.", "journal": "PLoS One", "authors": ["MacConaill LE", "Campbell CD", "Kehoe SM", "Bass AJ", "Hatton C", "Niu L", "Davis M", "Yao K", "Hanna M", "Mondal C", "Luongo L", "Emery CM", "Baker AC", "Philips J", "Goff DJ", "Fiorentino M", "Rubin MA", "Polyak K", "Chan J", "Wang Y", "Fletcher JA", "Santagata S", "Corso G", "Roviello F", "Shivdasani R", "Kieran MW", "Ligon KL", "Stiles CD", "Hahn WC", "Meyerson ML", "Garraway LA"], "date": "2009-11-18T00:00:00Z", "year": 2009, "snippets": [{"_id": "19924296@11470", "snip_text": "Tissue Type Gene Amino acid N %   Brain (astrocytoma, ganglioglioma, glioblastoma) BRAF V600E 22 14.2    EGFR T263P 1 0.6    PDGFRA D842V 1 0.6    PIK3CA R88Q 1 0.6     H1047R 1 0.6   Breast (lobular and ductal carcinoma) AKT1 E17K 1 1.9    PIK3CA R88Q 1 1.9     N345K 1 1.9     E542K 1 1.9     E545K 2 3.8     H1047R 9 17.0   Colon (adenocarcinoma) AKT1 E17K 1 0.6    BRAF D594G 2 1.3     L597Q 1 0.6     V600E 13 8.2    KRAS A146T 1 0.6     G12A/C/D/S/V 45 28.3     G13C/D 13 8.2     Q61H/L 2 1.3    NRAS Q61K 1 0.6    PIK3CA R88Q 1 0.6     E542K 2 1.3     E545G/K 13 8.2     H1047R 2 1.3    PTEN R130Q/* 2 1.3     R233* 2 1.3     K267fs*9 2 1.3   Endometrium (adenocarcinoma) AKT1 E17K 1 4.3    BRAF G466A 1 4.3    FGFR2 S252W 1 4.3     C382R 1 4.3    KRAS G12A/V 3 13.0     G13D 1 4.3    PIK3CA R88Q 1 4.3     C420R 1 4.3     H701P 1 4.3     H1047R 4 17.4    PTEN R130G/Q/* 6 26.1     R173H 1 4.3     N323fs*2 1 4.3   Esophagus (adenocarcinoma and squamous carcinoma) AKT1 E17K 1 0.9    PIK3CA E542K 2 1.7     E545K 1 0.9     H1047R 1 0.9   Gastric (adenocarcinoma) AKT1 E17K 1 0.5    EGFR L858M 1 0.5    ERBB2 L755S 3 1.5     V777L 1 0.5    KRAS G12C/D 11 5.5     G13C/D 5 2.5    PIK3CA R88Q 1 0.5     C420R 2 1.0     E542K 8 4.0     E545K 8 4.0     H1047R 10 5.0    PTEN K267fs*9 3 1.5     N323fs*2 1 0.5     N323fs*21 1 0.5   GI tract (GIST) KIT Y503_F504insAY 7 21.2     W557G 2 6.1     W557_K558del 2 6.1     W557_V559>C/F 4 12.1     V559D 1 3.0     V560D 2 6.1     V560del 2 6.1     L576P 1 3.0     K642E 2 6.1     V654A 3 9.1     D816H 1 3.0     N822K 2 6.1     Y823D 1 3.0    PDGFRA D842V 1 3.0   Kidney (renal cell carcinoma) VHL L89H 1 3.8   Lung (adenocarcinoma) EGFR L858R 3 11.5    HRAS Q61L 1 3.8    KRAS G12C/D 4 15.4     Q61H 2 7.7   Ovary (adenocarcinoma) BRAF V600E 1 11.1   Prostate (adenocarcinoma) AKT1 E17K 1 1.1    FGFR3 F384L 1 1.1    PIK3CA H1047R 1 1.1     G1049R 1 1.1    PTEN R173H 1 1.1   Thyroid (papillary carcinoma) BRAF V600E 4 57.1   ", "section": "table", "mentions": ["1014|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "154|4|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|R88Q", "846|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "125|6|gene|ncbi_gene@5156|PDGFRA", "1239|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "390|5|variant|litvar@rs121913366##&&&litvar@#673#&&&litvar@CA16602257#rs121913366##|L597Q", "1870|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "1030|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "1423|8|variant|litvar@rs121913517##&&&litvar@#3815#|V559>C/F", "740|5|variant|litvar@rs121913474##&&&litvar@#2263#&&&litvar@CA16602866#rs121913474##|C382R", "1782|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1315|6|variant|litvar@rs121913291##&&&litvar@#5728#|N323fs", "327|5|disease|ncbi_mesh@D003108|Colon", "1493|5|variant|litvar@rs121913513##&&&litvar@#3815#&&&litvar@CA16602401#rs121913513##|L576P", "521|6|gene|ncbi_gene@5290|PIK3CA", "1525|5|variant|litvar@rs121913523##&&&litvar@#3815#&&&litvar@CA16602402#rs121913523##|V654A", "88|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "105|4|gene|ncbi_gene@1956|EGFR", "443|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12A/C", "1400|7|variant|litvar@#3815#p.K558del&&&litvar@#3815#|K558del", "863|4|gene|ncbi_gene@5728|PTEN", "406|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "263|5|variant|litvar@rs121913284##&&&litvar@#5290#&&&litvar@CA16602517#rs121913284##|N345K", "1443|5|variant|litvar@rs121913517##&&&litvar@#3815#&&&litvar@CA123522#rs121913517##|V559D", "311|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "295|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "528|4|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|R88Q", "1094|5|variant|litvar@rs121913443##&&&litvar@#1956#&&&litvar@CA135930#rs121913443##|L858M", "1070|4|gene|ncbi_gene@207|AKT1", "83|4|gene|ncbi_gene@673|BRAF", "169|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "998|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "868|7|variant|litvar@rs121909229##&&&litvar@#5728#|R130G/Q", "1151|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12C/D", "814|5|variant|litvar@rs121913272##&&&litvar@#5290#&&&litvar@CA180900#rs121913272##|C420R", "1169|6|variant|litvar@rs121434595##&&&litvar@#4893#|G13C/D", "1595|5|variant|litvar@rs121908585##&&&litvar@#5156#&&&litvar@CA123194#rs121908585##|D842V", "374|5|variant|litvar@rs121913338##&&&litvar@#673#&&&litvar@CA123657#rs121913338##|D594G", "698|4|gene|ncbi_gene@673|BRAF", "1588|6|gene|ncbi_gene@5156|PDGFRA", "1823|4|gene|ncbi_gene@207|AKT1", "663|14|disease|ncbi_mesh@D000230|adenocarcinoma", "578|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "633|6|variant|litvar@rs121913289##&&&litvar@#5728#|K267fs", "1848|5|variant|litvar@rs1302148730##&&&litvar@#207#|F384L", "1704|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "1109|5|gene|ncbi_gene@2064|ERBB2", "905|6|variant|litvar@rs121913291##&&&litvar@#5728#|N323fs", "1054|14|disease|ncbi_mesh@D000230|adenocarcinoma", "147|6|gene|ncbi_gene@5290|PIK3CA", "1741|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "502|4|gene|ncbi_gene@4893|NRAS", "1573|5|variant|litvar@rs1057519761##&&&litvar@#3815#|Y823D", "369|4|gene|ncbi_gene@673|BRAF", "889|5|variant|litvar@rs121913294##&&&litvar@#5728#&&&litvar@CA60209#rs121913294##|R173H", "778|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1639|3|gene|ncbi_gene@7428|VHL", "69|12|disease|ncbi_mesh@D005909|glioblastoma", "1509|5|variant|litvar@rs121913512##&&&litvar@#3815#&&&litvar@CA123547#rs121913512##|K642E", "132|5|variant|litvar@rs121908585##&&&litvar@#5156#&&&litvar@CA123194#rs121908585##|D842V", "830|5|variant|litvar@rs121913282##&&&litvar@#5290#&&&litvar@CA16602519#rs121913282##|H701P", "1185|6|gene|ncbi_gene@5290|PIK3CA", "1908|5|variant|litvar@rs121913294##&&&litvar@#5728#&&&litvar@CA60209#rs121913294##|R173H", "1353|14|variant|litvar@#3815#c.503,504insY,AY&&&litvar@#3815#|Y503_F504insAY", "1541|5|variant|litvar@rs121913506##&&&litvar@#3815#&&&litvar@CA123540#rs121913506##|D816H", "191|29|disease|ncbi_mesh@D018299|(lobular and ductal carcinoma", "1678|4|gene|ncbi_gene@1956|EGFR", "1277|6|variant|litvar@rs121913289##&&&litvar@#5728#|K267fs", "427|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "41|11|disease|ncbi_mesh@D001254|astrocytoma", "1192|4|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|R88Q", "1296|6|variant|litvar@rs121913291##&&&litvar@#5728#|N323fs", "1115|5|variant|litvar@rs121913470##&&&litvar@#2064#&&&litvar@CA16602502#rs121913470##|L755S", "1723|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12C/D", "1146|4|gene|ncbi_gene@3845|KRAS", "1207|5|variant|litvar@rs121913272##&&&litvar@#5290#&&&litvar@CA180900#rs121913272##|C420R", "972|4|gene|ncbi_gene@207|AKT1", "1255|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "559|7|variant|litvar@rs104886003##&&&litvar@#5290#|E545G/K", "792|6|gene|ncbi_gene@5290|PIK3CA", "703|5|variant|litvar@rs121913351##&&&litvar@#673#&&&litvar@CA16602535#rs121913351##|G466A", "1557|5|variant|litvar@rs121913514##&&&litvar@#3815#&&&litvar@CA16602411#rs121913514##|N822K", "241|6|gene|ncbi_gene@5290|PIK3CA", "54|13|disease|ncbi_mesh@D018303|ganglioglioma", "1662|14|disease|ncbi_mesh@D000230|adenocarcinoma", "679|4|gene|ncbi_gene@207|AKT1", "933|14|disease|ncbi_mesh@D000230|adenocarcinoma", "799|4|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|R88Q", "422|4|gene|ncbi_gene@3845|KRAS", "760|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12A/V", "1643|4|variant|litvar@rs5030807##&&&litvar@#7428#&&&litvar@CA16602514#rs5030807##|L89H", "543|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "1131|5|variant|litvar@rs121913471##&&&litvar@#2064#&&&litvar@CA135387#rs121913471##|V777L", "1617|20|disease|ncbi_mesh@D002292|renal cell carcinoma", "1379|5|variant|litvar@rs121913235##&&&litvar@#3815#&&&litvar@CA16603140#rs121913235##|W557G", "248|4|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|R88Q", "1957|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1223|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "718|5|gene|ncbi_gene@2263|FGFR2", "1777|4|gene|ncbi_gene@673|BRAF", "1272|4|gene|ncbi_gene@5728|PTEN", "1699|4|gene|ncbi_gene@3265|HRAS", "599|5|variant|litvar@rs121909229##&&&litvar@#5728#&&&litvar@CA437#rs121909229##|R130Q", "991|6|gene|ncbi_gene@5290|PIK3CA", "486|6|variant|litvar@rs11554290##&&&litvar@#4893#|Q61H/L", "1952|4|gene|ncbi_gene@673|BRAF", "1718|4|gene|ncbi_gene@3845|KRAS", "1761|14|disease|ncbi_mesh@D000230|adenocarcinoma", "1089|4|gene|ncbi_gene@1956|EGFR", "1475|7|variant|litvar@rs121913685##&&&litvar@#3815#&&&litvar@CA123529#rs121913685##|V560del", "222|4|gene|ncbi_gene@207|AKT1", "350|4|gene|ncbi_gene@207|AKT1", "594|4|gene|ncbi_gene@5728|PTEN", "334|14|disease|ncbi_mesh@D000230|adenocarcinoma", "1349|3|gene|ncbi_gene@3815|KIT", "1863|6|gene|ncbi_gene@5290|PIK3CA", "724|5|variant|litvar@rs79184941##&&&litvar@#2263#&&&litvar@CA122985#rs79184941##|S252W", "1807|14|disease|ncbi_mesh@D000230|adenocarcinoma", "507|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "468|6|variant|litvar@rs121434595##&&&litvar@#4893#|G13C/D", "1683|5|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|L858R", "279|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "1459|5|variant|litvar@rs121913521##&&&litvar@#3815#&&&litvar@CA16602396#rs121913521##|V560D", "1887|6|variant|litvar@rs121913277##&&&litvar@#5290#&&&litvar@CA16602520#rs121913277##|G1049R", "110|5|variant|litvar@rs1057519829##&&&litvar@#1956#|T263P", "1903|4|gene|ncbi_gene@5728|PTEN", "755|4|gene|ncbi_gene@3845|KRAS"], "figure_id": "pone-0007887-t002", "text_hl": "Tissue Type Gene Amino acid N %   Brain (astrocytoma, ganglioglioma, glioblastoma) BRAF V600E 22 14.2    EGFR T263P 1 0.6    PDGFRA D842V 1 0.6    PIK3CA R88Q 1 0.6     H1047R 1 0.6   Breast (lobular and ductal carcinoma) AKT1 E17K 1 1.9    PIK3CA R88Q 1 1.9     N345K 1 1.9     E542K 1 1.9     E545K 2 3.8     H1047R 9 17.0   Colon (adenocarcinoma) AKT1 E17K 1 0.6    BRAF D594G 2 1.3     L597Q 1 0.6     V600E 13 8.2    KRAS <m>A146T</m> 1 0.6     G12A/C/D/S/V 45 28.3     G13C/D 13 8.2     Q61H/L 2 1.3    NRAS Q61K 1 0.6    PIK3CA R88Q 1 0.6     E542K 2 1.3     E545G/K 13 8.2     H1047R 2 1.3    PTEN R130Q/* 2 1.3     R233* 2 1.3     K267fs*9 2 1.3   Endometrium (adenocarcinoma) AKT1 E17K 1 4.3    BRAF G466A 1 4.3    FGFR2 S252W 1 4.3     C382R 1 4.3    KRAS G12A/V 3 13.0     G13D 1 4.3    PIK3CA R88Q 1 4.3     C420R 1 4.3     H701P 1 4.3     H1047R 4 17.4    PTEN R130G/Q/* 6 26.1     R173H 1 4.3     N323fs*2 1 4.3   Esophagus (adenocarcinoma and squamous carcinoma) AKT1 E17K 1 0.9    PIK3CA E542K 2 1.7     E545K 1 0.9     H1047R 1 0.9   Gastric (adenocarcinoma) AKT1 E17K 1 0.5    EGFR L858M 1 0.5    ERBB2 L755S 3 1.5     V777L 1 0.5    KRAS G12C/D 11 5.5     G13C/D 5 2.5    PIK3CA R88Q 1 0.5     C420R 2 1.0     E542K 8 4.0     E545K 8 4.0     H1047R 10 5.0    PTEN K267fs*9 3 1.5     N323fs*2 1 0.5     N323fs*21 1 0.5   GI tract (GIST) KIT Y503_F504insAY 7 21.2     W557G 2 6.1     W557_K558del 2 6.1     W557_V559>C/F 4 12.1     V559D 1 3.0     V560D 2 6.1     V560del 2 6.1     L576P 1 3.0     K642E 2 6.1     V654A 3 9.1     D816H 1 3.0     N822K 2 6.1     Y823D 1 3.0    PDGFRA D842V 1 3.0   Kidney (renal cell carcinoma) VHL L89H 1 3.8   Lung (adenocarcinoma) EGFR L858R 3 11.5    HRAS Q61L 1 3.8    KRAS G12C/D 4 15.4     Q61H 2 7.7   Ovary (adenocarcinoma) BRAF V600E 1 11.1   Prostate (adenocarcinoma) AKT1 E17K 1 1.1    FGFR3 F384L 1 1.1    PIK3CA H1047R 1 1.1     G1049R 1 1.1    PTEN R173H 1 1.1   Thyroid (papillary carcinoma) BRAF V600E 4 57.1   "}], "citations": {"NLM": "MacConaill LE, Campbell CD, Kehoe SM, Bass AJ, Hatton C, Niu L, Davis M, Yao K, Hanna M, Mondal C, Luongo L, Emery CM, Baker AC, Philips J, Goff DJ, Fiorentino M, Rubin MA, Polyak K, Chan J, Wang Y, Fletcher JA, Santagata S, Corso G, Roviello F, Shivdasani R, Kieran MW, Ligon KL, Stiles CD, Hahn WC, Meyerson ML, Garraway LA. Profiling critical cancer gene mutations in clinical tumor samples. PLoS One. PMID: 19924296", "BibTeX": "@article{19924296, title={Profiling critical cancer gene mutations in clinical tumor samples.}, author={MacConaill LE and Campbell CD and Kehoe SM and Bass AJ and Hatton C and Niu L and Davis M and Yao K and Hanna M and Mondal C and Luongo L and Emery CM and Baker AC and Philips J and Goff DJ and Fiorentino M and Rubin MA and Polyak K and Chan J and Wang Y and Fletcher JA and Santagata S and Corso G and Roviello F and Shivdasani R and Kieran MW and Ligon KL and Stiles CD and Hahn WC and Meyerson ML and Garraway LA}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 37841325, "pmcid": "PMC10570560", "title": "Beyond structural bioinformatics for genomics with dynamics characterization of an expanded KRAS mutational landscape", "journal": "Comput Struct Biotechnol J", "authors": ["Ratnasinghe BD", "Haque N", "Wagenknecht JB", "Jensen DR", "Valdivia Esparza GK", "Leverence EN", "Milech De Assuncao T", "Mathison AJ", "Lomberk G", "Smith BC", "Volkman BF", "Urrutia R", "Zimmermann MT"], "date": "2023-10-05T00:00:00Z", "year": 2023, "snippets": [{"_id": "37841325@30757", "snip_text": "Also, mutants with a high sum of square residuals (SSR) in both GDP and GTP simulations, such as N26I, Q61L, and A146T, overly favor the SOS1 binding conformation regardless of the nucleotide-bound state.", "section": "discussion", "mentions": ["137|4|gene|ncbi_gene@6654|SOS1", "97|4|variant|litvar@rs794727277##|N26I", "103|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|Q61L", "64|3|chemical|ncbi_mesh@D006153|GDP", "181|10|chemical|ncbi_mesh@D009711|nucleotide", "72|3|chemical|ncbi_mesh@D006160|GTP", "113|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Also, mutants with a high sum of square residuals (SSR) in both GDP and GTP simulations, such as N26I, Q61L, and <m>A146T</m>, overly favor the SOS1 binding conformation regardless of the nucleotide-bound state."}], "citations": {"NLM": "Ratnasinghe BD, Haque N, Wagenknecht JB, Jensen DR, Valdivia Esparza GK, Leverence EN, Milech De Assuncao T, Mathison AJ, Lomberk G, Smith BC, Volkman BF, Urrutia R, Zimmermann MT. Beyond structural bioinformatics for genomics with dynamics characterization of an expanded KRAS mutational landscape Comput Struct Biotechnol J. PMID: 37841325", "BibTeX": "@article{37841325, title={Beyond structural bioinformatics for genomics with dynamics characterization of an expanded KRAS mutational landscape}, author={Ratnasinghe BD and Haque N and Wagenknecht JB and Jensen DR and Valdivia Esparza GK and Leverence EN and Milech De Assuncao T and Mathison AJ and Lomberk G and Smith BC and Volkman BF and Urrutia R and Zimmermann MT}, journal={Comput Struct Biotechnol J}}"}, "is_sup_mat_match": false}, {"pmid": 27121310, "pmcid": "PMC5122332", "title": "NRAS germline variant G138R and multiple rare somatic mutations on APC in colorectal cancer patients in Taiwan by next generation sequencing.", "journal": "Oncotarget", "authors": ["Chang PY", "Chen JS", "Chang NC", "Chang SC", "Wang MC", "Tsai SH", "Wen YH", "Tsai WS", "Chan EC", "Lu JJ"], "date": "2016-06-21T00:00:00Z", "year": 2016, "snippets": [{"_id": "27121310@13994", "snip_text": "Gene Variant serial no Coding sequence Transcript Variant type Variant effect Patient no   TP53 1 c.524G>A NM_000546 COSM10648_p.R175H nonsynonymous missense 4    2 c.637C>T NM_000546 COSM10654_p.R213* stop gain 3    3 c.844C>T NM_000546 COSM10704_p.R282W nonsynonymous missense 1    4 c.818G>A NM_000546 COSM10660_p.R273H nonsynonymous missense 1    5 c.814G>A NM_000546 COSM10891_p.V272M nonsynonymous missense 1    6 c.797delG NM_000546 COSM44187_p.G266fs frameshift 1    7 c.796G>A NM_000546 COSM10794_p.G266R nonsynonymous missense 1    8 c.743G>A NM_000546 COSM10662_p.R248Q nonsynonymous missense 1    9 c.742C>T NM_000546 COSM10656_p.R248W nonsynonymous missense 1    10 c.592G>T NM_000546 COSM44241_p.E198* stop gain 1    11 c.586C>T NM_000546 COSM10705_p.R196* stop gain 1    12 c.536A>G NM_000546 COSM10889_p.H179R nonsynonymous missense 1    13 c.476C>T NM_000546 COSM11148_p.A159V nonsynonymous missense 1    14 c.469G>T NM_000546 COSM10670_p.V157F nonsynonymous missense 1    15 c.455C>T NM_000546 COSM10790_p.P152L nonsynonymous missense 1    16 c.406C>T NM_000546 COSM11166_p.Q136* stop gain 1    17 c.379T>C NM_000546 COSM44687_p.S127P nonsynonymous missense 1    18 c.294_297delTTCC NM_000546 COSM278467_p.S99fs*23 frameshift +stop gain 1    19 c.277_278insCCTGGCCCCT NM_000546 p.L93fs frameshift 1   KRAS 1 c.35G>T NM_033360 COSM520_p.G12V nonsynonymous missense 8    2 c.38G>A NM_033360 COSM532_p.G13D nonsynonymous missense 5    3 c.35G>A NM_033360 COSM521_p.G12D nonsynonymous missense 4   KRAS 4 c.436G>A NM_033360 COSM19404_p.A146T nonsynonymous missense 2    5 c.34G>A NM_033360 COSM517_p.G12S nonsynonymous missense 1    6 c.179G>A NM_033360 COSM87290_p.G60D nonsynonymous missense 1    7 c.183A>C NM_033360 COSM554_p.Q61H nonsynonymous missense 1   APC 1 c.2626C>T NM_000038 COSM18852_p.R876* stop gain 3    2 c.3340C>T NM_000038 COSM13125_p.R1114* stop gain 2    3 c.3921_3925delAAAAG NM_000038 COSM18764_p.E1309fs*4 frameshift+stop gain 1    4 c.3964G>T NM_000038 COSM18702_p.E1322* stop gain 1    5 c.4330C>T NM_000038 COSM19021_p.Q1444* stop gain 1    6 c.4484G>T NM_000038 COSM99778_p.S1495I nonsynonymous missense 1    7 c.4661dupA NM_000038 p.E1554fs frameshift 2    8 c.3360delA NM_000038 p.G1120fs frameshift 1    9 c.4282delG NM_000038 p.G1428fs frameshift 1    10 c.4285delC NM_000038 p.Q1429fs frameshift 1    11 c.4313_4314insCACCT NM_000038 p.T1438fs frameshift 1    12 c.4348_4357delCGAGAAGTAC NM_000038 p.1450_1453fs frameshift 1    13 c.4475C>T NM_000038 p.A1492V nonsynonymous missense 1    14 c.4486_4493delACTCCAGA NM_000038 p.1496_1498fs frameshift 1    15 c.4501T>G NM_000038 p.S1501A nonsynonymous missense 1   PIK3CA 1 c.1633G>A NM_006218 COSM763_p.E545K nonsynonymous missense 4    2 c.263G>A NM_006218 COSM746_p.R88Q nonsynonymous missense 2    3 c.1035T>A NM_006218 COSM754_p.N345K nonsynonymous missense 2    4 c.331A>G NM_006218 COSM13570_p.K111E nonsynonymous missense 1    5 c.333G>T NM_006218 COSM27505_p.K111N nonsynonymous missense 1    6 c.1258T>C NM_006218 COSM757_p.C420R nonsynonymous missense 1   PIK3CA 7 c.3073A>G NM_006218 COSM771_p.T1025A nonsynonymous missense 1    8 c.248T>C NM_006218 p.F83S nonsynonymous missense 1    9 c.3073A>C NM_006218 p.T1025P nonsynonymous missense 1   SMAD4 1 c.1082G>A NM_005359 COSM14122_p.R361H nonsynonymous missense 2    2 c.353C>T NM_005359 COSM14215_p.A118V nonsynonymous missense 1    3 c.1081C>T NM_005359 COSM14140_p.R361C nonsynonymous missense 1    4 c.1496G>A NM_005359 COSM14221_p.C499Y nonsynonymous missense 1    5 c.344G>A NM_005359 p.C115Y nonsynonymous missense 1    6 c.1586T>C NM_005359 p.L529S nonsynonymous missense 1   FBXW7 1 c.1154G>A NM_018315 COSM117308_p.R385H nonsynonymous missense 2    2 c.1273C>T NM_018315 COSM74637_p.R425C nonsynonymous missense 1    3 c.1504T>A NM_018315 COSM1427667_p.S502T nonsynonymous missense 1    4 c.562_563delAT NM_018315 COSM1052123_p.M188fs*18 frameshift+stop gain 1   NRAS 1 c.182A>G NM_002524 COSM584_p.Q61R nonsynonymous missense 2    2 c.181C>A NM_002524 COSM580_p.Q61K nonsynonymous missense 1   BRAF 1 c.1799T>A NM_004333 COSM476_p.V600E nonsynonymous missense 1    2 c.1780G>A NM_004333 COSM27639_p.D594N nonsynonymous missense 1   CTNNB1 1 c.121A>G NM_001904 COSM5664_p.T41A nonsynonymous missense 1    2 c.131_133delCTT NM_001904 COSM33668_p.S45del frameshift 1   GNAS 1 c.602G>A NM_001077489 COSM27895_p.R201H nonsynonymous missense 1   AKT1 1 c.49G>A NM_001014432 COSM33765_p.E17K nonsynonymous missense 1   ATM 1 c.9023G>A NM_000051 COSM21626_p.R3008H nonsynonymous missense 1   ERBB4 1 c.1825G>A NM_001042599 COSM131772_p.D609N nonsynonymous missense 1   FGFR3 1 c.1153T>G NM_001163213 p.F383V nonsynonymous missense 1   ERBB2 1 c.2618A>G NM_004448 p.D873G nonsynonymous missense 1   FGFR1 1 c.95C>A NM_023106 p.A32D nonsynonymous missense 1   PDGFRA 1 c.2470G>A NM_006206 p.V824I nonsynonymous missense 1   EGFR 1 c.344A>C NM_005228 p.N115T nonsynonymous missense 1   KDR 1 c.794C>T NM_002253 p.S265L nonsynonymous missense 1   PTEN 1 c.71A>T NM_000314 p.D24V nonsynonymous missense 1   ", "section": "table", "mentions": ["353|8|variant|litvar@rs121912657##&&&litvar@#7157#&&&litvar@CA427#rs121912657##|c.814G>A", "4909|7|variant|litvar@rs948405432##&&&litvar@#55294#|p.N115T", "3327|8|variant|litvar@rs1482240339##&&&litvar@#55294#|c.353C>T", "4002|8|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C>A", "2252|10|variant|litvar@#5290#c.4282delG&&&litvar@#5290#|c.4282delG", "1837|9|variant|litvar@rs121913331##&&&litvar@#324#&&&litvar@CA10582306#rs121913331##|c.3340C>T", "4166|7|variant|litvar@rs397516896##&&&litvar@#673#&&&litvar@CA135095#rs397516896##|p.D594N", "165|8|variant|litvar@rs397516436##&&&litvar@#7157#&&&litvar@CA301#rs397516436##|c.637C>T", "127|7|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|p.R175H", "3028|7|variant|litvar@rs121913272##&&&litvar@#5290#&&&litvar@CA180900#rs121913272##|p.C420R", "3938|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A>G", "4517|8|variant|litvar@#5290#p.R3008H&&&litvar@#5290#|p.R3008H", "4275|15|variant|litvar@#673#p.L131_133del&&&litvar@#673#|c.131_133delCTT", "4696|5|gene|ncbi_gene@2064|ERBB2", "4311|8|variant|litvar@rs587776850##&&&litvar@#1499#&&&litvar@CA250690#rs587776850##|p.S45del", "954|7|variant|litvar@rs121912654##&&&litvar@#7157#&&&litvar@CA222#rs121912654##|p.V157F", "2605|9|variant|litvar@#324#c.4501T>G&&&litvar@#324#|c.4501T>G", "3681|7|variant|litvar@rs1057519895##&&&litvar@#55294#|p.R385H", "993|8|variant|litvar@rs587782705##&&&litvar@#7157#&&&litvar@CA204#rs587782705##|c.455C>T", "4416|7|variant|litvar@rs201100551##&&&litvar@#5728#&&&litvar@CA5590238#rs201100551##|c.49G>A", "4070|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "2866|8|variant|litvar@rs1057519933##&&&litvar@#5290#|c.331A>G", "248|7|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|p.R282W", "2828|7|variant|litvar@rs121913284##&&&litvar@#5290#&&&litvar@CA16602517#rs121913284##|p.N345K", "4724|7|variant|litvar@rs762269030##&&&litvar@#5156#|p.D873G", "2499|8|variant|litvar@rs185411044##&&&litvar@#324#|p.A1492V", "4890|8|variant|litvar@rs948405432##&&&litvar@#55294#|c.344A>C", "544|8|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|c.743G>A", "2175|9|variant|litvar@#324#p.E1554fsX&&&litvar@#324#|p.E1554fs", "4063|4|gene|ncbi_gene@673|BRAF", "708|7|variant|litvar@#3845#p.E198*&&&litvar@#3845#|p.E198*", "1296|7|variant|litvar@rs63749872##&&&litvar@#4436#|p.L93fs", "2154|10|variant|litvar@#324#c.4661dupA&&&litvar@#324#|c.4661dupA", "4848|7|variant|litvar@rs370600501##&&&litvar@#5156#&&&litvar@CA2922875#rs370600501##|p.V824I", "4944|3|gene|ncbi_gene@3791|KDR", "4759|5|gene|ncbi_gene@2260|FGFR1", "2625|8|variant|litvar@#324#p.S1501A&&&litvar@#324#|p.S1501A", "2085|9|variant|litvar@rs80357389##&&&litvar@#672#&&&litvar@CA2876#rs80357389##|c.4484G>T", "2273|9|variant|litvar@#5290#p.G1428fsX&&&litvar@#5290#|p.G1428fs", "1519|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "2933|8|variant|litvar@rs1198714974##&&&litvar@#4893#|c.333G>T", "315|7|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|p.R273H", "4661|7|variant|litvar@#2064#p.F383V&&&litvar@#2064#|p.F383V", "3289|7|variant|litvar@rs377767347##&&&litvar@#4089#&&&litvar@CA128097#rs377767347##|p.R361H", "4342|8|variant|litvar@rs139217250##&&&litvar@#5156#&&&litvar@CA96849162#rs139217250##|c.602G>A", "4969|7|variant|litvar@rs539911006##&&&litvar@#3791#|p.S265L", "1612|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "2411|24|variant|litvar@#5290#c.4348_4357delCGAGAAGTAC&&&litvar@#5290#|c.4348_4357delCGAGAAGTAC", "450|8|variant|litvar@rs886039855##&&&litvar@#7157#|p.G266fs", "3462|9|variant|litvar@rs182572604##&&&litvar@#2064#&&&litvar@CA8533997#rs182572604##|c.1496G>A", "3587|9|variant|litvar@rs751285566##&&&litvar@#5156#|c.1586T>C", "3749|7|variant|litvar@rs149680468##&&&litvar@#55294#&&&litvar@CA16602253#rs149680468##|p.R425C", "1812|7|variant|litvar@#324#p.R876*&&&litvar@#324#|p.R876*", "1678|6|variant|litvar@rs754898711##&&&litvar@#4292#&&&litvar@CA27896#rs754898711##|p.G60D", "2698|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "1061|8|variant|litvar@rs876658325##&&&litvar@#324#&&&litvar@CA10578293#rs876658325##|c.406C>T", "1326|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "4210|8|variant|litvar@rs1460882520##&&&litvar@#2260#|c.121A>G", "2661|6|gene|ncbi_gene@5290|PIK3CA", "2670|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G>A", "3894|11|variant|litvar@#4893#p.M188fsX18&&&litvar@#4893#|p.M188fs*18", "382|7|variant|litvar@rs121912657##&&&litvar@#7157#&&&litvar@CA427#rs121912657##|p.V272M", "1973|9|variant|litvar@#324#c.3964G>T&&&litvar@#324#|c.3964G>T", "3356|7|variant|litvar@rs752669159##&&&litvar@#5156#|p.A118V", "5004|4|gene|ncbi_gene@5728|PTEN", "506|7|variant|litvar@rs1057519990##&&&litvar@#7157#|p.G266R", "3158|6|variant|litvar@rs11540652##&&&litvar@#7157#|p.F83S", "194|7|variant|litvar@#7157#p.R213*&&&litvar@#7157#|p.R213*", "2539|22|variant|litvar@#5290#c.4486_4493delACTCCAGA&&&litvar@#5290#|c.4486_4493delACTCCAGA", "1548|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "2800|9|variant|litvar@rs121913284##&&&litvar@#5290#&&&litvar@CA16602517#rs121913284##|c.1035T>A", "2962|7|variant|litvar@rs769270327##&&&litvar@#7157#&&&litvar@CA2656#rs769270327##|p.K111N", "2763|6|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|p.R88Q", "1452|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "857|8|variant|litvar@rs1257143633##&&&litvar@#324#|c.476C>T", "1145|7|variant|litvar@rs1221709596##&&&litvar@#3265#|p.S127P", "3259|9|variant|litvar@rs377767347##&&&litvar@#4089#&&&litvar@CA128097#rs377767347##|c.1082G>A", "1319|4|gene|ncbi_gene@3845|KRAS", "1893|19|variant|litvar@#324#c.3921_3925delAAAAG&&&litvar@#324#|c.3921_3925delAAAAG", "2115|8|variant|litvar@rs80357389##|p.S1495I", "3931|4|gene|ncbi_gene@4893|NRAS", "2352|19|variant|litvar@#5290#c.4313_4314insCACCT&&&litvar@#5290#|c.4313_4314insCACCT", "3195|9|variant|litvar@rs397517202##|c.3073A>C", "2029|9|variant|litvar@rs758815860##&&&litvar@#324#&&&litvar@CA40871#rs758815860##|c.4330C>T", "3719|9|variant|litvar@rs149680468##&&&litvar@#55294#&&&litvar@CA16602253#rs149680468##|c.1273C>T", "1389|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "1782|9|variant|litvar@rs121913333##&&&litvar@#324#&&&litvar@CA338207#rs121913333##|c.2626C>T", "734|8|variant|litvar@rs397516435##&&&litvar@#7157#&&&litvar@CA282#rs397516435##|c.586C>T", "789|8|variant|litvar@rs763736188##&&&litvar@#3845#&&&litvar@CA6486823#rs763736188##|c.536A>G", "1022|7|variant|litvar@rs587782705##&&&litvar@#7157#&&&litvar@CA204#rs587782705##|p.P152L", "3063|6|gene|ncbi_gene@5290|PIK3CA", "4767|7|variant|litvar@rs764472307##&&&litvar@#5156#|c.95C>A", "3650|9|variant|litvar@rs1057519895##&&&litvar@#55294#|c.1154G>A", "2895|7|variant|litvar@rs1057519933##&&&litvar@#5290#|p.K111E", "3072|9|variant|litvar@rs397517202##&&&litvar@#5290#&&&litvar@CA136374#rs397517202##|c.3073A>G", "4098|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "611|8|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|c.742C>T", "573|7|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|p.R248Q", "91|4|gene|ncbi_gene@7157|TP53", "4638|9|variant|litvar@rs532476931##&&&litvar@#324#&&&litvar@CA26764#rs532476931##|c.1153T>G", "4487|9|variant|litvar@#5290#c.9023G>A&&&litvar@#5290#|c.9023G>A", "5011|7|variant|litvar@rs869025573##&&&litvar@#4893#&&&litvar@CA356968#rs869025573##|c.71A>T", "4883|4|gene|ncbi_gene@1956|EGFR", "1742|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "1933|11|variant|litvar@rs121913224##&&&litvar@#324#|p.E1309fs*4", "5029|6|variant|litvar@rs869025573##|p.D24V", "1352|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "2203|10|variant|litvar@#324#c.3360delA&&&litvar@#324#|c.3360delA", "1649|8|variant|litvar@rs730882002##&&&litvar@#7157#&&&litvar@CA273#rs730882002##|c.179G>A", "3819|7|variant|litvar@rs761961392##&&&litvar@#5156#&&&litvar@CA2922577#rs761961392##|p.S502T", "4374|7|variant|litvar@rs573154688##&&&litvar@#7157#&&&litvar@CA533#rs573154688##|p.R201H", "1184|16|variant|litvar@rs730882015##&&&litvar@#7157#|c.294_297delTTCC", "78|7|species|ncbi_taxonomy@9606|Patient", "3100|8|variant|litvar@rs397517202##&&&litvar@#5290#&&&litvar@CA136374#rs397517202##|p.T1025A", "3215|8|variant|litvar@rs397517202##|p.T1025P", "4447|6|variant|litvar@rs201100551##&&&litvar@#5728#|p.E17K", "4704|9|variant|litvar@rs762269030##&&&litvar@#5156#|c.2618A>G", "1263|22|variant|litvar@#3845#c.277_278insCCTGGCCCCT&&&litvar@#3845#|c.277_278insCCTGGCCCCT", "1776|3|gene|ncbi_gene@324|APC", "219|8|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|c.844C>T", "1222|10|variant|litvar@#3845#p.SfsX99,23&&&litvar@#3845#|p.S99fs*23", "2382|9|variant|litvar@rs397509178##&&&litvar@#672#|p.T1438fs", "1715|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA180922#rs17851045##|c.183A>C", "4819|6|gene|ncbi_gene@5156|PDGFRA", "1478|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "2323|9|variant|litvar@rs80359439##&&&litvar@#675#|p.Q1429fs", "3787|9|variant|litvar@rs761961392##&&&litvar@#5156#|c.1504T>A", "1867|8|variant|litvar@#324#p.R1114*&&&litvar@#324#|p.R1114*", "1090|7|variant|litvar@#3845#p.Q136*&&&litvar@#3845#|p.Q136*", "2302|10|variant|litvar@#5290#c.4285delC&&&litvar@#5290#|c.4285delC", "1415|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "1586|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G>A", "4238|6|variant|litvar@rs1225779973##&&&litvar@#5290#|p.T41A", "3530|8|variant|litvar@rs876659844##&&&litvar@#4089#&&&litvar@CA10580974#rs876659844##|c.344G>A", "679|8|variant|litvar@rs121909630##&&&litvar@#2260#&&&litvar@CA130217#rs121909630##|c.592G>T", "3492|7|variant|litvar@rs182572604##&&&litvar@#2064#|p.C499Y", "2736|8|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|c.263G>A", "1116|8|variant|litvar@rs781137961##&&&litvar@#2064#&&&litvar@CA8533636#rs781137961##|c.379T>C", "420|9|variant|litvar@#7157#c.797delG&&&litvar@#7157#|c.797delG", "3394|9|variant|litvar@rs80338963##&&&litvar@#4089#&&&litvar@CA128095#rs80338963##|c.1081C>T", "4785|6|variant|litvar@rs765615419##&&&litvar@#2260#&&&litvar@CA4718764#rs765615419##|p.A32D", "2224|9|variant|litvar@#5290#p.G1120fsX&&&litvar@#5290#|p.G1120fs", "3607|7|variant|litvar@rs751285566##&&&litvar@#5156#|p.L529S", "98|8|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|c.524G>A", "886|7|variant|litvar@rs81002884##&&&litvar@#675#|p.A159V", "3000|9|variant|litvar@rs121913272##&&&litvar@#5290#&&&litvar@CA180900#rs121913272##|c.1258T>C", "3857|14|variant|litvar@#4893#c.562_563delAT&&&litvar@#4893#|c.562_563delAT", "3251|5|gene|ncbi_gene@4089|SMAD4", "286|8|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|c.818G>A", "4561|9|variant|litvar@rs147863331##&&&litvar@#324#&&&litvar@CA6055#rs147863331##|c.1825G>A", "4595|7|variant|litvar@rs772795566##&&&litvar@#324#&&&litvar@CA29805#rs772795566##|p.D609N", "4950|8|variant|litvar@rs539911006##&&&litvar@#3791#&&&litvar@CA160333#rs539911006##|c.794C>T", "3424|7|variant|litvar@rs80338963##&&&litvar@#4089#&&&litvar@CA128095#rs80338963##|p.R361C", "2003|8|variant|litvar@#324#p.E1322*&&&litvar@#324#|p.E1322*", "925|8|variant|litvar@rs121912654##&&&litvar@#7157#&&&litvar@CA222#rs121912654##|c.469G>T", "4029|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "3965|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "3549|7|variant|litvar@rs948405432##&&&litvar@#55294#&&&litvar@CA108587069#rs948405432##|p.C115Y", "763|7|variant|litvar@#3845#p.R196*&&&litvar@#3845#|p.R196*", "818|7|variant|litvar@rs1057519991##&&&litvar@#7157#|p.H179R", "4828|9|variant|litvar@rs370600501##&&&litvar@#5156#&&&litvar@CA2922875#rs370600501##|c.2470G>A", "2059|8|variant|litvar@#324#p.Q1444*&&&litvar@#324#|p.Q1444*", "3642|5|gene|ncbi_gene@55294|FBXW7", "4136|9|variant|litvar@rs397516896##&&&litvar@#673#&&&litvar@CA135095#rs397516896##|c.1780G>A", "640|7|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|p.R248W", "1512|4|gene|ncbi_gene@3845|KRAS", "477|8|variant|litvar@rs1057519990##&&&litvar@#7157#|c.796G>A", "2479|9|variant|litvar@rs185411044##&&&litvar@#324#&&&litvar@CA39986#rs185411044##|c.4475C>T", "3139|8|variant|litvar@rs779332376##&&&litvar@#5156#&&&litvar@CA2922251#rs779332376##|c.248T>C"], "figure_id": "T3", "text_hl": "Gene Variant serial no Coding sequence Transcript Variant type Variant effect Patient no   TP53 1 c.524G>A NM_000546 COSM10648_p.R175H nonsynonymous missense 4    2 c.637C>T NM_000546 COSM10654_p.R213* stop gain 3    3 c.844C>T NM_000546 COSM10704_p.R282W nonsynonymous missense 1    4 c.818G>A NM_000546 COSM10660_p.R273H nonsynonymous missense 1    5 c.814G>A NM_000546 COSM10891_p.V272M nonsynonymous missense 1    6 c.797delG NM_000546 COSM44187_p.G266fs frameshift 1    7 c.796G>A NM_000546 COSM10794_p.G266R nonsynonymous missense 1    8 c.743G>A NM_000546 COSM10662_p.R248Q nonsynonymous missense 1    9 c.742C>T NM_000546 COSM10656_p.R248W nonsynonymous missense 1    10 c.592G>T NM_000546 COSM44241_p.E198* stop gain 1    11 c.586C>T NM_000546 COSM10705_p.R196* stop gain 1    12 c.536A>G NM_000546 COSM10889_p.H179R nonsynonymous missense 1    13 c.476C>T NM_000546 COSM11148_p.A159V nonsynonymous missense 1    14 c.469G>T NM_000546 COSM10670_p.V157F nonsynonymous missense 1    15 c.455C>T NM_000546 COSM10790_p.P152L nonsynonymous missense 1    16 c.406C>T NM_000546 COSM11166_p.Q136* stop gain 1    17 c.379T>C NM_000546 COSM44687_p.S127P nonsynonymous missense 1    18 c.294_297delTTCC NM_000546 COSM278467_p.S99fs*23 frameshift +stop gain 1    19 c.277_278insCCTGGCCCCT NM_000546 p.L93fs frameshift 1   KRAS 1 c.35G>T NM_033360 COSM520_p.G12V nonsynonymous missense 8    2 c.38G>A NM_033360 COSM532_p.G13D nonsynonymous missense 5    3 c.35G>A NM_033360 COSM521_p.G12D nonsynonymous missense 4   KRAS 4 c.436G>A NM_033360 COSM19404_p.A146T nonsynonymous missense 2    5 c.34G>A NM_033360 COSM517_p.G12S nonsynonymous missense 1    6 c.179G>A NM_033360 COSM87290_p.G60D nonsynonymous missense 1    7 c.183A>C NM_033360 COSM554_p.Q61H nonsynonymous missense 1   APC 1 c.2626C>T NM_000038 COSM18852_p.R876* stop gain 3    2 c.3340C>T NM_000038 COSM13125_p.R1114* stop gain 2    3 c.3921_3925delAAAAG NM_000038 COSM18764_p.E1309fs*4 frameshift+stop gain 1    4 c.3964G>T NM_000038 COSM18702_p.E1322* stop gain 1    5 c.4330C>T NM_000038 COSM19021_p.Q1444* stop gain 1    6 c.4484G>T NM_000038 COSM99778_p.S1495I nonsynonymous missense 1    7 c.4661dupA NM_000038 p.E1554fs frameshift 2    8 c.3360delA NM_000038 p.G1120fs frameshift 1    9 c.4282delG NM_000038 p.G1428fs frameshift 1    10 c.4285delC NM_000038 p.Q1429fs frameshift 1    11 c.4313_4314insCACCT NM_000038 p.T1438fs frameshift 1    12 c.4348_4357delCGAGAAGTAC NM_000038 p.1450_1453fs frameshift 1    13 c.4475C>T NM_000038 p.A1492V nonsynonymous missense 1    14 c.4486_4493delACTCCAGA NM_000038 p.1496_1498fs frameshift 1    15 c.4501T>G NM_000038 p.S1501A nonsynonymous missense 1   PIK3CA 1 c.1633G>A NM_006218 COSM763_p.E545K nonsynonymous missense 4    2 c.263G>A NM_006218 COSM746_p.R88Q nonsynonymous missense 2    3 c.1035T>A NM_006218 COSM754_p.N345K nonsynonymous missense 2    4 c.331A>G NM_006218 COSM13570_p.K111E nonsynonymous missense 1    5 c.333G>T NM_006218 COSM27505_p.K111N nonsynonymous missense 1    6 c.1258T>C NM_006218 COSM757_p.C420R nonsynonymous missense 1   PIK3CA 7 c.3073A>G NM_006218 COSM771_p.T1025A nonsynonymous missense 1    8 c.248T>C NM_006218 p.F83S nonsynonymous missense 1    9 c.3073A>C NM_006218 p.T1025P nonsynonymous missense 1   SMAD4 1 c.1082G>A NM_005359 COSM14122_p.R361H nonsynonymous missense 2    2 c.353C>T NM_005359 COSM14215_p.A118V nonsynonymous missense 1    3 c.1081C>T NM_005359 COSM14140_p.R361C nonsynonymous missense 1    4 c.1496G>A NM_005359 COSM14221_p.C499Y nonsynonymous missense 1    5 c.344G>A NM_005359 p.C115Y nonsynonymous missense 1    6 c.1586T>C NM_005359 p.L529S nonsynonymous missense 1   FBXW7 1 c.1154G>A NM_018315 COSM117308_p.R385H nonsynonymous missense 2    2 c.1273C>T NM_018315 COSM74637_p.R425C nonsynonymous missense 1    3 c.1504T>A NM_018315 COSM1427667_p.S502T nonsynonymous missense 1    4 c.562_563delAT NM_018315 COSM1052123_p.M188fs*18 frameshift+stop gain 1   NRAS 1 c.182A>G NM_002524 COSM584_p.Q61R nonsynonymous missense 2    2 c.181C>A NM_002524 COSM580_p.Q61K nonsynonymous missense 1   BRAF 1 c.1799T>A NM_004333 COSM476_p.V600E nonsynonymous missense 1    2 c.1780G>A NM_004333 COSM27639_p.D594N nonsynonymous missense 1   CTNNB1 1 c.121A>G NM_001904 COSM5664_p.T41A nonsynonymous missense 1    2 c.131_133delCTT NM_001904 COSM33668_p.S45del frameshift 1   GNAS 1 c.602G>A NM_001077489 COSM27895_p.R201H nonsynonymous missense 1   AKT1 1 c.49G>A NM_001014432 COSM33765_p.E17K nonsynonymous missense 1   ATM 1 c.9023G>A NM_000051 COSM21626_p.R3008H nonsynonymous missense 1   ERBB4 1 c.1825G>A NM_001042599 COSM131772_p.D609N nonsynonymous missense 1   FGFR3 1 c.1153T>G NM_001163213 p.F383V nonsynonymous missense 1   ERBB2 1 c.2618A>G NM_004448 p.D873G nonsynonymous missense 1   FGFR1 1 c.95C>A NM_023106 p.A32D nonsynonymous missense 1   PDGFRA 1 c.2470G>A NM_006206 p.V824I nonsynonymous missense 1   EGFR 1 c.344A>C NM_005228 p.N115T nonsynonymous missense 1   KDR 1 c.794C>T NM_002253 p.S265L nonsynonymous missense 1   PTEN 1 c.71A>T NM_000314 p.D24V nonsynonymous missense 1   "}], "citations": {"NLM": "Chang PY, Chen JS, Chang NC, Chang SC, Wang MC, Tsai SH, Wen YH, Tsai WS, Chan EC, Lu JJ. NRAS germline variant G138R and multiple rare somatic mutations on APC in colorectal cancer patients in Taiwan by next generation sequencing. Oncotarget. PMID: 27121310", "BibTeX": "@article{27121310, title={NRAS germline variant G138R and multiple rare somatic mutations on APC in colorectal cancer patients in Taiwan by next generation sequencing.}, author={Chang PY and Chen JS and Chang NC and Chang SC and Wang MC and Tsai SH and Wen YH and Tsai WS and Chan EC and Lu JJ}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 26315110, "pmcid": "PMC4673235", "title": "Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility.", "journal": "Oncotarget", "authors": ["Alvi MA", "McArt DG", "Kelly P", "Fuchs MA", "Alderdice M", "McCabe CM", "Bingham V", "McGready C", "Tripathi S", "Emmert-Streib F", "Loughrey MB", "McQuaid S", "Maxwell P", "Hamilton PW", "Turkington R", "James JA", "Wilson RH", "Salto-Tellez M"], "date": "2015-08-28T00:00:00Z", "year": 2015, "snippets": [{"_id": "26315110@15553", "snip_text": "c.351A > C (substitution) in codon 117 just like c.436G > C (Substitution) has therapeutic implications in colorectal cancer and is known confer reduced sensitivity to anti-EGFR antibodies like cetuximab/panitumumab.", "section": "discussion", "mentions": ["194|9|chemical|ncbi_mesh@D000068818|cetuximab", "173|4|gene|ncbi_gene@1956|EGFR", "204|11|chemical|ncbi_mesh@D000077544|panitumumab", "107|17|disease|ncbi_mesh@D015179|colorectal cancer", "0|10|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|c.351A > C", "49|10|variant|litvar@rs121913527##&&&litvar@#3845#|c.436G > C"], "text_hl": "c.351A > C (substitution) in codon 117 just like c.436G > C (Substitution) has therapeutic implications in colorectal cancer and is known confer reduced sensitivity to anti-EGFR antibodies like cetuximab/panitumumab."}], "citations": {"NLM": "Alvi MA, McArt DG, Kelly P, Fuchs MA, Alderdice M, McCabe CM, Bingham V, McGready C, Tripathi S, Emmert-Streib F, Loughrey MB, McQuaid S, Maxwell P, Hamilton PW, Turkington R, James JA, Wilson RH, Salto-Tellez M. Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility. Oncotarget. PMID: 26315110", "BibTeX": "@article{26315110, title={Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility.}, author={Alvi MA and McArt DG and Kelly P and Fuchs MA and Alderdice M and McCabe CM and Bingham V and McGready C and Tripathi S and Emmert-Streib F and Loughrey MB and McQuaid S and Maxwell P and Hamilton PW and Turkington R and James JA and Wilson RH and Salto-Tellez M}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 26709701, "pmcid": "PMC4692403", "title": "KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.", "journal": "PLoS One", "authors": ["Chattopadhyay N", "Berger AJ", "Koenig E", "Bannerman B", "Garnsey J", "Bernard H", "Hales P", "Maldonado Lopez A", "Yang Y", "Donelan J", "Jordan K", "Tirrell S", "Stringer B", "Xia C", "Hather G", "Galvin K", "Manfredi M", "Rhodes N", "Amidon B"], "date": "2015-12-28T00:00:00Z", "year": 2015, "snippets": [{"_id": "26709701@9671", "snip_text": "For the KRAS gene, the mutations tested are G12 A/C/D/F/R/S/V, G13 A/C/D/R/S/V, L19F, Q22K, T58I, A59T/V, G60D, Q61 E/H/K/L/P/R and A146T.", "section": "methods", "mentions": ["86|4|variant|litvar@rs121913236##&&&litvar@#3845#&&&litvar@CA16602771#rs121913236##|Q22K", "132|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "8|4|gene|ncbi_gene@3845|KRAS", "63|7|variant|litvar@rs112445441##&&&litvar@#3845#|G13 A/C", "106|4|variant|litvar@#3845#p.G60D&&&litvar@#3845#|G60D", "44|7|variant|litvar@rs121913529##&&&litvar@#3845#|G12 A/C", "80|4|variant|litvar@rs121913538##&&&litvar@#3845#&&&litvar@CA210356#rs121913538##|L19F", "98|6|variant|litvar@rs121913528##&&&litvar@#3845#|A59T/V", "92|4|variant|litvar@rs104894364##&&&litvar@#3845#&&&litvar@CA256480#rs104894364##|T58I", "112|7|variant|litvar@rs17851045##&&&litvar@#3845#|Q61 E/H"], "text_hl": "For the KRAS gene, the mutations tested are G12 A/C/D/F/R/S/V, G13 A/C/D/R/S/V, L19F, Q22K, T58I, A59T/V, G60D, Q61 E/H/K/L/P/R and <m>A146T</m>."}], "citations": {"NLM": "Chattopadhyay N, Berger AJ, Koenig E, Bannerman B, Garnsey J, Bernard H, Hales P, Maldonado Lopez A, Yang Y, Donelan J, Jordan K, Tirrell S, Stringer B, Xia C, Hather G, Galvin K, Manfredi M, Rhodes N, Amidon B. KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism. PLoS One. PMID: 26709701", "BibTeX": "@article{26709701, title={KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.}, author={Chattopadhyay N and Berger AJ and Koenig E and Bannerman B and Garnsey J and Bernard H and Hales P and Maldonado Lopez A and Yang Y and Donelan J and Jordan K and Tirrell S and Stringer B and Xia C and Hather G and Galvin K and Manfredi M and Rhodes N and Amidon B}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 29562441, "pmcid": "PMC7342576", "title": "[Spectrum of somatic mutations and their prognostic significance in adult patients with B cell acute lymphoblastic leukemia].", "journal": "Zhonghua Xue Ye Xue Za Zhi", "authors": ["Feng J", "Gong XY", "Jia YJ", "Liu KQ", "Li Y", "Dong XB", "Fang QY", "Ru K", "Li QH", "Wang HJ", "Zhao XL", "Jia YN", "Song Y", "Tian Z", "Wang M", "Tang KJ", "Wang JX", "Mi YC"], "date": "2018-02-14T00:00:00Z", "year": 2018, "snippets": [{"_id": "29562441@6700", "snip_text": "               FAT1 p.R1257Q p.V3694I p.A4551G p.T1679I p.T1492S p.E1141D p.D1113N   SF1 p.M449V p.M475V p.M600V p.Y476C p.T474A p.Y476C p.A1574T p.T2321M p.G2480S   NRAS p.G12D p.G12A p.G12S p.Q61K p.G12V p.G12D p.G12C   CREBBP p.L513I p.L551I p.A254T   PTPN11 p.D61Y p.P491S p.S502T p.E76G p.A72D p.K308D p.T73I   JAK2 p.R683G p.D873N p.R683S p.P933Q p.T875N p.V617F   DIS3 p.S557 p.S587F   MPL p.R321Q   KMT2D p.R3714K p.V401M p.M3349V p.R2401H   EP300 p.S507G   RUNX1 p.I114I p.I87I p.R177X p.R204X p.R135K p.R162K p.R293X p.R320X   TP53 p.R116W p.R209W p.R248W p.R89W p.S109F p.S202F p.S241F p.S82F p.R123P p.R150P p.R243P p.R282P p.R124L p.R151L p.R244L p.R283L p.I112V p.Y220C p.A144V   EZH2 p.R628C p.R640C p.R670C p.R679C p.R684C p.D146H p.D674-Y675delinsX p.D730-Y731delinsX   KRAS p.G60D p.G13D p.A146T p.A18D p.G12D   SF3B1 p.R625C p.G740R p.K700E p.D907Y p.L747W   JAK1 p.S703I p.Y652H p.A701V p.S646F   CSF3R p.P733T p.P760T   UNC13D p.G863D   ", "section": "table", "mentions": ["137|8|variant|litvar@#4893#p.A1574T&&&litvar@#4893#|p.A1574T", "907|7|variant|litvar@rs151047872##&&&litvar@#3716#&&&litvar@CA892794#rs151047872##|p.S646F", "185|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "668|7|variant|litvar@rs775836436##&&&litvar@#3845#&&&litvar@CA6486889#rs775836436##|p.I112V", "397|7|variant|litvar@rs149265851##&&&litvar@#4352#&&&litvar@CA160847#rs149265851##|p.R321Q", "146|8|variant|litvar@#4893#p.T2321M&&&litvar@#4893#|p.T2321M", "806|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "566|6|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|p.R89W", "222|6|gene|ncbi_gene@1387|CREBBP", "199|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "852|7|variant|litvar@rs559063155##&&&litvar@#23451#&&&litvar@CA2042597#rs559063155##|p.K700E", "814|6|variant|litvar@#23451#p.A18D&&&litvar@#23451#|p.A18D", "74|8|variant|litvar@rs144526682##&&&litvar@#2195#&&&litvar@CA3167037#rs144526682##|p.D1113N", "573|7|variant|litvar@rs28934573##&&&litvar@#7157#&&&litvar@CA359#rs28934573##|p.S109F", "628|7|variant|litvar@rs730882008##&&&litvar@#7157#|p.R282P", "213|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "495|7|variant|litvar@#7157#p.R204X&&&litvar@#7157#|p.R204X", "550|7|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|p.R209W", "85|3|gene|ncbi_gene@7536|SF1", "472|7|variant|litvar@#7157#p.I114I&&&litvar@#7157#|p.I114I", "899|7|variant|litvar@rs117679986##&&&litvar@#3716#&&&litvar@CA23903465#rs117679986##|p.A701V", "321|7|variant|litvar@rs1057519721##&&&litvar@#3717#|p.R683G", "931|7|variant|litvar@#201294#p.P760T&&&litvar@#201294#|p.P760T", "660|7|variant|litvar@#2146#p.R283L&&&litvar@#2146#|p.R283L", "47|8|variant|litvar@rs145905687##&&&litvar@#2195#|p.T1679I", "371|7|gene|ncbi_gene@22894|DIS3 p.", "707|7|variant|litvar@rs587783626##&&&litvar@#2146#&&&litvar@CA271512#rs587783626##|p.R640C", "353|7|variant|litvar@rs1057520016##&&&litvar@#3717#|p.T875N", "292|6|variant|litvar@rs121918454##&&&litvar@#5781#|p.A72D", "480|6|variant|litvar@rs1389746826##&&&litvar@#3718#|p.I87I", "29|8|variant|litvar@rs150034185##&&&litvar@#2195#&&&litvar@CA3165189#rs150034185##|p.V3694I", "229|7|variant|litvar@rs61753381##&&&litvar@#1387#&&&litvar@CA248673#rs61753381##|p.L513I", "422|7|variant|litvar@rs200102669##&&&litvar@#8085#&&&litvar@CA6548548#rs200102669##|p.V401M", "38|8|variant|litvar@rs148468016##&&&litvar@#2195#&&&litvar@CA3164479#rs148468016##|p.A4551G", "836|7|variant|litvar@rs775623976##&&&litvar@#23451#&&&litvar@CA2042638#rs775623976##|p.R625C", "620|7|variant|litvar@rs730882008##&&&litvar@#7157#|p.R243P", "891|7|variant|litvar@rs1423397744##&&&litvar@#2322#|p.Y652H", "97|7|variant|litvar@rs758897629##&&&litvar@#7536#|p.M475V", "868|7|variant|litvar@#3716#p.L747W&&&litvar@#3716#|p.L747W", "542|7|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|p.R116W", "652|7|variant|litvar@rs1333471306##&&&litvar@#201294#|p.R244L", "206|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "766|18|variant|litvar@#3845#p.X730,731delins&&&litvar@#3845#|p.D730-Y731delinsX", "345|7|variant|litvar@#22894#p.P933Q&&&litvar@#22894#|p.P933Q", "923|7|variant|litvar@rs1280676418##&&&litvar@#7468#|p.P733T", "699|7|variant|litvar@rs587783626##&&&litvar@#2146#&&&litvar@CA271512#rs587783626##|p.R628C", "676|7|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|p.Y220C", "821|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "941|6|gene|ncbi_gene@201294|UNC13D", "612|7|variant|litvar@rs730882008##&&&litvar@#7157#|p.R150P", "285|6|variant|litvar@rs121918465##&&&litvar@#5781#&&&litvar@CA123044#rs121918465##|p.E76G", "245|7|variant|litvar@rs148781922##&&&litvar@#1387#&&&litvar@CA158186#rs148781922##|p.A254T", "407|5|gene|ncbi_gene@8085|KMT2D", "439|8|variant|litvar@rs375115132##&&&litvar@#8085#&&&litvar@CA6547106#rs375115132##|p.R2401H", "511|7|variant|litvar@rs765345307##&&&litvar@#171023#&&&litvar@CA9808110#rs765345307##|p.R162K", "883|7|variant|litvar@#3716#p.S703I&&&litvar@#3716#|p.S703I", "89|7|variant|litvar@rs758897629##&&&litvar@#7536#|p.M449V", "860|7|variant|litvar@#3716#p.D907Y&&&litvar@#3716#|p.D907Y", "337|7|variant|litvar@rs1057519723##&&&litvar@#3717#|p.R683S", "121|7|variant|litvar@rs147412519##&&&litvar@#7536#|p.T474A", "636|7|variant|litvar@#2146#p.R124L&&&litvar@#2146#|p.R124L", "830|5|gene|ncbi_gene@23451|SF3B1", "430|8|variant|litvar@rs80149580##&&&litvar@#8085#&&&litvar@CA147653#rs80149580##|p.M3349V", "723|7|variant|litvar@rs587783626##&&&litvar@#2146#&&&litvar@CA271512#rs587783626##|p.R679C", "361|7|variant|litvar@rs77375493##&&&litvar@#3717#&&&litvar@CA124183#rs77375493##|p.V617F", "948|7|variant|litvar@rs140184929##&&&litvar@#201294#&&&litvar@CA8772459#rs140184929##|p.G863D", "604|7|variant|litvar@rs730882008##&&&litvar@#7157#|p.R123P", "171|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "581|7|variant|litvar@rs28934573##&&&litvar@#7157#&&&litvar@CA359#rs28934573##|p.S202F", "237|7|variant|litvar@rs61753381##&&&litvar@#1387#&&&litvar@CA248673#rs61753381##|p.L551I", "413|8|variant|litvar@rs186696516##&&&litvar@#8085#&&&litvar@CA160603#rs186696516##|p.R3714K", "558|7|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|p.R248W", "269|7|variant|litvar@rs397507539##&&&litvar@#5781#&&&litvar@CA261543#rs397507539##|p.P491S", "527|7|variant|litvar@#7157#p.R320X&&&litvar@#7157#|p.R320X", "329|7|variant|litvar@#3717#p.D873N&&&litvar@#3717#|p.D873N", "113|7|variant|litvar@rs758897629##&&&litvar@#7536#|p.Y476C", "715|7|variant|litvar@rs587783626##&&&litvar@#2146#&&&litvar@CA271512#rs587783626##|p.R670C", "65|8|variant|litvar@rs188190037##&&&litvar@#2195#&&&litvar@CA3167019#rs188190037##|p.E1141D", "316|4|gene|ncbi_gene@3717|JAK2", "792|6|variant|litvar@rs121918461##&&&litvar@#5781#&&&litvar@CA177665#rs121918461##|p.G60D", "56|8|variant|litvar@rs181526716##&&&litvar@#2195#|p.T1492S", "844|7|variant|litvar@rs587783627##&&&litvar@#2146#&&&litvar@CA271515#rs587783627##|p.G740R", "105|7|variant|litvar@rs758897629##&&&litvar@#7536#|p.M600V", "20|8|variant|litvar@rs188188069##&&&litvar@#2195#&&&litvar@CA3166914#rs188188069##|p.R1257Q", "255|6|gene|ncbi_gene@5781|PTPN11", "519|7|variant|litvar@#7157#p.R293X&&&litvar@#7157#|p.R293X", "537|4|gene|ncbi_gene@7157|TP53", "393|3|gene|ncbi_gene@4352|MPL", "129|7|variant|litvar@rs758897629##&&&litvar@#7536#|p.Y476C", "684|7|variant|litvar@rs1202674798##&&&litvar@#3845#|p.A144V", "739|7|variant|litvar@rs2302427##&&&litvar@#2146#&&&litvar@CA159195#rs2302427##|p.D146H", "178|6|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|p.G12A", "299|7|variant|litvar@#3717#p.K308D&&&litvar@#3717#|p.K308D", "694|4|gene|ncbi_gene@2146|EZH2", "487|7|variant|litvar@#7157#p.R177X&&&litvar@#7157#|p.R177X", "166|4|gene|ncbi_gene@4893|NRAS", "15|4|gene|ncbi_gene@2195|FAT1", "192|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "456|7|variant|litvar@rs1171974048##&&&litvar@#7536#|p.S507G", "307|6|variant|litvar@rs121918462##&&&litvar@#5781#&&&litvar@CA256752#rs121918462##|p.T73I", "644|7|variant|litvar@#2146#p.R151L&&&litvar@#2146#|p.R151L", "878|4|gene|ncbi_gene@3716|JAK1", "799|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "277|7|variant|litvar@rs121918458##&&&litvar@#5781#&&&litvar@CA180739#rs121918458##|p.S502T", "787|4|gene|ncbi_gene@3845|KRAS", "731|7|variant|litvar@rs587783626##&&&litvar@#2146#&&&litvar@CA271512#rs587783626##|p.R684C", "597|6|variant|litvar@rs28934573##&&&litvar@#7157#&&&litvar@CA359#rs28934573##|p.S82F", "589|7|variant|litvar@rs28934573##&&&litvar@#7157#&&&litvar@CA359#rs28934573##|p.S241F", "155|8|variant|litvar@#4893#p.G2480S&&&litvar@#4893#|p.G2480S", "262|6|variant|litvar@rs397507510##&&&litvar@#5781#&&&litvar@CA10576907#rs397507510##|p.D61Y", "383|7|variant|litvar@rs144957541##&&&litvar@#22894#&&&litvar@CA7001219#rs144957541##|p.S587F", "503|7|variant|litvar@rs1064796681##&&&litvar@#7157#|p.R135K"], "figure_id": "t01", "text_hl": "               FAT1 p.R1257Q p.V3694I p.A4551G p.T1679I p.T1492S p.E1141D p.D1113N   SF1 p.M449V p.M475V p.M600V p.Y476C p.T474A p.Y476C p.A1574T p.T2321M p.G2480S   NRAS p.G12D p.G12A p.G12S p.Q61K p.G12V p.G12D p.G12C   CREBBP p.L513I p.L551I p.A254T   PTPN11 p.D61Y p.P491S p.S502T p.E76G p.A72D p.K308D p.T73I   JAK2 p.R683G p.D873N p.R683S p.P933Q p.T875N p.V617F   DIS3 p.S557 p.S587F   MPL p.R321Q   KMT2D p.R3714K p.V401M p.M3349V p.R2401H   EP300 p.S507G   RUNX1 p.I114I p.I87I p.R177X p.R204X p.R135K p.R162K p.R293X p.R320X   TP53 p.R116W p.R209W p.R248W p.R89W p.S109F p.S202F p.S241F p.S82F p.R123P p.R150P p.R243P p.R282P p.R124L p.R151L p.R244L p.R283L p.I112V p.Y220C p.A144V   EZH2 p.R628C p.R640C p.R670C p.R679C p.R684C p.D146H p.D674-Y675delinsX p.D730-Y731delinsX   KRAS p.G60D p.G13D <m>p.A146T</m> p.A18D p.G12D   SF3B1 p.R625C p.G740R p.K700E p.D907Y p.L747W   JAK1 p.S703I p.Y652H p.A701V p.S646F   CSF3R p.P733T p.P760T   UNC13D p.G863D   "}], "citations": {"NLM": "Feng J, Gong XY, Jia YJ, Liu KQ, Li Y, Dong XB, Fang QY, Ru K, Li QH, Wang HJ, Zhao XL, Jia YN, Song Y, Tian Z, Wang M, Tang KJ, Wang JX, Mi YC. [Spectrum of somatic mutations and their prognostic significance in adult patients with B cell acute lymphoblastic leukemia]. Zhonghua Xue Ye Xue Za Zhi. PMID: 29562441", "BibTeX": "@article{29562441, title={[Spectrum of somatic mutations and their prognostic significance in adult patients with B cell acute lymphoblastic leukemia].}, author={Feng J and Gong XY and Jia YJ and Liu KQ and Li Y and Dong XB and Fang QY and Ru K and Li QH and Wang HJ and Zhao XL and Jia YN and Song Y and Tian Z and Wang M and Tang KJ and Wang JX and Mi YC}, journal={Zhonghua Xue Ye Xue Za Zhi}}"}, "is_sup_mat_match": false}, {"pmid": 31645898, "pmcid": "PMC6791388", "title": "PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors.", "journal": "Oncotarget", "authors": ["Smith AM", "Zhang CRC", "Cristino AS", "Grady JP", "Fink JL", "Moore AS"], "date": "2019-10-08T00:00:00Z", "year": 2019, "snippets": [{"_id": "31645898@5765", "snip_text": "Pedatric Cell line Cytogenetics Sequence Features PD0325901 AZD6244 MEK162 GSK1120212 CI1040 TAK733 AS703026 Ara-C Daunorubicin Etoposide    MV-4-11 MLL-AF4 FLT3-ITD 0.17** 0.41* 0.33** 0.003*** 6.9 0.089** 0.41** 1.6 0.048 0.056    THP-1 MLL-AF9 TP53(R174fs*3), NRAS (G12D) 0.19*** 0.3** 0.43** 0.08*** 2.2* 0.23*** 0.23*** 6.7 0.122 1.9    CMK Myeloid leukaemia associated with Down Syndrome. Complex TP53(D49H and M133K), CDKN2A (M1_*157del), JAK3 (A572V), GATA1(E2fs*37) >20 >20 >20 >20 >20 >20 >20 0.48 0.076 4.5    AML-193 Complex karyotype with 4% polyploidy NRAS (G13V) 0.24* 2.9 2.1 0.14* 4.8 0.25* 0.42* 2.6 0.057 3.4    Kasumi-1 t (8;21)(q22; q22) RUNX1-CBFA2T1; c-KIT mut (N822K), TP53 (R248Q) 0.2 1.7 1.1 0 004 6.5 0.051 0.31 0.15 0.028 0.53    M-07e t (11;21)(p11; p13) CREBBP (Q2208H) 0.11 1.1 0.34 0.006 4.8 0.038 0.08 0.033 0.0069 0.18   Adult ME1 CBFB-MYH11  0.003 0.022 0.037 0.00004 0.55 0.005 0.08 0.41 0.36 18   HL-60 MLL-AF6 CDKN2A (R80* and P135L), NRAS (Q61L), t (6,11)(q27; q23) 0.001 0.12 0.02 0.001 0.73 0.001 0.007 0.64 0.02 1.3   ML-2 KMT2A-AFDN CREBBP (L1090*) NOTCH1(P2514fs*4), KRAS (A146T), CDKN2A (M1*157del) 0.004 0.066 0.047 0.001 0.68 0.01 0.02 0.069 0.011 0.16   HEL Hypertriploid with 2.3% polyploidy JAK2 (V617F), TP53 (M133K), CDKN2A (M1_*157del) >20 >20 >20 >20 >20 >20 >20 0.085 0.12 1.6   OCI-AML3 Hyperdiploid (+1, +5, +8, der (1) t(1;18)(p11; q11), i (5p), del (13)(q13q21), dup (17)(q21q25)) DNMT3A (R882C), NPM1 (W288fs*12) 0.008 0.07 0.04 9.20E-05 1.1 0.004 0.02 >20 0.019 0.47   Median all    0.11 0.3 0.33 0.003 2.2 0.038 0.08 0.445 0.048 1.3   ", "section": "table", "mentions": ["417|5|variant|litvar@#7157#p.M133K&&&litvar@#7157#|M133K", "572|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "269|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "141|7|chemical||MV-4-11", "1076|6|gene|ncbi_gene@1387|CREBBP", "861|3|gene|ncbi_gene@4199|ME1", "403|4|gene|ncbi_gene@7157|TP53", "342|3|disease||CMK", "792|6|variant|litvar@rs142545779##&&&litvar@#1387#&&&litvar@CA171804#rs142545779##|Q2208H", "247|4|gene|ncbi_gene@7157|TP53", "380|13|disease|ncbi_mesh@D004314|Down Syndrome", "521|3|disease|ncbi_mesh@D054218|AML", "1269|6|gene|ncbi_gene@1029|CDKN2A", "665|7|gene|ncbi_gene@862|CBFA2T1", "408|4|variant|litvar@rs587780728##&&&litvar@#7157#&&&litvar@CA57#rs587780728##|D49H", "699|5|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|R248Q", "948|6|gene|ncbi_gene@1029|CDKN2A", "965|5|variant|litvar@#4893#p.P135L&&&litvar@#4893#|P135L", "425|6|gene|ncbi_gene@1029|CDKN2A", "460|5|gene|ncbi_gene@2623|GATA1", "685|5|variant|litvar@rs121913514##&&&litvar@#3815#&&&litvar@CA16602411#rs121913514##|N822K", "1462|9|variant|litvar@rs587776806##&&&litvar@#4869#|W288fs*12", "1136|6|variant|litvar@#3718#c.157del&&&litvar@#3718#|157del", "60|7|chemical|ncbi_mesh@C517975|AZD6244", "239|7|gene|ncbi_gene@4297|MLL-AF9", "973|4|gene|ncbi_gene@4893|NRAS", "1117|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "870|5|gene|ncbi_gene@4629|MYH11", "693|4|gene|ncbi_gene@7157|TP53", "1111|4|gene|ncbi_gene@3845|KRAS", "252|6|variant|litvar@rs864309495##&&&litvar@#7157#|R174fs", "452|5|variant|litvar@rs121913504##&&&litvar@#3718#&&&litvar@CA16602504#rs121913504##|A572V", "1440|6|gene|ncbi_gene@1788|DNMT3A", "346|17|disease|ncbi_mesh@D015458|Myeloid leukaemia", "68|6|chemical|ncbi_mesh@C581313|MEK162", "446|4|gene|ncbi_gene@3718|JAK3", "157|4|gene|ncbi_gene@2322|FLT3", "784|6|gene|ncbi_gene@1387|CREBBP", "1448|5|variant|litvar@rs377577594##&&&litvar@#1788#&&&litvar@CA1555491#rs377577594##|R882C", "115|22|chemical||Daunorubicin Etoposide", "659|5|gene|ncbi_gene@861|RUNX1", "979|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "566|4|gene|ncbi_gene@4893|NRAS", "50|9|chemical|ncbi_mesh@C506614|PD0325901", "1334|8|disease||OCI-AML3", "1456|4|gene|ncbi_gene@4869|NPM1", "263|4|gene|ncbi_gene@4893|NRAS", "1099|7|variant|litvar@#3845#p.P2514fsX&&&litvar@#3845#|P2514fs", "1261|5|variant|litvar@#7157#p.M133K&&&litvar@#7157#|M133K", "233|5|cellline||THP-1", "1255|4|gene|ncbi_gene@7157|TP53", "1125|6|gene|ncbi_gene@1029|CDKN2A", "437|6|variant|litvar@#3718#c.157del&&&litvar@#3718#|157del", "75|10|chemical|ncbi_mesh@C560077|GSK1120212", "1281|6|variant|litvar@#3718#c.157del&&&litvar@#3718#|157del", "100|8|chemical|ncbi_mesh@C550600|AS703026", "865|4|gene|ncbi_gene@865|CBFB", "109|5|chemical|ncbi_mesh@D003561|Ara-C", "93|6|chemical|ncbi_mesh@C558666|TAK733", "674|5|gene|ncbi_gene@3815|c-KIT"], "figure_id": "T1", "text_hl": "Pedatric Cell line Cytogenetics Sequence Features PD0325901 AZD6244 MEK162 GSK1120212 CI1040 TAK733 AS703026 Ara-C Daunorubicin Etoposide    MV-4-11 MLL-AF4 FLT3-ITD 0.17** 0.41* 0.33** 0.003*** 6.9 0.089** 0.41** 1.6 0.048 0.056    THP-1 MLL-AF9 TP53(R174fs*3), NRAS (G12D) 0.19*** 0.3** 0.43** 0.08*** 2.2* 0.23*** 0.23*** 6.7 0.122 1.9    CMK Myeloid leukaemia associated with Down Syndrome. Complex TP53(D49H and M133K), CDKN2A (M1_*157del), JAK3 (A572V), GATA1(E2fs*37) >20 >20 >20 >20 >20 >20 >20 0.48 0.076 4.5    AML-193 Complex karyotype with 4% polyploidy NRAS (G13V) 0.24* 2.9 2.1 0.14* 4.8 0.25* 0.42* 2.6 0.057 3.4    Kasumi-1 t (8;21)(q22; q22) RUNX1-CBFA2T1; c-KIT mut (N822K), TP53 (R248Q) 0.2 1.7 1.1 0 004 6.5 0.051 0.31 0.15 0.028 0.53    M-07e t (11;21)(p11; p13) CREBBP (Q2208H) 0.11 1.1 0.34 0.006 4.8 0.038 0.08 0.033 0.0069 0.18   Adult ME1 CBFB-MYH11  0.003 0.022 0.037 0.00004 0.55 0.005 0.08 0.41 0.36 18   HL-60 MLL-AF6 CDKN2A (R80* and P135L), NRAS (Q61L), t (6,11)(q27; q23) 0.001 0.12 0.02 0.001 0.73 0.001 0.007 0.64 0.02 1.3   ML-2 KMT2A-AFDN CREBBP (L1090*) NOTCH1(P2514fs*4), KRAS (<m>A146T</m>), CDKN2A (M1*157del) 0.004 0.066 0.047 0.001 0.68 0.01 0.02 0.069 0.011 0.16   HEL Hypertriploid with 2.3% polyploidy JAK2 (V617F), TP53 (M133K), CDKN2A (M1_*157del) >20 >20 >20 >20 >20 >20 >20 0.085 0.12 1.6   OCI-AML3 Hyperdiploid (+1, +5, +8, der (1) t(1;18)(p11; q11), i (5p), del (13)(q13q21), dup (17)(q21q25)) DNMT3A (R882C), NPM1 (W288fs*12) 0.008 0.07 0.04 9.20E-05 1.1 0.004 0.02 >20 0.019 0.47   Median all    0.11 0.3 0.33 0.003 2.2 0.038 0.08 0.445 0.048 1.3   "}], "citations": {"NLM": "Smith AM, Zhang CRC, Cristino AS, Grady JP, Fink JL, Moore AS. PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors. Oncotarget. PMID: 31645898", "BibTeX": "@article{31645898, title={PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors.}, author={Smith AM and Zhang CRC and Cristino AS and Grady JP and Fink JL and Moore AS}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 35887862, "pmcid": "PMC9324356", "title": "Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study.", "journal": "J Clin Med", "authors": ["Illini O", "Fabikan H", "Hochmair MJ", "Weinlinger C", "Krenbek D", "Brcic L", "Setinek U", "Terbuch A", "Absenger G", "Konji\u0107 S", "Valipour A"], "date": "2022-07-15T00:00:00Z", "year": 2022, "snippets": [{"_id": "35887862@37969", "snip_text": "KRAS Mutation, n (%) 1 All Patients(N = 665)   G12C 314 (47.2)   G12V 103 (15.5)   G12D 86 (12.9)   G12A 40 (6.0)   G13D 23 (3.5)   G13C 23 (3.5)   Q61H 16 (2.4)   G12S 15 (2.3)   G12F 9 (1.4)   G12R 6 (0.9)   G13V 4 (0.6)   Q61L 3 (0.5)   Q61R 2 (0.3)   L19F 2 (0.3)   A146T 2 (0.3)   E63K 2 (0.3)   G12H 1 (0.2)   G12I 1 (0.2)   G12Y 1 (0.2)   G13Dup 1 (0.2)   G13E 1 (0.2)   G13Y 1 (0.2)   G13delinsAGG 1 (0.2)   Q22K 1 (0.2)   P34R 1 (0.2)   A146P 1 (0.2)   A59E 1 (0.2)   T35P 1 (0.2)   A146V 1 (0.2)   K5N 1 (0.2)   P34R 1 (0.2)   ", "section": "table", "mentions": ["331|4|variant|litvar@rs121913529##&&&litvar@#3845#|G12Y", "225|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|Q61L", "0|4|gene|ncbi_gene@3845|KRAS", "363|4|variant|litvar@rs112445441##&&&litvar@#3845#|G13E", "83|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "164|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "301|4|variant|litvar@rs121913529##&&&litvar@#3845#|G12H", "65|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "148|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "416|4|variant|litvar@rs121913236##&&&litvar@#3845#&&&litvar@CA16602771#rs121913236##|Q22K", "255|4|variant|litvar@rs121913538##&&&litvar@#3845#&&&litvar@CA210356#rs121913538##|L19F", "462|4|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|A59E", "47|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "240|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|Q61R", "522|4|variant|litvar@rs104894366##&&&litvar@#3845#&&&litvar@CA280040#rs104894366##|P34R", "210|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "132|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "477|4|variant|litvar@#3845#p.T35P&&&litvar@#3845#|T35P", "316|4|variant|litvar@rs121913529##&&&litvar@#3845#|G12I", "100|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "446|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "180|4|variant|litvar@rs121913529##&&&litvar@#3845#|G12F", "286|4|variant|litvar@rs1195801490##&&&litvar@#79811#|E63K", "431|4|variant|litvar@rs104894366##&&&litvar@#3845#&&&litvar@CA280040#rs104894366##|P34R", "346|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "378|4|variant|litvar@rs112445441##&&&litvar@#3845#|G13Y", "195|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "492|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "27|8|species|ncbi_taxonomy@9606|Patients", "270|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "figure_id": "jcm-11-04098-t001", "text_hl": "KRAS Mutation, n (%) 1 All Patients(N = 665)   G12C 314 (47.2)   G12V 103 (15.5)   G12D 86 (12.9)   G12A 40 (6.0)   G13D 23 (3.5)   G13C 23 (3.5)   Q61H 16 (2.4)   G12S 15 (2.3)   G12F 9 (1.4)   G12R 6 (0.9)   G13V 4 (0.6)   Q61L 3 (0.5)   Q61R 2 (0.3)   L19F 2 (0.3)   <m>A146T</m> 2 (0.3)   E63K 2 (0.3)   G12H 1 (0.2)   G12I 1 (0.2)   G12Y 1 (0.2)   G13Dup 1 (0.2)   G13E 1 (0.2)   G13Y 1 (0.2)   G13delinsAGG 1 (0.2)   Q22K 1 (0.2)   P34R 1 (0.2)   A146P 1 (0.2)   A59E 1 (0.2)   T35P 1 (0.2)   A146V 1 (0.2)   K5N 1 (0.2)   P34R 1 (0.2)   "}], "citations": {"NLM": "Illini O, Fabikan H, Hochmair MJ, Weinlinger C, Krenbek D, Brcic L, Setinek U, Terbuch A, Absenger G, Konji\u0107 S, Valipour A. Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study. J Clin Med. PMID: 35887862", "BibTeX": "@article{35887862, title={Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study.}, author={Illini O and Fabikan H and Hochmair MJ and Weinlinger C and Krenbek D and Brcic L and Setinek U and Terbuch A and Absenger G and Konji\u0107 S and Valipour A}, journal={J Clin Med}}"}, "is_sup_mat_match": false}, {"pmid": 36328595, "pmcid": "PMC9644417", "title": "Myeloma immunoglobulin rearrangement and translocation detection through targeted capture sequencing", "journal": "Life Sci Alliance", "authors": ["Chow S", "Kis O", "Mulder DT", "Danesh A", "Bruce J", "Wang TT", "Reece D", "Bhalis N", "Neri P", "Sabatini PJ", "Keats J", "Trudel S", "Pugh TJ"], "date": "2022-11-03T00:00:00Z", "year": 2022, "snippets": [{"_id": "36328595@29858", "snip_text": "Patient\tGenomic alteration/marker\tClinical bone marrow FISH\tBone marrow sequencing\tcfDNA contemporaneous samples\tcfDNA follow-up 1 samples\tcfDNA follow-up 2 samples\t \tt(4;14)\tt(11;14)\tt(14;16)\t \tPatient R\tt(11;14)\tNegative\tDetected\tNegative\tDetected\tDetected\t\t\t \t\tIGHV3-66/D3-22/J5\t\t\t\tDetected (0.69)\t\t\t\t \t\tIGLV2-23/J2\t\t\t\tDetected (0.8)\t\t\t\t \t\tNRAS p.Q61K\t\t\t\tDetected (0.58)\tDetected (0.016)\t\t\t \t\tFAM46C p.F274L\t\t\t\tDetected (0.46)\tDetected (0.0062)\t\t\t \t\tLTB p.P75L\t\t\t\tDetected (0.50)\t\tDetected (0.43)\t\t \tPatient S\tt(4;14)\tDetected\tNegative\tNegative\tDetected\tDetected\tDetected\t\t \t\tIGKV1-37/J3\t\t\t\tDetected (0.61)\tDetected (0.61)\tDetected (0.82)\t\t \t\tIGKV1-5/J4\t\t\t\tDetected (0.11)\tDetected (0.11)\tDetected (0.12)\t\t \t\tKRAS p.A146T\t\t\t\tDetected (0.19)\t\tDetected (0.065)\t\t \t\tFAM46C p.D150Y\t\t\t\tDetected (0.23)\t\t\t\t \t\tPRKD2 p.Y566C\t\t\t\tDetected (0.65)\tPRKD2 p.Y566C (0.040)\tDetected (0.11)\t\t \tPatient T\tNo translocations detected\tNegative\tNo translocations detected\t\t\t\t \t\tIGKV3-11/J3\t\t\t\tDetected (0.62)\tDetected (0.55)\t\t\t \t\tIGHV2-5/D3-3/J6\t\t\t\tDetected (0.21)\t\t\t\t \t\tKRAS p.Q61H\t\t\t\tDetected (0.047)\tDetected (0.015)\t\t\t \t\tPRDM1 p.P66S\t\t\t\tDetected (0.39)\tDetected (0.46)\t\t\t \tPatient U\tt(12;14)\tNegative\tt(12;14)\tt(12;14)\tt(12;14)\t\t \t\tIGKV4-1/J2\t\t\t\tDetected (0.59)\tDetected (0.04)\tDetected (0.21)\t\t \t\tMAX p.R27W\t\t\t\tDetected (0.90)\tDetected (0.54)\tDetected (0.65)\tSample failed for mutation calls\t \t\tKRAS p.G13D\t\t\t\tDetected (0.080)\tDetected (0.19)\tDetected (0.091)\t\t \t\tCYLD p.G930G\t\t\t\t\t\tDetected (0.017)\t\t \tPatient V\tt(12;14)\tNegative\tt(12;14)\tt(12;14)\t\t\t \t\tIGKV1-39/J1\t\t\t\tDetected (0.68)\tDetected (0.70)\t\t\t \t\tIGKV4-1/J4\t\t\t\tDetected (0.29)\tDetected (0.29)\t\t\t \t\tKRAS p.G12V\t\t\t\tDetected (0.45)\tSample fail for mutations\t\t\t \t\tBRAF p.D594N\t\t\t\tDetected (0.45)\t\t\t\t \tPatient W\tNo translocations detected\tNegative\tNo translocations detected\tNo translocations detected\t\t\t \t\tNo V(D)J rearrangement found\t\t\t\t\t\t\t\t \t\tIDH1 p.F86I\t\t\t\tDetected (0.091)\tDetected (0.085)\tDetected (0.089)\t\t \t\tATR p.E650K\t\t\t\tDetected (0.089)\tDetected (0.094)\tDetected (0.089)\t\t \t\tPIK3CA p.H59P\t\t\t\tDetected (0.41)\tDetected (0.38)\tDetected (0.37)\t\t \t\tCYLD p.L135M\t\t\t\t\tDetected (0.044)\t\t\t \t\tCYLD p.G930G\t\t\t\t\tDetected (0.045)\t\t\t \t\tIKZF3 p.S88R\t\t\t\t\tDetected (0.039)\t\t\t \tPatient X\tNo translocations detected\tNegative\tNo translocations detected\tNo translocations detected\t\t\t \t\tIGLV1-44/J2\t\t\t\tDetected (0.83)\tDetected (0.0069)\tDetected (0.0099)\t\t \t\tNRAS p.G13R (0.35)\t\t\t\tDetected (0.35)\t\tDetected (0.73)\t\t \t\tFAM46C p.G37V (0.25)\t\t\t\tDetected (0.25)\t\t\t\t \t\tMAX p.R51W (0.72)\t\t\t\tDetected (0.72)\t\t\t\t \tPatient Y\tNo translocations detected\tNegative\tNo translocations detected\tNo translocations detected\t\t\t \t\tIGKV3-20/J2\t\t\t\tDetected (0.55)\tDetected (0.54)\t\t\t \t\tEGR1 p.S42T\t\t\t\tDetected (0.41)\tDetected (0.34)\t\t\t \t\tKRAS p.G13D\t\t\t\tDetected (0.79)\tDetected (0.48)\t\t\t \t\tZFHX4 p.P3167P\t\t\t\t\tDetected (0.014)\t\t\t \t", "section": "table", "mentions": ["1647|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "845|7|variant|litvar@#3845#p.Y566C&&&litvar@#3845#|p.Y566C", "1287|6|variant|litvar@#3845#p.R27W&&&litvar@#3845#|p.R27W", "2032|6|variant|litvar@#3845#p.H59P&&&litvar@#3845#|p.H59P", "348|6|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA180750#rs121913238##|p.Q61K", "1890|6|variant|litvar@#3845#p.F86I&&&litvar@#3845#|p.F86I", "1642|4|gene|ncbi_gene@3845|KRAS", "712|4|gene|ncbi_gene@3845|KRAS", "1057|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "2800|8|variant|litvar@#3845#p.P3167P&&&litvar@#3845#|p.P3167P", "2391|6|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|p.G13R", "1052|4|gene|ncbi_gene@3845|KRAS", "717|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "403|7|variant|litvar@#3845#p.F274L&&&litvar@#3845#|p.F274L", "2099|7|variant|litvar@#3845#p.L135M&&&litvar@#3845#|p.L135M", "2495|6|variant|litvar@#3845#p.R51W&&&litvar@#3845#|p.R51W", "1386|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "1959|7|variant|litvar@#3845#p.E650K&&&litvar@#3845#|p.E650K", "2747|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "1709|7|variant|litvar@#3845#p.D594N&&&litvar@#3845#|p.D594N", "457|6|variant|litvar@rs1301762360##&&&litvar@#6382#|p.P75L", "812|7|variant|litvar@#3845#p.Y566C&&&litvar@#3845#|p.Y566C", "1381|4|gene|ncbi_gene@3845|KRAS", "2138|7|variant|litvar@#3845#p.G930G&&&litvar@#3845#|p.G930G", "2178|6|variant|litvar@#3845#p.S88R&&&litvar@#3845#|p.S88R", "2742|4|gene|ncbi_gene@3845|KRAS", "773|7|variant|litvar@#3845#p.D150Y&&&litvar@#3845#|p.D150Y", "1455|7|variant|litvar@#3845#p.G930G&&&litvar@#3845#|p.G930G", "2695|6|variant|litvar@#3845#p.S42T&&&litvar@#3845#|p.S42T", "2452|6|variant|litvar@#3845#p.G37V&&&litvar@#3845#|p.G37V", "1112|6|variant|litvar@#3845#p.P66S&&&litvar@#3845#|p.P66S"], "figure_id": "tbl4", "text_hl": "Patient\tGenomic alteration/marker\tClinical bone marrow FISH\tBone marrow sequencing\tcfDNA contemporaneous samples\tcfDNA follow-up 1 samples\tcfDNA follow-up 2 samples\t \tt(4;14)\tt(11;14)\tt(14;16)\t \tPatient R\tt(11;14)\tNegative\tDetected\tNegative\tDetected\tDetected\t\t\t \t\tIGHV3-66/D3-22/J5\t\t\t\tDetected (0.69)\t\t\t\t \t\tIGLV2-23/J2\t\t\t\tDetected (0.8)\t\t\t\t \t\tNRAS p.Q61K\t\t\t\tDetected (0.58)\tDetected (0.016)\t\t\t \t\tFAM46C p.F274L\t\t\t\tDetected (0.46)\tDetected (0.0062)\t\t\t \t\tLTB p.P75L\t\t\t\tDetected (0.50)\t\tDetected (0.43)\t\t \tPatient S\tt(4;14)\tDetected\tNegative\tNegative\tDetected\tDetected\tDetected\t\t \t\tIGKV1-37/J3\t\t\t\tDetected (0.61)\tDetected (0.61)\tDetected (0.82)\t\t \t\tIGKV1-5/J4\t\t\t\tDetected (0.11)\tDetected (0.11)\tDetected (0.12)\t\t \t\tKRAS <m>p.A146T</m>\t\t\t\tDetected (0.19)\t\tDetected (0.065)\t\t \t\tFAM46C p.D150Y\t\t\t\tDetected (0.23)\t\t\t\t \t\tPRKD2 p.Y566C\t\t\t\tDetected (0.65)\tPRKD2 p.Y566C (0.040)\tDetected (0.11)\t\t \tPatient T\tNo translocations detected\tNegative\tNo translocations detected\t\t\t\t \t\tIGKV3-11/J3\t\t\t\tDetected (0.62)\tDetected (0.55)\t\t\t \t\tIGHV2-5/D3-3/J6\t\t\t\tDetected (0.21)\t\t\t\t \t\tKRAS p.Q61H\t\t\t\tDetected (0.047)\tDetected (0.015)\t\t\t \t\tPRDM1 p.P66S\t\t\t\tDetected (0.39)\tDetected (0.46)\t\t\t \tPatient U\tt(12;14)\tNegative\tt(12;14)\tt(12;14)\tt(12;14)\t\t \t\tIGKV4-1/J2\t\t\t\tDetected (0.59)\tDetected (0.04)\tDetected (0.21)\t\t \t\tMAX p.R27W\t\t\t\tDetected (0.90)\tDetected (0.54)\tDetected (0.65)\tSample failed for mutation calls\t \t\tKRAS p.G13D\t\t\t\tDetected (0.080)\tDetected (0.19)\tDetected (0.091)\t\t \t\tCYLD p.G930G\t\t\t\t\t\tDetected (0.017)\t\t \tPatient V\tt(12;14)\tNegative\tt(12;14)\tt(12;14)\t\t\t \t\tIGKV1-39/J1\t\t\t\tDetected (0.68)\tDetected (0.70)\t\t\t \t\tIGKV4-1/J4\t\t\t\tDetected (0.29)\tDetected (0.29)\t\t\t \t\tKRAS p.G12V\t\t\t\tDetected (0.45)\tSample fail for mutations\t\t\t \t\tBRAF p.D594N\t\t\t\tDetected (0.45)\t\t\t\t \tPatient W\tNo translocations detected\tNegative\tNo translocations detected\tNo translocations detected\t\t\t \t\tNo V(D)J rearrangement found\t\t\t\t\t\t\t\t \t\tIDH1 p.F86I\t\t\t\tDetected (0.091)\tDetected (0.085)\tDetected (0.089)\t\t \t\tATR p.E650K\t\t\t\tDetected (0.089)\tDetected (0.094)\tDetected (0.089)\t\t \t\tPIK3CA p.H59P\t\t\t\tDetected (0.41)\tDetected (0.38)\tDetected (0.37)\t\t \t\tCYLD p.L135M\t\t\t\t\tDetected (0.044)\t\t\t \t\tCYLD p.G930G\t\t\t\t\tDetected (0.045)\t\t\t \t\tIKZF3 p.S88R\t\t\t\t\tDetected (0.039)\t\t\t \tPatient X\tNo translocations detected\tNegative\tNo translocations detected\tNo translocations detected\t\t\t \t\tIGLV1-44/J2\t\t\t\tDetected (0.83)\tDetected (0.0069)\tDetected (0.0099)\t\t \t\tNRAS p.G13R (0.35)\t\t\t\tDetected (0.35)\t\tDetected (0.73)\t\t \t\tFAM46C p.G37V (0.25)\t\t\t\tDetected (0.25)\t\t\t\t \t\tMAX p.R51W (0.72)\t\t\t\tDetected (0.72)\t\t\t\t \tPatient Y\tNo translocations detected\tNegative\tNo translocations detected\tNo translocations detected\t\t\t \t\tIGKV3-20/J2\t\t\t\tDetected (0.55)\tDetected (0.54)\t\t\t \t\tEGR1 p.S42T\t\t\t\tDetected (0.41)\tDetected (0.34)\t\t\t \t\tKRAS p.G13D\t\t\t\tDetected (0.79)\tDetected (0.48)\t\t\t \t\tZFHX4 p.P3167P\t\t\t\t\tDetected (0.014)\t\t\t \t"}], "citations": {"NLM": "Chow S, Kis O, Mulder DT, Danesh A, Bruce J, Wang TT, Reece D, Bhalis N, Neri P, Sabatini PJ, Keats J, Trudel S, Pugh TJ. Myeloma immunoglobulin rearrangement and translocation detection through targeted capture sequencing Life Sci Alliance. PMID: 36328595", "BibTeX": "@article{36328595, title={Myeloma immunoglobulin rearrangement and translocation detection through targeted capture sequencing}, author={Chow S and Kis O and Mulder DT and Danesh A and Bruce J and Wang TT and Reece D and Bhalis N and Neri P and Sabatini PJ and Keats J and Trudel S and Pugh TJ}, journal={Life Sci Alliance}}"}, "is_sup_mat_match": false}, {"pmid": 28201998, "pmcid": "PMC5312443", "title": "Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples.", "journal": "BMC Cancer", "authors": ["Weyn C", "Van Raemdonck S", "Dendooven R", "Maes V", "Zwaenepoel K", "Lambin S", "Pauwels P"], "date": "2017-02-16T00:00:00Z", "year": 2017, "snippets": [{"_id": "28201998@4686", "snip_text": "The Idylla  KRAS Mutation Test (Biocartis, Mechelen, Belgium) is CE-IVD labeled and allows characterization of 21 hot-spot KRAS mutations in exons 2, 3 and 4, namely G12D, G12A, G12C, G13D, G12V, G12S, G12R, A59T/E/G, Q61H, Q61K, Q61R/L, K117N and A146P/T/V.", "section": "introduction", "mentions": ["248|7|variant|litvar@rs121913527##&&&litvar@#3845#|A146P/T", "12|4|gene|ncbi_gene@3845|KRAS", "166|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "184|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "208|6|variant|litvar@rs121913528##&&&litvar@#3845#|A59T/E", "178|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "196|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "123|4|gene|ncbi_gene@3845|KRAS", "4|6|chemical||Idylla", "190|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "224|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "218|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "202|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "172|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "230|6|variant|litvar@rs121913240##&&&litvar@#3845#|Q61R/L", "238|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N"], "text_hl": "The Idylla  KRAS Mutation Test (Biocartis, Mechelen, Belgium) is CE-IVD labeled and allows characterization of 21 hot-spot KRAS mutations in exons 2, 3 and 4, namely G12D, G12A, G12C, G13D, G12V, G12S, G12R, A59T/E/G, Q61H, Q61K, Q61R/L, K117N and A146P/T/V."}], "citations": {"NLM": "Weyn C, Van Raemdonck S, Dendooven R, Maes V, Zwaenepoel K, Lambin S, Pauwels P. Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples. BMC Cancer. PMID: 28201998", "BibTeX": "@article{28201998, title={Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples.}, author={Weyn C and Van Raemdonck S and Dendooven R and Maes V and Zwaenepoel K and Lambin S and Pauwels P}, journal={BMC Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 29762787, "pmcid": "PMC6030971", "title": "LitVar: a semantic search engine for linking genomic variant data in PubMed and PMC.", "journal": "Nucleic Acids Res", "authors": ["Allot A", "Peng Y", "Wei CH", "Lee K", "Phan L", "Lu Z"], "date": "2018-05-14T00:00:00Z", "year": 2018, "snippets": [{"_id": "29762787@527", "snip_text": "In addition, the same genetic variant can be mentioned in publications with various names (e.g. 'A146T' versus 'c.436G>A' versus 'rs121913527').", "section": "abstract", "mentions": ["97|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "112|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "130|11|variant|litvar@rs121913527##&&&litvar@#3845#|rs121913527"], "text_hl": "In addition, the same genetic variant can be mentioned in publications with various names (e.g. '<m>A146T</m>' versus 'c.436G>A' versus 'rs121913527')."}], "citations": {"NLM": "Allot A, Peng Y, Wei CH, Lee K, Phan L, Lu Z. LitVar: a semantic search engine for linking genomic variant data in PubMed and PMC. Nucleic Acids Res. PMID: 29762787", "BibTeX": "@article{29762787, title={LitVar: a semantic search engine for linking genomic variant data in PubMed and PMC.}, author={Allot A and Peng Y and Wei CH and Lee K and Phan L and Lu Z}, journal={Nucleic Acids Res}}"}, "is_sup_mat_match": false}, {"pmid": 38456804, "pmcid": "PMC11061612", "title": "Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations", "journal": "Cancer Discov", "authors": ["Bashi AC", "Coker EA", "Bulusu KC", "Jaaks P", "Crafter C", "Lightfoot H", "Milo M", "McCarten K", "Jenkins DF", "van der Meer D", "Lynch JT", "Barthorpe S", "Andersen CL", "Barry ST", "Beck A", "Cidado J", "Gordon JA", "Hall C", "Hall J", "Mali I", "Mironenko T", "Mongeon K", "Morris J", "Richardson L", "Smith PD", "Tavana O", "Tolley C", "Thomas F", "Willis BS", "Yang W", "O'Connor MJ", "McDermott U", "Critchlow SE", "Drew L", "Fawell SE", "Mettetal JT", "Garnett MJ"], "date": "2024-05-01T00:00:00Z", "year": 2024, "snippets": [{"_id": "38456804@32139", "snip_text": "These cell lines predominantly harbored alterations in MAPK pathway family members including OCI-AML5 (SOS1N2337Y, NF1K1385R), ML-2 (KRASA146T), HL-60 (NRASQ61L), and Nomo-1 (KRASG13D).", "section": "results", "mentions": ["167|6|gene|ncbi_gene@23420|Nomo-1", "156|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "145|5|cellline||HL-60", "127|4|cellline||ML-2", "133|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T", "93|8|cellline||OCI-AML5"], "text_hl": "These cell lines predominantly harbored alterations in MAPK pathway family members including OCI-AML5 (SOS1N2337Y, NF1K1385R), ML-2 (KRASA146T), HL-60 (NRASQ61L), and Nomo-1 (KRASG13D)."}], "citations": {"NLM": "Bashi AC, Coker EA, Bulusu KC, Jaaks P, Crafter C, Lightfoot H, Milo M, McCarten K, Jenkins DF, van der Meer D, Lynch JT, Barthorpe S, Andersen CL, Barry ST, Beck A, Cidado J, Gordon JA, Hall C, Hall J, Mali I, Mironenko T, Mongeon K, Morris J, Richardson L, Smith PD, Tavana O, Tolley C, Thomas F, Willis BS, Yang W, O'Connor MJ, McDermott U, Critchlow SE, Drew L, Fawell SE, Mettetal JT, Garnett MJ. Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations Cancer Discov. PMID: 38456804", "BibTeX": "@article{38456804, title={Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations}, author={Bashi AC and Coker EA and Bulusu KC and Jaaks P and Crafter C and Lightfoot H and Milo M and McCarten K and Jenkins DF and van der Meer D and Lynch JT and Barthorpe S and Andersen CL and Barry ST and Beck A and Cidado J and Gordon JA and Hall C and Hall J and Mali I and Mironenko T and Mongeon K and Morris J and Richardson L and Smith PD and Tavana O and Tolley C and Thomas F and Willis BS and Yang W and O'Connor MJ and McDermott U and Critchlow SE and Drew L and Fawell SE and Mettetal JT and Garnett MJ}, journal={Cancer Discov}}"}, "is_sup_mat_match": false}, {"pmid": 38586204, "pmcid": "PMC10996017", "title": "Simultaneous blastic plasmacytoid dendritic cell neoplasm and myelofibrosis: A case report", "journal": "Oncol Lett", "authors": ["Luo F", "Li B", "Li J", "Li Y"], "date": "2024-03-22T00:00:00Z", "year": 2024, "snippets": [{"_id": "38586204@46664", "snip_text": "Mutant gene\tChromosome\tMutation location, exon\tNucleotide alteration\tAmino acid alteration\tdbSNP reference no.\tMutation frequency\tSequencing depth, X\t \tDIS3\t13q22.1\t17\tc.2339G>C\tp.R780T\t-\t0.166\t1,661\t \tNRAS\t1p13.2\t4\tc.436G>A\tp.A146T\t-\t0.045\t1,474\t \tNRAS\t1p13.2\t2\tc.35G>A\tp.G12D\trs121913237\t0.017\t2,051\t \tNRAS\t1p13.2\t2\tc.34G>A\tp.G12S\trs121913250\t0.035\t2,044\t \tTET2\t4q24\t3\tc.2245C>T\tp.Q749*\t-\t0.011\t1,881\t \tTET2\t4q24\t5\tc.3578G>A\tp.C1193Y\t-\t0.580\t1,573\t \tTET2\t4q24\t11\tc.4794T>G\tp.Y1598*\t-\t0.182\t1,994\t \tCSMD1\t8p23.2\t14\tc.2012G>A\tp.R671H\trs376413480\t0.137\t1,576\t \tTET2\t4q24\t9\tc.4160A>G\tp.N1387S\t-\t0.039\t1,272\t \tBCORL1\tXq26.1\t4\tc.469G>A\tp.A157T\trs147775035\t0.998\t996\t \tPDGFRA\t4q12\t15\tc.2153G>A\tp.R718Q\trs367722824\t0.667\t1,443\t \t", "section": "table", "mentions": ["625|6|variant|litvar@rs147775035##&&&litvar@#63035#&&&litvar@CA10514126#rs147775035##|469G>A", "465|9|variant|litvar@#54790#c.4794T>G&&&litvar@#54790#|c.4794T>G", "697|11|variant|litvar@rs367722824##&&&litvar@#5156#|rs367722824", "500|5|gene|ncbi_gene@64478|CSMD1", "427|8|variant|litvar@#54790#p.C1193Y&&&litvar@#54790#|p.C1193Y", "526|7|variant|litvar@rs376413480##&&&litvar@#64478#|p.R671H", "178|7|variant|litvar@#22894#p.R780T&&&litvar@#22894#|p.R780T", "218|6|variant|litvar@rs139849066##&&&litvar@#22894#&&&litvar@CA252141184#rs139849066##|436G>A", "634|5|variant|litvar@rs147775035##&&&litvar@#63035#&&&litvar@CA10514126#rs147775035##|A157T", "202|4|gene|ncbi_gene@4893|NRAS", "518|7|variant|litvar@rs376413480##&&&litvar@#64478#|2012G>A", "534|11|variant|litvar@rs376413480##&&&litvar@#64478#|rs376413480", "560|4|gene|ncbi_gene@54790|TET2", "574|7|variant|litvar@rs1052160399##&&&litvar@#81608#|4160A>G", "664|6|gene|ncbi_gene@5156|PDGFRA", "582|8|variant|litvar@rs1422916349##&&&litvar@#54790#|p.N1387S", "640|11|variant|litvar@rs147775035##&&&litvar@#63035#|rs147775035", "152|4|gene|ncbi_gene@22894|DIS3", "227|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "170|7|variant|litvar@#22894#c.2339G>C&&&litvar@#22894#|2339G>C", "373|7|variant|litvar@rs558231202##&&&litvar@#4893#&&&litvar@CA29048847#rs558231202##|2245C>T", "689|7|variant|litvar@rs367722824##&&&litvar@#5156#&&&litvar@CA2922757#rs367722824##|p.R718Q", "249|4|gene|ncbi_gene@4893|NRAS", "278|11|variant|litvar@rs121913237##&&&litvar@#4893#|rs121913237", "304|4|gene|ncbi_gene@4893|NRAS", "405|4|gene|ncbi_gene@54790|TET2", "419|7|variant|litvar@rs560807863##&&&litvar@#64478#|3578G>A", "333|11|variant|litvar@rs121913250##&&&litvar@#4893#|rs121913250", "359|4|gene|ncbi_gene@54790|TET2", "271|6|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA130425#rs121913237##|p.G12D", "681|7|variant|litvar@rs367722824##&&&litvar@#5156#&&&litvar@CA2922757#rs367722824##|2153G>A", "265|5|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|35G>A", "320|5|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA180753#rs121913250##|34G>A", "452|4|gene|ncbi_gene@54790|TET2", "326|6|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA180753#rs121913250##|p.G12S", "607|6|gene|ncbi_gene@63035|BCORL1"], "figure_id": "tII-ol-27-5-14354", "text_hl": "Mutant gene\tChromosome\tMutation location, exon\tNucleotide alteration\tAmino acid alteration\tdbSNP reference no.\tMutation frequency\tSequencing depth, X\t \tDIS3\t13q22.1\t17\tc.2339G>C\tp.R780T\t-\t0.166\t1,661\t \tNRAS\t1p13.2\t4\tc.436G>A\t<m>p.A146T</m>\t-\t0.045\t1,474\t \tNRAS\t1p13.2\t2\tc.35G>A\tp.G12D\trs121913237\t0.017\t2,051\t \tNRAS\t1p13.2\t2\tc.34G>A\tp.G12S\trs121913250\t0.035\t2,044\t \tTET2\t4q24\t3\tc.2245C>T\tp.Q749*\t-\t0.011\t1,881\t \tTET2\t4q24\t5\tc.3578G>A\tp.C1193Y\t-\t0.580\t1,573\t \tTET2\t4q24\t11\tc.4794T>G\tp.Y1598*\t-\t0.182\t1,994\t \tCSMD1\t8p23.2\t14\tc.2012G>A\tp.R671H\trs376413480\t0.137\t1,576\t \tTET2\t4q24\t9\tc.4160A>G\tp.N1387S\t-\t0.039\t1,272\t \tBCORL1\tXq26.1\t4\tc.469G>A\tp.A157T\trs147775035\t0.998\t996\t \tPDGFRA\t4q12\t15\tc.2153G>A\tp.R718Q\trs367722824\t0.667\t1,443\t \t"}], "citations": {"NLM": "Luo F, Li B, Li J, Li Y. Simultaneous blastic plasmacytoid dendritic cell neoplasm and myelofibrosis: A case report Oncol Lett. PMID: 38586204", "BibTeX": "@article{38586204, title={Simultaneous blastic plasmacytoid dendritic cell neoplasm and myelofibrosis: A case report}, author={Luo F and Li B and Li J and Li Y}, journal={Oncol Lett}}"}, "is_sup_mat_match": false}, {"pmid": 24885062, "pmcid": "PMC4051153", "title": "Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.", "journal": "Mol Cancer", "authors": ["Imamura Y", "Lochhead P", "Yamauchi M", "Kuchiba A", "Qian ZR", "Liao X", "Nishihara R", "Jung S", "Wu K", "Nosho K", "Wang YE", "Peng S", "Bass AJ", "Haigis KM", "Meyerhardt JA", "Chan AT", "Fuchs CS", "Ogino S"], "date": "2014-05-31T00:00:00Z", "year": 2014, "snippets": [{"_id": "24885062@5931", "snip_text": "Codon Nucleotide change Amino acid change Codon change No. of cases Proportion among 1267 cases   Any Any Any Any 505 40%   12 Any Any Any 344 27%   13 Any Any Any 115 9.1%   61 Any Any Any 19 1.5%   146 Any Any Any 40 3.2%   Mutations identified in only one of codons 12, 13, 61 and 146       12 c.34G>A p.G12S GGT>AGT 12 1.0%   12 c.34G>C p.G12R GGT>CGT 7 0.6%   12 c.34G>T p.G12C GGT>TGT 43 3.4%   12 c.35G>A p.G12D GGT>GAT 157 12%   12 c.35G>C p.G12A GGT>GCT 20 1.6%   12 c.35G>T p.G12V GGT>GTT 93 7.3%   12 c.35_36delinsCA p.G12A GGT>GCA 1 0.1%   13 c.37G>C p.G13R GGC>CGC 1 0.1%   13 c.37G>T p.G13C GGC>TGC 2 0.2%   13 c.38G>A p.G13D GGC>GAC 103 8.1%   13 c.38G>T p.G13V GGC>GTC 2 0.2%   61 c.182A>G p.Q61R CAA>CGA 2 0.2%   61 c.182A>T p.Q61L CAA>CTA 4 0.3%   61 c.183A>C p.Q61H CAA>CAC 7 0.6%   60, 61 c.180_181delinsAA p.Q61K GGT + CAA>GGA + AAA 4 0.3%   146 c.436G>A p.A146T GCA>ACA 21 1.7%   146 c.436G>C p.A146P GCA>CCA 3 0.2%   146 c.437C>T p.A146V GCA>GTA 11 0.9%   Mutations identified in two or more of codons 12, 13, 61 and 146       12, 13 c.35G>A, c.38G>A p.G12D, p.G13D GGT>GAT, GGC>GAC 4 0.3%   12, 13 c.35G>T, c.37G>T p.G12V, p.G13C GGT>GTT, GGC>TGC 1 0.1%   12, c.35G>T, p.G12V, GGT>GTT, GGT + CAA>GGA + AAA 1 0.1%   60, 61 c.180_181delinsAA p.Q61K   12, 146 c.34G>C, c.436G>A p.G12R, p.A146T GGT>CGT, GCA>ACA 1 0.1%   12, 146 c.34G>T, c.436G>A p.G12C, p.A146T GGT>TGT, GCA>ACA 1 0.1%   12, 146 c.34G>T, c.437C>T p.G12C, p.A146V GGT>TGT, GCA>GTA 1 0.1%   12, 146 c.35G>T, c.436G>A p.G12V, p.A146T GGT>GTT, GCA>ACA 1 0.1%   13, 146 c.38G>A, c.436G>A p.G13D, p.A146T GGC>GAC, GCA>ACA 1 0.1%   12, 13, 61 c.35G>A, c.38G>A, c.183A>T p.G12D, p.G13D, p.Q61H GGT>GAT, GGC>GAC, CAA>CAT 1 0.1%   ", "section": "table", "mentions": ["1485|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "1324|7|variant|litvar@#3845#|GCA>ACA", "867|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "884|7|variant|litvar@#3845#|GCA>ACA", "341|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "1659|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "333|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>C", "1596|7|variant|litvar@#3845#|GCA>ACA", "297|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G>A", "1633|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "1216|7|variant|litvar@#3845#|CAA>GGA", "484|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1683|7|variant|litvar@#3845#|GGC>GAC", "605|7|variant|litvar@#3845#|GGC>TGC", "1587|7|variant|litvar@#3845#|GGC>GAC", "448|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "305|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "876|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "1503|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1519|7|variant|litvar@#3845#|GGT>GTT", "1624|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "491|7|variant|litvar@#3845#|GGT>GTT", "1528|7|variant|litvar@#3845#|GCA>ACA", "1184|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "312|7|variant|litvar@#3845#|GGT>AGT", "1349|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>T", "809|17|variant|litvar@#3845#c.180_181delinsAA&&&litvar@#3845#|c.180_181delinsAA", "404|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "1246|17|variant|litvar@#3845#c.180_181delinsAA&&&litvar@#3845#|c.180_181delinsAA", "1367|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "1451|7|variant|litvar@#3845#|GGT>TGT", "662|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|c.38G>T", "1579|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "840|7|variant|litvar@#3845#|CAA>GGA", "1066|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "923|7|variant|litvar@#3845#|GCA>CCA", "455|7|variant|litvar@#3845#|GGT>GCT", "633|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "706|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "570|7|variant|litvar@#3845#|GGC>CGC", "670|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|p.G13V", "419|7|variant|litvar@#3845#|GGT>GAT", "733|8|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|c.182A>T", "1057|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "1642|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|c.183A>T", "1426|8|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C>T", "1443|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "1089|7|variant|litvar@#3845#|GGT>GAT", "1299|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "528|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "1154|7|variant|litvar@#3845#|GGT>GTT", "1131|7|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA135570#rs121913535##|c.37G>T", "915|7|variant|litvar@rs121913527##&&&litvar@#3845#|p.A146P", "1358|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "1553|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "590|7|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA135570#rs121913535##|c.37G>T", "1667|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "1571|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "1122|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "1692|7|variant|litvar@#3845#|CAA>CAT", "1139|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "598|6|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|p.G13C", "827|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "677|7|variant|litvar@#3845#|GGC>GTC", "383|7|variant|litvar@#3845#|GGT>TGT", "1417|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>T", "1201|7|variant|litvar@#3845#|GGT>GTT", "535|7|variant|litvar@#3845#|GGT>GCA", "778|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "348|7|variant|litvar@#3845#|GGT>CGT", "476|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "1264|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "1674|7|variant|litvar@#3845#|GGT>GAT", "1290|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "1307|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "440|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>C", "512|15|variant|litvar@#3845#c.35_36delinsCA&&&litvar@#3845#|c.35_36delinsCA", "555|7|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|c.37G>C", "742|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "1562|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "1651|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1435|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "785|7|variant|litvar@#3845#|CAA>CAC", "906|8|variant|litvar@rs121913527##&&&litvar@#3845#|c.436G>C", "1460|7|variant|litvar@#3845#|GCA>GTA", "563|6|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|p.G13R", "412|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "749|7|variant|litvar@#3845#|CAA>CTA", "1281|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>C", "1082|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "1074|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "625|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "1147|6|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|p.G13C", "368|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>T", "1494|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "1511|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "1383|7|variant|litvar@#3845#|GGT>TGT", "1392|7|variant|litvar@#3845#|GCA>ACA", "1193|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1098|7|variant|litvar@#3845#|GGC>GAC", "1163|7|variant|litvar@#3845#|GGC>TGC", "376|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "713|7|variant|litvar@#3845#|CAA>CGA", "640|7|variant|litvar@#3845#|GGC>GAC", "769|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA180922#rs17851045##|c.183A>C", "1375|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "944|8|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C>T", "961|7|variant|litvar@#3845#|GCA>GTA", "1315|7|variant|litvar@#3845#|GGT>CGT", "953|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "697|8|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|c.182A>G"], "figure_id": "T1", "text_hl": "Codon Nucleotide change Amino acid change Codon change No. of cases Proportion among 1267 cases   Any Any Any Any 505 40%   12 Any Any Any 344 27%   13 Any Any Any 115 9.1%   61 Any Any Any 19 1.5%   146 Any Any Any 40 3.2%   Mutations identified in only one of codons 12, 13, 61 and 146       12 c.34G>A p.G12S GGT>AGT 12 1.0%   12 c.34G>C p.G12R GGT>CGT 7 0.6%   12 c.34G>T p.G12C GGT>TGT 43 3.4%   12 c.35G>A p.G12D GGT>GAT 157 12%   12 c.35G>C p.G12A GGT>GCT 20 1.6%   12 c.35G>T p.G12V GGT>GTT 93 7.3%   12 c.35_36delinsCA p.G12A GGT>GCA 1 0.1%   13 c.37G>C p.G13R GGC>CGC 1 0.1%   13 c.37G>T p.G13C GGC>TGC 2 0.2%   13 c.38G>A p.G13D GGC>GAC 103 8.1%   13 c.38G>T p.G13V GGC>GTC 2 0.2%   61 c.182A>G p.Q61R CAA>CGA 2 0.2%   61 c.182A>T p.Q61L CAA>CTA 4 0.3%   61 c.183A>C p.Q61H CAA>CAC 7 0.6%   60, 61 c.180_181delinsAA p.Q61K GGT + CAA>GGA + AAA 4 0.3%   146 c.436G>A <m>p.A146T</m> GCA>ACA 21 1.7%   146 c.436G>C p.A146P GCA>CCA 3 0.2%   146 c.437C>T p.A146V GCA>GTA 11 0.9%   Mutations identified in two or more of codons 12, 13, 61 and 146       12, 13 c.35G>A, c.38G>A p.G12D, p.G13D GGT>GAT, GGC>GAC 4 0.3%   12, 13 c.35G>T, c.37G>T p.G12V, p.G13C GGT>GTT, GGC>TGC 1 0.1%   12, c.35G>T, p.G12V, GGT>GTT, GGT + CAA>GGA + AAA 1 0.1%   60, 61 c.180_181delinsAA p.Q61K   12, 146 c.34G>C, c.436G>A p.G12R, <m>p.A146T</m> GGT>CGT, GCA>ACA 1 0.1%   12, 146 c.34G>T, c.436G>A p.G12C, <m>p.A146T</m> GGT>TGT, GCA>ACA 1 0.1%   12, 146 c.34G>T, c.437C>T p.G12C, p.A146V GGT>TGT, GCA>GTA 1 0.1%   12, 146 c.35G>T, c.436G>A p.G12V, <m>p.A146T</m> GGT>GTT, GCA>ACA 1 0.1%   13, 146 c.38G>A, c.436G>A p.G13D, <m>p.A146T</m> GGC>GAC, GCA>ACA 1 0.1%   12, 13, 61 c.35G>A, c.38G>A, c.183A>T p.G12D, p.G13D, p.Q61H GGT>GAT, GGC>GAC, CAA>CAT 1 0.1%   "}], "citations": {"NLM": "Imamura Y, Lochhead P, Yamauchi M, Kuchiba A, Qian ZR, Liao X, Nishihara R, Jung S, Wu K, Nosho K, Wang YE, Peng S, Bass AJ, Haigis KM, Meyerhardt JA, Chan AT, Fuchs CS, Ogino S. Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review. Mol Cancer. PMID: 24885062", "BibTeX": "@article{24885062, title={Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.}, author={Imamura Y and Lochhead P and Yamauchi M and Kuchiba A and Qian ZR and Liao X and Nishihara R and Jung S and Wu K and Nosho K and Wang YE and Peng S and Bass AJ and Haigis KM and Meyerhardt JA and Chan AT and Fuchs CS and Ogino S}, journal={Mol Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 30588011, "pmcid": "PMC6294057", "title": "c.1439delA frameshift deletion mutation in familial adenomatous polyposis.", "journal": "Onco Targets Ther", "authors": ["Ma DJ", "Wang BS", "Yue JB", "Li ZJ", "Sun YL"], "date": "2018-12-11T00:00:00Z", "year": 2018, "snippets": [{"_id": "30588011@16139", "snip_text": "Test items Exons/codons Type of mutation Test results      KRAS/NRAS/BRAF joint mutation detection KRAS Exon-2 G12S, G12D Wild type   KRAS Exon-2 G12C, G12R, G12V, G12A, G13C Mutant   KRAS Exon-2 G13D Wild type   KRAS Exon-3 Q61L, Q61R, Q61H Wild type   KRAS Exon-4 K117N, A146T, A146V, A146P Wild type   NRAS Exon-2 G12D, G12S Wild type   NRAS Exon-2 G13D Wild type   NRAS Exon-2 G13R, G12C, G12V, G12A, G13V Wild type   NRAS Exon-3 Q61R, Q61K, Q61L, Q61H Wild type   NRAS Exon-4 A146T Wild type   BRAF Exon-15 V600E Wild type   ", "section": "table", "mentions": ["305|4|gene|ncbi_gene@4893|NRAS", "434|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|Q61R", "99|4|gene|ncbi_gene@3845|KRAS", "266|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "164|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "237|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "393|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "280|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "352|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "499|4|gene|ncbi_gene@673|BRAF", "196|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "399|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "440|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "64|4|gene|ncbi_gene@4893|NRAS", "146|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "59|4|gene|ncbi_gene@3845|KRAS", "381|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "422|4|gene|ncbi_gene@4893|NRAS", "69|4|gene|ncbi_gene@673|BRAF", "152|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "170|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "225|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|Q61L", "273|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "340|4|gene|ncbi_gene@4893|NRAS", "469|4|gene|ncbi_gene@4893|NRAS", "317|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "446|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|Q61L", "111|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "184|4|gene|ncbi_gene@3845|KRAS", "287|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "231|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|Q61R", "512|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "158|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "323|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "387|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "405|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "254|4|gene|ncbi_gene@3845|KRAS", "134|4|gene|ncbi_gene@3845|KRAS", "369|4|gene|ncbi_gene@4893|NRAS", "481|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "452|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "213|4|gene|ncbi_gene@3845|KRAS", "117|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D"], "figure_id": "t1-ott-11-8987", "text_hl": "Test items Exons/codons Type of mutation Test results      KRAS/NRAS/BRAF joint mutation detection KRAS Exon-2 G12S, G12D Wild type   KRAS Exon-2 G12C, G12R, G12V, G12A, G13C Mutant   KRAS Exon-2 G13D Wild type   KRAS Exon-3 Q61L, Q61R, Q61H Wild type   KRAS Exon-4 K117N, <m>A146T</m>, A146V, A146P Wild type   NRAS Exon-2 G12D, G12S Wild type   NRAS Exon-2 G13D Wild type   NRAS Exon-2 G13R, G12C, G12V, G12A, G13V Wild type   NRAS Exon-3 Q61R, Q61K, Q61L, Q61H Wild type   NRAS Exon-4 <m>A146T</m> Wild type   BRAF Exon-15 V600E Wild type   "}], "citations": {"NLM": "Ma DJ, Wang BS, Yue JB, Li ZJ, Sun YL. c.1439delA frameshift deletion mutation in familial adenomatous polyposis. Onco Targets Ther. PMID: 30588011", "BibTeX": "@article{30588011, title={c.1439delA frameshift deletion mutation in familial adenomatous polyposis.}, author={Ma DJ and Wang BS and Yue JB and Li ZJ and Sun YL}, journal={Onco Targets Ther}}"}, "is_sup_mat_match": false}, {"pmid": 35312176, "pmcid": "PMC9385586", "title": "Relationship between perioperative oncological evaluation and recurrence using circulating tumor DNA with KRAS mutation in patients with colorectal cancer.", "journal": "Cancer Med", "authors": ["Hayashi T", "Yoshida Y", "Yamada T", "Tanaka K", "Shimaoka H", "Kajitani R", "Munechika T", "Nagano H", "Matsumoto Y", "Komono A", "Sakamoto R", "Aisu N", "Yoshimatsu G", "Yoshimura F", "Hasegawa S"], "date": "2022-03-21T00:00:00Z", "year": 2022, "snippets": [{"_id": "35312176@539", "snip_text": "METHODS: Among 304 cases of colorectal cancer surgery, ctDNA was sampled from the perioperative blood of 84 patients with CRC with KRAS mutation (exon 4 p.A146T, exon 4 p.A146V, exon 2 p.G12A, exon 2 p.G12C, exon 2 p.G12D, exon 2 p.G12S, exon 2 p.G12V, exon 2 p.G13D, exon 3 p.Q61H) and analyzed using the digital polymerase chain reaction system.", "section": "abstract", "mentions": ["200|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "245|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "122|3|disease|ncbi_mesh@D015179|CRC", "108|8|species|ncbi_taxonomy@9606|patients", "260|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "28|17|disease|ncbi_mesh@D015179|colorectal cancer", "185|6|variant|litvar@##p.G12A|p.G12A", "169|7|variant|litvar@##p.A146V|p.A146V", "275|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "153|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "230|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "215|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D"], "text_hl": "METHODS: Among 304 cases of colorectal cancer surgery, ctDNA was sampled from the perioperative blood of 84 patients with CRC with KRAS mutation (exon 4 <m>p.A146T</m>, exon 4 p.A146V, exon 2 p.G12A, exon 2 p.G12C, exon 2 p.G12D, exon 2 p.G12S, exon 2 p.G12V, exon 2 p.G13D, exon 3 p.Q61H) and analyzed using the digital polymerase chain reaction system."}], "citations": {"NLM": "Hayashi T, Yoshida Y, Yamada T, Tanaka K, Shimaoka H, Kajitani R, Munechika T, Nagano H, Matsumoto Y, Komono A, Sakamoto R, Aisu N, Yoshimatsu G, Yoshimura F, Hasegawa S. Relationship between perioperative oncological evaluation and recurrence using circulating tumor DNA with KRAS mutation in patients with colorectal cancer. Cancer Med. PMID: 35312176", "BibTeX": "@article{35312176, title={Relationship between perioperative oncological evaluation and recurrence using circulating tumor DNA with KRAS mutation in patients with colorectal cancer.}, author={Hayashi T and Yoshida Y and Yamada T and Tanaka K and Shimaoka H and Kajitani R and Munechika T and Nagano H and Matsumoto Y and Komono A and Sakamoto R and Aisu N and Yoshimatsu G and Yoshimura F and Hasegawa S}, journal={Cancer Med}}"}, "is_sup_mat_match": false}, {"pmid": 25790293, "pmcid": "PMC4377644", "title": "Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia.", "journal": "Nat Commun", "authors": ["Ma X", "Edmonson M", "Yergeau D", "Muzny DM", "Hampton OA", "Rusch M", "Song G", "Easton J", "Harvey RC", "Wheeler DA", "Ma J", "Doddapaneni H", "Vadodaria B", "Wu G", "Nagahawatte P", "Carroll WL", "Chen IM", "Gastier-Foster JM", "Relling MV", "Smith MA", "Devidas M", "Guidry Auvil JM", "Downing JR", "Loh ML", "Willman CL", "Gerhard DS", "Mullighan CG", "Hunger SP", "Zhang J"], "date": "2015-03-19T00:00:00Z", "year": 2015, "snippets": [{"_id": "25790293@8619", "snip_text": "For example, PAPJIB had subclonal mutations of KRAS p.Ala146Thr, NRAS p.Gly13Asp and PTPN11 p.Ser502Pro with MAFs of 0.021, 0.025 and 0.233, respectively, at diagnosis, and persistence of only the NRAS p.Gly13Asp mutation with MAF increased 10-fold to 0.234 at relapse.", "section": "results", "mentions": ["65|4|gene|ncbi_gene@4893|NRAS", "52|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "197|4|gene|ncbi_gene@4893|NRAS", "85|6|gene|ncbi_gene@5781|PTPN11", "202|10|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.Gly13Asp", "70|10|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.Gly13Asp", "92|11|variant|litvar@#5781#p.S502P&&&litvar@#5781#|p.Ser502Pro", "47|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "For example, PAPJIB had subclonal mutations of KRAS <m>p.Ala146Thr</m>, NRAS p.Gly13Asp and PTPN11 p.Ser502Pro with MAFs of 0.021, 0.025 and 0.233, respectively, at diagnosis, and persistence of only the NRAS p.Gly13Asp mutation with MAF increased 10-fold to 0.234 at relapse."}], "citations": {"NLM": "Ma X, Edmonson M, Yergeau D, Muzny DM, Hampton OA, Rusch M, Song G, Easton J, Harvey RC, Wheeler DA, Ma J, Doddapaneni H, Vadodaria B, Wu G, Nagahawatte P, Carroll WL, Chen IM, Gastier-Foster JM, Relling MV, Smith MA, Devidas M, Guidry Auvil JM, Downing JR, Loh ML, Willman CL, Gerhard DS, Mullighan CG, Hunger SP, Zhang J. Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. Nat Commun. PMID: 25790293", "BibTeX": "@article{25790293, title={Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia.}, author={Ma X and Edmonson M and Yergeau D and Muzny DM and Hampton OA and Rusch M and Song G and Easton J and Harvey RC and Wheeler DA and Ma J and Doddapaneni H and Vadodaria B and Wu G and Nagahawatte P and Carroll WL and Chen IM and Gastier-Foster JM and Relling MV and Smith MA and Devidas M and Guidry Auvil JM and Downing JR and Loh ML and Willman CL and Gerhard DS and Mullighan CG and Hunger SP and Zhang J}, journal={Nat Commun}}"}, "is_sup_mat_match": false}, {"pmid": 34094546, "pmcid": "PMC8165703", "title": "Drug sensitivity profile of minor KRAS mutations in colorectal cancer using mix culture assay: The effect of AMG-510, a novel KRAS G12C selective inhibitor, on colon cancer cells is markedly enhanced by the combined inhibition of MEK and BCL-XL.", "journal": "Mol Clin Oncol", "authors": ["Kitazawa M", "Miyagawa Y", "Koyama M", "Nakamura S", "Hondo N", "Miyazaki S", "Muranaka F", "Tokumaru S", "Yamamoto Y", "Ehara T", "Kuroiwa M", "Tanaka H", "Komatsu D", "Takeoka M", "Soejima Y"], "date": "2021-07-01T00:00:00Z", "year": 2021, "snippets": [{"_id": "34094546@727", "snip_text": "The current study focused on minor KRAS mutations (G12A, G12C, G12S, Q61H and A146T) and evaluated whether these were resistant to anti-EGFR antibodies using a mix culture assay.", "section": "abstract", "mentions": ["51|4|variant|litvar@#1956#c.12G>A&&&litvar@#1956#|G12A", "57|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "78|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "136|4|gene|ncbi_gene@1956|EGFR", "63|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "69|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H"], "text_hl": "The current study focused on minor KRAS mutations (G12A, G12C, G12S, Q61H and <m>A146T</m>) and evaluated whether these were resistant to anti-EGFR antibodies using a mix culture assay."}], "citations": {"NLM": "Kitazawa M, Miyagawa Y, Koyama M, Nakamura S, Hondo N, Miyazaki S, Muranaka F, Tokumaru S, Yamamoto Y, Ehara T, Kuroiwa M, Tanaka H, Komatsu D, Takeoka M, Soejima Y. Drug sensitivity profile of minor KRAS mutations in colorectal cancer using mix culture assay: The effect of AMG-510, a novel KRAS G12C selective inhibitor, on colon cancer cells is markedly enhanced by the combined inhibition of MEK and BCL-XL. Mol Clin Oncol. PMID: 34094546", "BibTeX": "@article{34094546, title={Drug sensitivity profile of minor KRAS mutations in colorectal cancer using mix culture assay: The effect of AMG-510, a novel KRAS G12C selective inhibitor, on colon cancer cells is markedly enhanced by the combined inhibition of MEK and BCL-XL.}, author={Kitazawa M and Miyagawa Y and Koyama M and Nakamura S and Hondo N and Miyazaki S and Muranaka F and Tokumaru S and Yamamoto Y and Ehara T and Kuroiwa M and Tanaka H and Komatsu D and Takeoka M and Soejima Y}, journal={Mol Clin Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 30481508, "pmcid": "PMC6467705", "title": "Clinical validation of coexisting driver mutations in colorectal cancers", "journal": "Hum Pathol", "authors": ["Zheng G", "Tseng LH", "Haley L", "Ibrahim J", "Bynum J", "Xian R", "Gocke CD", "Eshleman JR", "Lin MT"], "date": "2019-04-01T00:00:00Z", "year": 2019, "snippets": [{"_id": "30481508@12529", "snip_text": "Coexisting KRAS p.A146T and NRAS p.Q61R mutations were detected in CRC0125.", "section": "results", "mentions": ["33|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "11|4|gene|ncbi_gene@3845|KRAS", "28|4|gene|ncbi_gene@4893|NRAS", "16|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T"], "text_hl": "Coexisting KRAS <m>p.A146T</m> and NRAS p.Q61R mutations were detected in CRC0125."}], "citations": {"NLM": "Zheng G, Tseng LH, Haley L, Ibrahim J, Bynum J, Xian R, Gocke CD, Eshleman JR, Lin MT. Clinical validation of coexisting driver mutations in colorectal cancers Hum Pathol. PMID: 30481508", "BibTeX": "@article{30481508, title={Clinical validation of coexisting driver mutations in colorectal cancers}, author={Zheng G and Tseng LH and Haley L and Ibrahim J and Bynum J and Xian R and Gocke CD and Eshleman JR and Lin MT}, journal={Hum Pathol}}"}, "is_sup_mat_match": false}, {"pmid": 35944066, "pmcid": "PMC9534304", "title": "Functional and biological heterogeneity of KRASQ61 mutations", "journal": "Sci Signal", "authors": ["Huynh MV", "Hobbs GA", "Schaefer A", "Pierobon M", "Carey LM", "Diehl JN", "DeLiberty JM", "Thurman RD", "Cooke AR", "Goodwin CM", "Cook JH", "Lin L", "Waters AM", "Rashid NU", "Petricoin EF 3rd", "Campbell SL", "Haigis KM", "Simeone DM", "Lyssiotis CA", "Cox AD", "Der CJ"], "date": "2022-08-09T00:00:00Z", "year": 2022, "snippets": [{"_id": "35944066@4949", "snip_text": "Ectopic expression of different KRAS mutants in the zebrafish pancreas showed that KRASQ61L/R potently caused tumorigenesis, but also determined that KRAS mutants that are not found in pancreatic cancer (for example, A146T) were equally potent.", "section": "introduction", "mentions": ["217|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "150|4|gene|ncbi_gene@16653|KRAS", "52|9|species|ncbi_taxonomy@7955|zebrafish", "185|17|disease|ncbi_mesh@D010190|pancreatic cancer", "32|4|gene|ncbi_gene@16653|KRAS"], "text_hl": "Ectopic expression of different KRAS mutants in the zebrafish pancreas showed that KRASQ61L/R potently caused tumorigenesis, but also determined that KRAS mutants that are not found in pancreatic cancer (for example, <m>A146T</m>) were equally potent."}], "citations": {"NLM": "Huynh MV, Hobbs GA, Schaefer A, Pierobon M, Carey LM, Diehl JN, DeLiberty JM, Thurman RD, Cooke AR, Goodwin CM, Cook JH, Lin L, Waters AM, Rashid NU, Petricoin EF 3rd, Campbell SL, Haigis KM, Simeone DM, Lyssiotis CA, Cox AD, Der CJ. Functional and biological heterogeneity of KRASQ61 mutations Sci Signal. PMID: 35944066", "BibTeX": "@article{35944066, title={Functional and biological heterogeneity of KRASQ61 mutations}, author={Huynh MV and Hobbs GA and Schaefer A and Pierobon M and Carey LM and Diehl JN and DeLiberty JM and Thurman RD and Cooke AR and Goodwin CM and Cook JH and Lin L and Waters AM and Rashid NU and Petricoin EF 3rd and Campbell SL and Haigis KM and Simeone DM and Lyssiotis CA and Cox AD and Der CJ}, journal={Sci Signal}}"}, "is_sup_mat_match": false}, {"pmid": 30971271, "pmcid": "PMC6456974", "title": "Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.", "journal": "Mol Cancer", "authors": ["Xu K", "Park D", "Magis AT", "Zhang J", "Zhou W", "Sica GL", "Ramalingam SS", "Curran WJ", "Deng X"], "date": "2019-04-10T00:00:00Z", "year": 2019, "snippets": [{"_id": "30971271@4300", "snip_text": "Beyond the most common hotspot alleles in exons 2 and 3, mutations in exon 4 of KRAS, including K117 N and A146T, have also been found in patients with colorectal cancer.", "section": "introduction", "mentions": ["107|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "80|4|gene|ncbi_gene@3845|KRAS", "96|6|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117 N", "138|8|species|ncbi_taxonomy@9606|patients", "152|17|disease|ncbi_mesh@D015179|colorectal cancer"], "text_hl": "Beyond the most common hotspot alleles in exons 2 and 3, mutations in exon 4 of KRAS, including K117 N and <m>A146T</m>, have also been found in patients with colorectal cancer."}], "citations": {"NLM": "Xu K, Park D, Magis AT, Zhang J, Zhou W, Sica GL, Ramalingam SS, Curran WJ, Deng X. Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy. Mol Cancer. PMID: 30971271", "BibTeX": "@article{30971271, title={Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.}, author={Xu K and Park D and Magis AT and Zhang J and Zhou W and Sica GL and Ramalingam SS and Curran WJ and Deng X}, journal={Mol Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 27283993, "pmcid": "PMC4906406", "title": "Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.", "journal": "Nat Commun", "authors": ["Chabon JJ", "Simmons AD", "Lovejoy AF", "Esfahani MS", "Newman AM", "Haringsma HJ", "Kurtz DM", "Stehr H", "Scherer F", "Karlovich CA", "Harding TC", "Durkin KA", "Otterson GA", "Purcell WT", "Camidge DR", "Goldman JW", "Sequist LV", "Piotrowska Z", "Wakelee HA", "Neal JW", "Alizadeh AA", "Diehn M"], "date": "2016-06-10T00:00:00Z", "year": 2016, "snippets": [{"_id": "27283993@12413", "snip_text": "Intriguingly, we also observed the emergence of distinct KRAS activating mutations (G12A, Q61H and A146T) in three patients, none of whom had evidence of these lesions in their pre-treatment plasma specimens.", "section": "results", "mentions": ["84|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "57|4|gene|ncbi_gene@3845|KRAS", "99|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "115|8|species|ncbi_taxonomy@9606|patients", "90|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H"], "text_hl": "Intriguingly, we also observed the emergence of distinct KRAS activating mutations (G12A, Q61H and <m>A146T</m>) in three patients, none of whom had evidence of these lesions in their pre-treatment plasma specimens."}], "citations": {"NLM": "Chabon JJ, Simmons AD, Lovejoy AF, Esfahani MS, Newman AM, Haringsma HJ, Kurtz DM, Stehr H, Scherer F, Karlovich CA, Harding TC, Durkin KA, Otterson GA, Purcell WT, Camidge DR, Goldman JW, Sequist LV, Piotrowska Z, Wakelee HA, Neal JW, Alizadeh AA, Diehn M. Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. Nat Commun. PMID: 27283993", "BibTeX": "@article{27283993, title={Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.}, author={Chabon JJ and Simmons AD and Lovejoy AF and Esfahani MS and Newman AM and Haringsma HJ and Kurtz DM and Stehr H and Scherer F and Karlovich CA and Harding TC and Durkin KA and Otterson GA and Purcell WT and Camidge DR and Goldman JW and Sequist LV and Piotrowska Z and Wakelee HA and Neal JW and Alizadeh AA and Diehn M}, journal={Nat Commun}}"}, "is_sup_mat_match": false}, {"pmid": 35463360, "pmcid": "PMC9023070", "title": "Preclinical Models for Acquired Resistance to Third-Generation EGFR Inhibitors in NSCLC: Functional Studies and Drug Combinations Used to Overcome Resistance.", "journal": "Front Oncol", "authors": ["Mahfoudhi E", "Ricordel C", "Lecuyer G", "Mouric C", "Lena H", "Pedeux R"], "date": "2022-04-07T00:00:00Z", "year": 2022, "snippets": [{"_id": "35463360@25928", "snip_text": "KRAS G12A, Q61H, and A146T variants were found in patients treated with rociletinib that were not detected in their pre-treatment plasma specimens.", "section": "other", "mentions": ["21|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "72|11|chemical|ncbi_mesh@C000589977|rociletinib", "0|4|gene|ncbi_gene@3845|KRAS", "50|8|species|ncbi_taxonomy@9606|patients", "11|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "5|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A"], "text_hl": "KRAS G12A, Q61H, and <m>A146T</m> variants were found in patients treated with rociletinib that were not detected in their pre-treatment plasma specimens."}], "citations": {"NLM": "Mahfoudhi E, Ricordel C, Lecuyer G, Mouric C, Lena H, Pedeux R. Preclinical Models for Acquired Resistance to Third-Generation EGFR Inhibitors in NSCLC: Functional Studies and Drug Combinations Used to Overcome Resistance. Front Oncol. PMID: 35463360", "BibTeX": "@article{35463360, title={Preclinical Models for Acquired Resistance to Third-Generation EGFR Inhibitors in NSCLC: Functional Studies and Drug Combinations Used to Overcome Resistance.}, author={Mahfoudhi E and Ricordel C and Lecuyer G and Mouric C and Lena H and Pedeux R}, journal={Front Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 29455654, "pmcid": "PMC5817792", "title": "Third generation EGFR TKIs: current data and future directions.", "journal": "Mol Cancer", "authors": ["Tan CS", "Kumarakulasinghe NB", "Huang YQ", "Ang YLE", "Choo JR", "Goh BC", "Soo RA"], "date": "2018-02-19T00:00:00Z", "year": 2018, "snippets": [{"_id": "29455654@31202", "snip_text": "KRAS G12S, G12A, Q61H, A146T and G12D mutation had been reported post third generation EGFR TKI.", "section": "introduction", "mentions": ["23|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "5|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "87|4|gene|ncbi_gene@1956|EGFR", "33|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "17|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "0|4|gene|ncbi_gene@3845|KRAS", "11|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A"], "text_hl": "KRAS G12S, G12A, Q61H, <m>A146T</m> and G12D mutation had been reported post third generation EGFR TKI."}], "citations": {"NLM": "Tan CS, Kumarakulasinghe NB, Huang YQ, Ang YLE, Choo JR, Goh BC, Soo RA. Third generation EGFR TKIs: current data and future directions. Mol Cancer. PMID: 29455654", "BibTeX": "@article{29455654, title={Third generation EGFR TKIs: current data and future directions.}, author={Tan CS and Kumarakulasinghe NB and Huang YQ and Ang YLE and Choo JR and Goh BC and Soo RA}, journal={Mol Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 36831331, "pmcid": "PMC9954675", "title": "SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 Modulation.", "journal": "Cells", "authors": ["Costa D", "Ven\u00e8 R", "Coco S", "Longo L", "Tosetti F", "Scabini S", "Mastracci L", "Grillo F", "Poggi A", "Benelli R"], "date": "2023-02-20T00:00:00Z", "year": 2023, "snippets": [{"_id": "36831331@43180", "snip_text": "ID  Set Loc MS Status Stage UICC T N M G Molecular Diagnostic of Tumor Tissue Mutation Status by NGS   CTNNB1 FBXW7 MET ERBB2 KRAS NRAS BRAF DDR2 PIK3CA PTEN ALK SMAD4 TP53   OMCR17-062TK Exp T MSS III 3 2a  3       Q61R   3236T>C    R248Q   OMCR17-068TK Exp L MSS III 3 1b  2             TACTT->A R273C   OMCR18-016TK Exp T MSI II 3 0  2   R465H  L755S            OMCR18-021TK Exp S MSS IV 3 2a 1a 2 KRAS G12V     G12V           OMCR18-025TK Exp R MSS I 2 0  2  G34E R505C     V600E         OMCR18-035TK Exp R MSS II 4b 0  2              S241 fs*22    OMCR18-059TK Exp RT MSS I 2 0  2      G60V  V471dup      N131 del    OMCR18-060TK Exp RT MSS II 3 0  2 KRAS/BRAF/NRAS WT                OMCR19-003TK Val R MSS III 2 1b  3 KRAS G12A    N873G G12A        R282W   OMCR19-006TK Val RT MSS I 2 0  2   1418+1G>A   A59T      R1212H  R196P   OMCR19-009TK Val R MSS III 4a 2a  3 KRAS G12R; PIK3CA Q546K     G12R    Q546K    R273C   OMCR19-010TK Val T MSS II 3 0  1           T232N fsTer11; N323M fsTer21  L1165H  R181H   OMCR19-011TK Val R MSS III 3 1b  3      A146P  G469V  M1043V    R282W   OMCR19-015TK Val S MSS III 3 1b  2 KRAS G12A   R988C  G12A           OMCR19-016TK Val R MSI II 3 0  3 BRAF wt T41A        E545K 801+2T>C   P152R fsTer18    OMCR19-017TK Val RT MSS II 3 0  2                 OMCR19-024TK Val T MSS II 3 0  2      G12C   M441I        OMCR19-030TK Val T MSS III 3 2a  2 KRAS G12D      G12D       R135 Ter Q104R fsTer19   OMCR19-034TK Val R MSS IV 3 2b 1a 2 KRAS G13V     G13V    E542K    R175H   OMCR19-040TK Val R MSS III 3 2a  2      G12A        R175H   OMCR19-041TK Val R MSS III 3 2a  3   R505C   G12V    G1049R   S178 Ter R213 Ter   OMCR20-002TK Val R MSS II 3 0  2      G12D           OMCR13-011TK Ad R MSS III 4a 2b  3 BRAF K601E       K601E         OMCR15-045TK Ad R MSS II 3 0  2    N375S  G12V        R282W   OMCR16-005TK Ad R MSS IV 4a 2a 1b 4 BRAF V600E S23N      V600E      G244S   ", "section": "table", "mentions": ["298|5|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|R273C", "289|8|variant|litvar@#3845#|TACTT->A", "1472|4|gene|ncbi_gene@3845|KRAS", "968|5|variant|litvar@rs774904862##&&&litvar@#238#&&&litvar@CA1594897#rs774904862##|T232N", "141|4|gene|ncbi_gene@4921|DDR2", "890|5|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123338#rs121913286##|Q546K", "1758|5|variant|litvar@rs121913364##&&&litvar@#673#&&&litvar@CA123645#rs121913364##|K601E", "103|6|gene|ncbi_gene@1499|CTNNB1", "65|5|disease|ncbi_mesh@D009369|Tumor", "1486|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "1385|4|gene|ncbi_gene@3845|KRAS", "463|4|variant|litvar@rs28931589##&&&litvar@#1499#&&&litvar@CA127277#rs28931589##|G34E", "158|3|gene|ncbi_gene@238|ALK", "729|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "478|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1337|5|variant|litvar@rs34722354##&&&litvar@#4921#&&&litvar@CA31810116#rs34722354##|M441I", "1477|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "1188|4|gene|ncbi_gene@673|BRAF", "1061|5|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA135085#rs121913355##|G469V", "820|6|variant|litvar@rs143790259##&&&litvar@#238#&&&litvar@CA44655498#rs143790259##|R1212H", "743|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "341|5|variant|litvar@rs1057519895##&&&litvar@#55294#|R465H", "900|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "666|4|gene|ncbi_gene@4893|NRAS", "1616|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "877|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "1608|5|variant|litvar@rs149680468##&&&litvar@#55294#&&&litvar@CA16602253#rs149680468##|R505C", "597|7|variant|litvar@#673#p.V471dup&&&litvar@#673#|V471dup", "1746|5|variant|litvar@rs121913364##&&&litvar@#673#&&&litvar@CA123645#rs121913364##|K601E", "1494|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "755|5|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|R282W", "1054|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "1126|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "1214|8|variant|litvar@#673#c.801+2T>C&&&litvar@#673#|801+2T>C", "1875|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1741|4|gene|ncbi_gene@673|BRAF", "153|4|gene|ncbi_gene@5728|PTEN", "1140|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "401|4|gene|ncbi_gene@3845|KRAS", "348|5|variant|litvar@rs121913470##&&&litvar@#2064#&&&litvar@CA16602502#rs121913470##|L755S", "1225|5|variant|litvar@rs587778718##&&&litvar@#7157#&&&litvar@CA272#rs587778718##|P152R", "131|4|gene|ncbi_gene@4893|NRAS", "1691|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1196|4|variant|litvar@rs1225779973##&&&litvar@#5290#|T41A", "223|7|variant|litvar@rs1458728213##&&&litvar@#5728#|3236T>C", "136|4|gene|ncbi_gene@673|BRAF", "168|4|gene|ncbi_gene@7157|TP53", "1078|5|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|R282W", "1891|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "116|3|gene|ncbi_gene@79811|MET", "1330|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "591|4|variant|litvar@rs727503108##&&&litvar@#3845#&&&litvar@CA176493#rs727503108##|G60V", "724|4|gene|ncbi_gene@3845|KRAS", "883|6|gene|ncbi_gene@5290|PIK3CA", "468|5|variant|litvar@rs149680468##&&&litvar@#55294#&&&litvar@CA16602253#rs149680468##|R505C", "234|5|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|R248Q", "983|5|variant|litvar@#5728#p.N323M&&&litvar@#5728#|N323M", "1881|4|variant|litvar@rs1338288228##&&&litvar@#1113#|S23N", "998|6|variant|litvar@#5290#p.L1165H&&&litvar@#5290#|L1165H", "1208|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "120|5|gene|ncbi_gene@2064|ERBB2", "1551|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "1390|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1400|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "162|5|gene|ncbi_gene@4089|SMAD4", "1006|5|variant|litvar@rs397514495##&&&litvar@#7157#&&&litvar@CA259#rs397514495##|R181H", "661|4|gene|ncbi_gene@673|BRAF", "872|4|gene|ncbi_gene@3845|KRAS", "656|4|gene|ncbi_gene@3845|KRAS", "1420|5|variant|litvar@#3845#p.Q104R&&&litvar@#3845#|Q104R", "1902|5|variant|litvar@rs1057519989##&&&litvar@#7157#|G244S", "216|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "1068|6|variant|litvar@rs1057519936##&&&litvar@#5290#|M1043V", "828|5|variant|litvar@rs483352697##&&&litvar@#7157#&&&litvar@CA10580934#rs483352697##|R196P", "1121|4|gene|ncbi_gene@3845|KRAS", "1814|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "737|5|variant|litvar@#3845#p.N873G&&&litvar@#3845#|N873G", "1563|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H", "1503|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H", "1624|6|variant|litvar@rs121913277##&&&litvar@#5290#&&&litvar@CA16602520#rs121913277##|G1049R", "146|6|gene|ncbi_gene@5290|PIK3CA", "406|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "798|9|variant|litvar@rs1371675972##&&&litvar@#55294#|1418+1G>A", "1870|4|gene|ncbi_gene@673|BRAF", "415|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "126|4|gene|ncbi_gene@3845|KRAS", "908|5|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123338#rs121913286##|Q546K", "1807|5|variant|litvar@rs1462861861##&&&litvar@#55294#|N375S", "1133|5|variant|litvar@#3845#p.R988C&&&litvar@#3845#|R988C", "917|5|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|R273C", "1826|5|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|R282W", "110|5|gene|ncbi_gene@55294|FBXW7", "810|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T"], "figure_id": "cells-12-00664-t001", "text_hl": "ID  Set Loc MS Status Stage UICC T N M G Molecular Diagnostic of Tumor Tissue Mutation Status by NGS   CTNNB1 FBXW7 MET ERBB2 KRAS NRAS BRAF DDR2 PIK3CA PTEN ALK SMAD4 TP53   OMCR17-062TK Exp T MSS III 3 2a  3       Q61R   3236T>C    R248Q   OMCR17-068TK Exp L MSS III 3 1b  2             TACTT->A R273C   OMCR18-016TK Exp T MSI II 3 0  2   R465H  L755S            OMCR18-021TK Exp S MSS IV 3 2a 1a 2 KRAS G12V     G12V           OMCR18-025TK Exp R MSS I 2 0  2  G34E R505C     V600E         OMCR18-035TK Exp R MSS II 4b 0  2              S241 fs*22    OMCR18-059TK Exp RT MSS I 2 0  2      G60V  V471dup      N131 del    OMCR18-060TK Exp RT MSS II 3 0  2 KRAS/BRAF/NRAS WT                OMCR19-003TK Val R MSS III 2 1b  3 KRAS G12A    N873G G12A        R282W   OMCR19-006TK Val RT MSS I 2 0  2   1418+1G>A   A59T      R1212H  R196P   OMCR19-009TK Val R MSS III 4a 2a  3 KRAS G12R; PIK3CA Q546K     G12R    Q546K    R273C   OMCR19-010TK Val T MSS II 3 0  1           T232N fsTer11; N323M fsTer21  L1165H  R181H   OMCR19-011TK Val R MSS III 3 1b  3      A146P  G469V  M1043V    R282W   OMCR19-015TK Val S MSS III 3 1b  2 KRAS G12A   R988C  G12A           OMCR19-016TK Val R MSI II 3 0  3 BRAF wt T41A        E545K 801+2T>C   P152R fsTer18    OMCR19-017TK Val RT MSS II 3 0  2                 OMCR19-024TK Val T MSS II 3 0  2      G12C   M441I        OMCR19-030TK Val T MSS III 3 2a  2 KRAS G12D      G12D       R135 Ter Q104R fsTer19   OMCR19-034TK Val R MSS IV 3 2b 1a 2 KRAS G13V     G13V    E542K    R175H   OMCR19-040TK Val R MSS III 3 2a  2      G12A        R175H   OMCR19-041TK Val R MSS III 3 2a  3   R505C   G12V    G1049R   S178 Ter R213 Ter   OMCR20-002TK Val R MSS II 3 0  2      G12D           OMCR13-011TK Ad R MSS III 4a 2b  3 BRAF K601E       K601E         OMCR15-045TK Ad R MSS II 3 0  2    N375S  G12V        R282W   OMCR16-005TK Ad R MSS IV 4a 2a 1b 4 BRAF V600E S23N      V600E      G244S   "}], "citations": {"NLM": "Costa D, Ven\u00e8 R, Coco S, Longo L, Tosetti F, Scabini S, Mastracci L, Grillo F, Poggi A, Benelli R. SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 Modulation. Cells. PMID: 36831331", "BibTeX": "@article{36831331, title={SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 Modulation.}, author={Costa D and Ven\u00e8 R and Coco S and Longo L and Tosetti F and Scabini S and Mastracci L and Grillo F and Poggi A and Benelli R}, journal={Cells}}"}, "is_sup_mat_match": false}, {"pmid": 25695693, "pmcid": "PMC5015593", "title": "Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors", "journal": "Clin Cancer Res", "authors": ["Goswami RS", "Patel KP", "Singh RR", "Meric-Bernstam F", "Kopetz ES", "Subbiah V", "Alvarez RH", "Davies MA", "Jabbar KJ", "Roy-Chowdhuri S", "Lazar AJ", "Medeiros LJ", "Broaddus RR", "Luthra R", "Routbort MJ"], "date": "2015-06-01T00:00:00Z", "year": 2015, "snippets": [{"_id": "25695693@24597", "snip_text": "Site of novel mutations\tPrimary site\tMutations in primary\tMutations in metastasis\t \tMetastasis\tBreast\tPIK3CA:c.1633G>A p.E545K\tPIK3CA:c.1633G>A p.E545KTP53:c.853G>A p.E285K\t \tBreast\t\tPTEN:c.733C>T p.Q245*\t \tBreast\tHRAS:c.34G>A p.G12S\tHRAS:c.34G>Ap.G12SSMAD4:c.1553T>C p.I518T\t \tBreast\tPIK3CA:c.1633G>A p.E545K\tPIK3CA:c.1633G>A p.E545KPTPN11:c.173A>G p.N58S\t \tBreast\t\tTP53:c.839G>T p.R280I\t \tBreast\t\tKRAS:c.34G>C p.G12R\t \tBreast\t\tKRAS:c.35G>T p.G12V\t \tBreast\t\tPIK3CA:c.278G>C p.R93P\t \tColon\tPIK3CA:c.1624G>A p.E542KKRAS:c.35G>T p.G12V\tPIK3CA:c.1624G>A p.E542KKRAS:c.35G>T p.G12VSMAD4:c.1081C>A p.R361S\t \tColon\t\tPIK3CA:c.1624G>A p.E542K\t \tColon\tAPC:c.3340C>T p.R1114*TP53:c.742C>T p.R248WPIK3CA:c.3140A>Gp.H1047RKRAS:c.436G>A p.A146T\tAPC:c.3340C>T p.R1114*TP53:c.742C>T p.R248WPIK3CA:c.3140A>G p.H1047RKRAS:c.436G>A p.A146TPIK3CA:c.1030G>A p.V344MAPC:c.4348C>T p.R1450*\t \tColon\tTP53:c.818G>A p.R273HKRAS:c.38G>A p.G13D\tTP53:c.818G>A p.R273HKRAS:c.38G>A p.G13DPIK3CA:c.1638G>T p.Q546H\t \tColon\tKRAS:c.35G>A p.G12D\tKRAS:c.35G>A p.G12DTP53:c.844C>T p.R282WPIK3CA:c.1633G>A p.E545K\t \tColon\tTP53:c.809T>C p.F270S\tTP53:c.809T>C p.F270SNRAS:c.183A>C p.Q61H\t \tGastric\t\tAPC:c.4396G>T p.G1466*\t \tLung\t\tFBXW7:c.1436G>A p.R479Q\t \tMelanoma\tCDKN2A:c.158_159delp.M53fsNRAS:c.181C>A p.Q61K\tCDKN2A:c.158_159del p.M53fsNRAS:c.181C>A p.Q61KCTNNB1:c.133T>C p.S45P\t \tRenal cell\t\tTP53:c.742C>T p.R248W\t \tRenal cell\t\tTP53:c.581T>G p.L194R\t \tSarcoma\t\tFBXW7:c.1698G>A p.W566*\t \tPrimary\tBreast\tTP53:c.602T>A p.L201*\t\t \tBreast\tTP53:c.526T>Ap.C176STP53:c.581T>G p.L194R\tTP53:c.526T>A p.C176S\t \tBreast\tPIK3CA:c.1624G>A p.E542K\t\t \tBreast\tTP53:c.722C>A p.S241YABL1:c.844G>C p.E282QPIK3CA:c.1633G>A p.E545KPTEN:c.511C>T p.Q171*\tTP53:c.722C>A p.S241YABL1:c.844G>C p.E282QPIK3CA:c.1633G>A p.E545K\t \tColon\tKRAS:c.35G>A p.G12DFBXW7:c.1375G>A p.G459RAPC:c.2626C>T p.R876*\tKRAS:c.35G>A p.G12DFBXW7:c.1375G>A p.G459R\t \tColon\tAPC:c.4495G>T p.G1499*NRAS:c.35G>T p.G12VPIK3CA:c.1637A>G p.Q546RTP53:c.581T>A p.L194H\tAPC:c.4495G>T p.G1499*NRAS:c.35G>T p.G12VPIK3CA:c.1637A>G p.Q546R\t \tColon\tAPC:c.3883G>T p.E1295*TP53:c.817C>T p.R273CSMAD4:c.1082G>A p.R361H\tAPC:c.3883G>T p.E1295*TP53:c.817C>T p.R273C\t \tColon\tTP53:c.527G>A p.C176YKRAS:c.38G>A p.G13DSMAD4:c.1529G>T p.G510V\tTP53:c.527G>A p.C176YKRAS:c.38G>A p.G13D\t \tMelanoma\tMLH1:c.1151T>A p.V384DNRAS:c.182A>G p.Q61RKIT:c.1621A>C p.M541L\tMLH1:c.1151T>A p.V384DNRAS:c.182A>G p.Q61R\t \tMelanoma\tBRAF:c.1406G>A p.G469EKRAS:c.40G>A p.V14I\tBRAF:c.1406G>A p.G469E\t \tSarcoma\tTP53:c.535C>A p.H179N\t\t \tThyroid\tBRAF:c.1799T>A p.V600EAKT1:c.49G>A p.E17K\tBRAF:c.1799T>A p.V600E\t \tBoth\tSmall intestine\tTP53:c.856G>A p.E286KERBB2:c.2524G>A p.V842I\tTP53:c.856G>A p.E286KERBB4:c.2817G>T p.L939FSMAD4:c.380G>T p.C127FKRAS:c.35G>A p.G12D\t \tBreast\tTP53:c.626_627del p.R209fs\tTP53:c.524G>A p.R175H\t \tColon\tKRAS:c.35G>T p.G12VTP53:c.273G>A p.W91*\tKRAS:c.35G>T p.G12VTP53:c.725G>A p.C242YPIK3CA:c.3140A>G p.H1047R\t \tColon\tPIK3CA:c.263G>A p.R88QKRAS:c.38G>A p.G13D\tPIK3CA:c.263G>A p.R88QGNAS:c.602G>A p.R201H\t \tColon\tAPC:c.3927_3931delp.E1309fsKRAS:c.35G>T p.G12V\tAPC:c.3927_3931delp.E1309fsPIK3CA:c.263G>A p.R88Q\t \tSarcoma\tTP53:c.818G>A p.R273HCSF1R:c.950A>G p.E317G\tTP53:c.844C>T p.R282WTP53:c.871A>G p.K291ECSF1R:c.923A>G p.N308S\t \t", "section": "table", "mentions": ["1970|3|gene|ncbi_gene@324|APC", "2803|10|variant|litvar@#3845#|p.G12VTP53", "2643|8|variant|litvar@rs786201059##&&&litvar@#7157#&&&litvar@CA464#rs786201059##|c.856G>A", "2454|7|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|p.G469E", "1088|8|variant|litvar@rs1057519986##&&&litvar@#7157#|c.809T>C", "534|6|gene|ncbi_gene@5290|PIK3CA", "1698|8|variant|litvar@rs28934573##&&&litvar@#7157#|c.722C>A", "2472|4|gene|ncbi_gene@7157|TP53", "188|8|variant|litvar@rs786202918##&&&litvar@#5728#&&&litvar@CA193#rs786202918##|c.733C>T", "350|6|variant|litvar@rs751437780##&&&litvar@#5781#&&&litvar@CA6798530#rs751437780##|p.N58S", "2486|7|variant|litvar@rs587780070##&&&litvar@#7157#|p.H179N", "736|9|variant|litvar@rs121913331##&&&litvar@#324#&&&litvar@CA10582306#rs121913331##|c.3340C>T", "1003|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1396|8|variant|litvar@rs1057519998##&&&litvar@#7157#|c.581T>G", "1752|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "3045|3|gene|ncbi_gene@324|APC", "828|9|variant|litvar@rs1322313189##&&&litvar@#324#|c.1030G>A", "1440|7|variant|litvar@#55294#p.W566*&&&litvar@#55294#|p.W566*", "1867|7|variant|litvar@rs758535166##&&&litvar@#324#|p.G459R", "2058|12|variant|litvar@#324#p.E1295fsX53&&&litvar@#324#|p.E1295*TP53", "1676|8|variant|litvar@rs1365861429##&&&litvar@#7157#|c.511C>T", "2505|4|gene|ncbi_gene@673|BRAF", "1587|7|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.E542K", "2738|12|variant|litvar@#7157#c.626_627del&&&litvar@#7157#|c.626_627del", "746|12|variant|litvar@#324#p.R1114fsX53&&&litvar@#324#|p.R1114*TP53", "2795|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "2665|9|variant|litvar@rs760026760##&&&litvar@#2778#&&&litvar@CA9927256#rs760026760##|c.2817G>T", "876|4|gene|ncbi_gene@7157|TP53", "1334|6|variant|litvar@rs121913407##&&&litvar@#1499#&&&litvar@CA127285#rs121913407##|p.S45P", "1023|10|variant|litvar@#3845#|p.G12DTP53", "2261|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "2904|6|gene|ncbi_gene@5290|PIK3CA", "1360|8|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|c.742C>T", "1931|9|variant|litvar@rs747418061##&&&litvar@#324#&&&litvar@CA29022#rs747418061##|c.1637A>G", "2325|9|variant|litvar@rs3822214##&&&litvar@#3815#&&&litvar@CA160347#rs3822214##|c.1621A>C", "1997|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "2593|4|gene|ncbi_gene@7157|TP53", "2424|7|variant|litvar@rs876660754##&&&litvar@#7157#&&&litvar@CA10577579#rs876660754##|c.40G>A", "1832|4|gene|ncbi_gene@3845|KRAS", "1685|7|variant|litvar@#7157#p.Q171*&&&litvar@#7157#|p.Q171*", "1479|7|variant|litvar@rs573154688##&&&litvar@#7157#|p.L201*", "404|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>C", "1768|4|gene|ncbi_gene@3845|KRAS", "1497|4|gene|ncbi_gene@7157|TP53", "2675|12|variant|litvar@#7157#|p.L939FSMAD4", "1312|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "2115|9|variant|litvar@rs138367627##&&&litvar@#324#&&&litvar@CA9712#rs138367627##|c.3883G>T", "2765|8|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|c.524G>A", "3088|6|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|p.R88Q", "2005|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "2953|8|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|c.263G>A", "1953|8|variant|litvar@rs1057519998##&&&litvar@#7157#|c.581T>A", "2717|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "2163|4|gene|ncbi_gene@7157|TP53", "2877|9|variant|litvar@rs1292530466##&&&litvar@#324#|c.3140A>G", "3110|8|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|c.818G>A", "3175|8|variant|litvar@rs769727966##&&&litvar@#324#&&&litvar@CA50760#rs769727966##|c.871A>G", "2510|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "1522|8|variant|litvar@rs1057519998##&&&litvar@#7157#|c.581T>G", "2093|9|variant|litvar@rs764134245##&&&litvar@#324#&&&litvar@CA16023858#rs764134245##|c.1082G>A", "2125|12|variant|litvar@#324#p.E1295fsX53&&&litvar@#324#|p.E1295*TP53", "583|9|variant|litvar@rs1472028496##&&&litvar@#5728#|c.1081C>A", "2688|8|variant|litvar@rs398123322##&&&litvar@#5728#&&&litvar@CA428#rs398123322##|c.380G>T", "657|12|variant|litvar@#324#p.R1114fsX53&&&litvar@#324#|p.R1114*TP53", "2219|7|variant|litvar@rs377767371##&&&litvar@#4089#&&&litvar@CA259255#rs377767371##|p.G510V", "1962|7|variant|litvar@rs1057519998##&&&litvar@#7157#|p.L194H", "1814|9|variant|litvar@rs121913333##&&&litvar@#324#&&&litvar@CA338207#rs121913333##|c.2626C>T", "434|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "1205|7|variant|litvar@rs866987936##&&&litvar@#55294#&&&litvar@CA16602856#rs866987936##|p.R479Q", "1664|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "1303|8|variant|litvar@rs876658468##&&&litvar@#7157#|c.181C>A", "1883|3|gene|ncbi_gene@324|APC", "670|8|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|c.742C>T", "2379|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "2540|6|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|p.E17K", "2939|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "995|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "1781|11|variant|litvar@#3845#|p.G12DFBXW7", "2843|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1654|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G>A", "2209|9|variant|litvar@rs377767371##&&&litvar@#4089#&&&litvar@CA259255#rs377767371##|c.1529G>T", "917|4|gene|ncbi_gene@7157|TP53", "2638|4|gene|ncbi_gene@7157|TP53", "2147|7|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|p.R273C", "399|4|gene|ncbi_gene@3845|KRAS", "183|4|gene|ncbi_gene@5728|PTEN", "197|7|variant|litvar@#5728#p.Q245*&&&litvar@#5728#|p.Q245*", "2028|7|variant|litvar@rs747418061##&&&litvar@#324#&&&litvar@CA29022#rs747418061##|p.Q546R", "2189|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "2335|7|variant|litvar@rs3822214##&&&litvar@#3815#&&&litvar@CA160347#rs3822214##|p.M541L", "2232|8|variant|litvar@rs786202962##&&&litvar@#7157#&&&litvar@CA254#rs786202962##|c.527G>A", "2071|8|variant|litvar@rs775126020##&&&litvar@#324#&&&litvar@CA16038#rs775126020##|c.817C>T", "3154|8|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|c.844C>T", "1742|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G>A", "367|4|gene|ncbi_gene@7157|TP53", "165|7|variant|litvar@rs112431538##&&&litvar@#7157#&&&litvar@CA16620615#rs112431538##|p.E285K", "381|7|variant|litvar@rs121912660##&&&litvar@#7157#&&&litvar@CA447#rs121912660##|p.R280I", "1010|4|gene|ncbi_gene@3845|KRAS", "1034|8|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|c.844C>T", "1910|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "3149|4|gene|ncbi_gene@7157|TP53", "490|6|gene|ncbi_gene@5290|PIK3CA", "1255|8|variant|litvar@rs876658468##&&&litvar@#7157#|c.181C>A", "1015|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "1465|4|gene|ncbi_gene@7157|TP53", "2946|6|gene|ncbi_gene@5290|PIK3CA", "3038|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "2709|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "2760|4|gene|ncbi_gene@7157|TP53", "1539|4|gene|ncbi_gene@7157|TP53", "2774|7|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|p.R175H", "647|9|variant|litvar@rs121913331##&&&litvar@#324#&&&litvar@CA10582306#rs121913331##|c.3340C>T", "610|6|gene|ncbi_gene@5290|PIK3CA", "459|6|gene|ncbi_gene@5290|PIK3CA", "2733|4|gene|ncbi_gene@7157|TP53", "2477|8|variant|litvar@rs587780070##&&&litvar@#7157#|c.535C>A", "317|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G>A", "429|4|gene|ncbi_gene@3845|KRAS", "3206|7|variant|litvar@rs121918455##&&&litvar@#5781#&&&litvar@CA235328#rs121918455##|p.N308S", "1158|3|gene|ncbi_gene@324|APC", "902|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "1897|12|variant|litvar@#324#p.G1499fsXNRAS&&&litvar@#324#|p.G1499*NRAS", "2138|8|variant|litvar@rs775126020##&&&litvar@#324#&&&litvar@CA16038#rs775126020##|c.817C>T", "2402|9|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|c.1406G>A", "2532|7|variant|litvar@rs1358493187##&&&litvar@#7157#|c.49G>A", "156|8|variant|litvar@rs112431538##&&&litvar@#7157#&&&litvar@CA16620615#rs112431538##|c.853G>A", "782|9|variant|litvar@rs1292530466##&&&litvar@#324#|c.3140A>G", "2044|3|gene|ncbi_gene@324|APC", "134|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G>A", "1105|4|gene|ncbi_gene@7157|TP53", "1605|4|gene|ncbi_gene@7157|TP53", "881|8|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|c.818G>A", "1845|11|variant|litvar@#3845#|p.G12DFBXW7", "627|7|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.E542K", "2835|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "497|9|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|c.1624G>A", "732|3|gene|ncbi_gene@324|APC", "617|9|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|c.1624G>A", "563|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "2982|7|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|p.R201H", "2814|8|variant|litvar@rs876660548##&&&litvar@#7157#&&&litvar@CA10580953#rs876660548##|c.273G>A", "2598|8|variant|litvar@rs786201059##&&&litvar@#7157#&&&litvar@CA464#rs786201059##|c.856G>A", "2253|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "1083|4|gene|ncbi_gene@7157|TP53", "310|6|gene|ncbi_gene@5290|PIK3CA", "1693|4|gene|ncbi_gene@7157|TP53", "859|8|variant|litvar@#7157#p.R1450*&&&litvar@#7157#|p.R1450*", "2547|4|gene|ncbi_gene@673|BRAF", "1278|12|variant|litvar@#7157#c.158_159del&&&litvar@#7157#|c.158_159del", "2790|4|gene|ncbi_gene@3845|KRAS", "1424|5|gene|ncbi_gene@55294|FBXW7", "1793|9|variant|litvar@rs758535166##&&&litvar@#324#&&&litvar@CA27225#rs758535166##|c.1375G>A", "1577|9|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|c.1624G>A", "246|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "239|7|variant|litvar@rs765433422##&&&litvar@#5728#&&&litvar@CA60311#rs765433422##|c.34G>A", "759|8|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|c.742C>T", "2751|8|variant|litvar@rs1057517840##&&&litvar@#7157#|p.R209fs", "1131|8|variant|litvar@rs780363627##&&&litvar@#7157#&&&litvar@CA8354901#rs780363627##|c.183A>C", "1631|8|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA453#rs28934574##|c.844G>C", "127|6|gene|ncbi_gene@5290|PIK3CA", "1470|8|variant|litvar@rs1242767881##&&&litvar@#324#|c.602T>A", "2168|8|variant|litvar@rs786202962##&&&litvar@#7157#&&&litvar@CA254#rs786202962##|c.527G>A", "2306|8|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|c.182A>G", "974|7|variant|litvar@rs1057519940##&&&litvar@#5290#|p.Q546H", "2620|9|variant|litvar@rs1060503270##&&&litvar@#324#|c.2524G>A", "2432|6|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|p.V14I", "2111|3|gene|ncbi_gene@324|APC", "1355|4|gene|ncbi_gene@7157|TP53", "327|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "2103|7|variant|litvar@rs377767347##&&&litvar@#4089#&&&litvar@CA128097#rs377767347##|p.R361H", "466|8|variant|litvar@rs1163661746##&&&litvar@#324#|c.278G>C", "593|7|variant|litvar@rs1472028496##&&&litvar@#5728#|p.R361S", "1325|8|variant|litvar@rs147002414##&&&litvar@#7157#&&&litvar@CA287488531#rs147002414##|c.133T>C", "1719|8|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA453#rs28934574##|c.844G>C", "2562|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "2397|4|gene|ncbi_gene@673|BRAF", "1369|7|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|p.R248W", "268|7|variant|litvar@rs371453363##&&&litvar@#324#|p.I518T", "285|6|gene|ncbi_gene@5290|PIK3CA", "1773|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "2552|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "1974|9|variant|litvar@rs587782349##&&&litvar@#324#&&&litvar@CA10578376#rs587782349##|c.4495G>T", "3141|7|variant|litvar@rs1466028373##&&&litvar@#2778#|p.E317G", "715|8|variant|litvar@rs763181290##&&&litvar@#324#&&&litvar@CA38866#rs763181290##|c.436G>A", "964|9|variant|litvar@rs1057519940##&&&litvar@#5290#|c.1638G>T", "2973|8|variant|litvar@rs573154688##&&&litvar@#7157#&&&litvar@CA533#rs573154688##|c.602G>A", "1824|7|variant|litvar@#3845#p.R876*&&&litvar@#3845#|p.R876*", "1553|7|variant|litvar@rs967461896##&&&litvar@#7157#&&&litvar@CA16602996#rs967461896##|p.C176S", "1570|6|gene|ncbi_gene@5290|PIK3CA", "814|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "2823|6|variant|litvar@#3845#p.91dup&&&litvar@#3845#|p.W91*", "2854|8|variant|litvar@rs121912655##&&&litvar@#7157#&&&litvar@CA361#rs121912655##|c.725G>A", "951|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "3105|4|gene|ncbi_gene@7157|TP53", "102|6|gene|ncbi_gene@5290|PIK3CA", "922|8|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|c.818G>A", "2048|9|variant|litvar@rs138367627##&&&litvar@#324#&&&litvar@CA9712#rs138367627##|c.3883G>T", "1887|9|variant|litvar@rs587782349##&&&litvar@#324#&&&litvar@CA10578376#rs587782349##|c.4495G>T", "2931|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "1110|8|variant|litvar@rs1057519986##&&&litvar@#7157#|c.809T>C", "2998|3|gene|ncbi_gene@324|APC", "2830|4|gene|ncbi_gene@3845|KRAS", "258|9|variant|litvar@rs371453363##&&&litvar@#324#&&&litvar@CA28394#rs371453363##|c.1553T>C", "1057|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G>A", "2887|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.H1047R", "1140|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "1189|5|gene|ncbi_gene@55294|FBXW7", "990|4|gene|ncbi_gene@3845|KRAS", "372|8|variant|litvar@rs121912660##&&&litvar@#7157#&&&litvar@CA447#rs121912660##|c.839G>T", "1984|12|variant|litvar@#324#p.G1499fsXNRAS&&&litvar@#324#|p.G1499*NRAS", "2444|9|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|c.1406G>A", "1119|7|variant|litvar@rs1057519986##&&&litvar@#7157#|p.F270S", "2348|9|variant|litvar@#673#c.1151T>A&&&litvar@#673#|c.1151T>A", "475|6|variant|litvar@rs1163661746##&&&litvar@#324#|p.R93P", "1430|9|variant|litvar@rs750857896##&&&litvar@#324#&&&litvar@CA124982568#rs750857896##|c.1698G>A", "2018|9|variant|litvar@rs747418061##&&&litvar@#324#&&&litvar@CA29022#rs747418061##|c.1637A>G", "1857|9|variant|litvar@rs758535166##&&&litvar@#324#&&&litvar@CA27225#rs758535166##|c.1375G>A", "2630|7|variant|litvar@rs769874747##&&&litvar@#4893#&&&litvar@CA1020824#rs769874747##|p.V842I", "2284|9|variant|litvar@#673#c.1151T>A&&&litvar@#673#|c.1151T>A", "292|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G>A", "2911|8|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|c.263G>A", "341|8|variant|litvar@rs1131691885##&&&litvar@#5728#|c.173A>G", "519|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "3132|8|variant|litvar@rs1159579789##&&&litvar@#7157#|c.950A>G", "1172|8|variant|litvar@#55294#p.1466dup&&&litvar@#55294#|p.G1466*", "1391|4|gene|ncbi_gene@7157|TP53", "1405|7|variant|litvar@rs1057519998##&&&litvar@#7157#|p.L194R", "571|11|variant|litvar@#5290#|p.G12VSMAD4", "1544|8|variant|litvar@rs967461896##&&&litvar@#7157#&&&litvar@CA16602996#rs967461896##|c.526T>A", "412|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "805|8|variant|litvar@rs763181290##&&&litvar@#324#&&&litvar@CA38866#rs763181290##|c.436G>A", "2227|4|gene|ncbi_gene@7157|TP53", "2370|8|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|c.182A>G", "1195|9|variant|litvar@rs866987936##&&&litvar@#55294#&&&litvar@CA16602856#rs866987936##|c.1436G>A", "3030|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "541|9|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|c.1624G>A", "109|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G>A", "849|9|variant|litvar@rs121913332##&&&litvar@#324#&&&litvar@CA9465#rs121913332##|c.4348C>T", "3197|8|variant|litvar@rs786201507##&&&litvar@#5728#&&&litvar@CA228#rs786201507##|c.923A>G", "1837|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "643|3|gene|ncbi_gene@324|APC", "1067|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "1610|8|variant|litvar@rs28934573##&&&litvar@#7157#|c.722C>A", "2439|4|gene|ncbi_gene@673|BRAF", "2197|11|variant|litvar@#7157#|p.G13DSMAD4", "3079|8|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|c.263G>A", "943|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "1531|7|variant|litvar@rs1057519998##&&&litvar@#7157#|p.L194R", "1162|9|variant|litvar@#324#c.4396G>T&&&litvar@#324#|c.4396G>T"], "figure_id": "T1", "text_hl": "Site of novel mutations\tPrimary site\tMutations in primary\tMutations in metastasis\t \tMetastasis\tBreast\tPIK3CA:c.1633G>A p.E545K\tPIK3CA:c.1633G>A p.E545KTP53:c.853G>A p.E285K\t \tBreast\t\tPTEN:c.733C>T p.Q245*\t \tBreast\tHRAS:c.34G>A p.G12S\tHRAS:c.34G>Ap.G12SSMAD4:c.1553T>C p.I518T\t \tBreast\tPIK3CA:c.1633G>A p.E545K\tPIK3CA:c.1633G>A p.E545KPTPN11:c.173A>G p.N58S\t \tBreast\t\tTP53:c.839G>T p.R280I\t \tBreast\t\tKRAS:c.34G>C p.G12R\t \tBreast\t\tKRAS:c.35G>T p.G12V\t \tBreast\t\tPIK3CA:c.278G>C p.R93P\t \tColon\tPIK3CA:c.1624G>A p.E542KKRAS:c.35G>T p.G12V\tPIK3CA:c.1624G>A p.E542KKRAS:c.35G>T p.G12VSMAD4:c.1081C>A p.R361S\t \tColon\t\tPIK3CA:c.1624G>A p.E542K\t \tColon\tAPC:c.3340C>T p.R1114*TP53:c.742C>T p.R248WPIK3CA:c.3140A>Gp.H1047RKRAS:c.436G>A <m>p.A146T</m>\tAPC:c.3340C>T p.R1114*TP53:c.742C>T p.R248WPIK3CA:c.3140A>G p.H1047RKRAS:c.436G>A p.A146TPIK3CA:c.1030G>A p.V344MAPC:c.4348C>T p.R1450*\t \tColon\tTP53:c.818G>A p.R273HKRAS:c.38G>A p.G13D\tTP53:c.818G>A p.R273HKRAS:c.38G>A p.G13DPIK3CA:c.1638G>T p.Q546H\t \tColon\tKRAS:c.35G>A p.G12D\tKRAS:c.35G>A p.G12DTP53:c.844C>T p.R282WPIK3CA:c.1633G>A p.E545K\t \tColon\tTP53:c.809T>C p.F270S\tTP53:c.809T>C p.F270SNRAS:c.183A>C p.Q61H\t \tGastric\t\tAPC:c.4396G>T p.G1466*\t \tLung\t\tFBXW7:c.1436G>A p.R479Q\t \tMelanoma\tCDKN2A:c.158_159delp.M53fsNRAS:c.181C>A p.Q61K\tCDKN2A:c.158_159del p.M53fsNRAS:c.181C>A p.Q61KCTNNB1:c.133T>C p.S45P\t \tRenal cell\t\tTP53:c.742C>T p.R248W\t \tRenal cell\t\tTP53:c.581T>G p.L194R\t \tSarcoma\t\tFBXW7:c.1698G>A p.W566*\t \tPrimary\tBreast\tTP53:c.602T>A p.L201*\t\t \tBreast\tTP53:c.526T>Ap.C176STP53:c.581T>G p.L194R\tTP53:c.526T>A p.C176S\t \tBreast\tPIK3CA:c.1624G>A p.E542K\t\t \tBreast\tTP53:c.722C>A p.S241YABL1:c.844G>C p.E282QPIK3CA:c.1633G>A p.E545KPTEN:c.511C>T p.Q171*\tTP53:c.722C>A p.S241YABL1:c.844G>C p.E282QPIK3CA:c.1633G>A p.E545K\t \tColon\tKRAS:c.35G>A p.G12DFBXW7:c.1375G>A p.G459RAPC:c.2626C>T p.R876*\tKRAS:c.35G>A p.G12DFBXW7:c.1375G>A p.G459R\t \tColon\tAPC:c.4495G>T p.G1499*NRAS:c.35G>T p.G12VPIK3CA:c.1637A>G p.Q546RTP53:c.581T>A p.L194H\tAPC:c.4495G>T p.G1499*NRAS:c.35G>T p.G12VPIK3CA:c.1637A>G p.Q546R\t \tColon\tAPC:c.3883G>T p.E1295*TP53:c.817C>T p.R273CSMAD4:c.1082G>A p.R361H\tAPC:c.3883G>T p.E1295*TP53:c.817C>T p.R273C\t \tColon\tTP53:c.527G>A p.C176YKRAS:c.38G>A p.G13DSMAD4:c.1529G>T p.G510V\tTP53:c.527G>A p.C176YKRAS:c.38G>A p.G13D\t \tMelanoma\tMLH1:c.1151T>A p.V384DNRAS:c.182A>G p.Q61RKIT:c.1621A>C p.M541L\tMLH1:c.1151T>A p.V384DNRAS:c.182A>G p.Q61R\t \tMelanoma\tBRAF:c.1406G>A p.G469EKRAS:c.40G>A p.V14I\tBRAF:c.1406G>A p.G469E\t \tSarcoma\tTP53:c.535C>A p.H179N\t\t \tThyroid\tBRAF:c.1799T>A p.V600EAKT1:c.49G>A p.E17K\tBRAF:c.1799T>A p.V600E\t \tBoth\tSmall intestine\tTP53:c.856G>A p.E286KERBB2:c.2524G>A p.V842I\tTP53:c.856G>A p.E286KERBB4:c.2817G>T p.L939FSMAD4:c.380G>T p.C127FKRAS:c.35G>A p.G12D\t \tBreast\tTP53:c.626_627del p.R209fs\tTP53:c.524G>A p.R175H\t \tColon\tKRAS:c.35G>T p.G12VTP53:c.273G>A p.W91*\tKRAS:c.35G>T p.G12VTP53:c.725G>A p.C242YPIK3CA:c.3140A>G p.H1047R\t \tColon\tPIK3CA:c.263G>A p.R88QKRAS:c.38G>A p.G13D\tPIK3CA:c.263G>A p.R88QGNAS:c.602G>A p.R201H\t \tColon\tAPC:c.3927_3931delp.E1309fsKRAS:c.35G>T p.G12V\tAPC:c.3927_3931delp.E1309fsPIK3CA:c.263G>A p.R88Q\t \tSarcoma\tTP53:c.818G>A p.R273HCSF1R:c.950A>G p.E317G\tTP53:c.844C>T p.R282WTP53:c.871A>G p.K291ECSF1R:c.923A>G p.N308S\t \t"}], "citations": {"NLM": "Goswami RS, Patel KP, Singh RR, Meric-Bernstam F, Kopetz ES, Subbiah V, Alvarez RH, Davies MA, Jabbar KJ, Roy-Chowdhuri S, Lazar AJ, Medeiros LJ, Broaddus RR, Luthra R, Routbort MJ. Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors Clin Cancer Res. PMID: 25695693", "BibTeX": "@article{25695693, title={Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors}, author={Goswami RS and Patel KP and Singh RR and Meric-Bernstam F and Kopetz ES and Subbiah V and Alvarez RH and Davies MA and Jabbar KJ and Roy-Chowdhuri S and Lazar AJ and Medeiros LJ and Broaddus RR and Luthra R and Routbort MJ}, journal={Clin Cancer Res}}"}, "is_sup_mat_match": false}, {"pmid": 33923068, "pmcid": "PMC8123354", "title": "Discovering the Mutational Profile of Early Colorectal Lesions: A Translational Impact.", "journal": "Cancers (Basel)", "authors": ["Alquati C", "Prossomariti A", "Piazzi G", "Buttitta F", "Bazzoli F", "Laghi L", "Ricciardiello L"], "date": "2021-04-25T00:00:00Z", "year": 2021, "snippets": [{"_id": "33923068@19353", "snip_text": "Somatic KRAS mutations (G12V and A146T) have also been observed above all in MMR-P adenomas, rather than MMR-D.", "section": "other", "mentions": ["77|14|disease|ncbi_mesh@C536928|MMR-P adenomas", "33|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "24|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "8|4|gene|ncbi_gene@3845|KRAS", "105|6|disease|ncbi_mesh@C536928|MMR-D."], "text_hl": "Somatic KRAS mutations (G12V and <m>A146T</m>) have also been observed above all in MMR-P adenomas, rather than MMR-D."}], "citations": {"NLM": "Alquati C, Prossomariti A, Piazzi G, Buttitta F, Bazzoli F, Laghi L, Ricciardiello L. Discovering the Mutational Profile of Early Colorectal Lesions: A Translational Impact. Cancers (Basel). PMID: 33923068", "BibTeX": "@article{33923068, title={Discovering the Mutational Profile of Early Colorectal Lesions: A Translational Impact.}, author={Alquati C and Prossomariti A and Piazzi G and Buttitta F and Bazzoli F and Laghi L and Ricciardiello L}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 21386094, "pmcid": "PMC3437993", "title": "Ubiquitination of Ras enhances activation and facilitates binding to select downstream effectors", "journal": "Sci Signal", "authors": ["Sasaki AT", "Carracedo A", "Locasale JW", "Anastasiou D", "Takeuchi K", "Kahoud ER", "Haviv S", "Asara JM", "Pandolfi PP", "Cantley LC"], "date": "2011-03-08T00:00:00Z", "year": 2011, "snippets": [{"_id": "21386094@8048", "snip_text": "Other activating mutations in the Ras-G5 domain, A146T and A146V, which are proximal to the identified ubiquitination site, Lys147, have also been found in human cancers.", "section": "results", "mentions": ["49|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "162|7|disease|ncbi_mesh@D009369|cancers", "156|5|species|ncbi_taxonomy@9606|human", "124|6|variant|litvar@rs1135401776##&&&litvar@#3845#|Lys147", "59|5|variant|litvar@rs121917759##&&&litvar@#3265#&&&litvar@CA256494#rs121917759##|A146V"], "text_hl": "Other activating mutations in the Ras-G5 domain, <m>A146T</m> and A146V, which are proximal to the identified ubiquitination site, Lys147, have also been found in human cancers."}], "citations": {"NLM": "Sasaki AT, Carracedo A, Locasale JW, Anastasiou D, Takeuchi K, Kahoud ER, Haviv S, Asara JM, Pandolfi PP, Cantley LC. Ubiquitination of Ras enhances activation and facilitates binding to select downstream effectors Sci Signal. PMID: 21386094", "BibTeX": "@article{21386094, title={Ubiquitination of Ras enhances activation and facilitates binding to select downstream effectors}, author={Sasaki AT and Carracedo A and Locasale JW and Anastasiou D and Takeuchi K and Kahoud ER and Haviv S and Asara JM and Pandolfi PP and Cantley LC}, journal={Sci Signal}}"}, "is_sup_mat_match": false}, {"pmid": 32665851, "pmcid": "PMC7333923", "title": " BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy", "journal": "Gastroenterol Rep (Oxf)", "authors": ["Li ZN", "Zhao L", "Yu LF", "Wei MJ"], "date": "2020-06-15T00:00:00Z", "year": 2020, "snippets": [{"_id": "32665851@3060", "snip_text": "KRAS mutations occur in approximately 44% of mCRC, with the majority observed in codons 12 and 13 of exon 2 (80% are G12D, G12V, G12C, G12A, and G13D) and less commonly in codon 61 of exon 3 (5% are Q61H, Q61L, and Q61R) and codon 146 of exon 4 (2% are A146T and A146V).", "section": "introduction", "mentions": ["123|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "145|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "129|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "253|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "135|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "215|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "0|4|gene|ncbi_gene@3845|KRAS", "205|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "199|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "117|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "263|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V"], "text_hl": "KRAS mutations occur in approximately 44% of mCRC, with the majority observed in codons 12 and 13 of exon 2 (80% are G12D, G12V, G12C, G12A, and G13D) and less commonly in codon 61 of exon 3 (5% are Q61H, Q61L, and Q61R) and codon 146 of exon 4 (2% are <m>A146T</m> and A146V)."}], "citations": {"NLM": "Li ZN, Zhao L, Yu LF, Wei MJ.  BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy Gastroenterol Rep (Oxf). PMID: 32665851", "BibTeX": "@article{32665851, title={ BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy}, author={Li ZN and Zhao L and Yu LF and Wei MJ}, journal={Gastroenterol Rep (Oxf)}}"}, "is_sup_mat_match": false}, {"pmid": 25164765, "pmcid": "PMC4189196", "title": "Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions.", "journal": "Genome Biol", "authors": ["Brannon AR", "Vakiani E", "Sylvester BE", "Scott SN", "McDermott G", "Shah RH", "Kania K", "Viale A", "Oschwald DM", "Vacic V", "Emde AK", "Cercek A", "Yaeger R", "Kemeny NE", "Saltz LB", "Shia J", "D'Angelica MI", "Weiser MR", "Solit DB", "Berger MF"], "date": "2014-08-28T00:00:00Z", "year": 2014, "snippets": [], "citations": {"NLM": "Brannon AR, Vakiani E, Sylvester BE, Scott SN, McDermott G, Shah RH, Kania K, Viale A, Oschwald DM, Vacic V, Emde AK, Cercek A, Yaeger R, Kemeny NE, Saltz LB, Shia J, D'Angelica MI, Weiser MR, Solit DB, Berger MF. Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions. Genome Biol. PMID: 25164765", "BibTeX": "@article{25164765, title={Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions.}, author={Brannon AR and Vakiani E and Sylvester BE and Scott SN and McDermott G and Shah RH and Kania K and Viale A and Oschwald DM and Vacic V and Emde AK and Cercek A and Yaeger R and Kemeny NE and Saltz LB and Shia J and D'Angelica MI and Weiser MR and Solit DB and Berger MF}, journal={Genome Biol}}"}, "is_sup_mat_match": true}, {"pmid": 31521947, "pmcid": "PMC6745489", "title": "Rectal cancer sub-clones respond differentially to neoadjuvant therapy.", "journal": "Neoplasia", "authors": ["Frydrych LM", "Ulintz P", "Bankhead A", "Sifuentes C", "Greenson J", "Maguire L", "Irwin R", "Fearon ER", "Hardiman KM"], "date": "2019-10-01T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Frydrych LM, Ulintz P, Bankhead A, Sifuentes C, Greenson J, Maguire L, Irwin R, Fearon ER, Hardiman KM. Rectal cancer sub-clones respond differentially to neoadjuvant therapy. Neoplasia. PMID: 31521947", "BibTeX": "@article{31521947, title={Rectal cancer sub-clones respond differentially to neoadjuvant therapy.}, author={Frydrych LM and Ulintz P and Bankhead A and Sifuentes C and Greenson J and Maguire L and Irwin R and Fearon ER and Hardiman KM}, journal={Neoplasia}}"}, "is_sup_mat_match": true}, {"pmid": 30545397, "pmcid": "PMC6293660", "title": "Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways.", "journal": "J Hematol Oncol", "authors": ["Tessoulin B", "Moreau-Aubry A", "Descamps G", "Gomez-Bougie P", "Ma\u00efga S", "Gaignard A", "Chiron D", "M\u00e9noret E", "Le Gouill S", "Moreau P", "Amiot M", "Pellat-Deceunynck C"], "date": "2018-12-13T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Tessoulin B, Moreau-Aubry A, Descamps G, Gomez-Bougie P, Ma\u00efga S, Gaignard A, Chiron D, M\u00e9noret E, Le Gouill S, Moreau P, Amiot M, Pellat-Deceunynck C. Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways. J Hematol Oncol. PMID: 30545397", "BibTeX": "@article{30545397, title={Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways.}, author={Tessoulin B and Moreau-Aubry A and Descamps G and Gomez-Bougie P and Ma\u00efga S and Gaignard A and Chiron D and M\u00e9noret E and Le Gouill S and Moreau P and Amiot M and Pellat-Deceunynck C}, journal={J Hematol Oncol}}"}, "is_sup_mat_match": true}, {"pmid": 25372287, "pmcid": "PMC4221102", "title": "High-throughput sequencing and copy number variation detection using formalin fixed embedded tissue in metastatic gastric cancer.", "journal": "PLoS One", "authors": ["Kim S", "Lee J", "Hong ME", "Do IG", "Kang SY", "Ha SY", "Kim ST", "Park SH", "Kang WK", "Choi MG", "Lee JH", "Sohn TS", "Bae JM", "Kim S", "Kim DH", "Kim KM"], "date": "2014-11-05T00:00:00Z", "year": 2014, "snippets": [], "citations": {"NLM": "Kim S, Lee J, Hong ME, Do IG, Kang SY, Ha SY, Kim ST, Park SH, Kang WK, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Kim DH, Kim KM. High-throughput sequencing and copy number variation detection using formalin fixed embedded tissue in metastatic gastric cancer. PLoS One. PMID: 25372287", "BibTeX": "@article{25372287, title={High-throughput sequencing and copy number variation detection using formalin fixed embedded tissue in metastatic gastric cancer.}, author={Kim S and Lee J and Hong ME and Do IG and Kang SY and Ha SY and Kim ST and Park SH and Kang WK and Choi MG and Lee JH and Sohn TS and Bae JM and Kim S and Kim DH and Kim KM}, journal={PLoS One}}"}, "is_sup_mat_match": true}, {"pmid": 28186126, "pmcid": "PMC5309787", "title": "Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.", "journal": "Nat Commun", "authors": ["Sch\u00fctte M", "Risch T", "Abdavi-Azar N", "Boehnke K", "Schumacher D", "Keil M", "Yildiriman R", "Jandrasits C", "Borodina T", "Amstislavskiy V", "Worth CL", "Schweiger C", "Liebs S", "Lange M", "Warnatz HJ", "Butcher LM", "Barrett JE", "Sultan M", "Wierling C", "Golob-Schwarzl N", "Lax S", "Uranitsch S", "Becker M", "Welte Y", "Regan JL", "Silvestrov M", "Kehler I", "Fusi A", "Kessler T", "Herwig R", "Landegren U", "Wienke D", "Nilsson M", "Velasco JA", "Garin-Chesa P", "Reinhard C", "Beck S", "Sch\u00e4fer R", "Regenbrecht CR", "Henderson D", "Lange B", "Haybaeck J", "Keilholz U", "Hoffmann J", "Lehrach H", "Yaspo ML"], "date": "2017-02-10T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Sch\u00fctte M, Risch T, Abdavi-Azar N, Boehnke K, Schumacher D, Keil M, Yildiriman R, Jandrasits C, Borodina T, Amstislavskiy V, Worth CL, Schweiger C, Liebs S, Lange M, Warnatz HJ, Butcher LM, Barrett JE, Sultan M, Wierling C, Golob-Schwarzl N, Lax S, Uranitsch S, Becker M, Welte Y, Regan JL, Silvestrov M, Kehler I, Fusi A, Kessler T, Herwig R, Landegren U, Wienke D, Nilsson M, Velasco JA, Garin-Chesa P, Reinhard C, Beck S, Sch\u00e4fer R, Regenbrecht CR, Henderson D, Lange B, Haybaeck J, Keilholz U, Hoffmann J, Lehrach H, Yaspo ML. Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors. Nat Commun. PMID: 28186126", "BibTeX": "@article{28186126, title={Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.}, author={Sch\u00fctte M and Risch T and Abdavi-Azar N and Boehnke K and Schumacher D and Keil M and Yildiriman R and Jandrasits C and Borodina T and Amstislavskiy V and Worth CL and Schweiger C and Liebs S and Lange M and Warnatz HJ and Butcher LM and Barrett JE and Sultan M and Wierling C and Golob-Schwarzl N and Lax S and Uranitsch S and Becker M and Welte Y and Regan JL and Silvestrov M and Kehler I and Fusi A and Kessler T and Herwig R and Landegren U and Wienke D and Nilsson M and Velasco JA and Garin-Chesa P and Reinhard C and Beck S and Sch\u00e4fer R and Regenbrecht CR and Henderson D and Lange B and Haybaeck J and Keilholz U and Hoffmann J and Lehrach H and Yaspo ML}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 30811471, "pmcid": "PMC6392303", "title": "Integrated routine workflow using next-generation sequencing and a fully-automated platform for the detection of KRAS, NRAS and BRAF mutations in formalin-fixed paraffin embedded samples with poor DNA quality in patients with colorectal carcinoma.", "journal": "PLoS One", "authors": ["Franczak C", "Dubouis L", "Gilson P", "Husson M", "Rouyer M", "Demange J", "Leroux A", "Merlin JL", "Harl\u00e9 A"], "date": "2019-02-27T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Franczak C, Dubouis L, Gilson P, Husson M, Rouyer M, Demange J, Leroux A, Merlin JL, Harl\u00e9 A. Integrated routine workflow using next-generation sequencing and a fully-automated platform for the detection of KRAS, NRAS and BRAF mutations in formalin-fixed paraffin embedded samples with poor DNA quality in patients with colorectal carcinoma. PLoS One. PMID: 30811471", "BibTeX": "@article{30811471, title={Integrated routine workflow using next-generation sequencing and a fully-automated platform for the detection of KRAS, NRAS and BRAF mutations in formalin-fixed paraffin embedded samples with poor DNA quality in patients with colorectal carcinoma.}, author={Franczak C and Dubouis L and Gilson P and Husson M and Rouyer M and Demange J and Leroux A and Merlin JL and Harl\u00e9 A}, journal={PLoS One}}"}, "is_sup_mat_match": true}, {"pmid": 29416733, "pmcid": "PMC5788601", "title": "Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas.", "journal": "Oncotarget", "authors": ["Gandolfi G", "Ragazzi M", "de Biase D", "Visani M", "Zanetti E", "Torricelli F", "Sancisi V", "Gugnoni M", "Manzotti G", "Braglia L", "Cavuto S", "Merlo DF", "Tallini G", "Frasoldati A", "Piana S", "Ciarrocchi A"], "date": "2017-12-01T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Gandolfi G, Ragazzi M, de Biase D, Visani M, Zanetti E, Torricelli F, Sancisi V, Gugnoni M, Manzotti G, Braglia L, Cavuto S, Merlo DF, Tallini G, Frasoldati A, Piana S, Ciarrocchi A. Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas. Oncotarget. PMID: 29416733", "BibTeX": "@article{29416733, title={Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas.}, author={Gandolfi G and Ragazzi M and de Biase D and Visani M and Zanetti E and Torricelli F and Sancisi V and Gugnoni M and Manzotti G and Braglia L and Cavuto S and Merlo DF and Tallini G and Frasoldati A and Piana S and Ciarrocchi A}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 27590521, "pmcid": "PMC5325426", "title": "Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.", "journal": "Oncotarget", "authors": ["Lindqvist CM", "Lundmark A", "Nordlund J", "Freyhult E", "Ekman D", "Carlsson Alml\u00f6f J", "Raine A", "\u00d6vern\u00e4s E", "Abrahamsson J", "Frost BM", "Grand\u00e9r D", "Heyman M", "Palle J", "Forestier E", "L\u00f6nnerholm G", "Berglund EC", "Syv\u00e4nen AC"], "date": "2016-09-27T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Lindqvist CM, Lundmark A, Nordlund J, Freyhult E, Ekman D, Carlsson Alml\u00f6f J, Raine A, \u00d6vern\u00e4s E, Abrahamsson J, Frost BM, Grand\u00e9r D, Heyman M, Palle J, Forestier E, L\u00f6nnerholm G, Berglund EC, Syv\u00e4nen AC. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes. Oncotarget. PMID: 27590521", "BibTeX": "@article{27590521, title={Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.}, author={Lindqvist CM and Lundmark A and Nordlund J and Freyhult E and Ekman D and Carlsson Alml\u00f6f J and Raine A and \u00d6vern\u00e4s E and Abrahamsson J and Frost BM and Grand\u00e9r D and Heyman M and Palle J and Forestier E and L\u00f6nnerholm G and Berglund EC and Syv\u00e4nen AC}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 29123093, "pmcid": "PMC5680209", "title": "Prevalence and detection of low-allele-fraction variants in clinical cancer samples.", "journal": "Nat Commun", "authors": ["Shin HT", "Choi YL", "Yun JW", "Kim NKD", "Kim SY", "Jeon HJ", "Nam JY", "Lee C", "Ryu D", "Kim SC", "Park K", "Lee E", "Bae JS", "Son DS", "Joung JG", "Lee J", "Kim ST", "Ahn MJ", "Lee SH", "Ahn JS", "Lee WY", "Oh BY", "Park YH", "Lee JE", "Lee KH", "Kim HC", "Kim KM", "Im YH", "Park K", "Park PJ", "Park WY"], "date": "2017-11-09T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Shin HT, Choi YL, Yun JW, Kim NKD, Kim SY, Jeon HJ, Nam JY, Lee C, Ryu D, Kim SC, Park K, Lee E, Bae JS, Son DS, Joung JG, Lee J, Kim ST, Ahn MJ, Lee SH, Ahn JS, Lee WY, Oh BY, Park YH, Lee JE, Lee KH, Kim HC, Kim KM, Im YH, Park K, Park PJ, Park WY. Prevalence and detection of low-allele-fraction variants in clinical cancer samples. Nat Commun. PMID: 29123093", "BibTeX": "@article{29123093, title={Prevalence and detection of low-allele-fraction variants in clinical cancer samples.}, author={Shin HT and Choi YL and Yun JW and Kim NKD and Kim SY and Jeon HJ and Nam JY and Lee C and Ryu D and Kim SC and Park K and Lee E and Bae JS and Son DS and Joung JG and Lee J and Kim ST and Ahn MJ and Lee SH and Ahn JS and Lee WY and Oh BY and Park YH and Lee JE and Lee KH and Kim HC and Kim KM and Im YH and Park K and Park PJ and Park WY}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 23700467, "pmcid": "PMC3660257", "title": "Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing.", "journal": "PLoS One", "authors": ["Han SW", "Kim HP", "Shin JY", "Jeong EG", "Lee WC", "Lee KH", "Won JK", "Kim TY", "Oh DY", "Im SA", "Bang YJ", "Jeong SY", "Park KJ", "Park JG", "Kang GH", "Seo JS", "Kim JI", "Kim TY"], "date": "2013-05-21T00:00:00Z", "year": 2013, "snippets": [], "citations": {"NLM": "Han SW, Kim HP, Shin JY, Jeong EG, Lee WC, Lee KH, Won JK, Kim TY, Oh DY, Im SA, Bang YJ, Jeong SY, Park KJ, Park JG, Kang GH, Seo JS, Kim JI, Kim TY. Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing. PLoS One. PMID: 23700467", "BibTeX": "@article{23700467, title={Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing.}, author={Han SW and Kim HP and Shin JY and Jeong EG and Lee WC and Lee KH and Won JK and Kim TY and Oh DY and Im SA and Bang YJ and Jeong SY and Park KJ and Park JG and Kang GH and Seo JS and Kim JI and Kim TY}, journal={PLoS One}}"}, "is_sup_mat_match": true}, {"pmid": 33066758, "pmcid": "PMC7566057", "title": "Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients.", "journal": "BMC Cancer", "authors": ["Xu X", "Yu Y", "Shen M", "Liu M", "Wu S", "Liang L", "Huang F", "Zhang C", "Guo W", "Liu T"], "date": "2020-10-16T00:00:00Z", "year": 2020, "snippets": [{"_id": "33066758@13182", "snip_text": "Gene Exon Mutational hotspots No. (%) (N = 57)   KRAS 2 G12D 10 (17.5)   G12V 10 (17.5)   G13D 5 (8.8)   G12A 4 (7.0)   G12S 3 (5.3)   G12C 2 (3.5)   G13C 1 (1.8)   G13V 1 (1.8)   V14I + G12A 1 (1.8)   3 Q61H 4 (7.0)   4 A146T 4 (7.0)   K117N 1 (1.8)   K117R 1 (1.8)   NRAS 3 Q61K 1 (1.8)   PIK3CA 9 E545K 5 (8.8)   E542K 3 (5.3)   T544I 1 (1.8)   D549N 1 (1.8)   Q546K 1 (1.8)   Q546P 1 (1.8)   E545G 1 (1.8)   20 H1047R 2 (3.5)   H1047Y 1 (1.8)   BRAF 15 V600E 3 (5.3)   K601E 1 (1.8)   ", "section": "table", "mentions": ["90|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "300|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "276|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "120|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "457|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "150|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "415|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "473|5|variant|litvar@rs121913364##&&&litvar@#673#&&&litvar@CA123645#rs121913364##|K601E", "56|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "49|4|gene|ncbi_gene@3845|KRAS", "187|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "291|6|gene|ncbi_gene@5290|PIK3CA", "253|5|variant|litvar@#3845#p.K117R&&&litvar@#3845#|K117R", "180|4|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|V14I", "237|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "221|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "449|4|gene|ncbi_gene@673|BRAF", "204|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "135|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "73|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "432|6|variant|litvar@rs121913281##&&&litvar@#5290#&&&litvar@CA130471#rs121913281##|H1047Y", "105|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "396|5|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123336#rs121913274##|E545G", "316|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "364|5|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123338#rs121913286##|Q546K", "380|5|variant|litvar@rs397517201##&&&litvar@#5290#|Q546P", "165|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "348|5|variant|litvar@rs1057519699##&&&litvar@#5290#|D549N", "332|5|variant|litvar@#5290#p.T544I&&&litvar@#5290#|T544I"], "figure_id": "Tab3", "text_hl": "Gene Exon Mutational hotspots No. (%) (N = 57)   KRAS 2 G12D 10 (17.5)   G12V 10 (17.5)   G13D 5 (8.8)   G12A 4 (7.0)   G12S 3 (5.3)   G12C 2 (3.5)   G13C 1 (1.8)   G13V 1 (1.8)   V14I + G12A 1 (1.8)   3 Q61H 4 (7.0)   4 <m>A146T</m> 4 (7.0)   K117N 1 (1.8)   K117R 1 (1.8)   NRAS 3 Q61K 1 (1.8)   PIK3CA 9 E545K 5 (8.8)   E542K 3 (5.3)   T544I 1 (1.8)   D549N 1 (1.8)   Q546K 1 (1.8)   Q546P 1 (1.8)   E545G 1 (1.8)   20 H1047R 2 (3.5)   H1047Y 1 (1.8)   BRAF 15 V600E 3 (5.3)   K601E 1 (1.8)   "}], "citations": {"NLM": "Xu X, Yu Y, Shen M, Liu M, Wu S, Liang L, Huang F, Zhang C, Guo W, Liu T. Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients. BMC Cancer. PMID: 33066758", "BibTeX": "@article{33066758, title={Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients.}, author={Xu X and Yu Y and Shen M and Liu M and Wu S and Liang L and Huang F and Zhang C and Guo W and Liu T}, journal={BMC Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 36675180, "pmcid": "PMC9863259", "title": "Selective Eradication of Colon Cancer Cells Harboring PI3K and/or MAPK Pathway Mutations in 3D Culture by Combined PI3K/AKT/mTOR Pathway and MEK Inhibition.", "journal": "Int J Mol Sci", "authors": ["Atanasova VS", "Riedl A", "Strobl M", "Flandorfer J", "Unterleuthner D", "Weindorfer C", "Neuhold P", "Stang S", "Hengstschl\u00e4ger M", "Bergmann M", "Dolznig H"], "date": "2023-01-14T00:00:00Z", "year": 2023, "snippets": [{"_id": "36675180@27628", "snip_text": "Interestingly, the KRAS mutations are the same in both patients (Ala146Thr).", "section": "discussion", "mentions": ["19|4|gene|ncbi_gene@3845|KRAS", "65|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|Ala146Thr", "55|8|species|ncbi_taxonomy@9606|patients"], "text_hl": "Interestingly, the KRAS mutations are the same in both patients (<m>Ala146Thr</m>)."}], "citations": {"NLM": "Atanasova VS, Riedl A, Strobl M, Flandorfer J, Unterleuthner D, Weindorfer C, Neuhold P, Stang S, Hengstschl\u00e4ger M, Bergmann M, Dolznig H. Selective Eradication of Colon Cancer Cells Harboring PI3K and/or MAPK Pathway Mutations in 3D Culture by Combined PI3K/AKT/mTOR Pathway and MEK Inhibition. Int J Mol Sci. PMID: 36675180", "BibTeX": "@article{36675180, title={Selective Eradication of Colon Cancer Cells Harboring PI3K and/or MAPK Pathway Mutations in 3D Culture by Combined PI3K/AKT/mTOR Pathway and MEK Inhibition.}, author={Atanasova VS and Riedl A and Strobl M and Flandorfer J and Unterleuthner D and Weindorfer C and Neuhold P and Stang S and Hengstschl\u00e4ger M and Bergmann M and Dolznig H}, journal={Int J Mol Sci}}"}, "is_sup_mat_match": false}, {"pmid": 26214590, "pmcid": "PMC4916843", "title": "Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas", "journal": "Nat Genet", "authors": ["Krauthammer M", "Kong Y", "Bacchiocchi A", "Evans P", "Pornputtapong N", "Wu C", "McCusker JP", "Ma S", "Cheng E", "Straub R", "Serin M", "Bosenberg M", "Ariyan S", "Narayan D", "Sznol M", "Kluger HM", "Mane S", "Schlessinger J", "Lifton RP", "Halaban R"], "date": "2015-09-01T00:00:00Z", "year": 2015, "snippets": [{"_id": "26214590@11330", "snip_text": "Finally, two NF1-mutant melanomas (YUROG NF1Q1218* and YUCAS NF1FS-Indel) contained KRASA146T and KRASQ22K, respectively, known activating mutations in colorectal cancer.", "section": "results", "mentions": ["24|9|disease|ncbi_mesh@D008545|melanomas", "152|17|disease|ncbi_mesh@D015179|colorectal cancer", "84|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T", "13|3|gene|ncbi_gene@4763|NF1"], "text_hl": "Finally, two NF1-mutant melanomas (YUROG NF1Q1218* and YUCAS NF1FS-Indel) contained KRASA146T and KRASQ22K, respectively, known activating mutations in colorectal cancer."}], "citations": {"NLM": "Krauthammer M, Kong Y, Bacchiocchi A, Evans P, Pornputtapong N, Wu C, McCusker JP, Ma S, Cheng E, Straub R, Serin M, Bosenberg M, Ariyan S, Narayan D, Sznol M, Kluger HM, Mane S, Schlessinger J, Lifton RP, Halaban R. Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas Nat Genet. PMID: 26214590", "BibTeX": "@article{26214590, title={Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas}, author={Krauthammer M and Kong Y and Bacchiocchi A and Evans P and Pornputtapong N and Wu C and McCusker JP and Ma S and Cheng E and Straub R and Serin M and Bosenberg M and Ariyan S and Narayan D and Sznol M and Kluger HM and Mane S and Schlessinger J and Lifton RP and Halaban R}, journal={Nat Genet}}"}, "is_sup_mat_match": false}, {"pmid": 35046095, "pmcid": "PMC9394389", "title": "Expanding the Reach of Precision Oncology by Drugging All KRAS Mutants.", "journal": "Cancer Discov", "authors": ["Hofmann MH", "Gerlach D", "Misale S", "Petronczki M", "Kraut N"], "date": "2022-01-19T00:00:00Z", "year": 2022, "snippets": [{"_id": "35046095@36193", "snip_text": "Based on their distinct structural properties that impinge on signaling, particular attention needs to be given to special KRAS mutants, such as KRAS G12R (the third most predominant alteration in PDAC), A146T (especially in CRC), and Q61H mutations.", "section": "introduction", "mentions": ["197|4|disease|ncbi_mesh@D010190|PDAC", "150|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "145|4|gene|ncbi_gene@3845|KRAS", "235|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "204|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "225|3|disease|ncbi_mesh@D015179|CRC", "123|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "Based on their distinct structural properties that impinge on signaling, particular attention needs to be given to special KRAS mutants, such as KRAS G12R (the third most predominant alteration in PDAC), <m>A146T</m> (especially in CRC), and Q61H mutations."}], "citations": {"NLM": "Hofmann MH, Gerlach D, Misale S, Petronczki M, Kraut N. Expanding the Reach of Precision Oncology by Drugging All KRAS Mutants. Cancer Discov. PMID: 35046095", "BibTeX": "@article{35046095, title={Expanding the Reach of Precision Oncology by Drugging All KRAS Mutants.}, author={Hofmann MH and Gerlach D and Misale S and Petronczki M and Kraut N}, journal={Cancer Discov}}"}, "is_sup_mat_match": false}, {"pmid": 34015890, "pmcid": "PMC8756135", "title": "Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations.", "journal": "Cancer Res Treat", "authors": ["Choi YJ", "Choi JY", "Kim JW", "Lim AR", "Lee Y", "Chang WJ", "Lee S", "Sung JS", "Chung HJ", "Lee JW", "Kang EJ", "Kim JS", "Lim T", "Kim HS", "Kim YJ", "Ahn MS", "Kim YS", "Park JH", "Lim S", "Cho SS", "Cho JH", "Shin SW", "Park KH", "Kim YH"], "date": "2021-05-20T00:00:00Z", "year": 2021, "snippets": [{"_id": "34015890@11735", "snip_text": "Of the 25 cases where the KRAS mutation was detected in NGS but not in the orthogonal analysis, five showed uncommon codon sites that were not well covered by orthogonal PCR (three A146T, one codon 38, and one codon 184), one G12V, six G12D, three G13C, nine G13D, and one G13R.", "section": "results", "mentions": ["273|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "248|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "259|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "236|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "26|4|gene|ncbi_gene@3845|KRAS", "226|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "181|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Of the 25 cases where the KRAS mutation was detected in NGS but not in the orthogonal analysis, five showed uncommon codon sites that were not well covered by orthogonal PCR (three <m>A146T</m>, one codon 38, and one codon 184), one G12V, six G12D, three G13C, nine G13D, and one G13R."}], "citations": {"NLM": "Choi YJ, Choi JY, Kim JW, Lim AR, Lee Y, Chang WJ, Lee S, Sung JS, Chung HJ, Lee JW, Kang EJ, Kim JS, Lim T, Kim HS, Kim YJ, Ahn MS, Kim YS, Park JH, Lim S, Cho SS, Cho JH, Shin SW, Park KH, Kim YH. Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations. Cancer Res Treat. PMID: 34015890", "BibTeX": "@article{34015890, title={Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations.}, author={Choi YJ and Choi JY and Kim JW and Lim AR and Lee Y and Chang WJ and Lee S and Sung JS and Chung HJ and Lee JW and Kang EJ and Kim JS and Lim T and Kim HS and Kim YJ and Ahn MS and Kim YS and Park JH and Lim S and Cho SS and Cho JH and Shin SW and Park KH and Kim YH}, journal={Cancer Res Treat}}"}, "is_sup_mat_match": false}, {"pmid": 34525976, "pmcid": "PMC8442437", "title": "Infrequent RAS mutation is not associated with specific histological phenotype in gliomas.", "journal": "BMC Cancer", "authors": ["Makino Y", "Arakawa Y", "Yoshioka E", "Shofuda T", "Minamiguchi S", "Kawauchi T", "Tanji M", "Kanematsu D", "Nonaka M", "Okita Y", "Kodama Y", "Mano M", "Hirose T", "Mineharu Y", "Miyamoto S", "Kanemura Y"], "date": "2021-09-15T00:00:00Z", "year": 2021, "snippets": [{"_id": "34525976@21593", "snip_text": "Author (publish year) Target of the study Age Sex Histology RAS mutation Other mutations   Maltzman (1997)  46 brain tumors 5 F fibrillary astrocytoma NRAS Q61E     12 F fibrillary astrocytoma NRAS Q61E     4 F pilocytic astrocytoma NRAS Q61E    Knobbe (2004)  94 glioblastomas NA NA glioblastoma NRAS G12D     NA NA gliosarcoma NRAS G12D    Janzarik (2007)  25 astrocytoma NA NA pilocytic astrocytoma KRAS G12A    Jeuken (2007)  93 gliomas NA NA anaplastic oligodendroglioma NRAS G10E    Schiffman(2010)  41 astrocytomas 14 NA glioblastoma KRAS G12V    Cin(2011)  125 pilocytic astrocytomas 11 NA Pilocytic astrocytoma KRAS E63K     1 NA Pilocytic astrocytoma KRAS G12A    Chi (2012)  218 gliomas NA NA glioblastoma KRAS G61R     NA NA glioblastoma with oligodendroglioma component KRAS G12A IDH1 R132H    NA NA glioblastoma KRAS G12C    Theeler (2014) 40 pilocytic astrocytoma 18 M pilocytic astrocytoma NRAS G12D     25 M pilocytic astrocytoma NRAS G12D     34 M pilocytic astrocytoma NRAS G12D     46 M pilocytic astrocytoma KRAS G12S BRAF-KIAA 1549 fusion   Milinkovic (2014) 5 cerebellar glioblastomas 42 M glioblastoma KRAS c.7_8insT, HRAS T4H TP53 R273P    41 M glioblastoma KRAS c.7_8insT, HRAS T4H TP53 exon9 deletion, G298D(second surgery)    64 M glioblastoma HRAS T4H     36 M glioblastoma KRAS c.177_178insA, HRAS T4H TP53 C176R    49 M glioblastoma HRAS exon2 insertion    Wakimoto (2014)  20 gliomas. IDH-mutant 60 M oligoastrocytoma KRAS G12R IDH1 R132H, AKT1 E17K, PIK3CA H1047L, 1p/19q codeletion    41 F astrocytoma KRAS G13D IDH1 R132H, 1p/19q codeletion    33 F oligodendroglioma KRAS G13R IDH1 R132H, 1p/19q codeletion    54 M glioblastoma with oligodendroglioma component KRAS G12A IDH1 R132H, 1p/19q codeletion   Samel (2016)  case report 44 F glioblastoma (high grade area) KRAS exon2 EGFR exon18, BRAF exon15, TP53(IHC expression)   Ballester (2017)  381 diffuse gliomas NA NA anaplastic oligodendroglioma KRAS G60S IDH1R132H, CDKN2A P75L, JAK3 G712D, MPL A519T    NA NA anaplastic oligodendroglioma KRAS G12D     NA NA glioblastoma KRAS G12A IDH1 R132H, TP53 Q104*    NA NA glioblastoma KRAS A146T IDH1 R132H, CDKN2A R58, KIT A814V, PIK3CA E545K, TP53 G245S    NA NA glioblastoma NRAS Q61K TP53 E180K    NA NA glioblastoma NRAS Q61K     NA NA oligodendroglioma NRAS G12C IDH1 R132H   Pekmezci (2018)  40 gangliogliomas 32 F ganglioglioma KRAS Q61K     24 M ganglioglioma KRAS Q61K    Reinhardt (2018) 64 anaplastic pilocytic astrocytomas NA F anaplastic pilocytic astrocytoma KRAS Q61H MAPK alteration, CDKN2A/B deletion/mutation, ATRX loss/mutation, MGMTp methylation    NA F anaplastic pilocytic astrocytoma KRAS V14A MAPK alteration, CDKN2A/B deletion/mutation, ATRX loss/mutation, MGMTp methylation   Chau (2019)  case report 24 F pilocytic astrocytoma KRAS E63K RAD1 F475L, NOTCH3 S502F, JAK1 c.6 + 1G > T   Shittenhelm (2019)  186 gliomas 51 M oligodendroglioma KRAS G12R IDH1 mutant, 1p/19q codeletion, TERTp    48 F oligodendroglioma KRAS G12C IDH1 mutant, 1p/19q codeletion, TERTp    39 F glioblastoma KRAS Q61L TERTp mutation   Zou (2019)  13 pleomorphic xanthoastrocytomas 50 M pleomorphic xanthoastrocytoma KRAS Q61H NOTCH2 R2298W, MEN1 G219, CHEK1 P318A, PARP4 L482F, FANC1 L1253V, FANCA Q1437K, TP53 R248Q, NOTCH3 R1666W, CCNE1 I298, NOTCH1 N454    29 F pleomorphic xanthoastrocytoma KRAS Q61K    ", "section": "table", "mentions": ["2579|5|gene|ncbi_gene@4255|MGMTp", "362|11|disease|ncbi_mesh@D001254|astrocytoma", "798|5|variant|litvar@rs121913500##&&&litvar@#3417#&&&litvar@CA170874#rs121913500##|R132H", "1706|4|gene|ncbi_gene@3417|IDH1", "1183|4|gene|ncbi_gene@3845|KRAS", "1351|12|disease|ncbi_mesh@D005909|glioblastoma", "1408|7|disease|ncbi_mesh@D005910|gliomas", "3331|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "2304|5|variant|litvar@rs121913500##&&&litvar@#3417#&&&litvar@CA170874#rs121913500##|R132H", "3147|4|gene|ncbi_gene@3845|KRAS", "329|4|gene|ncbi_gene@4893|NRAS", "233|4|gene|ncbi_gene@4893|NRAS", "788|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "481|4|variant|litvar@#4893#p.G10E&&&litvar@#4893#|G10E", "476|4|gene|ncbi_gene@4893|NRAS", "2150|3|gene|ncbi_gene@3815|KIT", "925|21|disease|ncbi_mesh@D001254|pilocytic astrocytoma", "1113|12|disease|ncbi_mesh@D005909|glioblastoma", "151|4|gene|ncbi_gene@4893|NRAS", "2952|17|disease|ncbi_mesh@D009837|oligodendroglioma", "3117|29|disease|ncbi_mesh@D001254|pleomorphic xanthoastrocytoma", "2531|6|gene|ncbi_gene@1029|CDKN2A", "3196|5|gene|ncbi_gene@143|PARP4", "1007|21|disease|ncbi_mesh@D001254|pilocytic astrocytoma", "3012|5|gene|ncbi_gene@7015|TERTp", "3223|5|gene|ncbi_gene@2175|FANCA", "1303|4|gene|ncbi_gene@3845|KRAS", "1308|13|variant|litvar@#3845#c.177_178insA&&&litvar@#3845#|c.177_178insA", "1490|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|H1047L", "181|11|disease|ncbi_mesh@D001254|astrocytoma", "1904|28|disease|ncbi_mesh@D009837|anaplastic oligodendroglioma", "1460|4|gene|ncbi_gene@3417|IDH1", "666|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "1668|17|disease|ncbi_mesh@D009837|oligodendroglioma", "2906|4|gene|ncbi_gene@3417|IDH1", "1800|4|gene|ncbi_gene@3845|KRAS", "2616|21|disease|ncbi_mesh@D001254|pilocytic astrocytoma", "1126|4|gene|ncbi_gene@3845|KRAS", "284|12|disease|ncbi_mesh@D005909|glioblastoma", "1998|28|disease|ncbi_mesh@D009837|anaplastic oligodendroglioma", "947|4|gene|ncbi_gene@4893|NRAS", "906|4|gene|ncbi_gene@4893|NRAS", "3237|4|gene|ncbi_gene@7157|TP53", "433|7|disease|ncbi_mesh@D005910|gliomas", "1039|4|gene|ncbi_gene@673|BRAF", "1094|13|disease|ncbi_mesh@D005909|glioblastomas", "598|21|disease|ncbi_mesh@D001254|Pilocytic astrocytoma", "2821|4|gene|ncbi_gene@3716|JAK1", "3270|4|variant|litvar@#898#|I298", "2027|4|gene|ncbi_gene@3845|KRAS", "2082|4|gene|ncbi_gene@7157|TP53", "2509|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "911|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2180|5|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|G245S", "2800|5|variant|litvar@rs959926480##&&&litvar@#5290#|F475L", "2294|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "302|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2289|4|gene|ncbi_gene@4893|NRAS", "297|4|gene|ncbi_gene@4893|NRAS", "1131|9|variant|litvar@#3845#c.7_8insT&&&litvar@#3845#|c.7_8insT", "1524|11|disease|ncbi_mesh@D001254|astrocytoma", "2638|4|gene|ncbi_gene@3845|KRAS", "3264|5|gene|ncbi_gene@898|CCNE1", "2115|4|gene|ncbi_gene@3845|KRAS", "1947|5|variant|litvar@rs121913500##&&&litvar@#3417#&&&litvar@CA170874#rs121913500##|R132H", "334|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "3152|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "2175|4|gene|ncbi_gene@7157|TP53", "238|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA16602362#rs121913254##|Q61E", "793|4|gene|ncbi_gene@3417|IDH1", "1584|17|disease|ncbi_mesh@D009837|oligodendroglioma", "2795|4|gene|ncbi_gene@5810|RAD1", "966|21|disease|ncbi_mesh@D001254|pilocytic astrocytoma", "2665|6|gene|ncbi_gene@1029|CDKN2A", "546|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "2154|5|variant|litvar@rs763666690##&&&litvar@#1956#&&&litvar@CA4266115#rs763666690##|A814V", "2299|4|gene|ncbi_gene@3417|IDH1", "2131|5|variant|litvar@rs121913500##&&&litvar@#3417#&&&litvar@CA170874#rs121913500##|R132H", "156|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA16602362#rs121913254##|Q61E", "2208|4|gene|ncbi_gene@4893|NRAS", "2223|5|variant|litvar@rs17882252##&&&litvar@#7157#&&&litvar@CA17#rs17882252##|E180K", "3276|6|gene|ncbi_gene@4851|NOTCH1", "1954|6|gene|ncbi_gene@1029|CDKN2A", "2975|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "380|21|disease|ncbi_mesh@D001254|pilocytic astrocytoma", "690|7|disease|ncbi_mesh@D005910|gliomas", "2047|12|disease|ncbi_mesh@D005909|glioblastoma", "2102|12|disease|ncbi_mesh@D005909|glioblastoma", "1961|4|variant|litvar@rs772411700##&&&litvar@#1029#&&&litvar@CA5012201#rs772411700##|P75L", "2138|6|gene|ncbi_gene@1029|CDKN2A", "509|12|disease|ncbi_mesh@D001254|astrocytomas", "755|17|disease|ncbi_mesh@D009837|oligodendroglioma", "1323|4|gene|ncbi_gene@3265|HRAS", "3202|5|variant|litvar@rs573731097##&&&litvar@#3718#&&&litvar@CA306136462#rs573731097##|L482F", "1837|4|gene|ncbi_gene@7157|TP53", "2443|22|disease|ncbi_mesh@D001254|pilocytic astrocytomas", "1979|3|gene|ncbi_gene@4352|MPL", "952|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2366|4|gene|ncbi_gene@3845|KRAS", "813|12|disease|ncbi_mesh@D005909|glioblastoma", "1536|4|gene|ncbi_gene@3845|KRAS", "111|12|disease|ncbi_mesh@D001932|brain tumors", "1551|5|variant|litvar@rs121913500##&&&litvar@#3417#&&&litvar@CA170874#rs121913500##|R132H", "447|28|disease|ncbi_mesh@D009837|anaplastic oligodendroglioma", "1472|4|gene|ncbi_gene@207|AKT1", "1811|4|gene|ncbi_gene@1956|EGFR", "2120|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "407|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "2195|12|disease|ncbi_mesh@D005909|glioblastoma", "2399|4|gene|ncbi_gene@3845|KRAS", "2032|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2713|5|gene|ncbi_gene@4255|MGMTp", "2878|17|disease|ncbi_mesh@D009837|oligodendroglioma", "3026|12|disease|ncbi_mesh@D005909|glioblastoma", "1142|4|gene|ncbi_gene@3265|HRAS", "3215|6|variant|litvar@#2175#p.L1253V&&&litvar@#2175#|L1253V", "1546|4|gene|ncbi_gene@3417|IDH1", "3081|30|disease|ncbi_mesh@D001254|pleomorphic xanthoastrocytomas", "1769|12|disease|ncbi_mesh@D005909|glioblastoma", "1450|4|gene|ncbi_gene@3845|KRAS", "1337|5|variant|litvar@rs967461896##&&&litvar@#7157#|C176R", "2643|4|variant|litvar@rs1057519747##&&&litvar@#7157#|V14A", "2065|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "193|4|gene|ncbi_gene@4893|NRAS", "2790|4|variant|litvar@rs121917756##&&&litvar@#3265#&&&litvar@CA122551#rs121917756##|E63K", "1602|4|gene|ncbi_gene@3845|KRAS", "139|11|disease|ncbi_mesh@D001254|astrocytoma", "1617|5|variant|litvar@rs121913500##&&&litvar@#3417#&&&litvar@CA170874#rs121913500##|R132H", "3049|5|gene|ncbi_gene@7015|TERTp", "3242|5|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|R248Q", "857|21|disease|ncbi_mesh@D001254|pilocytic astrocytoma", "3183|5|gene|ncbi_gene@1111|CHEK1", "1208|4|gene|ncbi_gene@7157|TP53", "2213|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "831|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "3039|4|gene|ncbi_gene@3845|KRAS", "198|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA16602362#rs121913254##|Q61E", "625|4|variant|litvar@rs121917756##&&&litvar@#3265#&&&litvar@CA122551#rs121917756##|E63K", "1933|4|gene|ncbi_gene@3845|KRAS", "2980|4|gene|ncbi_gene@3417|IDH1", "988|4|gene|ncbi_gene@4893|NRAS", "717|4|gene|ncbi_gene@3845|KRAS", "1938|4|variant|litvar@rs104894359##&&&litvar@#3845#&&&litvar@CA256484#rs104894359##|G60S", "1199|4|gene|ncbi_gene@3265|HRAS", "3157|6|gene|ncbi_gene@4853|NOTCH2", "3249|6|gene|ncbi_gene@4854|NOTCH3", "211|21|disease|ncbi_mesh@D001254|pilocytic astrocytoma", "2865|7|disease|ncbi_mesh@D005910|gliomas", "1701|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "1967|4|gene|ncbi_gene@3718|JAK3", "3326|4|gene|ncbi_gene@3845|KRAS", "1156|5|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA10580917#rs28934576##|R273P", "2271|17|disease|ncbi_mesh@D009837|oligodendroglioma", "2371|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "2938|5|gene|ncbi_gene@7015|TERTp", "704|12|disease|ncbi_mesh@D005909|glioblastoma", "1259|12|disease|ncbi_mesh@D005909|glioblastoma", "639|21|disease|ncbi_mesh@D001254|Pilocytic astrocytoma", "1983|5|variant|litvar@rs1326565450##&&&litvar@#3815#|A519T", "3164|6|variant|litvar@rs1270274564##&&&litvar@#4853#|R2298W", "1151|4|gene|ncbi_gene@7157|TP53", "3229|6|variant|litvar@#2175#p.Q1437K&&&litvar@#2175#|Q1437K", "2404|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "2814|5|variant|litvar@rs778571943##&&&litvar@#4854#&&&litvar@CA9263615#rs778571943##|S502F", "1465|5|variant|litvar@rs121913500##&&&litvar@#3417#&&&litvar@CA170874#rs121913500##|R132H", "2075|5|variant|litvar@rs121913500##&&&litvar@#3417#&&&litvar@CA170874#rs121913500##|R132H", "2807|6|gene|ncbi_gene@4854|NOTCH3", "3256|6|variant|litvar@rs1379085406##&&&litvar@#4854#|R1666W", "317|11|disease|ncbi_mesh@D018316|gliosarcoma", "1541|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "737|12|disease|ncbi_mesh@D005909|glioblastoma", "3296|29|disease|ncbi_mesh@D001254|pleomorphic xanthoastrocytoma", "1455|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "1417|3|gene|ncbi_gene@3417|IDH", "569|22|disease|ncbi_mesh@D001254|pilocytic astrocytomas", "2070|4|gene|ncbi_gene@3417|IDH1", "1650|12|disease|ncbi_mesh@D005909|glioblastoma", "884|21|disease|ncbi_mesh@D001254|pilocytic astrocytoma", "2238|12|disease|ncbi_mesh@D005909|glioblastoma", "2896|4|gene|ncbi_gene@3845|KRAS", "2168|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "2901|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "2161|6|gene|ncbi_gene@5290|PIK3CA", "1607|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "3172|4|gene|ncbi_gene@4221|MEN1", "1029|4|gene|ncbi_gene@3845|KRAS", "1272|4|gene|ncbi_gene@3265|HRAS", "2482|21|disease|ncbi_mesh@D001254|pilocytic astrocytoma", "1332|4|gene|ncbi_gene@7157|TP53", "1364|4|gene|ncbi_gene@3265|HRAS", "1170|12|disease|ncbi_mesh@D005909|glioblastoma", "2218|4|gene|ncbi_gene@7157|TP53", "3044|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "1188|9|variant|litvar@#3845#c.7_8insT&&&litvar@#3845#|c.7_8insT", "1972|5|variant|litvar@#3718#p.G712D&&&litvar@#3718#|G712D", "1612|4|gene|ncbi_gene@3417|IDH1", "1034|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "1433|16|disease|ncbi_mesh@D001254|oligoastrocytoma", "2126|4|gene|ncbi_gene@3417|IDH1", "993|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "722|4|variant|litvar@rs730880457##&&&litvar@#3265#|G61R", "528|12|disease|ncbi_mesh@D005909|glioblastoma", "2256|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "3189|5|variant|litvar@#1111#p.P318A&&&litvar@#1111#|P318A", "1824|4|gene|ncbi_gene@673|BRAF", "1229|5|variant|litvar@#898#p.G298D&&&litvar@#898#|G298D", "2251|4|gene|ncbi_gene@4893|NRAS", "1711|5|variant|litvar@rs121913500##&&&litvar@#3417#&&&litvar@CA170874#rs121913500##|R132H", "264|13|disease|ncbi_mesh@D005909|glioblastomas", "2763|21|disease|ncbi_mesh@D001254|pilocytic astrocytoma", "2832|6|variant|litvar@#3716#c.1G>T&&&litvar@#3716#|1G > T", "1483|6|gene|ncbi_gene@5290|PIK3CA", "2504|4|gene|ncbi_gene@3845|KRAS", "1882|15|disease|ncbi_mesh@D005910|diffuse gliomas", "1290|12|disease|ncbi_mesh@D005909|glioblastoma"], "figure_id": "Tab3", "text_hl": "Author (publish year) Target of the study Age Sex Histology RAS mutation Other mutations   Maltzman (1997)  46 brain tumors 5 F fibrillary astrocytoma NRAS Q61E     12 F fibrillary astrocytoma NRAS Q61E     4 F pilocytic astrocytoma NRAS Q61E    Knobbe (2004)  94 glioblastomas NA NA glioblastoma NRAS G12D     NA NA gliosarcoma NRAS G12D    Janzarik (2007)  25 astrocytoma NA NA pilocytic astrocytoma KRAS G12A    Jeuken (2007)  93 gliomas NA NA anaplastic oligodendroglioma NRAS G10E    Schiffman(2010)  41 astrocytomas 14 NA glioblastoma KRAS G12V    Cin(2011)  125 pilocytic astrocytomas 11 NA Pilocytic astrocytoma KRAS E63K     1 NA Pilocytic astrocytoma KRAS G12A    Chi (2012)  218 gliomas NA NA glioblastoma KRAS G61R     NA NA glioblastoma with oligodendroglioma component KRAS G12A IDH1 R132H    NA NA glioblastoma KRAS G12C    Theeler (2014) 40 pilocytic astrocytoma 18 M pilocytic astrocytoma NRAS G12D     25 M pilocytic astrocytoma NRAS G12D     34 M pilocytic astrocytoma NRAS G12D     46 M pilocytic astrocytoma KRAS G12S BRAF-KIAA 1549 fusion   Milinkovic (2014) 5 cerebellar glioblastomas 42 M glioblastoma KRAS c.7_8insT, HRAS T4H TP53 R273P    41 M glioblastoma KRAS c.7_8insT, HRAS T4H TP53 exon9 deletion, G298D(second surgery)    64 M glioblastoma HRAS T4H     36 M glioblastoma KRAS c.177_178insA, HRAS T4H TP53 C176R    49 M glioblastoma HRAS exon2 insertion    Wakimoto (2014)  20 gliomas. IDH-mutant 60 M oligoastrocytoma KRAS G12R IDH1 R132H, AKT1 E17K, PIK3CA H1047L, 1p/19q codeletion    41 F astrocytoma KRAS G13D IDH1 R132H, 1p/19q codeletion    33 F oligodendroglioma KRAS G13R IDH1 R132H, 1p/19q codeletion    54 M glioblastoma with oligodendroglioma component KRAS G12A IDH1 R132H, 1p/19q codeletion   Samel (2016)  case report 44 F glioblastoma (high grade area) KRAS exon2 EGFR exon18, BRAF exon15, TP53(IHC expression)   Ballester (2017)  381 diffuse gliomas NA NA anaplastic oligodendroglioma KRAS G60S IDH1R132H, CDKN2A P75L, JAK3 G712D, MPL A519T    NA NA anaplastic oligodendroglioma KRAS G12D     NA NA glioblastoma KRAS G12A IDH1 R132H, TP53 Q104*    NA NA glioblastoma KRAS <m>A146T</m> IDH1 R132H, CDKN2A R58, KIT A814V, PIK3CA E545K, TP53 G245S    NA NA glioblastoma NRAS Q61K TP53 E180K    NA NA glioblastoma NRAS Q61K     NA NA oligodendroglioma NRAS G12C IDH1 R132H   Pekmezci (2018)  40 gangliogliomas 32 F ganglioglioma KRAS Q61K     24 M ganglioglioma KRAS Q61K    Reinhardt (2018) 64 anaplastic pilocytic astrocytomas NA F anaplastic pilocytic astrocytoma KRAS Q61H MAPK alteration, CDKN2A/B deletion/mutation, ATRX loss/mutation, MGMTp methylation    NA F anaplastic pilocytic astrocytoma KRAS V14A MAPK alteration, CDKN2A/B deletion/mutation, ATRX loss/mutation, MGMTp methylation   Chau (2019)  case report 24 F pilocytic astrocytoma KRAS E63K RAD1 F475L, NOTCH3 S502F, JAK1 c.6 + 1G > T   Shittenhelm (2019)  186 gliomas 51 M oligodendroglioma KRAS G12R IDH1 mutant, 1p/19q codeletion, TERTp    48 F oligodendroglioma KRAS G12C IDH1 mutant, 1p/19q codeletion, TERTp    39 F glioblastoma KRAS Q61L TERTp mutation   Zou (2019)  13 pleomorphic xanthoastrocytomas 50 M pleomorphic xanthoastrocytoma KRAS Q61H NOTCH2 R2298W, MEN1 G219, CHEK1 P318A, PARP4 L482F, FANC1 L1253V, FANCA Q1437K, TP53 R248Q, NOTCH3 R1666W, CCNE1 I298, NOTCH1 N454    29 F pleomorphic xanthoastrocytoma KRAS Q61K    "}], "citations": {"NLM": "Makino Y, Arakawa Y, Yoshioka E, Shofuda T, Minamiguchi S, Kawauchi T, Tanji M, Kanematsu D, Nonaka M, Okita Y, Kodama Y, Mano M, Hirose T, Mineharu Y, Miyamoto S, Kanemura Y. Infrequent RAS mutation is not associated with specific histological phenotype in gliomas. BMC Cancer. PMID: 34525976", "BibTeX": "@article{34525976, title={Infrequent RAS mutation is not associated with specific histological phenotype in gliomas.}, author={Makino Y and Arakawa Y and Yoshioka E and Shofuda T and Minamiguchi S and Kawauchi T and Tanji M and Kanematsu D and Nonaka M and Okita Y and Kodama Y and Mano M and Hirose T and Mineharu Y and Miyamoto S and Kanemura Y}, journal={BMC Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 33087330, "pmcid": "PMC7785657", "title": "Expanded low allele frequency RAS and BRAF V600E testing in metastatic colorectal cancer as predictive biomarkers for cetuximab in the randomized CO.17 trial", "journal": "Clin Cancer Res", "authors": ["Loree JM", "Dowers A", "Tu D", "Jonker DJ", "Edelstein DL", "Quinn H", "Holtrup F", "Price T", "Zalcberg JR", "Moore MJ", "Karapetis CS", "O'Callaghan CJ", "Waring P", "Kennecke HF", "Hamilton SR", "Kopetz S"], "date": "2021-01-01T00:00:00Z", "year": 2021, "snippets": [{"_id": "33087330@13069", "snip_text": "In these six tumors, 3 KRAS (G12V, A59T, A59T) and 3 NRAS mutations (G13R, A146T, A59T) were identified.", "section": "results", "mentions": ["75|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "53|4|gene|ncbi_gene@4893|NRAS", "35|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "23|4|gene|ncbi_gene@3845|KRAS", "29|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "69|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "82|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "41|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "13|6|disease|ncbi_mesh@D009369|tumors"], "text_hl": "In these six tumors, 3 KRAS (G12V, A59T, A59T) and 3 NRAS mutations (G13R, <m>A146T</m>, A59T) were identified."}], "citations": {"NLM": "Loree JM, Dowers A, Tu D, Jonker DJ, Edelstein DL, Quinn H, Holtrup F, Price T, Zalcberg JR, Moore MJ, Karapetis CS, O'Callaghan CJ, Waring P, Kennecke HF, Hamilton SR, Kopetz S. Expanded low allele frequency RAS and BRAF V600E testing in metastatic colorectal cancer as predictive biomarkers for cetuximab in the randomized CO.17 trial Clin Cancer Res. PMID: 33087330", "BibTeX": "@article{33087330, title={Expanded low allele frequency RAS and BRAF V600E testing in metastatic colorectal cancer as predictive biomarkers for cetuximab in the randomized CO.17 trial}, author={Loree JM and Dowers A and Tu D and Jonker DJ and Edelstein DL and Quinn H and Holtrup F and Price T and Zalcberg JR and Moore MJ and Karapetis CS and O'Callaghan CJ and Waring P and Kennecke HF and Hamilton SR and Kopetz S}, journal={Clin Cancer Res}}"}, "is_sup_mat_match": false}, {"pmid": 36069770, "pmcid": "PMC9451540", "title": "Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesis.", "journal": "Elife", "authors": ["Le Roux \u00d6", "Pershing NLK", "Kaltenbrun E", "Newman NJ", "Everitt JI", "Baldelli E", "Pierobon M", "Petricoin EF", "Counter CM"], "date": "2022-09-07T00:00:00Z", "year": 2022, "snippets": [{"_id": "36069770@121482", "snip_text": "In conclusion, this study supports the possibility that qualitative signaling preferences of KRAS mutants may drive tumor initiation, in agreement with several recent studies showing mutation-specific signaling, such as KRAS A146T and KRAS G12R.", "section": "other", "mentions": ["93|4|gene|ncbi_gene@3845|KRAS", "240|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "220|4|gene|ncbi_gene@3845|KRAS", "235|4|gene|ncbi_gene@3845|KRAS", "225|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "116|5|disease|ncbi_mesh@D009369|tumor"], "text_hl": "In conclusion, this study supports the possibility that qualitative signaling preferences of KRAS mutants may drive tumor initiation, in agreement with several recent studies showing mutation-specific signaling, such as KRAS A146T and KRAS G12R."}], "citations": {"NLM": "Le Roux \u00d6, Pershing NLK, Kaltenbrun E, Newman NJ, Everitt JI, Baldelli E, Pierobon M, Petricoin EF, Counter CM. Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesis. Elife. PMID: 36069770", "BibTeX": "@article{36069770, title={Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesis.}, author={Le Roux \u00d6 and Pershing NLK and Kaltenbrun E and Newman NJ and Everitt JI and Baldelli E and Pierobon M and Petricoin EF and Counter CM}, journal={Elife}}"}, "is_sup_mat_match": false}, {"pmid": 32947236, "pmcid": "PMC7502368", "title": "KRAS and PIK3CA bi-mutations predict a poor prognosis in colorectal cancer patients: A single-site report.", "journal": "Transl Oncol", "authors": ["Luo Q", "Chen D", "Fan X", "Fu X", "Ma T", "Chen D"], "date": "2020-12-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "32947236@9807", "snip_text": " KRAS Exon 2 Exon 3 Exon 4   PIK3CA  p.G12S p.G12D p.G12A p.G12V p.G12C p.G12P p.G13D p.G13C p.A59T p.Q61K p.Q61H p.A146T   Exon 9 p.E542K    6 1 1    1     p.E545K 1 11  4 1  6 1 1   1   p.E545D    1           p.E545A 1 1 1            p.E545G       1        Exon 20 p.H1047L 1 5 1 2   2    1    p.H1047R  1  1           p.E545G, p.H1047Y         1      ", "section": "table", "mentions": ["79|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "330|8|variant|litvar@rs121913281##&&&litvar@#5290#&&&litvar@CA130471#rs121913281##|p.H1047Y", "1|4|gene|ncbi_gene@3845|KRAS", "107|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "100|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "29|6|gene|ncbi_gene@5290|PIK3CA", "157|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "296|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.H1047R", "114|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "51|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "321|7|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123336#rs121913274##|p.E545G", "236|7|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123336#rs121913274##|p.E545G", "72|6|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12P", "267|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|p.H1047L", "211|7|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123342#rs121913274##|p.E545A", "65|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "58|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "131|7|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.E542K", "188|7|variant|litvar@rs121913275##&&&litvar@#5290#&&&litvar@CA210104#rs121913275##|p.E545D", "44|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "37|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "93|6|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|p.A59T", "86|6|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|p.G13C"], "figure_id": "t0005", "text_hl": " KRAS Exon 2 Exon 3 Exon 4   PIK3CA  p.G12S p.G12D p.G12A p.G12V p.G12C p.G12P p.G13D p.G13C p.A59T p.Q61K p.Q61H <m>p.A146T</m>   Exon 9 p.E542K    6 1 1    1     p.E545K 1 11  4 1  6 1 1   1   p.E545D    1           p.E545A 1 1 1            p.E545G       1        Exon 20 p.H1047L 1 5 1 2   2    1    p.H1047R  1  1           p.E545G, p.H1047Y         1      "}], "citations": {"NLM": "Luo Q, Chen D, Fan X, Fu X, Ma T, Chen D. KRAS and PIK3CA bi-mutations predict a poor prognosis in colorectal cancer patients: A single-site report. Transl Oncol. PMID: 32947236", "BibTeX": "@article{32947236, title={KRAS and PIK3CA bi-mutations predict a poor prognosis in colorectal cancer patients: A single-site report.}, author={Luo Q and Chen D and Fan X and Fu X and Ma T and Chen D}, journal={Transl Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 35267628, "pmcid": "PMC8909472", "title": "Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance.", "journal": "Cancers (Basel)", "authors": ["Reita D", "Pabst L", "Pencreach E", "Gu\u00e9rin E", "Dano L", "Rimelen V", "Voegeli AC", "Vallat L", "Mascaux C", "Beau-Faller M"], "date": "2022-03-04T00:00:00Z", "year": 2022, "snippets": [{"_id": "35267628@10434", "snip_text": "Less common variants such as Q61H/L/R/K interfere with coordination of the molecule involved in hydrolysis, whereas A146T enhances the propensity for nucleotide exchange (Figure 2B).", "section": "introduction", "mentions": ["29|6|variant|litvar@rs17851045##&&&litvar@#3845#|Q61H/L", "116|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Less common variants such as Q61H/L/R/K interfere with coordination of the molecule involved in hydrolysis, whereas <m>A146T</m> enhances the propensity for nucleotide exchange (Figure 2B)."}], "citations": {"NLM": "Reita D, Pabst L, Pencreach E, Gu\u00e9rin E, Dano L, Rimelen V, Voegeli AC, Vallat L, Mascaux C, Beau-Faller M. Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance. Cancers (Basel). PMID: 35267628", "BibTeX": "@article{35267628, title={Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance.}, author={Reita D and Pabst L and Pencreach E and Gu\u00e9rin E and Dano L and Rimelen V and Voegeli AC and Vallat L and Mascaux C and Beau-Faller M}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 38589574, "pmcid": "PMC11111408", "title": "Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy", "journal": "Nature", "authors": ["Holderfield M", "Lee BJ", "Jiang J", "Tomlinson A", "Seamon KJ", "Mira A", "Patrucco E", "Goodhart G", "Dilly J", "Gindin Y", "Dinglasan N", "Wang Y", "Lai LP", "Cai S", "Jiang L", "Nasholm N", "Shifrin N", "Blaj C", "Shah H", "Evans JW", "Montazer N", "Lai O", "Shi J", "Ahler E", "Quintana E", "Chang S", "Salvador A", "Marquez A", "Cregg J", "Liu Y", "Milin A", "Chen A", "Ziv TB", "Parsons D", "Knox JE", "Klomp JE", "Roth J", "Rees M", "Ronan M", "Cuevas-Navarro A", "Hu F", "Lito P", "Santamaria D", "Aguirre AJ", "Waters AM", "Der CJ", "Ambrogio C", "Wang Z", "Gill AL", "Koltun ES", "Smith JAM", "Wildes D", "Singh M"], "date": "2024-04-08T00:00:00Z", "year": 2024, "snippets": [{"_id": "38589574@19177", "snip_text": "pERK suppression by RMC-7977 typically appeared complete across cells expressing various KRAS(G12X) mutants, but consistently reached a plateau in wild-type KRAS, KRASG12A, KRASQ61H, KRASQ61R, KRASG13D and KRASA146T cells; by contrast and as expected, trametinib reduced pERK similarly in all cells, including the BRAFV600E MEFs (Extended Data Fig. 6a).", "section": "other", "mentions": ["252|10|chemical|ncbi_mesh@C560077|trametinib", "318|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "324|4|cellline||MEFs", "94|4|variant|litvar@rs1183625015##&&&litvar@#5879#|G12X", "20|8|chemical||RMC-7977", "157|4|gene|ncbi_gene@3845|KRAS", "206|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T", "89|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "pERK suppression by RMC-7977 typically appeared complete across cells expressing various KRAS(G12X) mutants, but consistently reached a plateau in wild-type KRAS, KRASG12A, KRASQ61H, KRASQ61R, KRASG13D and KRASA146T cells; by contrast and as expected, trametinib reduced pERK similarly in all cells, including the BRAFV600E MEFs (Extended Data Fig. 6a)."}], "citations": {"NLM": "Holderfield M, Lee BJ, Jiang J, Tomlinson A, Seamon KJ, Mira A, Patrucco E, Goodhart G, Dilly J, Gindin Y, Dinglasan N, Wang Y, Lai LP, Cai S, Jiang L, Nasholm N, Shifrin N, Blaj C, Shah H, Evans JW, Montazer N, Lai O, Shi J, Ahler E, Quintana E, Chang S, Salvador A, Marquez A, Cregg J, Liu Y, Milin A, Chen A, Ziv TB, Parsons D, Knox JE, Klomp JE, Roth J, Rees M, Ronan M, Cuevas-Navarro A, Hu F, Lito P, Santamaria D, Aguirre AJ, Waters AM, Der CJ, Ambrogio C, Wang Z, Gill AL, Koltun ES, Smith JAM, Wildes D, Singh M. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy Nature. PMID: 38589574", "BibTeX": "@article{38589574, title={Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy}, author={Holderfield M and Lee BJ and Jiang J and Tomlinson A and Seamon KJ and Mira A and Patrucco E and Goodhart G and Dilly J and Gindin Y and Dinglasan N and Wang Y and Lai LP and Cai S and Jiang L and Nasholm N and Shifrin N and Blaj C and Shah H and Evans JW and Montazer N and Lai O and Shi J and Ahler E and Quintana E and Chang S and Salvador A and Marquez A and Cregg J and Liu Y and Milin A and Chen A and Ziv TB and Parsons D and Knox JE and Klomp JE and Roth J and Rees M and Ronan M and Cuevas-Navarro A and Hu F and Lito P and Santamaria D and Aguirre AJ and Waters AM and Der CJ and Ambrogio C and Wang Z and Gill AL and Koltun ES and Smith JAM and Wildes D and Singh M}, journal={Nature}}"}, "is_sup_mat_match": false}, {"pmid": 34403504, "pmcid": "PMC8418479", "title": "Cross-platform comparison of next-generation sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for detecting KRAS/NRAS/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients.", "journal": "J Clin Lab Anal", "authors": ["Xu X", "Huang F", "Cao M", "Chen X", "Wang H", "Jiang H", "Yu Y", "Shen M", "Yang Y", "Wang B", "Liu T", "Guo W"], "date": "2021-09-01T00:00:00Z", "year": 2021, "snippets": [{"_id": "34403504@17765", "snip_text": "Four cycles of mFOLFOX6 were administered since November 2017 and a decrease of mutant allele frequency (KRAS A146T) was observed (Figure 5B and Table S6).", "section": "results", "mentions": ["105|4|gene|ncbi_gene@3845|KRAS", "15|8|chemical||mFOLFOX6", "110|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Four cycles of mFOLFOX6 were administered since November 2017 and a decrease of mutant allele frequency (KRAS <m>A146T</m>) was observed (Figure 5B and Table S6)."}], "citations": {"NLM": "Xu X, Huang F, Cao M, Chen X, Wang H, Jiang H, Yu Y, Shen M, Yang Y, Wang B, Liu T, Guo W. Cross-platform comparison of next-generation sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for detecting KRAS/NRAS/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients. J Clin Lab Anal. PMID: 34403504", "BibTeX": "@article{34403504, title={Cross-platform comparison of next-generation sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for detecting KRAS/NRAS/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients.}, author={Xu X and Huang F and Cao M and Chen X and Wang H and Jiang H and Yu Y and Shen M and Yang Y and Wang B and Liu T and Guo W}, journal={J Clin Lab Anal}}"}, "is_sup_mat_match": false}, {"pmid": 25267307, "pmcid": "PMC4198623", "title": "KRAS and BRAF mutational status in colon cancer from Albanian patients", "journal": "Diagn Pathol", "authors": ["Martinetti D", "Costanzo R", "Kadare S", "Alimehmeti M", "Colarossi C", "Canzonieri V", "Berretta M", "Memeo L"], "date": "2014-09-30T00:00:00Z", "year": 2014, "snippets": [{"_id": "25267307@747", "snip_text": "Out of the 159 cases, 28 (17,6%) showed KRAS mutation (13 G12D, 4 G12C, 4 G12V, 3 G12A, 2 G13 D, 1 G12S and 1 A146T), and 10 (6,3%) showed BRAF mutation (all V600E).", "section": "abstract", "mentions": ["99|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "74|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "58|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "66|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "158|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "82|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "40|4|gene|ncbi_gene@3845|KRAS", "139|4|gene|ncbi_gene@673|BRAF", "110|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "90|5|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13 D"], "text_hl": "Out of the 159 cases, 28 (17,6%) showed KRAS mutation (13 G12D, 4 G12C, 4 G12V, 3 G12A, 2 G13 D, 1 G12S and 1 <m>A146T</m>), and 10 (6,3%) showed BRAF mutation (all V600E)."}], "citations": {"NLM": "Martinetti D, Costanzo R, Kadare S, Alimehmeti M, Colarossi C, Canzonieri V, Berretta M, Memeo L. KRAS and BRAF mutational status in colon cancer from Albanian patients Diagn Pathol. PMID: 25267307", "BibTeX": "@article{25267307, title={KRAS and BRAF mutational status in colon cancer from Albanian patients}, author={Martinetti D and Costanzo R and Kadare S and Alimehmeti M and Colarossi C and Canzonieri V and Berretta M and Memeo L}, journal={Diagn Pathol}}"}, "is_sup_mat_match": false}, {"pmid": 36040039, "pmcid": "PMC9561227", "title": "Brown Tumors Belong to the Spectrum of KRAS-driven Neoplasms", "journal": "Am J Surg Pathol", "authors": ["Turek D", "Haefliger S", "Ameline B", "Alborelli I", "Calgua B", "Hartmann W", "Harder D", "Flanagan AM", "Amary F", "Baumhoer D"], "date": "2022-08-30T00:00:00Z", "year": 2022, "snippets": [{"_id": "36040039@7882", "snip_text": "Patient #\tAge at Diagnosis (y)\tSex\tTumor Localization\tRadiology\tType of Hyperparathyreoidism\tFU Time (mo)\tKRAS\tFGFR1\tTRPV4\tProcedure\tTumor Content (%)\tTumor Size (cm)\t \t1\t35\tF\tRight maxilla\tNA\tSecondary\tNA\tG12D (AF=0.27)\tWT\tWT\tCurettage\t80\tNA\t \t2\t70\tM\tLeft humerus\tNA\tSecondary\tNA\tA146P (AF=0.15)\tWT\tWT\tCurettage\t80\tNA\t \t3\t33\tF\tRight mandible\tX-ray\tSecondary\t5\tA146T (AF=0.02)\tWT\tWT\tResection\t80\t4\t \t4\t68\tM\tRight zygomatic arch\tCT\tSecondary\tNA\tWT\tWT\tWT\tCurettage\t80\t4\t \t5\t77\tM\tRight upper pubic ramus\tCT\tSecondary\tNA\tA146V (AF=0.15)\tWT\tWT\tBiopsy\t70\t5\t \t6\t73\tM\tRight hand, distal phalanx III\tX-ray\tNA\tNA\tWT\tWT\tWT\tCurettage\t90\t2\t \t7\t41\tM\tNA\tNA\tSecondary\t36\tK117R (AF=0.26)\tWT\tWT\tBiopsy\t80\tNA\t \t8\t65\tM\tNA\tNA\tSecondary\t3\tA146T (AF=0.21)\tWT\tWT\tBiopsy\t80\tNA\t \t9\t28\tF\tBilateral hands\tNA\tNA\tNA\tWT\tWT\tWT\tResection\t80\tNA\t \t10\t43\tF\tRight femur\tNA\tPrimary\tNA\tWT\tWT\tWT\tCurettage\t20\tNA\t \t11\t41\tM\tOs sacrum\tNA\tSecondary\tNA\tG12D (AF=0.24)\tWT\tWT\tBiopsy\t90\tNA\t \t12\t76\tF\tNA\tNA\tSecondary\t1\tG13C (AF=0.16)\tWT\tWT\tBiopsy\t20\tNA\t \t13\t58\tM\tLeft humerus, capitulum\tX-ray, MRI\tPrimary\tNA\tQ22K (AF=0.21)\tWT\tWT\tCurettage\t80\t2\t \t14\t82\tM\tRight hand, proximal Phalanx IV\tX-ray, MRI\tSecondary\tNA\tA146V (AF=0.24)\tWT\tWT\tCurettage\t90\t2\t \t15\t18\tF\tLeft tibia, proximal\tNA\tPrimary\t13\tWT\tWT\tWT\tCurettage\t50\tNA\t \t16\t63\tM\tLeft os ilium\tNA\tSecondary\t38\tWT\tWT\tWT\tBiopsy\t50\tNA\t \t", "section": "table", "mentions": ["517|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "0|7|species|ncbi_taxonomy@9606|Patient", "1162|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "106|4|gene|ncbi_gene@3845|KRAS", "655|5|variant|litvar@#59341#p.K117R&&&litvar@#59341#|K117R", "206|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "281|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "111|5|gene|ncbi_gene@2260|FGFR1", "1060|4|variant|litvar@rs121913236##&&&litvar@#3845#&&&litvar@CA16602771#rs121913236##|Q22K", "117|5|gene|ncbi_gene@59341|TRPV4", "970|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "717|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "361|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "908|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D"], "figure_id": "T1", "text_hl": "Patient #\tAge at Diagnosis (y)\tSex\tTumor Localization\tRadiology\tType of Hyperparathyreoidism\tFU Time (mo)\tKRAS\tFGFR1\tTRPV4\tProcedure\tTumor Content (%)\tTumor Size (cm)\t \t1\t35\tF\tRight maxilla\tNA\tSecondary\tNA\tG12D (AF=0.27)\tWT\tWT\tCurettage\t80\tNA\t \t2\t70\tM\tLeft humerus\tNA\tSecondary\tNA\tA146P (AF=0.15)\tWT\tWT\tCurettage\t80\tNA\t \t3\t33\tF\tRight mandible\tX-ray\tSecondary\t5\t<m>A146T</m> (AF=0.02)\tWT\tWT\tResection\t80\t4\t \t4\t68\tM\tRight zygomatic arch\tCT\tSecondary\tNA\tWT\tWT\tWT\tCurettage\t80\t4\t \t5\t77\tM\tRight upper pubic ramus\tCT\tSecondary\tNA\tA146V (AF=0.15)\tWT\tWT\tBiopsy\t70\t5\t \t6\t73\tM\tRight hand, distal phalanx III\tX-ray\tNA\tNA\tWT\tWT\tWT\tCurettage\t90\t2\t \t7\t41\tM\tNA\tNA\tSecondary\t36\tK117R (AF=0.26)\tWT\tWT\tBiopsy\t80\tNA\t \t8\t65\tM\tNA\tNA\tSecondary\t3\t<m>A146T</m> (AF=0.21)\tWT\tWT\tBiopsy\t80\tNA\t \t9\t28\tF\tBilateral hands\tNA\tNA\tNA\tWT\tWT\tWT\tResection\t80\tNA\t \t10\t43\tF\tRight femur\tNA\tPrimary\tNA\tWT\tWT\tWT\tCurettage\t20\tNA\t \t11\t41\tM\tOs sacrum\tNA\tSecondary\tNA\tG12D (AF=0.24)\tWT\tWT\tBiopsy\t90\tNA\t \t12\t76\tF\tNA\tNA\tSecondary\t1\tG13C (AF=0.16)\tWT\tWT\tBiopsy\t20\tNA\t \t13\t58\tM\tLeft humerus, capitulum\tX-ray, MRI\tPrimary\tNA\tQ22K (AF=0.21)\tWT\tWT\tCurettage\t80\t2\t \t14\t82\tM\tRight hand, proximal Phalanx IV\tX-ray, MRI\tSecondary\tNA\tA146V (AF=0.24)\tWT\tWT\tCurettage\t90\t2\t \t15\t18\tF\tLeft tibia, proximal\tNA\tPrimary\t13\tWT\tWT\tWT\tCurettage\t50\tNA\t \t16\t63\tM\tLeft os ilium\tNA\tSecondary\t38\tWT\tWT\tWT\tBiopsy\t50\tNA\t \t"}], "citations": {"NLM": "Turek D, Haefliger S, Ameline B, Alborelli I, Calgua B, Hartmann W, Harder D, Flanagan AM, Amary F, Baumhoer D. Brown Tumors Belong to the Spectrum of KRAS-driven Neoplasms Am J Surg Pathol. PMID: 36040039", "BibTeX": "@article{36040039, title={Brown Tumors Belong to the Spectrum of KRAS-driven Neoplasms}, author={Turek D and Haefliger S and Ameline B and Alborelli I and Calgua B and Hartmann W and Harder D and Flanagan AM and Amary F and Baumhoer D}, journal={Am J Surg Pathol}}"}, "is_sup_mat_match": false}, {"pmid": 34684076, "pmcid": "PMC8539053", "title": "Evaluation of KRAS Concomitant Mutations in Advanced Lung Adenocarcinoma Patients.", "journal": "Medicina (Kaunas)", "authors": ["Aran V", "Zalis M", "Montella T", "de Sousa CAM", "Ferrari BL", "Gil Ferreira C"], "date": "2021-09-29T00:00:00Z", "year": 2021, "snippets": [{"_id": "34684076@11083", "snip_text": "Of the mutant samples, the most frequent mutation types were G12D (6/24), followed by G12V (5/24), G12C/G12A (3/24), G13D/Q61L (2/24), and G12F/G13V/A146T/Q61H (1/24).", "section": "results", "mentions": ["99|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "61|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "144|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "122|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "149|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "139|4|variant|litvar@rs121913530##&&&litvar@#3845#|G12F", "86|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "104|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "155|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "117|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D"], "text_hl": "Of the mutant samples, the most frequent mutation types were G12D (6/24), followed by G12V (5/24), G12C/G12A (3/24), G13D/Q61L (2/24), and G12F/G13V/<m>A146T</m>/Q61H (1/24)."}], "citations": {"NLM": "Aran V, Zalis M, Montella T, de Sousa CAM, Ferrari BL, Gil Ferreira C. Evaluation of KRAS Concomitant Mutations in Advanced Lung Adenocarcinoma Patients. Medicina (Kaunas). PMID: 34684076", "BibTeX": "@article{34684076, title={Evaluation of KRAS Concomitant Mutations in Advanced Lung Adenocarcinoma Patients.}, author={Aran V and Zalis M and Montella T and de Sousa CAM and Ferrari BL and Gil Ferreira C}, journal={Medicina (Kaunas)}}"}, "is_sup_mat_match": false}, {"pmid": 33250696, "pmcid": "PMC7670341", "title": "STK11 p.F354L Germline Mutation in a Case of Multiple Gastrointestinal Tumors.", "journal": "Case Rep Gastroenterol", "authors": ["Kojima Y", "Ohtsuka K", "Ishii S", "Aso N", "Ohki A", "Hashimoto Y", "Takeuchi H", "Ohnishi H", "Abe N"], "date": "2020-10-28T00:00:00Z", "year": 2020, "snippets": [{"_id": "33250696@976", "snip_text": "In addition, somatic mutations coexisted in the tumor samples, including KRAS p.A146T, TP53 p.G238X, and APC p.T1556fs in the duodenal adenoma; TP53 p.G238Y and APC p.T1556fs in the gastric adenoma; and TP53 p.R282W in the rectal adenocarcinoma and metastatic liver cancer.", "section": "abstract", "mentions": ["203|4|gene|ncbi_gene@7157|TP53", "92|7|variant|litvar@#7157#p.G238X&&&litvar@#7157#|p.G238X", "109|9|variant|litvar@rs587783031##&&&litvar@#324#|p.T1556fs", "165|9|variant|litvar@rs587783031##&&&litvar@#324#|p.T1556fs", "105|3|gene|ncbi_gene@324|APC", "144|4|gene|ncbi_gene@7157|TP53", "73|4|gene|ncbi_gene@3845|KRAS", "208|7|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|p.R282W", "87|4|gene|ncbi_gene@7157|TP53", "161|3|gene|ncbi_gene@324|APC", "223|21|disease|ncbi_mesh@D000230|rectal adenocarcinoma", "149|7|variant|litvar@#7157#p.G238Y&&&litvar@#7157#|p.G238Y", "78|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "249|23|disease|ncbi_mesh@D006528|metastatic liver cancer", "182|15|disease|ncbi_mesh@D000236|gastric adenoma", "126|16|disease|ncbi_mesh@D004382|duodenal adenoma", "48|5|disease|ncbi_mesh@D009369|tumor"], "text_hl": "In addition, somatic mutations coexisted in the tumor samples, including KRAS <m>p.A146T</m>, TP53 p.G238X, and APC p.T1556fs in the duodenal adenoma; TP53 p.G238Y and APC p.T1556fs in the gastric adenoma; and TP53 p.R282W in the rectal adenocarcinoma and metastatic liver cancer."}], "citations": {"NLM": "Kojima Y, Ohtsuka K, Ishii S, Aso N, Ohki A, Hashimoto Y, Takeuchi H, Ohnishi H, Abe N. STK11 p.F354L Germline Mutation in a Case of Multiple Gastrointestinal Tumors. Case Rep Gastroenterol. PMID: 33250696", "BibTeX": "@article{33250696, title={STK11 p.F354L Germline Mutation in a Case of Multiple Gastrointestinal Tumors.}, author={Kojima Y and Ohtsuka K and Ishii S and Aso N and Ohki A and Hashimoto Y and Takeuchi H and Ohnishi H and Abe N}, journal={Case Rep Gastroenterol}}"}, "is_sup_mat_match": false}, {"pmid": 32219061, "pmcid": "PMC7078327", "title": "Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe  Panel", "journal": "Front Oncol", "authors": ["Malapelle U", "Pepe F", "Pisapia P", "Sgariglia R", "Nacchio M", "De Luca C", "Lacalamita R", "Tommasi S", "Pinto R", "Palomba G", "Palmieri G", "Vacirca D", "Barberis M", "Bottillo I", "Grammatico P", "Grillo LR", "Costa V", "Smeraglio R", "Bruzzese D", "Troncone G"], "date": "2020-03-11T00:00:00Z", "year": 2020, "snippets": [{"_id": "32219061@7616", "snip_text": "\tFed II\tParticipating institutions\t \tSample\tGene\tMutation\tFrequencies (%)\tGene\tMutation\tFrequencies (%)\t \t1\tPIK3CA\tp.R88Q\t15.9\tPIK3CA\tp.R88Q\t15.9; 15.9; 15.6; 15.8\t \t\tPDGFRalpha\tp.V824V\t47.8\tPDGFR\tp.V824V\t47.1; 51.2; 47.7; 42.6\t \t2\tKRAS\tp.G12C\t18.9\tKRAS\tp.G12C\t18.9; 16.8; 22.8; 18.9\t \t3\tKRAS\tp.G12V\t42.0\tKRAS\tp.G12V\t41.3; 39.9; 37.1; 42.3\t \t4\tNRAS\tp.G12D\t36.1\tNRAS\tp.G12D\t38.9; 36.3; 39.8; 34.9\t \t5\tKRAS\tp.A146T\t31.0\tKRAS\tp.A146T\t31.1; 31.1; 23.7; NA\t \t\tKIT\tp.M541L\t53.4\tKIT\tp.M541L\t53.1; 53.1; 47.1; NA\t \t6\tKRAS\tp.G13D\t57.9\tKRAS\tp.G13D\t57.4; 57.4; 58.0; 65.3\t \t7\tKRAS\tp.G12C\t36.4\tKRAS\tp.G12C\t35.1; 35.1; 40.5; 32.4\t \t\tKIT\tp.M541L\t58.4\tKIT\tp.M541L\t58.4; 58.4; 60.3; 58.3\t \t8\tKRAS\tp.G12D\t18.1\tKRAS\tp.G12D\t18.4; 18.4; 18.7; 21.8\t \t\tPIK3CA\tp.E545K\t11.0\tPIK3CA\tp.E545K\t11.5; 11.5; 9.9; 9.3\t \t\tKIT\tp.M541L\t100.0\tKIT\tp.M541L\t99.8; 99.8; 100.0; 99.7\t \t9\tKRAS\tp.G12V\t22.0\tKRAS\tp.G12V\t22.3; 22.3; 24.0; 22.0\t \t10\tKRAS\tp.G12V\t11.0\tKRAS\tp.G12V\t11.0; 11.0; 7.5; 9.3\t \t\tPIK3CA\tp.E542K\t10.8\tPIK3CA\tp.E542K\t10.7; 10.7; 11.8; 10.5\t \t11\tKRAS\tp.G12D\t14.9\tKRAS\tp.G12D\t14.4; 19.3; 17.6; 15.7\t \t12\t-\tWT\t-\t-\tWT\t-\t \t13\tKRAS\tp.G12S\t27.8\tKRAS\tp.G12S\t27.1; 31.5; 27.0; 36.5\t \t14\tPDGFRalpha\tp.V824V\t99.1\tPDGFR\tp.V824V\t99.1; 99.2; 99.1; 99.4\t \t15\t-\tWT\t-\t-\tWT\t-\t \t16\tKIT\tp.M541L\t50.4\tKIT\tp.M541L\t46.8; 51.2; 50.3; 54.0\t \t17\tKRAS\tp.G13D\t45.2\tKRAS\tp.G13D\t44.6; 46.5; 45.3; 46.2\t \t\tPDGFR\tp.V824V\t18.9\tPDGFR\tp.V824V\t19.7; 13.7; 18.4; 20.6\t \t18\tKRAS\tp.G12A\t6.1\tKRAS\tp.G12A\t6.3; 5.8; 5.5; 6.2\t \t\tPDGFRalpha\tp.V824V\t45.8\tPDGFR\tp.V824V\t43.9; 47.6; 46.5; 48.1\t \t19\t-\tWT\t-\t-\tWT\t-\t \t20\tEGFR\tp.E746_S752>V\t43.8\tEGFR\tp.E746_S752>V\t45.4; 51.1; 45.5; 40.9\t \t", "section": "table", "mentions": ["232|4|gene|ncbi_gene@3845|KRAS", "570|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "305|4|gene|ncbi_gene@3845|KRAS", "698|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1433|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "1412|4|gene|ncbi_gene@3845|KRAS", "134|6|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|p.R88Q", "681|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "731|6|gene|ncbi_gene@5290|PIK3CA", "1301|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "1357|7|variant|litvar@rs2228230##&&&litvar@#5156#&&&litvar@CA2922877#rs2228230##|p.V824V", "1243|7|variant|litvar@rs3822214##&&&litvar@#3815#&&&litvar@CA160347#rs3822214##|p.M541L", "310|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "738|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "1026|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1165|7|variant|litvar@rs2228230##&&&litvar@#5156#&&&litvar@CA2922877#rs2228230##|p.V824V", "922|4|gene|ncbi_gene@3845|KRAS", "344|4|gene|ncbi_gene@4893|NRAS", "509|4|gene|ncbi_gene@3845|KRAS", "1097|4|gene|ncbi_gene@3845|KRAS", "1313|4|gene|ncbi_gene@3845|KRAS", "108|6|gene|ncbi_gene@5290|PIK3CA", "751|6|gene|ncbi_gene@5290|PIK3CA", "1473|7|variant|litvar@rs2228230##&&&litvar@#5156#&&&litvar@CA2922877#rs2228230##|p.V824V", "1184|7|variant|litvar@rs2228230##&&&litvar@#5156#&&&litvar@CA2922877#rs2228230##|p.V824V", "1417|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "366|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "794|7|variant|litvar@rs3822214##&&&litvar@#3815#&&&litvar@CA160347#rs3822214##|p.M541L", "418|4|gene|ncbi_gene@3845|KRAS", "1492|7|variant|litvar@rs2228230##&&&litvar@#5156#&&&litvar@CA2922877#rs2228230##|p.V824V", "127|6|gene|ncbi_gene@5290|PIK3CA", "1038|4|gene|ncbi_gene@3845|KRAS", "853|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "459|7|variant|litvar@rs3822214##&&&litvar@#3815#&&&litvar@CA160347#rs3822214##|p.M541L", "531|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "693|4|gene|ncbi_gene@3845|KRAS", "1119|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "565|4|gene|ncbi_gene@3845|KRAS", "637|3|gene|ncbi_gene@3815|KIT", "758|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "423|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "1428|4|gene|ncbi_gene@3845|KRAS", "1239|3|gene|ncbi_gene@3815|KIT", "965|7|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.E542K", "587|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "676|4|gene|ncbi_gene@3845|KRAS", "1296|4|gene|ncbi_gene@3845|KRAS", "808|3|gene|ncbi_gene@3815|KIT", "1154|10|gene|ncbi_gene@5156|PDGFRalpha", "978|6|gene|ncbi_gene@5290|PIK3CA", "1021|4|gene|ncbi_gene@3845|KRAS", "115|6|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|p.R88Q", "455|3|gene|ncbi_gene@3815|KIT", "865|4|gene|ncbi_gene@3845|KRAS", "1260|7|variant|litvar@rs3822214##&&&litvar@#3815#&&&litvar@CA160347#rs3822214##|p.M541L", "1043|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "361|4|gene|ncbi_gene@4893|NRAS", "910|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1462|10|gene|ncbi_gene@5156|PDGFRalpha", "254|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "526|4|gene|ncbi_gene@3845|KRAS", "1114|4|gene|ncbi_gene@3845|KRAS", "985|7|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.E542K", "641|7|variant|litvar@rs3822214##&&&litvar@#3815#&&&litvar@CA160347#rs3822214##|p.M541L", "178|7|variant|litvar@rs2228230##&&&litvar@#5156#&&&litvar@CA2922877#rs2228230##|p.V824V", "1376|7|variant|litvar@rs2228230##&&&litvar@#5156#&&&litvar@CA2922877#rs2228230##|p.V824V", "870|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "476|7|variant|litvar@rs3822214##&&&litvar@#3815#&&&litvar@CA160347#rs3822214##|p.M541L", "582|4|gene|ncbi_gene@3845|KRAS", "197|7|variant|litvar@rs2228230##&&&litvar@#5156#&&&litvar@CA2922877#rs2228230##|p.V824V", "848|4|gene|ncbi_gene@3845|KRAS", "624|7|variant|litvar@rs3822214##&&&litvar@#3815#&&&litvar@CA160347#rs3822214##|p.M541L", "288|4|gene|ncbi_gene@3845|KRAS", "812|7|variant|litvar@rs3822214##&&&litvar@#3815#&&&litvar@CA160347#rs3822214##|p.M541L", "1256|3|gene|ncbi_gene@3815|KIT", "958|6|gene|ncbi_gene@5290|PIK3CA", "237|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "1547|4|gene|ncbi_gene@1956|EGFR", "1571|4|gene|ncbi_gene@1956|EGFR", "293|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "905|4|gene|ncbi_gene@3845|KRAS", "400|4|gene|ncbi_gene@3845|KRAS", "472|3|gene|ncbi_gene@3815|KIT", "249|4|gene|ncbi_gene@3845|KRAS", "790|3|gene|ncbi_gene@3815|KIT", "927|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "405|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "349|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "514|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "167|10|gene|ncbi_gene@5156|PDGFRalpha", "1102|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "1318|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "620|3|gene|ncbi_gene@3815|KIT"], "figure_id": "T1", "text_hl": "\tFed II\tParticipating institutions\t \tSample\tGene\tMutation\tFrequencies (%)\tGene\tMutation\tFrequencies (%)\t \t1\tPIK3CA\tp.R88Q\t15.9\tPIK3CA\tp.R88Q\t15.9; 15.9; 15.6; 15.8\t \t\tPDGFRalpha\tp.V824V\t47.8\tPDGFR\tp.V824V\t47.1; 51.2; 47.7; 42.6\t \t2\tKRAS\tp.G12C\t18.9\tKRAS\tp.G12C\t18.9; 16.8; 22.8; 18.9\t \t3\tKRAS\tp.G12V\t42.0\tKRAS\tp.G12V\t41.3; 39.9; 37.1; 42.3\t \t4\tNRAS\tp.G12D\t36.1\tNRAS\tp.G12D\t38.9; 36.3; 39.8; 34.9\t \t5\tKRAS\t<m>p.A146T</m>\t31.0\tKRAS\t<m>p.A146T</m>\t31.1; 31.1; 23.7; NA\t \t\tKIT\tp.M541L\t53.4\tKIT\tp.M541L\t53.1; 53.1; 47.1; NA\t \t6\tKRAS\tp.G13D\t57.9\tKRAS\tp.G13D\t57.4; 57.4; 58.0; 65.3\t \t7\tKRAS\tp.G12C\t36.4\tKRAS\tp.G12C\t35.1; 35.1; 40.5; 32.4\t \t\tKIT\tp.M541L\t58.4\tKIT\tp.M541L\t58.4; 58.4; 60.3; 58.3\t \t8\tKRAS\tp.G12D\t18.1\tKRAS\tp.G12D\t18.4; 18.4; 18.7; 21.8\t \t\tPIK3CA\tp.E545K\t11.0\tPIK3CA\tp.E545K\t11.5; 11.5; 9.9; 9.3\t \t\tKIT\tp.M541L\t100.0\tKIT\tp.M541L\t99.8; 99.8; 100.0; 99.7\t \t9\tKRAS\tp.G12V\t22.0\tKRAS\tp.G12V\t22.3; 22.3; 24.0; 22.0\t \t10\tKRAS\tp.G12V\t11.0\tKRAS\tp.G12V\t11.0; 11.0; 7.5; 9.3\t \t\tPIK3CA\tp.E542K\t10.8\tPIK3CA\tp.E542K\t10.7; 10.7; 11.8; 10.5\t \t11\tKRAS\tp.G12D\t14.9\tKRAS\tp.G12D\t14.4; 19.3; 17.6; 15.7\t \t12\t-\tWT\t-\t-\tWT\t-\t \t13\tKRAS\tp.G12S\t27.8\tKRAS\tp.G12S\t27.1; 31.5; 27.0; 36.5\t \t14\tPDGFRalpha\tp.V824V\t99.1\tPDGFR\tp.V824V\t99.1; 99.2; 99.1; 99.4\t \t15\t-\tWT\t-\t-\tWT\t-\t \t16\tKIT\tp.M541L\t50.4\tKIT\tp.M541L\t46.8; 51.2; 50.3; 54.0\t \t17\tKRAS\tp.G13D\t45.2\tKRAS\tp.G13D\t44.6; 46.5; 45.3; 46.2\t \t\tPDGFR\tp.V824V\t18.9\tPDGFR\tp.V824V\t19.7; 13.7; 18.4; 20.6\t \t18\tKRAS\tp.G12A\t6.1\tKRAS\tp.G12A\t6.3; 5.8; 5.5; 6.2\t \t\tPDGFRalpha\tp.V824V\t45.8\tPDGFR\tp.V824V\t43.9; 47.6; 46.5; 48.1\t \t19\t-\tWT\t-\t-\tWT\t-\t \t20\tEGFR\tp.E746_S752>V\t43.8\tEGFR\tp.E746_S752>V\t45.4; 51.1; 45.5; 40.9\t \t"}], "citations": {"NLM": "Malapelle U, Pepe F, Pisapia P, Sgariglia R, Nacchio M, De Luca C, Lacalamita R, Tommasi S, Pinto R, Palomba G, Palmieri G, Vacirca D, Barberis M, Bottillo I, Grammatico P, Grillo LR, Costa V, Smeraglio R, Bruzzese D, Troncone G. Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe  Panel Front Oncol. PMID: 32219061", "BibTeX": "@article{32219061, title={Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe  Panel}, author={Malapelle U and Pepe F and Pisapia P and Sgariglia R and Nacchio M and De Luca C and Lacalamita R and Tommasi S and Pinto R and Palomba G and Palmieri G and Vacirca D and Barberis M and Bottillo I and Grammatico P and Grillo LR and Costa V and Smeraglio R and Bruzzese D and Troncone G}, journal={Front Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 20147967, "pmcid": "PMC2837563", "title": "Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours - implications for personalised cancer medicine", "journal": "Br J Cancer", "authors": ["Smith G", "Bounds R", "Wolf H", "Steele RJ", "Carey FA", "Wolf CR"], "date": "2010-02-16T00:00:00Z", "year": 2010, "snippets": [{"_id": "20147967@764", "snip_text": "Four additional K-Ras mutations (Leu19Phe (1 out of 106 tumours), Lys117Asn (1 out of 106), Ala146Thr (7 out of 106) and Arg164Gln (1 out of 106)) were identified.", "section": "abstract", "mentions": ["66|9|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|Lys117Asn", "33|8|variant|litvar@rs121913538##&&&litvar@#3845#&&&litvar@CA210356#rs121913538##|Leu19Phe", "16|5|gene|ncbi_gene@3845|K-Ras", "92|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|Ala146Thr", "121|9|variant|litvar@rs372793780##&&&litvar@#3845#&&&litvar@CA135580#rs372793780##|Arg164Gln"], "text_hl": "Four additional K-Ras mutations (Leu19Phe (1 out of 106 tumours), Lys117Asn (1 out of 106), <m>Ala146Thr</m> (7 out of 106) and Arg164Gln (1 out of 106)) were identified."}], "citations": {"NLM": "Smith G, Bounds R, Wolf H, Steele RJ, Carey FA, Wolf CR. Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours - implications for personalised cancer medicine Br J Cancer. PMID: 20147967", "BibTeX": "@article{20147967, title={Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours - implications for personalised cancer medicine}, author={Smith G and Bounds R and Wolf H and Steele RJ and Carey FA and Wolf CR}, journal={Br J Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 30949599, "pmcid": "PMC6430077", "title": "KRAS and NRAS pyrosequencing screening in Tunisian colorectal cancer patients in 2015.", "journal": "Heliyon", "authors": ["Jouini R", "Ferchichi M", "BenBrahim E", "Ayari I", "Khanchel F", "Koubaa W", "Saidi O", "Allani R", "Chadli-Debbiche A"], "date": "2019-03-19T00:00:00Z", "year": 2019, "snippets": [{"_id": "30949599@10065", "snip_text": "Mutations outside KRAS exon 2 included NRAS Q61H in 3 cases (3%), NRAS G12D and A146T, each in 2 cases (2%).", "section": "results", "mentions": ["39|4|gene|ncbi_gene@4893|NRAS", "18|4|gene|ncbi_gene@3845|KRAS", "80|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "44|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "71|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "66|4|gene|ncbi_gene@4893|NRAS"], "text_hl": "Mutations outside KRAS exon 2 included NRAS Q61H in 3 cases (3%), NRAS G12D and <m>A146T</m>, each in 2 cases (2%)."}], "citations": {"NLM": "Jouini R, Ferchichi M, BenBrahim E, Ayari I, Khanchel F, Koubaa W, Saidi O, Allani R, Chadli-Debbiche A. KRAS and NRAS pyrosequencing screening in Tunisian colorectal cancer patients in 2015. Heliyon. PMID: 30949599", "BibTeX": "@article{30949599, title={KRAS and NRAS pyrosequencing screening in Tunisian colorectal cancer patients in 2015.}, author={Jouini R and Ferchichi M and BenBrahim E and Ayari I and Khanchel F and Koubaa W and Saidi O and Allani R and Chadli-Debbiche A}, journal={Heliyon}}"}, "is_sup_mat_match": false}, {"pmid": 27064574, "pmcid": "PMC4827807", "title": "Heterogeneity of KRAS Mutation Status in Rectal Cancer.", "journal": "PLoS One", "authors": ["Jo P", "K\u00f6nig A", "Schirmer M", "Kitz J", "Conradi LC", "Azizian A", "Bernhardt M", "Wolff HA", "Grade M", "Ghadimi M", "Str\u00f6bel P", "Schildhaus HU", "Gaedcke J"], "date": "2016-04-11T00:00:00Z", "year": 2016, "snippets": [{"_id": "27064574@18142", "snip_text": "PatientID KRAS mutation status SNaPshot  assay KRAS mutation status Therascreen  assay   Index rectoscopy Resected sample Index rectoscopy Resected sample   36 A146T wild-type A146T A146T   41 G13D wild-type G13D G13D   44 G12V wild-type G12V G12V   47 G12V wild-type G12V G12V   39 G12V wild-type NA NA   26 G12A wild-type NA NA   ", "section": "table", "mentions": ["160|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "10|4|gene|ncbi_gene@3845|KRAS", "283|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "253|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "47|4|gene|ncbi_gene@3845|KRAS", "268|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "309|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "238|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "182|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "208|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "273|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "193|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "243|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "213|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "223|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "176|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "figure_id": "pone.0153278.t002", "text_hl": "PatientID KRAS mutation status SNaPshot  assay KRAS mutation status Therascreen  assay   Index rectoscopy Resected sample Index rectoscopy Resected sample   36 <m>A146T</m> wild-type <m>A146T</m> <m>A146T</m>   41 G13D wild-type G13D G13D   44 G12V wild-type G12V G12V   47 G12V wild-type G12V G12V   39 G12V wild-type NA NA   26 G12A wild-type NA NA   "}], "citations": {"NLM": "Jo P, K\u00f6nig A, Schirmer M, Kitz J, Conradi LC, Azizian A, Bernhardt M, Wolff HA, Grade M, Ghadimi M, Str\u00f6bel P, Schildhaus HU, Gaedcke J. Heterogeneity of KRAS Mutation Status in Rectal Cancer. PLoS One. PMID: 27064574", "BibTeX": "@article{27064574, title={Heterogeneity of KRAS Mutation Status in Rectal Cancer.}, author={Jo P and K\u00f6nig A and Schirmer M and Kitz J and Conradi LC and Azizian A and Bernhardt M and Wolff HA and Grade M and Ghadimi M and Str\u00f6bel P and Schildhaus HU and Gaedcke J}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 32079091, "pmcid": "PMC7072554", "title": "Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines.", "journal": "Cancers (Basel)", "authors": ["Wei\u00dfbach S", "Heredia-Guerrero SC", "Barnsteiner S", "Gro\u00dfhans L", "Bodem J", "Starz H", "Langer C", "Appenzeller S", "Knop S", "Steinbrunn T", "Rost S", "Einsele H", "Bargou RC", "Rosenwald A", "St\u00fchmer T", "Leich E"], "date": "2020-02-16T00:00:00Z", "year": 2020, "snippets": [{"_id": "32079091@992", "snip_text": "Moreover, the functional impact of KRASp.G12A and the exon-4 mutations p.A146T and p.A146V on different survival pathways was investigated.", "section": "abstract", "mentions": ["71|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "39|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "83|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V"], "text_hl": "Moreover, the functional impact of KRASp.G12A and the exon-4 mutations <m>p.A146T</m> and p.A146V on different survival pathways was investigated."}], "citations": {"NLM": "Wei\u00dfbach S, Heredia-Guerrero SC, Barnsteiner S, Gro\u00dfhans L, Bodem J, Starz H, Langer C, Appenzeller S, Knop S, Steinbrunn T, Rost S, Einsele H, Bargou RC, Rosenwald A, St\u00fchmer T, Leich E. Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines. Cancers (Basel). PMID: 32079091", "BibTeX": "@article{32079091, title={Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines.}, author={Wei\u00dfbach S and Heredia-Guerrero SC and Barnsteiner S and Gro\u00dfhans L and Bodem J and Starz H and Langer C and Appenzeller S and Knop S and Steinbrunn T and Rost S and Einsele H and Bargou RC and Rosenwald A and St\u00fchmer T and Leich E}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 38600547, "pmcid": "PMC11005154", "title": "Lack of shared neoantigens in prevalent mutations in cancer", "journal": "J Transl Med", "authors": ["Ragone C", "Cavalluzzo B", "Mauriello A", "Tagliamonte M", "Buonaguro L"], "date": "2024-04-10T00:00:00Z", "year": 2024, "snippets": [{"_id": "38600547@26629", "snip_text": "MISSENSE\tTOP FREQ\tFRAMESHIFT\tTOP FREQ\t \tBCORN1459S\t\tACVR2AK437Rfs*5\tStomach\t \tBRAFV640E/V600E\tColon, Skin, Thyroid\tAPCT1556Nfs*3\t\t \tBRAFV640M\t\tBCORL1P1681Qfs*20\t\t \tERBB2S310F\t\tGLI1G274Afs*6\t\t \tFBXW7R465C\t\tJAK1K860Nfs*16\t\t \tFBXW7R465H\t\tJAK1P430Rfs*2\t\t \tFBXW7R479Q\t\tNPM1W317Cfs*12\t\t \tFBXW7R505C\t\tPTENK267Rfs*9\t\t \tFBXW7R505G\t\tPTENT319*\t\t \tFGFR2S252W\t\tRPL22K15Rfs*5\tCorpus Uteri\t \tFGFR3S249C\tBladder\tSALL4V995Ffs*14\t\t \tGNAQQ209P\t\tZMYM2K1044Rfs*33\t\t \tHRASQ61R\tAdrenal gland\t\t\t \tIDH1R132C\t\t\t\t \tIDH1R132H\tBrain\t\t\t \tKRASA146T\t\t\t\t \tKRASG12A\t\t\t\t \tKRASG12C\tLung\t\t\t \tKRASG12D\tPancreas, Rectum\t\t\t \tKRASG12R\t\t\t\t \tKRASG12S\t\t\t\t \tKRASG12V\t\t\t\t \tKRASG13D\t\t\t\t \tKRAS Q61H\t\t\t\t \tNRASG12D\t\t\t\t \tNRASG13D\t\t\t\t \tNRASG13R\t\t\t\t \tNRASQ61K\t\t\t\t \tNRASQ61L\t\t\t\t \tNRASQ61R\tHematopoietic\t\t\t \tPIK3CAC420R\t\t\t\t \tPIK3CAE542K\t\t\t\t \tPIK3CAE545K\tCervix uteri, Larynx\t\t\t \tPIK3CAH1047R\tBreast\t\t\t \tPOLEP286R\t\t\t\t \tPTENR130G\tUterus\t\t\t \tPTENR130Q\t\t\t\t \tTP53G245S\t\t\t\t \tTP53H179R\t\t\t\t \tTP53H193R\t\t\t\t \tTP53I195T\t\t\t\t \tTP53R175H\tOvary, Esophagus\t\t\t \tTP53R248Q\t\t\t\t \tTP53R248W\tBones\t\t\t \tTP53R273C\t\t\t\t \tTP53R273H\t\t\t\t \tTP53R273L\t\t\t\t \tTP53R282W\t\t\t\t \tTP53V157F\t\t\t\t \tTP53Y220C\t\t\t\t \t", "section": "table", "mentions": ["257|5|variant|litvar@#3105#p.R479Q&&&litvar@#3105#|R479Q", "1074|5|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|R282W", "82|5|variant|litvar@#7157#p.V640E&&&litvar@#7157#|V640E", "888|5|variant|litvar@#3105#p.R130Q&&&litvar@#3105#|R130Q", "948|5|variant|litvar@rs760043106##&&&litvar@#7157#&&&litvar@CA2232#rs760043106##|I195T", "415|9|variant|litvar@rs121913492##&&&litvar@#2776#&&&litvar@CA16602436#rs121913492##|GNAQQ209P", "1044|5|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|R273H", "646|4|variant|litvar@#3105#p.Q61H&&&litvar@#3105#|Q61H", "1029|5|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|R273C", "903|5|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|G245S", "228|5|variant|litvar@#3105#p.R465H&&&litvar@#3105#|R465H", "382|5|variant|litvar@#3105#p.S249C&&&litvar@#3105#|S249C", "776|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "994|5|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|R248Q", "1059|5|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA1530#rs28934576##|R273L", "88|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "169|5|variant|litvar@#3105#p.S310F&&&litvar@#3105#|S310F", "508|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T", "341|5|variant|litvar@#3105#p.S252W&&&litvar@#3105#|S252W"], "figure_id": "Tab7", "text_hl": "MISSENSE\tTOP FREQ\tFRAMESHIFT\tTOP FREQ\t \tBCORN1459S\t\tACVR2AK437Rfs*5\tStomach\t \tBRAFV640E/V600E\tColon, Skin, Thyroid\tAPCT1556Nfs*3\t\t \tBRAFV640M\t\tBCORL1P1681Qfs*20\t\t \tERBB2S310F\t\tGLI1G274Afs*6\t\t \tFBXW7R465C\t\tJAK1K860Nfs*16\t\t \tFBXW7R465H\t\tJAK1P430Rfs*2\t\t \tFBXW7R479Q\t\tNPM1W317Cfs*12\t\t \tFBXW7R505C\t\tPTENK267Rfs*9\t\t \tFBXW7R505G\t\tPTENT319*\t\t \tFGFR2S252W\t\tRPL22K15Rfs*5\tCorpus Uteri\t \tFGFR3S249C\tBladder\tSALL4V995Ffs*14\t\t \tGNAQQ209P\t\tZMYM2K1044Rfs*33\t\t \tHRASQ61R\tAdrenal gland\t\t\t \tIDH1R132C\t\t\t\t \tIDH1R132H\tBrain\t\t\t \tKRASA146T\t\t\t\t \tKRASG12A\t\t\t\t \tKRASG12C\tLung\t\t\t \tKRASG12D\tPancreas, Rectum\t\t\t \tKRASG12R\t\t\t\t \tKRASG12S\t\t\t\t \tKRASG12V\t\t\t\t \tKRASG13D\t\t\t\t \tKRAS Q61H\t\t\t\t \tNRASG12D\t\t\t\t \tNRASG13D\t\t\t\t \tNRASG13R\t\t\t\t \tNRASQ61K\t\t\t\t \tNRASQ61L\t\t\t\t \tNRASQ61R\tHematopoietic\t\t\t \tPIK3CAC420R\t\t\t\t \tPIK3CAE542K\t\t\t\t \tPIK3CAE545K\tCervix uteri, Larynx\t\t\t \tPIK3CAH1047R\tBreast\t\t\t \tPOLEP286R\t\t\t\t \tPTENR130G\tUterus\t\t\t \tPTENR130Q\t\t\t\t \tTP53G245S\t\t\t\t \tTP53H179R\t\t\t\t \tTP53H193R\t\t\t\t \tTP53I195T\t\t\t\t \tTP53R175H\tOvary, Esophagus\t\t\t \tTP53R248Q\t\t\t\t \tTP53R248W\tBones\t\t\t \tTP53R273C\t\t\t\t \tTP53R273H\t\t\t\t \tTP53R273L\t\t\t\t \tTP53R282W\t\t\t\t \tTP53V157F\t\t\t\t \tTP53Y220C\t\t\t\t \t"}], "citations": {"NLM": "Ragone C, Cavalluzzo B, Mauriello A, Tagliamonte M, Buonaguro L. Lack of shared neoantigens in prevalent mutations in cancer J Transl Med. PMID: 38600547", "BibTeX": "@article{38600547, title={Lack of shared neoantigens in prevalent mutations in cancer}, author={Ragone C and Cavalluzzo B and Mauriello A and Tagliamonte M and Buonaguro L}, journal={J Transl Med}}"}, "is_sup_mat_match": false}, {"pmid": 26512781, "pmcid": "PMC4747370", "title": "A set of defined oncogenic mutation alleles seems to better predict the response to cetuximab in CRC patient-derived xenograft than KRAS 12/13 mutations.", "journal": "Oncotarget", "authors": ["Chen D", "Huang X", "Cai J", "Guo S", "Qian W", "Wery JP", "Li QX"], "date": "2015-12-01T00:00:00Z", "year": 2015, "snippets": [{"_id": "26512781@1306", "snip_text": "Furthermore, majority of the non-/partial responders tend to have certain activating oncogenic alleles (one or more of the following common ones: K/N-RAS-G12V/D, -A146T, -Q61H/R, BRAF-V600E, AKT1-L52R and PIK3CA-E545G/K).", "section": "abstract", "mentions": ["205|6|gene|ncbi_gene@5290|PIK3CA", "171|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "212|5|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123336#rs121913274##|E545G", "191|4|gene|ncbi_gene@207|AKT1", "154|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12V/D", "163|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "184|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "196|4|variant|litvar@#207#p.L52R&&&litvar@#207#|L52R", "179|4|gene|ncbi_gene@673|BRAF"], "text_hl": "Furthermore, majority of the non-/partial responders tend to have certain activating oncogenic alleles (one or more of the following common ones: K/N-RAS-G12V/D, -<m>A146T</m>, -Q61H/R, BRAF-V600E, AKT1-L52R and PIK3CA-E545G/K)."}], "citations": {"NLM": "Chen D, Huang X, Cai J, Guo S, Qian W, Wery JP, Li QX. A set of defined oncogenic mutation alleles seems to better predict the response to cetuximab in CRC patient-derived xenograft than KRAS 12/13 mutations. Oncotarget. PMID: 26512781", "BibTeX": "@article{26512781, title={A set of defined oncogenic mutation alleles seems to better predict the response to cetuximab in CRC patient-derived xenograft than KRAS 12/13 mutations.}, author={Chen D and Huang X and Cai J and Guo S and Qian W and Wery JP and Li QX}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 26335936, "pmcid": "PMC4557483", "title": "The Italian external quality assessment for RAS testing in colorectal carcinoma identifies methods-related inter-laboratory differences.", "journal": "J Transl Med", "authors": ["Normanno N", "Pinto C", "Castiglione F", "Fenizia F", "Barberis M", "Marchetti A", "Fontanini G", "De Rosa G", "Taddei GL"], "date": "2015-09-03T00:00:00Z", "year": 2015, "snippets": [{"_id": "26335936@9094", "snip_text": "Sample ID KRASa BRAFa NRASa   A1 WT WT WT   A2 WT WT WT   A3 WT WT WT   A4 WT WT WT   A5 WT WT WT   A6 WT p.V600E (c.1799T > A) (27.6 %) WT   A7 p.A146T (c.436G > A) (27.6 %) WT WT   A8 p.G12D (c.35G > A) (24.2 %) WT WT   A9 WT WT p.G12D (c.35G > A) (18.1 %)   A10 WT WT p.Q61K (c.181C > A) (74.6 %)   B1 WT WT WT   B2 WT WT WT   B3 WT WT WT   B4 WT WT WT   B5 WT WT WT   B6 p.G12D (c.35G > A) (27.7 %) WT WT   B7 p.A146T (c.436G > A) (62 %) WT WT   B8 WT WT p.Q61R (c.182A > G) (29.5 %)   B9 WT WT p.G12S (c.34G > A) (45.2 %)   B10 WT p.V600E (c.1799T > A) (36.9 %) WT   ", "section": "table", "mentions": ["145|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "499|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "154|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "106|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "194|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "423|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "536|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "507|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G > A", "186|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "467|10|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|c.182A > G", "414|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "115|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T > A", "383|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "239|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "279|10|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA180750#rs121913238##|c.181C > A", "271|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "545|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T > A", "459|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "375|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "231|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D"], "figure_id": "Tab2", "text_hl": "Sample ID KRASa BRAFa NRASa   A1 WT WT WT   A2 WT WT WT   A3 WT WT WT   A4 WT WT WT   A5 WT WT WT   A6 WT p.V600E (c.1799T > A) (27.6 %) WT   A7 <m>p.A146T</m> (c.436G > A) (27.6 %) WT WT   A8 p.G12D (c.35G > A) (24.2 %) WT WT   A9 WT WT p.G12D (c.35G > A) (18.1 %)   A10 WT WT p.Q61K (c.181C > A) (74.6 %)   B1 WT WT WT   B2 WT WT WT   B3 WT WT WT   B4 WT WT WT   B5 WT WT WT   B6 p.G12D (c.35G > A) (27.7 %) WT WT   B7 <m>p.A146T</m> (c.436G > A) (62 %) WT WT   B8 WT WT p.Q61R (c.182A > G) (29.5 %)   B9 WT WT p.G12S (c.34G > A) (45.2 %)   B10 WT p.V600E (c.1799T > A) (36.9 %) WT   "}], "citations": {"NLM": "Normanno N, Pinto C, Castiglione F, Fenizia F, Barberis M, Marchetti A, Fontanini G, De Rosa G, Taddei GL. The Italian external quality assessment for RAS testing in colorectal carcinoma identifies methods-related inter-laboratory differences. J Transl Med. PMID: 26335936", "BibTeX": "@article{26335936, title={The Italian external quality assessment for RAS testing in colorectal carcinoma identifies methods-related inter-laboratory differences.}, author={Normanno N and Pinto C and Castiglione F and Fenizia F and Barberis M and Marchetti A and Fontanini G and De Rosa G and Taddei GL}, journal={J Transl Med}}"}, "is_sup_mat_match": false}, {"pmid": 38613732, "pmcid": "PMC11111497", "title": "Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Analysis", "journal": "Target Oncol", "authors": ["Basso M", "Signorelli C", "Calegari MA", "Lucchetti J", "Zurlo IV", "Dell'Aquila E", "Arrivi G", "Zoratto F", "Santamaria F", "Saltarelli R", "Trovato G", "Caira G", "Angotti L", "Schirripa M", "Anghelone A", "Schietroma F", "Chilelli MG", "Salvatore L", "Pozzo C", "Tortora G"], "date": "2024-04-13T00:00:00Z", "year": 2024, "snippets": [{"_id": "38613732@12357", "snip_text": "RAS mutation\tPatients (%)\t \tNo mutation (all wild-type)\t270 (46.3)\t \tKras Codon 12\t212 (36.4)\t \t G12D\t63 (10.8)\t \t G12V\t53\t \t G12C\t17 (2.9)\t \t G12R\t3\t \t G12S\t9\t \t G12A\t14\t \t G12V/D/A\t19\t \t G12X\t34\t \tKras Codon 13\t49 (8.4)\t \t G13D\t40\t \t G13C\t1\t \t G13A\t1\t \t G13X\t7\t \tRare mutations\t51 (8.7)\t \t Kras A146X\t8\t \t Kras A146T\t6\t \t Kras A146V\t1\t \t Kras G61X\t2\t \t Kras Q61K\t1\t \t Kras K117X\t2\t \t Kras A146G\t1\t \t Kras A59T\t1\t \t Kras Q22K\t1\t \tKras codon 61 not further specified\t3\t \t Nras G12A\t3\t \t Nras G61L\t3\t \t Nras Q61H\t3\t \t Nras Q61X\t4\t \t Nras Q61L\t2\t \t Nras Q61R\t2\t \t Nras Q61K\t2\t \t Nras G61A\t2\t \t Nras A117X\t2\t \t Nras G61C\t1\t \t Nras A11P\t1\t \t", "section": "table", "mentions": ["402|4|gene|ncbi_gene@3845|Kras", "370|4|gene|ncbi_gene@3845|Kras", "163|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "517|4|gene|ncbi_gene@4893|Nras", "292|4|gene|ncbi_gene@3845|Kras", "613|4|variant|litvar@rs587778113##&&&litvar@#673#|G61C", "324|4|gene|ncbi_gene@3845|Kras", "623|4|gene|ncbi_gene@4893|Nras", "407|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "246|4|variant|litvar@rs193929331##&&&litvar@#3845#&&&litvar@CA250291#rs193929331##|G13A", "256|4|variant|litvar@rs112445441##&&&litvar@#3845#|G13X", "577|4|gene|ncbi_gene@4893|Nras", "522|4|variant|litvar@rs121913254##&&&litvar@#4893#|Q61X", "628|4|variant|litvar@#4893#p.A11P&&&litvar@#4893#|A11P", "597|5|variant|litvar@#4893#p.A117X&&&litvar@#4893#|A117X", "477|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "582|4|variant|litvar@rs373129709##&&&litvar@#1956#&&&litvar@CA4265111#rs373129709##|G61A", "174|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "431|4|gene|ncbi_gene@3845|Kras", "391|5|variant|litvar@rs1484032303##&&&litvar@#1956#|A146G", "417|4|gene|ncbi_gene@3845|Kras", "472|4|gene|ncbi_gene@4893|Nras", "313|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "532|4|gene|ncbi_gene@4893|Nras", "592|4|gene|ncbi_gene@4893|Nras", "422|4|variant|litvar@rs121913236##&&&litvar@#3845#&&&litvar@CA16602771#rs121913236##|Q22K", "69|4|gene|ncbi_gene@3845|Kras", "143|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "537|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "386|4|gene|ncbi_gene@3845|Kras", "97|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "225|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "308|4|gene|ncbi_gene@3845|Kras", "340|4|gene|ncbi_gene@3845|Kras", "487|4|gene|ncbi_gene@4893|Nras", "189|4|variant|litvar@rs121913529##&&&litvar@#3845#|G12X", "552|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "345|4|variant|litvar@rs121913254##&&&litvar@#4893#|G61X", "492|4|variant|litvar@rs121913254##&&&litvar@#4893#|G61L", "547|4|gene|ncbi_gene@4893|Nras", "375|5|variant|litvar@#4893#p.K117X&&&litvar@#4893#|K117X", "502|4|gene|ncbi_gene@4893|Nras", "360|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "153|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "126|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "199|4|gene|ncbi_gene@3845|Kras", "329|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "355|4|gene|ncbi_gene@3845|Kras", "562|4|gene|ncbi_gene@4893|Nras", "297|5|variant|litvar@rs1484032303##&&&litvar@#1956#|A146X", "507|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "236|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "567|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "608|4|gene|ncbi_gene@4893|Nras"], "figure_id": "Tab1", "text_hl": "RAS mutation\tPatients (%)\t \tNo mutation (all wild-type)\t270 (46.3)\t \tKras Codon 12\t212 (36.4)\t \t G12D\t63 (10.8)\t \t G12V\t53\t \t G12C\t17 (2.9)\t \t G12R\t3\t \t G12S\t9\t \t G12A\t14\t \t G12V/D/A\t19\t \t G12X\t34\t \tKras Codon 13\t49 (8.4)\t \t G13D\t40\t \t G13C\t1\t \t G13A\t1\t \t G13X\t7\t \tRare mutations\t51 (8.7)\t \t Kras A146X\t8\t \t Kras <m>A146T</m>\t6\t \t Kras A146V\t1\t \t Kras G61X\t2\t \t Kras Q61K\t1\t \t Kras K117X\t2\t \t Kras A146G\t1\t \t Kras A59T\t1\t \t Kras Q22K\t1\t \tKras codon 61 not further specified\t3\t \t Nras G12A\t3\t \t Nras G61L\t3\t \t Nras Q61H\t3\t \t Nras Q61X\t4\t \t Nras Q61L\t2\t \t Nras Q61R\t2\t \t Nras Q61K\t2\t \t Nras G61A\t2\t \t Nras A117X\t2\t \t Nras G61C\t1\t \t Nras A11P\t1\t \t"}], "citations": {"NLM": "Basso M, Signorelli C, Calegari MA, Lucchetti J, Zurlo IV, Dell'Aquila E, Arrivi G, Zoratto F, Santamaria F, Saltarelli R, Trovato G, Caira G, Angotti L, Schirripa M, Anghelone A, Schietroma F, Chilelli MG, Salvatore L, Pozzo C, Tortora G. Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Analysis Target Oncol. PMID: 38613732", "BibTeX": "@article{38613732, title={Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Analysis}, author={Basso M and Signorelli C and Calegari MA and Lucchetti J and Zurlo IV and Dell'Aquila E and Arrivi G and Zoratto F and Santamaria F and Saltarelli R and Trovato G and Caira G and Angotti L and Schirripa M and Anghelone A and Schietroma F and Chilelli MG and Salvatore L and Pozzo C and Tortora G}, journal={Target Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 35409398, "pmcid": "PMC8999796", "title": "Identification of Codon 146 KRAS Variants in Isolated Epidermal Nevus and Multiple Lesions in Oculoectodermal Syndrome: Confirmation of the Phenotypic Continuum of Mosaic RASopathies.", "journal": "Int J Mol Sci", "authors": ["Beyens A", "Dequeker L", "Brems H", "Janssens S", "Syryn H", "D'Hooghe A", "De Paepe P", "Vanwalleghem L", "Stockman A", "Vankwikelberge E", "De Schepper S", "Goeteyn M", "Delbeke P", "Callewaert B"], "date": "2022-04-06T00:00:00Z", "year": 2022, "snippets": [{"_id": "35409398@9556", "snip_text": "Subsequent next-generation sequencing analysis on DNA directly extracted from a skin biopsy taken in the linear hyperpigmentation was able to identify a mosaic missense variant (c.436G > A, p.(Ala146Thr)) in the KRAS gene, illustrated by variant frequencies of 60% in cells of the epidermis and 22% in the dermis/hypodermis.", "section": "results", "mentions": ["112|17|disease|ncbi_mesh@D017495|hyperpigmentation", "212|4|gene|ncbi_gene@3845|KRAS", "190|13|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.(Ala146Thr)", "178|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A"], "text_hl": "Subsequent next-generation sequencing analysis on DNA directly extracted from a skin biopsy taken in the linear hyperpigmentation was able to identify a mosaic missense variant (c.436G > A, p.(<m>Ala146Thr</m>)) in the KRAS gene, illustrated by variant frequencies of 60% in cells of the epidermis and 22% in the dermis/hypodermis."}], "citations": {"NLM": "Beyens A, Dequeker L, Brems H, Janssens S, Syryn H, D'Hooghe A, De Paepe P, Vanwalleghem L, Stockman A, Vankwikelberge E, De Schepper S, Goeteyn M, Delbeke P, Callewaert B. Identification of Codon 146 KRAS Variants in Isolated Epidermal Nevus and Multiple Lesions in Oculoectodermal Syndrome: Confirmation of the Phenotypic Continuum of Mosaic RASopathies. Int J Mol Sci. PMID: 35409398", "BibTeX": "@article{35409398, title={Identification of Codon 146 KRAS Variants in Isolated Epidermal Nevus and Multiple Lesions in Oculoectodermal Syndrome: Confirmation of the Phenotypic Continuum of Mosaic RASopathies.}, author={Beyens A and Dequeker L and Brems H and Janssens S and Syryn H and D'Hooghe A and De Paepe P and Vanwalleghem L and Stockman A and Vankwikelberge E and De Schepper S and Goeteyn M and Delbeke P and Callewaert B}, journal={Int J Mol Sci}}"}, "is_sup_mat_match": false}, {"pmid": 36563789, "title": "Development of a high-throughput TR-FRET screening assay for a fast-cycling KRAS mutant.", "journal": "SLAS Discov", "authors": ["Larson JE", "Hardy PB", "Schomburg NK", "Wang X", "Kireev D", "Rossman KL", "Pearce KH"], "date": "2022-12-20T00:00:00Z", "year": 2022, "snippets": [{"_id": "36563789@691", "snip_text": "Herein, we focused on the KRAS mutant A146T, found in colorectal cancers, that exhibits a \"fast-cycling\" nucleotide mechanism as a driver for oncogenic activation.", "section": "abstract", "mentions": ["38|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "26|4|gene|ncbi_gene@3845|KRAS", "54|18|disease|ncbi_mesh@D015179|colorectal cancers"], "text_hl": "Herein, we focused on the KRAS mutant <m>A146T</m>, found in colorectal cancers, that exhibits a \"fast-cycling\" nucleotide mechanism as a driver for oncogenic activation."}], "citations": {"NLM": "Larson JE, Hardy PB, Schomburg NK, Wang X, Kireev D, Rossman KL, Pearce KH. Development of a high-throughput TR-FRET screening assay for a fast-cycling KRAS mutant. SLAS Discov. PMID: 36563789", "BibTeX": "@article{36563789, title={Development of a high-throughput TR-FRET screening assay for a fast-cycling KRAS mutant.}, author={Larson JE and Hardy PB and Schomburg NK and Wang X and Kireev D and Rossman KL and Pearce KH}, journal={SLAS Discov}}"}, "is_sup_mat_match": false}, {"pmid": 35159069, "pmcid": "PMC8833999", "title": "RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study.", "journal": "Cancers (Basel)", "authors": ["Nicolazzo C", "Belardinilli F", "Vestri A", "Magri V", "De Renzi G", "De Meo M", "Caponnetto S", "Di Nicolantonio F", "Cortesi E", "Giannini G", "Gazzaniga P"], "date": "2022-02-04T00:00:00Z", "year": 2022, "snippets": [{"_id": "35159069@28334", "snip_text": "Pt. N. Bevacizumab RAS Mutation Tissue/Plasma Baseline Timing of RAS Conversion (Months) ctDNA Confirmation Test   1 no KRAS G12V 3 NGS TP53 c.524G>A p.R175H   5 yes KRAS G12V 9 methylation MSC ITGA4 EYA4   7 yes KRAS G12V 9 NGS SMAD4 c.1522G>T p.G508C   9 yes KRAS G12V 3 NGS TP53 c.659A>G p.Y220C   22 yes KRAS G12V 3 NGS SMAD4 c.1522G>T p.G508C   27 yes KRAS G12V 9 NGS TP53: c.659A>G p.Y220C   39 yes KRAS G12V 6 NGS PIK3CA c.1625A>T p.E542V   24 yes KRAS G12V 3 none    2 no NRAS G12C 3 methylation MAP3K MSC ITGA4 EYA4   8 yes KRAS G12C 6 NGS TP53: c.527G>T p.C176F   26 yes KRAS G12C 3 methylation MAP3K EYA4   33 yes KRAS G12C 12 NGS PIK3CA: c.3062A>G p. Y1021C   36 yes KRAS G12C 6 methylation MAP3K MSC ITGA4 EYA4 GRIA4   3 yes KRAS G12D 6 NGS TP53 c.743G>A p.R248Q   6 yes KRAS G12D 3 NGS PTEN c.209+6T>C   16 yes KRAS G12D 3 NGS TP53 c.743G>A p.R248Q   21 yes KRAS G12D 6 NGS TP53 c.524G>A p.R175H   23 yes KRAS G12D 9 none    28 yes KRAS G12D 3 NGS PIK3CA: c.3062A>G p. Y1021C   30 yes KRAS G12D 3 NGS TP53 c.844C>T p.R282W   37 yes KRAS G12D 9 NGS TP53 c.517G>A p.V173M   34 yes KRAS G12D 6 none    35 yes KRAS G12D 9 NGS FBXW7 c.1513C>T p.R505C; AKT1 c.49G>A p.E17K   32 yes KRAS G12D 6 none    38 yes KRAS G12D 9 NGS TP53 c.524G>A p.R175H   43 yes KRAS G12D 12 NGS PIK3CA c.1625A>T p.E542V   17 yes KRAS G12A 6 methylation MAP3K MSC ITGA4 EYA4 GRIA4   19 yes KRAS G12A 6 NGS PIK3CA c.3140A>G p.H1047R   41 yes KRAS G12A 6 methylation EYA4 GRIA4   14 yes KRAS G13D 3 NGS MAP2K1 c.171G>T p.K57N   20 yes KRAS G13D 6 methylation MAP3K MSC ITGA4 EYA4 GRIA4   4 yes KRAS A146t 3 none    25 yes KRAS A146T 6 NGS TP53 c.817C>T p.T273C   29 yes KRAS A146T 9 methylation MAP3K ITGA4 EYA4 GRIA4   42 yes KRAS A146T 12 NGS DDR2 c.1376C>T p.S459F   12 yes KRAS Q61K 3 NGS TP53: c.659A>G p.Y220C   13 yes KRAS Q61K 6 NGS PIK3CA: c.3062A>G p. Y1021C   40 yes KRAS Q61H 12 NGS TP53 c.401T>C p.F134S   11 yes NRAS G12D 3 NGS FBXW7 c.1513C>T p.R505C   10 yes NRAS G12D 6 none    15 yes NRAS G12D 9 none    18 yes NRAS A146T 3 methylation ITGA4 EYA4   31 yes NRAS Q61R 3 NGS SMAD4 c.989A>C p.E330A   ", "section": "table", "mentions": ["428|9|variant|litvar@rs1057519927##&&&litvar@#5290#|c.1625A>T", "480|4|gene|ncbi_gene@4893|NRAS", "150|7|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|p.R175H", "1349|5|gene|ncbi_gene@3676|ITGA4", "1004|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1431|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "1824|6|gene|ncbi_gene@5290|PIK3CA", "663|6|variant|litvar@rs121913288##&&&litvar@#5290#&&&litvar@CA16602699#rs121913288##|Y1021C", "1523|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "362|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1776|4|gene|ncbi_gene@7157|TP53", "194|5|gene|ncbi_gene@3676|ITGA4", "266|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1658|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1166|7|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|c.49G>A", "1288|9|variant|litvar@rs1057519927##&&&litvar@#5290#|c.1625A>T", "1883|8|variant|litvar@rs1057519747##&&&litvar@#7157#|c.401T>C", "1931|9|variant|litvar@rs149680468##&&&litvar@#55294#&&&litvar@CA16602253#rs149680468##|c.1513C>T", "713|5|gene|ncbi_gene@3676|ITGA4", "2088|7|variant|litvar@rs281875324##&&&litvar@#4089#|p.E330A", "611|4|gene|ncbi_gene@2070|EYA4", "1486|6|gene|ncbi_gene@5604|MAP2K1", "877|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "421|6|gene|ncbi_gene@5290|PIK3CA", "1195|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "120|4|gene|ncbi_gene@3845|KRAS", "1222|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "330|9|variant|litvar@rs121913361##&&&litvar@#673#&&&litvar@CA135098#rs121913361##|c.1522G>T", "277|4|gene|ncbi_gene@7157|TP53", "171|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1475|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1136|5|gene|ncbi_gene@55294|FBXW7", "1098|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2012|4|gene|ncbi_gene@4893|NRAS", "520|4|gene|ncbi_gene@2070|EYA4", "768|7|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|p.R248Q", "245|7|variant|litvar@rs121913361##&&&litvar@#673#&&&litvar@CA16602422#rs121913361##|p.G508C", "1622|4|gene|ncbi_gene@7157|TP53", "218|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1076|7|variant|litvar@rs876660754##&&&litvar@#7157#&&&litvar@CA10577579#rs876660754##|p.V173M", "888|4|gene|ncbi_gene@7157|TP53", "1281|6|gene|ncbi_gene@5290|PIK3CA", "1990|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1558|4|gene|ncbi_gene@2070|EYA4", "1455|5|gene|ncbi_gene@2893|GRIA4", "1866|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "549|4|gene|ncbi_gene@7157|TP53", "1958|4|gene|ncbi_gene@4893|NRAS", "1380|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "485|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "650|9|variant|litvar@rs121913288##&&&litvar@#5290#&&&litvar@CA16602699#rs121913288##|c.3062A>G", "1493|8|variant|litvar@rs869025608##&&&litvar@#5604#&&&litvar@CA356995#rs869025608##|c.171G>T", "789|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1360|5|gene|ncbi_gene@2893|GRIA4", "1161|4|gene|ncbi_gene@207|AKT1", "846|8|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|c.743G>A", "1067|8|variant|litvar@rs876660754##&&&litvar@#7157#&&&litvar@CA10577579#rs876660754##|c.517G>A", "1695|5|gene|ncbi_gene@2893|GRIA4", "308|4|gene|ncbi_gene@3845|KRAS", "951|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1142|9|variant|litvar@rs149680468##&&&litvar@#55294#&&&litvar@CA16602253#rs149680468##|c.1513C>T", "373|4|gene|ncbi_gene@7157|TP53", "455|4|gene|ncbi_gene@3845|KRAS", "1653|4|gene|ncbi_gene@3845|KRAS", "642|6|gene|ncbi_gene@5290|PIK3CA", "2073|5|gene|ncbi_gene@4089|SMAD4", "924|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "324|5|gene|ncbi_gene@4089|SMAD4", "125|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1408|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.H1047R", "141|8|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|c.524G>A", "1470|4|gene|ncbi_gene@3845|KRAS", "291|7|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|p.Y220C", "724|5|gene|ncbi_gene@2893|GRIA4", "983|6|variant|litvar@rs121913288##&&&litvar@#5290#&&&litvar@CA16602699#rs121913288##|Y1021C", "213|4|gene|ncbi_gene@3845|KRAS", "1610|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "2037|5|gene|ncbi_gene@3676|ITGA4", "438|7|variant|litvar@rs1057519927##&&&litvar@#5290#|p.E542V", "1636|7|variant|litvar@#7157#p.T273C&&&litvar@#7157#|p.T273C", "1502|6|variant|litvar@rs869025608##&&&litvar@#5604#&&&litvar@CA356995#rs869025608##|p.K57N", "586|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "902|7|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|p.R175H", "719|4|gene|ncbi_gene@2070|EYA4", "229|5|gene|ncbi_gene@4089|SMAD4", "1233|4|gene|ncbi_gene@7157|TP53", "1605|4|gene|ncbi_gene@3845|KRAS", "2079|8|variant|litvar@rs281875324##&&&litvar@#4089#|c.989A>C", "1552|5|gene|ncbi_gene@3676|ITGA4", "1963|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "830|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1450|4|gene|ncbi_gene@2070|EYA4", "1298|7|variant|litvar@rs1057519927##&&&litvar@#5290#|p.E542V", "1941|7|variant|litvar@rs149680468##&&&litvar@#55294#&&&litvar@CA16602253#rs149680468##|p.R505C", "1020|8|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|c.844C>T", "1808|4|gene|ncbi_gene@3845|KRAS", "564|7|variant|litvar@rs786202962##&&&litvar@#7157#|p.C176F", "743|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1051|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "759|8|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|c.743G>A", "684|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "2057|4|gene|ncbi_gene@4893|NRAS", "1015|4|gene|ncbi_gene@7157|TP53", "1029|7|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|p.R282W", "1690|4|gene|ncbi_gene@2070|EYA4", "841|4|gene|ncbi_gene@7157|TP53", "1627|8|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|c.817C>T", "1878|4|gene|ncbi_gene@7157|TP53", "1355|4|gene|ncbi_gene@2070|EYA4", "313|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1791|7|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|p.Y220C", "410|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "7|11|chemical|ncbi_mesh@D000068258|Bevacizumab", "405|4|gene|ncbi_gene@3845|KRAS", "460|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1845|6|variant|litvar@rs121913288##&&&litvar@#5290#&&&litvar@CA16602699#rs121913288##|Y1021C", "2062|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "1765|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "1582|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146t", "1760|4|gene|ncbi_gene@3845|KRAS", "235|9|variant|litvar@rs121913361##&&&litvar@#673#&&&litvar@CA135098#rs121913361##|c.1522G>T", "1684|5|gene|ncbi_gene@3676|ITGA4", "1269|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "136|4|gene|ncbi_gene@7157|TP53", "970|9|variant|litvar@rs121913288##&&&litvar@#5290#&&&litvar@CA16602699#rs121913288##|c.3062A>G", "555|8|variant|litvar@rs786202962##&&&litvar@#7157#|c.527G>T", "1577|4|gene|ncbi_gene@3845|KRAS", "388|7|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|p.Y220C", "1247|7|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|p.R175H", "1320|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "514|5|gene|ncbi_gene@3676|ITGA4", "1518|4|gene|ncbi_gene@3845|KRAS", "1743|7|variant|litvar@rs1042738234##&&&litvar@#2070#|p.S459F", "357|4|gene|ncbi_gene@3845|KRAS", "261|4|gene|ncbi_gene@3845|KRAS", "962|6|gene|ncbi_gene@5290|PIK3CA", "1782|8|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|c.659A>G", "1398|9|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A>G", "1914|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1152|7|variant|litvar@rs149680468##&&&litvar@#55294#&&&litvar@CA16602253#rs149680468##|p.R505C", "1909|4|gene|ncbi_gene@4893|NRAS", "1813|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "1125|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1733|9|variant|litvar@rs1042738234##&&&litvar@#2070#&&&litvar@CA148073527#rs1042738234##|c.1376C>T", "340|7|variant|litvar@rs121913361##&&&litvar@#673#&&&litvar@CA16602422#rs121913361##|p.G508C", "282|8|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|c.659A>G", "2043|4|gene|ncbi_gene@2070|EYA4", "1925|5|gene|ncbi_gene@55294|FBXW7", "166|4|gene|ncbi_gene@3845|KRAS", "754|4|gene|ncbi_gene@7157|TP53", "538|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "1563|5|gene|ncbi_gene@2893|GRIA4", "1174|6|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|p.E17K", "379|8|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|c.659A>G", "1062|4|gene|ncbi_gene@7157|TP53", "2017|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "630|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "893|8|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|c.524G>A", "855|7|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|p.R248Q", "1715|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1892|7|variant|litvar@rs1057519747##&&&litvar@#7157#|p.F134S", "1985|4|gene|ncbi_gene@4893|NRAS", "1391|6|gene|ncbi_gene@5290|PIK3CA", "1832|9|variant|litvar@rs121913288##&&&litvar@#5290#&&&litvar@CA16602699#rs121913288##|c.3062A>G", "805|10|variant|litvar@#7157#c.209+6T>C&&&litvar@#7157#|c.209+6T>C", "1238|8|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|c.524G>A", "1861|4|gene|ncbi_gene@3845|KRAS", "1710|4|gene|ncbi_gene@3845|KRAS", "200|4|gene|ncbi_gene@2070|EYA4"], "figure_id": "cancers-14-00802-t002", "text_hl": "Pt. N. Bevacizumab RAS Mutation Tissue/Plasma Baseline Timing of RAS Conversion (Months) ctDNA Confirmation Test   1 no KRAS G12V 3 NGS TP53 c.524G>A p.R175H   5 yes KRAS G12V 9 methylation MSC ITGA4 EYA4   7 yes KRAS G12V 9 NGS SMAD4 c.1522G>T p.G508C   9 yes KRAS G12V 3 NGS TP53 c.659A>G p.Y220C   22 yes KRAS G12V 3 NGS SMAD4 c.1522G>T p.G508C   27 yes KRAS G12V 9 NGS TP53: c.659A>G p.Y220C   39 yes KRAS G12V 6 NGS PIK3CA c.1625A>T p.E542V   24 yes KRAS G12V 3 none    2 no NRAS G12C 3 methylation MAP3K MSC ITGA4 EYA4   8 yes KRAS G12C 6 NGS TP53: c.527G>T p.C176F   26 yes KRAS G12C 3 methylation MAP3K EYA4   33 yes KRAS G12C 12 NGS PIK3CA: c.3062A>G p. Y1021C   36 yes KRAS G12C 6 methylation MAP3K MSC ITGA4 EYA4 GRIA4   3 yes KRAS G12D 6 NGS TP53 c.743G>A p.R248Q   6 yes KRAS G12D 3 NGS PTEN c.209+6T>C   16 yes KRAS G12D 3 NGS TP53 c.743G>A p.R248Q   21 yes KRAS G12D 6 NGS TP53 c.524G>A p.R175H   23 yes KRAS G12D 9 none    28 yes KRAS G12D 3 NGS PIK3CA: c.3062A>G p. Y1021C   30 yes KRAS G12D 3 NGS TP53 c.844C>T p.R282W   37 yes KRAS G12D 9 NGS TP53 c.517G>A p.V173M   34 yes KRAS G12D 6 none    35 yes KRAS G12D 9 NGS FBXW7 c.1513C>T p.R505C; AKT1 c.49G>A p.E17K   32 yes KRAS G12D 6 none    38 yes KRAS G12D 9 NGS TP53 c.524G>A p.R175H   43 yes KRAS G12D 12 NGS PIK3CA c.1625A>T p.E542V   17 yes KRAS G12A 6 methylation MAP3K MSC ITGA4 EYA4 GRIA4   19 yes KRAS G12A 6 NGS PIK3CA c.3140A>G p.H1047R   41 yes KRAS G12A 6 methylation EYA4 GRIA4   14 yes KRAS G13D 3 NGS MAP2K1 c.171G>T p.K57N   20 yes KRAS G13D 6 methylation MAP3K MSC ITGA4 EYA4 GRIA4   4 yes KRAS <m>A146t</m> 3 none    25 yes KRAS <m>A146T</m> 6 NGS TP53 c.817C>T p.T273C   29 yes KRAS <m>A146T</m> 9 methylation MAP3K ITGA4 EYA4 GRIA4   42 yes KRAS <m>A146T</m> 12 NGS DDR2 c.1376C>T p.S459F   12 yes KRAS Q61K 3 NGS TP53: c.659A>G p.Y220C   13 yes KRAS Q61K 6 NGS PIK3CA: c.3062A>G p. Y1021C   40 yes KRAS Q61H 12 NGS TP53 c.401T>C p.F134S   11 yes NRAS G12D 3 NGS FBXW7 c.1513C>T p.R505C   10 yes NRAS G12D 6 none    15 yes NRAS G12D 9 none    18 yes NRAS <m>A146T</m> 3 methylation ITGA4 EYA4   31 yes NRAS Q61R 3 NGS SMAD4 c.989A>C p.E330A   "}], "citations": {"NLM": "Nicolazzo C, Belardinilli F, Vestri A, Magri V, De Renzi G, De Meo M, Caponnetto S, Di Nicolantonio F, Cortesi E, Giannini G, Gazzaniga P. RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study. Cancers (Basel). PMID: 35159069", "BibTeX": "@article{35159069, title={RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study.}, author={Nicolazzo C and Belardinilli F and Vestri A and Magri V and De Renzi G and De Meo M and Caponnetto S and Di Nicolantonio F and Cortesi E and Giannini G and Gazzaniga P}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 34940123, "pmcid": "PMC8929001", "title": "Molecular Genetics of Pre-B Acute Lymphoblastic Leukemia Sister Cell Lines during Disease Progression.", "journal": "Curr Issues Mol Biol", "authors": ["Quentmeier H", "Pommerenke C", "Drexler HG"], "date": "2021-11-30T00:00:00Z", "year": 2021, "snippets": [{"_id": "34940123@516", "snip_text": "All five pairs of cell lines carry alterations that are typical for this disease: loss of tumor suppressors (CDKN2A, CDKN2B), expression of fusion genes (ETV6-RUNX1, BCR-ABL1, MEF2D-BCL9) or of genes targeted by point mutations (KRAS A146T, NRAS G12C, PAX5 R38H).", "section": "abstract", "mentions": ["109|6|gene|ncbi_gene@1029|CDKN2A", "182|4|gene|ncbi_gene@77578|BCL9", "176|5|gene|ncbi_gene@17261|MEF2D", "246|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "252|4|gene|ncbi_gene@5079|PAX5", "159|5|gene|ncbi_gene@861|RUNX1", "229|4|gene|ncbi_gene@3845|KRAS", "117|6|gene|ncbi_gene@1030|CDKN2B", "234|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "90|5|disease|ncbi_mesh@D009369|tumor", "257|4|variant|litvar@#5079#p.R38H&&&litvar@#5079#|R38H", "241|4|gene|ncbi_gene@4893|NRAS", "154|4|gene|ncbi_gene@2120|ETV6", "166|8|gene|ncbi_gene@613|BCR-ABL1"], "text_hl": "All five pairs of cell lines carry alterations that are typical for this disease: loss of tumor suppressors (CDKN2A, CDKN2B), expression of fusion genes (ETV6-RUNX1, BCR-ABL1, MEF2D-BCL9) or of genes targeted by point mutations (KRAS <m>A146T</m>, NRAS G12C, PAX5 R38H)."}], "citations": {"NLM": "Quentmeier H, Pommerenke C, Drexler HG. Molecular Genetics of Pre-B Acute Lymphoblastic Leukemia Sister Cell Lines during Disease Progression. Curr Issues Mol Biol. PMID: 34940123", "BibTeX": "@article{34940123, title={Molecular Genetics of Pre-B Acute Lymphoblastic Leukemia Sister Cell Lines during Disease Progression.}, author={Quentmeier H and Pommerenke C and Drexler HG}, journal={Curr Issues Mol Biol}}"}, "is_sup_mat_match": false}, {"pmid": 39071917, "pmcid": "PMC11283146", "title": "Plasma-Derived Cell-Free DNA for the Diagnosis of Ocular-Involving Histiocytosis", "journal": "Ophthalmol Sci", "authors": ["Francis JH", "Arcila ME", "Sigler A", "Bossert DF", "Abramson DH", "Diamond EL"], "date": "2024-04-15T00:00:00Z", "year": 2024, "snippets": [{"_id": "39071917@8253", "snip_text": "Patient\tAge at Diagnosis (Yrs)\tGender\tHistiocytosis Subtype\tOther Sites of Disease\tEye Findings\tMutational Status\tcfDNA Testing\tcfDNA VAF\tSite of Solid Tissue Confirmation\t \t1\t55.1\tM\tECD\tBone, brain, CV, pulmonary, retro, abdomen\tChoroid, orbit\tBRAF V600E\tNGS, ddPCR\t0.95%\tPerirenal\t \t2\t52.5\tM\tECD\tBone, brain, retro, abdomen\tChoroid, dysmotility\tBRAF V600E\tNGS\t0.85%\tPerirenal and tibia*\t \t3\t47.8\tM\tXG\tNone\tOrbit\tKRAS K117N\tNGS\t0.07%\tOrbit*\t \t4\t25.5\tM\tECD/LCH\tBone, CV, skin\tSclera, orbit, eyelid\tBRAF M484_P490 deletion\tNGS, ddPCR\t0.48%\tSkin (eyelid)\t \t5\t79.4\tF\tRDD\tPulmonary, nasopharynx\tChoroid, CN VI palsy\tKRAS in-frame insertion Y64_S65insVS\tNGS\t3.48%\tNasopharyngeal\t \t6\t68.9\tF\tECD\tBone, skin, LN\tChoroid, eyelid\tBRAF V600E\tNGS, ddPCR\t0.54%\tSkin (eyelid)\t \t7\t47.1\tF\tECD\tNeuro (DI), bone, brain, CV, retro\tChoroid\tBRAF V600E\tNGS, ddPCR\t1.81%\tPerirenal\t \t8\t49.6\tF\tRDD\tBone, retro, LN\tChoroid\tMAP2K1 K57T, KRAS A146P\tNGS\t0.37% KRAS, 0.12% MAP2K1\tLymph node\t \t9\t22.1\tM\tECD/LCH\tNeuro (dura), bone, skin\tOrbit\tBRAF V600E\tNGS, ddPCR\t0.46%\tTemporal lobe\t \t10\t66.2\tF\tECD\tNeuro (dura), bone, brain, CV\tChoroid\tBRAF V600E\tNGS, ddPCR\t0.07%\tDura\t \t11\t37.8\tM\tECD\tNeuro (dura, pituitary), bone, brain, CV, skin, testes\tOptic nerve\tBRAF V600E\tNGS, ddPCR\t0.52%\tTestes\t \t12\t67.7\tM\tECD\tNeuro (DI), bone, brain, CV, retro, skin\tSclerochoroidal, eyelid\tBRAF V600E\tNGS, ddPCR\t0.06%\tSkin (eyelid)\t \t13\t61.8\tF\tECD\tBone\tChoroid, orbit\tARAF S213A\tNGS, ddPCR\t0.89%\tBone\t \t14\t34.4\tM\tECD\tNeuro (DI), bone, brain, retro, LN\tUvea (uveitis)\tBRAF V600E\tNGS\t0.08%\tLymph node*\t \t", "section": "table", "mentions": ["820|4|gene|ncbi_gene@673|BRAF", "915|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "725|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "347|4|gene|ncbi_gene@673|BRAF", "1417|4|gene|ncbi_gene@369|ARAF", "1339|4|gene|ncbi_gene@673|BRAF", "1107|4|gene|ncbi_gene@673|BRAF", "1228|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "250|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "910|4|gene|ncbi_gene@3845|KRAS", "612|4|gene|ncbi_gene@3845|KRAS", "414|4|gene|ncbi_gene@3845|KRAS", "943|6|gene|ncbi_gene@5604|MAP2K1", "1112|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "245|4|gene|ncbi_gene@673|BRAF", "1516|4|gene|ncbi_gene@673|BRAF", "720|4|gene|ncbi_gene@673|BRAF", "897|6|gene|ncbi_gene@5604|MAP2K1", "1011|4|gene|ncbi_gene@673|BRAF", "931|4|gene|ncbi_gene@3845|KRAS", "352|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "825|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "498|4|gene|ncbi_gene@673|BRAF", "1422|5|variant|litvar@#369#p.S213A&&&litvar@#369#|S213A", "1521|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "419|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "1016|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1223|4|gene|ncbi_gene@673|BRAF", "1344|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "904|4|variant|litvar@rs1057519909##&&&litvar@#5604#|K57T"], "figure_id": "tbl1", "text_hl": "Patient\tAge at Diagnosis (Yrs)\tGender\tHistiocytosis Subtype\tOther Sites of Disease\tEye Findings\tMutational Status\tcfDNA Testing\tcfDNA VAF\tSite of Solid Tissue Confirmation\t \t1\t55.1\tM\tECD\tBone, brain, CV, pulmonary, retro, abdomen\tChoroid, orbit\tBRAF V600E\tNGS, ddPCR\t0.95%\tPerirenal\t \t2\t52.5\tM\tECD\tBone, brain, retro, abdomen\tChoroid, dysmotility\tBRAF V600E\tNGS\t0.85%\tPerirenal and tibia*\t \t3\t47.8\tM\tXG\tNone\tOrbit\tKRAS K117N\tNGS\t0.07%\tOrbit*\t \t4\t25.5\tM\tECD/LCH\tBone, CV, skin\tSclera, orbit, eyelid\tBRAF M484_P490 deletion\tNGS, ddPCR\t0.48%\tSkin (eyelid)\t \t5\t79.4\tF\tRDD\tPulmonary, nasopharynx\tChoroid, CN VI palsy\tKRAS in-frame insertion Y64_S65insVS\tNGS\t3.48%\tNasopharyngeal\t \t6\t68.9\tF\tECD\tBone, skin, LN\tChoroid, eyelid\tBRAF V600E\tNGS, ddPCR\t0.54%\tSkin (eyelid)\t \t7\t47.1\tF\tECD\tNeuro (DI), bone, brain, CV, retro\tChoroid\tBRAF V600E\tNGS, ddPCR\t1.81%\tPerirenal\t \t8\t49.6\tF\tRDD\tBone, retro, LN\tChoroid\tMAP2K1 K57T, KRAS A146P\tNGS\t0.37% KRAS, 0.12% MAP2K1\tLymph node\t \t9\t22.1\tM\tECD/LCH\tNeuro (dura), bone, skin\tOrbit\tBRAF V600E\tNGS, ddPCR\t0.46%\tTemporal lobe\t \t10\t66.2\tF\tECD\tNeuro (dura), bone, brain, CV\tChoroid\tBRAF V600E\tNGS, ddPCR\t0.07%\tDura\t \t11\t37.8\tM\tECD\tNeuro (dura, pituitary), bone, brain, CV, skin, testes\tOptic nerve\tBRAF V600E\tNGS, ddPCR\t0.52%\tTestes\t \t12\t67.7\tM\tECD\tNeuro (DI), bone, brain, CV, retro, skin\tSclerochoroidal, eyelid\tBRAF V600E\tNGS, ddPCR\t0.06%\tSkin (eyelid)\t \t13\t61.8\tF\tECD\tBone\tChoroid, orbit\tARAF S213A\tNGS, ddPCR\t0.89%\tBone\t \t14\t34.4\tM\tECD\tNeuro (DI), bone, brain, retro, LN\tUvea (uveitis)\tBRAF V600E\tNGS\t0.08%\tLymph node*\t \t"}], "citations": {"NLM": "Francis JH, Arcila ME, Sigler A, Bossert DF, Abramson DH, Diamond EL. Plasma-Derived Cell-Free DNA for the Diagnosis of Ocular-Involving Histiocytosis Ophthalmol Sci. PMID: 39071917", "BibTeX": "@article{39071917, title={Plasma-Derived Cell-Free DNA for the Diagnosis of Ocular-Involving Histiocytosis}, author={Francis JH and Arcila ME and Sigler A and Bossert DF and Abramson DH and Diamond EL}, journal={Ophthalmol Sci}}"}, "is_sup_mat_match": false}, {"pmid": 31097693, "pmcid": "PMC6522484", "title": "MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer.", "journal": "Nat Commun", "authors": ["Zhan T", "Ambrosi G", "Wandmacher AM", "Rauscher B", "Betge J", "Rindtorff N", "H\u00e4ussler RS", "Hinsenkamp I", "Bamberg L", "Hessling B", "M\u00fcller-Decker K", "Erdmann G", "Burgermeister E", "Ebert MP", "Boutros M"], "date": "2019-05-16T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Zhan T, Ambrosi G, Wandmacher AM, Rauscher B, Betge J, Rindtorff N, H\u00e4ussler RS, Hinsenkamp I, Bamberg L, Hessling B, M\u00fcller-Decker K, Erdmann G, Burgermeister E, Ebert MP, Boutros M. MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer. Nat Commun. PMID: 31097693", "BibTeX": "@article{31097693, title={MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer.}, author={Zhan T and Ambrosi G and Wandmacher AM and Rauscher B and Betge J and Rindtorff N and H\u00e4ussler RS and Hinsenkamp I and Bamberg L and Hessling B and M\u00fcller-Decker K and Erdmann G and Burgermeister E and Ebert MP and Boutros M}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 30857943, "pmcid": "PMC6442234", "title": "Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancer.", "journal": "EBioMedicine", "authors": ["Liu X", "Liu L", "Ji Y", "Li C", "Wei T", "Yang X", "Zhang Y", "Cai X", "Gao Y", "Xu W", "Rao S", "Jin D", "Lou W", "Qiu Z", "Wang X"], "date": "2019-03-01T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Liu X, Liu L, Ji Y, Li C, Wei T, Yang X, Zhang Y, Cai X, Gao Y, Xu W, Rao S, Jin D, Lou W, Qiu Z, Wang X. Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancer. EBioMedicine. PMID: 30857943", "BibTeX": "@article{30857943, title={Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancer.}, author={Liu X and Liu L and Ji Y and Li C and Wei T and Yang X and Zhang Y and Cai X and Gao Y and Xu W and Rao S and Jin D and Lou W and Qiu Z and Wang X}, journal={EBioMedicine}}"}, "is_sup_mat_match": true}, {"pmid": 22675565, "pmcid": "PMC3366948", "title": "High accuracy mutation detection in leukemia on a selected panel of cancer genes.", "journal": "PLoS One", "authors": ["Kalender Atak Z", "De Keersmaecker K", "Gianfelici V", "Geerdens E", "Vandepoel R", "Pauwels D", "Porcu M", "Lahortiga I", "Brys V", "Dirks WG", "Quentmeier H", "Cloos J", "Cuppens H", "Uyttebroeck A", "Vandenberghe P", "Cools J", "Aerts S"], "date": "2012-01-01T00:00:00Z", "year": 2012, "snippets": [], "citations": {"NLM": "Kalender Atak Z, De Keersmaecker K, Gianfelici V, Geerdens E, Vandepoel R, Pauwels D, Porcu M, Lahortiga I, Brys V, Dirks WG, Quentmeier H, Cloos J, Cuppens H, Uyttebroeck A, Vandenberghe P, Cools J, Aerts S. High accuracy mutation detection in leukemia on a selected panel of cancer genes. PLoS One. PMID: 22675565", "BibTeX": "@article{22675565, title={High accuracy mutation detection in leukemia on a selected panel of cancer genes.}, author={Kalender Atak Z and De Keersmaecker K and Gianfelici V and Geerdens E and Vandepoel R and Pauwels D and Porcu M and Lahortiga I and Brys V and Dirks WG and Quentmeier H and Cloos J and Cuppens H and Uyttebroeck A and Vandenberghe P and Cools J and Aerts S}, journal={PLoS One}}"}, "is_sup_mat_match": true}, {"pmid": 25326804, "pmcid": "PMC4313872", "title": "Age-related mutations associated with clonal hematopoietic expansion and malignancies.", "journal": "Nat Med", "authors": ["Xie M", "Lu C", "Wang J", "McLellan MD", "Johnson KJ", "Wendl MC", "McMichael JF", "Schmidt HK", "Yellapantula V", "Miller CA", "Ozenberger BA", "Welch JS", "Link DC", "Walter MJ", "Mardis ER", "Dipersio JF", "Chen F", "Wilson RK", "Ley TJ", "Ding L"], "date": "2014-12-01T00:00:00Z", "year": 2014, "snippets": [], "citations": {"NLM": "Xie M, Lu C, Wang J, McLellan MD, Johnson KJ, Wendl MC, McMichael JF, Schmidt HK, Yellapantula V, Miller CA, Ozenberger BA, Welch JS, Link DC, Walter MJ, Mardis ER, Dipersio JF, Chen F, Wilson RK, Ley TJ, Ding L. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med. PMID: 25326804", "BibTeX": "@article{25326804, title={Age-related mutations associated with clonal hematopoietic expansion and malignancies.}, author={Xie M and Lu C and Wang J and McLellan MD and Johnson KJ and Wendl MC and McMichael JF and Schmidt HK and Yellapantula V and Miller CA and Ozenberger BA and Welch JS and Link DC and Walter MJ and Mardis ER and Dipersio JF and Chen F and Wilson RK and Ley TJ and Ding L}, journal={Nat Med}}"}, "is_sup_mat_match": true}, {"pmid": 28504689, "pmcid": "PMC5523069", "title": "Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation.", "journal": "Oncogenesis", "authors": ["Xu J", "Pfarr N", "Endris V", "Mai EK", "Md Hanafiah NH", "Lehners N", "Penzel R", "Weichert W", "Ho AD", "Schirmacher P", "Goldschmidt H", "Andrulis M", "Raab MS"], "date": "2017-05-15T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Xu J, Pfarr N, Endris V, Mai EK, Md Hanafiah NH, Lehners N, Penzel R, Weichert W, Ho AD, Schirmacher P, Goldschmidt H, Andrulis M, Raab MS. Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation. Oncogenesis. PMID: 28504689", "BibTeX": "@article{28504689, title={Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation.}, author={Xu J and Pfarr N and Endris V and Mai EK and Md Hanafiah NH and Lehners N and Penzel R and Weichert W and Ho AD and Schirmacher P and Goldschmidt H and Andrulis M and Raab MS}, journal={Oncogenesis}}"}, "is_sup_mat_match": true}, {"pmid": 26797410, "pmcid": "PMC5036215", "title": "Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases.", "journal": "J Clin Pathol", "authors": ["Malapelle U", "Pisapia P", "Sgariglia R", "Vigliar E", "Biglietto M", "Carlomagno C", "Giuffr\u00e8 G", "Bellevicine C", "Troncone G"], "date": "2016-09-01T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Malapelle U, Pisapia P, Sgariglia R, Vigliar E, Biglietto M, Carlomagno C, Giuffr\u00e8 G, Bellevicine C, Troncone G. Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases. J Clin Pathol. PMID: 26797410", "BibTeX": "@article{26797410, title={Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases.}, author={Malapelle U and Pisapia P and Sgariglia R and Vigliar E and Biglietto M and Carlomagno C and Giuffr\u00e8 G and Bellevicine C and Troncone G}, journal={J Clin Pathol}}"}, "is_sup_mat_match": true}, {"pmid": 28796828, "pmcid": "PMC5552132", "title": "Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples.", "journal": "PLoS One", "authors": ["Bussolati G", "Annaratone L", "Berrino E", "Miglio U", "Panero M", "Cupo M", "Gugliotta P", "Venesio T", "Sapino A", "Marchi\u00f2 C"], "date": "2017-08-10T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Bussolati G, Annaratone L, Berrino E, Miglio U, Panero M, Cupo M, Gugliotta P, Venesio T, Sapino A, Marchi\u00f2 C. Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples. PLoS One. PMID: 28796828", "BibTeX": "@article{28796828, title={Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples.}, author={Bussolati G and Annaratone L and Berrino E and Miglio U and Panero M and Cupo M and Gugliotta P and Venesio T and Sapino A and Marchi\u00f2 C}, journal={PLoS One}}"}, "is_sup_mat_match": true}, {"pmid": 26009992, "pmcid": "PMC4695201", "title": "Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay.", "journal": "Oncotarget", "authors": ["Park K", "Choi MK", "Jung HH", "Do IG", "Lee KH", "Ahn T", "Kil WH", "Kim SW", "Lee JE", "Nam SJ", "Kim DH", "Ahn JS", "Im YH", "Park YH"], "date": "2015-09-15T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Park K, Choi MK, Jung HH, Do IG, Lee KH, Ahn T, Kil WH, Kim SW, Lee JE, Nam SJ, Kim DH, Ahn JS, Im YH, Park YH. Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay. Oncotarget. PMID: 26009992", "BibTeX": "@article{26009992, title={Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay.}, author={Park K and Choi MK and Jung HH and Do IG and Lee KH and Ahn T and Kil WH and Kim SW and Lee JE and Nam SJ and Kim DH and Ahn JS and Im YH and Park YH}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 29263839, "pmcid": "PMC5677944", "title": "Identification of potentially oncogenic alterations from tumor-only samples reveals Fanconi anemia pathway mutations in bladder carcinomas.", "journal": "NPJ Genom Med", "authors": ["Madubata CJ", "Roshan-Ghias A", "Chu T", "Resnick S", "Zhao J", "Arnes L", "Wang J", "Rabadan R"], "date": "2017-10-03T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Madubata CJ, Roshan-Ghias A, Chu T, Resnick S, Zhao J, Arnes L, Wang J, Rabadan R. Identification of potentially oncogenic alterations from tumor-only samples reveals Fanconi anemia pathway mutations in bladder carcinomas. NPJ Genom Med. PMID: 29263839", "BibTeX": "@article{29263839, title={Identification of potentially oncogenic alterations from tumor-only samples reveals Fanconi anemia pathway mutations in bladder carcinomas.}, author={Madubata CJ and Roshan-Ghias A and Chu T and Resnick S and Zhao J and Arnes L and Wang J and Rabadan R}, journal={NPJ Genom Med}}"}, "is_sup_mat_match": true}, {"pmid": 31032472, "pmcid": "PMC6484865", "title": "Genomic Assessment of Blood-Derived Circulating Tumor DNA in Patients With Colorectal Cancers: Correlation With Tissue Sequencing, Therapeutic Response, and Survival.", "journal": "JCO Precis Oncol", "authors": ["Kato S", "Schwaederl\u00e9 MC", "Fanta PT", "Okamura R", "Leichman L", "Lippman SM", "Lanman RB", "Raymond VM", "Talasaz A", "Kurzrock R"], "date": "2019-01-01T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Kato S, Schwaederl\u00e9 MC, Fanta PT, Okamura R, Leichman L, Lippman SM, Lanman RB, Raymond VM, Talasaz A, Kurzrock R. Genomic Assessment of Blood-Derived Circulating Tumor DNA in Patients With Colorectal Cancers: Correlation With Tissue Sequencing, Therapeutic Response, and Survival. JCO Precis Oncol. PMID: 31032472", "BibTeX": "@article{31032472, title={Genomic Assessment of Blood-Derived Circulating Tumor DNA in Patients With Colorectal Cancers: Correlation With Tissue Sequencing, Therapeutic Response, and Survival.}, author={Kato S and Schwaederl\u00e9 MC and Fanta PT and Okamura R and Leichman L and Lippman SM and Lanman RB and Raymond VM and Talasaz A and Kurzrock R}, journal={JCO Precis Oncol}}"}, "is_sup_mat_match": true}, {"pmid": 34771595, "pmcid": "PMC8582471", "title": "Mismatch Repair Status in Patient-Derived Colorectal Cancer Organoids Does Not Affect Intrinsic Tumor Cell Sensitivity to Systemic Therapy.", "journal": "Cancers (Basel)", "authors": ["K\u00fc\u00e7\u00fckk\u00f6se E", "Wensink GE", "Roelse CM", "van Schelven SJ", "Raats DAE", "Boj SF", "Koopman M", "Laoukili J", "Roodhart JML", "Kranenburg O"], "date": "2021-10-29T00:00:00Z", "year": 2021, "snippets": [{"_id": "34771595@27069", "snip_text": "Organoid MMR Status (IHC) KRAS Status BRAF Status Source of Tissue Primary Tumor Location (Sidedness)   dMMR1 MLH1/PMS2 WT V600E Metastatic Left   (liver)   dMMR2 MLH1/PMS2 WT WT Metastatic Left   (inguinal lymph node)   dMMR3 MSH2/MSH6 A146T WT Metastatic Right   (peritoneum)   dMMR4 MLH1/PMS2 A146T V600E Primary Right   (synchronous metastatic disease)   dMMR5 MLH1/PMS2 WT WT Primary Right   (unknown if synchronous)   dMMR6 MLH1/PMS2 WT V600E Primary Right   (unknown if synchronous)   pMMR1 Normal WT V600E Primary Right   (synchronous metastatic disease)   pMMR2 Normal G12A WT Metastatic Right   (liver)   pMMR3 Normal WT WT Metastatic Right   (liver)   pMMR4 Normal G12V WT Primary Unknown   (unknown if synchronous)   pMMR5 Normal G12A WT Primary Right   (synchronous metastatic disease)   pMMR6 Normal WT WT Primary Unknown   (unknown if synchronous)   ", "section": "table", "mentions": ["168|4|gene|ncbi_gene@5395|PMS2", "232|4|gene|ncbi_gene@2956|MSH6", "370|4|gene|ncbi_gene@5395|PMS2", "26|4|gene|ncbi_gene@3845|KRAS", "163|4|gene|ncbi_gene@4292|MLH1", "742|4|variant|litvar@rs267607726##&&&litvar@#4292#&&&litvar@CA9611#rs267607726##|G12A", "75|5|disease|ncbi_mesh@D009369|Tumor", "115|4|gene|ncbi_gene@5395|PMS2", "779|18|disease|ncbi_mesh@D000092182|metastatic disease", "296|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "543|18|disease|ncbi_mesh@D000092182|metastatic disease", "435|4|gene|ncbi_gene@5395|PMS2", "443|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "676|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "337|18|disease|ncbi_mesh@D000092182|metastatic disease", "508|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "237|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "430|4|gene|ncbi_gene@4292|MLH1", "110|4|gene|ncbi_gene@4292|MLH1", "38|4|gene|ncbi_gene@673|BRAF", "302|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "286|4|gene|ncbi_gene@4292|MLH1", "578|4|variant|litvar@rs267607726##&&&litvar@#4292#&&&litvar@CA9611#rs267607726##|G12A", "227|4|gene|ncbi_gene@4436|MSH2", "291|4|gene|ncbi_gene@5395|PMS2", "123|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "365|4|gene|ncbi_gene@4292|MLH1"], "figure_id": "cancers-13-05434-t001", "text_hl": "Organoid MMR Status (IHC) KRAS Status BRAF Status Source of Tissue Primary Tumor Location (Sidedness)   dMMR1 MLH1/PMS2 WT V600E Metastatic Left   (liver)   dMMR2 MLH1/PMS2 WT WT Metastatic Left   (inguinal lymph node)   dMMR3 MSH2/MSH6 <m>A146T</m> WT Metastatic Right   (peritoneum)   dMMR4 MLH1/PMS2 <m>A146T</m> V600E Primary Right   (synchronous metastatic disease)   dMMR5 MLH1/PMS2 WT WT Primary Right   (unknown if synchronous)   dMMR6 MLH1/PMS2 WT V600E Primary Right   (unknown if synchronous)   pMMR1 Normal WT V600E Primary Right   (synchronous metastatic disease)   pMMR2 Normal G12A WT Metastatic Right   (liver)   pMMR3 Normal WT WT Metastatic Right   (liver)   pMMR4 Normal G12V WT Primary Unknown   (unknown if synchronous)   pMMR5 Normal G12A WT Primary Right   (synchronous metastatic disease)   pMMR6 Normal WT WT Primary Unknown   (unknown if synchronous)   "}], "citations": {"NLM": "K\u00fc\u00e7\u00fckk\u00f6se E, Wensink GE, Roelse CM, van Schelven SJ, Raats DAE, Boj SF, Koopman M, Laoukili J, Roodhart JML, Kranenburg O. Mismatch Repair Status in Patient-Derived Colorectal Cancer Organoids Does Not Affect Intrinsic Tumor Cell Sensitivity to Systemic Therapy. Cancers (Basel). PMID: 34771595", "BibTeX": "@article{34771595, title={Mismatch Repair Status in Patient-Derived Colorectal Cancer Organoids Does Not Affect Intrinsic Tumor Cell Sensitivity to Systemic Therapy.}, author={K\u00fc\u00e7\u00fckk\u00f6se E and Wensink GE and Roelse CM and van Schelven SJ and Raats DAE and Boj SF and Koopman M and Laoukili J and Roodhart JML and Kranenburg O}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 34064232, "pmcid": "PMC8196854", "title": "KRAS G12C Mutations in NSCLC: From Target to Resistance.", "journal": "Cancers (Basel)", "authors": ["Addeo A", "Banna GL", "Friedlaender A"], "date": "2021-05-21T00:00:00Z", "year": 2021, "snippets": [{"_id": "34064232@9238", "snip_text": "On the other hand, KRAS A146T, which is the most common KRAS mutation in digestive cancers, has GTP-hydrolysis equivalent to that in wild-type KRAS.", "section": "other", "mentions": ["24|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "56|4|gene|ncbi_gene@3845|KRAS", "96|3|chemical|ncbi_mesh@D006160|GTP", "19|4|gene|ncbi_gene@3845|KRAS", "143|4|gene|ncbi_gene@3845|KRAS", "73|17|disease|ncbi_mesh@D009369|digestive cancers"], "text_hl": "On the other hand, KRAS <m>A146T</m>, which is the most common KRAS mutation in digestive cancers, has GTP-hydrolysis equivalent to that in wild-type KRAS."}], "citations": {"NLM": "Addeo A, Banna GL, Friedlaender A. KRAS G12C Mutations in NSCLC: From Target to Resistance. Cancers (Basel). PMID: 34064232", "BibTeX": "@article{34064232, title={KRAS G12C Mutations in NSCLC: From Target to Resistance.}, author={Addeo A and Banna GL and Friedlaender A}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 23991070, "pmcid": "PMC3749116", "title": "Development and validation of a clinical trial patient stratification assay that interrogates 27 mutation sites in MAPK pathway genes.", "journal": "PLoS One", "authors": ["Chang KC", "Galuska S", "Weiner R", "Marton MJ"], "date": "2013-08-21T00:00:00Z", "year": 2013, "snippets": [{"_id": "23991070@16559", "snip_text": "BRAF KRAS NRAS   CodonNumber WTCodon MutantCodon ProteinDescription CodonNumber WTCodon MutantCodon ProteinDescription CodonNumber WTCodon MutantCodon ProteinDescription   466 GGA GAA G466E 12 GGT AGT G12S 12 GGT GAT G12D   466 GGA GTA G466V 12 GGT TGT G12C 12 GGT GTT G12V   592 ATA GTA I592V 12 GGT GAT G12D 13 GGT CGT G13R   594 GAT GTT D594V 12 GGT GCT G12A 13 GGT GAT G13D   594 GAT GAA D594E 12 GGT GTT G12V 61 CAA AAA Q61K   594 GAT GAG D594E 13 GGC CGC G13R 61 CAA CGA Q61R   596 GGT CGT G596R 13 GGC GAC G13D 61 CAA CTA Q61L   597 CTA TCA L597S 61 CAA AAA Q61K 61 CAA CAC Q61H   600 GTG GAG V600E 61 CAA CTA Q61L 61 CAA CAT Q61H   600 GTG AGG V600R 61 CAA CAC Q61H       600 GTG AAG V600K 61 CAA CAT Q61H       600 GTG GAT V600D 146 GCA ACA A146T       601 AAA GAA K601E 146 GCA GTA A146T       ", "section": "table", "mentions": ["288|5|variant|litvar@rs121913363##&&&litvar@#673#&&&litvar@CA16602533#rs121913363##|I592V", "305|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "669|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "581|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "269|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "496|5|variant|litvar@rs121913361##&&&litvar@#673#&&&litvar@CA16602422#rs121913361##|G596R", "652|5|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16021333#rs121913227##|V600R", "340|5|variant|litvar@rs121913338##&&&litvar@#673#&&&litvar@CA16602425#rs121913338##|D594V", "357|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "477|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "513|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "633|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "184|5|variant|litvar@rs121913351##&&&litvar@#673#&&&litvar@CA16602535#rs121913351##|G466E", "201|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "321|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "548|5|variant|litvar@rs121913368##&&&litvar@#673#&&&litvar@CA16602421#rs121913368##|L597S", "5|4|gene|ncbi_gene@541140|KRAS", "392|5|variant|litvar@rs121913337##&&&litvar@#673#&&&litvar@CA16602424#rs121913337##|D594E", "732|5|variant|litvar@rs121913377##&&&litvar@#673#&&&litvar@CA16602419#rs121913377##|V600D", "0|4|gene|ncbi_gene@536051|BRAF", "10|4|gene|ncbi_gene@4893|NRAS", "565|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "373|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "750|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "236|5|variant|litvar@rs121913351##&&&litvar@#673#&&&litvar@CA123647#rs121913351##|G466V", "253|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "409|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "792|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "529|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "774|5|variant|litvar@rs121913364##&&&litvar@#673#&&&litvar@CA123645#rs121913364##|K601E", "444|5|variant|litvar@rs121913337##&&&litvar@#673#&&&litvar@CA16602424#rs121913337##|D594E", "217|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "600|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "617|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "692|5|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16602420#rs121913227##|V600K", "461|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "709|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "425|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K"], "figure_id": "pone-0072239-t002", "text_hl": "BRAF KRAS NRAS   CodonNumber WTCodon MutantCodon ProteinDescription CodonNumber WTCodon MutantCodon ProteinDescription CodonNumber WTCodon MutantCodon ProteinDescription   466 GGA GAA G466E 12 GGT AGT G12S 12 GGT GAT G12D   466 GGA GTA G466V 12 GGT TGT G12C 12 GGT GTT G12V   592 ATA GTA I592V 12 GGT GAT G12D 13 GGT CGT G13R   594 GAT GTT D594V 12 GGT GCT G12A 13 GGT GAT G13D   594 GAT GAA D594E 12 GGT GTT G12V 61 CAA AAA Q61K   594 GAT GAG D594E 13 GGC CGC G13R 61 CAA CGA Q61R   596 GGT CGT G596R 13 GGC GAC G13D 61 CAA CTA Q61L   597 CTA TCA L597S 61 CAA AAA Q61K 61 CAA CAC Q61H   600 GTG GAG V600E 61 CAA CTA Q61L 61 CAA CAT Q61H   600 GTG AGG V600R 61 CAA CAC Q61H       600 GTG AAG V600K 61 CAA CAT Q61H       600 GTG GAT V600D 146 GCA ACA <m>A146T</m>       601 AAA GAA K601E 146 GCA GTA <m>A146T</m>       "}], "citations": {"NLM": "Chang KC, Galuska S, Weiner R, Marton MJ. Development and validation of a clinical trial patient stratification assay that interrogates 27 mutation sites in MAPK pathway genes. PLoS One. PMID: 23991070", "BibTeX": "@article{23991070, title={Development and validation of a clinical trial patient stratification assay that interrogates 27 mutation sites in MAPK pathway genes.}, author={Chang KC and Galuska S and Weiner R and Marton MJ}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 33784337, "pmcid": "PMC8009361", "title": "Mutation status and prognostic value of KRAS and NRAS mutations in Moroccan colon cancer patients: A first report.", "journal": "PLoS One", "authors": ["El Agy F", "El Bardai S", "El Otmani I", "Benbrahim Z", "Karim MH", "Mazaz K", "Benjelloun EB", "Ousadden A", "El Abkari M", "Ibrahimi SA", "Chbani L"], "date": "2021-03-30T00:00:00Z", "year": 2021, "snippets": [{"_id": "33784337@17351", "snip_text": "The main mutant types were K117N and A146T with a percentage of (3/77, 3.9%) followed by A146P and A146V (1/77, 1.3%).", "section": "results", "mentions": ["99|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "37|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "89|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "27|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N"], "text_hl": "The main mutant types were K117N and <m>A146T</m> with a percentage of (3/77, 3.9%) followed by A146P and A146V (1/77, 1.3%)."}], "citations": {"NLM": "El Agy F, El Bardai S, El Otmani I, Benbrahim Z, Karim MH, Mazaz K, Benjelloun EB, Ousadden A, El Abkari M, Ibrahimi SA, Chbani L. Mutation status and prognostic value of KRAS and NRAS mutations in Moroccan colon cancer patients: A first report. PLoS One. PMID: 33784337", "BibTeX": "@article{33784337, title={Mutation status and prognostic value of KRAS and NRAS mutations in Moroccan colon cancer patients: A first report.}, author={El Agy F and El Bardai S and El Otmani I and Benbrahim Z and Karim MH and Mazaz K and Benjelloun EB and Ousadden A and El Abkari M and Ibrahimi SA and Chbani L}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 37154160, "pmcid": "PMC10243805", "title": "Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibition", "journal": "JCI Insight", "authors": ["Sheppard SE", "March ME", "Seiler C", "Matsuoka LS", "Kim SE", "Kao C", "Rubin AI", "Battig MR", "Khalek N", "Schindewolf E", "O'Connor N", "Pinto E", "Priestley JR", "Sanders VR", "Niazi R", "Ganguly A", "Hou C", "Slater D", "Frieden IJ", "Huynh T", "Shieh JT", "Krantz ID", "Guerrero JC", "Surrey LF", "Biko DM", "Laje P", "Castelo-Soccio L", "Nakano TA", "Snyder K", "Smith CL", "Li D", "Dori Y", "Hakonarson H"], "date": "2023-05-08T00:00:00Z", "year": 2023, "snippets": [{"_id": "37154160@13566", "snip_text": "Somatic Overgrowth and Vascular Malformation Panel Version 3 and research exome sequencing identified a mosaic pathogenic variant in KRAS p.Ala146Thr (c.436G > T, NM_033360.4) at 3.3%-3.4% VAF in the scrotal tissue.", "section": "results", "mentions": ["138|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "151|10|variant|litvar@rs121913527##&&&litvar@#3845#|c.436G > T", "133|4|gene|ncbi_gene@541140|KRAS"], "text_hl": "Somatic Overgrowth and Vascular Malformation Panel Version 3 and research exome sequencing identified a mosaic pathogenic variant in KRAS <m>p.Ala146Thr</m> (c.436G > T, NM_033360.4) at 3.3%-3.4% VAF in the scrotal tissue."}], "citations": {"NLM": "Sheppard SE, March ME, Seiler C, Matsuoka LS, Kim SE, Kao C, Rubin AI, Battig MR, Khalek N, Schindewolf E, O'Connor N, Pinto E, Priestley JR, Sanders VR, Niazi R, Ganguly A, Hou C, Slater D, Frieden IJ, Huynh T, Shieh JT, Krantz ID, Guerrero JC, Surrey LF, Biko DM, Laje P, Castelo-Soccio L, Nakano TA, Snyder K, Smith CL, Li D, Dori Y, Hakonarson H. Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibition JCI Insight. PMID: 37154160", "BibTeX": "@article{37154160, title={Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibition}, author={Sheppard SE and March ME and Seiler C and Matsuoka LS and Kim SE and Kao C and Rubin AI and Battig MR and Khalek N and Schindewolf E and O'Connor N and Pinto E and Priestley JR and Sanders VR and Niazi R and Ganguly A and Hou C and Slater D and Frieden IJ and Huynh T and Shieh JT and Krantz ID and Guerrero JC and Surrey LF and Biko DM and Laje P and Castelo-Soccio L and Nakano TA and Snyder K and Smith CL and Li D and Dori Y and Hakonarson H}, journal={JCI Insight}}"}, "is_sup_mat_match": false}, {"pmid": 31653970, "pmcid": "PMC6814827", "title": "Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients.", "journal": "Sci Rep", "authors": ["Bray SM", "Lee J", "Kim ST", "Hur JY", "Ebert PJ", "Calley JN", "Wulur IH", "Gopalappa T", "Wong SS", "Qian HR", "Ting JC", "Liu J", "Willard MD", "Novosiadly RD", "Park YS", "Park JO", "Lim HY", "Kang WK", "Aggarwal A", "Kim HC", "Reinhard C"], "date": "2019-10-25T00:00:00Z", "year": 2019, "snippets": [{"_id": "31653970@759", "snip_text": "In cetuximab-sensitive patients, we found KRAS K117N and A146T mutations in addition to BRAF V600E, AKT1 E17K, PIK3CA E542K, and FGFR1 or ERBB2 amplifications.", "section": "abstract", "mentions": ["42|4|gene|ncbi_gene@3845|KRAS", "118|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "3|9|chemical|ncbi_mesh@D000068818|cetuximab", "47|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "100|9|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|AKT1 E17K", "88|4|gene|ncbi_gene@673|BRAF", "93|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "23|8|species|ncbi_taxonomy@9606|patients", "57|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "111|6|gene|ncbi_gene@5290|PIK3CA", "129|5|gene|ncbi_gene@2260|FGFR1", "138|5|gene|ncbi_gene@2064|ERBB2"], "text_hl": "In cetuximab-sensitive patients, we found KRAS K117N and <m>A146T</m> mutations in addition to BRAF V600E, AKT1 E17K, PIK3CA E542K, and FGFR1 or ERBB2 amplifications."}], "citations": {"NLM": "Bray SM, Lee J, Kim ST, Hur JY, Ebert PJ, Calley JN, Wulur IH, Gopalappa T, Wong SS, Qian HR, Ting JC, Liu J, Willard MD, Novosiadly RD, Park YS, Park JO, Lim HY, Kang WK, Aggarwal A, Kim HC, Reinhard C. Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients. Sci Rep. PMID: 31653970", "BibTeX": "@article{31653970, title={Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients.}, author={Bray SM and Lee J and Kim ST and Hur JY and Ebert PJ and Calley JN and Wulur IH and Gopalappa T and Wong SS and Qian HR and Ting JC and Liu J and Willard MD and Novosiadly RD and Park YS and Park JO and Lim HY and Kang WK and Aggarwal A and Kim HC and Reinhard C}, journal={Sci Rep}}"}, "is_sup_mat_match": false}, {"pmid": 34087169, "pmcid": "PMC8744210", "title": "The to and fro of Rho", "journal": "Structure", "authors": ["Westover KD"], "date": "2021-06-03T00:00:00Z", "year": 2021, "snippets": [{"_id": "34087169@2866", "snip_text": "On the one hand, K-Ras mutations such as V14I and A146T give rise to large movements in switch 1, more extreme than seen in state 1 structures, and this consistently results in high rates of GDP dissociation and GEF-stimulated nucleotide exchange in K-Ras (Figure 1C).", "section": "abstract", "mentions": ["227|10|chemical|ncbi_mesh@D009711|nucleotide", "191|3|chemical|ncbi_mesh@D006153|GDP", "41|4|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|V14I", "17|5|gene|ncbi_gene@3845|K-Ras", "212|3|gene|ncbi_gene@9181|GEF", "250|5|gene|ncbi_gene@3845|K-Ras", "50|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "On the one hand, K-Ras mutations such as V14I and <m>A146T</m> give rise to large movements in switch 1, more extreme than seen in state 1 structures, and this consistently results in high rates of GDP dissociation and GEF-stimulated nucleotide exchange in K-Ras (Figure 1C)."}], "citations": {"NLM": "Westover KD. The to and fro of Rho Structure. PMID: 34087169", "BibTeX": "@article{34087169, title={The to and fro of Rho}, author={Westover KD}, journal={Structure}}"}, "is_sup_mat_match": false}, {"pmid": 28492226, "pmcid": "PMC5437268", "title": "Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates", "journal": "Nat Commun", "authors": ["Kis O", "Kaedbey R", "Chow S", "Danesh A", "Dowar M", "Li T", "Li Z", "Liu J", "Mansour M", "Masih-Khan E", "Zhang T", "Bratman SV", "Oza AM", "Kamel-Reid S", "Trudel S", "Pugh TJ"], "date": "2017-05-11T00:00:00Z", "year": 2017, "snippets": [{"_id": "28492226@18296", "snip_text": "Two of these patients progressed with increasing kappa light chains and corresponding increases in AFs of NRAS p.Q61K and KRAS p.A146T (MYL-003 and MYL-018, respectively).", "section": "results", "mentions": ["111|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "122|4|gene|ncbi_gene@3845|KRAS", "106|4|gene|ncbi_gene@4893|NRAS", "127|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "13|8|species|ncbi_taxonomy@9606|patients"], "text_hl": "Two of these patients progressed with increasing kappa light chains and corresponding increases in AFs of NRAS p.Q61K and KRAS <m>p.A146T</m> (MYL-003 and MYL-018, respectively)."}], "citations": {"NLM": "Kis O, Kaedbey R, Chow S, Danesh A, Dowar M, Li T, Li Z, Liu J, Mansour M, Masih-Khan E, Zhang T, Bratman SV, Oza AM, Kamel-Reid S, Trudel S, Pugh TJ. Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates Nat Commun. PMID: 28492226", "BibTeX": "@article{28492226, title={Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates}, author={Kis O and Kaedbey R and Chow S and Danesh A and Dowar M and Li T and Li Z and Liu J and Mansour M and Masih-Khan E and Zhang T and Bratman SV and Oza AM and Kamel-Reid S and Trudel S and Pugh TJ}, journal={Nat Commun}}"}, "is_sup_mat_match": false}, {"pmid": 32079384, "pmcid": "PMC7057728", "title": "The Prognostic Value of 18F-FDG PET/CT and KRAS Mutation in Colorectal Cancers", "journal": "Mol Imaging Radionucl Ther", "authors": ["Arslan E", "Aksoy T", "G\u00fcrsu RU", "Dursun N", "\u00c7akar E", "\u00c7ermik TF"], "date": "2020-02-17T00:00:00Z", "year": 2020, "snippets": [{"_id": "32079384@8486", "snip_text": "+ ___ Ala146Thr (G436A) (GCA>ACA)", "section": "methods", "mentions": ["17|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|G436A", "6|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|Ala146Thr", "25|7|variant|litvar@#3845#|GCA>ACA"], "text_hl": "+ ___ <m>Ala146Thr</m> (G436A) (GCA>ACA)"}], "citations": {"NLM": "Arslan E, Aksoy T, G\u00fcrsu RU, Dursun N, \u00c7akar E, \u00c7ermik TF. The Prognostic Value of 18F-FDG PET/CT and KRAS Mutation in Colorectal Cancers Mol Imaging Radionucl Ther. PMID: 32079384", "BibTeX": "@article{32079384, title={The Prognostic Value of 18F-FDG PET/CT and KRAS Mutation in Colorectal Cancers}, author={Arslan E and Aksoy T and G\u00fcrsu RU and Dursun N and \u00c7akar E and \u00c7ermik TF}, journal={Mol Imaging Radionucl Ther}}"}, "is_sup_mat_match": false}, {"pmid": 34741450, "pmcid": "PMC8683541", "title": "Association between somatic RET mutations and clinical and genetic characteristics in patients with metastatic colorectal cancer", "journal": "Cancer Med", "authors": ["Yang YZ", "Hu WM", "Xia LP", "He WZ"], "date": "2021-12-01T00:00:00Z", "year": 2021, "snippets": [{"_id": "34741450@6567", "snip_text": "Patient ID\tGenomic alterations\t \t1\tRET, EX3, R177W; RAS wild-type; BRAF wild-type; MSS\t \t2\tRET, EX3, R133C; KRAS A146T; BRAF wild-type; MSS\t \t3\tRET, EX5, V351I; RAS wild-type; BRAF wild-type; MSI-high\t \t4\tRET, EX6, N359T; RAS wild-type; BRAF wild-type; MSS\t \t5\tRET, EX7, T451M; KRAS G12D; BRAF wild-type; MSS\t \t6\tRET, EX7, V485L; NRAS Q61L; BRAF wild-type; MSI-high\t \t7\tRET, EX10, E616del; KRAS G12D; BRAF wild-type; MSI-high\t \t8\tRET, EX10, E623G; KRAS G13D; BRAF wild-type; MSS\t \t9\tRET, EX11, V642F; RAS wild-type; BRAF wild-type; MSS\t \t10\tRET, EX11, K662M; RAS wild-type; BRAF wild-type; MSS\t \t11\tRET, EX11, P695S; KRAS G13D; BRAF wild-type; MSI-high\t \t12\tRET, EX11, V706M; RAS wild-type; BRAF wild-type; MSS\t \t13\tRET, EX15, V871I; RAS wild-type; BRAF wild-type; MSI-high\t \t14\tRET, EX15, V871I; KRAS G13D; BRAF wild-type; MSI-high\t \t15\tRET, EX15, S891L; RAS wild-type; BRAF wild-type; MSS\t \t16\tRET, EX15, S891L; RAS wild-type; BRAF K601E; MSS\t \t", "section": "table", "mentions": ["483|3|gene|ncbi_gene@5979|RET", "313|3|gene|ncbi_gene@5979|RET", "453|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "283|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "67|4|gene|ncbi_gene@673|BRAF", "622|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "790|5|variant|litvar@rs145170911##&&&litvar@#5979#&&&litvar@CA8940#rs145170911##|V871I", "101|5|variant|litvar@#5979#p.R133C&&&litvar@#5979#|R133C", "237|4|gene|ncbi_gene@673|BRAF", "441|5|variant|litvar@#5979#p.E623G&&&litvar@#5979#|E623G", "271|5|variant|litvar@rs774092678##&&&litvar@#5979#&&&litvar@CA7541#rs774092678##|T451M", "658|3|gene|ncbi_gene@5979|RET", "144|3|gene|ncbi_gene@5979|RET", "610|5|variant|litvar@#5979#p.P695S&&&litvar@#5979#|P695S", "628|4|gene|ncbi_gene@673|BRAF", "871|4|gene|ncbi_gene@673|BRAF", "599|3|gene|ncbi_gene@5979|RET", "802|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "552|5|variant|litvar@#5979#p.K662M&&&litvar@#5979#|K662M", "289|4|gene|ncbi_gene@673|BRAF", "335|4|variant|litvar@#673#p.Q61L&&&litvar@#673#|Q61L", "370|3|gene|ncbi_gene@5979|RET", "323|5|variant|litvar@#5979#p.V485L&&&litvar@#5979#|V485L", "838|3|gene|ncbi_gene@5979|RET", "35|3|gene|ncbi_gene@5979|RET", "808|4|gene|ncbi_gene@673|BRAF", "574|4|gene|ncbi_gene@673|BRAF", "381|7|variant|litvar@rs377767399##&&&litvar@#5979#&&&litvar@CA7965#rs377767399##|E616del", "779|3|gene|ncbi_gene@5979|RET", "0|7|species|ncbi_taxonomy@9606|Patient", "395|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "459|4|gene|ncbi_gene@673|BRAF", "749|4|gene|ncbi_gene@673|BRAF", "541|3|gene|ncbi_gene@5979|RET", "934|5|variant|litvar@rs121913364##&&&litvar@#673#&&&litvar@CA123645#rs121913364##|K601E", "91|3|gene|ncbi_gene@5979|RET", "430|3|gene|ncbi_gene@5979|RET", "205|3|gene|ncbi_gene@5979|RET", "261|3|gene|ncbi_gene@5979|RET", "727|5|variant|litvar@rs145170911##&&&litvar@#5979#&&&litvar@CA8940#rs145170911##|V871I", "120|4|gene|ncbi_gene@673|BRAF", "154|5|variant|litvar@rs777716061##&&&litvar@#5979#&&&litvar@CA7417#rs777716061##|V351I", "907|5|variant|litvar@rs139773221##&&&litvar@#324#&&&litvar@CA34039#rs139773221##|S891L", "716|3|gene|ncbi_gene@5979|RET", "45|5|variant|litvar@rs765654609##&&&litvar@#5979#&&&litvar@CA16612782#rs765654609##|R177W", "341|4|gene|ncbi_gene@673|BRAF", "669|5|variant|litvar@rs137855422##&&&litvar@#5979#&&&litvar@CA37364#rs137855422##|V706M", "494|5|variant|litvar@#5979#p.V642F&&&litvar@#5979#|V642F", "929|4|gene|ncbi_gene@673|BRAF", "113|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "176|4|gene|ncbi_gene@673|BRAF", "401|4|gene|ncbi_gene@673|BRAF", "516|4|gene|ncbi_gene@673|BRAF", "896|3|gene|ncbi_gene@5979|RET", "215|5|variant|litvar@#5979#p.N359T&&&litvar@#5979#|N359T", "849|5|variant|litvar@rs139773221##&&&litvar@#324#&&&litvar@CA34039#rs139773221##|S891L", "691|4|gene|ncbi_gene@673|BRAF"], "figure_id": "cam44400-tbl-0001", "text_hl": "Patient ID\tGenomic alterations\t \t1\tRET, EX3, R177W; RAS wild-type; BRAF wild-type; MSS\t \t2\tRET, EX3, R133C; KRAS <m>A146T</m>; BRAF wild-type; MSS\t \t3\tRET, EX5, V351I; RAS wild-type; BRAF wild-type; MSI-high\t \t4\tRET, EX6, N359T; RAS wild-type; BRAF wild-type; MSS\t \t5\tRET, EX7, T451M; KRAS G12D; BRAF wild-type; MSS\t \t6\tRET, EX7, V485L; NRAS Q61L; BRAF wild-type; MSI-high\t \t7\tRET, EX10, E616del; KRAS G12D; BRAF wild-type; MSI-high\t \t8\tRET, EX10, E623G; KRAS G13D; BRAF wild-type; MSS\t \t9\tRET, EX11, V642F; RAS wild-type; BRAF wild-type; MSS\t \t10\tRET, EX11, K662M; RAS wild-type; BRAF wild-type; MSS\t \t11\tRET, EX11, P695S; KRAS G13D; BRAF wild-type; MSI-high\t \t12\tRET, EX11, V706M; RAS wild-type; BRAF wild-type; MSS\t \t13\tRET, EX15, V871I; RAS wild-type; BRAF wild-type; MSI-high\t \t14\tRET, EX15, V871I; KRAS G13D; BRAF wild-type; MSI-high\t \t15\tRET, EX15, S891L; RAS wild-type; BRAF wild-type; MSS\t \t16\tRET, EX15, S891L; RAS wild-type; BRAF K601E; MSS\t \t"}], "citations": {"NLM": "Yang YZ, Hu WM, Xia LP, He WZ. Association between somatic RET mutations and clinical and genetic characteristics in patients with metastatic colorectal cancer Cancer Med. PMID: 34741450", "BibTeX": "@article{34741450, title={Association between somatic RET mutations and clinical and genetic characteristics in patients with metastatic colorectal cancer}, author={Yang YZ and Hu WM and Xia LP and He WZ}, journal={Cancer Med}}"}, "is_sup_mat_match": false}, {"pmid": 28196074, "pmcid": "PMC5308858", "title": "Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.", "journal": "PLoS Med", "authors": ["Hamblin A", "Wordsworth S", "Fermont JM", "Page S", "Kaur K", "Camps C", "Kaisaki P", "Gupta A", "Talbot D", "Middleton M", "Henderson S", "Cutts A", "Vavoulis DV", "Housby N", "Tomlinson I", "Taylor JC", "Schuh A"], "date": "2017-02-14T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Hamblin A, Wordsworth S, Fermont JM, Page S, Kaur K, Camps C, Kaisaki P, Gupta A, Talbot D, Middleton M, Henderson S, Cutts A, Vavoulis DV, Housby N, Tomlinson I, Taylor JC, Schuh A. Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service. PLoS Med. PMID: 28196074", "BibTeX": "@article{28196074, title={Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.}, author={Hamblin A and Wordsworth S and Fermont JM and Page S and Kaur K and Camps C and Kaisaki P and Gupta A and Talbot D and Middleton M and Henderson S and Cutts A and Vavoulis DV and Housby N and Tomlinson I and Taylor JC and Schuh A}, journal={PLoS Med}}"}, "is_sup_mat_match": true}, {"pmid": 25523272, "pmcid": "PMC4320586", "title": "Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas", "journal": "BMC Cancer", "authors": ["Tone AA", "McConechy MK", "Yang W", "Ding J", "Yip S", "Kong E", "Wong KK", "Gershenson DM", "Mackay H", "Shah S", "Gilks B", "Tinker AV", "Clarke B", "McAlpine JN", "Huntsman D"], "date": "2014-12-18T00:00:00Z", "year": 2014, "snippets": [], "citations": {"NLM": "Tone AA, McConechy MK, Yang W, Ding J, Yip S, Kong E, Wong KK, Gershenson DM, Mackay H, Shah S, Gilks B, Tinker AV, Clarke B, McAlpine JN, Huntsman D. Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas BMC Cancer. PMID: 25523272", "BibTeX": "@article{25523272, title={Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas}, author={Tone AA and McConechy MK and Yang W and Ding J and Yip S and Kong E and Wong KK and Gershenson DM and Mackay H and Shah S and Gilks B and Tinker AV and Clarke B and McAlpine JN and Huntsman D}, journal={BMC Cancer}}"}, "is_sup_mat_match": true}, {"pmid": 37012232, "pmcid": "PMC10070353", "title": "Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues", "journal": "Nat Commun", "authors": ["Abelin JG", "Bergstrom EJ", "Rivera KD", "Taylor HB", "Klaeger S", "Xu C", "Verzani EK", "Jackson White C", "Woldemichael HB", "Virshup M", "Olive ME", "Maynard M", "Vartany SA", "Allen JD", "Phulphagar K", "Harry Kane M", "Rachimi S", "Mani DR", "Gillette MA", "Satpathy S", "Clauser KR", "Udeshi ND", "Carr SA"], "date": "2023-04-03T00:00:00Z", "year": 2023, "snippets": [], "citations": {"NLM": "Abelin JG, Bergstrom EJ, Rivera KD, Taylor HB, Klaeger S, Xu C, Verzani EK, Jackson White C, Woldemichael HB, Virshup M, Olive ME, Maynard M, Vartany SA, Allen JD, Phulphagar K, Harry Kane M, Rachimi S, Mani DR, Gillette MA, Satpathy S, Clauser KR, Udeshi ND, Carr SA. Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues Nat Commun. PMID: 37012232", "BibTeX": "@article{37012232, title={Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues}, author={Abelin JG and Bergstrom EJ and Rivera KD and Taylor HB and Klaeger S and Xu C and Verzani EK and Jackson White C and Woldemichael HB and Virshup M and Olive ME and Maynard M and Vartany SA and Allen JD and Phulphagar K and Harry Kane M and Rachimi S and Mani DR and Gillette MA and Satpathy S and Clauser KR and Udeshi ND and Carr SA}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 27018799, "pmcid": "PMC4907374", "title": "Integrated digital error suppression for improved detection of circulating tumor DNA", "journal": "Nat Biotechnol", "authors": ["Newman AM", "Lovejoy AF", "Klass DM", "Kurtz DM", "Chabon JJ", "Scherer F", "Stehr H", "Liu CL", "Bratman SV", "Say C", "Zhou L", "Carter JN", "West RB", "Sledge GW", "Shrager JB", "Loo BW Jr", "Neal JW", "Wakelee HA", "Diehn M", "Alizadeh AA"], "date": "2016-05-01T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Newman AM, Lovejoy AF, Klass DM, Kurtz DM, Chabon JJ, Scherer F, Stehr H, Liu CL, Bratman SV, Say C, Zhou L, Carter JN, West RB, Sledge GW, Shrager JB, Loo BW Jr, Neal JW, Wakelee HA, Diehn M, Alizadeh AA. Integrated digital error suppression for improved detection of circulating tumor DNA Nat Biotechnol. PMID: 27018799", "BibTeX": "@article{27018799, title={Integrated digital error suppression for improved detection of circulating tumor DNA}, author={Newman AM and Lovejoy AF and Klass DM and Kurtz DM and Chabon JJ and Scherer F and Stehr H and Liu CL and Bratman SV and Say C and Zhou L and Carter JN and West RB and Sledge GW and Shrager JB and Loo BW Jr and Neal JW and Wakelee HA and Diehn M and Alizadeh AA}, journal={Nat Biotechnol}}"}, "is_sup_mat_match": true}, {"pmid": 28315634, "pmcid": "PMC5357332", "title": "Comparing mutation calls in fixed tumour samples between the affymetrix OncoScan  array and PCR based next-generation sequencing", "journal": "BMC Med Genomics", "authors": ["Wood HM", "Foster JM", "Taylor M", "Tinkler-Hundal E", "Togneri FS", "Wojtowicz P", "Oumie A", "Spink KG", "Brew F", "Quirke P"], "date": "2017-03-18T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Wood HM, Foster JM, Taylor M, Tinkler-Hundal E, Togneri FS, Wojtowicz P, Oumie A, Spink KG, Brew F, Quirke P. Comparing mutation calls in fixed tumour samples between the affymetrix OncoScan  array and PCR based next-generation sequencing BMC Med Genomics. PMID: 28315634", "BibTeX": "@article{28315634, title={Comparing mutation calls in fixed tumour samples between the affymetrix OncoScan  array and PCR based next-generation sequencing}, author={Wood HM and Foster JM and Taylor M and Tinkler-Hundal E and Togneri FS and Wojtowicz P and Oumie A and Spink KG and Brew F and Quirke P}, journal={BMC Med Genomics}}"}, "is_sup_mat_match": true}, {"pmid": 30202019, "pmcid": "PMC6131170", "title": "The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature.", "journal": "Nat Commun", "authors": ["Inman GJ", "Wang J", "Nagano A", "Alexandrov LB", "Purdie KJ", "Taylor RG", "Sherwood V", "Thomson J", "Hogan S", "Spender LC", "South AP", "Stratton M", "Chelala C", "Harwood CA", "Proby CM", "Leigh IM"], "date": "2018-09-10T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Inman GJ, Wang J, Nagano A, Alexandrov LB, Purdie KJ, Taylor RG, Sherwood V, Thomson J, Hogan S, Spender LC, South AP, Stratton M, Chelala C, Harwood CA, Proby CM, Leigh IM. The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature. Nat Commun. PMID: 30202019", "BibTeX": "@article{30202019, title={The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature.}, author={Inman GJ and Wang J and Nagano A and Alexandrov LB and Purdie KJ and Taylor RG and Sherwood V and Thomson J and Hogan S and Spender LC and South AP and Stratton M and Chelala C and Harwood CA and Proby CM and Leigh IM}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 35788175, "pmcid": "PMC9307482", "title": "Longitudinal dynamics of clonal hematopoiesis identifies gene-specific fitness effects.", "journal": "Nat Med", "authors": ["Robertson NA", "Latorre-Crespo E", "Terradas-Terradas M", "Lemos-Portela J", "Purcell AC", "Livesey BJ", "Hillary RF", "Murphy L", "Fawkes A", "MacGillivray L", "Copland M", "Marioni RE", "Marsh JA", "Harris SE", "Cox SR", "Deary IJ", "Schumacher LJ", "Kirschner K", "Chandra T"], "date": "2022-07-01T00:00:00Z", "year": 2022, "snippets": [], "citations": {"NLM": "Robertson NA, Latorre-Crespo E, Terradas-Terradas M, Lemos-Portela J, Purcell AC, Livesey BJ, Hillary RF, Murphy L, Fawkes A, MacGillivray L, Copland M, Marioni RE, Marsh JA, Harris SE, Cox SR, Deary IJ, Schumacher LJ, Kirschner K, Chandra T. Longitudinal dynamics of clonal hematopoiesis identifies gene-specific fitness effects. Nat Med. PMID: 35788175", "BibTeX": "@article{35788175, title={Longitudinal dynamics of clonal hematopoiesis identifies gene-specific fitness effects.}, author={Robertson NA and Latorre-Crespo E and Terradas-Terradas M and Lemos-Portela J and Purcell AC and Livesey BJ and Hillary RF and Murphy L and Fawkes A and MacGillivray L and Copland M and Marioni RE and Marsh JA and Harris SE and Cox SR and Deary IJ and Schumacher LJ and Kirschner K and Chandra T}, journal={Nat Med}}"}, "is_sup_mat_match": true}, {"pmid": 26918361, "pmcid": "PMC4771964", "title": "Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients.", "journal": "Blood Cancer J", "authors": ["Kortuem KM", "Braggio E", "Bruins L", "Barrio S", "Shi CS", "Zhu YX", "Tibes R", "Viswanatha D", "Votruba P", "Ahmann G", "Fonseca R", "Jedlowski P", "Schlam I", "Kumar S", "Bergsagel PL", "Stewart AK"], "date": "2016-02-26T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Kortuem KM, Braggio E, Bruins L, Barrio S, Shi CS, Zhu YX, Tibes R, Viswanatha D, Votruba P, Ahmann G, Fonseca R, Jedlowski P, Schlam I, Kumar S, Bergsagel PL, Stewart AK. Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients. Blood Cancer J. PMID: 26918361", "BibTeX": "@article{26918361, title={Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients.}, author={Kortuem KM and Braggio E and Bruins L and Barrio S and Shi CS and Zhu YX and Tibes R and Viswanatha D and Votruba P and Ahmann G and Fonseca R and Jedlowski P and Schlam I and Kumar S and Bergsagel PL and Stewart AK}, journal={Blood Cancer J}}"}, "is_sup_mat_match": true}, {"pmid": 31345222, "pmcid": "PMC6657027", "title": "Systematic analysis of the intersection of disease mutations with protein modifications.", "journal": "BMC Med Genomics", "authors": ["Simpson CM", "Zhang B", "Hornbeck PV", "Gnad F"], "date": "2019-07-25T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Simpson CM, Zhang B, Hornbeck PV, Gnad F. Systematic analysis of the intersection of disease mutations with protein modifications. BMC Med Genomics. PMID: 31345222", "BibTeX": "@article{31345222, title={Systematic analysis of the intersection of disease mutations with protein modifications.}, author={Simpson CM and Zhang B and Hornbeck PV and Gnad F}, journal={BMC Med Genomics}}"}, "is_sup_mat_match": true}, {"pmid": 25742471, "pmcid": "PMC4402458", "title": "Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients.", "journal": "Br J Cancer", "authors": ["Wong SQ", "Fellowes A", "Doig K", "Ellul J", "Bosma TJ", "Irwin D", "Vedururu R", "Tan AY", "Weiss J", "Chan KS", "Lucas M", "Thomas DM", "Dobrovic A", "Parisot JP", "Fox SB"], "date": "2015-04-14T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Wong SQ, Fellowes A, Doig K, Ellul J, Bosma TJ, Irwin D, Vedururu R, Tan AY, Weiss J, Chan KS, Lucas M, Thomas DM, Dobrovic A, Parisot JP, Fox SB. Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients. Br J Cancer. PMID: 25742471", "BibTeX": "@article{25742471, title={Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients.}, author={Wong SQ and Fellowes A and Doig K and Ellul J and Bosma TJ and Irwin D and Vedururu R and Tan AY and Weiss J and Chan KS and Lucas M and Thomas DM and Dobrovic A and Parisot JP and Fox SB}, journal={Br J Cancer}}"}, "is_sup_mat_match": true}, {"pmid": 30934598, "pmcid": "PMC6468462", "title": "A Simple and Highly Specific MassARRAY-Based Stool DNA Assay to Prioritize Follow-up Decisions in Fecal Immunochemical Test-Positive Individuals.", "journal": "Cancers (Basel)", "authors": ["Chang PY", "Chen CC", "Chiang JM", "Chang SC", "Wang MC", "Chen JS", "Tsai WS", "You JF", "Lu JJ"], "date": "2019-03-25T00:00:00Z", "year": 2019, "snippets": [{"_id": "30934598@11167", "snip_text": "In total, 10 variants were detected in stool samples (p.R876*, p.R1114* and p.R1450* in APC; p.G12A, p.G12D, p.G12V, p.G13D and p.A146T in KRAS; p.R175H in TP53; p.E545K in PIK3CA).The mutation detection rate was independent of the lesion location (Figure 4C), but it was found to be affected by lesion size (Figure 4D).", "section": "results", "mentions": ["173|6|gene|ncbi_gene@5290|PIK3CA", "63|8|variant|litvar@#324#p.R1114*&&&litvar@#324#|p.R1114*", "93|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "54|7|variant|litvar@#324#p.R876*&&&litvar@#324#|p.R876*", "128|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "109|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "139|4|gene|ncbi_gene@3845|KRAS", "162|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "76|15|variant|litvar@rs587782678##&&&litvar@#324#|p.R1450* in APC", "145|7|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|p.R175H", "156|4|gene|ncbi_gene@7157|TP53", "117|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "101|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D"], "text_hl": "In total, 10 variants were detected in stool samples (p.R876*, p.R1114* and p.R1450* in APC; p.G12A, p.G12D, p.G12V, p.G13D and <m>p.A146T</m> in KRAS; p.R175H in TP53; p.E545K in PIK3CA).The mutation detection rate was independent of the lesion location (Figure 4C), but it was found to be affected by lesion size (Figure 4D)."}], "citations": {"NLM": "Chang PY, Chen CC, Chiang JM, Chang SC, Wang MC, Chen JS, Tsai WS, You JF, Lu JJ. A Simple and Highly Specific MassARRAY-Based Stool DNA Assay to Prioritize Follow-up Decisions in Fecal Immunochemical Test-Positive Individuals. Cancers (Basel). PMID: 30934598", "BibTeX": "@article{30934598, title={A Simple and Highly Specific MassARRAY-Based Stool DNA Assay to Prioritize Follow-up Decisions in Fecal Immunochemical Test-Positive Individuals.}, author={Chang PY and Chen CC and Chiang JM and Chang SC and Wang MC and Chen JS and Tsai WS and You JF and Lu JJ}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 26691448, "pmcid": "PMC4687048", "title": "Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases.", "journal": "Sci Rep", "authors": ["Zhang J", "Zheng J", "Yang Y", "Lu J", "Gao J", "Lu T", "Sun J", "Jiang H", "Zhu Y", "Zheng Y", "Liang Z", "Liu T"], "date": "2015-12-22T00:00:00Z", "year": 2015, "snippets": [{"_id": "26691448@32012", "snip_text": "Gene Exon Codon Mutation Numbers of mutations (% of 1, 110)   KRAS 2 12, 13 G12S, G12D, G12C, G12R, G12V, G12A, G13C, G13D, 443 (40.0)   KRAS 3 61 Q61L, Q61R, Q61H 16 (1.4)   KRAS 4 117, 146 K117N, A146T, A146V, A146P 45 (4.1)   NRAS 2 12, 13 G12D, G12S, G13R, G12C, G12V, G12A, G13V, 24 (2.2)   NRAS 3 61 Q61R, Q61K, Q61L, Q61H 19 (1.7)   NRAS 4 146 A146T 0 (0)   BRAF 15 600 V600E, V600K, V600R, V600D 34 (3.1)   PIK3CA 20 1047 H1047R, H1047L 39 (3.5)   ", "section": "table", "mentions": ["306|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "324|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "118|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "255|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "159|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "377|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "415|6|gene|ncbi_gene@5290|PIK3CA", "261|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "100|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "438|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|H1047L", "212|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "62|6|gene|ncbi_gene@3845|KRAS 2", "198|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "279|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "391|5|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16021333#rs121913227##|V600R", "243|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "82|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "147|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "76|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "312|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "106|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "430|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "175|4|gene|ncbi_gene@3845|KRAS", "351|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "249|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "88|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "267|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "398|5|variant|litvar@rs121913377##&&&litvar@#673#&&&litvar@CA16602419#rs121913377##|V600D", "318|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "191|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "153|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "384|5|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16602420#rs121913227##|V600K", "273|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "112|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "205|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "94|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "365|4|gene|ncbi_gene@673|BRAF"], "figure_id": "t1", "text_hl": "Gene Exon Codon Mutation Numbers of mutations (% of 1, 110)   KRAS 2 12, 13 G12S, G12D, G12C, G12R, G12V, G12A, G13C, G13D, 443 (40.0)   KRAS 3 61 Q61L, Q61R, Q61H 16 (1.4)   KRAS 4 117, 146 K117N, <m>A146T</m>, A146V, A146P 45 (4.1)   NRAS 2 12, 13 G12D, G12S, G13R, G12C, G12V, G12A, G13V, 24 (2.2)   NRAS 3 61 Q61R, Q61K, Q61L, Q61H 19 (1.7)   NRAS 4 146 <m>A146T</m> 0 (0)   BRAF 15 600 V600E, V600K, V600R, V600D 34 (3.1)   PIK3CA 20 1047 H1047R, H1047L 39 (3.5)   "}], "citations": {"NLM": "Zhang J, Zheng J, Yang Y, Lu J, Gao J, Lu T, Sun J, Jiang H, Zhu Y, Zheng Y, Liang Z, Liu T. Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases. Sci Rep. PMID: 26691448", "BibTeX": "@article{26691448, title={Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases.}, author={Zhang J and Zheng J and Yang Y and Lu J and Gao J and Lu T and Sun J and Jiang H and Zhu Y and Zheng Y and Liang Z and Liu T}, journal={Sci Rep}}"}, "is_sup_mat_match": false}, {"pmid": 37326340, "pmcid": "PMC10281467", "title": "Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancer", "journal": "Cancer Biol Ther", "authors": ["Lee CL", "Cremona M", "Farrelly A", "Workman JA", "Kennedy S", "Aslam R", "Carr A", "Madden S", "O'Neill B", "Hennessy BT", "Toomey S"], "date": "2023-12-31T00:00:00Z", "year": 2023, "snippets": [{"_id": "37326340@6803", "snip_text": "Cell Line\tMutational Status\tIC50Palbociclib\tIC50PD0325901\tIC50Gedatolisib\tPalbociclib + PD0325901Doses\tPalbociclib + GedatolisibDoses\t \tCaco-2(ATCC HTB-37)\tWild-Type\t>15 microM\t4.0 microM\t1200 nM\t5 microM +5 microM\t5 microM +1 microM\t \tDLD-1(ATCC CCL-221)\tKRAS G13DPIK3CA E545K\t>15 microM\t13 microM\t183 nM\t2 microM +5 microM\t2 microM +200 nM\t \tLS411N(ATCC CRL-2159)\tBRAF V600E\t0.8 microM\t0.001 microM\t76 nM\t2 microM +5 microM\t2 microM +200 nM\t \tLS1034(ATCC CRL-2158)\tKRAS A146T\t>15 microM\t0.013 microM\t7200 nM\t3 microM +500 nM\t3 microM +400 nM\t \tSNUC4(KCLB 0000C4)\tPIK3CA E545G\t1.7 microM\t0.014 microM\t400 nM\t3 microM +25 nM\t3 microM +400 nM\t \t", "section": "table", "mentions": ["371|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "366|4|gene|ncbi_gene@673|BRAF", "256|4|gene|ncbi_gene@3845|KRAS", "565|6|gene|ncbi_gene@5290|PIK3CA", "472|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "572|5|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123336#rs121913274##|E545G", "272|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "467|4|gene|ncbi_gene@3845|KRAS"], "figure_id": "t0001", "text_hl": "Cell Line\tMutational Status\tIC50Palbociclib\tIC50PD0325901\tIC50Gedatolisib\tPalbociclib + PD0325901Doses\tPalbociclib + GedatolisibDoses\t \tCaco-2(ATCC HTB-37)\tWild-Type\t>15 microM\t4.0 microM\t1200 nM\t5 microM +5 microM\t5 microM +1 microM\t \tDLD-1(ATCC CCL-221)\tKRAS G13DPIK3CA E545K\t>15 microM\t13 microM\t183 nM\t2 microM +5 microM\t2 microM +200 nM\t \tLS411N(ATCC CRL-2159)\tBRAF V600E\t0.8 microM\t0.001 microM\t76 nM\t2 microM +5 microM\t2 microM +200 nM\t \tLS1034(ATCC CRL-2158)\tKRAS <m>A146T</m>\t>15 microM\t0.013 microM\t7200 nM\t3 microM +500 nM\t3 microM +400 nM\t \tSNUC4(KCLB 0000C4)\tPIK3CA E545G\t1.7 microM\t0.014 microM\t400 nM\t3 microM +25 nM\t3 microM +400 nM\t \t"}], "citations": {"NLM": "Lee CL, Cremona M, Farrelly A, Workman JA, Kennedy S, Aslam R, Carr A, Madden S, O'Neill B, Hennessy BT, Toomey S. Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancer Cancer Biol Ther. PMID: 37326340", "BibTeX": "@article{37326340, title={Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancer}, author={Lee CL and Cremona M and Farrelly A and Workman JA and Kennedy S and Aslam R and Carr A and Madden S and O'Neill B and Hennessy BT and Toomey S}, journal={Cancer Biol Ther}}"}, "is_sup_mat_match": false}, {"pmid": 34976316, "pmcid": "PMC8688876", "title": "Enhanced interpretation of 935 hotspot and non-hotspot RAS variants using evidence-based structural bioinformatics.", "journal": "Comput Struct Biotechnol J", "authors": ["Tripathi S", "Dsouza NR", "Mathison AJ", "Leverence E", "Urrutia R", "Zimmermann MT"], "date": "2021-12-11T00:00:00Z", "year": 2021, "snippets": [{"_id": "34976316@16725", "snip_text": "C4 identifies similarities among A146T/V and G13V/D but differences among non-hotspot variants A146T/V and hotspot variants G12A/R/S as well as Q61L/P/H.", "section": "results", "mentions": ["45|6|variant|litvar@rs112445441##&&&litvar@#3845#|G13V/D", "33|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "124|8|variant|litvar@rs121913529##&&&litvar@#3845#|G12A/R/S", "144|6|variant|litvar@rs121913240##&&&litvar@#3845#|Q61L/P", "95|7|variant|litvar@rs121913527##&&&litvar@#3845#|A146T/V"], "text_hl": "C4 identifies similarities among <m>A146T</m>/V and G13V/D but differences among non-hotspot variants <m>A146T</m>/V and hotspot variants G12A/R/S as well as Q61L/P/H."}], "citations": {"NLM": "Tripathi S, Dsouza NR, Mathison AJ, Leverence E, Urrutia R, Zimmermann MT. Enhanced interpretation of 935 hotspot and non-hotspot RAS variants using evidence-based structural bioinformatics. Comput Struct Biotechnol J. PMID: 34976316", "BibTeX": "@article{34976316, title={Enhanced interpretation of 935 hotspot and non-hotspot RAS variants using evidence-based structural bioinformatics.}, author={Tripathi S and Dsouza NR and Mathison AJ and Leverence E and Urrutia R and Zimmermann MT}, journal={Comput Struct Biotechnol J}}"}, "is_sup_mat_match": false}, {"pmid": 34248561, "pmcid": "PMC8255711", "title": "Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer.", "journal": "Case Rep Oncol", "authors": ["Gorshein E", "Matsuda K", "Riedlinger G", "Sokol L", "Rodriguez-Rodriguez L", "Eladoumikdachi F", "Grandhi M", "Ganesan S", "Toppmeyer DL", "Potdevin L", "Toomey K", "Hirshfield KM", "Chan N"], "date": "2021-06-18T00:00:00Z", "year": 2021, "snippets": [{"_id": "34248561@5560", "snip_text": "This revealed the presence of the following genomic alterations: AKT1 E17K; KRAS A146T; NUP93 E14K; and TP53 loss, R213.", "section": "other", "mentions": ["104|4|gene|ncbi_gene@7157|TP53", "88|5|gene|ncbi_gene@9688|NUP93", "94|4|variant|litvar@rs528073782##&&&litvar@#9688#&&&litvar@CA281482204#rs528073782##|E14K", "81|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "76|4|gene|ncbi_gene@3845|KRAS", "65|9|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|AKT1 E17K"], "text_hl": "This revealed the presence of the following genomic alterations: AKT1 E17K; KRAS <m>A146T</m>; NUP93 E14K; and TP53 loss, R213."}], "citations": {"NLM": "Gorshein E, Matsuda K, Riedlinger G, Sokol L, Rodriguez-Rodriguez L, Eladoumikdachi F, Grandhi M, Ganesan S, Toppmeyer DL, Potdevin L, Toomey K, Hirshfield KM, Chan N. Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer. Case Rep Oncol. PMID: 34248561", "BibTeX": "@article{34248561, title={Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer.}, author={Gorshein E and Matsuda K and Riedlinger G and Sokol L and Rodriguez-Rodriguez L and Eladoumikdachi F and Grandhi M and Ganesan S and Toppmeyer DL and Potdevin L and Toomey K and Hirshfield KM and Chan N}, journal={Case Rep Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 35046094, "pmcid": "PMC8983508", "title": "A Structure is Worth a Thousand Words: New Insights for RAS and RAF Regulation.", "journal": "Cancer Discov", "authors": ["Simanshu DK", "Morrison DK"], "date": "2022-04-01T00:00:00Z", "year": 2022, "snippets": [{"_id": "35046094@12965", "snip_text": "The A146T mutation is the fourth most common KRAS alteration (Fig. 1), and it is frequently observed in colorectal and hematopoietic cancers.", "section": "other", "mentions": ["4|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "45|4|gene|ncbi_gene@3845|KRAS", "104|36|disease|ncbi_mesh@D015179|colorectal and hematopoietic cancers"], "text_hl": "The <m>A146T</m> mutation is the fourth most common KRAS alteration (Fig. 1), and it is frequently observed in colorectal and hematopoietic cancers."}], "citations": {"NLM": "Simanshu DK, Morrison DK. A Structure is Worth a Thousand Words: New Insights for RAS and RAF Regulation. Cancer Discov. PMID: 35046094", "BibTeX": "@article{35046094, title={A Structure is Worth a Thousand Words: New Insights for RAS and RAF Regulation.}, author={Simanshu DK and Morrison DK}, journal={Cancer Discov}}"}, "is_sup_mat_match": false}, {"pmid": 29666387, "pmcid": "PMC5904111", "title": "Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients.", "journal": "Sci Rep", "authors": ["Guo F", "Gong H", "Zhao H", "Chen J", "Zhang Y", "Zhang L", "Shi X", "Zhang A", "Jin H", "Zhang J", "He Y"], "date": "2018-04-17T00:00:00Z", "year": 2018, "snippets": [{"_id": "29666387@16263", "snip_text": "In exon 4, the most common mutation was 436G>A (A146T), followed by 351A>T (K117N), 437C>T (A146V), 350A>G (K117R), 436G>C (A146P) and 441G>T (K147N).", "section": "results", "mentions": ["92|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "76|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "40|6|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|436G>A", "48|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "100|6|variant|litvar@rs758945260##&&&litvar@#1956#&&&litvar@CA4265234#rs758945260##|350A>G", "108|5|variant|litvar@rs104894227##&&&litvar@#3265#&&&litvar@CA256490#rs104894227##|K117R", "84|6|variant|litvar@rs1057519725##&&&litvar@#3845#|437C>T", "135|6|variant|litvar@#673#c.441G>T&&&litvar@#673#|441G>T", "68|6|variant|litvar@rs770248150##&&&litvar@#3845#|351A>T", "116|6|variant|litvar@rs121913527##&&&litvar@#3845#|436G>C", "124|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "143|5|variant|litvar@#673#p.K147N&&&litvar@#673#|K147N"], "text_hl": "In exon 4, the most common mutation was 436G>A (<m>A146T</m>), followed by 351A>T (K117N), 437C>T (A146V), 350A>G (K117R), 436G>C (A146P) and 441G>T (K147N)."}], "citations": {"NLM": "Guo F, Gong H, Zhao H, Chen J, Zhang Y, Zhang L, Shi X, Zhang A, Jin H, Zhang J, He Y. Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients. Sci Rep. PMID: 29666387", "BibTeX": "@article{29666387, title={Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients.}, author={Guo F and Gong H and Zhao H and Chen J and Zhang Y and Zhang L and Shi X and Zhang A and Jin H and Zhang J and He Y}, journal={Sci Rep}}"}, "is_sup_mat_match": false}, {"pmid": 31876604, "pmcid": "PMC9281533", "title": "Analysis of Intestinal Metaplasia Without Dysplasia in the Urinary Bladder Reveal Only Rare Mutations Associated With Colorectal Adenocarcinoma", "journal": "Appl Immunohistochem Mol Morphol", "authors": ["Amin A", "Murati-Amador B", "Lombardo KA", "Jackson CL", "Grada Z", "Palsgrove DN", "Matoso A"], "date": "2020-11-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "31876604@8120", "snip_text": "Most common KRAS mutations were at p.G12D (3 cases, 50%), with the rest of the cases showing mutation in p.G12S, p.G13D, and p.A146T (1 case each).", "section": "results", "mentions": ["125|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "113|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "35|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "105|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "12|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "Most common KRAS mutations were at p.G12D (3 cases, 50%), with the rest of the cases showing mutation in p.G12S, p.G13D, and <m>p.A146T</m> (1 case each)."}], "citations": {"NLM": "Amin A, Murati-Amador B, Lombardo KA, Jackson CL, Grada Z, Palsgrove DN, Matoso A. Analysis of Intestinal Metaplasia Without Dysplasia in the Urinary Bladder Reveal Only Rare Mutations Associated With Colorectal Adenocarcinoma Appl Immunohistochem Mol Morphol. PMID: 31876604", "BibTeX": "@article{31876604, title={Analysis of Intestinal Metaplasia Without Dysplasia in the Urinary Bladder Reveal Only Rare Mutations Associated With Colorectal Adenocarcinoma}, author={Amin A and Murati-Amador B and Lombardo KA and Jackson CL and Grada Z and Palsgrove DN and Matoso A}, journal={Appl Immunohistochem Mol Morphol}}"}, "is_sup_mat_match": false}, {"pmid": 26819545, "pmcid": "PMC4721683", "title": "Correlation between Gene Variants, Signaling Pathways, and Efficacy of Chemotherapy Drugs against Colon Cancers", "journal": "Cancer Inform", "authors": ["Tripathi S", "Belkacemi L", "Cheung MS", "Bose RN"], "date": "2016-01-20T00:00:00Z", "year": 2016, "snippets": [{"_id": "26819545@13436", "snip_text": "Moreover, neither oxaliplatin nor 5-FU activity is correlated with the variant A146T of KRAS from HCC_2998 (indicated by X in Tables 1 and 2).", "section": "results", "mentions": ["18|11|chemical|ncbi_mesh@D000077150|oxaliplatin", "88|4|gene|ncbi_gene@3845|KRAS", "34|4|chemical|ncbi_mesh@D005472|5-FU", "79|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Moreover, neither oxaliplatin nor 5-FU activity is correlated with the variant <m>A146T</m> of KRAS from HCC_2998 (indicated by X in Tables 1 and 2)."}], "citations": {"NLM": "Tripathi S, Belkacemi L, Cheung MS, Bose RN. Correlation between Gene Variants, Signaling Pathways, and Efficacy of Chemotherapy Drugs against Colon Cancers Cancer Inform. PMID: 26819545", "BibTeX": "@article{26819545, title={Correlation between Gene Variants, Signaling Pathways, and Efficacy of Chemotherapy Drugs against Colon Cancers}, author={Tripathi S and Belkacemi L and Cheung MS and Bose RN}, journal={Cancer Inform}}"}, "is_sup_mat_match": false}, {"pmid": 23263490, "pmcid": "PMC3785128", "title": "Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas", "journal": "Nat Genet", "authors": ["Palles C", "Cazier JB", "Howarth KM", "Domingo E", "Jones AM", "Broderick P", "Kemp Z", "Spain SL", "Guarino E", "Salguero I", "Sherborne A", "Chubb D", "Carvajal-Carmona LG", "Ma Y", "Kaur K", "Dobbins S", "Barclay E", "Gorman M", "Martin L", "Kovac MB", "Humphray S", "CORGI Consortium.", "WGS500 Consortium.", "Lucassen A", "Holmes CC", "Bentley D", "Donnelly P", "Taylor J", "Petridis C", "Roylance R", "Sawyer EJ", "Kerr DJ", "Clark S", "Grimes J", "Kearsey SE", "Thomas HJ", "McVean G", "Houlston RS", "Tomlinson I"], "date": "2013-02-01T00:00:00Z", "year": 2013, "snippets": [{"_id": "23263490@47456", "snip_text": "Family\tPatient\tSomatic mutations\t \t2702\t1\tAPC Q1338X (C>T); FBXW7 R465C (C>T)\t \t2702\t2\tNone found\t \t2702\t3\tAPC R1114X (C>T), Q1338X (C>T); KRAS G12D (G>A), A146T (A>C)\t \tA\t1\tNone found\t \tI\t1\tAPC Q1338X (C>T); KRAS A146T (A>C); FBXW7 R479Q (G>A)\t \tI\t2\tAPC Q1338X (C>T); KRAS G12D (G>A) x 3\t \tF\t1\tNone found\t \tK\t1\tAPC R1114X (C>T)\t \tC\t1\tNone found\t \tH\t1\tNone found\t \t", "section": "table", "mentions": ["203|3|variant|litvar@#3845#|C>T", "42|3|gene|ncbi_gene@324|APC", "240|3|variant|litvar@#673#|G>A", "107|3|gene|ncbi_gene@324|APC", "125|6|variant|litvar@rs121913327##&&&litvar@#324#&&&litvar@CA8865#rs121913327##|Q1338X", "60|5|gene|ncbi_gene@55294|FBXW7", "269|4|gene|ncbi_gene@3845|KRAS", "156|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "263|3|variant|litvar@#3845#|C>T", "274|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "195|6|variant|litvar@rs121913327##&&&litvar@#324#&&&litvar@CA8865#rs121913327##|Q1338X", "324|3|variant|litvar@#3845#|C>T", "163|3|variant|litvar@#55294#|A>C", "150|3|variant|litvar@#673#|G>A", "255|6|variant|litvar@rs121913327##&&&litvar@#324#&&&litvar@CA8865#rs121913327##|Q1338X", "191|3|gene|ncbi_gene@324|APC", "251|3|gene|ncbi_gene@324|APC", "227|5|gene|ncbi_gene@55294|FBXW7", "66|5|variant|litvar@rs867384286##&&&litvar@#55294#&&&litvar@CA16602851#rs867384286##|R465C", "316|6|variant|litvar@rs121913331##&&&litvar@#324#&&&litvar@CA10582306#rs121913331##|R1114X", "54|3|variant|litvar@#3845#|C>T", "119|3|variant|litvar@#3845#|C>T", "214|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "73|3|variant|litvar@#3845#|C>T", "139|4|gene|ncbi_gene@3845|KRAS", "133|3|variant|litvar@#3845#|C>T", "312|3|gene|ncbi_gene@324|APC", "46|6|variant|litvar@rs121913327##&&&litvar@#324#&&&litvar@CA8865#rs121913327##|Q1338X", "144|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "280|3|variant|litvar@#673#|G>A", "233|5|variant|litvar@rs866987936##&&&litvar@#55294#&&&litvar@CA16602856#rs866987936##|R479Q", "221|3|variant|litvar@#55294#|A>C", "111|6|variant|litvar@rs121913331##&&&litvar@#324#&&&litvar@CA10582306#rs121913331##|R1114X", "209|4|gene|ncbi_gene@3845|KRAS"], "figure_id": "T1", "text_hl": "Family\tPatient\tSomatic mutations\t \t2702\t1\tAPC Q1338X (C>T); FBXW7 R465C (C>T)\t \t2702\t2\tNone found\t \t2702\t3\tAPC R1114X (C>T), Q1338X (C>T); KRAS G12D (G>A), <m>A146T</m> (A>C)\t \tA\t1\tNone found\t \tI\t1\tAPC Q1338X (C>T); KRAS <m>A146T</m> (A>C); FBXW7 R479Q (G>A)\t \tI\t2\tAPC Q1338X (C>T); KRAS G12D (G>A) x 3\t \tF\t1\tNone found\t \tK\t1\tAPC R1114X (C>T)\t \tC\t1\tNone found\t \tH\t1\tNone found\t \t"}], "citations": {"NLM": "Palles C, Cazier JB, Howarth KM, Domingo E, Jones AM, Broderick P, Kemp Z, Spain SL, Guarino E, Salguero I, Sherborne A, Chubb D, Carvajal-Carmona LG, Ma Y, Kaur K, Dobbins S, Barclay E, Gorman M, Martin L, Kovac MB, Humphray S, CORGI Consortium., WGS500 Consortium., Lucassen A, Holmes CC, Bentley D, Donnelly P, Taylor J, Petridis C, Roylance R, Sawyer EJ, Kerr DJ, Clark S, Grimes J, Kearsey SE, Thomas HJ, McVean G, Houlston RS, Tomlinson I. Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas Nat Genet. PMID: 23263490", "BibTeX": "@article{23263490, title={Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas}, author={Palles C and Cazier JB and Howarth KM and Domingo E and Jones AM and Broderick P and Kemp Z and Spain SL and Guarino E and Salguero I and Sherborne A and Chubb D and Carvajal-Carmona LG and Ma Y and Kaur K and Dobbins S and Barclay E and Gorman M and Martin L and Kovac MB and Humphray S and CORGI Consortium. and WGS500 Consortium. and Lucassen A and Holmes CC and Bentley D and Donnelly P and Taylor J and Petridis C and Roylance R and Sawyer EJ and Kerr DJ and Clark S and Grimes J and Kearsey SE and Thomas HJ and McVean G and Houlston RS and Tomlinson I}, journal={Nat Genet}}"}, "is_sup_mat_match": false}, {"pmid": 32079091, "pmcid": "PMC7072554", "title": "Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines.", "journal": "Cancers (Basel)", "authors": ["Wei\u00dfbach S", "Heredia-Guerrero SC", "Barnsteiner S", "Gro\u00dfhans L", "Bodem J", "Starz H", "Langer C", "Appenzeller S", "Knop S", "Steinbrunn T", "Rost S", "Einsele H", "Bargou RC", "Rosenwald A", "St\u00fchmer T", "Leich E"], "date": "2020-02-16T00:00:00Z", "year": 2020, "snippets": [{"_id": "32079091@992", "snip_text": "Moreover, the functional impact of KRASp.G12A and the exon-4 mutations p.A146T and p.A146V on different survival pathways was investigated.", "section": "abstract", "mentions": ["71|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "39|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "83|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V"], "text_hl": "Moreover, the functional impact of KRASp.G12A and the exon-4 mutations <m>p.A146T</m> and p.A146V on different survival pathways was investigated."}], "citations": {"NLM": "Wei\u00dfbach S, Heredia-Guerrero SC, Barnsteiner S, Gro\u00dfhans L, Bodem J, Starz H, Langer C, Appenzeller S, Knop S, Steinbrunn T, Rost S, Einsele H, Bargou RC, Rosenwald A, St\u00fchmer T, Leich E. Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines. Cancers (Basel). PMID: 32079091", "BibTeX": "@article{32079091, title={Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines.}, author={Wei\u00dfbach S and Heredia-Guerrero SC and Barnsteiner S and Gro\u00dfhans L and Bodem J and Starz H and Langer C and Appenzeller S and Knop S and Steinbrunn T and Rost S and Einsele H and Bargou RC and Rosenwald A and St\u00fchmer T and Leich E}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 38600547, "pmcid": "PMC11005154", "title": "Lack of shared neoantigens in prevalent mutations in cancer", "journal": "J Transl Med", "authors": ["Ragone C", "Cavalluzzo B", "Mauriello A", "Tagliamonte M", "Buonaguro L"], "date": "2024-04-10T00:00:00Z", "year": 2024, "snippets": [{"_id": "38600547@26629", "snip_text": "MISSENSE\tTOP FREQ\tFRAMESHIFT\tTOP FREQ\t \tBCORN1459S\t\tACVR2AK437Rfs*5\tStomach\t \tBRAFV640E/V600E\tColon, Skin, Thyroid\tAPCT1556Nfs*3\t\t \tBRAFV640M\t\tBCORL1P1681Qfs*20\t\t \tERBB2S310F\t\tGLI1G274Afs*6\t\t \tFBXW7R465C\t\tJAK1K860Nfs*16\t\t \tFBXW7R465H\t\tJAK1P430Rfs*2\t\t \tFBXW7R479Q\t\tNPM1W317Cfs*12\t\t \tFBXW7R505C\t\tPTENK267Rfs*9\t\t \tFBXW7R505G\t\tPTENT319*\t\t \tFGFR2S252W\t\tRPL22K15Rfs*5\tCorpus Uteri\t \tFGFR3S249C\tBladder\tSALL4V995Ffs*14\t\t \tGNAQQ209P\t\tZMYM2K1044Rfs*33\t\t \tHRASQ61R\tAdrenal gland\t\t\t \tIDH1R132C\t\t\t\t \tIDH1R132H\tBrain\t\t\t \tKRASA146T\t\t\t\t \tKRASG12A\t\t\t\t \tKRASG12C\tLung\t\t\t \tKRASG12D\tPancreas, Rectum\t\t\t \tKRASG12R\t\t\t\t \tKRASG12S\t\t\t\t \tKRASG12V\t\t\t\t \tKRASG13D\t\t\t\t \tKRAS Q61H\t\t\t\t \tNRASG12D\t\t\t\t \tNRASG13D\t\t\t\t \tNRASG13R\t\t\t\t \tNRASQ61K\t\t\t\t \tNRASQ61L\t\t\t\t \tNRASQ61R\tHematopoietic\t\t\t \tPIK3CAC420R\t\t\t\t \tPIK3CAE542K\t\t\t\t \tPIK3CAE545K\tCervix uteri, Larynx\t\t\t \tPIK3CAH1047R\tBreast\t\t\t \tPOLEP286R\t\t\t\t \tPTENR130G\tUterus\t\t\t \tPTENR130Q\t\t\t\t \tTP53G245S\t\t\t\t \tTP53H179R\t\t\t\t \tTP53H193R\t\t\t\t \tTP53I195T\t\t\t\t \tTP53R175H\tOvary, Esophagus\t\t\t \tTP53R248Q\t\t\t\t \tTP53R248W\tBones\t\t\t \tTP53R273C\t\t\t\t \tTP53R273H\t\t\t\t \tTP53R273L\t\t\t\t \tTP53R282W\t\t\t\t \tTP53V157F\t\t\t\t \tTP53Y220C\t\t\t\t \t", "section": "table", "mentions": ["257|5|variant|litvar@#3105#p.R479Q&&&litvar@#3105#|R479Q", "1074|5|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|R282W", "82|5|variant|litvar@#7157#p.V640E&&&litvar@#7157#|V640E", "888|5|variant|litvar@#3105#p.R130Q&&&litvar@#3105#|R130Q", "948|5|variant|litvar@rs760043106##&&&litvar@#7157#&&&litvar@CA2232#rs760043106##|I195T", "415|9|variant|litvar@rs121913492##&&&litvar@#2776#&&&litvar@CA16602436#rs121913492##|GNAQQ209P", "1044|5|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|R273H", "646|4|variant|litvar@#3105#p.Q61H&&&litvar@#3105#|Q61H", "1029|5|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|R273C", "903|5|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|G245S", "228|5|variant|litvar@#3105#p.R465H&&&litvar@#3105#|R465H", "382|5|variant|litvar@#3105#p.S249C&&&litvar@#3105#|S249C", "776|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "994|5|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|R248Q", "1059|5|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA1530#rs28934576##|R273L", "88|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "169|5|variant|litvar@#3105#p.S310F&&&litvar@#3105#|S310F", "508|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T", "341|5|variant|litvar@#3105#p.S252W&&&litvar@#3105#|S252W"], "figure_id": "Tab7", "text_hl": "MISSENSE\tTOP FREQ\tFRAMESHIFT\tTOP FREQ\t \tBCORN1459S\t\tACVR2AK437Rfs*5\tStomach\t \tBRAFV640E/V600E\tColon, Skin, Thyroid\tAPCT1556Nfs*3\t\t \tBRAFV640M\t\tBCORL1P1681Qfs*20\t\t \tERBB2S310F\t\tGLI1G274Afs*6\t\t \tFBXW7R465C\t\tJAK1K860Nfs*16\t\t \tFBXW7R465H\t\tJAK1P430Rfs*2\t\t \tFBXW7R479Q\t\tNPM1W317Cfs*12\t\t \tFBXW7R505C\t\tPTENK267Rfs*9\t\t \tFBXW7R505G\t\tPTENT319*\t\t \tFGFR2S252W\t\tRPL22K15Rfs*5\tCorpus Uteri\t \tFGFR3S249C\tBladder\tSALL4V995Ffs*14\t\t \tGNAQQ209P\t\tZMYM2K1044Rfs*33\t\t \tHRASQ61R\tAdrenal gland\t\t\t \tIDH1R132C\t\t\t\t \tIDH1R132H\tBrain\t\t\t \tKRASA146T\t\t\t\t \tKRASG12A\t\t\t\t \tKRASG12C\tLung\t\t\t \tKRASG12D\tPancreas, Rectum\t\t\t \tKRASG12R\t\t\t\t \tKRASG12S\t\t\t\t \tKRASG12V\t\t\t\t \tKRASG13D\t\t\t\t \tKRAS Q61H\t\t\t\t \tNRASG12D\t\t\t\t \tNRASG13D\t\t\t\t \tNRASG13R\t\t\t\t \tNRASQ61K\t\t\t\t \tNRASQ61L\t\t\t\t \tNRASQ61R\tHematopoietic\t\t\t \tPIK3CAC420R\t\t\t\t \tPIK3CAE542K\t\t\t\t \tPIK3CAE545K\tCervix uteri, Larynx\t\t\t \tPIK3CAH1047R\tBreast\t\t\t \tPOLEP286R\t\t\t\t \tPTENR130G\tUterus\t\t\t \tPTENR130Q\t\t\t\t \tTP53G245S\t\t\t\t \tTP53H179R\t\t\t\t \tTP53H193R\t\t\t\t \tTP53I195T\t\t\t\t \tTP53R175H\tOvary, Esophagus\t\t\t \tTP53R248Q\t\t\t\t \tTP53R248W\tBones\t\t\t \tTP53R273C\t\t\t\t \tTP53R273H\t\t\t\t \tTP53R273L\t\t\t\t \tTP53R282W\t\t\t\t \tTP53V157F\t\t\t\t \tTP53Y220C\t\t\t\t \t"}], "citations": {"NLM": "Ragone C, Cavalluzzo B, Mauriello A, Tagliamonte M, Buonaguro L. Lack of shared neoantigens in prevalent mutations in cancer J Transl Med. PMID: 38600547", "BibTeX": "@article{38600547, title={Lack of shared neoantigens in prevalent mutations in cancer}, author={Ragone C and Cavalluzzo B and Mauriello A and Tagliamonte M and Buonaguro L}, journal={J Transl Med}}"}, "is_sup_mat_match": false}, {"pmid": 26512781, "pmcid": "PMC4747370", "title": "A set of defined oncogenic mutation alleles seems to better predict the response to cetuximab in CRC patient-derived xenograft than KRAS 12/13 mutations.", "journal": "Oncotarget", "authors": ["Chen D", "Huang X", "Cai J", "Guo S", "Qian W", "Wery JP", "Li QX"], "date": "2015-12-01T00:00:00Z", "year": 2015, "snippets": [{"_id": "26512781@1306", "snip_text": "Furthermore, majority of the non-/partial responders tend to have certain activating oncogenic alleles (one or more of the following common ones: K/N-RAS-G12V/D, -A146T, -Q61H/R, BRAF-V600E, AKT1-L52R and PIK3CA-E545G/K).", "section": "abstract", "mentions": ["205|6|gene|ncbi_gene@5290|PIK3CA", "171|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "212|5|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123336#rs121913274##|E545G", "191|4|gene|ncbi_gene@207|AKT1", "154|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12V/D", "163|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "184|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "196|4|variant|litvar@#207#p.L52R&&&litvar@#207#|L52R", "179|4|gene|ncbi_gene@673|BRAF"], "text_hl": "Furthermore, majority of the non-/partial responders tend to have certain activating oncogenic alleles (one or more of the following common ones: K/N-RAS-G12V/D, -<m>A146T</m>, -Q61H/R, BRAF-V600E, AKT1-L52R and PIK3CA-E545G/K)."}], "citations": {"NLM": "Chen D, Huang X, Cai J, Guo S, Qian W, Wery JP, Li QX. A set of defined oncogenic mutation alleles seems to better predict the response to cetuximab in CRC patient-derived xenograft than KRAS 12/13 mutations. Oncotarget. PMID: 26512781", "BibTeX": "@article{26512781, title={A set of defined oncogenic mutation alleles seems to better predict the response to cetuximab in CRC patient-derived xenograft than KRAS 12/13 mutations.}, author={Chen D and Huang X and Cai J and Guo S and Qian W and Wery JP and Li QX}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 26335936, "pmcid": "PMC4557483", "title": "The Italian external quality assessment for RAS testing in colorectal carcinoma identifies methods-related inter-laboratory differences.", "journal": "J Transl Med", "authors": ["Normanno N", "Pinto C", "Castiglione F", "Fenizia F", "Barberis M", "Marchetti A", "Fontanini G", "De Rosa G", "Taddei GL"], "date": "2015-09-03T00:00:00Z", "year": 2015, "snippets": [{"_id": "26335936@9094", "snip_text": "Sample ID KRASa BRAFa NRASa   A1 WT WT WT   A2 WT WT WT   A3 WT WT WT   A4 WT WT WT   A5 WT WT WT   A6 WT p.V600E (c.1799T > A) (27.6 %) WT   A7 p.A146T (c.436G > A) (27.6 %) WT WT   A8 p.G12D (c.35G > A) (24.2 %) WT WT   A9 WT WT p.G12D (c.35G > A) (18.1 %)   A10 WT WT p.Q61K (c.181C > A) (74.6 %)   B1 WT WT WT   B2 WT WT WT   B3 WT WT WT   B4 WT WT WT   B5 WT WT WT   B6 p.G12D (c.35G > A) (27.7 %) WT WT   B7 p.A146T (c.436G > A) (62 %) WT WT   B8 WT WT p.Q61R (c.182A > G) (29.5 %)   B9 WT WT p.G12S (c.34G > A) (45.2 %)   B10 WT p.V600E (c.1799T > A) (36.9 %) WT   ", "section": "table", "mentions": ["145|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "499|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "154|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "106|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "194|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "423|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "536|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "507|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G > A", "186|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "467|10|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|c.182A > G", "414|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "115|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T > A", "383|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "239|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "279|10|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA180750#rs121913238##|c.181C > A", "271|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "545|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T > A", "459|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "375|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "231|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D"], "figure_id": "Tab2", "text_hl": "Sample ID KRASa BRAFa NRASa   A1 WT WT WT   A2 WT WT WT   A3 WT WT WT   A4 WT WT WT   A5 WT WT WT   A6 WT p.V600E (c.1799T > A) (27.6 %) WT   A7 <m>p.A146T</m> (c.436G > A) (27.6 %) WT WT   A8 p.G12D (c.35G > A) (24.2 %) WT WT   A9 WT WT p.G12D (c.35G > A) (18.1 %)   A10 WT WT p.Q61K (c.181C > A) (74.6 %)   B1 WT WT WT   B2 WT WT WT   B3 WT WT WT   B4 WT WT WT   B5 WT WT WT   B6 p.G12D (c.35G > A) (27.7 %) WT WT   B7 <m>p.A146T</m> (c.436G > A) (62 %) WT WT   B8 WT WT p.Q61R (c.182A > G) (29.5 %)   B9 WT WT p.G12S (c.34G > A) (45.2 %)   B10 WT p.V600E (c.1799T > A) (36.9 %) WT   "}], "citations": {"NLM": "Normanno N, Pinto C, Castiglione F, Fenizia F, Barberis M, Marchetti A, Fontanini G, De Rosa G, Taddei GL. The Italian external quality assessment for RAS testing in colorectal carcinoma identifies methods-related inter-laboratory differences. J Transl Med. PMID: 26335936", "BibTeX": "@article{26335936, title={The Italian external quality assessment for RAS testing in colorectal carcinoma identifies methods-related inter-laboratory differences.}, author={Normanno N and Pinto C and Castiglione F and Fenizia F and Barberis M and Marchetti A and Fontanini G and De Rosa G and Taddei GL}, journal={J Transl Med}}"}, "is_sup_mat_match": false}, {"pmid": 38613732, "pmcid": "PMC11111497", "title": "Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Analysis", "journal": "Target Oncol", "authors": ["Basso M", "Signorelli C", "Calegari MA", "Lucchetti J", "Zurlo IV", "Dell'Aquila E", "Arrivi G", "Zoratto F", "Santamaria F", "Saltarelli R", "Trovato G", "Caira G", "Angotti L", "Schirripa M", "Anghelone A", "Schietroma F", "Chilelli MG", "Salvatore L", "Pozzo C", "Tortora G"], "date": "2024-04-13T00:00:00Z", "year": 2024, "snippets": [{"_id": "38613732@12357", "snip_text": "RAS mutation\tPatients (%)\t \tNo mutation (all wild-type)\t270 (46.3)\t \tKras Codon 12\t212 (36.4)\t \t G12D\t63 (10.8)\t \t G12V\t53\t \t G12C\t17 (2.9)\t \t G12R\t3\t \t G12S\t9\t \t G12A\t14\t \t G12V/D/A\t19\t \t G12X\t34\t \tKras Codon 13\t49 (8.4)\t \t G13D\t40\t \t G13C\t1\t \t G13A\t1\t \t G13X\t7\t \tRare mutations\t51 (8.7)\t \t Kras A146X\t8\t \t Kras A146T\t6\t \t Kras A146V\t1\t \t Kras G61X\t2\t \t Kras Q61K\t1\t \t Kras K117X\t2\t \t Kras A146G\t1\t \t Kras A59T\t1\t \t Kras Q22K\t1\t \tKras codon 61 not further specified\t3\t \t Nras G12A\t3\t \t Nras G61L\t3\t \t Nras Q61H\t3\t \t Nras Q61X\t4\t \t Nras Q61L\t2\t \t Nras Q61R\t2\t \t Nras Q61K\t2\t \t Nras G61A\t2\t \t Nras A117X\t2\t \t Nras G61C\t1\t \t Nras A11P\t1\t \t", "section": "table", "mentions": ["402|4|gene|ncbi_gene@3845|Kras", "370|4|gene|ncbi_gene@3845|Kras", "163|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "517|4|gene|ncbi_gene@4893|Nras", "292|4|gene|ncbi_gene@3845|Kras", "613|4|variant|litvar@rs587778113##&&&litvar@#673#|G61C", "324|4|gene|ncbi_gene@3845|Kras", "623|4|gene|ncbi_gene@4893|Nras", "407|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "246|4|variant|litvar@rs193929331##&&&litvar@#3845#&&&litvar@CA250291#rs193929331##|G13A", "256|4|variant|litvar@rs112445441##&&&litvar@#3845#|G13X", "577|4|gene|ncbi_gene@4893|Nras", "522|4|variant|litvar@rs121913254##&&&litvar@#4893#|Q61X", "628|4|variant|litvar@#4893#p.A11P&&&litvar@#4893#|A11P", "597|5|variant|litvar@#4893#p.A117X&&&litvar@#4893#|A117X", "477|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "582|4|variant|litvar@rs373129709##&&&litvar@#1956#&&&litvar@CA4265111#rs373129709##|G61A", "174|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "431|4|gene|ncbi_gene@3845|Kras", "391|5|variant|litvar@rs1484032303##&&&litvar@#1956#|A146G", "417|4|gene|ncbi_gene@3845|Kras", "472|4|gene|ncbi_gene@4893|Nras", "313|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "532|4|gene|ncbi_gene@4893|Nras", "592|4|gene|ncbi_gene@4893|Nras", "422|4|variant|litvar@rs121913236##&&&litvar@#3845#&&&litvar@CA16602771#rs121913236##|Q22K", "69|4|gene|ncbi_gene@3845|Kras", "143|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "537|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "386|4|gene|ncbi_gene@3845|Kras", "97|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "225|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "308|4|gene|ncbi_gene@3845|Kras", "340|4|gene|ncbi_gene@3845|Kras", "487|4|gene|ncbi_gene@4893|Nras", "189|4|variant|litvar@rs121913529##&&&litvar@#3845#|G12X", "552|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "345|4|variant|litvar@rs121913254##&&&litvar@#4893#|G61X", "492|4|variant|litvar@rs121913254##&&&litvar@#4893#|G61L", "547|4|gene|ncbi_gene@4893|Nras", "375|5|variant|litvar@#4893#p.K117X&&&litvar@#4893#|K117X", "502|4|gene|ncbi_gene@4893|Nras", "360|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "153|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "126|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "199|4|gene|ncbi_gene@3845|Kras", "329|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "355|4|gene|ncbi_gene@3845|Kras", "562|4|gene|ncbi_gene@4893|Nras", "297|5|variant|litvar@rs1484032303##&&&litvar@#1956#|A146X", "507|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "236|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "567|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "608|4|gene|ncbi_gene@4893|Nras"], "figure_id": "Tab1", "text_hl": "RAS mutation\tPatients (%)\t \tNo mutation (all wild-type)\t270 (46.3)\t \tKras Codon 12\t212 (36.4)\t \t G12D\t63 (10.8)\t \t G12V\t53\t \t G12C\t17 (2.9)\t \t G12R\t3\t \t G12S\t9\t \t G12A\t14\t \t G12V/D/A\t19\t \t G12X\t34\t \tKras Codon 13\t49 (8.4)\t \t G13D\t40\t \t G13C\t1\t \t G13A\t1\t \t G13X\t7\t \tRare mutations\t51 (8.7)\t \t Kras A146X\t8\t \t Kras <m>A146T</m>\t6\t \t Kras A146V\t1\t \t Kras G61X\t2\t \t Kras Q61K\t1\t \t Kras K117X\t2\t \t Kras A146G\t1\t \t Kras A59T\t1\t \t Kras Q22K\t1\t \tKras codon 61 not further specified\t3\t \t Nras G12A\t3\t \t Nras G61L\t3\t \t Nras Q61H\t3\t \t Nras Q61X\t4\t \t Nras Q61L\t2\t \t Nras Q61R\t2\t \t Nras Q61K\t2\t \t Nras G61A\t2\t \t Nras A117X\t2\t \t Nras G61C\t1\t \t Nras A11P\t1\t \t"}], "citations": {"NLM": "Basso M, Signorelli C, Calegari MA, Lucchetti J, Zurlo IV, Dell'Aquila E, Arrivi G, Zoratto F, Santamaria F, Saltarelli R, Trovato G, Caira G, Angotti L, Schirripa M, Anghelone A, Schietroma F, Chilelli MG, Salvatore L, Pozzo C, Tortora G. Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Analysis Target Oncol. PMID: 38613732", "BibTeX": "@article{38613732, title={Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Analysis}, author={Basso M and Signorelli C and Calegari MA and Lucchetti J and Zurlo IV and Dell'Aquila E and Arrivi G and Zoratto F and Santamaria F and Saltarelli R and Trovato G and Caira G and Angotti L and Schirripa M and Anghelone A and Schietroma F and Chilelli MG and Salvatore L and Pozzo C and Tortora G}, journal={Target Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 35409398, "pmcid": "PMC8999796", "title": "Identification of Codon 146 KRAS Variants in Isolated Epidermal Nevus and Multiple Lesions in Oculoectodermal Syndrome: Confirmation of the Phenotypic Continuum of Mosaic RASopathies.", "journal": "Int J Mol Sci", "authors": ["Beyens A", "Dequeker L", "Brems H", "Janssens S", "Syryn H", "D'Hooghe A", "De Paepe P", "Vanwalleghem L", "Stockman A", "Vankwikelberge E", "De Schepper S", "Goeteyn M", "Delbeke P", "Callewaert B"], "date": "2022-04-06T00:00:00Z", "year": 2022, "snippets": [{"_id": "35409398@9556", "snip_text": "Subsequent next-generation sequencing analysis on DNA directly extracted from a skin biopsy taken in the linear hyperpigmentation was able to identify a mosaic missense variant (c.436G > A, p.(Ala146Thr)) in the KRAS gene, illustrated by variant frequencies of 60% in cells of the epidermis and 22% in the dermis/hypodermis.", "section": "results", "mentions": ["112|17|disease|ncbi_mesh@D017495|hyperpigmentation", "212|4|gene|ncbi_gene@3845|KRAS", "190|13|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.(Ala146Thr)", "178|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A"], "text_hl": "Subsequent next-generation sequencing analysis on DNA directly extracted from a skin biopsy taken in the linear hyperpigmentation was able to identify a mosaic missense variant (c.436G > A, p.(<m>Ala146Thr</m>)) in the KRAS gene, illustrated by variant frequencies of 60% in cells of the epidermis and 22% in the dermis/hypodermis."}], "citations": {"NLM": "Beyens A, Dequeker L, Brems H, Janssens S, Syryn H, D'Hooghe A, De Paepe P, Vanwalleghem L, Stockman A, Vankwikelberge E, De Schepper S, Goeteyn M, Delbeke P, Callewaert B. Identification of Codon 146 KRAS Variants in Isolated Epidermal Nevus and Multiple Lesions in Oculoectodermal Syndrome: Confirmation of the Phenotypic Continuum of Mosaic RASopathies. Int J Mol Sci. PMID: 35409398", "BibTeX": "@article{35409398, title={Identification of Codon 146 KRAS Variants in Isolated Epidermal Nevus and Multiple Lesions in Oculoectodermal Syndrome: Confirmation of the Phenotypic Continuum of Mosaic RASopathies.}, author={Beyens A and Dequeker L and Brems H and Janssens S and Syryn H and D'Hooghe A and De Paepe P and Vanwalleghem L and Stockman A and Vankwikelberge E and De Schepper S and Goeteyn M and Delbeke P and Callewaert B}, journal={Int J Mol Sci}}"}, "is_sup_mat_match": false}, {"pmid": 36563789, "title": "Development of a high-throughput TR-FRET screening assay for a fast-cycling KRAS mutant.", "journal": "SLAS Discov", "authors": ["Larson JE", "Hardy PB", "Schomburg NK", "Wang X", "Kireev D", "Rossman KL", "Pearce KH"], "date": "2022-12-20T00:00:00Z", "year": 2022, "snippets": [{"_id": "36563789@691", "snip_text": "Herein, we focused on the KRAS mutant A146T, found in colorectal cancers, that exhibits a \"fast-cycling\" nucleotide mechanism as a driver for oncogenic activation.", "section": "abstract", "mentions": ["38|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "26|4|gene|ncbi_gene@3845|KRAS", "54|18|disease|ncbi_mesh@D015179|colorectal cancers"], "text_hl": "Herein, we focused on the KRAS mutant <m>A146T</m>, found in colorectal cancers, that exhibits a \"fast-cycling\" nucleotide mechanism as a driver for oncogenic activation."}], "citations": {"NLM": "Larson JE, Hardy PB, Schomburg NK, Wang X, Kireev D, Rossman KL, Pearce KH. Development of a high-throughput TR-FRET screening assay for a fast-cycling KRAS mutant. SLAS Discov. PMID: 36563789", "BibTeX": "@article{36563789, title={Development of a high-throughput TR-FRET screening assay for a fast-cycling KRAS mutant.}, author={Larson JE and Hardy PB and Schomburg NK and Wang X and Kireev D and Rossman KL and Pearce KH}, journal={SLAS Discov}}"}, "is_sup_mat_match": false}, {"pmid": 35159069, "pmcid": "PMC8833999", "title": "RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study.", "journal": "Cancers (Basel)", "authors": ["Nicolazzo C", "Belardinilli F", "Vestri A", "Magri V", "De Renzi G", "De Meo M", "Caponnetto S", "Di Nicolantonio F", "Cortesi E", "Giannini G", "Gazzaniga P"], "date": "2022-02-04T00:00:00Z", "year": 2022, "snippets": [{"_id": "35159069@28334", "snip_text": "Pt. N. Bevacizumab RAS Mutation Tissue/Plasma Baseline Timing of RAS Conversion (Months) ctDNA Confirmation Test   1 no KRAS G12V 3 NGS TP53 c.524G>A p.R175H   5 yes KRAS G12V 9 methylation MSC ITGA4 EYA4   7 yes KRAS G12V 9 NGS SMAD4 c.1522G>T p.G508C   9 yes KRAS G12V 3 NGS TP53 c.659A>G p.Y220C   22 yes KRAS G12V 3 NGS SMAD4 c.1522G>T p.G508C   27 yes KRAS G12V 9 NGS TP53: c.659A>G p.Y220C   39 yes KRAS G12V 6 NGS PIK3CA c.1625A>T p.E542V   24 yes KRAS G12V 3 none    2 no NRAS G12C 3 methylation MAP3K MSC ITGA4 EYA4   8 yes KRAS G12C 6 NGS TP53: c.527G>T p.C176F   26 yes KRAS G12C 3 methylation MAP3K EYA4   33 yes KRAS G12C 12 NGS PIK3CA: c.3062A>G p. Y1021C   36 yes KRAS G12C 6 methylation MAP3K MSC ITGA4 EYA4 GRIA4   3 yes KRAS G12D 6 NGS TP53 c.743G>A p.R248Q   6 yes KRAS G12D 3 NGS PTEN c.209+6T>C   16 yes KRAS G12D 3 NGS TP53 c.743G>A p.R248Q   21 yes KRAS G12D 6 NGS TP53 c.524G>A p.R175H   23 yes KRAS G12D 9 none    28 yes KRAS G12D 3 NGS PIK3CA: c.3062A>G p. Y1021C   30 yes KRAS G12D 3 NGS TP53 c.844C>T p.R282W   37 yes KRAS G12D 9 NGS TP53 c.517G>A p.V173M   34 yes KRAS G12D 6 none    35 yes KRAS G12D 9 NGS FBXW7 c.1513C>T p.R505C; AKT1 c.49G>A p.E17K   32 yes KRAS G12D 6 none    38 yes KRAS G12D 9 NGS TP53 c.524G>A p.R175H   43 yes KRAS G12D 12 NGS PIK3CA c.1625A>T p.E542V   17 yes KRAS G12A 6 methylation MAP3K MSC ITGA4 EYA4 GRIA4   19 yes KRAS G12A 6 NGS PIK3CA c.3140A>G p.H1047R   41 yes KRAS G12A 6 methylation EYA4 GRIA4   14 yes KRAS G13D 3 NGS MAP2K1 c.171G>T p.K57N   20 yes KRAS G13D 6 methylation MAP3K MSC ITGA4 EYA4 GRIA4   4 yes KRAS A146t 3 none    25 yes KRAS A146T 6 NGS TP53 c.817C>T p.T273C   29 yes KRAS A146T 9 methylation MAP3K ITGA4 EYA4 GRIA4   42 yes KRAS A146T 12 NGS DDR2 c.1376C>T p.S459F   12 yes KRAS Q61K 3 NGS TP53: c.659A>G p.Y220C   13 yes KRAS Q61K 6 NGS PIK3CA: c.3062A>G p. Y1021C   40 yes KRAS Q61H 12 NGS TP53 c.401T>C p.F134S   11 yes NRAS G12D 3 NGS FBXW7 c.1513C>T p.R505C   10 yes NRAS G12D 6 none    15 yes NRAS G12D 9 none    18 yes NRAS A146T 3 methylation ITGA4 EYA4   31 yes NRAS Q61R 3 NGS SMAD4 c.989A>C p.E330A   ", "section": "table", "mentions": ["428|9|variant|litvar@rs1057519927##&&&litvar@#5290#|c.1625A>T", "480|4|gene|ncbi_gene@4893|NRAS", "150|7|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|p.R175H", "1349|5|gene|ncbi_gene@3676|ITGA4", "1004|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1431|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "1824|6|gene|ncbi_gene@5290|PIK3CA", "663|6|variant|litvar@rs121913288##&&&litvar@#5290#&&&litvar@CA16602699#rs121913288##|Y1021C", "1523|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "362|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1776|4|gene|ncbi_gene@7157|TP53", "194|5|gene|ncbi_gene@3676|ITGA4", "266|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1658|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1166|7|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|c.49G>A", "1288|9|variant|litvar@rs1057519927##&&&litvar@#5290#|c.1625A>T", "1883|8|variant|litvar@rs1057519747##&&&litvar@#7157#|c.401T>C", "1931|9|variant|litvar@rs149680468##&&&litvar@#55294#&&&litvar@CA16602253#rs149680468##|c.1513C>T", "713|5|gene|ncbi_gene@3676|ITGA4", "2088|7|variant|litvar@rs281875324##&&&litvar@#4089#|p.E330A", "611|4|gene|ncbi_gene@2070|EYA4", "1486|6|gene|ncbi_gene@5604|MAP2K1", "877|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "421|6|gene|ncbi_gene@5290|PIK3CA", "1195|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "120|4|gene|ncbi_gene@3845|KRAS", "1222|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "330|9|variant|litvar@rs121913361##&&&litvar@#673#&&&litvar@CA135098#rs121913361##|c.1522G>T", "277|4|gene|ncbi_gene@7157|TP53", "171|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1475|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1136|5|gene|ncbi_gene@55294|FBXW7", "1098|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2012|4|gene|ncbi_gene@4893|NRAS", "520|4|gene|ncbi_gene@2070|EYA4", "768|7|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|p.R248Q", "245|7|variant|litvar@rs121913361##&&&litvar@#673#&&&litvar@CA16602422#rs121913361##|p.G508C", "1622|4|gene|ncbi_gene@7157|TP53", "218|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1076|7|variant|litvar@rs876660754##&&&litvar@#7157#&&&litvar@CA10577579#rs876660754##|p.V173M", "888|4|gene|ncbi_gene@7157|TP53", "1281|6|gene|ncbi_gene@5290|PIK3CA", "1990|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1558|4|gene|ncbi_gene@2070|EYA4", "1455|5|gene|ncbi_gene@2893|GRIA4", "1866|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "549|4|gene|ncbi_gene@7157|TP53", "1958|4|gene|ncbi_gene@4893|NRAS", "1380|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "485|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "650|9|variant|litvar@rs121913288##&&&litvar@#5290#&&&litvar@CA16602699#rs121913288##|c.3062A>G", "1493|8|variant|litvar@rs869025608##&&&litvar@#5604#&&&litvar@CA356995#rs869025608##|c.171G>T", "789|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1360|5|gene|ncbi_gene@2893|GRIA4", "1161|4|gene|ncbi_gene@207|AKT1", "846|8|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|c.743G>A", "1067|8|variant|litvar@rs876660754##&&&litvar@#7157#&&&litvar@CA10577579#rs876660754##|c.517G>A", "1695|5|gene|ncbi_gene@2893|GRIA4", "308|4|gene|ncbi_gene@3845|KRAS", "951|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1142|9|variant|litvar@rs149680468##&&&litvar@#55294#&&&litvar@CA16602253#rs149680468##|c.1513C>T", "373|4|gene|ncbi_gene@7157|TP53", "455|4|gene|ncbi_gene@3845|KRAS", "1653|4|gene|ncbi_gene@3845|KRAS", "642|6|gene|ncbi_gene@5290|PIK3CA", "2073|5|gene|ncbi_gene@4089|SMAD4", "924|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "324|5|gene|ncbi_gene@4089|SMAD4", "125|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1408|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.H1047R", "141|8|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|c.524G>A", "1470|4|gene|ncbi_gene@3845|KRAS", "291|7|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|p.Y220C", "724|5|gene|ncbi_gene@2893|GRIA4", "983|6|variant|litvar@rs121913288##&&&litvar@#5290#&&&litvar@CA16602699#rs121913288##|Y1021C", "213|4|gene|ncbi_gene@3845|KRAS", "1610|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "2037|5|gene|ncbi_gene@3676|ITGA4", "438|7|variant|litvar@rs1057519927##&&&litvar@#5290#|p.E542V", "1636|7|variant|litvar@#7157#p.T273C&&&litvar@#7157#|p.T273C", "1502|6|variant|litvar@rs869025608##&&&litvar@#5604#&&&litvar@CA356995#rs869025608##|p.K57N", "586|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "902|7|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|p.R175H", "719|4|gene|ncbi_gene@2070|EYA4", "229|5|gene|ncbi_gene@4089|SMAD4", "1233|4|gene|ncbi_gene@7157|TP53", "1605|4|gene|ncbi_gene@3845|KRAS", "2079|8|variant|litvar@rs281875324##&&&litvar@#4089#|c.989A>C", "1552|5|gene|ncbi_gene@3676|ITGA4", "1963|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "830|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1450|4|gene|ncbi_gene@2070|EYA4", "1298|7|variant|litvar@rs1057519927##&&&litvar@#5290#|p.E542V", "1941|7|variant|litvar@rs149680468##&&&litvar@#55294#&&&litvar@CA16602253#rs149680468##|p.R505C", "1020|8|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|c.844C>T", "1808|4|gene|ncbi_gene@3845|KRAS", "564|7|variant|litvar@rs786202962##&&&litvar@#7157#|p.C176F", "743|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1051|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "759|8|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|c.743G>A", "684|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "2057|4|gene|ncbi_gene@4893|NRAS", "1015|4|gene|ncbi_gene@7157|TP53", "1029|7|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|p.R282W", "1690|4|gene|ncbi_gene@2070|EYA4", "841|4|gene|ncbi_gene@7157|TP53", "1627|8|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|c.817C>T", "1878|4|gene|ncbi_gene@7157|TP53", "1355|4|gene|ncbi_gene@2070|EYA4", "313|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1791|7|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|p.Y220C", "410|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "7|11|chemical|ncbi_mesh@D000068258|Bevacizumab", "405|4|gene|ncbi_gene@3845|KRAS", "460|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1845|6|variant|litvar@rs121913288##&&&litvar@#5290#&&&litvar@CA16602699#rs121913288##|Y1021C", "2062|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "1765|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "1582|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146t", "1760|4|gene|ncbi_gene@3845|KRAS", "235|9|variant|litvar@rs121913361##&&&litvar@#673#&&&litvar@CA135098#rs121913361##|c.1522G>T", "1684|5|gene|ncbi_gene@3676|ITGA4", "1269|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "136|4|gene|ncbi_gene@7157|TP53", "970|9|variant|litvar@rs121913288##&&&litvar@#5290#&&&litvar@CA16602699#rs121913288##|c.3062A>G", "555|8|variant|litvar@rs786202962##&&&litvar@#7157#|c.527G>T", "1577|4|gene|ncbi_gene@3845|KRAS", "388|7|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|p.Y220C", "1247|7|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|p.R175H", "1320|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "514|5|gene|ncbi_gene@3676|ITGA4", "1518|4|gene|ncbi_gene@3845|KRAS", "1743|7|variant|litvar@rs1042738234##&&&litvar@#2070#|p.S459F", "357|4|gene|ncbi_gene@3845|KRAS", "261|4|gene|ncbi_gene@3845|KRAS", "962|6|gene|ncbi_gene@5290|PIK3CA", "1782|8|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|c.659A>G", "1398|9|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A>G", "1914|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1152|7|variant|litvar@rs149680468##&&&litvar@#55294#&&&litvar@CA16602253#rs149680468##|p.R505C", "1909|4|gene|ncbi_gene@4893|NRAS", "1813|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "1125|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1733|9|variant|litvar@rs1042738234##&&&litvar@#2070#&&&litvar@CA148073527#rs1042738234##|c.1376C>T", "340|7|variant|litvar@rs121913361##&&&litvar@#673#&&&litvar@CA16602422#rs121913361##|p.G508C", "282|8|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|c.659A>G", "2043|4|gene|ncbi_gene@2070|EYA4", "1925|5|gene|ncbi_gene@55294|FBXW7", "166|4|gene|ncbi_gene@3845|KRAS", "754|4|gene|ncbi_gene@7157|TP53", "538|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "1563|5|gene|ncbi_gene@2893|GRIA4", "1174|6|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|p.E17K", "379|8|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|c.659A>G", "1062|4|gene|ncbi_gene@7157|TP53", "2017|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "630|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "893|8|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|c.524G>A", "855|7|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|p.R248Q", "1715|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1892|7|variant|litvar@rs1057519747##&&&litvar@#7157#|p.F134S", "1985|4|gene|ncbi_gene@4893|NRAS", "1391|6|gene|ncbi_gene@5290|PIK3CA", "1832|9|variant|litvar@rs121913288##&&&litvar@#5290#&&&litvar@CA16602699#rs121913288##|c.3062A>G", "805|10|variant|litvar@#7157#c.209+6T>C&&&litvar@#7157#|c.209+6T>C", "1238|8|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|c.524G>A", "1861|4|gene|ncbi_gene@3845|KRAS", "1710|4|gene|ncbi_gene@3845|KRAS", "200|4|gene|ncbi_gene@2070|EYA4"], "figure_id": "cancers-14-00802-t002", "text_hl": "Pt. N. Bevacizumab RAS Mutation Tissue/Plasma Baseline Timing of RAS Conversion (Months) ctDNA Confirmation Test   1 no KRAS G12V 3 NGS TP53 c.524G>A p.R175H   5 yes KRAS G12V 9 methylation MSC ITGA4 EYA4   7 yes KRAS G12V 9 NGS SMAD4 c.1522G>T p.G508C   9 yes KRAS G12V 3 NGS TP53 c.659A>G p.Y220C   22 yes KRAS G12V 3 NGS SMAD4 c.1522G>T p.G508C   27 yes KRAS G12V 9 NGS TP53: c.659A>G p.Y220C   39 yes KRAS G12V 6 NGS PIK3CA c.1625A>T p.E542V   24 yes KRAS G12V 3 none    2 no NRAS G12C 3 methylation MAP3K MSC ITGA4 EYA4   8 yes KRAS G12C 6 NGS TP53: c.527G>T p.C176F   26 yes KRAS G12C 3 methylation MAP3K EYA4   33 yes KRAS G12C 12 NGS PIK3CA: c.3062A>G p. Y1021C   36 yes KRAS G12C 6 methylation MAP3K MSC ITGA4 EYA4 GRIA4   3 yes KRAS G12D 6 NGS TP53 c.743G>A p.R248Q   6 yes KRAS G12D 3 NGS PTEN c.209+6T>C   16 yes KRAS G12D 3 NGS TP53 c.743G>A p.R248Q   21 yes KRAS G12D 6 NGS TP53 c.524G>A p.R175H   23 yes KRAS G12D 9 none    28 yes KRAS G12D 3 NGS PIK3CA: c.3062A>G p. Y1021C   30 yes KRAS G12D 3 NGS TP53 c.844C>T p.R282W   37 yes KRAS G12D 9 NGS TP53 c.517G>A p.V173M   34 yes KRAS G12D 6 none    35 yes KRAS G12D 9 NGS FBXW7 c.1513C>T p.R505C; AKT1 c.49G>A p.E17K   32 yes KRAS G12D 6 none    38 yes KRAS G12D 9 NGS TP53 c.524G>A p.R175H   43 yes KRAS G12D 12 NGS PIK3CA c.1625A>T p.E542V   17 yes KRAS G12A 6 methylation MAP3K MSC ITGA4 EYA4 GRIA4   19 yes KRAS G12A 6 NGS PIK3CA c.3140A>G p.H1047R   41 yes KRAS G12A 6 methylation EYA4 GRIA4   14 yes KRAS G13D 3 NGS MAP2K1 c.171G>T p.K57N   20 yes KRAS G13D 6 methylation MAP3K MSC ITGA4 EYA4 GRIA4   4 yes KRAS <m>A146t</m> 3 none    25 yes KRAS <m>A146T</m> 6 NGS TP53 c.817C>T p.T273C   29 yes KRAS <m>A146T</m> 9 methylation MAP3K ITGA4 EYA4 GRIA4   42 yes KRAS <m>A146T</m> 12 NGS DDR2 c.1376C>T p.S459F   12 yes KRAS Q61K 3 NGS TP53: c.659A>G p.Y220C   13 yes KRAS Q61K 6 NGS PIK3CA: c.3062A>G p. Y1021C   40 yes KRAS Q61H 12 NGS TP53 c.401T>C p.F134S   11 yes NRAS G12D 3 NGS FBXW7 c.1513C>T p.R505C   10 yes NRAS G12D 6 none    15 yes NRAS G12D 9 none    18 yes NRAS <m>A146T</m> 3 methylation ITGA4 EYA4   31 yes NRAS Q61R 3 NGS SMAD4 c.989A>C p.E330A   "}], "citations": {"NLM": "Nicolazzo C, Belardinilli F, Vestri A, Magri V, De Renzi G, De Meo M, Caponnetto S, Di Nicolantonio F, Cortesi E, Giannini G, Gazzaniga P. RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study. Cancers (Basel). PMID: 35159069", "BibTeX": "@article{35159069, title={RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study.}, author={Nicolazzo C and Belardinilli F and Vestri A and Magri V and De Renzi G and De Meo M and Caponnetto S and Di Nicolantonio F and Cortesi E and Giannini G and Gazzaniga P}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 34940123, "pmcid": "PMC8929001", "title": "Molecular Genetics of Pre-B Acute Lymphoblastic Leukemia Sister Cell Lines during Disease Progression.", "journal": "Curr Issues Mol Biol", "authors": ["Quentmeier H", "Pommerenke C", "Drexler HG"], "date": "2021-11-30T00:00:00Z", "year": 2021, "snippets": [{"_id": "34940123@516", "snip_text": "All five pairs of cell lines carry alterations that are typical for this disease: loss of tumor suppressors (CDKN2A, CDKN2B), expression of fusion genes (ETV6-RUNX1, BCR-ABL1, MEF2D-BCL9) or of genes targeted by point mutations (KRAS A146T, NRAS G12C, PAX5 R38H).", "section": "abstract", "mentions": ["109|6|gene|ncbi_gene@1029|CDKN2A", "182|4|gene|ncbi_gene@77578|BCL9", "176|5|gene|ncbi_gene@17261|MEF2D", "246|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "252|4|gene|ncbi_gene@5079|PAX5", "159|5|gene|ncbi_gene@861|RUNX1", "229|4|gene|ncbi_gene@3845|KRAS", "117|6|gene|ncbi_gene@1030|CDKN2B", "234|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "90|5|disease|ncbi_mesh@D009369|tumor", "257|4|variant|litvar@#5079#p.R38H&&&litvar@#5079#|R38H", "241|4|gene|ncbi_gene@4893|NRAS", "154|4|gene|ncbi_gene@2120|ETV6", "166|8|gene|ncbi_gene@613|BCR-ABL1"], "text_hl": "All five pairs of cell lines carry alterations that are typical for this disease: loss of tumor suppressors (CDKN2A, CDKN2B), expression of fusion genes (ETV6-RUNX1, BCR-ABL1, MEF2D-BCL9) or of genes targeted by point mutations (KRAS <m>A146T</m>, NRAS G12C, PAX5 R38H)."}], "citations": {"NLM": "Quentmeier H, Pommerenke C, Drexler HG. Molecular Genetics of Pre-B Acute Lymphoblastic Leukemia Sister Cell Lines during Disease Progression. Curr Issues Mol Biol. PMID: 34940123", "BibTeX": "@article{34940123, title={Molecular Genetics of Pre-B Acute Lymphoblastic Leukemia Sister Cell Lines during Disease Progression.}, author={Quentmeier H and Pommerenke C and Drexler HG}, journal={Curr Issues Mol Biol}}"}, "is_sup_mat_match": false}, {"pmid": 39071917, "pmcid": "PMC11283146", "title": "Plasma-Derived Cell-Free DNA for the Diagnosis of Ocular-Involving Histiocytosis", "journal": "Ophthalmol Sci", "authors": ["Francis JH", "Arcila ME", "Sigler A", "Bossert DF", "Abramson DH", "Diamond EL"], "date": "2024-04-15T00:00:00Z", "year": 2024, "snippets": [{"_id": "39071917@8253", "snip_text": "Patient\tAge at Diagnosis (Yrs)\tGender\tHistiocytosis Subtype\tOther Sites of Disease\tEye Findings\tMutational Status\tcfDNA Testing\tcfDNA VAF\tSite of Solid Tissue Confirmation\t \t1\t55.1\tM\tECD\tBone, brain, CV, pulmonary, retro, abdomen\tChoroid, orbit\tBRAF V600E\tNGS, ddPCR\t0.95%\tPerirenal\t \t2\t52.5\tM\tECD\tBone, brain, retro, abdomen\tChoroid, dysmotility\tBRAF V600E\tNGS\t0.85%\tPerirenal and tibia*\t \t3\t47.8\tM\tXG\tNone\tOrbit\tKRAS K117N\tNGS\t0.07%\tOrbit*\t \t4\t25.5\tM\tECD/LCH\tBone, CV, skin\tSclera, orbit, eyelid\tBRAF M484_P490 deletion\tNGS, ddPCR\t0.48%\tSkin (eyelid)\t \t5\t79.4\tF\tRDD\tPulmonary, nasopharynx\tChoroid, CN VI palsy\tKRAS in-frame insertion Y64_S65insVS\tNGS\t3.48%\tNasopharyngeal\t \t6\t68.9\tF\tECD\tBone, skin, LN\tChoroid, eyelid\tBRAF V600E\tNGS, ddPCR\t0.54%\tSkin (eyelid)\t \t7\t47.1\tF\tECD\tNeuro (DI), bone, brain, CV, retro\tChoroid\tBRAF V600E\tNGS, ddPCR\t1.81%\tPerirenal\t \t8\t49.6\tF\tRDD\tBone, retro, LN\tChoroid\tMAP2K1 K57T, KRAS A146P\tNGS\t0.37% KRAS, 0.12% MAP2K1\tLymph node\t \t9\t22.1\tM\tECD/LCH\tNeuro (dura), bone, skin\tOrbit\tBRAF V600E\tNGS, ddPCR\t0.46%\tTemporal lobe\t \t10\t66.2\tF\tECD\tNeuro (dura), bone, brain, CV\tChoroid\tBRAF V600E\tNGS, ddPCR\t0.07%\tDura\t \t11\t37.8\tM\tECD\tNeuro (dura, pituitary), bone, brain, CV, skin, testes\tOptic nerve\tBRAF V600E\tNGS, ddPCR\t0.52%\tTestes\t \t12\t67.7\tM\tECD\tNeuro (DI), bone, brain, CV, retro, skin\tSclerochoroidal, eyelid\tBRAF V600E\tNGS, ddPCR\t0.06%\tSkin (eyelid)\t \t13\t61.8\tF\tECD\tBone\tChoroid, orbit\tARAF S213A\tNGS, ddPCR\t0.89%\tBone\t \t14\t34.4\tM\tECD\tNeuro (DI), bone, brain, retro, LN\tUvea (uveitis)\tBRAF V600E\tNGS\t0.08%\tLymph node*\t \t", "section": "table", "mentions": ["820|4|gene|ncbi_gene@673|BRAF", "915|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "725|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "347|4|gene|ncbi_gene@673|BRAF", "1417|4|gene|ncbi_gene@369|ARAF", "1339|4|gene|ncbi_gene@673|BRAF", "1107|4|gene|ncbi_gene@673|BRAF", "1228|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "250|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "910|4|gene|ncbi_gene@3845|KRAS", "612|4|gene|ncbi_gene@3845|KRAS", "414|4|gene|ncbi_gene@3845|KRAS", "943|6|gene|ncbi_gene@5604|MAP2K1", "1112|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "245|4|gene|ncbi_gene@673|BRAF", "1516|4|gene|ncbi_gene@673|BRAF", "720|4|gene|ncbi_gene@673|BRAF", "897|6|gene|ncbi_gene@5604|MAP2K1", "1011|4|gene|ncbi_gene@673|BRAF", "931|4|gene|ncbi_gene@3845|KRAS", "352|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "825|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "498|4|gene|ncbi_gene@673|BRAF", "1422|5|variant|litvar@#369#p.S213A&&&litvar@#369#|S213A", "1521|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "419|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "1016|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1223|4|gene|ncbi_gene@673|BRAF", "1344|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "904|4|variant|litvar@rs1057519909##&&&litvar@#5604#|K57T"], "figure_id": "tbl1", "text_hl": "Patient\tAge at Diagnosis (Yrs)\tGender\tHistiocytosis Subtype\tOther Sites of Disease\tEye Findings\tMutational Status\tcfDNA Testing\tcfDNA VAF\tSite of Solid Tissue Confirmation\t \t1\t55.1\tM\tECD\tBone, brain, CV, pulmonary, retro, abdomen\tChoroid, orbit\tBRAF V600E\tNGS, ddPCR\t0.95%\tPerirenal\t \t2\t52.5\tM\tECD\tBone, brain, retro, abdomen\tChoroid, dysmotility\tBRAF V600E\tNGS\t0.85%\tPerirenal and tibia*\t \t3\t47.8\tM\tXG\tNone\tOrbit\tKRAS K117N\tNGS\t0.07%\tOrbit*\t \t4\t25.5\tM\tECD/LCH\tBone, CV, skin\tSclera, orbit, eyelid\tBRAF M484_P490 deletion\tNGS, ddPCR\t0.48%\tSkin (eyelid)\t \t5\t79.4\tF\tRDD\tPulmonary, nasopharynx\tChoroid, CN VI palsy\tKRAS in-frame insertion Y64_S65insVS\tNGS\t3.48%\tNasopharyngeal\t \t6\t68.9\tF\tECD\tBone, skin, LN\tChoroid, eyelid\tBRAF V600E\tNGS, ddPCR\t0.54%\tSkin (eyelid)\t \t7\t47.1\tF\tECD\tNeuro (DI), bone, brain, CV, retro\tChoroid\tBRAF V600E\tNGS, ddPCR\t1.81%\tPerirenal\t \t8\t49.6\tF\tRDD\tBone, retro, LN\tChoroid\tMAP2K1 K57T, KRAS A146P\tNGS\t0.37% KRAS, 0.12% MAP2K1\tLymph node\t \t9\t22.1\tM\tECD/LCH\tNeuro (dura), bone, skin\tOrbit\tBRAF V600E\tNGS, ddPCR\t0.46%\tTemporal lobe\t \t10\t66.2\tF\tECD\tNeuro (dura), bone, brain, CV\tChoroid\tBRAF V600E\tNGS, ddPCR\t0.07%\tDura\t \t11\t37.8\tM\tECD\tNeuro (dura, pituitary), bone, brain, CV, skin, testes\tOptic nerve\tBRAF V600E\tNGS, ddPCR\t0.52%\tTestes\t \t12\t67.7\tM\tECD\tNeuro (DI), bone, brain, CV, retro, skin\tSclerochoroidal, eyelid\tBRAF V600E\tNGS, ddPCR\t0.06%\tSkin (eyelid)\t \t13\t61.8\tF\tECD\tBone\tChoroid, orbit\tARAF S213A\tNGS, ddPCR\t0.89%\tBone\t \t14\t34.4\tM\tECD\tNeuro (DI), bone, brain, retro, LN\tUvea (uveitis)\tBRAF V600E\tNGS\t0.08%\tLymph node*\t \t"}], "citations": {"NLM": "Francis JH, Arcila ME, Sigler A, Bossert DF, Abramson DH, Diamond EL. Plasma-Derived Cell-Free DNA for the Diagnosis of Ocular-Involving Histiocytosis Ophthalmol Sci. PMID: 39071917", "BibTeX": "@article{39071917, title={Plasma-Derived Cell-Free DNA for the Diagnosis of Ocular-Involving Histiocytosis}, author={Francis JH and Arcila ME and Sigler A and Bossert DF and Abramson DH and Diamond EL}, journal={Ophthalmol Sci}}"}, "is_sup_mat_match": false}, {"pmid": 36620501, "pmcid": "PMC9822779", "title": "The Prevalence of BRAF, PIK3CA, and RAS Mutations in Indian Patients with Colorectal Cancer", "journal": "South Asian J Cancer", "authors": ["Shetty O", "Vengurlekar V", "Kapoor A", "Kamble V", "Gurav M", "Bhargava P", "Srinivas S", "Ramaswamy A", "Ramadwar M", "Saklani AP", "Desouza A", "Ostwal V"], "date": "2022-04-25T00:00:00Z", "year": 2022, "snippets": [{"_id": "36620501@9815", "snip_text": "Other mutations observed in KRAS gene were p.G13D ( n  = 3, 7.14%), p.Q61L ( n  = 2, 4.76%), p.G12A ( n  = 2,4.76%), p.A146T ( n  = 1, 2.38%), p.Q61H ( n  = 1, 2.38%), p.A131T ( n  = 1, 2.38%), p.G13S ( n  = 1, 2.38%), p.G13C, ( n  = 1, 2.38%), and p.A134V ( n  = 1, 2.38%) ( Supplementary Fig. S3 , available online only) One patient had complex mutation of KRAS exon 2: c.35G > A (p.G12D).", "section": "results", "mentions": ["249|7|variant|litvar@rs397517141##&&&litvar@#3265#&&&litvar@CA135986#rs397517141##|p.A134V", "359|4|gene|ncbi_gene@3845|KRAS", "372|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "168|7|variant|litvar@#3845#p.A131T&&&litvar@#3845#|p.A131T", "194|6|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA16602445#rs121913535##|p.G13S", "383|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "117|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "28|4|gene|ncbi_gene@3845|KRAS", "68|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "143|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "43|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "327|7|species|ncbi_taxonomy@9606|patient", "219|6|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|p.G13C", "93|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A"], "text_hl": "Other mutations observed in KRAS gene were p.G13D ( n  = 3, 7.14%), p.Q61L ( n  = 2, 4.76%), p.G12A ( n  = 2,4.76%), <m>p.A146T</m> ( n  = 1, 2.38%), p.Q61H ( n  = 1, 2.38%), p.A131T ( n  = 1, 2.38%), p.G13S ( n  = 1, 2.38%), p.G13C, ( n  = 1, 2.38%), and p.A134V ( n  = 1, 2.38%) ( Supplementary Fig. S3 , available online only) One patient had complex mutation of KRAS exon 2: c.35G > A (p.G12D)."}], "citations": {"NLM": "Shetty O, Vengurlekar V, Kapoor A, Kamble V, Gurav M, Bhargava P, Srinivas S, Ramaswamy A, Ramadwar M, Saklani AP, Desouza A, Ostwal V. The Prevalence of BRAF, PIK3CA, and RAS Mutations in Indian Patients with Colorectal Cancer South Asian J Cancer. PMID: 36620501", "BibTeX": "@article{36620501, title={The Prevalence of BRAF, PIK3CA, and RAS Mutations in Indian Patients with Colorectal Cancer}, author={Shetty O and Vengurlekar V and Kapoor A and Kamble V and Gurav M and Bhargava P and Srinivas S and Ramaswamy A and Ramadwar M and Saklani AP and Desouza A and Ostwal V}, journal={South Asian J Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 35619874, "pmcid": "PMC9124608", "title": "KRAS/NRAS/BRAF Mutation Rate in Saudi Academic Hospital Patients With Colorectal Cancer.", "journal": "Cureus", "authors": ["Saharti S"], "date": "2022-04-22T00:00:00Z", "year": 2022, "snippets": [{"_id": "35619874@7482", "snip_text": "  Frequency Percent   KRAS G12D 17 18.3   G12V 6 6.5   G12S 4 4.3   G13D 3 3.2   G12A 3 3.2   Q61H 2 2.2   K117N 2 2.2   A146T 2 2.2   G12R 1 1.1   G12C 1 1.1   G138E 1 1.1   NRAS Q61K 1 1.1   Q61L 1 1.1   BRAF V600E 2 2.2   Triple negative 47 50.5   Total 93 100.0   ", "section": "table", "mentions": ["81|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "121|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "211|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "148|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "175|4|gene|ncbi_gene@4893|NRAS", "22|4|gene|ncbi_gene@3845|KRAS", "161|5|variant|litvar@rs754870563##&&&litvar@#3845#&&&litvar@CA6486880#rs754870563##|G138E", "42|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "68|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "180|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "27|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "206|4|gene|ncbi_gene@673|BRAF", "135|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "55|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "193|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "107|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "94|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H"], "figure_id": "TAB1", "text_hl": "  Frequency Percent   KRAS G12D 17 18.3   G12V 6 6.5   G12S 4 4.3   G13D 3 3.2   G12A 3 3.2   Q61H 2 2.2   K117N 2 2.2   <m>A146T</m> 2 2.2   G12R 1 1.1   G12C 1 1.1   G138E 1 1.1   NRAS Q61K 1 1.1   Q61L 1 1.1   BRAF V600E 2 2.2   Triple negative 47 50.5   Total 93 100.0   "}], "citations": {"NLM": "Saharti S. KRAS/NRAS/BRAF Mutation Rate in Saudi Academic Hospital Patients With Colorectal Cancer. Cureus. PMID: 35619874", "BibTeX": "@article{35619874, title={KRAS/NRAS/BRAF Mutation Rate in Saudi Academic Hospital Patients With Colorectal Cancer.}, author={Saharti S}, journal={Cureus}}"}, "is_sup_mat_match": false}, {"pmid": 35394121, "pmcid": "PMC9554448", "title": "The prevalence and real-world therapeutic analysis of Chinese patients with KRAS-Mutant Non-Small Cell lung cancer", "journal": "Cancer Med", "authors": ["Chen H", "Huang D", "Lin G", "Yang X", "Zhuo M", "Chi Y", "Zhai X", "Jia B", "Wang J", "Wang Y", "Li J", "An T", "Wu M", "Wang Z", "Zhao J"], "date": "2022-04-08T00:00:00Z", "year": 2022, "snippets": [{"_id": "35394121@10986", "snip_text": "Other types of mutations included G12R/S, G13C/D, Q61H/K/L, A59T/G, K117N, and A146V/T.", "section": "results", "mentions": ["79|7|variant|litvar@rs121913527##&&&litvar@#3845#|A146V/T", "68|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "42|6|variant|litvar@rs112445441##&&&litvar@#3845#|G13C/D", "60|4|variant|litvar@rs1057519991##&&&litvar@#7157#|A59T", "50|6|variant|litvar@rs17851045##&&&litvar@#3845#|Q61H/K", "34|6|variant|litvar@rs121913530##&&&litvar@#3845#|G12R/S"], "text_hl": "Other types of mutations included G12R/S, G13C/D, Q61H/K/L, A59T/G, K117N, and A146V/T."}], "citations": {"NLM": "Chen H, Huang D, Lin G, Yang X, Zhuo M, Chi Y, Zhai X, Jia B, Wang J, Wang Y, Li J, An T, Wu M, Wang Z, Zhao J. The prevalence and real-world therapeutic analysis of Chinese patients with KRAS-Mutant Non-Small Cell lung cancer Cancer Med. PMID: 35394121", "BibTeX": "@article{35394121, title={The prevalence and real-world therapeutic analysis of Chinese patients with KRAS-Mutant Non-Small Cell lung cancer}, author={Chen H and Huang D and Lin G and Yang X and Zhuo M and Chi Y and Zhai X and Jia B and Wang J and Wang Y and Li J and An T and Wu M and Wang Z and Zhao J}, journal={Cancer Med}}"}, "is_sup_mat_match": false}, {"pmid": 33938493, "pmcid": "PMC9351589", "title": "A randomized phase II trial of adjuvant hepatic arterial infusion and systemic therapy with or without panitumumab after hepatic resection of KRAS wild-type colorectal cancer", "journal": "Ann Surg", "authors": ["Kemeny NE", "Chou JF", "Capanu M", "Chatila WK", "Shi H", "Sanchez-Vega F", "Kingham TP", "Connell LC", "Jarnagin WR", "D'Angelica MI"], "date": "2021-04-30T00:00:00Z", "year": 2021, "snippets": [{"_id": "33938493@15399", "snip_text": "One patient with BRAF mutation and 3 others had KRAS exon 4 p.A146T mutations.", "section": "results", "mentions": ["48|4|gene|ncbi_gene@3845|KRAS", "17|4|gene|ncbi_gene@673|BRAF", "60|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "4|7|species|ncbi_taxonomy@9606|patient"], "text_hl": "One patient with BRAF mutation and 3 others had KRAS exon 4 <m>p.A146T</m> mutations."}], "citations": {"NLM": "Kemeny NE, Chou JF, Capanu M, Chatila WK, Shi H, Sanchez-Vega F, Kingham TP, Connell LC, Jarnagin WR, D'Angelica MI. A randomized phase II trial of adjuvant hepatic arterial infusion and systemic therapy with or without panitumumab after hepatic resection of KRAS wild-type colorectal cancer Ann Surg. PMID: 33938493", "BibTeX": "@article{33938493, title={A randomized phase II trial of adjuvant hepatic arterial infusion and systemic therapy with or without panitumumab after hepatic resection of KRAS wild-type colorectal cancer}, author={Kemeny NE and Chou JF and Capanu M and Chatila WK and Shi H and Sanchez-Vega F and Kingham TP and Connell LC and Jarnagin WR and D'Angelica MI}, journal={Ann Surg}}"}, "is_sup_mat_match": false}, {"pmid": 31678118, "pmcid": "PMC6937383", "title": "Therapeutic Targeting of RAS: New Hope for Drugging the \"Undruggable\"", "journal": "Biochim Biophys Acta Mol Cell Res", "authors": ["Khan I", "Rhett JM", "O'Bryan JP"], "date": "2019-10-31T00:00:00Z", "year": 2019, "snippets": [{"_id": "31678118@11674", "snip_text": "Haigis and colleagues demonstrated that KRAS(G12D) and KRAS(A146T) exhibit distinct biologic and signaling outputs in the pancreas and colon suggesting that such tissue specific phenotypes are due to allele-specific signaling properties and engagement of different signaling pathways by various RAS mutants.", "section": "other", "mentions": ["45|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "40|4|gene|ncbi_gene@3845|KRAS", "55|4|gene|ncbi_gene@3845|KRAS", "60|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Haigis and colleagues demonstrated that KRAS(G12D) and KRAS(<m>A146T</m>) exhibit distinct biologic and signaling outputs in the pancreas and colon suggesting that such tissue specific phenotypes are due to allele-specific signaling properties and engagement of different signaling pathways by various RAS mutants."}], "citations": {"NLM": "Khan I, Rhett JM, O'Bryan JP. Therapeutic Targeting of RAS: New Hope for Drugging the \"Undruggable\" Biochim Biophys Acta Mol Cell Res. PMID: 31678118", "BibTeX": "@article{31678118, title={Therapeutic Targeting of RAS: New Hope for Drugging the \"Undruggable\"}, author={Khan I and Rhett JM and O'Bryan JP}, journal={Biochim Biophys Acta Mol Cell Res}}"}, "is_sup_mat_match": false}, {"pmid": 35373279, "pmcid": "PMC8988514", "title": "Classification of KRAS activating mutations and the implications for therapeutic intervention", "journal": "Cancer Discov", "authors": ["Johnson C", "Burkhart DL", "Haigis KM"], "date": "2022-04-01T00:00:00Z", "year": 2022, "snippets": [{"_id": "35373279@20760", "snip_text": "Indeed, V14I exhibits enhanced nucleotide exchange and shares structural similarities with another oncogenic hyperexchange mutant, A146T.", "section": "other", "mentions": ["131|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "8|4|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|V14I"], "text_hl": "Indeed, V14I exhibits enhanced nucleotide exchange and shares structural similarities with another oncogenic hyperexchange mutant, <m>A146T</m>."}], "citations": {"NLM": "Johnson C, Burkhart DL, Haigis KM. Classification of KRAS activating mutations and the implications for therapeutic intervention Cancer Discov. PMID: 35373279", "BibTeX": "@article{35373279, title={Classification of KRAS activating mutations and the implications for therapeutic intervention}, author={Johnson C and Burkhart DL and Haigis KM}, journal={Cancer Discov}}"}, "is_sup_mat_match": false}, {"pmid": 36765865, "pmcid": "PMC9913259", "title": "Patterns of Somatic Variants in Colorectal Adenoma and Carcinoma Tissue and Matched Plasma Samples from the Hungarian Oncogenome Program.", "journal": "Cancers (Basel)", "authors": ["Kalm\u00e1r A", "Galamb O", "Szab\u00f3 G", "Pipek O", "Medgyes-Horv\u00e1th A", "Bart\u00e1k BK", "Nagy ZB", "Szigeti KA", "Zsigrai S", "Csabai I", "Igaz P", "Moln\u00e1r B", "Tak\u00e1cs I"], "date": "2023-01-31T00:00:00Z", "year": 2023, "snippets": [{"_id": "36765865@25596", "snip_text": "Mutations outside of these codons were observed in adenomas (L23R 1/27 patients) and with a higher presence in CRC cases (A146T, K117N, Q61H, A146V, D33E 1/51 (0.019) patients) (Figure 5a).", "section": "results", "mentions": ["71|8|species|ncbi_taxonomy@9606|patients", "129|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "136|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "111|3|disease|ncbi_mesh@D015179|CRC", "167|8|species|ncbi_taxonomy@9606|patients", "61|4|variant|litvar@rs730880472##&&&litvar@#3845#&&&litvar@CA296092#rs730880472##|L23R", "122|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "51|8|disease|ncbi_mesh@D000236|adenomas", "142|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "149|4|variant|litvar@rs1368774604##&&&litvar@#1756#|D33E"], "text_hl": "Mutations outside of these codons were observed in adenomas (L23R 1/27 patients) and with a higher presence in CRC cases (<m>A146T</m>, K117N, Q61H, A146V, D33E 1/51 (0.019) patients) (Figure 5a)."}], "citations": {"NLM": "Kalm\u00e1r A, Galamb O, Szab\u00f3 G, Pipek O, Medgyes-Horv\u00e1th A, Bart\u00e1k BK, Nagy ZB, Szigeti KA, Zsigrai S, Csabai I, Igaz P, Moln\u00e1r B, Tak\u00e1cs I. Patterns of Somatic Variants in Colorectal Adenoma and Carcinoma Tissue and Matched Plasma Samples from the Hungarian Oncogenome Program. Cancers (Basel). PMID: 36765865", "BibTeX": "@article{36765865, title={Patterns of Somatic Variants in Colorectal Adenoma and Carcinoma Tissue and Matched Plasma Samples from the Hungarian Oncogenome Program.}, author={Kalm\u00e1r A and Galamb O and Szab\u00f3 G and Pipek O and Medgyes-Horv\u00e1th A and Bart\u00e1k BK and Nagy ZB and Szigeti KA and Zsigrai S and Csabai I and Igaz P and Moln\u00e1r B and Tak\u00e1cs I}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 23752269, "pmcid": "PMC3964313", "title": "Network quantification of EGFR signaling unveils potential for targeted combination therapy", "journal": "Mol Syst Biol", "authors": ["Klinger B", "Sieber A", "Fritsche-Guenther R", "Witzel F", "Berry L", "Schumacher D", "Yan Y", "Durek P", "Merchant M", "Sch\u00e4fer R", "Sers C", "Bl\u00fcthgen N"], "date": "2013-01-01T00:00:00Z", "year": 2013, "snippets": [{"_id": "23752269@53741", "snip_text": "Gene symbol\tLIM1215\tHCT116\tSW403\tSW480\tHT29\tRKO\tTCGA patients\t \tABL1\tP309A\tY257C\t \t \t \t \t_\t \tAPC\t \tK1462R\t \tA1457T/K1462R\t \t \t_\t \tBRAF\t \t \t \t \tV600E*\tV600E*\t13\t \tCTNNB1\tT41AH\t \t \t \t \t \t_\t \tFGFR3\t \tS400R\t \tS400R\t \t \t_\t \tKRAS\tA146T\tG13D*\tG12V*,H\tG12V*,H\t \t \t6,8,28\t \tPIK3CA\t \tH1047R*\t \t \t \tH1047R*\t4\t \tSMAD4\t \t \t \t \tQ311X*,H\t \t_\t \tSMO\t \tV404M\t \t \t \t \t_\t \tSTK11\t \tG58S\t \tG58S\t \t \t_\t \tTP53\t \t \tR273HH\tR273HH\tR273H*,H\t \t26\t \t", "section": "table", "mentions": ["224|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "314|5|variant|litvar@#3845#p.Q311X&&&litvar@#3845#|Q311X", "361|4|variant|litvar@rs771984423##&&&litvar@#64132#|G58S", "274|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "244|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "219|4|gene|ncbi_gene@3845|KRAS", "230|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "69|5|variant|litvar@rs1246360388##&&&litvar@#5295#|P309A", "288|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "368|4|variant|litvar@rs771984423##&&&litvar@#64132#|G58S", "143|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "404|5|variant|litvar@#3845#p.R273H&&&litvar@#3845#|R273H", "150|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "130|4|gene|ncbi_gene@673|BRAF", "99|6|variant|litvar@#673#p.K1462R&&&litvar@#673#|K1462R", "236|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "115|6|variant|litvar@#673#p.K1462R&&&litvar@#673#|K1462R", "205|5|variant|litvar@#3845#p.S400R&&&litvar@#3845#|S400R", "108|6|variant|litvar@rs550191535##&&&litvar@#1950#|A1457T", "197|5|variant|litvar@#3845#p.S400R&&&litvar@#3845#|S400R", "335|5|variant|litvar@#3845#p.V404M&&&litvar@#3845#|V404M"], "figure_id": "t1", "text_hl": "Gene symbol\tLIM1215\tHCT116\tSW403\tSW480\tHT29\tRKO\tTCGA patients\t \tABL1\tP309A\tY257C\t \t \t \t \t_\t \tAPC\t \tK1462R\t \tA1457T/K1462R\t \t \t_\t \tBRAF\t \t \t \t \tV600E*\tV600E*\t13\t \tCTNNB1\tT41AH\t \t \t \t \t \t_\t \tFGFR3\t \tS400R\t \tS400R\t \t \t_\t \tKRAS\t<m>A146T</m>\tG13D*\tG12V*,H\tG12V*,H\t \t \t6,8,28\t \tPIK3CA\t \tH1047R*\t \t \t \tH1047R*\t4\t \tSMAD4\t \t \t \t \tQ311X*,H\t \t_\t \tSMO\t \tV404M\t \t \t \t \t_\t \tSTK11\t \tG58S\t \tG58S\t \t \t_\t \tTP53\t \t \tR273HH\tR273HH\tR273H*,H\t \t26\t \t"}], "citations": {"NLM": "Klinger B, Sieber A, Fritsche-Guenther R, Witzel F, Berry L, Schumacher D, Yan Y, Durek P, Merchant M, Sch\u00e4fer R, Sers C, Bl\u00fcthgen N. Network quantification of EGFR signaling unveils potential for targeted combination therapy Mol Syst Biol. PMID: 23752269", "BibTeX": "@article{23752269, title={Network quantification of EGFR signaling unveils potential for targeted combination therapy}, author={Klinger B and Sieber A and Fritsche-Guenther R and Witzel F and Berry L and Schumacher D and Yan Y and Durek P and Merchant M and Sch\u00e4fer R and Sers C and Bl\u00fcthgen N}, journal={Mol Syst Biol}}"}, "is_sup_mat_match": false}, {"pmid": 32934818, "pmcid": "PMC7469563", "title": "Panel-based next-generation sequencing facilitates the characterization of childhood acute myeloid leukemia in clinical settings.", "journal": "Biomed Rep", "authors": ["Ishida H", "Iguchi A", "Aoe M", "Nishiuchi R", "Matsubara T", "Keino D", "Sanada M", "Shimada A"], "date": "2020-11-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "32934818@27873", "snip_text": "A, Relapsed AML   UPN Disease subtype SNVs at diagnosis (VAF) SNVs at relapse (VAF)   1 FAB M5 KRASp.G12V (0.296) None   2 FAB M6 (RAEB) PTPN11p.G60V(0.83) PTPN11 p.V45L (0.10) PTPN11p.G60V(0.44)   3 FAB M7 (non-Down-syndrome) KRAS p.A146T (0.09) None   4 FAB M5 None None   5 FAB M7 (non-Down-syndrome) GATA1p.R270W (0.43) KRAS p.G12A (0.43) IKZF1 p.F154Y (0.38)aIKZF1p.L161H (0.38)a GATA1p.R270W(0.23) KRAS p.G12A (0.19) IKZF1p.F154Y(0.17)aIKZF1p.F161H(0.17)a   6 FAB M2 FLT3-ITD (0.572) FLT3-ITD (0.689)   7 FAB M2 PTPN11 p.I479F (0.40) + c.1473-1481dela PTPN11p.I479F (0.35) + c.1473-1481dela   8 FAB M7 (non-Down-syndrome) GATA1 p.P50fs (0.30) GATA1 p.P50fs (0.05)   9 FAB M4 KRAS p.G12V (0.41) SMARCA4p.R979Q (0.06)a MLH1p.A586S (0.06)a   10 FAB M5b KRAS p.G13D (0.32) RUNX1p.Q390fs(0.2)   11 FAB M1 GATA2 p.R362Q (0.11) CEBPAp.Q312HR (0.99)a CEBPAp.D63fs(0.37)aCEBPAp.Q312HR (0.39)a   12 T/Myeloid JAK3 p.L857P (0.10) NOTCH1p.V1721E (0.33) STAT5Bp.N642H(0.11) NF1 p.L2317H (0.05)a JAK3 p.L857P (0.13) NOTCH1p.V1721E (0.33) IL7R p.L243GTARCV (0.10)aVHL p.L85fs (0.11)   13 FAB M7 (non-Down-syndrome) None None   14 FAB M4 U2AF1 p.R35L (0.53) KRAS p.G12D (0.37) KRAS p.G12D (0.23)   15 T/Myeloid TP53 p.K164E (0.998) PHF6 p.R274fs (0.724) NPM1 p.L287fs (0.579) TP53 p.K164E (0.858) PHF6p.R274fs (0.611) NPM1 p.L287fs (0.53) MPLp.A486V(0.064)a   B, Non-relapsed AML   UPN Disease subtype SNVs at diagnosis (VAF) SNVs at relapse (VAF)   16 FAB M3 None -   17 FAB M3 None -   18 FAB M5a None -   19 FAB M4Eo KIT p.D816Y (0.28) -       WT1 p.H448Y (0.22)a -       NRAS p.Q61K (0.08) -   20 FAB M2 JAK3 p.M511I (0.13) -   21 AML with myelodysplasia-related changes None -   22 FAB M2 NRAS p.G13D (0.37) -       WT1 p.D447N (0.34) -   23 FAB M2 NRAS p.Q61K (0.25) -   24 FAB M2 KRAS p.G12D (0.52) -   25 FAB M5 None -   26 FAB M5 FLT3 p.D839G (0.21) -       FLT3 p.Y591D (0.08) -       FLT3 p.D839N (0.07) -   27 FAB M2 KIT p.N822K (0.43) -   ", "section": "table", "mentions": ["1372|11|disease|ncbi_mesh@D004194|UPN Disease", "409|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "1857|4|gene|ncbi_gene@2322|FLT3", "324|4|gene|ncbi_gene@3845|KRAS", "1715|7|variant|litvar@rs28941778##&&&litvar@#7490#&&&litvar@CA16338#rs28941778##|p.D447N", "1862|7|variant|litvar@rs1057520043##&&&litvar@#2322#|p.Y591D", "1684|4|gene|ncbi_gene@4893|NRAS", "466|3|gene|ncbi_gene@2187|FAB", "707|7|variant|litvar@rs797045981##&&&litvar@#6597#&&&litvar@CA208733#rs797045981##|p.R979Q", "1481|3|gene|ncbi_gene@2187|FAB", "761|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "1244|4|gene|ncbi_gene@4869|NPM1", "256|3|gene|ncbi_gene@2187|FAB", "649|5|gene|ncbi_gene@2623|GATA1", "1822|3|gene|ncbi_gene@2187|FAB", "971|8|variant|litvar@rs587778215##&&&litvar@#1387#&&&litvar@CA158195#rs587778215##|p.L2317H", "1222|4|gene|ncbi_gene@84295|PHF6", "1510|3|gene|ncbi_gene@3815|KIT", "1537|3|gene|ncbi_gene@7490|WT1", "143|6|variant|litvar@rs397507509##&&&litvar@#5781#&&&litvar@CA284662#rs397507509##|p.G60V", "525|7|variant|litvar@#5781#p.I479F&&&litvar@#5781#|p.I479F", "343|5|gene|ncbi_gene@10320|IKZF1", "1829|4|gene|ncbi_gene@2322|FLT3", "780|8|variant|litvar@#2187#p.Q390fsX&&&litvar@#2187#|p.Q390fs", "511|3|gene|ncbi_gene@2187|FAB", "1153|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1634|14|disease|ncbi_mesh@D009436|myelodysplasia", "490|4|gene|ncbi_gene@2322|FLT3", "756|4|gene|ncbi_gene@3845|KRAS", "1541|7|variant|litvar@rs1131691257##&&&litvar@#4763#|p.H448Y", "812|7|variant|litvar@rs867160952##&&&litvar@#2624#&&&litvar@CA83376555#rs867160952##|p.R362Q", "1912|3|gene|ncbi_gene@2187|FAB", "1744|4|gene|ncbi_gene@4893|NRAS", "1271|7|variant|litvar@rs879254249##&&&litvar@#7157#&&&litvar@CA10584591#rs879254249##|p.K164E", "967|3|gene|ncbi_gene@4763|NF1", "349|7|variant|litvar@#10320#p.F154Y&&&litvar@#10320#|p.F154Y", "12|3|disease|ncbi_mesh@D015470|AML", "1565|4|gene|ncbi_gene@4893|NRAS", "329|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "1777|4|gene|ncbi_gene@3845|KRAS", "212|13|disease|ncbi_mesh@D004314|Down-syndrome", "1598|4|gene|ncbi_gene@3718|JAK3", "1689|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "1167|4|gene|ncbi_gene@3845|KRAS", "518|6|gene|ncbi_gene@5781|PTPN11", "156|6|gene|ncbi_gene@5781|PTPN11", "806|5|gene|ncbi_gene@2624|GATA2", "993|7|variant|litvar@rs768942227##&&&litvar@#3718#&&&litvar@CA9301572#rs768942227##|p.L857P", "1603|7|variant|litvar@rs752661478##&&&litvar@#3718#&&&litvar@CA9301867#rs752661478##|p.M511I", "601|3|gene|ncbi_gene@2187|FAB", "309|7|variant|litvar@rs1315549918##&&&litvar@#7490#|p.R270W", "1919|3|gene|ncbi_gene@3815|KIT", "748|3|gene|ncbi_gene@2187|FAB", "1134|6|variant|litvar@rs1057519998##&&&litvar@#7157#|p.R35L", "1191|1|disease|ncbi_mesh@D001260|T", "628|5|gene|ncbi_gene@2623|GATA1", "1121|3|gene|ncbi_gene@2187|FAB", "232|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "1201|4|gene|ncbi_gene@7157|TP53", "655|7|variant|litvar@#2623#p.P50fsX&&&litvar@#2623#|p.P50fs", "613|13|disease|ncbi_mesh@D004314|Down-syndrome", "1266|4|gene|ncbi_gene@7157|TP53", "1313|8|variant|litvar@rs63751639##&&&litvar@#4292#|p.L287fs", "1677|3|gene|ncbi_gene@2187|FAB", "1059|7|variant|litvar@#2187#p.L85fsX&&&litvar@#2187#|p.L85fs", "1737|3|gene|ncbi_gene@2187|FAB", "1206|7|variant|litvar@rs879254249##&&&litvar@#7157#&&&litvar@CA10584591#rs879254249##|p.K164E", "1249|8|variant|litvar@rs63751639##&&&litvar@#4292#|p.L287fs", "1514|7|variant|litvar@rs121913506##&&&litvar@#3815#&&&litvar@CA280196#rs121913506##|p.D816Y", "200|3|gene|ncbi_gene@2187|FAB", "289|13|disease|ncbi_mesh@D004314|Down-syndrome", "99|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "564|7|variant|litvar@#5781#p.I479F&&&litvar@#5781#|p.I479F", "1770|3|gene|ncbi_gene@2187|FAB", "390|7|variant|litvar@rs1315549918##&&&litvar@#7490#|p.R270W", "1227|8|variant|litvar@#84295#p.R274fsX&&&litvar@#84295#|p.R274fs", "473|4|gene|ncbi_gene@2322|FLT3", "1711|3|gene|ncbi_gene@7490|WT1", "1366|3|disease|ncbi_mesh@D015470|AML", "123|3|gene|ncbi_gene@2187|FAB", "1803|3|gene|ncbi_gene@2187|FAB", "404|4|gene|ncbi_gene@3845|KRAS", "634|7|variant|litvar@#2623#p.P50fsX&&&litvar@#2623#|p.P50fs", "674|3|gene|ncbi_gene@2187|FAB", "1332|7|variant|litvar@rs1252551527##&&&litvar@#6777#|p.A486V", "183|6|variant|litvar@rs397507509##&&&litvar@#5781#&&&litvar@CA284662#rs397507509##|p.G60V", "988|4|gene|ncbi_gene@3718|JAK3", "681|4|gene|ncbi_gene@3845|KRAS", "1501|3|gene|ncbi_gene@2187|FAB", "1749|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "227|4|gene|ncbi_gene@3845|KRAS", "1570|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "1834|7|variant|litvar@rs991132188##&&&litvar@#2322#&&&litvar@CA16602483#rs991132188##|p.D839G", "131|4|disease|ncbi_mesh@D000754|RAEB", "447|7|variant|litvar@#2623#p.F161H&&&litvar@#2623#|p.F161H", "88|3|gene|ncbi_gene@2187|FAB", "1782|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "827|6|gene|ncbi_gene@1050|CEBPAp", "1014|8|variant|litvar@#3575#p.V1721E&&&litvar@#3575#|p.V1721E", "1443|3|gene|ncbi_gene@2187|FAB", "18|11|disease|ncbi_mesh@D004194|UPN Disease", "277|3|gene|ncbi_gene@2187|FAB", "1885|4|gene|ncbi_gene@2322|FLT3", "1091|13|disease|ncbi_mesh@D004314|Down-syndrome", "1172|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "588|8|variant|litvar@#2187#|1481dela", "1890|7|variant|litvar@rs755956826##&&&litvar@#4763#&&&litvar@CA8485994#rs755956826##|p.D839N", "686|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1308|4|gene|ncbi_gene@4869|NPM1", "1462|3|gene|ncbi_gene@2187|FAB", "163|6|variant|litvar@#5781#p.V45L&&&litvar@#5781#|p.V45L", "1923|7|variant|litvar@rs121913514##&&&litvar@#3815#&&&litvar@CA16602411#rs121913514##|p.N822K", "1291|8|variant|litvar@#84295#p.R274fsX&&&litvar@#84295#|p.R274fs", "1591|3|gene|ncbi_gene@2187|FAB", "854|7|variant|litvar@rs1060502121##&&&litvar@#1050#|p.D63fs", "905|4|gene|ncbi_gene@3718|JAK3", "1148|4|gene|ncbi_gene@3845|KRAS", "428|7|variant|litvar@#10320#p.F154Y&&&litvar@#10320#|p.F154Y", "910|7|variant|litvar@rs768942227##&&&litvar@#3718#&&&litvar@CA9301572#rs768942227##|p.L857P", "799|3|gene|ncbi_gene@2187|FAB", "369|7|variant|litvar@#2623#p.L161H&&&litvar@#2623#|p.L161H", "1625|3|disease|ncbi_mesh@D015470|AML", "1030|4|gene|ncbi_gene@3575|IL7R", "1079|3|gene|ncbi_gene@2187|FAB", "1128|5|gene|ncbi_gene@7307|U2AF1", "727|7|variant|litvar@#2187#p.A586S&&&litvar@#2187#|p.A586S", "953|7|variant|litvar@#4763#p.N642H&&&litvar@#4763#|p.N642H", "931|8|variant|litvar@#3575#p.V1721E&&&litvar@#3575#|p.V1721E"], "figure_id": "tII-br-0-0-01353", "text_hl": "A, Relapsed AML   UPN Disease subtype SNVs at diagnosis (VAF) SNVs at relapse (VAF)   1 FAB M5 KRASp.G12V (0.296) None   2 FAB M6 (RAEB) PTPN11p.G60V(0.83) PTPN11 p.V45L (0.10) PTPN11p.G60V(0.44)   3 FAB M7 (non-Down-syndrome) KRAS <m>p.A146T</m> (0.09) None   4 FAB M5 None None   5 FAB M7 (non-Down-syndrome) GATA1p.R270W (0.43) KRAS p.G12A (0.43) IKZF1 p.F154Y (0.38)aIKZF1p.L161H (0.38)a GATA1p.R270W(0.23) KRAS p.G12A (0.19) IKZF1p.F154Y(0.17)aIKZF1p.F161H(0.17)a   6 FAB M2 FLT3-ITD (0.572) FLT3-ITD (0.689)   7 FAB M2 PTPN11 p.I479F (0.40) + c.1473-1481dela PTPN11p.I479F (0.35) + c.1473-1481dela   8 FAB M7 (non-Down-syndrome) GATA1 p.P50fs (0.30) GATA1 p.P50fs (0.05)   9 FAB M4 KRAS p.G12V (0.41) SMARCA4p.R979Q (0.06)a MLH1p.A586S (0.06)a   10 FAB M5b KRAS p.G13D (0.32) RUNX1p.Q390fs(0.2)   11 FAB M1 GATA2 p.R362Q (0.11) CEBPAp.Q312HR (0.99)a CEBPAp.D63fs(0.37)aCEBPAp.Q312HR (0.39)a   12 T/Myeloid JAK3 p.L857P (0.10) NOTCH1p.V1721E (0.33) STAT5Bp.N642H(0.11) NF1 p.L2317H (0.05)a JAK3 p.L857P (0.13) NOTCH1p.V1721E (0.33) IL7R p.L243GTARCV (0.10)aVHL p.L85fs (0.11)   13 FAB M7 (non-Down-syndrome) None None   14 FAB M4 U2AF1 p.R35L (0.53) KRAS p.G12D (0.37) KRAS p.G12D (0.23)   15 T/Myeloid TP53 p.K164E (0.998) PHF6 p.R274fs (0.724) NPM1 p.L287fs (0.579) TP53 p.K164E (0.858) PHF6p.R274fs (0.611) NPM1 p.L287fs (0.53) MPLp.A486V(0.064)a   B, Non-relapsed AML   UPN Disease subtype SNVs at diagnosis (VAF) SNVs at relapse (VAF)   16 FAB M3 None -   17 FAB M3 None -   18 FAB M5a None -   19 FAB M4Eo KIT p.D816Y (0.28) -       WT1 p.H448Y (0.22)a -       NRAS p.Q61K (0.08) -   20 FAB M2 JAK3 p.M511I (0.13) -   21 AML with myelodysplasia-related changes None -   22 FAB M2 NRAS p.G13D (0.37) -       WT1 p.D447N (0.34) -   23 FAB M2 NRAS p.Q61K (0.25) -   24 FAB M2 KRAS p.G12D (0.52) -   25 FAB M5 None -   26 FAB M5 FLT3 p.D839G (0.21) -       FLT3 p.Y591D (0.08) -       FLT3 p.D839N (0.07) -   27 FAB M2 KIT p.N822K (0.43) -   "}], "citations": {"NLM": "Ishida H, Iguchi A, Aoe M, Nishiuchi R, Matsubara T, Keino D, Sanada M, Shimada A. Panel-based next-generation sequencing facilitates the characterization of childhood acute myeloid leukemia in clinical settings. Biomed Rep. PMID: 32934818", "BibTeX": "@article{32934818, title={Panel-based next-generation sequencing facilitates the characterization of childhood acute myeloid leukemia in clinical settings.}, author={Ishida H and Iguchi A and Aoe M and Nishiuchi R and Matsubara T and Keino D and Sanada M and Shimada A}, journal={Biomed Rep}}"}, "is_sup_mat_match": false}, {"pmid": 28632725, "pmcid": "PMC5537494", "title": "The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab.", "journal": "Br J Cancer", "authors": ["Demurtas L", "Puzzoni M", "Giampieri R", "Ziranu P", "Pusceddu V", "Mandolesi A", "Cremolini C", "Masi G", "Gelsomino F", "Antoniotti C", "Loretelli C", "Meriggi F", "Zaniboni A", "Falcone A", "Cascinu S", "Scartozzi M"], "date": "2017-07-25T00:00:00Z", "year": 2017, "snippets": [{"_id": "28632725@8498", "snip_text": "The kit for K-ras evaluates hot-spots mutations in codons 12, 13, 59, 61, 117 and 146 of K-ras gene (predominantly G12D, G12A, G12V, G12S, G12R, G12C, G13D, A59T, Q61H, K117N, A146T).", "section": "methods", "mentions": ["12|5|gene|ncbi_gene@3845|K-ras", "89|5|gene|ncbi_gene@3845|K-ras", "145|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "163|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "151|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "115|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "121|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "127|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "169|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "157|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "133|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "139|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "176|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "The kit for K-ras evaluates hot-spots mutations in codons 12, 13, 59, 61, 117 and 146 of K-ras gene (predominantly G12D, G12A, G12V, G12S, G12R, G12C, G13D, A59T, Q61H, K117N, <m>A146T</m>)."}], "citations": {"NLM": "Demurtas L, Puzzoni M, Giampieri R, Ziranu P, Pusceddu V, Mandolesi A, Cremolini C, Masi G, Gelsomino F, Antoniotti C, Loretelli C, Meriggi F, Zaniboni A, Falcone A, Cascinu S, Scartozzi M. The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab. Br J Cancer. PMID: 28632725", "BibTeX": "@article{28632725, title={The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab.}, author={Demurtas L and Puzzoni M and Giampieri R and Ziranu P and Pusceddu V and Mandolesi A and Cremolini C and Masi G and Gelsomino F and Antoniotti C and Loretelli C and Meriggi F and Zaniboni A and Falcone A and Cascinu S and Scartozzi M}, journal={Br J Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 35205799, "pmcid": "PMC8870112", "title": "Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies", "journal": "Cancers (Basel)", "authors": ["Rachiglio AM", "Forgione L", "Pasquale R", "Barone CA", "Maiello E", "Antonuzzo L", "Cassata A", "Tonini G", "Bordonaro R", "Rosati G", "Zaniboni A", "Lonardi S", "Ferrari D", "Frassineti GL", "Tamberi S", "Pisconti S", "Di Fabio F", "Roma C", "Orlandi A", "Latiano T", "Damato A", "Tortora G", "Pinto C", "Normanno N"], "date": "2022-02-18T00:00:00Z", "year": 2022, "snippets": [{"_id": "35205799@33560", "snip_text": "ID\tARM\tBaseline\t8 Weeks\tPD\tPD3 Months\t \t01-0001\tB\t-\t-\t-\t-\t \t01-0002\tB\t-\tKRAS: p.G12S; BRAF: p.V600E/D\t-\t-\t \t01-0005\tA\t-\t-\tNRAS: p.Q61R/K\t-\t \t01-0007\tA\t-\t-\t-\t-\t \t01-0008\tB\t-\t-\tKRAS: p.G12C\tNA\t \t01-0010\tA\tKRAS: p.G12R\t-\t-\tNA\t \t01-0011\tB\tKRAS: p.G12A\t-\tKRAS: p.G12A\tKRAS: p.G12A\t \t01-0012\tB\t-\t-\t-\tNA\t \t01-0013\tB\t-\t-\t-\tNA\t \t01-0014\tB\tKRAS: p.A59T/E/G\t-\tKRAS: p.A59T/E/G\tInvalid\t \t01-0015\tA\t-\tNA\t-\tNA\t \t01-0017\tB\t-\tKRAS: p.G12A\tBRAF: p.V600E/D\t-\t \t01-0019\tA\tKRAS: p.G12D\tKRAS: p.G12D\tKRAS p.G12D\tNA\t \t01-0024\tB\t-\t-\tNRAS: p.Q61H\t-\t \t01-0027\tB\t-\t-\tKRAS: p.G12R\t-\t \t01-0028\tA\t-\t-\t-\tKRAS: p.G12V; NRAS: p.Q61H\t \t01-0030\tB\t-\t-\t-\t-\t \t01-0031\tB\t-\tNA\t-\t-\t \t01-0032\tB\t-\t-\t-\tNA\t \t01-0033\tB\t-\tNRAS: p.A59T\t-\t-\t \t01-0036\tA\t-\tNA\t-\t-\t \t01-0038\tB\t-\tNRAS: p.G12A/V\t-\t-\t \t61-0001\tB\t-\tNA\tBRAF: p.V600E/D\tNA\t \t61-0003\tA\t-\t-\t-\t-\t \t06-0002\tB\t-\tNA\tKRAS: p.A146P/T/V; BRAF: p.V600E/D\tNA\t \t29-0001\tB\tBRAF: p.V600E/D \tBRAF: p.V600E/D\t*\tNA\t \t26-0002\tB\t-\t-\tBRAF: p.V600E/D\t-\t \t33-0004\tB\t-\t-\tNRAS: p.Q61R/K; BRAF: p.V600E/D\tNA\t \t63-0006\tB\t-\t-\t-\tNA\t \t73-0001\tB\tNRAS: p.Q61H\t-\t-\tNA\t \t57-0002\tA\t-\tKRAS: p.A146P/T/V\t-\t-\t \t57-0003\tA\t-\t-\t-\t-\t \t57-0005\tB\t-\t-\t-\tNA\t \t57-0006\tB\t-\t-\tKRAS: p.G12C\t-\t \t19-0006\tB\t-\t-\t-\tNA\t \t65-0004\tB\t-\t-\t-\tNA\t \t70-0001\tB\t-\t-\t-\t-\t \t", "section": "table", "mentions": ["466|4|gene|ncbi_gene@3845|KRAS", "250|4|gene|ncbi_gene@3845|KRAS", "677|4|gene|ncbi_gene@4893|NRAS", "547|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "453|4|gene|ncbi_gene@3845|KRAS", "580|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "541|4|gene|ncbi_gene@3845|KRAS", "484|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "729|4|gene|ncbi_gene@4893|NRAS", "336|8|variant|litvar@rs121913528##&&&litvar@#3845#|p.A59T/E", "821|4|gene|ncbi_gene@3845|KRAS", "209|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "243|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "959|4|gene|ncbi_gene@4893|NRAS", "269|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "574|4|gene|ncbi_gene@3845|KRAS", "256|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "416|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "588|4|gene|ncbi_gene@4893|NRAS", "510|4|gene|ncbi_gene@4893|NRAS", "894|9|variant|litvar@rs113488022##&&&litvar@#673#|p.V600E/D", "175|4|gene|ncbi_gene@3845|KRAS", "472|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "128|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "827|7|variant|litvar@rs121913527##&&&litvar@#3845#|p.A146P", "931|9|variant|litvar@rs113488022##&&&litvar@#673#|p.V600E/D", "1061|4|gene|ncbi_gene@3845|KRAS", "410|4|gene|ncbi_gene@3845|KRAS", "1033|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "263|4|gene|ncbi_gene@3845|KRAS", "1140|4|gene|ncbi_gene@3845|KRAS", "122|4|gene|ncbi_gene@4893|NRAS", "888|4|gene|ncbi_gene@673|BRAF", "92|9|variant|litvar@rs113488022##&&&litvar@#673#|p.V600E/D", "735|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "72|4|gene|ncbi_gene@3845|KRAS", "965|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "765|4|gene|ncbi_gene@673|BRAF", "846|9|variant|litvar@rs113488022##&&&litvar@#673#|p.V600E/D", "181|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "86|4|gene|ncbi_gene@673|BRAF", "594|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "516|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "871|4|gene|ncbi_gene@673|BRAF", "1027|4|gene|ncbi_gene@4893|NRAS", "429|9|variant|litvar@rs113488022##&&&litvar@#673#|p.V600E/D", "330|4|gene|ncbi_gene@3845|KRAS", "349|4|gene|ncbi_gene@3845|KRAS", "1146|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "235|4|gene|ncbi_gene@3845|KRAS", "683|6|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|p.A59T", "355|8|variant|litvar@rs121913528##&&&litvar@#3845#|p.A59T/E", "981|9|variant|litvar@rs113488022##&&&litvar@#673#|p.V600E/D", "840|4|gene|ncbi_gene@673|BRAF", "423|4|gene|ncbi_gene@673|BRAF", "203|4|gene|ncbi_gene@3845|KRAS", "771|9|variant|litvar@rs113488022##&&&litvar@#673#|p.V600E/D", "479|4|gene|ncbi_gene@3845|KRAS", "78|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "459|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "925|4|gene|ncbi_gene@673|BRAF", "1067|7|variant|litvar@rs121913527##&&&litvar@#3845#|p.A146P", "975|4|gene|ncbi_gene@673|BRAF", "877|9|variant|litvar@rs113488022##&&&litvar@#673#|p.V600E/D"], "figure_id": "cancers-14-01052-t001", "text_hl": "ID\tARM\tBaseline\t8 Weeks\tPD\tPD3 Months\t \t01-0001\tB\t-\t-\t-\t-\t \t01-0002\tB\t-\tKRAS: p.G12S; BRAF: p.V600E/D\t-\t-\t \t01-0005\tA\t-\t-\tNRAS: p.Q61R/K\t-\t \t01-0007\tA\t-\t-\t-\t-\t \t01-0008\tB\t-\t-\tKRAS: p.G12C\tNA\t \t01-0010\tA\tKRAS: p.G12R\t-\t-\tNA\t \t01-0011\tB\tKRAS: p.G12A\t-\tKRAS: p.G12A\tKRAS: p.G12A\t \t01-0012\tB\t-\t-\t-\tNA\t \t01-0013\tB\t-\t-\t-\tNA\t \t01-0014\tB\tKRAS: p.A59T/E/G\t-\tKRAS: p.A59T/E/G\tInvalid\t \t01-0015\tA\t-\tNA\t-\tNA\t \t01-0017\tB\t-\tKRAS: p.G12A\tBRAF: p.V600E/D\t-\t \t01-0019\tA\tKRAS: p.G12D\tKRAS: p.G12D\tKRAS p.G12D\tNA\t \t01-0024\tB\t-\t-\tNRAS: p.Q61H\t-\t \t01-0027\tB\t-\t-\tKRAS: p.G12R\t-\t \t01-0028\tA\t-\t-\t-\tKRAS: p.G12V; NRAS: p.Q61H\t \t01-0030\tB\t-\t-\t-\t-\t \t01-0031\tB\t-\tNA\t-\t-\t \t01-0032\tB\t-\t-\t-\tNA\t \t01-0033\tB\t-\tNRAS: p.A59T\t-\t-\t \t01-0036\tA\t-\tNA\t-\t-\t \t01-0038\tB\t-\tNRAS: p.G12A/V\t-\t-\t \t61-0001\tB\t-\tNA\tBRAF: p.V600E/D\tNA\t \t61-0003\tA\t-\t-\t-\t-\t \t06-0002\tB\t-\tNA\tKRAS: p.A146P/T/V; BRAF: p.V600E/D\tNA\t \t29-0001\tB\tBRAF: p.V600E/D \tBRAF: p.V600E/D\t*\tNA\t \t26-0002\tB\t-\t-\tBRAF: p.V600E/D\t-\t \t33-0004\tB\t-\t-\tNRAS: p.Q61R/K; BRAF: p.V600E/D\tNA\t \t63-0006\tB\t-\t-\t-\tNA\t \t73-0001\tB\tNRAS: p.Q61H\t-\t-\tNA\t \t57-0002\tA\t-\tKRAS: p.A146P/T/V\t-\t-\t \t57-0003\tA\t-\t-\t-\t-\t \t57-0005\tB\t-\t-\t-\tNA\t \t57-0006\tB\t-\t-\tKRAS: p.G12C\t-\t \t19-0006\tB\t-\t-\t-\tNA\t \t65-0004\tB\t-\t-\t-\tNA\t \t70-0001\tB\t-\t-\t-\t-\t \t"}], "citations": {"NLM": "Rachiglio AM, Forgione L, Pasquale R, Barone CA, Maiello E, Antonuzzo L, Cassata A, Tonini G, Bordonaro R, Rosati G, Zaniboni A, Lonardi S, Ferrari D, Frassineti GL, Tamberi S, Pisconti S, Di Fabio F, Roma C, Orlandi A, Latiano T, Damato A, Tortora G, Pinto C, Normanno N. Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies Cancers (Basel). PMID: 35205799", "BibTeX": "@article{35205799, title={Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies}, author={Rachiglio AM and Forgione L and Pasquale R and Barone CA and Maiello E and Antonuzzo L and Cassata A and Tonini G and Bordonaro R and Rosati G and Zaniboni A and Lonardi S and Ferrari D and Frassineti GL and Tamberi S and Pisconti S and Di Fabio F and Roma C and Orlandi A and Latiano T and Damato A and Tortora G and Pinto C and Normanno N}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 28899979, "pmcid": "PMC5868529", "title": "- No Title -", "journal": "J Clin Pathol", "authors": ["Johnston L", "Power M", "Sloan P", "Long A", "Silmon A", "Chaffey B", "Lisgo AJ", "Little L", "Vercauteren E", "Steiniche T", "Meyer T", "Simpson J"], "date": "2018-04-01T00:00:00Z", "year": 2018, "snippets": [{"_id": "28899979@5867", "snip_text": "Gene Exon Codon Mutation Protein Nucleotide change Genetic call   NRAS 2 12 G12D p.(Gly12Asp) c.35G>A G12D   G12C p.(Gly12Cys) c.34G>T G12C   G12S p.(Gly12Ser) c.34G>A G12S   G12A p.(Gly12Ala) c.35G>C G12A/V   G12V p.(Gly12Val) c.35G>T   13 G13D p.(Gly13Asp) c.38G>A G13D   G13R p.(Gly12Arg) c.37G>C G12R/V   G12V p.(Gly13Va) c.38G>T   3 59 A59T p.(Ala59Thr) c.175G>A A59T   61 Q61K p.(Gln61Lys) c.181A>G Q61K   Q61R p.(Gln61Arg) c.182A>G Q61R   Q61L p.(Gln61Leu) c.182A>T Q61L   Q61H p.(Gln61His) c.183A>T Q61H   Q61H p.(Gln61His) c.183A>T   4 117 K117N p.(Lys117Asn) c.351G>C K11N    K117N p.(Lys117Asn) c.351G>T    A146T p.(Ala146Thr) c.426G>A A146T/V    A146V p.(Ala146Val) c.437C>T   BRAF 15 600 V600E p.(Val600Glu) c.1799T>A V600E/D   V600E p.(Val600Glu) c.1799_1800delinsAA   V600D p.(Val600Asp) c.1799_1800delinsAC   600 V600K p.(Val600Lys) c.1798_1799delinsAA V600K/R   V600R p.(Val600Arg) c.1798_1799delinsAA   ", "section": "table", "mentions": ["228|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA261525#rs121913237##|c.35G>T", "638|8|variant|litvar@#673#c.426G>A&&&litvar@#673#|c.426G>A", "480|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "180|12|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|p.(Gly12Ala)", "127|7|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|c.34G>T", "439|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "210|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "761|19|variant|litvar@#673#c.1799_1800delinsAA&&&litvar@#673#|c.1799_1800delinsAA", "747|13|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.(Val600Glu)", "109|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "606|8|variant|litvar@rs1268659696##&&&litvar@#207#|c.351G>T", "578|4|variant|litvar@#673#p.K11N&&&litvar@#673#|K11N", "160|7|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA180753#rs121913250##|c.34G>A", "201|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "555|13|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.(Lys117Asn)", "396|8|variant|litvar@rs1265063696##&&&litvar@#673#|c.181A>G", "142|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "473|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "741|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "879|5|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16021333#rs121913227##|V600R", "446|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "102|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "368|4|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|A59T", "267|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "549|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "417|12|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.(Gln61Arg)", "405|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "309|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "678|8|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C>T", "135|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "519|12|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.(Gln61His)", "721|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "378|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "259|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "76|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "430|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A>G", "241|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "168|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "532|8|variant|litvar@rs121913255##&&&litvar@#4893#&&&litvar@CA16042285#rs121913255##|c.183A>T", "451|12|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.(Gln61Leu)", "292|7|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|c.37G>C", "647|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "664|13|variant|litvar@rs1057519725##&&&litvar@#3845#|p.(Ala146Val)", "274|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "412|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "300|6|variant|litvar@rs121913250##&&&litvar@#4893#|G12R/V", "346|12|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|p.(Ala59Thr)", "464|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|c.182A>T", "383|12|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.(Gln61Lys)", "849|19|variant|litvar@#4893#c.1798_1799delinsAA&&&litvar@#4893#|c.1798_1799delinsAA", "624|13|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.(Ala146Thr)", "81|12|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.(Gly12Asp)", "193|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G>C", "707|13|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.(Val600Glu)", "885|13|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16021333#rs121913227##|p.(Val600Arg)", "835|13|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16602420#rs121913227##|p.(Val600Lys)", "899|19|variant|litvar@#4893#c.1798_1799delinsAA&&&litvar@#4893#|c.1798_1799delinsAA", "803|19|variant|litvar@#673#c.1799_1800delinsAC&&&litvar@#673#|c.1799_1800delinsAC", "789|13|variant|litvar@rs121913377##&&&litvar@#673#&&&litvar@CA16602419#rs121913377##|p.(Val600Asp)", "359|8|variant|litvar@rs371504803##&&&litvar@#673#&&&litvar@CA4517023#rs371504803##|c.175G>A", "246|12|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.(Gly13Asp)", "658|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "514|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "869|5|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16602420#rs121913227##|V600K", "592|13|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.(Lys117Asn)", "498|8|variant|litvar@rs121913255##&&&litvar@#4893#&&&litvar@CA16042285#rs121913255##|c.183A>T", "114|12|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.(Gly12Cys)", "485|12|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.(Gln61His)", "689|4|gene|ncbi_gene@673|BRAF", "326|7|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|c.38G>T", "279|12|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.(Gly12Arg)", "586|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "215|12|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.(Gly12Val)", "341|4|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|A59T", "147|12|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.(Gly12Ser)", "783|5|variant|litvar@rs121913377##&&&litvar@#673#&&&litvar@CA16602419#rs121913377##|V600D", "731|7|variant|litvar@rs113488022##&&&litvar@#673#|V600E/D", "507|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "701|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "94|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G>A", "569|8|variant|litvar@rs767291079##&&&litvar@#22882#&&&litvar@CA4862148#rs767291079##|c.351G>C"], "figure_id": "T1", "text_hl": "Gene Exon Codon Mutation Protein Nucleotide change Genetic call   NRAS 2 12 G12D p.(Gly12Asp) c.35G>A G12D   G12C p.(Gly12Cys) c.34G>T G12C   G12S p.(Gly12Ser) c.34G>A G12S   G12A p.(Gly12Ala) c.35G>C G12A/V   G12V p.(Gly12Val) c.35G>T   13 G13D p.(Gly13Asp) c.38G>A G13D   G13R p.(Gly12Arg) c.37G>C G12R/V   G12V p.(Gly13Va) c.38G>T   3 59 A59T p.(Ala59Thr) c.175G>A A59T   61 Q61K p.(Gln61Lys) c.181A>G Q61K   Q61R p.(Gln61Arg) c.182A>G Q61R   Q61L p.(Gln61Leu) c.182A>T Q61L   Q61H p.(Gln61His) c.183A>T Q61H   Q61H p.(Gln61His) c.183A>T   4 117 K117N p.(Lys117Asn) c.351G>C K11N    K117N p.(Lys117Asn) c.351G>T    <m>A146T</m> p.(<m>Ala146Thr</m>) c.426G>A <m>A146T</m>/V    A146V p.(Ala146Val) c.437C>T   BRAF 15 600 V600E p.(Val600Glu) c.1799T>A V600E/D   V600E p.(Val600Glu) c.1799_1800delinsAA   V600D p.(Val600Asp) c.1799_1800delinsAC   600 V600K p.(Val600Lys) c.1798_1799delinsAA V600K/R   V600R p.(Val600Arg) c.1798_1799delinsAA   "}], "citations": {"NLM": "Johnston L, Power M, Sloan P, Long A, Silmon A, Chaffey B, Lisgo AJ, Little L, Vercauteren E, Steiniche T, Meyer T, Simpson J. - No Title - J Clin Pathol. PMID: 28899979", "BibTeX": "@article{28899979, title={- No Title -}, author={Johnston L and Power M and Sloan P and Long A and Silmon A and Chaffey B and Lisgo AJ and Little L and Vercauteren E and Steiniche T and Meyer T and Simpson J}, journal={J Clin Pathol}}"}, "is_sup_mat_match": false}, {"pmid": 26172297, "pmcid": "PMC4695154", "title": "LINE-1 hypomethylation in normal colon mucosa is associated with poor survival in Chinese patients with sporadic colon cancer", "journal": "Oncotarget", "authors": ["Zhuo C", "Li Q", "Wu Y", "Li Y", "Nie J", "Li D", "Peng J", "Lian P", "Li B", "Cai G", "Li X", "Cai S"], "date": "2015-09-15T00:00:00Z", "year": 2015, "snippets": [{"_id": "26172297@9450", "snip_text": "Gene\tAnalyzed mutation points\tN of mutation\tCodon\tSubtotal in codon\tTotal\tOverall mutation rate (%)\t \tBRAF\tc.1798G>A/T\t0\tV600\t5\t5\t3.94\t \t\tc.1799T>A\t4\t\t\t\t\t \t\tc.1799T>G\t1\t\t\t\t\t \t\tc.1799T>C\t0\t\t\t\t\t \tKRAS\tc.34G>A/C/T\t10\tG12\t38\t52\t40.94\t \t\tc.35G>A/C/T\t28\t\t\t\t\t \t\tc. 37G>A/C/T\t1\tG13\t10\t\t\t \t\tc. 38G>A/C/T\t9\t\t\t\t\t \t\tc. 181C>A/G/T\t0\tQ61\t2\t\t\t \t\tc. 182A>C/G/T\t0\t\t\t\t\t \t\tc. 183A>C/T\t2\t\t\t\t\t \t\tc.436G>A/C\t1\tA146\t2\t\t\t \t\tc.437C>T\t1\t\t\t\t\t \tNRAS\tc. 34G>A/C/T\t1\tG12\t2\t3\t2.36\t \t\tc. 35G>A/C/T\t1\t\t\t\t\t \t\tc.37G/38G>A/C/T\t0\tG13\t0\t\t\t \t\tc.181C>A/G/T\t0\tQ61\t1\t\t\t \t\tc. 182A>C/G/T\t1\t\t\t\t\t \t\tc.183A>C/T\t0\t\t\t\t\t \tPIK3CA\tc.1624G>A/C\t2\tE542\t2\t7\t5.51\t \t\tc.1633G>A/C\t0\tE545\t0\t\t\t \t\tc.1636C>A/G\t1\tE546\t2\t\t\t \t\tc.1637A>C/G/T\t1\t\t\t\t\t \t\tc.3139C>T\t0\tH1047\t3\t\t\t \t\tc.3140A>G/T\t3\t\t\t\t\t \t\tc.3145G>A/C\t0\tG1049\t0\t\t\t \t", "section": "table", "mentions": ["425|7|variant|litvar@rs121913530##&&&litvar@#3845#|34G>A/C", "731|11|variant|litvar@rs121913277##&&&litvar@#5290#|c.3145G>A/C", "233|9|variant|litvar@rs121913529##&&&litvar@#3845#|c.35G>A/C", "285|5|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|38G>A", "334|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA10602732#rs11554290##|182A>C", "685|9|variant|litvar@rs121913281##&&&litvar@#5290#&&&litvar@CA130471#rs121913281##|c.3139C>T", "636|11|variant|litvar@rs121913286##&&&litvar@#5290#|c.1636C>A/G", "102|4|gene|ncbi_gene@673|BRAF", "157|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA281998#rs113488022##|c.1799T>G", "375|10|variant|litvar@rs121913527##&&&litvar@#3845#|c.436G>A/C", "176|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA16602736#rs113488022##|c.1799T>C", "481|7|variant|litvar@rs112445441##&&&litvar@#3845#|38G>A/C", "199|9|variant|litvar@rs121913530##&&&litvar@#3845#|c.34G>A/C", "610|11|variant|litvar@rs104886003##&&&litvar@#5290#|c.1633G>A/C", "291|3|variant|litvar@#4893#|C/T", "362|3|variant|litvar@#4893#|C/T", "718|3|variant|litvar@#5290#|G/T", "258|7|variant|litvar@#3845#c.37G>A,C&&&litvar@#3845#|37G>A/C", "194|4|gene|ncbi_gene@3845|KRAS", "579|11|variant|litvar@rs121913273##&&&litvar@#5290#|c.1624G>A/C", "560|3|variant|litvar@#4893#|C/T", "672|3|variant|litvar@#5290#|G/T", "417|4|gene|ncbi_gene@4893|NRAS", "506|8|variant|litvar@rs121913254##&&&litvar@#4893#|181C>A/G", "400|8|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C>T", "540|3|variant|litvar@#5290#|G/T", "572|6|gene|ncbi_gene@5290|PIK3CA", "462|3|variant|litvar@#4893#|C/T", "138|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "533|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA10602732#rs11554290##|182A>C", "107|11|variant|litvar@rs121913378##&&&litvar@#673#|c.1798G>A/T"], "figure_id": "T2", "text_hl": "Gene\tAnalyzed mutation points\tN of mutation\tCodon\tSubtotal in codon\tTotal\tOverall mutation rate (%)\t \tBRAF\tc.1798G>A/T\t0\tV600\t5\t5\t3.94\t \t\tc.1799T>A\t4\t\t\t\t\t \t\tc.1799T>G\t1\t\t\t\t\t \t\tc.1799T>C\t0\t\t\t\t\t \tKRAS\tc.34G>A/C/T\t10\tG12\t38\t52\t40.94\t \t\tc.35G>A/C/T\t28\t\t\t\t\t \t\tc. 37G>A/C/T\t1\tG13\t10\t\t\t \t\tc. 38G>A/C/T\t9\t\t\t\t\t \t\tc. 181C>A/G/T\t0\tQ61\t2\t\t\t \t\tc. 182A>C/G/T\t0\t\t\t\t\t \t\tc. 183A>C/T\t2\t\t\t\t\t \t\tc.436G>A/C\t1\tA146\t2\t\t\t \t\tc.437C>T\t1\t\t\t\t\t \tNRAS\tc. 34G>A/C/T\t1\tG12\t2\t3\t2.36\t \t\tc. 35G>A/C/T\t1\t\t\t\t\t \t\tc.37G/38G>A/C/T\t0\tG13\t0\t\t\t \t\tc.181C>A/G/T\t0\tQ61\t1\t\t\t \t\tc. 182A>C/G/T\t1\t\t\t\t\t \t\tc.183A>C/T\t0\t\t\t\t\t \tPIK3CA\tc.1624G>A/C\t2\tE542\t2\t7\t5.51\t \t\tc.1633G>A/C\t0\tE545\t0\t\t\t \t\tc.1636C>A/G\t1\tE546\t2\t\t\t \t\tc.1637A>C/G/T\t1\t\t\t\t\t \t\tc.3139C>T\t0\tH1047\t3\t\t\t \t\tc.3140A>G/T\t3\t\t\t\t\t \t\tc.3145G>A/C\t0\tG1049\t0\t\t\t \t"}], "citations": {"NLM": "Zhuo C, Li Q, Wu Y, Li Y, Nie J, Li D, Peng J, Lian P, Li B, Cai G, Li X, Cai S. LINE-1 hypomethylation in normal colon mucosa is associated with poor survival in Chinese patients with sporadic colon cancer Oncotarget. PMID: 26172297", "BibTeX": "@article{26172297, title={LINE-1 hypomethylation in normal colon mucosa is associated with poor survival in Chinese patients with sporadic colon cancer}, author={Zhuo C and Li Q and Wu Y and Li Y and Nie J and Li D and Peng J and Lian P and Li B and Cai G and Li X and Cai S}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 32990679, "pmcid": "PMC7710308", "title": "KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in mice", "journal": "JCI Insight", "authors": ["Wong JC", "Perez-Mancera PA", "Huang TQ", "Kim J", "Grego-Bessa J", "Del Pilar Alzamora M", "Kogan SC", "Sharir A", "Keefe SH", "Morales CE", "Schanze D", "Castel P", "Hirose K", "Huang GN", "Zenker M", "Sheppard D", "Klein OD", "Tuveson DA", "Braun BS", "Shannon K"], "date": "2020-11-05T00:00:00Z", "year": 2020, "snippets": [{"_id": "32990679@18380", "snip_text": "This system has been widely used to investigate the functional consequences of individual gain- and loss-of-function mutations in the hematopoietic compartment of genetically engineered mouse models, including KrasG12D and KrasA146T mice.", "section": "results", "mentions": ["223|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KrasA146T", "186|5|species|ncbi_taxonomy@10090|mouse", "233|4|species|ncbi_taxonomy@10090|mice"], "text_hl": "This system has been widely used to investigate the functional consequences of individual gain- and loss-of-function mutations in the hematopoietic compartment of genetically engineered mouse models, including KrasG12D and KrasA146T mice."}], "citations": {"NLM": "Wong JC, Perez-Mancera PA, Huang TQ, Kim J, Grego-Bessa J, Del Pilar Alzamora M, Kogan SC, Sharir A, Keefe SH, Morales CE, Schanze D, Castel P, Hirose K, Huang GN, Zenker M, Sheppard D, Klein OD, Tuveson DA, Braun BS, Shannon K. KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in mice JCI Insight. PMID: 32990679", "BibTeX": "@article{32990679, title={KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in mice}, author={Wong JC and Perez-Mancera PA and Huang TQ and Kim J and Grego-Bessa J and Del Pilar Alzamora M and Kogan SC and Sharir A and Keefe SH and Morales CE and Schanze D and Castel P and Hirose K and Huang GN and Zenker M and Sheppard D and Klein OD and Tuveson DA and Braun BS and Shannon K}, journal={JCI Insight}}"}, "is_sup_mat_match": false}, {"pmid": 32792368, "pmcid": "PMC7642097", "title": "An in vivo KRAS allelic series reveals distinct phenotypes of common oncogenic variants", "journal": "Cancer Discov", "authors": ["Zafra MP", "Parsons MJ", "Kim J", "Alonso-Curbelo D", "Goswami S", "Schatoff EM", "Han T", "Katti A", "Fernandez MTC", "Wilkinson JE", "Piskounova E", "Dow LE"], "date": "2020-11-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "32792368@36549", "snip_text": "Similarly, KRASA146T mutations commonly co-occur with MAPK pathway mutations in CRC, and Poulin et al recently showed using a similar Cre-conditional Kras approach, that KRASA146T mutations are poorly transforming in the colon and pancreas, like KRASG13D.", "section": "discussion", "mentions": ["11|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T", "150|4|gene|ncbi_gene@3845|Kras", "80|3|disease|ncbi_mesh@D015179|CRC", "170|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T"], "text_hl": "Similarly, KRASA146T mutations commonly co-occur with MAPK pathway mutations in CRC, and Poulin et al recently showed using a similar Cre-conditional Kras approach, that KRASA146T mutations are poorly transforming in the colon and pancreas, like KRASG13D."}], "citations": {"NLM": "Zafra MP, Parsons MJ, Kim J, Alonso-Curbelo D, Goswami S, Schatoff EM, Han T, Katti A, Fernandez MTC, Wilkinson JE, Piskounova E, Dow LE. An in vivo KRAS allelic series reveals distinct phenotypes of common oncogenic variants Cancer Discov. PMID: 32792368", "BibTeX": "@article{32792368, title={An in vivo KRAS allelic series reveals distinct phenotypes of common oncogenic variants}, author={Zafra MP and Parsons MJ and Kim J and Alonso-Curbelo D and Goswami S and Schatoff EM and Han T and Katti A and Fernandez MTC and Wilkinson JE and Piskounova E and Dow LE}, journal={Cancer Discov}}"}, "is_sup_mat_match": false}, {"pmid": 28927094, "pmcid": "PMC5588060", "title": "Genomic markers of ovarian adenocarcinoma and its relevancy to the effectiveness of chemotherapy.", "journal": "Oncol Lett", "authors": ["Englert-Golon M", "Burchardt B", "Budny B", "D\u0119bicki S", "Majchrzycka B", "Wrotkowska E", "Jasi\u0144ski P", "Ziemnicka K", "S\u0142opie\u0144 R", "Rucha\u0142a M", "Sajdak S"], "date": "2017-09-01T00:00:00Z", "year": 2017, "snippets": [{"_id": "28927094@54089", "snip_text": "Mutation Type AA change CDS change Cosmic ID   NRAS:p.Q61R:c.182A>G Missense p.Q61R c.182A>G COSM584   NRAS:p.Q61L:c.182A>T Missense p.Q61L c.182A>T COSM583   NRAS:p.Q61K:c.181C>A Missense p.Q61K c.181C>A COSM580   NRAS:p.G12V:c.35G>T Missense p.G12V c.35G>T COSM566   NRAS:p.G12D:c.35G>A Missense p.G12D c.35G>A COSM564   NRAS:p.G12S/C:c.34G>A/T Missense p.G12S  p.G12C c.34G>A  c.34G>T COSM563  COSM562   IDH1:p.R132H:c.395G>A Missense p.R132H c.395G>A COSM28746   PIK3CA:p.E542K:c.1624G>A Missense p.E542K c.1624G>A COSM760   PIK3CA:p.E545K:c.1633G>A Missense p.E545K c.1633G>A COSM763   PIK3CA:p.Q546K:c.1636C>A Missense p.Q546K c.1636C>A COSM766   PIK3CA:p.H1047R:c.3140A>G Missense p.H1047R c.3140A>G COSM775   PIK3CA:p.H1047L:c.3140A>T Missense p.H1047L c.3140A>T COSM776   EGFR:p.G719S:c.2155G>A Missense p.G719S c.2155G>A COSM6252   EGFR:p.G719C:c.2155G>T Missense p.G719C c.2155G>T COSM6253   EGFR:p.G719A:c.2156G>C Missense p.G719A c.2156G>C COSM6239   EGFR:p.E746_A750del:c.2235_2249del15 In-frame p.E746_A750delELREA c.2235_2249del15 COSM6223   EGFR:p.E746_A750del:c.2236_2250del15 In-frame p.E746_A750delELREA c.2236_2250del15 COSM6225   EGFR:p.E746_T751>A:c.2237_2251del15 Deletion In-frame p.E746_T751>A c.2237_2251del15 COSM12678   EGFR:p.L747_E749P/del:c.2239_2248>C/G Various p.L747_A750>P  p.L747_E749delLRE c.2239_2248TTAAGAGAAG >C  c.2239_2247 delTTAAGAGAA COSM12 382  COSM6218   EGFR:p.L747_T751del:c.2240_2254del15 In-Frame p.L747_T751delLREAT c.2240_2254del15 COSM12369   EGFR:p.L747_P753>S:c.2240_2257del18 Deletion In-frame p.L747_P753>S c.2240_2257del18 COSM12370   EGFR:p.V769_D770insASV:c.2307_2308ins9 In-frame p.V769_D770insASV c.2307_2308ins GCCAGCGTG COSM12376   EGFR:p.D770_N771insSVD:c.2311_2312ins9 In-frame p.D770_N771insSVD c.2311_2312ins GCGTGGACA COSM13428   EGFR:p.H773_V774insNPH:c.2319_2320ins9 In-frame p.H773_V774insNPH c.2319_2320ins AACCCCCAC COSM12381   EGFR:p.T790M:c.2369C>T Missense p.T790M c.2369C>T COSM6240   EGFR:p.L858R:c.2573T>G Missense p.L858R c.2573T>G COSM6224   EGFR:p.L861Q:c.2582T>A Missense p.L861Q c.2582T>A COSM6213   BRAF:p.V600K:c.1798_1799GT>AA Missense p.V600K c.1798_1799GT>AA COSM473   BRAF:p.V600E:c.1799T>A Missense p.V600E c.1799T>A COSM476   BRAF:p.G469E:c.1406G>A Missense p.G469E c.1406G>A COSM461   BRAF:p.G469A:c.1406G>C Missense p.G469A c.1406G>C COSM460   PTEN:p.R130G:c.388C>G Missense p.R130G c.388C>G COSM5219   PTEN:p.R130*:c.388C>T Nonsense p.R130* c.388C>T COSM5152   PTEN:p.R130Q/fs*4:c.389G>A/delG Various p.R130Q  p.R130fs*4 c.389G>A  c.389delG COSM5033  COSM5817   PTEN:p.R159S:c.477G>T Missense p.R159S c.477G>T COSM5287   PTEN:p.R233*:c.697C>T Nonsense p.R233* c.697C>T COSM5154   PTEN:p.P248fs*5:c.741_742insA Frame-Shift p.P248fs*5 c.741_742insA COSM4986   PTEN:p.K267fs*9:c.800delA Frame-Shift p.K267fs*9 c.800delA COSM5809   KRAS:p.A146P:c.436G>C Missense p.A146P c.436G>C COSM19905   KRAS:p.Q61H:c.183A>T Missense p.Q61H c.183A>T COSM555   KRAS:p.Q61H:c.183A>C Missense p.Q61H c.183A>C COSM554   KRAS:p.Q61K/K:c.180_181TC>TA/AA Missense p.Q61K c.181C>A  c. 180_181TC>AA COSM549  COSM87298   KRAS:p.G13D:c.38G>A Missense p.G13D c.38G>A COSM532   KRAS:p.G12D/V:c.35G>A/T Missense p.G12D  p.G12V c.35G>A  c.35G>T COSM521  COSM520   KRAS:p.G12A:c.35G>C Missense p.G12A c.35G>C COSM522   KRAS:p.G12C/S:c.34G>T/A Missense p.G12C  p.G12S c.34G>T  c.34G>A COSM516  COSM517   IDH2:p.R172K:c.515G>A Missense p.R172K c.515G>A COSM33733   IDH2:p.R140Q:c.419G>A Missense p.R140Q c.419G>A COSM41590   TP53:p.R306*:c.916C>T Nonsense p.R306* c.916C>T COSM10663   TP53:p.R282W:c.844C>T Missense p.R282W c.844C>T COSM10704   TP53:p.R273H/L:c.818G>A/T Missense p.R273H  p.R273L c.818G>A  c.818G>T COSM10660  COSM10779   TP53:p.R273C/S:c.817C>T/A Missense p.R273C  p.R273S c.817C>T  c.817C>A COSM10659  COSM43909   TP53:p.R249S:c.747G>T Missense p.R249S c.747G>T COSM10817   TP53:p.R248Q/L:c.743G>A/T Missense p.R248Q  p.R248L c.743G>A  c.743G>T COSM10662  COSM6549   TP53:p.R248W:c.742C>T Missense p.R248W c.742C>T COSM10656   TP53:p.G245S/C:c.733G>A/T Missense p.G245S  p.G245C c.733G>A  c.733G>T COSM6932  COSM11081   TP53:p.Y220C:c.659A>G Missense p.Y220C c.659A>G COSM10758   TP53:p.R213*:c.637C>T Nonsense p.R213* c.637C>T COSM10654   TP53:p.R196*:c.586C>T Nonsense p.R196* c.586C>T COSM10705   TP53:p.H179R:c.536A>G Missense p.H179R c.536A>G COSM10889   TP53:p.C176F:c.527G>T Missense p.C176F c.527G>T COSM10645   TP53:p.R175H:c.524G>A Missense p.R175H c.524G>A COSM10648   TP53:p.Y163C:c.488A>G Missense p.Y163C c.488A>G COSM10808   TP53:p.V157F:c.469G>T Missense p.V157F c.469G>T COSM10670   ", "section": "table", "mentions": ["1702|17|variant|litvar@#4298#p.N,SVD770_,771ins&&&litvar@#4298#|p.D770_N771insSVD", "1823|15|variant|litvar@#4298#c.2319_2320ins9&&&litvar@#4298#|c.2319_2320ins9", "52|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "269|4|gene|ncbi_gene@4893|NRAS", "1617|15|variant|litvar@#4298#c.2307_2308ins9&&&litvar@#4298#|c.2307_2308ins9", "3707|7|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|p.R273C", "3652|7|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA1530#rs28934576##|p.R273L", "4102|4|gene|ncbi_gene@7157|TP53", "2200|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "3891|7|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|p.R248Q", "3179|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "2233|9|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|c.1406G>A", "3488|4|gene|ncbi_gene@7157|TP53", "1152|4|gene|ncbi_gene@1956|EGFR", "2293|9|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA123655#rs121913355##|c.1406G>C", "4342|4|gene|ncbi_gene@7157|TP53", "3548|4|gene|ncbi_gene@7157|TP53", "4402|4|gene|ncbi_gene@7157|TP53", "77|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "3341|7|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA180753#rs121913250##|c.34G>A", "3608|4|gene|ncbi_gene@7157|TP53", "1414|7|variant|litvar@#4298#c.751delT&&&litvar@#4298#|T751del", "1565|16|variant|litvar@rs121913438##&&&litvar@#1956#|c.2240_2257del18", "2057|7|variant|litvar@rs121913444##&&&litvar@#1956#&&&litvar@CA176021#rs121913444##|p.L861Q", "3071|7|cellline||COSM549", "140|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|c.182A>T", "3980|7|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|p.R248W", "2953|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA180922#rs17851045##|c.183A>C", "697|9|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A>G", "298|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "794|9|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126722#rs28929495##|c.2155G>A", "1642|17|variant|litvar@#4298#p.D,ASV769_,770ins&&&litvar@#4298#|p.V769_D770insASV", "1660|14|variant|litvar@#4298#c.2307_2308ins&&&litvar@#4298#|c.2307_2308ins", "3954|7|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|p.R248W", "3160|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G>A", "2086|4|gene|ncbi_gene@673|BRAF", "1402|4|gene|ncbi_gene@1956|EGFR", "3220|7|cellline||COSM520", "4009|4|gene|ncbi_gene@7157|TP53", "2657|8|variant|litvar@rs121909219##&&&litvar@#5728#&&&litvar@CA549#rs121909219##|c.697C>T", "660|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.H1047R", "2252|7|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|p.G469E", "3754|8|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|c.817C>T", "366|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "328|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "251|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA261525#rs121913237##|c.35G>T", "2285|7|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|p.G469A", "1964|4|gene|ncbi_gene@1956|EGFR", "1908|7|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|p.T790M", "1391|8|cellline||COSM6218", "3194|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G>A", "446|8|variant|litvar@rs1201628323##&&&litvar@#4298#|c.395G>A", "1328|21|variant|litvar@#4298#|c.2239_2248TTAAGAGAAG", "1805|17|variant|litvar@#4298#p.V,NPH773_,774ins&&&litvar@#4298#|p.H773_V774insNPH", "3717|10|variant|litvar@rs121913343##&&&litvar@#7157#|c.817C>T/A", "3433|7|variant|litvar@rs121913502##&&&litvar@#3418#&&&litvar@CA124277#rs121913502##|p.R140Q", "2838|8|variant|litvar@rs121913527##&&&litvar@#3845#|c.436G>C", "1996|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "4053|7|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA369#rs28934575##|p.G245C", "2507|10|variant|litvar@rs121913292##&&&litvar@#5728#|p.R130fs*4", "1310|17|variant|litvar@#4298#p.E,LRE747_,749del&&&litvar@#4298#|p.L747_E749delLRE", "3097|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "420|8|variant|litvar@rs1201628323##&&&litvar@#4298#|c.395G>A", "598|7|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123338#rs121913286##|p.Q546K", "2946|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "3104|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "786|7|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126722#rs28929495##|p.G719S", "3670|8|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA1530#rs28934576##|c.818G>T", "4441|8|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|c.524G>A", "3038|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "2498|7|variant|litvar@rs121909229##&&&litvar@#5728#&&&litvar@CA437#rs121909229##|p.R130Q", "3746|7|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA1542#rs121913343##|p.R273S", "1594|4|gene|ncbi_gene@1956|EGFR", "2030|7|variant|litvar@rs121913444##&&&litvar@#1956#&&&litvar@CA176021#rs121913444##|p.L861Q", "874|7|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126719#rs28929495##|p.G719C", "438|7|variant|litvar@rs1318503196##&&&litvar@#9901#|p.R132H", "4415|8|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|c.524G>A", "2458|4|gene|ncbi_gene@5728|PTEN", "752|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|p.H1047L", "2971|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "2399|4|gene|ncbi_gene@5728|PTEN", "3230|4|gene|ncbi_gene@3845|KRAS", "4071|8|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA369#rs28934575##|c.733G>T", "908|7|variant|litvar@rs121913428##&&&litvar@#1956#&&&litvar@CA135775#rs121913428##|p.G719A", "2340|4|gene|ncbi_gene@5728|PTEN", "563|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "380|7|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|c.34G>T", "412|7|variant|litvar@rs1318503196##&&&litvar@#9901#|p.R132H", "2598|8|variant|litvar@rs1057519724##&&&litvar@#5728#|c.477G>T", "2133|16|variant|litvar@#4298#c.1798_1799GT>AA&&&litvar@#4298#|c.1798_1799GT>AA", "4433|7|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|p.R175H", "2730|13|variant|litvar@rs587782341##&&&litvar@#5728#|c.741_742insA", "3289|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "1745|17|variant|litvar@#4298#p.N,SVD770_,771ins&&&litvar@#4298#|p.D770_N771insSVD", "2004|9|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|c.2573T>G", "84|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A>G", "2631|8|variant|litvar@rs121909219##&&&litvar@#5728#&&&litvar@CA549#rs121909219##|c.697C>T", "2125|7|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16602420#rs121913227##|p.V600K", "4201|8|variant|litvar@rs397516436##&&&litvar@#7157#&&&litvar@CA301#rs397516436##|c.637C>T", "2528|9|variant|litvar@rs121913292##&&&litvar@#5728#|c.389delG", "3045|8|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C>A", "2771|9|variant|litvar@rs121913289##&&&litvar@#5728#|c.800delA", "2572|8|variant|litvar@rs1057519724##&&&litvar@#5728#|c.477G>T", "1977|9|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|c.2573T>G", "2476|8|variant|litvar@rs121909229##&&&litvar@#5728#&&&litvar@CA437#rs121909229##|c.389G>A", "3835|8|variant|litvar@rs28934571##&&&litvar@#7157#&&&litvar@CA392#rs28934571##|c.747G>T", "501|7|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.E542K", "4407|7|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|p.R175H", "47|4|gene|ncbi_gene@4893|NRAS", "2804|9|variant|litvar@rs121913289##&&&litvar@#5728#|c.800delA", "4381|8|variant|litvar@rs786202962##&&&litvar@#7157#|c.527G>T", "220|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "4175|8|variant|litvar@rs397516436##&&&litvar@#7157#&&&litvar@CA301#rs397516436##|c.637C>T", "3259|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "2099|16|variant|litvar@#4298#c.1798_1799GT>AA&&&litvar@#4298#|c.1798_1799GT>AA", "1516|16|variant|litvar@rs121913438##&&&litvar@#1956#|c.2240_2257del18", "3459|7|variant|litvar@rs121913502##&&&litvar@#3418#&&&litvar@CA124277#rs121913502##|p.R140Q", "1058|4|gene|ncbi_gene@1956|EGFR", "2719|10|variant|litvar@rs587782341##&&&litvar@#5728#|p.P248fs*5", "2915|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "2192|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "4355|8|variant|litvar@rs786202962##&&&litvar@#7157#|c.527G>T", "1697|4|gene|ncbi_gene@1956|EGFR", "903|4|gene|ncbi_gene@1956|EGFR", "847|7|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126719#rs28929495##|p.G719C", "3266|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>C", "3643|7|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|p.R273H", "3211|7|cellline||COSM521", "3325|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "3358|7|cellline||COSM517", "2225|7|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|p.G469E", "571|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G>A", "1047|8|cellline||COSM6223", "3827|7|variant|litvar@rs28934571##&&&litvar@#7157#&&&litvar@CA392#rs28934571##|p.R249S", "4141|8|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|c.659A>G", "2280|4|gene|ncbi_gene@673|BRAF", "4282|4|gene|ncbi_gene@7157|TP53", "3203|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA261525#rs121913237##|c.35G>T", "1468|16|variant|litvar@#4298#c.2240_2254del15&&&litvar@#4298#|c.2240_2254del15", "544|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G>A", "3407|8|variant|litvar@rs121913503##&&&litvar@#3418#&&&litvar@CA16602462#rs121913503##|c.515G>A", "2890|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "164|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "3332|7|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|c.34G>T", "3613|7|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|p.R273H", "1124|16|variant|litvar@#4298#c.2236_2250del15&&&litvar@#4298#|c.2236_2250del15", "1010|19|variant|litvar@#4298#p.A,ELREA746,750del&&&litvar@#4298#|p.E746_A750delELREA", "3801|7|variant|litvar@rs28934571##&&&litvar@#7157#&&&litvar@CA392#rs28934571##|p.R249S", "3625|6|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|818G>A", "467|6|gene|ncbi_gene@5290|PIK3CA", "4462|4|gene|ncbi_gene@7157|TP53", "4115|8|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|c.659A>G", "3861|7|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|p.R248Q", "4522|4|gene|ncbi_gene@7157|TP53", "3587|8|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|c.844C>T", "3381|8|variant|litvar@rs121913503##&&&litvar@#3418#&&&litvar@CA16602462#rs121913503##|c.515G>A", "633|9|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123338#rs121913286##|c.1636C>A", "781|4|gene|ncbi_gene@1956|EGFR", "482|9|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|c.1624G>A", "323|4|gene|ncbi_gene@4893|NRAS", "821|9|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126722#rs28929495##|c.2155G>A", "1848|17|variant|litvar@#4298#p.V,NPH773_,774ins&&&litvar@#4298#|p.H773_V774insNPH", "1866|14|variant|litvar@#4298#c.2319_2320ins&&&litvar@#4298#|c.2319_2320ins", "1271|15|variant|litvar@#4298#|c.2239_2248>C/G", "2760|10|variant|litvar@rs121913289##&&&litvar@#5728#|p.K267fs*9", "2922|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|c.183A>T", "3561|8|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|c.844C>T", "4133|7|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|p.Y220C", "3702|4|gene|ncbi_gene@7157|TP53", "2623|7|variant|litvar@#4298#p.R233*&&&litvar@#4298#|p.R233*", "2978|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA180922#rs17851045##|c.183A>C", "305|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G>A", "2793|10|variant|litvar@rs121913289##&&&litvar@#5728#|p.K267fs*9", "4193|7|variant|litvar@#4298#p.R213*&&&litvar@#4298#|p.R213*", "1213|6|variant|litvar@rs779144029##&&&litvar@#4300#|T751>A", "3399|7|variant|litvar@rs121913503##&&&litvar@#3418#&&&litvar@CA16602462#rs121913503##|p.R172K", "3809|8|variant|litvar@rs28934571##&&&litvar@#7157#&&&litvar@CA392#rs28934571##|c.747G>T", "4026|6|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|733G>A", "2564|7|variant|litvar@rs1057519724##&&&litvar@#5728#|p.R159S", "855|9|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126719#rs28929495##|c.2155G>T", "2864|8|variant|litvar@rs121913527##&&&litvar@#3845#|c.436G>C", "2173|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "2941|4|gene|ncbi_gene@3845|KRAS", "2320|9|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA123655#rs121913355##|c.1406G>C", "4107|7|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|p.Y220C", "356|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "943|9|variant|litvar@rs121913428##&&&litvar@#1956#&&&litvar@CA135775#rs121913428##|c.2156G>C", "2897|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|c.183A>T", "3579|7|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|p.R282W", "4167|7|variant|litvar@#4298#p.R213*&&&litvar@#4298#|p.R213*", "3373|7|variant|litvar@rs121913503##&&&litvar@#3418#&&&litvar@CA16602462#rs121913503##|p.R172K", "371|7|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA180753#rs121913250##|c.34G>A", "1220|16|variant|litvar@#4298#c.2237_2251del15&&&litvar@#4298#|c.2237_2251del15", "4222|4|gene|ncbi_gene@7157|TP53", "733|9|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|c.3140A>T", "108|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "3660|8|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|c.818G>A", "3856|4|gene|ncbi_gene@7157|TP53", "1497|4|gene|ncbi_gene@1956|EGFR", "4347|7|variant|litvar@rs786202962##&&&litvar@#7157#|p.C176F", "3553|7|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|p.R282W", "3908|8|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|c.743G>A", "1800|4|gene|ncbi_gene@1956|EGFR", "2682|10|variant|litvar@rs587782341##&&&litvar@#5728#|p.P248fs*5", "283|5|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|35G>A", "2856|7|variant|litvar@rs121913527##&&&litvar@#3845#|p.A146P", "3949|4|gene|ncbi_gene@7157|TP53", "3121|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "4561|8|variant|litvar@rs121912654##&&&litvar@#7157#&&&litvar@CA222#rs121912654##|c.469G>T", "984|16|variant|litvar@#4298#c.2235_2249del15&&&litvar@#4298#|c.2235_2249del15", "1261|5|variant|litvar@#4298#p.E749P&&&litvar@#4298#|E749P", "227|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA261525#rs121913237##|c.35G>T", "724|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|p.H1047L", "688|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.H1047R", "3092|4|gene|ncbi_gene@3845|KRAS", "1448|19|variant|litvar@#4298#p.T,LREAT747,751del&&&litvar@#4298#|p.L747_T751delLREAT", "2830|7|variant|litvar@rs121913527##&&&litvar@#3845#|p.A146P", "2091|7|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16602420#rs121913227##|p.V600K", "3128|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "3764|8|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA1542#rs121913343##|c.817C>A", "1763|14|variant|litvar@#4298#c.2311_2312ins&&&litvar@#4298#|c.2311_2312ins", "3187|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "3011|14|variant|litvar@#4298#c.180_181TC>TA&&&litvar@#4298#|c.180_181TC>TA", "4162|4|gene|ncbi_gene@7157|TP53", "3151|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "3368|4|gene|ncbi_gene@3418|IDH2", "2693|13|variant|litvar@rs587782341##&&&litvar@#5728#|c.741_742insA", "3900|7|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA10580924#rs11540652##|p.R248L", "115|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|c.182A>T", "2438|8|variant|litvar@rs121909224##&&&litvar@#5728#&&&litvar@CA433#rs121909224##|c.388C>T", "3428|4|gene|ncbi_gene@3418|IDH2", "215|4|gene|ncbi_gene@4893|NRAS", "1969|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "2379|8|variant|litvar@rs1463850736##&&&litvar@#3845#|c.388C>G", "171|8|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C>A", "2649|7|variant|litvar@#4298#p.R233*&&&litvar@#4298#|p.R233*", "274|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1171|16|variant|litvar@#4298#c.2237_2251del15&&&litvar@#4298#|c.2237_2251del15", "2412|8|variant|litvar@rs121909224##&&&litvar@#5728#&&&litvar@CA433#rs121909224##|c.388C>T", "2590|7|variant|litvar@rs1057519724##&&&litvar@#5728#|p.R159S", "3796|4|gene|ncbi_gene@7157|TP53", "1249|4|gene|ncbi_gene@1956|EGFR", "625|7|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123338#rs121913286##|p.Q546K", "2025|4|gene|ncbi_gene@1956|EGFR", "3918|8|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA10580924#rs11540652##|c.743G>T", "474|7|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.E542K", "2755|4|gene|ncbi_gene@5728|PTEN", "2065|9|variant|litvar@rs121913444##&&&litvar@#1956#&&&litvar@CA176021#rs121913444##|c.2582T>A", "2353|8|variant|litvar@rs1463850736##&&&litvar@#3845#|c.388C>G", "3284|4|gene|ncbi_gene@3845|KRAS", "189|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "2430|7|variant|litvar@rs121909224##&&&litvar@#5728#|p.R130*", "244|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "2825|4|gene|ncbi_gene@3845|KRAS", "1903|4|gene|ncbi_gene@1956|EGFR", "3058|12|variant|litvar@#4298#c.180_181TC>AA&&&litvar@#4298#|180_181TC>AA", "2885|4|gene|ncbi_gene@3845|KRAS", "1943|9|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|c.2369C>T", "2371|7|variant|litvar@rs121909224##&&&litvar@#5728#&&&litvar@CA16602437#rs121909224##|p.R130G", "4373|7|variant|litvar@rs786202962##&&&litvar@#7157#|p.C176F", "2165|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "2463|7|variant|litvar@rs121909229##&&&litvar@#5728#&&&litvar@CA437#rs121909229##|p.R130Q", "2312|7|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|p.G469A", "536|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "3349|7|cellline||COSM516", "935|7|variant|litvar@rs121913428##&&&litvar@#1956#&&&litvar@CA135775#rs121913428##|p.G719A", "2404|7|variant|litvar@rs121909224##&&&litvar@#5728#|p.R130*", "4535|8|variant|litvar@rs121912654##&&&litvar@#7157#&&&litvar@CA222#rs121912654##|c.469G>T", "1422|16|variant|litvar@#4298#c.2240_2254del15&&&litvar@#4298#|c.2240_2254del15", "1237|9|cellline||COSM12678", "3317|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "4553|7|variant|litvar@rs121912654##&&&litvar@#7157#&&&litvar@CA222#rs121912654##|p.V157F", "1164|6|variant|litvar@rs779144029##&&&litvar@#4300#|T751>A", "2345|7|variant|litvar@rs121909224##&&&litvar@#5728#&&&litvar@CA16602437#rs121909224##|p.R130G", "4261|8|variant|litvar@rs397516435##&&&litvar@#7157#&&&litvar@CA282#rs397516435##|c.586C>T", "1078|16|variant|litvar@#4298#c.2236_2250del15&&&litvar@#4298#|c.2236_2250del15", "3467|8|variant|litvar@rs121913502##&&&litvar@#3418#&&&litvar@CA124277#rs121913502##|c.419G>A", "4321|8|variant|litvar@rs1057519991##&&&litvar@#7157#|c.536A>G", "3527|8|variant|litvar@rs121913344##&&&litvar@#7157#&&&litvar@CA495#rs121913344##|c.916C>T", "813|7|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126722#rs28929495##|p.G719S", "4501|8|variant|litvar@rs148924904##&&&litvar@#7157#&&&litvar@CA240#rs148924904##|c.488A>G", "3080|9|cellline||COSM87298", "3242|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>C", "1063|14|variant|litvar@#4298#p.A746,750del&&&litvar@#4298#|p.E746_A750del", "4295|8|variant|litvar@rs1057519991##&&&litvar@#7157#|c.536A>G", "3501|8|variant|litvar@rs121913344##&&&litvar@#7157#&&&litvar@CA495#rs121913344##|c.916C>T", "3002|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "2559|4|gene|ncbi_gene@5728|PTEN", "4014|7|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|p.G245S", "1030|16|variant|litvar@#4298#c.2235_2249del15&&&litvar@#4298#|c.2235_2249del15", "529|6|gene|ncbi_gene@5290|PIK3CA", "2160|4|gene|ncbi_gene@673|BRAF", "717|6|gene|ncbi_gene@5290|PIK3CA", "2220|4|gene|ncbi_gene@673|BRAF", "4475|8|variant|litvar@rs148924904##&&&litvar@#7157#&&&litvar@CA240#rs148924904##|c.488A>G", "3988|8|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|c.742C>T", "653|6|gene|ncbi_gene@5290|PIK3CA", "59|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A>G", "2260|9|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|c.1406G>A", "4253|7|variant|litvar@#4298#p.R196*&&&litvar@#4298#|p.R196*", "4313|7|variant|litvar@rs1057519991##&&&litvar@#7157#|p.H179R", "3519|7|variant|litvar@#4298#p.R306*&&&litvar@#4298#|p.R306*", "3298|9|variant|litvar@rs121913530##&&&litvar@#3845#|c.34G>T/A", "1916|9|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|c.2369C>T", "916|9|variant|litvar@rs121913428##&&&litvar@#1956#&&&litvar@CA135775#rs121913428##|c.2156G>C", "3962|8|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|c.742C>T", "4227|7|variant|litvar@#4298#p.R196*&&&litvar@#4298#|p.R196*", "4044|7|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|p.G245S", "669|9|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A>G", "4493|7|variant|litvar@rs148924904##&&&litvar@#7157#&&&litvar@CA240#rs148924904##|p.Y163C", "4287|7|variant|litvar@rs1057519991##&&&litvar@#7157#|p.H179R", "591|6|gene|ncbi_gene@5290|PIK3CA", "3493|7|variant|litvar@#4298#p.R306*&&&litvar@#4298#|p.R306*", "761|9|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|c.3140A>T", "964|4|gene|ncbi_gene@1956|EGFR", "3873|6|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|743G>A", "1599|17|variant|litvar@#4298#p.D,ASV769_,770ins&&&litvar@#4298#|p.V769_D770insASV", "3235|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "1720|15|variant|litvar@#4298#c.2311_2312ins9&&&litvar@#4298#|c.2311_2312ins9", "1104|14|variant|litvar@#4298#p.A746,750del&&&litvar@#4298#|p.E746_A750del", "3737|7|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|p.R273C", "2677|4|gene|ncbi_gene@5728|PTEN", "4467|7|variant|litvar@rs148924904##&&&litvar@#7157#&&&litvar@CA240#rs148924904##|p.Y163C", "509|9|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|c.1624G>A", "2518|8|variant|litvar@rs121909229##&&&litvar@#5728#&&&litvar@CA437#rs121909229##|c.389G>A", "3146|4|gene|ncbi_gene@3845|KRAS", "4527|7|variant|litvar@rs121912654##&&&litvar@#7157#&&&litvar@CA222#rs121912654##|p.V157F", "133|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "2618|4|gene|ncbi_gene@5728|PTEN", "2038|9|variant|litvar@rs121913444##&&&litvar@#1956#&&&litvar@CA176021#rs121913444##|c.2582T>A", "842|4|gene|ncbi_gene@1956|EGFR", "882|9|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126719#rs28929495##|c.2155G>T", "4235|8|variant|litvar@rs397516435##&&&litvar@#7157#&&&litvar@CA282#rs397516435##|c.586C>T", "196|8|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C>A", "3441|8|variant|litvar@rs121913502##&&&litvar@#3418#&&&litvar@CA124277#rs121913502##|c.419G>A", "339|5|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA180753#rs121913250##|34G>A", "606|9|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123338#rs121913286##|c.1636C>A", "4061|8|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|c.733G>A", "1935|7|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|p.T790M"], "figure_id": "tIV-ol-0-0-6590", "text_hl": "Mutation Type AA change CDS change Cosmic ID   NRAS:p.Q61R:c.182A>G Missense p.Q61R c.182A>G COSM584   NRAS:p.Q61L:c.182A>T Missense p.Q61L c.182A>T COSM583   NRAS:p.Q61K:c.181C>A Missense p.Q61K c.181C>A COSM580   NRAS:p.G12V:c.35G>T Missense p.G12V c.35G>T COSM566   NRAS:p.G12D:c.35G>A Missense p.G12D c.35G>A COSM564   NRAS:p.G12S/C:c.34G>A/T Missense p.G12S  p.G12C c.34G>A  c.34G>T COSM563  COSM562   IDH1:p.R132H:c.395G>A Missense p.R132H c.395G>A COSM28746   PIK3CA:p.E542K:c.1624G>A Missense p.E542K c.1624G>A COSM760   PIK3CA:p.E545K:c.1633G>A Missense p.E545K c.1633G>A COSM763   PIK3CA:p.Q546K:c.1636C>A Missense p.Q546K c.1636C>A COSM766   PIK3CA:p.H1047R:c.3140A>G Missense p.H1047R c.3140A>G COSM775   PIK3CA:p.H1047L:c.3140A>T Missense p.H1047L c.3140A>T COSM776   EGFR:p.G719S:c.2155G>A Missense p.G719S c.2155G>A COSM6252   EGFR:p.G719C:c.2155G>T Missense p.G719C c.2155G>T COSM6253   EGFR:p.G719A:c.2156G>C Missense p.G719A c.2156G>C COSM6239   EGFR:p.E746_A750del:c.2235_2249del15 In-frame p.E746_A750delELREA c.2235_2249del15 COSM6223   EGFR:p.E746_A750del:c.2236_2250del15 In-frame p.E746_A750delELREA c.2236_2250del15 COSM6225   EGFR:p.E746_T751>A:c.2237_2251del15 Deletion In-frame p.E746_T751>A c.2237_2251del15 COSM12678   EGFR:p.L747_E749P/del:c.2239_2248>C/G Various p.L747_A750>P  p.L747_E749delLRE c.2239_2248TTAAGAGAAG >C  c.2239_2247 delTTAAGAGAA COSM12 382  COSM6218   EGFR:p.L747_T751del:c.2240_2254del15 In-Frame p.L747_T751delLREAT c.2240_2254del15 COSM12369   EGFR:p.L747_P753>S:c.2240_2257del18 Deletion In-frame p.L747_P753>S c.2240_2257del18 COSM12370   EGFR:p.V769_D770insASV:c.2307_2308ins9 In-frame p.V769_D770insASV c.2307_2308ins GCCAGCGTG COSM12376   EGFR:p.D770_N771insSVD:c.2311_2312ins9 In-frame p.D770_N771insSVD c.2311_2312ins GCGTGGACA COSM13428   EGFR:p.H773_V774insNPH:c.2319_2320ins9 In-frame p.H773_V774insNPH c.2319_2320ins AACCCCCAC COSM12381   EGFR:p.T790M:c.2369C>T Missense p.T790M c.2369C>T COSM6240   EGFR:p.L858R:c.2573T>G Missense p.L858R c.2573T>G COSM6224   EGFR:p.L861Q:c.2582T>A Missense p.L861Q c.2582T>A COSM6213   BRAF:p.V600K:c.1798_1799GT>AA Missense p.V600K c.1798_1799GT>AA COSM473   BRAF:p.V600E:c.1799T>A Missense p.V600E c.1799T>A COSM476   BRAF:p.G469E:c.1406G>A Missense p.G469E c.1406G>A COSM461   BRAF:p.G469A:c.1406G>C Missense p.G469A c.1406G>C COSM460   PTEN:p.R130G:c.388C>G Missense p.R130G c.388C>G COSM5219   PTEN:p.R130*:c.388C>T Nonsense p.R130* c.388C>T COSM5152   PTEN:p.R130Q/fs*4:c.389G>A/delG Various p.R130Q  p.R130fs*4 c.389G>A  c.389delG COSM5033  COSM5817   PTEN:p.R159S:c.477G>T Missense p.R159S c.477G>T COSM5287   PTEN:p.R233*:c.697C>T Nonsense p.R233* c.697C>T COSM5154   PTEN:p.P248fs*5:c.741_742insA Frame-Shift p.P248fs*5 c.741_742insA COSM4986   PTEN:p.K267fs*9:c.800delA Frame-Shift p.K267fs*9 c.800delA COSM5809   KRAS:p.A146P:c.436G>C Missense p.A146P c.436G>C COSM19905   KRAS:p.Q61H:c.183A>T Missense p.Q61H c.183A>T COSM555   KRAS:p.Q61H:c.183A>C Missense p.Q61H c.183A>C COSM554   KRAS:p.Q61K/K:c.180_181TC>TA/AA Missense p.Q61K c.181C>A  c. 180_181TC>AA COSM549  COSM87298   KRAS:p.G13D:c.38G>A Missense p.G13D c.38G>A COSM532   KRAS:p.G12D/V:c.35G>A/T Missense p.G12D  p.G12V c.35G>A  c.35G>T COSM521  COSM520   KRAS:p.G12A:c.35G>C Missense p.G12A c.35G>C COSM522   KRAS:p.G12C/S:c.34G>T/A Missense p.G12C  p.G12S c.34G>T  c.34G>A COSM516  COSM517   IDH2:p.R172K:c.515G>A Missense p.R172K c.515G>A COSM33733   IDH2:p.R140Q:c.419G>A Missense p.R140Q c.419G>A COSM41590   TP53:p.R306*:c.916C>T Nonsense p.R306* c.916C>T COSM10663   TP53:p.R282W:c.844C>T Missense p.R282W c.844C>T COSM10704   TP53:p.R273H/L:c.818G>A/T Missense p.R273H  p.R273L c.818G>A  c.818G>T COSM10660  COSM10779   TP53:p.R273C/S:c.817C>T/A Missense p.R273C  p.R273S c.817C>T  c.817C>A COSM10659  COSM43909   TP53:p.R249S:c.747G>T Missense p.R249S c.747G>T COSM10817   TP53:p.R248Q/L:c.743G>A/T Missense p.R248Q  p.R248L c.743G>A  c.743G>T COSM10662  COSM6549   TP53:p.R248W:c.742C>T Missense p.R248W c.742C>T COSM10656   TP53:p.G245S/C:c.733G>A/T Missense p.G245S  p.G245C c.733G>A  c.733G>T COSM6932  COSM11081   TP53:p.Y220C:c.659A>G Missense p.Y220C c.659A>G COSM10758   TP53:p.R213*:c.637C>T Nonsense p.R213* c.637C>T COSM10654   TP53:p.R196*:c.586C>T Nonsense p.R196* c.586C>T COSM10705   TP53:p.H179R:c.536A>G Missense p.H179R c.536A>G COSM10889   TP53:p.C176F:c.527G>T Missense p.C176F c.527G>T COSM10645   TP53:p.R175H:c.524G>A Missense p.R175H c.524G>A COSM10648   TP53:p.Y163C:c.488A>G Missense p.Y163C c.488A>G COSM10808   TP53:p.V157F:c.469G>T Missense p.V157F c.469G>T COSM10670   "}], "citations": {"NLM": "Englert-Golon M, Burchardt B, Budny B, D\u0119bicki S, Majchrzycka B, Wrotkowska E, Jasi\u0144ski P, Ziemnicka K, S\u0142opie\u0144 R, Rucha\u0142a M, Sajdak S. Genomic markers of ovarian adenocarcinoma and its relevancy to the effectiveness of chemotherapy. Oncol Lett. PMID: 28927094", "BibTeX": "@article{28927094, title={Genomic markers of ovarian adenocarcinoma and its relevancy to the effectiveness of chemotherapy.}, author={Englert-Golon M and Burchardt B and Budny B and D\u0119bicki S and Majchrzycka B and Wrotkowska E and Jasi\u0144ski P and Ziemnicka K and S\u0142opie\u0144 R and Rucha\u0142a M and Sajdak S}, journal={Oncol Lett}}"}, "is_sup_mat_match": false}, {"pmid": 30857358, "pmcid": "PMC6468673", "title": "The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients.", "journal": "Cancers (Basel)", "authors": ["Rachiglio AM", "Fenizia F", "Piccirillo MC", "Galetta D", "Crin\u00f2 L", "Vincenzi B", "Barletta E", "Pinto C", "Ferra\u00f9 F", "Lambiase M", "Montanino A", "Roma C", "Ludovini V", "Montagna ES", "De Luca A", "Rocco G", "Botti G", "Perrone F", "Morabito A", "Normanno N"], "date": "2019-03-10T00:00:00Z", "year": 2019, "snippets": [{"_id": "30857358@31484", "snip_text": "PatientID EGFR KRAS PFS BR   NGS (VAF) ddPCR (VAF) NGS (VAF) ddPCR (VAF)   1512# p.E746_A750del (40%) - p.Gly12Cys (3%) Codon 12/13 mutation (1.93%) 13.19 PR   1616# p.E746_A750del (58.9%) - p.Gly13Asp (11.8%) Codon 12/13 mutation (10%) 12.3 PR   3426# mutation not detected Ex19 del (2.5%) p.Gly12Asp (38%) Codon 12/13 mutation (33%) 4.83 SD   3981# mutation not detected Ex19 del (1.2%) p.Gly12Cys (15%) Codon 12/13 mutation (12%) 2.7 PD   4733# p.E746_A750 > DP (2.6%) - p.Gly12Ala (10.7%) Codon 12/13 mutation (9.3%) 0.43 PD   4840# mutation not detected Ex19 del (0,5%) 1 p.Gly13Cys (10.1%) Codon 12/13 mutation (0.4%) 1 2.14 PD   4990# mutation not detected Ex19 del (0.7%) p.Gly13Cys (28%) Codon 12/13 mutation (24%) 1.18 PD   5074# p.E746_A750del (12.8%);p.L858R (16.9%) - p.Gly12Cys (3.3%) Codon 12/13 mutation (0.13%) 3.26 PD   5374# mutation not detected Ex19 del (1.8%) p.Gly12Cys (13.4%) Codon 12/13 mutation (11%) 4.64 PR   6541# p.E746_A750del (47.2%) - p.Gly13Asp (12.7%) Codon 12/13 mutation (11.3%) 0.06 NE   6545# p.L858R (75%) - p.Ala59Thr (6.2%) Tissue and plasma not available 9.87 SD   6548# p.L858R (55.9%) - p.Gln61His (3.3%) p.Gln61His (0.43%) 6.48 PD   7567# p.L858R (35.4%); p.T790M (0.9%) - p.Gly12Cys (9.2%) Codon 12/13 mutation (8.7%) 12.43 PR   7964# p.E746_A750del (56.4%) - p.Ala146Thr (2%) p.Ala146Thr (0.4%) 51.58 CR   ", "section": "table", "mentions": ["1308|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "1115|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "882|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.Gly12Cys", "10|4|gene|ncbi_gene@1956|EGFR", "969|10|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.Gly13Asp", "680|10|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|p.Gly13Cys", "1203|7|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|p.T790M", "577|10|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|p.Gly13Cys", "15|4|gene|ncbi_gene@3845|KRAS", "191|10|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.Gly13Asp", "763|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "1283|14|variant|litvar@#3845#p.A746,750del&&&litvar@#3845#|p.E746_A750del", "1133|10|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Gln61His", "104|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.Gly12Cys", "1325|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "474|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.Gly12Ala", "389|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.Gly12Cys", "740|14|variant|litvar@#3845#p.A746,750del&&&litvar@#3845#|p.E746_A750del", "1151|10|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Gln61His", "781|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.Gly12Cys", "81|14|variant|litvar@#3845#p.A746,750del&&&litvar@#3845#|p.E746_A750del", "166|14|variant|litvar@#3845#p.A746,750del&&&litvar@#3845#|p.E746_A750del", "1220|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.Gly12Cys", "291|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.Gly12Asp", "1186|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "1033|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "1049|10|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|p.Ala59Thr", "944|14|variant|litvar@#3845#p.A746,750del&&&litvar@#3845#|p.E746_A750del"], "figure_id": "cancers-11-00341-t002", "text_hl": "PatientID EGFR KRAS PFS BR   NGS (VAF) ddPCR (VAF) NGS (VAF) ddPCR (VAF)   1512# p.E746_A750del (40%) - p.Gly12Cys (3%) Codon 12/13 mutation (1.93%) 13.19 PR   1616# p.E746_A750del (58.9%) - p.Gly13Asp (11.8%) Codon 12/13 mutation (10%) 12.3 PR   3426# mutation not detected Ex19 del (2.5%) p.Gly12Asp (38%) Codon 12/13 mutation (33%) 4.83 SD   3981# mutation not detected Ex19 del (1.2%) p.Gly12Cys (15%) Codon 12/13 mutation (12%) 2.7 PD   4733# p.E746_A750 > DP (2.6%) - p.Gly12Ala (10.7%) Codon 12/13 mutation (9.3%) 0.43 PD   4840# mutation not detected Ex19 del (0,5%) 1 p.Gly13Cys (10.1%) Codon 12/13 mutation (0.4%) 1 2.14 PD   4990# mutation not detected Ex19 del (0.7%) p.Gly13Cys (28%) Codon 12/13 mutation (24%) 1.18 PD   5074# p.E746_A750del (12.8%);p.L858R (16.9%) - p.Gly12Cys (3.3%) Codon 12/13 mutation (0.13%) 3.26 PD   5374# mutation not detected Ex19 del (1.8%) p.Gly12Cys (13.4%) Codon 12/13 mutation (11%) 4.64 PR   6541# p.E746_A750del (47.2%) - p.Gly13Asp (12.7%) Codon 12/13 mutation (11.3%) 0.06 NE   6545# p.L858R (75%) - p.Ala59Thr (6.2%) Tissue and plasma not available 9.87 SD   6548# p.L858R (55.9%) - p.Gln61His (3.3%) p.Gln61His (0.43%) 6.48 PD   7567# p.L858R (35.4%); p.T790M (0.9%) - p.Gly12Cys (9.2%) Codon 12/13 mutation (8.7%) 12.43 PR   7964# p.E746_A750del (56.4%) - <m>p.Ala146Thr</m> (2%) <m>p.Ala146Thr</m> (0.4%) 51.58 CR   "}], "citations": {"NLM": "Rachiglio AM, Fenizia F, Piccirillo MC, Galetta D, Crin\u00f2 L, Vincenzi B, Barletta E, Pinto C, Ferra\u00f9 F, Lambiase M, Montanino A, Roma C, Ludovini V, Montagna ES, De Luca A, Rocco G, Botti G, Perrone F, Morabito A, Normanno N. The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients. Cancers (Basel). PMID: 30857358", "BibTeX": "@article{30857358, title={The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients.}, author={Rachiglio AM and Fenizia F and Piccirillo MC and Galetta D and Crin\u00f2 L and Vincenzi B and Barletta E and Pinto C and Ferra\u00f9 F and Lambiase M and Montanino A and Roma C and Ludovini V and Montagna ES and De Luca A and Rocco G and Botti G and Perrone F and Morabito A and Normanno N}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 32118627, "pmcid": "PMC7225029", "title": "Genetic basis of extramedullary plasmablastic transformation of multiple myeloma", "journal": "Am J Surg Pathol", "authors": ["Liu Y", "Jelloul F", "Zhang Y", "Bhavsar T", "Ho C", "Rao M", "Lewis NE", "Cimera R", "Baik J", "Sigler A", "Sen F", "Yabe M", "Roshal M", "Landgren O", "Dogan A", "Xiao W"], "date": "2020-06-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "32118627@37667", "snip_text": "\tCase 1\tCase 2\tCase 3\tCase 5\tCase 6\tCase 10\t \tBM\tTissue\tBM\tTissue\tTissue\tBM\tTissue\tTissue\tTissue\t \tTP53\tNone\tNone\tNone\tNone\tNone\tNone\tDetected\tDetected\tNone\t \tRAS-MAPK\tKRAS p.G13R\tKRAS p.G13R\tBRAF p.V600E\tBRAF p.V600E\tKRAS p.G12A, AURKA p.F346L\tNF1 p.H1826N\tERF p.M76I\tKRAS p.Q61L, SGK1 p.N460S\tKRAS p.A146P\t \tEpigenetic/ transcriptional regulator\tARID1A p.Q288Rfs*75\tARID1A p.Q288Rfs*75\tKMT2C p.L3046P, HIST1H1E p.L45P\tKMT2C p.L3046P, HIST1H1E p.L45P\tFAT1 p.E890K, CREBBP p.I1730V, RXRA p.S224N, TFC3 p.A565T, NKX2-1 p.A146T, TET3 p.E653K, KMT2D p.R4282*, KMT2C p.Q3061E, KDM5C p.E23*, HDAC4 p.P522L, HIST1H3A p.E134Q, HIST1H2AM p.E122K\tTET2 p.P480S, DNMT3A p.A3S, HIST1H2AL p.A15G, ARID4A p.E872*, NCOR2 p.S1970Y\tTET2 p.P480S, DNMT3A p.A3S, HIST1H2AL p.A15G, LATS1 p.E817K, YAP1 p.S163C, FAT1 p.M240I, BCORL1 p.S1970Y\tNone\tTET2 p.L615fs*24, T1592fs*4, FLT3 p.Y572C\t \tPI3K\tNone\tNone\tNone\tNone\tPIK3R2 p.S191*, MST1R p.D493Y\tPIK3R2 p.V284M\tPIK3R2 p.V284M\tNone\tNone\t \tNF-kB\tNone\tNone\tNone\tNone\tTRAF5 p.E419Rfs*29\tCYLD p.D678Rfs*3\tNone\tNone\tNone\t \tCell cycle\tNone\tNone\tNone\tNone\tCDKN2C p.A77E, ATM p.E1669K, BARD1 p.E649_E655del, BAP1 p.S596T, RECQL4 p.E1046K\tNone\tNone\tNone\tNone\t \tOthers\tNone\tNone\tNone\tNone\tEIF1AX p.E99K, DIS3 p.I779F, IL7R p.L69V, P2RY8 p.P290R, CRBN p.X5_splice\tSAMHD1 p.G176E\tSAMHD1 p.G176E, MGA p.E1245Q\tSH2B3 p.P363S\tNone\t \t", "section": "table", "mentions": ["1213|6|variant|litvar@rs374278232##&&&litvar@#10019#&&&litvar@CA6789772#rs374278232##|p.E99K", "691|7|variant|litvar@#4609#p.E872*&&&litvar@#4609#|p.E872*", "457|7|variant|litvar@#4609#p.E890K&&&litvar@#4609#|p.E890K", "924|6|gene|ncbi_gene@5296|PIK3R2", "99|4|gene|ncbi_gene@7157|TP53", "185|6|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|p.G13R", "1118|7|variant|litvar@#4609#p.E655del&&&litvar@#4609#|E655del", "269|4|gene|ncbi_gene@3845|KRAS", "1330|7|variant|litvar@rs1338558798##&&&litvar@#54790#|p.P363S", "1132|7|variant|litvar@#4609#p.S596T&&&litvar@#4609#|p.S596T", "1076|6|gene|ncbi_gene@1031|CDKN2C", "715|4|gene|ncbi_gene@54790|TET2", "1302|7|variant|litvar@#4609#p.G176E&&&litvar@#4609#|p.G176E", "205|4|gene|ncbi_gene@673|BRAF", "355|12|variant|litvar@#4609#p.Q288RfsX75&&&litvar@#4609#|p.Q288Rfs*75", "998|12|variant|litvar@rs756183569##&&&litvar@#7188#|p.E419Rfs*29", "720|7|variant|litvar@rs868978693##&&&litvar@#8242#|p.P480S", "1148|8|variant|litvar@rs747512737##&&&litvar@#4486#|p.E1046K", "1221|4|gene|ncbi_gene@22894|DIS3", "931|7|variant|litvar@rs1212577459##&&&litvar@#5296#|p.V284M", "547|8|variant|litvar@#4609#p.R4282*&&&litvar@#4609#|p.R4282*", "557|5|gene|ncbi_gene@58508|KMT2C", "790|4|gene|ncbi_gene@2195|FAT1", "518|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "173|6|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|p.G13R", "375|12|variant|litvar@#4609#p.Q288RfsX75&&&litvar@#4609#|p.Q288Rfs*75", "643|7|variant|litvar@rs868978693##&&&litvar@#8242#|p.P480S", "854|4|gene|ncbi_gene@2322|FLT3", "348|6|gene|ncbi_gene@8289|ARID1A", "1095|8|variant|litvar@rs757608351##&&&litvar@#63035#&&&litvar@CA10514855#rs757608351##|p.E1669K", "420|5|gene|ncbi_gene@58508|KMT2C", "776|4|gene|ncbi_gene@10413|YAP1", "767|7|variant|litvar@rs568745490##&&&litvar@#2322#&&&litvar@CA6928268#rs568745490##|p.E817K", "729|6|gene|ncbi_gene@1788|DNMT3A", "1324|5|gene|ncbi_gene@10019|SH2B3", "1083|6|variant|litvar@#4609#p.A77E&&&litvar@#4609#|p.A77E", "1315|8|variant|litvar@#4609#p.E1245Q&&&litvar@#4609#|p.E1245Q", "593|7|variant|litvar@rs748952048##&&&litvar@#5926#|p.P522L", "859|7|variant|litvar@rs121913491##&&&litvar@#2322#&&&litvar@CA6928567#rs121913491##|p.Y572C", "388|5|gene|ncbi_gene@58508|KMT2C", "781|7|variant|litvar@#4609#p.S163C&&&litvar@#4609#|p.S163C", "901|7|variant|litvar@#4609#p.S191*&&&litvar@#4609#|p.S191*", "502|7|variant|litvar@rs779491090##&&&litvar@#25939#&&&litvar@CA9844439#rs779491090##|p.A565T", "630|7|variant|litvar@rs778934233##&&&litvar@#8332#&&&litvar@CA3679840#rs778934233##|p.E122K", "413|6|variant|litvar@rs773910439##&&&litvar@#5926#|p.L45P", "761|5|gene|ncbi_gene@9113|LATS1", "218|4|gene|ncbi_gene@3845|KRAS", "684|6|gene|ncbi_gene@5926|ARID4A", "804|6|gene|ncbi_gene@63035|BCORL1", "1240|6|variant|litvar@#4609#p.L69V&&&litvar@#4609#|p.L69V", "706|8|variant|litvar@#4609#p.S1970Y&&&litvar@#4609#|p.S1970Y", "368|6|gene|ncbi_gene@8289|ARID1A", "168|4|gene|ncbi_gene@3845|KRAS", "258|3|gene|ncbi_gene@2077|ERF", "916|7|variant|litvar@#4609#p.D493Y&&&litvar@#4609#|p.D493Y", "1295|6|gene|ncbi_gene@25939|SAMHD1", "426|8|variant|litvar@#4609#p.L3046P&&&litvar@#4609#|p.L3046P", "676|6|variant|litvar@rs775263760##&&&litvar@#22894#&&&litvar@CA7001797#rs775263760##|p.A15G", "245|3|gene|ncbi_gene@4763|NF1", "436|8|gene|ncbi_gene@3008|HIST1H1E", "237|7|variant|litvar@#4609#p.F346L&&&litvar@#4609#|p.F346L", "825|4|gene|ncbi_gene@54790|TET2", "473|8|variant|litvar@#4609#p.I1730V&&&litvar@#4609#|p.I1730V", "210|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "404|8|gene|ncbi_gene@3008|HIST1H1E", "992|5|gene|ncbi_gene@7188|TRAF5", "197|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "231|5|gene|ncbi_gene@6790|AURKA", "192|4|gene|ncbi_gene@673|BRAF", "223|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "939|6|gene|ncbi_gene@5296|PIK3R2", "249|8|variant|litvar@#4609#p.H1826N&&&litvar@#4609#|p.H1826N", "1311|3|gene|ncbi_gene@23269|MGA", "532|7|variant|litvar@rs1367367961##&&&litvar@#2322#|p.E653K", "910|5|gene|ncbi_gene@4486|MST1R", "638|4|gene|ncbi_gene@54790|TET2", "262|6|variant|litvar@#4609#p.M76I&&&litvar@#4609#|p.M76I", "1016|11|variant|litvar@#4609#p.D678RfsX3&&&litvar@#4609#|p.D678Rfs*3", "736|5|variant|litvar@#4609#p.A3S&&&litvar@#4609#|p.A3S", "946|7|variant|litvar@rs1212577459##&&&litvar@#5296#|p.V284M", "274|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "611|7|variant|litvar@#4609#p.E134Q&&&litvar@#4609#|p.E134Q", "843|9|variant|litvar@#4609#p.T1592fsX4&&&litvar@#4609#|T1592fs*4", "700|5|gene|ncbi_gene@9612|NCOR2", "1254|7|variant|litvar@rs55819519##&&&litvar@#7157#|p.P290R", "894|6|gene|ncbi_gene@5296|PIK3R2", "1226|7|variant|litvar@rs138452282##&&&litvar@#23269#|p.I779F", "1280|6|gene|ncbi_gene@25939|SAMHD1", "659|5|variant|litvar@#4609#p.A3S&&&litvar@#4609#|p.A3S", "811|8|variant|litvar@#4609#p.S1970Y&&&litvar@#4609#|p.S1970Y", "795|7|variant|litvar@rs769737415##&&&litvar@#10413#|p.M240I", "1287|7|variant|litvar@#4609#p.G176E&&&litvar@#4609#|p.G176E", "180|4|gene|ncbi_gene@3845|KRAS", "445|6|variant|litvar@rs773910439##&&&litvar@#5926#|p.L45P", "743|9|gene|ncbi_gene@8332|HIST1H2AL", "295|4|gene|ncbi_gene@3845|KRAS", "1011|4|gene|ncbi_gene@1540|CYLD", "488|7|variant|litvar@rs1397229874##&&&litvar@#4763#|p.S224N", "753|6|variant|litvar@rs775263760##&&&litvar@#22894#&&&litvar@CA7001797#rs775263760##|p.A15G", "282|4|gene|ncbi_gene@6446|SGK1", "563|8|variant|litvar@#4609#p.Q3061E&&&litvar@#4609#|p.Q3061E", "579|6|variant|litvar@#4609#p.23dup&&&litvar@#4609#|p.E23*", "652|6|gene|ncbi_gene@1788|DNMT3A", "394|8|variant|litvar@#4609#p.L3046P&&&litvar@#4609#|p.L3046P", "666|9|gene|ncbi_gene@8332|HIST1H2AL", "573|5|gene|ncbi_gene@8242|KDM5C", "452|4|gene|ncbi_gene@2195|FAT1", "869|4|gene|ncbi_gene@5293|PI3K", "300|7|variant|litvar@rs121913527##&&&litvar@#3845#|p.A146P", "830|11|variant|litvar@#4609#p.L615fsX24&&&litvar@#4609#|p.L615fs*24", "287|7|variant|litvar@rs1171390403##&&&litvar@#6446#|p.N460S"], "figure_id": "T4", "text_hl": "\tCase 1\tCase 2\tCase 3\tCase 5\tCase 6\tCase 10\t \tBM\tTissue\tBM\tTissue\tTissue\tBM\tTissue\tTissue\tTissue\t \tTP53\tNone\tNone\tNone\tNone\tNone\tNone\tDetected\tDetected\tNone\t \tRAS-MAPK\tKRAS p.G13R\tKRAS p.G13R\tBRAF p.V600E\tBRAF p.V600E\tKRAS p.G12A, AURKA p.F346L\tNF1 p.H1826N\tERF p.M76I\tKRAS p.Q61L, SGK1 p.N460S\tKRAS p.A146P\t \tEpigenetic/ transcriptional regulator\tARID1A p.Q288Rfs*75\tARID1A p.Q288Rfs*75\tKMT2C p.L3046P, HIST1H1E p.L45P\tKMT2C p.L3046P, HIST1H1E p.L45P\tFAT1 p.E890K, CREBBP p.I1730V, RXRA p.S224N, TFC3 p.A565T, NKX2-1 <m>p.A146T</m>, TET3 p.E653K, KMT2D p.R4282*, KMT2C p.Q3061E, KDM5C p.E23*, HDAC4 p.P522L, HIST1H3A p.E134Q, HIST1H2AM p.E122K\tTET2 p.P480S, DNMT3A p.A3S, HIST1H2AL p.A15G, ARID4A p.E872*, NCOR2 p.S1970Y\tTET2 p.P480S, DNMT3A p.A3S, HIST1H2AL p.A15G, LATS1 p.E817K, YAP1 p.S163C, FAT1 p.M240I, BCORL1 p.S1970Y\tNone\tTET2 p.L615fs*24, T1592fs*4, FLT3 p.Y572C\t \tPI3K\tNone\tNone\tNone\tNone\tPIK3R2 p.S191*, MST1R p.D493Y\tPIK3R2 p.V284M\tPIK3R2 p.V284M\tNone\tNone\t \tNF-kB\tNone\tNone\tNone\tNone\tTRAF5 p.E419Rfs*29\tCYLD p.D678Rfs*3\tNone\tNone\tNone\t \tCell cycle\tNone\tNone\tNone\tNone\tCDKN2C p.A77E, ATM p.E1669K, BARD1 p.E649_E655del, BAP1 p.S596T, RECQL4 p.E1046K\tNone\tNone\tNone\tNone\t \tOthers\tNone\tNone\tNone\tNone\tEIF1AX p.E99K, DIS3 p.I779F, IL7R p.L69V, P2RY8 p.P290R, CRBN p.X5_splice\tSAMHD1 p.G176E\tSAMHD1 p.G176E, MGA p.E1245Q\tSH2B3 p.P363S\tNone\t \t"}], "citations": {"NLM": "Liu Y, Jelloul F, Zhang Y, Bhavsar T, Ho C, Rao M, Lewis NE, Cimera R, Baik J, Sigler A, Sen F, Yabe M, Roshal M, Landgren O, Dogan A, Xiao W. Genetic basis of extramedullary plasmablastic transformation of multiple myeloma Am J Surg Pathol. PMID: 32118627", "BibTeX": "@article{32118627, title={Genetic basis of extramedullary plasmablastic transformation of multiple myeloma}, author={Liu Y and Jelloul F and Zhang Y and Bhavsar T and Ho C and Rao M and Lewis NE and Cimera R and Baik J and Sigler A and Sen F and Yabe M and Roshal M and Landgren O and Dogan A and Xiao W}, journal={Am J Surg Pathol}}"}, "is_sup_mat_match": false}, {"pmid": 36193123, "pmcid": "PMC9525778", "title": "The Number of Intraoperative Intestinal Venous Circulating Tumor Cells Is a Prognostic Factor for Colorectal Cancer Patients.", "journal": "Evid Based Complement Alternat Med", "authors": ["Liu Z", "Gu Y", "Yu F", "Zhou L", "Cheng X", "Jiang H", "Huang Y", "Zhang Y", "Xu T", "Qian W", "Li X"], "date": "2022-09-23T00:00:00Z", "year": 2022, "snippets": [{"_id": "36193123@39459", "snip_text": "Gene Exon Codon Mutation Numbers of mutations (% of 162)   KRAS 2 12, 13 G12S, G12D, G12C, G12R, G12V, G12A, G13C, G13D 66 (40.74%)   3 61 Q61L, Q61R, Q61H 3 (1.86%)   4 117, 146 K117N, A146T, A146V, A146P 5 (3.09%)   ", "section": "table", "mentions": ["97|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "145|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "193|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "186|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "115|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "79|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "200|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "139|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "179|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "91|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "109|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "103|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "151|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "73|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "59|4|gene|ncbi_gene@3845|KRAS", "85|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C"], "figure_id": "tab3", "text_hl": "Gene Exon Codon Mutation Numbers of mutations (% of 162)   KRAS 2 12, 13 G12S, G12D, G12C, G12R, G12V, G12A, G13C, G13D 66 (40.74%)   3 61 Q61L, Q61R, Q61H 3 (1.86%)   4 117, 146 K117N, <m>A146T</m>, A146V, A146P 5 (3.09%)   "}], "citations": {"NLM": "Liu Z, Gu Y, Yu F, Zhou L, Cheng X, Jiang H, Huang Y, Zhang Y, Xu T, Qian W, Li X. The Number of Intraoperative Intestinal Venous Circulating Tumor Cells Is a Prognostic Factor for Colorectal Cancer Patients. Evid Based Complement Alternat Med. PMID: 36193123", "BibTeX": "@article{36193123, title={The Number of Intraoperative Intestinal Venous Circulating Tumor Cells Is a Prognostic Factor for Colorectal Cancer Patients.}, author={Liu Z and Gu Y and Yu F and Zhou L and Cheng X and Jiang H and Huang Y and Zhang Y and Xu T and Qian W and Li X}, journal={Evid Based Complement Alternat Med}}"}, "is_sup_mat_match": false}, {"pmid": 32727882, "pmcid": "PMC7484242", "title": "Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas", "journal": "Mol Cancer Ther", "authors": ["Gilardi M", "Wang Z", "Proietto M", "Chill\u00e0 A", "Calleja-Valera JL", "Goto Y", "Vanoni M", "Janes MR", "Mikulski Z", "Gualberto A", "Molinolo AA", "Ferrara N", "Gutkind JS", "Burrows F"], "date": "2020-09-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "32727882@16561", "snip_text": "In addition, because widespread differences exist within individual residues and hotspot gene mutations of amino acids and tumor types, the expansion of the study to include PDX models increased the range of hotspot mutations to include A146T (HN1420 model), G12S (HN2579), G13R (HN2581) and K117N (HN3504) (Fig. 1D).", "section": "results", "mentions": ["274|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "292|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "123|5|disease|ncbi_mesh@D009369|tumor", "259|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "237|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "In addition, because widespread differences exist within individual residues and hotspot gene mutations of amino acids and tumor types, the expansion of the study to include PDX models increased the range of hotspot mutations to include <m>A146T</m> (HN1420 model), G12S (HN2579), G13R (HN2581) and K117N (HN3504) (Fig. 1D)."}], "citations": {"NLM": "Gilardi M, Wang Z, Proietto M, Chill\u00e0 A, Calleja-Valera JL, Goto Y, Vanoni M, Janes MR, Mikulski Z, Gualberto A, Molinolo AA, Ferrara N, Gutkind JS, Burrows F. Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas Mol Cancer Ther. PMID: 32727882", "BibTeX": "@article{32727882, title={Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas}, author={Gilardi M and Wang Z and Proietto M and Chill\u00e0 A and Calleja-Valera JL and Goto Y and Vanoni M and Janes MR and Mikulski Z and Gualberto A and Molinolo AA and Ferrara N and Gutkind JS and Burrows F}, journal={Mol Cancer Ther}}"}, "is_sup_mat_match": false}, {"pmid": 36044716, "pmcid": "PMC9489170", "title": "Durable Response to Nivolumab in a Patient With Hepatic Sarcomatoid Carcinoma: Evolutive Characterization of Genomic and Immunohistochemical PD-L1 Expression Findings.", "journal": "JCO Precis Oncol", "authors": ["Queiroz MM", "Munhoz RR", "Masotti C", "Souza LM", "Lima LGCA", "Asprino PF", "Begnami MDFS", "Camargo AA", "Bettoni F"], "date": "2022-08-01T00:00:00Z", "year": 2022, "snippets": [{"_id": "36044716@5586", "snip_text": "Next-generation sequencing revealed CD274 (PD-L1) and PDCD1LG2 (PD-L2) amplifications, CDKN2A/B loss, deletion of exons 2-7 of the CTNNB1 gene, and KRAS A146T, PIK3CA E542K, and FANCC A349fs*25 somatic mutations.", "section": "other", "mentions": ["43|5|gene|ncbi_gene@29126|PD-L1", "36|5|gene|ncbi_gene@29126|CD274", "54|8|gene|ncbi_gene@80380|PDCD1LG2", "167|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "153|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "131|6|gene|ncbi_gene@1499|CTNNB1", "184|6|variant|litvar@#2176#p.A349fsX&&&litvar@#2176#|A349fs", "64|5|gene|ncbi_gene@80380|PD-L2", "160|6|gene|ncbi_gene@5290|PIK3CA", "178|5|gene|ncbi_gene@2176|FANCC", "148|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "Next-generation sequencing revealed CD274 (PD-L1) and PDCD1LG2 (PD-L2) amplifications, CDKN2A/B loss, deletion of exons 2-7 of the CTNNB1 gene, and KRAS <m>A146T</m>, PIK3CA E542K, and FANCC A349fs*25 somatic mutations."}], "citations": {"NLM": "Queiroz MM, Munhoz RR, Masotti C, Souza LM, Lima LGCA, Asprino PF, Begnami MDFS, Camargo AA, Bettoni F. Durable Response to Nivolumab in a Patient With Hepatic Sarcomatoid Carcinoma: Evolutive Characterization of Genomic and Immunohistochemical PD-L1 Expression Findings. JCO Precis Oncol. PMID: 36044716", "BibTeX": "@article{36044716, title={Durable Response to Nivolumab in a Patient With Hepatic Sarcomatoid Carcinoma: Evolutive Characterization of Genomic and Immunohistochemical PD-L1 Expression Findings.}, author={Queiroz MM and Munhoz RR and Masotti C and Souza LM and Lima LGCA and Asprino PF and Begnami MDFS and Camargo AA and Bettoni F}, journal={JCO Precis Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 32428838, "pmcid": "PMC7232108", "title": "Tumor Location Is Associated With the Prevalence of Braf And Pik3ca Mutations in Patients with Wild-Type Ras Colorectal Cancer: A Prospective Multi-Center Cohort Study in Japan.", "journal": "Transl Oncol", "authors": ["Taniguchi H", "Uehara K", "Nakayama G", "Nakayama H", "Aiba T", "Hattori N", "Kataoka M", "Nakano Y", "Kawase Y", "Okochi O", "Matsuoka H", "Utsunomiya S", "Sakamoto E", "Mori Y", "Umeda S", "Shikano T", "Komori K", "Tajika M", "Kadowaki S", "Muro K", "Yatabe Y"], "date": "2020-07-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "32428838@8661", "snip_text": "We also used Genosearch  Mu-Pack , which detects mutations in KRAS codons 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H) and 146 (A146T, A146S, A146P, A146E, A146V, and A146G); NRAS codons 12 (G12A, G12D, G12C, G12S, G12R, and G12V), 13 (G13A, G13D, G13C, G13S, G13R, and G13V), and 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H); PIK3CA codons 542 (E542K), 545 (E545K), 546 (E546K), and 1047 (H1047R and H1047L); and BRAF V600 (V600E, V600K, V600D, and V600R).", "section": "methods", "mentions": ["127|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "208|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "448|5|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16021333#rs121913227##|V600R", "112|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "370|5|variant|litvar@#5290#p.E546K&&&litvar@#5290#|E546K", "259|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "155|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "62|4|gene|ncbi_gene@3845|KRAS", "190|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "241|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "296|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "269|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "357|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "214|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "344|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "196|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "90|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "302|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "423|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "134|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146S", "224|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "166|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146G", "247|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13C", "417|4|variant|litvar@rs121913227##&&&litvar@#673#|V600", "96|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "437|5|variant|litvar@rs121913377##&&&litvar@#673#&&&litvar@CA16602419#rs121913377##|V600D", "148|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146E", "284|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "388|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "412|4|gene|ncbi_gene@673|BRAF", "174|4|gene|ncbi_gene@4893|NRAS", "84|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "202|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "308|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "78|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "325|6|gene|ncbi_gene@5290|PIK3CA", "290|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "235|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602364#rs121434596##|G13A", "253|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA16602674#rs121434595##|G13S", "318|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "102|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "430|5|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16602420#rs121913227##|V600K", "141|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "399|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|H1047L"], "text_hl": "We also used Genosearch  Mu-Pack , which detects mutations in KRAS codons 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H) and 146 (<m>A146T</m>, A146S, A146P, A146E, A146V, and A146G); NRAS codons 12 (G12A, G12D, G12C, G12S, G12R, and G12V), 13 (G13A, G13D, G13C, G13S, G13R, and G13V), and 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H); PIK3CA codons 542 (E542K), 545 (E545K), 546 (E546K), and 1047 (H1047R and H1047L); and BRAF V600 (V600E, V600K, V600D, and V600R)."}], "citations": {"NLM": "Taniguchi H, Uehara K, Nakayama G, Nakayama H, Aiba T, Hattori N, Kataoka M, Nakano Y, Kawase Y, Okochi O, Matsuoka H, Utsunomiya S, Sakamoto E, Mori Y, Umeda S, Shikano T, Komori K, Tajika M, Kadowaki S, Muro K, Yatabe Y. Tumor Location Is Associated With the Prevalence of Braf And Pik3ca Mutations in Patients with Wild-Type Ras Colorectal Cancer: A Prospective Multi-Center Cohort Study in Japan. Transl Oncol. PMID: 32428838", "BibTeX": "@article{32428838, title={Tumor Location Is Associated With the Prevalence of Braf And Pik3ca Mutations in Patients with Wild-Type Ras Colorectal Cancer: A Prospective Multi-Center Cohort Study in Japan.}, author={Taniguchi H and Uehara K and Nakayama G and Nakayama H and Aiba T and Hattori N and Kataoka M and Nakano Y and Kawase Y and Okochi O and Matsuoka H and Utsunomiya S and Sakamoto E and Mori Y and Umeda S and Shikano T and Komori K and Tajika M and Kadowaki S and Muro K and Yatabe Y}, journal={Transl Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 35256486, "pmcid": "PMC7614788", "title": "FOCUS4 biomarker laboratories: from the benefits to the practical and logistical issues faced during 6 years of centralised testing", "journal": "J Clin Pathol", "authors": ["Richman SD", "Hemmings G", "Roberts H", "Gallop N", "Dodds R", "Wilkinson L", "Davis J", "White R", "Yates E", "Jasani B", "Brown L", "Maughan TS", "Butler R", "Quirke P", "Adams R"], "date": "2022-03-07T00:00:00Z", "year": 2022, "snippets": [{"_id": "35256486@17232", "snip_text": "Sample ID\tLeeds pyrosequencing (VAF)\tCardiff pyrosequencing (VAF)\tCardiff NGS (VAF)\t \tSample 4\tBRAF c.1799T>A (52%)\tBRAF c.1799T>A (50%)\tBRAF c.1799T>A (50%)TP53 c.844C>T (68%)\t \tSample 5\tKRAS c.35G>A (42%)PIK3CA c.1633G>A (51%)\tKRAS c.35G>A (55%)PIK3CA c.1633G>A (41%)\tKRAS c.35G>A (36%)PIK3CA c.1633G>A (50%)\t \tSample 6\tKRAS c.436G>A (72%)\tKRAS c.436G>A (100%)\tKRAS c.436G>A (72%)TP53 c.832C>T (66%)\t \t", "section": "table", "mentions": ["363|4|gene|ncbi_gene@3845|KRAS", "234|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "247|6|gene|ncbi_gene@5290|PIK3CA", "100|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "254|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G>A", "157|4|gene|ncbi_gene@7157|TP53", "95|4|gene|ncbi_gene@673|BRAF", "295|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G>A", "206|6|gene|ncbi_gene@5290|PIK3CA", "288|6|gene|ncbi_gene@5290|PIK3CA", "322|4|gene|ncbi_gene@3845|KRAS", "382|4|gene|ncbi_gene@7157|TP53", "121|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "347|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "116|4|gene|ncbi_gene@673|BRAF", "270|4|gene|ncbi_gene@3845|KRAS", "213|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G>A", "327|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "142|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "368|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "137|4|gene|ncbi_gene@673|BRAF", "188|4|gene|ncbi_gene@3845|KRAS", "193|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "275|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "162|8|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|c.844C>T", "229|4|gene|ncbi_gene@3845|KRAS", "387|8|variant|litvar@rs17849781##&&&litvar@#7157#|c.832C>T", "342|4|gene|ncbi_gene@3845|KRAS"], "figure_id": "T3", "text_hl": "Sample ID\tLeeds pyrosequencing (VAF)\tCardiff pyrosequencing (VAF)\tCardiff NGS (VAF)\t \tSample 4\tBRAF c.1799T>A (52%)\tBRAF c.1799T>A (50%)\tBRAF c.1799T>A (50%)TP53 c.844C>T (68%)\t \tSample 5\tKRAS c.35G>A (42%)PIK3CA c.1633G>A (51%)\tKRAS c.35G>A (55%)PIK3CA c.1633G>A (41%)\tKRAS c.35G>A (36%)PIK3CA c.1633G>A (50%)\t \tSample 6\tKRAS c.436G>A (72%)\tKRAS c.436G>A (100%)\tKRAS c.436G>A (72%)TP53 c.832C>T (66%)\t \t"}], "citations": {"NLM": "Richman SD, Hemmings G, Roberts H, Gallop N, Dodds R, Wilkinson L, Davis J, White R, Yates E, Jasani B, Brown L, Maughan TS, Butler R, Quirke P, Adams R. FOCUS4 biomarker laboratories: from the benefits to the practical and logistical issues faced during 6 years of centralised testing J Clin Pathol. PMID: 35256486", "BibTeX": "@article{35256486, title={FOCUS4 biomarker laboratories: from the benefits to the practical and logistical issues faced during 6 years of centralised testing}, author={Richman SD and Hemmings G and Roberts H and Gallop N and Dodds R and Wilkinson L and Davis J and White R and Yates E and Jasani B and Brown L and Maughan TS and Butler R and Quirke P and Adams R}, journal={J Clin Pathol}}"}, "is_sup_mat_match": false}, {"pmid": 37989729, "pmcid": "PMC10663560", "title": "Targetable lesions and proteomes predict therapy sensitivity through disease evolution in pediatric acute lymphoblastic leukemia", "journal": "Nat Commun", "authors": ["Lorentzian AC", "Rever J", "Ergin EK", "Guo M", "Akella NM", "Rolf N", "James Lim C", "Reid GSD", "Maxwell CA", "Lange PF"], "date": "2023-11-21T00:00:00Z", "year": 2023, "snippets": [{"_id": "37989729@6776", "snip_text": "At time of relapse of pediatric ALL, clonal evolution is frequently convergent, and includes the outgrowth of clones defined by a different mutational site within the same affected gene; for example, a relapse clone with KRAS.A146T replaces the diagnostic KRAS.G12D clone.", "section": "results", "mentions": ["261|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "226|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "At time of relapse of pediatric ALL, clonal evolution is frequently convergent, and includes the outgrowth of clones defined by a different mutational site within the same affected gene; for example, a relapse clone with KRAS.A146T replaces the diagnostic KRAS.G12D clone."}], "citations": {"NLM": "Lorentzian AC, Rever J, Ergin EK, Guo M, Akella NM, Rolf N, James Lim C, Reid GSD, Maxwell CA, Lange PF. Targetable lesions and proteomes predict therapy sensitivity through disease evolution in pediatric acute lymphoblastic leukemia Nat Commun. PMID: 37989729", "BibTeX": "@article{37989729, title={Targetable lesions and proteomes predict therapy sensitivity through disease evolution in pediatric acute lymphoblastic leukemia}, author={Lorentzian AC and Rever J and Ergin EK and Guo M and Akella NM and Rolf N and James Lim C and Reid GSD and Maxwell CA and Lange PF}, journal={Nat Commun}}"}, "is_sup_mat_match": false}, {"pmid": 21763698, "pmcid": "PMC4177034", "title": "Structural and Functional Impact of Cancer Related Missense Somatic Mutations", "journal": "J Mol Biol", "authors": ["Shi Z", "Moult J"], "date": "2011-10-21T00:00:00Z", "year": 2011, "snippets": [{"_id": "21763698@20479", "snip_text": "A146T, K117N and G13D in KRAS all appear to weaken GTP/GDP binding, and are also destabilizing to different degrees.", "section": "results", "mentions": ["51|3|chemical|ncbi_mesh@D006160|GTP", "25|4|gene|ncbi_gene@3845|KRAS", "55|3|chemical|ncbi_mesh@D006153|GDP", "7|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "0|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "17|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D"], "text_hl": "<m>A146T</m>, K117N and G13D in KRAS all appear to weaken GTP/GDP binding, and are also destabilizing to different degrees."}], "citations": {"NLM": "Shi Z, Moult J. Structural and Functional Impact of Cancer Related Missense Somatic Mutations J Mol Biol. PMID: 21763698", "BibTeX": "@article{21763698, title={Structural and Functional Impact of Cancer Related Missense Somatic Mutations}, author={Shi Z and Moult J}, journal={J Mol Biol}}"}, "is_sup_mat_match": false}, {"pmid": 30705875, "pmcid": "PMC6344461", "title": "Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic.", "journal": "Front Oncol", "authors": ["Ghatalia P", "Smith CH", "Winer A", "Gou J", "Kiedrowski LA", "Slifker M", "Saltzberg PD", "Bubes N", "Anari FM", "Kasireddy V", "Varshavsky A", "Liu Y", "Ross EA", "El-Deiry WS"], "date": "2019-01-17T00:00:00Z", "year": 2019, "snippets": [{"_id": "30705875@15237", "snip_text": "One patient post-cetuximab anti-EGFR therapy had five KRAS gene mutations (A146T*, G12V, G13D, G60R, K117N), 3 EGFR alterations (N493D, P373S, Y1172Y), 7 p53 mutations (A161T, C176R, Q354R*, R282W, p.Lys382fs, p.Ser2fs*, p.Val73fs), among others.", "section": "results", "mentions": ["183|5|variant|litvar@rs752142489##&&&litvar@#7157#&&&litvar@CA810#rs752142489##|Q354R", "176|5|variant|litvar@rs967461896##&&&litvar@#7157#|C176R", "210|8|variant|litvar@#7157#p.S2fsX&&&litvar@#7157#|p.Ser2fs", "89|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "75|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "17|9|chemical|ncbi_mesh@D000068818|cetuximab", "83|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "143|6|variant|litvar@#7157#p.Y1172Y&&&litvar@#7157#|Y1172Y", "32|4|gene|ncbi_gene@1956|EGFR", "169|5|variant|litvar@rs193920817##&&&litvar@#7157#&&&litvar@CA234#rs193920817##|A161T", "101|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "54|4|gene|ncbi_gene@3845|KRAS", "111|4|gene|ncbi_gene@1956|EGFR", "95|4|variant|litvar@rs104894359##&&&litvar@#3845#&&&litvar@CA273416#rs104894359##|G60R", "198|10|variant|litvar@#7157#p.K382fsX&&&litvar@#7157#|p.Lys382fs", "129|5|variant|litvar@rs180177040##&&&litvar@#673#&&&litvar@CA279976#rs180177040##|N493D", "154|3|gene|ncbi_gene@7157|p53", "4|7|species|ncbi_taxonomy@9606|patient", "136|5|variant|litvar@#7157#p.P373S&&&litvar@#7157#|P373S", "221|9|variant|litvar@rs730882018##&&&litvar@#7157#|p.Val73fs", "191|5|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|R282W"], "text_hl": "One patient post-cetuximab anti-EGFR therapy had five KRAS gene mutations (<m>A146T</m>*, G12V, G13D, G60R, K117N), 3 EGFR alterations (N493D, P373S, Y1172Y), 7 p53 mutations (A161T, C176R, Q354R*, R282W, p.Lys382fs, p.Ser2fs*, p.Val73fs), among others."}], "citations": {"NLM": "Ghatalia P, Smith CH, Winer A, Gou J, Kiedrowski LA, Slifker M, Saltzberg PD, Bubes N, Anari FM, Kasireddy V, Varshavsky A, Liu Y, Ross EA, El-Deiry WS. Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic. Front Oncol. PMID: 30705875", "BibTeX": "@article{30705875, title={Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic.}, author={Ghatalia P and Smith CH and Winer A and Gou J and Kiedrowski LA and Slifker M and Saltzberg PD and Bubes N and Anari FM and Kasireddy V and Varshavsky A and Liu Y and Ross EA and El-Deiry WS}, journal={Front Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 29908105, "pmcid": "PMC6113428", "title": "Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer", "journal": "Cancer Sci", "authors": ["Osumi H", "Shinozaki E", "Mashima T", "Wakatsuki T", "Suenaga M", "Ichimura T", "Ogura M", "Ota Y", "Nakayama I", "Takahari D", "Chin K", "Miki Y", "Yamaguchi K"], "date": "2018-08-01T00:00:00Z", "year": 2018, "snippets": [{"_id": "29908105@10245", "snip_text": "KRAS codon 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H); KRAS codon 146 (A146T, A146S, A146P, A146E, A146V, and A146G); BRAF codon 600 (V600E); NRAS codon 12 (G12S, G12C, G12R, G12D, G12V, and G12A), codon 13 (G13S, G13C, G13R, G13D, G13V, and G13A), and codon 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H); and PIK3CA exon 9 codon 542 (E542K), codon 545 (E545K), codon 546 (E546K), and exon 20 codon 1047 (H1047R and H1047L) were analyzed using Luminex (xMAP) technology (GENOSEARCH Mu-PACK; MBL).", "section": "methods", "mentions": ["243|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602364#rs121434596##|G13A", "27|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "270|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "93|5|variant|litvar@rs1484032303##&&&litvar@#1956#|A146E", "215|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13C", "111|5|variant|litvar@rs1484032303##&&&litvar@#1956#|A146G", "0|4|gene|ncbi_gene@3845|KRAS", "119|4|gene|ncbi_gene@673|BRAF", "298|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "221|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "276|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "135|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "143|4|gene|ncbi_gene@4893|NRAS", "56|4|gene|ncbi_gene@3845|KRAS", "33|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "170|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "176|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "15|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "72|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "404|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "100|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "86|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "158|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "334|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "209|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA16602674#rs121434595##|G13S", "39|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "264|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "282|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "227|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "21|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "309|6|gene|ncbi_gene@5290|PIK3CA", "288|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "49|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "353|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "372|5|variant|litvar@#5290#p.E546K&&&litvar@#5290#|E546K", "164|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "182|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "192|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "415|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|H1047L", "79|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146S", "233|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V"], "text_hl": "KRAS codon 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H); KRAS codon 146 (<m>A146T</m>, A146S, A146P, A146E, A146V, and A146G); BRAF codon 600 (V600E); NRAS codon 12 (G12S, G12C, G12R, G12D, G12V, and G12A), codon 13 (G13S, G13C, G13R, G13D, G13V, and G13A), and codon 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H); and PIK3CA exon 9 codon 542 (E542K), codon 545 (E545K), codon 546 (E546K), and exon 20 codon 1047 (H1047R and H1047L) were analyzed using Luminex (xMAP) technology (GENOSEARCH Mu-PACK; MBL)."}], "citations": {"NLM": "Osumi H, Shinozaki E, Mashima T, Wakatsuki T, Suenaga M, Ichimura T, Ogura M, Ota Y, Nakayama I, Takahari D, Chin K, Miki Y, Yamaguchi K. Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer Cancer Sci. PMID: 29908105", "BibTeX": "@article{29908105, title={Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer}, author={Osumi H and Shinozaki E and Mashima T and Wakatsuki T and Suenaga M and Ichimura T and Ogura M and Ota Y and Nakayama I and Takahari D and Chin K and Miki Y and Yamaguchi K}, journal={Cancer Sci}}"}, "is_sup_mat_match": false}, {"pmid": 35069704, "pmcid": "PMC8766716", "title": "Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal Cancer.", "journal": "Front Genet", "authors": ["Stasik S", "Mende M", "Schuster C", "Mahler S", "Aust D", "Tannapfel A", "Reinacher-Schick A", "Baretton G", "Krippendorf C", "Bornh\u00e4user M", "Ehninger G", "Folprecht G", "Thiede C"], "date": "2022-01-05T00:00:00Z", "year": 2022, "snippets": [{"_id": "35069704@21504", "snip_text": "Patient characteristic TNM classification ctDNA marker Time to detection of recurrence [d]   Pat Gender Age (years) UICC pT pN M Gene HGVS p.HGVS Imaging ctDNA     Pat#1 Male 77 IV 4 2 1 KRAS c.35G > A p.Gly12Asp 764 647 117   Pat#2 Male 66 IV 4 2 1 KRAS c.35G > A p.Gly12Asp 962 962 0   Pat#3 Female 81 III 3 1 0 KRAS c.35G > T p.Gly12Val 903 752 151   Pat#4 Female 53 IV 3 0 1 KRAS c.35G > T p.Gly12Val 226 226 0   Pat#5 Female 62 II 4 0 0 KRAS c.34G > T p.Gly12Cys 305 n.d n.a   Pat#6 Female 72 IV 3 1 1 KRAS c.40G > A p.Val14Ile 163 109 54   Pat#7 Male 74 III 3 1 0 KRAS c.175G > A p.Ala59Thr 268 42 226   Pat#8 Male 63 III 3 1 0 KRAS c.436G > A p.Ala146Thr 228 116 112   Pat#9 Male 70 III 3 2 0 KRAS c.350A > G p.Lys117Arg 397 315 82   Pat#10 Male 54 IV 3 2 1 NRAS c.38G > A p.Gly13Asp 227 192 35   Pat#11 Male 50 IV 4 1 1 NRAS c.182A > G p.Gln61Arg 463 326 137   Pat#12 Male 54 IV 4 2 1 TP53 c.584T > C p.Ile195Thr 427 318 109   Pat#13 Male 77 IV 4 1 1 TP53 c.743G > A p.Arg248Gln 269 98 171   Pat#14 Male 70 IV 3 1 1 TP53 c.742C > T p.Arg248Trp 381 195 186   ", "section": "table", "mentions": ["250|4|gene|ncbi_gene@3845|KRAS", "457|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.Gly12Cys", "893|4|gene|ncbi_gene@7157|TP53", "379|4|gene|ncbi_gene@3845|KRAS", "586|10|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|p.Ala59Thr", "765|4|gene|ncbi_gene@4893|NRAS", "716|11|variant|litvar@rs587782329##&&&litvar@#7157#&&&litvar@CA391#rs587782329##|p.Lys117Arg", "705|10|variant|litvar@rs587782329##&&&litvar@#7157#&&&litvar@CA391#rs587782329##|c.350A > G", "898|10|variant|litvar@rs760043106##&&&litvar@#7157#&&&litvar@CA2232#rs760043106##|c.584T > C", "265|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.Gly12Asp", "329|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.Gly12Val", "522|10|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|p.Val14Ile", "394|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.Gly12Val", "187|4|gene|ncbi_gene@3845|KRAS", "909|11|variant|litvar@rs760043106##&&&litvar@#7157#&&&litvar@CA2232#rs760043106##|p.Ile195Thr", "447|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G > T", "512|9|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|c.40G > A", "319|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "959|4|gene|ncbi_gene@7157|TP53", "780|10|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.Gly13Asp", "844|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Gln61Arg", "202|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.Gly12Asp", "1024|4|gene|ncbi_gene@7157|TP53", "255|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "770|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "0|7|species|ncbi_taxonomy@9606|Patient", "384|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "964|10|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|c.743G > A", "975|11|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|p.Arg248Gln", "1029|10|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|c.742C > T", "570|4|gene|ncbi_gene@3845|KRAS", "634|4|gene|ncbi_gene@3845|KRAS", "192|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "650|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "575|10|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|c.175G > A", "639|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "1040|11|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|p.Arg248Trp", "442|4|gene|ncbi_gene@3845|KRAS", "828|4|gene|ncbi_gene@4893|NRAS", "700|4|gene|ncbi_gene@3845|KRAS", "314|4|gene|ncbi_gene@3845|KRAS", "507|4|gene|ncbi_gene@3845|KRAS", "833|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A > G"], "figure_id": "T1", "text_hl": "Patient characteristic TNM classification ctDNA marker Time to detection of recurrence [d]   Pat Gender Age (years) UICC pT pN M Gene HGVS p.HGVS Imaging ctDNA     Pat#1 Male 77 IV 4 2 1 KRAS c.35G > A p.Gly12Asp 764 647 117   Pat#2 Male 66 IV 4 2 1 KRAS c.35G > A p.Gly12Asp 962 962 0   Pat#3 Female 81 III 3 1 0 KRAS c.35G > T p.Gly12Val 903 752 151   Pat#4 Female 53 IV 3 0 1 KRAS c.35G > T p.Gly12Val 226 226 0   Pat#5 Female 62 II 4 0 0 KRAS c.34G > T p.Gly12Cys 305 n.d n.a   Pat#6 Female 72 IV 3 1 1 KRAS c.40G > A p.Val14Ile 163 109 54   Pat#7 Male 74 III 3 1 0 KRAS c.175G > A p.Ala59Thr 268 42 226   Pat#8 Male 63 III 3 1 0 KRAS c.436G > A <m>p.Ala146Thr</m> 228 116 112   Pat#9 Male 70 III 3 2 0 KRAS c.350A > G p.Lys117Arg 397 315 82   Pat#10 Male 54 IV 3 2 1 NRAS c.38G > A p.Gly13Asp 227 192 35   Pat#11 Male 50 IV 4 1 1 NRAS c.182A > G p.Gln61Arg 463 326 137   Pat#12 Male 54 IV 4 2 1 TP53 c.584T > C p.Ile195Thr 427 318 109   Pat#13 Male 77 IV 4 1 1 TP53 c.743G > A p.Arg248Gln 269 98 171   Pat#14 Male 70 IV 3 1 1 TP53 c.742C > T p.Arg248Trp 381 195 186   "}], "citations": {"NLM": "Stasik S, Mende M, Schuster C, Mahler S, Aust D, Tannapfel A, Reinacher-Schick A, Baretton G, Krippendorf C, Bornh\u00e4user M, Ehninger G, Folprecht G, Thiede C. Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal Cancer. Front Genet. PMID: 35069704", "BibTeX": "@article{35069704, title={Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal Cancer.}, author={Stasik S and Mende M and Schuster C and Mahler S and Aust D and Tannapfel A and Reinacher-Schick A and Baretton G and Krippendorf C and Bornh\u00e4user M and Ehninger G and Folprecht G and Thiede C}, journal={Front Genet}}"}, "is_sup_mat_match": false}, {"pmid": 32341551, "pmcid": "PMC7787056", "title": "The duality of human oncoproteins: drivers of cancer and congenital disorders", "journal": "Nat Rev Cancer", "authors": ["Castel P", "Rauen KA", "McCormick F"], "date": "2020-07-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "32341551@6194", "snip_text": "Furthermore, the signalling output of the KRAS-A146T mutant, the encoding allele of which is found only in gastrointestinal tumours, is strikingly different from that of the most common G12D variant, though still oncogenic.", "section": "other", "mentions": ["186|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "47|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "42|4|gene|ncbi_gene@3845|KRAS", "107|24|disease|ncbi_mesh@D005770|gastrointestinal tumours"], "text_hl": "Furthermore, the signalling output of the KRAS-<m>A146T</m> mutant, the encoding allele of which is found only in gastrointestinal tumours, is strikingly different from that of the most common G12D variant, though still oncogenic."}], "citations": {"NLM": "Castel P, Rauen KA, McCormick F. The duality of human oncoproteins: drivers of cancer and congenital disorders Nat Rev Cancer. PMID: 32341551", "BibTeX": "@article{32341551, title={The duality of human oncoproteins: drivers of cancer and congenital disorders}, author={Castel P and Rauen KA and McCormick F}, journal={Nat Rev Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 30150883, "pmcid": "PMC6103235", "title": "Quality and practical aspects of pathological and molecular diagnostics in metastatic colorectal cancer (mCRC).", "journal": "Contemp Oncol (Pozn)", "authors": ["Tysarowski A", "Nasierowska-Guttmejer A"], "date": "2018-01-01T00:00:00Z", "year": 2018, "snippets": [{"_id": "30150883@19031", "snip_text": "Gene Exon Codon Mutation name (protein level) Mutation name (nucleotide level)   KRAS  12 p.Gly12Asp c.35G > A   p.Gly12Val c.35G > T   p.Gly12Cys c.34G > T   p.Gly12Arg c.34G > C   p.Gly12Ser c.34G > A   p.Gly12Ala c.35G > C   2 13 p.Gly13Asp c.38G > A   p.Gly13Cys c.37G > T   p.Gly13Arg c.37G > C   p.Gly13Ser c.37G > A   p.Gly13Ala c.38G > C   p.Gly13Val c.38G > T   3 59 p.Ala59Thr c.175G > A   p.Ala59Glu c.176C > A   p.Ala59Gly c.176C > G   61 p.Gln61Lys c.181C > A   p.Gln61Lys c.180_181TC > AA   p.Gln61Leu c.182A > T   p.Gln61Arg c.182A > G   p.Gln61His c.183A > C   p.Gln61His c.183A > T   4 117 p.Lys117Asn c.351A > C   p.Lys117Asn c.351A > T   146 p.Ala146Thr c.436G > A   p.Ala146Pro c.436G > C   p.Ala146Val c.437C > T   NRAS 2 12 p.Gly12Cys c.34G > T   p.Gly12Ser c.34G > A   p.Gly12Ala c.35G > C   p.Gly12Asp c.35G > A   p.Gly12Val c.35G > T   13 p.Gly13Arg c.37G > C   p.Gly13Val c.38G > T   p.Gly13Asp c.38G > A   3 59 p.Ala59Thr c.175G > A   61 p.Gln61Lys c.181C > A   p.Gln61Leu c.182A > T   p.Gln61Arg c.182A > G   p.Gln61His c.183A > T   p.Gln61His c.183A > C   4 117 p.Lys117Asn c.351G > C   p.Lys117Asn c.351G > T   146 p.Ala146Thr c.436G > A   p.Ala146Val c.437C > T   BRAF 15 600 p.Val600Glu c.1799T > A   ", "section": "table", "mentions": ["746|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.Gly12Cys", "673|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "313|9|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA16602674#rs121434595##|c.37G > A", "723|10|variant|litvar@rs763725375##&&&litvar@#4292#|c.437C > T", "989|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Gln61Leu", "1182|10|variant|litvar@rs763725375##&&&litvar@#4292#|c.437C > T", "267|9|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA16602248#rs121434595##|c.37G > T", "838|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.Gly12Val", "976|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C > A", "182|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.Gly12Ser", "302|10|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA16602674#rs121434595##|p.Gly13Ser", "159|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.Gly12Arg", "359|9|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|c.38G > T", "769|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.Gly12Ser", "1116|11|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.Lys117Asn", "256|10|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|p.Gly13Cys", "113|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.Gly12Val", "233|10|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.Gly13Asp", "949|10|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|c.175G > A", "348|10|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|p.Gly13Val", "205|10|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|p.Gly12Ala", "325|10|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602364#rs121434596##|p.Gly13Ala", "607|11|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.Lys117Asn", "921|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "1024|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A > G", "898|9|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|c.38G > T", "376|10|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|p.Ala59Thr", "1145|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "1157|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "588|10|variant|litvar@rs121913255##&&&litvar@#4893#&&&litvar@CA16042285#rs121913255##|c.183A > T", "887|10|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|p.Gly13Val", "1195|4|gene|ncbi_gene@673|BRAF", "803|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > C", "698|10|variant|litvar@rs779123278##&&&litvar@#2956#|c.436G > C", "529|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Gln61Arg", "780|9|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA180753#rs121913250##|c.34G > A", "757|9|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|c.34G > T", "451|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Gln61Lys", "124|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA261525#rs121913237##|c.35G > T", "644|10|variant|litvar@rs770248150##&&&litvar@#3845#|c.351A > T", "736|4|gene|ncbi_gene@4893|NRAS", "101|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "910|10|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.Gly13Asp", "1048|10|variant|litvar@rs121913255##&&&litvar@#4893#&&&litvar@CA16042285#rs121913255##|c.183A > T", "632|11|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.Lys117Asn", "216|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > C", "826|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "1219|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T > A", "553|10|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Gln61His", "1091|11|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.Lys117Asn", "170|9|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|c.34G > C", "290|9|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|c.37G > C", "411|10|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|c.176C > A", "336|9|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602364#rs121434596##|c.38G > C", "815|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.Gly12Asp", "1170|11|variant|litvar@rs1057519725##&&&litvar@#3845#|p.Ala146Val", "792|10|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|p.Gly12Ala", "136|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.Gly12Cys", "475|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Gln61Lys", "540|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A > G", "90|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.Gly12Asp", "661|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "462|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C > A", "1072|10|variant|litvar@rs121913255##&&&litvar@#4893#|c.183A > C", "577|10|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Gln61His", "619|10|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|c.351A > C", "1013|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Gln61Arg", "435|10|variant|litvar@rs1060500116##&&&litvar@#5728#|c.176C > G", "1207|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.Val600Glu", "1000|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|c.182A > T", "1128|10|variant|litvar@rs769554703##&&&litvar@#5395#&&&litvar@CA51542#rs769554703##|c.351G > T", "279|10|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|p.Gly13Arg", "486|16|variant|litvar@#4893#c.180_181TC>AA&&&litvar@#4893#|c.180_181TC > AA", "1037|10|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Gln61His", "875|9|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|c.37G > C", "564|10|variant|litvar@rs121913255##&&&litvar@#4893#|c.183A > C", "505|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Gln61Leu", "686|11|variant|litvar@rs121913527##&&&litvar@#3845#|p.Ala146Pro", "849|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA261525#rs121913237##|c.35G > T", "400|10|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|p.Ala59Glu", "1061|10|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Gln61His", "965|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Gln61Lys", "193|9|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA180753#rs121913250##|c.34G > A", "387|10|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|c.175G > A", "147|9|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|c.34G > T", "864|10|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|p.Gly13Arg", "424|10|variant|litvar@rs763572530##&&&litvar@#1956#|p.Ala59Gly", "938|10|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|p.Ala59Thr", "516|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|c.182A > T", "244|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "1103|10|variant|litvar@rs114185660##&&&litvar@#5395#&&&litvar@CA13290#rs114185660##|c.351G > C", "711|11|variant|litvar@rs1057519725##&&&litvar@#3845#|p.Ala146Val"], "figure_id": "t0002", "text_hl": "Gene Exon Codon Mutation name (protein level) Mutation name (nucleotide level)   KRAS  12 p.Gly12Asp c.35G > A   p.Gly12Val c.35G > T   p.Gly12Cys c.34G > T   p.Gly12Arg c.34G > C   p.Gly12Ser c.34G > A   p.Gly12Ala c.35G > C   2 13 p.Gly13Asp c.38G > A   p.Gly13Cys c.37G > T   p.Gly13Arg c.37G > C   p.Gly13Ser c.37G > A   p.Gly13Ala c.38G > C   p.Gly13Val c.38G > T   3 59 p.Ala59Thr c.175G > A   p.Ala59Glu c.176C > A   p.Ala59Gly c.176C > G   61 p.Gln61Lys c.181C > A   p.Gln61Lys c.180_181TC > AA   p.Gln61Leu c.182A > T   p.Gln61Arg c.182A > G   p.Gln61His c.183A > C   p.Gln61His c.183A > T   4 117 p.Lys117Asn c.351A > C   p.Lys117Asn c.351A > T   146 <m>p.Ala146Thr</m> c.436G > A   p.Ala146Pro c.436G > C   p.Ala146Val c.437C > T   NRAS 2 12 p.Gly12Cys c.34G > T   p.Gly12Ser c.34G > A   p.Gly12Ala c.35G > C   p.Gly12Asp c.35G > A   p.Gly12Val c.35G > T   13 p.Gly13Arg c.37G > C   p.Gly13Val c.38G > T   p.Gly13Asp c.38G > A   3 59 p.Ala59Thr c.175G > A   61 p.Gln61Lys c.181C > A   p.Gln61Leu c.182A > T   p.Gln61Arg c.182A > G   p.Gln61His c.183A > T   p.Gln61His c.183A > C   4 117 p.Lys117Asn c.351G > C   p.Lys117Asn c.351G > T   146 <m>p.Ala146Thr</m> c.436G > A   p.Ala146Val c.437C > T   BRAF 15 600 p.Val600Glu c.1799T > A   "}], "citations": {"NLM": "Tysarowski A, Nasierowska-Guttmejer A. Quality and practical aspects of pathological and molecular diagnostics in metastatic colorectal cancer (mCRC). Contemp Oncol (Pozn). PMID: 30150883", "BibTeX": "@article{30150883, title={Quality and practical aspects of pathological and molecular diagnostics in metastatic colorectal cancer (mCRC).}, author={Tysarowski A and Nasierowska-Guttmejer A}, journal={Contemp Oncol (Pozn)}}"}, "is_sup_mat_match": false}, {"pmid": 38607003, "pmcid": "PMC11011035", "title": "Hippo Signaling at the Hallmarks of Cancer and Drug Resistance", "journal": "Cells", "authors": ["Kumar R", "Hong W"], "date": "2024-03-22T00:00:00Z", "year": 2024, "snippets": [{"_id": "38607003@19605", "snip_text": "In addition to KRAS amplification, a broad range of allelic mutations including G12A/C/D/F/V/S, G13C/D, V41, L19F, Q22K, D33E, Q61H, K117N, and A146V/T makes it challenging to tackle mutant K-RAS-driven diseases.", "section": "other", "mentions": ["121|4|variant|litvar@rs1064795989##&&&litvar@#1029#|D33E", "144|7|variant|litvar@rs121913527##&&&litvar@#3845#|A146V/T", "133|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "15|4|gene|ncbi_gene@3845|KRAS", "127|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "80|6|variant|litvar@rs121913530##&&&litvar@#3845#|G12A/C", "190|5|gene|ncbi_gene@3845|K-RAS", "109|4|variant|litvar@rs121913538##&&&litvar@#3845#&&&litvar@CA210356#rs121913538##|L19F", "115|4|variant|litvar@rs121913236##&&&litvar@#3845#&&&litvar@CA16602771#rs121913236##|Q22K", "96|6|variant|litvar@rs112445441##&&&litvar@#3845#|G13C/D"], "text_hl": "In addition to KRAS amplification, a broad range of allelic mutations including G12A/C/D/F/V/S, G13C/D, V41, L19F, Q22K, D33E, Q61H, K117N, and A146V/T makes it challenging to tackle mutant K-RAS-driven diseases."}], "citations": {"NLM": "Kumar R, Hong W. Hippo Signaling at the Hallmarks of Cancer and Drug Resistance Cells. PMID: 38607003", "BibTeX": "@article{38607003, title={Hippo Signaling at the Hallmarks of Cancer and Drug Resistance}, author={Kumar R and Hong W}, journal={Cells}}"}, "is_sup_mat_match": false}, {"pmid": 30139386, "pmcid": "PMC6108145", "title": "Personalized treatment based on mini patient-derived xenografts and WES/RNA sequencing in a patient with metastatic duodenal adenocarcinoma.", "journal": "Cancer Commun (Lond)", "authors": ["Zhao P", "Chen H", "Wen D", "Mou S", "Zhang F", "Zheng S"], "date": "2018-08-23T00:00:00Z", "year": 2018, "snippets": [{"_id": "30139386@1354", "snip_text": "DNA-WES and RNA sequencing identified KRAS mutation (A146T), TP53 (C229Yfs*10) and RICTOR amplification in the metastatic duodenal adenocarcinoma.", "section": "abstract", "mentions": ["122|23|disease|ncbi_mesh@D000230|duodenal adenocarcinoma", "67|10|variant|litvar@#7157#p.C229YfsX10&&&litvar@#7157#|C229Yfs*10", "53|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "61|4|gene|ncbi_gene@7157|TP53", "83|6|gene|ncbi_gene@253260|RICTOR", "38|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "DNA-WES and RNA sequencing identified KRAS mutation (<m>A146T</m>), TP53 (C229Yfs*10) and RICTOR amplification in the metastatic duodenal adenocarcinoma."}], "citations": {"NLM": "Zhao P, Chen H, Wen D, Mou S, Zhang F, Zheng S. Personalized treatment based on mini patient-derived xenografts and WES/RNA sequencing in a patient with metastatic duodenal adenocarcinoma. Cancer Commun (Lond). PMID: 30139386", "BibTeX": "@article{30139386, title={Personalized treatment based on mini patient-derived xenografts and WES/RNA sequencing in a patient with metastatic duodenal adenocarcinoma.}, author={Zhao P and Chen H and Wen D and Mou S and Zhang F and Zheng S}, journal={Cancer Commun (Lond)}}"}, "is_sup_mat_match": false}, {"pmid": 31998419, "pmcid": "PMC6977322", "title": "Analysis of Molecular Pretreated Tumor Profiles as Predictive Biomarkers of Therapeutic Response and Survival Outcomes after Neoadjuvant Therapy for Rectal Cancer in Moroccan Population.", "journal": "Dis Markers", "authors": ["El Otmani I", "El Agy F", "El Baradai S", "Bouguenouch L", "Lahmidani N", "El Abkari M", "Benajah DA", "Toughrai I", "El Bouhaddouti H", "Mouaqit O", "Ibn Majdoub Hassani K", "Mazaz K", "Benjelloun EB", "Ousadden A", "El Rhazi K", "Bouhafa T", "Benbrahim Z", "Ouldim K", "Ibrahimi SA", "Ait Taleb K", "Chbani L"], "date": "2020-01-11T00:00:00Z", "year": 2020, "snippets": [{"_id": "31998419@1565", "snip_text": "KRAS mutations detected at codon 146 (A146T, A146V) was associated with the appearance of recurrence and distant metastasis (p = 0.019).", "section": "abstract", "mentions": ["0|4|gene|ncbi_gene@3845|KRAS", "113|10|disease|ncbi_mesh@D009362|metastasis", "45|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "38|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "KRAS mutations detected at codon 146 (<m>A146T</m>, A146V) was associated with the appearance of recurrence and distant metastasis (p = 0.019)."}], "citations": {"NLM": "El Otmani I, El Agy F, El Baradai S, Bouguenouch L, Lahmidani N, El Abkari M, Benajah DA, Toughrai I, El Bouhaddouti H, Mouaqit O, Ibn Majdoub Hassani K, Mazaz K, Benjelloun EB, Ousadden A, El Rhazi K, Bouhafa T, Benbrahim Z, Ouldim K, Ibrahimi SA, Ait Taleb K, Chbani L. Analysis of Molecular Pretreated Tumor Profiles as Predictive Biomarkers of Therapeutic Response and Survival Outcomes after Neoadjuvant Therapy for Rectal Cancer in Moroccan Population. Dis Markers. PMID: 31998419", "BibTeX": "@article{31998419, title={Analysis of Molecular Pretreated Tumor Profiles as Predictive Biomarkers of Therapeutic Response and Survival Outcomes after Neoadjuvant Therapy for Rectal Cancer in Moroccan Population.}, author={El Otmani I and El Agy F and El Baradai S and Bouguenouch L and Lahmidani N and El Abkari M and Benajah DA and Toughrai I and El Bouhaddouti H and Mouaqit O and Ibn Majdoub Hassani K and Mazaz K and Benjelloun EB and Ousadden A and El Rhazi K and Bouhafa T and Benbrahim Z and Ouldim K and Ibrahimi SA and Ait Taleb K and Chbani L}, journal={Dis Markers}}"}, "is_sup_mat_match": false}, {"pmid": 30578081, "pmcid": "PMC6355728", "title": "DNA methylation changes and somatic mutations as tumorigenic events in Lynch syndrome-associated adenomas retaining mismatch repair protein expression", "journal": "EBioMedicine", "authors": ["M\u00e4ki-Nevala S", "Valo S", "Ristim\u00e4ki A", "Sarhadi V", "Knuutila S", "Nystr\u00f6m M", "Renkonen-Sinisalo L", "Lepist\u00f6 A", "Mecklin JP", "Peltom\u00e4ki P"], "date": "2019-01-01T00:00:00Z", "year": 2019, "snippets": [{"_id": "30578081@30364", "snip_text": "Patient ID\tSample ID\tDysplasia grade\tGermline mutation\tHypermethylated CIMP markers\tHypermethylated candidate TSGs\tSomatic mutations (VAF %)\tMSI status\tCIMP status\t \t73\t148Ad\tLOW\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tIGF2\tNone\tNone\tMSS\t(-)\t \t3\t164Ad\tLOW\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tND\tND\tNone\tMSSa\tND\t \t16\t187Ad\tLOW\tMSH6 c.900dup\tNEUROG1\tSFRP1\tCTNBB1 p.Ser45Phe (37)\tMSS\t(-)\t \t95\t197Ad\tLOW\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tND\tSFRP1\tNone\tND\tND\t \t13\t248Ad\tLOW\tMSH2 c.1667_1671del\tCDKN2A\tSFRP2, SLC5A8, SFRP1\tKRAS p.Gly12Asp (7)\tMSSa\t(-)\t \t17\t249Ad\tLOW\tMLH1 c.546-2A > G\tMLH1, IGF2, NEUROG1, CDKN2A, CRABP1\tSFRP2, HOXD1, SFRP1\tEGFR p.Ala767Val (5), KRAS p.Gly12Val (8), PIK3CA p.Arg693His (5), SMAD4 p.Pro514Ser (5), TP53 p.Arg282Trp (6); p.Pro250Leu (5); p.Gly244Ser (5)\tMSSa\t(+)\t \t45\t259Ad\tLOW\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tNEUROG1\tSFRP2, SFRP1\tNone\tMSS\t(-)\t \t76\t264Ad\tLOW\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tNEUROG1, CDKN2A, CRABP1\tSFRP1\tKRAS p.Gly12Val (29), SMAD4 p.Pro102Leu (18)\tMSSa\t(-)\t \t95\t268Ad\tLOW\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tMLH1, IGF2, NEUROG1, CRABP1\tnone\tCTNNB1 p.Thr41Ala (5)\tMSS\t(-)\t \t101\t271Ad\tLOW\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tnone\tSFRP1\tNone\tMSS\t(-)\t \t12\t670Ad\tLOW\tMSH2 c.1552_1553_del\tND\tSFRP2, CDH1, HOXD1, SLC5A8, SFRP1\tFBXW7 p.Arg465His (7), KRAS p.Ala146Thr (10)\tND\tND\t \t16\t672Ad\tLOW\tMSH6 c.900dup\tND\tSFRP2, CDH1, HOXD1, SLC5A8, SFRP1\tNone\tND\tND\t \t73\t677Ad\tHIGH\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tNone\tSFRP2, SFRP1\tNone\tND\t(-)\t \t112\t686Ad\tHIGH\tMSH6 c.3195_3199del\tIGF2, NEUROG1, CDKN2A, CRABP1\tSFRP2, SLC5A8, SFRP1\tKRAS p.Ala146Thr (45), TP53 p.Glu180Lys (5)\tMSS\t(-)\t \t120\t690Ad\tLOW\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tNone\tSFRP2, CDH1, HOXD1, SOCS1, SLC5A8, SFRP1\tNone\tND\t(-)\t \t123\t693Ad\tLOW\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tIGF2, NEUROG1, CDKN2A\tSFRP2, CDH1, HOXD1, SFRP5, SOCS1, SLC5A8, SFRP1\tNone\tMSS\t(-)\t \t", "section": "table", "mentions": ["539|4|gene|ncbi_gene@3845|KRAS", "1429|6|gene|ncbi_gene@216225|SLC5A8", "1519|5|gene|ncbi_gene@6423|SFRP2", "1118|7|gene|ncbi_gene@4762|NEUROG1", "613|7|gene|ncbi_gene@4762|NEUROG1", "630|6|gene|ncbi_gene@1381|CRABP1", "1762|5|gene|ncbi_gene@3231|HOXD1", "1611|5|gene|ncbi_gene@6423|SFRP2", "518|5|gene|ncbi_gene@6423|SFRP2", "511|6|gene|ncbi_gene@1029|CDKN2A", "1749|5|gene|ncbi_gene@6423|SFRP2", "1146|10|variant|litvar@rs121913412##&&&litvar@#1499#&&&litvar@CA74088767#rs121913412##|p.Thr41Ala", "987|5|gene|ncbi_gene@6422|SFRP1", "338|4|gene|ncbi_gene@2956|MSH6", "459|5|gene|ncbi_gene@6422|SFRP1", "525|6|gene|ncbi_gene@216225|SLC5A8", "274|16|variant|litvar@#4292#c.2247_1897-402del&&&litvar@#4292#|2247_1897-402del", "1626|5|gene|ncbi_gene@6422|SFRP1", "1587|7|gene|ncbi_gene@4762|NEUROG1", "1604|6|gene|ncbi_gene@1381|CRABP1", "1700|4|gene|ncbi_gene@17350|MLH1", "1897|5|gene|ncbi_gene@3231|HOXD1", "1891|4|gene|ncbi_gene@12550|CDH1", "426|16|variant|litvar@#4292#c.2247_1897-402del&&&litvar@#4292#|2247_1897-402del", "1106|4|gene|ncbi_gene@17350|MLH1", "601|4|gene|ncbi_gene@17350|MLH1", "1526|5|gene|ncbi_gene@6422|SFRP1", "0|7|species|ncbi_taxonomy@9606|Patient", "1292|5|gene|ncbi_gene@6423|SFRP2", "179|4|gene|ncbi_gene@17350|MLH1", "1397|8|variant|litvar@rs863225421##&&&litvar@#2956#|c.900dup", "360|5|gene|ncbi_gene@6422|SFRP1", "1769|5|gene|ncbi_gene@8651|SOCS1", "684|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.Gly12Val", "1312|6|gene|ncbi_gene@216225|SLC5A8", "1021|11|variant|litvar@rs1318605058##&&&litvar@#3845#|p.Pro102Leu", "1818|4|gene|ncbi_gene@17350|MLH1", "1185|4|gene|ncbi_gene@17350|MLH1", "1112|4|gene|ncbi_gene@3481|IGF2", "607|4|gene|ncbi_gene@3481|IGF2", "1884|5|gene|ncbi_gene@6423|SFRP2", "1877|6|gene|ncbi_gene@1029|CDKN2A", "1926|5|gene|ncbi_gene@6422|SFRP1", "840|16|variant|litvar@#4292#c.2247_1897-402del&&&litvar@#4292#|2247_1897-402del", "1776|6|gene|ncbi_gene@216225|SLC5A8", "1320|5|gene|ncbi_gene@6422|SFRP1", "1392|4|gene|ncbi_gene@2956|MSH6", "1076|16|variant|litvar@#4292#c.2247_1897-402del&&&litvar@#4292#|2247_1897-402del", "637|5|gene|ncbi_gene@6423|SFRP2", "588|12|variant|litvar@rs267607759##&&&litvar@#4292#&&&litvar@CA10978#rs267607759##|c.546-2A > G", "1756|4|gene|ncbi_gene@12550|CDH1", "1234|5|gene|ncbi_gene@6422|SFRP1", "544|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.Gly12Asp", "1139|6|gene|ncbi_gene@1499|CTNNB1", "885|5|gene|ncbi_gene@6422|SFRP1", "651|5|gene|ncbi_gene@6422|SFRP1", "1655|4|gene|ncbi_gene@7157|TP53", "1904|5|gene|ncbi_gene@54612|SFRP5", "707|11|variant|litvar@rs1336500564##&&&litvar@#5290#|p.Arg693His", "1326|5|gene|ncbi_gene@55294|FBXW7", "1632|4|gene|ncbi_gene@3845|KRAS", "1416|4|gene|ncbi_gene@12550|CDH1", "1409|5|gene|ncbi_gene@6423|SFRP2", "260|4|gene|ncbi_gene@17350|MLH1", "1354|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "352|7|gene|ncbi_gene@4762|NEUROG1", "1862|4|gene|ncbi_gene@3481|IGF2", "747|4|gene|ncbi_gene@7157|TP53", "1273|15|variant|litvar@#4436#c.1552_1553_del&&&litvar@#4436#|c.1552_1553_del", "343|8|variant|litvar@rs863225421##&&&litvar@#2956#|c.900dup", "700|6|gene|ncbi_gene@5290|PIK3CA", "730|11|variant|litvar@rs1221103079##&&&litvar@#4089#|p.Pro514Ser", "412|4|gene|ncbi_gene@17350|MLH1", "533|5|gene|ncbi_gene@6422|SFRP1", "1015|5|gene|ncbi_gene@4089|SMAD4", "662|11|variant|litvar@rs397517107##&&&litvar@#1956#&&&litvar@CA135837#rs397517107##|p.Ala767Val", "1618|6|gene|ncbi_gene@216225|SLC5A8", "1437|5|gene|ncbi_gene@6422|SFRP1", "963|7|gene|ncbi_gene@4762|NEUROG1", "980|6|gene|ncbi_gene@1381|CRABP1", "1332|11|variant|litvar@rs1057519895##&&&litvar@#55294#|p.Arg465His", "491|4|gene|ncbi_gene@4436|MSH2", "786|11|variant|litvar@rs1057519989##&&&litvar@#7157#|p.Gly244Ser", "878|5|gene|ncbi_gene@6423|SFRP2", "644|5|gene|ncbi_gene@3231|HOXD1", "679|4|gene|ncbi_gene@3845|KRAS", "1127|6|gene|ncbi_gene@1381|CRABP1", "1305|5|gene|ncbi_gene@3231|HOXD1", "622|6|gene|ncbi_gene@1029|CDKN2A", "193|16|variant|litvar@#4292#c.2247_1897-402del&&&litvar@#4292#|2247_1897-402del", "583|4|gene|ncbi_gene@17350|MLH1", "1299|4|gene|ncbi_gene@12550|CDH1", "1868|7|gene|ncbi_gene@4762|NEUROG1", "1349|4|gene|ncbi_gene@3845|KRAS", "1596|6|gene|ncbi_gene@1029|CDKN2A", "826|4|gene|ncbi_gene@17350|MLH1", "657|4|gene|ncbi_gene@1956|EGFR", "1911|5|gene|ncbi_gene@8651|SOCS1", "972|6|gene|ncbi_gene@1029|CDKN2A", "1561|4|gene|ncbi_gene@2956|MSH6", "1832|16|variant|litvar@#4292#c.2247_1897-402del&&&litvar@#4292#|2247_1897-402del", "373|10|variant|litvar@rs121913409##&&&litvar@#1499#&&&litvar@CA127283#rs121913409##|p.Ser45Phe", "1918|6|gene|ncbi_gene@216225|SLC5A8", "1268|4|gene|ncbi_gene@4436|MSH2", "1784|5|gene|ncbi_gene@6422|SFRP1", "1062|4|gene|ncbi_gene@17350|MLH1", "919|4|gene|ncbi_gene@17350|MLH1", "933|16|variant|litvar@#4292#c.2247_1897-402del&&&litvar@#4292#|2247_1897-402del", "1199|16|variant|litvar@#4292#c.2247_1897-402del&&&litvar@#4292#|2247_1897-402del", "993|4|gene|ncbi_gene@3845|KRAS", "769|11|variant|litvar@rs1064794311##&&&litvar@#7157#|p.Pro250Leu", "1581|4|gene|ncbi_gene@3481|IGF2", "1660|11|variant|litvar@rs17882252##&&&litvar@#7157#&&&litvar@CA17#rs17882252##|p.Glu180Lys", "1470|4|gene|ncbi_gene@17350|MLH1", "1637|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "724|5|gene|ncbi_gene@4089|SMAD4", "1422|5|gene|ncbi_gene@3231|HOXD1", "1484|16|variant|litvar@#4292#c.2247_1897-402del&&&litvar@#4292#|2247_1897-402del", "998|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.Gly12Val", "870|7|gene|ncbi_gene@4762|NEUROG1", "223|4|gene|ncbi_gene@3481|IGF2", "752|11|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|p.Arg282Trp", "1714|16|variant|litvar@#4292#c.2247_1897-402del&&&litvar@#4292#|2247_1897-402del"], "figure_id": "t0015", "text_hl": "Patient ID\tSample ID\tDysplasia grade\tGermline mutation\tHypermethylated CIMP markers\tHypermethylated candidate TSGs\tSomatic mutations (VAF %)\tMSI status\tCIMP status\t \t73\t148Ad\tLOW\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tIGF2\tNone\tNone\tMSS\t(-)\t \t3\t164Ad\tLOW\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tND\tND\tNone\tMSSa\tND\t \t16\t187Ad\tLOW\tMSH6 c.900dup\tNEUROG1\tSFRP1\tCTNBB1 p.Ser45Phe (37)\tMSS\t(-)\t \t95\t197Ad\tLOW\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tND\tSFRP1\tNone\tND\tND\t \t13\t248Ad\tLOW\tMSH2 c.1667_1671del\tCDKN2A\tSFRP2, SLC5A8, SFRP1\tKRAS p.Gly12Asp (7)\tMSSa\t(-)\t \t17\t249Ad\tLOW\tMLH1 c.546-2A > G\tMLH1, IGF2, NEUROG1, CDKN2A, CRABP1\tSFRP2, HOXD1, SFRP1\tEGFR p.Ala767Val (5), KRAS p.Gly12Val (8), PIK3CA p.Arg693His (5), SMAD4 p.Pro514Ser (5), TP53 p.Arg282Trp (6); p.Pro250Leu (5); p.Gly244Ser (5)\tMSSa\t(+)\t \t45\t259Ad\tLOW\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tNEUROG1\tSFRP2, SFRP1\tNone\tMSS\t(-)\t \t76\t264Ad\tLOW\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tNEUROG1, CDKN2A, CRABP1\tSFRP1\tKRAS p.Gly12Val (29), SMAD4 p.Pro102Leu (18)\tMSSa\t(-)\t \t95\t268Ad\tLOW\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tMLH1, IGF2, NEUROG1, CRABP1\tnone\tCTNNB1 p.Thr41Ala (5)\tMSS\t(-)\t \t101\t271Ad\tLOW\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tnone\tSFRP1\tNone\tMSS\t(-)\t \t12\t670Ad\tLOW\tMSH2 c.1552_1553_del\tND\tSFRP2, CDH1, HOXD1, SLC5A8, SFRP1\tFBXW7 p.Arg465His (7), KRAS <m>p.Ala146Thr</m> (10)\tND\tND\t \t16\t672Ad\tLOW\tMSH6 c.900dup\tND\tSFRP2, CDH1, HOXD1, SLC5A8, SFRP1\tNone\tND\tND\t \t73\t677Ad\tHIGH\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tNone\tSFRP2, SFRP1\tNone\tND\t(-)\t \t112\t686Ad\tHIGH\tMSH6 c.3195_3199del\tIGF2, NEUROG1, CDKN2A, CRABP1\tSFRP2, SLC5A8, SFRP1\tKRAS <m>p.Ala146Thr</m> (45), TP53 p.Glu180Lys (5)\tMSS\t(-)\t \t120\t690Ad\tLOW\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tNone\tSFRP2, CDH1, HOXD1, SOCS1, SLC5A8, SFRP1\tNone\tND\t(-)\t \t123\t693Ad\tLOW\tMLH1 c.1731 + 2247_1897-402del (Mutation 1)\tIGF2, NEUROG1, CDKN2A\tSFRP2, CDH1, HOXD1, SFRP5, SOCS1, SLC5A8, SFRP1\tNone\tMSS\t(-)\t \t"}], "citations": {"NLM": "M\u00e4ki-Nevala S, Valo S, Ristim\u00e4ki A, Sarhadi V, Knuutila S, Nystr\u00f6m M, Renkonen-Sinisalo L, Lepist\u00f6 A, Mecklin JP, Peltom\u00e4ki P. DNA methylation changes and somatic mutations as tumorigenic events in Lynch syndrome-associated adenomas retaining mismatch repair protein expression EBioMedicine. PMID: 30578081", "BibTeX": "@article{30578081, title={DNA methylation changes and somatic mutations as tumorigenic events in Lynch syndrome-associated adenomas retaining mismatch repair protein expression}, author={M\u00e4ki-Nevala S and Valo S and Ristim\u00e4ki A and Sarhadi V and Knuutila S and Nystr\u00f6m M and Renkonen-Sinisalo L and Lepist\u00f6 A and Mecklin JP and Peltom\u00e4ki P}, journal={EBioMedicine}}"}, "is_sup_mat_match": false}, {"pmid": 24170544, "pmcid": "PMC4141655", "title": "Modeling RAS phenotype in colorectal cancer uncovers novel molecular traits of RAS dependency and improves prediction of response to targeted agents in patients", "journal": "Clin Cancer Res", "authors": ["Guinney J", "Fert\u00e9 C", "Dry J", "McEwen R", "Manceau G", "Kao KJ", "Chang KM", "Bendtsen C", "Hudson K", "Huang E", "Dougherty B", "Ducreux M", "Soria JC", "Friend S", "Derry J", "Laurent-Puig P"], "date": "2014-01-01T00:00:00Z", "year": 2014, "snippets": [{"_id": "24170544@8887", "snip_text": "The RIS of KRAS p.A146T and p.G13D samples was significantly lower than samples with a KRAS codon 12 mutations mutation (Figure 1B).", "section": "results", "mentions": ["11|4|gene|ncbi_gene@3845|KRAS", "16|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "28|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "4|3|gene|ncbi_gene@51285|RIS", "87|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "The RIS of KRAS <m>p.A146T</m> and p.G13D samples was significantly lower than samples with a KRAS codon 12 mutations mutation (Figure 1B)."}], "citations": {"NLM": "Guinney J, Fert\u00e9 C, Dry J, McEwen R, Manceau G, Kao KJ, Chang KM, Bendtsen C, Hudson K, Huang E, Dougherty B, Ducreux M, Soria JC, Friend S, Derry J, Laurent-Puig P. Modeling RAS phenotype in colorectal cancer uncovers novel molecular traits of RAS dependency and improves prediction of response to targeted agents in patients Clin Cancer Res. PMID: 24170544", "BibTeX": "@article{24170544, title={Modeling RAS phenotype in colorectal cancer uncovers novel molecular traits of RAS dependency and improves prediction of response to targeted agents in patients}, author={Guinney J and Fert\u00e9 C and Dry J and McEwen R and Manceau G and Kao KJ and Chang KM and Bendtsen C and Hudson K and Huang E and Dougherty B and Ducreux M and Soria JC and Friend S and Derry J and Laurent-Puig P}, journal={Clin Cancer Res}}"}, "is_sup_mat_match": false}, {"pmid": 26980732, "pmcid": "PMC4951343", "title": "Genomic markers of panitumumab resistance including ERBB2/ HER2 in a phase II study of KRAS wild-type (wt) metastatic colorectal cancer (mCRC).", "journal": "Oncotarget", "authors": ["Barry GS", "Cheang MC", "Chang HL", "Kennecke HF"], "date": "2016-04-05T00:00:00Z", "year": 2016, "snippets": [{"_id": "26980732@8792", "snip_text": "This G to A transition mutation produced an A146T amino acid change.", "section": "results", "mentions": ["5|6|variant|litvar@#3845#|G to A", "44|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "This G to A transition mutation produced an <m>A146T</m> amino acid change."}], "citations": {"NLM": "Barry GS, Cheang MC, Chang HL, Kennecke HF. Genomic markers of panitumumab resistance including ERBB2/ HER2 in a phase II study of KRAS wild-type (wt) metastatic colorectal cancer (mCRC). Oncotarget. PMID: 26980732", "BibTeX": "@article{26980732, title={Genomic markers of panitumumab resistance including ERBB2/ HER2 in a phase II study of KRAS wild-type (wt) metastatic colorectal cancer (mCRC).}, author={Barry GS and Cheang MC and Chang HL and Kennecke HF}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 36139605, "pmcid": "PMC9496947", "title": "Molecular Divergence upon EGFR-TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR-Sensitizing Mutation.", "journal": "Cancers (Basel)", "authors": ["Serna-Blasco R", "S\u00e1nchez-Herrero E", "Robado de Lope L", "Sanz-Moreno S", "Rodr\u00edguez-Festa A", "Ares-Trotta D", "Cruz-Berm\u00fadez A", "Franco F", "S\u00e1nchez-Hern\u00e1ndez A", "Campayo MJ", "Garc\u00eda-Gir\u00f3n C", "D\u00f3mine M", "Blasco A", "S\u00e1nchez JM", "Oramas J", "Bosch-Barrera J", "Sala M\u00c1", "Sereno M", "Romero A", "Provencio M"], "date": "2022-09-13T00:00:00Z", "year": 2022, "snippets": [{"_id": "36139605@16746", "snip_text": "Eight oncogenic variants in KRAS, namely, p.G12C, p.G12V, p.G12S, p.G12D, p.G15V, p.Q61R, p.Q61H, and p.A146T were detected in seven samples (5.6%) (Table 3).", "section": "results", "mentions": ["42|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "28|4|gene|ncbi_gene@3845|KRAS", "90|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "74|6|variant|litvar@rs1453167097##&&&litvar@#7157#|p.G15V", "58|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "102|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "50|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "82|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "66|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D"], "text_hl": "Eight oncogenic variants in KRAS, namely, p.G12C, p.G12V, p.G12S, p.G12D, p.G15V, p.Q61R, p.Q61H, and <m>p.A146T</m> were detected in seven samples (5.6%) (Table 3)."}], "citations": {"NLM": "Serna-Blasco R, S\u00e1nchez-Herrero E, Robado de Lope L, Sanz-Moreno S, Rodr\u00edguez-Festa A, Ares-Trotta D, Cruz-Berm\u00fadez A, Franco F, S\u00e1nchez-Hern\u00e1ndez A, Campayo MJ, Garc\u00eda-Gir\u00f3n C, D\u00f3mine M, Blasco A, S\u00e1nchez JM, Oramas J, Bosch-Barrera J, Sala M\u00c1, Sereno M, Romero A, Provencio M. Molecular Divergence upon EGFR-TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR-Sensitizing Mutation. Cancers (Basel). PMID: 36139605", "BibTeX": "@article{36139605, title={Molecular Divergence upon EGFR-TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR-Sensitizing Mutation.}, author={Serna-Blasco R and S\u00e1nchez-Herrero E and Robado de Lope L and Sanz-Moreno S and Rodr\u00edguez-Festa A and Ares-Trotta D and Cruz-Berm\u00fadez A and Franco F and S\u00e1nchez-Hern\u00e1ndez A and Campayo MJ and Garc\u00eda-Gir\u00f3n C and D\u00f3mine M and Blasco A and S\u00e1nchez JM and Oramas J and Bosch-Barrera J and Sala M\u00c1 and Sereno M and Romero A and Provencio M}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 38347643, "pmcid": "PMC10863183", "title": "Oncogenic alterations in advanced NSCLC: a molecular super-highway", "journal": "Biomark Res", "authors": ["Friedlaender A", "Perol M", "Banna GL", "Parikh K", "Addeo A"], "date": "2024-02-12T00:00:00Z", "year": 2024, "snippets": [{"_id": "38347643@39708", "snip_text": "On the other hand, KRAS A146T, which is the most common KRAS mutation in gastrointestinal cancers, does not involve dysregulated GTP hydrolysis.", "section": "introduction", "mentions": ["24|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "19|4|gene|ncbi_gene@3845|KRAS", "56|4|gene|ncbi_gene@3845|KRAS", "129|3|chemical|ncbi_mesh@D006160|GTP"], "text_hl": "On the other hand, KRAS <m>A146T</m>, which is the most common KRAS mutation in gastrointestinal cancers, does not involve dysregulated GTP hydrolysis."}], "citations": {"NLM": "Friedlaender A, Perol M, Banna GL, Parikh K, Addeo A. Oncogenic alterations in advanced NSCLC: a molecular super-highway Biomark Res. PMID: 38347643", "BibTeX": "@article{38347643, title={Oncogenic alterations in advanced NSCLC: a molecular super-highway}, author={Friedlaender A and Perol M and Banna GL and Parikh K and Addeo A}, journal={Biomark Res}}"}, "is_sup_mat_match": false}, {"pmid": 30472330, "title": "A Novel Multiplex Droplet Digital PCR Assay to Identify and Quantify KRAS Mutations in Clinical Specimens.", "journal": "J Mol Diagn", "authors": ["Alcaide M", "Cheung M", "Bushell K", "Arthur SE", "Wong HL", "Karasinska J", "Renouf D", "Schaeffer DF", "McNamara S", "Tertre MCD", "Batist G", "Kennecke HF", "Karsan A", "Morin RD"], "date": "2018-11-22T00:00:00Z", "year": 2018, "snippets": [{"_id": "30472330@963", "snip_text": "We have validated 13 mutations (G12S, G12R, G12D, G12A, G12V, G12C, G13D, G60V, Q61H, Q61L, A146V, A146T, and A146P) and focal KRAS amplifications by conducting this assay in a cohort of 100 DNA samples extracted from fresh frozen tumor biopsies, formaldehyde-fixed, paraffin-embedded tissue, and liquid biopsy specimens.", "section": "abstract", "mentions": ["44|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "62|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "110|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "127|4|gene|ncbi_gene@3845|KRAS", "56|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "99|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "74|4|variant|litvar@rs727503108##&&&litvar@#3845#&&&litvar@CA176493#rs727503108##|G60V", "92|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "86|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|Q61L", "68|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "38|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "247|12|chemical|ncbi_mesh@D005557|formaldehyde", "50|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "267|8|chemical|ncbi_mesh@D010232|paraffin", "231|5|disease|ncbi_mesh@D009369|tumor", "32|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "80|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H"], "text_hl": "We have validated 13 mutations (G12S, G12R, G12D, G12A, G12V, G12C, G13D, G60V, Q61H, Q61L, A146V, <m>A146T</m>, and A146P) and focal KRAS amplifications by conducting this assay in a cohort of 100 DNA samples extracted from fresh frozen tumor biopsies, formaldehyde-fixed, paraffin-embedded tissue, and liquid biopsy specimens."}], "citations": {"NLM": "Alcaide M, Cheung M, Bushell K, Arthur SE, Wong HL, Karasinska J, Renouf D, Schaeffer DF, McNamara S, Tertre MCD, Batist G, Kennecke HF, Karsan A, Morin RD. A Novel Multiplex Droplet Digital PCR Assay to Identify and Quantify KRAS Mutations in Clinical Specimens. J Mol Diagn. PMID: 30472330", "BibTeX": "@article{30472330, title={A Novel Multiplex Droplet Digital PCR Assay to Identify and Quantify KRAS Mutations in Clinical Specimens.}, author={Alcaide M and Cheung M and Bushell K and Arthur SE and Wong HL and Karasinska J and Renouf D and Schaeffer DF and McNamara S and Tertre MCD and Batist G and Kennecke HF and Karsan A and Morin RD}, journal={J Mol Diagn}}"}, "is_sup_mat_match": false}, {"pmid": 29029440, "pmcid": "PMC5630340", "title": "Colorectal carcinoma with osseous metaplasia", "journal": "Oncotarget", "authors": ["Liu X", "Xu J", "Chen L"], "date": "2017-06-20T00:00:00Z", "year": 2017, "snippets": [{"_id": "29029440@6107", "snip_text": "Examination for KRAS/NRAS/BRAF mutations revealed a KRAS exon 4 mutation (K117N, A146T, A146V or A146P), but neither NRAS nor BRAF gene mutation was found.", "section": "results", "mentions": ["97|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "81|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "52|4|gene|ncbi_gene@3845|KRAS", "117|4|gene|ncbi_gene@4893|NRAS", "26|4|gene|ncbi_gene@673|BRAF", "74|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "126|4|gene|ncbi_gene@673|BRAF", "16|4|gene|ncbi_gene@3845|KRAS", "88|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "21|4|gene|ncbi_gene@4893|NRAS"], "text_hl": "Examination for KRAS/NRAS/BRAF mutations revealed a KRAS exon 4 mutation (K117N, <m>A146T</m>, A146V or A146P), but neither NRAS nor BRAF gene mutation was found."}], "citations": {"NLM": "Liu X, Xu J, Chen L. Colorectal carcinoma with osseous metaplasia Oncotarget. PMID: 29029440", "BibTeX": "@article{29029440, title={Colorectal carcinoma with osseous metaplasia}, author={Liu X and Xu J and Chen L}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 35070984, "pmcid": "PMC8766810", "title": "Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer.", "journal": "Front Oncol", "authors": ["Shen M", "Qi R", "Ren J", "Lv D", "Yang H"], "date": "2022-01-05T00:00:00Z", "year": 2022, "snippets": [{"_id": "35070984@10636", "snip_text": "For example, although substitutions of KRAS G12, G13, and Q61 attenuate GTP hydrolysis capacity, other mutations such as KRAS A146T maintained hydrolysis levels similar to wild-type (WT) KRAS.", "section": "other", "mentions": ["49|3|variant|litvar@rs112445441##&&&litvar@#3845#|G13", "39|4|gene|ncbi_gene@3845|KRAS", "72|3|chemical|ncbi_mesh@D006160|GTP", "44|3|variant|litvar@rs121913529##&&&litvar@#3845#|G12", "126|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "121|4|gene|ncbi_gene@3845|KRAS", "187|4|gene|ncbi_gene@3845|KRAS", "58|3|variant|litvar@rs137853081##&&&litvar@#6794#|Q61"], "text_hl": "For example, although substitutions of KRAS G12, G13, and Q61 attenuate GTP hydrolysis capacity, other mutations such as KRAS <m>A146T</m> maintained hydrolysis levels similar to wild-type (WT) KRAS."}], "citations": {"NLM": "Shen M, Qi R, Ren J, Lv D, Yang H. Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer. Front Oncol. PMID: 35070984", "BibTeX": "@article{35070984, title={Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer.}, author={Shen M and Qi R and Ren J and Lv D and Yang H}, journal={Front Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 28683746, "pmcid": "PMC5498998", "title": "Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies", "journal": "Mol Cancer", "authors": ["Berg KCG", "Eide PW", "Eilertsen IA", "Johannessen B", "Bruun J", "Danielsen SA", "Bj\u00f8rnslett M", "Meza-Zepeda LA", "Ekn\u00e6s M", "Lind GE", "Myklebost O", "Skotheim RI", "Sveen A", "Lothe RA"], "date": "2017-07-06T00:00:00Z", "year": 2017, "snippets": [{"_id": "28683746@22723", "snip_text": "\tTP53\tKRAS\tBRAF\tPIK3CA\tPTEN\tMSI\tCIMP\t \tCaCo2\tp.E204X\twt\twt\twt\twt\tMSS\tCIMP-\t \tCL-11a\tp.S215N\tp.V14I; p.Q61H\twt\twt\twt\tMSS\tCIMP+\t \tCL-34a\tp.S127P; p.K382fs\twt\tp.V600E\twt\twt\tMSI\tCIMP+\t \tCL-40a\tp.R248Q\tp.G12D\twt\twt\twt\tMSS\tCIMP+\t \tCo115\twt\twt\tp.V600E\twt\tp.E157fs; p.R233X\tMSI\tCIMP+\t \tColo205b\tp.Y107fs; p.Y103fs\twt\tp.V600E\twt\twt\tMSS\tCIMP+\t \tColo320\tp.R248W\twt\twt\twt\twt\tMSS\tCIMP-\t \tColo678a\twt\tp.G12D\twt\twt\twt\tMSS\tCIMP+\t \tDLD-1\tp.S241F\tp.G13D\twt\tp.E545K; p.D549N\twt\tMSI\tCIMP+\t \tEB\twt\tp.G12D\twt\tp.E545K\twt\tMSS\tCIMP+\t \tFRI\tp.C277F\tp.G13D\twt\tp.E545K\twt\tMSS\tCIMP-\t \tHCC2998b\tp.R213X\tp.A146T\twt\twt\tp.Y46C; p.R130Q; p.F341V\tMSS\tCIMP-\t \tHCT116\twt\tp.G13D\twt\tp.H1047R\twt\tMSI\tCIMP+\t \tHCT15\tp.S241F\tp.G13D\twt\tp.E545K; p.D549N\twt\tMSI\tCIMP+\t \tHT29\tp.R273H\twt\tp.V600E; p.T119Sc\twt\twt\tMSS\tCIMP+\t \tIS1\tp.Y163H\tp.G12D\twt\twt\twt\tMSS\tCIMP-\t \tIS3\tp.Y163H\tp.G12D\twt\twt\twt\tMSS\tCIMP-\t \tKM12b\tp.P72fs; p.H179R\twt\tp.P403fs\twt\tp.G129X; p.K267fs\tMSI\tCIMP+\t \tLoVo\twt\tp.G13D; p.V14A\twt\twt\twt\tMSI\tCIMP-\t \tLS1034\tp.G245S\tp.A146T\twt\twt\twt\tMSS\tCIMP-\t \tLS174T\twt\tp.G12D\tp.D211Gc\tp.H1047R\twt\tMSI\tCIMP-\t \tNCI-H508\tp.R273H\twt\tp.G596R\tp.E545K\twt\tMSS\tCIMP-\t \tRKO\twt\twt\tp.V600E\tp.H1047R\twt\tMSI\tCIMP+\t \tSW1116\tp.A159D\tp.G12A\twt\twt\twt\tMSS\tCIMP-\t \tSW1463a\tp.R248Q\tp.G12C\twt\twt\twt\tMSS\tCIMP-\t \tSW403a\tp.E51X\tp.G12V\twt\twt\twt\tMSS\tCIMP-\t \tSW48\twt\twt\tp.R347Xc\tp.G914Rc\twt\tMSI\tCIMP+\t \tSW480\tp.R273H; p.P309S\tp.G12V\twt\twt\twt\tMSS\tCIMP-\t \tSW620\tp.R273H; p.P309S\tp.G12V\twt\twt\twt\tMSS\tCIMP-\t \tSW837a\tp.R248W\tp.G12C\twt\twt\twt\tMSS\tCIMP+\t \tSW948\tp.G117fs\tp.Q61L\twt\tp.E542K\twt\tMSS\tCIMP-\t \tTC71\tp.C176Y; p.R213X\tp.G12D\twt\tp.R88Qc\tp.R233X\tMSI\tCIMP-\t \tV9P\tp.G245D\twt\twt\twt\twt\tMSS\tCIMP-\t \tWiDr\tp.R273H\twt\tp.V600E; p.T119Sc\twt\twt\tMSS\tCIMP+\t \t", "section": "table", "mentions": ["819|7|variant|litvar@#260402#p.Y163H&&&litvar@#260402#|p.Y163H", "691|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "439|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "881|8|variant|litvar@#260402#p.P403fsX&&&litvar@#260402#|p.P403fs", "787|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "681|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "248|8|variant|litvar@#5728#p.E157fsX&&&litvar@#5728#|p.E157fs", "1215|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "779|7|variant|litvar@#260402#p.Y163H&&&litvar@#260402#|p.Y163H", "429|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "45|7|variant|litvar@#5728#p.E204X&&&litvar@#5728#|p.E204X", "1436|7|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|p.R248W", "1130|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.H1047R", "16|6|gene|ncbi_gene@5290|PIK3CA", "586|6|variant|litvar@#260402#p.Y46C&&&litvar@#260402#|p.Y46C", "1446|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "564|7|variant|litvar@#260402#p.R213X&&&litvar@#260402#|p.R213X", "984|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "156|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "1161|7|variant|litvar@#260402#p.A159D&&&litvar@#260402#|p.A159D", "144|8|variant|litvar@#5728#p.K382fsX&&&litvar@#5728#|p.K382fs", "23|4|gene|ncbi_gene@5728|PTEN", "1171|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12A", "522|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "974|7|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|p.G245S", "1584|7|variant|litvar@#260402#p.G245D&&&litvar@#260402#|p.G245D", "775|3|gene|ncbi_gene@260402|IS1", "189|7|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|p.R248Q", "633|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "6|4|gene|ncbi_gene@3845|KRAS", "1525|7|variant|litvar@#260402#p.C176Y&&&litvar@#260402#|p.C176Y", "287|8|variant|litvar@#5728#p.Y107fsX&&&litvar@#5728#|p.Y107fs", "1542|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1248|6|variant|litvar@#260402#p.E51X&&&litvar@#260402#|p.E51X", "902|8|variant|litvar@#260402#p.K267fsX&&&litvar@#260402#|p.K267fs", "1089|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "594|7|variant|litvar@rs121909229##&&&litvar@#5728#&&&litvar@CA437#rs121909229##|p.R130Q", "1342|7|variant|litvar@#260402#p.P309S&&&litvar@#260402#|p.P309S", "1487|6|variant|litvar@#673#p.Q61L&&&litvar@#673#|p.Q61L", "11|4|gene|ncbi_gene@673|BRAF", "1384|7|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|p.R273H", "1401|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "92|6|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|p.V14I", "728|7|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|p.R273H", "673|7|variant|litvar@rs28934573##&&&litvar@#7157#&&&litvar@CA359#rs28934573##|p.S241F", "1122|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "1205|7|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|p.R248Q", "1632|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "1037|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.H1047R", "827|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "893|7|variant|litvar@#260402#p.G129X&&&litvar@#260402#|p.G129X", "387|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "237|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "574|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1255|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "643|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.H1047R", "1021|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "421|7|variant|litvar@rs28934573##&&&litvar@#7157#&&&litvar@CA359#rs28934573##|p.S241F", "343|7|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|p.R248W", "939|6|variant|litvar@rs104894365##&&&litvar@#3845#|p.V14A", "1560|7|variant|litvar@rs121909219##&&&litvar@#5728#&&&litvar@CA549#rs121909219##|p.R233X", "532|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "514|7|variant|litvar@#260402#p.C277F&&&litvar@#260402#|p.C277F", "1621|7|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|p.R273H", "739|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "1|4|gene|ncbi_gene@7157|TP53", "477|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1070|7|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|p.R273H", "100|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "1497|7|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.E542K", "487|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "197|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "931|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "1534|7|variant|litvar@#260402#p.R213X&&&litvar@#260402#|p.R213X", "258|7|variant|litvar@rs121909219##&&&litvar@#5728#&&&litvar@CA549#rs121909219##|p.R233X", "84|7|variant|litvar@rs587782177##&&&litvar@#7157#|p.S215N", "309|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "603|7|variant|litvar@#260402#p.F341V&&&litvar@#260402#|p.F341V", "297|8|variant|litvar@#5728#p.Y103fsX&&&litvar@#5728#|p.Y103fs", "135|7|variant|litvar@#5728#p.S127P&&&litvar@#5728#|p.S127P", "1333|7|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|p.R273H", "1350|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "861|7|variant|litvar@#260402#p.P72fsX&&&litvar@#260402#|p.P72fs", "700|7|variant|litvar@#260402#p.D549N&&&litvar@#260402#|p.D549N", "1393|7|variant|litvar@#260402#p.P309S&&&litvar@#260402#|p.P309S", "870|7|variant|litvar@#260402#p.H179R&&&litvar@#260402#|p.H179R", "1081|7|variant|litvar@#260402#p.G596R&&&litvar@#260402#|p.G596R", "448|7|variant|litvar@#260402#p.D549N&&&litvar@#260402#|p.D549N"], "figure_id": "Tab1", "text_hl": "\tTP53\tKRAS\tBRAF\tPIK3CA\tPTEN\tMSI\tCIMP\t \tCaCo2\tp.E204X\twt\twt\twt\twt\tMSS\tCIMP-\t \tCL-11a\tp.S215N\tp.V14I; p.Q61H\twt\twt\twt\tMSS\tCIMP+\t \tCL-34a\tp.S127P; p.K382fs\twt\tp.V600E\twt\twt\tMSI\tCIMP+\t \tCL-40a\tp.R248Q\tp.G12D\twt\twt\twt\tMSS\tCIMP+\t \tCo115\twt\twt\tp.V600E\twt\tp.E157fs; p.R233X\tMSI\tCIMP+\t \tColo205b\tp.Y107fs; p.Y103fs\twt\tp.V600E\twt\twt\tMSS\tCIMP+\t \tColo320\tp.R248W\twt\twt\twt\twt\tMSS\tCIMP-\t \tColo678a\twt\tp.G12D\twt\twt\twt\tMSS\tCIMP+\t \tDLD-1\tp.S241F\tp.G13D\twt\tp.E545K; p.D549N\twt\tMSI\tCIMP+\t \tEB\twt\tp.G12D\twt\tp.E545K\twt\tMSS\tCIMP+\t \tFRI\tp.C277F\tp.G13D\twt\tp.E545K\twt\tMSS\tCIMP-\t \tHCC2998b\tp.R213X\t<m>p.A146T</m>\twt\twt\tp.Y46C; p.R130Q; p.F341V\tMSS\tCIMP-\t \tHCT116\twt\tp.G13D\twt\tp.H1047R\twt\tMSI\tCIMP+\t \tHCT15\tp.S241F\tp.G13D\twt\tp.E545K; p.D549N\twt\tMSI\tCIMP+\t \tHT29\tp.R273H\twt\tp.V600E; p.T119Sc\twt\twt\tMSS\tCIMP+\t \tIS1\tp.Y163H\tp.G12D\twt\twt\twt\tMSS\tCIMP-\t \tIS3\tp.Y163H\tp.G12D\twt\twt\twt\tMSS\tCIMP-\t \tKM12b\tp.P72fs; p.H179R\twt\tp.P403fs\twt\tp.G129X; p.K267fs\tMSI\tCIMP+\t \tLoVo\twt\tp.G13D; p.V14A\twt\twt\twt\tMSI\tCIMP-\t \tLS1034\tp.G245S\t<m>p.A146T</m>\twt\twt\twt\tMSS\tCIMP-\t \tLS174T\twt\tp.G12D\tp.D211Gc\tp.H1047R\twt\tMSI\tCIMP-\t \tNCI-H508\tp.R273H\twt\tp.G596R\tp.E545K\twt\tMSS\tCIMP-\t \tRKO\twt\twt\tp.V600E\tp.H1047R\twt\tMSI\tCIMP+\t \tSW1116\tp.A159D\tp.G12A\twt\twt\twt\tMSS\tCIMP-\t \tSW1463a\tp.R248Q\tp.G12C\twt\twt\twt\tMSS\tCIMP-\t \tSW403a\tp.E51X\tp.G12V\twt\twt\twt\tMSS\tCIMP-\t \tSW48\twt\twt\tp.R347Xc\tp.G914Rc\twt\tMSI\tCIMP+\t \tSW480\tp.R273H; p.P309S\tp.G12V\twt\twt\twt\tMSS\tCIMP-\t \tSW620\tp.R273H; p.P309S\tp.G12V\twt\twt\twt\tMSS\tCIMP-\t \tSW837a\tp.R248W\tp.G12C\twt\twt\twt\tMSS\tCIMP+\t \tSW948\tp.G117fs\tp.Q61L\twt\tp.E542K\twt\tMSS\tCIMP-\t \tTC71\tp.C176Y; p.R213X\tp.G12D\twt\tp.R88Qc\tp.R233X\tMSI\tCIMP-\t \tV9P\tp.G245D\twt\twt\twt\twt\tMSS\tCIMP-\t \tWiDr\tp.R273H\twt\tp.V600E; p.T119Sc\twt\twt\tMSS\tCIMP+\t \t"}], "citations": {"NLM": "Berg KCG, Eide PW, Eilertsen IA, Johannessen B, Bruun J, Danielsen SA, Bj\u00f8rnslett M, Meza-Zepeda LA, Ekn\u00e6s M, Lind GE, Myklebost O, Skotheim RI, Sveen A, Lothe RA. Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies Mol Cancer. PMID: 28683746", "BibTeX": "@article{28683746, title={Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies}, author={Berg KCG and Eide PW and Eilertsen IA and Johannessen B and Bruun J and Danielsen SA and Bj\u00f8rnslett M and Meza-Zepeda LA and Ekn\u00e6s M and Lind GE and Myklebost O and Skotheim RI and Sveen A and Lothe RA}, journal={Mol Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 37958763, "pmcid": "PMC10648112", "title": "Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing", "journal": "Int J Mol Sci", "authors": ["Fernandez SV", "Tan YF", "Rao S", "Fittipaldi P", "Sheriff F", "Borghaei H", "Dotan E", "Winn JS", "Edelman MJ", "Treat J", "Judd J", "Alpaugh RK", "Wang YL", "Yu JQ", "Wasik M", "Baldwin DA"], "date": "2023-10-30T00:00:00Z", "year": 2023, "snippets": [{"_id": "37958763@51092", "snip_text": "Cancer Type\tPatient ID#\tVariant\tVAFPre-Treat.\tVAFPost-Treat.\tCT Scan\t\t \tNSCLCStage IV\tCH-067\tTP53 G245V (exon 7)- Path.\tMonth 00.95%\tMonth 10.32%\tCompared Months 1 vs. -3:Lung and subcimal betterOverall: better(Month 11 under this treatment continue responding)\tMonth 11- Alive\t \tNSCLCStage IV\tHN-008\tEGFR E746_750del (exon19)-PathTP53 N239D (exon 7)- Path.\tMonth 038%33%\tMonth 3(Osimertinib)Not detected 1Not detected 2\tCompared Months 3 vs. 0:Improvement of liver and bone metastasesOverall: better(Month 24: progression)\tMonth 33-Expired(new brain met.)\t \tNSCLCStage IV\tLTW-047\tBRAF G265R (exon 6)- Lik. Path.\tMonth 014.3%\tMonth 322.57%\tCompared Months 4 vs. -1:Lung lesion: stableOverall: same(Month 17: progression)\tMonth 23- Alive\t \tColonStage IV\tRA-027\tKRAS A146T (exon 4)- Path.PIK3CA E545K (exon 10)-Path.TP53 R282W (exon 8)- Path.RAF1 R191I (exon 5)- Unc. sig.\tMonth 04.58%5.10%5.17%6.24%\tMonth 15.33%7.18%7.61%7.92%\tCompared Months-2 vs. 1:New hepatic lesions and portacaval lymph nodesOverall: worst\tMonth 15-Expired\t \tColonStage IV\tEW-034\tKRAS G12C (exon 2)- Path.TP53 R273H (exon 8)- Path.APC S1407fs*3 (exon16)-Lik.Path.\tMonth 01.62%47.39%51% G\tMonth 15.52%4.47%12.60%\tCompared Months 3 vs. 0:Decrease in hepatic tumor burdenOverall: better(Month 9: progression)\tMonth 22-Expired\t \tColonStage IV\tMM-015\tAPC P1443Lfs*30 (exon 16)-Path.BRAF K483E (exon 12)-Lik.Path.KRAS A146V (exon 4)- Path.TP53 R275H (exon 5)- Path.\tMonth 073.48%69% G39.4%71.44%\tMonth 10.94%2.19%1.99%0.83%\tCompared Months 4 vs. -1:Decreasing hepatic and adrenal metastases.Overall: better(Month 3: treatment stopped due toxicity)\tMonth 8- Expired\t \tColonStage IV\tMB-051\tKRAS G12S (exon 2)- Path.TP53 R273H (exon 8)- Path.APC P1319fs*2 (exon 16)- Path.\tMonth 010.82%11%14%\tMonth 12.01%1.86%2.68%\tCompared Months 3 vs. 0:Liver and lung metastases did not show changeOverall: same(Month 7: progression)\tMonth 9- Expired\t \tColonStage IV\tSVO-002\tAPC Y935* (exon 16)- Path.APC P1440fs*33 (exon 16)- Path.KRAS A146T (exon 4)- Path.TP53 E51* (exon 4)- Path.\tMonth 03%3.72%7.65%5.85% R\tMonth 20.54%0.31%1.65%1.63% R\tCompared Months 3 vs. 0:Decreasing hepatic met. Overall: better(Month 12: progression)\tMonth 34-Alive(stable disease)\t \tColonStage IV\tKRS-014\tAPC R564* (exon 14)- Path.NRAS Q61K (exon 3)- Path.TP53 D259Y (exon 7)- Path.\tMonth 030.09%0.28%19.28%\tMonth 24.44%Not detected3.25%\tCompared Months 3 vs. -1:Liver metastases worst and new lung and brain met.Overall: worst(Month 6: progression)\tMonth 15- Expired\t \tBreastStage IV\tCA-062\tPIK3CA I69N (exon 2)- Unc. Sig.PIK3CA H1047R (exon 21)- Path.\tMonth 029.34%27.46%\tMonth 220.67%22.23%\tCompared Months 2 vs. 0:Liver met. worse; lung and bone met. stableOverall: worst(Month 3: progression)\tMonth 13- Expired\t \t", "section": "table", "mentions": ["786|6|gene|ncbi_gene@5290|PIK3CA", "2008|4|gene|ncbi_gene@7157|TP53", "581|4|gene|ncbi_gene@673|BRAF", "301|4|gene|ncbi_gene@1956|EGFR", "1987|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "2284|4|gene|ncbi_gene@7157|TP53", "760|4|gene|ncbi_gene@3845|KRAS", "2527|4|variant|litvar@#5290#p.I69N&&&litvar@#5290#|I69N", "2558|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "1354|5|variant|litvar@rs397507474##&&&litvar@#673#|K483E", "1322|11|variant|litvar@#324#p.P1443LfsX30&&&litvar@#324#|P1443Lfs*30", "1077|4|gene|ncbi_gene@7157|TP53", "1103|3|gene|ncbi_gene@324|APC", "845|5|variant|litvar@#5894#p.R191I&&&litvar@#5894#|R191I", "1705|3|gene|ncbi_gene@324|APC", "1925|3|gene|ncbi_gene@324|APC", "2678|3|gene|ncbi_gene@79811|met", "1410|5|variant|litvar@#7157#p.R275H&&&litvar@#7157#|R275H", "1982|4|gene|ncbi_gene@3845|KRAS", "2233|3|gene|ncbi_gene@324|APC", "336|5|variant|litvar@rs876660807##&&&litvar@#7157#&&&litvar@CA10580926#rs876660807##|N239D", "1679|4|gene|ncbi_gene@7157|TP53", "98|5|variant|litvar@rs121912656##&&&litvar@#7157#&&&litvar@CA1743#rs121912656##|G245V", "1955|10|variant|litvar@rs1131691145##&&&litvar@#324#|P1440fs*33", "1349|4|gene|ncbi_gene@673|BRAF", "1405|4|gene|ncbi_gene@7157|TP53", "840|4|gene|ncbi_gene@5894|RAF1", "1384|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "2551|6|gene|ncbi_gene@5290|PIK3CA", "93|4|gene|ncbi_gene@7157|TP53", "586|5|variant|litvar@rs397516905##&&&litvar@#673#|G265R", "1107|7|variant|litvar@rs863225353##&&&litvar@#324#|S1407fs", "2652|3|gene|ncbi_gene@79811|met", "1052|4|gene|ncbi_gene@3845|KRAS", "819|5|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|R282W", "2259|4|gene|ncbi_gene@4893|NRAS", "765|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "2437|3|gene|ncbi_gene@79811|met", "306|11|variant|litvar@#1956#p.E746_750del&&&litvar@#1956#|E746_750del", "1057|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "2134|3|gene|ncbi_gene@79811|met", "1659|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "1379|4|gene|ncbi_gene@3845|KRAS", "1951|3|gene|ncbi_gene@324|APC", "1654|4|gene|ncbi_gene@3845|KRAS", "2264|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "2520|6|gene|ncbi_gene@5290|PIK3CA", "1709|7|variant|litvar@rs1057517558##&&&litvar@#324#|P1319fs", "2289|5|variant|litvar@rs761250116##&&&litvar@#5424#|D259Y", "1318|3|gene|ncbi_gene@324|APC", "814|4|gene|ncbi_gene@7157|TP53", "551|3|gene|ncbi_gene@79811|met", "1684|5|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|R273H", "1082|5|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|R273H", "793|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K"], "figure_id": "ijms-24-15779-t006", "text_hl": "Cancer Type\tPatient ID#\tVariant\tVAFPre-Treat.\tVAFPost-Treat.\tCT Scan\t\t \tNSCLCStage IV\tCH-067\tTP53 G245V (exon 7)- Path.\tMonth 00.95%\tMonth 10.32%\tCompared Months 1 vs. -3:Lung and subcimal betterOverall: better(Month 11 under this treatment continue responding)\tMonth 11- Alive\t \tNSCLCStage IV\tHN-008\tEGFR E746_750del (exon19)-PathTP53 N239D (exon 7)- Path.\tMonth 038%33%\tMonth 3(Osimertinib)Not detected 1Not detected 2\tCompared Months 3 vs. 0:Improvement of liver and bone metastasesOverall: better(Month 24: progression)\tMonth 33-Expired(new brain met.)\t \tNSCLCStage IV\tLTW-047\tBRAF G265R (exon 6)- Lik. Path.\tMonth 014.3%\tMonth 322.57%\tCompared Months 4 vs. -1:Lung lesion: stableOverall: same(Month 17: progression)\tMonth 23- Alive\t \tColonStage IV\tRA-027\tKRAS A146T (exon 4)- Path.PIK3CA E545K (exon 10)-Path.TP53 R282W (exon 8)- Path.RAF1 R191I (exon 5)- Unc. sig.\tMonth 04.58%5.10%5.17%6.24%\tMonth 15.33%7.18%7.61%7.92%\tCompared Months-2 vs. 1:New hepatic lesions and portacaval lymph nodesOverall: worst\tMonth 15-Expired\t \tColonStage IV\tEW-034\tKRAS G12C (exon 2)- Path.TP53 R273H (exon 8)- Path.APC S1407fs*3 (exon16)-Lik.Path.\tMonth 01.62%47.39%51% G\tMonth 15.52%4.47%12.60%\tCompared Months 3 vs. 0:Decrease in hepatic tumor burdenOverall: better(Month 9: progression)\tMonth 22-Expired\t \tColonStage IV\tMM-015\tAPC P1443Lfs*30 (exon 16)-Path.BRAF K483E (exon 12)-Lik.Path.KRAS A146V (exon 4)- Path.TP53 R275H (exon 5)- Path.\tMonth 073.48%69% G39.4%71.44%\tMonth 10.94%2.19%1.99%0.83%\tCompared Months 4 vs. -1:Decreasing hepatic and adrenal metastases.Overall: better(Month 3: treatment stopped due toxicity)\tMonth 8- Expired\t \tColonStage IV\tMB-051\tKRAS G12S (exon 2)- Path.TP53 R273H (exon 8)- Path.APC P1319fs*2 (exon 16)- Path.\tMonth 010.82%11%14%\tMonth 12.01%1.86%2.68%\tCompared Months 3 vs. 0:Liver and lung metastases did not show changeOverall: same(Month 7: progression)\tMonth 9- Expired\t \tColonStage IV\tSVO-002\tAPC Y935* (exon 16)- Path.APC P1440fs*33 (exon 16)- Path.KRAS A146T (exon 4)- Path.TP53 E51* (exon 4)- Path.\tMonth 03%3.72%7.65%5.85% R\tMonth 20.54%0.31%1.65%1.63% R\tCompared Months 3 vs. 0:Decreasing hepatic met. Overall: better(Month 12: progression)\tMonth 34-Alive(stable disease)\t \tColonStage IV\tKRS-014\tAPC R564* (exon 14)- Path.NRAS Q61K (exon 3)- Path.TP53 D259Y (exon 7)- Path.\tMonth 030.09%0.28%19.28%\tMonth 24.44%Not detected3.25%\tCompared Months 3 vs. -1:Liver metastases worst and new lung and brain met.Overall: worst(Month 6: progression)\tMonth 15- Expired\t \tBreastStage IV\tCA-062\tPIK3CA I69N (exon 2)- Unc. Sig.PIK3CA H1047R (exon 21)- Path.\tMonth 029.34%27.46%\tMonth 220.67%22.23%\tCompared Months 2 vs. 0:Liver met. worse; lung and bone met. stableOverall: worst(Month 3: progression)\tMonth 13- Expired\t \t"}], "citations": {"NLM": "Fernandez SV, Tan YF, Rao S, Fittipaldi P, Sheriff F, Borghaei H, Dotan E, Winn JS, Edelman MJ, Treat J, Judd J, Alpaugh RK, Wang YL, Yu JQ, Wasik M, Baldwin DA. Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing Int J Mol Sci. PMID: 37958763", "BibTeX": "@article{37958763, title={Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing}, author={Fernandez SV and Tan YF and Rao S and Fittipaldi P and Sheriff F and Borghaei H and Dotan E and Winn JS and Edelman MJ and Treat J and Judd J and Alpaugh RK and Wang YL and Yu JQ and Wasik M and Baldwin DA}, journal={Int J Mol Sci}}"}, "is_sup_mat_match": false}, {"pmid": 24642870, "pmcid": "PMC4049792", "title": "Characterization of rare transforming KRAS mutations in sporadic colorectal cancer.", "journal": "Cancer Biol Ther", "authors": ["Tong JH", "Lung RW", "Sin FM", "Law PP", "Kang W", "Chan AW", "Ma BB", "Mak TW", "Ng SS", "To KF"], "date": "2014-06-01T00:00:00Z", "year": 2014, "snippets": [{"_id": "24642870@7158", "snip_text": "Mutation Frequency Percentage   Codon 12 505 75.1%   G12D 252 37.5%   G12V 135 20.1%   G12C 46 6.8%   G12S 33 4.9%   G12A 29 4.3%   G12R 10 1.5%   Codon13 130 19.3%   G13D 128 19.0%   G13C 2 0.3%   Codon 61 17 2.5%   Q61H 9 1.3%   Q61L 5 0.7%   Q61K 1 0.1%   Q61R 2 0.3%   Codon 146 18 2.7%   A146T 18 2.7%   Others 2 0.3%   c.30_31insGGA, p.G10_A11insG 1 0.1%   c.33_34insGGAGCT:p.A11_G12insGA 1 0.1%   Total 672a 100%   ", "section": "table", "mentions": ["363|16|variant|litvar@#3845#c.33_34insGGAGCT&&&litvar@#3845#|c.33_34insGGAGCT", "102|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "184|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "231|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "132|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "245|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "325|13|variant|litvar@#3845#p.G30_31ins&&&litvar@#3845#|c.30_31insGGA", "70|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "167|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "217|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "259|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "293|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "53|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "380|14|variant|litvar@#3845#p.GA12ins&&&litvar@#3845#|p.A11_G12insGA", "87|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "117|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A"], "figure_id": "T2", "text_hl": "Mutation Frequency Percentage   Codon 12 505 75.1%   G12D 252 37.5%   G12V 135 20.1%   G12C 46 6.8%   G12S 33 4.9%   G12A 29 4.3%   G12R 10 1.5%   Codon13 130 19.3%   G13D 128 19.0%   G13C 2 0.3%   Codon 61 17 2.5%   Q61H 9 1.3%   Q61L 5 0.7%   Q61K 1 0.1%   Q61R 2 0.3%   Codon 146 18 2.7%   <m>A146T</m> 18 2.7%   Others 2 0.3%   c.30_31insGGA, p.G10_A11insG 1 0.1%   c.33_34insGGAGCT:p.A11_G12insGA 1 0.1%   Total 672a 100%   "}], "citations": {"NLM": "Tong JH, Lung RW, Sin FM, Law PP, Kang W, Chan AW, Ma BB, Mak TW, Ng SS, To KF. Characterization of rare transforming KRAS mutations in sporadic colorectal cancer. Cancer Biol Ther. PMID: 24642870", "BibTeX": "@article{24642870, title={Characterization of rare transforming KRAS mutations in sporadic colorectal cancer.}, author={Tong JH and Lung RW and Sin FM and Law PP and Kang W and Chan AW and Ma BB and Mak TW and Ng SS and To KF}, journal={Cancer Biol Ther}}"}, "is_sup_mat_match": false}, {"pmid": 30634950, "pmcid": "PMC6329170", "title": "Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review.", "journal": "BMC Cancer", "authors": ["Abe M", "Watanabe K", "Shinozaki-Ushiku A", "Ushiku T", "Abe T", "Fujihara Y", "Amano Y", "Zong L", "Wang CP", "Kubo E", "Inaki R", "Kinoshita N", "Yamashita S", "Takai D", "Ushijima T", "Nagase T", "Hoshi K"], "date": "2019-01-11T00:00:00Z", "year": 2019, "snippets": [{"_id": "30634950@14050", "snip_text": "In salivary grand cancer, two sarcomatoid salivary duct carcinomas were reported to show KRAS mutations (A146T and Q61H).", "section": "discussion", "mentions": ["105|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "115|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "89|4|gene|ncbi_gene@3845|KRAS", "3|21|disease|ncbi_mesh@D009369|salivary grand cancer", "30|36|disease|ncbi_mesh@D002292|sarcomatoid salivary duct carcinomas"], "text_hl": "In salivary grand cancer, two sarcomatoid salivary duct carcinomas were reported to show KRAS mutations (<m>A146T</m> and Q61H)."}], "citations": {"NLM": "Abe M, Watanabe K, Shinozaki-Ushiku A, Ushiku T, Abe T, Fujihara Y, Amano Y, Zong L, Wang CP, Kubo E, Inaki R, Kinoshita N, Yamashita S, Takai D, Ushijima T, Nagase T, Hoshi K. Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review. BMC Cancer. PMID: 30634950", "BibTeX": "@article{30634950, title={Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review.}, author={Abe M and Watanabe K and Shinozaki-Ushiku A and Ushiku T and Abe T and Fujihara Y and Amano Y and Zong L and Wang CP and Kubo E and Inaki R and Kinoshita N and Yamashita S and Takai D and Ushijima T and Nagase T and Hoshi K}, journal={BMC Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 36902296, "pmcid": "PMC10003572", "title": "KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas", "journal": "Int J Mol Sci", "authors": ["Martianov AS", "Mitiushkina NV", "Ershova AN", "Martynenko DE", "Bubnov MG", "Amankwah P", "Yanus GA", "Aleksakhina SN", "Tiurin VI", "Venina AR", "Anuskina AA", "Gorgul YA", "Shestakova AD", "Maidin MA", "Belyaev AM", "Baboshkina LS", "Iyevleva AG", "Imyanitov EN"], "date": "2023-03-02T00:00:00Z", "year": 2023, "snippets": [{"_id": "36902296@5148", "snip_text": "A total of 3913/4137 (94.6%) mutations affected hot-spots and had a frequency above 1% among KRAS-mutated CRCs (G12D: 1193 (28.8%), G12V: 874 (21.1%), G13D: 727 (17.6%), G12C: 276 (6.7%), A146T: 235 (5.7%), G12A: 206 (5.0%), G12S: 200 (4.8%), Q61H: 108 (2.6%), A146V: 51 (1.2%), G12R: 43 (1.0%)).", "section": "results", "mentions": ["151|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "207|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "132|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "106|4|disease|ncbi_mesh@D009369|CRCs", "93|4|gene|ncbi_gene@3845|KRAS", "170|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "112|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "243|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "188|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "261|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V"], "text_hl": "A total of 3913/4137 (94.6%) mutations affected hot-spots and had a frequency above 1% among KRAS-mutated CRCs (G12D: 1193 (28.8%), G12V: 874 (21.1%), G13D: 727 (17.6%), G12C: 276 (6.7%), <m>A146T</m>: 235 (5.7%), G12A: 206 (5.0%), G12S: 200 (4.8%), Q61H: 108 (2.6%), A146V: 51 (1.2%), G12R: 43 (1.0%))."}], "citations": {"NLM": "Martianov AS, Mitiushkina NV, Ershova AN, Martynenko DE, Bubnov MG, Amankwah P, Yanus GA, Aleksakhina SN, Tiurin VI, Venina AR, Anuskina AA, Gorgul YA, Shestakova AD, Maidin MA, Belyaev AM, Baboshkina LS, Iyevleva AG, Imyanitov EN. KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas Int J Mol Sci. PMID: 36902296", "BibTeX": "@article{36902296, title={KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas}, author={Martianov AS and Mitiushkina NV and Ershova AN and Martynenko DE and Bubnov MG and Amankwah P and Yanus GA and Aleksakhina SN and Tiurin VI and Venina AR and Anuskina AA and Gorgul YA and Shestakova AD and Maidin MA and Belyaev AM and Baboshkina LS and Iyevleva AG and Imyanitov EN}, journal={Int J Mol Sci}}"}, "is_sup_mat_match": false}, {"pmid": 23396385, "pmcid": "PMC3584721", "title": "Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules.", "journal": "Blood Cancer J", "authors": ["Leich E", "Wei\u00dfbach S", "Klein HU", "Grieb T", "Pischimarov J", "St\u00fchmer T", "Chatterjee M", "Steinbrunn T", "Langer C", "Eilers M", "Knop S", "Einsele H", "Bargou R", "Rosenwald A"], "date": "2013-02-08T00:00:00Z", "year": 2013, "snippets": [{"_id": "23396385@17564", "snip_text": "For example, in the cell line AMO1, mutations potentially affecting the mitogen-activated protein kinase pathway were found for EGFR, ERBB3, KRAS (A146T) and MAP2K2.", "section": "results", "mentions": ["128|4|gene|ncbi_gene@1956|EGFR", "141|4|gene|ncbi_gene@3845|KRAS", "134|5|gene|ncbi_gene@2065|ERBB3", "158|6|gene|ncbi_gene@5605|MAP2K2", "147|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "For example, in the cell line AMO1, mutations potentially affecting the mitogen-activated protein kinase pathway were found for EGFR, ERBB3, KRAS (<m>A146T</m>) and MAP2K2."}], "citations": {"NLM": "Leich E, Wei\u00dfbach S, Klein HU, Grieb T, Pischimarov J, St\u00fchmer T, Chatterjee M, Steinbrunn T, Langer C, Eilers M, Knop S, Einsele H, Bargou R, Rosenwald A. Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules. Blood Cancer J. PMID: 23396385", "BibTeX": "@article{23396385, title={Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules.}, author={Leich E and Wei\u00dfbach S and Klein HU and Grieb T and Pischimarov J and St\u00fchmer T and Chatterjee M and Steinbrunn T and Langer C and Eilers M and Knop S and Einsele H and Bargou R and Rosenwald A}, journal={Blood Cancer J}}"}, "is_sup_mat_match": false}, {"pmid": 37421589, "pmcid": "PMC10777533", "title": "Characterizing dry mass and volume changes in human multiple myeloma cells upon treatment with proteotoxic and genotoxic drugs", "journal": "Clin Exp Med", "authors": ["Liu X", "Moscvin M", "Oh S", "Chen T", "Choi W", "Evans B", "Rowell SM", "Nadeem O", "Mo CC", "Sperling AS", "Anderson KC", "Yaqoob Z", "Bianchi G", "Sung Y"], "date": "2023-11-01T00:00:00Z", "year": 2023, "snippets": [{"_id": "37421589@28399", "snip_text": "Furthermore, our observations were reproducible on 4 MM cell lines characterized by different genetic mutations: RPMI8226 is characterized by t(16:22) and t(8:22), G12A heterozygous mutation in KRAS, and a E285K homozygous mutation in TP53; MM.1S harbors a t(14:16) and a t(8:14), a heterozygous G12A KRAS mutation and is TP53 wild type (WT); KMS20 carries a G12S homozygous mutation in KRAS and a Y126X homozygous mutation in TP53; AMO1 harbors a t(12:14), heterozygous A146T KRAS mutation and is WT for TP53.", "section": "discussion", "mentions": ["301|4|gene|ncbi_gene@3845|KRAS", "206|5|variant|litvar@rs112431538##&&&litvar@#7157#&&&litvar@CA16620615#rs112431538##|E285K", "359|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "241|5|cellline||MM.1S", "322|4|gene|ncbi_gene@7157|TP53", "113|8|cellline||RPMI8226", "235|4|gene|ncbi_gene@7157|TP53", "164|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "471|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "53|2|disease|ncbi_mesh@D009101|MM", "343|5|cellline||KMS20", "194|4|gene|ncbi_gene@3845|KRAS", "387|4|gene|ncbi_gene@3845|KRAS", "477|4|gene|ncbi_gene@3845|KRAS", "398|5|variant|litvar@#3845#p.Y126X&&&litvar@#3845#|Y126X", "296|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "505|4|gene|ncbi_gene@7157|TP53", "427|4|gene|ncbi_gene@7157|TP53"], "text_hl": "Furthermore, our observations were reproducible on 4 MM cell lines characterized by different genetic mutations: RPMI8226 is characterized by t(16:22) and t(8:22), G12A heterozygous mutation in KRAS, and a E285K homozygous mutation in TP53; MM.1S harbors a t(14:16) and a t(8:14), a heterozygous G12A KRAS mutation and is TP53 wild type (WT); KMS20 carries a G12S homozygous mutation in KRAS and a Y126X homozygous mutation in TP53; AMO1 harbors a t(12:14), heterozygous <m>A146T</m> KRAS mutation and is WT for TP53."}], "citations": {"NLM": "Liu X, Moscvin M, Oh S, Chen T, Choi W, Evans B, Rowell SM, Nadeem O, Mo CC, Sperling AS, Anderson KC, Yaqoob Z, Bianchi G, Sung Y. Characterizing dry mass and volume changes in human multiple myeloma cells upon treatment with proteotoxic and genotoxic drugs Clin Exp Med. PMID: 37421589", "BibTeX": "@article{37421589, title={Characterizing dry mass and volume changes in human multiple myeloma cells upon treatment with proteotoxic and genotoxic drugs}, author={Liu X and Moscvin M and Oh S and Chen T and Choi W and Evans B and Rowell SM and Nadeem O and Mo CC and Sperling AS and Anderson KC and Yaqoob Z and Bianchi G and Sung Y}, journal={Clin Exp Med}}"}, "is_sup_mat_match": false}, {"pmid": 27689078, "pmcid": "PMC5023838", "title": "Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?", "journal": "Biomed Res Int", "authors": ["Martinez-Useros J", "Garcia-Foncillas J"], "date": "2016-01-01T00:00:00Z", "year": 2016, "snippets": [{"_id": "27689078@44272", "snip_text": "Manufacturer Methods KRAS codons Mutations Exons Commercial kit  Mean sensitivity  References   Roche Real-time PCR 12 and 13 G12A; G12D; G12R; G12C; G12S; G12V; G13D 2 Cobas  KRAS Mutation Test 2.8%    Qiagen Pyrosequencing 12, 13, 61 G12A; G12D; G12R; G12C; G12S; G12V; G13D; Q61H; Q61L; Q61R; Q61H; Q61E 2 and 3 Therascreen  KRAS Pyro 2.3%    Qiagen Pyrosequencing  59, 61, 117, 146 A59T; A59G; Q61H; Q61L; Q61R; Q61H; Q61E; K117N; K117N; A146T; A146P; A146V 3 and 4 RAS Extension Pyro V2 4.1%    Qiagen Real-time PCR 12 and 13 G12A; G12D; G12R; G12C; G12S; G12V; G13D 2 THERASCREEN KRAS RGQ PCR 3.5%    ", "section": "table", "mentions": ["586|4|gene|ncbi_gene@3845|KRAS", "549|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "260|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "398|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "416|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "21|4|gene|ncbi_gene@3845|KRAS", "302|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "150|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "531|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "242|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "132|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "296|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "456|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "555|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "266|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "428|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "156|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "284|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|Q61L", "422|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "537|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "248|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "442|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "386|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "290|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|Q61R", "138|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "404|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|Q61L", "561|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "162|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "410|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|Q61R", "543|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "254|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "392|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59G", "126|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "144|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "272|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "328|4|gene|ncbi_gene@3845|KRAS", "176|4|gene|ncbi_gene@3845|KRAS", "435|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "236|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "567|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "278|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "449|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P"], "figure_id": "tab3", "text_hl": "Manufacturer Methods KRAS codons Mutations Exons Commercial kit  Mean sensitivity  References   Roche Real-time PCR 12 and 13 G12A; G12D; G12R; G12C; G12S; G12V; G13D 2 Cobas  KRAS Mutation Test 2.8%    Qiagen Pyrosequencing 12, 13, 61 G12A; G12D; G12R; G12C; G12S; G12V; G13D; Q61H; Q61L; Q61R; Q61H; Q61E 2 and 3 Therascreen  KRAS Pyro 2.3%    Qiagen Pyrosequencing  59, 61, 117, 146 A59T; A59G; Q61H; Q61L; Q61R; Q61H; Q61E; K117N; K117N; <m>A146T</m>; A146P; A146V 3 and 4 RAS Extension Pyro V2 4.1%    Qiagen Real-time PCR 12 and 13 G12A; G12D; G12R; G12C; G12S; G12V; G13D 2 THERASCREEN KRAS RGQ PCR 3.5%    "}], "citations": {"NLM": "Martinez-Useros J, Garcia-Foncillas J. Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis? Biomed Res Int. PMID: 27689078", "BibTeX": "@article{27689078, title={Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?}, author={Martinez-Useros J and Garcia-Foncillas J}, journal={Biomed Res Int}}"}, "is_sup_mat_match": false}, {"pmid": 32914004, "pmcid": "PMC7450915", "title": "Exploitation of Precision Medicine Trials Data: Examples of Long Responders From the SHIVA01 Trial.", "journal": "JCO Precis Oncol", "authors": ["Basse C", "Morel C", "Callens C", "Pierron G", "Servois V", "Vincent-Salomon A", "Jobard A", "Alt M", "Ricci F", "Loirat D", "Sablin MP", "Bretagne M", "Saint-Ghislain M", "Hescot S", "Gon\u00e7alves A", "Tredan O", "Dubot C", "Gavoille C", "Delord JP", "Campone M", "Isambert N", "Belin L", "Bieche I", "Kamal M", "Le Tourneau C"], "date": "2018-10-19T00:00:00Z", "year": 2018, "snippets": [{"_id": "32914004@10581", "snip_text": "Theonly patient with breast cancer treated with everolimus who experienced a complete response had a PIK3CA mutation (Glu545Lys), as well as a KRAS mutation (Ala146Thr), associated with heterozygous deletions in the ATM, BRCA2, CDH1, PTEN, RB1, SMAD4, and TP53 genes (Table 2 and Data Supplement).", "section": "results", "mentions": ["240|3|gene|ncbi_gene@5925|RB1", "221|5|gene|ncbi_gene@675|BRCA2", "234|4|gene|ncbi_gene@5728|PTEN", "158|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|Ala146Thr", "101|6|gene|ncbi_gene@5290|PIK3CA", "228|4|gene|ncbi_gene@999|CDH1", "216|3|gene|ncbi_gene@472|ATM", "48|10|chemical|ncbi_mesh@D000068338|everolimus", "256|4|gene|ncbi_gene@7157|TP53", "21|13|disease|ncbi_mesh@D001943|breast cancer", "245|5|gene|ncbi_gene@4089|SMAD4", "8|7|species|ncbi_taxonomy@9606|patient", "143|4|gene|ncbi_gene@3845|KRAS", "118|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|Glu545Lys"], "text_hl": "Theonly patient with breast cancer treated with everolimus who experienced a complete response had a PIK3CA mutation (Glu545Lys), as well as a KRAS mutation (<m>Ala146Thr</m>), associated with heterozygous deletions in the ATM, BRCA2, CDH1, PTEN, RB1, SMAD4, and TP53 genes (Table 2 and Data Supplement)."}], "citations": {"NLM": "Basse C, Morel C, Callens C, Pierron G, Servois V, Vincent-Salomon A, Jobard A, Alt M, Ricci F, Loirat D, Sablin MP, Bretagne M, Saint-Ghislain M, Hescot S, Gon\u00e7alves A, Tredan O, Dubot C, Gavoille C, Delord JP, Campone M, Isambert N, Belin L, Bieche I, Kamal M, Le Tourneau C. Exploitation of Precision Medicine Trials Data: Examples of Long Responders From the SHIVA01 Trial. JCO Precis Oncol. PMID: 32914004", "BibTeX": "@article{32914004, title={Exploitation of Precision Medicine Trials Data: Examples of Long Responders From the SHIVA01 Trial.}, author={Basse C and Morel C and Callens C and Pierron G and Servois V and Vincent-Salomon A and Jobard A and Alt M and Ricci F and Loirat D and Sablin MP and Bretagne M and Saint-Ghislain M and Hescot S and Gon\u00e7alves A and Tredan O and Dubot C and Gavoille C and Delord JP and Campone M and Isambert N and Belin L and Bieche I and Kamal M and Le Tourneau C}, journal={JCO Precis Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 30053901, "pmcid": "PMC6064051", "title": "Integrative omics analyses broaden treatment targets in human cancer.", "journal": "Genome Med", "authors": ["Sengupta S", "Sun SQ", "Huang KL", "Oh C", "Bailey MH", "Varghese R", "Wyczalkowski MA", "Ning J", "Tripathi P", "McMichael JF", "Johnson KJ", "Kandoth C", "Welch J", "Ma C", "Wendl MC", "Payne SH", "Feny\u00f6 D", "Townsend RR", "Dipersio JF", "Chen F", "Ding L"], "date": "2018-07-27T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Sengupta S, Sun SQ, Huang KL, Oh C, Bailey MH, Varghese R, Wyczalkowski MA, Ning J, Tripathi P, McMichael JF, Johnson KJ, Kandoth C, Welch J, Ma C, Wendl MC, Payne SH, Feny\u00f6 D, Townsend RR, Dipersio JF, Chen F, Ding L. Integrative omics analyses broaden treatment targets in human cancer. Genome Med. PMID: 30053901", "BibTeX": "@article{30053901, title={Integrative omics analyses broaden treatment targets in human cancer.}, author={Sengupta S and Sun SQ and Huang KL and Oh C and Bailey MH and Varghese R and Wyczalkowski MA and Ning J and Tripathi P and McMichael JF and Johnson KJ and Kandoth C and Welch J and Ma C and Wendl MC and Payne SH and Feny\u00f6 D and Townsend RR and Dipersio JF and Chen F and Ding L}, journal={Genome Med}}"}, "is_sup_mat_match": true}, {"pmid": 27063598, "pmcid": "PMC4972641", "title": "Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia.", "journal": "Leukemia", "authors": ["Madan V", "Shyamsunder P", "Han L", "Mayakonda A", "Nagata Y", "Sundaresan J", "Kanojia D", "Yoshida K", "Ganesan S", "Hattori N", "Fulton N", "Tan KT", "Alpermann T", "Kuo MC", "Rostami S", "Matthews J", "Sanada M", "Liu LZ", "Shiraishi Y", "Miyano S", "Chendamarai E", "Hou HA", "Malnassy G", "Ma T", "Garg M", "Ding LW", "Sun QY", "Chien W", "Ikezoe T", "Lill M", "Biondi A", "Larson RA", "Powell BL", "L\u00fcbbert M", "Chng WJ", "Tien HF", "Heuser M", "Ganser A", "Koren-Michowitz M", "Kornblau SM", "Kantarjian HM", "Nowak D", "Hofmann WK", "Yang H", "Stock W", "Ghavamzadeh A", "Alimoghaddam K", "Haferlach T", "Ogawa S", "Shih LY", "Mathews V", "Koeffler HP"], "date": "2016-08-01T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Madan V, Shyamsunder P, Han L, Mayakonda A, Nagata Y, Sundaresan J, Kanojia D, Yoshida K, Ganesan S, Hattori N, Fulton N, Tan KT, Alpermann T, Kuo MC, Rostami S, Matthews J, Sanada M, Liu LZ, Shiraishi Y, Miyano S, Chendamarai E, Hou HA, Malnassy G, Ma T, Garg M, Ding LW, Sun QY, Chien W, Ikezoe T, Lill M, Biondi A, Larson RA, Powell BL, L\u00fcbbert M, Chng WJ, Tien HF, Heuser M, Ganser A, Koren-Michowitz M, Kornblau SM, Kantarjian HM, Nowak D, Hofmann WK, Yang H, Stock W, Ghavamzadeh A, Alimoghaddam K, Haferlach T, Ogawa S, Shih LY, Mathews V, Koeffler HP. Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia. Leukemia. PMID: 27063598", "BibTeX": "@article{27063598, title={Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia.}, author={Madan V and Shyamsunder P and Han L and Mayakonda A and Nagata Y and Sundaresan J and Kanojia D and Yoshida K and Ganesan S and Hattori N and Fulton N and Tan KT and Alpermann T and Kuo MC and Rostami S and Matthews J and Sanada M and Liu LZ and Shiraishi Y and Miyano S and Chendamarai E and Hou HA and Malnassy G and Ma T and Garg M and Ding LW and Sun QY and Chien W and Ikezoe T and Lill M and Biondi A and Larson RA and Powell BL and L\u00fcbbert M and Chng WJ and Tien HF and Heuser M and Ganser A and Koren-Michowitz M and Kornblau SM and Kantarjian HM and Nowak D and Hofmann WK and Yang H and Stock W and Ghavamzadeh A and Alimoghaddam K and Haferlach T and Ogawa S and Shih LY and Mathews V and Koeffler HP}, journal={Leukemia}}"}, "is_sup_mat_match": true}, {"pmid": 31744909, "pmcid": "PMC7306982", "title": "Genomic and transcriptomic profiling of carcinogenesis in patients with familial adenomatous polyposis.", "journal": "Gut", "authors": ["Li J", "Wang R", "Zhou X", "Wang W", "Gao S", "Mao Y", "Wu X", "Guo L", "Liu H", "Wen L", "Fu W", "Tang F"], "date": "2020-07-01T00:00:00Z", "year": 2020, "snippets": [], "citations": {"NLM": "Li J, Wang R, Zhou X, Wang W, Gao S, Mao Y, Wu X, Guo L, Liu H, Wen L, Fu W, Tang F. Genomic and transcriptomic profiling of carcinogenesis in patients with familial adenomatous polyposis. Gut. PMID: 31744909", "BibTeX": "@article{31744909, title={Genomic and transcriptomic profiling of carcinogenesis in patients with familial adenomatous polyposis.}, author={Li J and Wang R and Zhou X and Wang W and Gao S and Mao Y and Wu X and Guo L and Liu H and Wen L and Fu W and Tang F}, journal={Gut}}"}, "is_sup_mat_match": true}, {"pmid": 31253177, "pmcid": "PMC6599263", "title": "Evolving neoantigen profiles in colorectal cancers with DNA repair defects.", "journal": "Genome Med", "authors": ["Rospo G", "Lorenzato A", "Amirouchene-Angelozzi N", "Magr\u00ec A", "Cancelliere C", "Corti G", "Negrino C", "Amodio V", "Montone M", "Bartolini A", "Barault L", "Novara L", "Isella C", "Medico E", "Bertotti A", "Trusolino L", "Germano G", "Di Nicolantonio F", "Bardelli A"], "date": "2019-06-28T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Rospo G, Lorenzato A, Amirouchene-Angelozzi N, Magr\u00ec A, Cancelliere C, Corti G, Negrino C, Amodio V, Montone M, Bartolini A, Barault L, Novara L, Isella C, Medico E, Bertotti A, Trusolino L, Germano G, Di Nicolantonio F, Bardelli A. Evolving neoantigen profiles in colorectal cancers with DNA repair defects. Genome Med. PMID: 31253177", "BibTeX": "@article{31253177, title={Evolving neoantigen profiles in colorectal cancers with DNA repair defects.}, author={Rospo G and Lorenzato A and Amirouchene-Angelozzi N and Magr\u00ec A and Cancelliere C and Corti G and Negrino C and Amodio V and Montone M and Bartolini A and Barault L and Novara L and Isella C and Medico E and Bertotti A and Trusolino L and Germano G and Di Nicolantonio F and Bardelli A}, journal={Genome Med}}"}, "is_sup_mat_match": true}, {"pmid": 28978093, "pmcid": "PMC5620233", "title": "Molecular characterization of circulating colorectal tumor cells defines genetic signatures for individualized cancer care.", "journal": "Oncotarget", "authors": ["Kong SL", "Liu X", "Suhaimi NM", "Koh KJH", "Hu M", "Lee DYS", "Cima I", "Phyo WM", "Lee EXW", "Tai JA", "Foong YM", "Vo JH", "Koh PK", "Zhang T", "Ying JY", "Lim B", "Tan MH", "Hillmer AM"], "date": "2017-07-10T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Kong SL, Liu X, Suhaimi NM, Koh KJH, Hu M, Lee DYS, Cima I, Phyo WM, Lee EXW, Tai JA, Foong YM, Vo JH, Koh PK, Zhang T, Ying JY, Lim B, Tan MH, Hillmer AM. Molecular characterization of circulating colorectal tumor cells defines genetic signatures for individualized cancer care. Oncotarget. PMID: 28978093", "BibTeX": "@article{28978093, title={Molecular characterization of circulating colorectal tumor cells defines genetic signatures for individualized cancer care.}, author={Kong SL and Liu X and Suhaimi NM and Koh KJH and Hu M and Lee DYS and Cima I and Phyo WM and Lee EXW and Tai JA and Foong YM and Vo JH and Koh PK and Zhang T and Ying JY and Lim B and Tan MH and Hillmer AM}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 26474073, "pmcid": "PMC4608804", "title": "Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA.", "journal": "PLoS One", "authors": ["Lanman RB", "Mortimer SA", "Zill OA", "Sebisanovic D", "Lopez R", "Blau S", "Collisson EA", "Divers SG", "Hoon DS", "Kopetz ES", "Lee J", "Nikolinakos PG", "Baca AM", "Kermani BG", "Eltoukhy H", "Talasaz A"], "date": "2015-10-16T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Lanman RB, Mortimer SA, Zill OA, Sebisanovic D, Lopez R, Blau S, Collisson EA, Divers SG, Hoon DS, Kopetz ES, Lee J, Nikolinakos PG, Baca AM, Kermani BG, Eltoukhy H, Talasaz A. Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA. PLoS One. PMID: 26474073", "BibTeX": "@article{26474073, title={Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA.}, author={Lanman RB and Mortimer SA and Zill OA and Sebisanovic D and Lopez R and Blau S and Collisson EA and Divers SG and Hoon DS and Kopetz ES and Lee J and Nikolinakos PG and Baca AM and Kermani BG and Eltoukhy H and Talasaz A}, journal={PLoS One}}"}, "is_sup_mat_match": true}, {"pmid": 28556593, "pmcid": "PMC5504316", "title": "Comparative molecular profiling of HPV-induced squamous cell carcinomas.", "journal": "Cancer Med", "authors": ["Koncar RF", "Feldman R", "Bahassi EM", "Hashemi Sadraei N"], "date": "2017-07-01T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Koncar RF, Feldman R, Bahassi EM, Hashemi Sadraei N. Comparative molecular profiling of HPV-induced squamous cell carcinomas. Cancer Med. PMID: 28556593", "BibTeX": "@article{28556593, title={Comparative molecular profiling of HPV-induced squamous cell carcinomas.}, author={Koncar RF and Feldman R and Bahassi EM and Hashemi Sadraei N}, journal={Cancer Med}}"}, "is_sup_mat_match": true}, {"pmid": 25245095, "pmcid": "PMC4202150", "title": "Selective targeting of KRAS-mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-mutant cells.", "journal": "Oncotarget", "authors": ["Hara T", "Jones MF", "Subramanian M", "Li XL", "Ou O", "Zhu Y", "Yang Y", "Wakefield LM", "Hussain SP", "Gaedcke J", "Ried T", "Luo J", "Caplen NJ", "Lal A"], "date": "2014-09-15T00:00:00Z", "year": 2014, "snippets": [], "citations": {"NLM": "Hara T, Jones MF, Subramanian M, Li XL, Ou O, Zhu Y, Yang Y, Wakefield LM, Hussain SP, Gaedcke J, Ried T, Luo J, Caplen NJ, Lal A. Selective targeting of KRAS-mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-mutant cells. Oncotarget. PMID: 25245095", "BibTeX": "@article{25245095, title={Selective targeting of KRAS-mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-mutant cells.}, author={Hara T and Jones MF and Subramanian M and Li XL and Ou O and Zhu Y and Yang Y and Wakefield LM and Hussain SP and Gaedcke J and Ried T and Luo J and Caplen NJ and Lal A}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 35402275, "pmcid": "PMC8987589", "title": "Genetic Characteristics Associated With Drug Resistance in Lung Cancer and Colorectal Cancer Using Whole Exome Sequencing of Cell-Free DNA", "journal": "Front Oncol", "authors": ["Lee JW", "Park YS", "Choi JY", "Chang WJ", "Lee S", "Sung JS", "Kim B", "Lee SB", "Lee SY", "Choi J", "Kim YH"], "date": "2022-03-24T00:00:00Z", "year": 2022, "snippets": [], "citations": {"NLM": "Lee JW, Park YS, Choi JY, Chang WJ, Lee S, Sung JS, Kim B, Lee SB, Lee SY, Choi J, Kim YH. Genetic Characteristics Associated With Drug Resistance in Lung Cancer and Colorectal Cancer Using Whole Exome Sequencing of Cell-Free DNA Front Oncol. PMID: 35402275", "BibTeX": "@article{35402275, title={Genetic Characteristics Associated With Drug Resistance in Lung Cancer and Colorectal Cancer Using Whole Exome Sequencing of Cell-Free DNA}, author={Lee JW and Park YS and Choi JY and Chang WJ and Lee S and Sung JS and Kim B and Lee SB and Lee SY and Choi J and Kim YH}, journal={Front Oncol}}"}, "is_sup_mat_match": true}, {"pmid": 26047463, "pmcid": "PMC4478584", "title": "Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma", "journal": "Elife", "authors": ["Unni AM", "Lockwood WW", "Zejnullahu K", "Lee-Lin SQ", "Varmus H"], "date": "2015-06-05T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Unni AM, Lockwood WW, Zejnullahu K, Lee-Lin SQ, Varmus H. Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma Elife. PMID: 26047463", "BibTeX": "@article{26047463, title={Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma}, author={Unni AM and Lockwood WW and Zejnullahu K and Lee-Lin SQ and Varmus H}, journal={Elife}}"}, "is_sup_mat_match": true}, {"pmid": 30925167, "pmcid": "PMC6457557", "title": "Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D cultures", "journal": "PLoS Genet", "authors": ["Schumacher D", "Andrieux G", "Boehnke K", "Keil M", "Silvestri A", "Silvestrov M", "Keilholz U", "Haybaeck J", "Erdmann G", "Sachse C", "Templin M", "Hoffmann J", "Boerries M", "Sch\u00e4fer R", "Regenbrecht CRA"], "date": "2019-03-29T00:00:00Z", "year": 2019, "snippets": [{"_id": "30925167@31503", "snip_text": "Eight KRAS G12V/S/D cultures were resistant to EGFR inhibition by gefitinib, as were four KRASG13D and three NRASQ61K cultures, one KRASA146T and one BRAFV600E culture.", "section": "discussion", "mentions": ["150|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|BRAFV600E", "132|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T", "66|9|chemical|ncbi_mesh@D000077156|gefitinib", "11|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12V/S", "47|4|gene|ncbi_gene@1956|EGFR", "6|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "Eight KRAS G12V/S/D cultures were resistant to EGFR inhibition by gefitinib, as were four KRASG13D and three NRASQ61K cultures, one KRASA146T and one BRAFV600E culture."}], "citations": {"NLM": "Schumacher D, Andrieux G, Boehnke K, Keil M, Silvestri A, Silvestrov M, Keilholz U, Haybaeck J, Erdmann G, Sachse C, Templin M, Hoffmann J, Boerries M, Sch\u00e4fer R, Regenbrecht CRA. Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D cultures PLoS Genet. PMID: 30925167", "BibTeX": "@article{30925167, title={Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D cultures}, author={Schumacher D and Andrieux G and Boehnke K and Keil M and Silvestri A and Silvestrov M and Keilholz U and Haybaeck J and Erdmann G and Sachse C and Templin M and Hoffmann J and Boerries M and Sch\u00e4fer R and Regenbrecht CRA}, journal={PLoS Genet}}"}, "is_sup_mat_match": false}, {"pmid": 30785867, "pmcid": "PMC6724511", "title": "Isoform-specific Ras signaling is growth factor dependent.", "journal": "Mol Biol Cell", "authors": ["Hood FE", "Klinger B", "Newlaczyl AU", "Sieber A", "Dorel M", "Oliver SP", "Coulson JM", "Bl\u00fcthgen N", "Prior IA"], "date": "2019-02-20T00:00:00Z", "year": 2019, "snippets": [{"_id": "30785867@22664", "snip_text": "The A146T mutation that is observed in <0.05% of colon cancers had a negligible effect on LIM1215 cell KRAS activity.", "section": "results", "mentions": ["103|4|gene|ncbi_gene@3845|KRAS", "4|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "90|7|cellline||LIM1215", "49|13|disease|ncbi_mesh@D015179|colon cancers"], "text_hl": "The <m>A146T</m> mutation that is observed in <0.05% of colon cancers had a negligible effect on LIM1215 cell KRAS activity."}], "citations": {"NLM": "Hood FE, Klinger B, Newlaczyl AU, Sieber A, Dorel M, Oliver SP, Coulson JM, Bl\u00fcthgen N, Prior IA. Isoform-specific Ras signaling is growth factor dependent. Mol Biol Cell. PMID: 30785867", "BibTeX": "@article{30785867, title={Isoform-specific Ras signaling is growth factor dependent.}, author={Hood FE and Klinger B and Newlaczyl AU and Sieber A and Dorel M and Oliver SP and Coulson JM and Bl\u00fcthgen N and Prior IA}, journal={Mol Biol Cell}}"}, "is_sup_mat_match": false}, {"pmid": 26071483, "pmcid": "PMC4609254", "title": "Exome sequencing reveals AMER1 as a frequently mutated gene in colorectal cancer", "journal": "Clin Cancer Res", "authors": ["Sanz-Pamplona R", "Lopez-Doriga A", "Par\u00e9-Brunet L", "L\u00e1zaro K", "Bellido F", "Alonso MH", "Auss\u00f3 S", "Guin\u00f3 E", "Beltr\u00e1n S", "Castro-Giner F", "Gut M", "Sanjuan X", "Closa A", "Cordero D", "Mor\u00f3n-Duran FD", "Soriano A", "Salazar R", "Valle L", "Moreno V"], "date": "2015-10-15T00:00:00Z", "year": 2015, "snippets": [{"_id": "26071483@15152", "snip_text": "As a methodological validation of the overall discovery pipeline of SNVs, six mutations in KRAS (Q61H, A146T, G12V, G12D, G12S, G13D), and seven in TP53 (G245D, R248Q, R237H, R273C, R175H, R282W, R213*, G245S) were tested using KASPar genotyping assays in the Fluidigm Biomark platform (dynamic arrays), achieving 65% concordance.", "section": "results", "mentions": ["196|5|variant|litvar@#7157#p.R213*&&&litvar@#7157#|R213*", "189|5|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|R282W", "182|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H", "110|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "128|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "122|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "203|5|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|G245S", "103|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "97|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "154|5|variant|litvar@rs121912656##&&&litvar@#7157#&&&litvar@CA371#rs121912656##|G245D", "91|4|gene|ncbi_gene@3845|KRAS", "148|4|gene|ncbi_gene@7157|TP53", "116|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "175|5|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|R273C", "168|5|variant|litvar@rs530670052##&&&litvar@#324#&&&litvar@CA48853#rs530670052##|R237H", "161|5|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|R248Q"], "text_hl": "As a methodological validation of the overall discovery pipeline of SNVs, six mutations in KRAS (Q61H, <m>A146T</m>, G12V, G12D, G12S, G13D), and seven in TP53 (G245D, R248Q, R237H, R273C, R175H, R282W, R213*, G245S) were tested using KASPar genotyping assays in the Fluidigm Biomark platform (dynamic arrays), achieving 65% concordance."}], "citations": {"NLM": "Sanz-Pamplona R, Lopez-Doriga A, Par\u00e9-Brunet L, L\u00e1zaro K, Bellido F, Alonso MH, Auss\u00f3 S, Guin\u00f3 E, Beltr\u00e1n S, Castro-Giner F, Gut M, Sanjuan X, Closa A, Cordero D, Mor\u00f3n-Duran FD, Soriano A, Salazar R, Valle L, Moreno V. Exome sequencing reveals AMER1 as a frequently mutated gene in colorectal cancer Clin Cancer Res. PMID: 26071483", "BibTeX": "@article{26071483, title={Exome sequencing reveals AMER1 as a frequently mutated gene in colorectal cancer}, author={Sanz-Pamplona R and Lopez-Doriga A and Par\u00e9-Brunet L and L\u00e1zaro K and Bellido F and Alonso MH and Auss\u00f3 S and Guin\u00f3 E and Beltr\u00e1n S and Castro-Giner F and Gut M and Sanjuan X and Closa A and Cordero D and Mor\u00f3n-Duran FD and Soriano A and Salazar R and Valle L and Moreno V}, journal={Clin Cancer Res}}"}, "is_sup_mat_match": false}, {"pmid": 37557892, "pmcid": "PMC10413918", "title": "Novel applications of histopathological markers to distinguish prognostic subgroups in colorectal adenocarcinoma", "journal": "Ann Med", "authors": ["Yuan Y", "Ren W", "Zhu J", "Ji S", "Yang Q"], "date": "2023-01-01T00:00:00Z", "year": 2023, "snippets": [{"_id": "37557892@9353", "snip_text": "In the study, the mutations of KRAS/NRAS/BRAF (KNB) were tested using the AmoyDx  human KRAS/NRAS/BRAF mutations detection kit (ADx-KN04-MX, Xiamen, China), which is commercially used to test the KRAS mutations at exon 2 (G12A/C/D/V/S, G13D), exon 3 (Q61H) and exon 4 (K117N, A146V/P/T), NRAS mutations at exon 2 (G12D) and exon 3 (Q61R/K), BRAF mutations at exon 15 (V600E).", "section": "methods", "mentions": ["82|5|species|ncbi_taxonomy@9606|human", "332|6|variant|litvar@rs11554290##&&&litvar@#4893#|Q61R/K", "276|7|variant|litvar@rs121913527##&&&litvar@#3845#|A146V/P", "222|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12A/C", "93|4|gene|ncbi_gene@4893|NRAS", "31|4|gene|ncbi_gene@3845|KRAS", "88|4|gene|ncbi_gene@3845|KRAS", "251|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "196|4|gene|ncbi_gene@3845|KRAS", "341|4|gene|ncbi_gene@673|BRAF", "98|4|gene|ncbi_gene@673|BRAF", "36|4|gene|ncbi_gene@4893|NRAS", "269|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "368|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "288|4|gene|ncbi_gene@4893|NRAS", "41|4|gene|ncbi_gene@673|BRAF", "314|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "236|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D"], "text_hl": "In the study, the mutations of KRAS/NRAS/BRAF (KNB) were tested using the AmoyDx  human KRAS/NRAS/BRAF mutations detection kit (ADx-KN04-MX, Xiamen, China), which is commercially used to test the KRAS mutations at exon 2 (G12A/C/D/V/S, G13D), exon 3 (Q61H) and exon 4 (K117N, A146V/P/T), NRAS mutations at exon 2 (G12D) and exon 3 (Q61R/K), BRAF mutations at exon 15 (V600E)."}], "citations": {"NLM": "Yuan Y, Ren W, Zhu J, Ji S, Yang Q. Novel applications of histopathological markers to distinguish prognostic subgroups in colorectal adenocarcinoma Ann Med. PMID: 37557892", "BibTeX": "@article{37557892, title={Novel applications of histopathological markers to distinguish prognostic subgroups in colorectal adenocarcinoma}, author={Yuan Y and Ren W and Zhu J and Ji S and Yang Q}, journal={Ann Med}}"}, "is_sup_mat_match": false}, {"pmid": 34820593, "pmcid": "PMC8608264", "title": "KRAS A146 Mutations Are Associated With Distinct Clinical Behavior in Patients With Colorectal Liver Metastases.", "journal": "JCO Precis Oncol", "authors": ["van 't Erve I", "Wesdorp NJ", "Medina JE", "Ferreira L", "Leal A", "Huiskens J", "Bolhuis K", "van Waesberghe JTM", "Swijnenburg RJ", "van den Broek D", "Velculescu VE", "Kazemier G", "Punt CJA", "Meijer GA", "Fijneman RJA"], "date": "2021-11-17T00:00:00Z", "year": 2021, "snippets": [{"_id": "34820593@6535", "snip_text": "For patients with an established KRAS mutation on the basis of tumor analysis, liquid biopsy mutation analyses were performed using four droplet digital polymerase chain reaction (ddPCR; Bio-Rad, Hercules, CA) screening kits, namely ddPCR KRAS G12/G13 (#1863506), ddPCR KRAS Q61 (#12001626), ddPCR KRAS K117N (#10049047), and ddPCR KRAS A146T (#10049550).", "section": "methods", "mentions": ["270|4|gene|ncbi_gene@3845|KRAS", "248|3|variant|litvar@rs112445441##&&&litvar@#3845#|G13", "4|8|species|ncbi_taxonomy@9606|patients", "298|4|gene|ncbi_gene@3845|KRAS", "303|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "244|3|variant|litvar@rs121913530##&&&litvar@#3845#|G12", "33|4|gene|ncbi_gene@3845|KRAS", "337|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "63|5|disease|ncbi_mesh@D009369|tumor", "332|4|gene|ncbi_gene@3845|KRAS", "239|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "For patients with an established KRAS mutation on the basis of tumor analysis, liquid biopsy mutation analyses were performed using four droplet digital polymerase chain reaction (ddPCR; Bio-Rad, Hercules, CA) screening kits, namely ddPCR KRAS G12/G13 (#1863506), ddPCR KRAS Q61 (#12001626), ddPCR KRAS K117N (#10049047), and ddPCR KRAS <m>A146T</m> (#10049550)."}], "citations": {"NLM": "van 't Erve I, Wesdorp NJ, Medina JE, Ferreira L, Leal A, Huiskens J, Bolhuis K, van Waesberghe JTM, Swijnenburg RJ, van den Broek D, Velculescu VE, Kazemier G, Punt CJA, Meijer GA, Fijneman RJA. KRAS A146 Mutations Are Associated With Distinct Clinical Behavior in Patients With Colorectal Liver Metastases. JCO Precis Oncol. PMID: 34820593", "BibTeX": "@article{34820593, title={KRAS A146 Mutations Are Associated With Distinct Clinical Behavior in Patients With Colorectal Liver Metastases.}, author={van 't Erve I and Wesdorp NJ and Medina JE and Ferreira L and Leal A and Huiskens J and Bolhuis K and van Waesberghe JTM and Swijnenburg RJ and van den Broek D and Velculescu VE and Kazemier G and Punt CJA and Meijer GA and Fijneman RJA}, journal={JCO Precis Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 30655771, "pmcid": "PMC6313205", "title": "Correlation between microsatellite instability and RAS gene mutation and stage III colorectal cancer.", "journal": "Oncol Lett", "authors": ["Niu W", "Wang G", "Feng J", "Li Z", "Li C", "Shan B"], "date": "2019-01-01T00:00:00Z", "year": 2019, "snippets": [{"_id": "30655771@22246", "snip_text": "Gene exon Gene mutations n (%)   KRAS     Exon 2 p.G12D 31 (35.63)    p.G12V 14 (16.09)    p.G12A 5 (5.75)    p.G12C 4 (4.60)    p.G12S 4 (4.60)    p.G12R 1 (1.15)    p.G13D 19 (21.84)     Exon 3 p.A59T 1 (1.15)    p.Q61H 1 (1.15)     Exon 4 p.A146T 4 (4.60)    p.A146V 1 (1.15)    Others 2 (2.30)     Total  87 (48.33)   NRAS     Exon 2 p.G12D 2 (40.00)     Exon 3 p.A18T 1 (20.00)    p.Q61L 1 (20.00)    p.Q61R 1 (20.00)     Total  5 (2.78)   ", "section": "table", "mentions": ["338|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "49|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "196|6|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|p.A59T", "91|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "70|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "167|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "215|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "262|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "33|4|gene|ncbi_gene@3845|KRAS", "110|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "322|4|gene|ncbi_gene@4893|NRAS", "406|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "242|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "386|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "129|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "148|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "366|6|variant|litvar@rs121913248##&&&litvar@#4893#&&&litvar@CA16602497#rs121913248##|p.A18T"], "figure_id": "tII-ol-0-0-9611", "text_hl": "Gene exon Gene mutations n (%)   KRAS     Exon 2 p.G12D 31 (35.63)    p.G12V 14 (16.09)    p.G12A 5 (5.75)    p.G12C 4 (4.60)    p.G12S 4 (4.60)    p.G12R 1 (1.15)    p.G13D 19 (21.84)     Exon 3 p.A59T 1 (1.15)    p.Q61H 1 (1.15)     Exon 4 <m>p.A146T</m> 4 (4.60)    p.A146V 1 (1.15)    Others 2 (2.30)     Total  87 (48.33)   NRAS     Exon 2 p.G12D 2 (40.00)     Exon 3 p.A18T 1 (20.00)    p.Q61L 1 (20.00)    p.Q61R 1 (20.00)     Total  5 (2.78)   "}], "citations": {"NLM": "Niu W, Wang G, Feng J, Li Z, Li C, Shan B. Correlation between microsatellite instability and RAS gene mutation and stage III colorectal cancer. Oncol Lett. PMID: 30655771", "BibTeX": "@article{30655771, title={Correlation between microsatellite instability and RAS gene mutation and stage III colorectal cancer.}, author={Niu W and Wang G and Feng J and Li Z and Li C and Shan B}, journal={Oncol Lett}}"}, "is_sup_mat_match": false}, {"pmid": 33644183, "pmcid": "PMC7896647", "title": "Heterochronic triple primary malignancies with Epstein-Barr virus infection and tumor protein 53 gene mutation: A case report and review of literature.", "journal": "World J Clin Cases", "authors": ["Peng WX", "Liu X", "Wang QF", "Zhou XY", "Luo ZG", "Hu XC"], "date": "2021-02-16T00:00:00Z", "year": 2021, "snippets": [{"_id": "33644183@12218", "snip_text": "The following pathogenic/probably pathogenic variations were detected in the paraffin tissue deoxyribonucleic acid: (1) KRAS (NM_033360.3) missense mutation in exon 4 c.436G > A (p.Ala146Thr), AF 34.43%; (2) APC (NM_000038.5) nonsense mutation in exon 16 c.3340C>T (p.Arg1114*), AF 20.54%; (3) APC (NM_000038.5 code shift mutation in exon 16 c.4127_4128del (p.Tyr1376fs), AF 22.71%; (4) TP53 (NM_000546.5) nonsense mutation in exon 9 c.991C>T (p.Gln331*), AF 3.71% (Figure 5A); (5) TP53 (NM_000546.5) missense mutation in exon 8 c.844C>T (p.Arg282Trp), AF 37.89% (Figure 5B); and (6) single nucleotide polymorphisms of drug metabolism-related enzymes indicated that bilirubin UDP-glucuronosyltransferase 1A1*28, bilirubin UDP-glucuronosyltransferase 1A1*6, cytochrome P450 2D6*10, dihydropyrimidine dehydrogenase*2A, and dihydropyrimidine dehydrogenase*13 were wild type.", "section": "other", "mentions": ["266|10|variant|litvar@#324#p.R1114*&&&litvar@#324#|p.Arg1114*", "666|9|chemical|ncbi_mesh@D001663|bilirubin", "712|9|chemical|ncbi_mesh@D001663|bilirubin", "722|31|gene|ncbi_gene@54658|UDP-glucuronosyltransferase 1A1", "255|9|variant|litvar@rs121913331##&&&litvar@#324#&&&litvar@CA10582306#rs121913331##|c.3340C>T", "167|10|variant|litvar@rs763181290##&&&litvar@#324#&&&litvar@CA38866#rs763181290##|c.436G > A", "482|4|gene|ncbi_gene@7157|TP53", "444|9|variant|litvar@#7157#p.Q331*&&&litvar@#7157#|p.Gln331*", "208|3|gene|ncbi_gene@324|APC", "358|11|variant|litvar@#7157#p.Y1376fsX&&&litvar@#7157#|p.Tyr1376fs", "120|4|gene|ncbi_gene@3845|KRAS", "342|14|variant|litvar@#7157#c.4127_4128del&&&litvar@#7157#|c.4127_4128del", "434|8|variant|litvar@rs863225307##&&&litvar@#324#&&&litvar@CA279782#rs863225307##|c.991C>T", "539|11|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|p.Arg282Trp", "387|4|gene|ncbi_gene@7157|TP53", "179|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "294|3|gene|ncbi_gene@324|APC", "676|31|gene|ncbi_gene@54658|UDP-glucuronosyltransferase 1A1", "529|8|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|c.844C>T"], "text_hl": "The following pathogenic/probably pathogenic variations were detected in the paraffin tissue deoxyribonucleic acid: (1) KRAS (NM_033360.3) missense mutation in exon 4 c.436G > A (<m>p.Ala146Thr</m>), AF 34.43%; (2) APC (NM_000038.5) nonsense mutation in exon 16 c.3340C>T (p.Arg1114*), AF 20.54%; (3) APC (NM_000038.5 code shift mutation in exon 16 c.4127_4128del (p.Tyr1376fs), AF 22.71%; (4) TP53 (NM_000546.5) nonsense mutation in exon 9 c.991C>T (p.Gln331*), AF 3.71% (Figure 5A); (5) TP53 (NM_000546.5) missense mutation in exon 8 c.844C>T (p.Arg282Trp), AF 37.89% (Figure 5B); and (6) single nucleotide polymorphisms of drug metabolism-related enzymes indicated that bilirubin UDP-glucuronosyltransferase 1A1*28, bilirubin UDP-glucuronosyltransferase 1A1*6, cytochrome P450 2D6*10, dihydropyrimidine dehydrogenase*2A, and dihydropyrimidine dehydrogenase*13 were wild type."}], "citations": {"NLM": "Peng WX, Liu X, Wang QF, Zhou XY, Luo ZG, Hu XC. Heterochronic triple primary malignancies with Epstein-Barr virus infection and tumor protein 53 gene mutation: A case report and review of literature. World J Clin Cases. PMID: 33644183", "BibTeX": "@article{33644183, title={Heterochronic triple primary malignancies with Epstein-Barr virus infection and tumor protein 53 gene mutation: A case report and review of literature.}, author={Peng WX and Liu X and Wang QF and Zhou XY and Luo ZG and Hu XC}, journal={World J Clin Cases}}"}, "is_sup_mat_match": false}, {"pmid": 32628708, "pmcid": "PMC7337295", "title": "KRAS, NRAS, and BRAF mutation prevalence, clinicopathological association, and their application in a predictive model in Mexican patients with metastatic colorectal cancer: A retrospective cohort study.", "journal": "PLoS One", "authors": ["Sanchez-Ibarra HE", "Jiang X", "Gallegos-Gonzalez EY", "Cavazos-Gonz\u00e1lez AC", "Chen Y", "Morcos F", "Barrera-Salda\u00f1a HA"], "date": "2020-07-06T00:00:00Z", "year": 2020, "snippets": [{"_id": "32628708@15311", "snip_text": "Gene Location No. Mutated Cases per Gene   Codon KRAS (n = 225, %) NRAS (n = 20, %) BRAF (n = 18, %)   Codon 12 162 (72%) 6 (30%) N/A   G12V 40 (18%) 0(0%) N/A   G12D 73 (32%) 6 (30%) N/A   G12C 17 (8%) 0(0%) N/A   G12A 17 (8%) 0(0%) N/A   G12S 11 (5%) 0(0%) N/A   G12R 2 (1%) 0(0%) N/A   G12V/D/A  1 (0.4%) 0(0%) N/A   G12C/S  1 (0.4%) 0(0%) N/A   Codon 13 36 (16%) 2 (10%) N/A   G13A 36 (16%) 0(0%) N/A   G13D 0(0%) 1 (5%) N/A   G13R/V  0(0%) 1 (5%) N/A   Codon 59 2 (1%) 0(0%) N/A   A59T/V  2 (1%) 0(0%) N/A   Codon 61 10 (4%) 11 (55%) N/A   Q61H 2 (1%) 1 (5%) N/A   Q61K 2 (1%) 3 (15%) N/A   Q61L/R  6 (3%) 7 (35%) N/A   Codon 117 2 (1%) 1 (5%) N/A   K117N/R/E  2 (1%) 1 (5%) N/A   Codon 146 13 (6%) 0(0%) N/A   A146P/T/V  13 (6%) 0(0%) N/A   Codon 600 N/A N/A 18 (100%)   V600E/D  N/A N/A 18 (100%)   ", "section": "table", "mentions": ["67|4|gene|ncbi_gene@4893|NRAS", "407|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "545|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "320|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "431|6|variant|litvar@rs121434596##&&&litvar@#4893#|G13R/V", "486|6|variant|litvar@rs730880965##&&&litvar@#4893#|A59T/V", "240|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "570|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "162|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "265|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "49|4|gene|ncbi_gene@3845|KRAS", "716|9|variant|litvar@rs121913527##&&&litvar@#3845#|A146P/T/V", "596|6|variant|litvar@rs11554290##&&&litvar@#4893#|Q61L/R", "84|4|gene|ncbi_gene@673|BRAF", "777|7|variant|litvar@rs113488022##&&&litvar@#673#|V600E/D", "215|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "289|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "381|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602364#rs121434596##|G13A", "655|9|variant|litvar@rs770248150##&&&litvar@#3845#|K117N/R/E"], "figure_id": "pone.0235490.t002", "text_hl": "Gene Location No. Mutated Cases per Gene   Codon KRAS (n = 225, %) NRAS (n = 20, %) BRAF (n = 18, %)   Codon 12 162 (72%) 6 (30%) N/A   G12V 40 (18%) 0(0%) N/A   G12D 73 (32%) 6 (30%) N/A   G12C 17 (8%) 0(0%) N/A   G12A 17 (8%) 0(0%) N/A   G12S 11 (5%) 0(0%) N/A   G12R 2 (1%) 0(0%) N/A   G12V/D/A  1 (0.4%) 0(0%) N/A   G12C/S  1 (0.4%) 0(0%) N/A   Codon 13 36 (16%) 2 (10%) N/A   G13A 36 (16%) 0(0%) N/A   G13D 0(0%) 1 (5%) N/A   G13R/V  0(0%) 1 (5%) N/A   Codon 59 2 (1%) 0(0%) N/A   A59T/V  2 (1%) 0(0%) N/A   Codon 61 10 (4%) 11 (55%) N/A   Q61H 2 (1%) 1 (5%) N/A   Q61K 2 (1%) 3 (15%) N/A   Q61L/R  6 (3%) 7 (35%) N/A   Codon 117 2 (1%) 1 (5%) N/A   K117N/R/E  2 (1%) 1 (5%) N/A   Codon 146 13 (6%) 0(0%) N/A   A146P/T/V  13 (6%) 0(0%) N/A   Codon 600 N/A N/A 18 (100%)   V600E/D  N/A N/A 18 (100%)   "}], "citations": {"NLM": "Sanchez-Ibarra HE, Jiang X, Gallegos-Gonzalez EY, Cavazos-Gonz\u00e1lez AC, Chen Y, Morcos F, Barrera-Salda\u00f1a HA. KRAS, NRAS, and BRAF mutation prevalence, clinicopathological association, and their application in a predictive model in Mexican patients with metastatic colorectal cancer: A retrospective cohort study. PLoS One. PMID: 32628708", "BibTeX": "@article{32628708, title={KRAS, NRAS, and BRAF mutation prevalence, clinicopathological association, and their application in a predictive model in Mexican patients with metastatic colorectal cancer: A retrospective cohort study.}, author={Sanchez-Ibarra HE and Jiang X and Gallegos-Gonzalez EY and Cavazos-Gonz\u00e1lez AC and Chen Y and Morcos F and Barrera-Salda\u00f1a HA}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 24859378, "pmcid": "PMC4171587", "title": "Impact of specific KRAS mutation in exon 2 on clinical outcome of chemotherapy- and radiotherapy-treated colorectal adenocarcinoma patients.", "journal": "Mol Diagn Ther", "authors": ["Roszkowski K", "Zurawski B", "Jozwicki W", "Basta P", "Lewandowska MA"], "date": "2014-10-01T00:00:00Z", "year": 2014, "snippets": [{"_id": "24859378@14132", "snip_text": "c Filter: FAM 465-510; amplification curves represent the following PCs in exon 2: G12C, G12D, G12S, G13V, G13R; in exon 3: Q61K, Q61R, Q61L, Q61H; and in exon 4: A146T (C p in the range 27.03-29.03).", "section": "figure_legend", "mentions": ["89|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "107|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "95|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "101|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "83|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "136|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "130|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "142|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "124|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "163|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "figure_id": "Fig3", "text_hl": "c Filter: FAM 465-510; amplification curves represent the following PCs in exon 2: G12C, G12D, G12S, G13V, G13R; in exon 3: Q61K, Q61R, Q61L, Q61H; and in exon 4: <m>A146T</m> (C p in the range 27.03-29.03)."}], "citations": {"NLM": "Roszkowski K, Zurawski B, Jozwicki W, Basta P, Lewandowska MA. Impact of specific KRAS mutation in exon 2 on clinical outcome of chemotherapy- and radiotherapy-treated colorectal adenocarcinoma patients. Mol Diagn Ther. PMID: 24859378", "BibTeX": "@article{24859378, title={Impact of specific KRAS mutation in exon 2 on clinical outcome of chemotherapy- and radiotherapy-treated colorectal adenocarcinoma patients.}, author={Roszkowski K and Zurawski B and Jozwicki W and Basta P and Lewandowska MA}, journal={Mol Diagn Ther}}"}, "is_sup_mat_match": false}, {"pmid": 27146902, "pmcid": "PMC4857423", "title": "Clinical significance of frequent somatic mutations detected by high-throughput targeted sequencing in archived colorectal cancer samples.", "journal": "J Transl Med", "authors": ["Dallol A", "Buhmeida A", "Al-Ahwal MS", "Al-Maghrabi J", "Bajouh O", "Al-Khayyat S", "Alam R", "Abusanad A", "Turki R", "Elaimi A", "Alhadrami HA", "Abuzenadah M", "Banni H", "Al-Qahtani MH", "Abuzenadah AM"], "date": "2016-05-04T00:00:00Z", "year": 2016, "snippets": [{"_id": "27146902@8424", "snip_text": "Gene Mutations detected   TP53 p.Ala69Val, p.Pro72Ala, p.Pro72Ser, p.Thr81Ile, p.Pro82Leu, p.Ala84Val, p.Pro87Leu, p.Trp91Ter, p.Ser94Ter, p.Ser95Phe, p.Ser96Phe, p.Pro98Leu, p.Ser99Phe, p.Gln100Ter, p.Arg110Leu, p.Leu130Ile, p.Lys132Arg, p.Cys135Ter, p.Leu137Gln, p.Pro151Thr, p.Pro152Leu, p.Gly154Asp, p.Gly154Ser, p.Arg156His, p.Val157Ile, p.Val157Phe, p.Ala161Thr, p.Tyr163Cys, p.Gln165Ter, p.Ser166Leu, p.His168Pro, p.His168Tyr, p.Glu171Lys, p.Val172Ile, p.Val173Ala, p.Val173Met, p.Arg175His, p.Arg175Leu, p.Pro177Ser, p.His179Arg, p.His179Tyr, p.Cys182Tyr, p.Ser183Leu, p.Gly187Ser, p.Pro190 fs, p.Arg196Ter, p.Gly199Glu, p.Arg202Cys, p.Arg209 fs, p.Thr211Ile, p.Arg213Ter, p.Ser215Asn, p.Val216Met, p.Tyr220Asn, p.Tyr220Cys, p.Glu221Gly, p.Gly226Ser, p.Cys229Tyr, p.Tyr234Cys, p.Cys238Tyr, p.Ser240Arg, p.Ser240Asn, p.Gly244Asp, p.Gly245Ser, p.Met246Val, p.Arg248Gln, p.Arg248Trp, p.Arg249Ser, p.Thr253Ile, p.Glu258Gln, p.Gly266Arg, p.Gly266Glu, p.Arg267Gln, p.Ser269Asn, p.Glu271Lys, p.Val272Met, p.Arg273Cys, p.Arg273His, p.Cys275Phe, p.Cys277Phe, p.Gly279Glu, p.Arg280Lys, p.Asp281Asn, p.Arg282Trp, p.Glu285Lys, p.Glu287Lys, p.Arg290His, p.Pro300Leu, p.Pro300Ser, p.Gly302Glu, p.Arg306Ter, p.Glu336Lys, c.559 + 3G > C, c.560-1G > C, c.376-1G > A   APC p.Asn869Thr, p.Arg876Ter, p.Arg1114Ter, p.Glu1286Ter, p.Ala1296 fs, p.Ala1299Val, p.Ile1307Lys, p.Ile1307 fs, p.Glu1309Ter, p.Glu1309 fs, p.Ala1351Thr, p.Ser1356Ter, p.Ser1360Tyr, p.Gln1367Ter, p.Glu1374Ter, p.Gln1378Ter, p.Glu1379Ter, p.Pro1439Leu, p.Arg1450Ter, p.Glu1461Lys, p.Ser1465 fs, p.Leu1488 fs, p.Leu1488Ter, p.His1490Leu, p.His1490 fs, p.Ser1495 fs, p.Ser1501 fs, p.Thr1556 fs, p.Glu1576Lys, p.Glu1577Ter   KRAS p.Ala11Val, p.Gly12Val, p.Gly12Ser, p.Gly12Asp, p.Gly13Asp, p.Val14Ile, p.Gln22Lys, p.Gln61His, p.Ala146Thr   PIK3CA p.Arg88Gln, p.Arg108His, p.Leu339Ile, p.Asn345Lys, p.Asp350Gly, p.Cys420Arg, p.Pro539His, p.Glu542Lys, p.Glu545Asp, p.Glu545Gly, p.Glu545Lys, p.Gln546His, p.Arg1023Ter, p.Thr1025Ala, p.Asn1044Ser, p.His1047Arg, p.His1048Arg, p.Ala1066Thr, p.Ter1069 fs   PTEN p.Lys6Glu, p.Glu7Ter, p.Asp24Asn, p.Gln110Ter, p.Asp115Asn, p.Cys124Tyr, p.Ala126Val, p.Arg130Gln, p.Gly165Glu, p.Ser170Asn, p.Gln171Ter, p.Arg173Cys, p.Pro246Leu, p.Val255Ile, p.Glu256Lys, p.Pro339Ser   SMAD4 p.Arg100Met, p.Arg135Ter, p.Gln245Ter, p.Gln248Ter, p.Thr259Ile, p.Glu330Lys, p.Ser343Ter, p.Gly352Arg, p.Arg361His, p.Arg361His, p.Arg361His, p.Cys499Tyr, p.Arg531Gln   EGFR p.Gly109Glu, p.Gly696Arg, p.Pro699Ser, p.Gly719Ser, p.Gly719Cys, p.Gly721Ser, p.Trp731Ter, p.Glu746Lys, p.Thr751Ile, p.Ala755Thr, p.Glu758Lys, p.Leu858Met, p.Gly863Asp, p.Ala864Val, p.Gly873Glu   FBXW7 p.Arg465Cys, p.Arg465His, p.Met467Ile, p.Arg479Gln, p.Arg479Pro, p.Arg479Ter   BRAF p.Gly469Val, p.Gly469Ala, p.Val600Glu, p.Lys601Glu   RB1 p.Ile680Thr, p.Leu683Phe   RET p.Cys618Tyr, p.Asp627Gly, p.Glu884Val, p.Glu901Lys, p.Leu923Phe   ATM p.Val410Ala, p.Phe858Leu, p.Thr1735 fs, p.Leu2866Val   NOTCH1 p.Arg1598His, p.His1601Leu, p.Pro2438Ser, p.Gln2440Ter   STK11 p.Glu165Lys, p.Gly171Ser, p.Gly279Arg, p.Phe354Leu   KIT p.Pro37Ser, p.Arg49His, p.Asp52Asn, p.Asp572Asn   KDR p.Lys270Asn, p.Gly1145Glu, p.Pro1354Ser   CDH1 pThr342Ile, p.Thr399Ile   PTPN11 p.Glu69Lys, p.Thr73Ile, p.Glu76Lys   ERBB2 p.Met774Ile, p.Val851Met, p.Thr862Ala, p.His878Tyr   SMO p.Val404Met, p.Leu412Phe, p.Pro634Leu   CTNNB1 p.Met12Ile, p.Pro16Ser, p.Val22Ile, p.Ser37Phe   VHL p.Gln132Ter, p.Arg161Gln, p.Arg167Gln, c.341-1G > A   CDKN2A p.Glu88Lys, p.Arg99Trp, p.Asp125Asn, p.Arg128Gln   FLT3 p.Ser446Leu, p.Lys602Arg, p.Trp603Ter   IDH2 p.Arg140Gln, p.Arg140Trp   FGFR3 p.Asp643Asn, p.Ala719Thr   MPL p.Ala506Thr, p.Ala519Val, p.Ala519Thr   PDGFRA p.Pro553Leu, p.Glu563Lys   NRAS p.Gln61Arg   MET c.2942-20_2943del22, p.Asn375Ser   MLH1 p.His381Arg   HRAS p.Glu63Lys   JAK3 p.Ala573Val   AKT1 p.Glu49Lys   ERBB4 p.Pro616Ser   JAK3 p.Ala572Thr   SMARCB1 p.Arg190Gln   ABL1 p.Thr334Ile   ", "section": "table", "mentions": ["3220|10|variant|litvar@rs587781589##&&&litvar@#7157#&&&litvar@CA331#rs587781589##|p.Thr73Ile", "3784|4|gene|ncbi_gene@3265|HRAS", "1188|11|variant|litvar@rs121913344##&&&litvar@#7157#&&&litvar@CA495#rs121913344##|p.Arg306Ter", "26|4|gene|ncbi_gene@7157|TP53", "2267|5|gene|ncbi_gene@4089|SMAD4", "1687|10|variant|litvar@rs778016997##&&&litvar@#5156#|p.Ala11Val", "2097|11|variant|litvar@rs1114167629##&&&litvar@#5728#|p.Gln110Ter", "2474|11|variant|litvar@#1956#p.P699S&&&litvar@#1956#|p.Pro699Ser", "67|10|variant|litvar@rs63751069##&&&litvar@#4292#&&&litvar@CA9387#rs63751069##|p.Thr81Ile", "941|11|variant|litvar@rs193920774##&&&litvar@#7157#&&&litvar@CA421#rs193920774##|p.Gly266Glu", "1097|11|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|p.Arg282Trp", "1868|11|variant|litvar@rs121913272##&&&litvar@#5290#&&&litvar@CA180900#rs121913272##|p.Cys420Arg", "3493|11|variant|litvar@rs766480411##&&&litvar@#2322#&&&litvar@CA6928731#rs766480411##|p.Asp125Asn", "3603|11|variant|litvar@#2261#p.D643N&&&litvar@#2261#|p.Asp643Asn", "1443|12|variant|litvar@rs121913328##&&&litvar@#324#&&&litvar@CA16030309#rs121913328##|p.Gln1367Ter", "239|11|variant|litvar@rs764085979##&&&litvar@#4292#|p.Cys135Ter", "395|11|variant|litvar@rs766309690##&&&litvar@#2322#&&&litvar@CA6928791#rs766309690##|p.Ser166Leu", "1797|6|gene|ncbi_gene@5290|PIK3CA", "1162|11|variant|litvar@rs752430684##&&&litvar@#4292#|p.Pro300Ser", "2954|12|variant|litvar@#472#p.R1598H&&&litvar@#472#|p.Arg1598His", "1071|11|variant|litvar@rs121912660##&&&litvar@#7157#|p.Arg280Lys", "1513|12|variant|litvar@rs121913332##&&&litvar@#324#&&&litvar@CA9465#rs121913332##|p.Arg1450Ter", "3404|3|gene|ncbi_gene@7428|VHL", "2351|11|variant|litvar@#4089#p.S343X&&&litvar@#4089#|p.Ser343Ter", "3839|5|gene|ncbi_gene@2066|ERBB4", "369|11|variant|litvar@rs148924904##&&&litvar@#7157#&&&litvar@CA240#rs148924904##|p.Tyr163Cys", "1569|12|variant|litvar@#3845#p.L1488X&&&litvar@#3845#|p.Leu1488Ter", "1045|11|variant|litvar@rs763098116##&&&litvar@#7157#&&&litvar@CA1518#rs763098116##|p.Cys277Phe", "3647|11|variant|litvar@rs574458765##&&&litvar@#472#&&&litvar@CA6264827#rs574458765##|p.Ala519Val", "668|11|variant|litvar@rs587781392##&&&litvar@#324#&&&litvar@CA11131#rs587781392##|p.Arg213Ter", "3551|11|variant|litvar@rs1064794226##&&&litvar@#324#|p.Trp603Ter", "139|10|variant|litvar@rs146221748##&&&litvar@#324#&&&litvar@CA16021955#rs146221748##|p.Ser95Phe", "2325|11|variant|litvar@rs786202113##&&&litvar@#4089#&&&litvar@CA191715#rs786202113##|p.Thr259Ile", "3765|4|gene|ncbi_gene@4292|MLH1", "103|10|variant|litvar@rs1420675064##&&&litvar@#7157#|p.Pro87Leu", "3481|10|variant|litvar@rs34886500##&&&litvar@#1029#&&&litvar@CA190730072#rs34886500##|p.Arg99Trp", "3821|4|gene|ncbi_gene@207|AKT1", "3308|11|variant|litvar@rs786204178##&&&litvar@#324#&&&litvar@CA5349#rs786204178##|p.Val404Met", "2905|11|variant|litvar@rs1800056##&&&litvar@#472#&&&litvar@CA157086#rs1800056##|p.Phe858Leu", "1222|6|variant|litvar@rs1309176439##&&&litvar@#55294#|3G > C", "3681|11|variant|litvar@rs1060501502##&&&litvar@#5156#|p.Pro553Leu", "2299|11|variant|litvar@rs786202918##&&&litvar@#5728#&&&litvar@CA193#rs786202918##|p.Gln245Ter", "2791|11|variant|litvar@#673#p.I680T&&&litvar@#673#|p.Ile680Thr", "2644|5|gene|ncbi_gene@55294|FBXW7", "2240|11|variant|litvar@rs937391131##&&&litvar@#55294#&&&litvar@CA108586891#rs937391131##|p.Glu256Lys", "3277|11|variant|litvar@rs777679881##&&&litvar@#2066#&&&litvar@CA2087704#rs777679881##|p.Thr862Ala", "3208|10|variant|litvar@rs1299878535##&&&litvar@#3418#|p.Glu69Lys", "616|11|variant|litvar@rs149302013##&&&litvar@#4292#&&&litvar@CA11707#rs149302013##|p.Gly199Glu", "55|10|variant|litvar@rs587782769##&&&litvar@#7157#&&&litvar@CA3069#rs587782769##|p.Pro72Ser", "1735|10|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.Gly13Asp", "2273|11|variant|litvar@rs1373151037##&&&litvar@#1499#|p.Arg100Met", "2539|11|variant|litvar@rs121913427##&&&litvar@#1956#&&&litvar@CA16602724#rs121913427##|p.Glu746Lys", "2214|11|variant|litvar@rs587782350##&&&litvar@#5728#&&&litvar@CA559#rs587782350##|p.Pro246Leu", "3251|11|variant|litvar@rs587778073##&&&litvar@#472#&&&litvar@CA6265328#rs587778073##|p.Met774Ile", "915|11|variant|litvar@rs774604680##&&&litvar@#324#&&&litvar@CA49018#rs774604680##|p.Glu258Gln", "1842|11|variant|litvar@rs121913284##&&&litvar@#5290#&&&litvar@CA16602517#rs121913284##|p.Asn345Lys", "2982|12|variant|litvar@rs786203234##&&&litvar@#324#|p.Pro2438Ser", "213|11|variant|litvar@rs121909229##&&&litvar@#5728#|p.Leu130Ile", "2513|11|variant|litvar@#1956#p.G721S&&&litvar@#1956#|p.Gly721Ser", "1303|12|variant|litvar@rs1211642532##&&&litvar@#324#|p.Glu1286Ter", "3802|4|gene|ncbi_gene@3718|JAK3", "1136|11|variant|litvar@rs55819519##&&&litvar@#7157#&&&litvar@CA468#rs55819519##|p.Arg290His", "889|11|variant|litvar@rs28934571##&&&litvar@#7157#&&&litvar@CA392#rs28934571##|p.Arg249Ser", "1244|12|variant|litvar@rs868137297##&&&litvar@#7157#&&&litvar@CA287488727#rs868137297##|c.376-1G > A", "2015|12|variant|litvar@rs777515607##&&&litvar@#79811#|p.His1048Arg", "1816|11|variant|litvar@rs886042002##&&&litvar@#5290#&&&litvar@CA10602871#rs886042002##|p.Arg108His", "3086|10|variant|litvar@rs1191401517##&&&litvar@#324#|p.Arg49His", "2702|11|variant|litvar@rs866987936##&&&litvar@#55294#|p.Arg479Pro", "187|11|variant|litvar@rs1373151037##&&&litvar@#1499#|p.Gln100Ter", "2487|11|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126722#rs28929495##|p.Gly719Ser", "1110|11|variant|litvar@rs112431538##&&&litvar@#7157#&&&litvar@CA16620615#rs112431538##|p.Glu285Lys", "863|11|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|p.Arg248Gln", "1387|9|variant|litvar@rs1321583762##&&&litvar@#324#|p.Glu1309", "3462|6|gene|ncbi_gene@1029|CDKN2A", "3525|11|variant|litvar@rs201256911##&&&litvar@#2322#&&&litvar@CA6928697#rs201256911##|p.Ser446Leu", "2676|11|variant|litvar@rs747739964##&&&litvar@#324#&&&litvar@CA27797#rs747739964##|p.Met467Ile", "3141|12|variant|litvar@#472#p.G1145E&&&litvar@#472#|p.Gly1145Glu", "2429|11|variant|litvar@rs1330512770##&&&litvar@#1956#|p.Arg531Gln", "1457|12|variant|litvar@#324#p.E1374X&&&litvar@#324#|p.Glu1374Ter", "2461|11|variant|litvar@rs879254178##&&&litvar@#472#&&&litvar@CA10584328#rs879254178##|p.Gly696Arg", "2617|11|variant|litvar@#55294#p.A864V&&&litvar@#55294#|p.Ala864Val", "2063|9|variant|litvar@rs760228905##&&&litvar@#1956#&&&litvar@CA4265147#rs760228905##|p.Lys6Glu", "1933|11|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.Glu545Lys", "1084|11|variant|litvar@rs764146326##&&&litvar@#7157#&&&litvar@CA1503#rs764146326##|p.Asp281Asn", "837|11|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|p.Gly245Ser", "1771|10|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Gln61His", "460|11|variant|litvar@rs1057519747##&&&litvar@#7157#|p.Val173Ala", "2650|11|variant|litvar@rs867384286##&&&litvar@#55294#&&&litvar@CA16602851#rs867384286##|p.Arg465Cys", "2760|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.Val600Glu", "1527|12|variant|litvar@rs1325458165##&&&litvar@#324#|p.Glu1461Lys", "2996|12|variant|litvar@#472#p.Q2440X&&&litvar@#472#|p.Gln2440Ter", "590|8|variant|litvar@rs190988940##&&&litvar@#324#|p.Pro190", "2591|11|variant|litvar@rs121913443##&&&litvar@#1956#&&&litvar@CA135930#rs121913443##|p.Leu858Met", "1804|10|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|p.Arg88Gln", "1907|11|variant|litvar@rs121913275##&&&litvar@#5290#&&&litvar@CA210104#rs121913275##|p.Glu545Asp", "2085|10|variant|litvar@rs786201995##&&&litvar@#5728#&&&litvar@CA185#rs786201995##|p.Asp24Asn", "3321|11|variant|litvar@#7428#p.L412F&&&litvar@#7428#|p.Leu412Phe", "1058|11|variant|litvar@rs1064793881##&&&litvar@#7157#|p.Gly279Glu", "2074|9|variant|litvar@#5728#p.E7X&&&litvar@#5728#|p.Glu7Ter", "811|11|variant|litvar@rs749141162##&&&litvar@#5156#|p.Ser240Asn", "1583|12|variant|litvar@#3845#p.H1490L&&&litvar@#3845#|p.His1490Leu", "434|11|variant|litvar@rs587781845##&&&litvar@#7157#&&&litvar@CA249#rs587781845##|p.Glu171Lys", "2734|11|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA135085#rs121913355##|p.Gly469Val", "2565|11|variant|litvar@rs587780590##&&&litvar@#324#|p.Ala755Thr", "2188|11|variant|litvar@rs786204864##&&&litvar@#5728#&&&litvar@CA494#rs786204864##|p.Gln171Ter", "1881|11|variant|litvar@#5290#p.P539H&&&litvar@#5290#|p.Pro539His", "3506|11|variant|litvar@rs971657556##&&&litvar@#1029#|p.Arg128Gln", "1653|12|variant|litvar@#3845#p.E1576K&&&litvar@#3845#|p.Glu1576Lys", "3694|11|variant|litvar@rs146197533##&&&litvar@#2066#&&&litvar@CA65172145#rs146197533##|p.Glu563Lys", "408|11|variant|litvar@rs1207038641##&&&litvar@#55294#|p.His168Pro", "3905|11|variant|litvar@rs1244451002##&&&litvar@#6598#|p.Thr334Ile", "564|11|variant|litvar@rs5030823##&&&litvar@#7428#&&&litvar@CA41537#rs5030823##|p.Ser183Leu", "2804|11|variant|litvar@#673#p.L683F&&&litvar@#673#|p.Leu683Phe", "3565|4|gene|ncbi_gene@3418|IDH2", "1276|11|variant|litvar@rs121913333##&&&litvar@#324#&&&litvar@CA338207#rs121913333##|p.Arg876Ter", "127|10|variant|litvar@#7157#p.S94X&&&litvar@#7157#|p.Ser94Ter", "3155|12|variant|litvar@rs1060503266##&&&litvar@#324#|p.Pro1354Ser", "31|10|variant|litvar@rs756233241##&&&litvar@#7157#&&&litvar@CA287489112#rs756233241##|p.Ala69Val", "2162|11|variant|litvar@rs1260903787##&&&litvar@#7157#|p.Gly165Glu", "1855|11|variant|litvar@rs1248977747##&&&litvar@#79811#|p.Asp350Gly", "1471|12|variant|litvar@rs121913329##&&&litvar@#324#&&&litvar@CA16030382#rs121913329##|p.Gln1378Ter", "91|10|variant|litvar@rs587781937##&&&litvar@#472#&&&litvar@CA166128#rs587781937##|p.Ala84Val", "629|11|variant|litvar@rs587780072##&&&litvar@#7157#&&&litvar@CA288#rs587780072##|p.Arg202Cys", "3469|10|variant|litvar@rs1332564623##&&&litvar@#55294#|p.Glu88Lys", "382|11|variant|litvar@rs730882001##&&&litvar@#7157#&&&litvar@CA243#rs730882001##|p.Gln165Ter", "538|11|variant|litvar@rs587780070##&&&litvar@#7157#&&&litvar@CA256#rs587780070##|p.His179Tyr", "3421|11|variant|litvar@rs730882035##&&&litvar@#7428#&&&litvar@CA20413#rs730882035##|p.Arg161Gln", "2136|11|variant|litvar@rs1114167656##&&&litvar@#5728#|p.Ala126Val", "3713|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Gln61Arg", "681|11|variant|litvar@rs587782177##&&&litvar@#7157#|p.Ser215Asn", "603|11|variant|litvar@rs397516435##&&&litvar@#7157#&&&litvar@CA282#rs397516435##|p.Arg196Ter", "356|11|variant|litvar@rs193920817##&&&litvar@#7157#&&&litvar@CA234#rs193920817##|p.Ala161Thr", "512|11|variant|litvar@rs147002414##&&&litvar@#7157#&&&litvar@CA287488531#rs147002414##|p.Pro177Ser", "1959|12|variant|litvar@rs749783044##&&&litvar@#1956#&&&litvar@CA4266319#rs749783044##|p.Arg1023Ter", "1759|10|variant|litvar@rs121913236##&&&litvar@#3845#&&&litvar@CA16602771#rs121913236##|p.Gln22Lys", "43|10|variant|litvar@rs587782769##&&&litvar@#7157#&&&litvar@CA70#rs587782769##|p.Pro72Ala", "3110|11|variant|litvar@rs397516896##&&&litvar@#673#&&&litvar@CA135095#rs397516896##|p.Asp572Asn", "902|11|variant|litvar@rs1385545762##&&&litvar@#2322#|p.Thr253Ile", "1723|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.Gly12Asp", "2110|11|variant|litvar@rs878853946##&&&litvar@#5728#&&&litvar@CA10582768#rs878853946##|p.Asp115Asn", "3886|11|variant|litvar@rs190988940##&&&litvar@#324#|p.Arg190Gln", "655|11|variant|litvar@#324#p.T211I&&&litvar@#324#|p.Thr211Ile", "3845|11|variant|litvar@rs1280930048##&&&litvar@#4292#|p.Pro616Ser", "577|11|variant|litvar@rs776167460##&&&litvar@#7157#&&&litvar@CA2385#rs776167460##|p.Gly187Ser", "3056|11|variant|litvar@rs786203815##&&&litvar@#472#&&&litvar@CA197924#rs786203815##|p.Phe354Leu", "2029|12|variant|litvar@rs377675303##&&&litvar@#79811#|p.Ala1066Thr", "486|11|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|p.Arg175His", "1667|12|variant|litvar@#3845#p.E1577X&&&litvar@#3845#|p.Glu1577Ter", "1345|12|variant|litvar@rs1801155##&&&litvar@#324#&&&litvar@CA8761#rs1801155##|p.Ile1307Lys", "876|11|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|p.Arg248Trp", "1032|11|variant|litvar@rs863224451##&&&litvar@#7157#|p.Cys275Phe", "785|11|variant|litvar@rs763098116##&&&litvar@#7157#&&&litvar@CA438#rs763098116##|p.Cys238Tyr", "2874|11|variant|litvar@#472#p.L923F&&&litvar@#472#|p.Leu923Phe", "3030|11|variant|litvar@rs1479337697##&&&litvar@#79811#|p.Gly171Ser", "3074|10|variant|litvar@rs768986469##&&&litvar@#145270#|p.Pro37Ser", "3355|10|variant|litvar@rs121913529##&&&litvar@#3845#|p.Met12Ile", "850|11|variant|litvar@rs587781464##&&&litvar@#324#&&&litvar@CA14344#rs587781464##|p.Met246Val", "1006|11|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|p.Arg273Cys", "759|11|variant|litvar@rs1064793603##&&&litvar@#7157#|p.Cys229Tyr", "2416|11|variant|litvar@#1956#p.C499Y&&&litvar@#1956#|p.Cys499Tyr", "3187|11|variant|litvar@rs1044486319##&&&litvar@#4292#&&&litvar@CA72813691#rs1044486319##|p.Thr399Ile", "1973|12|variant|litvar@rs397517202##&&&litvar@#5290#&&&litvar@CA136374#rs397517202##|p.Thr1025Ala", "1597|9|variant|litvar@#3845#|p.His1490", "824|11|variant|litvar@rs985033810##&&&litvar@#7157#|p.Gly244Asp", "1829|11|variant|litvar@rs1428379257##&&&litvar@#5290#|p.Leu339Ile", "2443|4|gene|ncbi_gene@1956|EGFR", "980|11|variant|litvar@rs1060501191##&&&litvar@#7157#|p.Glu271Lys", "3630|3|gene|ncbi_gene@4352|MPL", "3447|12|variant|litvar@rs5030817##&&&litvar@#7428#&&&litvar@CA20389#rs5030817##|c.341-1G > A", "2715|11|variant|litvar@rs771567933##&&&litvar@#5156#&&&litvar@CA2922566#rs771567933##|p.Arg479Ter", "3232|10|variant|litvar@rs753954415##&&&litvar@#4893#&&&litvar@CA1020752#rs753954415##|p.Glu76Lys", "733|11|variant|litvar@#324#p.E221G&&&litvar@#324#|p.Glu221Gly", "1331|12|variant|litvar@rs730881249##&&&litvar@#324#&&&litvar@CA8903#rs730881249##|p.Ala1299Val", "2390|11|variant|litvar@rs377767347##&&&litvar@#4089#&&&litvar@CA128097#rs377767347##|p.Arg361His", "3379|10|variant|litvar@rs1306544787##&&&litvar@#5728#|p.Val22Ile", "3597|5|gene|ncbi_gene@2261|FGFR3", "3583|11|variant|litvar@rs267606870##&&&litvar@#3418#&&&litvar@CA16602464#rs267606870##|p.Arg140Trp", "3864|11|variant|litvar@rs397516896##|p.Ala572Thr", "1682|4|gene|ncbi_gene@3845|KRAS", "954|11|variant|litvar@rs587780075##&&&litvar@#7157#&&&litvar@CA424#rs587780075##|p.Arg267Gln", "3789|10|variant|litvar@rs121917756##&&&litvar@#3265#&&&litvar@CA122551#rs121917756##|p.Glu63Lys", "2689|11|variant|litvar@rs866987936##&&&litvar@#55294#&&&litvar@CA16602856#rs866987936##|p.Arg479Gln", "3616|11|variant|litvar@rs17882190##&&&litvar@#2261#&&&litvar@CA159722#rs17882190##|p.Ala719Thr", "707|11|variant|litvar@rs530941076##&&&litvar@#7157#|p.Tyr220Asn", "330|11|variant|litvar@rs121912654##&&&litvar@#7157#&&&litvar@CA220#rs121912654##|p.Val157Ile", "163|10|variant|litvar@rs1245723119##&&&litvar@#7157#|p.Pro98Leu", "1415|12|variant|litvar@#324#p.S1356X&&&litvar@#324#|p.Ser1356Ter", "2630|11|variant|litvar@rs1161829243##&&&litvar@#79811#|p.Gly873Glu", "3730|19|variant|litvar@#79811#c.2942-20_2943del22&&&litvar@#79811#|c.2942-20_2943del22", "928|11|variant|litvar@rs1057519990##&&&litvar@#7157#|p.Gly266Arg", "551|11|variant|litvar@rs1268298845##&&&litvar@#324#|p.Cys182Tyr", "2663|11|variant|litvar@rs1057519895##&&&litvar@#55294#|p.Arg465His", "3434|11|variant|litvar@rs5030821##&&&litvar@#7428#&&&litvar@CA20454#rs5030821##|p.Arg167Gln", "3391|10|variant|litvar@rs74727182##&&&litvar@#324#&&&litvar@CA6173#rs74727182##|p.Ser37Phe", "304|11|variant|litvar@rs137852789##&&&litvar@#7157#&&&litvar@CA206#rs137852789##|p.Gly154Ser", "1485|12|variant|litvar@rs121913326##&&&litvar@#324#&&&litvar@CA16030390#rs121913326##|p.Glu1379Ter", "3520|4|gene|ncbi_gene@2322|FLT3", "2604|11|variant|litvar@rs1203302510##&&&litvar@#1956#|p.Gly863Asp", "3726|3|gene|ncbi_gene@79811|MET", "115|10|variant|litvar@rs876660548##&&&litvar@#7157#&&&litvar@CA10580953#rs876660548##|p.Trp91Ter", "525|11|variant|litvar@rs1057519991##&&&litvar@#7157#|p.His179Arg", "3770|11|variant|litvar@#4292#p.H381R&&&litvar@#4292#|p.His381Arg", "2848|11|variant|litvar@#472#p.E884V&&&litvar@#472#|p.Glu884Val", "175|10|variant|litvar@rs191257018##&&&litvar@#4292#&&&litvar@CA26647#rs191257018##|p.Ser99Phe", "1699|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.Gly12Val", "278|11|variant|litvar@rs587782705##&&&litvar@#7157#&&&litvar@CA204#rs587782705##|p.Pro152Leu", "79|10|variant|litvar@rs534447939##&&&litvar@#7157#&&&litvar@CA80#rs534447939##|p.Pro82Leu", "2578|11|variant|litvar@#55294#p.E758K&&&litvar@#55294#|p.Glu758Lys", "2201|11|variant|litvar@rs121913293##&&&litvar@#5728#&&&litvar@CA498#rs121913293##|p.Arg173Cys", "3128|11|variant|litvar@rs754284825##&&&litvar@#3418#|p.Lys270Asn", "1201|11|variant|litvar@rs1474909212##&&&litvar@#2261#|p.Glu336Lys", "2058|4|gene|ncbi_gene@5728|PTEN", "499|11|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA252#rs28934578##|p.Arg175Leu", "1359|9|variant|litvar@#324#|p.Ile1307", "2822|11|variant|litvar@rs773758373##&&&litvar@#2322#&&&litvar@CA6928352#rs773758373##|p.Cys618Tyr", "1401|12|variant|litvar@#324#p.A1351T&&&litvar@#324#|p.Ala1351Thr", "3538|11|variant|litvar@rs779688631##&&&litvar@#2322#&&&litvar@CA6928545#rs779688631##|p.Lys602Arg", "252|11|variant|litvar@rs5030822##&&&litvar@#7428#&&&litvar@CA70052370#rs5030822##|p.Leu137Gln", "3826|10|variant|litvar@rs1277340795##&&&litvar@#3265#|p.Glu49Lys", "2729|4|gene|ncbi_gene@673|BRAF", "2175|11|variant|litvar@rs758945260##&&&litvar@#1956#&&&litvar@CA4265234#rs758945260##|p.Ser170Asn", "1429|12|variant|litvar@#324#p.S1360Y&&&litvar@#324#|p.Ser1360Tyr", "3367|10|variant|litvar@rs1442416937##&&&litvar@#3845#|p.Pro16Ser", "1175|11|variant|litvar@rs750487805##&&&litvar@#324#&&&litvar@CA16024115#rs750487805##|p.Gly302Glu", "798|11|variant|litvar@rs764342812##&&&litvar@#7157#|p.Ser240Arg", "1747|10|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|p.Val14Ile", "3043|11|variant|litvar@rs1064793881##&&&litvar@#7157#|p.Gly279Arg", "473|11|variant|litvar@rs876660754##&&&litvar@#7157#&&&litvar@CA10577579#rs876660754##|p.Val173Met", "1711|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.Gly12Ser", "2892|11|variant|litvar@rs56128736##&&&litvar@#472#&&&litvar@CA157210#rs56128736##|p.Val410Ala", "2364|11|variant|litvar@rs121912581##&&&litvar@#4089#&&&litvar@CA128090#rs121912581##|p.Gly352Arg", "3859|4|gene|ncbi_gene@3718|JAK3", "3674|6|gene|ncbi_gene@5156|PDGFRA", "1263|11|variant|litvar@#324#p.N869T&&&litvar@#324#|p.Asn869Thr", "3708|4|gene|ncbi_gene@4893|NRAS", "3878|7|gene|ncbi_gene@6598|SMARCB1", "2149|11|variant|litvar@rs121909229##&&&litvar@#5728#&&&litvar@CA437#rs121909229##|p.Arg130Gln", "151|10|variant|litvar@rs1484791833##&&&litvar@#2066#|p.Ser96Phe", "3751|11|variant|litvar@rs763189331##&&&litvar@#4292#&&&litvar@CA28235#rs763189331##|p.Asn375Ser", "772|11|variant|litvar@rs587780073##&&&litvar@#7157#&&&litvar@CA337#rs587780073##|p.Tyr234Cys", "3017|11|variant|litvar@rs528463800##&&&litvar@#4292#&&&litvar@CA29702#rs528463800##|p.Glu165Lys", "3660|11|variant|litvar@rs767897109##&&&litvar@#324#|p.Ala519Thr", "2338|11|variant|litvar@rs377767342##&&&litvar@#4089#&&&litvar@CA128087#rs377767342##|p.Glu330Lys", "3807|11|variant|litvar@rs146672976##&&&litvar@#2261#&&&litvar@CA2810547#rs146672976##|p.Ala573Val", "2123|11|variant|litvar@rs876660535##&&&litvar@#5728#&&&litvar@CA10578914#rs876660535##|p.Cys124Tyr", "746|11|variant|litvar@rs747207971##&&&litvar@#79811#|p.Gly226Ser", "2932|12|variant|litvar@rs368666328##&&&litvar@#472#&&&litvar@CA194948#rs368666328##|p.Leu2866Val", "1783|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "3176|9|variant|litvar@rs1235446603##&&&litvar@#2322#|Thr342Ile", "2403|11|variant|litvar@rs377767347##&&&litvar@#4089#&&&litvar@CA128097#rs377767347##|p.Arg361His", "1987|12|variant|litvar@rs1064793838##&&&litvar@#5290#|p.Asn1044Ser", "3408|11|variant|litvar@rs5030813##&&&litvar@#7428#&&&litvar@CA10606205#rs5030813##|p.Gln132Ter", "3634|11|variant|litvar@rs763504517##&&&litvar@#4352#&&&litvar@CA806926#rs763504517##|p.Ala506Thr", "2312|11|variant|litvar@#4089#p.Q248X&&&litvar@#4089#|p.Gln248Ter", "2253|11|variant|litvar@rs1404735609##&&&litvar@#79811#|p.Pro339Ser", "3290|11|variant|litvar@#7428#p.H878Y&&&litvar@#7428#|p.His878Tyr", "720|11|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|p.Tyr220Cys", "343|11|variant|litvar@rs121912654##&&&litvar@#7157#&&&litvar@CA222#rs121912654##|p.Val157Phe", "1373|12|variant|litvar@rs1321583762##&&&litvar@#324#|p.Glu1309Ter", "2377|11|variant|litvar@rs377767347##&&&litvar@#4089#&&&litvar@CA128097#rs377767347##|p.Arg361His", "1259|3|gene|ncbi_gene@324|APC", "2286|11|variant|litvar@rs377767326##&&&litvar@#4089#&&&litvar@CA259169#rs377767326##|p.Arg135Ter", "2552|11|variant|litvar@rs727504316##&&&litvar@#1956#&&&litvar@CA180736#rs727504316##|p.Thr751Ile", "1019|11|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|p.Arg273His", "1946|11|variant|litvar@rs1057519940##&&&litvar@#5290#|p.Gln546His", "2227|11|variant|litvar@rs749132706##&&&litvar@#1956#&&&litvar@CA4265413#rs749132706##|p.Val255Ile", "3264|11|variant|litvar@rs537545486##&&&litvar@#2066#&&&litvar@CA65143846#rs537545486##|p.Val851Met", "694|11|variant|litvar@rs730882025##&&&litvar@#7157#&&&litvar@CA308#rs730882025##|p.Val216Met", "317|11|variant|litvar@rs371524413##&&&litvar@#7157#&&&litvar@CA216#rs371524413##|p.Arg156His", "226|11|variant|litvar@rs1057519996##&&&litvar@#7157#|p.Lys132Arg", "2773|11|variant|litvar@rs121913364##&&&litvar@#673#&&&litvar@CA123645#rs121913364##|p.Lys601Glu", "2526|11|variant|litvar@rs121913467##&&&litvar@#1956#&&&litvar@CA16602723#rs121913467##|p.Trp731Ter", "1555|9|variant|litvar@#3845#|p.Leu1488", "1499|12|variant|litvar@#3845#p.P1439L&&&litvar@#3845#|p.Pro1439Leu", "2448|11|variant|litvar@#1956#p.G109E&&&litvar@#1956#|p.Gly109Glu", "2968|12|variant|litvar@#472#p.H1601L&&&litvar@#472#|p.His1601Leu", "993|11|variant|litvar@rs121912657##&&&litvar@#7157#&&&litvar@CA427#rs121912657##|p.Val272Met", "3098|10|variant|litvar@rs536951646##&&&litvar@#5728#&&&litvar@CA211451142#rs536951646##|p.Asp52Asn", "1149|11|variant|litvar@rs780313125##&&&litvar@#2261#|p.Pro300Leu", "1920|11|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123336#rs121913274##|p.Glu545Gly", "3334|11|variant|litvar@#7428#p.P634L&&&litvar@#7428#|p.Pro634Leu", "2861|11|variant|litvar@#472#p.E901K&&&litvar@#472#|p.Glu901Lys", "291|11|variant|litvar@rs762846821##&&&litvar@#7157#&&&litvar@CA2547#rs762846821##|p.Gly154Asp", "1289|12|variant|litvar@rs121913331##&&&litvar@#324#&&&litvar@CA10582306#rs121913331##|p.Arg1114Ter", "447|11|variant|litvar@rs587782224##&&&litvar@#5728#&&&litvar@CA295#rs587782224##|p.Val172Ile", "200|11|variant|litvar@rs11540654##&&&litvar@#7157#&&&litvar@CA2845#rs11540654##|p.Arg110Leu", "2747|11|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|p.Gly469Ala", "1230|12|variant|litvar@#324#c.560-1G>C&&&litvar@#324#|c.560-1G > C", "2001|12|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.His1047Arg", "2500|11|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126719#rs28929495##|p.Gly719Cys", "967|11|variant|litvar@rs1355502804##&&&litvar@#472#|p.Ser269Asn", "1123|11|variant|litvar@rs587782006##&&&litvar@#7157#&&&litvar@CA466#rs587782006##|p.Glu287Lys", "1894|11|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.Glu542Lys", "2835|11|variant|litvar@#472#p.D627G&&&litvar@#472#|p.Asp627Gly", "265|11|variant|litvar@rs28934874##&&&litvar@#7157#&&&litvar@CA198#rs28934874##|p.Pro151Thr", "2888|3|gene|ncbi_gene@472|ATM", "421|11|variant|litvar@rs1313797876##&&&litvar@#3845#|p.His168Tyr", "3570|11|variant|litvar@rs121913502##&&&litvar@#3418#&&&litvar@CA124277#rs121913502##|p.Arg140Gln"], "figure_id": "Tab2", "text_hl": "Gene Mutations detected   TP53 p.Ala69Val, p.Pro72Ala, p.Pro72Ser, p.Thr81Ile, p.Pro82Leu, p.Ala84Val, p.Pro87Leu, p.Trp91Ter, p.Ser94Ter, p.Ser95Phe, p.Ser96Phe, p.Pro98Leu, p.Ser99Phe, p.Gln100Ter, p.Arg110Leu, p.Leu130Ile, p.Lys132Arg, p.Cys135Ter, p.Leu137Gln, p.Pro151Thr, p.Pro152Leu, p.Gly154Asp, p.Gly154Ser, p.Arg156His, p.Val157Ile, p.Val157Phe, p.Ala161Thr, p.Tyr163Cys, p.Gln165Ter, p.Ser166Leu, p.His168Pro, p.His168Tyr, p.Glu171Lys, p.Val172Ile, p.Val173Ala, p.Val173Met, p.Arg175His, p.Arg175Leu, p.Pro177Ser, p.His179Arg, p.His179Tyr, p.Cys182Tyr, p.Ser183Leu, p.Gly187Ser, p.Pro190 fs, p.Arg196Ter, p.Gly199Glu, p.Arg202Cys, p.Arg209 fs, p.Thr211Ile, p.Arg213Ter, p.Ser215Asn, p.Val216Met, p.Tyr220Asn, p.Tyr220Cys, p.Glu221Gly, p.Gly226Ser, p.Cys229Tyr, p.Tyr234Cys, p.Cys238Tyr, p.Ser240Arg, p.Ser240Asn, p.Gly244Asp, p.Gly245Ser, p.Met246Val, p.Arg248Gln, p.Arg248Trp, p.Arg249Ser, p.Thr253Ile, p.Glu258Gln, p.Gly266Arg, p.Gly266Glu, p.Arg267Gln, p.Ser269Asn, p.Glu271Lys, p.Val272Met, p.Arg273Cys, p.Arg273His, p.Cys275Phe, p.Cys277Phe, p.Gly279Glu, p.Arg280Lys, p.Asp281Asn, p.Arg282Trp, p.Glu285Lys, p.Glu287Lys, p.Arg290His, p.Pro300Leu, p.Pro300Ser, p.Gly302Glu, p.Arg306Ter, p.Glu336Lys, c.559 + 3G > C, c.560-1G > C, c.376-1G > A   APC p.Asn869Thr, p.Arg876Ter, p.Arg1114Ter, p.Glu1286Ter, p.Ala1296 fs, p.Ala1299Val, p.Ile1307Lys, p.Ile1307 fs, p.Glu1309Ter, p.Glu1309 fs, p.Ala1351Thr, p.Ser1356Ter, p.Ser1360Tyr, p.Gln1367Ter, p.Glu1374Ter, p.Gln1378Ter, p.Glu1379Ter, p.Pro1439Leu, p.Arg1450Ter, p.Glu1461Lys, p.Ser1465 fs, p.Leu1488 fs, p.Leu1488Ter, p.His1490Leu, p.His1490 fs, p.Ser1495 fs, p.Ser1501 fs, p.Thr1556 fs, p.Glu1576Lys, p.Glu1577Ter   KRAS p.Ala11Val, p.Gly12Val, p.Gly12Ser, p.Gly12Asp, p.Gly13Asp, p.Val14Ile, p.Gln22Lys, p.Gln61His, <m>p.Ala146Thr</m>   PIK3CA p.Arg88Gln, p.Arg108His, p.Leu339Ile, p.Asn345Lys, p.Asp350Gly, p.Cys420Arg, p.Pro539His, p.Glu542Lys, p.Glu545Asp, p.Glu545Gly, p.Glu545Lys, p.Gln546His, p.Arg1023Ter, p.Thr1025Ala, p.Asn1044Ser, p.His1047Arg, p.His1048Arg, p.Ala1066Thr, p.Ter1069 fs   PTEN p.Lys6Glu, p.Glu7Ter, p.Asp24Asn, p.Gln110Ter, p.Asp115Asn, p.Cys124Tyr, p.Ala126Val, p.Arg130Gln, p.Gly165Glu, p.Ser170Asn, p.Gln171Ter, p.Arg173Cys, p.Pro246Leu, p.Val255Ile, p.Glu256Lys, p.Pro339Ser   SMAD4 p.Arg100Met, p.Arg135Ter, p.Gln245Ter, p.Gln248Ter, p.Thr259Ile, p.Glu330Lys, p.Ser343Ter, p.Gly352Arg, p.Arg361His, p.Arg361His, p.Arg361His, p.Cys499Tyr, p.Arg531Gln   EGFR p.Gly109Glu, p.Gly696Arg, p.Pro699Ser, p.Gly719Ser, p.Gly719Cys, p.Gly721Ser, p.Trp731Ter, p.Glu746Lys, p.Thr751Ile, p.Ala755Thr, p.Glu758Lys, p.Leu858Met, p.Gly863Asp, p.Ala864Val, p.Gly873Glu   FBXW7 p.Arg465Cys, p.Arg465His, p.Met467Ile, p.Arg479Gln, p.Arg479Pro, p.Arg479Ter   BRAF p.Gly469Val, p.Gly469Ala, p.Val600Glu, p.Lys601Glu   RB1 p.Ile680Thr, p.Leu683Phe   RET p.Cys618Tyr, p.Asp627Gly, p.Glu884Val, p.Glu901Lys, p.Leu923Phe   ATM p.Val410Ala, p.Phe858Leu, p.Thr1735 fs, p.Leu2866Val   NOTCH1 p.Arg1598His, p.His1601Leu, p.Pro2438Ser, p.Gln2440Ter   STK11 p.Glu165Lys, p.Gly171Ser, p.Gly279Arg, p.Phe354Leu   KIT p.Pro37Ser, p.Arg49His, p.Asp52Asn, p.Asp572Asn   KDR p.Lys270Asn, p.Gly1145Glu, p.Pro1354Ser   CDH1 pThr342Ile, p.Thr399Ile   PTPN11 p.Glu69Lys, p.Thr73Ile, p.Glu76Lys   ERBB2 p.Met774Ile, p.Val851Met, p.Thr862Ala, p.His878Tyr   SMO p.Val404Met, p.Leu412Phe, p.Pro634Leu   CTNNB1 p.Met12Ile, p.Pro16Ser, p.Val22Ile, p.Ser37Phe   VHL p.Gln132Ter, p.Arg161Gln, p.Arg167Gln, c.341-1G > A   CDKN2A p.Glu88Lys, p.Arg99Trp, p.Asp125Asn, p.Arg128Gln   FLT3 p.Ser446Leu, p.Lys602Arg, p.Trp603Ter   IDH2 p.Arg140Gln, p.Arg140Trp   FGFR3 p.Asp643Asn, p.Ala719Thr   MPL p.Ala506Thr, p.Ala519Val, p.Ala519Thr   PDGFRA p.Pro553Leu, p.Glu563Lys   NRAS p.Gln61Arg   MET c.2942-20_2943del22, p.Asn375Ser   MLH1 p.His381Arg   HRAS p.Glu63Lys   JAK3 p.Ala573Val   AKT1 p.Glu49Lys   ERBB4 p.Pro616Ser   JAK3 p.Ala572Thr   SMARCB1 p.Arg190Gln   ABL1 p.Thr334Ile   "}], "citations": {"NLM": "Dallol A, Buhmeida A, Al-Ahwal MS, Al-Maghrabi J, Bajouh O, Al-Khayyat S, Alam R, Abusanad A, Turki R, Elaimi A, Alhadrami HA, Abuzenadah M, Banni H, Al-Qahtani MH, Abuzenadah AM. Clinical significance of frequent somatic mutations detected by high-throughput targeted sequencing in archived colorectal cancer samples. J Transl Med. PMID: 27146902", "BibTeX": "@article{27146902, title={Clinical significance of frequent somatic mutations detected by high-throughput targeted sequencing in archived colorectal cancer samples.}, author={Dallol A and Buhmeida A and Al-Ahwal MS and Al-Maghrabi J and Bajouh O and Al-Khayyat S and Alam R and Abusanad A and Turki R and Elaimi A and Alhadrami HA and Abuzenadah M and Banni H and Al-Qahtani MH and Abuzenadah AM}, journal={J Transl Med}}"}, "is_sup_mat_match": false}, {"pmid": 32582557, "pmcid": "PMC7296099", "title": "Clinicopathological Characteristics and Mutation Spectrum of Colorectal Adenocarcinoma With Mucinous Component in a Chinese Cohort: Comparison With Classical Adenocarcinoma.", "journal": "Front Oncol", "authors": ["Chen J", "Zhou L", "Gao J", "Lu T", "Wang J", "Wu H", "Liang Z"], "date": "2020-06-09T00:00:00Z", "year": 2020, "snippets": [{"_id": "32582557@20419", "snip_text": "Forty-eight of the mutations were point mutation (13 of G12D, 10 of G12V, 9 of G13D, 8 of A146T, 2 of Q61R, 1 of A146V, 1 of G12C, 1 of G12S, 1 of Q61H, 1 of A146T and G13D, 1 of T20M and G13D), with only one insertion (G12_G13insA).", "section": "results", "mentions": ["56|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "158|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "113|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "79|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "68|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "179|4|variant|litvar@#3845#p.T20M&&&litvar@#3845#|T20M", "168|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "188|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "90|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "136|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "125|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "147|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "102|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R"], "text_hl": "Forty-eight of the mutations were point mutation (13 of G12D, 10 of G12V, 9 of G13D, 8 of <m>A146T</m>, 2 of Q61R, 1 of A146V, 1 of G12C, 1 of G12S, 1 of Q61H, 1 of <m>A146T</m> and G13D, 1 of T20M and G13D), with only one insertion (G12_G13insA)."}], "citations": {"NLM": "Chen J, Zhou L, Gao J, Lu T, Wang J, Wu H, Liang Z. Clinicopathological Characteristics and Mutation Spectrum of Colorectal Adenocarcinoma With Mucinous Component in a Chinese Cohort: Comparison With Classical Adenocarcinoma. Front Oncol. PMID: 32582557", "BibTeX": "@article{32582557, title={Clinicopathological Characteristics and Mutation Spectrum of Colorectal Adenocarcinoma With Mucinous Component in a Chinese Cohort: Comparison With Classical Adenocarcinoma.}, author={Chen J and Zhou L and Gao J and Lu T and Wang J and Wu H and Liang Z}, journal={Front Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 27335808, "pmcid": "PMC4906127", "title": "Diagnostic RAS mutation analysis by polymerase chain reaction (PCR)", "journal": "Biomol Detect Quantif", "authors": ["Cree IA"], "date": "2016-06-06T00:00:00Z", "year": 2016, "snippets": [{"_id": "27335808@20655", "snip_text": "Exon\tCodon\tExample Mutations\t \t2\t12\tG12C (c.34G > T)\t \t\t\tG12R (c.34G > C)\t \t\t\tG12S (c.34G > A)\t \t\t\tG12A (c.35G > C)\t \t\t\tG12D (c.35G > A)\t \t\t\tG12V (c.35G > T)\t \t\t13\tG13D (c.38G > A)\t \t3\t59\tA59E (c.176C > A)\t \t\t\tA59G (c.176C > G)\t \t\t\tA59T (c.175G > A)\t \t\t61\tQ61K (c.181C > A)\t \t\t\tQ61L (c.182A > T)\t \t\t\tQ61R (c.182A > G)\t \t\t\tQ61H (c.183A > C)\t \t\t\tQ61H (c.183A > T)\t \t4\t117\tK117N (c.351A > C)\t \t\t146\tA146P (c.436G > C)\t \t\t\tA146T (c.436G > A)\t \t\t\tA146V (c.437C > T)\t \t", "section": "table", "mentions": ["232|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "99|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "306|10|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|c.182A > G", "164|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "42|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G > T", "141|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "84|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G > A", "256|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "126|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "210|4|variant|litvar@rs763572530##&&&litvar@#1956#|A59G", "403|10|variant|litvar@rs121913527##&&&litvar@#3845#|c.436G > C", "36|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "344|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "238|10|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|c.175G > A", "449|10|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C > T", "396|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "188|4|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|A59E", "419|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "426|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "284|10|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|c.182A > T", "78|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "442|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "377|10|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|c.351A > C", "216|10|variant|litvar@rs763572530##&&&litvar@#1956#|c.176C > G", "262|10|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA180750#rs121913238##|c.181C > A", "120|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "322|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "370|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "63|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G > C", "194|10|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|c.176C > A", "105|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > C", "147|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "350|10|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|c.183A > T", "57|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "328|10|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA180922#rs17851045##|c.183A > C", "170|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "300|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "278|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L"], "figure_id": "tbl0005", "text_hl": "Exon\tCodon\tExample Mutations\t \t2\t12\tG12C (c.34G > T)\t \t\t\tG12R (c.34G > C)\t \t\t\tG12S (c.34G > A)\t \t\t\tG12A (c.35G > C)\t \t\t\tG12D (c.35G > A)\t \t\t\tG12V (c.35G > T)\t \t\t13\tG13D (c.38G > A)\t \t3\t59\tA59E (c.176C > A)\t \t\t\tA59G (c.176C > G)\t \t\t\tA59T (c.175G > A)\t \t\t61\tQ61K (c.181C > A)\t \t\t\tQ61L (c.182A > T)\t \t\t\tQ61R (c.182A > G)\t \t\t\tQ61H (c.183A > C)\t \t\t\tQ61H (c.183A > T)\t \t4\t117\tK117N (c.351A > C)\t \t\t146\tA146P (c.436G > C)\t \t\t\t<m>A146T</m> (c.436G > A)\t \t\t\tA146V (c.437C > T)\t \t"}], "citations": {"NLM": "Cree IA. Diagnostic RAS mutation analysis by polymerase chain reaction (PCR) Biomol Detect Quantif. PMID: 27335808", "BibTeX": "@article{27335808, title={Diagnostic RAS mutation analysis by polymerase chain reaction (PCR)}, author={Cree IA}, journal={Biomol Detect Quantif}}"}, "is_sup_mat_match": false}, {"pmid": 32810928, "pmcid": "PMC8247027", "title": "Pathogenic postzygotic mosaicism in the tyrosine receptor kinase pathway: potential unidentified human disease hidden away in a few cells.", "journal": "FEBS J", "authors": ["Tiemann-Boege I", "Mair T", "Yasari A", "Zurovec M"], "date": "2021-05-01T00:00:00Z", "year": 2021, "snippets": [{"_id": "32810928@11909", "snip_text": "Syndrome Genes and substitutions Level of mosaicism Affected tissue Time of onset Ref.   Proteus AKT1 (E17K) Level and phenotype of Proteus greatly depend on the timing of the mutation, the affected tissue type, or restriction to certain germ layer. Asymmetrically and irregularly growing tissues mainly in skin, bone, and adipose tissue; increased risk in thrombosis and subsequent pulmonary embolism 6-18 months after birth [31, 64]   PROS; for example, Klippel-Trenaunay PIK3CA (E545K, E454G, H1047R, H1047L) < 1% detected by NGS CLVM (capillary, lymphatic, and venous malformations), skin and tissue with lesions, and buccal cells Phenotype dependent on mutation type and distribution [32, 65]   FD/MAS GNAS (R201H, R201C) Unknown; 'obligatory mosaic' Endoderm, mesoderm, and ectoderm Children and young adults [66]   SWS GNAQ (R183Q) Mutant allele in affected tissues ranged from 1% to 18% Skin specially face, eye, nervous, and neurological anomalies Infants [35]   PPV and extensive dermal melanocytosis GNA11 (R183C, R183S)GNAQ (R183Q, Q209P) Low level of postzygotic mutations; percentage of mosaicism in skin was lowest with 1.5% Dermal melanocytosis (Mongolian blue spots), ocular melanocytosis, vascular birthmarks, and neurological abnormalities Infants [41, 67, 68, 69, 70]   NCM NRAS (Q61R, Q61K) Affected cutaneous and neurological tissues Development in neural crest and neuroectoderm; skin and central nerve system Children [36, 37]   SFMS HRAS (G13R)KRAS (G12D)NRAS (Q61R) Mutation frequency of 52% in head nevus sebaceous, 13% in hyperpigmented lesions, and 24.3% in lip nevus sebaceous tissues Nevus sebaceous, neurological anomalies, eye, skeletal, height, brain, head, genitourinary, cardiovascular, neoplasia From birth onwards [38, 39]   OES KRAS (A146T, A146V, G13D, L19F) RASopathy; frequency < 40% of tissues Skin; epibulbar dermoids and congenital scalp lesions (aplasia cutis congenita; ACC) Children [71, 72]   Encephalocraniocutaneous Lipomatosis (ECCL) FGFR1 (K656E, N546K)KRAS (A146T) Alternate allele fraction of 23-55% in fibroblasts from affected tissues; not detected in saliva or blood Cutaneous, ocular, and CNS; nevus psiloliparus as hallmark of ECCL Children [71, 73, 74]   ", "section": "table", "mentions": ["1037|5|variant|litvar@rs397514698##&&&litvar@#2776#&&&litvar@CA143805#rs397514698##|R183Q", "474|6|gene|ncbi_gene@5290|PIK3CA", "789|8|species|ncbi_taxonomy@9606|Children", "1550|22|disease|ncbi_mesh@C537836|hyperpigmented lesions", "1486|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "539|46|disease|ncbi_mesh@D008209|capillary, lymphatic, and venous malformations", "1458|4|gene|ncbi_gene@3265|HRAS", "832|5|variant|litvar@rs397514698##&&&litvar@#2776#&&&litvar@CA143805#rs397514698##|R183Q", "1162|20|disease|ncbi_mesh@D049328|Mongolian blue spots", "1464|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "2012|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "456|17|disease|ncbi_mesh@D007715|Klippel-Trenaunay", "1433|8|species|ncbi_taxonomy@9606|Children", "1773|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "713|5|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|R201H", "1917|3|disease|ncbi_mesh@D004476|ACC", "2006|4|gene|ncbi_gene@3845|KRAS", "1767|4|gene|ncbi_gene@3845|KRAS", "1011|5|gene|ncbi_gene@2767|GNA11", "972|3|disease|ncbi_mesh@D020752|PPV", "1866|24|disease|ncbi_mesh@D004476|congenital scalp lesions", "700|2|disease|ncbi_mesh@D000795|FD", "1140|20|disease|ncbi_mesh@C535835|Dermal melanocytosis", "437|4|disease|ncbi_mesh@C537340|PROS", "1591|15|disease|ncbi_mesh@D054000|nevus sebaceous", "1300|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "489|5|variant|litvar@rs367955950##&&&litvar@#2260#&&&litvar@CA4718399#rs367955950##|E454G", "1044|5|variant|litvar@rs121913492##&&&litvar@#2776#&&&litvar@CA16602436#rs121913492##|Q209P", "1986|5|gene|ncbi_gene@2260|FGFR1", "1615|15|disease|ncbi_mesh@D054000|Nevus sebaceous", "1922|8|species|ncbi_taxonomy@9606|Children", "1475|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1763|3|disease|ncbi_mesh@C563969|OES", "496|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "2187|4|disease|ncbi_mesh@C535736|ECCL", "957|7|species|ncbi_taxonomy@9606|Infants", "1980|4|disease|ncbi_mesh@C535736|ECCL", "921|35|disease|ncbi_mesh@D009421|nervous, and neurological anomalies", "990|20|disease|ncbi_mesh@C535835|dermal melanocytosis", "1018|5|variant|litvar@rs776549085##&&&litvar@#2260#|R183C", "1793|4|variant|litvar@rs121913538##&&&litvar@#3845#&&&litvar@CA210356#rs121913538##|L19F", "482|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "1031|4|gene|ncbi_gene@2776|GNAQ", "1942|36|disease|ncbi_mesh@C535736|Encephalocraniocutaneous Lipomatosis", "1632|22|disease|ncbi_mesh@D009421|neurological anomalies", "1993|5|variant|litvar@rs869320694##&&&litvar@#2260#&&&litvar@CA358862#rs869320694##|K656E", "1526|15|disease|ncbi_mesh@D054000|nevus sebaceous", "2125|26|disease|ncbi_mesh@D002494|Cutaneous, ocular, and CNS", "357|10|disease|ncbi_mesh@D013927|thrombosis", "1843|18|disease|ncbi_mesh@D003884|epibulbar dermoids", "707|4|gene|ncbi_gene@2778|GNAS", "1705|27|disease|ncbi_mesh@D009369|, cardiovascular, neoplasia", "383|18|disease|ncbi_mesh@D011655|pulmonary embolism", "1294|4|gene|ncbi_gene@4893|NRAS", "1025|5|variant|litvar@rs776549085##&&&litvar@#2260#&&&litvar@CA4718358#rs776549085##|R183S", "826|4|gene|ncbi_gene@2776|GNAQ", "1469|4|gene|ncbi_gene@3845|KRAS", "1892|23|disease|ncbi_mesh@D004476|aplasia cutis congenita", "97|4|gene|ncbi_gene@207|AKT1", "533|4|disease||CLVM", "504|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|H1047L", "2192|8|species|ncbi_taxonomy@9606|Children", "1787|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1259|7|species|ncbi_taxonomy@9606|Infants", "1780|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "1480|4|gene|ncbi_gene@4893|NRAS", "1799|9|disease||RASopathy", "2000|5|variant|litvar@rs779707422##&&&litvar@#2260#&&&litvar@CA357830#rs779707422##|N546K", "1306|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "2153|18|disease|ncbi_mesh@D009506|nevus psiloliparus"], "figure_id": "febs15528-tbl-0001", "text_hl": "Syndrome Genes and substitutions Level of mosaicism Affected tissue Time of onset Ref.   Proteus AKT1 (E17K) Level and phenotype of Proteus greatly depend on the timing of the mutation, the affected tissue type, or restriction to certain germ layer. Asymmetrically and irregularly growing tissues mainly in skin, bone, and adipose tissue; increased risk in thrombosis and subsequent pulmonary embolism 6-18 months after birth [31, 64]   PROS; for example, Klippel-Trenaunay PIK3CA (E545K, E454G, H1047R, H1047L) < 1% detected by NGS CLVM (capillary, lymphatic, and venous malformations), skin and tissue with lesions, and buccal cells Phenotype dependent on mutation type and distribution [32, 65]   FD/MAS GNAS (R201H, R201C) Unknown; 'obligatory mosaic' Endoderm, mesoderm, and ectoderm Children and young adults [66]   SWS GNAQ (R183Q) Mutant allele in affected tissues ranged from 1% to 18% Skin specially face, eye, nervous, and neurological anomalies Infants [35]   PPV and extensive dermal melanocytosis GNA11 (R183C, R183S)GNAQ (R183Q, Q209P) Low level of postzygotic mutations; percentage of mosaicism in skin was lowest with 1.5% Dermal melanocytosis (Mongolian blue spots), ocular melanocytosis, vascular birthmarks, and neurological abnormalities Infants [41, 67, 68, 69, 70]   NCM NRAS (Q61R, Q61K) Affected cutaneous and neurological tissues Development in neural crest and neuroectoderm; skin and central nerve system Children [36, 37]   SFMS HRAS (G13R)KRAS (G12D)NRAS (Q61R) Mutation frequency of 52% in head nevus sebaceous, 13% in hyperpigmented lesions, and 24.3% in lip nevus sebaceous tissues Nevus sebaceous, neurological anomalies, eye, skeletal, height, brain, head, genitourinary, cardiovascular, neoplasia From birth onwards [38, 39]   OES KRAS (<m>A146T</m>, A146V, G13D, L19F) RASopathy; frequency < 40% of tissues Skin; epibulbar dermoids and congenital scalp lesions (aplasia cutis congenita; ACC) Children [71, 72]   Encephalocraniocutaneous Lipomatosis (ECCL) FGFR1 (K656E, N546K)KRAS (<m>A146T</m>) Alternate allele fraction of 23-55% in fibroblasts from affected tissues; not detected in saliva or blood Cutaneous, ocular, and CNS; nevus psiloliparus as hallmark of ECCL Children [71, 73, 74]   "}], "citations": {"NLM": "Tiemann-Boege I, Mair T, Yasari A, Zurovec M. Pathogenic postzygotic mosaicism in the tyrosine receptor kinase pathway: potential unidentified human disease hidden away in a few cells. FEBS J. PMID: 32810928", "BibTeX": "@article{32810928, title={Pathogenic postzygotic mosaicism in the tyrosine receptor kinase pathway: potential unidentified human disease hidden away in a few cells.}, author={Tiemann-Boege I and Mair T and Yasari A and Zurovec M}, journal={FEBS J}}"}, "is_sup_mat_match": false}, {"pmid": 32466784, "pmcid": "PMC7257555", "title": "A novel NGS-based microsatellite instability (MSI) status classifier with 9 loci for colorectal cancer patients.", "journal": "J Transl Med", "authors": ["Zheng K", "Wan H", "Zhang J", "Shan G", "Chai N", "Li D", "Fang N", "Liu L", "Zhang J", "Du R", "Wu Q", "Li X", "Zhang C"], "date": "2020-05-28T00:00:00Z", "year": 2020, "snippets": [{"_id": "32466784@17843", "snip_text": "Gene Hotspot Number of variant cases   Total MSI-H MSS   KRAS p.G12V/S/D/A 16 3 13   p.G13D 7 5 2   p.Q61H 2 0 2   p.A146T 4 3 1   NRAS p.Q61R/H/L 3 0 3   BRAF p.V600E 4 4 0   TCF7L2 p.E384fs 10 10 0   RNF43 p.G659fs 7 7 0   TGFBR2 p.E125fs 6 6 0   QKI p.K132fs 4 4 0   CARD11 p.R555fs 3 3 0   BCORL1 p.S1679fs 3 3 0   JAK3 p.Q39fs 2 2 0   BCOR p.Q1156fs 2 2 0   ", "section": "table", "mentions": ["183|8|variant|litvar@#6934#p.E384fsX&&&litvar@#6934#|p.E384fs", "249|3|gene|ncbi_gene@9444|QKI", "345|9|variant|litvar@#54880#p.Q1156fsX&&&litvar@#54880#|p.Q1156fs", "202|5|gene|ncbi_gene@54894|RNF43", "324|7|variant|litvar@#3718#p.Q39fsX&&&litvar@#3718#|p.Q39fs", "115|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "340|4|gene|ncbi_gene@54880|BCOR", "100|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "62|8|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12V/S", "270|6|gene|ncbi_gene@84433|CARD11", "232|8|variant|litvar@#7048#p.E125fsX&&&litvar@#7048#|p.E125fs", "176|6|gene|ncbi_gene@6934|TCF7L2", "155|4|gene|ncbi_gene@673|BRAF", "136|8|variant|litvar@rs11554290##&&&litvar@#4893#|p.Q61R/H", "131|4|gene|ncbi_gene@4893|NRAS", "85|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "253|8|variant|litvar@rs786203589##&&&litvar@#7157#|p.K132fs", "294|6|gene|ncbi_gene@63035|BCORL1", "71|3|variant|litvar@#3845#|D/A", "160|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "57|4|gene|ncbi_gene@3845|KRAS", "225|6|gene|ncbi_gene@7048|TGFBR2", "301|9|variant|litvar@#63035#p.S1679fsX&&&litvar@#63035#|p.S1679fs", "45|5|disease|ncbi_mesh@D053842|MSI-H", "277|8|variant|litvar@rs63750806##&&&litvar@#4436#|p.R555fs", "319|4|gene|ncbi_gene@3718|JAK3", "208|8|variant|litvar@#54894#p.G659fsX&&&litvar@#54894#|p.G659fs"], "figure_id": "Tab3", "text_hl": "Gene Hotspot Number of variant cases   Total MSI-H MSS   KRAS p.G12V/S/D/A 16 3 13   p.G13D 7 5 2   p.Q61H 2 0 2   <m>p.A146T</m> 4 3 1   NRAS p.Q61R/H/L 3 0 3   BRAF p.V600E 4 4 0   TCF7L2 p.E384fs 10 10 0   RNF43 p.G659fs 7 7 0   TGFBR2 p.E125fs 6 6 0   QKI p.K132fs 4 4 0   CARD11 p.R555fs 3 3 0   BCORL1 p.S1679fs 3 3 0   JAK3 p.Q39fs 2 2 0   BCOR p.Q1156fs 2 2 0   "}], "citations": {"NLM": "Zheng K, Wan H, Zhang J, Shan G, Chai N, Li D, Fang N, Liu L, Zhang J, Du R, Wu Q, Li X, Zhang C. A novel NGS-based microsatellite instability (MSI) status classifier with 9 loci for colorectal cancer patients. J Transl Med. PMID: 32466784", "BibTeX": "@article{32466784, title={A novel NGS-based microsatellite instability (MSI) status classifier with 9 loci for colorectal cancer patients.}, author={Zheng K and Wan H and Zhang J and Shan G and Chai N and Li D and Fang N and Liu L and Zhang J and Du R and Wu Q and Li X and Zhang C}, journal={J Transl Med}}"}, "is_sup_mat_match": false}, {"pmid": 36849965, "pmcid": "PMC9969638", "title": "Mixed small cell neuroendocrine carcinoma and squamous cell carcinoma covered by tubulovillous adenoma in the rectum: a case report and detailed molecular analyses.", "journal": "World J Surg Oncol", "authors": ["He F", "He X", "Cui M", "Wang Y"], "date": "2023-02-27T00:00:00Z", "year": 2023, "snippets": [{"_id": "36849965@6966", "snip_text": "Gene Mutations Abundance (%)   Adenoma NEC SCC   KRAS c.436G>A (p.A146T) 25.5 28.3 31.7   BRCA1 c.4987-2A>G 45.3 34.2 27.7   CDK4 Copy number amplification - CN: 4.6 -   TP53 c.159G>A (p.W53*) 41.6 85.2 79.8   APC c.3964G>T (p.E1322*) 52.3 94.0 78.3   FBXW7 c.217C>T (p.Q73*) 27.6 47.5 37.3   FBXW7 c.372+1G>A 26.4 44.2 32.4   RB1 c.1963dup (p.Y655Lfs*13) - 67.3% 71.2%   RNF43 c.131del (p.Q44Rfs*7) 25.5 52.1 53.6   FLT4 c.1426C>T (p.R476W) 28.9 49.6 52.5   KMT2B c.74G>A (p.R25Q) - - 22.7   MLH3 c.484A>G (p.M162V) 49.4 7.3 14.3   PDGFRB c.886A>T (p.S296C) 22.2 6.2 8.8   PKHD1 c.11006C>T (p.S3669L) 26.3 60.9 53.1   TMB Mutations/Mbases 6.2 8.2 10.3   Low < 10 Low Low High   High >=10      Microsatellite  Stable Stable Stable   ", "section": "table", "mentions": ["474|6|variant|litvar@rs1044896377##&&&litvar@#54894#&&&litvar@CA292015224#rs1044896377##|p.R25Q", "185|6|variant|litvar@#7157#p.53dup&&&litvar@#7157#|p.W53*", "96|11|variant|litvar@rs397509212##&&&litvar@#672#&&&litvar@CA3132#rs397509212##|c.4987-2A>G", "268|6|variant|litvar@#55294#p.73dup&&&litvar@#55294#|p.Q73*", "508|7|variant|litvar@rs188493164##&&&litvar@#27030#&&&litvar@CA7276018#rs188493164##|p.M162V", "388|10|variant|litvar@#54894#p.Q44RfsX7&&&litvar@#54894#|p.Q44Rfs*7", "574|5|gene|ncbi_gene@5314|PKHD1", "592|8|variant|litvar@rs554782195##&&&litvar@#5314#&&&litvar@CA3850973#rs554782195##|p.S3669L", "225|8|variant|litvar@#324#p.E1322*&&&litvar@#324#|p.E1322*", "49|4|gene|ncbi_gene@3845|KRAS", "459|5|gene|ncbi_gene@9757|KMT2B", "372|5|gene|ncbi_gene@54894|RNF43", "550|7|variant|litvar@rs764858967##&&&litvar@#5159#&&&litvar@CA3508167#rs764858967##|p.S296C", "342|12|variant|litvar@rs397508924##&&&litvar@#672#&&&litvar@CA327793#rs397508924##|p.Y655Lfs*13", "175|8|variant|litvar@rs1064794618##&&&litvar@#7157#|c.159G>A", "214|9|variant|litvar@rs764773634##&&&litvar@#9757#&&&litvar@CA9384927#rs764773634##|c.3964G>T", "417|4|gene|ncbi_gene@2324|FLT4", "64|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "258|8|variant|litvar@rs1057520008##&&&litvar@#7157#|c.217C>T", "210|3|gene|ncbi_gene@324|APC", "170|4|gene|ncbi_gene@7157|TP53", "378|8|variant|litvar@#54894#c.131del&&&litvar@#54894#|c.131del", "498|8|variant|litvar@rs188493164##&&&litvar@#27030#&&&litvar@CA7276018#rs188493164##|c.484A>G", "31|15|disease|ncbi_mesh@D002294|Adenoma NEC SCC", "299|10|variant|litvar@#55294#c.372+1G>A&&&litvar@#55294#|c.372+1G>A", "465|7|variant|litvar@rs1407730273##&&&litvar@#5159#|c.74G>A", "54|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "90|5|gene|ncbi_gene@672|BRCA1", "125|4|gene|ncbi_gene@1019|CDK4", "540|8|variant|litvar@rs764858967##&&&litvar@#5159#&&&litvar@CA3508167#rs764858967##|c.886A>T", "422|9|variant|litvar@rs756924526##&&&litvar@#2324#&&&litvar@CA3606728#rs756924526##|c.1426C>T", "433|7|variant|litvar@rs756924526##&&&litvar@#2324#&&&litvar@CA3606728#rs756924526##|p.R476W", "331|9|variant|litvar@rs397508924##&&&litvar@#672#|c.1963dup", "580|10|variant|litvar@rs554782195##&&&litvar@#5314#&&&litvar@CA3850973#rs554782195##|c.11006C>T", "293|5|gene|ncbi_gene@55294|FBXW7", "493|4|gene|ncbi_gene@27030|MLH3", "533|6|gene|ncbi_gene@5159|PDGFRB", "252|5|gene|ncbi_gene@55294|FBXW7", "327|3|gene|ncbi_gene@5925|RB1"], "figure_id": "Tab1", "text_hl": "Gene Mutations Abundance (%)   Adenoma NEC SCC   KRAS c.436G>A (<m>p.A146T</m>) 25.5 28.3 31.7   BRCA1 c.4987-2A>G 45.3 34.2 27.7   CDK4 Copy number amplification - CN: 4.6 -   TP53 c.159G>A (p.W53*) 41.6 85.2 79.8   APC c.3964G>T (p.E1322*) 52.3 94.0 78.3   FBXW7 c.217C>T (p.Q73*) 27.6 47.5 37.3   FBXW7 c.372+1G>A 26.4 44.2 32.4   RB1 c.1963dup (p.Y655Lfs*13) - 67.3% 71.2%   RNF43 c.131del (p.Q44Rfs*7) 25.5 52.1 53.6   FLT4 c.1426C>T (p.R476W) 28.9 49.6 52.5   KMT2B c.74G>A (p.R25Q) - - 22.7   MLH3 c.484A>G (p.M162V) 49.4 7.3 14.3   PDGFRB c.886A>T (p.S296C) 22.2 6.2 8.8   PKHD1 c.11006C>T (p.S3669L) 26.3 60.9 53.1   TMB Mutations/Mbases 6.2 8.2 10.3   Low < 10 Low Low High   High >=10      Microsatellite  Stable Stable Stable   "}], "citations": {"NLM": "He F, He X, Cui M, Wang Y. Mixed small cell neuroendocrine carcinoma and squamous cell carcinoma covered by tubulovillous adenoma in the rectum: a case report and detailed molecular analyses. World J Surg Oncol. PMID: 36849965", "BibTeX": "@article{36849965, title={Mixed small cell neuroendocrine carcinoma and squamous cell carcinoma covered by tubulovillous adenoma in the rectum: a case report and detailed molecular analyses.}, author={He F and He X and Cui M and Wang Y}, journal={World J Surg Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 25943333, "pmcid": "PMC4424481", "title": "Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab.", "journal": "J Transl Med", "authors": ["Giampieri R", "Mandolesi A", "Abouelkhair KM", "Loretelli C", "Del Prete M", "Faloppi L", "Maristella B", "Ibrahim EM", "Scarpelli M", "Cascinu S", "Scartozzi M"], "date": "2015-05-07T00:00:00Z", "year": 2015, "snippets": [{"_id": "25943333@8155", "snip_text": "The variants of codons 12, 13, 59, 61, 117 and 146 of the K-RAS gene (G12D, G12A, G12V, G12S, G12R, G12C, G13D, G13C in exon 2; A59P, A59T, A59S, A59G, A59E, A59V, Q61K, Q61E, Q61R, Q61L, Q61P, Q61H in exon 3; K117Q, K117E, K117T, K117I, K117R, K117N, A146P, A146T, A146S, A146G, A146E, A146V in exon 4) have been analysed via pyrosequencing using the \"Anti-EGFR MoAb response kit (KRAS status) (Diatech Pharmacogenetics.", "section": "methods", "mentions": ["224|5|variant|litvar@#1956#p.K117T&&&litvar@#1956#|K117T", "266|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146S", "164|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "182|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "280|5|variant|litvar@rs1240818498##&&&litvar@#3479#|A146E", "100|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "231|5|variant|litvar@#1956#p.K117I&&&litvar@#1956#|K117I", "128|4|variant|litvar@rs763572530##&&&litvar@#1956#|A59P", "146|4|variant|litvar@rs763572530##&&&litvar@#1956#|A59G", "82|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "140|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA354836#rs121913528##|A59S", "188|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "358|4|gene|ncbi_gene@1956|EGFR", "245|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "76|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "217|5|variant|litvar@#1956#p.K117E&&&litvar@#1956#|K117E", "106|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "152|4|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|A59E", "170|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "273|5|variant|litvar@rs374619740##&&&litvar@#2065#&&&litvar@CA6621966#rs374619740##|A146G", "259|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "382|4|gene|ncbi_gene@3845|KRAS", "287|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "88|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "58|5|gene|ncbi_gene@3845|K-RAS", "158|4|variant|litvar@rs104886029##&&&litvar@#3845#&&&litvar@CA269881#rs104886029##|A59V", "194|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "70|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "134|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "112|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "176|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "210|5|variant|litvar@#1956#p.K117Q&&&litvar@#1956#|K117Q", "94|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "252|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "238|5|variant|litvar@#1956#p.K117R&&&litvar@#1956#|K117R"], "text_hl": "The variants of codons 12, 13, 59, 61, 117 and 146 of the K-RAS gene (G12D, G12A, G12V, G12S, G12R, G12C, G13D, G13C in exon 2; A59P, A59T, A59S, A59G, A59E, A59V, Q61K, Q61E, Q61R, Q61L, Q61P, Q61H in exon 3; K117Q, K117E, K117T, K117I, K117R, K117N, A146P, <m>A146T</m>, A146S, A146G, A146E, A146V in exon 4) have been analysed via pyrosequencing using the \"Anti-EGFR MoAb response kit (KRAS status) (Diatech Pharmacogenetics."}], "citations": {"NLM": "Giampieri R, Mandolesi A, Abouelkhair KM, Loretelli C, Del Prete M, Faloppi L, Maristella B, Ibrahim EM, Scarpelli M, Cascinu S, Scartozzi M. Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab. J Transl Med. PMID: 25943333", "BibTeX": "@article{25943333, title={Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab.}, author={Giampieri R and Mandolesi A and Abouelkhair KM and Loretelli C and Del Prete M and Faloppi L and Maristella B and Ibrahim EM and Scarpelli M and Cascinu S and Scartozzi M}, journal={J Transl Med}}"}, "is_sup_mat_match": false}, {"pmid": 30719547, "pmcid": "PMC6611891", "title": "European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projects.", "journal": "Virchows Arch", "authors": ["Keppens C", "Dufraing K", "van Krieken HJ", "Siebers AG", "Kafatos G", "Lowe K", "Demonty G", "Dequeker EMC"], "date": "2019-07-01T00:00:00Z", "year": 2019, "snippets": [{"_id": "30719547@34659", "snip_text": "Error rates were highest for a case containing the c.436G > A p.(Ala146Thr) variant (15.4%, n = 123) in 2016, and for the c.176C > A p.(Ala59Glu) variant (24.8%, n = 105) in 2017.", "section": "discussion", "mentions": ["51|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "136|8|variant|litvar@rs1291197787##&&&litvar@#2710#|Ala59Glu", "65|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|Ala146Thr", "122|10|variant|litvar@rs1291197787##&&&litvar@#2710#|c.176C > A"], "text_hl": "Error rates were highest for a case containing the c.436G > A p.(<m>Ala146Thr</m>) variant (15.4%, n = 123) in 2016, and for the c.176C > A p.(Ala59Glu) variant (24.8%, n = 105) in 2017."}], "citations": {"NLM": "Keppens C, Dufraing K, van Krieken HJ, Siebers AG, Kafatos G, Lowe K, Demonty G, Dequeker EMC. European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projects. Virchows Arch. PMID: 30719547", "BibTeX": "@article{30719547, title={European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projects.}, author={Keppens C and Dufraing K and van Krieken HJ and Siebers AG and Kafatos G and Lowe K and Demonty G and Dequeker EMC}, journal={Virchows Arch}}"}, "is_sup_mat_match": false}, {"pmid": 31160330, "title": "RAS Mutations Are Not Created Equal.", "journal": "Cancer Discov", "authors": ["Hobbs GA", "Der CJ"], "date": "2019-06-01T00:00:00Z", "year": 2019, "snippets": [{"_id": "31160330@37", "snip_text": "In this issue of Cancer Discovery, Poulin and colleagues apply structural, biochemical, and biological profiling of two mutants of KRAS, one found most frequently in all cancers (G12D) and one found nearly exclusively in colorectal cancer (A146T).", "section": "abstract", "mentions": ["17|6|disease|ncbi_mesh@D009369|Cancer", "179|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "170|7|disease|ncbi_mesh@D009369|cancers", "221|17|disease|ncbi_mesh@D015179|colorectal cancer", "240|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "131|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "In this issue of Cancer Discovery, Poulin and colleagues apply structural, biochemical, and biological profiling of two mutants of KRAS, one found most frequently in all cancers (G12D) and one found nearly exclusively in colorectal cancer (<m>A146T</m>)."}], "citations": {"NLM": "Hobbs GA, Der CJ. RAS Mutations Are Not Created Equal. Cancer Discov. PMID: 31160330", "BibTeX": "@article{31160330, title={RAS Mutations Are Not Created Equal.}, author={Hobbs GA and Der CJ}, journal={Cancer Discov}}"}, "is_sup_mat_match": false}, {"pmid": 33802849, "pmcid": "PMC8002639", "title": "Recent Updates on the Significance of KRAS Mutations in Colorectal Cancer Biology.", "journal": "Cells", "authors": ["L\u00e1szl\u00f3 L", "Kurilla A", "Tak\u00e1cs T", "Kudlik G", "Koprivanacz K", "Buday L", "Vas V"], "date": "2021-03-17T00:00:00Z", "year": 2021, "snippets": [{"_id": "33802849@9230", "snip_text": "The glutamine residue at position 61, the glycine residues at positions at 12 and 13, and the alanine residue at position 146, which form the GDP/GTP pocket, are indicated with colours.", "section": "figure_legend", "mentions": ["4|32|variant|litvar@#4192#|glutamine residue at position 61", "94|31|variant|litvar@rs121913527##&&&litvar@#3845#|alanine residue at position 146", "142|3|chemical|ncbi_mesh@D006153|GDP", "146|3|chemical|ncbi_mesh@D006160|GTP"], "figure_id": "cells-10-00667-f002", "text_hl": "The glutamine residue at position 61, the glycine residues at positions at 12 and 13, and the alanine residue at position 146, which form the GDP/GTP pocket, are indicated with colours."}], "citations": {"NLM": "L\u00e1szl\u00f3 L, Kurilla A, Tak\u00e1cs T, Kudlik G, Koprivanacz K, Buday L, Vas V. Recent Updates on the Significance of KRAS Mutations in Colorectal Cancer Biology. Cells. PMID: 33802849", "BibTeX": "@article{33802849, title={Recent Updates on the Significance of KRAS Mutations in Colorectal Cancer Biology.}, author={L\u00e1szl\u00f3 L and Kurilla A and Tak\u00e1cs T and Kudlik G and Koprivanacz K and Buday L and Vas V}, journal={Cells}}"}, "is_sup_mat_match": false}, {"pmid": 26970110, "title": "Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis.", "journal": "Clin Genet", "authors": ["Boppudi S", "B\u00f6gershausen N", "Hove HB", "Percin EF", "Aslan D", "Dvorsky R", "Kayhan G", "Li Y", "Cursiefen C", "Tantcheva-Poor I", "Toft PB", "Bartsch O", "Lissewski C", "Wieland I", "Jakubiczka S", "Wollnik B", "Ahmadian MR", "Heindl LM", "Zenker M"], "date": "2016-10-01T00:00:00Z", "year": 2016, "snippets": [{"_id": "26970110@812", "snip_text": "In all four cases, Sanger sequencing of the KRAS gene in DNA from lesional tissue detected mutations affecting codon 146 (p.Ala146Val, p.Ala146Thr) at variable levels of mosaicism.", "section": "abstract", "mentions": ["44|4|gene|ncbi_gene@3845|KRAS", "135|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "122|11|variant|litvar@rs1057519725##&&&litvar@#3845#|p.Ala146Val"], "text_hl": "In all four cases, Sanger sequencing of the KRAS gene in DNA from lesional tissue detected mutations affecting codon 146 (p.Ala146Val, <m>p.Ala146Thr</m>) at variable levels of mosaicism."}], "citations": {"NLM": "Boppudi S, B\u00f6gershausen N, Hove HB, Percin EF, Aslan D, Dvorsky R, Kayhan G, Li Y, Cursiefen C, Tantcheva-Poor I, Toft PB, Bartsch O, Lissewski C, Wieland I, Jakubiczka S, Wollnik B, Ahmadian MR, Heindl LM, Zenker M. Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis. Clin Genet. PMID: 26970110", "BibTeX": "@article{26970110, title={Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis.}, author={Boppudi S and B\u00f6gershausen N and Hove HB and Percin EF and Aslan D and Dvorsky R and Kayhan G and Li Y and Cursiefen C and Tantcheva-Poor I and Toft PB and Bartsch O and Lissewski C and Wieland I and Jakubiczka S and Wollnik B and Ahmadian MR and Heindl LM and Zenker M}, journal={Clin Genet}}"}, "is_sup_mat_match": false}, {"pmid": 26243863, "pmcid": "PMC4527087", "title": "HER2 activating mutations are targets for colorectal cancer treatment", "journal": "Cancer Discov", "authors": ["Kavuri SM", "Jain N", "Galimi F", "Cottino F", "Leto SM", "Migliardi G", "Searleman AC", "Shen W", "Monsey J", "Trusolino L", "Jacobs SA", "Bertotti A", "Bose R"], "date": "2015-08-01T00:00:00Z", "year": 2015, "snippets": [{"_id": "26243863@4715", "snip_text": "The co-occurring KRAS mutations included 4 cases of codon 12/13 mutations and 2 cases of exon 4 mutations (KRAS K117N and A146T).", "section": "results", "mentions": ["17|4|gene|ncbi_gene@3845|KRAS", "112|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "107|4|gene|ncbi_gene@3845|KRAS", "122|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "The co-occurring KRAS mutations included 4 cases of codon 12/13 mutations and 2 cases of exon 4 mutations (KRAS K117N and <m>A146T</m>)."}], "citations": {"NLM": "Kavuri SM, Jain N, Galimi F, Cottino F, Leto SM, Migliardi G, Searleman AC, Shen W, Monsey J, Trusolino L, Jacobs SA, Bertotti A, Bose R. HER2 activating mutations are targets for colorectal cancer treatment Cancer Discov. PMID: 26243863", "BibTeX": "@article{26243863, title={HER2 activating mutations are targets for colorectal cancer treatment}, author={Kavuri SM and Jain N and Galimi F and Cottino F and Leto SM and Migliardi G and Searleman AC and Shen W and Monsey J and Trusolino L and Jacobs SA and Bertotti A and Bose R}, journal={Cancer Discov}}"}, "is_sup_mat_match": false}, {"pmid": 25705018, "pmcid": "PMC4336936", "title": "Comparative analysis of KRAS codon 12, 13, 18, 61, and 117 mutations using human MCF10A isogenic cell lines.", "journal": "Sci Rep", "authors": ["Stolze B", "Reinhart S", "Bulllinger L", "Fr\u00f6hling S", "Scholl C"], "date": "2015-02-23T00:00:00Z", "year": 2015, "snippets": [{"_id": "25705018@2951", "snip_text": "For example, experiments with murine NIH/3T3 cells showed that codon 12 mutations protected from apoptosis and promoted anchorage-independent growth more strongly than codon 13 mutations, and KRAS-K117N and A146T are associated with lower levels of GTP-bound RAS compared to G12D in transfected HEK293FT cells.", "section": "abstract", "mentions": ["30|6|species|ncbi_taxonomy@10090|murine", "295|8|cellline||HEK293FT", "249|3|chemical|ncbi_mesh@D006160|GTP", "207|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "197|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "37|7|cellline||NIH/3T3", "192|4|gene|ncbi_gene@16653|KRAS", "275|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D"], "text_hl": "For example, experiments with murine NIH/3T3 cells showed that codon 12 mutations protected from apoptosis and promoted anchorage-independent growth more strongly than codon 13 mutations, and KRAS-K117N and <m>A146T</m> are associated with lower levels of GTP-bound RAS compared to G12D in transfected HEK293FT cells."}], "citations": {"NLM": "Stolze B, Reinhart S, Bulllinger L, Fr\u00f6hling S, Scholl C. Comparative analysis of KRAS codon 12, 13, 18, 61, and 117 mutations using human MCF10A isogenic cell lines. Sci Rep. PMID: 25705018", "BibTeX": "@article{25705018, title={Comparative analysis of KRAS codon 12, 13, 18, 61, and 117 mutations using human MCF10A isogenic cell lines.}, author={Stolze B and Reinhart S and Bulllinger L and Fr\u00f6hling S and Scholl C}, journal={Sci Rep}}"}, "is_sup_mat_match": false}, {"pmid": 34211852, "pmcid": "PMC8239306", "title": "High-Density of FcgammaRIIIA+ (CD16+) Tumor-Associated Neutrophils in Metastases Improves the Therapeutic Response of Cetuximab in Metastatic Colorectal Cancer Patients, Independently of the HLA-E/CD94-NKG2A Axis", "journal": "Front Oncol", "authors": ["Denis Musquer M", "Jouand N", "Pere M", "Lamer JE", "B\u00e9zieau S", "Matysiak T", "Faroux R", "Caroli Bosc FX", "Rousselet MC", "Leclair F", "Mosnier JF", "Toquet C", "Gervois N", "Bossard C"], "date": "2021-06-15T00:00:00Z", "year": 2021, "snippets": [{"_id": "34211852@6801", "snip_text": "Additional mutations were found in 4 patients (two 436G>A mutations in KRAS exon 4 in both primary tumor and paired metastasis, one 351A>C mutation in KRAS exon 4 in a primary tumor and one 181C>A mutation in NRAS exon 3 in a metastasis), thus resulting in 39 patients with a wild-type RAS status eligible for the current study.", "section": "methods", "mentions": ["132|6|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|351A>C", "37|8|species|ncbi_taxonomy@9606|patients", "51|6|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|436G>A", "260|8|species|ncbi_taxonomy@9606|patients", "209|4|gene|ncbi_gene@4893|NRAS", "190|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|181C>A", "151|4|gene|ncbi_gene@3845|KRAS", "71|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "Additional mutations were found in 4 patients (two 436G>A mutations in KRAS exon 4 in both primary tumor and paired metastasis, one 351A>C mutation in KRAS exon 4 in a primary tumor and one 181C>A mutation in NRAS exon 3 in a metastasis), thus resulting in 39 patients with a wild-type RAS status eligible for the current study."}], "citations": {"NLM": "Denis Musquer M, Jouand N, Pere M, Lamer JE, B\u00e9zieau S, Matysiak T, Faroux R, Caroli Bosc FX, Rousselet MC, Leclair F, Mosnier JF, Toquet C, Gervois N, Bossard C. High-Density of FcgammaRIIIA+ (CD16+) Tumor-Associated Neutrophils in Metastases Improves the Therapeutic Response of Cetuximab in Metastatic Colorectal Cancer Patients, Independently of the HLA-E/CD94-NKG2A Axis Front Oncol. PMID: 34211852", "BibTeX": "@article{34211852, title={High-Density of FcgammaRIIIA+ (CD16+) Tumor-Associated Neutrophils in Metastases Improves the Therapeutic Response of Cetuximab in Metastatic Colorectal Cancer Patients, Independently of the HLA-E/CD94-NKG2A Axis}, author={Denis Musquer M and Jouand N and Pere M and Lamer JE and B\u00e9zieau S and Matysiak T and Faroux R and Caroli Bosc FX and Rousselet MC and Leclair F and Mosnier JF and Toquet C and Gervois N and Bossard C}, journal={Front Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 37141389, "pmcid": "PMC10187917", "title": "An integrated model for predicting KRAS dependency", "journal": "PLoS Comput Biol", "authors": ["Tsai YS", "Chareddy YS", "Price BA", "Parker JS", "Pecot CV"], "date": "2023-05-04T00:00:00Z", "year": 2023, "snippets": [{"_id": "37141389@35756", "snip_text": "Activating mutations in these cell lines include the following: KRAS:A146A, A146T, R164, T74P and any mutations at G12, G13, Q61; BRAF:L597R, V226M, G466V, R682Q, G464E, N581Y, G464V, G469A, L597V, G596R and any mutations at V600; NRAS:A146V, E132K and any mutations at G12, G13, Q61; HRAS:T58T and any mutations at G12, G13, Q61.", "section": "methods", "mentions": ["64|4|gene|ncbi_gene@3845|KRAS", "285|4|gene|ncbi_gene@3265|HRAS", "135|5|variant|litvar@rs121913366##&&&litvar@#673#&&&litvar@CA123649#rs121913366##|L597R", "120|3|variant|litvar@rs112445441##&&&litvar@#3845#|G13", "243|5|variant|litvar@rs1456325880##&&&litvar@#4893#|E132K", "290|4|variant|litvar@rs746639086##&&&litvar@#3265#&&&litvar@CA5779390#rs746639086##|T58T", "316|3|variant|litvar@rs121913529##&&&litvar@#3845#|G12", "76|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "236|5|variant|litvar@rs121917759##&&&litvar@#3265#&&&litvar@CA256494#rs121917759##|A146V", "156|5|variant|litvar@rs186127441##&&&litvar@#29967#|R682Q", "270|3|variant|litvar@rs121913529##&&&litvar@#3845#|G12", "149|5|variant|litvar@rs121913351##&&&litvar@#673#&&&litvar@CA123647#rs121913351##|G466V", "69|5|variant|litvar@rs1305285506##&&&litvar@#3845#|A146A", "142|5|variant|litvar@rs483352695##&&&litvar@#7157#&&&litvar@CA374#rs483352695##|V226M", "231|4|gene|ncbi_gene@4893|NRAS", "321|3|variant|litvar@rs112445441##&&&litvar@#3845#|G13", "184|5|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|G469A", "89|4|variant|litvar@#3845#p.T74P&&&litvar@#3845#|T74P", "177|5|variant|litvar@rs121913348##&&&litvar@#673#&&&litvar@CA135076#rs121913348##|G464V", "130|4|gene|ncbi_gene@673|BRAF", "170|5|variant|litvar@rs1456202829##&&&litvar@#6935#|N581Y", "275|3|variant|litvar@rs112445441##&&&litvar@#3845#|G13", "163|5|variant|litvar@rs121913348##&&&litvar@#673#&&&litvar@CA250636#rs121913348##|G464E", "115|3|variant|litvar@rs121913529##&&&litvar@#3845#|G12", "198|5|variant|litvar@rs121913361##&&&litvar@#673#&&&litvar@CA16602422#rs121913361##|G596R", "191|5|variant|litvar@rs121913369##&&&litvar@#673#&&&litvar@CA123651#rs121913369##|L597V"], "text_hl": "Activating mutations in these cell lines include the following: KRAS:A146A, <m>A146T</m>, R164, T74P and any mutations at G12, G13, Q61; BRAF:L597R, V226M, G466V, R682Q, G464E, N581Y, G464V, G469A, L597V, G596R and any mutations at V600; NRAS:A146V, E132K and any mutations at G12, G13, Q61; HRAS:T58T and any mutations at G12, G13, Q61."}], "citations": {"NLM": "Tsai YS, Chareddy YS, Price BA, Parker JS, Pecot CV. An integrated model for predicting KRAS dependency PLoS Comput Biol. PMID: 37141389", "BibTeX": "@article{37141389, title={An integrated model for predicting KRAS dependency}, author={Tsai YS and Chareddy YS and Price BA and Parker JS and Pecot CV}, journal={PLoS Comput Biol}}"}, "is_sup_mat_match": false}, {"pmid": 30754629, "pmcid": "PMC6384902", "title": "Drug Sensitivity Screening and Targeted Pathway Analysis Reveal a Multi-Driver Proliferative Mechanism and Suggest a Strategy of Combination Targeted Therapy for Colorectal Cancer Cells.", "journal": "Molecules", "authors": ["Shen J", "Li L", "Yang T", "Cheng N", "Sun G"], "date": "2019-02-11T00:00:00Z", "year": 2019, "snippets": [{"_id": "30754629@52150", "snip_text": "Cell Line Pik3ca Mutations Braf Mutations KRAS Mutations Cancer Census Mutations Coding Mutations   HCT-15 E545K, D549N none G13D 321 11348   HCT-116 H1047R none G13D 163 4318   LS-1034 None none A146T 10 207   LS-123 None none G12S 13 483   LS-411N None V600E none 209 7141   LS-174T H1047R D211G G12D 127 3517   LS-513 None none G12D 21 444   NCI-H747 None none G13D 14 377   RKO H1047R V600E none 155 4762   SK-CO-1 None none G12V 16 443   ", "section": "table", "mentions": ["331|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "228|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "57|6|disease|ncbi_mesh@D009369|Cancer", "162|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "178|7|disease|ncbi_mesh@D007888|LS-1034", "364|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "42|4|gene|ncbi_gene@3845|KRAS", "125|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "211|6|disease|ncbi_mesh@D007888|LS-123", "27|4|gene|ncbi_gene@673|Braf", "292|5|variant|litvar@rs779646370##&&&litvar@#2185#&&&litvar@CA4688351#rs779646370##|D211G", "285|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "255|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "345|8|cellline||NCI-H747", "114|5|variant|litvar@rs1057519699##&&&litvar@#5290#|D549N", "107|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "298|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "10|6|gene|ncbi_gene@5290|Pik3ca", "389|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "411|7|cellline||SK-CO-1", "196|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "429|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "382|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "142|7|cellline||HCT-116", "150|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R"], "figure_id": "molecules-24-00623-t002", "text_hl": "Cell Line Pik3ca Mutations Braf Mutations KRAS Mutations Cancer Census Mutations Coding Mutations   HCT-15 E545K, D549N none G13D 321 11348   HCT-116 H1047R none G13D 163 4318   LS-1034 None none <m>A146T</m> 10 207   LS-123 None none G12S 13 483   LS-411N None V600E none 209 7141   LS-174T H1047R D211G G12D 127 3517   LS-513 None none G12D 21 444   NCI-H747 None none G13D 14 377   RKO H1047R V600E none 155 4762   SK-CO-1 None none G12V 16 443   "}], "citations": {"NLM": "Shen J, Li L, Yang T, Cheng N, Sun G. Drug Sensitivity Screening and Targeted Pathway Analysis Reveal a Multi-Driver Proliferative Mechanism and Suggest a Strategy of Combination Targeted Therapy for Colorectal Cancer Cells. Molecules. PMID: 30754629", "BibTeX": "@article{30754629, title={Drug Sensitivity Screening and Targeted Pathway Analysis Reveal a Multi-Driver Proliferative Mechanism and Suggest a Strategy of Combination Targeted Therapy for Colorectal Cancer Cells.}, author={Shen J and Li L and Yang T and Cheng N and Sun G}, journal={Molecules}}"}, "is_sup_mat_match": false}, {"pmid": 35796015, "pmcid": "PMC9291252", "title": "Differences in actionable genomic alterations between brain metastases and non-brain metastases in patients with non-small cell lung cancer.", "journal": "Int J Oncol", "authors": ["Nian R", "Jiang H", "Zhao J", "Hou W", "Zhang H", "Ma J", "Lv P", "Jiang L", "Wang Y", "Xu Y", "Wu S", "Lou J", "Li W"], "date": "2022-09-01T00:00:00Z", "year": 2022, "snippets": [{"_id": "35796015@17318", "snip_text": "p.G12D, p.G12V, p.Q61H, and p.A146T, 3.85 vs.", "section": "results", "mentions": ["8|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "28|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "16|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "0|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D"], "text_hl": "p.G12D, p.G12V, p.Q61H, and <m>p.A146T</m>, 3.85 vs."}], "citations": {"NLM": "Nian R, Jiang H, Zhao J, Hou W, Zhang H, Ma J, Lv P, Jiang L, Wang Y, Xu Y, Wu S, Lou J, Li W. Differences in actionable genomic alterations between brain metastases and non-brain metastases in patients with non-small cell lung cancer. Int J Oncol. PMID: 35796015", "BibTeX": "@article{35796015, title={Differences in actionable genomic alterations between brain metastases and non-brain metastases in patients with non-small cell lung cancer.}, author={Nian R and Jiang H and Zhao J and Hou W and Zhang H and Ma J and Lv P and Jiang L and Wang Y and Xu Y and Wu S and Lou J and Li W}, journal={Int J Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 35563733, "pmcid": "PMC9105487", "title": "Prognostic and Immunotherapeutic Roles of KRAS in Pan-Cancer.", "journal": "Cells", "authors": ["Yang K", "Li C", "Liu Y", "Gu X", "Jiang L", "Shi L"], "date": "2022-04-22T00:00:00Z", "year": 2022, "snippets": [{"_id": "35563733@25775", "snip_text": "There are more than 10 different types of KRAS mutations, including KRAS G12D, G12V, G12C, G13D, Q61H, G12R, G12A, G12S, A146T, and G61L.", "section": "discussion", "mentions": ["91|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "79|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "97|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "85|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "68|4|gene|ncbi_gene@3845|KRAS", "103|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "121|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "109|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "132|4|variant|litvar@#3845#p.G61L&&&litvar@#3845#|G61L", "42|4|gene|ncbi_gene@3845|KRAS", "115|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "73|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D"], "text_hl": "There are more than 10 different types of KRAS mutations, including KRAS G12D, G12V, G12C, G13D, Q61H, G12R, G12A, G12S, <m>A146T</m>, and G61L."}], "citations": {"NLM": "Yang K, Li C, Liu Y, Gu X, Jiang L, Shi L. Prognostic and Immunotherapeutic Roles of KRAS in Pan-Cancer. Cells. PMID: 35563733", "BibTeX": "@article{35563733, title={Prognostic and Immunotherapeutic Roles of KRAS in Pan-Cancer.}, author={Yang K and Li C and Liu Y and Gu X and Jiang L and Shi L}, journal={Cells}}"}, "is_sup_mat_match": false}, {"pmid": 22821884, "pmcid": "PMC4166655", "title": "A Novel HRAS Substitution (c.266C>G; p.S89C) Resulting in Decreased Downstream Signaling Suggests a New Dimension of RAS Pathway Dysregulation in Human Development", "journal": "Am J Med Genet A", "authors": ["Gripp KW", "Bifeld E", "Stabley DL", "Hopkins E", "Meien S", "Vinette K", "Sol-Church K", "Rosenberger G"], "date": "2012-09-01T00:00:00Z", "year": 2012, "snippets": [{"_id": "22821884@27480", "snip_text": "Based on structural considerations or by inference of information derived from KRAS, similar consequences on HRAS activation and downstream signal-inghavebeen proposed for the disease-associated HRAS amino acid substitution p.Q22K, p.T58I, p.E63K, p.A146V, and p.A146T.", "section": "discussion", "mentions": ["261|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "248|7|variant|litvar@rs121917759##&&&litvar@#3265#&&&litvar@CA256494#rs121917759##|p.A146V", "224|6|variant|litvar@rs121917757##&&&litvar@#3265#&&&litvar@CA122553#rs121917757##|p.Q22K", "109|4|gene|ncbi_gene@3265|HRAS", "232|6|variant|litvar@rs121917758##&&&litvar@#3265#&&&litvar@CA341206#rs121917758##|p.T58I", "79|4|gene|ncbi_gene@3845|KRAS", "195|4|gene|ncbi_gene@3265|HRAS", "240|6|variant|litvar@rs121917756##&&&litvar@#3265#&&&litvar@CA122551#rs121917756##|p.E63K"], "text_hl": "Based on structural considerations or by inference of information derived from KRAS, similar consequences on HRAS activation and downstream signal-inghavebeen proposed for the disease-associated HRAS amino acid substitution p.Q22K, p.T58I, p.E63K, p.A146V, and <m>p.A146T</m>."}], "citations": {"NLM": "Gripp KW, Bifeld E, Stabley DL, Hopkins E, Meien S, Vinette K, Sol-Church K, Rosenberger G. A Novel HRAS Substitution (c.266C>G; p.S89C) Resulting in Decreased Downstream Signaling Suggests a New Dimension of RAS Pathway Dysregulation in Human Development Am J Med Genet A. PMID: 22821884", "BibTeX": "@article{22821884, title={A Novel HRAS Substitution (c.266C>G; p.S89C) Resulting in Decreased Downstream Signaling Suggests a New Dimension of RAS Pathway Dysregulation in Human Development}, author={Gripp KW and Bifeld E and Stabley DL and Hopkins E and Meien S and Vinette K and Sol-Church K and Rosenberger G}, journal={Am J Med Genet A}}"}, "is_sup_mat_match": false}, {"pmid": 36359850, "pmcid": "PMC9657932", "title": "Enhancing an Oxidative \"Trojan Horse\" Action of Vitamin C with Arsenic Trioxide for Effective Suppression of KRAS-Mutant Cancers: A Promising Path at the Bedside.", "journal": "Cells", "authors": ["Burska AN", "Ilyassova B", "Dildabek A", "Khamijan M", "Begimbetova D", "Moln\u00e1r F", "Sarbassov DD"], "date": "2022-11-01T00:00:00Z", "year": 2022, "snippets": [{"_id": "36359850@10830", "snip_text": "The KRAS mutations at positions G12, G13, Q61, and A146 are located at the effector lobe and lead to a shift toward the active KRAS form through impairing nucleotide hydrolysis and/or activating nucleotide exchange.", "section": "other", "mentions": ["127|4|gene|ncbi_gene@3845|KRAS", "37|3|variant|litvar@rs112445441##&&&litvar@#3845#|G13", "4|4|gene|ncbi_gene@3845|KRAS", "32|3|variant|litvar@rs121913529##&&&litvar@#3845#|G12", "51|4|variant|litvar@rs121913527##&&&litvar@#3845#|A146"], "text_hl": "The KRAS mutations at positions G12, G13, Q61, and A146 are located at the effector lobe and lead to a shift toward the active KRAS form through impairing nucleotide hydrolysis and/or activating nucleotide exchange."}], "citations": {"NLM": "Burska AN, Ilyassova B, Dildabek A, Khamijan M, Begimbetova D, Moln\u00e1r F, Sarbassov DD. Enhancing an Oxidative \"Trojan Horse\" Action of Vitamin C with Arsenic Trioxide for Effective Suppression of KRAS-Mutant Cancers: A Promising Path at the Bedside. Cells. PMID: 36359850", "BibTeX": "@article{36359850, title={Enhancing an Oxidative \"Trojan Horse\" Action of Vitamin C with Arsenic Trioxide for Effective Suppression of KRAS-Mutant Cancers: A Promising Path at the Bedside.}, author={Burska AN and Ilyassova B and Dildabek A and Khamijan M and Begimbetova D and Moln\u00e1r F and Sarbassov DD}, journal={Cells}}"}, "is_sup_mat_match": false}, {"pmid": 34337566, "pmcid": "PMC8324497", "title": "ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors.", "journal": "Cell Rep Med", "authors": ["Portelinha A", "Thompson S", "Smith RA", "Da Silva Ferreira M", "Asgari Z", "Knezevic A", "Seshan V", "de Stanchina E", "Gupta S", "Denis L", "Younes A", "Reddy S"], "date": "2021-07-21T00:00:00Z", "year": 2021, "snippets": [{"_id": "34337566@11200", "snip_text": "The compound was particularly potent against KRASA146T mutant cell line NU-DHL-1, NRASG13D mutant cell line MINO, and BRAFV600E mutant lymphoma cell line U-2973, with IC50 values of 100, 200, and 300 nM, respectively (Table 2).", "section": "results", "mentions": ["118|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|BRAFV600E", "108|4|cellline||MINO", "72|8|cellline||NU-DHL-1", "135|8|disease|ncbi_mesh@D008223|lymphoma", "45|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T", "154|6|cellline||U-2973"], "text_hl": "The compound was particularly potent against KRASA146T mutant cell line NU-DHL-1, NRASG13D mutant cell line MINO, and BRAFV600E mutant lymphoma cell line U-2973, with IC50 values of 100, 200, and 300 nM, respectively (Table 2)."}], "citations": {"NLM": "Portelinha A, Thompson S, Smith RA, Da Silva Ferreira M, Asgari Z, Knezevic A, Seshan V, de Stanchina E, Gupta S, Denis L, Younes A, Reddy S. ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors. Cell Rep Med. PMID: 34337566", "BibTeX": "@article{34337566, title={ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors.}, author={Portelinha A and Thompson S and Smith RA and Da Silva Ferreira M and Asgari Z and Knezevic A and Seshan V and de Stanchina E and Gupta S and Denis L and Younes A and Reddy S}, journal={Cell Rep Med}}"}, "is_sup_mat_match": false}, {"pmid": 36583506, "pmcid": "PMC10134345", "title": "An innovative single-base extension method for synchronous detection of point mutations and MSI status in colorectal cancer", "journal": "Cancer Med", "authors": ["Liang L", "Li X", "Nong L", "Cai W", "Zhang J", "Liu P", "Li T"], "date": "2022-12-30T00:00:00Z", "year": 2022, "snippets": [{"_id": "36583506@6160", "snip_text": "MASE-CE assay was developed to detect seven mutations in KRAS (G12C/G12D/G13D/A146T), NRAS (G12C/G12D) and BRAF (V600E) as well as five MSI loci (D2S123/D5S346/D17S250/BAT-25/BAT-26) simultaneously.", "section": "methods", "mentions": ["97|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "92|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "63|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "73|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "113|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "57|4|gene|ncbi_gene@3845|KRAS", "78|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "86|4|gene|ncbi_gene@4893|NRAS", "68|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "107|4|gene|ncbi_gene@673|BRAF"], "text_hl": "MASE-CE assay was developed to detect seven mutations in KRAS (G12C/G12D/G13D/<m>A146T</m>), NRAS (G12C/G12D) and BRAF (V600E) as well as five MSI loci (D2S123/D5S346/D17S250/BAT-25/BAT-26) simultaneously."}], "citations": {"NLM": "Liang L, Li X, Nong L, Cai W, Zhang J, Liu P, Li T. An innovative single-base extension method for synchronous detection of point mutations and MSI status in colorectal cancer Cancer Med. PMID: 36583506", "BibTeX": "@article{36583506, title={An innovative single-base extension method for synchronous detection of point mutations and MSI status in colorectal cancer}, author={Liang L and Li X and Nong L and Cai W and Zhang J and Liu P and Li T}, journal={Cancer Med}}"}, "is_sup_mat_match": false}, {"pmid": 38290249, "pmcid": "PMC10859238", "title": "Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression", "journal": "Transl Oncol", "authors": ["Del Re M", "Luculli GI", "Petrini I", "Sbrana A", "Scotti V", "Perez DM", "Livi L", "Crucitta S", "Iannopollo M", "Mazzoni F", "Ruglioni M", "Tibaldi C", "Olmetto E", "Stasi I", "Baldini E", "Allegrini G", "Antonuzzo L", "Morelli F", "Pierini A", "Panzeri N", "Fogli S", "Chella A", "Rolfo C", "Danesi R"], "date": "2024-03-01T00:00:00Z", "year": 2024, "snippets": [{"_id": "38290249@13055", "snip_text": "The concomitant presence of a druggable driver variant and other driver events was found in 4 cases, including ALK-EML4 fusion together with MET and EGFR amplification, EGFR and MET amplification, ROS1-CD74 fusion in association with ROS1 non-synonymus variants (p.G2101A, p.G2095A, p.G2032R, p.G2026R, p.F2004C, p.F1998C, p.L1946V, p.L1941V), BRAF p.V600E in combination with KRAS p.A146P and IDH1 p.R132C.", "section": "results", "mentions": ["283|8|variant|litvar@rs1057519788##&&&litvar@#6098#|p.G2032R", "149|4|gene|ncbi_gene@1956|EGFR", "293|8|variant|litvar@#6098#p.G2026R&&&litvar@#6098#|p.G2026R", "323|8|variant|litvar@#673#p.L1946V&&&litvar@#673#|p.L1946V", "349|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "111|3|gene|ncbi_gene@238|ALK", "263|8|variant|litvar@rs886041257##&&&litvar@#673#|p.G2101A", "399|7|variant|litvar@rs121913499##&&&litvar@#3417#&&&litvar@CA16602374#rs121913499##|p.R132C", "377|4|gene|ncbi_gene@3845|KRAS", "234|4|gene|ncbi_gene@6098|ROS1", "178|3|gene|ncbi_gene@79811|MET", "273|8|variant|litvar@#6098#p.G2095A&&&litvar@#6098#|p.G2095A", "115|4|gene|ncbi_gene@27436|EML4", "141|3|gene|ncbi_gene@79811|MET", "382|7|variant|litvar@rs121913527##&&&litvar@#3845#|p.A146P", "303|8|variant|litvar@#6098#p.F2004C&&&litvar@#6098#|p.F2004C", "394|4|gene|ncbi_gene@3417|IDH1", "169|4|gene|ncbi_gene@1956|EGFR", "197|4|gene|ncbi_gene@6098|ROS1", "333|8|variant|litvar@#673#p.L1941V&&&litvar@#673#|p.L1941V", "344|4|gene|ncbi_gene@673|BRAF", "313|8|variant|litvar@#673#p.F1998C&&&litvar@#673#|p.F1998C", "202|4|gene|ncbi_gene@972|CD74"], "text_hl": "The concomitant presence of a druggable driver variant and other driver events was found in 4 cases, including ALK-EML4 fusion together with MET and EGFR amplification, EGFR and MET amplification, ROS1-CD74 fusion in association with ROS1 non-synonymus variants (p.G2101A, p.G2095A, p.G2032R, p.G2026R, p.F2004C, p.F1998C, p.L1946V, p.L1941V), BRAF p.V600E in combination with KRAS p.A146P and IDH1 p.R132C."}], "citations": {"NLM": "Del Re M, Luculli GI, Petrini I, Sbrana A, Scotti V, Perez DM, Livi L, Crucitta S, Iannopollo M, Mazzoni F, Ruglioni M, Tibaldi C, Olmetto E, Stasi I, Baldini E, Allegrini G, Antonuzzo L, Morelli F, Pierini A, Panzeri N, Fogli S, Chella A, Rolfo C, Danesi R. Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression Transl Oncol. PMID: 38290249", "BibTeX": "@article{38290249, title={Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression}, author={Del Re M and Luculli GI and Petrini I and Sbrana A and Scotti V and Perez DM and Livi L and Crucitta S and Iannopollo M and Mazzoni F and Ruglioni M and Tibaldi C and Olmetto E and Stasi I and Baldini E and Allegrini G and Antonuzzo L and Morelli F and Pierini A and Panzeri N and Fogli S and Chella A and Rolfo C and Danesi R}, journal={Transl Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 31940389, "pmcid": "PMC6961936", "title": "Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer.", "journal": "PLoS One", "authors": ["Franczak C", "Witz A", "Geoffroy K", "Demange J", "Rouyer M", "Husson M", "Massard V", "Gavoille C", "Lambert A", "Gilson P", "Gambier N", "Scala-Bertola J", "Merlin JL", "Harl\u00e9 A"], "date": "2020-01-15T00:00:00Z", "year": 2020, "snippets": [{"_id": "31940389@5351", "snip_text": "Cell-line ATCC  reference Gene Exon Reference Sequence Coding DNA Sequence mutationAmino Acid mutation Mutation   ML-2 CVCL_1418TM KRAS 4 NM_033360.2 c.436G>Ap.(Ala146Thr) Heterozygous   SW620 CCL-227TM KRAS 2 NM_033360.2 c.35G>Tp.(Gly12Val) Homozygous   HT29 HTB-38TM BRAF 15 NM_004333.4 c.1799T>Ap.(Val600Glu) Heterozygous   MZ2 CVCL-1435TM NRAS 3 NM_002525.4 c.181C>Ap.(Gln61Lys) Heterozygous   ", "section": "table", "mentions": ["260|8|cellline||HTB-38TM", "119|11|cellline||CVCL_1418TM", "140|9|cellline||_033360.2", "301|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|Val600Glu", "193|9|cellline||CCL-227TM", "373|8|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Gln61Lys", "269|4|gene|ncbi_gene@673|BRAF", "187|5|cellline||SW620", "255|4|cellline||HT29", "161|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|Ala146Thr", "232|8|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|Gly12Val", "131|4|gene|ncbi_gene@3845|KRAS", "203|4|gene|ncbi_gene@3845|KRAS", "114|4|cellline||ML-2"], "figure_id": "pone.0227294.t001", "text_hl": "Cell-line ATCC  reference Gene Exon Reference Sequence Coding DNA Sequence mutationAmino Acid mutation Mutation   ML-2 CVCL_1418TM KRAS 4 NM_033360.2 c.436G>Ap.(<m>Ala146Thr</m>) Heterozygous   SW620 CCL-227TM KRAS 2 NM_033360.2 c.35G>Tp.(Gly12Val) Homozygous   HT29 HTB-38TM BRAF 15 NM_004333.4 c.1799T>Ap.(Val600Glu) Heterozygous   MZ2 CVCL-1435TM NRAS 3 NM_002525.4 c.181C>Ap.(Gln61Lys) Heterozygous   "}], "citations": {"NLM": "Franczak C, Witz A, Geoffroy K, Demange J, Rouyer M, Husson M, Massard V, Gavoille C, Lambert A, Gilson P, Gambier N, Scala-Bertola J, Merlin JL, Harl\u00e9 A. Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer. PLoS One. PMID: 31940389", "BibTeX": "@article{31940389, title={Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer.}, author={Franczak C and Witz A and Geoffroy K and Demange J and Rouyer M and Husson M and Massard V and Gavoille C and Lambert A and Gilson P and Gambier N and Scala-Bertola J and Merlin JL and Harl\u00e9 A}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 38785486, "pmcid": "PMC11120216", "title": "Real-World Evidence Study of Patients with KRAS-Mutated NSCLC in Finland", "journal": "Curr Oncol", "authors": ["Anttalainen A", "Pietarinen P", "Tuominen S", "Mattila R", "Mutka A", "Knuuttila A"], "date": "2024-05-11T00:00:00Z", "year": 2024, "snippets": [{"_id": "38785486@10638", "snip_text": "A total of 383 patients (64%; 90% in adenocarcinomas and 19% in other NSCLCs) were tested for genetic alterations with NGS and of these 35 (9%) had the KRAS G12C mutation, 74 (19%) other KRAS mutation (Gly12Val; n = 28, Gly12Asp; n = 15, Gly12Ala; n = 11, Gly61His; n = 8, Gly12Ser; n < 5, Gly13Cys; n < 5, Gly12Arg; n < 5, Ala146Thr; n < 5, Gln61Leu; n < 5, Gln61Lys; n < 5, Gly12Phe; n < 5, Gly13Asp; n < 5), 68 (18%) other driver mutation (BRAF; n = 14, EGFR; n = 40, MET or HER2; n = 14), and 206 (54%) did not have any driver mutations detected.", "section": "results", "mentions": ["220|8|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|Gly12Asp", "478|4|gene|ncbi_gene@2064|HER2", "342|8|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|Gln61Leu", "70|6|disease||NSCLCs", "152|4|gene|ncbi_gene@3845|KRAS", "393|8|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|Gly13Asp", "273|8|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|Gly12Ser", "202|8|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|Gly12Val", "187|4|gene|ncbi_gene@3845|KRAS", "157|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "359|8|variant|litvar@rs144460286##&&&litvar@#1956#&&&litvar@CA4265428#rs144460286##|Gln61Lys", "37|15|disease|ncbi_mesh@D000230|adenocarcinomas", "290|8|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|Gly13Cys", "256|8|variant|litvar@rs121913240##&&&litvar@#3845#|Gly61His", "443|4|gene|ncbi_gene@673|BRAF", "324|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|Ala146Thr", "471|3|gene|ncbi_gene@79811|MET", "238|8|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|Gly12Ala", "15|8|species|ncbi_taxonomy@9606|patients", "457|4|gene|ncbi_gene@1956|EGFR", "376|8|variant|litvar@rs121913530##&&&litvar@#3845#|Gly12Phe", "307|8|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|Gly12Arg"], "text_hl": "A total of 383 patients (64%; 90% in adenocarcinomas and 19% in other NSCLCs) were tested for genetic alterations with NGS and of these 35 (9%) had the KRAS G12C mutation, 74 (19%) other KRAS mutation (Gly12Val; n = 28, Gly12Asp; n = 15, Gly12Ala; n = 11, Gly61His; n = 8, Gly12Ser; n < 5, Gly13Cys; n < 5, Gly12Arg; n < 5, <m>Ala146Thr</m>; n < 5, Gln61Leu; n < 5, Gln61Lys; n < 5, Gly12Phe; n < 5, Gly13Asp; n < 5), 68 (18%) other driver mutation (BRAF; n = 14, EGFR; n = 40, MET or HER2; n = 14), and 206 (54%) did not have any driver mutations detected."}], "citations": {"NLM": "Anttalainen A, Pietarinen P, Tuominen S, Mattila R, Mutka A, Knuuttila A. Real-World Evidence Study of Patients with KRAS-Mutated NSCLC in Finland Curr Oncol. PMID: 38785486", "BibTeX": "@article{38785486, title={Real-World Evidence Study of Patients with KRAS-Mutated NSCLC in Finland}, author={Anttalainen A and Pietarinen P and Tuominen S and Mattila R and Mutka A and Knuuttila A}, journal={Curr Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 31681616, "pmcid": "PMC6813200", "title": "A Comparative Analysis of Individual RAS Mutations in Cancer Biology.", "journal": "Front Oncol", "authors": ["Mu\u00f1oz-Maldonado C", "Zimmer Y", "Medov\u00e1 M"], "date": "2019-10-18T00:00:00Z", "year": 2019, "snippets": [{"_id": "31681616@65244", "snip_text": "For example, NRAS A146T can be found in the leukemic cell lines NALM6 and ML-216, while HRAS K117N and A146T germline mutations have been identified in a small number of patients with Costello syndrome and KRAS V14I in patients with Noonan syndrome.", "section": "other", "mentions": ["74|6|cellline||ML-216", "184|17|disease|ncbi_mesh@D056685|Costello syndrome", "44|8|disease|ncbi_mesh@D007938|leukemic", "88|4|gene|ncbi_gene@3265|HRAS", "64|5|cellline||NALM6", "18|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "13|4|gene|ncbi_gene@4893|NRAS", "93|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "170|8|species|ncbi_taxonomy@9606|patients", "206|4|gene|ncbi_gene@3845|KRAS", "219|8|species|ncbi_taxonomy@9606|patients", "233|15|disease|ncbi_mesh@D009634|Noonan syndrome", "211|4|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|V14I", "103|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "For example, NRAS A146T can be found in the leukemic cell lines NALM6 and ML-216, while HRAS K117N and A146T germline mutations have been identified in a small number of patients with Costello syndrome and KRAS V14I in patients with Noonan syndrome."}], "citations": {"NLM": "Mu\u00f1oz-Maldonado C, Zimmer Y, Medov\u00e1 M. A Comparative Analysis of Individual RAS Mutations in Cancer Biology. Front Oncol. PMID: 31681616", "BibTeX": "@article{31681616, title={A Comparative Analysis of Individual RAS Mutations in Cancer Biology.}, author={Mu\u00f1oz-Maldonado C and Zimmer Y and Medov\u00e1 M}, journal={Front Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 39361706, "pmcid": "PMC11605356", "title": "Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms*", "journal": "Blood Adv", "authors": ["Ozkaya N", "Melloul Benizri S", "Venkataraman G", "Karai LJ", "Fraitag S", "Razanamahery J", "Pittaluga S", "Battistella M", "Pack S", "Le Pelletier F", "Xi L", "Moreau A", "Lee I", "H\u00e9lias-Rodzewicz Z", "Donadieu J", "Haroche J MD, PhD", "Raffeld M", "Jaffe ES", "Emile JF"], "date": "2024-09-23T00:00:00Z", "year": 2024, "snippets": [{"_id": "39361706@18271", "snip_text": "Six cases had activating NRAS mutations, 2 of which co-occurred with activating cancer-associated KRAS mutations (namely p.K117N and p.A146T), 2 with BRAF p.V600E, 1 with activating BRAF p.F595L along with inactivating NF1-splice site 4577+1G>A mutations, and 1 with 2 inactivating NF1 mutations (NF1 p.R1276Q and NF1 p.Y2556*).", "section": "results", "mentions": ["150|4|gene|ncbi_gene@673|BRAF", "301|8|variant|litvar@rs137854556##&&&litvar@#4763#&&&litvar@CA219546#rs137854556##|p.R1276Q", "182|4|gene|ncbi_gene@673|BRAF", "80|6|disease|ncbi_mesh@D009369|cancer", "314|3|gene|ncbi_gene@4763|NF1", "121|7|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.K117N", "282|3|gene|ncbi_gene@4763|NF1", "155|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "98|4|gene|ncbi_gene@3845|KRAS", "25|4|gene|ncbi_gene@4893|NRAS", "133|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "318|8|variant|litvar@#4763#p.Y2556*&&&litvar@#4763#|p.Y2556*", "297|3|gene|ncbi_gene@4763|NF1", "235|9|variant|litvar@rs1279529138##&&&litvar@#4763#|4577+1G>A", "219|3|gene|ncbi_gene@4763|NF1", "187|7|variant|litvar@rs121913341##&&&litvar@#673#&&&litvar@CA295915#rs121913341##|p.F595L"], "text_hl": "Six cases had activating NRAS mutations, 2 of which co-occurred with activating cancer-associated KRAS mutations (namely p.K117N and <m>p.A146T</m>), 2 with BRAF p.V600E, 1 with activating BRAF p.F595L along with inactivating NF1-splice site 4577+1G>A mutations, and 1 with 2 inactivating NF1 mutations (NF1 p.R1276Q and NF1 p.Y2556*)."}], "citations": {"NLM": "Ozkaya N, Melloul Benizri S, Venkataraman G, Karai LJ, Fraitag S, Razanamahery J, Pittaluga S, Battistella M, Pack S, Le Pelletier F, Xi L, Moreau A, Lee I, H\u00e9lias-Rodzewicz Z, Donadieu J, Haroche J MD, PhD, Raffeld M, Jaffe ES, Emile JF. Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms* Blood Adv. PMID: 39361706", "BibTeX": "@article{39361706, title={Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms*}, author={Ozkaya N and Melloul Benizri S and Venkataraman G and Karai LJ and Fraitag S and Razanamahery J and Pittaluga S and Battistella M and Pack S and Le Pelletier F and Xi L and Moreau A and Lee I and H\u00e9lias-Rodzewicz Z and Donadieu J and Haroche J MD, PhD and Raffeld M and Jaffe ES and Emile JF}, journal={Blood Adv}}"}, "is_sup_mat_match": false}, {"pmid": 39086951, "pmcid": "PMC11288880", "title": "Venetoclax combined with azacitidine in blastic plasmacytoid dendritic cell neoplasm: a case report and comprehensive review on the current and future treatment", "journal": "Front Med (Lausanne)", "authors": ["Wang X", "Guo J", "Liu Y", "Zheng N", "Xu S", "Wu L", "Yuan R", "Xue L", "Li J"], "date": "2024-07-17T00:00:00Z", "year": 2024, "snippets": [{"_id": "39086951@9424", "snip_text": "Gene name\tRef. Sequence\tExon\tChromosome location\tNucleotide change\tProtein change\trs\tFrequency\t \tTET2\tNM_001127208\t5\t4q24\tc.3578G>A\tp.C1193Y\t-\t58.00%\t \tTET2\tNM_001127208\t11\t4q24\tc.4794 T>G\tp.Y1598*\t-\t18.20%\t \tTET2\tNM_001127208\t9\t4q24\tc.4160A>G\tp. N1387S\t-\t3.90%\t \tTET2\tNM_001127208\t3\t4q24\tc.2245C>T\tp.Q749*\t-\t1.10%\t \tNRAS\tNM_002524\t4\t1p13.2\tc.436G>A\tp. A146T\t-\t4.50%\t \tNRAS\tNM_002524\t2\t1p13.2\tc.34G>A\tp. G12S\trs121913250\t3.50%\t \tNRAS\tNM_002524\t2\t1p13.2\tc.35G>A\tp. G12D\trs121913237\t1.70%\t \tBCORL1\tNM_021946\t4\tXq26.1\tc.469G>A\tp. A157T\trs147775035\t99.80%\t \tPDGFRA\tNM_006206\t15\t4q12\tc.2153G>A\tp. R718Q\trs367722824\t66.70%\t \tDIS3\tNM_014953\t17\t13q22.1\tc.2339G>C\tp. R780T\t-\t16.60%\t \tCSMD1\tNM_033225\t14\t8p23.2\tc.2012G>A\tp. R671H\trs376413480\t13.70%\t \t", "section": "table", "mentions": ["353|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "97|4|gene|ncbi_gene@54790|TET2", "152|4|gene|ncbi_gene@54790|TET2", "589|8|variant|litvar@rs367722824##&&&litvar@#5156#&&&litvar@CA2922757#rs367722824##|p. R718Q", "453|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G>A", "581|7|variant|litvar@rs367722824##&&&litvar@#5156#&&&litvar@CA2922757#rs367722824##|2153G>A", "703|7|variant|litvar@rs376413480##&&&litvar@#64478#|2012G>A", "393|7|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA180753#rs121913250##|c.34G>A", "515|8|variant|litvar@rs1428929660##&&&litvar@#3563#|c.469G>A", "178|10|variant|litvar@#54790#c.4794T>G&&&litvar@#54790#|c.4794 T>G", "122|9|variant|litvar@#54790#c.3578G>A&&&litvar@#54790#|c.3578G>A", "527|5|variant|litvar@#54790#c.157A>T&&&litvar@#54790#|A157T", "645|9|variant|litvar@#54790#c.2339G>C&&&litvar@#54790#|c.2339G>C", "469|11|variant|litvar@rs121913237##&&&litvar@#4893#|rs121913237", "655|8|variant|litvar@#54790#p.R780T&&&litvar@#54790#|p. R780T", "598|11|variant|litvar@rs367722824##&&&litvar@#5156#|rs367722824", "401|7|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA180753#rs121913250##|p. G12S", "264|4|gene|ncbi_gene@54790|TET2", "291|7|variant|litvar@#54790#c.2245C>T&&&litvar@#54790#|2245C>T", "409|11|variant|litvar@rs121913250##&&&litvar@#4893#|rs121913250", "711|8|variant|litvar@rs376413480##&&&litvar@#64478#|p. R671H", "244|9|variant|litvar@rs1422916349##&&&litvar@#54790#|p. N1387S", "461|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA130425#rs121913237##|p. G12D", "236|7|variant|litvar@#54790#g.4160A>G&&&litvar@#54790#|4160A>G", "132|8|variant|litvar@#54790#p.C1193Y&&&litvar@#54790#|p.C1193Y", "341|8|variant|litvar@rs1413727559##&&&litvar@#170482#|c.436G>A", "209|4|gene|ncbi_gene@54790|TET2", "720|11|variant|litvar@rs376413480##&&&litvar@#64478#|rs376413480"], "figure_id": "tab2", "text_hl": "Gene name\tRef. Sequence\tExon\tChromosome location\tNucleotide change\tProtein change\trs\tFrequency\t \tTET2\tNM_001127208\t5\t4q24\tc.3578G>A\tp.C1193Y\t-\t58.00%\t \tTET2\tNM_001127208\t11\t4q24\tc.4794 T>G\tp.Y1598*\t-\t18.20%\t \tTET2\tNM_001127208\t9\t4q24\tc.4160A>G\tp. N1387S\t-\t3.90%\t \tTET2\tNM_001127208\t3\t4q24\tc.2245C>T\tp.Q749*\t-\t1.10%\t \tNRAS\tNM_002524\t4\t1p13.2\tc.436G>A\tp. <m>A146T</m>\t-\t4.50%\t \tNRAS\tNM_002524\t2\t1p13.2\tc.34G>A\tp. G12S\trs121913250\t3.50%\t \tNRAS\tNM_002524\t2\t1p13.2\tc.35G>A\tp. G12D\trs121913237\t1.70%\t \tBCORL1\tNM_021946\t4\tXq26.1\tc.469G>A\tp. A157T\trs147775035\t99.80%\t \tPDGFRA\tNM_006206\t15\t4q12\tc.2153G>A\tp. R718Q\trs367722824\t66.70%\t \tDIS3\tNM_014953\t17\t13q22.1\tc.2339G>C\tp. R780T\t-\t16.60%\t \tCSMD1\tNM_033225\t14\t8p23.2\tc.2012G>A\tp. R671H\trs376413480\t13.70%\t \t"}], "citations": {"NLM": "Wang X, Guo J, Liu Y, Zheng N, Xu S, Wu L, Yuan R, Xue L, Li J. Venetoclax combined with azacitidine in blastic plasmacytoid dendritic cell neoplasm: a case report and comprehensive review on the current and future treatment Front Med (Lausanne). PMID: 39086951", "BibTeX": "@article{39086951, title={Venetoclax combined with azacitidine in blastic plasmacytoid dendritic cell neoplasm: a case report and comprehensive review on the current and future treatment}, author={Wang X and Guo J and Liu Y and Zheng N and Xu S and Wu L and Yuan R and Xue L and Li J}, journal={Front Med (Lausanne)}}"}, "is_sup_mat_match": false}, {"pmid": 30952657, "pmcid": "PMC6548671", "title": "Tissue-specific oncogenic activity of K-RasA146T", "journal": "Cancer Discov", "authors": ["Poulin EJ", "Bera AK", "Lu J", "Lin YJ", "Strasser SD", "Paulo JA", "Huang TQ", "Morales C", "Yan W", "Cook J", "Nowak JA", "Brubaker DK", "Joughin BA", "Johnson CW", "DeStefanis RA", "Ghazi PC", "Gondi S", "Wales TE", "Iacob RE", "Bogdanova L", "Gierut JJ", "Li Y", "Engen JR", "Perez-Mancera PA", "Braun BS", "Gygi SP", "Lauffenburger DA", "Westover KD", "Haigis KM"], "date": "2019-06-01T00:00:00Z", "year": 2019, "snippets": [{"_id": "30952657@0", "snip_text": "Tissue-specific oncogenic activity of K-RasA146T", "section": "title", "mentions": ["38|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|K-RasA146T"], "text_hl": "Tissue-specific oncogenic activity of K-RasA146T"}], "citations": {"NLM": "Poulin EJ, Bera AK, Lu J, Lin YJ, Strasser SD, Paulo JA, Huang TQ, Morales C, Yan W, Cook J, Nowak JA, Brubaker DK, Joughin BA, Johnson CW, DeStefanis RA, Ghazi PC, Gondi S, Wales TE, Iacob RE, Bogdanova L, Gierut JJ, Li Y, Engen JR, Perez-Mancera PA, Braun BS, Gygi SP, Lauffenburger DA, Westover KD, Haigis KM. Tissue-specific oncogenic activity of K-RasA146T Cancer Discov. PMID: 30952657", "BibTeX": "@article{30952657, title={Tissue-specific oncogenic activity of K-RasA146T}, author={Poulin EJ and Bera AK and Lu J and Lin YJ and Strasser SD and Paulo JA and Huang TQ and Morales C and Yan W and Cook J and Nowak JA and Brubaker DK and Joughin BA and Johnson CW and DeStefanis RA and Ghazi PC and Gondi S and Wales TE and Iacob RE and Bogdanova L and Gierut JJ and Li Y and Engen JR and Perez-Mancera PA and Braun BS and Gygi SP and Lauffenburger DA and Westover KD and Haigis KM}, journal={Cancer Discov}}"}, "is_sup_mat_match": false}, {"pmid": 39118889, "pmcid": "PMC11304142", "title": "Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare KRAS mutations: a real-world retrospective study", "journal": "Transl Lung Cancer Res", "authors": ["Jiang H", "Li Y", "Wang Y", "Zou B", "Chen Y", "Zhang Y", "Husain H", "Forest F", "Qian F", "Zhang L", "Zhou C", "Liu H", "Wang D", "Zhang W", "Lu J", "Han B"], "date": "2024-07-30T00:00:00Z", "year": 2024, "snippets": [{"_id": "39118889@9430", "snip_text": "The enrolling process (A), distribution of KRAS mutation subtypes (B), and specific composition of rare KRAS mutations (C), the others included G12L (n=1), G12F (n=3), A146T (n=1), A59G (n=1), Q61K (n=1), G13Y (n=1), A59T (n=1) and G12I (n=1).", "section": "figure_legend", "mentions": ["232|4|variant|litvar@rs121913529##&&&litvar@#3845#|G12I", "181|4|variant|litvar@rs1057519991##&&&litvar@#7157#|A59G", "144|4|variant|litvar@rs121913529##&&&litvar@#3845#|G12L", "217|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "193|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA180750#rs121913238##|Q61K", "168|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "104|4|gene|ncbi_gene@24525|KRAS", "156|4|variant|litvar@rs121913529##&&&litvar@#3845#|G12F", "205|4|variant|litvar@rs112445441##&&&litvar@#3845#|G13Y", "43|4|gene|ncbi_gene@24525|KRAS"], "figure_id": "f1", "text_hl": "The enrolling process (A), distribution of KRAS mutation subtypes (B), and specific composition of rare KRAS mutations (C), the others included G12L (n=1), G12F (n=3), <m>A146T</m> (n=1), A59G (n=1), Q61K (n=1), G13Y (n=1), A59T (n=1) and G12I (n=1)."}], "citations": {"NLM": "Jiang H, Li Y, Wang Y, Zou B, Chen Y, Zhang Y, Husain H, Forest F, Qian F, Zhang L, Zhou C, Liu H, Wang D, Zhang W, Lu J, Han B. Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare KRAS mutations: a real-world retrospective study Transl Lung Cancer Res. PMID: 39118889", "BibTeX": "@article{39118889, title={Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare KRAS mutations: a real-world retrospective study}, author={Jiang H and Li Y and Wang Y and Zou B and Chen Y and Zhang Y and Husain H and Forest F and Qian F and Zhang L and Zhou C and Liu H and Wang D and Zhang W and Lu J and Han B}, journal={Transl Lung Cancer Res}}"}, "is_sup_mat_match": false}, {"pmid": 30891959, "pmcid": "PMC6503218", "title": "Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies.", "journal": "Mol Genet Genomic Med", "authors": ["Chacon-Camacho OF", "Lopez-Moreno D", "Morales-Sanchez MA", "Hofmann E", "Pacheco-Quito M", "Wieland I", "Cortes-Gonzalez V", "Villanueva-Mendoza C", "Zenker M", "Zenteno JC"], "date": "2019-03-19T00:00:00Z", "year": 2019, "snippets": [{"_id": "30891959@1087", "snip_text": "RESULTS: In DNA from biopsies, mosaicism for pathogenic variants, including KRAS p.Ala146Thr in two OES subjects, FGFR1 p.Asn546Lys and KRAS p.Ala146Val in ECCL patients, and KRAS p.Gly12Asp in both SFMS patients, was demonstrated.", "section": "abstract", "mentions": ["180|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.Gly12Asp", "199|4|disease|ncbi_mesh@D054000|SFMS", "204|8|species|ncbi_taxonomy@9606|patients", "100|3|disease|ncbi_mesh@C563969|OES", "175|4|gene|ncbi_gene@3845|KRAS", "120|11|variant|litvar@rs779707422##&&&litvar@#2260#&&&litvar@CA357830#rs779707422##|p.Asn546Lys", "156|4|disease|ncbi_mesh@C537339|ECCL", "114|5|gene|ncbi_gene@2260|FGFR1", "76|4|gene|ncbi_gene@3845|KRAS", "136|4|gene|ncbi_gene@3845|KRAS", "141|11|variant|litvar@rs1057519725##&&&litvar@#3845#|p.Ala146Val", "81|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "161|8|species|ncbi_taxonomy@9606|patients"], "text_hl": "RESULTS: In DNA from biopsies, mosaicism for pathogenic variants, including KRAS <m>p.Ala146Thr</m> in two OES subjects, FGFR1 p.Asn546Lys and KRAS p.Ala146Val in ECCL patients, and KRAS p.Gly12Asp in both SFMS patients, was demonstrated."}], "citations": {"NLM": "Chacon-Camacho OF, Lopez-Moreno D, Morales-Sanchez MA, Hofmann E, Pacheco-Quito M, Wieland I, Cortes-Gonzalez V, Villanueva-Mendoza C, Zenker M, Zenteno JC. Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies. Mol Genet Genomic Med. PMID: 30891959", "BibTeX": "@article{30891959, title={Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies.}, author={Chacon-Camacho OF and Lopez-Moreno D and Morales-Sanchez MA and Hofmann E and Pacheco-Quito M and Wieland I and Cortes-Gonzalez V and Villanueva-Mendoza C and Zenker M and Zenteno JC}, journal={Mol Genet Genomic Med}}"}, "is_sup_mat_match": false}, {"pmid": 38113333, "pmcid": "PMC10791543", "title": "RHOAL57V drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling", "journal": "Sci Signal", "authors": ["Schaefer A", "Hodge RG", "Zhang H", "Hobbs GA", "Dilly J", "Huynh MV", "Goodwin CM", "Zhang F", "Diehl JN", "Pierobon M", "Baldelli E", "Javaid S", "Guthrie K", "Rashid NU", "Petricoin EF", "Cox AD", "Hahn WC", "Aguirre AJ", "Bass AJ", "Der CJ"], "date": "2023-12-19T00:00:00Z", "year": 2023, "snippets": [{"_id": "38113333@14163", "snip_text": "The RAC1P29S mutation found primarily in melanoma and the atypical KRASA146T mutation in colon cancer induce a gain-of-function fast cycling phenotype by enhancing intrinsic nucleotide exchange to favor formation of GTP-bound proteins.", "section": "results", "mentions": ["41|8|disease|ncbi_mesh@D008545|melanoma", "89|12|disease|ncbi_mesh@D015179|colon cancer", "67|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T", "216|3|chemical|ncbi_mesh@D006160|GTP", "174|10|chemical|ncbi_mesh@D009711|nucleotide"], "text_hl": "The RAC1P29S mutation found primarily in melanoma and the atypical KRASA146T mutation in colon cancer induce a gain-of-function fast cycling phenotype by enhancing intrinsic nucleotide exchange to favor formation of GTP-bound proteins."}], "citations": {"NLM": "Schaefer A, Hodge RG, Zhang H, Hobbs GA, Dilly J, Huynh MV, Goodwin CM, Zhang F, Diehl JN, Pierobon M, Baldelli E, Javaid S, Guthrie K, Rashid NU, Petricoin EF, Cox AD, Hahn WC, Aguirre AJ, Bass AJ, Der CJ. RHOAL57V drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling Sci Signal. PMID: 38113333", "BibTeX": "@article{38113333, title={RHOAL57V drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling}, author={Schaefer A and Hodge RG and Zhang H and Hobbs GA and Dilly J and Huynh MV and Goodwin CM and Zhang F and Diehl JN and Pierobon M and Baldelli E and Javaid S and Guthrie K and Rashid NU and Petricoin EF and Cox AD and Hahn WC and Aguirre AJ and Bass AJ and Der CJ}, journal={Sci Signal}}"}, "is_sup_mat_match": false}, {"pmid": 24508317, "pmcid": "PMC4428571", "title": "Molecular characterization of gallbladder cancer using somatic mutation profiling.", "journal": "Hum Pathol", "authors": ["Javle M", "Rashid A", "Churi C", "Kar S", "Zuo M", "Eterovic AK", "Nogueras-Gonzalez GM", "Janku F", "Shroff RT", "Aloia TA", "Vauthey JN", "Curley S", "Mills G", "Roa I"], "date": "2014-04-01T00:00:00Z", "year": 2014, "snippets": [{"_id": "24508317@23090", "snip_text": "AKT1_E17K_G49A FGFR1_S125L_C374T MET_Y1248C_A3743G   AKT2_E17K_G49A FGFR2_N549KK_T1647GA MET_Y1248HD_T3742CG   AKT3_E17K_G49A FGFR2_S252W_C755G MET_Y1253D_T3757G   ALK_F1174CS_T3521GC FGFR3_G370C_G1108T MGA_T1747N_C5421A   ALK_F1174L_C3522AG FGFR3_G380R_G1138A NRAS_A146T_G436A   ALK_F1174LIV_T3520CAG FGFR3_G697C_G2089T NRAS_G12DAV_G35ACT   ALK_F1245C_T3734G FGFR3_K650MT_A1949TC NRAS_G12SRC_G34ACT   ALK_F1245L_C3735AG FGFR3_R248C_C742T NRAS_G13DAV_G38ACT   ALK_F1245VI_T3733GA FGFR3_S249C_C746G NRAS_G13SRC_G37ACT   ALK_I1171N_T3512A FGFR3_Y373C_A1118G NRAS_Q61EKX_C181GAT   ALK_R1275QL_G3824AT FOXL2_C134W_C402G NRAS_Q61HHQ_A183TCG   BCOR_N1407STI_A4220GCT GNA11_Q209LP_A626TC NRAS_Q61RPL_A182GCT   BRAF_D594GV_A1781GT GNA11_R183C_C547T PDGFRA_D842V_A2525T   BRAF_E586K_G1756A GNAQ_Q209H_A627T PDGFRA_D842YN_G2524TA   BRAF_G464EVA_G1391ATC GNAQ_Q209LPR_A626TCG PDGFRA_N659K_C1977A   BRAF_G466EVA_G1397ATC GNAS_R201H_G602A PDGFRA_N659Y_A1975T   BRAF_G466R_G1396CA GNAS_R201SC_C601AT PDGFRA_V561D_T1682A   BRAF_G469EVA_G1406ATC GRM3_E870K_G2608A PIK3CA_A1046V_C3137T   BRAF_G469R_G1405CA IDH1_G70D_G209A PIK3CA_C420R_T1258C   BRAF_K601E_A1801G IDH1_R132CGS_C394TGA PIK3CA_E110K_G328A   BRAF_L597RQ_T1790GA IDH1_R132HL_G395AT PIK3CA_E418K_G1252A   BRAF_V600_G1800 IDH1_V178I_G532A PIK3CA_E453K_G1357A   BRAF_V600EAG_T1799ACG_F IDH2_R140LQ_G419TA PIK3CA_E542KQ_G1624AC   BRAF_V600EAG_T1799ACG_R IDH2_R140W_C418T PIK3CA_E542VG_A1625TG   BRAF_V600LM_G1798TA IDH2_R172GW_A514GT PIK3CA_E545AGV_A1634CGT   CC2D1A_L913V_C3036G IDH2_R172MK_G515TA PIK3CA_E545D_G1635CT   CDK4_R24C_C70T IDH2_R172S_G516T PIK3CA_E545KQ_G1633AC   CDK4_R24H_G71A JAK2_V617F_G1849T PIK3CA_F909L_C2727G   CSMD1_A409S_G1225T KIT_D816GVA_A2447GTC PIK3CA_G118D_G353A   CSMD1_Q3005X_C9013T KIT_D816HNY_G2446CAT PIK3CA_H1047RL_A3140GT_F   CTNNB1_D32AGV_A95CGT KIT_K642E_A1924G PIK3CA_H1047RL_A3140GT_R   CTNNB1_D32HNY_G94CAT KIT_L576P_T1727C PIK3CA_H1047Y_C3139T   CTNNB1_G34EVA_G101ATC KIT_N566D_A1696G PIK3CA_H701P_A2102C   CTNNB1_H36PRY_A107CGT KIT_N822KNK_T2466GCA PIK3CA_K111N_G333C   CTNNB1_I35NST_T104AGC KIT_N822YHD_A2464TCG PIK3CA_M1043I_G3129ATC   CTNNB1_S33APT_T97GCA KIT_R634W_C1900T PIK3CA_M1043V_A3127G   CTNNB1_S37CFY_C110GTA KIT_V559ADG_T1676CAG PIK3CA_N345K_T1035A   CTNNB1_S45APT_T133GCA KIT_V560DGA_T1679AGC PIK3CA_P539R_C1616G   CTNNB1_S45CFY_C134GTA KIT_V825A_T2474C PIK3CA_Q060K_C178A   CTNNB1_T41APS_A121GCT KIT_Y553N_T1657A PIK3CA_Q546EK_C1636GA   CTNNB1_T41INS_C122TAG KRAS_A146PT_G436CA PIK3CA_Q546LPR_A1637TCG   EGFR_G719CS_G2155TA KRAS_G10R_G28A PIK3CA_R088Q_G263A   EGFR_K860I_A2579T KRAS_G12DAV_G35ACT PIK3CA_S405F_C1214T   EGFR_L858R_T2573G KRAS_G12SRC_G34ACT PIK3CA_T1025SA_A3073TG   EGFR_L861QR_T2582AG KRAS_G13DAV_G38ACT PIK3CA_Y1021C_A3062G   EGFR_S720P_T2158C KRAS_G13SRC_G37ACT PIK3CA_Y1021HN_T3061CA   EGFR_T790M_C2369T KRAS_Q61EKX_C181GAT PPP2R1A_W257G_T769G   EGFR_T854I_C2561T KRAS_Q61HHQ_A183CTG RAF1_A319S_G955T   EGFR_Y813C_A2438G KRAS_Q61LPR_A182TCG RAF1_L613V_C1837G   EPHA3_K761NN_G2283TC MAP2K2_E207KQ_G619AC RAF1_N115S_A344G   FBXO4_L23Q_T68A MAP2K7_D290D_C870T RAF1_Q335H_G1005C   FBXO4_P76T_C226A MAP2K7_R162H_G485A RAF1_S259A_T775G   FBXO4_S8R_C24AG MAP2K7_S271T_T811A RAF1_Y340D_T1018G   FBXW7_R465C_C1393T MAP2K7_S311L_C932T RET_M918T_T2753C   FBXW7_R465HL_G1394AT MET_H1112RL_A3335GT RPL22_K15TRM_A44CGT   FBXW7_R479QL_G1436AT MET_H1112Y_C3334T SFRS9_Y192X_C722A   FBXW7_R505CS_C1513TA MET_M1268T_T3803C SMO_A324T_G970A   FBXW7_R505HLP_G1514ATC MET_N375S_A1124G SRC_Q531X_C1591T   FBXW7_S582L_C1745T MET_R988C_C2962T TGM2_S212P_T734C   FGFR1_P252T_C754A MET_T1010I_C3029T    ", "section": "table", "mentions": ["2850|5|variant|litvar@rs587783064##&&&litvar@#7157#&&&litvar@CA48#rs587783064##|W257G", "835|8|variant|litvar@#673#p.G1391I&&&litvar@#673#|G1391ATC", "33|3|gene|ncbi_gene@79811|MET", "3416|6|variant|litvar@rs1414686637##&&&litvar@#2956#|T3803C", "1008|4|gene|ncbi_gene@673|BRAF", "2492|8|variant|litvar@rs182825432##&&&litvar@#5789#&&&litvar@CA4983240#rs182825432##|A1637TCG", "878|6|variant|litvar@#673#p.C1977A&&&litvar@#673#|C1977A", "3283|3|gene|ncbi_gene@79811|MET", "2359|5|variant|litvar@#5290#p.Q060K&&&litvar@#5290#|Q060K", "439|4|gene|ncbi_gene@4893|NRAS", "3357|6|variant|litvar@rs1376578057##&&&litvar@#55294#|C3334T", "1920|6|variant|litvar@rs1046247273##&&&litvar@#55294#&&&litvar@CA108609683#rs1046247273##|C3139T", "2979|5|gene|ncbi_gene@2042|EPHA3", "3567|5|variant|litvar@#79811#p.C754A&&&litvar@#79811#|C754A", "3190|5|variant|litvar@rs1426597631##&&&litvar@#2099#|Y340D", "2352|6|gene|ncbi_gene@5290|PIK3CA", "2282|8|variant|litvar@rs376711468##&&&litvar@#5789#|T1679AGC", "900|8|variant|litvar@#673#p.G1397I&&&litvar@#673#|G1397ATC", "2533|4|variant|litvar@rs1170252840##&&&litvar@#6657#|G28A", "2655|6|gene|ncbi_gene@5290|PIK3CA", "735|5|variant|litvar@#5156#p.C547T&&&litvar@#5156#|C547T", "184|5|gene|ncbi_gene@2261|FGFR3", "1188|4|gene|ncbi_gene@673|BRAF", "2596|6|gene|ncbi_gene@5290|PIK3CA", "321|4|gene|ncbi_gene@4893|NRAS", "768|5|variant|litvar@rs121913340##&&&litvar@#673#&&&litvar@CA135092#rs121913340##|E586K", "1395|4|gene|ncbi_gene@3418|IDH2", "2629|6|variant|litvar@#3845#p.T2573G&&&litvar@#3845#|T2573G", "1119|6|variant|litvar@#673#p.T1258C&&&litvar@#673#|T1258C", "1705|8|variant|litvar@rs200399245##&&&litvar@#324#&&&litvar@CA13674#rs200399245##|A2447GTC", "2570|6|variant|litvar@#3845#p.A2579T&&&litvar@#3845#|A2579T", "3142|5|variant|litvar@#26272#p.T775G&&&litvar@#26272#|T775G", "1776|6|gene|ncbi_gene@5290|PIK3CA", "2636|4|gene|ncbi_gene@3845|KRAS", "2097|6|gene|ncbi_gene@5290|PIK3CA", "1071|4|gene|ncbi_gene@673|BRAF", "2902|4|gene|ncbi_gene@5894|RAF1", "1868|6|gene|ncbi_gene@1499|CTNNB1", "3500|5|gene|ncbi_gene@55294|FBXW7", "2939|4|gene|ncbi_gene@3845|KRAS", "2399|5|variant|litvar@rs1057519704##&&&litvar@#3815#|Y553N", "207|6|variant|litvar@rs199702761##&&&litvar@#23269#|T1747N", "280|3|gene|ncbi_gene@238|ALK", "0|9|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|AKT1_E17K", "2226|6|gene|ncbi_gene@5290|PIK3CA", "3441|5|gene|ncbi_gene@55294|FBXW7", "3455|8|variant|litvar@#79811#p.G1514I&&&litvar@#79811#|G1514ATC", "148|6|variant|litvar@#79811#p.Y1253D&&&litvar@#79811#|Y1253D", "132|5|variant|litvar@rs79184941##&&&litvar@#2263#&&&litvar@CA122985#rs79184941##|S252W", "2551|5|variant|litvar@rs776041038##&&&litvar@#3417#|G263A", "1240|6|variant|litvar@#673#p.G1252A&&&litvar@#673#|G1252A", "2167|6|variant|litvar@rs1057519936##&&&litvar@#5290#|M1043V", "1174|5|variant|litvar@rs775517144##&&&litvar@#3417#&&&litvar@CA2079051#rs775517144##|E110K", "203|3|gene|ncbi_gene@23269|MGA", "661|5|gene|ncbi_gene@2767|GNA11", "3577|6|variant|litvar@rs752727004##&&&litvar@#5789#&&&litvar@CA4983935#rs752727004##|T1010I", "3433|5|variant|litvar@rs1064163##&&&litvar@#25#&&&litvar@CA200652325#rs1064163##|G970A", "1547|5|variant|litvar@rs121913275##&&&litvar@#5290#&&&litvar@CA210104#rs121913275##|E545D", "1824|3|gene|ncbi_gene@3815|KIT", "2104|6|variant|litvar@rs121913283##&&&litvar@#5290#&&&litvar@CA183868#rs121913283##|M1043I", "2875|6|variant|litvar@#3845#p.C2561T&&&litvar@#3845#|C2561T", "3086|6|variant|litvar@#26272#p.G1005C&&&litvar@#26272#|G1005C", "3481|3|gene|ncbi_gene@6714|SRC", "1834|6|variant|litvar@rs199904481##&&&litvar@#324#|A1924G", "1347|6|gene|ncbi_gene@5290|PIK3CA", "214|6|variant|litvar@rs1485891060##&&&litvar@#208#|C5421A", "1436|4|gene|ncbi_gene@673|BRAF", "786|5|variant|litvar@rs1431020185##&&&litvar@#4869#|Q209H", "1990|6|gene|ncbi_gene@1499|CTNNB1", "1624|4|variant|litvar@rs756533684##&&&litvar@#26272#|R24H", "1727|5|variant|litvar@rs762126667##&&&litvar@#3417#|G353A", "933|5|variant|litvar@rs1057519700##&&&litvar@#5156#|N659Y", "1090|4|gene|ncbi_gene@3417|IDH1", "549|6|variant|litvar@#4893#p.A1118G&&&litvar@#4893#|A1118G", "3185|4|gene|ncbi_gene@5894|RAF1", "993|5|variant|litvar@rs121908586##&&&litvar@#5156#&&&litvar@CA123203#rs121908586##|V561D", "2174|6|variant|litvar@rs1114167533##&&&litvar@#4221#|A3127G", "1041|6|variant|litvar@#5290#p.G2608A&&&litvar@#5290#|G2608A", "1975|5|variant|litvar@rs121913282##&&&litvar@#5290#&&&litvar@CA16602519#rs121913282##|H701P", "2477|6|gene|ncbi_gene@5290|PIK3CA", "3584|6|variant|litvar@rs1258111176##&&&litvar@#4286#|C3029T", "822|4|gene|ncbi_gene@673|BRAF", "3056|6|gene|ncbi_gene@5609|MAP2K7", "616|4|gene|ncbi_gene@4893|NRAS", "763|4|gene|ncbi_gene@673|BRAF", "523|6|variant|litvar@rs1057519698##&&&litvar@#238#|I1171N", "498|4|gene|ncbi_gene@4893|NRAS", "1270|5|variant|litvar@rs34218846##&&&litvar@#3417#&&&litvar@CA160063#rs34218846##|V178I", "121|4|variant|litvar@rs757542528##&&&litvar@#4170#&&&litvar@CA1079281#rs757542528##|G49A", "3547|5|variant|litvar@#2260#p.T734C&&&litvar@#2260#|T734C", "2577|4|gene|ncbi_gene@3845|KRAS", "2458|4|gene|ncbi_gene@3845|KRAS", "2111|8|variant|litvar@#1499#p.G3129I&&&litvar@#1499#|G3129ATC", "3101|4|variant|litvar@rs748157192##&&&litvar@#1024#|P76T", "948|4|gene|ncbi_gene@673|BRAF", "1317|8|variant|litvar@rs1164269956##&&&litvar@#23269#|T1799ACG", "2894|7|variant|litvar@rs760399082##&&&litvar@#208#|A183CTG", "1568|4|variant|litvar@rs746389879##&&&litvar@#26272#|R24C", "2443|6|variant|litvar@#1499#c.41insT&&&litvar@#1499#|T41INS", "58|4|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|E17K", "2012|3|gene|ncbi_gene@3815|KIT", "2004|7|variant|litvar@#3815#p.A107R&&&litvar@#3815#|A107CGT", "2809|5|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|T790M", "1475|6|gene|ncbi_gene@5290|PIK3CA", "1276|5|variant|litvar@rs573381420##&&&litvar@#5789#&&&litvar@CA4984474#rs573381420##|G532A", "1686|6|variant|litvar@#3815#p.G1225T&&&litvar@#3815#|G1225T", "3573|3|gene|ncbi_gene@79811|MET", "1180|5|variant|litvar@rs397516813##&&&litvar@#5894#&&&litvar@CA134687#rs397516813##|G328A", "748|5|variant|litvar@rs121908585##&&&litvar@#5156#&&&litvar@CA123194#rs121908585##|D842V", "1767|8|variant|litvar@#5290#p.G2446H&&&litvar@#5290#|G2446CAT", "741|6|gene|ncbi_gene@5156|PDGFRA", "568|7|variant|litvar@#238#p.C181D&&&litvar@#238#|C181GAT", "3075|4|gene|ncbi_gene@5894|RAF1", "3485|5|variant|litvar@rs121913314##&&&litvar@#6714#&&&litvar@CA122517#rs121913314##|Q531X", "774|6|variant|litvar@#673#p.G1756A&&&litvar@#673#|G1756A", "3026|5|variant|litvar@rs587778016##&&&litvar@#25#&&&litvar@CA156557#rs587778016##|N115S", "1893|5|variant|litvar@rs121913513##&&&litvar@#3815#&&&litvar@CA16602401#rs121913513##|L576P", "3491|6|variant|litvar@#55294#p.C1591T&&&litvar@#55294#|C1591T", "3237|5|variant|litvar@#5979#p.C932T&&&litvar@#5979#|C932T", "2248|6|gene|ncbi_gene@1499|CTNNB1", "2882|4|gene|ncbi_gene@3845|KRAS", "360|5|gene|ncbi_gene@2261|FGFR3", "926|6|gene|ncbi_gene@5156|PDGFRA", "693|7|variant|litvar@rs1168405597##&&&litvar@#2042#|A182GCT", "10|4|variant|litvar@rs757542528##&&&litvar@#4170#&&&litvar@CA1079281#rs757542528##|G49A", "1384|8|variant|litvar@rs1164269956##&&&litvar@#23269#|T1799ACG", "2233|5|variant|litvar@rs121913284##&&&litvar@#5290#&&&litvar@CA16602517#rs121913284##|N345K", "723|5|gene|ncbi_gene@2767|GNA11", "578|3|gene|ncbi_gene@238|ALK", "3119|5|variant|litvar@rs746407532##&&&litvar@#208#|R162H", "3529|6|variant|litvar@#79811#p.C2962T&&&litvar@#79811#|C2962T", "556|4|gene|ncbi_gene@4893|NRAS", "604|5|variant|litvar@rs142638017##&&&litvar@#2260#|C134W", "2373|6|gene|ncbi_gene@1499|CTNNB1", "21|5|variant|litvar@rs121913473##&&&litvar@#2260#&&&litvar@CA4718768#rs121913473##|S125L", "3211|5|variant|litvar@rs867384286##&&&litvar@#55294#&&&litvar@CA16602851#rs867384286##|R465C", "302|5|gene|ncbi_gene@2261|FGFR3", "519|3|gene|ncbi_gene@238|ALK", "1106|6|gene|ncbi_gene@5290|PIK3CA", "2964|5|variant|litvar@rs80338797##&&&litvar@#5894#&&&litvar@CA257066#rs80338797##|L613V", "2834|7|variant|litvar@#238#p.C181D&&&litvar@#238#|C181GAT", "1882|6|variant|litvar@#3815#p.G94H&&&litvar@#3815#|G94CAT", "1328|4|gene|ncbi_gene@3418|IDH2", "2742|4|gene|ncbi_gene@1956|EGFR", "1841|6|gene|ncbi_gene@5290|PIK3CA", "486|5|variant|litvar@rs121913483##&&&litvar@#2261#&&&litvar@CA126380#rs121913483##|S249C", "729|5|variant|litvar@rs760399082##&&&litvar@#208#|R183C", "1139|6|variant|litvar@#3417#p.A1801G&&&litvar@#3417#|A1801G", "3196|6|variant|litvar@#55294#p.T1018G&&&litvar@#55294#|T1018G", "1295|6|variant|litvar@rs769487408##&&&litvar@#23269#|G1357A", "1583|5|variant|litvar@rs1057519736##&&&litvar@#3418#|R172S", "427|5|variant|litvar@rs121913482##&&&litvar@#2261#&&&litvar@CA126378#rs121913482##|R248C", "1048|6|gene|ncbi_gene@5290|PIK3CA", "1265|4|gene|ncbi_gene@3417|IDH1", "254|6|variant|litvar@rs1413989131##&&&litvar@#5789#|G1138A", "2528|4|variant|litvar@rs759328818##&&&litvar@#26272#|G10R", "1146|4|gene|ncbi_gene@3417|IDH1", "2088|8|variant|litvar@rs4705693##&&&litvar@#324#|A2464TCG", "2609|6|variant|litvar@#1956#p.C1214T&&&litvar@#1956#|C1214T", "346|6|variant|litvar@rs863225283##&&&litvar@#238#&&&litvar@CA279597#rs863225283##|F1245C", "2122|6|gene|ncbi_gene@1499|CTNNB1", "261|4|gene|ncbi_gene@4893|NRAS", "2270|3|gene|ncbi_gene@3815|KIT", "2680|4|gene|ncbi_gene@1956|EGFR", "2262|7|variant|litvar@rs1398523811##&&&litvar@#2913#|T133GCA", "914|5|variant|litvar@rs371689982##&&&litvar@#27#&&&litvar@CA1265059#rs371689982##|R201H", "530|6|variant|litvar@rs141974346##&&&litvar@#55294#&&&litvar@CA108609628#rs141974346##|T3512A", "1589|5|variant|litvar@#5290#p.G516T&&&litvar@#5290#|G516T", "2804|4|gene|ncbi_gene@1956|EGFR", "2436|6|gene|ncbi_gene@1499|CTNNB1", "3370|5|variant|litvar@rs778921501##&&&litvar@#4221#|Y192X", "999|6|variant|litvar@rs1165603009##&&&litvar@#324#|T1682A", "3063|5|variant|litvar@rs546802383##&&&litvar@#5609#&&&litvar@CA9148679#rs546802383##|D290D", "2864|4|gene|ncbi_gene@1956|EGFR", "1634|10|variant|litvar@#3717#p.V61F&&&litvar@#3717#|JAK2_V617F", "272|5|variant|litvar@rs752863627##&&&litvar@#79811#|G436A", "1412|6|gene|ncbi_gene@5290|PIK3CA", "2395|3|gene|ncbi_gene@3815|KIT", "2387|7|variant|litvar@rs1002590995##&&&litvar@#5781#|A121GCT", "1021|8|variant|litvar@#2913#p.G1406I&&&litvar@#2913#|G1406ATC", "3247|5|variant|litvar@rs74799832##&&&litvar@#5979#&&&litvar@CA9082#rs74799832##|M918T", "1055|6|variant|litvar@rs1219554154##&&&litvar@#238#|A1046V", "1693|3|gene|ncbi_gene@3815|KIT", "2712|6|variant|litvar@#5290#p.G38T&&&litvar@#5290#|G38ACT", "792|5|variant|litvar@rs750079420##&&&litvar@#2913#&&&litvar@CA4324289#rs750079420##|A627T", "353|6|variant|litvar@rs775699235##&&&litvar@#1499#|T3734G", "2772|6|variant|litvar@#5290#p.G37T&&&litvar@#5290#|G37ACT", "3166|6|gene|ncbi_gene@5609|MAP2K7", "2033|6|gene|ncbi_gene@5290|PIK3CA", "2298|5|variant|litvar@rs121913285##&&&litvar@#5290#&&&litvar@CA16602696#rs121913285##|P539R", "1456|4|gene|ncbi_gene@3418|IDH2", "2313|6|gene|ncbi_gene@1499|CTNNB1", "242|5|gene|ncbi_gene@2261|FGFR3", "1095|4|variant|litvar@rs760987652##&&&litvar@#238#&&&litvar@CA1595024#rs760987652##|G70D", "68|5|gene|ncbi_gene@2263|FGFR2", "293|8|variant|litvar@#2261#p.T3520Q&&&litvar@#2261#|T3520CAG", "460|3|gene|ncbi_gene@238|ALK", "1062|6|variant|litvar@rs1335541973##&&&litvar@#4286#|C3137T", "2959|4|gene|ncbi_gene@5894|RAF1", "1955|5|variant|litvar@rs1057519705##&&&litvar@#3815#|N566D", "1755|3|gene|ncbi_gene@3815|KIT", "1371|4|gene|ncbi_gene@673|BRAF", "2136|6|variant|litvar@rs749275497##&&&litvar@#5894#&&&litvar@CA2259750#rs749275497##|T97GCA", "2779|6|gene|ncbi_gene@5290|PIK3CA", "3051|4|variant|litvar@rs200825042##&&&litvar@#55294#|T68A", "610|5|variant|litvar@#4893#p.C402G&&&litvar@#4893#|C402G", "2450|7|variant|litvar@#3845#p.C122X&&&litvar@#3845#|C122TAG", "2217|8|variant|litvar@#5290#p.T1676Q&&&litvar@#5290#|T1676CAG", "652|8|variant|litvar@#2767#p.A4220A&&&litvar@#2767#|A4220GCT", "308|5|variant|litvar@rs121913480##&&&litvar@#2261#&&&litvar@CA16602701#rs121913480##|G697C", "342|3|gene|ncbi_gene@238|ALK", "2365|5|variant|litvar@rs34218846##&&&litvar@#3417#|C178A", "1578|4|gene|ncbi_gene@3418|IDH2", "1981|6|variant|litvar@#1499#p.A2102C&&&litvar@#1499#|A2102C", "223|3|gene|ncbi_gene@238|ALK", "3384|5|gene|ncbi_gene@55294|FBXW7", "3000|6|gene|ncbi_gene@5605|MAP2K2", "492|5|variant|litvar@#4893#p.C746G&&&litvar@#4893#|C746G", "2856|5|variant|litvar@#1956#p.T769G&&&litvar@#1956#|T769G", "164|3|gene|ncbi_gene@238|ALK", "2753|6|variant|litvar@#3845#p.T2158C&&&litvar@#3845#|T2158C", "190|5|variant|litvar@rs121913479##&&&litvar@#2261#&&&litvar@CA129946#rs121913479##|G370C", "3325|5|gene|ncbi_gene@55294|FBXW7", "1659|5|variant|litvar@rs867182279##&&&litvar@#1956#&&&litvar@CA158940652#rs867182279##|F909L", "433|5|variant|litvar@#4893#p.C742T&&&litvar@#4893#|C742T", "1076|5|variant|litvar@rs121913357##&&&litvar@#673#&&&litvar@CA123653#rs121913357##|G469R", "3095|5|gene|ncbi_gene@26272|FBXO4", "3376|5|variant|litvar@#55294#p.C722A&&&litvar@#55294#|C722A", "703|4|gene|ncbi_gene@673|BRAF", "1113|5|variant|litvar@rs121913272##&&&litvar@#5290#&&&litvar@CA180900#rs121913272##|C420R", "2335|3|gene|ncbi_gene@3815|KIT", "3468|5|variant|litvar@rs1462861861##&&&litvar@#55294#|N375S", "116|4|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|E17K", "1490|8|variant|litvar@#5290#p.A1634R&&&litvar@#5290#|A1634CGT", "2405|6|variant|litvar@rs1165603009##&&&litvar@#324#|T1657A", "1508|5|variant|litvar@rs780429736##&&&litvar@#3643#&&&litvar@CA9135467#rs780429736##|L913V", "1951|3|gene|ncbi_gene@3815|KIT", "2970|6|variant|litvar@#2042#p.C1837G&&&litvar@#2042#|C1837G", "2538|6|gene|ncbi_gene@5290|PIK3CA", "3069|5|variant|litvar@rs780967013##&&&litvar@#1956#&&&litvar@CA4266397#rs780967013##|C870T", "2291|6|gene|ncbi_gene@5290|PIK3CA", "2147|5|variant|litvar@rs144369407##&&&litvar@#3815#&&&litvar@CA2923610#rs144369407##|R634W", "3561|5|variant|litvar@rs121913472##&&&litvar@#2260#&&&litvar@CA16602744#rs121913472##|P252T", "3506|5|variant|litvar@rs772521999##&&&litvar@#79811#|S582L", "53|4|gene|ncbi_gene@208|AKT2", "1234|5|variant|litvar@rs397517199##&&&litvar@#5290#&&&litvar@CA136365#rs397517199##|E418K", "3512|6|variant|litvar@#79811#p.C1745T&&&litvar@#79811#|C1745T", "1741|6|variant|litvar@#3815#p.Q3005X&&&litvar@#3815#|Q3005X", "537|5|gene|ncbi_gene@2261|FGFR3", "1645|6|variant|litvar@#5290#p.G1849T&&&litvar@#5290#|G1849T", "1889|3|gene|ncbi_gene@3815|KIT", "1128|4|gene|ncbi_gene@673|BRAF", "1721|5|variant|litvar@rs587777790##&&&litvar@#5290#&&&litvar@CA170883#rs587777790##|G118D", "2719|6|gene|ncbi_gene@5290|PIK3CA", "1714|6|gene|ncbi_gene@5290|PIK3CA", "2412|6|gene|ncbi_gene@5290|PIK3CA", "939|6|variant|litvar@#673#p.A1975T&&&litvar@#673#|A1975T", "3136|5|variant|litvar@rs3730271##&&&litvar@#5894#|S259A", "2951|7|variant|litvar@rs1270443958##&&&litvar@#2042#|A182TCG", "333|6|variant|litvar@#5290#p.G35T&&&litvar@#5290#|G35ACT", "3040|5|gene|ncbi_gene@26272|FBXO4", "393|6|variant|litvar@#5290#p.G34T&&&litvar@#5290#|G34ACT", "2040|5|variant|litvar@rs1057519934##&&&litvar@#5290#|K111N", "3173|5|variant|litvar@rs1340005700##&&&litvar@#5605#|S271T", "2926|5|variant|litvar@rs760735153##&&&litvar@#2045#|Y813C", "1899|6|variant|litvar@#5290#p.T1727C&&&litvar@#5290#|T1727C", "1803|6|gene|ncbi_gene@1499|CTNNB1", "2143|3|gene|ncbi_gene@3815|KIT", "1748|6|variant|litvar@rs557501608##&&&litvar@#673#&&&litvar@CA168214876#rs557501608##|C9013T", "1249|4|gene|ncbi_gene@673|BRAF", "1652|6|gene|ncbi_gene@5290|PIK3CA", "887|4|gene|ncbi_gene@673|BRAF", "3217|6|variant|litvar@#5609#p.C1393T&&&litvar@#5609#|C1393T", "1943|7|variant|litvar@#3815#p.G101I&&&litvar@#3815#|G101ATC", "2700|4|gene|ncbi_gene@3845|KRAS", "2339|5|variant|litvar@rs121913524##&&&litvar@#3815#&&&litvar@CA16602706#rs121913524##|V825A", "2932|6|variant|litvar@#3845#p.A2438G&&&litvar@#3845#|A2438G", "2726|6|variant|litvar@rs121913288##&&&litvar@#5290#&&&litvar@CA16602699#rs121913288##|Y1021C", "2760|4|gene|ncbi_gene@3845|KRAS", "3106|5|variant|litvar@#5609#p.C226A&&&litvar@#5609#|C226A", "3262|5|gene|ncbi_gene@55294|FBXW7", "2068|7|variant|litvar@rs1410219254##&&&litvar@#4286#|T104AGC", "510|6|variant|litvar@#5290#p.G37T&&&litvar@#5290#|G37ACT", "2523|4|gene|ncbi_gene@3845|KRAS", "1929|6|gene|ncbi_gene@1499|CTNNB1", "1961|6|variant|litvar@#5290#p.A1696G&&&litvar@#5290#|A1696G", "1906|6|gene|ncbi_gene@5290|PIK3CA", "451|6|variant|litvar@#5290#p.G38T&&&litvar@#5290#|G38ACT", "1400|5|variant|litvar@rs267606870##&&&litvar@#3418#&&&litvar@CA16602464#rs267606870##|R140W", "3231|5|variant|litvar@rs768927167##&&&litvar@#79811#|S311L", "1167|6|gene|ncbi_gene@5290|PIK3CA", "3080|5|variant|litvar@rs776197565##&&&litvar@#324#&&&litvar@CA26840#rs776197565##|Q335H", "2815|6|variant|litvar@#3845#p.C2369T&&&litvar@#3845#|C2369T", "872|5|variant|litvar@rs1057519700##&&&litvar@#5156#|N659K", "1282|6|gene|ncbi_gene@5290|PIK3CA", "1227|6|gene|ncbi_gene@5290|PIK3CA", "144|3|gene|ncbi_gene@79811|MET", "89|3|gene|ncbi_gene@79811|MET", "138|5|variant|litvar@rs144102777##&&&litvar@#2324#&&&litvar@CA133212127#rs144102777##|C755G", "314|6|variant|litvar@#4893#p.G2089T&&&litvar@#4893#|G2089T", "2733|6|variant|litvar@rs1450761639##&&&litvar@#2956#|A3062G", "2822|4|gene|ncbi_gene@3845|KRAS", "628|7|variant|litvar@rs1184933986##&&&litvar@#4286#|A183TCG", "3243|3|gene|ncbi_gene@5979|RET", "2054|6|gene|ncbi_gene@1499|CTNNB1", "63|4|variant|litvar@rs757542528##&&&litvar@#4170#&&&litvar@CA1079281#rs757542528##|G49A", "15|5|gene|ncbi_gene@2260|FGFR1", "3205|5|gene|ncbi_gene@55294|FBXW7", "3150|5|gene|ncbi_gene@26272|FBXO4", "381|4|gene|ncbi_gene@4893|NRAS", "3409|6|variant|litvar@rs1369921827##&&&litvar@#3643#|M1268T", "1828|5|variant|litvar@rs121913512##&&&litvar@#3815#&&&litvar@CA123547#rs121913512##|K642E", "2183|6|gene|ncbi_gene@1499|CTNNB1", "1629|4|variant|litvar@rs750928419##&&&litvar@#2913#|G71A", "3519|3|gene|ncbi_gene@79811|MET", "3350|6|variant|litvar@rs1060500933##&&&litvar@#7249#|H1112Y", "1968|6|gene|ncbi_gene@5290|PIK3CA", "1304|4|gene|ncbi_gene@673|BRAF", "1208|4|gene|ncbi_gene@3417|IDH1", "2623|5|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|L858R", "2239|6|variant|litvar@rs779405200##&&&litvar@#27#|T1035A", "3405|3|gene|ncbi_gene@79811|MET", "1035|5|variant|litvar@rs780967013##&&&litvar@#1956#&&&litvar@CA4266397#rs780967013##|E870K", "3131|4|gene|ncbi_gene@5894|RAF1", "3541|5|variant|litvar@rs756204103##&&&litvar@#26272#|S212P", "3179|5|variant|litvar@rs751342391##&&&litvar@#1956#&&&litvar@CA4266330#rs751342391##|T811A", "2747|5|variant|litvar@rs1060500753##&&&litvar@#5979#|S720P", "2564|5|variant|litvar@#1956#p.K860I&&&litvar@#1956#|K860I", "3346|3|gene|ncbi_gene@79811|MET", "798|6|gene|ncbi_gene@5156|PDGFRA", "3427|5|variant|litvar@rs1347903359##&&&litvar@#79811#|A324T", "681|4|gene|ncbi_gene@4893|NRAS", "2921|4|gene|ncbi_gene@1956|EGFR", "480|5|gene|ncbi_gene@2261|FGFR3", "2304|6|variant|litvar@#1499#p.C1616G&&&litvar@#1499#|C1616G", "3125|5|variant|litvar@rs1467063797##&&&litvar@#79811#|G485A", "2153|6|variant|litvar@#5290#p.C1900T&&&litvar@#5290#|C1900T", "27|5|variant|litvar@#79811#p.C374T&&&litvar@#79811#|C374T", "421|5|gene|ncbi_gene@2261|FGFR3", "37|6|variant|litvar@rs1490489610##&&&litvar@#7249#|Y1248C", "2046|5|variant|litvar@#1499#p.G333C&&&litvar@#1499#|G333C", "2024|8|variant|litvar@rs763954916##&&&litvar@#324#|T2466GCA", "266|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "3046|4|variant|litvar@rs1234918359##&&&litvar@#3643#|L23Q", "2076|3|gene|ncbi_gene@3815|KIT", "1680|5|variant|litvar@rs1327567130##&&&litvar@#5156#|A409S", "857|7|variant|litvar@rs764840082##&&&litvar@#7249#&&&litvar@CA276737715#rs764840082##|A626TCG", "248|5|variant|litvar@rs28931614##&&&litvar@#2261#&&&litvar@CA129944#rs28931614##|G380R", "406|6|variant|litvar@rs281864720##&&&litvar@#238#|F1245L", "1573|4|variant|litvar@rs760987652##&&&litvar@#238#&&&litvar@CA1595024#rs760987652##|C70T", "2603|5|variant|litvar@rs867280522##&&&litvar@#2324#&&&litvar@CA133221614#rs867280522##|S405F", "2869|5|variant|litvar@rs1180557682##&&&litvar@#25#|T854I", "2205|3|gene|ncbi_gene@3815|KIT", "3224|6|gene|ncbi_gene@5609|MAP2K7", "2197|7|variant|litvar@rs775517144##&&&litvar@#3417#|C110GTA", "865|6|gene|ncbi_gene@5156|PDGFRA", "2327|7|variant|litvar@rs142638017##&&&litvar@#2260#|C134GTA", "1540|6|gene|ncbi_gene@5290|PIK3CA", "1595|6|gene|ncbi_gene@5290|PIK3CA", "3316|6|variant|litvar@#55294#p.A44R&&&litvar@#55294#|A44CGT", "2160|6|gene|ncbi_gene@5290|PIK3CA", "402|3|gene|ncbi_gene@238|ALK", "3464|3|gene|ncbi_gene@79811|MET", "44|6|variant|litvar@rs951227334##&&&litvar@#238#&&&litvar@CA45005102#rs951227334##|A3743G", "920|5|variant|litvar@rs756415201##&&&litvar@#23269#|G602A", "543|5|variant|litvar@rs121913485##&&&litvar@#2261#&&&litvar@CA341413#rs121913485##|Y373C", "126|5|gene|ncbi_gene@2263|FGFR2", "2545|5|variant|litvar@#5290#p.R088Q&&&litvar@#5290#|R088Q", "2907|5|variant|litvar@rs143199326##&&&litvar@#79811#|A319S", "3021|4|gene|ncbi_gene@5894|RAF1", "3253|6|variant|litvar@#55294#p.T2753C&&&litvar@#55294#|T2753C", "1406|5|variant|litvar@rs397517199##&&&litvar@CA136365#rs397517199##|C418T", "196|6|variant|litvar@#23269#p.G1108T&&&litvar@#23269#|G1108T", "1665|6|variant|litvar@rs764260286##&&&litvar@#324#|C2727G", "155|6|variant|litvar@rs1289735668##&&&litvar@#2255#|T3757G", "1514|6|variant|litvar@rs1339954087##&&&litvar@#673#|C3036G", "3523|5|variant|litvar@rs61753795##&&&litvar@#2956#&&&litvar@CA69873#rs61753795##|R988C", "953|5|variant|litvar@rs121913353##&&&litvar@#673#&&&litvar@CA168090546#rs121913353##|G466R", "3555|5|gene|ncbi_gene@2260|FGFR1", "111|4|gene|ncbi_gene@10000|AKT3", "986|6|gene|ncbi_gene@5156|PDGFRA", "2345|6|variant|litvar@#5290#p.T2474C&&&litvar@#5290#|T2474C", "1913|6|variant|litvar@rs121913281##&&&litvar@#5290#&&&litvar@CA130471#rs121913281##|H1047Y", "1817|6|variant|litvar@#3815#p.A95R&&&litvar@#3815#|A95CGT", "1100|5|variant|litvar@rs587780669##&&&litvar@#2956#&&&litvar@CA7797#rs587780669##|G209A", "3032|5|variant|litvar@rs121918492##&&&litvar@#2263#&&&litvar@CA280171#rs121918492##|A344G", "284|6|variant|litvar@rs281864719##&&&litvar@#238#&&&litvar@CA277829#rs281864719##|F1174L", "2648|6|variant|litvar@#5290#p.G34T&&&litvar@#5290#|G34ACT", "1521|4|gene|ncbi_gene@3418|IDH2", "3112|6|gene|ncbi_gene@5609|MAP2K7", "2503|4|gene|ncbi_gene@1956|EGFR", "2913|5|variant|litvar@#1956#p.G955T&&&litvar@#1956#|G955T", "3474|6|variant|litvar@rs1413989131##&&&litvar@#5789#|A1124G", "2618|4|gene|ncbi_gene@1956|EGFR", "2589|6|variant|litvar@#5290#p.G35T&&&litvar@#5290#|G35ACT", "1030|4|gene|ncbi_gene@2913|GRM3", "1133|5|variant|litvar@rs121913364##&&&litvar@#673#&&&litvar@CA123645#rs121913364##|K601E", "1289|5|variant|litvar@rs1057519925##&&&litvar@#5290#|E453K", "1159|7|variant|litvar@#5290#p.C394X&&&litvar@#5290#|C394TGA", "2559|4|gene|ncbi_gene@1956|EGFR", "754|6|variant|litvar@rs372767911##&&&litvar@#23269#|A2525T"], "figure_id": "T4", "text_hl": "AKT1_E17K_G49A FGFR1_S125L_C374T MET_Y1248C_A3743G   AKT2_E17K_G49A FGFR2_N549KK_T1647GA MET_Y1248HD_T3742CG   AKT3_E17K_G49A FGFR2_S252W_C755G MET_Y1253D_T3757G   ALK_F1174CS_T3521GC FGFR3_G370C_G1108T MGA_T1747N_C5421A   ALK_F1174L_C3522AG FGFR3_G380R_G1138A NRAS_A146T_G436A   ALK_F1174LIV_T3520CAG FGFR3_G697C_G2089T NRAS_G12DAV_G35ACT   ALK_F1245C_T3734G FGFR3_K650MT_A1949TC NRAS_G12SRC_G34ACT   ALK_F1245L_C3735AG FGFR3_R248C_C742T NRAS_G13DAV_G38ACT   ALK_F1245VI_T3733GA FGFR3_S249C_C746G NRAS_G13SRC_G37ACT   ALK_I1171N_T3512A FGFR3_Y373C_A1118G NRAS_Q61EKX_C181GAT   ALK_R1275QL_G3824AT FOXL2_C134W_C402G NRAS_Q61HHQ_A183TCG   BCOR_N1407STI_A4220GCT GNA11_Q209LP_A626TC NRAS_Q61RPL_A182GCT   BRAF_D594GV_A1781GT GNA11_R183C_C547T PDGFRA_D842V_A2525T   BRAF_E586K_G1756A GNAQ_Q209H_A627T PDGFRA_D842YN_G2524TA   BRAF_G464EVA_G1391ATC GNAQ_Q209LPR_A626TCG PDGFRA_N659K_C1977A   BRAF_G466EVA_G1397ATC GNAS_R201H_G602A PDGFRA_N659Y_A1975T   BRAF_G466R_G1396CA GNAS_R201SC_C601AT PDGFRA_V561D_T1682A   BRAF_G469EVA_G1406ATC GRM3_E870K_G2608A PIK3CA_A1046V_C3137T   BRAF_G469R_G1405CA IDH1_G70D_G209A PIK3CA_C420R_T1258C   BRAF_K601E_A1801G IDH1_R132CGS_C394TGA PIK3CA_E110K_G328A   BRAF_L597RQ_T1790GA IDH1_R132HL_G395AT PIK3CA_E418K_G1252A   BRAF_V600_G1800 IDH1_V178I_G532A PIK3CA_E453K_G1357A   BRAF_V600EAG_T1799ACG_F IDH2_R140LQ_G419TA PIK3CA_E542KQ_G1624AC   BRAF_V600EAG_T1799ACG_R IDH2_R140W_C418T PIK3CA_E542VG_A1625TG   BRAF_V600LM_G1798TA IDH2_R172GW_A514GT PIK3CA_E545AGV_A1634CGT   CC2D1A_L913V_C3036G IDH2_R172MK_G515TA PIK3CA_E545D_G1635CT   CDK4_R24C_C70T IDH2_R172S_G516T PIK3CA_E545KQ_G1633AC   CDK4_R24H_G71A JAK2_V617F_G1849T PIK3CA_F909L_C2727G   CSMD1_A409S_G1225T KIT_D816GVA_A2447GTC PIK3CA_G118D_G353A   CSMD1_Q3005X_C9013T KIT_D816HNY_G2446CAT PIK3CA_H1047RL_A3140GT_F   CTNNB1_D32AGV_A95CGT KIT_K642E_A1924G PIK3CA_H1047RL_A3140GT_R   CTNNB1_D32HNY_G94CAT KIT_L576P_T1727C PIK3CA_H1047Y_C3139T   CTNNB1_G34EVA_G101ATC KIT_N566D_A1696G PIK3CA_H701P_A2102C   CTNNB1_H36PRY_A107CGT KIT_N822KNK_T2466GCA PIK3CA_K111N_G333C   CTNNB1_I35NST_T104AGC KIT_N822YHD_A2464TCG PIK3CA_M1043I_G3129ATC   CTNNB1_S33APT_T97GCA KIT_R634W_C1900T PIK3CA_M1043V_A3127G   CTNNB1_S37CFY_C110GTA KIT_V559ADG_T1676CAG PIK3CA_N345K_T1035A   CTNNB1_S45APT_T133GCA KIT_V560DGA_T1679AGC PIK3CA_P539R_C1616G   CTNNB1_S45CFY_C134GTA KIT_V825A_T2474C PIK3CA_Q060K_C178A   CTNNB1_T41APS_A121GCT KIT_Y553N_T1657A PIK3CA_Q546EK_C1636GA   CTNNB1_T41INS_C122TAG KRAS_A146PT_G436CA PIK3CA_Q546LPR_A1637TCG   EGFR_G719CS_G2155TA KRAS_G10R_G28A PIK3CA_R088Q_G263A   EGFR_K860I_A2579T KRAS_G12DAV_G35ACT PIK3CA_S405F_C1214T   EGFR_L858R_T2573G KRAS_G12SRC_G34ACT PIK3CA_T1025SA_A3073TG   EGFR_L861QR_T2582AG KRAS_G13DAV_G38ACT PIK3CA_Y1021C_A3062G   EGFR_S720P_T2158C KRAS_G13SRC_G37ACT PIK3CA_Y1021HN_T3061CA   EGFR_T790M_C2369T KRAS_Q61EKX_C181GAT PPP2R1A_W257G_T769G   EGFR_T854I_C2561T KRAS_Q61HHQ_A183CTG RAF1_A319S_G955T   EGFR_Y813C_A2438G KRAS_Q61LPR_A182TCG RAF1_L613V_C1837G   EPHA3_K761NN_G2283TC MAP2K2_E207KQ_G619AC RAF1_N115S_A344G   FBXO4_L23Q_T68A MAP2K7_D290D_C870T RAF1_Q335H_G1005C   FBXO4_P76T_C226A MAP2K7_R162H_G485A RAF1_S259A_T775G   FBXO4_S8R_C24AG MAP2K7_S271T_T811A RAF1_Y340D_T1018G   FBXW7_R465C_C1393T MAP2K7_S311L_C932T RET_M918T_T2753C   FBXW7_R465HL_G1394AT MET_H1112RL_A3335GT RPL22_K15TRM_A44CGT   FBXW7_R479QL_G1436AT MET_H1112Y_C3334T SFRS9_Y192X_C722A   FBXW7_R505CS_C1513TA MET_M1268T_T3803C SMO_A324T_G970A   FBXW7_R505HLP_G1514ATC MET_N375S_A1124G SRC_Q531X_C1591T   FBXW7_S582L_C1745T MET_R988C_C2962T TGM2_S212P_T734C   FGFR1_P252T_C754A MET_T1010I_C3029T    "}], "citations": {"NLM": "Javle M, Rashid A, Churi C, Kar S, Zuo M, Eterovic AK, Nogueras-Gonzalez GM, Janku F, Shroff RT, Aloia TA, Vauthey JN, Curley S, Mills G, Roa I. Molecular characterization of gallbladder cancer using somatic mutation profiling. Hum Pathol. PMID: 24508317", "BibTeX": "@article{24508317, title={Molecular characterization of gallbladder cancer using somatic mutation profiling.}, author={Javle M and Rashid A and Churi C and Kar S and Zuo M and Eterovic AK and Nogueras-Gonzalez GM and Janku F and Shroff RT and Aloia TA and Vauthey JN and Curley S and Mills G and Roa I}, journal={Hum Pathol}}"}, "is_sup_mat_match": false}, {"pmid": 31580526, "pmcid": "PMC6822247", "title": "Oncogenic Ras mutant causes the hyperactivation of NF-kappaB via acceleration of its transcriptional activation.", "journal": "Mol Oncol", "authors": ["Tago K", "Funakoshi-Tago M", "Ohta S", "Kawata H", "Saitoh H", "Horie H", "Aoki-Ohmura C", "Yamauchi J", "Tanaka A", "Matsugi J", "Yanagisawa K"], "date": "2019-10-03T00:00:00Z", "year": 2019, "snippets": [{"_id": "31580526@22723", "snip_text": "Current studies reported novel type of point mutation in K-Ras gene, such as K117N and A146T (Yoshino et al., 2015).", "section": "results", "mentions": ["87|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "77|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "57|5|gene|ncbi_gene@16653|K-Ras"], "text_hl": "Current studies reported novel type of point mutation in K-Ras gene, such as K117N and <m>A146T</m> (Yoshino et al., 2015)."}], "citations": {"NLM": "Tago K, Funakoshi-Tago M, Ohta S, Kawata H, Saitoh H, Horie H, Aoki-Ohmura C, Yamauchi J, Tanaka A, Matsugi J, Yanagisawa K. Oncogenic Ras mutant causes the hyperactivation of NF-kappaB via acceleration of its transcriptional activation. Mol Oncol. PMID: 31580526", "BibTeX": "@article{31580526, title={Oncogenic Ras mutant causes the hyperactivation of NF-kappaB via acceleration of its transcriptional activation.}, author={Tago K and Funakoshi-Tago M and Ohta S and Kawata H and Saitoh H and Horie H and Aoki-Ohmura C and Yamauchi J and Tanaka A and Matsugi J and Yanagisawa K}, journal={Mol Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 34764329, "pmcid": "PMC8586365", "title": "Integrative Bioinformatics approaches to therapeutic gene target selection in various cancers for Nitroglycerin.", "journal": "Sci Rep", "authors": ["Chinnappan J", "Ramu A", "V VR", "S AK"], "date": "2021-11-11T00:00:00Z", "year": 2021, "snippets": [{"_id": "34764329@20437", "snip_text": "STUDY PROTEIN CHANGE GENE CHR   a. Bladder cancer   Bladder Cancer (MSK/TCGA, 2020), Bladder Cancer (TCGA, Cell 2017), Bladder Cancer (MSKCC, Nat Genet 2016), Bladder Cancer (MSKCC, EurUrol 2014) E884K, T785S, R836H, V121F, Q390R, F359L, E59K, -402 fs, E736K, S380C, X901_splice, X762_splice, Q565E, E963Q, S174R, I715M, I886Tfs*9, EGFR-GRB10, RHBDD2-EGFR EGFR 7   Bladder Cancer (MSK/TCGA, 2020), Bladder Cancer (TCGA, Cell 2017), Bladder Cancer (MSKCC, EurUrol 2014) G13D, Q61L, Q61K, G13V, G13R, G12S, K117N, E162K, R149Gfs*23, D33N, E91K, S145* HRAS 11   Bladder Cancer (MSK/TCGA, 2020), Bladder Cancer (TCGA, Cell 2017) I182N, D335N, E18Q, R318W, R16I, V68L, E98K, E194Q, X11_splice MAPK3 16   b. Endometrial cancer   Endometrial Cancer (MSK, 2018) D770_P772dup, I664Sfs*41, A237V, N466T, Q820*, R138I, V660M, EGFR-intragenic EGFR 7   T74A, Q25H HRAS 11   K72N MAPK3 16   c. Melanoma   Melanoma (MSKCC, 2018), Melanomas (TCGA, Cell 2015), Melanoma (MSKCC, NEJM 2014) R252L, E114K, G983R, P589L, G796S, P753S, G729R, C264Y, S1045F, H47Y, V592I, S77F, N604D, R98Q, P694S, D1009N, P1178L, P100S, P622S, P644L, L1139F, S306L, P195L, R334C, S447F, D1152N, E967K, E829*, A419V, G63E, E922K, L541F, L101F, E319K, P512S, K737E, Q390K, Q982*, S364F, P934S, R958C, D303N, T594I, S116F, F359L, N234S, S227F, R574, P637S, P1019S, G901E, E1004K, S1028L, T909I, A118V, E1137K, P192S, P644S, D393N, G33N, P733S, S452F, P741S, A155V, H370Y, P243S, M825I, S220F, P100L, G131R, S169N, P411L, S912F, P272L, E245G, G575E, G322D, L1017F, P1073H, Q1095*, M137V, H418Y, A702V, P992S, N996S, P1059S, Q52*, E685K, A647V, L372H, X687_splice, EGFR-intragenic, EGFR-intragenic - Archer EGFR 7   Q61R, G13D, Q61K, G12D, G13R, G13C, G13S, G12N, G13N, A59V, A146T, E143K, A59Rfs*32, P174L, X38_splice HRAS 11   R87W, E362K, G102D, A303V, G374K, P328L, P169L, F185I, N140S, P336Q, C178R, R211W, L133Q, S159F, I89N, Q366*, G23R, P246F MAPK3 16   d. Non-small cell lung cancer   Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018), Non-Small Cell Lung Cancer (University of Turin, Lung Cancer 2017), Non-Small Cell Lung Cancer (TRACERx, NEJM & Nature 2017), Non-Small Cell Lung Cancer (MSKCC, J ClinOncol 2018), Non-small cell lung cancer (MSK, Science 2015) T790M, L858R, L861Q, G719A, E746_A750del, L747_S752del, L747_A750delinsP, S752_I759del, S768_D770dup, H773dup, N771_H773dup, P772_H773dup, D770_N771insY, V769_D770insSSV, L747P, R108K, E709A, T725M, T363A, Q787L, T725P, A864P, V774M, A839T, L707W, V765L, X210_splice, S306L, H870R, A13T, V616L, C1049R, R527W, R527W, S752F, L90F, L93I, L93F, P733S, A822T, E746Dfs*2, T751P, L438V, E746Nfs*2, L747*, K745Rfs*3, K745Rfs*3, E545*, A86T, Y299F, M111I, EGFR-intragenic EGFR 7   Non-Small Cell Lung Cancer (TRACERx, NEJM & Nature 2017) P34S HRAS 11   Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018) X57_splice MAPK3 16   ", "section": "table", "mentions": ["2702|26|disease|ncbi_mesh@D002289|Non-Small Cell Lung Cancer", "794|5|variant|litvar@#1956#p.Q820*&&&litvar@#1956#|Q820*", "432|14|disease|ncbi_mesh@D001749|Bladder Cancer", "1451|5|variant|litvar@rs760429548##&&&litvar@#3265#&&&litvar@CA5779212#rs760429548##|P100L", "1684|4|variant|litvar@rs28933406##&&&litvar@#3265#&&&litvar@CA122547#rs28933406##|Q61K", "1566|5|variant|litvar@rs762795214##&&&litvar@#1956#&&&litvar@CA4266233#rs762795214##|N996S", "1204|5|variant|litvar@rs547029591##&&&litvar@#54206#&&&litvar@CA569729#rs547029591##|E319K", "1507|5|variant|litvar@rs1300105161##&&&litvar@#2887#|G322D", "2511|4|variant|litvar@rs771431827##&&&litvar@#8503#|A13T", "2359|7|variant|litvar@#1956#p.H773dup&&&litvar@#1956#|H773dup", "1621|4|gene|ncbi_gene@1956|EGFR", "217|5|variant|litvar@#1956#p.V121F&&&litvar@#1956#|V121F", "2303|12|variant|litvar@#1956#c.752,759delS,I&&&litvar@#1956#|S752_I759del", "2517|5|variant|litvar@#1956#p.V616L&&&litvar@#1956#|V616L", "487|4|variant|litvar@rs104894226##&&&litvar@#3265#&&&litvar@CA296055#rs104894226##|G13V", "2340|12|variant|litvar@#1956#c.771,773dupN,H&&&litvar@#1956#|N771_H773dup", "801|5|variant|litvar@#1956#p.R138I&&&litvar@#1956#|R138I", "332|4|gene|ncbi_gene@1956|EGFR", "1875|5|variant|litvar@rs577158050##&&&litvar@#7534#|S159F", "1983|6|disease|ncbi_mesh@D009369|Cancer", "986|5|variant|litvar@rs780598157##&&&litvar@#6655#|G983R", "1757|5|variant|litvar@rs757431246##&&&litvar@#2887#&&&litvar@CA4262960#rs757431246##|P174L", "1812|5|variant|litvar@#3265#p.G374K&&&litvar@#3265#|G374K", "2400|5|variant|litvar@rs397517096##&&&litvar@#1956#&&&litvar@CA135800#rs397517096##|L747P", "224|5|variant|litvar@rs374257832##&&&litvar@#10188#|Q390R", "549|4|gene|ncbi_gene@3265|HRAS", "808|5|variant|litvar@rs1426364365##&&&litvar@#1956#|V660M", "664|4|variant|litvar@rs751137946##&&&litvar@#3265#&&&litvar@CA5779336#rs751137946##|E98K", "2470|5|variant|litvar@rs758222454##&&&litvar@#10188#&&&litvar@CA2776249#rs758222454##|L707W", "2070|26|disease|ncbi_mesh@D002289|Non-Small Cell Lung Cancer", "1746|9|variant|litvar@rs760228905##&&&litvar@#1956#|A59Rfs*32", "2802|3|disease||MSK", "1295|5|variant|litvar@rs1046438724##&&&litvar@#1956#&&&litvar@CA158910917#rs1046438724##|S227F", "993|5|variant|litvar@rs751570775##&&&litvar@#1956#|P589L", "1819|5|variant|litvar@rs1199223871##&&&litvar@#2977#|P328L", "2407|5|variant|litvar@rs1057519828##&&&litvar@#1956#|R108K", "2610|9|variant|litvar@#1956#p.E746NfsX2&&&litvar@#1956#|E746Nfs*2", "1232|5|variant|litvar@#1956#p.Q982*&&&litvar@#1956#|Q982*", "2532|5|variant|litvar@rs768627073##&&&litvar@#1956#&&&litvar@CA4265620#rs768627073##|R527W", "1978|3|disease||MSK", "2639|9|variant|litvar@#1956#p.K745RfsX3&&&litvar@#1956#|K745Rfs*3", "1091|5|variant|litvar@rs866460345##&&&litvar@#1956#&&&litvar@CA158898179#rs866460345##|P100S", "1000|5|variant|litvar@rs754426793##&&&litvar@#1956#&&&litvar@CA4266064#rs754426793##|G796S", "1055|5|variant|litvar@rs1207870979##&&&litvar@#2887#|N604D", "1826|5|variant|litvar@rs1255807955##&&&litvar@#5906#|P169L", "1211|5|variant|litvar@rs587778248##&&&litvar@#1956#&&&litvar@CA158438#rs587778248##|P512S", "1239|5|variant|litvar@rs747173721##&&&litvar@#5900#|S364F", "575|3|disease||MSK", "1395|5|variant|litvar@#1956#p.P733S&&&litvar@#1956#|P733S", "505|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "1720|4|variant|litvar@rs104894228##&&&litvar@#3265#|G13N", "1775|4|gene|ncbi_gene@3265|HRAS", "1368|5|variant|litvar@rs766682738##&&&litvar@#6464#&&&litvar@CA1133750#rs766682738##|P192S", "1805|5|variant|litvar@rs1393537562##&&&litvar@#5595#|A303V", "1638|4|gene|ncbi_gene@1956|EGFR", "1785|4|variant|litvar@rs750160678##&&&litvar@#5595#&&&litvar@CA8002900#rs750160678##|R87W", "1218|5|variant|litvar@rs757021030##&&&litvar@#8829#&&&litvar@CA5466223#rs757021030##|K737E", "519|10|variant|litvar@#3265#p.R149GfsX23&&&litvar@#3265#|R149Gfs*23", "1726|4|variant|litvar@rs104886029##&&&litvar@#3845#&&&litvar@CA269881#rs104886029##|A59V", "1882|4|variant|litvar@#5595#p.I89N&&&litvar@#5595#|I89N", "1402|5|variant|litvar@rs1226827460##&&&litvar@#1956#|S452F", "1690|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "512|5|variant|litvar@rs1245776198##&&&litvar@#3717#|E162K", "2317|12|variant|litvar@#1956#c.768,770dupS,D&&&litvar@#1956#|S768_D770dup", "2553|4|variant|litvar@rs750399097##&&&litvar@#1956#&&&litvar@CA4265170#rs750399097##|L90F", "2764|4|gene|ncbi_gene@3265|HRAS", "2524|6|variant|litvar@#1956#p.C1049R&&&litvar@#1956#|C1049R", "2229|5|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|T790M", "1177|4|variant|litvar@rs778901010##&&&litvar@#1956#&&&litvar@CA4265434#rs778901010##|G63E", "815|4|gene|ncbi_gene@1956|EGFR", "1225|5|variant|litvar@rs770114935##&&&litvar@#2887#|Q390K", "493|4|variant|litvar@rs104894228##&&&litvar@#3265#&&&litvar@CA129950#rs104894228##|G13R", "1587|5|variant|litvar@#1956#p.E685K&&&litvar@#1956#|E685K", "475|4|variant|litvar@rs121913233##&&&litvar@#3265#&&&litvar@CA16602500#rs121913233##|Q61L", "1409|5|variant|litvar@rs755566982##&&&litvar@#10188#|P741S", "2414|5|variant|litvar@rs397517085##&&&litvar@#1956#&&&litvar@CA135761#rs397517085##|E709A", "670|5|variant|litvar@#5595#p.E194Q&&&litvar@#5595#|E194Q", "531|4|variant|litvar@#3265#p.D33N&&&litvar@#3265#|D33N", "2210|3|disease||MSK", "2565|4|variant|litvar@rs758785950##&&&litvar@#4301#|L93F", "1465|5|variant|litvar@rs1047633844##&&&litvar@#6464#|S169N", "2236|5|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|L858R", "2657|4|variant|litvar@rs755629700##&&&litvar@#3091#&&&litvar@CA7215674#rs755629700##|A86T", "1346|5|variant|litvar@rs370951865##&&&litvar@#5900#|T909I", "2539|5|variant|litvar@rs768627073##&&&litvar@#1956#&&&litvar@CA4265620#rs768627073##|R527W", "1594|5|variant|litvar@#1956#p.A647V&&&litvar@#1956#|A647V", "1098|5|variant|litvar@rs111394985##&&&litvar@#1950#|P622S", "537|4|variant|litvar@rs1458275118##&&&litvar@#2887#|E91K", "652|4|variant|litvar@#5595#p.R16I&&&litvar@#5595#|R16I", "1007|5|variant|litvar@rs121913231##&&&litvar@#1956#&&&litvar@CA4266020#rs121913231##|P753S", "645|5|variant|litvar@rs755904687##&&&litvar@#5595#&&&litvar@CA8002722#rs755904687##|R318W", "1833|5|variant|litvar@#3265#p.F185I&&&litvar@#3265#|F185I", "2421|5|variant|litvar@rs767505234##&&&litvar@#1956#&&&litvar@CA4265987#rs767505234##|T725M", "68|3|disease||MSK", "840|4|variant|litvar@rs377444977##&&&litvar@#1956#&&&litvar@CA4265187#rs377444977##|T74A", "1028|6|variant|litvar@#1956#p.S1045F&&&litvar@#1956#|S1045F", "1062|4|variant|litvar@rs17289589##&&&litvar@#1956#&&&litvar@CA4265175#rs17289589##|R98Q", "1472|5|variant|litvar@rs774733224##&&&litvar@#2887#|P411L", "35|14|disease|ncbi_mesh@D001749|Bladder cancer", "759|7|variant|litvar@#1956#p.P772dup&&&litvar@#1956#|P772dup", "866|5|gene|ncbi_gene@5595|MAPK3", "2546|5|variant|litvar@rs587778158##&&&litvar@#867#&&&litvar@CA157860#rs587778158##|S752F", "1601|5|variant|litvar@#1956#p.L372H&&&litvar@#1956#|L372H", "356|4|gene|ncbi_gene@1956|EGFR", "1014|5|variant|litvar@rs1413950512##&&&litvar@#6654#|G729R", "1840|5|variant|litvar@rs373098408##&&&litvar@#2887#|N140S", "1696|4|variant|litvar@rs104894228##&&&litvar@#3265#&&&litvar@CA129950#rs104894228##|G13R", "2428|5|variant|litvar@rs1388727725##&&&litvar@#4881#|T363A", "1360|6|variant|litvar@rs780967013##&&&litvar@#1956#&&&litvar@CA4266397#rs780967013##|E1137K", "1538|5|variant|litvar@rs754854319##&&&litvar@#1956#&&&litvar@CA4265191#rs754854319##|M137V", "481|4|variant|litvar@rs28933406##&&&litvar@#3265#&&&litvar@CA122547#rs28933406##|Q61K", "1253|5|variant|litvar@rs774786316##&&&litvar@#1950#&&&litvar@CA3044218#rs774786316##|R958C", "1479|5|variant|litvar@#1956#p.S912F&&&litvar@#1956#|S912F", "253|5|variant|litvar@#1956#p.E736K&&&litvar@#1956#|E736K", "2331|7|variant|litvar@#1956#p.H773dup&&&litvar@#1956#|H773dup", "1338|6|variant|litvar@#1956#p.S1028L&&&litvar@#1956#|S1028L", "2002|26|disease|ncbi_mesh@D002289|Non-Small Cell Lung Cancer", "714|6|disease|ncbi_mesh@D009369|cancer", "1522|6|variant|litvar@rs1405007818##&&&litvar@#10188#|P1073H", "1323|5|variant|litvar@rs1396334354##&&&litvar@#1950#|G901E", "1021|5|variant|litvar@rs1307834849##&&&litvar@#7294#|C264Y", "1847|5|variant|litvar@#5595#p.P336Q&&&litvar@#5595#|P336Q", "2774|26|disease|ncbi_mesh@D002289|Non-Small Cell Lung Cancer", "1907|5|gene|ncbi_gene@5595|MAPK3", "1708|4|variant|litvar@rs104894228##&&&litvar@#3265#&&&litvar@CA16602769#rs104894228##|G13S", "1260|5|variant|litvar@rs1393537562##&&&litvar@#5595#|D303N", "1416|5|variant|litvar@rs1269551105##&&&litvar@#3265#|A155V", "260|5|variant|litvar@#1956#p.S380C&&&litvar@#1956#|S380C", "743|3|disease||MSK", "381|3|disease||MSK", "2128|26|disease|ncbi_mesh@D002289|Non-Small Cell Lung Cancer", "851|4|gene|ncbi_gene@3265|HRAS", "2243|5|variant|litvar@rs121913444##&&&litvar@#1956#&&&litvar@CA176021#rs121913444##|L861Q", "1714|4|variant|litvar@rs121913529##&&&litvar@#3845#|G12N", "293|5|variant|litvar@rs1258825984##&&&litvar@#3717#|Q565E", "1353|5|variant|litvar@rs747218330##&&&litvar@#29126#&&&litvar@CA4973733#rs747218330##|A118V", "559|14|disease|ncbi_mesh@D001749|Bladder Cancer", "1678|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "2051|11|disease|ncbi_mesh@D008175|Lung Cancer", "1120|5|variant|litvar@rs886041231##&&&litvar@#5894#&&&litvar@CA10602363#rs886041231##|S306L", "1036|4|variant|litvar@rs1418446263##&&&litvar@#6654#|H47Y", "1267|5|variant|litvar@rs778011429##&&&litvar@#1956#|T594I", "592|14|disease|ncbi_mesh@D001749|Bladder Cancer", "1423|5|variant|litvar@rs1428155517##&&&litvar@#10188#|H370Y", "2693|4|gene|ncbi_gene@1956|EGFR", "1382|5|variant|litvar@rs746500207##&&&litvar@#10188#|D393N", "238|4|variant|litvar@rs760228905##&&&litvar@#1956#&&&litvar@CA4265147#rs760228905##|E59K", "231|5|variant|litvar@rs189117311##&&&litvar@#54206#&&&litvar@CA569710#rs189117311##|F359L", "625|5|variant|litvar@#5595#p.I182N&&&litvar@#5595#|I182N", "2456|5|variant|litvar@rs567477136##&&&litvar@#1956#&&&litvar@CA158928427#rs567477136##|V774M", "1895|4|variant|litvar@rs1198853998##&&&litvar@#8503#|G23R", "2250|5|variant|litvar@rs121913428##&&&litvar@#1956#&&&litvar@CA135775#rs121913428##|G719A", "1246|5|variant|litvar@rs575565383##&&&litvar@#1956#&&&litvar@CA4266178#rs575565383##|P934S", "2257|12|variant|litvar@#1956#p.A746,750del&&&litvar@#1956#|E746_A750del", "2759|4|variant|litvar@rs1348427922##&&&litvar@#3265#|P34S", "1430|5|variant|litvar@rs770971170##&&&litvar@#7294#&&&litvar@CA2911975#rs770971170##|P243S", "1663|4|gene|ncbi_gene@1956|EGFR", "2435|5|variant|litvar@rs1417289012##&&&litvar@#10188#|Q787L", "1545|5|variant|litvar@rs1390766480##&&&litvar@#1956#|H418Y", "1183|5|variant|litvar@#1956#p.E922K&&&litvar@#1956#|E922K", "639|4|variant|litvar@#5595#p.E18Q&&&litvar@#5595#|E18Q", "1921|26|disease|ncbi_mesh@D002289|Non-small cell lung cancer", "632|5|variant|litvar@rs370559927##&&&litvar@#2887#|D335N", "2463|5|variant|litvar@rs1468532072##&&&litvar@#1956#|A839T", "1486|5|variant|litvar@rs368509783##&&&litvar@#2887#|P272L", "159|14|disease|ncbi_mesh@D001749|Bladder Cancer", "861|4|variant|litvar@rs1385832890##&&&litvar@#57414#|K72N", "196|5|variant|litvar@rs1434775922##&&&litvar@#5290#|E884K", "1049|4|variant|litvar@#1956#p.S77F&&&litvar@#1956#|S77F", "688|5|gene|ncbi_gene@5595|MAPK3", "1075|6|variant|litvar@rs148019583##&&&litvar@#1956#&&&litvar@CA4266241#rs148019583##|D1009N", "1308|5|variant|litvar@rs758660418##&&&litvar@#10188#|P637S", "780|5|variant|litvar@rs774900761##&&&litvar@#4301#|A237V", "1950|26|disease|ncbi_mesh@D002289|Non-Small Cell Lung Cancer", "1854|5|variant|litvar@rs1157393554##&&&litvar@#5294#|C178R", "2442|5|variant|litvar@rs1287952824##&&&litvar@#10188#|T725P", "2497|5|variant|litvar@rs886041231##&&&litvar@#5894#&&&litvar@CA10602363#rs886041231##|S306L", "499|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "1552|5|variant|litvar@rs549015965##&&&litvar@#1956#&&&litvar@CA158931884#rs549015965##|A702V", "1315|6|variant|litvar@#1956#p.P1019S&&&litvar@#1956#|P1019S", "1493|5|variant|litvar@rs1285397991##&&&litvar@#3717#|E245G", "1791|5|variant|litvar@rs747392494##&&&litvar@#5595#&&&litvar@CA8002671#rs747392494##|E362K", "203|5|variant|litvar@rs1240022065##&&&litvar@#5900#|T785S", "1732|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "52|14|disease|ncbi_mesh@D001749|Bladder Cancer", "787|5|variant|litvar@rs1057521091##&&&litvar@#6774#|N466T", "1375|5|variant|litvar@rs1180625027##&&&litvar@#6654#|P644S", "300|5|variant|litvar@rs748829715##&&&litvar@#3717#|E963Q", "831|4|gene|ncbi_gene@1956|EGFR", "469|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1861|5|variant|litvar@rs764219989##&&&litvar@#5595#&&&litvar@CA8002814#rs764219989##|R211W", "2449|5|variant|litvar@rs774138621##&&&litvar@#3717#|A864P", "1083|6|variant|litvar@rs775132991##&&&litvar@#6655#|P1178L", "2504|5|variant|litvar@rs1212691840##&&&litvar@#1950#|H870R", "85|14|disease|ncbi_mesh@D001749|Bladder Cancer", "344|6|gene|ncbi_gene@57414|RHBDD2", "1559|5|variant|litvar@rs1364225726##&&&litvar@#1956#|P992S", "1127|5|variant|litvar@rs771976712##&&&litvar@#5294#|P195L", "2596|5|variant|litvar@rs753706093##&&&litvar@#4301#&&&litvar@CA4099146#rs753706093##|T751P", "1274|5|variant|litvar@rs771024335##&&&litvar@#8482#|S116F", "1500|5|variant|litvar@rs1249099747##&&&litvar@#1956#|G575E", "658|4|variant|litvar@rs777549336##&&&litvar@#54979#|V68L", "1068|5|variant|litvar@#1956#p.P694S&&&litvar@#1956#|P694S", "972|5|variant|litvar@rs1231921999##&&&litvar@#2887#|R252L", "1798|5|variant|litvar@#3265#p.G102D&&&litvar@#3265#|G102D", "210|5|variant|litvar@rs146121458##&&&litvar@#1956#&&&litvar@CA4266108#rs146121458##|R836H", "1112|6|variant|litvar@rs1473630143##&&&litvar@#1956#|L1139F", "1458|5|variant|litvar@rs1485016142##&&&litvar@#1956#|G131R", "735|6|disease|ncbi_mesh@D009369|Cancer", "1739|5|variant|litvar@rs909222512##&&&litvar@#3265#&&&litvar@CA216882633#rs909222512##|E143K", "1156|5|variant|litvar@rs35479618##&&&litvar@#4881#&&&litvar@CA1118605#rs35479618##|E967K", "1389|4|variant|litvar@#3265#p.G33N&&&litvar@#3265#|G33N", "119|14|disease|ncbi_mesh@D001749|Bladder Cancer", "307|5|variant|litvar@rs764113295##&&&litvar@#2887#|S174R", "2585|9|variant|litvar@#1956#p.E746DfsX2&&&litvar@#1956#|E746Dfs*2", "2836|5|gene|ncbi_gene@5595|MAPK3", "1042|5|variant|litvar@rs144943614##&&&litvar@#1956#&&&litvar@CA4265691#rs144943614##|V592I", "1868|5|variant|litvar@#5595#p.L133Q&&&litvar@#5595#|L133Q", "2571|5|variant|litvar@#1956#p.P733S&&&litvar@#1956#|P733S", "1134|5|variant|litvar@rs1257784802##&&&litvar@#3091#|R334C", "2603|5|variant|litvar@#1956#p.L438V&&&litvar@#1956#|L438V", "2807|6|disease|ncbi_mesh@D009369|Cancer", "2663|5|variant|litvar@#1956#p.Y299F&&&litvar@#1956#|Y299F", "1281|5|variant|litvar@rs189117311##&&&litvar@#54206#&&&litvar@CA569710#rs189117311##|F359L", "1437|5|variant|litvar@rs1474170437##&&&litvar@#1956#|M825I", "1901|5|variant|litvar@#5595#p.P246F&&&litvar@#5595#|P246F", "1702|4|variant|litvar@rs104894228##&&&litvar@#3265#&&&litvar@CA129950#rs104894228##|G13C", "979|5|variant|litvar@rs1219568637##&&&litvar@#1956#|E114K", "1190|5|variant|litvar@rs1208487495##&&&litvar@#1956#|L541F", "2628|9|variant|litvar@#1956#p.K745RfsX3&&&litvar@#1956#|K745Rfs*3", "1330|6|variant|litvar@#1956#p.E1004K&&&litvar@#1956#|E1004K", "337|5|gene|ncbi_gene@2887|GRB10", "1163|5|variant|litvar@#1956#p.E829*&&&litvar@#1956#|E829*", "1573|6|variant|litvar@rs755238987##&&&litvar@#1956#&&&litvar@CA4266314#rs755238987##|P1059S", "314|5|variant|litvar@#1956#p.I715M&&&litvar@#1956#|I715M", "2182|26|disease|ncbi_mesh@D002289|Non-small cell lung cancer", "1514|6|variant|litvar@rs1345851089##&&&litvar@#1956#|L1017F", "2271|12|variant|litvar@#1956#c.747,752delL,S&&&litvar@#1956#|L747_S752del", "365|14|disease|ncbi_mesh@D001749|Bladder Cancer", "2578|5|variant|litvar@rs397517125##&&&litvar@#1956#&&&litvar@CA135908#rs397517125##|A822T", "1141|5|variant|litvar@rs1267396988##&&&litvar@#9846#|S447F", "2677|4|gene|ncbi_gene@1956|EGFR", "846|4|variant|litvar@rs182554585##&&&litvar@#2887#|Q25H", "321|9|variant|litvar@#1956#p.I886TfsX9&&&litvar@#1956#|I886Tfs*9", "1672|4|variant|litvar@rs121913233##&&&litvar@#3265#&&&litvar@CA173968#rs121913233##|Q61R", "1288|5|variant|litvar@rs753581888##&&&litvar@#2983#|N234S", "1105|5|variant|litvar@rs770443325##&&&litvar@#1956#&&&litvar@CA4265912#rs770443325##|P644L", "2670|5|variant|litvar@rs1488843432##&&&litvar@#1956#|M111I", "1444|5|variant|litvar@#1956#p.S220F&&&litvar@#1956#|S220F", "768|10|variant|litvar@#1956#p.I664SfsX41&&&litvar@#1956#|I664Sfs*41", "1197|5|variant|litvar@rs1187795193##&&&litvar@#1956#|L101F", "398|14|disease|ncbi_mesh@D001749|Bladder Cancer", "2477|5|variant|litvar@rs374873413##&&&litvar@#1956#&&&litvar@CA4266049#rs374873413##|V765L", "2559|4|variant|litvar@rs758785950##&&&litvar@#4301#|L93I", "351|4|gene|ncbi_gene@1956|EGFR", "1170|5|variant|litvar@rs766728119##&&&litvar@#4881#|A419V", "1148|6|variant|litvar@rs368892932##&&&litvar@#1956#&&&litvar@CA4266406#rs368892932##|D1152N"], "figure_id": "Tab2", "text_hl": "STUDY PROTEIN CHANGE GENE CHR   a. Bladder cancer   Bladder Cancer (MSK/TCGA, 2020), Bladder Cancer (TCGA, Cell 2017), Bladder Cancer (MSKCC, Nat Genet 2016), Bladder Cancer (MSKCC, EurUrol 2014) E884K, T785S, R836H, V121F, Q390R, F359L, E59K, -402 fs, E736K, S380C, X901_splice, X762_splice, Q565E, E963Q, S174R, I715M, I886Tfs*9, EGFR-GRB10, RHBDD2-EGFR EGFR 7   Bladder Cancer (MSK/TCGA, 2020), Bladder Cancer (TCGA, Cell 2017), Bladder Cancer (MSKCC, EurUrol 2014) G13D, Q61L, Q61K, G13V, G13R, G12S, K117N, E162K, R149Gfs*23, D33N, E91K, S145* HRAS 11   Bladder Cancer (MSK/TCGA, 2020), Bladder Cancer (TCGA, Cell 2017) I182N, D335N, E18Q, R318W, R16I, V68L, E98K, E194Q, X11_splice MAPK3 16   b. Endometrial cancer   Endometrial Cancer (MSK, 2018) D770_P772dup, I664Sfs*41, A237V, N466T, Q820*, R138I, V660M, EGFR-intragenic EGFR 7   T74A, Q25H HRAS 11   K72N MAPK3 16   c. Melanoma   Melanoma (MSKCC, 2018), Melanomas (TCGA, Cell 2015), Melanoma (MSKCC, NEJM 2014) R252L, E114K, G983R, P589L, G796S, P753S, G729R, C264Y, S1045F, H47Y, V592I, S77F, N604D, R98Q, P694S, D1009N, P1178L, P100S, P622S, P644L, L1139F, S306L, P195L, R334C, S447F, D1152N, E967K, E829*, A419V, G63E, E922K, L541F, L101F, E319K, P512S, K737E, Q390K, Q982*, S364F, P934S, R958C, D303N, T594I, S116F, F359L, N234S, S227F, R574, P637S, P1019S, G901E, E1004K, S1028L, T909I, A118V, E1137K, P192S, P644S, D393N, G33N, P733S, S452F, P741S, A155V, H370Y, P243S, M825I, S220F, P100L, G131R, S169N, P411L, S912F, P272L, E245G, G575E, G322D, L1017F, P1073H, Q1095*, M137V, H418Y, A702V, P992S, N996S, P1059S, Q52*, E685K, A647V, L372H, X687_splice, EGFR-intragenic, EGFR-intragenic - Archer EGFR 7   Q61R, G13D, Q61K, G12D, G13R, G13C, G13S, G12N, G13N, A59V, <m>A146T</m>, E143K, A59Rfs*32, P174L, X38_splice HRAS 11   R87W, E362K, G102D, A303V, G374K, P328L, P169L, F185I, N140S, P336Q, C178R, R211W, L133Q, S159F, I89N, Q366*, G23R, P246F MAPK3 16   d. Non-small cell lung cancer   Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018), Non-Small Cell Lung Cancer (University of Turin, Lung Cancer 2017), Non-Small Cell Lung Cancer (TRACERx, NEJM & Nature 2017), Non-Small Cell Lung Cancer (MSKCC, J ClinOncol 2018), Non-small cell lung cancer (MSK, Science 2015) T790M, L858R, L861Q, G719A, E746_A750del, L747_S752del, L747_A750delinsP, S752_I759del, S768_D770dup, H773dup, N771_H773dup, P772_H773dup, D770_N771insY, V769_D770insSSV, L747P, R108K, E709A, T725M, T363A, Q787L, T725P, A864P, V774M, A839T, L707W, V765L, X210_splice, S306L, H870R, A13T, V616L, C1049R, R527W, R527W, S752F, L90F, L93I, L93F, P733S, A822T, E746Dfs*2, T751P, L438V, E746Nfs*2, L747*, K745Rfs*3, K745Rfs*3, E545*, A86T, Y299F, M111I, EGFR-intragenic EGFR 7   Non-Small Cell Lung Cancer (TRACERx, NEJM & Nature 2017) P34S HRAS 11   Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018) X57_splice MAPK3 16   "}], "citations": {"NLM": "Chinnappan J, Ramu A, V VR, S AK. Integrative Bioinformatics approaches to therapeutic gene target selection in various cancers for Nitroglycerin. Sci Rep. PMID: 34764329", "BibTeX": "@article{34764329, title={Integrative Bioinformatics approaches to therapeutic gene target selection in various cancers for Nitroglycerin.}, author={Chinnappan J and Ramu A and V VR and S AK}, journal={Sci Rep}}"}, "is_sup_mat_match": false}, {"pmid": 34289984, "pmcid": "PMC9489045", "title": "Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer.", "journal": "Eur Respir Rev", "authors": ["Abdayem P", "Planchard D"], "date": "2021-07-20T00:00:00Z", "year": 2021, "snippets": [{"_id": "34289984@15723", "snip_text": "Acquired EGFR T790M mutation was not found in the osimertinib arm, and the most common acquired resistance mechanisms were off-target MET amplification (15% of patients), on-target EGFR C797S mutation (on-target, 7%), downstream PIK3CA, BRAF V600E and KRAS G12D/C and A146 T mutations (7%, 3% and 3%, respectively) as well as off-target HER2 amplification (2%).", "section": "other", "mentions": ["252|4|gene|ncbi_gene@3845|KRAS", "181|4|gene|ncbi_gene@1956|EGFR", "186|5|variant|litvar@rs1057519861##&&&litvar@#1956#|C797S", "237|4|gene|ncbi_gene@673|BRAF", "50|11|chemical|ncbi_mesh@C000596361|osimertinib", "160|8|species|ncbi_taxonomy@9606|patients", "337|4|gene|ncbi_gene@2064|HER2", "229|6|gene|ncbi_gene@5290|PIK3CA", "242|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "14|5|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|T790M", "134|3|gene|ncbi_gene@79811|MET", "257|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12D/C", "268|6|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146 T", "9|4|gene|ncbi_gene@1956|EGFR"], "text_hl": "Acquired EGFR T790M mutation was not found in the osimertinib arm, and the most common acquired resistance mechanisms were off-target MET amplification (15% of patients), on-target EGFR C797S mutation (on-target, 7%), downstream PIK3CA, BRAF V600E and KRAS G12D/C and A146 T mutations (7%, 3% and 3%, respectively) as well as off-target HER2 amplification (2%)."}], "citations": {"NLM": "Abdayem P, Planchard D. Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer. Eur Respir Rev. PMID: 34289984", "BibTeX": "@article{34289984, title={Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer.}, author={Abdayem P and Planchard D}, journal={Eur Respir Rev}}"}, "is_sup_mat_match": false}, {"pmid": 31614493, "pmcid": "PMC6826908", "title": "Human Colorectal Cancer from the Perspective of Mouse Models.", "journal": "Genes (Basel)", "authors": ["Stastna M", "Janeckova L", "Hrckulak D", "Kriz V", "Korinek V"], "date": "2019-10-11T00:00:00Z", "year": 2019, "snippets": [{"_id": "31614493@59526", "snip_text": "Most recently, a novel KrasA146T allele that mimics less frequent mutation in the Kras guanine nucleotide-binding domain found in human CRC was established and expressed after Fabp1cre-mediated recombination in the colon of wt and Apc2lox14/+ mice.", "section": "other", "mentions": ["136|3|disease|ncbi_mesh@D015179|CRC", "243|4|species|ncbi_taxonomy@10090|mice", "130|5|species|ncbi_taxonomy@9606|human", "23|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KrasA146T", "82|4|gene|ncbi_gene@16653|Kras"], "text_hl": "Most recently, a novel KrasA146T allele that mimics less frequent mutation in the Kras guanine nucleotide-binding domain found in human CRC was established and expressed after Fabp1cre-mediated recombination in the colon of wt and Apc2lox14/+ mice."}], "citations": {"NLM": "Stastna M, Janeckova L, Hrckulak D, Kriz V, Korinek V. Human Colorectal Cancer from the Perspective of Mouse Models. Genes (Basel). PMID: 31614493", "BibTeX": "@article{31614493, title={Human Colorectal Cancer from the Perspective of Mouse Models.}, author={Stastna M and Janeckova L and Hrckulak D and Kriz V and Korinek V}, journal={Genes (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 31390567, "pmcid": "PMC6709685", "title": "Isoform-Specific Destabilization of the Active Site Reveals a Molecular Mechanism of Intrinsic Activation of KRas G13D", "journal": "Cell Rep", "authors": ["Johnson CW", "Lin YJ", "Reid D", "Parker J", "Pavlopoulos S", "Dischinger P", "Graveel C", "Aguirre AJ", "Steensma M", "Haigis KM", "Mattos C"], "date": "2019-08-06T00:00:00Z", "year": 2019, "snippets": [{"_id": "31390567@2603", "snip_text": "Increase in the levels of Ras-GTP can occur by the impairment of intrinsic and GTPase-activating protein (GAP)-catalyzed GTP hydrolysis (e.g.  G12V, Q61L) or by increased intrinsic and guanine nucleotide exchange factor (GEF)-catalyzed nucleotide exchange activity (e.g.  G13D, A146T).", "section": "introduction", "mentions": ["272|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "236|10|chemical|ncbi_mesh@D009711|nucleotide", "278|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "143|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "221|3|gene|ncbi_gene@9181|GEF", "30|3|chemical|ncbi_mesh@D006160|GTP", "121|3|chemical|ncbi_mesh@D006160|GTP", "149|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L"], "text_hl": "Increase in the levels of Ras-GTP can occur by the impairment of intrinsic and GTPase-activating protein (GAP)-catalyzed GTP hydrolysis (e.g.  G12V, Q61L) or by increased intrinsic and guanine nucleotide exchange factor (GEF)-catalyzed nucleotide exchange activity (e.g.  G13D, <m>A146T</m>)."}], "citations": {"NLM": "Johnson CW, Lin YJ, Reid D, Parker J, Pavlopoulos S, Dischinger P, Graveel C, Aguirre AJ, Steensma M, Haigis KM, Mattos C. Isoform-Specific Destabilization of the Active Site Reveals a Molecular Mechanism of Intrinsic Activation of KRas G13D Cell Rep. PMID: 31390567", "BibTeX": "@article{31390567, title={Isoform-Specific Destabilization of the Active Site Reveals a Molecular Mechanism of Intrinsic Activation of KRas G13D}, author={Johnson CW and Lin YJ and Reid D and Parker J and Pavlopoulos S and Dischinger P and Graveel C and Aguirre AJ and Steensma M and Haigis KM and Mattos C}, journal={Cell Rep}}"}, "is_sup_mat_match": false}, {"pmid": 36284306, "pmcid": "PMC9597994", "title": "Drugging KRAS: current perspectives and state-of-art review.", "journal": "J Hematol Oncol", "authors": ["Parikh K", "Banna G", "Liu SV", "Friedlaender A", "Desai A", "Subbiah V", "Addeo A"], "date": "2022-10-25T00:00:00Z", "year": 2022, "snippets": [{"_id": "36284306@15984", "snip_text": "Notably, mutations in codons 117 (K117N/R) and 146 (A146T/V) are seen exclusively in colon cancers.", "section": "other", "mentions": ["85|13|disease|ncbi_mesh@D015179|colon cancers", "34|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "52|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Notably, mutations in codons 117 (K117N/R) and 146 (<m>A146T</m>/V) are seen exclusively in colon cancers."}], "citations": {"NLM": "Parikh K, Banna G, Liu SV, Friedlaender A, Desai A, Subbiah V, Addeo A. Drugging KRAS: current perspectives and state-of-art review. J Hematol Oncol. PMID: 36284306", "BibTeX": "@article{36284306, title={Drugging KRAS: current perspectives and state-of-art review.}, author={Parikh K and Banna G and Liu SV and Friedlaender A and Desai A and Subbiah V and Addeo A}, journal={J Hematol Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 35922812, "pmcid": "PMC9351107", "title": "Targeting KRAS mutant cancers: from druggable therapy to drug resistance.", "journal": "Mol Cancer", "authors": ["Zhu C", "Guan X", "Zhang X", "Luan X", "Song Z", "Cheng X", "Zhang W", "Qin JJ"], "date": "2022-08-04T00:00:00Z", "year": 2022, "snippets": [{"_id": "35922812@32325", "snip_text": "KRAS mutations, including G13D, A59S, K117N, and A146P, that are outside the drug-binding pocket and correlated with enhanced nucleotide exchange, are associated with milder drug resistance than G12R and Y96C mutations.", "section": "introduction", "mentions": ["204|4|variant|litvar@rs1352124464##&&&litvar@#9212#|Y96C", "49|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "38|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "26|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "0|4|gene|ncbi_gene@16653|KRAS", "32|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA354836#rs121913528##|A59S", "195|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R"], "text_hl": "KRAS mutations, including G13D, A59S, K117N, and A146P, that are outside the drug-binding pocket and correlated with enhanced nucleotide exchange, are associated with milder drug resistance than G12R and Y96C mutations."}], "citations": {"NLM": "Zhu C, Guan X, Zhang X, Luan X, Song Z, Cheng X, Zhang W, Qin JJ. Targeting KRAS mutant cancers: from druggable therapy to drug resistance. Mol Cancer. PMID: 35922812", "BibTeX": "@article{35922812, title={Targeting KRAS mutant cancers: from druggable therapy to drug resistance.}, author={Zhu C and Guan X and Zhang X and Luan X and Song Z and Cheng X and Zhang W and Qin JJ}, journal={Mol Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 34558640, "pmcid": "PMC8562388", "title": "Mechanisms and management of 3rd-generation EGFR-TKI resistance in advanced non-small cell lung cancer (Review).", "journal": "Int J Oncol", "authors": ["He J", "Huang Z", "Han L", "Gong Y", "Xie C"], "date": "2021-11-01T00:00:00Z", "year": 2021, "snippets": [{"_id": "34558640@32311", "snip_text": "KRAS mutations in the FLAURA study included A146T (1%), G12C (1%) and G12D (1%), and the incidence of the BRAF V600E mutation was 3% (3/91).", "section": "other", "mentions": ["106|4|gene|ncbi_gene@673|BRAF", "44|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "0|4|gene|ncbi_gene@3845|KRAS", "70|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "22|6|gene|ncbi_gene@6790|FLAURA", "111|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "56|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C"], "text_hl": "KRAS mutations in the FLAURA study included <m>A146T</m> (1%), G12C (1%) and G12D (1%), and the incidence of the BRAF V600E mutation was 3% (3/91)."}], "citations": {"NLM": "He J, Huang Z, Han L, Gong Y, Xie C. Mechanisms and management of 3rd-generation EGFR-TKI resistance in advanced non-small cell lung cancer (Review). Int J Oncol. PMID: 34558640", "BibTeX": "@article{34558640, title={Mechanisms and management of 3rd-generation EGFR-TKI resistance in advanced non-small cell lung cancer (Review).}, author={He J and Huang Z and Han L and Gong Y and Xie C}, journal={Int J Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 24800946, "pmcid": "PMC4037834", "title": "Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer.", "journal": "Br J Cancer", "authors": ["Takahashi N", "Yamada Y", "Furuta K", "Honma Y", "Iwasa S", "Takashima A", "Kato K", "Hamaguchi T", "Shimada Y"], "date": "2014-05-27T00:00:00Z", "year": 2014, "snippets": [{"_id": "24800946@35561", "snip_text": "  Pretreatment HGF level Pretreatment EREG level     High Low High Low   Number of patients 52 51 51 52   Pretreatment serum concentration (pg ml-1)   Median 1672.5 1154.8 1662.5 1175   Range 1361.8-3319.3 703.7-1337.1 1497.2-3731.5 562.3-1485.2   Serum concentration at PD (%)   Median 1990.2 1166 2188.4 1274.9   Range 1540.4-3391.1 786.2-1532.4 1725.8-3947.9 582.9-1710.5   Change of serum levels after treatment   Elevation (%) 25 (48.1) 35 (68.6) 28 (54.9) 31 (59.6)   No elevation (%) 27 (51.2) 16 (31.4) 22 (43.1) 21 (40.4)   Impossible to analyse (%) 0 0 1 (2.0) 0   Genomic mutations: total (%) 7 (13.4) 13 (25.5) 9 (17.6) 11 (21.1)   KRAS codon 61 (Q61H; N=2) 0 2 (4.0) 1 (2.0) 1 (1.9)   KRAS codon 146 (A146T; N=4, A146V; N=1) 1 (1.9) 4 (8.0) 1 (2.0) 4 (7.7)   BRAF codon 600 (V600E; N=2) 1 (1.9) 1 (2.0) 1 (2.0) 1 (1.9)   PIK3CA exon 9 (E545K; N=3, E545A; N=1) 1 (1.9) 3 (6.0) 2 (4.0) 2 (3.8)   PIK3CA exon 20 0 0 0 0   NRAS codon 12/13 (G13D: N=2) 1 (1.9) 1 (2.0) 1 (2.0) 1 (2.0)   NRAS codon 61 (Q61L; N=3, Q61E; N=1, Q61K; N=1) 3 (5.7) 2 (4.0) 3 (6.0) 2 (3.8)   ", "section": "table", "mentions": ["834|6|gene|ncbi_gene@5290|PIK3CA", "659|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "861|5|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123342#rs121913274##|E545A", "698|4|gene|ncbi_gene@3845|KRAS", "714|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "995|4|gene|ncbi_gene@4893|NRAS", "772|4|gene|ncbi_gene@673|BRAF", "644|4|gene|ncbi_gene@3845|KRAS", "83|8|species|ncbi_taxonomy@9606|patients", "726|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "38|4|gene|ncbi_gene@2069|EREG", "907|6|gene|ncbi_gene@5290|PIK3CA", "932|4|gene|ncbi_gene@4893|NRAS", "788|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1021|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA16602362#rs121913254##|Q61E", "950|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1032|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "1010|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "849|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "15|3|gene|ncbi_gene@3082|HGF"], "figure_id": "tbl2", "text_hl": "  Pretreatment HGF level Pretreatment EREG level     High Low High Low   Number of patients 52 51 51 52   Pretreatment serum concentration (pg ml-1)   Median 1672.5 1154.8 1662.5 1175   Range 1361.8-3319.3 703.7-1337.1 1497.2-3731.5 562.3-1485.2   Serum concentration at PD (%)   Median 1990.2 1166 2188.4 1274.9   Range 1540.4-3391.1 786.2-1532.4 1725.8-3947.9 582.9-1710.5   Change of serum levels after treatment   Elevation (%) 25 (48.1) 35 (68.6) 28 (54.9) 31 (59.6)   No elevation (%) 27 (51.2) 16 (31.4) 22 (43.1) 21 (40.4)   Impossible to analyse (%) 0 0 1 (2.0) 0   Genomic mutations: total (%) 7 (13.4) 13 (25.5) 9 (17.6) 11 (21.1)   KRAS codon 61 (Q61H; N=2) 0 2 (4.0) 1 (2.0) 1 (1.9)   KRAS codon 146 (<m>A146T</m>; N=4, A146V; N=1) 1 (1.9) 4 (8.0) 1 (2.0) 4 (7.7)   BRAF codon 600 (V600E; N=2) 1 (1.9) 1 (2.0) 1 (2.0) 1 (1.9)   PIK3CA exon 9 (E545K; N=3, E545A; N=1) 1 (1.9) 3 (6.0) 2 (4.0) 2 (3.8)   PIK3CA exon 20 0 0 0 0   NRAS codon 12/13 (G13D: N=2) 1 (1.9) 1 (2.0) 1 (2.0) 1 (2.0)   NRAS codon 61 (Q61L; N=3, Q61E; N=1, Q61K; N=1) 3 (5.7) 2 (4.0) 3 (6.0) 2 (3.8)   "}], "citations": {"NLM": "Takahashi N, Yamada Y, Furuta K, Honma Y, Iwasa S, Takashima A, Kato K, Hamaguchi T, Shimada Y. Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer. Br J Cancer. PMID: 24800946", "BibTeX": "@article{24800946, title={Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer.}, author={Takahashi N and Yamada Y and Furuta K and Honma Y and Iwasa S and Takashima A and Kato K and Hamaguchi T and Shimada Y}, journal={Br J Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 28708103, "pmcid": "PMC5536012", "title": "Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment.", "journal": "Int J Mol Sci", "authors": ["Bignucolo A", "De Mattia E", "Cecchin E", "Roncato R", "Toffoli G"], "date": "2017-07-14T00:00:00Z", "year": 2017, "snippets": [{"_id": "28708103@72722", "section": "table", "mentions": ["7366|8|disease||NRAS n.a", "3396|11|variant|litvar@rs121913274##&&&litvar@#5290#|rs121913274", "4009|7|species|ncbi_taxonomy@9606|patient", "1060|11|variant|litvar@rs113488022##&&&litvar@#673#|rs113488022", "6823|4|gene|ncbi_gene@3845|KRAS", "4644|11|variant|litvar@rs113488022##&&&litvar@#673#|rs113488022", "3297|6|gene|ncbi_gene@5290|PIK3CA", "5852|11|chemical|ncbi_mesh@C543333|Ramucirumab", "5387|7|chemical||FOLFIRI", "3341|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "3548|11|variant|litvar@rs121913281##&&&litvar@#5290#&&&litvar@CA130471#rs121913281##|c.3139C > T", "2041|4|disease|ncbi_mesh@D015179|mCRC", "6856|4|gene|ncbi_gene@3845|KRAS", "3489|11|cellline||NM_006218.3", "7920|3|disease||PAN", "5919|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "5760|4|gene|ncbi_gene@3845|KRAS", "2810|11|chemical|ncbi_mesh@C559147|regorafenib", "9859|4|gene|ncbi_gene@5728|PTEN", "3514|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|H1047L", "7942|5|chemical|ncbi_mesh@D000077146|CPT11", "1395|4|gene|ncbi_gene@3845|KRAS", "4220|8|chemical||mFOLFOX6", "10655|8|species|ncbi_taxonomy@9606|patients", "2961|4|gene|ncbi_gene@3845|KRAS", "9895|6|gene|ncbi_gene@5290|PIK3CA", "3917|11|variant|litvar@rs80338758##&&&litvar@#9968#&&&litvar@CA324786#rs80338758##|c.2881C > T", "6032|4|gene|ncbi_gene@3845|KRAS", "3053|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "10042|6|gene|ncbi_gene@5290|PIK3CA", "6037|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "6335|4|gene|ncbi_gene@3845|KRAS", "1983|6|chemical|ncbi_mesh@C410216|FOLFOX", "7838|11|variant|litvar@rs113488022##&&&litvar@#673#|rs113488022", "3190|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "2332|9|chemical||FOLFOXIRI", "2643|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1627|16|disease|ncbi_mesh@D009362|liver metastasis", "3061|11|variant|litvar@rs122193530##|rs122193530", "3433|5|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123336#rs121913274##|E545G", "6158|4|gene|ncbi_gene@3845|KRAS", "4736|8|disease||NRAS n.a", "10401|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "10327|11|cellline||NM_006218.3", "8048|3|chemical||BSC", "1299|8|species|ncbi_taxonomy@9606|patients", "9818|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "10459|7|chemical||FOLFIRI", "4714|11|variant|litvar@rs121913338##&&&litvar@#673#&&&litvar@CA123657#rs121913338##|c.1781A > G", "6003|4|disease|ncbi_mesh@D015179|mCRC", "6191|4|gene|ncbi_gene@3845|KRAS", "848|4|gene|ncbi_gene@673|BRAF", "1804|11|variant|litvar@rs113488022##&&&litvar@#673#|rs113488022", "3244|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "5889|4|gene|ncbi_gene@3845|KRAS", "6619|11|variant|litvar@rs112445441##&&&litvar@#3845#|rs112445441", "5457|4|gene|ncbi_gene@3845|KRAS", "5755|4|disease|ncbi_mesh@D015179|mCRC", "638|4|gene|ncbi_gene@673|BRAF", "10353|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|H1047L", "9805|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T > A", "3042|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > C", "7801|3|disease|ncbi_mesh@D015179|CRC", "7809|8|disease||NRAS n.a", "6959|4|disease|ncbi_mesh@D015179|mCRC", "373|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "10013|8|species|ncbi_taxonomy@9606|patients", "9902|11|variant|litvar@rs121913279##&&&litvar@#5290#|rs121913279", "465|4|gene|ncbi_gene@3845|KRAS", "3252|11|variant|litvar@rs121913527##&&&litvar@#3845#|rs121913527", "3127|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "556|7|chemical||FOLFIRI", "1354|6|disease|ncbi_mesh@D009369|tumors", "10540|4|gene|ncbi_gene@3845|KRAS", "10363|11|variant|litvar@rs104886003##&&&litvar@#5290#|rs104886003", "2750|3|chemical||BSC", "7949|11|chemical|ncbi_mesh@D000077150|Oxaliplatin", "2606|11|variant|litvar@rs113488022##&&&litvar@#673#|rs113488022", "5936|3|disease|ncbi_mesh@D019294|CTX", "9927|11|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A > G", "3987|4|disease|ncbi_mesh@D015179|mCRC", "150|4|gene|ncbi_gene@3845|KRAS", "3374|11|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G > A", "2244|4|chemical|ncbi_mesh@D005472|5-FU", "8679|4|disease|ncbi_mesh@D015179|mCRC", "6778|4|gene|ncbi_gene@3845|KRAS", "3466|11|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A > G", "8684|4|gene|ncbi_gene@3845|KRAS", "9776|4|gene|ncbi_gene@673|BRAF", "716|4|gene|ncbi_gene@673|BRAF", "1084|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T > A", "2443|8|species|ncbi_taxonomy@9606|patients", "6568|4|gene|ncbi_gene@673|BRAF", "7605|4|gene|ncbi_gene@3845|KRAS", "1106|4|gene|ncbi_gene@3845|KRAS", "8923|4|gene|ncbi_gene@4893|NRAS", "5574|8|species|ncbi_taxonomy@9606|patients", "3536|11|cellline||NM_006218.3", "10640|4|gene|ncbi_gene@3845|KRAS", "5308|11|chemical|ncbi_mesh@C543333|Ramucirumab", "1316|6|disease|ncbi_mesh@D009369|tumors", "136|11|chemical|ncbi_mesh@D000068258|Bevacizumab", "6652|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "3894|10|variant|litvar@rs80338758##&&&litvar@#9968#|rs80338758", "3011|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "6479|4|gene|ncbi_gene@673|BRAF", "4681|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "8247|8|species|ncbi_taxonomy@9606|patients", "2706|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "4208|8|chemical||mFOLFOX6", "2712|11|chemical|ncbi_mesh@C559147|Regorafenib", "1748|8|disease||NRAS n.a", "249|6|chemical|ncbi_mesh@D000069287|XELODA", "3166|11|variant|litvar@rs112445441##&&&litvar@#3845#|rs112445441", "4267|4|disease|ncbi_mesh@D015179|mCRC", "228|4|chemical||FUFA", "10340|11|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|c.3140A > T", "6231|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1993|5|chemical|ncbi_mesh@C519688|XELOX", "4396|4|gene|ncbi_gene@3845|KRAS", "10005|4|gene|ncbi_gene@3845|KRAS", "1055|4|gene|ncbi_gene@673|BRAF", "234|5|chemical|ncbi_mesh@C519688|XELOX", "3890|3|gene|ncbi_gene@3791|KDR", "4639|4|gene|ncbi_gene@673|BRAF", "7472|4|gene|ncbi_gene@3845|KRAS", "2929|11|chemical|ncbi_mesh@C559147|Regorafenib", "4026|11|variant|litvar@rs80338758##&&&litvar@#9968#&&&litvar@CA324786#rs80338758##|c.2881C > T", "4544|4|gene|ncbi_gene@4893|NRAS", "3147|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G > C", "1574|4|gene|ncbi_gene@673|BRAF", "9206|6|gene|ncbi_gene@5290|PIK3CA", "5039|6|gene|ncbi_gene@5295|PIK3R1", "6254|5|chemical|ncbi_mesh@D000077146|CPT11", "4477|8|chemical||mFOLFOX6", "3561|6|variant|litvar@rs121913281##&&&litvar@#5290#&&&litvar@CA130471#rs121913281##|H1047Y", "6330|4|disease|ncbi_mesh@D015179|mCRC", "1179|6|chemical|ncbi_mesh@C519688|CapeOX", "257|6|chemical|ncbi_mesh@D000077146|CAMPTO", "364|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "5673|3|gene|ncbi_gene@3791|KDR", "7216|4|gene|ncbi_gene@3845|KRAS", "6671|4|disease|ncbi_mesh@D015179|mCRC", "10702|8|species|ncbi_taxonomy@9606|patients", "2298|5|chemical|ncbi_mesh@C519688|XELOX", "9827|6|gene|ncbi_gene@5290|PIK3CA", "2324|7|chemical||FOLFIRI", "7973|3|chemical||BSC", "10480|7|chemical||FOLFIRI", "6175|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "9953|4|gene|ncbi_gene@1956|EGFR", "7601|3|disease|ncbi_mesh@D015179|CRC", "5695|5|variant|litvar@#3791#p.T771R&&&litvar@#3791#|T771R", "3022|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "3085|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G > T", "2011|6|chemical|ncbi_mesh@C410216|FOLFOX", "6220|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "10222|6|gene|ncbi_gene@5290|PIK3CA", "2147|8|disease||NRAS n.a", "5322|4|gene|ncbi_gene@3845|KRAS", "8472|8|disease||NRAS n.a", "4369|8|species|ncbi_taxonomy@9606|patients", "7833|4|gene|ncbi_gene@673|BRAF", "5030|5|variant|litvar@#5295#p.R345Q&&&litvar@#5295#|R345Q", "2652|11|chemical|ncbi_mesh@C559147|Regorafenib", "6511|4|gene|ncbi_gene@3845|KRAS", "1522|4|gene|ncbi_gene@3845|KRAS", "8568|4|gene|ncbi_gene@3845|KRAS", "10436|4|gene|ncbi_gene@3845|KRAS", "1841|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "6301|4|disease|ncbi_mesh@D015179|mCRC", "3328|11|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|c.1624G > A", "3420|11|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123336#rs121913274##|c.1634A > G", "9487|4|gene|ncbi_gene@5728|PTEN", "3672|4|disease|ncbi_mesh@D015179|mCRC", "10806|8|disease||NRAS n.a", "10388|11|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G > A", "3288|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "267|11|chemical|ncbi_mesh@D000077150|OXALIPLATIN", "2021|5|chemical|ncbi_mesh@C519688|XELOX", "7936|4|chemical|ncbi_mesh@D005472|5-FU", "1799|4|gene|ncbi_gene@673|BRAF", "5426|4|disease|ncbi_mesh@D015179|mCRC", "3362|11|cellline||NM_006218.3", "6796|8|species|ncbi_taxonomy@9606|patients", "2379|4|disease|ncbi_mesh@D015179|mCRC", "3232|10|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA180922#rs17851045##|c.183A > C", "10535|4|disease|ncbi_mesh@D015179|mCRC", "5362|7|chemical||FOLFIRI", "359|4|gene|ncbi_gene@3845|KRAS", "2970|6|gene|ncbi_gene@5290|PIK3CA", "7774|8|species|ncbi_taxonomy@9606|patients", "3479|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "2291|6|chemical|ncbi_mesh@C410216|FOLFOX", "3096|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "1168|7|chemical||FOLFOX6", "6544|8|disease||NRAS n.a", "8360|4|gene|ncbi_gene@3845|KRAS", "3524|11|variant|litvar@rs121913281##&&&litvar@#5290#|rs121913281", "7593|3|chemical||BSC", "8058|4|disease|ncbi_mesh@D015179|mCRC", "6909|3|chemical||BSC", "5953|5|chemical|ncbi_mesh@D000077146|CPT11", "4727|5|variant|litvar@rs121913338##&&&litvar@#673#&&&litvar@CA123657#rs121913338##|D594G", "219|7|chemical||FOLFIRI", "2671|11|variant|litvar@rs121913529##&&&litvar@#3845#|rs121913529", "4022|3|gene|ncbi_gene@3791|KDR", "2601|4|gene|ncbi_gene@673|BRAF", "2630|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T > A", "1219|4|disease|ncbi_mesh@D015179|mCRC", "9781|11|variant|litvar@rs113488022##&&&litvar@#673#|rs113488022", "1567|6|gene|ncbi_gene@5290|PIK3CA", "2312|10|chemical|ncbi_mesh@D000077146|irinotecan", "9073|4|gene|ncbi_gene@673|BRAF", "766|4|gene|ncbi_gene@673|BRAF", "5019|6|variant|litvar@#5295#p.C1546G&&&litvar@#5295#|C1546G", "6488|6|gene|ncbi_gene@5290|PIK3CA", "8604|3|disease||PAN", "6467|4|gene|ncbi_gene@3845|KRAS", "2666|4|gene|ncbi_gene@3845|KRAS", "241|6|chemical|ncbi_mesh@C520768|XELIRI", "3158|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "3930|5|variant|litvar@rs80338758##&&&litvar@#9968#&&&litvar@CA324786#rs80338758##|R961W", "307|4|disease|ncbi_mesh@D015179|mCRC", "4140|4|gene|ncbi_gene@3845|KRAS", "6614|4|gene|ncbi_gene@3845|KRAS", "9420|5|disease|ncbi_mesh@D009369|tumor", "6237|3|disease|ncbi_mesh@D019294|CTX", "7629|4|gene|ncbi_gene@1956|EGFR", "3209|10|variant|litvar@rs17851045##&&&litvar@#3845#|rs17851045", "160|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12A/V", "2457|4|gene|ncbi_gene@3845|KRAS", "2080|4|gene|ncbi_gene@4893|NRAS", "211|6|chemical|ncbi_mesh@C410216|FOLFOX", "3597|11|chemical|ncbi_mesh@C559147|Regorafenib", "6842|11|chemical|ncbi_mesh@D000077544|Panitumumab", "3501|11|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|c.3140A > T", "3350|11|variant|litvar@rs104886003##&&&litvar@#5290#|rs104886003", "3442|11|variant|litvar@rs121913279##&&&litvar@#5290#|rs121913279", "4690|11|variant|litvar@rs121913338##&&&litvar@#673#|rs121913338", "6588|6|gene|ncbi_gene@5290|PIK3CA", "1666|5|disease|ncbi_mesh@D009369|tumor", "3387|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "8279|4|gene|ncbi_gene@4893|NRAS", "10000|4|disease|ncbi_mesh@D015179|mCRC", "6196|11|variant|litvar@rs112445441##&&&litvar@#3845#|rs112445441", "5222|4|gene|ncbi_gene@1956|EGFR", "5894|11|variant|litvar@rs112445441##&&&litvar@#3845#|rs112445441", "3276|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "4498|8|chemical||mFOLFOX6", "4538|4|gene|ncbi_gene@3845|KRAS", "4668|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T > A", "7884|4|gene|ncbi_gene@3845|KRAS", "7529|3|chemical||BSC", "6783|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "8212|8|species|ncbi_taxonomy@9606|patients", "983|8|disease||NRAS n.a", "7788|4|gene|ncbi_gene@673|BRAF", "8257|4|gene|ncbi_gene@3845|KRAS", "5720|5|chemical|ncbi_mesh@D000077146|CPT11", "9940|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "2800|4|disease|ncbi_mesh@D015179|mCRC", "2278|11|chemical|ncbi_mesh@D000077150|oxaliplatin", "6964|4|gene|ncbi_gene@3845|KRAS", "3316|11|cellline||NM_006218.3", "6170|4|gene|ncbi_gene@3845|KRAS", "3116|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G > A", "3408|11|cellline||NM_006218.3", "6473|4|gene|ncbi_gene@4893|NRAS", "2072|4|gene|ncbi_gene@3845|KRAS", "6643|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "3937|11|chemical|ncbi_mesh@C559147|Regorafenib", "2219|4|gene|ncbi_gene@3845|KRAS", "4826|4|gene|ncbi_gene@5728|PTEN", "7862|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T > A", "6506|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "63|8|species|ncbi_taxonomy@9606|Patients", "8774|4|gene|ncbi_gene@3845|KRAS", "595|4|disease|ncbi_mesh@D015179|mCRC", "5561|4|gene|ncbi_gene@3845|KRAS", "1097|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "5682|11|variant|litvar@#3791#c.2312C>G&&&litvar@#3791#|c.2312C > G", "3726|4|gene|ncbi_gene@3845|KRAS", "9427|4|gene|ncbi_gene@5728|PTEN", "1480|6|disease|ncbi_mesh@D009369|tumors", "6658|3|disease|ncbi_mesh@D019294|CTX", "2729|3|chemical||BSC", "4553|4|gene|ncbi_gene@673|BRAF", "6901|3|chemical||BSC", "4095|11|chemical|ncbi_mesh@C559147|Regorafenib", "1913|4|gene|ncbi_gene@3845|KRAS", "1447|8|species|ncbi_taxonomy@9606|patients", "1828|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T > A", "4914|6|gene|ncbi_gene@5290|PIK3CA", "535|9|chemical||FOLFOXIRI", "10375|11|cellline||NM_006218.3", "5930|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1189|7|chemical||FOLFIRI", "3571|4|gene|ncbi_gene@3845|KRAS", "6340|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "5007|6|gene|ncbi_gene@5296|PIK3R2", "8075|4|gene|ncbi_gene@1956|EGFR", "5465|8|species|ncbi_taxonomy@9606|patients", "7075|4|gene|ncbi_gene@3845|KRAS", "3201|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "5782|11|variant|litvar@#3791#c.2312C>G&&&litvar@#3791#|c.2312C > G", "1850|6|gene|ncbi_gene@5290|PIK3CA", "7875|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "3304|11|variant|litvar@rs121913273##&&&litvar@#5290#|rs121913273", "2695|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "9670|8|disease||NRAS n.a"], "figure_id": "ijms-18-01522-t001", "snip_text": "Gene Rs Code Nucleotide Change and/or Location Therapy Setting Patients Population Ethnicity Clinical End-Points Main Effect Citation   Bevacizumab   KRAS n.a. G12A/V (exon 2) BV-based therapy (combination with FOLFOX, FOLFIRI, FUFA, XELOX, XELIRI, XELODA, CAMPTO or OXALIPLATIN) Fisrt-line and greater 404 mCRC Caucasian PFS OS At the multivariable analysis KRAS G12V and G12A mutations showed a lower PSF (HR = 2.18, p < 0.001) and OS (HR = 2.58, p < 0.001).     KRAS n.a. codons 12, 13 (exon 2) 59, 61 (exon 3) 117 and 146 (exon 4) FOLFOXIRI plus BV vs FOLFIRI plus BV (TRIBE) First-line 508 mCRC Caucasian  OS PFS RAS (HR = 1.49) and BRAF mutation (HR = 2.79) subgroups have shorter median OS compared with RAS/ BRAF wt subgroup (p < 0.0001) RAS (HR = 1.23) and BRAF (HR = 2.27) mutation subgroups have shorter median PFS compared with RAS and BRAF wt subgroup (p = 0.002) Comparing the two regimes, treatment effect was not significantly different across molecular subgroups    NRAS n.a. codons 12, 13 (exon 2) 59, 61 (exon 3) 117 and 146 (exon 4)   BRAF rs113488022 NM_004333.4:c.1799T > A (V600E)   KRAS n.a. codons 12, 13 (exon 2) 61 (exon 3) and 146 (exon 4) FOLFOX6 or CapeOX or FOLFIRI plus BV First-line 90 mCRC Japanese ORR PFS Even if not statistically significant, ORR was higher for patients with wt tumors (64.3%) compared to those with tumors that were only wt with respect to KRAS exon 2 (54.8%); the differences in ORR between patients with wt and mutant-type tumors were greater when considering only KRAS exon 2 mutations (6.8%) rather than RAS/PIK3CA/BRAF mutations (18.4%). At the multivariate analysis liver metastasis, unresectable primary tumor, RAS and BRAF tumor mutations resulted predictive for early progression.    NRAS n.a. codons 12, 13 (exon 2) and 61 (exon 3)   BRAF rs113488022 NM_004333.4:c.1799T > A (V600E)   PIK3CA n.a. codons 542, 545, 546 (exon 9) and 1047 (exon 20)   KRAS n.a. codons 12, 13 (exon 2) 59, 61 (exon 3) 117 and 146 (exon 4) FOLFOX or XELOX plus BV vs. FOLFOX or XELOX First-line 93 mCRC Caucasian ORR PFS OS RAS (KRAS or NRAS) mutations are not a prognostic marker for RR, PFS and OS     NRAS n.a. codons 12, 13 (exon 2) 59, 61 (exon 3) 117 and 146 (exon 4)   KRAS n.a. codons 12, 13  5-FU alone or in combination with oxaliplatin (FOLFOX/XELOX) and/or irinotecan (FOLFIRI/FOLFOXIRI) +- BV Preoperative chemotherapy 167 mCRC underwent pulmonary metastasectomy  Caucasian LRRFS OS For patients with KRAS exon 2 codon 12 mutations , perioperative BV was associated with a significant improvement in both LRRFS (p < 0.001) and OS (p < 0.001)    BRAF rs113488022 NM_004333.4:c.1799T > A (V600E)   Regorafenib   KRAS rs121913529 NM_004985.4:c.35G > A (G12D) Regorafenib plus BSC vs. placebo plus BSC (phase III CORRECT trial) Salvage-line CT 760 mCRC (505 regorafenib arm vs. 253 placebo arm) Caucasian, Asian, North American, Australian OS PFS PFS and OS were higher in the Regorafenib arm irrespective of KRAS and PIK3CA mutational status.    NM_004985.4:c.35G > T (G12V)   NM_004985.4:c.35G > C (G12A)   rs122193530 NM_004985.4:c.34G > T (G12C)   NM_004985.4:c.34G > A (G12S)   NM_004985.4:c.34G > C (G12R)   rs112445441 NM_004985.4:c.38G > A (G13D)   rs17851045 NM_004985.4:c.183A > C (Q61H)   rs121913527 NM_004985.4:c.436G > A (A146T)   PIK3CA rs121913273 NM_006218.3:c.1624G > A (E542K)   rs104886003 NM_006218.3:c.1633G > A (E545K)   rs121913274 NM_006218.3:c.1634A > G (E545G)   rs121913279 NM_006218.3:c.3140A > G (H1047R)   NM_006218.3:c.3140A > T (H1047L)   rs121913281 NM_006218.3:c.3139C > T (H1047Y)   KRAS n.a. Exons 2,3 and 4 Regorafenib (REBECCA observational trial) French compassionate program 654 mCRC Mostly caucasian OS In the multivariate analysis KRAS mutations were associated with shorter OS (HR:1.25; p = 0.016) in an independently manner from PS, number of metastatic sites and time of initial diagnosis    KDR rs80338758 NM_005120.2:c.2881C > T (R961W) Regorafenib monotherapy Second-line 1 case report mCRC  American RR The patient with KDR c.2881C > T mutation experienced excellent tolerance and response to Regorafenib administration.    Aflibercept   KRAS n.a. 9 mutation in codons 12, 13 (Exon 2) Ziv-aflibercept plus mFOLFOX6 vs mFOLFOX6 (phase II AFFIRM trial) First-line 93 mCRC (47 treated with Aflibercept) Asian/oriental, Black, Caucasian/white PFS (primary endpoint) Only patients with mutations in KRAS showed a not statistically significant trend to worse PFS when treated with mFOLFOX6 rather than mFOLFOX6 plus Aflibercept. Mutations in KRAS, NRAS and BRAF did not influenced PFS in both arms.     n.a. 6 mutation in codon 61 (Exon 3)    BRAF rs113488022 NM_004333.4:c.1799T > A (V600E)   rs121913338 NM_004333.4:c.1781A > G (D594G)   NRAS n.a. 12 mutations in codons 12,13 (exon 2)   n.a. 5 mutations in codon 61 (exon 3)   PTEN n.a. 2 deletions (codons 267,323)   n.a. 5 mutations (codons 85, 173, 233, 130)    PIK3CA n.a. 22 mutations (codons 345,38,420,539,542,545,546,88,901,1043,1047,1049,106,118)   PIK3R2 n.a. C1546G > A(R345Q)   PIK3R1 n.a. 17 mutations (codons 162,285,348,358,376,455,461,527,543,564,565,574,576,642,649,666,682) 5 insertions (codons 376,448,459,562-563,668-669) 2 deletions (codons 447,601)   EGFR n.a. 6 mutations (codons 289,858,719,790)2 deletions (codons 746-750, 746-750)   Ramucirumab   KRAS n.a. Codon 12,13 (Exon 2) RAM plus FOLFIRI vs. placebo plus FOLFIRI (RAISE trial) Second-line 1072 mCRC mostly White and Asian OS KRAS wt patients showed a trend to longer OS (HR = 0.82, p = 0.049) in RAM-arm compared to placebo arm; KRAS mutated patients showed a trend to longer OS (HR = 0.89, p = 0.263) in RAM-arm compared to placebo arm.    KDR n.a. c.2312C > G (T771R) RAM plus CTX plus CPT11 Second-line 1 case report of mCRC KRAS wt American n.a. c.2312C > G variant is probably an activating mutation in response to Ramucirumab treatment    Cetuximab   KRAS rs112445441 NM_004985.4: c.38G > A (G13D) CTX vs. CTX plus CPT11 (phase II trial) Second-line and greater 29 mCRC  Japanese PFS OS In the KRAS G13D mutant subgroup, PFS and OS were not statistically different between the two arms. CTX effectiveness was similar in KRAS wt and KRAS G13D mutated    KRAS rs112445441 NM_004985.4:c.38G > A (G13D) CTX vs. CTX plus CPT11 (phase II trial ICECREAM) Second-line 50 mCRC quadruple RAS wt and 50 mCRC KRAS G13D mutated  Australian PFS  Efficacy of CTX administered alone or in combinatorial regimens was similar in quadruple RAS wt (KRAS, NRAS, BRAF and PIK3CA wt) and in G13D KRAS mutated    n.a. Exons 3,4   NRAS n.a. Exons 2,3,4   BRAF n.a. Exon 15   PIK3CA n.a. Exons 9,20    KRAS rs112445441 NM_004985.4:c.38G>A (G13D) CTX  n.a. 98 mCRC Japanese OS PFS At the multivariate analysis there was a trend to better PFS (HR = 0.29; p = 0.07) in KRAS G13D mutated patients compared to other KRAS mutations.    Panitumumab   KRAS n.a. codons 12 and 13 (exon 2) PAN plus BSC vs. BSC (Phase III trial) Second line and greater 377 mCRC KRAS exon 2 wt Asian Caucasian and other ethnicities  OS PFS OS was significantly longer in PAN arm in both wt KRAS exon 2 (HR = 0.73, p = 0.0096) subgroup and wt RAS subgroup (HR = 0.70, p = 0.0135). PFS was significantly longer in PAN arm in both wt KRAS exon 2 (HR = 0.51, p < 0.0001) and wt RAS subgroup (HR=0.46, p < 0.0001).    n.a. codons 59 and 61 (exon 3)   n.a. codons 117 and 146 (exon 4)   NRAS n.a. codons 12 and 13 (exon 2)   n.a. codons 59 and 61 (exon 3)   n.a. codons 117 and 146 (exon 4)   KRAS n.a. Exons 2,3,4 PAN or CTX plus CT PAN or CTX plus BSC (Meta-analysis of 10 studies)  6 first-line 2 second-line 2 BSC 463 CRC KRAS wt n.a. OS PFS ORR EGFR-Is combined with chemotherapy do not significantly increase OS (HR: 0.91 p = 0.63), PFS (HR: 0.88 p = 0.33) and ORR (RR = 1.31 p = 0.25) in patients with BRAF mutated CRC.    NRAS n.a. Exons 2,3,4   BRAF rs113488022 NM_004333.4:c.1799T > A (V600E)   KRAS n.a. codons 12 and 13 (exon 2) PAN or CTX plus 5-FU, CPT11, Oxaliplatin based CT or BSC (Meta-analysis of 9 studies ) 6 first-line 2 second-line 1 third-line (BSC) 5948 mCRC n.a. PFS OS EGFR-Is efficacy was found to be significantly superior in terms of PFS (HR=0.60, p < 0.001) and OS (HR = 0.72, p = 0.008) in all RAS wt patients compared with RAS mutated patients (KRAS exon 3 and 4 and NRAS exon 2,3 and 4) No difference in terms of both PFS and OS was found between KRAS exon 2 mutated and new RAS mutated subgroups.    codons 59 and 61 (exon 3)   codons 117 and 146 (exon 4)   NRAS n.a. codons 12 and 13 (exon 2)   codons 59 and 61 (exon 3)   codons 117 and 146 (exon 4)   KRAS n.a. codons 59 and 61 (exon 3) PAN or CTX plus CT (Meta-analysis: 22 studies) first-line and greater 2395 mCRC KRAS exon 2 wt Caucasian, American, Asian, African, Australian ORR PFS OS From 5 studies: KRAS exons 3 and 4 mutations were significantly correlated with worse ORR (OR = 0.26) and shorter PFS (HR = 2.19) and OS (HR = 1.78) From 3 studies: NRAS exons 2,3 and 4 mutations showed a trend towards poor ORR (OR = 0.23), and significant worse PFS (HR = 2.30) and OS (HR = 1.85) From 17 studies: BRAF mutations were correlated with significant worse ORR (OR = 0.29) and shorter PFS (HR = 2.95) and OS (HR = 2.52) From 6 studies: PIK3CA exons 9 and 20 mutations were significant predictors of poor ORR (OR = 0.39) and were significantly associated with shorter OS (HR = 1.43); only a trend for worse PFS was detected. From 5 studies of primary tumor: PTEN mutations showed non-significant effect on ORR whereas PTEN mutations and/or reduced expression were significantly correlated with lower ORR (OR = 0.41) and shorter PFS (PFS = 2.6) and OS (HR = 1.77)    n.a. codons 117 and 146 (exon 4)   NRAS n.a. codons 12 and 13 (exon 2)   n.a. codons 59 and 61 (exon 3)   n.a. codons 117 and 146 (exon 4)   BRAF rs113488022 NM_004333.4:c.1799T > A (V600E)   PIK3CA n.a. exons 1,2,9,10,20   PTEN n.a. exons 1,2,3,4,5,6,7,8,9   PIK3CA rs121913279 NM_006218.3: c.3140A > G (H1047R) anti-EGFR mAb (Meta-analysis: 11 studies)  n.a. 864 mCRC KRAS wt patients n.a. ORR PFS OS All PIK3CA mutations were associated with overall reduced ORR (OR = 0.42 , p = 0.003) and the result remained significant considering only exon 20 mutated subset (OR = 0.21, p = 0.04) PIK3CA mutations were associated with shorter PFS (HR = 1.54, p = 0.006) and OS (HR = 1.4 p = 0.036)     NM_006218.3: c.3140A > T (H1047L)   rs104886003 NM_006218.3: c.1633G > A (E545K)   n.a. codon 542 (exon 9)   KRAS n.a. exon 3 and 4 FOLFIRI plus PAN vs. FOLFIRI (phase III trial) NCT0039183 second-line  1186 mCRC KRAS wt exon 2 n.a. PFS OS ORR PFS was significantly longer in the PAN-arm with respect to both the KRAS exon 2 wt patients (HR = 0.73, p = 0.004) and all RAS wt patients (HR = 0.70, p = 0.007); in the same analysis there was a trend to longer OS in the PAN-arm     NRAS n.a. exon 2,3 and 4   ", "text_hl": "Gene Rs Code Nucleotide Change and/or Location Therapy Setting Patients Population Ethnicity Clinical End-Points Main Effect Citation   Bevacizumab   KRAS n.a. G12A/V (exon 2) BV-based therapy (combination with FOLFOX, FOLFIRI, FUFA, XELOX, XELIRI, XELODA, CAMPTO or OXALIPLATIN) Fisrt-line and greater 404 mCRC Caucasian PFS OS At the multivariable analysis KRAS G12V and G12A mutations showed a lower PSF (HR = 2.18, p < 0.001) and OS (HR = 2.58, p < 0.001).     KRAS n.a. codons 12, 13 (exon 2) 59, 61 (exon 3) 117 and 146 (exon 4) FOLFOXIRI plus BV vs FOLFIRI plus BV (TRIBE) First-line 508 mCRC Caucasian  OS PFS RAS (HR = 1.49) and BRAF mutation (HR = 2.79) subgroups have shorter median OS compared with RAS/ BRAF wt subgroup (p < 0.0001) RAS (HR = 1.23) and BRAF (HR = 2.27) mutation subgroups have shorter median PFS compared with RAS and BRAF wt subgroup (p = 0.002) Comparing the two regimes, treatment effect was not significantly different across molecular subgroups    NRAS n.a. codons 12, 13 (exon 2) 59, 61 (exon 3) 117 and 146 (exon 4)   BRAF rs113488022 NM_004333.4:c.1799T > A (V600E)   KRAS n.a. codons 12, 13 (exon 2) 61 (exon 3) and 146 (exon 4) FOLFOX6 or CapeOX or FOLFIRI plus BV First-line 90 mCRC Japanese ORR PFS Even if not statistically significant, ORR was higher for patients with wt tumors (64.3%) compared to those with tumors that were only wt with respect to KRAS exon 2 (54.8%); the differences in ORR between patients with wt and mutant-type tumors were greater when considering only KRAS exon 2 mutations (6.8%) rather than RAS/PIK3CA/BRAF mutations (18.4%). At the multivariate analysis liver metastasis, unresectable primary tumor, RAS and BRAF tumor mutations resulted predictive for early progression.    NRAS n.a. codons 12, 13 (exon 2) and 61 (exon 3)   BRAF rs113488022 NM_004333.4:c.1799T > A (V600E)   PIK3CA n.a. codons 542, 545, 546 (exon 9) and 1047 (exon 20)   KRAS n.a. codons 12, 13 (exon 2) 59, 61 (exon 3) 117 and 146 (exon 4) FOLFOX or XELOX plus BV vs. FOLFOX or XELOX First-line 93 mCRC Caucasian ORR PFS OS RAS (KRAS or NRAS) mutations are not a prognostic marker for RR, PFS and OS     NRAS n.a. codons 12, 13 (exon 2) 59, 61 (exon 3) 117 and 146 (exon 4)   KRAS n.a. codons 12, 13  5-FU alone or in combination with oxaliplatin (FOLFOX/XELOX) and/or irinotecan (FOLFIRI/FOLFOXIRI) +- BV Preoperative chemotherapy 167 mCRC underwent pulmonary metastasectomy  Caucasian LRRFS OS For patients with KRAS exon 2 codon 12 mutations , perioperative BV was associated with a significant improvement in both LRRFS (p < 0.001) and OS (p < 0.001)    BRAF rs113488022 NM_004333.4:c.1799T > A (V600E)   Regorafenib   KRAS rs121913529 NM_004985.4:c.35G > A (G12D) Regorafenib plus BSC vs. placebo plus BSC (phase III CORRECT trial) Salvage-line CT 760 mCRC (505 regorafenib arm vs. 253 placebo arm) Caucasian, Asian, North American, Australian OS PFS PFS and OS were higher in the Regorafenib arm irrespective of KRAS and PIK3CA mutational status.    NM_004985.4:c.35G > T (G12V)   NM_004985.4:c.35G > C (G12A)   rs122193530 NM_004985.4:c.34G > T (G12C)   NM_004985.4:c.34G > A (G12S)   NM_004985.4:c.34G > C (G12R)   rs112445441 NM_004985.4:c.38G > A (G13D)   rs17851045 NM_004985.4:c.183A > C (Q61H)   rs121913527 NM_004985.4:c.436G > A (A146T)   PIK3CA rs121913273 NM_006218.3:c.1624G > A (E542K)   rs104886003 NM_006218.3:c.1633G > A (E545K)   rs121913274 NM_006218.3:c.1634A > G (E545G)   rs121913279 NM_006218.3:c.3140A > G (H1047R)   NM_006218.3:c.3140A > T (H1047L)   rs121913281 NM_006218.3:c.3139C > T (H1047Y)   KRAS n.a. Exons 2,3 and 4 Regorafenib (REBECCA observational trial) French compassionate program 654 mCRC Mostly caucasian OS In the multivariate analysis KRAS mutations were associated with shorter OS (HR:1.25; p = 0.016) in an independently manner from PS, number of metastatic sites and time of initial diagnosis    KDR rs80338758 NM_005120.2:c.2881C > T (R961W) Regorafenib monotherapy Second-line 1 case report mCRC  American RR The patient with KDR c.2881C > T mutation experienced excellent tolerance and response to Regorafenib administration.    Aflibercept   KRAS n.a. 9 mutation in codons 12, 13 (Exon 2) Ziv-aflibercept plus mFOLFOX6 vs mFOLFOX6 (phase II AFFIRM trial) First-line 93 mCRC (47 treated with Aflibercept) Asian/oriental, Black, Caucasian/white PFS (primary endpoint) Only patients with mutations in KRAS showed a not statistically significant trend to worse PFS when treated with mFOLFOX6 rather than mFOLFOX6 plus Aflibercept. Mutations in KRAS, NRAS and BRAF did not influenced PFS in both arms.     n.a. 6 mutation in codon 61 (Exon 3)    BRAF rs113488022 NM_004333.4:c.1799T > A (V600E)   rs121913338 NM_004333.4:c.1781A > G (D594G)   NRAS n.a. 12 mutations in codons 12,13 (exon 2)   n.a. 5 mutations in codon 61 (exon 3)   PTEN n.a. 2 deletions (codons 267,323)   n.a. 5 mutations (codons 85, 173, 233, 130)    PIK3CA n.a. 22 mutations (codons 345,38,420,539,542,545,546,88,901,1043,1047,1049,106,118)   PIK3R2 n.a. C1546G > A(R345Q)   PIK3R1 n.a. 17 mutations (codons 162,285,348,358,376,455,461,527,543,564,565,574,576,642,649,666,682) 5 insertions (codons 376,448,459,562-563,668-669) 2 deletions (codons 447,601)   EGFR n.a. 6 mutations (codons 289,858,719,790)2 deletions (codons 746-750, 746-750)   Ramucirumab   KRAS n.a. Codon 12,13 (Exon 2) RAM plus FOLFIRI vs. placebo plus FOLFIRI (RAISE trial) Second-line 1072 mCRC mostly White and Asian OS KRAS wt patients showed a trend to longer OS (HR = 0.82, p = 0.049) in RAM-arm compared to placebo arm; KRAS mutated patients showed a trend to longer OS (HR = 0.89, p = 0.263) in RAM-arm compared to placebo arm.    KDR n.a. c.2312C > G (T771R) RAM plus CTX plus CPT11 Second-line 1 case report of mCRC KRAS wt American n.a. c.2312C > G variant is probably an activating mutation in response to Ramucirumab treatment    Cetuximab   KRAS rs112445441 NM_004985.4: c.38G > A (G13D) CTX vs. CTX plus CPT11 (phase II trial) Second-line and greater 29 mCRC  Japanese PFS OS In the KRAS G13D mutant subgroup, PFS and OS were not statistically different between the two arms. CTX effectiveness was similar in KRAS wt and KRAS G13D mutated    KRAS rs112445441 NM_004985.4:c.38G > A (G13D) CTX vs. CTX plus CPT11 (phase II trial ICECREAM) Second-line 50 mCRC quadruple RAS wt and 50 mCRC KRAS G13D mutated  Australian PFS  Efficacy of CTX administered alone or in combinatorial regimens was similar in quadruple RAS wt (KRAS, NRAS, BRAF and PIK3CA wt) and in G13D KRAS mutated    n.a. Exons 3,4   NRAS n.a. Exons 2,3,4   BRAF n.a. Exon 15   PIK3CA n.a. Exons 9,20    KRAS rs112445441 NM_004985.4:c.38G>A (G13D) CTX  n.a. 98 mCRC Japanese OS PFS At the multivariate analysis there was a trend to better PFS (HR = 0.29; p = 0.07) in KRAS G13D mutated patients compared to other KRAS mutations.    Panitumumab   KRAS n.a. codons 12 and 13 (exon 2) PAN plus BSC vs. BSC (Phase III trial) Second line and greater 377 mCRC KRAS exon 2 wt Asian Caucasian and other ethnicities  OS PFS OS was significantly longer in PAN arm in both wt KRAS exon 2 (HR = 0.73, p = 0.0096) subgroup and wt RAS subgroup (HR = 0.70, p = 0.0135). PFS was significantly longer in PAN arm in both wt KRAS exon 2 (HR = 0.51, p < 0.0001) and wt RAS subgroup (HR=0.46, p < 0.0001).    n.a. codons 59 and 61 (exon 3)   n.a. codons 117 and 146 (exon 4)   NRAS n.a. codons 12 and 13 (exon 2)   n.a. codons 59 and 61 (exon 3)   n.a. codons 117 and 146 (exon 4)   KRAS n.a. Exons 2,3,4 PAN or CTX plus CT PAN or CTX plus BSC (Meta-analysis of 10 studies)  6 first-line 2 second-line 2 BSC 463 CRC KRAS wt n.a. OS PFS ORR EGFR-Is combined with chemotherapy do not significantly increase OS (HR: 0.91 p = 0.63), PFS (HR: 0.88 p = 0.33) and ORR (RR = 1.31 p = 0.25) in patients with BRAF mutated CRC.    NRAS n.a. Exons 2,3,4   BRAF rs113488022 NM_004333.4:c.1799T > A (V600E)   KRAS n.a. codons 12 and 13 (exon 2) PAN or CTX plus 5-FU, CPT11, Oxaliplatin based CT or BSC (Meta-analysis of 9 studies ) 6 first-line 2 second-line 1 third-line (BSC) 5948 mCRC n.a. PFS OS EGFR-Is efficacy was found to be significantly superior in terms of PFS (HR=0.60, p < 0.001) and OS (HR = 0.72, p = 0.008) in all RAS wt patients compared with RAS mutated patients (KRAS exon 3 and 4 and NRAS exon 2,3 and 4) No difference in terms of both PFS and OS was found between KRAS exon 2 mutated and new RAS mutated subgroups.    codons 59 and 61 (exon 3)   codons 117 and 146 (exon 4)   NRAS n.a. codons 12 and 13 (exon 2)   codons 59 and 61 (exon 3)   codons 117 and 146 (exon 4)   KRAS n.a. codons 59 and 61 (exon 3) PAN or CTX plus CT (Meta-analysis: 22 studies) first-line and greater 2395 mCRC KRAS exon 2 wt Caucasian, American, Asian, African, Australian ORR PFS OS From 5 studies: KRAS exons 3 and 4 mutations were significantly correlated with worse ORR (OR = 0.26) and shorter PFS (HR = 2.19) and OS (HR = 1.78) From 3 studies: NRAS exons 2,3 and 4 mutations showed a trend towards poor ORR (OR = 0.23), and significant worse PFS (HR = 2.30) and OS (HR = 1.85) From 17 studies: BRAF mutations were correlated with significant worse ORR (OR = 0.29) and shorter PFS (HR = 2.95) and OS (HR = 2.52) From 6 studies: PIK3CA exons 9 and 20 mutations were significant predictors of poor ORR (OR = 0.39) and were significantly associated with shorter OS (HR = 1.43); only a trend for worse PFS was detected. From 5 studies of primary tumor: PTEN mutations showed non-significant effect on ORR whereas PTEN mutations and/or reduced expression were significantly correlated with lower ORR (OR = 0.41) and shorter PFS (PFS = 2.6) and OS (HR = 1.77)    n.a. codons 117 and 146 (exon 4)   NRAS n.a. codons 12 and 13 (exon 2)   n.a. codons 59 and 61 (exon 3)   n.a. codons 117 and 146 (exon 4)   BRAF rs113488022 NM_004333.4:c.1799T > A (V600E)   PIK3CA n.a. exons 1,2,9,10,20   PTEN n.a. exons 1,2,3,4,5,6,7,8,9   PIK3CA rs121913279 NM_006218.3: c.3140A > G (H1047R) anti-EGFR mAb (Meta-analysis: 11 studies)  n.a. 864 mCRC KRAS wt patients n.a. ORR PFS OS All PIK3CA mutations were associated with overall reduced ORR (OR = 0.42 , p = 0.003) and the result remained significant considering only exon 20 mutated subset (OR = 0.21, p = 0.04) PIK3CA mutations were associated with shorter PFS (HR = 1.54, p = 0.006) and OS (HR = 1.4 p = 0.036)     NM_006218.3: c.3140A > T (H1047L)   rs104886003 NM_006218.3: c.1633G > A (E545K)   n.a. codon 542 (exon 9)   KRAS n.a. exon 3 and 4 FOLFIRI plus PAN vs. FOLFIRI (phase III trial) NCT0039183 second-line  1186 mCRC KRAS wt exon 2 n.a. PFS OS ORR PFS was significantly longer in the PAN-arm with respect to both the KRAS exon 2 wt patients (HR = 0.73, p = 0.004) and all RAS wt patients (HR = 0.70, p = 0.007); in the same analysis there was a trend to longer OS in the PAN-arm     NRAS n.a. exon 2,3 and 4   "}], "citations": {"NLM": "Bignucolo A, De Mattia E, Cecchin E, Roncato R, Toffoli G. Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment. Int J Mol Sci. PMID: 28708103", "BibTeX": "@article{28708103, title={Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment.}, author={Bignucolo A and De Mattia E and Cecchin E and Roncato R and Toffoli G}, journal={Int J Mol Sci}}"}, "is_sup_mat_match": false}, {"pmid": 29904702, "pmcid": "PMC5998651", "title": "Detailed overview on the mutations detected by and the sensitivity of the GeneReader NGS sequencing platform.", "journal": "Data Brief", "authors": ["L\u00fcsebrink J", "Pieper M", "Tillmann RL", "Brockmann M", "Schildgen O", "Schildgen V"], "date": "2018-05-04T00:00:00Z", "year": 2018, "snippets": [{"_id": "29904702@1776", "snip_text": "Gene Nucleotide substitution/ Amino Acid substitution Total % Clinical specimen Interlaboratory test samples   Total  107 100 44 63   BRAF Total 18 16,82 7 11   c.1397G>C/ p.G466A 1 0,93 1 -   c.1406G>C/ p.G469A 1 0,93 1 -   c.1799T>A/ p.V600E 13 12,15 4 9   c.1798_1799delGTinsAA/ p.V600K 3 2,80 1 2   EGFR Total 39 36,45 10 29   c.2127_2129delAAC/ p.E709_T710delinsD 1 0,93 - 1   c.2156G>C/ p.G719A 1 0,93 1 -   c.2254_227delTCTCC/ p.S725_I759del 1 0,93 1 -   c.2222C>T/ p.P741L 1 0,93 1 -   c.2237_2255delAATTAAGAGAAGCAACATCinsT/ p.E746_S752delinsV 3 2,80 1 2   c.2235_2249delGGAATTAAGAGAAGC/ p.E746_A750del 3 2,80 3 -   c.2248G>C/ p.A750P 1 0,93 - 1   c.2281G>A/ p.D761N 1 0,93 - 1   c.2369C>T/ p.T790M 12 11,21 1 11   c.2573T>G/ p.L858R 11 10,28 - 11   c.2582T>A/ p.L861Q 1 0,93 1 -   c.2596G>A/ p.E866K 1 0,93 1 -   KIT Total 2 1,87 1 1   c.1509_1510insGCCTAT/ p.Y503_F504insAY 1 0,93 1 -   c.2447A>T/p.D816V 1 0,93 - 1   KRAS Total 29 27,10 19 10   c.34G>A/ p.G12S 1 0,93 - 1   c.34G>T/ p.G12C 2 1,87 2 -   c.35G>A/ p.G12D 4 3,74 4 -   c.35G>C/ p.G12A 2 1,87 1 1   c.35G>T/ p.G12V 9 8,41 6 3   c.38G>A/ p.G13D 4 3,74 2 2   c.183A>T/ p.Q61H 4 3,74 2 2   c.351A>T/ p.K117N 1 0,93 1 -   c.436G>A/ p.A146T 2 1,87 1 1   NRAS Total 9 8,41 3 6   c.35G>A/ p.G12D 1 0,93 - 1   c.181C>A/ p.Q61K 1 0,93 - 1   c.182A>G/ p.Q61R 1 0,93 1 -   c.182A>T/ p.Q61L 5 4,67 1 4   c.437C>T/ p.A146V 1 0,93 1 -   PIK3CA Total 10 9,35 4 6   c.1633G>A/ p.E545K 5 4,67 2 3   c.317_318delGCinsTT/ p.G106V 1 0,93 1 -   c.331A>G/ p.K111E 1 0,93 1 -   c.3140A>G/ p.H1047R 1 0,93 - 1   c.3129G>T/ p.M1043I 1 0,93 - 1   c.263G>A/ p.R88Q 1 0,93 - 1   ", "section": "table", "mentions": ["907|7|variant|litvar@rs121913507##&&&litvar@#3815#&&&litvar@CA123513#rs121913507##|p.D816V", "1052|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "1072|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA261525#rs121913237##|c.35G>T", "596|14|variant|litvar@#3815#p.A746,750del&&&litvar@#3815#|p.E746_A750del", "393|7|variant|litvar@rs121913428##&&&litvar@#1956#&&&litvar@CA135775#rs121913428##|p.G719A", "1170|7|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.K117N", "1604|6|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|p.R88Q", "259|21|variant|litvar@#1956#c.1798_1799delinsGT,AA&&&litvar@#1956#|c.1798_1799delGTinsAA", "1315|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "897|9|variant|litvar@rs121913507##&&&litvar@#3815#&&&litvar@CA123513#rs121913507##|c.2447A>T", "1130|8|variant|litvar@rs121913255##&&&litvar@#4893#&&&litvar@CA16042285#rs121913255##|c.183A>T", "565|29|variant|litvar@rs121913421##&&&litvar@#1956#|c.2235_2249delGGAATTAAGAGAAGC", "723|9|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|c.2573T>G", "1594|8|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|c.263G>A", "734|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "303|4|gene|ncbi_gene@1956|EGFR", "1305|8|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|c.182A>G", "994|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "688|9|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|c.2369C>T", "1043|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G>C", "699|7|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|p.T790M", "1222|4|gene|ncbi_gene@4893|NRAS", "624|9|variant|litvar@rs121913229##&&&litvar@#1956#&&&litvar@CA135812#rs121913229##|c.2248G>C", "1110|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "1528|9|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A>G", "656|9|variant|litvar@rs121913418##&&&litvar@#1956#&&&litvar@CA16602543#rs121913418##|c.2281G>A", "956|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G>A", "1275|8|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C>A", "667|7|variant|litvar@rs121913418##&&&litvar@#1956#&&&litvar@CA16602543#rs121913418##|p.D761N", "282|7|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16602420#rs121913227##|p.V600K", "225|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "822|3|gene|ncbi_gene@3815|KIT", "204|7|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|p.G469A", "1246|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G>A", "1423|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G>A", "1561|9|variant|litvar@rs121913283##&&&litvar@#5290#&&&litvar@CA210107#rs121913283##|c.3129G>T", "236|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "801|7|variant|litvar@rs756703787##&&&litvar@#1956#&&&litvar@CA4266116#rs756703787##|p.E866K", "382|9|variant|litvar@rs121913428##&&&litvar@#1956#&&&litvar@CA135775#rs121913428##|c.2156G>C", "1476|7|variant|litvar@rs1057519930##&&&litvar@#5290#|p.G106V", "965|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "1335|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|c.182A>T", "1201|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "985|7|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|c.34G>T", "769|7|variant|litvar@rs121913444##&&&litvar@#1956#&&&litvar@CA176021#rs121913444##|p.L861Q", "414|18|variant|litvar@#1956#c.2254_227delTCTCC&&&litvar@#1956#|c.2254_227delTCTCC", "1140|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "1255|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1497|8|variant|litvar@rs776195467##&&&litvar@#4893#&&&litvar@CA1020725#rs776195467##|c.331A>G", "494|37|variant|litvar@#1956#c.2237_2255delinsAATTAAGAGAAGCAACATC,T&&&litvar@#1956#|c.2237_2255delAATTAAGAGAAGCAACATCinsT", "1081|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "331|17|variant|litvar@#1956#p.N2127_2129del&&&litvar@#1956#|c.2127_2129delAAC", "845|20|variant|litvar@#3815#c.1509_1510insGCCTAT&&&litvar@#3815#|c.1509_1510insGCCTAT", "1101|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "867|16|variant|litvar@#3815#p.AY503,504ins&&&litvar@#3815#|p.Y503_F504insAY", "1014|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G>A", "462|9|variant|litvar@#1956#c.2222C>T&&&litvar@#1956#|c.2222C>T", "1455|19|variant|litvar@#5290#c.317_318delinsGC,TT&&&litvar@#5290#|c.317_318delGCinsTT", "441|7|variant|litvar@#1956#p.I759del&&&litvar@#1956#|I759del", "1539|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.H1047R", "473|7|variant|litvar@#1956#p.P741L&&&litvar@#1956#|p.P741L", "1365|8|variant|litvar@rs17847065##&&&litvar@#2099#&&&litvar@CA4052170#rs17847065##|c.437C>T", "928|4|gene|ncbi_gene@3845|KRAS", "1191|8|variant|litvar@rs755969956##&&&litvar@#5290#&&&litvar@CA2710540#rs755969956##|c.436G>A", "1285|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "1572|8|variant|litvar@rs121913283##&&&litvar@#5290#&&&litvar@CA183868#rs121913283##|p.M1043I", "193|9|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA123655#rs121913355##|c.1406G>C", "1023|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "790|9|variant|litvar@rs756703787##&&&litvar@#1956#&&&litvar@CA4266116#rs756703787##|c.2596G>A", "134|4|gene|ncbi_gene@673|BRAF", "1507|7|variant|litvar@rs1057519933##&&&litvar@#5290#|p.K111E", "1434|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "1396|6|gene|ncbi_gene@5290|PIK3CA", "635|7|variant|litvar@rs121913229##&&&litvar@#1956#&&&litvar@CA135812#rs121913229##|p.A750P", "161|9|variant|litvar@rs121913351##&&&litvar@#673#&&&litvar@CA16602743#rs121913351##|c.1397G>C", "1345|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "1160|8|variant|litvar@rs770248150##&&&litvar@#3845#|c.351A>T", "172|7|variant|litvar@rs121913351##&&&litvar@#673#&&&litvar@CA16602535#rs121913351##|p.G466A", "1375|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "758|9|variant|litvar@rs121913444##&&&litvar@#1956#&&&litvar@CA176021#rs121913444##|c.2582T>A"], "figure_id": "t0005", "text_hl": "Gene Nucleotide substitution/ Amino Acid substitution Total % Clinical specimen Interlaboratory test samples   Total  107 100 44 63   BRAF Total 18 16,82 7 11   c.1397G>C/ p.G466A 1 0,93 1 -   c.1406G>C/ p.G469A 1 0,93 1 -   c.1799T>A/ p.V600E 13 12,15 4 9   c.1798_1799delGTinsAA/ p.V600K 3 2,80 1 2   EGFR Total 39 36,45 10 29   c.2127_2129delAAC/ p.E709_T710delinsD 1 0,93 - 1   c.2156G>C/ p.G719A 1 0,93 1 -   c.2254_227delTCTCC/ p.S725_I759del 1 0,93 1 -   c.2222C>T/ p.P741L 1 0,93 1 -   c.2237_2255delAATTAAGAGAAGCAACATCinsT/ p.E746_S752delinsV 3 2,80 1 2   c.2235_2249delGGAATTAAGAGAAGC/ p.E746_A750del 3 2,80 3 -   c.2248G>C/ p.A750P 1 0,93 - 1   c.2281G>A/ p.D761N 1 0,93 - 1   c.2369C>T/ p.T790M 12 11,21 1 11   c.2573T>G/ p.L858R 11 10,28 - 11   c.2582T>A/ p.L861Q 1 0,93 1 -   c.2596G>A/ p.E866K 1 0,93 1 -   KIT Total 2 1,87 1 1   c.1509_1510insGCCTAT/ p.Y503_F504insAY 1 0,93 1 -   c.2447A>T/p.D816V 1 0,93 - 1   KRAS Total 29 27,10 19 10   c.34G>A/ p.G12S 1 0,93 - 1   c.34G>T/ p.G12C 2 1,87 2 -   c.35G>A/ p.G12D 4 3,74 4 -   c.35G>C/ p.G12A 2 1,87 1 1   c.35G>T/ p.G12V 9 8,41 6 3   c.38G>A/ p.G13D 4 3,74 2 2   c.183A>T/ p.Q61H 4 3,74 2 2   c.351A>T/ p.K117N 1 0,93 1 -   c.436G>A/ <m>p.A146T</m> 2 1,87 1 1   NRAS Total 9 8,41 3 6   c.35G>A/ p.G12D 1 0,93 - 1   c.181C>A/ p.Q61K 1 0,93 - 1   c.182A>G/ p.Q61R 1 0,93 1 -   c.182A>T/ p.Q61L 5 4,67 1 4   c.437C>T/ p.A146V 1 0,93 1 -   PIK3CA Total 10 9,35 4 6   c.1633G>A/ p.E545K 5 4,67 2 3   c.317_318delGCinsTT/ p.G106V 1 0,93 1 -   c.331A>G/ p.K111E 1 0,93 1 -   c.3140A>G/ p.H1047R 1 0,93 - 1   c.3129G>T/ p.M1043I 1 0,93 - 1   c.263G>A/ p.R88Q 1 0,93 - 1   "}], "citations": {"NLM": "L\u00fcsebrink J, Pieper M, Tillmann RL, Brockmann M, Schildgen O, Schildgen V. Detailed overview on the mutations detected by and the sensitivity of the GeneReader NGS sequencing platform. Data Brief. PMID: 29904702", "BibTeX": "@article{29904702, title={Detailed overview on the mutations detected by and the sensitivity of the GeneReader NGS sequencing platform.}, author={L\u00fcsebrink J and Pieper M and Tillmann RL and Brockmann M and Schildgen O and Schildgen V}, journal={Data Brief}}"}, "is_sup_mat_match": false}, {"pmid": 34209415, "pmcid": "PMC8268142", "title": "Predictive and Prognostic Value of BRAF and NRAS Mutation of 159 Sentinel Lymph Node Cases in Melanoma-A Retrospective Single-Institute Study.", "journal": "Cancers (Basel)", "authors": ["Liszkay G", "M\u00e1trai Z", "Czirbesz K", "Jani N", "Bencze E", "Kenessey I"], "date": "2021-06-30T00:00:00Z", "year": 2021, "snippets": [{"_id": "34209415@8642", "snip_text": "K117Nc, K117Nt, A146T, and A146V in NRAS exon 4", "section": "methods", "mentions": ["36|4|gene|ncbi_gene@4893|NRAS", "27|5|variant|litvar@rs121917759##&&&litvar@#3265#&&&litvar@CA256494#rs121917759##|A146V", "16|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "K117Nc, K117Nt, <m>A146T</m>, and A146V in NRAS exon 4"}], "citations": {"NLM": "Liszkay G, M\u00e1trai Z, Czirbesz K, Jani N, Bencze E, Kenessey I. Predictive and Prognostic Value of BRAF and NRAS Mutation of 159 Sentinel Lymph Node Cases in Melanoma-A Retrospective Single-Institute Study. Cancers (Basel). PMID: 34209415", "BibTeX": "@article{34209415, title={Predictive and Prognostic Value of BRAF and NRAS Mutation of 159 Sentinel Lymph Node Cases in Melanoma-A Retrospective Single-Institute Study.}, author={Liszkay G and M\u00e1trai Z and Czirbesz K and Jani N and Bencze E and Kenessey I}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 32467349, "pmcid": "PMC7415636", "title": "Insulin-like growth factor-1 receptor expression and disease recurrence and survival in patients with resected pancreatic ductal adenocarcinoma", "journal": "Cancer Epidemiol Biomarkers Prev", "authors": ["Du C", "da Silva A", "Morales-Oyarvide V", "Dias Costa A", "Kozak MM", "Dunne RF", "Rubinson DA", "Perez K", "Masugi Y", "Hamada T", "Brais LK", "Yuan C", "Babic A", "Ducar MD", "Thorner AR", "Aguirre A", "Kulke MH", "Ng K", "Clancy TE", "Findeis-Hosey JJ", "Chang DT", "Hornick JL", "Fuchs CS", "Ogino S", "Koong AC", "Hezel AF", "Wolpin BM", "Nowak JA"], "date": "2020-08-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "32467349@39898", "snip_text": "G12C (N =2), G13D (N=1), A146T (N=1).", "section": "table", "mentions": ["25|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "0|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "13|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D"], "figure_id": "T2", "text_hl": "G12C (N =2), G13D (N=1), <m>A146T</m> (N=1)."}], "citations": {"NLM": "Du C, da Silva A, Morales-Oyarvide V, Dias Costa A, Kozak MM, Dunne RF, Rubinson DA, Perez K, Masugi Y, Hamada T, Brais LK, Yuan C, Babic A, Ducar MD, Thorner AR, Aguirre A, Kulke MH, Ng K, Clancy TE, Findeis-Hosey JJ, Chang DT, Hornick JL, Fuchs CS, Ogino S, Koong AC, Hezel AF, Wolpin BM, Nowak JA. Insulin-like growth factor-1 receptor expression and disease recurrence and survival in patients with resected pancreatic ductal adenocarcinoma Cancer Epidemiol Biomarkers Prev. PMID: 32467349", "BibTeX": "@article{32467349, title={Insulin-like growth factor-1 receptor expression and disease recurrence and survival in patients with resected pancreatic ductal adenocarcinoma}, author={Du C and da Silva A and Morales-Oyarvide V and Dias Costa A and Kozak MM and Dunne RF and Rubinson DA and Perez K and Masugi Y and Hamada T and Brais LK and Yuan C and Babic A and Ducar MD and Thorner AR and Aguirre A and Kulke MH and Ng K and Clancy TE and Findeis-Hosey JJ and Chang DT and Hornick JL and Fuchs CS and Ogino S and Koong AC and Hezel AF and Wolpin BM and Nowak JA}, journal={Cancer Epidemiol Biomarkers Prev}}"}, "is_sup_mat_match": false}, {"pmid": 33845897, "pmcid": "PMC8042687", "title": "Targeted exome sequencing identifies mutational landscape in a cohort of 1500 Chinese patients with non-small cell lung carcinoma (NSCLC).", "journal": "Hum Genomics", "authors": ["Zhou YJ", "Zheng W", "Zeng QH", "Ye Y", "Wang C", "Fang C", "Liu CJ", "Niu L", "Wu LM"], "date": "2021-04-12T00:00:00Z", "year": 2021, "snippets": [{"_id": "33845897@11196", "snip_text": "In addition, we have also found pA146T in two tissue samples.", "section": "results", "mentions": ["33|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "In addition, we have also found pA146T in two tissue samples."}], "citations": {"NLM": "Zhou YJ, Zheng W, Zeng QH, Ye Y, Wang C, Fang C, Liu CJ, Niu L, Wu LM. Targeted exome sequencing identifies mutational landscape in a cohort of 1500 Chinese patients with non-small cell lung carcinoma (NSCLC). Hum Genomics. PMID: 33845897", "BibTeX": "@article{33845897, title={Targeted exome sequencing identifies mutational landscape in a cohort of 1500 Chinese patients with non-small cell lung carcinoma (NSCLC).}, author={Zhou YJ and Zheng W and Zeng QH and Ye Y and Wang C and Fang C and Liu CJ and Niu L and Wu LM}, journal={Hum Genomics}}"}, "is_sup_mat_match": false}, {"pmid": 26773571, "pmcid": "PMC4794776", "title": "HRAS mutation prevalence and associated expression patterns in pheochromocytoma.", "journal": "Genes Chromosomes Cancer", "authors": ["Stenman A", "Welander J", "Gustavsson I", "Brunaud L", "B\u00e4ckdahl M", "S\u00f6derkvist P", "Gimm O", "Juhlin CC", "Larsson C"], "date": "2016-05-01T00:00:00Z", "year": 2016, "snippets": [{"_id": "26773571@17348", "snip_text": "Three HRAS mutations from this study are not reported in the table: G12R (n = 1), S145L (n = 1), and A146T (n = 1).", "section": "table", "mentions": ["68|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "101|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "82|5|variant|litvar@rs1372518536##&&&litvar@#8448#|S145L", "6|4|gene|ncbi_gene@3265|HRAS"], "figure_id": "gcc22347-tbl-0002", "text_hl": "Three HRAS mutations from this study are not reported in the table: G12R (n = 1), S145L (n = 1), and <m>A146T</m> (n = 1)."}], "citations": {"NLM": "Stenman A, Welander J, Gustavsson I, Brunaud L, B\u00e4ckdahl M, S\u00f6derkvist P, Gimm O, Juhlin CC, Larsson C. HRAS mutation prevalence and associated expression patterns in pheochromocytoma. Genes Chromosomes Cancer. PMID: 26773571", "BibTeX": "@article{26773571, title={HRAS mutation prevalence and associated expression patterns in pheochromocytoma.}, author={Stenman A and Welander J and Gustavsson I and Brunaud L and B\u00e4ckdahl M and S\u00f6derkvist P and Gimm O and Juhlin CC and Larsson C}, journal={Genes Chromosomes Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 29409705, "pmcid": "PMC6072630", "title": "Genetic status of KRAS influences Transforming Growth Factor-beta (TGF-beta) signaling: an insight into Neuropilin-1 (NRP1) mediated tumorigenesis", "journal": "Semin Cancer Biol", "authors": ["Vivekanandhan S", "Mukhopadhyay D"], "date": "2019-02-01T00:00:00Z", "year": 2019, "snippets": [{"_id": "29409705@7736", "snip_text": "Similarly, KRAS mutations K117N and A146T resulted in relatively lower amounts of RAS that was bound to GTP than G12D mutations in HEK293FT cells.", "section": "other", "mentions": ["11|4|gene|ncbi_gene@16653|KRAS", "104|3|chemical|ncbi_mesh@D006160|GTP", "131|8|cellline||HEK293FT", "26|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "113|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "36|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Similarly, KRAS mutations K117N and <m>A146T</m> resulted in relatively lower amounts of RAS that was bound to GTP than G12D mutations in HEK293FT cells."}], "citations": {"NLM": "Vivekanandhan S, Mukhopadhyay D. Genetic status of KRAS influences Transforming Growth Factor-beta (TGF-beta) signaling: an insight into Neuropilin-1 (NRP1) mediated tumorigenesis Semin Cancer Biol. PMID: 29409705", "BibTeX": "@article{29409705, title={Genetic status of KRAS influences Transforming Growth Factor-beta (TGF-beta) signaling: an insight into Neuropilin-1 (NRP1) mediated tumorigenesis}, author={Vivekanandhan S and Mukhopadhyay D}, journal={Semin Cancer Biol}}"}, "is_sup_mat_match": false}, {"pmid": 35378118, "pmcid": "PMC9398924", "title": "Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs", "journal": "J Mol Biol", "authors": ["Nussinov R", "Zhang M", "Maloney R", "Liu Y", "Tsai CJ", "Jang H"], "date": "2022-09-15T00:00:00Z", "year": 2022, "snippets": [{"_id": "35378118@15079", "snip_text": "Weaker drivers enhance the exchange of GDP by GTP, e.g.  A146T in KRas4B as well as influence the intrinsic hydrolysis.", "section": "other", "mentions": ["66|6|gene|ncbi_gene@3845|KRas4B", "46|3|chemical|ncbi_mesh@D006160|GTP", "39|3|chemical|ncbi_mesh@D006153|GDP", "57|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Weaker drivers enhance the exchange of GDP by GTP, e.g.  <m>A146T</m> in KRas4B as well as influence the intrinsic hydrolysis."}], "citations": {"NLM": "Nussinov R, Zhang M, Maloney R, Liu Y, Tsai CJ, Jang H. Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs J Mol Biol. PMID: 35378118", "BibTeX": "@article{35378118, title={Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs}, author={Nussinov R and Zhang M and Maloney R and Liu Y and Tsai CJ and Jang H}, journal={J Mol Biol}}"}, "is_sup_mat_match": false}, {"pmid": 35884381, "pmcid": "PMC9313302", "title": "Prognostic Value of KRAS Mutations in Colorectal Cancer Patients.", "journal": "Cancers (Basel)", "authors": ["Koulouridi A", "Karagianni M", "Messaritakis I", "Sfakianaki M", "Voutsina A", "Trypaki M", "Bachlitzanaki M", "Koustas E", "Karamouzis MV", "Ntavatzikos A", "Koumarianou A", "Androulakis N", "Mavroudis D", "Tzardi M", "Souglakos J"], "date": "2022-07-07T00:00:00Z", "year": 2022, "snippets": [{"_id": "35884381@23712", "snip_text": "KRAS Mutation Frequency (N = 539) %   G12D 190 33.1   G12V 121 21.2   G13D 96 16.7   G12C 28 4.8   G12S 27 4.7   G12A 21 3.6   A146T 15 2.6   A146A 6 1   A146V 6 1   Q61H 5 0.9   G12R 3 0.5   G13R 3 0.5   A59T 2 0.3   G13_V14 > D 2 0.3   G13C 2 0.3   K117N 2 0.3   Q61K 2 0.3   Q61L 2 0.3   Q61R 2 0.3   A146X 1 0.2   A59E 1 0.2   E62Q 1 0.2   G12S, G12V 1 0.2   ", "section": "table", "mentions": ["331|4|variant|litvar@#4893#p.E62Q&&&litvar@#4893#|E62Q", "179|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "0|4|gene|ncbi_gene@3845|KRAS", "99|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "166|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "142|5|variant|litvar@rs1305285506##&&&litvar@#3845#|A146A", "113|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "154|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "265|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "205|4|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|A59T", "318|4|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|A59E", "38|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "238|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13C", "350|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "70|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "54|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "127|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "344|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "192|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "304|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146X", "251|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "291|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "85|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "278|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L"], "figure_id": "cancers-14-03320-t004", "text_hl": "KRAS Mutation Frequency (N = 539) %   G12D 190 33.1   G12V 121 21.2   G13D 96 16.7   G12C 28 4.8   G12S 27 4.7   G12A 21 3.6   <m>A146T</m> 15 2.6   A146A 6 1   A146V 6 1   Q61H 5 0.9   G12R 3 0.5   G13R 3 0.5   A59T 2 0.3   G13_V14 > D 2 0.3   G13C 2 0.3   K117N 2 0.3   Q61K 2 0.3   Q61L 2 0.3   Q61R 2 0.3   A146X 1 0.2   A59E 1 0.2   E62Q 1 0.2   G12S, G12V 1 0.2   "}], "citations": {"NLM": "Koulouridi A, Karagianni M, Messaritakis I, Sfakianaki M, Voutsina A, Trypaki M, Bachlitzanaki M, Koustas E, Karamouzis MV, Ntavatzikos A, Koumarianou A, Androulakis N, Mavroudis D, Tzardi M, Souglakos J. Prognostic Value of KRAS Mutations in Colorectal Cancer Patients. Cancers (Basel). PMID: 35884381", "BibTeX": "@article{35884381, title={Prognostic Value of KRAS Mutations in Colorectal Cancer Patients.}, author={Koulouridi A and Karagianni M and Messaritakis I and Sfakianaki M and Voutsina A and Trypaki M and Bachlitzanaki M and Koustas E and Karamouzis MV and Ntavatzikos A and Koumarianou A and Androulakis N and Mavroudis D and Tzardi M and Souglakos J}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 30283732, "pmcid": "PMC6156365", "title": "KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer.", "journal": "Front Oncol", "authors": ["Meng Q", "Valentini D", "Rao M", "Maeurer M"], "date": "2018-09-19T00:00:00Z", "year": 2018, "snippets": [{"_id": "30283732@12070", "snip_text": "TIB supernatant samples in serum-free medium (no human serum or FBS) were incubated in three 12-plex peptide microarray chips [format described in, which was previously reported from our group for human serum IgG reactivity to the H1N1 influenza proteome] embedded with 12-mer peptides from the human KRAS protein (UniProt ID: P01116) covering the most frequently occurring point mutations associated with cancer: G12D, G12V, G12R, G12S, G12C, G13D, Q61K, Q61H, Q61R, and A146T.", "section": "other", "mentions": ["472|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "295|5|species|ncbi_taxonomy@9606|human", "432|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "444|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "462|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|Q61R", "406|6|disease|ncbi_mesh@D009369|cancer", "231|4|species|ncbi_taxonomy@114727|H1N1", "301|4|gene|ncbi_gene@3845|KRAS", "197|5|species|ncbi_taxonomy@9606|human", "49|5|species|ncbi_taxonomy@9606|human"], "text_hl": "TIB supernatant samples in serum-free medium (no human serum or FBS) were incubated in three 12-plex peptide microarray chips [format described in, which was previously reported from our group for human serum IgG reactivity to the H1N1 influenza proteome] embedded with 12-mer peptides from the human KRAS protein (UniProt ID: P01116) covering the most frequently occurring point mutations associated with cancer: G12D, G12V, G12R, G12S, G12C, G13D, Q61K, Q61H, Q61R, and <m>A146T</m>."}], "citations": {"NLM": "Meng Q, Valentini D, Rao M, Maeurer M. KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer. Front Oncol. PMID: 30283732", "BibTeX": "@article{30283732, title={KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer.}, author={Meng Q and Valentini D and Rao M and Maeurer M}, journal={Front Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 28769798, "pmcid": "PMC5513919", "title": "Molecular Characterization of Somatic Alterations in Dukes' B and C Colorectal Cancers by Targeted Sequencing.", "journal": "Front Pharmacol", "authors": ["Abdul SN", "Ab Mutalib NS", "Sean KS", "Syafruddin SE", "Ishak M", "Sagap I", "Mazlan L", "Rose IM", "Abu N", "Mokhtar NM", "Jamal R"], "date": "2017-07-18T00:00:00Z", "year": 2017, "snippets": [{"_id": "28769798@24686", "snip_text": "KRAS alterations were identified in five out of 19 patients: three in Dukes' B and two in Dukes' C. These were all missense alterations located at the known hotspot region at exon 2 (p.G12D, 2 alterations of p.G12V), exon 3 (p.Q61H) and exon 4 (p.A146T).", "section": "results", "mentions": ["208|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "245|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "183|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "0|4|gene|ncbi_gene@3845|KRAS", "225|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "51|8|species|ncbi_taxonomy@9606|patients"], "text_hl": "KRAS alterations were identified in five out of 19 patients: three in Dukes' B and two in Dukes' C. These were all missense alterations located at the known hotspot region at exon 2 (p.G12D, 2 alterations of p.G12V), exon 3 (p.Q61H) and exon 4 (<m>p.A146T</m>)."}], "citations": {"NLM": "Abdul SN, Ab Mutalib NS, Sean KS, Syafruddin SE, Ishak M, Sagap I, Mazlan L, Rose IM, Abu N, Mokhtar NM, Jamal R. Molecular Characterization of Somatic Alterations in Dukes' B and C Colorectal Cancers by Targeted Sequencing. Front Pharmacol. PMID: 28769798", "BibTeX": "@article{28769798, title={Molecular Characterization of Somatic Alterations in Dukes' B and C Colorectal Cancers by Targeted Sequencing.}, author={Abdul SN and Ab Mutalib NS and Sean KS and Syafruddin SE and Ishak M and Sagap I and Mazlan L and Rose IM and Abu N and Mokhtar NM and Jamal R}, journal={Front Pharmacol}}"}, "is_sup_mat_match": false}, {"pmid": 28137276, "pmcid": "PMC5282851", "title": "Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions.", "journal": "J Transl Med", "authors": ["Ivanov M", "Laktionov K", "Breder V", "Chernenko P", "Novikova E", "Telysheva E", "Musienko S", "Baranova A", "Mileyko V"], "date": "2017-01-31T00:00:00Z", "year": 2017, "snippets": [{"_id": "28137276@24476", "snip_text": "Of particular interest, the mutations of KRAS were detected in 5 samples including one sample with simultaneous presence of two KRAS mutations (p.Gly12Cys and p.Ala146Thr), though only two of the KRAS positive samples harbored high prevalent mutations, while the rest, thus, could not be validated with orthogonal methods.", "section": "results", "mentions": ["128|4|gene|ncbi_gene@3845|KRAS", "196|4|gene|ncbi_gene@3845|KRAS", "159|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "41|4|gene|ncbi_gene@3845|KRAS", "144|10|variant|litvar@rs104894229##&&&litvar@#3265#&&&litvar@CA129948#rs104894229##|p.Gly12Cys"], "text_hl": "Of particular interest, the mutations of KRAS were detected in 5 samples including one sample with simultaneous presence of two KRAS mutations (p.Gly12Cys and <m>p.Ala146Thr</m>), though only two of the KRAS positive samples harbored high prevalent mutations, while the rest, thus, could not be validated with orthogonal methods."}], "citations": {"NLM": "Ivanov M, Laktionov K, Breder V, Chernenko P, Novikova E, Telysheva E, Musienko S, Baranova A, Mileyko V. Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions. J Transl Med. PMID: 28137276", "BibTeX": "@article{28137276, title={Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions.}, author={Ivanov M and Laktionov K and Breder V and Chernenko P and Novikova E and Telysheva E and Musienko S and Baranova A and Mileyko V}, journal={J Transl Med}}"}, "is_sup_mat_match": false}, {"pmid": 28038940, "pmcid": "PMC5484535", "title": "Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors", "journal": "Bioorg Med Chem", "authors": ["Tan L", "Gurbani D", "Weisberg EL", "Jones DS", "Rao S", "Singer WD", "Bernard FM", "Mowafy S", "Jenney A", "Du G", "Nonami A", "Griffin JD", "Lauffenburger DA", "Westover KD", "Sorger PK", "Gray NS"], "date": "2017-02-15T00:00:00Z", "year": 2017, "snippets": [{"_id": "28038940@7210", "snip_text": "Cell lines included the mutant KRAS-expressing AML lines, SKM-1 (KRASK117N) and NOMO-1 (KRASG13D); mutant NRAS-expressing AML lines OCI-AML3 (NRASQ61L) and K052 (NRASG12R); ALL lines PF-382 (NRASG12S) and NALM6 (NRASA146T); and wild-type (WT) RAS-expressing AML lines MOLM14, HEL and U937.", "section": "discussion", "mentions": ["122|3|disease|ncbi_mesh@D015470|AML", "276|3|cellline||HEL", "58|5|cellline||SKM-1", "156|4|cellline||K052", "173|3|disease|ncbi_mesh@D054198|ALL", "132|8|cellline||OCI-AML3", "142|8|cellline||NRASQ61L", "47|3|disease|ncbi_mesh@D015470|AML", "258|3|disease|ncbi_mesh@D015470|AML", "106|4|gene|ncbi_gene@4893|NRAS", "195|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "268|6|cellline||MOLM14", "69|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "31|4|gene|ncbi_gene@3845|KRAS", "80|6|cellline||NOMO-1", "284|4|cellline||U937", "205|5|cellline||NALM6", "216|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "183|6|cellline||PF-382"], "text_hl": "Cell lines included the mutant KRAS-expressing AML lines, SKM-1 (KRASK117N) and NOMO-1 (KRASG13D); mutant NRAS-expressing AML lines OCI-AML3 (NRASQ61L) and K052 (NRASG12R); ALL lines PF-382 (NRASG12S) and NALM6 (NRASA146T); and wild-type (WT) RAS-expressing AML lines MOLM14, HEL and U937."}], "citations": {"NLM": "Tan L, Gurbani D, Weisberg EL, Jones DS, Rao S, Singer WD, Bernard FM, Mowafy S, Jenney A, Du G, Nonami A, Griffin JD, Lauffenburger DA, Westover KD, Sorger PK, Gray NS. Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors Bioorg Med Chem. PMID: 28038940", "BibTeX": "@article{28038940, title={Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors}, author={Tan L and Gurbani D and Weisberg EL and Jones DS and Rao S and Singer WD and Bernard FM and Mowafy S and Jenney A and Du G and Nonami A and Griffin JD and Lauffenburger DA and Westover KD and Sorger PK and Gray NS}, journal={Bioorg Med Chem}}"}, "is_sup_mat_match": false}, {"pmid": 33138022, "pmcid": "PMC7692129", "title": "NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program.", "journal": "Cancers (Basel)", "authors": ["Delcourt T", "Vanneste K", "Soumali MR", "Coucke W", "Ghislain V", "Hebrant A", "Van Valckenborgh E", "De Keersmaecker SCJ", "Roosens NH", "Van De Walle P", "Van Den Bulcke M", "Antoniou A"], "date": "2020-10-29T00:00:00Z", "year": 2020, "snippets": [{"_id": "33138022@71287", "snip_text": "Benchmark Sample Gene Variant (HGVS) Median Allelic Frequency 1 (SD) Z-Citations 2 Participant Success 3   2017/1 NGS-2017-001 BRAF p.(Val600Glu) 13.21 (0.60) 1/16 16/16   KRAS p.(Gly13Asp) 32.94 (0.64) 1/16 16/16   NRAS p.(Gln61Lys) 21.55 (1.17) 1/16 16/16   NGS-2017-002 BRAF p.(Val600Arg) 11.26 (1.13) 1/16 16/16   KRAS p.(Ala146Thr) 4 20.07 (2.31) 3/15 15/16   NRAS p.(Gly12Asp) 19.42 (2.24) 1/16 16/16   NGS-2017-003 BRAF p.(Val600Lys) 48.50 (2.95) 0/16 16/16   EGFR p.(Glu746-Ala750del) 35.70 (2.89) 2/15 15/16   EGFR p.(Gly719Ser) 11.10 (1.38) 1/15 15/16   KRAS p.(Gly12Ala) 4 18.24 (1.36) 1/15 15/16   NGS-2017-004 BRAF p.(Val600Met) 19.73 (0.83) 2/16 16/16   EGFR p.(Gly719Ser) 3.73 (0.50) 0/12 12/16   EGFR p.(Leu858Arg) 38.13 (0.96) 1/16 16/16   EGFR p.(Thr790Met) 38.00 (1.10) 3/16 16/16   KRAS p.(Gly12Cys) 4 5.16 (0.42) 1/15 15/16   KRAS p.(Gly13Asp) 29.07 (0.95) 0/16 16/16   2017/2 NGS-2017-005 TP53 p.(Glu171*) 34.30 (1.76) 1/15 15/15   KIT p.(Asp816Val) 19.03 (1.67) 1/15 15/15   IDH2 p.(Arg140Gln) 20.88 (1.11) 3/15 15/15   IDH1 p.(Arg132Gly) 5.30 (0.60) 1/15 15/15   FLT3 p.(Asp835Tyr) 4 11.46 (0.86) 1/14 14/15   NGS-2017-006 JAK2 p.(Val617Phe) 21.00 (0.87) 2/15 15/15   IDH2 p.(Arg172Ser) 30.95 (0.83) 1/14 14/15   IDH1 p.(Arg132Ser) 11.05 (1.12) 1/14 14/15   SF3B1 p.(Lys700Glu) 4 10.65 (1.24) 2/12 12/15   NGS-2017-007 SF3B1 p.(Lys666Asn) 4 24.76 (2.63) 2/15 15/15   TP53 p.(Ala161Asp) 47.45 (2.73) 2/14 14/15   TP53 p.(Tyr220Cys) 5.12 (0.63) 1/13 13/15   2018/1 NGS-2018-001 BRCA1 p.(Arg1443*) 11 (0.22) 1/8 12/12   BRCA2 p.(Asn1784Thrfs*7) 12 (0.13) 1/7 11/12   BRCA2 p.(Lys1691Asnfs*15) 13 (0.23) 1/7 11/12   NGS-2018-002 BRCA2 p.(Asn1784Thrfs*7) 20.7 (0.43) 1/7 11/12   NGS-2018-003 BRCA2 p.(Asn1784Thrfs*7) 25.6 (0.61) 0/7 11/12   BRCA2 p.(Ile2675Aspfs*6) 24 (0.68) 1/7 11/12   ", "section": "table", "mentions": ["1242|13|variant|litvar@rs121913499##&&&litvar@#3417#&&&litvar@CA16602376#rs121913499##|p.(Arg132Ser)", "472|20|variant||p.(Glu746-Ala750del)", "847|4|gene|ncbi_gene@3845|KRAS", "623|4|gene|ncbi_gene@673|BRAF", "1197|13|variant|litvar@rs1057519736##&&&litvar@#3418#|p.(Arg172Ser)", "83|11|species|ncbi_taxonomy@9606|Participant", "132|13|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.(Val600Glu)", "802|4|gene|ncbi_gene@3845|KRAS", "1092|13|variant|litvar@rs121913488##&&&litvar@#2322#&&&litvar@CA126347#rs121913488##|p.(Asp835Tyr)", "177|12|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.(Gly13Asp)", "519|4|gene|ncbi_gene@1956|EGFR", "1441|13|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|p.(Tyr220Cys)", "1152|13|variant|litvar@rs77375493##&&&litvar@#3717#&&&litvar@CA124183#rs77375493##|p.(Val617Phe)", "762|13|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|p.(Thr790Met)", "1349|13|variant|litvar@rs377023736##&&&litvar@#23451#&&&litvar@CA280929#rs377023736##|p.(Lys666Asn)", "1343|5|gene|ncbi_gene@23451|SF3B1", "717|13|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.(Leu858Arg)", "916|11|variant|litvar@#7157#|p.(Glu171*)", "1048|13|variant|litvar@rs121913499##&&&litvar@#3417#|p.(Arg132Gly)", "1500|5|gene|ncbi_gene@672|BRCA1", "273|4|gene|ncbi_gene@673|BRAF", "1237|4|gene|ncbi_gene@3417|IDH1", "172|4|gene|ncbi_gene@3845|KRAS", "998|4|gene|ncbi_gene@3418|IDH2", "365|4|gene|ncbi_gene@4893|NRAS", "1541|5|gene|ncbi_gene@675|BRCA2", "221|12|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.(Gln61Lys)", "1588|5|gene|ncbi_gene@675|BRCA2", "1717|15|variant|litvar@rs80359509##&&&litvar@#675#&&&litvar@CA22110#rs80359509##|p.(Asn1784Thrfs", "668|4|gene|ncbi_gene@1956|EGFR", "673|13|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126722#rs28929495##|p.(Gly719Ser)", "911|4|gene|ncbi_gene@7157|TP53", "1192|4|gene|ncbi_gene@3418|IDH2", "1288|13|variant|litvar@rs559063155##&&&litvar@#23451#&&&litvar@CA2042597#rs559063155##|p.(Lys700Glu)", "127|4|gene|ncbi_gene@673|BRAF", "958|13|variant|litvar@rs121913507##&&&litvar@#3815#&&&litvar@CA123513#rs121913507##|p.(Asp816Val)", "467|4|gene|ncbi_gene@1956|EGFR", "628|13|variant|litvar@rs121913378##&&&litvar@#673#&&&litvar@CA135101#rs121913378##|p.(Val600Met)", "1087|4|gene|ncbi_gene@2322|FLT3", "1436|4|gene|ncbi_gene@7157|TP53", "1147|4|gene|ncbi_gene@3717|JAK2", "564|4|gene|ncbi_gene@3845|KRAS", "757|4|gene|ncbi_gene@1956|EGFR", "370|12|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.(Gly12Asp)", "1649|5|gene|ncbi_gene@675|BRCA2", "1655|15|variant|litvar@rs80359509##&&&litvar@#675#&&&litvar@CA22110#rs80359509##|p.(Asn1784Thrfs", "1282|5|gene|ncbi_gene@23451|SF3B1", "422|4|gene|ncbi_gene@673|BRAF", "427|13|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16602420#rs121913227##|p.(Val600Lys)", "216|4|gene|ncbi_gene@4893|NRAS", "1391|4|gene|ncbi_gene@7157|TP53", "1396|13|variant|litvar@rs1064795691##&&&litvar@#7157#|p.(Ala161Asp)", "1760|5|gene|ncbi_gene@675|BRCA2", "524|13|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126722#rs28929495##|p.(Gly719Ser)", "712|4|gene|ncbi_gene@1956|EGFR", "852|12|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.(Gly13Asp)", "807|12|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.(Gly12Cys)", "1043|4|gene|ncbi_gene@3417|IDH1", "954|3|gene|ncbi_gene@3815|KIT", "569|12|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.(Gly12Ala)", "318|4|gene|ncbi_gene@3845|KRAS", "323|13|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.(Ala146Thr)", "1547|15|variant|litvar@rs80359509##&&&litvar@#675#&&&litvar@CA22110#rs80359509##|p.(Asn1784Thrfs", "1003|13|variant|litvar@rs121913502##&&&litvar@#3418#&&&litvar@CA124277#rs121913502##|p.(Arg140Gln)", "1711|5|gene|ncbi_gene@675|BRCA2", "1506|12|variant|litvar@#672#|p.(Arg1443*)", "278|13|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16021333#rs121913227##|p.(Val600Arg)"], "figure_id": "cancers-12-03180-t003", "text_hl": "Benchmark Sample Gene Variant (HGVS) Median Allelic Frequency 1 (SD) Z-Citations 2 Participant Success 3   2017/1 NGS-2017-001 BRAF p.(Val600Glu) 13.21 (0.60) 1/16 16/16   KRAS p.(Gly13Asp) 32.94 (0.64) 1/16 16/16   NRAS p.(Gln61Lys) 21.55 (1.17) 1/16 16/16   NGS-2017-002 BRAF p.(Val600Arg) 11.26 (1.13) 1/16 16/16   KRAS p.(Ala146Thr) 4 20.07 (2.31) 3/15 15/16   NRAS p.(Gly12Asp) 19.42 (2.24) 1/16 16/16   NGS-2017-003 BRAF p.(Val600Lys) 48.50 (2.95) 0/16 16/16   EGFR p.(Glu746-Ala750del) 35.70 (2.89) 2/15 15/16   EGFR p.(Gly719Ser) 11.10 (1.38) 1/15 15/16   KRAS p.(Gly12Ala) 4 18.24 (1.36) 1/15 15/16   NGS-2017-004 BRAF p.(Val600Met) 19.73 (0.83) 2/16 16/16   EGFR p.(Gly719Ser) 3.73 (0.50) 0/12 12/16   EGFR p.(Leu858Arg) 38.13 (0.96) 1/16 16/16   EGFR p.(Thr790Met) 38.00 (1.10) 3/16 16/16   KRAS p.(Gly12Cys) 4 5.16 (0.42) 1/15 15/16   KRAS p.(Gly13Asp) 29.07 (0.95) 0/16 16/16   2017/2 NGS-2017-005 TP53 p.(Glu171*) 34.30 (1.76) 1/15 15/15   KIT p.(Asp816Val) 19.03 (1.67) 1/15 15/15   IDH2 p.(Arg140Gln) 20.88 (1.11) 3/15 15/15   IDH1 p.(Arg132Gly) 5.30 (0.60) 1/15 15/15   FLT3 p.(Asp835Tyr) 4 11.46 (0.86) 1/14 14/15   NGS-2017-006 JAK2 p.(Val617Phe) 21.00 (0.87) 2/15 15/15   IDH2 p.(Arg172Ser) 30.95 (0.83) 1/14 14/15   IDH1 p.(Arg132Ser) 11.05 (1.12) 1/14 14/15   SF3B1 p.(Lys700Glu) 4 10.65 (1.24) 2/12 12/15   NGS-2017-007 SF3B1 p.(Lys666Asn) 4 24.76 (2.63) 2/15 15/15   TP53 p.(Ala161Asp) 47.45 (2.73) 2/14 14/15   TP53 p.(Tyr220Cys) 5.12 (0.63) 1/13 13/15   2018/1 NGS-2018-001 BRCA1 p.(Arg1443*) 11 (0.22) 1/8 12/12   BRCA2 p.(Asn1784Thrfs*7) 12 (0.13) 1/7 11/12   BRCA2 p.(Lys1691Asnfs*15) 13 (0.23) 1/7 11/12   NGS-2018-002 BRCA2 p.(Asn1784Thrfs*7) 20.7 (0.43) 1/7 11/12   NGS-2018-003 BRCA2 p.(Asn1784Thrfs*7) 25.6 (0.61) 0/7 11/12   BRCA2 p.(Ile2675Aspfs*6) 24 (0.68) 1/7 11/12   "}], "citations": {"NLM": "Delcourt T, Vanneste K, Soumali MR, Coucke W, Ghislain V, Hebrant A, Van Valckenborgh E, De Keersmaecker SCJ, Roosens NH, Van De Walle P, Van Den Bulcke M, Antoniou A. NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program. Cancers (Basel). PMID: 33138022", "BibTeX": "@article{33138022, title={NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program.}, author={Delcourt T and Vanneste K and Soumali MR and Coucke W and Ghislain V and Hebrant A and Van Valckenborgh E and De Keersmaecker SCJ and Roosens NH and Van De Walle P and Van Den Bulcke M and Antoniou A}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 26743474, "pmcid": "PMC4980656", "title": "Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas", "journal": "Mod Pathol", "authors": ["Karnezis AN", "Hoang LN", "Coatham M", "Ravn S", "Almadani N", "Tessier-Cloutier B", "Irving J", "Meng B", "Li X", "Chow C", "McAlpine J", "Kuo KT", "Mao TL", "Djordjevic B", "Soslow RA", "Huntsman DG", "Blake Gilks C", "K\u00f6bel M", "Lee CH"], "date": "2016-03-01T00:00:00Z", "year": 2016, "snippets": [{"_id": "26743474@34179", "snip_text": "Case\tAge\tHistology\tStage\tMMR IHC\tMutations in EC\tMutations in UC\tSMARCA4 IHC\tSMARCB1 IHC\t \t1\t54\t90% EC1, 10% UC\t1A\tMMR-intact\t\tMSH6 (A25S), PIK3R1 (K567E, R461X), PIK3R2 (R574Q), POLE (M1L, S459F), PTEN (R130L, S59X), SPOP (D140N)\tEC: Intact, UC: intact\tEC: Intact, UC: deficient\t \t2\t55\t20% EC2, 80% UC\t3B\tMLH1 and PMS2 loss\tARID1A (f.s. x 3, R1749K), CTNNB1 (S33A), FBXW7 (A423T), JAK1 (f.s.), PIK3CA (E545K), POLE (S2231N), PTEN (deletion, f.s.), RPL22 (f.s.)\tARID1A (f.s. x 3, R1749K), CTNNB1 (S33A), FBXW7 (A423T), JAK1 (f.s.), PIK3CA (E545K), POLE (S2231N), PTEN (deletion, f.s.), RPL22 (f.s.)\tEC: Intact, UC: intact\tEC: Intact, UC: intact\t \t3\t70\t10% EC1, 90% UC\t3C1\tPMS2 loss\t\tARID1A (f.s. x 2), FBXW7 (R399Q), KRAS (A146T), PIK3CA (E545A), POLE (R573L), PTEN (f.s.x 2, L139X), SMARCA4 (f.s. C1046R)\tEC: Intact, UC: deficient\tEC: Intact, UC: intact\t \t4\t73\t10% EC1, 90% UC\t1A\tMLH1 and PMS2 loss\t\tARID1A (W1498X), KRAS (G12A), PIK3CA (E545K, V344M), PTEN (K128N), SMARCA4 (f.s., Q756X), SPOP (E50K)\tEC: Intact, UC: deficient\tEC: Intact, UC: intact\t \t5\t66\t70% EC1, 30% UC\t1B\tPMS2 loss\tARID1A (f.s., N102S), CTNNB1 (T41A), JAK1 (f.s. x 2), MSH2 (f.s.), PIK3R1 (f.s.), PTEN (f.s.), RPL22 (f.s.), SMARCA4 (P327S)\tARID1A (f.s.), JAK1 (f.s. x 2), KRAS (G12D), MSH2 (f.s.), PTEN (f.s.), RPL22 (f.s.), SMARCA4 (f.s.x 2, R1203C)\tEC: Intact, UC: deficient\tEC: Intact, UC: intact\t \t6\t73\t30% EC1, 70% UC\t1B\tMLH1 and PMS2 loss\tFBXW7 (deletion), HRAS (R68W), JAK1 (f.s., Y412X), PIK3CA (N575K, H1047L), PTEN (Y68X, f.s.), PPP2R1A (R418Q)\tFBXW7 (R49P), JAK1 (f.s., Y412X), PIK3CA (N575K, H1047L), PTEN (Y68X, f.s.), PPP2R1A (R418Q)\tEC: Intact, UC: intact\tEC: Intact, UC: intact\t \t7\t51\t60% EC1, 40% UC\t3C2\tMLH1 and PMS2 loss\tARID1A (f.s.), JAK1 (f.s.), KRAS (G12V), PIK3R1 (deletion), PTEN (f.s.), RNF43 (f.s.), RPL22 (f.s.)\tARID1A (f.s.), JAK1 (f.s.), KRAS (G12V), PIK3R1 (deletion), POLE (R1284Q), PTEN (f.s.), RNF43 (f.s.), RPL22 (f.s.), SMARCA4 (f.s.), TP53 (R26C)\tEC: Intact, UC: deficient\tEC: Intact, UC: intact\t \t8\t46\t5% EC2, 95% UC\t1A\tMMR-intact\t\tARID1A (Q1172X), FGFR2 (E413D), MSH2 (E580X, K918N), PIK3CA (R93W, T1025A), PIK3R1 (E217K), PMS2 (R563X, E172A), POLE (V411L), PTEN (E299X), SPOP (K101T), SMARCA4 (R549C)\tEC: Intact, UC: intact\tEC: Intact, UC: deficient\t \t", "section": "table", "mentions": ["1213|6|gene|ncbi_gene@8289|ARID1A", "1586|4|gene|ncbi_gene@5728|PTEN", "901|6|gene|ncbi_gene@8289|ARID1A", "702|5|gene|ncbi_gene@55294|FBXW7", "1418|5|gene|ncbi_gene@55294|FBXW7", "1528|5|gene|ncbi_gene@55294|FBXW7", "2148|5|variant|litvar@#5395#p.E172A&&&litvar@#5395#|E172A", "761|4|gene|ncbi_gene@5728|PTEN", "367|5|gene|ncbi_gene@55294|FBXW7", "2088|5|variant|litvar@#5290#p.K918N&&&litvar@#5290#|K918N", "739|5|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123342#rs121913274##|E545A", "1197|7|gene|ncbi_gene@6597|SMARCA4", "1879|6|variant|litvar@#5728#p.R1284Q&&&litvar@#5728#|R1284Q", "1102|5|variant|litvar@rs1274671450##&&&litvar@#5395#|N102S", "140|6|gene|ncbi_gene@5295|PIK3R1", "2176|5|variant|litvar@rs1114167674##&&&litvar@#5728#|E299X", "1399|4|gene|ncbi_gene@4292|MLH1", "881|4|gene|ncbi_gene@4292|MLH1", "519|4|gene|ncbi_gene@3716|JAK1", "480|6|variant|litvar@rs370901533##&&&litvar@#8289#&&&litvar@CA707652#rs370901533##|R1749K", "2110|6|variant|litvar@rs397517202##&&&litvar@#5290#&&&litvar@CA136374#rs397517202##|T1025A", "190|5|variant|litvar@#5728#p.S459F&&&litvar@#5728#|S459F", "2127|5|variant|litvar@rs540361957##&&&litvar@#5295#&&&litvar@CA3290118#rs540361957##|E217K", "1155|6|gene|ncbi_gene@5295|PIK3R1", "65|7|gene|ncbi_gene@6597|SMARCA4", "2075|4|gene|ncbi_gene@4436|MSH2", "709|5|variant|litvar@rs866987936##&&&litvar@#55294#&&&litvar@CA16602856#rs866987936##|R399Q", "325|6|gene|ncbi_gene@8289|ARID1A", "374|5|variant|litvar@rs587778619##&&&litvar@#5395#&&&litvar@CA9449#rs587778619##|A423T", "417|6|variant|litvar@#5728#p.S2231N&&&litvar@#5728#|S2231N", "1493|4|gene|ncbi_gene@5728|PTEN", "1929|7|gene|ncbi_gene@6597|SMARCA4", "1741|4|gene|ncbi_gene@3845|KRAS", "1773|4|gene|ncbi_gene@5728|PTEN", "218|4|gene|ncbi_gene@8405|SPOP", "395|6|gene|ncbi_gene@5290|PIK3CA", "1245|4|gene|ncbi_gene@3845|KRAS", "1888|4|gene|ncbi_gene@5728|PTEN", "2104|4|variant|litvar@rs1264843487##&&&litvar@#5295#|R93W", "909|6|variant|litvar@#8289#p.W1498X&&&litvar@#8289#|W1498X", "155|5|variant|litvar@rs1057519838##&&&litvar@#5295#|R461X", "1713|6|gene|ncbi_gene@8289|ARID1A", "672|4|gene|ncbi_gene@5395|PMS2", "1251|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "224|5|variant|litvar@rs1269228161##&&&litvar@#5295#|D140N", "306|4|gene|ncbi_gene@4292|MLH1", "1408|4|gene|ncbi_gene@5395|PMS2", "1499|4|variant|litvar@rs773176120##&&&litvar@#5728#|Y68X", "1747|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "127|4|gene|ncbi_gene@2956|MSH6", "753|5|variant|litvar@rs761402403##&&&litvar@#5295#&&&litvar@CA3290461#rs761402403##|R573L", "1605|7|gene|ncbi_gene@5518|PPP2R1A", "2170|4|gene|ncbi_gene@5728|PTEN", "1592|4|variant|litvar@rs773176120##&&&litvar@#5728#|Y68X", "960|5|variant|litvar@rs1114167645##&&&litvar@#5728#|K128N", "1570|5|variant|litvar@rs1064796017##&&&litvar@#5728#|N575K", "1786|5|gene|ncbi_gene@54894|RNF43", "1170|4|gene|ncbi_gene@5728|PTEN", "776|5|variant|litvar@rs1085308048##&&&litvar@#5728#|L139X", "954|4|gene|ncbi_gene@5728|PTEN", "2190|5|variant|litvar@#8405#p.K101T&&&litvar@#8405#|K101T", "426|4|gene|ncbi_gene@5728|PTEN", "1521|5|variant|litvar@rs1486388431##&&&litvar@#5518#|R418Q", "211|4|variant|litvar@rs1060500116##&&&litvar@#5728#|S59X", "511|5|variant|litvar@rs587778619##&&&litvar@#5395#&&&litvar@CA9449#rs587778619##|A423T", "1258|4|gene|ncbi_gene@4436|MSH2", "2067|5|variant|litvar@rs1221484522##&&&litvar@#2956#|E413D", "918|4|gene|ncbi_gene@3845|KRAS", "1442|4|variant|litvar@rs2287499##&&&litvar@#7157#|R68W", "924|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "540|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "1183|5|gene|ncbi_gene@6146|RPL22", "1469|6|gene|ncbi_gene@5290|PIK3CA", "1847|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1535|4|variant|litvar@rs876660161##&&&litvar@#5395#&&&litvar@CA10578711#rs876660161##|R49P", "1512|7|gene|ncbi_gene@5518|PPP2R1A", "1206|5|variant|litvar@rs17881470##&&&litvar@#7157#|P327S", "504|5|gene|ncbi_gene@55294|FBXW7", "449|5|gene|ncbi_gene@6146|RPL22", "315|4|gene|ncbi_gene@5395|PMS2", "77|7|gene|ncbi_gene@6598|SMARCB1", "731|6|gene|ncbi_gene@5290|PIK3CA", "1142|4|gene|ncbi_gene@4436|MSH2", "2162|5|variant|litvar@rs1196350669##&&&litvar@#4292#|V411L", "991|4|gene|ncbi_gene@8405|SPOP", "784|7|gene|ncbi_gene@6597|SMARCA4", "1915|5|gene|ncbi_gene@6146|RPL22", "2198|7|gene|ncbi_gene@6597|SMARCA4", "1298|7|gene|ncbi_gene@6597|SMARCA4", "489|6|gene|ncbi_gene@1499|CTNNB1", "1542|4|gene|ncbi_gene@3716|JAK1", "1271|4|gene|ncbi_gene@5728|PTEN", "171|5|variant|litvar@#5296#p.R574Q&&&litvar@#5296#|R574Q", "968|7|gene|ncbi_gene@6597|SMARCA4", "462|6|gene|ncbi_gene@8289|ARID1A", "890|4|gene|ncbi_gene@5395|PMS2", "1461|5|variant|litvar@#5290#p.Y412X&&&litvar@#5290#|Y412X", "1694|4|gene|ncbi_gene@4292|MLH1", "2119|6|gene|ncbi_gene@5295|PIK3R1", "2081|5|variant|litvar@rs63751411##&&&litvar@#4436#&&&litvar@CA19142#rs63751411##|E580X", "554|6|variant|litvar@#5728#p.S2231N&&&litvar@#5728#|S2231N", "1841|4|gene|ncbi_gene@3845|KRAS", "204|5|variant|litvar@rs121909229##&&&litvar@#5728#|R130L", "198|4|gene|ncbi_gene@5728|PTEN", "939|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "723|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1316|6|variant|litvar@#6597#p.R1203C&&&litvar@#6597#|R1203C", "1614|5|variant|litvar@rs1486388431##&&&litvar@#5518#|R418Q", "717|4|gene|ncbi_gene@3845|KRAS", "1110|6|gene|ncbi_gene@1499|CTNNB1", "532|6|gene|ncbi_gene@5290|PIK3CA", "798|6|variant|litvar@#4292#p.C1046R&&&litvar@#4292#|C1046R", "2051|6|variant|litvar@#8289#p.Q1172X&&&litvar@#8289#|Q1172X", "1284|5|gene|ncbi_gene@6146|RPL22", "497|4|variant|litvar@rs1057519886##&&&litvar@#1499#|S33A", "2207|5|variant|litvar@rs1210247690##&&&litvar@#1499#|R549C", "1118|4|variant|litvar@rs121913412##&&&litvar@#1499#&&&litvar@CA74088767#rs121913412##|T41A", "1228|4|gene|ncbi_gene@3716|JAK1", "1728|4|gene|ncbi_gene@3716|JAK1", "1754|6|gene|ncbi_gene@5295|PIK3R1", "1562|6|gene|ncbi_gene@5290|PIK3CA", "946|5|variant|litvar@rs1057519942##&&&litvar@#5290#|V344M", "1484|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|H1047L", "1945|4|gene|ncbi_gene@7157|TP53", "563|4|gene|ncbi_gene@5728|PTEN", "983|5|variant|litvar@#8405#p.Q756X&&&litvar@#8405#|Q756X", "1449|4|gene|ncbi_gene@3716|JAK1", "148|5|variant|litvar@rs63751149##&&&litvar@#4436#|K567E", "1901|5|gene|ncbi_gene@54894|RNF43", "2184|4|gene|ncbi_gene@8405|SPOP", "1800|5|gene|ncbi_gene@6146|RPL22", "163|6|gene|ncbi_gene@5296|PIK3R2", "1577|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|H1047L", "1078|4|gene|ncbi_gene@5395|PMS2", "133|4|variant|litvar@rs267608026##&&&litvar@#2956#&&&litvar@CA16371#rs267608026##|A25S", "2135|4|gene|ncbi_gene@5395|PMS2", "1703|4|gene|ncbi_gene@5395|PMS2", "2096|6|gene|ncbi_gene@5290|PIK3CA", "1125|4|gene|ncbi_gene@3716|JAK1", "352|6|gene|ncbi_gene@1499|CTNNB1", "1951|4|variant|litvar@rs587780068##&&&litvar@#7157#&&&litvar@CA225#rs587780068##|R26C", "683|6|gene|ncbi_gene@8289|ARID1A", "2141|5|variant|litvar@rs587778618##&&&litvar@#5395#&&&litvar@CA10032#rs587778618##|R563X", "382|4|gene|ncbi_gene@3716|JAK1", "343|6|variant|litvar@rs370901533##&&&litvar@#8289#&&&litvar@CA707652#rs370901533##|R1749K", "931|6|gene|ncbi_gene@5290|PIK3CA", "586|5|gene|ncbi_gene@6146|RPL22", "997|4|variant|litvar@#8405#p.E50K&&&litvar@#8405#|E50K", "1828|4|gene|ncbi_gene@3716|JAK1", "1088|6|gene|ncbi_gene@8289|ARID1A", "1554|5|variant|litvar@#5290#p.Y412X&&&litvar@#5290#|Y412X", "1854|6|gene|ncbi_gene@5295|PIK3R1", "360|4|variant|litvar@rs1057519886##&&&litvar@#1499#|S33A", "1813|6|gene|ncbi_gene@8289|ARID1A", "403|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "2043|6|gene|ncbi_gene@8289|ARID1A", "2060|5|gene|ncbi_gene@2263|FGFR2", "1477|5|variant|litvar@rs1064796017##&&&litvar@#5728#|N575K"], "figure_id": "T1", "text_hl": "Case\tAge\tHistology\tStage\tMMR IHC\tMutations in EC\tMutations in UC\tSMARCA4 IHC\tSMARCB1 IHC\t \t1\t54\t90% EC1, 10% UC\t1A\tMMR-intact\t\tMSH6 (A25S), PIK3R1 (K567E, R461X), PIK3R2 (R574Q), POLE (M1L, S459F), PTEN (R130L, S59X), SPOP (D140N)\tEC: Intact, UC: intact\tEC: Intact, UC: deficient\t \t2\t55\t20% EC2, 80% UC\t3B\tMLH1 and PMS2 loss\tARID1A (f.s. x 3, R1749K), CTNNB1 (S33A), FBXW7 (A423T), JAK1 (f.s.), PIK3CA (E545K), POLE (S2231N), PTEN (deletion, f.s.), RPL22 (f.s.)\tARID1A (f.s. x 3, R1749K), CTNNB1 (S33A), FBXW7 (A423T), JAK1 (f.s.), PIK3CA (E545K), POLE (S2231N), PTEN (deletion, f.s.), RPL22 (f.s.)\tEC: Intact, UC: intact\tEC: Intact, UC: intact\t \t3\t70\t10% EC1, 90% UC\t3C1\tPMS2 loss\t\tARID1A (f.s. x 2), FBXW7 (R399Q), KRAS (<m>A146T</m>), PIK3CA (E545A), POLE (R573L), PTEN (f.s.x 2, L139X), SMARCA4 (f.s. C1046R)\tEC: Intact, UC: deficient\tEC: Intact, UC: intact\t \t4\t73\t10% EC1, 90% UC\t1A\tMLH1 and PMS2 loss\t\tARID1A (W1498X), KRAS (G12A), PIK3CA (E545K, V344M), PTEN (K128N), SMARCA4 (f.s., Q756X), SPOP (E50K)\tEC: Intact, UC: deficient\tEC: Intact, UC: intact\t \t5\t66\t70% EC1, 30% UC\t1B\tPMS2 loss\tARID1A (f.s., N102S), CTNNB1 (T41A), JAK1 (f.s. x 2), MSH2 (f.s.), PIK3R1 (f.s.), PTEN (f.s.), RPL22 (f.s.), SMARCA4 (P327S)\tARID1A (f.s.), JAK1 (f.s. x 2), KRAS (G12D), MSH2 (f.s.), PTEN (f.s.), RPL22 (f.s.), SMARCA4 (f.s.x 2, R1203C)\tEC: Intact, UC: deficient\tEC: Intact, UC: intact\t \t6\t73\t30% EC1, 70% UC\t1B\tMLH1 and PMS2 loss\tFBXW7 (deletion), HRAS (R68W), JAK1 (f.s., Y412X), PIK3CA (N575K, H1047L), PTEN (Y68X, f.s.), PPP2R1A (R418Q)\tFBXW7 (R49P), JAK1 (f.s., Y412X), PIK3CA (N575K, H1047L), PTEN (Y68X, f.s.), PPP2R1A (R418Q)\tEC: Intact, UC: intact\tEC: Intact, UC: intact\t \t7\t51\t60% EC1, 40% UC\t3C2\tMLH1 and PMS2 loss\tARID1A (f.s.), JAK1 (f.s.), KRAS (G12V), PIK3R1 (deletion), PTEN (f.s.), RNF43 (f.s.), RPL22 (f.s.)\tARID1A (f.s.), JAK1 (f.s.), KRAS (G12V), PIK3R1 (deletion), POLE (R1284Q), PTEN (f.s.), RNF43 (f.s.), RPL22 (f.s.), SMARCA4 (f.s.), TP53 (R26C)\tEC: Intact, UC: deficient\tEC: Intact, UC: intact\t \t8\t46\t5% EC2, 95% UC\t1A\tMMR-intact\t\tARID1A (Q1172X), FGFR2 (E413D), MSH2 (E580X, K918N), PIK3CA (R93W, T1025A), PIK3R1 (E217K), PMS2 (R563X, E172A), POLE (V411L), PTEN (E299X), SPOP (K101T), SMARCA4 (R549C)\tEC: Intact, UC: intact\tEC: Intact, UC: deficient\t \t"}], "citations": {"NLM": "Karnezis AN, Hoang LN, Coatham M, Ravn S, Almadani N, Tessier-Cloutier B, Irving J, Meng B, Li X, Chow C, McAlpine J, Kuo KT, Mao TL, Djordjevic B, Soslow RA, Huntsman DG, Blake Gilks C, K\u00f6bel M, Lee CH. Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas Mod Pathol. PMID: 26743474", "BibTeX": "@article{26743474, title={Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas}, author={Karnezis AN and Hoang LN and Coatham M and Ravn S and Almadani N and Tessier-Cloutier B and Irving J and Meng B and Li X and Chow C and McAlpine J and Kuo KT and Mao TL and Djordjevic B and Soslow RA and Huntsman DG and Blake Gilks C and K\u00f6bel M and Lee CH}, journal={Mod Pathol}}"}, "is_sup_mat_match": false}, {"pmid": 27852040, "pmcid": "PMC5471055", "title": "Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab.", "journal": "Oncotarget", "authors": ["Toledo RA", "Cubillo A", "Vega E", "Garralda E", "Alvarez R", "de la Varga LU", "Pascual JR", "S\u00e1nchez G", "Sarno F", "Prieto SH", "Perea S", "Lop\u00e9z-Casas PP", "L\u00f3pez-R\u00edos F", "Hidalgo M"], "date": "2017-05-23T00:00:00Z", "year": 2017, "snippets": [{"_id": "27852040@30697", "snip_text": "Life Technologies, USA) or FDA-approved Cobas mutation kits (Roche Molecular Diagnosis, Swiss): KRAS (G12S/R/C/V/A/D, G13D, Q61H, and A146T), NRAS (Q61K/R/L/H), BRAF (V600E), and PIK3CA (E542K, E545K/G, Q546K, M1043I, and H1047Y/R/L).", "section": "methods", "mentions": ["161|4|gene|ncbi_gene@673|BRAF", "210|6|variant|litvar@rs121913283##&&&litvar@#5290#&&&litvar@CA183868#rs121913283##|M1043I", "134|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "142|4|gene|ncbi_gene@4893|NRAS", "148|6|variant|litvar@rs11554290##&&&litvar@#4893#|Q61K/R", "222|10|variant|litvar@rs121913279##&&&litvar@#5290#|H1047Y/R/L", "96|4|gene|ncbi_gene@3845|KRAS", "118|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "194|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "179|6|gene|ncbi_gene@5290|PIK3CA", "187|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "203|5|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123338#rs121913286##|Q546K", "124|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "102|6|variant|litvar@rs121913530##&&&litvar@#3845#|G12S/R", "167|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E"], "text_hl": "Life Technologies, USA) or FDA-approved Cobas mutation kits (Roche Molecular Diagnosis, Swiss): KRAS (G12S/R/C/V/A/D, G13D, Q61H, and <m>A146T</m>), NRAS (Q61K/R/L/H), BRAF (V600E), and PIK3CA (E542K, E545K/G, Q546K, M1043I, and H1047Y/R/L)."}], "citations": {"NLM": "Toledo RA, Cubillo A, Vega E, Garralda E, Alvarez R, de la Varga LU, Pascual JR, S\u00e1nchez G, Sarno F, Prieto SH, Perea S, Lop\u00e9z-Casas PP, L\u00f3pez-R\u00edos F, Hidalgo M. Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab. Oncotarget. PMID: 27852040", "BibTeX": "@article{27852040, title={Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab.}, author={Toledo RA and Cubillo A and Vega E and Garralda E and Alvarez R and de la Varga LU and Pascual JR and S\u00e1nchez G and Sarno F and Prieto SH and Perea S and Lop\u00e9z-Casas PP and L\u00f3pez-R\u00edos F and Hidalgo M}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 28445144, "pmcid": "PMC5503526", "title": "Stroma-derived HGF drives metabolic adaptation of colorectal cancer to angiogenesis inhibitors.", "journal": "Oncotarget", "authors": ["Mira A", "Morello V", "C\u00e9spedes MV", "Perera T", "Comoglio PM", "Mangues R", "Michieli P"], "date": "2017-06-13T00:00:00Z", "year": 2017, "snippets": [{"_id": "28445144@15047", "snip_text": "   % apoptosisat 0.1% oxygen % apoptosisat 0.1 g/L glucose   CELL LINE KRAS BRAF CTR HGF CTR HGF   CACO-2 WT WT 3.7 +- 0.1 2.5 +- 0.2 7.3 +- 0.4 4.2 +- 0.1   COLO-320-DM WT WT 3.3 +- 0.2 2.4 +- 0.2 6.5 +- 0.4 3.3 +- 0.2   LIM-1215 WT WT 3.6 +- 0.3 2.4 +- 0.2 5.7 +- 0.4 4.1 +- 0.2   SW-48 WT WT 4.6 +- 0.4 3.6 +- 0.2 6.5 +- 0.4 3.9 +- 0.2   DLD-1 G13D WT 5.7 +- 0.4 4.3 +- 0.2 38.4 +- 1.3 20.6 +- 0.8   HCT-116 G13D WT 6.7 +- 1.2 4.5 +- 0.9 40.4 +- 1.8 21.4 +- 1.8   LOVO G13D WT 6.0 +- 0.4 4.4 +- 0.4 33.6 +- 1.0 17.1 +- 0.7   LS-1034 A146T WT 5.0 +- 0.4 3.0 +- 0.2 25.5 +- 1.7 12.5 +- 0.6   LS-123 G12S WT 5.2 +- 0.6 2.8 +- 0.3 20.1 +- 1.0 11.0 +- 0.9   LS-174T G12D WT 6.1 +- 0.4 4.3 +- 0.4 32.4 +- 1.2 20.5 +- 0.6   LS-180 G12D WT 6.6 +- 0.4 4.5 +- 0.3 26.1 +- 1.2 14.0 +- 0.7   SW-480 G12V WT 5.9 +- 0.2 4.0 +- 0.1 24.0 +- 0.9 12.3 +- 0.9   HT-29 WT V600E 7.5 +- 0.8 4.3 +- 0.3 22.9 +- 2.2 12.6 +- 1.3   RKO WT V600E 5.2 +- 0.3 3.0 +- 0.2 24.5 +- 0.6 12.1 +- 0.8   SW-1417 WT V600E 4.4 +- 0.2 2.1 +- 0.2 24.2 +- 0.8 11.8 +- 0.9   ", "section": "table", "mentions": ["347|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "600|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "664|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "158|8|cellline||COLO-320", "970|7|cellline||SW-1417", "916|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "283|5|cellline||SW-48", "403|7|cellline||HCT-116", "71|4|gene|ncbi_gene@3845|KRAS", "85|3|gene|ncbi_gene@3082|HGF", "472|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "536|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "981|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "909|3|cellline||RKO", "411|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "99|6|cellline||CACO-2", "93|3|gene|ncbi_gene@3082|HGF", "846|5|cellline||HT-29", "51|7|chemical|ncbi_mesh@D005947|glucose", "341|5|cellline||DLD-1", "790|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "855|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "727|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "222|8|cellline||LIM-1215", "22|6|chemical|ncbi_mesh@D010100|oxygen", "76|4|gene|ncbi_gene@673|BRAF"], "figure_id": "T1", "text_hl": "   % apoptosisat 0.1% oxygen % apoptosisat 0.1 g/L glucose   CELL LINE KRAS BRAF CTR HGF CTR HGF   CACO-2 WT WT 3.7 +- 0.1 2.5 +- 0.2 7.3 +- 0.4 4.2 +- 0.1   COLO-320-DM WT WT 3.3 +- 0.2 2.4 +- 0.2 6.5 +- 0.4 3.3 +- 0.2   LIM-1215 WT WT 3.6 +- 0.3 2.4 +- 0.2 5.7 +- 0.4 4.1 +- 0.2   SW-48 WT WT 4.6 +- 0.4 3.6 +- 0.2 6.5 +- 0.4 3.9 +- 0.2   DLD-1 G13D WT 5.7 +- 0.4 4.3 +- 0.2 38.4 +- 1.3 20.6 +- 0.8   HCT-116 G13D WT 6.7 +- 1.2 4.5 +- 0.9 40.4 +- 1.8 21.4 +- 1.8   LOVO G13D WT 6.0 +- 0.4 4.4 +- 0.4 33.6 +- 1.0 17.1 +- 0.7   LS-1034 <m>A146T</m> WT 5.0 +- 0.4 3.0 +- 0.2 25.5 +- 1.7 12.5 +- 0.6   LS-123 G12S WT 5.2 +- 0.6 2.8 +- 0.3 20.1 +- 1.0 11.0 +- 0.9   LS-174T G12D WT 6.1 +- 0.4 4.3 +- 0.4 32.4 +- 1.2 20.5 +- 0.6   LS-180 G12D WT 6.6 +- 0.4 4.5 +- 0.3 26.1 +- 1.2 14.0 +- 0.7   SW-480 G12V WT 5.9 +- 0.2 4.0 +- 0.1 24.0 +- 0.9 12.3 +- 0.9   HT-29 WT V600E 7.5 +- 0.8 4.3 +- 0.3 22.9 +- 2.2 12.6 +- 1.3   RKO WT V600E 5.2 +- 0.3 3.0 +- 0.2 24.5 +- 0.6 12.1 +- 0.8   SW-1417 WT V600E 4.4 +- 0.2 2.1 +- 0.2 24.2 +- 0.8 11.8 +- 0.9   "}], "citations": {"NLM": "Mira A, Morello V, C\u00e9spedes MV, Perera T, Comoglio PM, Mangues R, Michieli P. Stroma-derived HGF drives metabolic adaptation of colorectal cancer to angiogenesis inhibitors. Oncotarget. PMID: 28445144", "BibTeX": "@article{28445144, title={Stroma-derived HGF drives metabolic adaptation of colorectal cancer to angiogenesis inhibitors.}, author={Mira A and Morello V and C\u00e9spedes MV and Perera T and Comoglio PM and Mangues R and Michieli P}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 34520433, "pmcid": "PMC8670331", "title": "A review of research progress on mechanisms and overcoming strategies of acquired osimertinib resistance.", "journal": "Anticancer Drugs", "authors": ["Qu F", "Zhou Y", "Yu W"], "date": "2021-09-13T00:00:00Z", "year": 2021, "snippets": [{"_id": "34520433@14546", "snip_text": "In the Flaura study, KRAS mutations in patients who were treated with first-line osimertinib resistance are included: A146T (1%), G12C (1%), G12D (1%), A146T (1%), G12C (1%), G12D (1%) and BRAF V600E mutation occurred in 3% of patients (3/91).", "section": "other", "mentions": ["130|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "118|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "39|8|species|ncbi_taxonomy@9606|patients", "189|4|gene|ncbi_gene@673|BRAF", "175|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "164|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "227|8|species|ncbi_taxonomy@9606|patients", "141|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "194|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "7|6|gene|ncbi_gene@6790|Flaura", "152|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "21|4|gene|ncbi_gene@3845|KRAS", "81|11|chemical|ncbi_mesh@C000596361|osimertinib"], "text_hl": "In the Flaura study, KRAS mutations in patients who were treated with first-line osimertinib resistance are included: <m>A146T</m> (1%), G12C (1%), G12D (1%), <m>A146T</m> (1%), G12C (1%), G12D (1%) and BRAF V600E mutation occurred in 3% of patients (3/91)."}], "citations": {"NLM": "Qu F, Zhou Y, Yu W. A review of research progress on mechanisms and overcoming strategies of acquired osimertinib resistance. Anticancer Drugs. PMID: 34520433", "BibTeX": "@article{34520433, title={A review of research progress on mechanisms and overcoming strategies of acquired osimertinib resistance.}, author={Qu F and Zhou Y and Yu W}, journal={Anticancer Drugs}}"}, "is_sup_mat_match": false}, {"pmid": 34649278, "pmcid": "PMC8791580", "title": "Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival.", "journal": "Blood Adv", "authors": ["Chen T", "Ho M", "Briere J", "Moscvin M", "Czarnecki PG", "Anderson KC", "Blackwell TK", "Bianchi G"], "date": "2022-01-25T00:00:00Z", "year": 2022, "snippets": [{"_id": "34649278@34717", "snip_text": "KMS20 carries a G12S homozygous mutation in KRAS and a Y126X homozygous mutation in TP53; H929 is characterized by t(11;14), a G13D heterozygous mutation in NRAS, and TP53 WT status; and AMO1 harbors a t(12;14) heterozygous A146T KRAS mutation and WT TP53.", "section": "discussion", "mentions": ["167|4|gene|ncbi_gene@7157|TP53", "224|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "16|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "157|4|gene|ncbi_gene@4893|NRAS", "230|4|gene|ncbi_gene@3845|KRAS", "0|5|cellline||KMS20", "55|5|variant|litvar@#3845#p.Y126X&&&litvar@#3845#|Y126X", "44|4|gene|ncbi_gene@3845|KRAS", "251|4|gene|ncbi_gene@7157|TP53", "90|4|cellline||H929", "84|4|gene|ncbi_gene@7157|TP53", "127|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D"], "text_hl": "KMS20 carries a G12S homozygous mutation in KRAS and a Y126X homozygous mutation in TP53; H929 is characterized by t(11;14), a G13D heterozygous mutation in NRAS, and TP53 WT status; and AMO1 harbors a t(12;14) heterozygous <m>A146T</m> KRAS mutation and WT TP53."}], "citations": {"NLM": "Chen T, Ho M, Briere J, Moscvin M, Czarnecki PG, Anderson KC, Blackwell TK, Bianchi G. Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival. Blood Adv. PMID: 34649278", "BibTeX": "@article{34649278, title={Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival.}, author={Chen T and Ho M and Briere J and Moscvin M and Czarnecki PG and Anderson KC and Blackwell TK and Bianchi G}, journal={Blood Adv}}"}, "is_sup_mat_match": false}, {"pmid": 36849494, "pmcid": "PMC9971254", "title": "Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer.", "journal": "Nat Commun", "authors": ["Chmielecki J", "Gray JE", "Cheng Y", "Ohe Y", "Imamura F", "Cho BC", "Lin MC", "Majem M", "Shah R", "Rukazenkov Y", "Todd A", "Markovets A", "Barrett JC", "Hartmaier RJ", "Ramalingam SS"], "date": "2023-02-27T00:00:00Z", "year": 2023, "snippets": [{"_id": "36849494@10003", "snip_text": "Single acquired resistance mechanisms were detected in 23 (21%) patients, including nine (8%) with MET amplification, five (5%) with EGFR mutations, three (3%) with PIK3CA E545K, and one (1%) patient each with CDK6 amplification, CDK4 amplification, CCND1 amplification, KRAS A146T, BRAF V600E, and PIK3CA E453K.", "section": "results", "mentions": ["230|4|gene|ncbi_gene@1019|CDK4", "210|4|gene|ncbi_gene@1021|CDK6", "283|4|gene|ncbi_gene@673|BRAF", "276|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "165|6|gene|ncbi_gene@5290|PIK3CA", "64|8|species|ncbi_taxonomy@9606|patients", "271|4|gene|ncbi_gene@3845|KRAS", "172|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "288|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "99|3|gene|ncbi_gene@79811|MET", "299|6|gene|ncbi_gene@5290|PIK3CA", "133|4|gene|ncbi_gene@1956|EGFR", "250|5|gene|ncbi_gene@595|CCND1", "306|5|variant|litvar@rs1057519925##&&&litvar@#5290#|E453K", "192|7|species|ncbi_taxonomy@9606|patient"], "text_hl": "Single acquired resistance mechanisms were detected in 23 (21%) patients, including nine (8%) with MET amplification, five (5%) with EGFR mutations, three (3%) with PIK3CA E545K, and one (1%) patient each with CDK6 amplification, CDK4 amplification, CCND1 amplification, KRAS <m>A146T</m>, BRAF V600E, and PIK3CA E453K."}], "citations": {"NLM": "Chmielecki J, Gray JE, Cheng Y, Ohe Y, Imamura F, Cho BC, Lin MC, Majem M, Shah R, Rukazenkov Y, Todd A, Markovets A, Barrett JC, Hartmaier RJ, Ramalingam SS. Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer. Nat Commun. PMID: 36849494", "BibTeX": "@article{36849494, title={Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer.}, author={Chmielecki J and Gray JE and Cheng Y and Ohe Y and Imamura F and Cho BC and Lin MC and Majem M and Shah R and Rukazenkov Y and Todd A and Markovets A and Barrett JC and Hartmaier RJ and Ramalingam SS}, journal={Nat Commun}}"}, "is_sup_mat_match": false}, {"pmid": 36551560, "pmcid": "PMC9776941", "title": "Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study", "journal": "Cancers (Basel)", "authors": ["Valladares-Ayerbes M", "Garcia-Alfonso P", "Mu\u00f1oz Luengo J", "Pimentel Caceres PP", "Castillo Trujillo OA", "Vidal-Tocino R", "Llanos M", "Llorente Ayala B", "Limon Miron ML", "Salud A", "Cirera Nogueras L", "Garcia-Carbonero R", "Safont MJ", "Falco Ferrer E", "Aparicio J", "Vicente Conesa MA", "Guill\u00e9n-Ponce C", "Garcia-Teijido P", "Medina Magan MB", "Busquier I", "Salgado M", "Lloans\u00ed Vila A", "PERSEIDA Investigators"], "date": "2022-12-09T00:00:00Z", "year": 2022, "snippets": [{"_id": "36551560@9591", "snip_text": "The percentages of patients with mutations on different KRAS and NRAS exons (KRAS: exon 2, codons 12 [mutations: c.34G>A, c.34G>C, c.34G>T, c.35G>A, c.35G>C, c.35G>T] and 13 [c.38G>A]; exon 3, codon 61 [c.182A>T, c.183A>C, c.183A>T]; exon 4, codon 146 [c.436G>A]; NRAS: exon 2, codons 12 [c.35G>A] and 13 [c.38G>A]; exon 3, codon 61 [c.181C>A, c.182A>G, c.182A>T, c.183A>T, c.183A>C]) were also obtained.", "section": "methods", "mentions": ["354|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|c.182A>T", "364|8|variant|litvar@rs121913255##&&&litvar@#4893#&&&litvar@CA16042285#rs121913255##|c.183A>T", "203|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|c.182A>T", "140|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "149|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>C", "158|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "334|8|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C>A", "264|4|gene|ncbi_gene@4893|NRAS", "131|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>T", "122|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>C", "374|8|variant|litvar@rs121913255##&&&litvar@#4893#|c.183A>C", "213|8|variant|litvar@rs121913255##&&&litvar@#4893#|c.183A>C", "175|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "223|8|variant|litvar@rs121913255##&&&litvar@#4893#&&&litvar@CA16042285#rs121913255##|c.183A>T", "344|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A>G", "306|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "65|4|gene|ncbi_gene@4893|NRAS", "56|4|gene|ncbi_gene@3845|KRAS", "113|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G>A", "77|4|gene|ncbi_gene@3845|KRAS", "19|8|species|ncbi_taxonomy@9606|patients", "253|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "289|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A"], "text_hl": "The percentages of patients with mutations on different KRAS and NRAS exons (KRAS: exon 2, codons 12 [mutations: c.34G>A, c.34G>C, c.34G>T, c.35G>A, c.35G>C, c.35G>T] and 13 [c.38G>A]; exon 3, codon 61 [c.182A>T, c.183A>C, c.183A>T]; exon 4, codon 146 [c.436G>A]; NRAS: exon 2, codons 12 [c.35G>A] and 13 [c.38G>A]; exon 3, codon 61 [c.181C>A, c.182A>G, c.182A>T, c.183A>T, c.183A>C]) were also obtained."}], "citations": {"NLM": "Valladares-Ayerbes M, Garcia-Alfonso P, Mu\u00f1oz Luengo J, Pimentel Caceres PP, Castillo Trujillo OA, Vidal-Tocino R, Llanos M, Llorente Ayala B, Limon Miron ML, Salud A, Cirera Nogueras L, Garcia-Carbonero R, Safont MJ, Falco Ferrer E, Aparicio J, Vicente Conesa MA, Guill\u00e9n-Ponce C, Garcia-Teijido P, Medina Magan MB, Busquier I, Salgado M, Lloans\u00ed Vila A, PERSEIDA Investigators. Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study Cancers (Basel). PMID: 36551560", "BibTeX": "@article{36551560, title={Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study}, author={Valladares-Ayerbes M and Garcia-Alfonso P and Mu\u00f1oz Luengo J and Pimentel Caceres PP and Castillo Trujillo OA and Vidal-Tocino R and Llanos M and Llorente Ayala B and Limon Miron ML and Salud A and Cirera Nogueras L and Garcia-Carbonero R and Safont MJ and Falco Ferrer E and Aparicio J and Vicente Conesa MA and Guill\u00e9n-Ponce C and Garcia-Teijido P and Medina Magan MB and Busquier I and Salgado M and Lloans\u00ed Vila A and PERSEIDA Investigators}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 31597339, "pmcid": "PMC6827157", "title": "Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience", "journal": "Cancers (Basel)", "authors": ["Vitiello PP", "De Falco V", "Giunta EF", "Ciardiello D", "Cardone C", "Vitale P", "Zanaletti N", "Borrelli C", "Poliero L", "Terminiello M", "Arrichiello G", "Caputo V", "Famiglietti V", "Mattera Iacono V", "Marrone F", "Di Liello A", "Martini G", "Napolitano S", "Caraglia M", "Lombardi A", "Franco R", "De Vita F", "Morgillo F", "Troiani T", "Ciardiello F", "Martinelli E"], "date": "2019-10-08T00:00:00Z", "year": 2019, "snippets": [{"_id": "31597339@22853", "snip_text": "The mutations detected by the cartridges are: ctKRAS: exon 2 (G12 > C/R/S/A/D/V, G13 > D), exon 3 (A59 > E/G/T, Q61 > K/L/R/H), exon 4 (K117 > N, A146 > P/T/V); ctNRAS/BRAF/EGFR: NRAS exon 2 (G12 > C/S/A/D/V, G13 > D/V/R), exon 3 (A59 > T, Q61 > K/L/R/H), exon 4 (K117 > N, A146 > T/V), BRAF V600 > E/D/K/R, EGFR S492 > R. The limit of detection of the IdyllaTM platform for cfDNA is set at about 10,000 copies of WT DNA (about 30 ng) per milliliter.", "section": "methods", "mentions": ["168|4|gene|ncbi_gene@673|BRAF", "112|3|variant|litvar@#3845#|Q61", "231|7|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|A59 > T", "192|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12 > C", "313|8|variant|litvar@rs1057519860##&&&litvar@#1956#|S492 > R", "292|4|variant|litvar@rs113488022##&&&litvar@#673#|V600", "81|3|variant|litvar@rs112445441##&&&litvar@#3845#|G13", "274|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146 > T", "62|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12 > C", "287|4|gene|ncbi_gene@673|BRAF", "240|3|variant|litvar@#3845#|Q61", "209|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13 > D", "179|4|gene|ncbi_gene@4893|NRAS", "107|3|variant|litvar@#673#|G/T", "308|4|gene|ncbi_gene@1956|EGFR", "173|4|gene|ncbi_gene@1956|EGFR"], "text_hl": "The mutations detected by the cartridges are: ctKRAS: exon 2 (G12 > C/R/S/A/D/V, G13 > D), exon 3 (A59 > E/G/T, Q61 > K/L/R/H), exon 4 (K117 > N, A146 > P/T/V); ctNRAS/BRAF/EGFR: NRAS exon 2 (G12 > C/S/A/D/V, G13 > D/V/R), exon 3 (A59 > T, Q61 > K/L/R/H), exon 4 (K117 > N, A146 > T/V), BRAF V600 > E/D/K/R, EGFR S492 > R. The limit of detection of the IdyllaTM platform for cfDNA is set at about 10,000 copies of WT DNA (about 30 ng) per milliliter."}], "citations": {"NLM": "Vitiello PP, De Falco V, Giunta EF, Ciardiello D, Cardone C, Vitale P, Zanaletti N, Borrelli C, Poliero L, Terminiello M, Arrichiello G, Caputo V, Famiglietti V, Mattera Iacono V, Marrone F, Di Liello A, Martini G, Napolitano S, Caraglia M, Lombardi A, Franco R, De Vita F, Morgillo F, Troiani T, Ciardiello F, Martinelli E. Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience Cancers (Basel). PMID: 31597339", "BibTeX": "@article{31597339, title={Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience}, author={Vitiello PP and De Falco V and Giunta EF and Ciardiello D and Cardone C and Vitale P and Zanaletti N and Borrelli C and Poliero L and Terminiello M and Arrichiello G and Caputo V and Famiglietti V and Mattera Iacono V and Marrone F and Di Liello A and Martini G and Napolitano S and Caraglia M and Lombardi A and Franco R and De Vita F and Morgillo F and Troiani T and Ciardiello F and Martinelli E}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 34851763, "pmcid": "PMC8647259", "title": "Mutation analysis of a 10-gene panel for colorectal cancer in Huizhou, Guangdong Province of China.", "journal": "J Int Med Res", "authors": ["Li J", "Sun A", "Zhong G", "He Y", "Xiong H", "Yuan X"], "date": "2021-11-01T00:00:00Z", "year": 2021, "snippets": [{"_id": "34851763@8567", "snip_text": "There were 43 patients (50.6%) with KRAS mutations, including c.34G > A, c.34G > C, c.35G > T, c.35G > C, c.35G > A, c.38G > A, c.99T > G, c.176C > G, and c.436G > A. There were four patients (4.7%) with NRAS mutations, including c.34G > T, c.35G > T, c.38G > A, and c.38G > T. There were 17 patients (20%) with PIK3CA mutations, including c.253G > A, c.277C > T, c.1592T > C, c.1633G > A, c.1634A > G, c.1636C > G, c.1637A > G, c.2176G > A, and c.3140A > G. There were three patients (3.5%) with ERBB2 mutations, including c.2033G > A, c.2264T > C, c.2305G > T, and c.2329G > C. There were three patients (3.5%) with a BRAF mutation (c.1799T > A).", "section": "results", "mentions": ["183|8|species|ncbi_taxonomy@9606|patients", "403|11|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123331#rs121913286##|c.1636C > G", "267|9|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|c.38G > T", "106|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "84|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "36|4|gene|ncbi_gene@3845|KRAS", "155|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "597|8|species|ncbi_taxonomy@9606|patients", "390|11|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123336#rs121913274##|c.1634A > G", "14|8|species|ncbi_taxonomy@9606|patients", "62|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G > A", "117|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "446|11|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A > G", "377|11|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G > A", "352|10|variant|litvar@rs763786330##&&&litvar@#2064#&&&litvar@CA8533607#rs763786330##|c.277C > T", "241|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "537|11|variant|litvar@rs121913470##&&&litvar@#2064#&&&litvar@CA16602502#rs121913470##|c.2264T > C", "524|11|variant|litvar@rs1057519862##&&&litvar@#2064#|c.2033G > A", "497|5|gene|ncbi_gene@2064|ERBB2", "95|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > C", "635|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T > A", "364|11|variant|litvar@rs746397815##&&&litvar@#5156#&&&litvar@CA2922588#rs746397815##|c.1592T > C", "429|11|variant|litvar@rs867262025##&&&litvar@#5290#&&&litvar@CA16602910#rs867262025##|c.2176G > A", "340|10|variant|litvar@rs1272695341##&&&litvar@#2064#|c.253G > A", "567|11|variant|litvar@rs121913471##&&&litvar@#2064#|c.2329G > C", "128|9|variant|litvar@#3845#c.99T>G&&&litvar@#3845#|c.99T > G", "620|4|gene|ncbi_gene@673|BRAF", "252|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "550|11|variant|litvar@rs121913468##&&&litvar@#2064#|c.2305G > T", "292|8|species|ncbi_taxonomy@9606|patients", "312|6|gene|ncbi_gene@5290|PIK3CA", "416|11|variant|litvar@rs397517201##&&&litvar@#5290#&&&litvar@CA136371#rs397517201##|c.1637A > G", "73|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G > C", "139|10|variant|litvar@rs777307941##&&&litvar@#5156#&&&litvar@CA96847217#rs777307941##|c.176C > G", "204|4|gene|ncbi_gene@4893|NRAS", "476|8|species|ncbi_taxonomy@9606|patients", "230|9|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|c.34G > T"], "text_hl": "There were 43 patients (50.6%) with KRAS mutations, including c.34G > A, c.34G > C, c.35G > T, c.35G > C, c.35G > A, c.38G > A, c.99T > G, c.176C > G, and c.436G > A. There were four patients (4.7%) with NRAS mutations, including c.34G > T, c.35G > T, c.38G > A, and c.38G > T. There were 17 patients (20%) with PIK3CA mutations, including c.253G > A, c.277C > T, c.1592T > C, c.1633G > A, c.1634A > G, c.1636C > G, c.1637A > G, c.2176G > A, and c.3140A > G. There were three patients (3.5%) with ERBB2 mutations, including c.2033G > A, c.2264T > C, c.2305G > T, and c.2329G > C. There were three patients (3.5%) with a BRAF mutation (c.1799T > A)."}], "citations": {"NLM": "Li J, Sun A, Zhong G, He Y, Xiong H, Yuan X. Mutation analysis of a 10-gene panel for colorectal cancer in Huizhou, Guangdong Province of China. J Int Med Res. PMID: 34851763", "BibTeX": "@article{34851763, title={Mutation analysis of a 10-gene panel for colorectal cancer in Huizhou, Guangdong Province of China.}, author={Li J and Sun A and Zhong G and He Y and Xiong H and Yuan X}, journal={J Int Med Res}}"}, "is_sup_mat_match": false}, {"pmid": 34066481, "pmcid": "PMC8125778", "title": "Clinical Implication of Liquid Biopsy in Colorectal Cancer Patients Treated with Metastasectomy.", "journal": "Cancers (Basel)", "authors": ["Lee S", "Park YS", "Chang WJ", "Choi JY", "Lim A", "Kim B", "Lee SB", "Lee JW", "Kim SH", "Kim J", "Kwak JM", "Yoon KC", "Lee SH", "Kim YH"], "date": "2021-05-06T00:00:00Z", "year": 2021, "snippets": [{"_id": "34066481@34578", "snip_text": "No Synchronicity Variant Primary TissueVAF Metastatic TissueVAF MetaSite PreMctDNA PostMctDNA Recurence   No CTx  CTx  Rx CTx  Rx   ctNDA positive before metastasectomy   001 S TP53 I255F  49.8 SD 0.0 PR Liver0.1 cm 1.6 0.0 N   036 S APC R1114 * 44.2   31.0 PD Liver2.5 cm 21.0 0.0 N   APC R1450 * 21.5  17.0 11.0 0.0   KRAS G12D 46.5  34.0 19.0 0.0   008b S KRAS Q61R 48.8   53.7 PD Lung2.5 cm 9.6 0.0 Lung   TP53 R175H 49.5  54.1 6.4 0.0   028a S KRAS G12V 14.3   7.8 PD Liver 2.2 cm 0.0 0.0 PT   PIK3CA E545K 14.8  11. 1 1.3 0.0   PIK3CA G914R 14.9  10.2 0.0 0.0   SMAD4 E330Q 16.6  8.9 0.0 0.0   SMAD4 R361H/C 16.4  1.7 0.0 0.0   ctNDA negative before metastasectomy    004 S TP53 R273C 60.4   4.1 PR Liver0.8 cm 0.0 0.0 N   APC K1308 * 40.2  2.8 0.0 0.0   012 S KRAS G12V 14.6   0.0 CR Liver0 cm 0.0 0.0 N   PIK3CA H1047R 20.6  0.0 0.0 0.0   031b S APC R1114 * 8.1   11.6 SD Lung1.4 cm 0.0 0.0 N   APC E1345 * 8.1  15.4 0.0 0.0   KRAS G13C 13.4  9.1 0.0 0.0   042 M APC Q1378 * 47.5   36.2 PR Liver 2.5 cm 0.0 0.0 N   KRAS G12D 29.9  18.3 0.0 0.0   TP53 R175H 30.5  19.3 0.0 0.0   044 S CTNNB1 S45F 36.8   6.5 PR Liver2.2 cm 0.0 0.0 N   KRAS G12D 17.3  0.0 0.0 0.0   PTEN R335 * 5.2  0.0 0.0 0.0   057 S TP53 C275Y 26.5   36.9 SD Lung1.6 cm 0.0 0.0 N   091 S APC E1306 * 18.0   0.0 PR Liver0.8 cm 0.0 0.0 N   TP53 R175H 40.2  6.2 0.0 0.0   APC Q886 * 26.9  4.6 0.0 0.0   006 S KRAS G13C 37.2   10.7 PR Liver 1.6 cm 0.0 0.0 Bone   TP53 R306 * 34.9  9.1 0.0 0.0   011 M APC R876 * 30.6   0.0 PD Lung1.0 cm 0.0 0.0 Lung   KRAS E545K 34.3  2.2 0.0 0.0   TP53 R342 * 0.0  2.5 0.0 0.0   SMAD4 R361H 0.0  3.8 0.0 0.0   SMAD4 A118V 64.8  0.0 0.0 0.0   014 S KRAS Q61H 25.3   5.6 SD Liver 2.3 cm 0.0 0.0 PT   SMAD4 R361C 15.2  3.0 0.0 0.0   019 S PIK3CA G1049R  3.1 SD 3.6 SD Liver0.9 cm 0.0 0.0 Liver    020a S TP53 R196 *  38.5 SD 21.2 PR Liver2.5 cm 0.0 0.0 Liver   APC Q1294 *  25.4 13.8 0.0 0.0   027 S TP53 R175H  6.1 PR 2.6 PR Liver3.2 cm 0.0 0.0 Liver Lung    PTEN R335 *  1.1 0.0 0.0 0.0   037a S TP53 T211I 14.9   1.0 PR Liver0.5 cm 0.0 0.0 Liver    048 S APC R1450 *  1.5  0.0 PR Lung0.6 cm 0.0 0.0 Lung    CTNNB1 S37Y  0.0  21.2 0.0 0.0   KRAS G12D  1.4  0.0 0.0 0.0   PIK3CA E545K  2.0  0.0 0.0 0.0   TP53 R209Kfs  1.8  0 0.0 0.0   051b M KRAS G13S 0.0   1.1 PD Lung0.9 cm 0.0 0.0 Lung    PTEN R130Q 0.0   1.0 0.0 0.0   SMAD4 C115Y 0.0   1.2 0.0 0.0   TP53 R175H 10.7   40.0 0.0 0.0   052 S RB1 A201fs  0.0  5.5 PR Lung0.4 cm 0.0 0.0 Lung    055 S KRAS G13D 60.3   16.6 PR Liver3.5 cm 0.0 0.0 Liver    061b S TP53?  51.5 SD 27.1 SD Lung0.5 cm 0.0 0.0 Lung    APC H1490fs  30.2 19.5 0.0 0.0   063 S KRAS G12V BDL   5.3 PR Liver2.2 cm 0.0 0.0 Lung   KRAS A146T BDL   25.0 0.0 0.0   TP53 V173L BDL   2.4 0.0 0.0   APC P1381fs BDL   15.5 0.0 0.0   067 S TP53 M246R  23.2 SD 39.3 SD Rec 3.4 cm 0.0 0.0 PT   ", "section": "table", "mentions": ["177|4|gene|ncbi_gene@7157|TP53", "2177|6|gene|ncbi_gene@5290|PIK3CA", "2694|5|variant|litvar@rs876660754##&&&litvar@#7157#|V173L", "286|3|gene|ncbi_gene@324|APC", "534|6|gene|ncbi_gene@5290|PIK3CA", "1555|4|gene|ncbi_gene@7157|TP53", "2062|3|gene|ncbi_gene@324|APC", "1660|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "2248|4|gene|ncbi_gene@3845|KRAS", "1142|4|gene|ncbi_gene@3845|KRAS", "2147|4|gene|ncbi_gene@3845|KRAS", "1264|3|gene|ncbi_gene@324|APC", "325|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "935|4|gene|ncbi_gene@3845|KRAS", "2720|3|gene|ncbi_gene@324|APC", "940|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "2764|5|variant|litvar@rs587780074##&&&litvar@#7157#&&&litvar@CA376#rs587780074##|M246R", "1904|4|gene|ncbi_gene@7157|TP53", "820|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "2007|5|variant|litvar@#7157#p.T211I&&&litvar@#7157#|T211I", "1808|4|gene|ncbi_gene@7157|TP53", "903|3|gene|ncbi_gene@324|APC", "454|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1617|5|gene|ncbi_gene@4089|SMAD4", "2121|4|variant|litvar@#3845#p.S37Y&&&litvar@#3845#|S37Y", "1382|4|gene|ncbi_gene@3845|KRAS", "499|6|gene|ncbi_gene@5290|PIK3CA", "2002|4|gene|ncbi_gene@7157|TP53", "1319|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H", "2366|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H", "680|4|gene|ncbi_gene@7157|TP53", "729|3|gene|ncbi_gene@324|APC", "772|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "410|4|gene|ncbi_gene@7157|TP53", "1586|5|gene|ncbi_gene@4089|SMAD4", "2462|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1314|4|gene|ncbi_gene@7157|TP53", "1387|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "359|4|gene|ncbi_gene@3845|KRAS", "2361|4|gene|ncbi_gene@7157|TP53", "600|5|gene|ncbi_gene@4089|SMAD4", "2210|4|gene|ncbi_gene@7157|TP53", "1172|4|gene|ncbi_gene@5728|PTEN", "2724|7|variant|litvar@rs1131691145##&&&litvar@#324#|P1381fs", "1345|3|gene|ncbi_gene@324|APC", "1592|5|variant|litvar@rs377767347##&&&litvar@#4089#&&&litvar@CA128097#rs377767347##|R361H", "2335|5|variant|litvar@rs876659844##&&&litvar@#4089#&&&litvar@CA10580974#rs876659844##|C115Y", "541|5|variant|litvar@rs587776932##&&&litvar@#5290#&&&litvar@CA130467#rs587776932##|G914R", "2184|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "1655|4|gene|ncbi_gene@3845|KRAS", "2298|4|gene|ncbi_gene@5728|PTEN", "1865|3|gene|ncbi_gene@324|APC", "1054|4|gene|ncbi_gene@7157|TP53", "1909|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H", "2662|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "2518|4|gene|ncbi_gene@7157|TP53", "574|5|variant|litvar@#4089#p.E330Q&&&litvar@#4089#|E330Q", "1435|4|gene|ncbi_gene@7157|TP53", "320|4|gene|ncbi_gene@3845|KRAS", "1750|6|variant|litvar@rs121913277##&&&litvar@#5290#&&&litvar@CA16602520#rs121913277##|G1049R", "2253|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA16602445#rs121913535##|G13S", "1964|4|gene|ncbi_gene@5728|PTEN", "2657|4|gene|ncbi_gene@3845|KRAS", "971|3|gene|ncbi_gene@324|APC", "2152|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "449|4|gene|ncbi_gene@3845|KRAS", "2689|4|gene|ncbi_gene@7157|TP53", "1147|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2568|3|gene|ncbi_gene@324|APC", "1028|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "506|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "685|5|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|R273C", "1529|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "1023|4|gene|ncbi_gene@3845|KRAS", "2607|4|gene|ncbi_gene@3845|KRAS", "415|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H", "2329|5|gene|ncbi_gene@4089|SMAD4", "1524|4|gene|ncbi_gene@3845|KRAS", "2612|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1743|6|gene|ncbi_gene@5290|PIK3CA", "1705|5|gene|ncbi_gene@4089|SMAD4", "2404|6|variant|litvar@#7157#p.A201fsX&&&litvar@#7157#|A201fs", "606|7|variant|litvar@rs80338963##&&&litvar@#4089#|R361H/C", "2759|4|gene|ncbi_gene@7157|TP53", "767|4|gene|ncbi_gene@3845|KRAS", "2457|4|gene|ncbi_gene@3845|KRAS", "1214|5|variant|litvar@rs863224451##&&&litvar@#7157#&&&litvar@CA337141#rs863224451##|C275Y", "1623|5|variant|litvar@rs750600586##&&&litvar@#7157#&&&litvar@CA168#rs750600586##|A118V", "364|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|Q61R", "1473|3|gene|ncbi_gene@324|APC", "2303|5|variant|litvar@rs121909229##&&&litvar@#5728#&&&litvar@CA437#rs121909229##|R130Q", "1099|4|variant|litvar@#3845#p.S45F&&&litvar@#3845#|S45F", "1209|4|gene|ncbi_gene@7157|TP53", "1059|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H", "182|5|variant|litvar@rs1057519995##&&&litvar@#7157#|I255F", "234|3|gene|ncbi_gene@324|APC", "854|3|gene|ncbi_gene@324|APC", "2572|7|variant|litvar@#324#p.H1490fsX&&&litvar@#324#|H1490fs", "813|6|gene|ncbi_gene@5290|PIK3CA", "1711|5|variant|litvar@rs80338963##&&&litvar@#4089#&&&litvar@CA128095#rs80338963##|R361C", "568|5|gene|ncbi_gene@4089|SMAD4"], "figure_id": "cancers-13-02231-t004", "text_hl": "No Synchronicity Variant Primary TissueVAF Metastatic TissueVAF MetaSite PreMctDNA PostMctDNA Recurence   No CTx  CTx  Rx CTx  Rx   ctNDA positive before metastasectomy   001 S TP53 I255F  49.8 SD 0.0 PR Liver0.1 cm 1.6 0.0 N   036 S APC R1114 * 44.2   31.0 PD Liver2.5 cm 21.0 0.0 N   APC R1450 * 21.5  17.0 11.0 0.0   KRAS G12D 46.5  34.0 19.0 0.0   008b S KRAS Q61R 48.8   53.7 PD Lung2.5 cm 9.6 0.0 Lung   TP53 R175H 49.5  54.1 6.4 0.0   028a S KRAS G12V 14.3   7.8 PD Liver 2.2 cm 0.0 0.0 PT   PIK3CA E545K 14.8  11. 1 1.3 0.0   PIK3CA G914R 14.9  10.2 0.0 0.0   SMAD4 E330Q 16.6  8.9 0.0 0.0   SMAD4 R361H/C 16.4  1.7 0.0 0.0   ctNDA negative before metastasectomy    004 S TP53 R273C 60.4   4.1 PR Liver0.8 cm 0.0 0.0 N   APC K1308 * 40.2  2.8 0.0 0.0   012 S KRAS G12V 14.6   0.0 CR Liver0 cm 0.0 0.0 N   PIK3CA H1047R 20.6  0.0 0.0 0.0   031b S APC R1114 * 8.1   11.6 SD Lung1.4 cm 0.0 0.0 N   APC E1345 * 8.1  15.4 0.0 0.0   KRAS G13C 13.4  9.1 0.0 0.0   042 M APC Q1378 * 47.5   36.2 PR Liver 2.5 cm 0.0 0.0 N   KRAS G12D 29.9  18.3 0.0 0.0   TP53 R175H 30.5  19.3 0.0 0.0   044 S CTNNB1 S45F 36.8   6.5 PR Liver2.2 cm 0.0 0.0 N   KRAS G12D 17.3  0.0 0.0 0.0   PTEN R335 * 5.2  0.0 0.0 0.0   057 S TP53 C275Y 26.5   36.9 SD Lung1.6 cm 0.0 0.0 N   091 S APC E1306 * 18.0   0.0 PR Liver0.8 cm 0.0 0.0 N   TP53 R175H 40.2  6.2 0.0 0.0   APC Q886 * 26.9  4.6 0.0 0.0   006 S KRAS G13C 37.2   10.7 PR Liver 1.6 cm 0.0 0.0 Bone   TP53 R306 * 34.9  9.1 0.0 0.0   011 M APC R876 * 30.6   0.0 PD Lung1.0 cm 0.0 0.0 Lung   KRAS E545K 34.3  2.2 0.0 0.0   TP53 R342 * 0.0  2.5 0.0 0.0   SMAD4 R361H 0.0  3.8 0.0 0.0   SMAD4 A118V 64.8  0.0 0.0 0.0   014 S KRAS Q61H 25.3   5.6 SD Liver 2.3 cm 0.0 0.0 PT   SMAD4 R361C 15.2  3.0 0.0 0.0   019 S PIK3CA G1049R  3.1 SD 3.6 SD Liver0.9 cm 0.0 0.0 Liver    020a S TP53 R196 *  38.5 SD 21.2 PR Liver2.5 cm 0.0 0.0 Liver   APC Q1294 *  25.4 13.8 0.0 0.0   027 S TP53 R175H  6.1 PR 2.6 PR Liver3.2 cm 0.0 0.0 Liver Lung    PTEN R335 *  1.1 0.0 0.0 0.0   037a S TP53 T211I 14.9   1.0 PR Liver0.5 cm 0.0 0.0 Liver    048 S APC R1450 *  1.5  0.0 PR Lung0.6 cm 0.0 0.0 Lung    CTNNB1 S37Y  0.0  21.2 0.0 0.0   KRAS G12D  1.4  0.0 0.0 0.0   PIK3CA E545K  2.0  0.0 0.0 0.0   TP53 R209Kfs  1.8  0 0.0 0.0   051b M KRAS G13S 0.0   1.1 PD Lung0.9 cm 0.0 0.0 Lung    PTEN R130Q 0.0   1.0 0.0 0.0   SMAD4 C115Y 0.0   1.2 0.0 0.0   TP53 R175H 10.7   40.0 0.0 0.0   052 S RB1 A201fs  0.0  5.5 PR Lung0.4 cm 0.0 0.0 Lung    055 S KRAS G13D 60.3   16.6 PR Liver3.5 cm 0.0 0.0 Liver    061b S TP53?  51.5 SD 27.1 SD Lung0.5 cm 0.0 0.0 Lung    APC H1490fs  30.2 19.5 0.0 0.0   063 S KRAS G12V BDL   5.3 PR Liver2.2 cm 0.0 0.0 Lung   KRAS <m>A146T</m> BDL   25.0 0.0 0.0   TP53 V173L BDL   2.4 0.0 0.0   APC P1381fs BDL   15.5 0.0 0.0   067 S TP53 M246R  23.2 SD 39.3 SD Rec 3.4 cm 0.0 0.0 PT   "}], "citations": {"NLM": "Lee S, Park YS, Chang WJ, Choi JY, Lim A, Kim B, Lee SB, Lee JW, Kim SH, Kim J, Kwak JM, Yoon KC, Lee SH, Kim YH. Clinical Implication of Liquid Biopsy in Colorectal Cancer Patients Treated with Metastasectomy. Cancers (Basel). PMID: 34066481", "BibTeX": "@article{34066481, title={Clinical Implication of Liquid Biopsy in Colorectal Cancer Patients Treated with Metastasectomy.}, author={Lee S and Park YS and Chang WJ and Choi JY and Lim A and Kim B and Lee SB and Lee JW and Kim SH and Kim J and Kwak JM and Yoon KC and Lee SH and Kim YH}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 36204688, "pmcid": "PMC9529062", "title": "Duplex Sequencing Uncovers Recurrent Low-frequency Cancer-associated Mutations in Infant and Childhood KMT2A-rearranged Acute Leukemia.", "journal": "Hemasphere", "authors": ["Pilheden M", "Ahlgren L", "Hyrenius-Wittsten A", "Gonzalez-Pena V", "Sturesson H", "Hansen Marquart HV", "Lausen B", "Castor A", "Pronk CJ", "Barbany G", "Pokrovskaja Tamm K", "Fogelstrand L", "Lohi O", "Nor\u00e9n-Nystr\u00f6m U", "Asklin J", "Chen Y", "Song G", "Walsh M", "Ma J", "Zhang J", "Saal LH", "Gawad C", "Hagstr\u00f6m-Andersson AK"], "date": "2022-09-30T00:00:00Z", "year": 2022, "snippets": [{"_id": "36204688@22283", "snip_text": "Further, P28 had a KRASA146T, which never surpassed 4% of cells and P3 had a diagnostic TP53R248Q in 2% of cells which was lost at relapse.", "section": "results", "mentions": ["19|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T"], "text_hl": "Further, P28 had a KRASA146T, which never surpassed 4% of cells and P3 had a diagnostic TP53R248Q in 2% of cells which was lost at relapse."}], "citations": {"NLM": "Pilheden M, Ahlgren L, Hyrenius-Wittsten A, Gonzalez-Pena V, Sturesson H, Hansen Marquart HV, Lausen B, Castor A, Pronk CJ, Barbany G, Pokrovskaja Tamm K, Fogelstrand L, Lohi O, Nor\u00e9n-Nystr\u00f6m U, Asklin J, Chen Y, Song G, Walsh M, Ma J, Zhang J, Saal LH, Gawad C, Hagstr\u00f6m-Andersson AK. Duplex Sequencing Uncovers Recurrent Low-frequency Cancer-associated Mutations in Infant and Childhood KMT2A-rearranged Acute Leukemia. Hemasphere. PMID: 36204688", "BibTeX": "@article{36204688, title={Duplex Sequencing Uncovers Recurrent Low-frequency Cancer-associated Mutations in Infant and Childhood KMT2A-rearranged Acute Leukemia.}, author={Pilheden M and Ahlgren L and Hyrenius-Wittsten A and Gonzalez-Pena V and Sturesson H and Hansen Marquart HV and Lausen B and Castor A and Pronk CJ and Barbany G and Pokrovskaja Tamm K and Fogelstrand L and Lohi O and Nor\u00e9n-Nystr\u00f6m U and Asklin J and Chen Y and Song G and Walsh M and Ma J and Zhang J and Saal LH and Gawad C and Hagstr\u00f6m-Andersson AK}, journal={Hemasphere}}"}, "is_sup_mat_match": false}, {"pmid": 31668570, "pmcid": "PMC6945285", "title": "An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer.", "journal": "EBioMedicine", "authors": ["Wang H", "Lv Q", "Xu Y", "Cai Z", "Zheng J", "Cheng X", "Dai Y", "J\u00e4nne PA", "Ambrogio C", "K\u00f6hler J"], "date": "2019-10-23T00:00:00Z", "year": 2019, "snippets": [{"_id": "31668570@18855", "snip_text": "To investigate MEK/ERK inhibitor sensitivities for different KRAS mutant isoforms across cancer histotypes, we grouped cancer cell lines based on their KRAS mutation status into 12 groups (A146T, G12A, G12C, G12D, G12R, G12S, G12V, G13C, G13D, K117N, Q61H, Q61L).", "section": "results", "mentions": ["19|3|gene|ncbi_gene@5594|ERK", "202|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "214|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "232|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "15|3|gene|ncbi_gene@5609|MEK", "152|4|gene|ncbi_gene@3845|KRAS", "226|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "89|6|disease|ncbi_mesh@D009369|cancer", "251|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "196|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "238|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "61|4|gene|ncbi_gene@3845|KRAS", "119|6|disease|ncbi_mesh@D009369|cancer", "208|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "244|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "220|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "189|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "257|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L"], "text_hl": "To investigate MEK/ERK inhibitor sensitivities for different KRAS mutant isoforms across cancer histotypes, we grouped cancer cell lines based on their KRAS mutation status into 12 groups (<m>A146T</m>, G12A, G12C, G12D, G12R, G12S, G12V, G13C, G13D, K117N, Q61H, Q61L)."}], "citations": {"NLM": "Wang H, Lv Q, Xu Y, Cai Z, Zheng J, Cheng X, Dai Y, J\u00e4nne PA, Ambrogio C, K\u00f6hler J. An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer. EBioMedicine. PMID: 31668570", "BibTeX": "@article{31668570, title={An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer.}, author={Wang H and Lv Q and Xu Y and Cai Z and Zheng J and Cheng X and Dai Y and J\u00e4nne PA and Ambrogio C and K\u00f6hler J}, journal={EBioMedicine}}"}, "is_sup_mat_match": false}, {"pmid": 37046778, "pmcid": "PMC10093522", "title": "Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials", "journal": "Cancers (Basel)", "authors": ["Ciardiello D", "Napolitano S", "Famiglietti V", "Esposito L", "De Falco V", "Di Liello A", "Avallone A", "Maiello E", "Pietrantonio F", "Cremolini C", "Zampino MG", "Fazio N", "Troiani T", "Martinelli E", "Ciardiello F", "Martini G"], "date": "2023-04-01T00:00:00Z", "year": 2023, "snippets": [{"_id": "37046778@29717", "snip_text": "Type of RAS/BRAF Mutation\tNumber of Patients (32)\t \tBRAF V600E\t1\t \tKRAS A146P\t2\t \tKRAS A146PT\t1\t \tKRAS A146PV\t1\t \tKRAS G12A\t3\t \tKRAS G12C\t2\t \tKRAS G12D\t5\t \tKRAS G12S\t2\t \tKRAS G12V\t2\t \tKRAS G13D\t3\t \tKRAS Q61H\t6\t \tKRAS Q61H and BRAF V600E\t1\t \tKRAS Q61R\t1\t \tNRAS G13D\t1\t \tKRAS Q61L\t1\t \t", "section": "table", "mentions": ["241|4|gene|ncbi_gene@3845|KRAS", "161|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "170|4|gene|ncbi_gene@3845|KRAS", "57|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "12|4|gene|ncbi_gene@673|BRAF", "67|4|gene|ncbi_gene@3845|KRAS", "260|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "269|4|gene|ncbi_gene@3845|KRAS", "212|4|gene|ncbi_gene@3845|KRAS", "189|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "246|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "255|4|gene|ncbi_gene@4893|NRAS", "198|4|gene|ncbi_gene@3845|KRAS", "175|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "184|4|gene|ncbi_gene@3845|KRAS", "226|4|gene|ncbi_gene@673|BRAF", "274|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "203|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "114|4|gene|ncbi_gene@3845|KRAS", "98|4|gene|ncbi_gene@3845|KRAS", "52|4|gene|ncbi_gene@673|BRAF", "231|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "217|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "119|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "128|4|gene|ncbi_gene@3845|KRAS", "82|4|gene|ncbi_gene@3845|KRAS", "147|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "156|4|gene|ncbi_gene@3845|KRAS", "142|4|gene|ncbi_gene@3845|KRAS", "133|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "103|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P"], "figure_id": "cancers-15-02117-t002", "text_hl": "Type of RAS/BRAF Mutation\tNumber of Patients (32)\t \tBRAF V600E\t1\t \tKRAS A146P\t2\t \tKRAS A146PT\t1\t \tKRAS A146PV\t1\t \tKRAS G12A\t3\t \tKRAS G12C\t2\t \tKRAS G12D\t5\t \tKRAS G12S\t2\t \tKRAS G12V\t2\t \tKRAS G13D\t3\t \tKRAS Q61H\t6\t \tKRAS Q61H and BRAF V600E\t1\t \tKRAS Q61R\t1\t \tNRAS G13D\t1\t \tKRAS Q61L\t1\t \t"}], "citations": {"NLM": "Ciardiello D, Napolitano S, Famiglietti V, Esposito L, De Falco V, Di Liello A, Avallone A, Maiello E, Pietrantonio F, Cremolini C, Zampino MG, Fazio N, Troiani T, Martinelli E, Ciardiello F, Martini G. Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials Cancers (Basel). PMID: 37046778", "BibTeX": "@article{37046778, title={Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials}, author={Ciardiello D and Napolitano S and Famiglietti V and Esposito L and De Falco V and Di Liello A and Avallone A and Maiello E and Pietrantonio F and Cremolini C and Zampino MG and Fazio N and Troiani T and Martinelli E and Ciardiello F and Martini G}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 35260767, "pmcid": "PMC8904527", "title": "Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors.", "journal": "NPJ Precis Oncol", "authors": ["Berrino E", "Filippi R", "Visintin C", "Peirone S", "Fenocchio E", "Farinea G", "Veglio F", "Aglietta M", "Sapino A", "Cereda M", "Visintin R", "Pasini B", "Marchi\u00f2 C"], "date": "2022-03-08T00:00:00Z", "year": 2022, "snippets": [{"_id": "35260767@17540", "snip_text": "The urothelial carcinomas harbored three private mutations with specific annotation, two KRAS mutations (p.Gly13Asp and p.Ala146Thr) with resistance level R1, and the level 4 NF1 p.Arg2637Ter.", "section": "results", "mentions": ["179|12|variant|litvar@rs786201367##&&&litvar@#4763#&&&litvar@CA188413#rs786201367##|p.Arg2637Ter", "175|3|gene|ncbi_gene@4763|NF1", "89|4|gene|ncbi_gene@3845|KRAS", "120|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "4|21|disease|ncbi_mesh@D014523|urothelial carcinomas", "105|10|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.Gly13Asp"], "text_hl": "The urothelial carcinomas harbored three private mutations with specific annotation, two KRAS mutations (p.Gly13Asp and <m>p.Ala146Thr</m>) with resistance level R1, and the level 4 NF1 p.Arg2637Ter."}], "citations": {"NLM": "Berrino E, Filippi R, Visintin C, Peirone S, Fenocchio E, Farinea G, Veglio F, Aglietta M, Sapino A, Cereda M, Visintin R, Pasini B, Marchi\u00f2 C. Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors. NPJ Precis Oncol. PMID: 35260767", "BibTeX": "@article{35260767, title={Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors.}, author={Berrino E and Filippi R and Visintin C and Peirone S and Fenocchio E and Farinea G and Veglio F and Aglietta M and Sapino A and Cereda M and Visintin R and Pasini B and Marchi\u00f2 C}, journal={NPJ Precis Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 28892047, "pmcid": "PMC5764779", "title": "A system for detecting high impact-low frequency mutations in primary tumors and metastases", "journal": "Oncogene", "authors": ["Anjanappa M", "Hao Y", "Simpson ER", "Bhat-Nakshatri P", "Nelson JB", "Tersey SA", "Mirmira RG", "Cohen-Gadol AA", "Saadatzadeh MR", "Li L", "Fang F", "Nephew KP", "Miller KD", "Liu Y", "Nakshatri H"], "date": "2018-01-11T00:00:00Z", "year": 2018, "snippets": [{"_id": "28892047@13347", "snip_text": "A colon cancer liver metastasis showed expected mutations in APC (a frame shift and a stop codon; Table 2), and this metastasis also harbored KRAS A146T mutation, a KRAS mutation previously linked to MEK/ERK dependence and resistance to EGFR targeted therapies.", "section": "results", "mentions": ["147|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "200|3|gene|ncbi_gene@5609|MEK", "237|4|gene|ncbi_gene@1956|EGFR", "165|4|gene|ncbi_gene@3845|KRAS", "2|29|disease|ncbi_mesh@D015179|colon cancer liver metastasis", "142|4|gene|ncbi_gene@3845|KRAS", "117|10|disease|ncbi_mesh@D009362|metastasis", "204|3|gene|ncbi_gene@5594|ERK"], "text_hl": "A colon cancer liver metastasis showed expected mutations in APC (a frame shift and a stop codon; Table 2), and this metastasis also harbored KRAS <m>A146T</m> mutation, a KRAS mutation previously linked to MEK/ERK dependence and resistance to EGFR targeted therapies."}], "citations": {"NLM": "Anjanappa M, Hao Y, Simpson ER, Bhat-Nakshatri P, Nelson JB, Tersey SA, Mirmira RG, Cohen-Gadol AA, Saadatzadeh MR, Li L, Fang F, Nephew KP, Miller KD, Liu Y, Nakshatri H. A system for detecting high impact-low frequency mutations in primary tumors and metastases Oncogene. PMID: 28892047", "BibTeX": "@article{28892047, title={A system for detecting high impact-low frequency mutations in primary tumors and metastases}, author={Anjanappa M and Hao Y and Simpson ER and Bhat-Nakshatri P and Nelson JB and Tersey SA and Mirmira RG and Cohen-Gadol AA and Saadatzadeh MR and Li L and Fang F and Nephew KP and Miller KD and Liu Y and Nakshatri H}, journal={Oncogene}}"}, "is_sup_mat_match": false}, {"pmid": 36444585, "pmcid": "PMC9930961", "title": "Clinical Significance of Somatic Mutations in RAS/RAF/MAPK Signaling Pathway in Moroccan and North African Colorectal Cancer Patients.", "journal": "Asian Pac J Cancer Prev", "authors": ["Benmokhtar S", "Laraqui A", "El Boukhrissi F", "Hilali F", "Bajjou T", "Jafari M", "El Zaitouni S", "Baba W", "El Mchichi B", "Elannaz H", "Lahlou IA", "Chahdi H", "Oukabli M", "Mahfoud T", "Tanz R", "Ichou M", "Ennibi K", "Dakka N", "Sekhsokh Y"], "date": "2022-11-01T00:00:00Z", "year": 2022, "snippets": [{"_id": "36444585@14015", "snip_text": "Gene Exon Nucleotide Substitution Codon Substitution Amino Acid Substitution Number %     c.35G>A GGT>GAT p.G12D 17 37.7     c.34G>T GGT>TGT p.G12C 6 13.4    2 c.34G>A GGT>AGT p.G12S 4 8.9     c.38G>A GGC>GAC p.G13D 11 24.4     c.35G>T GGT>GTT p.G12V 3 6.6   KRAS  c.35G>C GGT>GCT p.G12A 1 2.2     c.182A>G CAA>CGA p.Q61R 1 2.2    3 c.183A>C CAA>CAC p.Q61H 2 4.4     c.182A>T CAA>CTA p.Q61L 1 2.2    4 c.436G>A GCA>ACA p.A146T 1 2.2     c.351A>C AAA>AAC p.K117N 1 2.2    2 c.38G>C GGT>GCT p.G13A 3 42.9     c.34G>C GGT>CGT p.G12R 1 14.2   NRAS 3 c.183A>T CAA>CAT p.Q61H 2 28.5     c.175G>A GCT>ACT p.A59T 1 14.2    4 c.351G>C AAG>AAC p.K117N 2 2.5     c.436G>A GCA>ACA p.A146T 1 14.2   ", "section": "table", "mentions": ["539|4|gene|ncbi_gene@24605|NRAS", "281|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "546|8|variant|litvar@rs121913255##&&&litvar@#4893#&&&litvar@CA16042285#rs121913255##|c.183A>T", "168|7|variant|litvar@#3845#|GGT>AGT", "298|8|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|c.182A>G", "90|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G>A", "669|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "228|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "350|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "367|8|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|c.182A>T", "265|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>C", "481|7|variant|litvar@#3845#|GGT>GCT", "176|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "652|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "437|8|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|c.351A>C", "489|6|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602364#rs121434596##|p.G13A", "160|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G>A", "201|7|variant|litvar@#3845#|GGC>GAC", "209|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "315|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "193|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "555|7|variant|litvar@#4893#|CAA>CAT", "307|7|variant|litvar@#3845#|CAA>CGA", "141|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "454|7|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.K117N", "661|7|variant|litvar@#4893#|GCA>ACA", "376|7|variant|litvar@#3845#|CAA>CTA", "133|7|variant|litvar@#3845#|GGT>TGT", "384|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "617|8|variant|litvar@rs770248150##&&&litvar@#3845#|c.351G>C", "473|7|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602364#rs121434596##|c.38G>C", "563|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "515|7|variant|litvar@#4893#|GGT>CGT", "446|7|variant|litvar@#4893#|AAA>AAC", "634|7|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.K117N", "523|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "98|7|variant|litvar@#3845#|GGT>GAT", "402|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "419|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "581|8|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|c.175G>A", "333|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA180922#rs17851045##|c.183A>C", "125|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>T", "106|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "507|7|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|c.34G>C", "259|4|gene|ncbi_gene@3845|KRAS", "273|7|variant|litvar@#3845#|GGT>GCT", "626|7|variant|litvar@#4893#|AAG>AAC", "411|7|variant|litvar@#4893#|GCA>ACA", "236|7|variant|litvar@#3845#|GGT>GTT", "244|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "590|7|variant|litvar@#4893#|GCT>ACT", "598|6|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|p.A59T", "342|7|variant|litvar@#4893#|CAA>CAC"], "figure_id": "T2", "text_hl": "Gene Exon Nucleotide Substitution Codon Substitution Amino Acid Substitution Number %     c.35G>A GGT>GAT p.G12D 17 37.7     c.34G>T GGT>TGT p.G12C 6 13.4    2 c.34G>A GGT>AGT p.G12S 4 8.9     c.38G>A GGC>GAC p.G13D 11 24.4     c.35G>T GGT>GTT p.G12V 3 6.6   KRAS  c.35G>C GGT>GCT p.G12A 1 2.2     c.182A>G CAA>CGA p.Q61R 1 2.2    3 c.183A>C CAA>CAC p.Q61H 2 4.4     c.182A>T CAA>CTA p.Q61L 1 2.2    4 c.436G>A GCA>ACA <m>p.A146T</m> 1 2.2     c.351A>C AAA>AAC p.K117N 1 2.2    2 c.38G>C GGT>GCT p.G13A 3 42.9     c.34G>C GGT>CGT p.G12R 1 14.2   NRAS 3 c.183A>T CAA>CAT p.Q61H 2 28.5     c.175G>A GCT>ACT p.A59T 1 14.2    4 c.351G>C AAG>AAC p.K117N 2 2.5     c.436G>A GCA>ACA <m>p.A146T</m> 1 14.2   "}], "citations": {"NLM": "Benmokhtar S, Laraqui A, El Boukhrissi F, Hilali F, Bajjou T, Jafari M, El Zaitouni S, Baba W, El Mchichi B, Elannaz H, Lahlou IA, Chahdi H, Oukabli M, Mahfoud T, Tanz R, Ichou M, Ennibi K, Dakka N, Sekhsokh Y. Clinical Significance of Somatic Mutations in RAS/RAF/MAPK Signaling Pathway in Moroccan and North African Colorectal Cancer Patients. Asian Pac J Cancer Prev. PMID: 36444585", "BibTeX": "@article{36444585, title={Clinical Significance of Somatic Mutations in RAS/RAF/MAPK Signaling Pathway in Moroccan and North African Colorectal Cancer Patients.}, author={Benmokhtar S and Laraqui A and El Boukhrissi F and Hilali F and Bajjou T and Jafari M and El Zaitouni S and Baba W and El Mchichi B and Elannaz H and Lahlou IA and Chahdi H and Oukabli M and Mahfoud T and Tanz R and Ichou M and Ennibi K and Dakka N and Sekhsokh Y}, journal={Asian Pac J Cancer Prev}}"}, "is_sup_mat_match": false}, {"pmid": 37628934, "pmcid": "PMC10454445", "title": "KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer", "journal": "Int J Mol Sci", "authors": ["Radanova M", "Mihaylova G", "Stoyanov GS", "Draganova V", "Zlatarov A", "Kolev N", "Dimitrova E", "Conev N", "Ivanova D"], "date": "2023-08-13T00:00:00Z", "year": 2023, "snippets": [{"_id": "37628934@8416", "snip_text": "All patients positive for KRAS exon 4 (n = 20) had mutations in codon 146, which could be c.436G>A p.Ala146Thr, c.436G>C p.Ala146Pro, or c. 437C>T p.Ala146Val.", "section": "results", "mentions": ["121|11|variant|litvar@rs121913527##&&&litvar@#3845#|p.Ala146Pro", "4|8|species|ncbi_taxonomy@9606|patients", "90|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "99|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "26|4|gene|ncbi_gene@3845|KRAS", "137|9|variant|litvar@rs1057519725##&&&litvar@#3845#|c. 437C>T", "147|11|variant|litvar@rs1057519725##&&&litvar@#3845#|p.Ala146Val", "112|8|variant|litvar@rs121913527##&&&litvar@#3845#|c.436G>C"], "text_hl": "All patients positive for KRAS exon 4 (n = 20) had mutations in codon 146, which could be c.436G>A <m>p.Ala146Thr</m>, c.436G>C p.Ala146Pro, or c. 437C>T p.Ala146Val."}], "citations": {"NLM": "Radanova M, Mihaylova G, Stoyanov GS, Draganova V, Zlatarov A, Kolev N, Dimitrova E, Conev N, Ivanova D. KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer Int J Mol Sci. PMID: 37628934", "BibTeX": "@article{37628934, title={KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer}, author={Radanova M and Mihaylova G and Stoyanov GS and Draganova V and Zlatarov A and Kolev N and Dimitrova E and Conev N and Ivanova D}, journal={Int J Mol Sci}}"}, "is_sup_mat_match": false}, {"pmid": 33226505, "pmcid": "PMC7683631", "title": "KRAS mutation effects on the 2-[18F]FDG PET uptake of colorectal adenocarcinoma metastases in the liver", "journal": "EJNMMI Res", "authors": ["Popovic M", "Talarico O", "van den Hoff J", "Kunin H", "Zhang Z", "Lafontaine D", "Dogan S", "Leung J", "Kaye E", "Czmielewski C", "Mayerhoefer ME", "Zanzonico P", "Yaeger R", "Sch\u00f6der H", "Humm JL", "Solomon SB", "Sofocleous CT", "Kirov AS"], "date": "2020-11-23T00:00:00Z", "year": 2020, "snippets": [{"_id": "33226505@21435", "snip_text": "Case #\tKRAS gene alteration and location\t \t2\tG13D (c.38G > A) exon 2\t \t5\tG12D (c.35G > A) exon 2\t \t6\tA146T (c.436G > A) exon 4\t \t7\tG12A (c.35G > C) exon 2\t \t8\tG12D (c.35G > A) exon 2\t \t9\tWhole gene amplification 12p12.1, FC:2.1\t \t11\tQ61H (c. 183A > C) exon 3\t \t14\tG13D (c.38G > A) exon 2\t \t15\tG12V (c.35G > T) exon 2\t \t16\tG12D (c.35G > A) exon 2\t \t23\tG12D (c.35G > A) exon 2\t \t24\tG13D (c.38G > A) exon 2\t \t25\tG12D (c.35G > A) exon 2\t \t28\tWhole gene amplification 12p12.1, FC: 23.0 (Inv. Panel)\t \t31\tQ61H (c.183A > T) exon 3\t \t32\tG13D (c.38G > A) exon 2\t \t35\tG12C (c.34 G > T) exon 2\t \t37\tWhole gene amplification 12p12.1, FC: 8.5\t \t", "section": "table", "mentions": ["569|5|variant|litvar@#3845#|G > T", "505|10|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|c.183A > T", "79|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "558|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "357|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "108|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "101|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "270|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "409|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "159|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "529|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "322|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "233|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "415|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "499|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "137|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > C", "328|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "380|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "45|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "51|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "293|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "165|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "73|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "264|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "386|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "242|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA180922#rs17851045##|183A > C", "299|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "131|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "351|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "7|4|gene|ncbi_gene@3845|KRAS", "535|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A"], "figure_id": "Tab2", "text_hl": "Case #\tKRAS gene alteration and location\t \t2\tG13D (c.38G > A) exon 2\t \t5\tG12D (c.35G > A) exon 2\t \t6\t<m>A146T</m> (c.436G > A) exon 4\t \t7\tG12A (c.35G > C) exon 2\t \t8\tG12D (c.35G > A) exon 2\t \t9\tWhole gene amplification 12p12.1, FC:2.1\t \t11\tQ61H (c. 183A > C) exon 3\t \t14\tG13D (c.38G > A) exon 2\t \t15\tG12V (c.35G > T) exon 2\t \t16\tG12D (c.35G > A) exon 2\t \t23\tG12D (c.35G > A) exon 2\t \t24\tG13D (c.38G > A) exon 2\t \t25\tG12D (c.35G > A) exon 2\t \t28\tWhole gene amplification 12p12.1, FC: 23.0 (Inv. Panel)\t \t31\tQ61H (c.183A > T) exon 3\t \t32\tG13D (c.38G > A) exon 2\t \t35\tG12C (c.34 G > T) exon 2\t \t37\tWhole gene amplification 12p12.1, FC: 8.5\t \t"}], "citations": {"NLM": "Popovic M, Talarico O, van den Hoff J, Kunin H, Zhang Z, Lafontaine D, Dogan S, Leung J, Kaye E, Czmielewski C, Mayerhoefer ME, Zanzonico P, Yaeger R, Sch\u00f6der H, Humm JL, Solomon SB, Sofocleous CT, Kirov AS. KRAS mutation effects on the 2-[18F]FDG PET uptake of colorectal adenocarcinoma metastases in the liver EJNMMI Res. PMID: 33226505", "BibTeX": "@article{33226505, title={KRAS mutation effects on the 2-[18F]FDG PET uptake of colorectal adenocarcinoma metastases in the liver}, author={Popovic M and Talarico O and van den Hoff J and Kunin H and Zhang Z and Lafontaine D and Dogan S and Leung J and Kaye E and Czmielewski C and Mayerhoefer ME and Zanzonico P and Yaeger R and Sch\u00f6der H and Humm JL and Solomon SB and Sofocleous CT and Kirov AS}, journal={EJNMMI Res}}"}, "is_sup_mat_match": false}, {"pmid": 34840814, "pmcid": "PMC8609982", "title": "Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer", "journal": "Future Sci OA", "authors": ["Taniguchi F", "Nyuya A", "Toshima T", "Yasui K", "Mori Y", "Okawaki M", "Kishimoto H", "Umeda Y", "Fujiwara T", "Tanioka H", "Yamaguchi Y", "Goel A", "Nagasaka T"], "date": "2021-11-05T00:00:00Z", "year": 2021, "snippets": [{"_id": "34840814@5986", "snip_text": "Panels show index values of 12 types of RAS exon 2 (G12S, G12C, G12R, G12D, G12V, G12A, G13S, G13C, G13R, G13D, G13V and G13A), eight types of RAS exon 3 (A59T, A59G, Q61K, Q61E, Q61L, Q61P, Q61R and Q61H), and four types of RAS exon 4 (K117N, A146T, A146P and A146V) mutations by PCR-rSSO indices of metastatic specimens in the patient.", "section": "figure_legend", "mentions": ["179|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "251|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "52|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "261|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "244|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "191|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "161|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59G", "64|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "112|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "58|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "106|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "185|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "76|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "70|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "329|7|species|ncbi_taxonomy@9606|patient", "88|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA16602445#rs121913535##|G13S", "121|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13A", "82|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "100|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "155|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "173|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "167|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "237|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "94|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C"], "figure_id": "F1", "text_hl": "Panels show index values of 12 types of RAS exon 2 (G12S, G12C, G12R, G12D, G12V, G12A, G13S, G13C, G13R, G13D, G13V and G13A), eight types of RAS exon 3 (A59T, A59G, Q61K, Q61E, Q61L, Q61P, Q61R and Q61H), and four types of RAS exon 4 (K117N, <m>A146T</m>, A146P and A146V) mutations by PCR-rSSO indices of metastatic specimens in the patient."}], "citations": {"NLM": "Taniguchi F, Nyuya A, Toshima T, Yasui K, Mori Y, Okawaki M, Kishimoto H, Umeda Y, Fujiwara T, Tanioka H, Yamaguchi Y, Goel A, Nagasaka T. Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer Future Sci OA. PMID: 34840814", "BibTeX": "@article{34840814, title={Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer}, author={Taniguchi F and Nyuya A and Toshima T and Yasui K and Mori Y and Okawaki M and Kishimoto H and Umeda Y and Fujiwara T and Tanioka H and Yamaguchi Y and Goel A and Nagasaka T}, journal={Future Sci OA}}"}, "is_sup_mat_match": false}, {"pmid": 29437753, "pmcid": "PMC5829675", "title": "Dynamic changes of circulating tumour DNA in surgical lung cancer patients: protocol for a prospective observational study", "journal": "BMJ Open", "authors": ["Chen K", "Zhao H", "Yang F", "Hui B", "Wang T", "Wang LT", "Shi Y", "Wang J"], "date": "2018-02-06T00:00:00Z", "year": 2018, "snippets": [{"_id": "29437753@15092", "snip_text": "The known mutations specifically targeted in the study are G719A/C/S (three variants, G719X), exon 19 deletions (16 variants), exon 20 insertions (three variants), S768I, T790M, C797S, exon 21 point mutations L858R and L861Q in EGFR; G12A/C/D/R/S/V (six variants, G12X), G13D, Q61E/H/K/L/P/R (six variants, Q61X), and A146T/P/V (three variants, A146X) in KRAS; exon 20 insertions (five variants) in ERBB2 and V600D/E/K/R (four variants, V600X) in BRAF; R88Q, E542K, E545K/D (two variants, E545X) and A1047R/L (two variants, A1047X) in PIK3CA; R175C/H (two variants, R175X), R248W/Q (two variants, R248X) and R273C/H (two variants, R273X) in TP53; MET exon 14 skipping and ALK, RET fusions.", "section": "methods", "mentions": ["466|7|variant|litvar@rs104886003##&&&litvar@#5290#|E545K/D", "453|4|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|R88Q", "59|5|variant|litvar@rs121913428##&&&litvar@#1956#&&&litvar@CA135775#rs121913428##|G719A", "228|4|gene|ncbi_gene@1956|EGFR", "277|6|variant|litvar@rs17851045##&&&litvar@#3845#|Q61E/H", "318|9|variant|litvar@rs121913527##&&&litvar@#3845#|A146T/P/V", "641|4|gene|ncbi_gene@7157|TP53", "459|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "597|5|variant|litvar@rs11540652##&&&litvar@#7157#|R248X", "437|5|variant|litvar@rs113488022##&&&litvar@#673#|V600X", "672|3|gene|ncbi_gene@238|ALK", "345|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146X", "171|5|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|T790M", "307|4|variant|litvar@rs17851045##&&&litvar@#3845#|Q61X", "677|3|gene|ncbi_gene@5979|RET", "566|5|variant|litvar@rs138729528##&&&litvar@#7157#|R175X", "535|6|gene|ncbi_gene@5290|PIK3CA", "543|5|variant|litvar@rs138729528##&&&litvar@#7157#&&&litvar@CA2442#rs138729528##|R175C", "574|7|variant|litvar@rs11540652##&&&litvar@#7157#|R248W/Q", "271|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "631|5|variant|litvar@rs150183574##&&&litvar@#2026#|R273X", "608|5|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|R273C", "409|7|variant|litvar@rs113488022##&&&litvar@#673#|V600D/E", "489|5|variant|litvar@rs104886003##&&&litvar@#5290#|E545X", "209|5|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|L858R", "647|3|gene|ncbi_gene@79811|MET", "500|6|variant|litvar@#5290#p.A1047R&&&litvar@#5290#|A1047R", "164|5|variant|litvar@rs121913465##&&&litvar@#1956#&&&litvar@CA135840#rs121913465##|S768I", "219|5|variant|litvar@rs121913444##&&&litvar@#1956#&&&litvar@CA176021#rs121913444##|L861Q", "86|5|variant|litvar@rs121913428##&&&litvar@#1956#|G719X", "264|4|variant|litvar@rs121913529##&&&litvar@#3845#|G12X", "355|4|gene|ncbi_gene@3845|KRAS", "65|3|variant|litvar@#1956#|C/S", "178|5|variant|litvar@rs1057519861##&&&litvar@#1956#|C797S", "234|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12A/C", "524|6|variant|litvar@#5290#p.A1047X&&&litvar@#5290#|A1047X", "447|4|gene|ncbi_gene@673|BRAF", "399|5|gene|ncbi_gene@2064|ERBB2"], "text_hl": "The known mutations specifically targeted in the study are G719A/C/S (three variants, G719X), exon 19 deletions (16 variants), exon 20 insertions (three variants), S768I, T790M, C797S, exon 21 point mutations L858R and L861Q in EGFR; G12A/C/D/R/S/V (six variants, G12X), G13D, Q61E/H/K/L/P/R (six variants, Q61X), and <m>A146T</m>/P/V (three variants, A146X) in KRAS; exon 20 insertions (five variants) in ERBB2 and V600D/E/K/R (four variants, V600X) in BRAF; R88Q, E542K, E545K/D (two variants, E545X) and A1047R/L (two variants, A1047X) in PIK3CA; R175C/H (two variants, R175X), R248W/Q (two variants, R248X) and R273C/H (two variants, R273X) in TP53; MET exon 14 skipping and ALK, RET fusions."}], "citations": {"NLM": "Chen K, Zhao H, Yang F, Hui B, Wang T, Wang LT, Shi Y, Wang J. Dynamic changes of circulating tumour DNA in surgical lung cancer patients: protocol for a prospective observational study BMJ Open. PMID: 29437753", "BibTeX": "@article{29437753, title={Dynamic changes of circulating tumour DNA in surgical lung cancer patients: protocol for a prospective observational study}, author={Chen K and Zhao H and Yang F and Hui B and Wang T and Wang LT and Shi Y and Wang J}, journal={BMJ Open}}"}, "is_sup_mat_match": false}, {"pmid": 38019254, "pmcid": "PMC10772755", "title": "Characteristic Mutational Damages in Gastric and Colorectal Adenocarcinomas", "journal": "Asian Pac J Cancer Prev", "authors": ["Yermekova S", "Orazgaliyeva M", "Goncharova T", "Rakhimbekova F", "Kaidarova D", "Shatkovskaya O"], "date": "2023-11-01T00:00:00Z", "year": 2023, "snippets": [{"_id": "38019254@17654", "snip_text": "Gene\tExon\taa change\tnt change\tCosmic ID\tPrimer No.\t \tKRAS\t2\tG12A\tc.35G>C\t522\t1RAS\t \t\t\tG12D\tc.35G>A\t521\t\t \t\t\tG12R\tc.34G>C\t518\t\t \t\t\tG12V\tc.35G>T\t520\t\t \t\t\tG13D\tc.38G>A\t532\t\t \t\t2\tG12C\tc.34G>T\t516\t2RAS\t \t\t\tG12S\tc.34G>A\t517\t\t \t\t3\tQ61H\tc.183A>T\t555\t3RAS\t \t\t\tQ61H\tc.183A>C\t554\t\t \t\t\tQ61L\tc.182A>T\t553\t\t \t\t\tQ61R\tc.182A>G\t552\t\t \t\t\tA59E\tc.176C>A\t547\t\t \t\t\tA59G\tc.176C>G\t28518\t\t \t\t\tA59T\tc.175G>A\t546\t\t \t\t4\tK117N(AAC)\tc.351A>C\t19940\t4RAS\t \t\t\tK117N(AAT)\tc.351A>T\t28519\t\t \t\t\tK117R\tc.350A>G\t1178068\t\t \t\t\tK117E\tc.349A>G\t1360831\t\t \t\t4\tA146T\tc.436G>A\t19404\t5RAS\t \t\t\tA146P\tc.436G>C\t19905\t\t \t\t\tA146V\tc.437C>T\t19900\t\t \tNRAS\t2\tG12D\tc.35G>A\t564\t6RAS\t \t\t\tG12C\tc.34G>T\t562\t\t \t\t\tG12S\tc.34G>TA\t563\t\t \t\t\tG13R\tc.37G>C\t569\t\t \t\t\tG13V\tc.38G>T\t574\t\t \t\t4\tK117R\tc.350A>G\t\t6RAS\t \t\t3\tQ61H (CAC)\tc.183A>C\t585\t7 RAS\t \t\t\tQ61H (CAT)\tc.183A>T\t586\t\t \t\t\tQ61L\tc.182A>T\t583\t\t \t\t\tQ61K\tc.181C>A\t580\t\t \t\t\tQ61R\tc.182A>G\t584\t\t \t\t3 and 4\tA146T\tc.436G>A\t1237325\t8RAS\t \t\t\tA59D\tc.176C>A\t253327\t\t \t\t\tA59T\tc.175G>A\t578\t\t \t", "section": "table", "mentions": ["281|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|182A>T", "137|5|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|35G>T", "258|6|variant|litvar@rs121913255##&&&litvar@#4893#|183A>C", "702|5|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|38G>T", "789|8|variant|litvar@rs121913255##&&&litvar@#4893#&&&litvar@CA16042285#rs121913255##|c.183A>T", "108|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "350|6|variant|litvar@rs587778718##&&&litvar@#7157#&&&litvar@CA272#rs587778718##|176C>G", "433|3|gene|ncbi_gene@5265|AAT", "553|6|variant|litvar@rs121913527##&&&litvar@#3845#|436G>C", "853|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "115|5|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|34G>C", "814|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|182A>T", "830|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "807|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "224|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "201|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "466|6|variant|litvar@rs104894227##&&&litvar@#3265#&&&litvar@CA256490#rs104894227##|350A>G", "948|6|variant|litvar@rs1432349243##&&&litvar@#760#|175G>A", "941|4|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|A59T", "744|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "883|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "571|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "175|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "602|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "368|4|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|A59T", "755|8|variant|litvar@rs121913255##&&&litvar@#4893#|c.183A>C", "922|6|variant|litvar@rs587778718##&&&litvar@#7157#|176C>A", "159|5|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|38G>A", "545|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "778|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "231|6|variant|litvar@rs121913255##&&&litvar@#4893#&&&litvar@CA16042285#rs121913255##|183A>T", "130|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "403|8|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|c.351A>C", "726|6|variant|litvar@rs104894227##&&&litvar@#3265#&&&litvar@CA256490#rs104894227##|350A>G", "486|5|variant|litvar@rs773992093##&&&litvar@#7157#&&&litvar@CA287495005#rs773992093##|K117E", "53|4|gene|ncbi_gene@24525|KRAS", "673|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "595|4|gene|ncbi_gene@24605|NRAS", "650|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "427|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "837|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|181C>A", "320|4|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|A59E", "86|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "657|5|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|34G>T", "297|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "274|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "628|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "860|6|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|182A>G", "251|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "515|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "750|3|gene|ncbi_gene@760|CAC", "93|5|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|35G>A", "343|4|variant|litvar@rs748631334##&&&litvar@#5295#|A59G", "680|5|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|37G>C", "494|6|variant|litvar@rs587782082##&&&litvar@#7157#|349A>G", "60|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "375|6|variant|litvar@rs1432349243##&&&litvar@#760#|175G>A", "392|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "208|5|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|34G>A", "152|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "635|5|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|34G>T", "718|5|variant|litvar@rs104894227##&&&litvar@#3265#&&&litvar@CA256490#rs104894227##|K117R", "438|8|variant|litvar@rs770248150##&&&litvar@#3845#|c.351A>T", "784|3|gene|ncbi_gene@847|CAT", "523|6|variant|litvar@rs537285845##&&&litvar@#5265#&&&litvar@CA7327497#rs537285845##|436G>A", "695|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "67|5|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|35G>C", "609|5|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|35G>A", "891|6|variant|litvar@rs537285845##&&&litvar@#5265#&&&litvar@CA7327497#rs537285845##|436G>A", "915|4|variant|litvar@rs748631334##&&&litvar@#5295#|A59D", "458|5|variant|litvar@rs104894227##&&&litvar@#3265#&&&litvar@CA256490#rs104894227##|K117R", "579|6|variant|litvar@rs1057519725##&&&litvar@#3845#|437C>T", "327|6|variant|litvar@rs587778718##&&&litvar@#7157#|176C>A", "304|6|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|182A>G"], "figure_id": "T1", "text_hl": "Gene\tExon\taa change\tnt change\tCosmic ID\tPrimer No.\t \tKRAS\t2\tG12A\tc.35G>C\t522\t1RAS\t \t\t\tG12D\tc.35G>A\t521\t\t \t\t\tG12R\tc.34G>C\t518\t\t \t\t\tG12V\tc.35G>T\t520\t\t \t\t\tG13D\tc.38G>A\t532\t\t \t\t2\tG12C\tc.34G>T\t516\t2RAS\t \t\t\tG12S\tc.34G>A\t517\t\t \t\t3\tQ61H\tc.183A>T\t555\t3RAS\t \t\t\tQ61H\tc.183A>C\t554\t\t \t\t\tQ61L\tc.182A>T\t553\t\t \t\t\tQ61R\tc.182A>G\t552\t\t \t\t\tA59E\tc.176C>A\t547\t\t \t\t\tA59G\tc.176C>G\t28518\t\t \t\t\tA59T\tc.175G>A\t546\t\t \t\t4\tK117N(AAC)\tc.351A>C\t19940\t4RAS\t \t\t\tK117N(AAT)\tc.351A>T\t28519\t\t \t\t\tK117R\tc.350A>G\t1178068\t\t \t\t\tK117E\tc.349A>G\t1360831\t\t \t\t4\t<m>A146T</m>\tc.436G>A\t19404\t5RAS\t \t\t\tA146P\tc.436G>C\t19905\t\t \t\t\tA146V\tc.437C>T\t19900\t\t \tNRAS\t2\tG12D\tc.35G>A\t564\t6RAS\t \t\t\tG12C\tc.34G>T\t562\t\t \t\t\tG12S\tc.34G>TA\t563\t\t \t\t\tG13R\tc.37G>C\t569\t\t \t\t\tG13V\tc.38G>T\t574\t\t \t\t4\tK117R\tc.350A>G\t\t6RAS\t \t\t3\tQ61H (CAC)\tc.183A>C\t585\t7 RAS\t \t\t\tQ61H (CAT)\tc.183A>T\t586\t\t \t\t\tQ61L\tc.182A>T\t583\t\t \t\t\tQ61K\tc.181C>A\t580\t\t \t\t\tQ61R\tc.182A>G\t584\t\t \t\t3 and 4\t<m>A146T</m>\tc.436G>A\t1237325\t8RAS\t \t\t\tA59D\tc.176C>A\t253327\t\t \t\t\tA59T\tc.175G>A\t578\t\t \t"}], "citations": {"NLM": "Yermekova S, Orazgaliyeva M, Goncharova T, Rakhimbekova F, Kaidarova D, Shatkovskaya O. Characteristic Mutational Damages in Gastric and Colorectal Adenocarcinomas Asian Pac J Cancer Prev. PMID: 38019254", "BibTeX": "@article{38019254, title={Characteristic Mutational Damages in Gastric and Colorectal Adenocarcinomas}, author={Yermekova S and Orazgaliyeva M and Goncharova T and Rakhimbekova F and Kaidarova D and Shatkovskaya O}, journal={Asian Pac J Cancer Prev}}"}, "is_sup_mat_match": false}, {"pmid": 35978873, "pmcid": "PMC9280739", "title": "Fecal gene detection based on next generation sequencing for colorectal cancer diagnosis", "journal": "World J Gastroenterol", "authors": ["He SY", "Li YC", "Wang Y", "Peng HL", "Zhou CL", "Zhang CM", "Chen SL", "Yin JF", "Lin M"], "date": "2022-07-07T00:00:00Z", "year": 2022, "snippets": [{"_id": "35978873@34754", "snip_text": "For the KRAS gene, the mutation sites of \"unknown clinical significance\" accounted for 10.00% (3/30), all of which were exon 4 A146T.", "section": "results", "mentions": ["8|4|gene|ncbi_gene@3845|KRAS", "127|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "For the KRAS gene, the mutation sites of \"unknown clinical significance\" accounted for 10.00% (3/30), all of which were exon 4 <m>A146T</m>."}], "citations": {"NLM": "He SY, Li YC, Wang Y, Peng HL, Zhou CL, Zhang CM, Chen SL, Yin JF, Lin M. Fecal gene detection based on next generation sequencing for colorectal cancer diagnosis World J Gastroenterol. PMID: 35978873", "BibTeX": "@article{35978873, title={Fecal gene detection based on next generation sequencing for colorectal cancer diagnosis}, author={He SY and Li YC and Wang Y and Peng HL and Zhou CL and Zhang CM and Chen SL and Yin JF and Lin M}, journal={World J Gastroenterol}}"}, "is_sup_mat_match": false}, {"pmid": 34698448, "title": "Feasibility and performance of the Idylla  NRAS/BRAF cartridge mutation assay on thyroid liquid-based fine-needle aspiration.", "journal": "Diagn Cytopathol", "authors": ["Hamadou M", "Lopez J", "Benzerdjeb N", "Cugnet-Anceau C", "Schnoering G", "Besan\u00e7on J", "Mezrag S", "Lapras V", "Denier ML", "Descotes F", "Decaussin-Petrucci M"], "date": "2021-10-26T00:00:00Z", "year": 2021, "snippets": [{"_id": "34698448@1162", "snip_text": "The other showed a false-positive NRAS p.A146T detection and a weak BRAF p.V600E detection.", "section": "abstract", "mentions": ["39|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "68|4|gene|ncbi_gene@673|BRAF", "73|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "34|4|gene|ncbi_gene@4893|NRAS"], "text_hl": "The other showed a false-positive NRAS <m>p.A146T</m> detection and a weak BRAF p.V600E detection."}], "citations": {"NLM": "Hamadou M, Lopez J, Benzerdjeb N, Cugnet-Anceau C, Schnoering G, Besan\u00e7on J, Mezrag S, Lapras V, Denier ML, Descotes F, Decaussin-Petrucci M. Feasibility and performance of the Idylla  NRAS/BRAF cartridge mutation assay on thyroid liquid-based fine-needle aspiration. Diagn Cytopathol. PMID: 34698448", "BibTeX": "@article{34698448, title={Feasibility and performance of the Idylla  NRAS/BRAF cartridge mutation assay on thyroid liquid-based fine-needle aspiration.}, author={Hamadou M and Lopez J and Benzerdjeb N and Cugnet-Anceau C and Schnoering G and Besan\u00e7on J and Mezrag S and Lapras V and Denier ML and Descotes F and Decaussin-Petrucci M}, journal={Diagn Cytopathol}}"}, "is_sup_mat_match": false}, {"pmid": 19075190, "title": "High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients.", "journal": "Blood", "authors": ["Tyner JW", "Erickson H", "Deininger MW", "Willis SG", "Eide CA", "Levine RL", "Heinrich MC", "Gattermann N", "Gilliland DG", "Druker BJ", "Loriaux MM"], "date": "2009-02-19T00:00:00Z", "year": 2009, "snippets": [{"_id": "19075190@735", "snip_text": "We detected 4 \"noncanonical\" point mutations in 7 patients: N-Ras(G60E), K-Ras(V14I), K-Ras(T74P), and K-Ras(A146T).", "section": "abstract", "mentions": ["66|4|variant|litvar@rs267606920##&&&litvar@#4893#&&&litvar@CA257021#rs267606920##|G60E", "103|5|gene|ncbi_gene@3845|K-Ras", "60|5|gene|ncbi_gene@4893|N-Ras", "73|5|gene|ncbi_gene@3845|K-Ras", "50|8|species|ncbi_taxonomy@9606|patients", "86|5|gene|ncbi_gene@3845|K-Ras", "79|4|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|V14I", "92|4|variant|litvar@#3845#p.T74P&&&litvar@#3845#|T74P", "109|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "We detected 4 \"noncanonical\" point mutations in 7 patients: N-Ras(G60E), K-Ras(V14I), K-Ras(T74P), and K-Ras(<m>A146T</m>)."}], "citations": {"NLM": "Tyner JW, Erickson H, Deininger MW, Willis SG, Eide CA, Levine RL, Heinrich MC, Gattermann N, Gilliland DG, Druker BJ, Loriaux MM. High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients. Blood. PMID: 19075190", "BibTeX": "@article{19075190, title={High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients.}, author={Tyner JW and Erickson H and Deininger MW and Willis SG and Eide CA and Levine RL and Heinrich MC and Gattermann N and Gilliland DG and Druker BJ and Loriaux MM}, journal={Blood}}"}, "is_sup_mat_match": false}, {"pmid": 28859058, "pmcid": "PMC5672930", "title": "Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations.", "journal": "Br J Cancer", "authors": ["Gollins S", "West N", "Sebag-Montefiore D", "Myint AS", "Saunders M", "Susnerwala S", "Quirke P", "Essapen S", "Samuel L", "Sizer B", "Worlding J", "Southward K", "Hemmings G", "Tinkler-Hundal E", "Taylor M", "Bottomley D", "Chambers P", "Lawrie E", "Lopes A", "Beare S"], "date": "2017-10-24T00:00:00Z", "year": 2017, "snippets": [{"_id": "28859058@34037", "snip_text": "Mutation Absolute number of mutations detected by PS Detail Absolute number ofadditionalmutations detected by NGS Detail (percentage mutated DNA)   Biopsy (78 samples total)   KRAS 12 27 2 x c.34G>A   1 x c.34G>T   12 x c.35G>A   2 x c.35G>C   10 x c.35G>T 5 1 x c.34G>C (5%)   2 x c.35G>A (6%, 8%)   2 x c.35G>T (5%, 6%)   KRAS 13 3 3 x c.38G>A 6 6 x c.38G>A (5%, 5%, 7%, 7%, 8%, 12%)   KRAS 61 0 : 0 :   KRAS 146 5 5 x c.436G>A 4 4 x c.436G>A (5%, 5%, 6%, 9%)   NRAS 12/13 2 c.35G>A   c.37G>C 0 :   NRAS 61 1 c.181C>A 0 :   BRAF 3 NA 0 :   PIK 542 5 5 x c.1624G>A 1 1 x c.1624G>A (5%)   PIK 545/546 5 3 x c.1633G>A   1 x c.1636C>A   1 x c.1637A>C 3 2 x c.1633G>A (5%, 10%)   1 x c.1636C>A (5%)   PIK 1047 1 c.3140A>G 2 c.3139C>T (6%)   c.3140A>G (7%)   Total 52   21     Number of patients with RAS (KRAS or NRAS) mutation by PS  37 (47%)   Number of patients with RAS (KRAS or NRAS) mutation by PS or NGS  44 (56%)   Number of patients with EGFR pathway mutation (KRAS, NRAS, BRAF or PIK3CA) by PS  45 (58%)   Number of patients with EGFR pathway mutation (KRAS, NRAS, BRAF or PIK3CA) by PS or NGS  50 (64%)   Resection (54 samples total)   KRAS 12 24 1 x c.34G>A   2 x c.34G>T   13 x c.35G>A   1 x c.35G>C   7 x c.35G>T 3 2 x c.34G>C (14%, 25%)   c.35G>C (7%)   KRAS 13 3 3 x c.38G>A 0 :   KRAS 61 0 : 0 :   KRAS 146 2 2 x c.436G>A 3 3 x c.436G>A (5%, 5%, 33%)a   NRAS 12/13 1 c.37G>C 0 :   NRAS 61 1 c.181C>A 0 :   BRAF 0 : 0 :   PIK 542 3 3 x c.1624G>A 1 c.1624G>A (5%)   PIK 545/546 0 : 1 c.1633G>A (10%)   PIK 1047 1 c.3140A>G 0 :   Total 35   8     Number of patients with RAS (KRAS or NRAS) mutation by PS  31 (57%)   Number of patients with RAS (KRAS or NRAS) mutation by PS or NGS  33 (61%)   Number of patients with EGFR pathway mutation (KRAS, NRAS, BRAF or PIK3CA) by PS  32 (59%)   Number of patients with EGFR pathway mutation (KRAS, NRAS, BRAF or PIK3CA) by PS or NGS  33 (61%)   ", "section": "table", "mentions": ["1251|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>C", "388|4|gene|ncbi_gene@3845|KRAS", "1857|4|gene|ncbi_gene@673|BRAF", "1173|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>T", "607|9|variant|litvar@rs778985185##&&&litvar@#1956#&&&litvar@CA4265650#rs778985185##|c.1633G>A", "1023|8|species|ncbi_taxonomy@9606|patients", "556|9|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|c.1624G>A", "1865|6|gene|ncbi_gene@5290|PIK3CA", "324|4|gene|ncbi_gene@3845|KRAS", "639|9|variant|litvar@rs397517201##&&&litvar@#5290#|c.1637A>C", "967|4|gene|ncbi_gene@3845|KRAS", "1266|4|gene|ncbi_gene@3845|KRAS", "681|9|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123338#rs121913286##|c.1636C>A", "338|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "1752|4|gene|ncbi_gene@3845|KRAS", "1405|8|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C>A", "1312|4|gene|ncbi_gene@3845|KRAS", "1327|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "1216|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "477|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "802|4|gene|ncbi_gene@3845|KRAS", "1188|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "1381|7|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|c.37G>C", "1060|4|gene|ncbi_gene@3845|KRAS", "1037|4|gene|ncbi_gene@1956|EGFR", "1230|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>C", "572|9|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|c.1624G>A", "655|9|variant|litvar@rs778985185##&&&litvar@#1956#&&&litvar@CA4265650#rs778985185##|c.1633G>A", "511|8|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C>A", "1395|4|gene|ncbi_gene@4893|NRAS", "1845|4|gene|ncbi_gene@3845|KRAS", "973|4|gene|ncbi_gene@4893|NRAS", "1342|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "1851|4|gene|ncbi_gene@4893|NRAS", "1449|9|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|c.1624G>A", "464|4|gene|ncbi_gene@4893|NRAS", "738|9|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A>G", "1066|4|gene|ncbi_gene@4893|NRAS", "249|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "1144|4|gene|ncbi_gene@3845|KRAS", "1496|9|variant|litvar@rs778985185##&&&litvar@#1956#&&&litvar@CA4265650#rs778985185##|c.1633G>A", "1568|8|species|ncbi_taxonomy@9606|patients", "1764|4|gene|ncbi_gene@673|BRAF", "1772|6|gene|ncbi_gene@5290|PIK3CA", "263|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>C", "1715|8|species|ncbi_taxonomy@9606|patients", "721|9|variant|litvar@rs121913281##&&&litvar@#5290#&&&litvar@CA130471#rs121913281##|c.3139C>T", "282|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "853|8|species|ncbi_taxonomy@9606|patients", "1638|8|species|ncbi_taxonomy@9606|patients", "1525|9|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A>G", "1808|8|species|ncbi_taxonomy@9606|patients", "1072|4|gene|ncbi_gene@673|BRAF", "436|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "1080|6|gene|ncbi_gene@5290|PIK3CA", "526|4|gene|ncbi_gene@673|BRAF", "880|4|gene|ncbi_gene@4893|NRAS", "352|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "191|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G>A", "1461|9|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|c.1624G>A", "1729|4|gene|ncbi_gene@1956|EGFR", "709|9|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A>G", "1665|4|gene|ncbi_gene@4893|NRAS", "1280|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "944|4|gene|ncbi_gene@1956|EGFR", "1587|4|gene|ncbi_gene@3845|KRAS", "205|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>T", "1202|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>C", "1822|4|gene|ncbi_gene@1956|EGFR", "1294|4|gene|ncbi_gene@3845|KRAS", "872|4|gene|ncbi_gene@3845|KRAS", "220|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "623|9|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123338#rs121913286##|c.1636C>A", "1758|4|gene|ncbi_gene@4893|NRAS", "1657|4|gene|ncbi_gene@3845|KRAS", "1368|4|gene|ncbi_gene@4893|NRAS", "234|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>C", "501|4|gene|ncbi_gene@4893|NRAS", "487|7|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|c.37G>C", "979|4|gene|ncbi_gene@673|BRAF", "783|8|species|ncbi_taxonomy@9606|patients", "406|4|gene|ncbi_gene@3845|KRAS", "987|6|gene|ncbi_gene@5290|PIK3CA", "1420|4|gene|ncbi_gene@673|BRAF", "930|8|species|ncbi_taxonomy@9606|patients", "176|4|gene|ncbi_gene@3845|KRAS", "1595|4|gene|ncbi_gene@4893|NRAS", "1159|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G>A", "421|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "305|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "810|4|gene|ncbi_gene@4893|NRAS"], "figure_id": "tbl4", "text_hl": "Mutation Absolute number of mutations detected by PS Detail Absolute number ofadditionalmutations detected by NGS Detail (percentage mutated DNA)   Biopsy (78 samples total)   KRAS 12 27 2 x c.34G>A   1 x c.34G>T   12 x c.35G>A   2 x c.35G>C   10 x c.35G>T 5 1 x c.34G>C (5%)   2 x c.35G>A (6%, 8%)   2 x c.35G>T (5%, 6%)   KRAS 13 3 3 x c.38G>A 6 6 x c.38G>A (5%, 5%, 7%, 7%, 8%, 12%)   KRAS 61 0 : 0 :   KRAS 146 5 5 x c.436G>A 4 4 x c.436G>A (5%, 5%, 6%, 9%)   NRAS 12/13 2 c.35G>A   c.37G>C 0 :   NRAS 61 1 c.181C>A 0 :   BRAF 3 NA 0 :   PIK 542 5 5 x c.1624G>A 1 1 x c.1624G>A (5%)   PIK 545/546 5 3 x c.1633G>A   1 x c.1636C>A   1 x c.1637A>C 3 2 x c.1633G>A (5%, 10%)   1 x c.1636C>A (5%)   PIK 1047 1 c.3140A>G 2 c.3139C>T (6%)   c.3140A>G (7%)   Total 52   21     Number of patients with RAS (KRAS or NRAS) mutation by PS  37 (47%)   Number of patients with RAS (KRAS or NRAS) mutation by PS or NGS  44 (56%)   Number of patients with EGFR pathway mutation (KRAS, NRAS, BRAF or PIK3CA) by PS  45 (58%)   Number of patients with EGFR pathway mutation (KRAS, NRAS, BRAF or PIK3CA) by PS or NGS  50 (64%)   Resection (54 samples total)   KRAS 12 24 1 x c.34G>A   2 x c.34G>T   13 x c.35G>A   1 x c.35G>C   7 x c.35G>T 3 2 x c.34G>C (14%, 25%)   c.35G>C (7%)   KRAS 13 3 3 x c.38G>A 0 :   KRAS 61 0 : 0 :   KRAS 146 2 2 x c.436G>A 3 3 x c.436G>A (5%, 5%, 33%)a   NRAS 12/13 1 c.37G>C 0 :   NRAS 61 1 c.181C>A 0 :   BRAF 0 : 0 :   PIK 542 3 3 x c.1624G>A 1 c.1624G>A (5%)   PIK 545/546 0 : 1 c.1633G>A (10%)   PIK 1047 1 c.3140A>G 0 :   Total 35   8     Number of patients with RAS (KRAS or NRAS) mutation by PS  31 (57%)   Number of patients with RAS (KRAS or NRAS) mutation by PS or NGS  33 (61%)   Number of patients with EGFR pathway mutation (KRAS, NRAS, BRAF or PIK3CA) by PS  32 (59%)   Number of patients with EGFR pathway mutation (KRAS, NRAS, BRAF or PIK3CA) by PS or NGS  33 (61%)   "}], "citations": {"NLM": "Gollins S, West N, Sebag-Montefiore D, Myint AS, Saunders M, Susnerwala S, Quirke P, Essapen S, Samuel L, Sizer B, Worlding J, Southward K, Hemmings G, Tinkler-Hundal E, Taylor M, Bottomley D, Chambers P, Lawrie E, Lopes A, Beare S. Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations. Br J Cancer. PMID: 28859058", "BibTeX": "@article{28859058, title={Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations.}, author={Gollins S and West N and Sebag-Montefiore D and Myint AS and Saunders M and Susnerwala S and Quirke P and Essapen S and Samuel L and Sizer B and Worlding J and Southward K and Hemmings G and Tinkler-Hundal E and Taylor M and Bottomley D and Chambers P and Lawrie E and Lopes A and Beare S}, journal={Br J Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 27101000, "pmcid": "PMC4839685", "title": "Validation and Application of a Custom-Designed Targeted Next-Generation Sequencing Panel for the Diagnostic Mutational Profiling of Solid Tumors", "journal": "PLoS One", "authors": ["Froyen G", "Broekmans A", "Hillen F", "Pat K", "Achten R", "Mebis J", "Rummens JL", "Willemse J", "Maes B"], "date": "2016-04-21T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Froyen G, Broekmans A, Hillen F, Pat K, Achten R, Mebis J, Rummens JL, Willemse J, Maes B. Validation and Application of a Custom-Designed Targeted Next-Generation Sequencing Panel for the Diagnostic Mutational Profiling of Solid Tumors PLoS One. PMID: 27101000", "BibTeX": "@article{27101000, title={Validation and Application of a Custom-Designed Targeted Next-Generation Sequencing Panel for the Diagnostic Mutational Profiling of Solid Tumors}, author={Froyen G and Broekmans A and Hillen F and Pat K and Achten R and Mebis J and Rummens JL and Willemse J and Maes B}, journal={PLoS One}}"}, "is_sup_mat_match": true}, {"pmid": 27924834, "pmcid": "PMC5141443", "title": "Activation induced deaminase mutational signature overlaps with CpG methylation sites in follicular lymphoma and other cancers.", "journal": "Sci Rep", "authors": ["Rogozin IB", "Lada AG", "Goncearenco A", "Green MR", "De S", "Nudelman G", "Panchenko AR", "Koonin EV", "Pavlov YI"], "date": "2016-12-07T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Rogozin IB, Lada AG, Goncearenco A, Green MR, De S, Nudelman G, Panchenko AR, Koonin EV, Pavlov YI. Activation induced deaminase mutational signature overlaps with CpG methylation sites in follicular lymphoma and other cancers. Sci Rep. PMID: 27924834", "BibTeX": "@article{27924834, title={Activation induced deaminase mutational signature overlaps with CpG methylation sites in follicular lymphoma and other cancers.}, author={Rogozin IB and Lada AG and Goncearenco A and Green MR and De S and Nudelman G and Panchenko AR and Koonin EV and Pavlov YI}, journal={Sci Rep}}"}, "is_sup_mat_match": true}, {"pmid": 29100312, "pmcid": "PMC5652706", "title": "Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases.", "journal": "Oncotarget", "authors": ["\u00d8strup O", "Dagenborg VJ", "R\u00f8dland EA", "Skarpeteig V", "Silwal-Pandit L", "Grzyb K", "Berstad AE", "Fretland \u00c5A", "M\u00e6landsmo GM", "B\u00f8rresen-Dale AL", "Ree AH", "Edwin B", "Nygaard V", "Flatmark K"], "date": "2017-07-18T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "\u00d8strup O, Dagenborg VJ, R\u00f8dland EA, Skarpeteig V, Silwal-Pandit L, Grzyb K, Berstad AE, Fretland \u00c5A, M\u00e6landsmo GM, B\u00f8rresen-Dale AL, Ree AH, Edwin B, Nygaard V, Flatmark K. Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases. Oncotarget. PMID: 29100312", "BibTeX": "@article{29100312, title={Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases.}, author={\u00d8strup O and Dagenborg VJ and R\u00f8dland EA and Skarpeteig V and Silwal-Pandit L and Grzyb K and Berstad AE and Fretland \u00c5A and M\u00e6landsmo GM and B\u00f8rresen-Dale AL and Ree AH and Edwin B and Nygaard V and Flatmark K}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 32539869, "pmcid": "PMC7294609", "title": "TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients.", "journal": "J Exp Clin Cancer Res", "authors": ["Dinami R", "Porru M", "Amoreo CA", "Sperduti I", "Mottolese M", "Buglioni S", "Marinelli D", "Maugeri-Sacc\u00e0 M", "Sacconi A", "Blandino G", "Leonetti C", "Di Rocco G", "Verdina A", "Spinella F", "Fiorentino F", "Ciliberto G", "Biroccio A", "Zizza P"], "date": "2020-06-15T00:00:00Z", "year": 2020, "snippets": [], "citations": {"NLM": "Dinami R, Porru M, Amoreo CA, Sperduti I, Mottolese M, Buglioni S, Marinelli D, Maugeri-Sacc\u00e0 M, Sacconi A, Blandino G, Leonetti C, Di Rocco G, Verdina A, Spinella F, Fiorentino F, Ciliberto G, Biroccio A, Zizza P. TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients. J Exp Clin Cancer Res. PMID: 32539869", "BibTeX": "@article{32539869, title={TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients.}, author={Dinami R and Porru M and Amoreo CA and Sperduti I and Mottolese M and Buglioni S and Marinelli D and Maugeri-Sacc\u00e0 M and Sacconi A and Blandino G and Leonetti C and Di Rocco G and Verdina A and Spinella F and Fiorentino F and Ciliberto G and Biroccio A and Zizza P}, journal={J Exp Clin Cancer Res}}"}, "is_sup_mat_match": true}, {"pmid": 30064409, "pmcid": "PMC6069868", "title": "Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma.", "journal": "BMC Urol", "authors": ["Kim YS", "Kim K", "Kwon GY", "Lee SJ", "Park SH"], "date": "2018-07-31T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Kim YS, Kim K, Kwon GY, Lee SJ, Park SH. Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma. BMC Urol. PMID: 30064409", "BibTeX": "@article{30064409, title={Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma.}, author={Kim YS and Kim K and Kwon GY and Lee SJ and Park SH}, journal={BMC Urol}}"}, "is_sup_mat_match": true}, {"pmid": 29873882, "pmcid": "PMC5989850", "title": "Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition.", "journal": "Cancer Sci", "authors": ["Yamazaki K", "Taniguchi H", "Yoshino T", "Akagi K", "Ishida H", "Ebi H", "Nakatani K", "Muro K", "Yatabe Y", "Yamaguchi K", "Tsuchihara K"], "date": "2018-06-01T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Yamazaki K, Taniguchi H, Yoshino T, Akagi K, Ishida H, Ebi H, Nakatani K, Muro K, Yatabe Y, Yamaguchi K, Tsuchihara K. Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition. Cancer Sci. PMID: 29873882", "BibTeX": "@article{29873882, title={Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition.}, author={Yamazaki K and Taniguchi H and Yoshino T and Akagi K and Ishida H and Ebi H and Nakatani K and Muro K and Yatabe Y and Yamaguchi K and Tsuchihara K}, journal={Cancer Sci}}"}, "is_sup_mat_match": true}, {"pmid": 32619037, "pmcid": "PMC7469806", "title": "Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study.", "journal": "Cancer Sci", "authors": ["Yasuda T", "Sanada M", "Nishijima D", "Kanamori T", "Iijima Y", "Hattori H", "Saito A", "Miyoshi H", "Ishikawa Y", "Asou N", "Usuki K", "Hirabayashi S", "Kato M", "Ri M", "Handa H", "Ishida T", "Shibayama H", "Abe M", "Iriyama C", "Karube K", "Nishikori M", "Ohshima K", "Kataoka K", "Yoshida K", "Shiraishi Y", "Goto H", "Adachi S", "Kobayashi R", "Kiyoi H", "Miyazaki Y", "Ogawa S", "Kurahashi H", "Yokoyama H", "Manabe A", "Iida S", "Tomita A", "Horibe K"], "date": "2020-09-01T00:00:00Z", "year": 2020, "snippets": [], "citations": {"NLM": "Yasuda T, Sanada M, Nishijima D, Kanamori T, Iijima Y, Hattori H, Saito A, Miyoshi H, Ishikawa Y, Asou N, Usuki K, Hirabayashi S, Kato M, Ri M, Handa H, Ishida T, Shibayama H, Abe M, Iriyama C, Karube K, Nishikori M, Ohshima K, Kataoka K, Yoshida K, Shiraishi Y, Goto H, Adachi S, Kobayashi R, Kiyoi H, Miyazaki Y, Ogawa S, Kurahashi H, Yokoyama H, Manabe A, Iida S, Tomita A, Horibe K. Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study. Cancer Sci. PMID: 32619037", "BibTeX": "@article{32619037, title={Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study.}, author={Yasuda T and Sanada M and Nishijima D and Kanamori T and Iijima Y and Hattori H and Saito A and Miyoshi H and Ishikawa Y and Asou N and Usuki K and Hirabayashi S and Kato M and Ri M and Handa H and Ishida T and Shibayama H and Abe M and Iriyama C and Karube K and Nishikori M and Ohshima K and Kataoka K and Yoshida K and Shiraishi Y and Goto H and Adachi S and Kobayashi R and Kiyoi H and Miyazaki Y and Ogawa S and Kurahashi H and Yokoyama H and Manabe A and Iida S and Tomita A and Horibe K}, journal={Cancer Sci}}"}, "is_sup_mat_match": true}, {"pmid": 23844038, "pmcid": "PMC3701070", "title": "Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF/MEK tool combination reduced skin lesions.", "journal": "PLoS One", "authors": ["King AJ", "Arnone MR", "Bleam MR", "Moss KG", "Yang J", "Fedorowicz KE", "Smitheman KN", "Erhardt JA", "Hughes-Earle A", "Kane-Carson LS", "Sinnamon RH", "Qi H", "Rheault TR", "Uehling DE", "Laquerre SG"], "date": "2013-07-03T00:00:00Z", "year": 2013, "snippets": [], "citations": {"NLM": "King AJ, Arnone MR, Bleam MR, Moss KG, Yang J, Fedorowicz KE, Smitheman KN, Erhardt JA, Hughes-Earle A, Kane-Carson LS, Sinnamon RH, Qi H, Rheault TR, Uehling DE, Laquerre SG. Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF/MEK tool combination reduced skin lesions. PLoS One. PMID: 23844038", "BibTeX": "@article{23844038, title={Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF/MEK tool combination reduced skin lesions.}, author={King AJ and Arnone MR and Bleam MR and Moss KG and Yang J and Fedorowicz KE and Smitheman KN and Erhardt JA and Hughes-Earle A and Kane-Carson LS and Sinnamon RH and Qi H and Rheault TR and Uehling DE and Laquerre SG}, journal={PLoS One}}"}, "is_sup_mat_match": true}, {"pmid": 26860319, "pmcid": "PMC4748640", "title": "LowMACA: exploiting protein family analysis for the identification of rare driver mutations in cancer.", "journal": "BMC Bioinformatics", "authors": ["Melloni GE", "de Pretis S", "Riva L", "Pelizzola M", "C\u00e9ol A", "Costanza J", "M\u00fcller H", "Zammataro L"], "date": "2016-02-09T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Melloni GE, de Pretis S, Riva L, Pelizzola M, C\u00e9ol A, Costanza J, M\u00fcller H, Zammataro L. LowMACA: exploiting protein family analysis for the identification of rare driver mutations in cancer. BMC Bioinformatics. PMID: 26860319", "BibTeX": "@article{26860319, title={LowMACA: exploiting protein family analysis for the identification of rare driver mutations in cancer.}, author={Melloni GE and de Pretis S and Riva L and Pelizzola M and C\u00e9ol A and Costanza J and M\u00fcller H and Zammataro L}, journal={BMC Bioinformatics}}"}, "is_sup_mat_match": true}, {"pmid": 30867008, "pmcid": "PMC6417284", "title": "Analysis of error profiles in deep next-generation sequencing data.", "journal": "Genome Biol", "authors": ["Ma X", "Shao Y", "Tian L", "Flasch DA", "Mulder HL", "Edmonson MN", "Liu Y", "Chen X", "Newman S", "Nakitandwe J", "Li Y", "Li B", "Shen S", "Wang Z", "Shurtleff S", "Robison LL", "Levy S", "Easton J", "Zhang J"], "date": "2019-03-14T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Ma X, Shao Y, Tian L, Flasch DA, Mulder HL, Edmonson MN, Liu Y, Chen X, Newman S, Nakitandwe J, Li Y, Li B, Shen S, Wang Z, Shurtleff S, Robison LL, Levy S, Easton J, Zhang J. Analysis of error profiles in deep next-generation sequencing data. Genome Biol. PMID: 30867008", "BibTeX": "@article{30867008, title={Analysis of error profiles in deep next-generation sequencing data.}, author={Ma X and Shao Y and Tian L and Flasch DA and Mulder HL and Edmonson MN and Liu Y and Chen X and Newman S and Nakitandwe J and Li Y and Li B and Shen S and Wang Z and Shurtleff S and Robison LL and Levy S and Easton J and Zhang J}, journal={Genome Biol}}"}, "is_sup_mat_match": true}, {"pmid": 33946899, "pmcid": "PMC8125529", "title": "Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection.", "journal": "Cancers (Basel)", "authors": ["Ardito F", "Razionale F", "Salvatore L", "Cenci T", "Vellone M", "Basso M", "Panettieri E", "Calegari MA", "Tortora G", "Martini M", "Giuliante F"], "date": "2021-04-29T00:00:00Z", "year": 2021, "snippets": [{"_id": "33946899@36378", "snip_text": "KRAS Mutation Analysis Primary Tumor, No. (%) CRLM, No. (%) p   KRAS mutation 33 (30.8) 36 (33.6)    Codon 12 16/33 (48.5) 21/36 (58.3%) 0.412   p.(Gly12Val) 6 7    p.(Gly12Asp) 4 7    p.(Gly12Ser) 2 2    p.(Gly12Cys) 2 2    p.(Gly12Ala) 2 2    p.(G12R/S/C) - 1    Codon 13 7/33 (21.2) 7/36 (19.4) 0.855   p.(Gly13Asp) 7 7    p.(Ala146Thr) 6/33 (18.1) 5/36 (13.9) 0.626   p.(Gln22Lys) 2/33 (6.1) 2/36 (5.6) 0.928   p.(Ala59Xaa) - 1/36 (2.8)    p.(Gln61Xaa) 2/33 (6.1)     ", "section": "table", "mentions": ["0|4|gene|ncbi_gene@3845|KRAS", "185|12|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.(Gly12Ser)", "205|12|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.(Gly12Cys)", "326|13|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.(Ala146Thr)", "415|12|variant|litvar@#3845#p.A59X&&&litvar@#3845#|p.(Ala59Xaa)", "165|12|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.(Gly12Asp)", "64|4|gene|ncbi_gene@3845|KRAS", "31|5|disease|ncbi_mesh@D009369|Tumor", "225|12|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.(Gly12Ala)", "145|12|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.(Gly12Val)", "306|12|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.(Gly13Asp)", "372|12|variant|litvar@rs121913236##&&&litvar@#3845#&&&litvar@CA16602771#rs121913236##|p.(Gln22Lys)", "444|12|variant|litvar@rs121913254##&&&litvar@#4893#|p.(Gln61Xaa)", "46|4|disease|ncbi_mesh@D009362|CRLM", "248|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R"], "figure_id": "cancers-13-02148-t002", "text_hl": "KRAS Mutation Analysis Primary Tumor, No. (%) CRLM, No. (%) p   KRAS mutation 33 (30.8) 36 (33.6)    Codon 12 16/33 (48.5) 21/36 (58.3%) 0.412   p.(Gly12Val) 6 7    p.(Gly12Asp) 4 7    p.(Gly12Ser) 2 2    p.(Gly12Cys) 2 2    p.(Gly12Ala) 2 2    p.(G12R/S/C) - 1    Codon 13 7/33 (21.2) 7/36 (19.4) 0.855   p.(Gly13Asp) 7 7    p.(<m>Ala146Thr</m>) 6/33 (18.1) 5/36 (13.9) 0.626   p.(Gln22Lys) 2/33 (6.1) 2/36 (5.6) 0.928   p.(Ala59Xaa) - 1/36 (2.8)    p.(Gln61Xaa) 2/33 (6.1)     "}], "citations": {"NLM": "Ardito F, Razionale F, Salvatore L, Cenci T, Vellone M, Basso M, Panettieri E, Calegari MA, Tortora G, Martini M, Giuliante F. Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection. Cancers (Basel). PMID: 33946899", "BibTeX": "@article{33946899, title={Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection.}, author={Ardito F and Razionale F and Salvatore L and Cenci T and Vellone M and Basso M and Panettieri E and Calegari MA and Tortora G and Martini M and Giuliante F}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 34944853, "pmcid": "PMC8699097", "title": "Therapeutic Targets of KRAS in Colorectal Cancer", "journal": "Cancers (Basel)", "authors": ["Rahman S", "Garrel S", "Gerber M", "Maitra R", "Goel S"], "date": "2021-12-11T00:00:00Z", "year": 2021, "snippets": [{"_id": "34944853@7120", "snip_text": "The majority of the KRAS mutations in the CRC are located in codons 12 and 13 of exon 2 (80% are G12A, G12C, G12D, G12S, G12V, G13C, G13D), and less frequently in codon 61 of exon 3 (5% are Q61H, Q61L, and Q61R) and codon 146 of exon 4 (2% are A146T and A146V).", "section": "other", "mentions": ["103|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "206|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "196|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "121|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "115|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "20|4|gene|ncbi_gene@3845|KRAS", "133|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "254|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "127|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "244|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "109|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "190|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "97|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A"], "text_hl": "The majority of the KRAS mutations in the CRC are located in codons 12 and 13 of exon 2 (80% are G12A, G12C, G12D, G12S, G12V, G13C, G13D), and less frequently in codon 61 of exon 3 (5% are Q61H, Q61L, and Q61R) and codon 146 of exon 4 (2% are <m>A146T</m> and A146V)."}], "citations": {"NLM": "Rahman S, Garrel S, Gerber M, Maitra R, Goel S. Therapeutic Targets of KRAS in Colorectal Cancer Cancers (Basel). PMID: 34944853", "BibTeX": "@article{34944853, title={Therapeutic Targets of KRAS in Colorectal Cancer}, author={Rahman S and Garrel S and Gerber M and Maitra R and Goel S}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 35727391, "pmcid": "PMC9395472", "title": "A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer.", "journal": "Invest New Drugs", "authors": ["Yuan D", "Tao Y", "Wang H", "Wang J", "Cao Y", "Cao W", "Pan S", "Yu Z"], "date": "2022-10-01T00:00:00Z", "year": 2022, "snippets": [{"_id": "35727391@12987", "snip_text": "Genes n (Frequency) Mutation   APC 77%(30/39) Y935*, Q1291*, R499*, W1049*, E1309*, E1306*, E1306*, Q1429*, E287*, Q1367*, E1309*, L698*, E1169*, R876*, K1370*, G524fs, T1556fs, T935fs, D1318fs, L1488fs, V1099fs, I1401fs, I1401fs, T1332fs, L1382fs, T1556fs, L1489fs, G2227V, G2227V, F1396L   TP53 72%(28/39) V157F, Y103fs, Y163C, R273H, A161T, Y220C, G108fs, R248Q, M237I, V157R, V157R, R282W, P152L, P152fs, G245S, R281H, G266V, R342*, R248W, R213*, C135F   KRAS 46%(18/39) G12V, G12D, T58T, G12S, A146T, Q61H, G13D, A59T   PIK3CA 13%(6/39) E545K, H419P, H1047R, I112F   ", "section": "table", "mentions": ["475|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "556|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "267|6|variant|litvar@rs786203367##&&&litvar@#324#|G2227V", "330|5|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|R273H", "292|4|gene|ncbi_gene@7157|TP53", "564|5|variant|litvar@#5290#p.I112F&&&litvar@#5290#|I112F", "401|6|variant|litvar@rs730882019##&&&litvar@#7157#|P152fs", "481|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "169|7|variant|litvar@rs587783031##&&&litvar@#324#|T1556fs", "525|6|gene|ncbi_gene@5290|PIK3CA", "542|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "308|5|variant|litvar@rs121912654##&&&litvar@#7157#&&&litvar@CA222#rs121912654##|V157F", "373|5|variant|litvar@rs121912654##&&&litvar@#7157#|V157R", "437|5|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|R248W", "351|6|variant|litvar@#7157#p.G108fsX&&&litvar@#7157#|G108fs", "423|5|variant|litvar@rs193920774##&&&litvar@#7157#&&&litvar@CA10580919#rs193920774##|G266V", "409|5|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|G245S", "315|6|variant|litvar@#7157#p.Y103fsX&&&litvar@#7157#|Y103fs", "323|5|variant|litvar@rs148924904##&&&litvar@#7157#&&&litvar@CA240#rs148924904##|Y163C", "387|5|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|R282W", "451|5|variant|litvar@rs587781991##&&&litvar@#7157#|C135F", "283|6|variant|litvar@#7157#p.F1396L&&&litvar@#7157#|F1396L", "518|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "359|5|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|R248Q", "337|5|variant|litvar@rs193920817##&&&litvar@#7157#&&&litvar@CA234#rs193920817##|A161T", "31|3|gene|ncbi_gene@324|APC", "459|4|gene|ncbi_gene@3845|KRAS", "178|6|variant|litvar@#7157#p.T935fsX&&&litvar@#7157#|T935fs", "487|4|variant|litvar@rs1439952973##&&&litvar@#3845#|T58T", "506|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "249|7|variant|litvar@rs587783031##&&&litvar@#324#|T1556fs", "240|7|variant|litvar@#7157#p.L1382fsX&&&litvar@#7157#|L1382fs", "231|7|variant|litvar@rs1114167544##&&&litvar@#324#|T1332fs", "258|7|variant|litvar@#7157#p.L1489fsX&&&litvar@#7157#|L1489fs", "549|5|variant|litvar@#5290#p.H419P&&&litvar@#5290#|H419P", "275|6|variant|litvar@rs786203367##&&&litvar@#324#|G2227V", "444|5|variant|litvar@#3845#p.R213*&&&litvar@#3845#|R213*", "366|5|variant|litvar@rs587782664##&&&litvar@#7157#&&&litvar@CA349#rs587782664##|M237I", "416|5|variant|litvar@rs771929085##&&&litvar@#1956#&&&litvar@CA4265435#rs771929085##|R281H", "222|7|variant|litvar@#7157#p.I1401fsX&&&litvar@#7157#|I1401fs", "161|6|variant|litvar@#7157#p.G524fsX&&&litvar@#7157#|G524fs", "394|5|variant|litvar@rs587782705##&&&litvar@#7157#&&&litvar@CA204#rs587782705##|P152L", "499|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "380|5|variant|litvar@rs121912654##&&&litvar@#7157#|V157R", "186|7|variant|litvar@#7157#p.D1318fsX&&&litvar@#7157#|D1318fs", "195|7|variant|litvar@rs1114167577##&&&litvar@#324#|L1488fs", "204|7|variant|litvar@rs1064794228##&&&litvar@#324#|V1099fs", "430|5|variant|litvar@#3845#p.R342*&&&litvar@#3845#|R342*", "493|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "512|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "213|7|variant|litvar@#7157#p.I1401fsX&&&litvar@#7157#|I1401fs", "344|5|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|Y220C"], "figure_id": "Tab2", "text_hl": "Genes n (Frequency) Mutation   APC 77%(30/39) Y935*, Q1291*, R499*, W1049*, E1309*, E1306*, E1306*, Q1429*, E287*, Q1367*, E1309*, L698*, E1169*, R876*, K1370*, G524fs, T1556fs, T935fs, D1318fs, L1488fs, V1099fs, I1401fs, I1401fs, T1332fs, L1382fs, T1556fs, L1489fs, G2227V, G2227V, F1396L   TP53 72%(28/39) V157F, Y103fs, Y163C, R273H, A161T, Y220C, G108fs, R248Q, M237I, V157R, V157R, R282W, P152L, P152fs, G245S, R281H, G266V, R342*, R248W, R213*, C135F   KRAS 46%(18/39) G12V, G12D, T58T, G12S, <m>A146T</m>, Q61H, G13D, A59T   PIK3CA 13%(6/39) E545K, H419P, H1047R, I112F   "}], "citations": {"NLM": "Yuan D, Tao Y, Wang H, Wang J, Cao Y, Cao W, Pan S, Yu Z. A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer. Invest New Drugs. PMID: 35727391", "BibTeX": "@article{35727391, title={A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer.}, author={Yuan D and Tao Y and Wang H and Wang J and Cao Y and Cao W and Pan S and Yu Z}, journal={Invest New Drugs}}"}, "is_sup_mat_match": false}, {"pmid": 30717682, "pmcid": "PMC6360678", "title": "Alterations in ERBB2 and BRCA and microsatellite instability as new personalized treatment options in small bowel carcinoma.", "journal": "BMC Gastroenterol", "authors": ["Quaas A", "Heydt C", "Waldschmidt D", "Alakus H", "Zander T", "Goeser T", "Kasper P", "Bruns C", "Brunn A", "Roth W", "Hartmann N", "Bunck A", "Schmidt M", "Buettner R", "Merkelbach-Bruse S"], "date": "2019-02-04T00:00:00Z", "year": 2019, "snippets": [{"_id": "30717682@7888", "snip_text": "N  BRCA TP53 ERBB2 KRAS MSI PIK3CA KEAP1   1 BRCA2 p.N986Ifs*5 p.R273C wt wt MSI wt p.Y490C   2 wt p.C135Y wt p.G12D n.a. wt wt   3 BRCA1 p.V1234Qfs*8 p.C275Y wt wt MSS wt wt   4 BRCA1 p.E1540* wt wt wt MSS wt p.R320L   5 wt p.G245S p.T862A wt MSS wt wt   6 wt wt wt p.G12 V MSS p.E545G wt   7 BRCA1 p.T77 M BRCA2 p.R1512C wt wt p.A146T MSI Lynch-syndrome p.E542K p.R202H   8 wt p.R175H wt p.G12 V MSS wt wt   9 wt wt. wt. p.G12C MSS wt wt   10 wt p.R248Q wt. wt MSS p.E542K wt   11 wt wt wt wt MSS wt wt   ", "section": "table", "mentions": ["203|3|chemical||MSS", "379|7|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|p.R175H", "3|4|gene|ncbi_gene@672|BRCA", "99|7|variant|litvar@rs587781991##&&&litvar@#7157#&&&litvar@CA160#rs587781991##|p.C135Y", "390|5|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12", "294|5|gene|ncbi_gene@672|BRCA1", "51|11|variant|litvar@rs886038081##&&&litvar@#675#&&&litvar@CA10586507#rs886038081##|p.N986Ifs*5", "329|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "8|4|gene|ncbi_gene@7157|TP53", "467|7|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.E542K", "233|7|variant|litvar@rs1358315577##&&&litvar@#6098#|p.T862A", "179|5|gene|ncbi_gene@672|BRCA1", "210|7|variant|litvar@rs1239985410##&&&litvar@#9817#|p.R320L", "308|5|gene|ncbi_gene@675|BRCA2", "279|7|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123336#rs121913274##|p.E545G", "151|7|variant|litvar@rs863224451##&&&litvar@#7157#&&&litvar@CA337141#rs863224451##|p.C275Y", "63|7|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|p.R273C", "267|5|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12", "185|8|variant|litvar@#672#p.E1540*&&&litvar@#672#|p.E1540*", "398|3|chemical||MSS", "341|14|disease|ncbi_mesh@D003123|Lynch-syndrome", "225|7|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|p.G245S", "314|8|variant|litvar@rs80358684##&&&litvar@#675#&&&litvar@CA20333#rs80358684##|p.R1512C", "19|4|gene|ncbi_gene@3845|KRAS", "110|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "35|5|gene|ncbi_gene@9817|KEAP1", "364|7|variant|litvar@rs775608603##&&&litvar@#9817#&&&litvar@CA9195639#rs775608603##|p.R202H", "84|7|variant|litvar@rs1331944146##&&&litvar@#79811#|p.Y490C", "138|12|variant|litvar@rs80357609##&&&litvar@#672#&&&litvar@CA2368#rs80357609##|p.V1234Qfs*8", "356|7|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.E542K", "132|5|gene|ncbi_gene@672|BRCA1", "13|5|gene|ncbi_gene@2064|ERBB2", "28|6|gene|ncbi_gene@5290|PIK3CA", "45|5|gene|ncbi_gene@675|BRCA2", "448|7|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|p.R248Q", "423|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C"], "figure_id": "Tab2", "text_hl": "N  BRCA TP53 ERBB2 KRAS MSI PIK3CA KEAP1   1 BRCA2 p.N986Ifs*5 p.R273C wt wt MSI wt p.Y490C   2 wt p.C135Y wt p.G12D n.a. wt wt   3 BRCA1 p.V1234Qfs*8 p.C275Y wt wt MSS wt wt   4 BRCA1 p.E1540* wt wt wt MSS wt p.R320L   5 wt p.G245S p.T862A wt MSS wt wt   6 wt wt wt p.G12 V MSS p.E545G wt   7 BRCA1 p.T77 M BRCA2 p.R1512C wt wt <m>p.A146T</m> MSI Lynch-syndrome p.E542K p.R202H   8 wt p.R175H wt p.G12 V MSS wt wt   9 wt wt. wt. p.G12C MSS wt wt   10 wt p.R248Q wt. wt MSS p.E542K wt   11 wt wt wt wt MSS wt wt   "}], "citations": {"NLM": "Quaas A, Heydt C, Waldschmidt D, Alakus H, Zander T, Goeser T, Kasper P, Bruns C, Brunn A, Roth W, Hartmann N, Bunck A, Schmidt M, Buettner R, Merkelbach-Bruse S. Alterations in ERBB2 and BRCA and microsatellite instability as new personalized treatment options in small bowel carcinoma. BMC Gastroenterol. PMID: 30717682", "BibTeX": "@article{30717682, title={Alterations in ERBB2 and BRCA and microsatellite instability as new personalized treatment options in small bowel carcinoma.}, author={Quaas A and Heydt C and Waldschmidt D and Alakus H and Zander T and Goeser T and Kasper P and Bruns C and Brunn A and Roth W and Hartmann N and Bunck A and Schmidt M and Buettner R and Merkelbach-Bruse S}, journal={BMC Gastroenterol}}"}, "is_sup_mat_match": false}, {"pmid": 30029640, "pmcid": "PMC6053835", "title": "Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.", "journal": "BMC Cancer", "authors": ["Mogensen MB", "Rossing M", "\u00d8strup O", "Larsen PN", "Heiberg Engel PJ", "J\u00f8rgensen LN", "Hogdall EV", "Eriksen J", "Ibsen P", "Jess P", "Grauslund M", "Nielsen HJ", "Nielsen FC", "Vainer B", "Osterlind K"], "date": "2018-07-20T00:00:00Z", "year": 2018, "snippets": [{"_id": "30029640@22012", "snip_text": "Of note, two different activating KRAS mutations (KRAS c.38G > A, KRAS c.436G > A) were identified in these tumours.", "section": "results", "mentions": ["71|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "55|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "108|7|disease|ncbi_mesh@D009369|tumours", "66|4|gene|ncbi_gene@3845|KRAS", "50|4|gene|ncbi_gene@3845|KRAS", "34|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "Of note, two different activating KRAS mutations (KRAS c.38G > A, KRAS c.436G > A) were identified in these tumours."}], "citations": {"NLM": "Mogensen MB, Rossing M, \u00d8strup O, Larsen PN, Heiberg Engel PJ, J\u00f8rgensen LN, Hogdall EV, Eriksen J, Ibsen P, Jess P, Grauslund M, Nielsen HJ, Nielsen FC, Vainer B, Osterlind K. Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing. BMC Cancer. PMID: 30029640", "BibTeX": "@article{30029640, title={Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.}, author={Mogensen MB and Rossing M and \u00d8strup O and Larsen PN and Heiberg Engel PJ and J\u00f8rgensen LN and Hogdall EV and Eriksen J and Ibsen P and Jess P and Grauslund M and Nielsen HJ and Nielsen FC and Vainer B and Osterlind K}, journal={BMC Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 31749831, "pmcid": "PMC6842958", "title": "Genomic Profiling of Driver Gene Mutations in Chinese Patients With Non-Small Cell Lung Cancer.", "journal": "Front Genet", "authors": ["Meng H", "Guo X", "Sun D", "Liang Y", "Lang J", "Han Y", "Lu Q", "Zhang Y", "An Y", "Tian G", "Yuan D", "Xu S", "Geng J"], "date": "2019-10-18T00:00:00Z", "year": 2019, "snippets": [{"_id": "31749831@14410", "snip_text": "Gene Alteration Frequency in SCC tissues Total frequency in SCC tissues(n = 134) Frequency in SCC blood Total frequency in SCC blood(n = 96)   BRAF V600E 0.7% (1/134) 0.7% 1.0% (1/96) 1.0%   EGFR Exon 19del 1.5% (2/134) 5.2% 2.1%(2/96) 8.3%    L858R 3.7% (5/134)  6.3% (6/96)    KRAS K117N 0.7% (1/134) 4.5% / 7.3%    G12C/D/V 3.0% (4/134)  3.1% (3/96)     Q61H /  1.0% (1/96)     A146T/P 0.7% (1/134)  3.1% (3/96)    MET Amplification 0.7% (1/134) 0.7% / /   PIK3CA E542K 2.2% (3/134) 9.0% 1.0% (1/96) 6.3%    E545Q/K 6.0% (8/134)  5.2% (5/96)     H1047R 0.7% (1/134)  /    ", "section": "table", "mentions": ["201|5|variant|litvar@#1956#c.19del&&&litvar@#1956#|19del", "123|3|disease|ncbi_mesh@D002294|SCC", "284|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "460|6|gene|ncbi_gene@5290|PIK3CA", "318|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12C/D", "191|4|gene|ncbi_gene@1956|EGFR", "29|3|disease|ncbi_mesh@D002294|SCC", "357|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "244|5|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|L858R", "60|3|disease|ncbi_mesh@D002294|SCC", "148|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "94|3|disease|ncbi_mesh@D002294|SCC", "279|4|gene|ncbi_gene@3845|KRAS", "511|7|variant|litvar@rs104886003##&&&litvar@#5290#|E545Q/K", "418|3|gene|ncbi_gene@79811|MET", "467|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "549|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "381|7|variant|litvar@rs121913527##&&&litvar@#3845#|A146T/P", "143|4|gene|ncbi_gene@673|BRAF"], "figure_id": "T4", "text_hl": "Gene Alteration Frequency in SCC tissues Total frequency in SCC tissues(n = 134) Frequency in SCC blood Total frequency in SCC blood(n = 96)   BRAF V600E 0.7% (1/134) 0.7% 1.0% (1/96) 1.0%   EGFR Exon 19del 1.5% (2/134) 5.2% 2.1%(2/96) 8.3%    L858R 3.7% (5/134)  6.3% (6/96)    KRAS K117N 0.7% (1/134) 4.5% / 7.3%    G12C/D/V 3.0% (4/134)  3.1% (3/96)     Q61H /  1.0% (1/96)     <m>A146T</m>/P 0.7% (1/134)  3.1% (3/96)    MET Amplification 0.7% (1/134) 0.7% / /   PIK3CA E542K 2.2% (3/134) 9.0% 1.0% (1/96) 6.3%    E545Q/K 6.0% (8/134)  5.2% (5/96)     H1047R 0.7% (1/134)  /    "}], "citations": {"NLM": "Meng H, Guo X, Sun D, Liang Y, Lang J, Han Y, Lu Q, Zhang Y, An Y, Tian G, Yuan D, Xu S, Geng J. Genomic Profiling of Driver Gene Mutations in Chinese Patients With Non-Small Cell Lung Cancer. Front Genet. PMID: 31749831", "BibTeX": "@article{31749831, title={Genomic Profiling of Driver Gene Mutations in Chinese Patients With Non-Small Cell Lung Cancer.}, author={Meng H and Guo X and Sun D and Liang Y and Lang J and Han Y and Lu Q and Zhang Y and An Y and Tian G and Yuan D and Xu S and Geng J}, journal={Front Genet}}"}, "is_sup_mat_match": false}, {"pmid": 34610968, "pmcid": "PMC10240575", "title": "Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion", "journal": "Cancer Res", "authors": ["Byron SA", "Hendricks WPD", "Nagulapally AB", "Kraveka JM", "Ferguson WS", "Brown VI", "Eslin DE", "Mitchell D", "Cornelius A", "Roberts W", "Isakoff MS", "Oesterheld JE", "Wada RK", "Rawwas J", "Neville K", "Zage PE", "Harrod VL", "Bergendahl G", "VanSickle E", "Dykema K", "Bond J", "Chou HC", "Wei JS", "Wen X", "Reardon HV", "Roos A", "Nasser S", "Izatt T", "Enriquez D", "Hegde AM", "Cisneros F", "Christofferson A", "Turner B", "Szelinger S", "Keats JJ", "Halperin RF", "Khan J", "Saulnier Sholler GL", "Trent JM"], "date": "2021-12-01T00:00:00Z", "year": 2021, "snippets": [{"_id": "34610968@66117", "snip_text": "Hotspot activating mutations include ACVR1 (R206H), ALK (F1174L, I1171T, R1275Q), BRAF (V600E), CTNNB1 (D32V), EGFR (exon 20 insertion mutation:A767_V769dup, tandem kinase domain duplication), FBXW7 (R465H), FGFR4 (V550L/E), H3F3A (K27M), HRAS/KRAS/NRAS (G12D, G13C/R, Q61K, A146T), MYCN (P44L), PDGFRA (V561D), PIK3CA (E542K, E545K, H1047R), PIK3R1 (N564D), PPM1D (exon 6 truncating mutation, S421*, E423fs, E525*), and PTPN11 (A72D, G503V, T507K).", "section": "figure_legend", "mentions": ["334|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "343|6|gene|ncbi_gene@5295|PIK3R1", "351|5|variant|litvar@rs1057519841##&&&litvar@#5295#|N564D", "200|5|variant|litvar@rs1057519895##&&&litvar@#55294#|R465H", "96|6|gene|ncbi_gene@1499|CTNNB1", "249|4|gene|ncbi_gene@4893|NRAS", "244|4|gene|ncbi_gene@3845|KRAS", "44|5|variant|litvar@rs121912678##&&&litvar@#90#&&&litvar@CA128036#rs121912678##|R206H", "111|4|gene|ncbi_gene@1956|EGFR", "312|6|gene|ncbi_gene@5290|PIK3CA", "320|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "73|6|variant|litvar@rs113994087##&&&litvar@#238#&&&litvar@CA341482#rs113994087##|R1275Q", "435|5|variant|litvar@rs397507546##&&&litvar@#5781#&&&litvar@CA282129#rs397507546##|G503V", "429|4|variant|litvar@rs121918454##&&&litvar@#5781#|A72D", "149|7|variant|litvar@#1956#p.V769dup&&&litvar@#1956#|V769dup", "255|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "65|6|variant|litvar@rs1057519698##&&&litvar@#238#|I1171T", "275|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "283|4|gene|ncbi_gene@4613|MYCN", "394|5|variant|litvar@#5781#p.S421*&&&litvar@#5781#|S421*", "269|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "37|5|gene|ncbi_gene@90|ACVR1", "215|5|variant|litvar@#2264#p.V550L&&&litvar@#2264#|V550L", "104|4|variant|litvar@rs121913396##&&&litvar@#1499#&&&litvar@CA16602683#rs121913396##|D32V", "232|4|variant|litvar@rs769861281##&&&litvar@#4004#&&&litvar@CA5872092#rs769861281##|K27M", "401|6|variant|litvar@#8493#p.E423fsX&&&litvar@#8493#|E423fs", "409|5|variant|litvar@#5781#p.E525*&&&litvar@#5781#|E525*", "193|5|gene|ncbi_gene@55294|FBXW7", "225|5|gene|ncbi_gene@3020|H3F3A", "52|3|gene|ncbi_gene@238|ALK", "57|6|variant|litvar@rs281864719##&&&litvar@#238#&&&litvar@CA277829#rs281864719##|F1174L", "82|4|gene|ncbi_gene@673|BRAF", "359|5|gene|ncbi_gene@8493|PPM1D", "296|6|gene|ncbi_gene@5156|PDGFRA", "304|5|variant|litvar@rs121908586##&&&litvar@#5156#&&&litvar@CA123203#rs121908586##|V561D", "88|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "442|5|variant|litvar@rs886039463##&&&litvar@#5781#&&&litvar@CA10588540#rs886039463##|T507K", "261|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13C", "327|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "208|5|gene|ncbi_gene@2264|FGFR4", "289|4|variant|litvar@rs1057519919##&&&litvar@#4613#|P44L", "421|6|gene|ncbi_gene@5781|PTPN11", "239|4|gene|ncbi_gene@3265|HRAS"], "figure_id": "F2", "text_hl": "Hotspot activating mutations include ACVR1 (R206H), ALK (F1174L, I1171T, R1275Q), BRAF (V600E), CTNNB1 (D32V), EGFR (exon 20 insertion mutation:A767_V769dup, tandem kinase domain duplication), FBXW7 (R465H), FGFR4 (V550L/E), H3F3A (K27M), HRAS/KRAS/NRAS (G12D, G13C/R, Q61K, A146T), MYCN (P44L), PDGFRA (V561D), PIK3CA (E542K, E545K, H1047R), PIK3R1 (N564D), PPM1D (exon 6 truncating mutation, S421*, E423fs, E525*), and PTPN11 (A72D, G503V, T507K)."}], "citations": {"NLM": "Byron SA, Hendricks WPD, Nagulapally AB, Kraveka JM, Ferguson WS, Brown VI, Eslin DE, Mitchell D, Cornelius A, Roberts W, Isakoff MS, Oesterheld JE, Wada RK, Rawwas J, Neville K, Zage PE, Harrod VL, Bergendahl G, VanSickle E, Dykema K, Bond J, Chou HC, Wei JS, Wen X, Reardon HV, Roos A, Nasser S, Izatt T, Enriquez D, Hegde AM, Cisneros F, Christofferson A, Turner B, Szelinger S, Keats JJ, Halperin RF, Khan J, Saulnier Sholler GL, Trent JM. Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion Cancer Res. PMID: 34610968", "BibTeX": "@article{34610968, title={Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion}, author={Byron SA and Hendricks WPD and Nagulapally AB and Kraveka JM and Ferguson WS and Brown VI and Eslin DE and Mitchell D and Cornelius A and Roberts W and Isakoff MS and Oesterheld JE and Wada RK and Rawwas J and Neville K and Zage PE and Harrod VL and Bergendahl G and VanSickle E and Dykema K and Bond J and Chou HC and Wei JS and Wen X and Reardon HV and Roos A and Nasser S and Izatt T and Enriquez D and Hegde AM and Cisneros F and Christofferson A and Turner B and Szelinger S and Keats JJ and Halperin RF and Khan J and Saulnier Sholler GL and Trent JM}, journal={Cancer Res}}"}, "is_sup_mat_match": false}, {"pmid": 35272765, "pmcid": "PMC8916776", "title": "A saturation-mutagenesis analysis of the interplay between stability and activation in Ras.", "journal": "Elife", "authors": ["Hidalgo F", "Nocka LM", "Shah NH", "Gorday K", "Latorraca NR", "Bandaru P", "Templeton S", "Lee D", "Karandur D", "Pelton JG", "Marqusee S", "Wemmer D", "Kuriyan J"], "date": "2022-03-11T00:00:00Z", "year": 2022, "snippets": [{"_id": "35272765@29003", "snip_text": "Furthermore, two such mutations - V14I and A146T - have been shown to facilitate nucleotide exchange by destabilization and opening of the GTP-binding site.", "section": "discussion", "mentions": ["34|4|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|V14I", "139|3|chemical|ncbi_mesh@D006160|GTP", "43|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Furthermore, two such mutations - V14I and <m>A146T</m> - have been shown to facilitate nucleotide exchange by destabilization and opening of the GTP-binding site."}], "citations": {"NLM": "Hidalgo F, Nocka LM, Shah NH, Gorday K, Latorraca NR, Bandaru P, Templeton S, Lee D, Karandur D, Pelton JG, Marqusee S, Wemmer D, Kuriyan J. A saturation-mutagenesis analysis of the interplay between stability and activation in Ras. Elife. PMID: 35272765", "BibTeX": "@article{35272765, title={A saturation-mutagenesis analysis of the interplay between stability and activation in Ras.}, author={Hidalgo F and Nocka LM and Shah NH and Gorday K and Latorraca NR and Bandaru P and Templeton S and Lee D and Karandur D and Pelton JG and Marqusee S and Wemmer D and Kuriyan J}, journal={Elife}}"}, "is_sup_mat_match": false}, {"pmid": 37958416, "pmcid": "PMC10649848", "title": "BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature", "journal": "Cancers (Basel)", "authors": ["Guerrero P", "Albarr\u00e1n V", "San Rom\u00e1n M", "Gonz\u00e1lez-Merino C", "Garc\u00eda de Quevedo C", "Moreno J", "Calvo JC", "Gonz\u00e1lez G", "Orejana I", "Chamorro J", "Mart\u00ednez-Delfrade \u00cd", "Mor\u00f3n B", "de Frutos B", "Ferreiro MR"], "date": "2023-10-31T00:00:00Z", "year": 2023, "snippets": [{"_id": "37958416@26811", "snip_text": "The most frequently observed resistance mechanism was KRAS alteration, particularly in exons 2 and 4 (G12D, G13D, A146T/V).", "section": "other", "mentions": ["54|4|gene|ncbi_gene@3845|KRAS", "114|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "102|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "108|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D"], "text_hl": "The most frequently observed resistance mechanism was KRAS alteration, particularly in exons 2 and 4 (G12D, G13D, <m>A146T</m>/V)."}], "citations": {"NLM": "Guerrero P, Albarr\u00e1n V, San Rom\u00e1n M, Gonz\u00e1lez-Merino C, Garc\u00eda de Quevedo C, Moreno J, Calvo JC, Gonz\u00e1lez G, Orejana I, Chamorro J, Mart\u00ednez-Delfrade \u00cd, Mor\u00f3n B, de Frutos B, Ferreiro MR. BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature Cancers (Basel). PMID: 37958416", "BibTeX": "@article{37958416, title={BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature}, author={Guerrero P and Albarr\u00e1n V and San Rom\u00e1n M and Gonz\u00e1lez-Merino C and Garc\u00eda de Quevedo C and Moreno J and Calvo JC and Gonz\u00e1lez G and Orejana I and Chamorro J and Mart\u00ednez-Delfrade \u00cd and Mor\u00f3n B and de Frutos B and Ferreiro MR}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 34860166, "pmcid": "PMC8880901", "title": "Evaluation of the Mutation Profile via Next-Generation Sequencing in a Turkish Population With Non-small Cell Lung Cancer.", "journal": "Balkan Med J", "authors": ["Kahraman \u00c7etin N", "Erdo\u011fdu \u0130H", "Bozkurt E", "Meteo\u011flu \u0130"], "date": "2021-11-01T00:00:00Z", "year": 2021, "snippets": [{"_id": "34860166@31046", "snip_text": "Gene Location N (296) cDNA Change (Respectively) Protein Change (Respectively)   KRAS, n = 121 Exon 2 47 c.34G>T p.G12C   24 c.35G>T p.G12V   18 c.35G>A p.G12D   10 c.35G>C p.G12A   4 c.37G>T p.G13C   3 c.38G>A p.G13D   Each 1 c.33_34delTGinsGT, c.34_35delGGinsTT, c.34G>A, c.34G>C, c.36T>C, c.39C>T p.G12C, p.G12F, p.G12S, p G12R, p.G12G, p.G13G   Exon 3 3 c.183A>T p.Q61H   2 c.183A>C p.Q61H   Exon 4 3 c.437C>T p.A146V   1 c.436G>A p.A146T   EGFR, n = 53 Exon 7 1 c.866C>T p.A289V   Exon 18 Each 1 c.2155G>A, c.2156G>C p.G719S, p.G719A   Exon 19 15 c.2235_2249delGGAATTAAGAGAAGC p.E746_750delEL   5 c.2237_2255delAATTAAGAGAAGCAACATCinsT p.E746_S752delinsV   3 c.2239_2247delTTAAGAGAA p.L747_E749del   Each 2 c.2236_2250delGAATTAAGAGAAGCA, c.2240_2254delTAAGAGAAGCAACAT, c.2248G>C p.E746_A750del, p.L747_T751del, p.750P   Each 1 c.2170G>A, c.2240_2257delTAAGAGAAGCAACATCTC, c.2247_2248delAG, c.2260A>G, c.2281G>A p.G724S, p.L747_P753delinsS, p.A750P, p K754E, p.D761N   Exon 20 2 c.2311_2319dupAACCCCCAC p.N771_H773dup   Each 1 c.2300_2308dupCCAGCGTGG, c.2320G>A p.A767_V769dup, p.V774M   Exon 21 5 c.2573T>G p.L858R   4 c.2582T>A p.L861Q   2 c.2543C>T p.P848L   1 c.2573_2574delTGinsGA p.L858R   PIK3CA, n = 33 Exon 2 Each 1 c.113G>A, c.331A>G p.R38H, p.K111E   Exon 8 2 c.1357G>C p.E453Q   1 c.1258T>C p.C420R   Exon 10 13 c.1633G>A p.E545K   Each 1 c.1624G>A, c.1634A>C, c.1637A>G, c.1638G>C p.E542K, p.E545A, p.Q546R, p Q546H   Exon 21 6 c.3140A>G p.H1047R   3 c.3140A>T p.H1047L   Each 1 c.3073A>G, c.3155C>A p.T1025A, p.T1052K   BRAF, n = 23 Exon 11 Each 2 c.1391G>T, c.1405G>C, c.1406G>T p.G464V, p.G469R, p.G469V   Each 1 c.1396G>A, c.1405G>A, c.1406G>C p.G466R, p.G469R, p.G469A   Exon 15 9 c.1799T>A p.V600E   2 c.1801A>G p.K601E   Each 1 c.1742A>T, c.1742A>G, c.1790T>G p.N581I, p.N581S, p.L597R   NF1, n = 19 Exon 18 1 c.2033dupC p.I679fs*21   Exon 19 8 c.2325+3A>G -   Exon 20 7 c.2392A>C p.K798Q   Exon 28 1 c.3814C>T p.Q1272*   Exon 36 1 c.5170A>T p.K1724*   Exon 42 1 c.6522_6523delGA p.E2174fs*46   ERBB2, n = 10 Exon 8 1 c.929C>A p.S310Y   Exon 19 1 c.2305G>T p.D769Y   Exon 20 7 c.2313_2324dupATACGTGATGGC p.Y772_A775dup   1 c.2312_2313insCTACGTGATGGC p.Y772_A775dup   TP53, n = 7 Exon 4 1 c.313G>T p.G105C   Exon 5 1 c.469G>T p.V157F   Exon 7 1 c.742C>T p.R246W   Exon 8 Each 1 c.817C>T, c.817C>G, c.823T>C, c.833C>A p.R273C, p.R273G, p.C275R, p P278H   Exon 9 1 c.961A>T p.K321*   PTEN Exon 6 7 c.407G>A p.C136Y   NRAS, n = 6 Exon 3 3 c.182A>T p.Q61L   2 c.181C>A p.Q61K   1 c.182A>G p.Q61R   RAF1, n = 5 Exon 7 3 c.770C>T p.S257L   2 c.776C>T p.S259F   LRP1B, n = 2 Exon 42 1 c.6852C>A p.Y2284*   Exon 50 1 c.8103C>A p.C2701*   KIT Exon 11 2 c.1676T>A p.V559D   ALK Exon 25 1 c.3824G>A p.R1275Q   ARID1A Exon 18 1 c.4495C>T p.Q1499*   CDKN2A Exon 2 1 c.457+2T>G -   MGA Exon 10 1 c.3463C>T p.R1155*   MUC16 Exon 3 1 c.22517C>A p.S7506*   PIK3R1 Exon 11 1 c.1312A>T p.K438*   SETD2 Exon 14 1 c.6190_6191delGA p.D2064fs*8   ", "section": "table", "mentions": ["2239|8|variant|litvar@rs121912654##&&&litvar@#7157#&&&litvar@CA222#rs121912654##|c.469G>T", "2394|7|variant|litvar@#5728#p.K321*&&&litvar@#5728#|p.K321*", "81|4|gene|ncbi_gene@3845|KRAS", "2050|7|variant|litvar@rs1057519816##&&&litvar@#2064#|p.S310Y", "2631|9|variant|litvar@rs367597756##&&&litvar@#23269#|c.8103C>A", "1072|7|variant|litvar@#5290#p.V769dup&&&litvar@#5290#|V769dup", "1868|11|variant|litvar@rs1057517848##&&&litvar@#4763#|c.2325+3A>G", "1986|16|variant|litvar@#2064#c.6522_6523delGA&&&litvar@#2064#|c.6522_6523delGA", "955|5|variant|litvar@rs397517101##&&&litvar@#1956#&&&litvar@CA135818#rs397517101##|K754E", "2546|7|variant|litvar@rs80338796##&&&litvar@#5894#&&&litvar@CA235334#rs80338796##|p.S257L", "1773|9|variant|litvar@rs121913366##&&&litvar@#673#&&&litvar@CA123649#rs121913366##|c.1790T>G", "1013|7|variant|litvar@#5290#p.H773dup&&&litvar@#5290#|H773dup", "2427|7|variant|litvar@rs786204859##&&&litvar@#5728#&&&litvar@CA451#rs786204859##|p.C136Y", "435|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "274|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>C", "1133|7|variant|litvar@rs121913444##&&&litvar@#1956#&&&litvar@CA176021#rs121913444##|p.L861Q", "2003|12|variant|litvar@rs1131691084##&&&litvar@#4763#|p.E2174fs*46", "1597|7|variant|litvar@rs121913348##&&&litvar@#673#&&&litvar@CA135076#rs121913348##|p.G464V", "2600|9|variant|litvar@#53353#c.6852C>A&&&litvar@#53353#|c.6852C>A", "1467|9|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|c.3140A>T", "2310|8|variant|litvar@rs587780076##&&&litvar@#7157#|c.817C>G", "2558|8|variant|litvar@rs397516827##&&&litvar@#5894#&&&litvar@CA339739#rs397516827##|c.776C>T", "173|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "1516|8|variant|litvar@rs397517202##&&&litvar@#5290#&&&litvar@CA136374#rs397517202##|p.T1025A", "1495|9|variant|litvar@rs397517202##&&&litvar@#5290#&&&litvar@CA136374#rs397517202##|c.3073A>G", "2710|8|variant|litvar@rs113994087##&&&litvar@#238#&&&litvar@CA341482#rs113994087##|p.R1275Q", "326|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "1376|9|variant|litvar@rs397517201##&&&litvar@#5290#&&&litvar@CA136371#rs397517201##|c.1637A>G", "2721|6|gene|ncbi_gene@8289|ARID1A", "1587|9|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA135085#rs121913355##|c.1406G>T", "2577|5|gene|ncbi_gene@53353|LRP1B", "184|7|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA135570#rs121913535##|c.37G>T", "2080|7|variant|litvar@rs121913468##&&&litvar@#2064#|p.D769Y", "1101|9|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|c.2573T>G", "1955|9|variant|litvar@rs767886690##&&&litvar@#53353#&&&litvar@CA1894983#rs767886690##|c.5170A>T", "125|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "1354|9|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|c.1624G>A", "1565|9|variant|litvar@rs121913348##&&&litvar@#673#&&&litvar@CA135076#rs121913348##|c.1391G>T", "2100|26|variant|litvar@rs397516976##&&&litvar@#2064#|c.2313_2324dupATACGTGATGGC", "915|7|variant|litvar@rs748011710##&&&litvar@#1956#&&&litvar@CA4266230#rs748011710##|p.G724S", "2041|8|variant|litvar@rs1057519816##&&&litvar@#2064#|c.929C>A", "2507|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "2686|3|gene|ncbi_gene@238|ALK", "1506|9|variant|litvar@#673#c.3155C>A&&&litvar@#673#|c.3155C>A", "2889|7|variant|litvar@#29072#p.K438*&&&litvar@#29072#|p.K438*", "2879|9|variant|litvar@rs1487370393##&&&litvar@#5894#|c.1312A>T", "1783|7|variant|litvar@rs121913370##&&&litvar@#673#|p.N581I", "1664|7|variant|litvar@rs121913353##&&&litvar@#673#&&&litvar@CA168090546#rs121913353##|p.G466R", "2700|9|variant|litvar@rs113994087##&&&litvar@#238#&&&litvar@CA341482#rs113994087##|c.3824G>A", "332|6|variant|litvar@rs759764705##&&&litvar@#4893#&&&litvar@CA1020785#rs759764705##|p.G12G", "387|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "1296|9|variant|litvar@rs121913272##&&&litvar@#5290#&&&litvar@CA180900#rs121913272##|c.1258T>C", "924|18|variant|litvar@#5290#p.S747,753delins&&&litvar@#5290#|p.L747_P753delinsS", "358|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|c.183A>T", "2368|5|variant|litvar@rs876659802##&&&litvar@#7157#|P278H", "2775|10|variant|litvar@#23269#c.457+2T>G&&&litvar@#23269#|c.457+2T>G", "2248|7|variant|litvar@rs121912654##&&&litvar@#7157#&&&litvar@CA222#rs121912654##|p.V157F", "1654|9|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA123655#rs121913355##|c.1406G>C", "522|7|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126722#rs28929495##|p.G719S", "1751|9|variant|litvar@rs121913370##&&&litvar@#673#|c.1742A>T", "300|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "1606|7|variant|litvar@rs121913357##&&&litvar@#673#&&&litvar@CA123653#rs121913357##|p.G469R", "982|23|variant|litvar@rs397517115##&&&litvar@#1956#|c.2311_2319dupAACCCCCAC", "2357|7|variant|litvar@rs1057519983##&&&litvar@#7157#|p.C275R", "1904|7|variant|litvar@rs1135402830##&&&litvar@#4763#|p.K798Q", "2276|7|variant|litvar@rs755592452##&&&litvar@#53353#|p.R246W", "2180|7|variant|litvar@#7157#c.775dupA&&&litvar@#7157#|A775dup", "1247|6|variant|litvar@rs772110575##&&&litvar@#5290#&&&litvar@CA2710498#rs772110575##|p.R38H", "1724|9|variant|litvar@rs121913364##&&&litvar@#673#&&&litvar@CA123645#rs121913364##|c.1801A>G", "165|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>C", "552|29|variant|litvar@rs121913421##&&&litvar@#1956#|c.2235_2249delGGAATTAAGAGAAGC", "1444|9|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A>G", "2320|8|variant|litvar@rs1057519983##&&&litvar@#7157#|c.823T>C", "1526|8|variant|litvar@#673#p.T1052K&&&litvar@#673#|p.T1052K", "113|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "2516|4|gene|ncbi_gene@5894|RAF1", "1111|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "2676|7|variant|litvar@rs121913517##&&&litvar@#3815#&&&litvar@CA123522#rs121913517##|p.V559D", "582|15|variant|litvar@#1956#p.E,EL746_750del&&&litvar@#1956#|p.E746_750delEL", "2652|3|gene|ncbi_gene@3815|KIT", "2899|5|gene|ncbi_gene@29072|SETD2", "2915|16|variant|litvar@#29072#c.6190_6191delGA&&&litvar@#29072#|c.6190_6191delGA", "1415|7|variant|litvar@rs397517201##&&&litvar@#5290#&&&litvar@CA136371#rs397517201##|p.Q546R", "211|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "367|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "1426|5|variant|litvar@rs1057519940##&&&litvar@#5290#|Q546H", "1844|11|variant|litvar@rs587781807##&&&litvar@#4763#|p.I679fs*21", "783|14|variant|litvar@#1956#p.A746,750del&&&litvar@#1956#|p.E746_A750del", "1397|7|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.E542K", "2537|8|variant|litvar@rs80338796##&&&litvar@#5894#&&&litvar@CA235334#rs80338796##|c.770C>T", "2748|8|variant|litvar@#1029#p.Q1499*&&&litvar@#1029#|p.Q1499*", "308|6|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12F", "1327|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G>A", "2348|7|variant|litvar@rs587780076##&&&litvar@#7157#&&&litvar@CA1422#rs587780076##|p.R273G", "340|6|variant|litvar@rs397517040##&&&litvar@#3845#&&&litvar@CA135576#rs397517040##|p.G13G", "2759|6|gene|ncbi_gene@1029|CDKN2A", "831|9|variant|litvar@rs1051753269##&&&litvar@#1956#&&&litvar@CA16602800#rs1051753269##|c.2170G>A", "1081|7|variant|litvar@rs567477136##&&&litvar@#1956#&&&litvar@CA158928427#rs567477136##|p.V774M", "2478|8|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C>A", "1792|7|variant|litvar@rs121913370##&&&litvar@#673#&&&litvar@CA180747#rs121913370##|p.N581S", "2418|8|variant|litvar@rs786204859##&&&litvar@#5728#&&&litvar@CA451#rs786204859##|c.407G>A", "962|7|variant|litvar@rs121913418##&&&litvar@#1956#&&&litvar@CA16602543#rs121913418##|p.D761N", "2339|7|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|p.R273C", "1576|9|variant|litvar@rs121913357##&&&litvar@#673#&&&litvar@CA123653#rs121913357##|c.1405G>C", "711|29|variant|litvar@rs727504233##&&&litvar@#1956#|c.2236_2250delGAATTAAGAGAAGCA", "806|7|variant|litvar@#1956#c.751delT&&&litvar@#1956#|T751del", "2220|7|variant|litvar@rs1303165645##&&&litvar@#5728#|p.G105C", "283|7|variant|litvar@rs1193776816##&&&litvar@#5295#|c.36T>C", "1387|9|variant|litvar@rs1405663804##&&&litvar@#94025#|c.1638G>C", "1145|9|variant|litvar@rs148934350##&&&litvar@#1956#&&&litvar@CA135927#rs148934350##|c.2543C>T", "265|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G>A", "1734|7|variant|litvar@rs121913364##&&&litvar@#673#&&&litvar@CA123645#rs121913364##|p.K601E", "531|7|variant|litvar@rs121913428##&&&litvar@#1956#&&&litvar@CA135775#rs121913428##|p.G719A", "153|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "773|9|variant|litvar@rs121913229##&&&litvar@#1956#&&&litvar@CA135812#rs121913229##|c.2248G>C", "2814|8|variant|litvar@#94025#p.R1155*&&&litvar@#94025#|p.R1155*", "1965|8|variant|litvar@#2064#p.K1724*&&&litvar@#2064#|p.K1724*", "2840|10|variant|litvar@#94025#c.22517C>A&&&litvar@#94025#|c.22517C>A", "2738|9|variant|litvar@rs1060500242##&&&litvar@#4763#|c.4495C>T", "1537|4|gene|ncbi_gene@673|BRAF", "1632|9|variant|litvar@rs121913353##&&&litvar@#673#&&&litvar@CA135079#rs121913353##|c.1396G>A", "2641|8|variant|litvar@#3815#p.2701dup&&&litvar@#3815#|p.C2701*", "1055|9|variant|litvar@rs567477136##&&&litvar@#1956#&&&litvar@CA158928427#rs567477136##|c.2320G>A", "894|9|variant|litvar@rs397517101##&&&litvar@#1956#&&&litvar@CA135818#rs397517101##|c.2260A>G", "2190|4|gene|ncbi_gene@7157|TP53", "694|7|variant|litvar@#1956#p.E749del&&&litvar@#1956#|E749del", "1337|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "2487|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "842|32|variant|litvar@#5290#c.2240_2257delTAAGAGAAGCAACATCTC&&&litvar@#5290#|c.2240_2257delTAAGAGAAGCAACATCTC", "1030|23|variant|litvar@rs727504263##&&&litvar@#1956#|c.2300_2308dupCCAGCGTGG", "2458|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|c.182A>T", "1702|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "663|23|variant|litvar@rs121913436##&&&litvar@#1956#|c.2239_2247delTTAAGAGAA", "1801|7|variant|litvar@rs121913366##&&&litvar@#673#&&&litvar@CA123649#rs121913366##|p.L597R", "2018|5|gene|ncbi_gene@2064|ERBB2", "1762|9|variant|litvar@rs121913370##&&&litvar@#673#&&&litvar@CA180747#rs121913370##|c.1742A>G", "203|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "2211|8|variant|litvar@rs1303165645##&&&litvar@#5728#|c.313G>T", "2567|7|variant|litvar@rs397516827##&&&litvar@#5894#&&&litvar@CA339739#rs397516827##|p.S259F", "414|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "2804|9|variant|litvar@rs528009988##&&&litvar@#23269#|c.3463C>T", "1643|9|variant|litvar@rs121913357##&&&litvar@#673#&&&litvar@CA180746#rs121913357##|c.1405G>A", "2070|9|variant|litvar@rs121913468##&&&litvar@#2064#|c.2305G>T", "246|17|variant|litvar@#3845#c.34_35delinsGG,TT&&&litvar@#3845#|c.34_35delGGinsTT", "602|37|variant|litvar@#1956#c.2237_2255delinsAATTAAGAGAAGCAACATC,T&&&litvar@#1956#|c.2237_2255delAATTAAGAGAAGCAACATCinsT", "2330|8|variant|litvar@rs876659802##&&&litvar@#7157#|c.833C>A", "2385|8|variant|litvar@rs771867284##&&&litvar@#53353#&&&litvar@CA1896137#rs771867284##|c.961A>T", "742|29|variant|litvar@rs121913442##&&&litvar@#1956#|c.2240_2254delTAAGAGAAGCAACAT", "1673|7|variant|litvar@rs121913357##&&&litvar@#673#&&&litvar@CA123653#rs121913357##|p.G469R", "1833|10|variant|litvar@rs587781807##&&&litvar@#4763#|c.2033dupC", "501|9|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126722#rs28929495##|c.2155G>A", "1306|7|variant|litvar@rs121913272##&&&litvar@#5290#&&&litvar@CA180900#rs121913272##|p.C420R", "905|9|variant|litvar@rs121913418##&&&litvar@#1956#&&&litvar@CA16602543#rs121913418##|c.2281G>A", "1477|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|p.H1047L", "145|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "1199|6|gene|ncbi_gene@5290|PIK3CA", "426|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "2267|8|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|c.742C>T", "292|7|variant|litvar@rs397517040##&&&litvar@#3845#&&&litvar@CA135576#rs397517040##|c.39C>T", "1167|21|variant|litvar@#5290#c.2573_2574delinsTG,GA&&&litvar@#5290#|c.2573_2574delTGinsGA", "1284|7|variant|litvar@rs1057519925##&&&litvar@#5290#|p.E453Q", "1155|7|variant|litvar@rs148934350##&&&litvar@#1956#&&&litvar@CA135927#rs148934350##|p.P848L", "1365|9|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123342#rs121913274##|c.1634A>C", "2404|4|gene|ncbi_gene@5728|PTEN", "944|7|variant|litvar@rs121913229##&&&litvar@#1956#&&&litvar@CA135812#rs121913229##|p.A750P", "815|6|variant|litvar@rs121913229##&&&litvar@#1956#|p.750P", "476|7|variant|litvar@rs149840192##&&&litvar@#1956#&&&litvar@CA16602664#rs149840192##|p.A289V", "2862|6|gene|ncbi_gene@5295|PIK3R1", "2300|8|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|c.817C>T", "512|9|variant|litvar@rs121913428##&&&litvar@#1956#&&&litvar@CA135775#rs121913428##|c.2156G>C", "2467|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "2498|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A>G", "1615|7|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA135085#rs121913355##|p.G469V", "105|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>T", "405|8|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C>T", "445|4|gene|ncbi_gene@1956|EGFR", "1811|3|gene|ncbi_gene@4763|NF1", "2437|4|gene|ncbi_gene@4893|NRAS", "876|16|variant|litvar@#5290#c.2247_2248delAG&&&litvar@#5290#|c.2247_2248delAG", "1274|9|variant|litvar@rs1057519925##&&&litvar@#5290#|c.1357G>C", "1934|8|variant|litvar@#2064#p.Q1272*&&&litvar@#2064#|p.Q1272*", "2134|7|variant|litvar@#7157#c.775dupA&&&litvar@#7157#|A775dup", "1123|9|variant|litvar@rs121913444##&&&litvar@#1956#&&&litvar@CA176021#rs121913444##|c.2582T>A", "1894|9|variant|litvar@rs1135402830##&&&litvar@#4763#|c.2392A>C", "1712|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "1189|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "378|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA180922#rs17851045##|c.183A>C", "316|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "2825|5|gene|ncbi_gene@94025|MUC16", "227|17|variant|litvar@#3845#c.33_34delinsTG,GT&&&litvar@#3845#|c.33_34delTGinsGT", "2666|9|variant|litvar@rs121913517##&&&litvar@#3815#&&&litvar@CA123522#rs121913517##|c.1676T>A", "192|6|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|p.G13C", "1228|8|variant|litvar@rs772110575##&&&litvar@#5290#&&&litvar@CA2710498#rs772110575##|c.113G>A", "2932|9|variant|litvar@#29072#p.D2064fsX&&&litvar@#29072#|p.D2064fs", "2790|3|gene|ncbi_gene@23269|MGA", "133|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "2146|26|variant|litvar@#7157#c.2312_2313insCTACGTGATGGC&&&litvar@#7157#|c.2312_2313insCTACGTGATGGC", "2610|8|variant|litvar@#53353#p.Y2284*&&&litvar@#53353#|p.Y2284*", "1406|7|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123342#rs121913274##|p.E545A", "1454|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.H1047R", "467|8|variant|litvar@rs149840192##&&&litvar@#1956#&&&litvar@CA16602664#rs149840192##|c.866C>T", "1238|8|variant|litvar@rs1057519933##&&&litvar@#5290#|c.331A>G", "1255|7|variant|litvar@rs1057519933##&&&litvar@#5290#|p.K111E", "1682|7|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|p.G469A", "1924|9|variant|litvar@rs115542291##&&&litvar@#29072#&&&litvar@CA2363318#rs115542291##|c.3814C>T"], "figure_id": "t3-bmj-38-6-382", "text_hl": "Gene Location N (296) cDNA Change (Respectively) Protein Change (Respectively)   KRAS, n = 121 Exon 2 47 c.34G>T p.G12C   24 c.35G>T p.G12V   18 c.35G>A p.G12D   10 c.35G>C p.G12A   4 c.37G>T p.G13C   3 c.38G>A p.G13D   Each 1 c.33_34delTGinsGT, c.34_35delGGinsTT, c.34G>A, c.34G>C, c.36T>C, c.39C>T p.G12C, p.G12F, p.G12S, p G12R, p.G12G, p.G13G   Exon 3 3 c.183A>T p.Q61H   2 c.183A>C p.Q61H   Exon 4 3 c.437C>T p.A146V   1 c.436G>A <m>p.A146T</m>   EGFR, n = 53 Exon 7 1 c.866C>T p.A289V   Exon 18 Each 1 c.2155G>A, c.2156G>C p.G719S, p.G719A   Exon 19 15 c.2235_2249delGGAATTAAGAGAAGC p.E746_750delEL   5 c.2237_2255delAATTAAGAGAAGCAACATCinsT p.E746_S752delinsV   3 c.2239_2247delTTAAGAGAA p.L747_E749del   Each 2 c.2236_2250delGAATTAAGAGAAGCA, c.2240_2254delTAAGAGAAGCAACAT, c.2248G>C p.E746_A750del, p.L747_T751del, p.750P   Each 1 c.2170G>A, c.2240_2257delTAAGAGAAGCAACATCTC, c.2247_2248delAG, c.2260A>G, c.2281G>A p.G724S, p.L747_P753delinsS, p.A750P, p K754E, p.D761N   Exon 20 2 c.2311_2319dupAACCCCCAC p.N771_H773dup   Each 1 c.2300_2308dupCCAGCGTGG, c.2320G>A p.A767_V769dup, p.V774M   Exon 21 5 c.2573T>G p.L858R   4 c.2582T>A p.L861Q   2 c.2543C>T p.P848L   1 c.2573_2574delTGinsGA p.L858R   PIK3CA, n = 33 Exon 2 Each 1 c.113G>A, c.331A>G p.R38H, p.K111E   Exon 8 2 c.1357G>C p.E453Q   1 c.1258T>C p.C420R   Exon 10 13 c.1633G>A p.E545K   Each 1 c.1624G>A, c.1634A>C, c.1637A>G, c.1638G>C p.E542K, p.E545A, p.Q546R, p Q546H   Exon 21 6 c.3140A>G p.H1047R   3 c.3140A>T p.H1047L   Each 1 c.3073A>G, c.3155C>A p.T1025A, p.T1052K   BRAF, n = 23 Exon 11 Each 2 c.1391G>T, c.1405G>C, c.1406G>T p.G464V, p.G469R, p.G469V   Each 1 c.1396G>A, c.1405G>A, c.1406G>C p.G466R, p.G469R, p.G469A   Exon 15 9 c.1799T>A p.V600E   2 c.1801A>G p.K601E   Each 1 c.1742A>T, c.1742A>G, c.1790T>G p.N581I, p.N581S, p.L597R   NF1, n = 19 Exon 18 1 c.2033dupC p.I679fs*21   Exon 19 8 c.2325+3A>G -   Exon 20 7 c.2392A>C p.K798Q   Exon 28 1 c.3814C>T p.Q1272*   Exon 36 1 c.5170A>T p.K1724*   Exon 42 1 c.6522_6523delGA p.E2174fs*46   ERBB2, n = 10 Exon 8 1 c.929C>A p.S310Y   Exon 19 1 c.2305G>T p.D769Y   Exon 20 7 c.2313_2324dupATACGTGATGGC p.Y772_A775dup   1 c.2312_2313insCTACGTGATGGC p.Y772_A775dup   TP53, n = 7 Exon 4 1 c.313G>T p.G105C   Exon 5 1 c.469G>T p.V157F   Exon 7 1 c.742C>T p.R246W   Exon 8 Each 1 c.817C>T, c.817C>G, c.823T>C, c.833C>A p.R273C, p.R273G, p.C275R, p P278H   Exon 9 1 c.961A>T p.K321*   PTEN Exon 6 7 c.407G>A p.C136Y   NRAS, n = 6 Exon 3 3 c.182A>T p.Q61L   2 c.181C>A p.Q61K   1 c.182A>G p.Q61R   RAF1, n = 5 Exon 7 3 c.770C>T p.S257L   2 c.776C>T p.S259F   LRP1B, n = 2 Exon 42 1 c.6852C>A p.Y2284*   Exon 50 1 c.8103C>A p.C2701*   KIT Exon 11 2 c.1676T>A p.V559D   ALK Exon 25 1 c.3824G>A p.R1275Q   ARID1A Exon 18 1 c.4495C>T p.Q1499*   CDKN2A Exon 2 1 c.457+2T>G -   MGA Exon 10 1 c.3463C>T p.R1155*   MUC16 Exon 3 1 c.22517C>A p.S7506*   PIK3R1 Exon 11 1 c.1312A>T p.K438*   SETD2 Exon 14 1 c.6190_6191delGA p.D2064fs*8   "}], "citations": {"NLM": "Kahraman \u00c7etin N, Erdo\u011fdu \u0130H, Bozkurt E, Meteo\u011flu \u0130. Evaluation of the Mutation Profile via Next-Generation Sequencing in a Turkish Population With Non-small Cell Lung Cancer. Balkan Med J. PMID: 34860166", "BibTeX": "@article{34860166, title={Evaluation of the Mutation Profile via Next-Generation Sequencing in a Turkish Population With Non-small Cell Lung Cancer.}, author={Kahraman \u00c7etin N and Erdo\u011fdu \u0130H and Bozkurt E and Meteo\u011flu \u0130}, journal={Balkan Med J}}"}, "is_sup_mat_match": false}, {"pmid": 36849494, "pmcid": "PMC9971254", "title": "Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer.", "journal": "Nat Commun", "authors": ["Chmielecki J", "Gray JE", "Cheng Y", "Ohe Y", "Imamura F", "Cho BC", "Lin MC", "Majem M", "Shah R", "Rukazenkov Y", "Todd A", "Markovets A", "Barrett JC", "Hartmaier RJ", "Ramalingam SS"], "date": "2023-02-27T00:00:00Z", "year": 2023, "snippets": [{"_id": "36849494@10003", "snip_text": "Single acquired resistance mechanisms were detected in 23 (21%) patients, including nine (8%) with MET amplification, five (5%) with EGFR mutations, three (3%) with PIK3CA E545K, and one (1%) patient each with CDK6 amplification, CDK4 amplification, CCND1 amplification, KRAS A146T, BRAF V600E, and PIK3CA E453K.", "section": "results", "mentions": ["230|4|gene|ncbi_gene@1019|CDK4", "210|4|gene|ncbi_gene@1021|CDK6", "283|4|gene|ncbi_gene@673|BRAF", "276|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "165|6|gene|ncbi_gene@5290|PIK3CA", "64|8|species|ncbi_taxonomy@9606|patients", "271|4|gene|ncbi_gene@3845|KRAS", "172|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "288|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "99|3|gene|ncbi_gene@79811|MET", "299|6|gene|ncbi_gene@5290|PIK3CA", "133|4|gene|ncbi_gene@1956|EGFR", "250|5|gene|ncbi_gene@595|CCND1", "306|5|variant|litvar@rs1057519925##&&&litvar@#5290#|E453K", "192|7|species|ncbi_taxonomy@9606|patient"], "text_hl": "Single acquired resistance mechanisms were detected in 23 (21%) patients, including nine (8%) with MET amplification, five (5%) with EGFR mutations, three (3%) with PIK3CA E545K, and one (1%) patient each with CDK6 amplification, CDK4 amplification, CCND1 amplification, KRAS <m>A146T</m>, BRAF V600E, and PIK3CA E453K."}], "citations": {"NLM": "Chmielecki J, Gray JE, Cheng Y, Ohe Y, Imamura F, Cho BC, Lin MC, Majem M, Shah R, Rukazenkov Y, Todd A, Markovets A, Barrett JC, Hartmaier RJ, Ramalingam SS. Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer. Nat Commun. PMID: 36849494", "BibTeX": "@article{36849494, title={Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer.}, author={Chmielecki J and Gray JE and Cheng Y and Ohe Y and Imamura F and Cho BC and Lin MC and Majem M and Shah R and Rukazenkov Y and Todd A and Markovets A and Barrett JC and Hartmaier RJ and Ramalingam SS}, journal={Nat Commun}}"}, "is_sup_mat_match": false}, {"pmid": 36551560, "pmcid": "PMC9776941", "title": "Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study", "journal": "Cancers (Basel)", "authors": ["Valladares-Ayerbes M", "Garcia-Alfonso P", "Mu\u00f1oz Luengo J", "Pimentel Caceres PP", "Castillo Trujillo OA", "Vidal-Tocino R", "Llanos M", "Llorente Ayala B", "Limon Miron ML", "Salud A", "Cirera Nogueras L", "Garcia-Carbonero R", "Safont MJ", "Falco Ferrer E", "Aparicio J", "Vicente Conesa MA", "Guill\u00e9n-Ponce C", "Garcia-Teijido P", "Medina Magan MB", "Busquier I", "Salgado M", "Lloans\u00ed Vila A", "PERSEIDA Investigators"], "date": "2022-12-09T00:00:00Z", "year": 2022, "snippets": [{"_id": "36551560@9591", "snip_text": "The percentages of patients with mutations on different KRAS and NRAS exons (KRAS: exon 2, codons 12 [mutations: c.34G>A, c.34G>C, c.34G>T, c.35G>A, c.35G>C, c.35G>T] and 13 [c.38G>A]; exon 3, codon 61 [c.182A>T, c.183A>C, c.183A>T]; exon 4, codon 146 [c.436G>A]; NRAS: exon 2, codons 12 [c.35G>A] and 13 [c.38G>A]; exon 3, codon 61 [c.181C>A, c.182A>G, c.182A>T, c.183A>T, c.183A>C]) were also obtained.", "section": "methods", "mentions": ["354|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|c.182A>T", "364|8|variant|litvar@rs121913255##&&&litvar@#4893#&&&litvar@CA16042285#rs121913255##|c.183A>T", "203|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|c.182A>T", "140|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "149|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>C", "158|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "334|8|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C>A", "264|4|gene|ncbi_gene@4893|NRAS", "131|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>T", "122|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G>C", "374|8|variant|litvar@rs121913255##&&&litvar@#4893#|c.183A>C", "213|8|variant|litvar@rs121913255##&&&litvar@#4893#|c.183A>C", "175|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "223|8|variant|litvar@rs121913255##&&&litvar@#4893#&&&litvar@CA16042285#rs121913255##|c.183A>T", "344|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A>G", "306|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "65|4|gene|ncbi_gene@4893|NRAS", "56|4|gene|ncbi_gene@3845|KRAS", "113|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G>A", "77|4|gene|ncbi_gene@3845|KRAS", "19|8|species|ncbi_taxonomy@9606|patients", "253|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "289|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A"], "text_hl": "The percentages of patients with mutations on different KRAS and NRAS exons (KRAS: exon 2, codons 12 [mutations: c.34G>A, c.34G>C, c.34G>T, c.35G>A, c.35G>C, c.35G>T] and 13 [c.38G>A]; exon 3, codon 61 [c.182A>T, c.183A>C, c.183A>T]; exon 4, codon 146 [c.436G>A]; NRAS: exon 2, codons 12 [c.35G>A] and 13 [c.38G>A]; exon 3, codon 61 [c.181C>A, c.182A>G, c.182A>T, c.183A>T, c.183A>C]) were also obtained."}], "citations": {"NLM": "Valladares-Ayerbes M, Garcia-Alfonso P, Mu\u00f1oz Luengo J, Pimentel Caceres PP, Castillo Trujillo OA, Vidal-Tocino R, Llanos M, Llorente Ayala B, Limon Miron ML, Salud A, Cirera Nogueras L, Garcia-Carbonero R, Safont MJ, Falco Ferrer E, Aparicio J, Vicente Conesa MA, Guill\u00e9n-Ponce C, Garcia-Teijido P, Medina Magan MB, Busquier I, Salgado M, Lloans\u00ed Vila A, PERSEIDA Investigators. Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study Cancers (Basel). PMID: 36551560", "BibTeX": "@article{36551560, title={Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study}, author={Valladares-Ayerbes M and Garcia-Alfonso P and Mu\u00f1oz Luengo J and Pimentel Caceres PP and Castillo Trujillo OA and Vidal-Tocino R and Llanos M and Llorente Ayala B and Limon Miron ML and Salud A and Cirera Nogueras L and Garcia-Carbonero R and Safont MJ and Falco Ferrer E and Aparicio J and Vicente Conesa MA and Guill\u00e9n-Ponce C and Garcia-Teijido P and Medina Magan MB and Busquier I and Salgado M and Lloans\u00ed Vila A and PERSEIDA Investigators}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 31597339, "pmcid": "PMC6827157", "title": "Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience", "journal": "Cancers (Basel)", "authors": ["Vitiello PP", "De Falco V", "Giunta EF", "Ciardiello D", "Cardone C", "Vitale P", "Zanaletti N", "Borrelli C", "Poliero L", "Terminiello M", "Arrichiello G", "Caputo V", "Famiglietti V", "Mattera Iacono V", "Marrone F", "Di Liello A", "Martini G", "Napolitano S", "Caraglia M", "Lombardi A", "Franco R", "De Vita F", "Morgillo F", "Troiani T", "Ciardiello F", "Martinelli E"], "date": "2019-10-08T00:00:00Z", "year": 2019, "snippets": [{"_id": "31597339@22853", "snip_text": "The mutations detected by the cartridges are: ctKRAS: exon 2 (G12 > C/R/S/A/D/V, G13 > D), exon 3 (A59 > E/G/T, Q61 > K/L/R/H), exon 4 (K117 > N, A146 > P/T/V); ctNRAS/BRAF/EGFR: NRAS exon 2 (G12 > C/S/A/D/V, G13 > D/V/R), exon 3 (A59 > T, Q61 > K/L/R/H), exon 4 (K117 > N, A146 > T/V), BRAF V600 > E/D/K/R, EGFR S492 > R. The limit of detection of the IdyllaTM platform for cfDNA is set at about 10,000 copies of WT DNA (about 30 ng) per milliliter.", "section": "methods", "mentions": ["168|4|gene|ncbi_gene@673|BRAF", "112|3|variant|litvar@#3845#|Q61", "231|7|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|A59 > T", "192|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12 > C", "313|8|variant|litvar@rs1057519860##&&&litvar@#1956#|S492 > R", "292|4|variant|litvar@rs113488022##&&&litvar@#673#|V600", "81|3|variant|litvar@rs112445441##&&&litvar@#3845#|G13", "274|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146 > T", "62|7|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12 > C", "287|4|gene|ncbi_gene@673|BRAF", "240|3|variant|litvar@#3845#|Q61", "209|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13 > D", "179|4|gene|ncbi_gene@4893|NRAS", "107|3|variant|litvar@#673#|G/T", "308|4|gene|ncbi_gene@1956|EGFR", "173|4|gene|ncbi_gene@1956|EGFR"], "text_hl": "The mutations detected by the cartridges are: ctKRAS: exon 2 (G12 > C/R/S/A/D/V, G13 > D), exon 3 (A59 > E/G/T, Q61 > K/L/R/H), exon 4 (K117 > N, A146 > P/T/V); ctNRAS/BRAF/EGFR: NRAS exon 2 (G12 > C/S/A/D/V, G13 > D/V/R), exon 3 (A59 > T, Q61 > K/L/R/H), exon 4 (K117 > N, A146 > T/V), BRAF V600 > E/D/K/R, EGFR S492 > R. The limit of detection of the IdyllaTM platform for cfDNA is set at about 10,000 copies of WT DNA (about 30 ng) per milliliter."}], "citations": {"NLM": "Vitiello PP, De Falco V, Giunta EF, Ciardiello D, Cardone C, Vitale P, Zanaletti N, Borrelli C, Poliero L, Terminiello M, Arrichiello G, Caputo V, Famiglietti V, Mattera Iacono V, Marrone F, Di Liello A, Martini G, Napolitano S, Caraglia M, Lombardi A, Franco R, De Vita F, Morgillo F, Troiani T, Ciardiello F, Martinelli E. Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience Cancers (Basel). PMID: 31597339", "BibTeX": "@article{31597339, title={Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience}, author={Vitiello PP and De Falco V and Giunta EF and Ciardiello D and Cardone C and Vitale P and Zanaletti N and Borrelli C and Poliero L and Terminiello M and Arrichiello G and Caputo V and Famiglietti V and Mattera Iacono V and Marrone F and Di Liello A and Martini G and Napolitano S and Caraglia M and Lombardi A and Franco R and De Vita F and Morgillo F and Troiani T and Ciardiello F and Martinelli E}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 34851763, "pmcid": "PMC8647259", "title": "Mutation analysis of a 10-gene panel for colorectal cancer in Huizhou, Guangdong Province of China.", "journal": "J Int Med Res", "authors": ["Li J", "Sun A", "Zhong G", "He Y", "Xiong H", "Yuan X"], "date": "2021-11-01T00:00:00Z", "year": 2021, "snippets": [{"_id": "34851763@8567", "snip_text": "There were 43 patients (50.6%) with KRAS mutations, including c.34G > A, c.34G > C, c.35G > T, c.35G > C, c.35G > A, c.38G > A, c.99T > G, c.176C > G, and c.436G > A. There were four patients (4.7%) with NRAS mutations, including c.34G > T, c.35G > T, c.38G > A, and c.38G > T. There were 17 patients (20%) with PIK3CA mutations, including c.253G > A, c.277C > T, c.1592T > C, c.1633G > A, c.1634A > G, c.1636C > G, c.1637A > G, c.2176G > A, and c.3140A > G. There were three patients (3.5%) with ERBB2 mutations, including c.2033G > A, c.2264T > C, c.2305G > T, and c.2329G > C. There were three patients (3.5%) with a BRAF mutation (c.1799T > A).", "section": "results", "mentions": ["183|8|species|ncbi_taxonomy@9606|patients", "403|11|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123331#rs121913286##|c.1636C > G", "267|9|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|c.38G > T", "106|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "84|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "36|4|gene|ncbi_gene@3845|KRAS", "155|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "597|8|species|ncbi_taxonomy@9606|patients", "390|11|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123336#rs121913274##|c.1634A > G", "14|8|species|ncbi_taxonomy@9606|patients", "62|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G > A", "117|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "446|11|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A > G", "377|11|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G > A", "352|10|variant|litvar@rs763786330##&&&litvar@#2064#&&&litvar@CA8533607#rs763786330##|c.277C > T", "241|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "537|11|variant|litvar@rs121913470##&&&litvar@#2064#&&&litvar@CA16602502#rs121913470##|c.2264T > C", "524|11|variant|litvar@rs1057519862##&&&litvar@#2064#|c.2033G > A", "497|5|gene|ncbi_gene@2064|ERBB2", "95|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > C", "635|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T > A", "364|11|variant|litvar@rs746397815##&&&litvar@#5156#&&&litvar@CA2922588#rs746397815##|c.1592T > C", "429|11|variant|litvar@rs867262025##&&&litvar@#5290#&&&litvar@CA16602910#rs867262025##|c.2176G > A", "340|10|variant|litvar@rs1272695341##&&&litvar@#2064#|c.253G > A", "567|11|variant|litvar@rs121913471##&&&litvar@#2064#|c.2329G > C", "128|9|variant|litvar@#3845#c.99T>G&&&litvar@#3845#|c.99T > G", "620|4|gene|ncbi_gene@673|BRAF", "252|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "550|11|variant|litvar@rs121913468##&&&litvar@#2064#|c.2305G > T", "292|8|species|ncbi_taxonomy@9606|patients", "312|6|gene|ncbi_gene@5290|PIK3CA", "416|11|variant|litvar@rs397517201##&&&litvar@#5290#&&&litvar@CA136371#rs397517201##|c.1637A > G", "73|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G > C", "139|10|variant|litvar@rs777307941##&&&litvar@#5156#&&&litvar@CA96847217#rs777307941##|c.176C > G", "204|4|gene|ncbi_gene@4893|NRAS", "476|8|species|ncbi_taxonomy@9606|patients", "230|9|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|c.34G > T"], "text_hl": "There were 43 patients (50.6%) with KRAS mutations, including c.34G > A, c.34G > C, c.35G > T, c.35G > C, c.35G > A, c.38G > A, c.99T > G, c.176C > G, and c.436G > A. There were four patients (4.7%) with NRAS mutations, including c.34G > T, c.35G > T, c.38G > A, and c.38G > T. There were 17 patients (20%) with PIK3CA mutations, including c.253G > A, c.277C > T, c.1592T > C, c.1633G > A, c.1634A > G, c.1636C > G, c.1637A > G, c.2176G > A, and c.3140A > G. There were three patients (3.5%) with ERBB2 mutations, including c.2033G > A, c.2264T > C, c.2305G > T, and c.2329G > C. There were three patients (3.5%) with a BRAF mutation (c.1799T > A)."}], "citations": {"NLM": "Li J, Sun A, Zhong G, He Y, Xiong H, Yuan X. Mutation analysis of a 10-gene panel for colorectal cancer in Huizhou, Guangdong Province of China. J Int Med Res. PMID: 34851763", "BibTeX": "@article{34851763, title={Mutation analysis of a 10-gene panel for colorectal cancer in Huizhou, Guangdong Province of China.}, author={Li J and Sun A and Zhong G and He Y and Xiong H and Yuan X}, journal={J Int Med Res}}"}, "is_sup_mat_match": false}, {"pmid": 34066481, "pmcid": "PMC8125778", "title": "Clinical Implication of Liquid Biopsy in Colorectal Cancer Patients Treated with Metastasectomy.", "journal": "Cancers (Basel)", "authors": ["Lee S", "Park YS", "Chang WJ", "Choi JY", "Lim A", "Kim B", "Lee SB", "Lee JW", "Kim SH", "Kim J", "Kwak JM", "Yoon KC", "Lee SH", "Kim YH"], "date": "2021-05-06T00:00:00Z", "year": 2021, "snippets": [{"_id": "34066481@34578", "snip_text": "No Synchronicity Variant Primary TissueVAF Metastatic TissueVAF MetaSite PreMctDNA PostMctDNA Recurence   No CTx  CTx  Rx CTx  Rx   ctNDA positive before metastasectomy   001 S TP53 I255F  49.8 SD 0.0 PR Liver0.1 cm 1.6 0.0 N   036 S APC R1114 * 44.2   31.0 PD Liver2.5 cm 21.0 0.0 N   APC R1450 * 21.5  17.0 11.0 0.0   KRAS G12D 46.5  34.0 19.0 0.0   008b S KRAS Q61R 48.8   53.7 PD Lung2.5 cm 9.6 0.0 Lung   TP53 R175H 49.5  54.1 6.4 0.0   028a S KRAS G12V 14.3   7.8 PD Liver 2.2 cm 0.0 0.0 PT   PIK3CA E545K 14.8  11. 1 1.3 0.0   PIK3CA G914R 14.9  10.2 0.0 0.0   SMAD4 E330Q 16.6  8.9 0.0 0.0   SMAD4 R361H/C 16.4  1.7 0.0 0.0   ctNDA negative before metastasectomy    004 S TP53 R273C 60.4   4.1 PR Liver0.8 cm 0.0 0.0 N   APC K1308 * 40.2  2.8 0.0 0.0   012 S KRAS G12V 14.6   0.0 CR Liver0 cm 0.0 0.0 N   PIK3CA H1047R 20.6  0.0 0.0 0.0   031b S APC R1114 * 8.1   11.6 SD Lung1.4 cm 0.0 0.0 N   APC E1345 * 8.1  15.4 0.0 0.0   KRAS G13C 13.4  9.1 0.0 0.0   042 M APC Q1378 * 47.5   36.2 PR Liver 2.5 cm 0.0 0.0 N   KRAS G12D 29.9  18.3 0.0 0.0   TP53 R175H 30.5  19.3 0.0 0.0   044 S CTNNB1 S45F 36.8   6.5 PR Liver2.2 cm 0.0 0.0 N   KRAS G12D 17.3  0.0 0.0 0.0   PTEN R335 * 5.2  0.0 0.0 0.0   057 S TP53 C275Y 26.5   36.9 SD Lung1.6 cm 0.0 0.0 N   091 S APC E1306 * 18.0   0.0 PR Liver0.8 cm 0.0 0.0 N   TP53 R175H 40.2  6.2 0.0 0.0   APC Q886 * 26.9  4.6 0.0 0.0   006 S KRAS G13C 37.2   10.7 PR Liver 1.6 cm 0.0 0.0 Bone   TP53 R306 * 34.9  9.1 0.0 0.0   011 M APC R876 * 30.6   0.0 PD Lung1.0 cm 0.0 0.0 Lung   KRAS E545K 34.3  2.2 0.0 0.0   TP53 R342 * 0.0  2.5 0.0 0.0   SMAD4 R361H 0.0  3.8 0.0 0.0   SMAD4 A118V 64.8  0.0 0.0 0.0   014 S KRAS Q61H 25.3   5.6 SD Liver 2.3 cm 0.0 0.0 PT   SMAD4 R361C 15.2  3.0 0.0 0.0   019 S PIK3CA G1049R  3.1 SD 3.6 SD Liver0.9 cm 0.0 0.0 Liver    020a S TP53 R196 *  38.5 SD 21.2 PR Liver2.5 cm 0.0 0.0 Liver   APC Q1294 *  25.4 13.8 0.0 0.0   027 S TP53 R175H  6.1 PR 2.6 PR Liver3.2 cm 0.0 0.0 Liver Lung    PTEN R335 *  1.1 0.0 0.0 0.0   037a S TP53 T211I 14.9   1.0 PR Liver0.5 cm 0.0 0.0 Liver    048 S APC R1450 *  1.5  0.0 PR Lung0.6 cm 0.0 0.0 Lung    CTNNB1 S37Y  0.0  21.2 0.0 0.0   KRAS G12D  1.4  0.0 0.0 0.0   PIK3CA E545K  2.0  0.0 0.0 0.0   TP53 R209Kfs  1.8  0 0.0 0.0   051b M KRAS G13S 0.0   1.1 PD Lung0.9 cm 0.0 0.0 Lung    PTEN R130Q 0.0   1.0 0.0 0.0   SMAD4 C115Y 0.0   1.2 0.0 0.0   TP53 R175H 10.7   40.0 0.0 0.0   052 S RB1 A201fs  0.0  5.5 PR Lung0.4 cm 0.0 0.0 Lung    055 S KRAS G13D 60.3   16.6 PR Liver3.5 cm 0.0 0.0 Liver    061b S TP53?  51.5 SD 27.1 SD Lung0.5 cm 0.0 0.0 Lung    APC H1490fs  30.2 19.5 0.0 0.0   063 S KRAS G12V BDL   5.3 PR Liver2.2 cm 0.0 0.0 Lung   KRAS A146T BDL   25.0 0.0 0.0   TP53 V173L BDL   2.4 0.0 0.0   APC P1381fs BDL   15.5 0.0 0.0   067 S TP53 M246R  23.2 SD 39.3 SD Rec 3.4 cm 0.0 0.0 PT   ", "section": "table", "mentions": ["177|4|gene|ncbi_gene@7157|TP53", "2177|6|gene|ncbi_gene@5290|PIK3CA", "2694|5|variant|litvar@rs876660754##&&&litvar@#7157#|V173L", "286|3|gene|ncbi_gene@324|APC", "534|6|gene|ncbi_gene@5290|PIK3CA", "1555|4|gene|ncbi_gene@7157|TP53", "2062|3|gene|ncbi_gene@324|APC", "1660|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "2248|4|gene|ncbi_gene@3845|KRAS", "1142|4|gene|ncbi_gene@3845|KRAS", "2147|4|gene|ncbi_gene@3845|KRAS", "1264|3|gene|ncbi_gene@324|APC", "325|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "935|4|gene|ncbi_gene@3845|KRAS", "2720|3|gene|ncbi_gene@324|APC", "940|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "2764|5|variant|litvar@rs587780074##&&&litvar@#7157#&&&litvar@CA376#rs587780074##|M246R", "1904|4|gene|ncbi_gene@7157|TP53", "820|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "2007|5|variant|litvar@#7157#p.T211I&&&litvar@#7157#|T211I", "1808|4|gene|ncbi_gene@7157|TP53", "903|3|gene|ncbi_gene@324|APC", "454|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1617|5|gene|ncbi_gene@4089|SMAD4", "2121|4|variant|litvar@#3845#p.S37Y&&&litvar@#3845#|S37Y", "1382|4|gene|ncbi_gene@3845|KRAS", "499|6|gene|ncbi_gene@5290|PIK3CA", "2002|4|gene|ncbi_gene@7157|TP53", "1319|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H", "2366|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H", "680|4|gene|ncbi_gene@7157|TP53", "729|3|gene|ncbi_gene@324|APC", "772|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "410|4|gene|ncbi_gene@7157|TP53", "1586|5|gene|ncbi_gene@4089|SMAD4", "2462|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1314|4|gene|ncbi_gene@7157|TP53", "1387|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "359|4|gene|ncbi_gene@3845|KRAS", "2361|4|gene|ncbi_gene@7157|TP53", "600|5|gene|ncbi_gene@4089|SMAD4", "2210|4|gene|ncbi_gene@7157|TP53", "1172|4|gene|ncbi_gene@5728|PTEN", "2724|7|variant|litvar@rs1131691145##&&&litvar@#324#|P1381fs", "1345|3|gene|ncbi_gene@324|APC", "1592|5|variant|litvar@rs377767347##&&&litvar@#4089#&&&litvar@CA128097#rs377767347##|R361H", "2335|5|variant|litvar@rs876659844##&&&litvar@#4089#&&&litvar@CA10580974#rs876659844##|C115Y", "541|5|variant|litvar@rs587776932##&&&litvar@#5290#&&&litvar@CA130467#rs587776932##|G914R", "2184|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "1655|4|gene|ncbi_gene@3845|KRAS", "2298|4|gene|ncbi_gene@5728|PTEN", "1865|3|gene|ncbi_gene@324|APC", "1054|4|gene|ncbi_gene@7157|TP53", "1909|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H", "2662|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "2518|4|gene|ncbi_gene@7157|TP53", "574|5|variant|litvar@#4089#p.E330Q&&&litvar@#4089#|E330Q", "1435|4|gene|ncbi_gene@7157|TP53", "320|4|gene|ncbi_gene@3845|KRAS", "1750|6|variant|litvar@rs121913277##&&&litvar@#5290#&&&litvar@CA16602520#rs121913277##|G1049R", "2253|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA16602445#rs121913535##|G13S", "1964|4|gene|ncbi_gene@5728|PTEN", "2657|4|gene|ncbi_gene@3845|KRAS", "971|3|gene|ncbi_gene@324|APC", "2152|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "449|4|gene|ncbi_gene@3845|KRAS", "2689|4|gene|ncbi_gene@7157|TP53", "1147|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2568|3|gene|ncbi_gene@324|APC", "1028|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "506|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "685|5|variant|litvar@rs121913343##&&&litvar@#7157#&&&litvar@CA432#rs121913343##|R273C", "1529|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "1023|4|gene|ncbi_gene@3845|KRAS", "2607|4|gene|ncbi_gene@3845|KRAS", "415|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H", "2329|5|gene|ncbi_gene@4089|SMAD4", "1524|4|gene|ncbi_gene@3845|KRAS", "2612|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1743|6|gene|ncbi_gene@5290|PIK3CA", "1705|5|gene|ncbi_gene@4089|SMAD4", "2404|6|variant|litvar@#7157#p.A201fsX&&&litvar@#7157#|A201fs", "606|7|variant|litvar@rs80338963##&&&litvar@#4089#|R361H/C", "2759|4|gene|ncbi_gene@7157|TP53", "767|4|gene|ncbi_gene@3845|KRAS", "2457|4|gene|ncbi_gene@3845|KRAS", "1214|5|variant|litvar@rs863224451##&&&litvar@#7157#&&&litvar@CA337141#rs863224451##|C275Y", "1623|5|variant|litvar@rs750600586##&&&litvar@#7157#&&&litvar@CA168#rs750600586##|A118V", "364|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|Q61R", "1473|3|gene|ncbi_gene@324|APC", "2303|5|variant|litvar@rs121909229##&&&litvar@#5728#&&&litvar@CA437#rs121909229##|R130Q", "1099|4|variant|litvar@#3845#p.S45F&&&litvar@#3845#|S45F", "1209|4|gene|ncbi_gene@7157|TP53", "1059|5|variant|litvar@rs28934578##&&&litvar@#7157#&&&litvar@CA251#rs28934578##|R175H", "182|5|variant|litvar@rs1057519995##&&&litvar@#7157#|I255F", "234|3|gene|ncbi_gene@324|APC", "854|3|gene|ncbi_gene@324|APC", "2572|7|variant|litvar@#324#p.H1490fsX&&&litvar@#324#|H1490fs", "813|6|gene|ncbi_gene@5290|PIK3CA", "1711|5|variant|litvar@rs80338963##&&&litvar@#4089#&&&litvar@CA128095#rs80338963##|R361C", "568|5|gene|ncbi_gene@4089|SMAD4"], "figure_id": "cancers-13-02231-t004", "text_hl": "No Synchronicity Variant Primary TissueVAF Metastatic TissueVAF MetaSite PreMctDNA PostMctDNA Recurence   No CTx  CTx  Rx CTx  Rx   ctNDA positive before metastasectomy   001 S TP53 I255F  49.8 SD 0.0 PR Liver0.1 cm 1.6 0.0 N   036 S APC R1114 * 44.2   31.0 PD Liver2.5 cm 21.0 0.0 N   APC R1450 * 21.5  17.0 11.0 0.0   KRAS G12D 46.5  34.0 19.0 0.0   008b S KRAS Q61R 48.8   53.7 PD Lung2.5 cm 9.6 0.0 Lung   TP53 R175H 49.5  54.1 6.4 0.0   028a S KRAS G12V 14.3   7.8 PD Liver 2.2 cm 0.0 0.0 PT   PIK3CA E545K 14.8  11. 1 1.3 0.0   PIK3CA G914R 14.9  10.2 0.0 0.0   SMAD4 E330Q 16.6  8.9 0.0 0.0   SMAD4 R361H/C 16.4  1.7 0.0 0.0   ctNDA negative before metastasectomy    004 S TP53 R273C 60.4   4.1 PR Liver0.8 cm 0.0 0.0 N   APC K1308 * 40.2  2.8 0.0 0.0   012 S KRAS G12V 14.6   0.0 CR Liver0 cm 0.0 0.0 N   PIK3CA H1047R 20.6  0.0 0.0 0.0   031b S APC R1114 * 8.1   11.6 SD Lung1.4 cm 0.0 0.0 N   APC E1345 * 8.1  15.4 0.0 0.0   KRAS G13C 13.4  9.1 0.0 0.0   042 M APC Q1378 * 47.5   36.2 PR Liver 2.5 cm 0.0 0.0 N   KRAS G12D 29.9  18.3 0.0 0.0   TP53 R175H 30.5  19.3 0.0 0.0   044 S CTNNB1 S45F 36.8   6.5 PR Liver2.2 cm 0.0 0.0 N   KRAS G12D 17.3  0.0 0.0 0.0   PTEN R335 * 5.2  0.0 0.0 0.0   057 S TP53 C275Y 26.5   36.9 SD Lung1.6 cm 0.0 0.0 N   091 S APC E1306 * 18.0   0.0 PR Liver0.8 cm 0.0 0.0 N   TP53 R175H 40.2  6.2 0.0 0.0   APC Q886 * 26.9  4.6 0.0 0.0   006 S KRAS G13C 37.2   10.7 PR Liver 1.6 cm 0.0 0.0 Bone   TP53 R306 * 34.9  9.1 0.0 0.0   011 M APC R876 * 30.6   0.0 PD Lung1.0 cm 0.0 0.0 Lung   KRAS E545K 34.3  2.2 0.0 0.0   TP53 R342 * 0.0  2.5 0.0 0.0   SMAD4 R361H 0.0  3.8 0.0 0.0   SMAD4 A118V 64.8  0.0 0.0 0.0   014 S KRAS Q61H 25.3   5.6 SD Liver 2.3 cm 0.0 0.0 PT   SMAD4 R361C 15.2  3.0 0.0 0.0   019 S PIK3CA G1049R  3.1 SD 3.6 SD Liver0.9 cm 0.0 0.0 Liver    020a S TP53 R196 *  38.5 SD 21.2 PR Liver2.5 cm 0.0 0.0 Liver   APC Q1294 *  25.4 13.8 0.0 0.0   027 S TP53 R175H  6.1 PR 2.6 PR Liver3.2 cm 0.0 0.0 Liver Lung    PTEN R335 *  1.1 0.0 0.0 0.0   037a S TP53 T211I 14.9   1.0 PR Liver0.5 cm 0.0 0.0 Liver    048 S APC R1450 *  1.5  0.0 PR Lung0.6 cm 0.0 0.0 Lung    CTNNB1 S37Y  0.0  21.2 0.0 0.0   KRAS G12D  1.4  0.0 0.0 0.0   PIK3CA E545K  2.0  0.0 0.0 0.0   TP53 R209Kfs  1.8  0 0.0 0.0   051b M KRAS G13S 0.0   1.1 PD Lung0.9 cm 0.0 0.0 Lung    PTEN R130Q 0.0   1.0 0.0 0.0   SMAD4 C115Y 0.0   1.2 0.0 0.0   TP53 R175H 10.7   40.0 0.0 0.0   052 S RB1 A201fs  0.0  5.5 PR Lung0.4 cm 0.0 0.0 Lung    055 S KRAS G13D 60.3   16.6 PR Liver3.5 cm 0.0 0.0 Liver    061b S TP53?  51.5 SD 27.1 SD Lung0.5 cm 0.0 0.0 Lung    APC H1490fs  30.2 19.5 0.0 0.0   063 S KRAS G12V BDL   5.3 PR Liver2.2 cm 0.0 0.0 Lung   KRAS <m>A146T</m> BDL   25.0 0.0 0.0   TP53 V173L BDL   2.4 0.0 0.0   APC P1381fs BDL   15.5 0.0 0.0   067 S TP53 M246R  23.2 SD 39.3 SD Rec 3.4 cm 0.0 0.0 PT   "}], "citations": {"NLM": "Lee S, Park YS, Chang WJ, Choi JY, Lim A, Kim B, Lee SB, Lee JW, Kim SH, Kim J, Kwak JM, Yoon KC, Lee SH, Kim YH. Clinical Implication of Liquid Biopsy in Colorectal Cancer Patients Treated with Metastasectomy. Cancers (Basel). PMID: 34066481", "BibTeX": "@article{34066481, title={Clinical Implication of Liquid Biopsy in Colorectal Cancer Patients Treated with Metastasectomy.}, author={Lee S and Park YS and Chang WJ and Choi JY and Lim A and Kim B and Lee SB and Lee JW and Kim SH and Kim J and Kwak JM and Yoon KC and Lee SH and Kim YH}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 36204688, "pmcid": "PMC9529062", "title": "Duplex Sequencing Uncovers Recurrent Low-frequency Cancer-associated Mutations in Infant and Childhood KMT2A-rearranged Acute Leukemia.", "journal": "Hemasphere", "authors": ["Pilheden M", "Ahlgren L", "Hyrenius-Wittsten A", "Gonzalez-Pena V", "Sturesson H", "Hansen Marquart HV", "Lausen B", "Castor A", "Pronk CJ", "Barbany G", "Pokrovskaja Tamm K", "Fogelstrand L", "Lohi O", "Nor\u00e9n-Nystr\u00f6m U", "Asklin J", "Chen Y", "Song G", "Walsh M", "Ma J", "Zhang J", "Saal LH", "Gawad C", "Hagstr\u00f6m-Andersson AK"], "date": "2022-09-30T00:00:00Z", "year": 2022, "snippets": [{"_id": "36204688@22283", "snip_text": "Further, P28 had a KRASA146T, which never surpassed 4% of cells and P3 had a diagnostic TP53R248Q in 2% of cells which was lost at relapse.", "section": "results", "mentions": ["19|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T"], "text_hl": "Further, P28 had a KRASA146T, which never surpassed 4% of cells and P3 had a diagnostic TP53R248Q in 2% of cells which was lost at relapse."}], "citations": {"NLM": "Pilheden M, Ahlgren L, Hyrenius-Wittsten A, Gonzalez-Pena V, Sturesson H, Hansen Marquart HV, Lausen B, Castor A, Pronk CJ, Barbany G, Pokrovskaja Tamm K, Fogelstrand L, Lohi O, Nor\u00e9n-Nystr\u00f6m U, Asklin J, Chen Y, Song G, Walsh M, Ma J, Zhang J, Saal LH, Gawad C, Hagstr\u00f6m-Andersson AK. Duplex Sequencing Uncovers Recurrent Low-frequency Cancer-associated Mutations in Infant and Childhood KMT2A-rearranged Acute Leukemia. Hemasphere. PMID: 36204688", "BibTeX": "@article{36204688, title={Duplex Sequencing Uncovers Recurrent Low-frequency Cancer-associated Mutations in Infant and Childhood KMT2A-rearranged Acute Leukemia.}, author={Pilheden M and Ahlgren L and Hyrenius-Wittsten A and Gonzalez-Pena V and Sturesson H and Hansen Marquart HV and Lausen B and Castor A and Pronk CJ and Barbany G and Pokrovskaja Tamm K and Fogelstrand L and Lohi O and Nor\u00e9n-Nystr\u00f6m U and Asklin J and Chen Y and Song G and Walsh M and Ma J and Zhang J and Saal LH and Gawad C and Hagstr\u00f6m-Andersson AK}, journal={Hemasphere}}"}, "is_sup_mat_match": false}, {"pmid": 31668570, "pmcid": "PMC6945285", "title": "An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer.", "journal": "EBioMedicine", "authors": ["Wang H", "Lv Q", "Xu Y", "Cai Z", "Zheng J", "Cheng X", "Dai Y", "J\u00e4nne PA", "Ambrogio C", "K\u00f6hler J"], "date": "2019-10-23T00:00:00Z", "year": 2019, "snippets": [{"_id": "31668570@18855", "snip_text": "To investigate MEK/ERK inhibitor sensitivities for different KRAS mutant isoforms across cancer histotypes, we grouped cancer cell lines based on their KRAS mutation status into 12 groups (A146T, G12A, G12C, G12D, G12R, G12S, G12V, G13C, G13D, K117N, Q61H, Q61L).", "section": "results", "mentions": ["19|3|gene|ncbi_gene@5594|ERK", "202|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "214|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "232|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "15|3|gene|ncbi_gene@5609|MEK", "152|4|gene|ncbi_gene@3845|KRAS", "226|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "89|6|disease|ncbi_mesh@D009369|cancer", "251|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "196|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "238|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "61|4|gene|ncbi_gene@3845|KRAS", "119|6|disease|ncbi_mesh@D009369|cancer", "208|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "244|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "220|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "189|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "257|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L"], "text_hl": "To investigate MEK/ERK inhibitor sensitivities for different KRAS mutant isoforms across cancer histotypes, we grouped cancer cell lines based on their KRAS mutation status into 12 groups (<m>A146T</m>, G12A, G12C, G12D, G12R, G12S, G12V, G13C, G13D, K117N, Q61H, Q61L)."}], "citations": {"NLM": "Wang H, Lv Q, Xu Y, Cai Z, Zheng J, Cheng X, Dai Y, J\u00e4nne PA, Ambrogio C, K\u00f6hler J. An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer. EBioMedicine. PMID: 31668570", "BibTeX": "@article{31668570, title={An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer.}, author={Wang H and Lv Q and Xu Y and Cai Z and Zheng J and Cheng X and Dai Y and J\u00e4nne PA and Ambrogio C and K\u00f6hler J}, journal={EBioMedicine}}"}, "is_sup_mat_match": false}, {"pmid": 37046778, "pmcid": "PMC10093522", "title": "Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials", "journal": "Cancers (Basel)", "authors": ["Ciardiello D", "Napolitano S", "Famiglietti V", "Esposito L", "De Falco V", "Di Liello A", "Avallone A", "Maiello E", "Pietrantonio F", "Cremolini C", "Zampino MG", "Fazio N", "Troiani T", "Martinelli E", "Ciardiello F", "Martini G"], "date": "2023-04-01T00:00:00Z", "year": 2023, "snippets": [{"_id": "37046778@29717", "snip_text": "Type of RAS/BRAF Mutation\tNumber of Patients (32)\t \tBRAF V600E\t1\t \tKRAS A146P\t2\t \tKRAS A146PT\t1\t \tKRAS A146PV\t1\t \tKRAS G12A\t3\t \tKRAS G12C\t2\t \tKRAS G12D\t5\t \tKRAS G12S\t2\t \tKRAS G12V\t2\t \tKRAS G13D\t3\t \tKRAS Q61H\t6\t \tKRAS Q61H and BRAF V600E\t1\t \tKRAS Q61R\t1\t \tNRAS G13D\t1\t \tKRAS Q61L\t1\t \t", "section": "table", "mentions": ["241|4|gene|ncbi_gene@3845|KRAS", "161|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "170|4|gene|ncbi_gene@3845|KRAS", "57|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "12|4|gene|ncbi_gene@673|BRAF", "67|4|gene|ncbi_gene@3845|KRAS", "260|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "269|4|gene|ncbi_gene@3845|KRAS", "212|4|gene|ncbi_gene@3845|KRAS", "189|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "246|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "255|4|gene|ncbi_gene@4893|NRAS", "198|4|gene|ncbi_gene@3845|KRAS", "175|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "184|4|gene|ncbi_gene@3845|KRAS", "226|4|gene|ncbi_gene@673|BRAF", "274|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "203|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "114|4|gene|ncbi_gene@3845|KRAS", "98|4|gene|ncbi_gene@3845|KRAS", "52|4|gene|ncbi_gene@673|BRAF", "231|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "217|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "119|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "128|4|gene|ncbi_gene@3845|KRAS", "82|4|gene|ncbi_gene@3845|KRAS", "147|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "156|4|gene|ncbi_gene@3845|KRAS", "142|4|gene|ncbi_gene@3845|KRAS", "133|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "103|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P"], "figure_id": "cancers-15-02117-t002", "text_hl": "Type of RAS/BRAF Mutation\tNumber of Patients (32)\t \tBRAF V600E\t1\t \tKRAS A146P\t2\t \tKRAS A146PT\t1\t \tKRAS A146PV\t1\t \tKRAS G12A\t3\t \tKRAS G12C\t2\t \tKRAS G12D\t5\t \tKRAS G12S\t2\t \tKRAS G12V\t2\t \tKRAS G13D\t3\t \tKRAS Q61H\t6\t \tKRAS Q61H and BRAF V600E\t1\t \tKRAS Q61R\t1\t \tNRAS G13D\t1\t \tKRAS Q61L\t1\t \t"}], "citations": {"NLM": "Ciardiello D, Napolitano S, Famiglietti V, Esposito L, De Falco V, Di Liello A, Avallone A, Maiello E, Pietrantonio F, Cremolini C, Zampino MG, Fazio N, Troiani T, Martinelli E, Ciardiello F, Martini G. Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials Cancers (Basel). PMID: 37046778", "BibTeX": "@article{37046778, title={Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials}, author={Ciardiello D and Napolitano S and Famiglietti V and Esposito L and De Falco V and Di Liello A and Avallone A and Maiello E and Pietrantonio F and Cremolini C and Zampino MG and Fazio N and Troiani T and Martinelli E and Ciardiello F and Martini G}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 35260767, "pmcid": "PMC8904527", "title": "Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors.", "journal": "NPJ Precis Oncol", "authors": ["Berrino E", "Filippi R", "Visintin C", "Peirone S", "Fenocchio E", "Farinea G", "Veglio F", "Aglietta M", "Sapino A", "Cereda M", "Visintin R", "Pasini B", "Marchi\u00f2 C"], "date": "2022-03-08T00:00:00Z", "year": 2022, "snippets": [{"_id": "35260767@17540", "snip_text": "The urothelial carcinomas harbored three private mutations with specific annotation, two KRAS mutations (p.Gly13Asp and p.Ala146Thr) with resistance level R1, and the level 4 NF1 p.Arg2637Ter.", "section": "results", "mentions": ["179|12|variant|litvar@rs786201367##&&&litvar@#4763#&&&litvar@CA188413#rs786201367##|p.Arg2637Ter", "175|3|gene|ncbi_gene@4763|NF1", "89|4|gene|ncbi_gene@3845|KRAS", "120|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "4|21|disease|ncbi_mesh@D014523|urothelial carcinomas", "105|10|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.Gly13Asp"], "text_hl": "The urothelial carcinomas harbored three private mutations with specific annotation, two KRAS mutations (p.Gly13Asp and <m>p.Ala146Thr</m>) with resistance level R1, and the level 4 NF1 p.Arg2637Ter."}], "citations": {"NLM": "Berrino E, Filippi R, Visintin C, Peirone S, Fenocchio E, Farinea G, Veglio F, Aglietta M, Sapino A, Cereda M, Visintin R, Pasini B, Marchi\u00f2 C. Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors. NPJ Precis Oncol. PMID: 35260767", "BibTeX": "@article{35260767, title={Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors.}, author={Berrino E and Filippi R and Visintin C and Peirone S and Fenocchio E and Farinea G and Veglio F and Aglietta M and Sapino A and Cereda M and Visintin R and Pasini B and Marchi\u00f2 C}, journal={NPJ Precis Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 28892047, "pmcid": "PMC5764779", "title": "A system for detecting high impact-low frequency mutations in primary tumors and metastases", "journal": "Oncogene", "authors": ["Anjanappa M", "Hao Y", "Simpson ER", "Bhat-Nakshatri P", "Nelson JB", "Tersey SA", "Mirmira RG", "Cohen-Gadol AA", "Saadatzadeh MR", "Li L", "Fang F", "Nephew KP", "Miller KD", "Liu Y", "Nakshatri H"], "date": "2018-01-11T00:00:00Z", "year": 2018, "snippets": [{"_id": "28892047@13347", "snip_text": "A colon cancer liver metastasis showed expected mutations in APC (a frame shift and a stop codon; Table 2), and this metastasis also harbored KRAS A146T mutation, a KRAS mutation previously linked to MEK/ERK dependence and resistance to EGFR targeted therapies.", "section": "results", "mentions": ["147|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "200|3|gene|ncbi_gene@5609|MEK", "237|4|gene|ncbi_gene@1956|EGFR", "165|4|gene|ncbi_gene@3845|KRAS", "2|29|disease|ncbi_mesh@D015179|colon cancer liver metastasis", "142|4|gene|ncbi_gene@3845|KRAS", "117|10|disease|ncbi_mesh@D009362|metastasis", "204|3|gene|ncbi_gene@5594|ERK"], "text_hl": "A colon cancer liver metastasis showed expected mutations in APC (a frame shift and a stop codon; Table 2), and this metastasis also harbored KRAS <m>A146T</m> mutation, a KRAS mutation previously linked to MEK/ERK dependence and resistance to EGFR targeted therapies."}], "citations": {"NLM": "Anjanappa M, Hao Y, Simpson ER, Bhat-Nakshatri P, Nelson JB, Tersey SA, Mirmira RG, Cohen-Gadol AA, Saadatzadeh MR, Li L, Fang F, Nephew KP, Miller KD, Liu Y, Nakshatri H. A system for detecting high impact-low frequency mutations in primary tumors and metastases Oncogene. PMID: 28892047", "BibTeX": "@article{28892047, title={A system for detecting high impact-low frequency mutations in primary tumors and metastases}, author={Anjanappa M and Hao Y and Simpson ER and Bhat-Nakshatri P and Nelson JB and Tersey SA and Mirmira RG and Cohen-Gadol AA and Saadatzadeh MR and Li L and Fang F and Nephew KP and Miller KD and Liu Y and Nakshatri H}, journal={Oncogene}}"}, "is_sup_mat_match": false}, {"pmid": 29682098, "pmcid": "PMC5845515", "title": "Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas.", "journal": "Dis Markers", "authors": ["Sadlecki P", "Grzanka D", "Grabiec M"], "date": "2018-02-25T00:00:00Z", "year": 2018, "snippets": [{"_id": "29682098@7869", "snip_text": "The Idylla NRAS Mutation Test is suitable for the qualitative detection of 18 NRAS mutations: 5 mutations in codon 12 (exon 2), including p.G12C (c.34G>T), p.G12S (c.34G>A), p.G12D (c.35G>A), p.G12A (c.35G>C), and p.G12V (c.35G>T); 3 mutations in codon 13 (exon 2), among them p.G13D (c.38G>A), p.G13V (c.38G>T), and p.G13R (c.37G>C); 1 mutation in codon 59 (exon 3), A59T (c.175G>A); 4 mutations in codon 61 (exon 3), namely, p.Q61K (c.181C>A), p.Q61L (c.182A>T), p.Q61R (c.182A>G), and p.Q61H (c.183A>C); 1 mutation in codon 117 (exon 4), p.K117N (c.351G>C;c.351G>T); and 2 mutations in codon 146 (exon 4), p.A146T (c.436G>A) and p.A146V (c.437C>T), as well as NRAS total and BRAF total (wild-type mutations treated as a sample processing control; data not shown by the system).", "section": "methods", "mentions": ["374|8|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|c.175G>A", "174|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "192|6|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|p.G12A", "222|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA261525#rs121913237##|c.35G>T", "641|8|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C>T", "427|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "11|4|gene|ncbi_gene@4893|NRAS", "435|8|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C>A", "317|6|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|p.G13R", "618|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "138|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "446|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "550|8|variant|litvar@rs767291079##&&&litvar@#22882#&&&litvar@CA4862148#rs767291079##|c.351G>C", "559|8|variant|litvar@rs1268659696##&&&litvar@#207#|c.351G>T", "663|4|gene|ncbi_gene@4893|NRAS", "295|6|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|p.G13V", "454|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|c.182A>T", "632|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "182|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G>A", "200|7|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G>C", "473|8|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A>G", "465|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "678|4|gene|ncbi_gene@673|BRAF", "277|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "164|7|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA180753#rs121913250##|c.34G>A", "488|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "609|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "496|8|variant|litvar@rs121913255##&&&litvar@#4893#|c.183A>C", "146|7|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|c.34G>T", "541|7|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.K117N", "325|7|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|c.37G>C", "214|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "285|7|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G>A", "78|4|gene|ncbi_gene@4893|NRAS", "368|4|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|A59T", "303|7|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|c.38G>T", "156|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "4|6|chemical||Idylla"], "text_hl": "The Idylla NRAS Mutation Test is suitable for the qualitative detection of 18 NRAS mutations: 5 mutations in codon 12 (exon 2), including p.G12C (c.34G>T), p.G12S (c.34G>A), p.G12D (c.35G>A), p.G12A (c.35G>C), and p.G12V (c.35G>T); 3 mutations in codon 13 (exon 2), among them p.G13D (c.38G>A), p.G13V (c.38G>T), and p.G13R (c.37G>C); 1 mutation in codon 59 (exon 3), A59T (c.175G>A); 4 mutations in codon 61 (exon 3), namely, p.Q61K (c.181C>A), p.Q61L (c.182A>T), p.Q61R (c.182A>G), and p.Q61H (c.183A>C); 1 mutation in codon 117 (exon 4), p.K117N (c.351G>C;c.351G>T); and 2 mutations in codon 146 (exon 4), <m>p.A146T</m> (c.436G>A) and p.A146V (c.437C>T), as well as NRAS total and BRAF total (wild-type mutations treated as a sample processing control; data not shown by the system)."}], "citations": {"NLM": "Sadlecki P, Grzanka D, Grabiec M. Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas. Dis Markers. PMID: 29682098", "BibTeX": "@article{29682098, title={Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas.}, author={Sadlecki P and Grzanka D and Grabiec M}, journal={Dis Markers}}"}, "is_sup_mat_match": false}, {"pmid": 27358379, "pmcid": "PMC4999563", "title": "Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group.", "journal": "Ann Oncol", "authors": ["Modest DP", "Ricard I", "Heinemann V", "Hegewisch-Becker S", "Schmiegel W", "Porschen R", "Stintzing S", "Graeven U", "Arnold D", "von Weikersthal LF", "Giessen-Jung C", "Stahler A", "Schmoll HJ", "Jung A", "Kirchner T", "Tannapfel A", "Reinacher-Schick A"], "date": "2016-09-01T00:00:00Z", "year": 2016, "snippets": [{"_id": "27358379@12849", "snip_text": "Besides KRAS exon 2 variants, KRAS mutations A146T (n = 18) and Q61H (n = 17) as well as NRAS mutation G12D (n = 11) were separately evaluated for efficacy end points, all other variants were less frequent (supplementary Table S1, available at Annals of Oncology online).", "section": "results", "mentions": ["45|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "64|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "30|4|gene|ncbi_gene@3845|KRAS", "8|4|gene|ncbi_gene@3845|KRAS", "89|4|gene|ncbi_gene@4893|NRAS", "103|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D"], "text_hl": "Besides KRAS exon 2 variants, KRAS mutations <m>A146T</m> (n = 18) and Q61H (n = 17) as well as NRAS mutation G12D (n = 11) were separately evaluated for efficacy end points, all other variants were less frequent (supplementary Table S1, available at Annals of Oncology online)."}], "citations": {"NLM": "Modest DP, Ricard I, Heinemann V, Hegewisch-Becker S, Schmiegel W, Porschen R, Stintzing S, Graeven U, Arnold D, von Weikersthal LF, Giessen-Jung C, Stahler A, Schmoll HJ, Jung A, Kirchner T, Tannapfel A, Reinacher-Schick A. Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group. Ann Oncol. PMID: 27358379", "BibTeX": "@article{27358379, title={Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group.}, author={Modest DP and Ricard I and Heinemann V and Hegewisch-Becker S and Schmiegel W and Porschen R and Stintzing S and Graeven U and Arnold D and von Weikersthal LF and Giessen-Jung C and Stahler A and Schmoll HJ and Jung A and Kirchner T and Tannapfel A and Reinacher-Schick A}, journal={Ann Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 28106345, "pmcid": "PMC5527457", "title": "Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing.", "journal": "Mol Oncol", "authors": ["Schmiegel W", "Scott RJ", "Dooley S", "Lewis W", "Meldrum CJ", "Pockney P", "Draganic B", "Smith S", "Hewitt C", "Philimore H", "Lucas A", "Shi E", "Namdarian K", "Chan T", "Acosta D", "Ping-Chang S", "Tannapfel A", "Reinacher-Schick A", "Uhl W", "Teschendorf C", "Wolters H", "Stern J", "Viebahn R", "Friess H", "Janssen KP", "Nitsche U", "Slotta-Huspenina J", "Pohl M", "Vangala D", "Baraniskin A", "Dockhorn-Dworniczak B", "Hegewisch-Becker S", "Ronga P", "Edelstein DL", "Jones FS", "Hahn S", "Fox SB"], "date": "2017-02-01T00:00:00Z", "year": 2017, "snippets": [{"_id": "28106345@17133", "snip_text": "KRAS NRAS   Exon Mutation Exon Mutation   2    G12S   G12R   G12C   G12D   G12A   G12V   G13D    2    G12S   G12R   G12C   G12D   G12A   G12V   G13D   G13R   G13V      3    A59T   Q61L   Q61Ha   Q61Ha 3    A59T   Q61L   Q61Ha   Q61Ha   Q61K   Q61R      4    K117Na   K117Na   A146T   A146V    4    K117Na   K117Na   A146T      ", "section": "table", "mentions": ["0|4|gene|ncbi_gene@3845|KRAS", "284|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "173|4|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|A59T", "47|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "102|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "158|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "276|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "123|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "68|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "116|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "180|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "109|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "61|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "151|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "54|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "206|4|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|A59T", "144|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "137|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "130|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "89|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "243|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "82|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "316|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "236|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "75|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "213|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "5|4|gene|ncbi_gene@4893|NRAS"], "figure_id": "mol212023-tbl-0002", "text_hl": "KRAS NRAS   Exon Mutation Exon Mutation   2    G12S   G12R   G12C   G12D   G12A   G12V   G13D    2    G12S   G12R   G12C   G12D   G12A   G12V   G13D   G13R   G13V      3    A59T   Q61L   Q61Ha   Q61Ha 3    A59T   Q61L   Q61Ha   Q61Ha   Q61K   Q61R      4    K117Na   K117Na   <m>A146T</m>   A146V    4    K117Na   K117Na   <m>A146T</m>      "}], "citations": {"NLM": "Schmiegel W, Scott RJ, Dooley S, Lewis W, Meldrum CJ, Pockney P, Draganic B, Smith S, Hewitt C, Philimore H, Lucas A, Shi E, Namdarian K, Chan T, Acosta D, Ping-Chang S, Tannapfel A, Reinacher-Schick A, Uhl W, Teschendorf C, Wolters H, Stern J, Viebahn R, Friess H, Janssen KP, Nitsche U, Slotta-Huspenina J, Pohl M, Vangala D, Baraniskin A, Dockhorn-Dworniczak B, Hegewisch-Becker S, Ronga P, Edelstein DL, Jones FS, Hahn S, Fox SB. Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing. Mol Oncol. PMID: 28106345", "BibTeX": "@article{28106345, title={Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing.}, author={Schmiegel W and Scott RJ and Dooley S and Lewis W and Meldrum CJ and Pockney P and Draganic B and Smith S and Hewitt C and Philimore H and Lucas A and Shi E and Namdarian K and Chan T and Acosta D and Ping-Chang S and Tannapfel A and Reinacher-Schick A and Uhl W and Teschendorf C and Wolters H and Stern J and Viebahn R and Friess H and Janssen KP and Nitsche U and Slotta-Huspenina J and Pohl M and Vangala D and Baraniskin A and Dockhorn-Dworniczak B and Hegewisch-Becker S and Ronga P and Edelstein DL and Jones FS and Hahn S and Fox SB}, journal={Mol Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 26138366, "pmcid": "PMC4506514", "title": "Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma", "journal": "Nat Commun", "authors": ["Seki M", "Nishimura R", "Yoshida K", "Shimamura T", "Shiraishi Y", "Sato Y", "Kato M", "Chiba K", "Tanaka H", "Hoshino N", "Nagae G", "Shiozawa Y", "Okuno Y", "Hosoi H", "Tanaka Y", "Okita H", "Miyachi M", "Souzaki R", "Taguchi T", "Koh K", "Hanada R", "Kato K", "Nomura Y", "Akiyama M", "Oka A", "Igarashi T", "Miyano S", "Aburatani H", "Hayashi Y", "Ogawa S", "Takita J"], "date": "2015-07-03T00:00:00Z", "year": 2015, "snippets": [{"_id": "26138366@34818", "snip_text": "Gene\tLocation\tN\tAmino-acid change\tHistology\tSample ID\t \tTP53\t17p\t2\tG245S\tERMS\tRMS_011M\t \t \t \t \tC176G\tNOS\tRMS_012P\t \tGAB1\t4q\t2\tS614R\tARMS\tRMS_004R\t \t \t \t \tN233I\tARMS\tRMS_006P\t \tKRAS\t12p\t2\tK117N\tERMS\tRMS_014P\t \t \t \t \tA146T\tERMS\tRMS_015P\t \tPTEN\t10q\t2\tG129R\tARMS\tRMS_001P\t \t \t \t \tA120P\tERMS\tRMS_009R\t \tARID1A\t1p\t2\tG1847fs\tARMS\tRMS_003R\t \t \t \t \tK1007_I1008fs\tARMS\tRMS_011M\t \tBCOR\tXp\t2\tS1243fs\tERMS\tRMS_014P\t \t \t \t \tE712fs\tMixed\tRMS_017P\t \tROBO1\t3p\t2\tE1113Q\tARMS\tRMS_005P\t \t \t \t \tY777C\tARMS\tRMS_007P\t \tAKAP9\t7q\t2\tG2652V\tARMS\tRMS_001M\t \t \t \t \tK2673N\tERMS\tRMS_009R\t \tDNAH5\t5p\t2\tS2920I\tERMS\tRMS_011M\t \t \t \t \tR3096Q, D3271N\tERMS\tRMS_008R\t \tFREM2\t13q\t2\tR1515H\tMixed\tRMS_017P\t \t \t \t \tQ1574L\tERMS\tRMS_008R\t \tC15orf2\t15q\t2\tG917A\tARMS\tRMS_003P\t \t \t \t \tV1147L\tERMS\tRMS_009R\t \tKIF21A\t12q\t2\tE766V\tMixed\tRMS_017P\t \t \t \t \tL956P\tERMS\tRMS_009R\t \tNEB\t2q\t2\tE637Q\tARMS\tRMS_001P\t \t \t \t \tD1595Y\tARMS\tRMS_003P\t \tPTPRO\t12p\t2\tR67T\tARMS\tRMS_002R\t \t \t \t \tN644S\tMixed\tRMS_017P\t \tCOL5A2\t2q\t2\tG203V\tARMS\tRMS_001P\t \t \t \t \tG756S\tARMS\tRMS_002P\t \tPXDNL\t8q\t2\tT877M\tARMS\tRMS_004R\t \t \t \t \tR1225Q\tARMS\tRMS_016M\t \tNLRC5\t16q\t2\tR341W\tARMS\tRMS_003P\t \t \t \t \tQ1169H\tARMS\tRMS_001P\t \tTTN\t2q\t4\tL18955Q, L18955I\tARMS\tRMS_001M\t \t \t \t \tG17007A\tARMS\tRMS_004R\t \t \t \t \tE5800A\tERMS\tRMS_009P\t \t \t \t \tQ9568K\tARMS\tRMS_017P\t \t", "section": "table", "mentions": ["570|6|variant|litvar@#54880#p.S2920I&&&litvar@#54880#|S2920I", "370|4|gene|ncbi_gene@54880|BCOR", "410|6|variant|litvar@#54880#p.E712fsX&&&litvar@#54880#|E712fs", "237|4|gene|ncbi_gene@5728|PTEN", "248|5|variant|litvar@rs786204929##&&&litvar@#5728#&&&litvar@CA429#rs786204929##|G129R", "1019|5|variant|litvar@#54880#p.T877M&&&litvar@#54880#|T877M", "607|6|variant|litvar@#54880#p.D3271N&&&litvar@#54880#|D3271N", "276|5|variant|litvar@rs730882000##&&&litvar@#7157#&&&litvar@CA233#rs730882000##|A120P", "507|6|variant|litvar@#54880#p.G2652V&&&litvar@#54880#|G2652V", "380|7|variant|litvar@#54880#p.S1243fsX&&&litvar@#54880#|S1243fs", "861|6|variant|litvar@#54880#p.D1595Y&&&litvar@#54880#|D1595Y", "1142|7|variant|litvar@#54880#p.L18955Q&&&litvar@#54880#|L18955Q", "1151|7|variant|litvar@#54880#p.L18955I&&&litvar@#54880#|L18955I", "599|6|variant|litvar@#54880#p.R3096Q&&&litvar@#54880#|R3096Q", "672|6|variant|litvar@#54880#p.Q1574L&&&litvar@#54880#|Q1574L", "923|5|variant|litvar@rs554193370##&&&litvar@#2308#&&&litvar@CA6958960#rs554193370##|N644S", "737|6|variant|litvar@#54880#p.V1147L&&&litvar@#54880#|V1147L", "474|5|variant|litvar@#54880#p.Y777C&&&litvar@#54880#|Y777C", "126|5|variant|litvar@#7157#p.S614R&&&litvar@#7157#|S614R", "536|6|variant|litvar@#54880#p.K2673N&&&litvar@#54880#|K2673N", "986|5|variant|litvar@#54880#p.G756S&&&litvar@#54880#|G756S", "709|5|variant|litvar@#54880#c.917G>A&&&litvar@#54880#|G917A", "773|5|variant|litvar@#54880#p.E766V&&&litvar@#54880#|E766V", "833|5|variant|litvar@#54880#p.E637Q&&&litvar@#54880#|E637Q", "896|4|variant|litvar@#54880#p.R67T&&&litvar@#54880#|R67T", "1211|6|variant|litvar@#54880#p.E5800A&&&litvar@#54880#|E5800A", "642|6|variant|litvar@#54880#p.R1515H&&&litvar@#54880#|R1515H", "154|5|variant|litvar@#5728#p.N233I&&&litvar@#5728#|N233I", "56|4|gene|ncbi_gene@7157|TP53", "1110|6|variant|litvar@#54880#p.Q1169H&&&litvar@#54880#|Q1169H", "958|5|variant|litvar@rs765799185##&&&litvar@#5077#|G203V", "445|6|variant|litvar@#54880#p.E1113Q&&&litvar@#54880#|E1113Q", "67|5|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|G245S", "95|5|variant|litvar@rs587778718##&&&litvar@#7157#&&&litvar@CA272#rs587778718##|C176G", "187|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "346|7|variant|litvar@#54880#p.I1008fsX&&&litvar@#54880#|I1008fs", "1181|7|variant|litvar@#54880#g.17007G>A&&&litvar@#54880#|G17007A", "1047|6|variant|litvar@#54880#p.R1225Q&&&litvar@#54880#|R1225Q", "215|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "310|7|variant|litvar@#54880#p.G1847fsX&&&litvar@#54880#|G1847fs", "1082|5|variant|litvar@#54880#p.R341W&&&litvar@#54880#|R341W", "802|5|variant|litvar@#54880#p.L956P&&&litvar@#54880#|L956P"], "figure_id": "t1", "text_hl": "Gene\tLocation\tN\tAmino-acid change\tHistology\tSample ID\t \tTP53\t17p\t2\tG245S\tERMS\tRMS_011M\t \t \t \t \tC176G\tNOS\tRMS_012P\t \tGAB1\t4q\t2\tS614R\tARMS\tRMS_004R\t \t \t \t \tN233I\tARMS\tRMS_006P\t \tKRAS\t12p\t2\tK117N\tERMS\tRMS_014P\t \t \t \t \t<m>A146T</m>\tERMS\tRMS_015P\t \tPTEN\t10q\t2\tG129R\tARMS\tRMS_001P\t \t \t \t \tA120P\tERMS\tRMS_009R\t \tARID1A\t1p\t2\tG1847fs\tARMS\tRMS_003R\t \t \t \t \tK1007_I1008fs\tARMS\tRMS_011M\t \tBCOR\tXp\t2\tS1243fs\tERMS\tRMS_014P\t \t \t \t \tE712fs\tMixed\tRMS_017P\t \tROBO1\t3p\t2\tE1113Q\tARMS\tRMS_005P\t \t \t \t \tY777C\tARMS\tRMS_007P\t \tAKAP9\t7q\t2\tG2652V\tARMS\tRMS_001M\t \t \t \t \tK2673N\tERMS\tRMS_009R\t \tDNAH5\t5p\t2\tS2920I\tERMS\tRMS_011M\t \t \t \t \tR3096Q, D3271N\tERMS\tRMS_008R\t \tFREM2\t13q\t2\tR1515H\tMixed\tRMS_017P\t \t \t \t \tQ1574L\tERMS\tRMS_008R\t \tC15orf2\t15q\t2\tG917A\tARMS\tRMS_003P\t \t \t \t \tV1147L\tERMS\tRMS_009R\t \tKIF21A\t12q\t2\tE766V\tMixed\tRMS_017P\t \t \t \t \tL956P\tERMS\tRMS_009R\t \tNEB\t2q\t2\tE637Q\tARMS\tRMS_001P\t \t \t \t \tD1595Y\tARMS\tRMS_003P\t \tPTPRO\t12p\t2\tR67T\tARMS\tRMS_002R\t \t \t \t \tN644S\tMixed\tRMS_017P\t \tCOL5A2\t2q\t2\tG203V\tARMS\tRMS_001P\t \t \t \t \tG756S\tARMS\tRMS_002P\t \tPXDNL\t8q\t2\tT877M\tARMS\tRMS_004R\t \t \t \t \tR1225Q\tARMS\tRMS_016M\t \tNLRC5\t16q\t2\tR341W\tARMS\tRMS_003P\t \t \t \t \tQ1169H\tARMS\tRMS_001P\t \tTTN\t2q\t4\tL18955Q, L18955I\tARMS\tRMS_001M\t \t \t \t \tG17007A\tARMS\tRMS_004R\t \t \t \t \tE5800A\tERMS\tRMS_009P\t \t \t \t \tQ9568K\tARMS\tRMS_017P\t \t"}], "citations": {"NLM": "Seki M, Nishimura R, Yoshida K, Shimamura T, Shiraishi Y, Sato Y, Kato M, Chiba K, Tanaka H, Hoshino N, Nagae G, Shiozawa Y, Okuno Y, Hosoi H, Tanaka Y, Okita H, Miyachi M, Souzaki R, Taguchi T, Koh K, Hanada R, Kato K, Nomura Y, Akiyama M, Oka A, Igarashi T, Miyano S, Aburatani H, Hayashi Y, Ogawa S, Takita J. Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma Nat Commun. PMID: 26138366", "BibTeX": "@article{26138366, title={Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma}, author={Seki M and Nishimura R and Yoshida K and Shimamura T and Shiraishi Y and Sato Y and Kato M and Chiba K and Tanaka H and Hoshino N and Nagae G and Shiozawa Y and Okuno Y and Hosoi H and Tanaka Y and Okita H and Miyachi M and Souzaki R and Taguchi T and Koh K and Hanada R and Kato K and Nomura Y and Akiyama M and Oka A and Igarashi T and Miyano S and Aburatani H and Hayashi Y and Ogawa S and Takita J}, journal={Nat Commun}}"}, "is_sup_mat_match": false}, {"pmid": 28815022, "pmcid": "PMC5558186", "title": "Modeling of RAS complexes supports roles in cancer for less studied partners.", "journal": "BMC Biophys", "authors": ["Engin HB", "Carlin D", "Pratt D", "Carter H"], "date": "2017-08-11T00:00:00Z", "year": 2017, "snippets": [{"_id": "28815022@21374", "snip_text": "RAS Isoform Interaction Partner Mutation Effect   HRAS BCL2 A146T stabilizing   HRAS FHOD1 G12D de-stabilizating   HRAS FHOD1 G13D de-stabilizating   HRAS FHOD1 Q61H stabilizing   HRAS RALGDS G12D stabilizing   HRAS RALGDS G13D stabilizing   HRAS RALGDS A59G stabilizing   KRAS RALGDS G13D stabilizing   ", "section": "table", "mentions": ["161|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "185|6|gene|ncbi_gene@5900|RALGDS", "115|4|gene|ncbi_gene@3265|HRAS", "60|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "247|6|gene|ncbi_gene@5900|RALGDS", "85|5|gene|ncbi_gene@29109|FHOD1", "150|4|gene|ncbi_gene@3265|HRAS", "242|4|gene|ncbi_gene@3265|HRAS", "180|4|gene|ncbi_gene@3265|HRAS", "91|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "254|4|variant|litvar@rs397517140##&&&litvar@#3265#&&&litvar@CA135984#rs397517140##|A59G", "278|6|gene|ncbi_gene@5900|RALGDS", "80|4|gene|ncbi_gene@3265|HRAS", "120|5|gene|ncbi_gene@29109|FHOD1", "55|4|gene|ncbi_gene@596|BCL2", "192|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "126|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "273|4|gene|ncbi_gene@3845|KRAS", "50|4|gene|ncbi_gene@3265|HRAS", "216|6|gene|ncbi_gene@5900|RALGDS", "155|5|gene|ncbi_gene@29109|FHOD1", "211|4|gene|ncbi_gene@3265|HRAS", "285|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "223|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D"], "figure_id": "Tab2", "text_hl": "RAS Isoform Interaction Partner Mutation Effect   HRAS BCL2 <m>A146T</m> stabilizing   HRAS FHOD1 G12D de-stabilizating   HRAS FHOD1 G13D de-stabilizating   HRAS FHOD1 Q61H stabilizing   HRAS RALGDS G12D stabilizing   HRAS RALGDS G13D stabilizing   HRAS RALGDS A59G stabilizing   KRAS RALGDS G13D stabilizing   "}], "citations": {"NLM": "Engin HB, Carlin D, Pratt D, Carter H. Modeling of RAS complexes supports roles in cancer for less studied partners. BMC Biophys. PMID: 28815022", "BibTeX": "@article{28815022, title={Modeling of RAS complexes supports roles in cancer for less studied partners.}, author={Engin HB and Carlin D and Pratt D and Carter H}, journal={BMC Biophys}}"}, "is_sup_mat_match": false}, {"pmid": 37364334, "pmcid": "PMC10319337", "title": "A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer", "journal": "Transl Oncol", "authors": ["Osumi H", "Takashima A", "Ooki A", "Yoshinari Y", "Wakatsuki T", "Hirano H", "Nakayama I", "Okita N", "Sawada R", "Ouchi K", "Fukuda K", "Fukuoka S", "Ogura M", "Takahari D", "Chin K", "Shoji H", "Kato K", "Ishizuka N", "Boku N", "Yamaguchi K", "Shinozaki E"], "date": "2023-09-01T00:00:00Z", "year": 2023, "snippets": [{"_id": "37364334@7963", "snip_text": "We examined 12 types of RAS exon 2 (G12S, G12C, G12R, G12D, G12V, G12A, G13S, G13C, G13R, G13D, G13V, and G13A), eight types of RAS exon 3 (A59T, A59G, Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H), and four types of RAS exon 4 (K117N, A146T, A146P, and A146V) mutations, as previously described.", "section": "methods", "mentions": ["140|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "60|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "48|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "158|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "78|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "152|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "170|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "90|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "106|4|variant|litvar@rs193929331##&&&litvar@#3845#&&&litvar@CA250291#rs193929331##|G13A", "164|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "223|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "72|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA16602445#rs121913535##|G13S", "248|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "146|4|variant|litvar@rs1029847964##&&&litvar@#7422#|A59G", "42|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "237|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "36|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "84|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "230|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "54|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "176|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "96|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "186|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "66|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A"], "text_hl": "We examined 12 types of RAS exon 2 (G12S, G12C, G12R, G12D, G12V, G12A, G13S, G13C, G13R, G13D, G13V, and G13A), eight types of RAS exon 3 (A59T, A59G, Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H), and four types of RAS exon 4 (K117N, <m>A146T</m>, A146P, and A146V) mutations, as previously described."}], "citations": {"NLM": "Osumi H, Takashima A, Ooki A, Yoshinari Y, Wakatsuki T, Hirano H, Nakayama I, Okita N, Sawada R, Ouchi K, Fukuda K, Fukuoka S, Ogura M, Takahari D, Chin K, Shoji H, Kato K, Ishizuka N, Boku N, Yamaguchi K, Shinozaki E. A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer Transl Oncol. PMID: 37364334", "BibTeX": "@article{37364334, title={A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer}, author={Osumi H and Takashima A and Ooki A and Yoshinari Y and Wakatsuki T and Hirano H and Nakayama I and Okita N and Sawada R and Ouchi K and Fukuda K and Fukuoka S and Ogura M and Takahari D and Chin K and Shoji H and Kato K and Ishizuka N and Boku N and Yamaguchi K and Shinozaki E}, journal={Transl Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 29755673, "pmcid": "PMC5945503", "title": "Role of epigenetic factors in the selection of the alternative splicing isoforms of human KRAS in colorectal cancer cell lines.", "journal": "Oncotarget", "authors": ["Riffo-Campos \u00c1L", "Gimeno-Valiente F", "Rodr\u00edguez FM", "Cervantes A", "L\u00f3pez-Rodas G", "Franco L", "Castillo J"], "date": "2018-04-17T00:00:00Z", "year": 2018, "snippets": [{"_id": "29755673@27942", "snip_text": "Cell line Relevant genotype Source   KRAS BRAF PIK3CA TP53   DLD1D-Mut1DWT7m G13D/wtG13D/-G12D*/- wt E545K; D549N S241F ATCC CCL-221Dr VogelsteinRiffo-Campos et al.   HCT116HAE6HAF1m G13D/wtG13D/-A146T/- wt H1047R wt ATCC CCL-247Johns Hopkins UniversityRoda et al.   RKO wt V600E H1047R wt Horizon Discovery   SW48 wt wt wt wt Horizon Discovery   Caco2 wt wt wt E204X ATCC HTB-37   ", "section": "table", "mentions": ["47|6|gene|ncbi_gene@5290|PIK3CA", "362|5|variant|litvar@#3845#p.E204X&&&litvar@#3845#|E204X", "90|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "37|4|gene|ncbi_gene@3845|KRAS", "101|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "125|9|cellline||CCL-221Dr", "42|4|gene|ncbi_gene@673|BRAF", "108|5|variant|litvar@rs1057519699##&&&litvar@#5290#|D549N", "190|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "183|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "207|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "54|4|gene|ncbi_gene@7157|TP53", "280|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "274|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "114|5|variant|litvar@rs28934573##&&&litvar@#7157#&&&litvar@CA359#rs28934573##|S241F", "196|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "figure_id": "T1", "text_hl": "Cell line Relevant genotype Source   KRAS BRAF PIK3CA TP53   DLD1D-Mut1DWT7m G13D/wtG13D/-G12D*/- wt E545K; D549N S241F ATCC CCL-221Dr VogelsteinRiffo-Campos et al.   HCT116HAE6HAF1m G13D/wtG13D/-<m>A146T</m>/- wt H1047R wt ATCC CCL-247Johns Hopkins UniversityRoda et al.   RKO wt V600E H1047R wt Horizon Discovery   SW48 wt wt wt wt Horizon Discovery   Caco2 wt wt wt E204X ATCC HTB-37   "}], "citations": {"NLM": "Riffo-Campos \u00c1L, Gimeno-Valiente F, Rodr\u00edguez FM, Cervantes A, L\u00f3pez-Rodas G, Franco L, Castillo J. Role of epigenetic factors in the selection of the alternative splicing isoforms of human KRAS in colorectal cancer cell lines. Oncotarget. PMID: 29755673", "BibTeX": "@article{29755673, title={Role of epigenetic factors in the selection of the alternative splicing isoforms of human KRAS in colorectal cancer cell lines.}, author={Riffo-Campos \u00c1L and Gimeno-Valiente F and Rodr\u00edguez FM and Cervantes A and L\u00f3pez-Rodas G and Franco L and Castillo J}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 35117215, "pmcid": "PMC8798181", "title": "Association between BRAF mutant classification and the efficacy of pemetrexed-based chemotherapy in Chinese advanced non-small cell lung cancer patients: a multicenter retrospective study.", "journal": "Transl Cancer Res", "authors": ["Lei L", "Wang WX", "Zhu YC", "Pu XX", "Fang Y", "Wang H", "Zhuang W", "Zhang YB", "Wang LP", "Xu CW", "Fang MY"], "date": "2020-10-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "35117215@20644", "snip_text": "The other two patients with KRAS A146T and EML4-ALK respectively did not receive any target therapies.", "section": "discussion", "mentions": ["14|8|species|ncbi_taxonomy@9606|patients", "33|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "28|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "The other two patients with KRAS <m>A146T</m> and EML4-ALK respectively did not receive any target therapies."}], "citations": {"NLM": "Lei L, Wang WX, Zhu YC, Pu XX, Fang Y, Wang H, Zhuang W, Zhang YB, Wang LP, Xu CW, Fang MY. Association between BRAF mutant classification and the efficacy of pemetrexed-based chemotherapy in Chinese advanced non-small cell lung cancer patients: a multicenter retrospective study. Transl Cancer Res. PMID: 35117215", "BibTeX": "@article{35117215, title={Association between BRAF mutant classification and the efficacy of pemetrexed-based chemotherapy in Chinese advanced non-small cell lung cancer patients: a multicenter retrospective study.}, author={Lei L and Wang WX and Zhu YC and Pu XX and Fang Y and Wang H and Zhuang W and Zhang YB and Wang LP and Xu CW and Fang MY}, journal={Transl Cancer Res}}"}, "is_sup_mat_match": false}, {"pmid": 37604687, "pmcid": "PMC10620118", "title": "Lasting response by vertical inhibition with cetuximab and trametinib in KRAS-mutated colorectal cancer patient-derived xenografts", "journal": "Mol Oncol", "authors": ["Reissig TM", "Ladigan-Badura S", "Steinberg A", "Maghnouj A", "Li T", "Verdoodt B", "Liffers ST", "Pohl M", "Wolters H", "Teschendorf C", "Viebahn R", "Admard J", "Casadei N", "Tannapfel A", "Schmiegel W", "Hahn SA", "Vangala DB"], "date": "2023-11-01T00:00:00Z", "year": 2023, "snippets": [{"_id": "37604687@10121", "snip_text": "Tumour\tUICC\tKRAS\tResponse to cetuximab and trametinib\tResponse to trametinib\t \tDay 28\tDay 59\tDay 28\tDay 59\t \tBoC51\tI\tG12D\tPD\tPD\t\t\t \tBoC64\tIV\tG12D\tPD\t\t\t\t \tBoC109\tIIIC\tG13D\tPD\t\t\t\t \tBoC117\tIVA\tG12D\tPD\tPD\tPD\tPD\t \tBoC122\tIIIB\tG12D\tPD\tPD\tPD\tPD\t \tBoC2\tIV\tG12D\tSD\tSD\tPD\tPD\t \tBoC19\tIIA\tA146T\tSD\t\t\t\t \tBoC56\tIIA\tG12C\tSD\tSD\t\t\t \tBoC78\tIIA\tG12D\tSD\tSD\t\t\t \tBoC136\tn.d.\tG12V\tSD\tSD\tPD\tPD\t \tBoC9\tIV\tG12D\tPR\tPR\t\t\t \tBoC14\tIIA\tA146T\tPR\tPR\t\t\t \tBoC46\tIIA\tG13D\tPR\t\t\t\t \tBoC47\tIIIB\tG12D\tPR\tPR\tSD\tSR\t \tBoC80\tIB\tG12V\tPR\tPR\t\t\t \tBoC105\tIIIB\tG12V\tPR\tPR\tSD\tSR\t \tBoC130\tIIIC\tG12D\tPR\tPR\t\t\t \tBoC137\tIVB\tG12D\tPR\tPR\tPD\tPD\t \tBoC147\tIIIB\tG12A\tPR\tPR\tSD\tSD\t \t", "section": "table", "mentions": ["301|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "12|4|gene|ncbi_gene@3845|KRAS", "510|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "221|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "141|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "326|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "598|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "455|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "166|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "483|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "541|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "380|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "190|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "431|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "353|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "567|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "277|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "405|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "117|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "248|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D"], "figure_id": "mol213510-tbl-0001", "text_hl": "Tumour\tUICC\tKRAS\tResponse to cetuximab and trametinib\tResponse to trametinib\t \tDay 28\tDay 59\tDay 28\tDay 59\t \tBoC51\tI\tG12D\tPD\tPD\t\t\t \tBoC64\tIV\tG12D\tPD\t\t\t\t \tBoC109\tIIIC\tG13D\tPD\t\t\t\t \tBoC117\tIVA\tG12D\tPD\tPD\tPD\tPD\t \tBoC122\tIIIB\tG12D\tPD\tPD\tPD\tPD\t \tBoC2\tIV\tG12D\tSD\tSD\tPD\tPD\t \tBoC19\tIIA\t<m>A146T</m>\tSD\t\t\t\t \tBoC56\tIIA\tG12C\tSD\tSD\t\t\t \tBoC78\tIIA\tG12D\tSD\tSD\t\t\t \tBoC136\tn.d.\tG12V\tSD\tSD\tPD\tPD\t \tBoC9\tIV\tG12D\tPR\tPR\t\t\t \tBoC14\tIIA\t<m>A146T</m>\tPR\tPR\t\t\t \tBoC46\tIIA\tG13D\tPR\t\t\t\t \tBoC47\tIIIB\tG12D\tPR\tPR\tSD\tSR\t \tBoC80\tIB\tG12V\tPR\tPR\t\t\t \tBoC105\tIIIB\tG12V\tPR\tPR\tSD\tSR\t \tBoC130\tIIIC\tG12D\tPR\tPR\t\t\t \tBoC137\tIVB\tG12D\tPR\tPR\tPD\tPD\t \tBoC147\tIIIB\tG12A\tPR\tPR\tSD\tSD\t \t"}], "citations": {"NLM": "Reissig TM, Ladigan-Badura S, Steinberg A, Maghnouj A, Li T, Verdoodt B, Liffers ST, Pohl M, Wolters H, Teschendorf C, Viebahn R, Admard J, Casadei N, Tannapfel A, Schmiegel W, Hahn SA, Vangala DB. Lasting response by vertical inhibition with cetuximab and trametinib in KRAS-mutated colorectal cancer patient-derived xenografts Mol Oncol. PMID: 37604687", "BibTeX": "@article{37604687, title={Lasting response by vertical inhibition with cetuximab and trametinib in KRAS-mutated colorectal cancer patient-derived xenografts}, author={Reissig TM and Ladigan-Badura S and Steinberg A and Maghnouj A and Li T and Verdoodt B and Liffers ST and Pohl M and Wolters H and Teschendorf C and Viebahn R and Admard J and Casadei N and Tannapfel A and Schmiegel W and Hahn SA and Vangala DB}, journal={Mol Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 37686416, "pmcid": "PMC10488195", "title": "ALK, ROS1, RET and NTRK1-3 Gene Fusions in Colorectal and Non-Colorectal Microsatellite-Unstable Cancers", "journal": "Int J Mol Sci", "authors": ["Mulkidjan RS", "Saitova ES", "Preobrazhenskaya EV", "Asadulaeva KA", "Bubnov MG", "Otradnova EA", "Terina DM", "Shulga SS", "Martynenko DE", "Semina MV", "Belogubova EV", "Tiurin VI", "Amankwah PS", "Martianov AS", "Imyanitov EN"], "date": "2023-09-02T00:00:00Z", "year": 2023, "snippets": [{"_id": "37686416@30693", "snip_text": "\tID\tSex\tAge, Years\tDiagnosis\tRAS/RAF Mutations\t5'/3'-End Expression Imbalance\tFusion\tMethod of Fusion Identification\t \t1.\tA9365\tm\t74\tCRC\tnegative\tALK\tSTRN::ALK (S5;ins53A20)\tNGS\t \t2.\tC1182\tf\t71\tCRC\tnegative\tALK\tEML4::ALK (E6;A20)\tPCR\t \t3.\tC3234\tf\t49\tCRC\tnegative\tALK\tSPTBN1::ALK (S7;A20)\tNGS\t \t4.\tD0934\tm\t70\tCRC\tnegative\tALK\tRBBP8::ALK (R8;A20)\tNGS\t \t5.\tP28580\tf\t66\tCRC\tnegative\tALK\tSPTBN1::ALK (S7;A20)\tNGS\t \t6.\tP30811\tm\t80\tCRC\tnegative\tALK\tEML4::ALK (E20;A20)\tPCR\t \t7.\tB9775\tf\t62\tCRC\tnegative\t-\tCCDC6::RET (C1;RE12)\tPCR\t \t8.\tC7622\tm\t58\tCRC\tnegative\t-\tCCDC6::RET (C1;RE12)\tPCR\t \t9.\tA7310\tm\t65\tCRC\tnegative\t-\tCCDC6::RET (C1;RE12)\tPCR\t \t10.\tP22395\tm\t62\tCRC\tnegative\t-\tCCDC6::RET (C1;RE12)\tPCR\t \t11.\tB8013\tf\t63\tCRC\tnegative\tRET\tNCOA4::RET (N8;R12)\tPCR\t \t12.\tC2542\tf\t67\tCRC\tnegative\tRET\tNCOA4::RET (N9del501;R12)\tNGS\t \t13.\tC4286\tm\t54\tCRC\tnegative\tRET\tNCOA4::RET (N9;R12)\tNGS\t \t14.\tP16667\tf\t65\tCRC\tnegative\tRET\tNCOA4::RET (N9;R12)\tNGS\t \t15.\tP24158\tf\t66\tCRC\tnegative\tRET\tCCDC6::RET (C1;RE12)\tPCR\t \t16.\tA4695\tf\t64\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t17.\tB2240\tf\t60\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t18.\tB9472\tm\t52\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t19.\tC1589\tf\t64\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t20.\tC6335\tf\t69\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t21.\tC6755\tm\t72\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t22.\tD0273\tm\t68\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t23.\tD1407\tf\t58\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t24.\tE2169\tm\t58\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t25.\tP18891\tf\t59\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N12)\tPCR\t \t26.\tP21693\tm\t86\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t27.\tE4114\tf\t69\tCRC\tnegative\tNTRK1\tLMNA::NTRK1 (L3;N10)\tPCR\t \t28.\tB9540\tm\t72\tCRC\tnegative\tNTRK1\tTPR::NTRK1 (T15;N10)\tNGS\t \t29.\tC4763\tm\t65\tCRC\tnegative\tNTRK1\tTPR::NTRK1 (T20;N11)\tNGS\t \t30.\tC7112\tf\t65\tCRC\tnegative\tNTRK1\tZKSCAN1::NTRK1 (Z3;N12)\tNGS\t \t31.\tD0155\tf\t81\tCRC\tnegative\tNTRK1\tLMNA::NTRK1 (L9ins44;del74N11)\tNGS\t \t32.\tB9665\tm\t74\tCRC\tnegative\tNTRK2\tETV6::NTRK2 (E5;N15)\tNGS\t \t33.\tA4890\tf\t65\tCRC\tnegative\tNTRK3\tEML4::NTRK3 (E2;N14)\tPCR\t \t34.\tB1263\tf\t58\tCRC\tnegative\t-\tEML4::NTRK3 (E2;N14)\tPCR\t \t35.\tB4631\tf\t68\tCRC\tnegative\tNTRK3\tEML4::NTRK3 (E2;N14)\tPCR\t \t36.\tC3968\tf\t70\tCRC\tnegative\tNTRK3\tEML4::NTRK3 (E2;N14)\tPCR\t \t37.\tC5878\tm\t57\tCRC\tnegative\tNTRK3\tETV6::NTRK3 (E5;N15)\tPCR\t \t38.\tC6430\tf\t72\tCRC\tnegative\tNTRK3\tEML4::NTRK3 (E2;N14)\tPCR\t \t39.\tC7912\tf\t54\tCRC\tnegative\tNTRK3\tEML4::NTRK3 (E2;N14)\tPCR\t \t40.\tD7461\tf\t61\tCRC\tnegative\tNTRK3\tETV6::NTRK3 (E5;N15)\tPCR\t \t41.\tP22904\tf\t68\tCRC\tnegative\tNTRK3\tEML4::NTRK3 (E2;N14)\tPCR\t \t42.\tP23972\tf\t67\tCRC\tnegative\tNTRK3\tETV6::NTRK3 (E5;N15)\tPCR\t \t43.\tB4561\tm\t31\tCRC\tKRAS p.A146T\tNTRK2\tETV6::NTRK2 (E5;N15)\tNGS\t \t44.\tC1274\tf\t73\tCRC\tBRAF p.V600E\t-\tETV6::NTRK3 (E5;N15)\tPCR\t \t45.\tC3231\tf\t76\tCRC\tBRAF p.V600E\tNTRK1\tLMNA::NTRK1 (L3;N10)\tPCR\t \t46.\tP29082\tf\t85\tCRC\tNRAS p.Q61K\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t47.\tC7527\tf\t71\tGC\tKRAS p.G12C\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t48.\tC4292\tf\t72\tCRC\tNegative\tALK\tnot defined\tn/a for NGS\t \t49.\tC8576\tm\t66\tCRC\tNegative\tALK\tnot defined\tn/a for NGS\t \t50.\tC2716\tm\t80\tCRC\tNegative\tRET\tnot defined\tn/a for NGS\t \t51.\tC5821\tm\t83\tCRC\tNegative\tRET\tnot defined\tn/a for NGS\t \t52.\tP15387\tm\t68\tCRC\tNegative\tRET\tnot defined\tn/a for NGS\t \t53.\tB9814\tf\t65\tCRC\tNegative\tNTRK1\tnot defined\tn/a for NGS\t \t54.\tC4831\tf\t60\tCRC\tNegative\tNTRK1\tnot defined\tn/a for NGS\t \t55.\tD0795\tm\t74\tCRC\tNegative\tNTRK1\tnot defined\tn/a for NGS\t \t56.\tC5665\tf\t68\tCRC\tNegative\tNTRK3\tnot defined\tn/a for NGS\t \t57.\tC9396\tm\t32\tCRC\tNegative\tNTRK3\tnot defined\tn/a for NGS\t \t58.\tD3390\tf\t80\tCRC\tNegative\tNTRK3\tnot defined\tn/a for NGS\t \t59.\tD5144\tm\t66\tCRC\tKRAS p.G12D\tNTRK3\tnot defined\tn/a for NGS\t \t60.\tA9663\tm\t66\tGC\tNegative\tNTRK1\tnot defined\tn/a for NGS\t \t61.\tC1642\tm\t83\tGC\tNegative\tNTRK1\tnot defined\tn/a for NGS\t \t62.\tE3046\tm\t34\tGC\tNegative\tNTRK3\tnot defined\tn/a for NGS\t \t63.\tC8708\tf\t67\tEC\tNegative\tNTRK3\tnot defined\tn/a for NGS\t \t64.\tD5486\tf\t71\tEC\tNegative\tNTRK3\tnot defined\tn/a for NGS\t \t65.\tD6096\tf\t64\tEC\tNegative\tNTRK3\tnot defined\tn/a for NGS\t \t", "section": "table", "mentions": ["2024|5|gene|ncbi_gene@4915|NTRK2", "33|3|gene|ncbi_gene@22882|RAF", "332|3|gene|ncbi_gene@238|ALK", "2803|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "3233|3|gene|ncbi_gene@5979|RET", "791|3|gene|ncbi_gene@5979|RET", "1827|5|gene|ncbi_gene@4914|NTRK1", "1033|5|gene|ncbi_gene@4914|NTRK1", "263|3|gene|ncbi_gene@238|ALK", "1460|5|gene|ncbi_gene@4914|NTRK1", "3291|5|gene|ncbi_gene@4914|NTRK1", "722|3|gene|ncbi_gene@5979|RET", "3351|5|gene|ncbi_gene@4914|NTRK1", "217|3|gene|ncbi_gene@238|ALK", "805|3|variant|litvar@rs121913529##&&&litvar@#3845#|R12", "3471|5|gene|ncbi_gene@4916|NTRK3", "2685|5|gene|ncbi_gene@4915|NTRK2", "2823|5|gene|ncbi_gene@4914|NTRK1", "438|3|gene|ncbi_gene@238|ALK", "2888|5|gene|ncbi_gene@4914|NTRK1", "1571|5|gene|ncbi_gene@4914|NTRK1", "962|3|gene|ncbi_gene@5979|RET", "1204|5|gene|ncbi_gene@4914|NTRK1", "1277|5|gene|ncbi_gene@4914|NTRK1", "3174|3|gene|ncbi_gene@5979|RET", "903|3|gene|ncbi_gene@5979|RET", "2012|5|gene|ncbi_gene@4915|NTRK2", "3000|3|gene|ncbi_gene@238|ALK", "1755|5|gene|ncbi_gene@4914|NTRK1", "3531|5|gene|ncbi_gene@4916|NTRK3", "2632|5|gene|ncbi_gene@4916|NTRK3", "3591|5|gene|ncbi_gene@4916|NTRK3", "1021|5|gene|ncbi_gene@4914|NTRK1", "1094|5|gene|ncbi_gene@4914|NTRK1", "2508|5|gene|ncbi_gene@4916|NTRK3", "504|3|gene|ncbi_gene@5979|RET", "2672|4|gene|ncbi_gene@3845|KRAS", "3116|3|gene|ncbi_gene@5979|RET", "2811|5|gene|ncbi_gene@4914|NTRK1", "674|3|gene|ncbi_gene@5979|RET", "146|3|gene|ncbi_gene@238|ALK", "844|3|gene|ncbi_gene@5979|RET", "1953|5|gene|ncbi_gene@4914|NTRK1", "2252|5|gene|ncbi_gene@4916|NTRK3", "156|3|gene|ncbi_gene@238|ALK", "2325|5|gene|ncbi_gene@4916|NTRK3", "2677|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "560|3|gene|ncbi_gene@5979|RET", "1706|5|gene|ncbi_gene@4914|NTRK1", "207|3|gene|ncbi_gene@238|ALK", "1816|5|gene|ncbi_gene@4914|NTRK1", "1509|5|gene|ncbi_gene@4914|NTRK1", "2869|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "2386|5|gene|ncbi_gene@4916|NTRK3", "973|3|gene|ncbi_gene@5979|RET", "1593|3|variant|litvar@rs121913529##&&&litvar@#3845#|N12", "3772|5|gene|ncbi_gene@4914|NTRK1", "2496|5|gene|ncbi_gene@4916|NTRK3", "3058|3|gene|ncbi_gene@238|ALK", "914|3|gene|ncbi_gene@5979|RET", "1877|5|gene|ncbi_gene@4914|NTRK1", "2570|5|gene|ncbi_gene@4916|NTRK3", "1583|5|gene|ncbi_gene@4914|NTRK1", "3642|4|gene|ncbi_gene@3845|KRAS", "1326|5|gene|ncbi_gene@4914|NTRK1", "2798|4|gene|ncbi_gene@673|BRAF", "1399|5|gene|ncbi_gene@4914|NTRK1", "2203|5|gene|ncbi_gene@4916|NTRK3", "2951|5|gene|ncbi_gene@4914|NTRK1", "855|3|gene|ncbi_gene@5979|RET", "2313|5|gene|ncbi_gene@4916|NTRK3", "1902|3|variant|litvar@rs121913529##&&&litvar@#3845#|N12", "1694|5|gene|ncbi_gene@4914|NTRK1", "741|3|variant|litvar@rs121913529##&&&litvar@#3845#|R12", "2927|4|gene|ncbi_gene@3845|KRAS", "3713|5|gene|ncbi_gene@4914|NTRK1", "1143|5|gene|ncbi_gene@4914|NTRK1", "2374|5|gene|ncbi_gene@4916|NTRK3", "2447|5|gene|ncbi_gene@4916|NTRK3", "2085|5|gene|ncbi_gene@4916|NTRK3", "3411|5|gene|ncbi_gene@4914|NTRK1", "448|3|gene|ncbi_gene@238|ALK", "3654|5|gene|ncbi_gene@4916|NTRK3", "3647|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "4008|5|gene|ncbi_gene@4916|NTRK3", "616|3|gene|ncbi_gene@5979|RET", "379|3|gene|ncbi_gene@238|ALK", "1521|5|gene|ncbi_gene@4914|NTRK1", "733|3|gene|ncbi_gene@5979|RET", "2558|5|gene|ncbi_gene@4916|NTRK3", "2864|4|gene|ncbi_gene@4893|NRAS", "1892|5|gene|ncbi_gene@4914|NTRK1", "1387|5|gene|ncbi_gene@4914|NTRK1", "2191|5|gene|ncbi_gene@4916|NTRK3", "2264|5|gene|ncbi_gene@4916|NTRK3", "3949|5|gene|ncbi_gene@4916|NTRK3", "2939|5|gene|ncbi_gene@4914|NTRK1", "1645|5|gene|ncbi_gene@4914|NTRK1", "3890|5|gene|ncbi_gene@4916|NTRK3", "1082|5|gene|ncbi_gene@4914|NTRK1", "1338|5|gene|ncbi_gene@4914|NTRK1", "1448|5|gene|ncbi_gene@4914|NTRK1", "922|3|variant|litvar@rs121913529##&&&litvar@#3845#|R12", "321|3|gene|ncbi_gene@238|ALK", "2073|5|gene|ncbi_gene@4916|NTRK3", "2435|5|gene|ncbi_gene@4916|NTRK3", "3831|5|gene|ncbi_gene@4916|NTRK3", "2932|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "780|3|gene|ncbi_gene@5979|RET", "2876|5|gene|ncbi_gene@4914|NTRK1", "275|3|gene|ncbi_gene@238|ALK", "863|3|variant|litvar@rs121913529##&&&litvar@#3845#|R12", "2737|4|gene|ncbi_gene@673|BRAF", "1155|5|gene|ncbi_gene@4914|NTRK1", "1265|5|gene|ncbi_gene@4914|NTRK1", "2142|5|gene|ncbi_gene@4916|NTRK3", "2697|5|gene|ncbi_gene@4915|NTRK2", "2620|5|gene|ncbi_gene@4916|NTRK3", "1633|5|gene|ncbi_gene@4914|NTRK1", "1216|5|gene|ncbi_gene@4914|NTRK1", "2742|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "391|3|gene|ncbi_gene@238|ALK", "2758|5|gene|ncbi_gene@4916|NTRK3", "1766|5|gene|ncbi_gene@4914|NTRK1", "1941|5|gene|ncbi_gene@4914|NTRK1"], "figure_id": "ijms-24-13610-t001", "text_hl": "\tID\tSex\tAge, Years\tDiagnosis\tRAS/RAF Mutations\t5'/3'-End Expression Imbalance\tFusion\tMethod of Fusion Identification\t \t1.\tA9365\tm\t74\tCRC\tnegative\tALK\tSTRN::ALK (S5;ins53A20)\tNGS\t \t2.\tC1182\tf\t71\tCRC\tnegative\tALK\tEML4::ALK (E6;A20)\tPCR\t \t3.\tC3234\tf\t49\tCRC\tnegative\tALK\tSPTBN1::ALK (S7;A20)\tNGS\t \t4.\tD0934\tm\t70\tCRC\tnegative\tALK\tRBBP8::ALK (R8;A20)\tNGS\t \t5.\tP28580\tf\t66\tCRC\tnegative\tALK\tSPTBN1::ALK (S7;A20)\tNGS\t \t6.\tP30811\tm\t80\tCRC\tnegative\tALK\tEML4::ALK (E20;A20)\tPCR\t \t7.\tB9775\tf\t62\tCRC\tnegative\t-\tCCDC6::RET (C1;RE12)\tPCR\t \t8.\tC7622\tm\t58\tCRC\tnegative\t-\tCCDC6::RET (C1;RE12)\tPCR\t \t9.\tA7310\tm\t65\tCRC\tnegative\t-\tCCDC6::RET (C1;RE12)\tPCR\t \t10.\tP22395\tm\t62\tCRC\tnegative\t-\tCCDC6::RET (C1;RE12)\tPCR\t \t11.\tB8013\tf\t63\tCRC\tnegative\tRET\tNCOA4::RET (N8;R12)\tPCR\t \t12.\tC2542\tf\t67\tCRC\tnegative\tRET\tNCOA4::RET (N9del501;R12)\tNGS\t \t13.\tC4286\tm\t54\tCRC\tnegative\tRET\tNCOA4::RET (N9;R12)\tNGS\t \t14.\tP16667\tf\t65\tCRC\tnegative\tRET\tNCOA4::RET (N9;R12)\tNGS\t \t15.\tP24158\tf\t66\tCRC\tnegative\tRET\tCCDC6::RET (C1;RE12)\tPCR\t \t16.\tA4695\tf\t64\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t17.\tB2240\tf\t60\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t18.\tB9472\tm\t52\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t19.\tC1589\tf\t64\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t20.\tC6335\tf\t69\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t21.\tC6755\tm\t72\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t22.\tD0273\tm\t68\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t23.\tD1407\tf\t58\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t24.\tE2169\tm\t58\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t25.\tP18891\tf\t59\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N12)\tPCR\t \t26.\tP21693\tm\t86\tCRC\tnegative\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t27.\tE4114\tf\t69\tCRC\tnegative\tNTRK1\tLMNA::NTRK1 (L3;N10)\tPCR\t \t28.\tB9540\tm\t72\tCRC\tnegative\tNTRK1\tTPR::NTRK1 (T15;N10)\tNGS\t \t29.\tC4763\tm\t65\tCRC\tnegative\tNTRK1\tTPR::NTRK1 (T20;N11)\tNGS\t \t30.\tC7112\tf\t65\tCRC\tnegative\tNTRK1\tZKSCAN1::NTRK1 (Z3;N12)\tNGS\t \t31.\tD0155\tf\t81\tCRC\tnegative\tNTRK1\tLMNA::NTRK1 (L9ins44;del74N11)\tNGS\t \t32.\tB9665\tm\t74\tCRC\tnegative\tNTRK2\tETV6::NTRK2 (E5;N15)\tNGS\t \t33.\tA4890\tf\t65\tCRC\tnegative\tNTRK3\tEML4::NTRK3 (E2;N14)\tPCR\t \t34.\tB1263\tf\t58\tCRC\tnegative\t-\tEML4::NTRK3 (E2;N14)\tPCR\t \t35.\tB4631\tf\t68\tCRC\tnegative\tNTRK3\tEML4::NTRK3 (E2;N14)\tPCR\t \t36.\tC3968\tf\t70\tCRC\tnegative\tNTRK3\tEML4::NTRK3 (E2;N14)\tPCR\t \t37.\tC5878\tm\t57\tCRC\tnegative\tNTRK3\tETV6::NTRK3 (E5;N15)\tPCR\t \t38.\tC6430\tf\t72\tCRC\tnegative\tNTRK3\tEML4::NTRK3 (E2;N14)\tPCR\t \t39.\tC7912\tf\t54\tCRC\tnegative\tNTRK3\tEML4::NTRK3 (E2;N14)\tPCR\t \t40.\tD7461\tf\t61\tCRC\tnegative\tNTRK3\tETV6::NTRK3 (E5;N15)\tPCR\t \t41.\tP22904\tf\t68\tCRC\tnegative\tNTRK3\tEML4::NTRK3 (E2;N14)\tPCR\t \t42.\tP23972\tf\t67\tCRC\tnegative\tNTRK3\tETV6::NTRK3 (E5;N15)\tPCR\t \t43.\tB4561\tm\t31\tCRC\tKRAS <m>p.A146T</m>\tNTRK2\tETV6::NTRK2 (E5;N15)\tNGS\t \t44.\tC1274\tf\t73\tCRC\tBRAF p.V600E\t-\tETV6::NTRK3 (E5;N15)\tPCR\t \t45.\tC3231\tf\t76\tCRC\tBRAF p.V600E\tNTRK1\tLMNA::NTRK1 (L3;N10)\tPCR\t \t46.\tP29082\tf\t85\tCRC\tNRAS p.Q61K\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t47.\tC7527\tf\t71\tGC\tKRAS p.G12C\tNTRK1\tTPM3::NTRK1 (T8;N10)\tPCR\t \t48.\tC4292\tf\t72\tCRC\tNegative\tALK\tnot defined\tn/a for NGS\t \t49.\tC8576\tm\t66\tCRC\tNegative\tALK\tnot defined\tn/a for NGS\t \t50.\tC2716\tm\t80\tCRC\tNegative\tRET\tnot defined\tn/a for NGS\t \t51.\tC5821\tm\t83\tCRC\tNegative\tRET\tnot defined\tn/a for NGS\t \t52.\tP15387\tm\t68\tCRC\tNegative\tRET\tnot defined\tn/a for NGS\t \t53.\tB9814\tf\t65\tCRC\tNegative\tNTRK1\tnot defined\tn/a for NGS\t \t54.\tC4831\tf\t60\tCRC\tNegative\tNTRK1\tnot defined\tn/a for NGS\t \t55.\tD0795\tm\t74\tCRC\tNegative\tNTRK1\tnot defined\tn/a for NGS\t \t56.\tC5665\tf\t68\tCRC\tNegative\tNTRK3\tnot defined\tn/a for NGS\t \t57.\tC9396\tm\t32\tCRC\tNegative\tNTRK3\tnot defined\tn/a for NGS\t \t58.\tD3390\tf\t80\tCRC\tNegative\tNTRK3\tnot defined\tn/a for NGS\t \t59.\tD5144\tm\t66\tCRC\tKRAS p.G12D\tNTRK3\tnot defined\tn/a for NGS\t \t60.\tA9663\tm\t66\tGC\tNegative\tNTRK1\tnot defined\tn/a for NGS\t \t61.\tC1642\tm\t83\tGC\tNegative\tNTRK1\tnot defined\tn/a for NGS\t \t62.\tE3046\tm\t34\tGC\tNegative\tNTRK3\tnot defined\tn/a for NGS\t \t63.\tC8708\tf\t67\tEC\tNegative\tNTRK3\tnot defined\tn/a for NGS\t \t64.\tD5486\tf\t71\tEC\tNegative\tNTRK3\tnot defined\tn/a for NGS\t \t65.\tD6096\tf\t64\tEC\tNegative\tNTRK3\tnot defined\tn/a for NGS\t \t"}], "citations": {"NLM": "Mulkidjan RS, Saitova ES, Preobrazhenskaya EV, Asadulaeva KA, Bubnov MG, Otradnova EA, Terina DM, Shulga SS, Martynenko DE, Semina MV, Belogubova EV, Tiurin VI, Amankwah PS, Martianov AS, Imyanitov EN. ALK, ROS1, RET and NTRK1-3 Gene Fusions in Colorectal and Non-Colorectal Microsatellite-Unstable Cancers Int J Mol Sci. PMID: 37686416", "BibTeX": "@article{37686416, title={ALK, ROS1, RET and NTRK1-3 Gene Fusions in Colorectal and Non-Colorectal Microsatellite-Unstable Cancers}, author={Mulkidjan RS and Saitova ES and Preobrazhenskaya EV and Asadulaeva KA and Bubnov MG and Otradnova EA and Terina DM and Shulga SS and Martynenko DE and Semina MV and Belogubova EV and Tiurin VI and Amankwah PS and Martianov AS and Imyanitov EN}, journal={Int J Mol Sci}}"}, "is_sup_mat_match": false}, {"pmid": 32034196, "pmcid": "PMC7005734", "title": "Validating a targeted next-generation sequencing assay and profiling somatic variants in Chinese non-small cell lung cancer patients", "journal": "Sci Rep", "authors": ["Jiang R", "Zhang B", "Teng X", "Hu P", "Xu S", "Zheng Z", "Liu R", "Tang T", "Ye F"], "date": "2020-02-07T00:00:00Z", "year": 2020, "snippets": [], "citations": {"NLM": "Jiang R, Zhang B, Teng X, Hu P, Xu S, Zheng Z, Liu R, Tang T, Ye F. Validating a targeted next-generation sequencing assay and profiling somatic variants in Chinese non-small cell lung cancer patients Sci Rep. PMID: 32034196", "BibTeX": "@article{32034196, title={Validating a targeted next-generation sequencing assay and profiling somatic variants in Chinese non-small cell lung cancer patients}, author={Jiang R and Zhang B and Teng X and Hu P and Xu S and Zheng Z and Liu R and Tang T and Ye F}, journal={Sci Rep}}"}, "is_sup_mat_match": true}, {"pmid": 36505399, "pmcid": "PMC9727402", "title": "An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy", "journal": "Front Immunol", "authors": ["Lin J", "Liu J", "Hao SG", "Lan B", "Zheng XB", "Xiong JN", "Zhang YQ", "Gao X", "Chen CB", "Chen L", "Huang YF", "Luo H", "Yi YT", "Yi X", "Lu JP", "Zheng XW", "Chen G", "Wang XF", "Chen Y"], "date": "2022-11-23T00:00:00Z", "year": 2022, "snippets": [], "citations": {"NLM": "Lin J, Liu J, Hao SG, Lan B, Zheng XB, Xiong JN, Zhang YQ, Gao X, Chen CB, Chen L, Huang YF, Luo H, Yi YT, Yi X, Lu JP, Zheng XW, Chen G, Wang XF, Chen Y. An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy Front Immunol. PMID: 36505399", "BibTeX": "@article{36505399, title={An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy}, author={Lin J and Liu J and Hao SG and Lan B and Zheng XB and Xiong JN and Zhang YQ and Gao X and Chen CB and Chen L and Huang YF and Luo H and Yi YT and Yi X and Lu JP and Zheng XW and Chen G and Wang XF and Chen Y}, journal={Front Immunol}}"}, "is_sup_mat_match": true}, {"pmid": 28170370, "pmcid": "PMC5355934", "title": "Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.", "journal": "Br J Cancer", "authors": ["Malapelle U", "Mayo de-Las-Casas C", "Rocco D", "Garzon M", "Pisapia P", "Jordana-Ariza N", "Russo M", "Sgariglia R", "De Luca C", "Pepe F", "Martinez-Bueno A", "Morales-Espinosa D", "Gonz\u00e1lez-Cao M", "Karachaliou N", "Viteri Ramirez S", "Bellevicine C", "Molina-Vila MA", "Rosell R", "Troncone G"], "date": "2017-03-14T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Malapelle U, Mayo de-Las-Casas C, Rocco D, Garzon M, Pisapia P, Jordana-Ariza N, Russo M, Sgariglia R, De Luca C, Pepe F, Martinez-Bueno A, Morales-Espinosa D, Gonz\u00e1lez-Cao M, Karachaliou N, Viteri Ramirez S, Bellevicine C, Molina-Vila MA, Rosell R, Troncone G. Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients. Br J Cancer. PMID: 28170370", "BibTeX": "@article{28170370, title={Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.}, author={Malapelle U and Mayo de-Las-Casas C and Rocco D and Garzon M and Pisapia P and Jordana-Ariza N and Russo M and Sgariglia R and De Luca C and Pepe F and Martinez-Bueno A and Morales-Espinosa D and Gonz\u00e1lez-Cao M and Karachaliou N and Viteri Ramirez S and Bellevicine C and Molina-Vila MA and Rosell R and Troncone G}, journal={Br J Cancer}}"}, "is_sup_mat_match": true}, {"pmid": 29703253, "pmcid": "PMC5921972", "title": "SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients.", "journal": "BMC Cancer", "authors": ["Mei Z", "Shao YW", "Lin P", "Cai X", "Wang B", "Ding Y", "Ma X", "Wu X", "Xia Y", "Zhu D", "Shu Y", "Fu Z", "Gu Y"], "date": "2018-04-27T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Mei Z, Shao YW, Lin P, Cai X, Wang B, Ding Y, Ma X, Wu X, Xia Y, Zhu D, Shu Y, Fu Z, Gu Y. SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients. BMC Cancer. PMID: 29703253", "BibTeX": "@article{29703253, title={SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients.}, author={Mei Z and Shao YW and Lin P and Cai X and Wang B and Ding Y and Ma X and Wu X and Xia Y and Zhu D and Shu Y and Fu Z and Gu Y}, journal={BMC Cancer}}"}, "is_sup_mat_match": true}, {"pmid": 30157175, "pmcid": "PMC6114281", "title": "BRAF and AXL oncogenes drive RIPK3 expression loss in cancer.", "journal": "PLoS Biol", "authors": ["Najafov A", "Zervantonakis IK", "Mookhtiar AK", "Greninger P", "March RJ", "Egan RK", "Luu HS", "Stover DG", "Matulonis UA", "Benes CH", "Yuan J"], "date": "2018-08-29T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Najafov A, Zervantonakis IK, Mookhtiar AK, Greninger P, March RJ, Egan RK, Luu HS, Stover DG, Matulonis UA, Benes CH, Yuan J. BRAF and AXL oncogenes drive RIPK3 expression loss in cancer. PLoS Biol. PMID: 30157175", "BibTeX": "@article{30157175, title={BRAF and AXL oncogenes drive RIPK3 expression loss in cancer.}, author={Najafov A and Zervantonakis IK and Mookhtiar AK and Greninger P and March RJ and Egan RK and Luu HS and Stover DG and Matulonis UA and Benes CH and Yuan J}, journal={PLoS Biol}}"}, "is_sup_mat_match": true}, {"pmid": 30850842, "pmcid": "PMC6610171", "title": "- No Title -", "journal": "Carcinogenesis", "authors": ["Makabe T", "Arai E", "Hirano T", "Ito N", "Fukamachi Y", "Takahashi Y", "Hirasawa A", "Yamagami W", "Susumu N", "Aoki D", "Kanai Y"], "date": "2019-07-04T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Makabe T, Arai E, Hirano T, Ito N, Fukamachi Y, Takahashi Y, Hirasawa A, Yamagami W, Susumu N, Aoki D, Kanai Y. - No Title - Carcinogenesis. PMID: 30850842", "BibTeX": "@article{30850842, title={- No Title -}, author={Makabe T and Arai E and Hirano T and Ito N and Fukamachi Y and Takahashi Y and Hirasawa A and Yamagami W and Susumu N and Aoki D and Kanai Y}, journal={Carcinogenesis}}"}, "is_sup_mat_match": true}, {"pmid": 31350822, "pmcid": "PMC6822250", "title": "RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancer.", "journal": "Mol Oncol", "authors": ["van Helden EJ", "Angus L", "Menke-van der Houven van Oordt CW", "Heideman DAM", "Boon E", "van Es SC", "Radema SA", "van Herpen CML", "de Groot DJA", "de Vries EGE", "Jansen MPHM", "Sleijfer S", "Verheul HMW"], "date": "2019-11-01T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "van Helden EJ, Angus L, Menke-van der Houven van Oordt CW, Heideman DAM, Boon E, van Es SC, Radema SA, van Herpen CML, de Groot DJA, de Vries EGE, Jansen MPHM, Sleijfer S, Verheul HMW. RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancer. Mol Oncol. PMID: 31350822", "BibTeX": "@article{31350822, title={RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancer.}, author={van Helden EJ and Angus L and Menke-van der Houven van Oordt CW and Heideman DAM and Boon E and van Es SC and Radema SA and van Herpen CML and de Groot DJA and de Vries EGE and Jansen MPHM and Sleijfer S and Verheul HMW}, journal={Mol Oncol}}"}, "is_sup_mat_match": true}, {"pmid": 26689913, "pmcid": "PMC4703835", "title": "Patterns and functional implications of rare germline variants across 12 cancer types", "journal": "Nat Commun", "authors": ["Lu C", "Xie M", "Wendl MC", "Wang J", "McLellan MD", "Leiserson MD", "Huang KL", "Wyczalkowski MA", "Jayasinghe R", "Banerjee T", "Ning J", "Tripathi P", "Zhang Q", "Niu B", "Ye K", "Schmidt HK", "Fulton RS", "McMichael JF", "Batra P", "Kandoth C", "Bharadwaj M", "Koboldt DC", "Miller CA", "Kanchi KL", "Eldred JM", "Larson DE", "Welch JS", "You M", "Ozenberger BA", "Govindan R", "Walter MJ", "Ellis MJ", "Mardis ER", "Graubert TA", "Dipersio JF", "Ley TJ", "Wilson RK", "Goodfellow PJ", "Raphael BJ", "Chen F", "Johnson KJ", "Parvin JD", "Ding L"], "date": "2015-12-22T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Lu C, Xie M, Wendl MC, Wang J, McLellan MD, Leiserson MD, Huang KL, Wyczalkowski MA, Jayasinghe R, Banerjee T, Ning J, Tripathi P, Zhang Q, Niu B, Ye K, Schmidt HK, Fulton RS, McMichael JF, Batra P, Kandoth C, Bharadwaj M, Koboldt DC, Miller CA, Kanchi KL, Eldred JM, Larson DE, Welch JS, You M, Ozenberger BA, Govindan R, Walter MJ, Ellis MJ, Mardis ER, Graubert TA, Dipersio JF, Ley TJ, Wilson RK, Goodfellow PJ, Raphael BJ, Chen F, Johnson KJ, Parvin JD, Ding L. Patterns and functional implications of rare germline variants across 12 cancer types Nat Commun. PMID: 26689913", "BibTeX": "@article{26689913, title={Patterns and functional implications of rare germline variants across 12 cancer types}, author={Lu C and Xie M and Wendl MC and Wang J and McLellan MD and Leiserson MD and Huang KL and Wyczalkowski MA and Jayasinghe R and Banerjee T and Ning J and Tripathi P and Zhang Q and Niu B and Ye K and Schmidt HK and Fulton RS and McMichael JF and Batra P and Kandoth C and Bharadwaj M and Koboldt DC and Miller CA and Kanchi KL and Eldred JM and Larson DE and Welch JS and You M and Ozenberger BA and Govindan R and Walter MJ and Ellis MJ and Mardis ER and Graubert TA and Dipersio JF and Ley TJ and Wilson RK and Goodfellow PJ and Raphael BJ and Chen F and Johnson KJ and Parvin JD and Ding L}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 24662245, "pmcid": "PMC4016990", "title": "Mutations in epigenetic regulators including SETD2 are gained during relapse in pediatric acute lymphoblastic leukemia", "journal": "Nat Commun", "authors": ["Mar BG", "Bullinger LB", "McLean KM", "Grauman PV", "Harris MH", "Stevenson K", "Neuberg DS", "Sinha AU", "Sallan SE", "Silverman LB", "Kung AL", "Lo Nigro L", "Ebert BL", "Armstrong SA"], "date": "2014-03-24T00:00:00Z", "year": 2014, "snippets": [], "citations": {"NLM": "Mar BG, Bullinger LB, McLean KM, Grauman PV, Harris MH, Stevenson K, Neuberg DS, Sinha AU, Sallan SE, Silverman LB, Kung AL, Lo Nigro L, Ebert BL, Armstrong SA. Mutations in epigenetic regulators including SETD2 are gained during relapse in pediatric acute lymphoblastic leukemia Nat Commun. PMID: 24662245", "BibTeX": "@article{24662245, title={Mutations in epigenetic regulators including SETD2 are gained during relapse in pediatric acute lymphoblastic leukemia}, author={Mar BG and Bullinger LB and McLean KM and Grauman PV and Harris MH and Stevenson K and Neuberg DS and Sinha AU and Sallan SE and Silverman LB and Kung AL and Lo Nigro L and Ebert BL and Armstrong SA}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 35399540, "pmcid": "PMC8974951", "title": "Integrated genomic analyses identify high-risk factors and actionable targets in T-cell acute lymphoblastic leukemia", "journal": "Blood Sci", "authors": ["Zhu H", "Dong B", "Zhang Y", "Wang M", "Rao J", "Cui B", "Liu Y", "Jiang Q", "Wang W", "Yang L", "Yu A", "Li Z", "Liu C", "Zhang L", "Huang X", "Zhu X", "Wu H"], "date": "2022-02-04T00:00:00Z", "year": 2022, "snippets": [], "citations": {"NLM": "Zhu H, Dong B, Zhang Y, Wang M, Rao J, Cui B, Liu Y, Jiang Q, Wang W, Yang L, Yu A, Li Z, Liu C, Zhang L, Huang X, Zhu X, Wu H. Integrated genomic analyses identify high-risk factors and actionable targets in T-cell acute lymphoblastic leukemia Blood Sci. PMID: 35399540", "BibTeX": "@article{35399540, title={Integrated genomic analyses identify high-risk factors and actionable targets in T-cell acute lymphoblastic leukemia}, author={Zhu H and Dong B and Zhang Y and Wang M and Rao J and Cui B and Liu Y and Jiang Q and Wang W and Yang L and Yu A and Li Z and Liu C and Zhang L and Huang X and Zhu X and Wu H}, journal={Blood Sci}}"}, "is_sup_mat_match": true}, {"pmid": 38805050, "pmcid": "PMC11133214", "title": "Temporal dynamics of RAS mutations in circulating tumor DNA in metastatic colorectal cancer: clinical significance of mutation loss during treatment", "journal": "J Cancer Res Clin Oncol", "authors": ["Iguchi K", "Shiozawa M", "Uchiyama M", "Asari M", "Numata K", "Rino Y", "Saito A"], "date": "2024-05-28T00:00:00Z", "year": 2024, "snippets": [{"_id": "38805050@6657", "snip_text": "We examined the presence of the following mutations for exon 2 (G12S, G12C, G12R, G12D, G12V, G12A, G13S, G13C, G13R, G13D, G13V, and G13A), exon 3 (A59T, A59G, Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H), and exon 4 (K117N, A146T, A146P, and A146V) of KRAS and NRAS.", "section": "methods", "mentions": ["76|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "195|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "124|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "179|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "94|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "149|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "88|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "134|4|variant|litvar@rs193929331##&&&litvar@#3845#&&&litvar@CA250291#rs193929331##|G13A", "161|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "106|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "173|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "155|4|variant|litvar@rs781085650##&&&litvar@#673#&&&litvar@CA4517046#rs781085650##|A59G", "214|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "70|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "118|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "167|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "239|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "185|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "249|4|gene|ncbi_gene@3845|KRAS", "258|4|gene|ncbi_gene@4893|NRAS", "82|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "100|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA16602445#rs121913535##|G13S", "221|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "228|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "112|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "64|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S"], "text_hl": "We examined the presence of the following mutations for exon 2 (G12S, G12C, G12R, G12D, G12V, G12A, G13S, G13C, G13R, G13D, G13V, and G13A), exon 3 (A59T, A59G, Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H), and exon 4 (K117N, <m>A146T</m>, A146P, and A146V) of KRAS and NRAS."}], "citations": {"NLM": "Iguchi K, Shiozawa M, Uchiyama M, Asari M, Numata K, Rino Y, Saito A. Temporal dynamics of RAS mutations in circulating tumor DNA in metastatic colorectal cancer: clinical significance of mutation loss during treatment J Cancer Res Clin Oncol. PMID: 38805050", "BibTeX": "@article{38805050, title={Temporal dynamics of RAS mutations in circulating tumor DNA in metastatic colorectal cancer: clinical significance of mutation loss during treatment}, author={Iguchi K and Shiozawa M and Uchiyama M and Asari M and Numata K and Rino Y and Saito A}, journal={J Cancer Res Clin Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 39410034, "pmcid": "PMC11475161", "title": "Clinical and Technical Validation of OncoIndx  Assay:A Comprehensive Genome Profiling Assay for Pan-Cancer Investigations", "journal": "Cancers (Basel)", "authors": ["Ramesh A", "Bharde A", "D'Souza A", "Jadhav B", "Prajapati S", "Hariramani K", "Basavalingegowda M", "Iyer S", "Halder S", "Deochake M", "Kothavade H", "Vasudevan A", "Uttarwar M", "Khandare J", "Shafi G"], "date": "2024-10-08T00:00:00Z", "year": 2024, "snippets": [{"_id": "39410034@30066", "snip_text": "S. No.\tGenes\tConcordant Genomic Findings from OncoIndx  Assay\tConcordance Levels Obtained from OncoIndx  Assay\t \t1\tEGFR\tL858RE746_A750delL747_S752del\t100%\t \t2\tALK\tNPM1-ALKALK-EML4 FusionG1202RG1269A\t100%\t \t3\tKRAS\tA146T\t100%\t \t4\tPIK3CA\tH1047R\t50%\t \t5\tBRCA2\tS636*\t100%\t \t", "section": "table", "mentions": ["163|4|gene|ncbi_gene@4869|NPM1", "250|5|gene|ncbi_gene@675|BRCA2", "208|4|gene|ncbi_gene@3845|KRAS", "115|4|gene|ncbi_gene@1956|EGFR", "213|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "175|4|gene|ncbi_gene@27436|EML4", "235|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "228|6|gene|ncbi_gene@5290|PIK3CA", "159|3|gene|ncbi_gene@238|ALK", "142|7|variant|litvar@#238#p.S752del&&&litvar@#238#|S752del"], "figure_id": "cancers-16-03415-t003", "text_hl": "S. No.\tGenes\tConcordant Genomic Findings from OncoIndx  Assay\tConcordance Levels Obtained from OncoIndx  Assay\t \t1\tEGFR\tL858RE746_A750delL747_S752del\t100%\t \t2\tALK\tNPM1-ALKALK-EML4 FusionG1202RG1269A\t100%\t \t3\tKRAS\t<m>A146T</m>\t100%\t \t4\tPIK3CA\tH1047R\t50%\t \t5\tBRCA2\tS636*\t100%\t \t"}], "citations": {"NLM": "Ramesh A, Bharde A, D'Souza A, Jadhav B, Prajapati S, Hariramani K, Basavalingegowda M, Iyer S, Halder S, Deochake M, Kothavade H, Vasudevan A, Uttarwar M, Khandare J, Shafi G. Clinical and Technical Validation of OncoIndx  Assay:A Comprehensive Genome Profiling Assay for Pan-Cancer Investigations Cancers (Basel). PMID: 39410034", "BibTeX": "@article{39410034, title={Clinical and Technical Validation of OncoIndx  Assay:A Comprehensive Genome Profiling Assay for Pan-Cancer Investigations}, author={Ramesh A and Bharde A and D'Souza A and Jadhav B and Prajapati S and Hariramani K and Basavalingegowda M and Iyer S and Halder S and Deochake M and Kothavade H and Vasudevan A and Uttarwar M and Khandare J and Shafi G}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 31711486, "pmcid": "PMC6849194", "title": "Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR.", "journal": "BMC Med Genomics", "authors": ["Nagakubo Y", "Hirotsu Y", "Amemiya K", "Oyama T", "Mochizuki H", "Omata M"], "date": "2019-11-11T00:00:00Z", "year": 2019, "snippets": [{"_id": "31711486@12556", "snip_text": " PCR-rSSO BNA-clamp PCR Deep sequencing by NGS   Sample No. Nucleotide changes Deduced amino acid changes Nucleotide changes Deduced amino acid changes Nucleotide changes Deduced amino acid changes   #1 Wild-type Wild-type c.180_181delTCinsAA KRAS Q61K c.180_181delTCinsAA KRAS Q61K   #2 c.34G > T NRAS G12C Wild-type Wild-type Wild-type Wild-type   #3 c.436G > A KRAS A146T c.436G > A KRAS A146T c.436G > A KRAS A146T   Wild-type Wild-type c.35G > A NRAS G12D c.35G > A NRAS G12D   #4 c.35G > C KRAS G12A c.35G > C KRAS G12A c.35G > C KRAS G12A   #5 c.35G > C KRAS G12A c.35G > C KRAS G12A c.35G > C KRAS G12A   #6 c.35G > C KRAS G12A c.35G > C KRAS G12A c.35G > C KRAS G12A   #7 c.34G > T KRAS G12C c.34G > T KRAS G12C c.34G > T KRAS G12C   #8 c.35G > A KRAS G12D c.35G > A KRAS G12D c.35G > A KRAS G12D   #9 c.35G > A KRAS G12D c.35G > A KRAS G12D c.35G > A KRAS G12D   #10 c.35G > A KRAS G12D c.35G > A KRAS G12D c.35G > A KRAS G12D   #11 c.35G > A KRAS G12D c.35G > A KRAS G12D c.35G > A KRAS G12D   #12 c.35G > A KRAS G12D c.35G > A KRAS G12D c.35G > A KRAS G12D   #13 c.35G > A KRAS G12D c.35G > A KRAS G12D c.35G > A KRAS G12D   #14 c.35G > A KRAS G12D c.35G > A KRAS G12D c.35G > A KRAS G12D   #15 c.35G > A KRAS G12D c.35G > A KRAS G12D c.35G > A KRAS G12D   #16 c.34G > A KRAS G12S c.34G > A KRAS G12S c.34G > A KRAS G12S   #17 c.34G > A KRAS G12S c.34G > A KRAS G12S c.34G > A KRAS G12S   #18 c.35G > T KRAS G12 V c.35G > T KRAS G12 V c.35G > T KRAS G12 V   #19 c.35G > T KRAS G12 V c.35G > T KRAS G12 V c.35G > T KRAS G12 V   #20 c.35G > T KRAS G12 V c.35G > T KRAS G12 V c.35G > T KRAS G12 V   #21 c.38G > A KRAS G13D c.38G > A KRAS G13D c.38G > A KRAS G13D   #22 c.38G > A KRAS G13D c.38G > A KRAS G13D c.38G > A KRAS G13D   #23 c.38G > A KRAS G13D c.38G > A KRAS G13D c.38G > A KRAS G13D   #24 c.38G > A KRAS G13D c.38G > A KRAS G13D c.38G > A KRAS G13D   #25 c.38G > A KRAS G13D c.38G > A KRAS G13D c.38G > A KRAS G13D   #26 c.182A > T KRAS Q61L c.182A > T KRAS Q61L c.182A > T KRAS Q61L   #27 c.436G > A KRAS A146T c.436G > A KRAS A146T c.436G > A KRAS A146T   #28 c.35G > A NRAS G12D c.35G > A NRAS G12D c.35G > A NRAS G12D   #29 c.38G > T NRAS G13 V c.38G > T NRAS G13 V c.38G > T NRAS G13 V   #30 c.181C > A NRAS Q61K c.181C > A NRAS Q61K c.181C > A NRAS Q61K   #31 c.181C > A NRAS Q61K c.181C > A NRAS Q61K c.181C > A NRAS Q61K   #32 c.182A > G NRAS Q61R c.182A > G NRAS Q61R c.182A > G NRAS Q61R   #33 NA NA c.1799 T > A BRAF V600E c.1799 T > A BRAF V600E   #34 NA NA c.1799 T > A BRAF V600E c.1799 T > A BRAF V600E   #35 NA NA c.1799 T > A BRAF V600E c.1799 T > A BRAF V600E   #36-50 Wild-type Wild-type Wild-type Wild-type Wild-type Wild-type   ", "section": "table", "mentions": ["1953|4|gene|ncbi_gene@3845|KRAS", "1825|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "912|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "761|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1647|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "476|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1064|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2308|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C > A", "461|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "1794|4|gene|ncbi_gene@3845|KRAS", "2133|4|gene|ncbi_gene@4893|NRAS", "1156|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2138|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2377|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A > G", "243|4|gene|ncbi_gene@3845|KRAS", "1303|4|gene|ncbi_gene@3845|KRAS", "1891|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "303|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "978|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1495|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "1713|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "2083|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "701|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G > T", "1979|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "1130|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2522|5|variant|litvar@#673#|T > A", "1942|10|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|c.182A > T", "451|4|gene|ncbi_gene@4893|NRAS", "1222|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1510|3|variant|litvar@rs121913530##&&&litvar@#3845#|G12", "1865|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1369|4|gene|ncbi_gene@3845|KRAS", "2255|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "273|4|gene|ncbi_gene@3845|KRAS", "2149|9|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|c.38G > T", "631|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "1196|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "616|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > C", "2022|4|gene|ncbi_gene@3845|KRAS", "2201|4|gene|ncbi_gene@4893|NRAS", "1447|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "1288|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "1931|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "2229|4|gene|ncbi_gene@4893|NRAS", "2234|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "756|4|gene|ncbi_gene@3845|KRAS", "2123|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "1262|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2498|5|variant|litvar@#673#|T > A", "353|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "2093|4|gene|ncbi_gene@4893|NRAS", "2558|5|variant|litvar@#673#|T > A", "1354|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "2414|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "2462|5|variant|litvar@#673#|T > A", "826|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2011|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "671|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "963|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "2388|4|gene|ncbi_gene@4893|NRAS", "1698|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "2218|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C > A", "2569|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "2118|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2473|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "892|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1543|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "1579|3|variant|litvar@rs121913530##&&&litvar@#3845#|G12", "801|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1627|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1044|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "586|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "1779|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "413|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1764|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "2303|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "866|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2340|4|gene|ncbi_gene@4893|NRAS", "2071|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1693|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "716|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "1110|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "811|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "1845|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1830|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "841|4|gene|ncbi_gene@3845|KRAS", "1667|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1759|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "656|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > C", "1911|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "2329|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C > A", "1328|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "441|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "1029|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "907|4|gene|ncbi_gene@3845|KRAS", "2103|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "1642|4|gene|ncbi_gene@3845|KRAS", "397|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "1273|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G > A", "471|4|gene|ncbi_gene@4893|NRAS", "1612|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "2528|4|gene|ncbi_gene@673|BRAF", "1516|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "2000|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "2191|9|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|c.38G > T", "1151|4|gene|ncbi_gene@3845|KRAS", "571|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > C", "1963|10|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|c.182A > T", "1394|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "1095|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "1531|3|variant|litvar@rs121913530##&&&litvar@#3845#|G12", "1886|4|gene|ncbi_gene@3845|KRAS", "2206|3|variant|litvar@rs112445441##&&&litvar@#3845#|G13", "2055|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "408|4|gene|ncbi_gene@3845|KRAS", "1247|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "2276|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "1974|4|gene|ncbi_gene@3845|KRAS", "1339|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G > A", "386|4|gene|ncbi_gene@3845|KRAS", "2170|9|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|c.38G > T", "2066|4|gene|ncbi_gene@3845|KRAS", "501|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "1217|4|gene|ncbi_gene@3845|KRAS", "1860|4|gene|ncbi_gene@3845|KRAS", "1176|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "486|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > C", "253|19|variant|litvar@#3845#c.180_181delinsTC,AA&&&litvar@#3845#|c.180_181delTCinsAA", "2185|3|variant|litvar@rs112445441##&&&litvar@#3845#|G13", "781|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "364|4|gene|ncbi_gene@3845|KRAS", "2250|4|gene|ncbi_gene@4893|NRAS", "2044|4|gene|ncbi_gene@3845|KRAS", "2509|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1313|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G > A", "2159|4|gene|ncbi_gene@4893|NRAS", "2398|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A > G", "1405|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "877|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "1283|4|gene|ncbi_gene@3845|KRAS", "1926|4|gene|ncbi_gene@3845|KRAS", "1242|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "223|19|variant|litvar@#3845#c.180_181delinsTC,AA&&&litvar@#3845#|c.180_181delTCinsAA", "696|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "1733|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "375|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "1379|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G > A", "851|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "2468|4|gene|ncbi_gene@673|BRAF", "541|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "2372|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "943|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "2409|4|gene|ncbi_gene@4893|NRAS", "2239|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C > A", "1678|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "821|4|gene|ncbi_gene@3845|KRAS", "2033|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "1564|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "973|4|gene|ncbi_gene@3845|KRAS", "1799|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "917|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "1708|4|gene|ncbi_gene@3845|KRAS", "766|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "2582|5|variant|litvar@#673#|T > A", "456|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1009|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "1652|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "2324|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "1744|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "736|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "1161|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "2287|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C > A", "1622|4|gene|ncbi_gene@3845|KRAS", "1896|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "1039|4|gene|ncbi_gene@3845|KRAS", "998|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "983|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "551|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > C", "1774|4|gene|ncbi_gene@3845|KRAS", "1075|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "1718|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "2298|4|gene|ncbi_gene@4893|NRAS", "2564|4|gene|ncbi_gene@673|BRAF", "1810|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "1420|3|variant|litvar@rs121913530##&&&litvar@#3845#|G12", "1958|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "1227|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "1688|4|gene|ncbi_gene@3845|KRAS", "1489|3|variant|litvar@rs121913530##&&&litvar@#3845#|G12", "2164|3|variant|litvar@rs112445441##&&&litvar@#3845#|G13", "1049|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "1840|4|gene|ncbi_gene@3845|KRAS", "1600|3|variant|litvar@rs121913530##&&&litvar@#3845#|G12", "1141|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "1784|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "526|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > C", "1349|4|gene|ncbi_gene@3845|KRAS", "1876|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "248|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "1293|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G > A", "606|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "887|4|gene|ncbi_gene@3845|KRAS", "1906|4|gene|ncbi_gene@3845|KRAS", "1323|4|gene|ncbi_gene@3845|KRAS", "2356|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A > G", "2260|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C > A", "1984|10|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|c.182A > T", "2113|4|gene|ncbi_gene@4893|NRAS", "1374|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "1359|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|c.34G > A", "831|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "278|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "1474|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "953|4|gene|ncbi_gene@3845|KRAS", "521|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "506|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > C", "958|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1995|4|gene|ncbi_gene@3845|KRAS", "1105|4|gene|ncbi_gene@3845|KRAS", "2593|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "681|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G > T", "2438|5|variant|litvar@#673#|T > A", "2271|4|gene|ncbi_gene@4893|NRAS", "651|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "897|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "932|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "746|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "2180|4|gene|ncbi_gene@4893|NRAS", "1024|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1632|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "1426|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "1171|4|gene|ncbi_gene@3845|KRAS", "591|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > C", "2098|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "776|4|gene|ncbi_gene@3845|KRAS", "2449|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1662|4|gene|ncbi_gene@3845|KRAS", "288|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G > T", "1754|4|gene|ncbi_gene@3845|KRAS", "566|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "721|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G > T", "1115|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "2393|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "1237|4|gene|ncbi_gene@3845|KRAS", "1207|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "1850|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "2533|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1389|4|gene|ncbi_gene@3845|KRAS", "1728|4|gene|ncbi_gene@3845|KRAS", "786|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "1585|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "2367|4|gene|ncbi_gene@4893|NRAS", "1181|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "636|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > C", "1308|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "1916|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "391|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1558|3|variant|litvar@rs121913530##&&&litvar@#3845#|G12", "2345|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "1462|3|variant|litvar@rs121913530##&&&litvar@#3845#|G12", "2588|4|gene|ncbi_gene@673|BRAF", "1019|4|gene|ncbi_gene@3845|KRAS", "369|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "2049|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "2319|4|gene|ncbi_gene@4893|NRAS", "1441|3|variant|litvar@rs121913530##&&&litvar@#3845#|G12", "846|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2027|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1085|4|gene|ncbi_gene@3845|KRAS", "2444|4|gene|ncbi_gene@673|BRAF", "1090|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2504|4|gene|ncbi_gene@673|BRAF", "1820|4|gene|ncbi_gene@3845|KRAS"], "figure_id": "Tab1", "text_hl": " PCR-rSSO BNA-clamp PCR Deep sequencing by NGS   Sample No. Nucleotide changes Deduced amino acid changes Nucleotide changes Deduced amino acid changes Nucleotide changes Deduced amino acid changes   #1 Wild-type Wild-type c.180_181delTCinsAA KRAS Q61K c.180_181delTCinsAA KRAS Q61K   #2 c.34G > T NRAS G12C Wild-type Wild-type Wild-type Wild-type   #3 c.436G > A KRAS <m>A146T</m> c.436G > A KRAS <m>A146T</m> c.436G > A KRAS <m>A146T</m>   Wild-type Wild-type c.35G > A NRAS G12D c.35G > A NRAS G12D   #4 c.35G > C KRAS G12A c.35G > C KRAS G12A c.35G > C KRAS G12A   #5 c.35G > C KRAS G12A c.35G > C KRAS G12A c.35G > C KRAS G12A   #6 c.35G > C KRAS G12A c.35G > C KRAS G12A c.35G > C KRAS G12A   #7 c.34G > T KRAS G12C c.34G > T KRAS G12C c.34G > T KRAS G12C   #8 c.35G > A KRAS G12D c.35G > A KRAS G12D c.35G > A KRAS G12D   #9 c.35G > A KRAS G12D c.35G > A KRAS G12D c.35G > A KRAS G12D   #10 c.35G > A KRAS G12D c.35G > A KRAS G12D c.35G > A KRAS G12D   #11 c.35G > A KRAS G12D c.35G > A KRAS G12D c.35G > A KRAS G12D   #12 c.35G > A KRAS G12D c.35G > A KRAS G12D c.35G > A KRAS G12D   #13 c.35G > A KRAS G12D c.35G > A KRAS G12D c.35G > A KRAS G12D   #14 c.35G > A KRAS G12D c.35G > A KRAS G12D c.35G > A KRAS G12D   #15 c.35G > A KRAS G12D c.35G > A KRAS G12D c.35G > A KRAS G12D   #16 c.34G > A KRAS G12S c.34G > A KRAS G12S c.34G > A KRAS G12S   #17 c.34G > A KRAS G12S c.34G > A KRAS G12S c.34G > A KRAS G12S   #18 c.35G > T KRAS G12 V c.35G > T KRAS G12 V c.35G > T KRAS G12 V   #19 c.35G > T KRAS G12 V c.35G > T KRAS G12 V c.35G > T KRAS G12 V   #20 c.35G > T KRAS G12 V c.35G > T KRAS G12 V c.35G > T KRAS G12 V   #21 c.38G > A KRAS G13D c.38G > A KRAS G13D c.38G > A KRAS G13D   #22 c.38G > A KRAS G13D c.38G > A KRAS G13D c.38G > A KRAS G13D   #23 c.38G > A KRAS G13D c.38G > A KRAS G13D c.38G > A KRAS G13D   #24 c.38G > A KRAS G13D c.38G > A KRAS G13D c.38G > A KRAS G13D   #25 c.38G > A KRAS G13D c.38G > A KRAS G13D c.38G > A KRAS G13D   #26 c.182A > T KRAS Q61L c.182A > T KRAS Q61L c.182A > T KRAS Q61L   #27 c.436G > A KRAS <m>A146T</m> c.436G > A KRAS <m>A146T</m> c.436G > A KRAS <m>A146T</m>   #28 c.35G > A NRAS G12D c.35G > A NRAS G12D c.35G > A NRAS G12D   #29 c.38G > T NRAS G13 V c.38G > T NRAS G13 V c.38G > T NRAS G13 V   #30 c.181C > A NRAS Q61K c.181C > A NRAS Q61K c.181C > A NRAS Q61K   #31 c.181C > A NRAS Q61K c.181C > A NRAS Q61K c.181C > A NRAS Q61K   #32 c.182A > G NRAS Q61R c.182A > G NRAS Q61R c.182A > G NRAS Q61R   #33 NA NA c.1799 T > A BRAF V600E c.1799 T > A BRAF V600E   #34 NA NA c.1799 T > A BRAF V600E c.1799 T > A BRAF V600E   #35 NA NA c.1799 T > A BRAF V600E c.1799 T > A BRAF V600E   #36-50 Wild-type Wild-type Wild-type Wild-type Wild-type Wild-type   "}], "citations": {"NLM": "Nagakubo Y, Hirotsu Y, Amemiya K, Oyama T, Mochizuki H, Omata M. Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR. BMC Med Genomics. PMID: 31711486", "BibTeX": "@article{31711486, title={Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR.}, author={Nagakubo Y and Hirotsu Y and Amemiya K and Oyama T and Mochizuki H and Omata M}, journal={BMC Med Genomics}}"}, "is_sup_mat_match": false}, {"pmid": 38791375, "pmcid": "PMC11120711", "title": "Tissue Elasticity as a Diagnostic Marker of Molecular Mutations in Morphologically Heterogeneous Colorectal Cancer", "journal": "Int J Mol Sci", "authors": ["Plekhanov AA", "Kozlov DS", "Shepeleva AA", "Kiseleva EB", "Shimolina LE", "Druzhkova IN", "Plekhanova MA", "Karabut MM", "Gubarkova EV", "Gavrina AI", "Krylov DP", "Sovetsky AA", "Gamayunov SV", "Kuznetsova DS", "Zaitsev VY", "Sirotkina MA", "Gladkova ND"], "date": "2024-05-14T00:00:00Z", "year": 2024, "snippets": [{"_id": "38791375@37582", "snip_text": "Patient #\tCRC Grade\tMorphological Heterogeneity\tMorphological Pattern\tAverage Stiffness (kPa)\tDriver Mutation\tMSR\t \tKRAS\tNRAS\tBRAF\t \t1\thigh\theterogeneous\tSolid\t1217.8\tA146T\t-\t-\tMSS\t \tMucinous\t1010.8\tA146T\t-\t-\tMSS\t \t2\tlow\thomogeneous\tComplex tubular\t866.4\tG13D\t-\t-\tMSS\t \t3\tlow\thomogeneous\tComplex tubular\t646.7\t-\t-\t-\tMSS\t \t4\thigh\theterogeneous\tSolid\t1237\tG12D\t-\t-\tMSS\t \tComplex tubular\t810\tG12D\t-\t-\tMSS\t \t5\tlow\thomogeneous\tComplex tubular\t718.3\t-\t-\t-\tMSS\t \t6\tlow\thomogeneous\tMucinous\t764.5\t-\t-\t-\tMSS\t \t7\tlow\thomogeneous\tComplex tubular\t711\t-\t-\t-\tMSS\t \t8\tlow\theterogeneous\tComplex tubular\t695\t-\t-\t-\tMSS\t \tSolid\t838.7\t-\t-\t-\tMSS\t \t9\tlow\thomogeneous\tComplex tubular\t784.4\t-\t-\tV600E\tMSS\t \t10\tlow\thomogeneous\tComplex tubular\t796.3\t-\t-\t-\tMSS\t \t11\tlow\thomogeneous\tComplex tubular\t951\tG12D\t-\t-\tMSS\t \t12\tlow\thomogeneous\tComplex tubular\t835.3\tG12D\t-\t-\tMSS\t \t13\tlow\thomogeneous\tMucinous\t998\t-\t-\t-\tMSS\t \t14\tlow\thomogeneous\tComplex tubular\t764.3\t-\t-\t-\tMSS\t \t15\tlow\theterogeneous\tComplex tubular\t890.2\tG13C\t-\t-\tMSS\t \tMucinous\t1084.1\tG13C\t-\t-\tMSS\t \t16\tlow\thomogeneous\tComplex tubular\t850.6\tG12D\t-\t-\tMSS\t \t17\tlow\thomogeneous\tComplex tubular\t553\t-\t-\t-\tMSS\t \t18\thigh\thomogeneous\tSolid\t849.6\t-\t-\t-\tMSS\t \t19\tlow\thomogeneous\tComplex tubular\t772,7\t-\t-\t-\tMSS\t \t20\thigh\theterogeneous\tSolid\t923\t-\t-\t-\tMSS\t \tComplex tubular\t705.5\t-\t-\t-\tMSS\t \t21\tlow\theterogeneous\tComplex tubular\t937.7\tG12V\t-\t-\tMSS\t \tMucinous\t840.8\t-\t-\t-\tMSS\t \t22\thigh\thomogeneous\tSolid\t863\tG13D\t-\t-\tMSS\t \t23\tlow\thomogeneous\tComplex tubular\t787.5\t-\t-\t-\tMSS\t \t24\tlow\thomogeneous\tComplex tubular\t758.3\t-\t-\t-\tMSS\t \t25\thigh\theterogeneous\tSolid\t875.5\t-\t-\t-\tMSI\t \tComplex tubular\t639.7\t-\t-\t-\tMSI\t \t26\tlow\thomogeneous\tComplex tubular\t755\t-\t-\tV600E\tMSS\t \t27\tlow\thomogeneous\tComplex tubular\t765.4\t-\t-\t-\tMSS\t \t28\thigh\thomogeneous\tSolid\t1148.4\tG12D\t-\t-\tMSI\t \t29\tlow\thomogeneous\tComplex tubular\t651\t-\t-\t-\tMSS\t \t30\thigh\thomogeneous\tSolid\t1082.8\tQ61L\t-\t-\tMSS\t \t31\thigh\thomogeneous\tSolid\t886\t-\t-\tV600E\tMSI\t \t32\tlow\thomogeneous\tComplex tubular\t677\t-\t-\t-\tMSS\t \t33\tlow\thomogeneous\tComplex tubular\t760.8\t-\t-\t-\tMSS\t \t34\thigh\thomogeneous\tSolid\t1227.6\tG12V\t-\t-\tMSS\t \t35\tlow\thomogeneous\tComplex tubular\t781.7\t-\t-\t-\tMSS\t \t36\tlow\thomogeneous\tComplex tubular\t812.8\t-\tQ61X\t-\tMSS\t \t37\thigh\thomogeneous\tSolid\t962.2\tG13D\t-\t-\tMSS\t \t38\tlow\thomogeneous\tComplex tubular\t614.7\t-\t-\t-\tMSS\t \t39\tlow\theterogeneous\tComplex tubular\t924.4\tG13C\t-\t-\tMSS\t \tMucinous\t970.2\tG13C\t-\t-\tMSS\t \t40\tlow\thomogeneous\tComplex tubular\t702.7\t-\t-\t-\tMSS\t \t41\thigh\thomogeneous\tSolid\t982.8\tG12V\t-\t-\tMSS\t \t42\tlow\thomogeneous\tComplex tubular\t743.4\t-\t-\t-\tMSS\t \t43\tlow\thomogeneous\tComplex tubular\t734.7\t-\t-\t-\tMSS\t \t44\tlow\thomogeneous\tComplex tubular\t697.2\t-\t-\t-\tMSS\t \t45\tlow\thomogeneous\tComplex tubular\t761.6\t-\t-\t-\tMSS\t \t46\thigh\thomogeneous\tSolid\t1127\tG12D\t-\t-\tMSS\t \t", "section": "table", "mentions": ["2224|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "0|7|species|ncbi_taxonomy@9606|Patient", "2365|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13C", "1673|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1357|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1919|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1429|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "2179|4|variant|litvar@rs121913254##&&&litvar@#4893#|Q61X", "116|4|gene|ncbi_gene@3845|KRAS", "671|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "1073|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2335|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13C", "1870|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "986|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13C", "2723|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "126|4|gene|ncbi_gene@673|BRAF", "1017|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13C", "121|4|gene|ncbi_gene@4893|NRAS", "1771|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2068|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "199|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "2465|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "167|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "figure_id": "ijms-25-05337-t0A1", "text_hl": "Patient #\tCRC Grade\tMorphological Heterogeneity\tMorphological Pattern\tAverage Stiffness (kPa)\tDriver Mutation\tMSR\t \tKRAS\tNRAS\tBRAF\t \t1\thigh\theterogeneous\tSolid\t1217.8\t<m>A146T</m>\t-\t-\tMSS\t \tMucinous\t1010.8\t<m>A146T</m>\t-\t-\tMSS\t \t2\tlow\thomogeneous\tComplex tubular\t866.4\tG13D\t-\t-\tMSS\t \t3\tlow\thomogeneous\tComplex tubular\t646.7\t-\t-\t-\tMSS\t \t4\thigh\theterogeneous\tSolid\t1237\tG12D\t-\t-\tMSS\t \tComplex tubular\t810\tG12D\t-\t-\tMSS\t \t5\tlow\thomogeneous\tComplex tubular\t718.3\t-\t-\t-\tMSS\t \t6\tlow\thomogeneous\tMucinous\t764.5\t-\t-\t-\tMSS\t \t7\tlow\thomogeneous\tComplex tubular\t711\t-\t-\t-\tMSS\t \t8\tlow\theterogeneous\tComplex tubular\t695\t-\t-\t-\tMSS\t \tSolid\t838.7\t-\t-\t-\tMSS\t \t9\tlow\thomogeneous\tComplex tubular\t784.4\t-\t-\tV600E\tMSS\t \t10\tlow\thomogeneous\tComplex tubular\t796.3\t-\t-\t-\tMSS\t \t11\tlow\thomogeneous\tComplex tubular\t951\tG12D\t-\t-\tMSS\t \t12\tlow\thomogeneous\tComplex tubular\t835.3\tG12D\t-\t-\tMSS\t \t13\tlow\thomogeneous\tMucinous\t998\t-\t-\t-\tMSS\t \t14\tlow\thomogeneous\tComplex tubular\t764.3\t-\t-\t-\tMSS\t \t15\tlow\theterogeneous\tComplex tubular\t890.2\tG13C\t-\t-\tMSS\t \tMucinous\t1084.1\tG13C\t-\t-\tMSS\t \t16\tlow\thomogeneous\tComplex tubular\t850.6\tG12D\t-\t-\tMSS\t \t17\tlow\thomogeneous\tComplex tubular\t553\t-\t-\t-\tMSS\t \t18\thigh\thomogeneous\tSolid\t849.6\t-\t-\t-\tMSS\t \t19\tlow\thomogeneous\tComplex tubular\t772,7\t-\t-\t-\tMSS\t \t20\thigh\theterogeneous\tSolid\t923\t-\t-\t-\tMSS\t \tComplex tubular\t705.5\t-\t-\t-\tMSS\t \t21\tlow\theterogeneous\tComplex tubular\t937.7\tG12V\t-\t-\tMSS\t \tMucinous\t840.8\t-\t-\t-\tMSS\t \t22\thigh\thomogeneous\tSolid\t863\tG13D\t-\t-\tMSS\t \t23\tlow\thomogeneous\tComplex tubular\t787.5\t-\t-\t-\tMSS\t \t24\tlow\thomogeneous\tComplex tubular\t758.3\t-\t-\t-\tMSS\t \t25\thigh\theterogeneous\tSolid\t875.5\t-\t-\t-\tMSI\t \tComplex tubular\t639.7\t-\t-\t-\tMSI\t \t26\tlow\thomogeneous\tComplex tubular\t755\t-\t-\tV600E\tMSS\t \t27\tlow\thomogeneous\tComplex tubular\t765.4\t-\t-\t-\tMSS\t \t28\thigh\thomogeneous\tSolid\t1148.4\tG12D\t-\t-\tMSI\t \t29\tlow\thomogeneous\tComplex tubular\t651\t-\t-\t-\tMSS\t \t30\thigh\thomogeneous\tSolid\t1082.8\tQ61L\t-\t-\tMSS\t \t31\thigh\thomogeneous\tSolid\t886\t-\t-\tV600E\tMSI\t \t32\tlow\thomogeneous\tComplex tubular\t677\t-\t-\t-\tMSS\t \t33\tlow\thomogeneous\tComplex tubular\t760.8\t-\t-\t-\tMSS\t \t34\thigh\thomogeneous\tSolid\t1227.6\tG12V\t-\t-\tMSS\t \t35\tlow\thomogeneous\tComplex tubular\t781.7\t-\t-\t-\tMSS\t \t36\tlow\thomogeneous\tComplex tubular\t812.8\t-\tQ61X\t-\tMSS\t \t37\thigh\thomogeneous\tSolid\t962.2\tG13D\t-\t-\tMSS\t \t38\tlow\thomogeneous\tComplex tubular\t614.7\t-\t-\t-\tMSS\t \t39\tlow\theterogeneous\tComplex tubular\t924.4\tG13C\t-\t-\tMSS\t \tMucinous\t970.2\tG13C\t-\t-\tMSS\t \t40\tlow\thomogeneous\tComplex tubular\t702.7\t-\t-\t-\tMSS\t \t41\thigh\thomogeneous\tSolid\t982.8\tG12V\t-\t-\tMSS\t \t42\tlow\thomogeneous\tComplex tubular\t743.4\t-\t-\t-\tMSS\t \t43\tlow\thomogeneous\tComplex tubular\t734.7\t-\t-\t-\tMSS\t \t44\tlow\thomogeneous\tComplex tubular\t697.2\t-\t-\t-\tMSS\t \t45\tlow\thomogeneous\tComplex tubular\t761.6\t-\t-\t-\tMSS\t \t46\thigh\thomogeneous\tSolid\t1127\tG12D\t-\t-\tMSS\t \t"}], "citations": {"NLM": "Plekhanov AA, Kozlov DS, Shepeleva AA, Kiseleva EB, Shimolina LE, Druzhkova IN, Plekhanova MA, Karabut MM, Gubarkova EV, Gavrina AI, Krylov DP, Sovetsky AA, Gamayunov SV, Kuznetsova DS, Zaitsev VY, Sirotkina MA, Gladkova ND. Tissue Elasticity as a Diagnostic Marker of Molecular Mutations in Morphologically Heterogeneous Colorectal Cancer Int J Mol Sci. PMID: 38791375", "BibTeX": "@article{38791375, title={Tissue Elasticity as a Diagnostic Marker of Molecular Mutations in Morphologically Heterogeneous Colorectal Cancer}, author={Plekhanov AA and Kozlov DS and Shepeleva AA and Kiseleva EB and Shimolina LE and Druzhkova IN and Plekhanova MA and Karabut MM and Gubarkova EV and Gavrina AI and Krylov DP and Sovetsky AA and Gamayunov SV and Kuznetsova DS and Zaitsev VY and Sirotkina MA and Gladkova ND}, journal={Int J Mol Sci}}"}, "is_sup_mat_match": false}, {"pmid": 16969076, "pmcid": "PMC2714972", "title": "Recurrent KRAS codon 146 mutations in human colorectal cancer.", "journal": "Cancer Biol Ther", "authors": ["Edkins S", "O'Meara S", "Parker A", "Stevens C", "Reis M", "Jones S", "Greenman C", "Davies H", "Dalgliesh G", "Forbes S", "Hunter C", "Smith R", "Stephens P", "Goldstraw P", "Nicholson A", "Chan TL", "Velculescu VE", "Yuen ST", "Leung SY", "Stratton MR", "Futreal PA"], "date": "2006-08-01T00:00:00Z", "year": 2006, "snippets": [{"_id": "16969076@5803", "snip_text": "Combining colorectal cancer primary tumor, xenograft and cell line data, 11 mutations (Table 1) were identified: 8 c.436G>A p.A146T, 2 c.437C>T p.A146V and 1 c.436G>C p.A146P.", "section": "results", "mentions": ["137|6|variant|litvar@rs1057519725##&&&litvar@#3845#|437C>T", "10|17|disease|ncbi_mesh@D015179|colorectal cancer", "117|6|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|436G>A", "167|7|variant|litvar@rs121913527##&&&litvar@#3845#|p.A146P", "36|5|disease|ncbi_mesh@D009369|tumor", "126|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "144|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "160|6|variant|litvar@rs121913527##&&&litvar@#3845#|436G>C"], "text_hl": "Combining colorectal cancer primary tumor, xenograft and cell line data, 11 mutations (Table 1) were identified: 8 c.436G>A <m>p.A146T</m>, 2 c.437C>T p.A146V and 1 c.436G>C p.A146P."}], "citations": {"NLM": "Edkins S, O'Meara S, Parker A, Stevens C, Reis M, Jones S, Greenman C, Davies H, Dalgliesh G, Forbes S, Hunter C, Smith R, Stephens P, Goldstraw P, Nicholson A, Chan TL, Velculescu VE, Yuen ST, Leung SY, Stratton MR, Futreal PA. Recurrent KRAS codon 146 mutations in human colorectal cancer. Cancer Biol Ther. PMID: 16969076", "BibTeX": "@article{16969076, title={Recurrent KRAS codon 146 mutations in human colorectal cancer.}, author={Edkins S and O'Meara S and Parker A and Stevens C and Reis M and Jones S and Greenman C and Davies H and Dalgliesh G and Forbes S and Hunter C and Smith R and Stephens P and Goldstraw P and Nicholson A and Chan TL and Velculescu VE and Yuen ST and Leung SY and Stratton MR and Futreal PA}, journal={Cancer Biol Ther}}"}, "is_sup_mat_match": false}, {"pmid": 20570890, "pmcid": "PMC2943514", "title": "Genomic and biological characterization of exon 4 KRAS mutations in human cancer", "journal": "Cancer Res", "authors": ["Janakiraman M", "Vakiani E", "Zeng Z", "Pratilas CA", "Taylor BS", "Chitale D", "Halilovic E", "Wilson M", "Huberman K", "Ricarte Filho JC", "Persaud Y", "Levine DA", "Fagin JA", "Jhanwar SC", "Mariadason JM", "Lash A", "Ladanyi M", "Saltz LB", "Heguy A", "Paty PB", "Solit DB"], "date": "2010-07-15T00:00:00Z", "year": 2010, "snippets": [{"_id": "20570890@701", "snip_text": "Exon 4 KRAS mutations, all of which were identified at amino acid residues K117 and A146, were associated with lower levels of GTP-bound RAS in isogenic models.", "section": "abstract", "mentions": ["7|4|gene|ncbi_gene@3845|KRAS", "75|4|variant|litvar@#3845#|K117", "127|3|gene|ncbi_gene@92170|GTP", "84|4|variant|litvar@rs121913527##&&&litvar@#3845#|A146"], "text_hl": "Exon 4 KRAS mutations, all of which were identified at amino acid residues K117 and A146, were associated with lower levels of GTP-bound RAS in isogenic models."}], "citations": {"NLM": "Janakiraman M, Vakiani E, Zeng Z, Pratilas CA, Taylor BS, Chitale D, Halilovic E, Wilson M, Huberman K, Ricarte Filho JC, Persaud Y, Levine DA, Fagin JA, Jhanwar SC, Mariadason JM, Lash A, Ladanyi M, Saltz LB, Heguy A, Paty PB, Solit DB. Genomic and biological characterization of exon 4 KRAS mutations in human cancer Cancer Res. PMID: 20570890", "BibTeX": "@article{20570890, title={Genomic and biological characterization of exon 4 KRAS mutations in human cancer}, author={Janakiraman M and Vakiani E and Zeng Z and Pratilas CA and Taylor BS and Chitale D and Halilovic E and Wilson M and Huberman K and Ricarte Filho JC and Persaud Y and Levine DA and Fagin JA and Jhanwar SC and Mariadason JM and Lash A and Ladanyi M and Saltz LB and Heguy A and Paty PB and Solit DB}, journal={Cancer Res}}"}, "is_sup_mat_match": false}, {"pmid": 39056802, "pmcid": "PMC11274496", "title": "KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways", "journal": "Cells", "authors": ["Mondal K", "Posa MK", "Shenoy RP", "Roychoudhury S"], "date": "2024-07-19T00:00:00Z", "year": 2024, "snippets": [{"_id": "39056802@16541", "snip_text": "Different types of KRAS mutations, namely, G12A, G12S, Q61H, A146T, and K117N, are also associated with different types of cancer.", "section": "other", "mentions": ["55|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "72|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "123|6|disease|ncbi_mesh@D009369|cancer", "19|4|gene|ncbi_gene@16653|KRAS", "61|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "43|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "49|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S"], "text_hl": "Different types of KRAS mutations, namely, G12A, G12S, Q61H, <m>A146T</m>, and K117N, are also associated with different types of cancer."}], "citations": {"NLM": "Mondal K, Posa MK, Shenoy RP, Roychoudhury S. KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways Cells. PMID: 39056802", "BibTeX": "@article{39056802, title={KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways}, author={Mondal K and Posa MK and Shenoy RP and Roychoudhury S}, journal={Cells}}"}, "is_sup_mat_match": false}, {"pmid": 26110767, "pmcid": "PMC4482484", "title": "EGF-Induced Acetylation of Heterogeneous Nuclear Ribonucleoproteins Is Dependent on KRAS Mutational Status in Colorectal Cancer Cells", "journal": "PLoS One", "authors": ["Roda D", "Castillo J", "Telechea-Fern\u00e1ndez M", "Gil A", "L\u00f3pez-Rodas G", "Franco L", "Gonz\u00e1lez-Rodr\u00edguez P", "Rosell\u00f3 S", "P\u00e9rez-Fidalgo JA", "Garc\u00eda-Trevijano ER", "Cervantes A", "Zaragoz\u00e1 R"], "date": "2015-06-25T00:00:00Z", "year": 2015, "snippets": [{"_id": "26110767@644", "snip_text": "Conversely, KRASA146T cells showed a full EGF-response in terms of signal transduction pathways, cell proliferation, migration or adhesion.", "section": "abstract", "mentions": ["12|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T", "42|3|gene|ncbi_gene@1950|EGF"], "text_hl": "Conversely, KRASA146T cells showed a full EGF-response in terms of signal transduction pathways, cell proliferation, migration or adhesion."}], "citations": {"NLM": "Roda D, Castillo J, Telechea-Fern\u00e1ndez M, Gil A, L\u00f3pez-Rodas G, Franco L, Gonz\u00e1lez-Rodr\u00edguez P, Rosell\u00f3 S, P\u00e9rez-Fidalgo JA, Garc\u00eda-Trevijano ER, Cervantes A, Zaragoz\u00e1 R. EGF-Induced Acetylation of Heterogeneous Nuclear Ribonucleoproteins Is Dependent on KRAS Mutational Status in Colorectal Cancer Cells PLoS One. PMID: 26110767", "BibTeX": "@article{26110767, title={EGF-Induced Acetylation of Heterogeneous Nuclear Ribonucleoproteins Is Dependent on KRAS Mutational Status in Colorectal Cancer Cells}, author={Roda D and Castillo J and Telechea-Fern\u00e1ndez M and Gil A and L\u00f3pez-Rodas G and Franco L and Gonz\u00e1lez-Rodr\u00edguez P and Rosell\u00f3 S and P\u00e9rez-Fidalgo JA and Garc\u00eda-Trevijano ER and Cervantes A and Zaragoz\u00e1 R}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 23548132, "pmcid": "PMC3623853", "title": "High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer.", "journal": "BMC Cancer", "authors": ["Guedes JG", "Veiga I", "Rocha P", "Pinto P", "Pinto C", "Pinheiro M", "Peixoto A", "Fragoso M", "Raimundo A", "Ferreira P", "Machado M", "Sousa N", "Lopes P", "Ara\u00fajo A", "Macedo J", "Alves F", "Coutinho C", "Henrique R", "Santos LL", "Teixeira MR"], "date": "2013-04-01T00:00:00Z", "year": 2013, "snippets": [{"_id": "23548132@11767", "snip_text": "  Mutation   No. of cases Total no. of cases (%)   Gene and exon cDNA sequence Protein sequence   KRAS exon 3 c.151_195dup p.Cys51_Ser65dup 1 10 (5.0%)   c.176_178del p.Ala59del 1   c.179G>T p.Gly60Val 1   c.181C>A p.Gln61Lys 1   c.182A>T p.Gln61Leu 3   c.182A>G p.Gln61Arg 2   c.183A>C p.Gln61His 1   KRAS exon 4 c.436G>A p.Ala146Thr 10 10 (5.0%)   BRAF exon 11 c.1397G>A p.Gly466Glu 1 1 (0.5%)   BRAF exon 15 c.1799 T>A pVal600Glu 8 9 (4.5%)   c.1808A>G p.Lys601Glu 1   PIK3CA exon 9 c.1624G>A p.Glu542Lys 5 14 (7.0%)   c.1633G>A p.Glu545Lys 5   c.1635G>T p.Glu545Asp 1   c.1636C>A p.Gln546Lys 3   PIK3CA exon 20 c.3129G>A p.Met1043Ile 1 3 (1.5%)   c.3140A>G p.His1047Arg 1   c.3140A>T p.His1047Leu 1   ", "section": "table", "mentions": ["287|10|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Gln61His", "625|12|variant|litvar@rs121913283##&&&litvar@#5290#&&&litvar@CA183868#rs121913283##|p.Met1043Ile", "532|11|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.Glu545Lys", "548|9|variant|litvar@rs121913275##&&&litvar@#5290#&&&litvar@CA210104#rs121913275##|c.1635G>T", "398|4|gene|ncbi_gene@673|BRAF", "302|4|gene|ncbi_gene@3845|KRAS", "496|11|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.Glu542Lys", "191|10|variant|litvar@rs727503108##&&&litvar@#3845#&&&litvar@CA176493#rs727503108##|p.Gly60Val", "373|11|variant|litvar@rs121913351##&&&litvar@#673#&&&litvar@CA16602535#rs121913351##|p.Gly466Glu", "123|16|variant|litvar@#3845#p.C,S51,65dup&&&litvar@#3845#|p.Cys51_Ser65dup", "230|8|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|c.182A>T", "215|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Gln61Lys", "456|11|variant|litvar@rs121913364##&&&litvar@#673#&&&litvar@CA123645#rs121913364##|p.Lys601Glu", "323|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "154|12|variant|litvar@#3845#c.176_178del&&&litvar@#3845#|c.176_178del", "600|6|gene|ncbi_gene@5290|PIK3CA", "678|9|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|c.3140A>T", "584|11|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123338#rs121913286##|p.Gln546Lys", "254|8|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|c.182A>G", "239|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Gln61Leu", "522|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G>A", "314|8|variant|litvar@rs755969956##&&&litvar@#5290#&&&litvar@CA2710540#rs755969956##|c.436G>A", "486|9|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|c.1624G>A", "278|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA180922#rs17851045##|c.183A>C", "472|6|gene|ncbi_gene@5290|PIK3CA", "688|12|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|p.His1047Leu", "110|12|variant|litvar@#3845#c.151_195dup&&&litvar@#3845#|c.151_195dup", "651|9|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A>G", "98|4|gene|ncbi_gene@3845|KRAS", "615|9|variant|litvar@rs121913283##&&&litvar@#5290#&&&litvar@CA183868#rs121913283##|c.3129G>A", "558|11|variant|litvar@rs121913275##&&&litvar@#5290#&&&litvar@CA210104#rs121913275##|p.Glu545Asp", "182|8|variant|litvar@rs727503108##&&&litvar@#3845#&&&litvar@CA176493#rs727503108##|c.179G>T", "350|4|gene|ncbi_gene@673|BRAF", "574|9|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123338#rs121913286##|c.1636C>A", "661|12|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.His1047Arg", "263|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Gln61Arg", "418|3|variant|litvar@#673#|T>A", "167|10|variant|litvar@#3845#p.A59del&&&litvar@#3845#|p.Ala59del", "363|9|variant|litvar@rs121913351##&&&litvar@#673#&&&litvar@CA16602535#rs121913351##|c.1397G>A", "446|9|variant|litvar@rs372569965##&&&litvar@#673#&&&litvar@CA4516655#rs372569965##|c.1808A>G", "423|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|Val600Glu", "206|8|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA180750#rs121913238##|c.181C>A"], "figure_id": "T1", "text_hl": "  Mutation   No. of cases Total no. of cases (%)   Gene and exon cDNA sequence Protein sequence   KRAS exon 3 c.151_195dup p.Cys51_Ser65dup 1 10 (5.0%)   c.176_178del p.Ala59del 1   c.179G>T p.Gly60Val 1   c.181C>A p.Gln61Lys 1   c.182A>T p.Gln61Leu 3   c.182A>G p.Gln61Arg 2   c.183A>C p.Gln61His 1   KRAS exon 4 c.436G>A <m>p.Ala146Thr</m> 10 10 (5.0%)   BRAF exon 11 c.1397G>A p.Gly466Glu 1 1 (0.5%)   BRAF exon 15 c.1799 T>A pVal600Glu 8 9 (4.5%)   c.1808A>G p.Lys601Glu 1   PIK3CA exon 9 c.1624G>A p.Glu542Lys 5 14 (7.0%)   c.1633G>A p.Glu545Lys 5   c.1635G>T p.Glu545Asp 1   c.1636C>A p.Gln546Lys 3   PIK3CA exon 20 c.3129G>A p.Met1043Ile 1 3 (1.5%)   c.3140A>G p.His1047Arg 1   c.3140A>T p.His1047Leu 1   "}], "citations": {"NLM": "Guedes JG, Veiga I, Rocha P, Pinto P, Pinto C, Pinheiro M, Peixoto A, Fragoso M, Raimundo A, Ferreira P, Machado M, Sousa N, Lopes P, Ara\u00fajo A, Macedo J, Alves F, Coutinho C, Henrique R, Santos LL, Teixeira MR. High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer. BMC Cancer. PMID: 23548132", "BibTeX": "@article{23548132, title={High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer.}, author={Guedes JG and Veiga I and Rocha P and Pinto P and Pinto C and Pinheiro M and Peixoto A and Fragoso M and Raimundo A and Ferreira P and Machado M and Sousa N and Lopes P and Ara\u00fajo A and Macedo J and Alves F and Coutinho C and Henrique R and Santos LL and Teixeira MR}, journal={BMC Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 38168015, "pmcid": "PMC11106141", "title": "Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives", "journal": "Virchows Arch", "authors": ["Simbolo M", "Centonze G", "Gkountakos A", "Monti V", "Maisonneuve P", "Golovco S", "Sabella G", "Del Gobbo A", "Gobbo S", "Ferrero S", "Fabbri A", "Pardo C", "Garzone G", "Prinzi N", "Pusceddu S", "Testi A", "Rolli L", "Mangogna A", "Bercich L", "Benvenuti MR", "Bria E", "Pilotto S", "Berruti A", "Pastorino U", "Capella C", "Infante M", "Milella M", "Scarpa A", "Milione M"], "date": "2024-05-01T00:00:00Z", "year": 2024, "snippets": [{"_id": "38168015@12862", "snip_text": "One case had a KRAS A146T mutation.", "section": "results", "mentions": ["15|4|gene|ncbi_gene@3845|KRAS", "20|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "One case had a KRAS <m>A146T</m> mutation."}], "citations": {"NLM": "Simbolo M, Centonze G, Gkountakos A, Monti V, Maisonneuve P, Golovco S, Sabella G, Del Gobbo A, Gobbo S, Ferrero S, Fabbri A, Pardo C, Garzone G, Prinzi N, Pusceddu S, Testi A, Rolli L, Mangogna A, Bercich L, Benvenuti MR, Bria E, Pilotto S, Berruti A, Pastorino U, Capella C, Infante M, Milella M, Scarpa A, Milione M. Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives Virchows Arch. PMID: 38168015", "BibTeX": "@article{38168015, title={Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives}, author={Simbolo M and Centonze G and Gkountakos A and Monti V and Maisonneuve P and Golovco S and Sabella G and Del Gobbo A and Gobbo S and Ferrero S and Fabbri A and Pardo C and Garzone G and Prinzi N and Pusceddu S and Testi A and Rolli L and Mangogna A and Bercich L and Benvenuti MR and Bria E and Pilotto S and Berruti A and Pastorino U and Capella C and Infante M and Milella M and Scarpa A and Milione M}, journal={Virchows Arch}}"}, "is_sup_mat_match": false}, {"pmid": 32579932, "pmcid": "PMC7326293", "title": "mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis.", "journal": "Cell Rep", "authors": ["Triki M", "Rinaldi G", "Planque M", "Broekaert D", "Winkelkotte AM", "Maier CR", "Janaki Raman S", "Vandekeere A", "Van Elsen J", "Orth MF", "Gr\u00fcnewald TGP", "Schulze A", "Fendt SM"], "date": "2020-06-23T00:00:00Z", "year": 2020, "snippets": [], "citations": {"NLM": "Triki M, Rinaldi G, Planque M, Broekaert D, Winkelkotte AM, Maier CR, Janaki Raman S, Vandekeere A, Van Elsen J, Orth MF, Gr\u00fcnewald TGP, Schulze A, Fendt SM. mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis. Cell Rep. PMID: 32579932", "BibTeX": "@article{32579932, title={mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis.}, author={Triki M and Rinaldi G and Planque M and Broekaert D and Winkelkotte AM and Maier CR and Janaki Raman S and Vandekeere A and Van Elsen J and Orth MF and Gr\u00fcnewald TGP and Schulze A and Fendt SM}, journal={Cell Rep}}"}, "is_sup_mat_match": true}, {"pmid": 25889064, "pmcid": "PMC4342810", "title": "Cross-laboratory validation of the OncoScan  FFPE Assay, a multiplex tool for whole genome tumour profiling.", "journal": "BMC Med Genomics", "authors": ["Foster JM", "Oumie A", "Togneri FS", "Vasques FR", "Hau D", "Taylor M", "Tinkler-Hundal E", "Southward K", "Medlow P", "McGreeghan-Crosby K", "Halfpenny I", "McMullan DJ", "Quirke P", "Keating KE", "Griffiths M", "Spink KG", "Brew F"], "date": "2015-02-18T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Foster JM, Oumie A, Togneri FS, Vasques FR, Hau D, Taylor M, Tinkler-Hundal E, Southward K, Medlow P, McGreeghan-Crosby K, Halfpenny I, McMullan DJ, Quirke P, Keating KE, Griffiths M, Spink KG, Brew F. Cross-laboratory validation of the OncoScan  FFPE Assay, a multiplex tool for whole genome tumour profiling. BMC Med Genomics. PMID: 25889064", "BibTeX": "@article{25889064, title={Cross-laboratory validation of the OncoScan  FFPE Assay, a multiplex tool for whole genome tumour profiling.}, author={Foster JM and Oumie A and Togneri FS and Vasques FR and Hau D and Taylor M and Tinkler-Hundal E and Southward K and Medlow P and McGreeghan-Crosby K and Halfpenny I and McMullan DJ and Quirke P and Keating KE and Griffiths M and Spink KG and Brew F}, journal={BMC Med Genomics}}"}, "is_sup_mat_match": true}, {"pmid": 29338072, "pmcid": "PMC5900732", "title": "Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.", "journal": "Cancer", "authors": ["Ross JS", "Fakih M", "Ali SM", "Elvin JA", "Schrock AB", "Suh J", "Vergilio JA", "Ramkissoon S", "Severson E", "Daniel S", "Fabrizio D", "Frampton G", "Sun J", "Miller VA", "Stephens PJ", "Gay LM"], "date": "2018-04-01T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Ross JS, Fakih M, Ali SM, Elvin JA, Schrock AB, Suh J, Vergilio JA, Ramkissoon S, Severson E, Daniel S, Fabrizio D, Frampton G, Sun J, Miller VA, Stephens PJ, Gay LM. Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3. Cancer. PMID: 29338072", "BibTeX": "@article{29338072, title={Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.}, author={Ross JS and Fakih M and Ali SM and Elvin JA and Schrock AB and Suh J and Vergilio JA and Ramkissoon S and Severson E and Daniel S and Fabrizio D and Frampton G and Sun J and Miller VA and Stephens PJ and Gay LM}, journal={Cancer}}"}, "is_sup_mat_match": true}, {"pmid": 25032700, "pmcid": "PMC4102467", "title": "NCI-60 whole exome sequencing and pharmacological CellMiner analyses.", "journal": "PLoS One", "authors": ["Reinhold WC", "Varma S", "Sousa F", "Sunshine M", "Abaan OD", "Davis SR", "Reinhold SW", "Kohn KW", "Morris J", "Meltzer PS", "Doroshow JH", "Pommier Y"], "date": "2014-07-17T00:00:00Z", "year": 2014, "snippets": [], "citations": {"NLM": "Reinhold WC, Varma S, Sousa F, Sunshine M, Abaan OD, Davis SR, Reinhold SW, Kohn KW, Morris J, Meltzer PS, Doroshow JH, Pommier Y. NCI-60 whole exome sequencing and pharmacological CellMiner analyses. PLoS One. PMID: 25032700", "BibTeX": "@article{25032700, title={NCI-60 whole exome sequencing and pharmacological CellMiner analyses.}, author={Reinhold WC and Varma S and Sousa F and Sunshine M and Abaan OD and Davis SR and Reinhold SW and Kohn KW and Morris J and Meltzer PS and Doroshow JH and Pommier Y}, journal={PLoS One}}"}, "is_sup_mat_match": true}, {"pmid": 25588929, "pmcid": "PMC4312462", "title": "Molecular characteristics of endometrial cancer coexisting with peritoneal malignant mesothelioma in Li-Fraumeni-like syndrome.", "journal": "BMC Cancer", "authors": ["Chao A", "Lai CH", "Lee YS", "Ueng SH", "Lin CY", "Wang TH"], "date": "2015-01-15T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Chao A, Lai CH, Lee YS, Ueng SH, Lin CY, Wang TH. Molecular characteristics of endometrial cancer coexisting with peritoneal malignant mesothelioma in Li-Fraumeni-like syndrome. BMC Cancer. PMID: 25588929", "BibTeX": "@article{25588929, title={Molecular characteristics of endometrial cancer coexisting with peritoneal malignant mesothelioma in Li-Fraumeni-like syndrome.}, author={Chao A and Lai CH and Lee YS and Ueng SH and Lin CY and Wang TH}, journal={BMC Cancer}}"}, "is_sup_mat_match": true}, {"pmid": 29543828, "pmcid": "PMC5854321", "title": "Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling.", "journal": "PLoS One", "authors": ["Plagnol V", "Woodhouse S", "Howarth K", "Lensing S", "Smith M", "Epstein M", "Madi M", "Smalley S", "Leroy C", "Hinton J", "de Kievit F", "Musgrave-Brown E", "Herd C", "Baker-Neblett K", "Brennan W", "Dimitrov P", "Campbell N", "Morris C", "Rosenfeld N", "Clark J", "Gale D", "Platt J", "Calaway J", "Jones G", "Forshew T"], "date": "2018-03-15T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Plagnol V, Woodhouse S, Howarth K, Lensing S, Smith M, Epstein M, Madi M, Smalley S, Leroy C, Hinton J, de Kievit F, Musgrave-Brown E, Herd C, Baker-Neblett K, Brennan W, Dimitrov P, Campbell N, Morris C, Rosenfeld N, Clark J, Gale D, Platt J, Calaway J, Jones G, Forshew T. Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling. PLoS One. PMID: 29543828", "BibTeX": "@article{29543828, title={Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling.}, author={Plagnol V and Woodhouse S and Howarth K and Lensing S and Smith M and Epstein M and Madi M and Smalley S and Leroy C and Hinton J and de Kievit F and Musgrave-Brown E and Herd C and Baker-Neblett K and Brennan W and Dimitrov P and Campbell N and Morris C and Rosenfeld N and Clark J and Gale D and Platt J and Calaway J and Jones G and Forshew T}, journal={PLoS One}}"}, "is_sup_mat_match": true}, {"pmid": 25348012, "pmcid": "PMC4232638", "title": "Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations.", "journal": "Genome Biol", "authors": ["Martelotto LG", "Ng CK", "De Filippo MR", "Zhang Y", "Piscuoglio S", "Lim RS", "Shen R", "Norton L", "Reis-Filho JS", "Weigelt B"], "date": "2014-10-28T00:00:00Z", "year": 2014, "snippets": [], "citations": {"NLM": "Martelotto LG, Ng CK, De Filippo MR, Zhang Y, Piscuoglio S, Lim RS, Shen R, Norton L, Reis-Filho JS, Weigelt B. Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations. Genome Biol. PMID: 25348012", "BibTeX": "@article{25348012, title={Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations.}, author={Martelotto LG and Ng CK and De Filippo MR and Zhang Y and Piscuoglio S and Lim RS and Shen R and Norton L and Reis-Filho JS and Weigelt B}, journal={Genome Biol}}"}, "is_sup_mat_match": true}, {"pmid": 26296973, "pmcid": "PMC4694854", "title": "Patient-derived cell models as preclinical tools for genome-directed targeted therapy.", "journal": "Oncotarget", "authors": ["Lee JY", "Kim SY", "Park C", "Kim NK", "Jang J", "Park K", "Yi JH", "Hong M", "Ahn T", "Rath O", "Schueler J", "Kim ST", "Do IG", "Lee S", "Park SH", "Ji YI", "Kim D", "Park JO", "Park YS", "Kang WK", "Kim KM", "Park WY", "Lim HY", "Lee J"], "date": "2015-09-22T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Lee JY, Kim SY, Park C, Kim NK, Jang J, Park K, Yi JH, Hong M, Ahn T, Rath O, Schueler J, Kim ST, Do IG, Lee S, Park SH, Ji YI, Kim D, Park JO, Park YS, Kang WK, Kim KM, Park WY, Lim HY, Lee J. Patient-derived cell models as preclinical tools for genome-directed targeted therapy. Oncotarget. PMID: 26296973", "BibTeX": "@article{26296973, title={Patient-derived cell models as preclinical tools for genome-directed targeted therapy.}, author={Lee JY and Kim SY and Park C and Kim NK and Jang J and Park K and Yi JH and Hong M and Ahn T and Rath O and Schueler J and Kim ST and Do IG and Lee S and Park SH and Ji YI and Kim D and Park JO and Park YS and Kang WK and Kim KM and Park WY and Lim HY and Lee J}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 26659599, "pmcid": "PMC4685989", "title": "Reproducible Analysis of Post-Translational Modifications in Proteomes:Application to Human Mutations", "journal": "PLoS One", "authors": ["Holehouse AS", "Naegle KM"], "date": "2015-12-14T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Holehouse AS, Naegle KM. Reproducible Analysis of Post-Translational Modifications in Proteomes:Application to Human Mutations PLoS One. PMID: 26659599", "BibTeX": "@article{26659599, title={Reproducible Analysis of Post-Translational Modifications in Proteomes:Application to Human Mutations}, author={Holehouse AS and Naegle KM}, journal={PLoS One}}"}, "is_sup_mat_match": true}, {"pmid": 25855536, "pmcid": "PMC4403382", "title": "Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets", "journal": "Nat Commun", "authors": ["Witkiewicz AK", "McMillan EA", "Balaji U", "Baek G", "Lin WC", "Mansour J", "Mollaee M", "Wagner KU", "Koduru P", "Yopp A", "Choti MA", "Yeo CJ", "McCue P", "White MA", "Knudsen ES"], "date": "2015-04-09T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Witkiewicz AK, McMillan EA, Balaji U, Baek G, Lin WC, Mansour J, Mollaee M, Wagner KU, Koduru P, Yopp A, Choti MA, Yeo CJ, McCue P, White MA, Knudsen ES. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets Nat Commun. PMID: 25855536", "BibTeX": "@article{25855536, title={Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets}, author={Witkiewicz AK and McMillan EA and Balaji U and Baek G and Lin WC and Mansour J and Mollaee M and Wagner KU and Koduru P and Yopp A and Choti MA and Yeo CJ and McCue P and White MA and Knudsen ES}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 36781844, "pmcid": "PMC9925790", "title": "Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma.", "journal": "Blood Cancer J", "authors": ["Mithraprabhu S", "Reynolds J", "Turner R", "Quach H", "Horvath N", "Kerridge I", "Kalff A", "Bergin K", "Hocking J", "Yuen F", "Khong T", "Durie BM", "Spencer A"], "date": "2023-02-13T00:00:00Z", "year": 2023, "snippets": [], "citations": {"NLM": "Mithraprabhu S, Reynolds J, Turner R, Quach H, Horvath N, Kerridge I, Kalff A, Bergin K, Hocking J, Yuen F, Khong T, Durie BM, Spencer A. Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma. Blood Cancer J. PMID: 36781844", "BibTeX": "@article{36781844, title={Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma.}, author={Mithraprabhu S and Reynolds J and Turner R and Quach H and Horvath N and Kerridge I and Kalff A and Bergin K and Hocking J and Yuen F and Khong T and Durie BM and Spencer A}, journal={Blood Cancer J}}"}, "is_sup_mat_match": true}, {"pmid": 33556149, "pmcid": "PMC7870065", "title": "Development and validation of a multigene variant profiling assay to guide targeted and immuno therapy selection in solid tumors.", "journal": "PLoS One", "authors": ["Akolkar D", "Patil D", "Srivastava N", "Patil R", "Datta V", "Apurwa S", "Yashwante N", "Dhasarathan R", "Gosavi R", "John J", "Khan S", "Jadhav N", "Mene P", "Ahire D", "Pawar S", "Bodke H", "Sahoo S", "Nile A", "Saindane D", "Darokar H", "Devhare P", "Srinivasan A", "Datar R"], "date": "2021-02-08T00:00:00Z", "year": 2021, "snippets": [], "citations": {"NLM": "Akolkar D, Patil D, Srivastava N, Patil R, Datta V, Apurwa S, Yashwante N, Dhasarathan R, Gosavi R, John J, Khan S, Jadhav N, Mene P, Ahire D, Pawar S, Bodke H, Sahoo S, Nile A, Saindane D, Darokar H, Devhare P, Srinivasan A, Datar R. Development and validation of a multigene variant profiling assay to guide targeted and immuno therapy selection in solid tumors. PLoS One. PMID: 33556149", "BibTeX": "@article{33556149, title={Development and validation of a multigene variant profiling assay to guide targeted and immuno therapy selection in solid tumors.}, author={Akolkar D and Patil D and Srivastava N and Patil R and Datta V and Apurwa S and Yashwante N and Dhasarathan R and Gosavi R and John J and Khan S and Jadhav N and Mene P and Ahire D and Pawar S and Bodke H and Sahoo S and Nile A and Saindane D and Darokar H and Devhare P and Srinivasan A and Datar R}, journal={PLoS One}}"}, "is_sup_mat_match": true}, {"pmid": 25794154, "pmcid": "PMC4368709", "title": "Protein domain-level landscape of cancer-type-specific somatic mutations.", "journal": "PLoS Comput Biol", "authors": ["Yang F", "Petsalaki E", "Rolland T", "Hill DE", "Vidal M", "Roth FP"], "date": "2015-03-20T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Yang F, Petsalaki E, Rolland T, Hill DE, Vidal M, Roth FP. Protein domain-level landscape of cancer-type-specific somatic mutations. PLoS Comput Biol. PMID: 25794154", "BibTeX": "@article{25794154, title={Protein domain-level landscape of cancer-type-specific somatic mutations.}, author={Yang F and Petsalaki E and Rolland T and Hill DE and Vidal M and Roth FP}, journal={PLoS Comput Biol}}"}, "is_sup_mat_match": true}, {"pmid": 36477656, "pmcid": "PMC9729215", "title": "Epithelial TGFbeta engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features.", "journal": "Nat Commun", "authors": ["Flanagan DJ", "Amirkhah R", "Vincent DF", "Gunduz N", "Gentaz P", "Cammareri P", "McCooey AJ", "McCorry AMB", "Fisher NC", "Davis HL", "Ridgway RA", "Lohuis J", "Leach JDG", "Jackstadt R", "Gilroy K", "Mariella E", "Nixon C", "Clark W", "Hedley A", "Markert EK", "Strathdee D", "Bartholin L", "Redmond KL", "Kerr EM", "Longley DB", "Ginty F", "Cho S", "Coleman HG", "Loughrey MB", "Bardelli A", "Maughan TS", "Campbell AD", "Lawler M", "Leedham SJ", "Barry ST", "Inman GJ", "van Rheenen J", "Dunne PD", "Sansom OJ"], "date": "2022-12-07T00:00:00Z", "year": 2022, "snippets": [], "citations": {"NLM": "Flanagan DJ, Amirkhah R, Vincent DF, Gunduz N, Gentaz P, Cammareri P, McCooey AJ, McCorry AMB, Fisher NC, Davis HL, Ridgway RA, Lohuis J, Leach JDG, Jackstadt R, Gilroy K, Mariella E, Nixon C, Clark W, Hedley A, Markert EK, Strathdee D, Bartholin L, Redmond KL, Kerr EM, Longley DB, Ginty F, Cho S, Coleman HG, Loughrey MB, Bardelli A, Maughan TS, Campbell AD, Lawler M, Leedham SJ, Barry ST, Inman GJ, van Rheenen J, Dunne PD, Sansom OJ. Epithelial TGFbeta engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features. Nat Commun. PMID: 36477656", "BibTeX": "@article{36477656, title={Epithelial TGFbeta engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features.}, author={Flanagan DJ and Amirkhah R and Vincent DF and Gunduz N and Gentaz P and Cammareri P and McCooey AJ and McCorry AMB and Fisher NC and Davis HL and Ridgway RA and Lohuis J and Leach JDG and Jackstadt R and Gilroy K and Mariella E and Nixon C and Clark W and Hedley A and Markert EK and Strathdee D and Bartholin L and Redmond KL and Kerr EM and Longley DB and Ginty F and Cho S and Coleman HG and Loughrey MB and Bardelli A and Maughan TS and Campbell AD and Lawler M and Leedham SJ and Barry ST and Inman GJ and van Rheenen J and Dunne PD and Sansom OJ}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 31133068, "pmcid": "PMC6537185", "title": "Clinical utility of custom-designed NGS panel testing in pediatric tumors.", "journal": "Genome Med", "authors": ["Surrey LF", "MacFarland SP", "Chang F", "Cao K", "Rathi KS", "Akgumus GT", "Gallo D", "Lin F", "Gleason A", "Raman P", "Aplenc R", "Bagatell R", "Minturn J", "Mosse Y", "Santi M", "Tasian SK", "Waanders AJ", "Sarmady M", "Maris JM", "Hunger SP", "Li MM"], "date": "2019-05-28T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Surrey LF, MacFarland SP, Chang F, Cao K, Rathi KS, Akgumus GT, Gallo D, Lin F, Gleason A, Raman P, Aplenc R, Bagatell R, Minturn J, Mosse Y, Santi M, Tasian SK, Waanders AJ, Sarmady M, Maris JM, Hunger SP, Li MM. Clinical utility of custom-designed NGS panel testing in pediatric tumors. Genome Med. PMID: 31133068", "BibTeX": "@article{31133068, title={Clinical utility of custom-designed NGS panel testing in pediatric tumors.}, author={Surrey LF and MacFarland SP and Chang F and Cao K and Rathi KS and Akgumus GT and Gallo D and Lin F and Gleason A and Raman P and Aplenc R and Bagatell R and Minturn J and Mosse Y and Santi M and Tasian SK and Waanders AJ and Sarmady M and Maris JM and Hunger SP and Li MM}, journal={Genome Med}}"}, "is_sup_mat_match": true}, {"pmid": 27899802, "pmcid": "PMC5508072", "title": "Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia.", "journal": "Leukemia", "authors": ["Vesely C", "Frech C", "Eckert C", "Cario G", "Mecklenbr\u00e4uker A", "Zur Stadt U", "Nebral K", "Kraler F", "Fischer S", "Attarbaschi A", "Schuster M", "Bock C", "Cav\u00e9 H", "von Stackelberg A", "Schrappe M", "Horstmann MA", "Mann G", "Haas OA", "Panzer-Gr\u00fcmayer R"], "date": "2017-07-01T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Vesely C, Frech C, Eckert C, Cario G, Mecklenbr\u00e4uker A, Zur Stadt U, Nebral K, Kraler F, Fischer S, Attarbaschi A, Schuster M, Bock C, Cav\u00e9 H, von Stackelberg A, Schrappe M, Horstmann MA, Mann G, Haas OA, Panzer-Gr\u00fcmayer R. Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia. Leukemia. PMID: 27899802", "BibTeX": "@article{27899802, title={Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia.}, author={Vesely C and Frech C and Eckert C and Cario G and Mecklenbr\u00e4uker A and Zur Stadt U and Nebral K and Kraler F and Fischer S and Attarbaschi A and Schuster M and Bock C and Cav\u00e9 H and von Stackelberg A and Schrappe M and Horstmann MA and Mann G and Haas OA and Panzer-Gr\u00fcmayer R}, journal={Leukemia}}"}, "is_sup_mat_match": true}, {"pmid": 34301788, "pmcid": "PMC8783930", "title": "Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing.", "journal": "Cancer Discov", "authors": ["Newman S", "Nakitandwe J", "Kesserwan CA", "Azzato EM", "Wheeler DA", "Rusch M", "Shurtleff S", "Hedges DJ", "Hamilton KV", "Foy SG", "Edmonson MN", "Thrasher A", "Bahrami A", "Orr BA", "Klco JM", "Gu J", "Harrison LW", "Wang L", "Clay MR", "Ouma A", "Silkov A", "Liu Y", "Zhang Z", "Liu Y", "Brady SW", "Zhou X", "Chang TC", "Pande M", "Davis E", "Becksfort J", "Patel A", "Wilkinson MR", "Rahbarinia D", "Kubal M", "Maciaszek JL", "Pastor V", "Knight J", "Gout AM", "Wang J", "Gu Z", "Mullighan CG", "McGee RB", "Quinn EA", "Nuccio R", "Mostafavi R", "Gerhardt EL", "Taylor LM", "Valdez JM", "Hines-Dowell SJ", "Pappo AS", "Robinson G", "Johnson LM", "Pui CH", "Ellison DW", "Downing JR", "Zhang J", "Nichols KE"], "date": "2021-12-01T00:00:00Z", "year": 2021, "snippets": [], "citations": {"NLM": "Newman S, Nakitandwe J, Kesserwan CA, Azzato EM, Wheeler DA, Rusch M, Shurtleff S, Hedges DJ, Hamilton KV, Foy SG, Edmonson MN, Thrasher A, Bahrami A, Orr BA, Klco JM, Gu J, Harrison LW, Wang L, Clay MR, Ouma A, Silkov A, Liu Y, Zhang Z, Liu Y, Brady SW, Zhou X, Chang TC, Pande M, Davis E, Becksfort J, Patel A, Wilkinson MR, Rahbarinia D, Kubal M, Maciaszek JL, Pastor V, Knight J, Gout AM, Wang J, Gu Z, Mullighan CG, McGee RB, Quinn EA, Nuccio R, Mostafavi R, Gerhardt EL, Taylor LM, Valdez JM, Hines-Dowell SJ, Pappo AS, Robinson G, Johnson LM, Pui CH, Ellison DW, Downing JR, Zhang J, Nichols KE. Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing. Cancer Discov. PMID: 34301788", "BibTeX": "@article{34301788, title={Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing.}, author={Newman S and Nakitandwe J and Kesserwan CA and Azzato EM and Wheeler DA and Rusch M and Shurtleff S and Hedges DJ and Hamilton KV and Foy SG and Edmonson MN and Thrasher A and Bahrami A and Orr BA and Klco JM and Gu J and Harrison LW and Wang L and Clay MR and Ouma A and Silkov A and Liu Y and Zhang Z and Liu Y and Brady SW and Zhou X and Chang TC and Pande M and Davis E and Becksfort J and Patel A and Wilkinson MR and Rahbarinia D and Kubal M and Maciaszek JL and Pastor V and Knight J and Gout AM and Wang J and Gu Z and Mullighan CG and McGee RB and Quinn EA and Nuccio R and Mostafavi R and Gerhardt EL and Taylor LM and Valdez JM and Hines-Dowell SJ and Pappo AS and Robinson G and Johnson LM and Pui CH and Ellison DW and Downing JR and Zhang J and Nichols KE}, journal={Cancer Discov}}"}, "is_sup_mat_match": true}, {"pmid": 21430775, "pmcid": "PMC3560292", "title": "Initial genome sequencing and analysis of multiple myeloma.", "journal": "Nature", "authors": ["Chapman MA", "Lawrence MS", "Keats JJ", "Cibulskis K", "Sougnez C", "Schinzel AC", "Harview CL", "Brunet JP", "Ahmann GJ", "Adli M", "Anderson KC", "Ardlie KG", "Auclair D", "Baker A", "Bergsagel PL", "Bernstein BE", "Drier Y", "Fonseca R", "Gabriel SB", "Hofmeister CC", "Jagannath S", "Jakubowiak AJ", "Krishnan A", "Levy J", "Liefeld T", "Lonial S", "Mahan S", "Mfuko B", "Monti S", "Perkins LM", "Onofrio R", "Pugh TJ", "Rajkumar SV", "Ramos AH", "Siegel DS", "Sivachenko A", "Stewart AK", "Trudel S", "Vij R", "Voet D", "Winckler W", "Zimmerman T", "Carpten J", "Trent J", "Hahn WC", "Garraway LA", "Meyerson M", "Lander ES", "Getz G", "Golub TR"], "date": "2011-03-24T00:00:00Z", "year": 2011, "snippets": [], "citations": {"NLM": "Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, Schinzel AC, Harview CL, Brunet JP, Ahmann GJ, Adli M, Anderson KC, Ardlie KG, Auclair D, Baker A, Bergsagel PL, Bernstein BE, Drier Y, Fonseca R, Gabriel SB, Hofmeister CC, Jagannath S, Jakubowiak AJ, Krishnan A, Levy J, Liefeld T, Lonial S, Mahan S, Mfuko B, Monti S, Perkins LM, Onofrio R, Pugh TJ, Rajkumar SV, Ramos AH, Siegel DS, Sivachenko A, Stewart AK, Trudel S, Vij R, Voet D, Winckler W, Zimmerman T, Carpten J, Trent J, Hahn WC, Garraway LA, Meyerson M, Lander ES, Getz G, Golub TR. Initial genome sequencing and analysis of multiple myeloma. Nature. PMID: 21430775", "BibTeX": "@article{21430775, title={Initial genome sequencing and analysis of multiple myeloma.}, author={Chapman MA and Lawrence MS and Keats JJ and Cibulskis K and Sougnez C and Schinzel AC and Harview CL and Brunet JP and Ahmann GJ and Adli M and Anderson KC and Ardlie KG and Auclair D and Baker A and Bergsagel PL and Bernstein BE and Drier Y and Fonseca R and Gabriel SB and Hofmeister CC and Jagannath S and Jakubowiak AJ and Krishnan A and Levy J and Liefeld T and Lonial S and Mahan S and Mfuko B and Monti S and Perkins LM and Onofrio R and Pugh TJ and Rajkumar SV and Ramos AH and Siegel DS and Sivachenko A and Stewart AK and Trudel S and Vij R and Voet D and Winckler W and Zimmerman T and Carpten J and Trent J and Hahn WC and Garraway LA and Meyerson M and Lander ES and Getz G and Golub TR}, journal={Nature}}"}, "is_sup_mat_match": true}, {"pmid": 31772163, "pmcid": "PMC6879617", "title": "Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes.", "journal": "Nat Commun", "authors": ["Nagata Y", "Makishima H", "Kerr CM", "Przychodzen BP", "Aly M", "Goyal A", "Awada H", "Asad MF", "Kuzmanovic T", "Suzuki H", "Yoshizato T", "Yoshida K", "Chiba K", "Tanaka H", "Shiraishi Y", "Miyano S", "Mukherjee S", "LaFramboise T", "Nazha A", "Sekeres MA", "Radivoyevitch T", "Haferlach T", "Ogawa S", "Maciejewski JP"], "date": "2019-11-26T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Nagata Y, Makishima H, Kerr CM, Przychodzen BP, Aly M, Goyal A, Awada H, Asad MF, Kuzmanovic T, Suzuki H, Yoshizato T, Yoshida K, Chiba K, Tanaka H, Shiraishi Y, Miyano S, Mukherjee S, LaFramboise T, Nazha A, Sekeres MA, Radivoyevitch T, Haferlach T, Ogawa S, Maciejewski JP. Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes. Nat Commun. PMID: 31772163", "BibTeX": "@article{31772163, title={Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes.}, author={Nagata Y and Makishima H and Kerr CM and Przychodzen BP and Aly M and Goyal A and Awada H and Asad MF and Kuzmanovic T and Suzuki H and Yoshizato T and Yoshida K and Chiba K and Tanaka H and Shiraishi Y and Miyano S and Mukherjee S and LaFramboise T and Nazha A and Sekeres MA and Radivoyevitch T and Haferlach T and Ogawa S and Maciejewski JP}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 25638164, "pmcid": "PMC4413663", "title": "Methylation of MGMT and ADAMTS14 in normal colon mucosa: biomarkers of a field defect for cancerization preferentially targeting elder African-Americans.", "journal": "Oncotarget", "authors": ["Alonso S", "Dai Y", "Yamashita K", "Horiuchi S", "Dai T", "Matsunaga A", "S\u00e1nchez-Mu\u00f1oz R", "Bilbao-Sieyro C", "D\u00edaz-Chico JC", "Chernov AV", "Strongin AY", "Perucho M"], "date": "2015-02-20T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Alonso S, Dai Y, Yamashita K, Horiuchi S, Dai T, Matsunaga A, S\u00e1nchez-Mu\u00f1oz R, Bilbao-Sieyro C, D\u00edaz-Chico JC, Chernov AV, Strongin AY, Perucho M. Methylation of MGMT and ADAMTS14 in normal colon mucosa: biomarkers of a field defect for cancerization preferentially targeting elder African-Americans. Oncotarget. PMID: 25638164", "BibTeX": "@article{25638164, title={Methylation of MGMT and ADAMTS14 in normal colon mucosa: biomarkers of a field defect for cancerization preferentially targeting elder African-Americans.}, author={Alonso S and Dai Y and Yamashita K and Horiuchi S and Dai T and Matsunaga A and S\u00e1nchez-Mu\u00f1oz R and Bilbao-Sieyro C and D\u00edaz-Chico JC and Chernov AV and Strongin AY and Perucho M}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 35643867, "pmcid": "PMC9252918", "title": "Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence.", "journal": "Leukemia", "authors": ["Misund K", "Hofste Op Bruinink D", "Coward E", "Hoogenboezem RM", "Rustad EH", "Sanders MA", "Rye M", "Sponaas AM", "van der Holt B", "Zweegman S", "Hovig E", "Meza-Zepeda LA", "Sundan A", "Myklebost O", "Sonneveld P", "Waage A"], "date": "2022-07-01T00:00:00Z", "year": 2022, "snippets": [], "citations": {"NLM": "Misund K, Hofste Op Bruinink D, Coward E, Hoogenboezem RM, Rustad EH, Sanders MA, Rye M, Sponaas AM, van der Holt B, Zweegman S, Hovig E, Meza-Zepeda LA, Sundan A, Myklebost O, Sonneveld P, Waage A. Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence. Leukemia. PMID: 35643867", "BibTeX": "@article{35643867, title={Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence.}, author={Misund K and Hofste Op Bruinink D and Coward E and Hoogenboezem RM and Rustad EH and Sanders MA and Rye M and Sponaas AM and van der Holt B and Zweegman S and Hovig E and Meza-Zepeda LA and Sundan A and Myklebost O and Sonneveld P and Waage A}, journal={Leukemia}}"}, "is_sup_mat_match": true}, {"pmid": 25730765, "pmcid": "PMC4553269", "title": "The landscape of somatic mutations in Infant MLL rearranged acute lymphoblastic leukemias", "journal": "Nat Genet", "authors": ["Andersson AK", "Ma J", "Wang J", "Chen X", "Gedman AL", "Dang J", "Nakitandwe J", "Holmfeldt L", "Parker M", "Easton J", "Huether R", "Kriwacki R", "Rusch M", "Wu G", "Li Y", "Mulder H", "Raimondi S", "Pounds S", "Kang G", "Shi L", "Becksfort J", "Gupta P", "Payne-Turner D", "Vadodaria B", "Boggs K", "Yergeau D", "Manne J", "Song G", "Edmonson M", "Nagahawatte P", "Wei L", "Cheng C", "Pei D", "Sutton R", "Venn NC", "Chetcuti A", "Rush A", "Catchpoole D", "Heldrup J", "Fioretos T", "Lu C", "Ding L", "Pui CH", "Shurtleff S", "Mullighan CG", "Mardis ER", "Wilson RK", "Gruber TA", "Zhang J", "Downing JR", "St. Jude Children's Research Hospital\u2013Washington University Pediatric Cancer Genome Project."], "date": "2015-04-01T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Andersson AK, Ma J, Wang J, Chen X, Gedman AL, Dang J, Nakitandwe J, Holmfeldt L, Parker M, Easton J, Huether R, Kriwacki R, Rusch M, Wu G, Li Y, Mulder H, Raimondi S, Pounds S, Kang G, Shi L, Becksfort J, Gupta P, Payne-Turner D, Vadodaria B, Boggs K, Yergeau D, Manne J, Song G, Edmonson M, Nagahawatte P, Wei L, Cheng C, Pei D, Sutton R, Venn NC, Chetcuti A, Rush A, Catchpoole D, Heldrup J, Fioretos T, Lu C, Ding L, Pui CH, Shurtleff S, Mullighan CG, Mardis ER, Wilson RK, Gruber TA, Zhang J, Downing JR, St. Jude Children's Research Hospital\u2013Washington University Pediatric Cancer Genome Project.. The landscape of somatic mutations in Infant MLL rearranged acute lymphoblastic leukemias Nat Genet. PMID: 25730765", "BibTeX": "@article{25730765, title={The landscape of somatic mutations in Infant MLL rearranged acute lymphoblastic leukemias}, author={Andersson AK and Ma J and Wang J and Chen X and Gedman AL and Dang J and Nakitandwe J and Holmfeldt L and Parker M and Easton J and Huether R and Kriwacki R and Rusch M and Wu G and Li Y and Mulder H and Raimondi S and Pounds S and Kang G and Shi L and Becksfort J and Gupta P and Payne-Turner D and Vadodaria B and Boggs K and Yergeau D and Manne J and Song G and Edmonson M and Nagahawatte P and Wei L and Cheng C and Pei D and Sutton R and Venn NC and Chetcuti A and Rush A and Catchpoole D and Heldrup J and Fioretos T and Lu C and Ding L and Pui CH and Shurtleff S and Mullighan CG and Mardis ER and Wilson RK and Gruber TA and Zhang J and Downing JR and St. Jude Children's Research Hospital\u2013Washington University Pediatric Cancer Genome Project.}, journal={Nat Genet}}"}, "is_sup_mat_match": true}, {"pmid": 29698444, "pmcid": "PMC5919577", "title": "Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice", "journal": "PLoS One", "authors": ["Prentice LM", "Miller RR", "Knaggs J", "Mazloomian A", "Aguirre Hernandez R", "Franchini P", "Parsa K", "Tessier-Cloutier B", "Lapuk A", "Huntsman D", "Schaeffer DF", "Sheffield BS"], "date": "2018-04-26T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Prentice LM, Miller RR, Knaggs J, Mazloomian A, Aguirre Hernandez R, Franchini P, Parsa K, Tessier-Cloutier B, Lapuk A, Huntsman D, Schaeffer DF, Sheffield BS. Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice PLoS One. PMID: 29698444", "BibTeX": "@article{29698444, title={Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice}, author={Prentice LM and Miller RR and Knaggs J and Mazloomian A and Aguirre Hernandez R and Franchini P and Parsa K and Tessier-Cloutier B and Lapuk A and Huntsman D and Schaeffer DF and Sheffield BS}, journal={PLoS One}}"}, "is_sup_mat_match": true}, {"pmid": 32087721, "pmcid": "PMC7036178", "title": "Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples", "journal": "J Transl Med", "authors": ["Toomey S", "Carr A", "Mezynski MJ", "Elamin Y", "Rafee S", "Cremona M", "Morgan C", "Madden S", "Abdul-Jalil KI", "Gately K", "Farrelly A", "Kay EW", "Kennedy S", "O'Byrne K", "Grogan L", "Breathnach O", "Morris PG", "Eustace AJ", "Fay J", "Cummins R", "O'Grady A", "Kalachand R", "O'Donovan N", "Kelleher F", "O'Reilly A", "Doherty M", "Crown J", "Hennessy BT"], "date": "2020-02-22T00:00:00Z", "year": 2020, "snippets": [], "citations": {"NLM": "Toomey S, Carr A, Mezynski MJ, Elamin Y, Rafee S, Cremona M, Morgan C, Madden S, Abdul-Jalil KI, Gately K, Farrelly A, Kay EW, Kennedy S, O'Byrne K, Grogan L, Breathnach O, Morris PG, Eustace AJ, Fay J, Cummins R, O'Grady A, Kalachand R, O'Donovan N, Kelleher F, O'Reilly A, Doherty M, Crown J, Hennessy BT. Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples J Transl Med. PMID: 32087721", "BibTeX": "@article{32087721, title={Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples}, author={Toomey S and Carr A and Mezynski MJ and Elamin Y and Rafee S and Cremona M and Morgan C and Madden S and Abdul-Jalil KI and Gately K and Farrelly A and Kay EW and Kennedy S and O'Byrne K and Grogan L and Breathnach O and Morris PG and Eustace AJ and Fay J and Cummins R and O'Grady A and Kalachand R and O'Donovan N and Kelleher F and O'Reilly A and Doherty M and Crown J and Hennessy BT}, journal={J Transl Med}}"}, "is_sup_mat_match": true}, {"pmid": 26437257, "pmcid": "PMC4593564", "title": "Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.", "journal": "PLoS One", "authors": ["Carneiro da Silva F", "Ferreira JR", "Torrezan GT", "Figueiredo MC", "Santos \u00c9M", "Nakagawa WT", "Brianese RC", "Petrolini de Oliveira L", "Begnani MD", "Aguiar-Junior S", "Rossi BM", "Ferreira Fde O", "Carraro DM"], "date": "2015-10-05T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Carneiro da Silva F, Ferreira JR, Torrezan GT, Figueiredo MC, Santos \u00c9M, Nakagawa WT, Brianese RC, Petrolini de Oliveira L, Begnani MD, Aguiar-Junior S, Rossi BM, Ferreira Fde O, Carraro DM. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome. PLoS One. PMID: 26437257", "BibTeX": "@article{26437257, title={Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.}, author={Carneiro da Silva F and Ferreira JR and Torrezan GT and Figueiredo MC and Santos \u00c9M and Nakagawa WT and Brianese RC and Petrolini de Oliveira L and Begnani MD and Aguiar-Junior S and Rossi BM and Ferreira Fde O and Carraro DM}, journal={PLoS One}}"}, "is_sup_mat_match": true}, {"pmid": 31384390, "pmcid": "PMC6659802", "title": "Oncologist uptake of comprehensive genomic profile guided targeted therapy.", "journal": "Oncotarget", "authors": ["Nesline MK", "DePietro P", "Dy GK", "Early A", "Papanicolau-Sengos A", "Conroy JM", "Lenzo FL", "Glenn ST", "Chen H", "Grand'Maison A", "Boland P", "Ernstoff MS", "Puzanov I", "Edge S", "Akers S", "Opyrchal M", "Chatta G", "Odunsi K", "Frederick P", "Lele S", "Gardner M", "Morrison C"], "date": "2019-07-23T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Nesline MK, DePietro P, Dy GK, Early A, Papanicolau-Sengos A, Conroy JM, Lenzo FL, Glenn ST, Chen H, Grand'Maison A, Boland P, Ernstoff MS, Puzanov I, Edge S, Akers S, Opyrchal M, Chatta G, Odunsi K, Frederick P, Lele S, Gardner M, Morrison C. Oncologist uptake of comprehensive genomic profile guided targeted therapy. Oncotarget. PMID: 31384390", "BibTeX": "@article{31384390, title={Oncologist uptake of comprehensive genomic profile guided targeted therapy.}, author={Nesline MK and DePietro P and Dy GK and Early A and Papanicolau-Sengos A and Conroy JM and Lenzo FL and Glenn ST and Chen H and Grand'Maison A and Boland P and Ernstoff MS and Puzanov I and Edge S and Akers S and Opyrchal M and Chatta G and Odunsi K and Frederick P and Lele S and Gardner M and Morrison C}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 30862934, "pmcid": "PMC6414622", "title": "Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures.", "journal": "Sci Rep", "authors": ["Schroeder MP", "Bastian L", "Eckert C", "G\u00f6kbuget N", "James AR", "Tanchez JO", "Schlee C", "Isaakidis K", "H\u00e4upl B", "Baum K", "Migueles Lozano OA", "Kouidri K", "Pan KT", "Urlaub H", "Schwartz S", "Burmeister T", "von Stackelberg A", "Hoelzer D", "Pfeiffer H", "Rieger MA", "G\u00f6llner S", "Oellerich T", "Horstman M", "Schrappe M", "Wolf J", "Kirschner-Schwabe R", "Br\u00fcggemann M", "M\u00fcller-Tidow C", "Serve H", "Neumann M", "Baldus CD"], "date": "2019-03-12T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Schroeder MP, Bastian L, Eckert C, G\u00f6kbuget N, James AR, Tanchez JO, Schlee C, Isaakidis K, H\u00e4upl B, Baum K, Migueles Lozano OA, Kouidri K, Pan KT, Urlaub H, Schwartz S, Burmeister T, von Stackelberg A, Hoelzer D, Pfeiffer H, Rieger MA, G\u00f6llner S, Oellerich T, Horstman M, Schrappe M, Wolf J, Kirschner-Schwabe R, Br\u00fcggemann M, M\u00fcller-Tidow C, Serve H, Neumann M, Baldus CD. Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures. Sci Rep. PMID: 30862934", "BibTeX": "@article{30862934, title={Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures.}, author={Schroeder MP and Bastian L and Eckert C and G\u00f6kbuget N and James AR and Tanchez JO and Schlee C and Isaakidis K and H\u00e4upl B and Baum K and Migueles Lozano OA and Kouidri K and Pan KT and Urlaub H and Schwartz S and Burmeister T and von Stackelberg A and Hoelzer D and Pfeiffer H and Rieger MA and G\u00f6llner S and Oellerich T and Horstman M and Schrappe M and Wolf J and Kirschner-Schwabe R and Br\u00fcggemann M and M\u00fcller-Tidow C and Serve H and Neumann M and Baldus CD}, journal={Sci Rep}}"}, "is_sup_mat_match": true}, {"pmid": 30042065, "pmcid": "PMC6088509", "title": "Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series.", "journal": "Lancet Gastroenterol Hepatol", "authors": ["Domingo E", "Camps C", "Kaisaki PJ", "Parsons MJ", "Mouradov D", "Pentony MM", "Makino S", "Palmieri M", "Ward RL", "Hawkins NJ", "Gibbs P", "Askautrud H", "Oukrif D", "Wang H", "Wood J", "Tomlinson E", "Bark Y", "Kaur K", "Johnstone EC", "Palles C", "Church DN", "Novelli M", "Danielsen HE", "Sherlock J", "Kerr D", "Kerr R", "Sieber O", "Taylor JC", "Tomlinson I"], "date": "2018-09-01T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Domingo E, Camps C, Kaisaki PJ, Parsons MJ, Mouradov D, Pentony MM, Makino S, Palmieri M, Ward RL, Hawkins NJ, Gibbs P, Askautrud H, Oukrif D, Wang H, Wood J, Tomlinson E, Bark Y, Kaur K, Johnstone EC, Palles C, Church DN, Novelli M, Danielsen HE, Sherlock J, Kerr D, Kerr R, Sieber O, Taylor JC, Tomlinson I. Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series. Lancet Gastroenterol Hepatol. PMID: 30042065", "BibTeX": "@article{30042065, title={Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series.}, author={Domingo E and Camps C and Kaisaki PJ and Parsons MJ and Mouradov D and Pentony MM and Makino S and Palmieri M and Ward RL and Hawkins NJ and Gibbs P and Askautrud H and Oukrif D and Wang H and Wood J and Tomlinson E and Bark Y and Kaur K and Johnstone EC and Palles C and Church DN and Novelli M and Danielsen HE and Sherlock J and Kerr D and Kerr R and Sieber O and Taylor JC and Tomlinson I}, journal={Lancet Gastroenterol Hepatol}}"}, "is_sup_mat_match": true}, {"pmid": 29561830, "pmcid": "PMC5923343", "title": "Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients.", "journal": "Cancers (Basel)", "authors": ["Heeke S", "Hofman V", "Long-Mira E", "Lespinet V", "Lalv\u00e9e S", "Bordone O", "Ribeyre C", "Tanga V", "Benzaquen J", "Leroy S", "Cohen C", "Mouroux J", "Marquette CH", "Ili\u00e9 M", "Hofman P"], "date": "2018-03-21T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Heeke S, Hofman V, Long-Mira E, Lespinet V, Lalv\u00e9e S, Bordone O, Ribeyre C, Tanga V, Benzaquen J, Leroy S, Cohen C, Mouroux J, Marquette CH, Ili\u00e9 M, Hofman P. Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients. Cancers (Basel). PMID: 29561830", "BibTeX": "@article{29561830, title={Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients.}, author={Heeke S and Hofman V and Long-Mira E and Lespinet V and Lalv\u00e9e S and Bordone O and Ribeyre C and Tanga V and Benzaquen J and Leroy S and Cohen C and Mouroux J and Marquette CH and Ili\u00e9 M and Hofman P}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": true}, {"pmid": 29535804, "pmcid": "PMC5828199", "title": "Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors.", "journal": "Oncotarget", "authors": ["Mehrotra M", "Singh RR", "Loghavi S", "Duose DY", "Barkoh BA", "Behrens C", "Patel KP", "Routbort MJ", "Kopetz S", "Broaddus RR", "Jeffrey Medeiros L", "Wistuba II", "Luthra R"], "date": "2017-10-24T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Mehrotra M, Singh RR, Loghavi S, Duose DY, Barkoh BA, Behrens C, Patel KP, Routbort MJ, Kopetz S, Broaddus RR, Jeffrey Medeiros L, Wistuba II, Luthra R. Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors. Oncotarget. PMID: 29535804", "BibTeX": "@article{29535804, title={Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors.}, author={Mehrotra M and Singh RR and Loghavi S and Duose DY and Barkoh BA and Behrens C and Patel KP and Routbort MJ and Kopetz S and Broaddus RR and Jeffrey Medeiros L and Wistuba II and Luthra R}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 31543384, "pmcid": "PMC6839402", "title": "A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations.", "journal": "Eur J Cancer", "authors": ["George SL", "Izquierdo E", "Campbell J", "Koutroumanidou E", "Proszek P", "Jamal S", "Hughes D", "Yuan L", "Marshall LV", "Carceller F", "Chisholm JC", "Vaidya S", "Mandeville H", "Angelini P", "Wasti A", "Bexelius T", "Thway K", "Gatz SA", "Clarke M", "Al-Lazikani B", "Barone G", "Anderson J", "Tweddle DA", "Gonzalez D", "Walker BA", "Barton J", "Depani S", "Eze J", "Ahmed SW", "Moreno L", "Pearson A", "Shipley J", "Jones C", "Hargrave D", "Jacques TS", "Hubank M", "Chesler L"], "date": "2019-11-01T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "George SL, Izquierdo E, Campbell J, Koutroumanidou E, Proszek P, Jamal S, Hughes D, Yuan L, Marshall LV, Carceller F, Chisholm JC, Vaidya S, Mandeville H, Angelini P, Wasti A, Bexelius T, Thway K, Gatz SA, Clarke M, Al-Lazikani B, Barone G, Anderson J, Tweddle DA, Gonzalez D, Walker BA, Barton J, Depani S, Eze J, Ahmed SW, Moreno L, Pearson A, Shipley J, Jones C, Hargrave D, Jacques TS, Hubank M, Chesler L. A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations. Eur J Cancer. PMID: 31543384", "BibTeX": "@article{31543384, title={A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations.}, author={George SL and Izquierdo E and Campbell J and Koutroumanidou E and Proszek P and Jamal S and Hughes D and Yuan L and Marshall LV and Carceller F and Chisholm JC and Vaidya S and Mandeville H and Angelini P and Wasti A and Bexelius T and Thway K and Gatz SA and Clarke M and Al-Lazikani B and Barone G and Anderson J and Tweddle DA and Gonzalez D and Walker BA and Barton J and Depani S and Eze J and Ahmed SW and Moreno L and Pearson A and Shipley J and Jones C and Hargrave D and Jacques TS and Hubank M and Chesler L}, journal={Eur J Cancer}}"}, "is_sup_mat_match": true}, {"pmid": 30683863, "pmcid": "PMC6347629", "title": "Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients.", "journal": "Nat Commun", "authors": ["Cafri G", "Yossef R", "Pasetto A", "Deniger DC", "Lu YC", "Parkhurst M", "Gartner JJ", "Jia L", "Ray S", "Ngo LT", "Jafferji M", "Sachs A", "Prickett T", "Robbins PF", "Rosenberg SA"], "date": "2019-01-25T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Cafri G, Yossef R, Pasetto A, Deniger DC, Lu YC, Parkhurst M, Gartner JJ, Jia L, Ray S, Ngo LT, Jafferji M, Sachs A, Prickett T, Robbins PF, Rosenberg SA. Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients. Nat Commun. PMID: 30683863", "BibTeX": "@article{30683863, title={Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients.}, author={Cafri G and Yossef R and Pasetto A and Deniger DC and Lu YC and Parkhurst M and Gartner JJ and Jia L and Ray S and Ngo LT and Jafferji M and Sachs A and Prickett T and Robbins PF and Rosenberg SA}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 29368620, "pmcid": "PMC6389067", "title": "Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry.", "journal": "Diagn Pathol", "authors": ["Bonaparte E", "Pesenti C", "Fontana L", "Falcone R", "Paganini L", "Marzorati A", "Ferrero S", "Nosotti M", "Mendogni P", "Bareggi C", "Sirchia SM", "Tabano S", "Bosari S", "Miozzo M"], "date": "2018-01-12T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Bonaparte E, Pesenti C, Fontana L, Falcone R, Paganini L, Marzorati A, Ferrero S, Nosotti M, Mendogni P, Bareggi C, Sirchia SM, Tabano S, Bosari S, Miozzo M. Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry. Diagn Pathol. PMID: 29368620", "BibTeX": "@article{29368620, title={Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry.}, author={Bonaparte E and Pesenti C and Fontana L and Falcone R and Paganini L and Marzorati A and Ferrero S and Nosotti M and Mendogni P and Bareggi C and Sirchia SM and Tabano S and Bosari S and Miozzo M}, journal={Diagn Pathol}}"}, "is_sup_mat_match": true}, {"pmid": 28371134, "pmcid": "PMC5430095", "title": "StrandAdvantage test for early-line and advanced-stage treatment decisions in solid tumors.", "journal": "Cancer Med", "authors": ["Sen M", "Katragadda S", "Ravichandran A", "Deshpande G", "Parulekar M", "Nayanala S", "Vittal V", "Shen W", "Phooi Nee Yong M", "Jacob J", "Parchuru S", "Dhanuskodi K", "Eyring K", "Agrawal P", "Agarwal S", "Shanmugam A", "Gupta S", "Vishwanath D", "Kumari K", "Hariharan AK", "Balaji SA", "Liang Q", "Robolledo B", "Gauribidanur Raghavendrachar V", "Oomer Farooque M", "Buresh CJ", "Ramamoorthy P", "Bahadur U", "Subramanian K", "Hariharan R", "Veeramachaneni V", "Sankaran S", "Gupta V"], "date": "2017-05-01T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Sen M, Katragadda S, Ravichandran A, Deshpande G, Parulekar M, Nayanala S, Vittal V, Shen W, Phooi Nee Yong M, Jacob J, Parchuru S, Dhanuskodi K, Eyring K, Agrawal P, Agarwal S, Shanmugam A, Gupta S, Vishwanath D, Kumari K, Hariharan AK, Balaji SA, Liang Q, Robolledo B, Gauribidanur Raghavendrachar V, Oomer Farooque M, Buresh CJ, Ramamoorthy P, Bahadur U, Subramanian K, Hariharan R, Veeramachaneni V, Sankaran S, Gupta V. StrandAdvantage test for early-line and advanced-stage treatment decisions in solid tumors. Cancer Med. PMID: 28371134", "BibTeX": "@article{28371134, title={StrandAdvantage test for early-line and advanced-stage treatment decisions in solid tumors.}, author={Sen M and Katragadda S and Ravichandran A and Deshpande G and Parulekar M and Nayanala S and Vittal V and Shen W and Phooi Nee Yong M and Jacob J and Parchuru S and Dhanuskodi K and Eyring K and Agrawal P and Agarwal S and Shanmugam A and Gupta S and Vishwanath D and Kumari K and Hariharan AK and Balaji SA and Liang Q and Robolledo B and Gauribidanur Raghavendrachar V and Oomer Farooque M and Buresh CJ and Ramamoorthy P and Bahadur U and Subramanian K and Hariharan R and Veeramachaneni V and Sankaran S and Gupta V}, journal={Cancer Med}}"}, "is_sup_mat_match": true}, {"pmid": 23243591, "pmcid": "PMC3518500", "title": "In silico prediction of tumor antigens derived from functional missense mutations of the cancer gene census.", "journal": "Oncoimmunology", "authors": ["Khalili JS", "Hanson RW", "Szallasi Z"], "date": "2012-11-01T00:00:00Z", "year": 2012, "snippets": [], "citations": {"NLM": "Khalili JS, Hanson RW, Szallasi Z. In silico prediction of tumor antigens derived from functional missense mutations of the cancer gene census. Oncoimmunology. PMID: 23243591", "BibTeX": "@article{23243591, title={In silico prediction of tumor antigens derived from functional missense mutations of the cancer gene census.}, author={Khalili JS and Hanson RW and Szallasi Z}, journal={Oncoimmunology}}"}, "is_sup_mat_match": true}, {"pmid": 27460824, "pmcid": "PMC4962446", "title": "The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.", "journal": "Genome Med", "authors": ["Garofalo A", "Sholl L", "Reardon B", "Taylor-Weiner A", "Amin-Mansour A", "Miao D", "Liu D", "Oliver N", "MacConaill L", "Ducar M", "Rojas-Rudilla V", "Giannakis M", "Ghazani A", "Gray S", "Janne P", "Garber J", "Joffe S", "Lindeman N", "Wagle N", "Garraway LA", "Van Allen EM"], "date": "2016-07-26T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Garofalo A, Sholl L, Reardon B, Taylor-Weiner A, Amin-Mansour A, Miao D, Liu D, Oliver N, MacConaill L, Ducar M, Rojas-Rudilla V, Giannakis M, Ghazani A, Gray S, Janne P, Garber J, Joffe S, Lindeman N, Wagle N, Garraway LA, Van Allen EM. The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine. Genome Med. PMID: 27460824", "BibTeX": "@article{27460824, title={The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.}, author={Garofalo A and Sholl L and Reardon B and Taylor-Weiner A and Amin-Mansour A and Miao D and Liu D and Oliver N and MacConaill L and Ducar M and Rojas-Rudilla V and Giannakis M and Ghazani A and Gray S and Janne P and Garber J and Joffe S and Lindeman N and Wagle N and Garraway LA and Van Allen EM}, journal={Genome Med}}"}, "is_sup_mat_match": true}, {"pmid": 24898935, "pmcid": "PMC4046135", "title": "Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies.", "journal": "Sci Rep", "authors": ["Yadav B", "Pemovska T", "Szwajda A", "Kulesskiy E", "Kontro M", "Karjalainen R", "Majumder MM", "Malani D", "Murum\u00e4gi A", "Knowles J", "Porkka K", "Heckman C", "Kallioniemi O", "Wennerberg K", "Aittokallio T"], "date": "2014-06-05T00:00:00Z", "year": 2014, "snippets": [], "citations": {"NLM": "Yadav B, Pemovska T, Szwajda A, Kulesskiy E, Kontro M, Karjalainen R, Majumder MM, Malani D, Murum\u00e4gi A, Knowles J, Porkka K, Heckman C, Kallioniemi O, Wennerberg K, Aittokallio T. Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies. Sci Rep. PMID: 24898935", "BibTeX": "@article{24898935, title={Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies.}, author={Yadav B and Pemovska T and Szwajda A and Kulesskiy E and Kontro M and Karjalainen R and Majumder MM and Malani D and Murum\u00e4gi A and Knowles J and Porkka K and Heckman C and Kallioniemi O and Wennerberg K and Aittokallio T}, journal={Sci Rep}}"}, "is_sup_mat_match": true}, {"pmid": 27448974, "pmcid": "PMC5341823", "title": "Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma.", "journal": "Oncotarget", "authors": ["Rachiglio AM", "Esposito Abate R", "Sacco A", "Pasquale R", "Fenizia F", "Lambiase M", "Morabito A", "Montanino A", "Rocco G", "Romano C", "Nappi A", "Iaffaioli RV", "Tatangelo F", "Botti G", "Ciardiello F", "Maiello MR", "De Luca A", "Normanno N"], "date": "2016-10-11T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Rachiglio AM, Esposito Abate R, Sacco A, Pasquale R, Fenizia F, Lambiase M, Morabito A, Montanino A, Rocco G, Romano C, Nappi A, Iaffaioli RV, Tatangelo F, Botti G, Ciardiello F, Maiello MR, De Luca A, Normanno N. Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma. Oncotarget. PMID: 27448974", "BibTeX": "@article{27448974, title={Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma.}, author={Rachiglio AM and Esposito Abate R and Sacco A and Pasquale R and Fenizia F and Lambiase M and Morabito A and Montanino A and Rocco G and Romano C and Nappi A and Iaffaioli RV and Tatangelo F and Botti G and Ciardiello F and Maiello MR and De Luca A and Normanno N}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 27409166, "pmcid": "PMC5226597", "title": "Comprehensive profiling and quantitation of oncogenic mutations in non small-cell lung carcinoma using single molecule amplification and re-sequencing technology.", "journal": "Oncotarget", "authors": ["Zhang S", "Xia B", "Jiang H", "Wang L", "Xu R", "Shi Y", "Zhang J", "Xu M", "Cram DS", "Ma S"], "date": "2016-08-02T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Zhang S, Xia B, Jiang H, Wang L, Xu R, Shi Y, Zhang J, Xu M, Cram DS, Ma S. Comprehensive profiling and quantitation of oncogenic mutations in non small-cell lung carcinoma using single molecule amplification and re-sequencing technology. Oncotarget. PMID: 27409166", "BibTeX": "@article{27409166, title={Comprehensive profiling and quantitation of oncogenic mutations in non small-cell lung carcinoma using single molecule amplification and re-sequencing technology.}, author={Zhang S and Xia B and Jiang H and Wang L and Xu R and Shi Y and Zhang J and Xu M and Cram DS and Ma S}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 24803665, "pmcid": "PMC4188041", "title": "Structure-energy-based predictions and network modelling of RASopathy and cancer missense mutations.", "journal": "Mol Syst Biol", "authors": ["Kiel C", "Serrano L"], "date": "2014-05-06T00:00:00Z", "year": 2014, "snippets": [], "citations": {"NLM": "Kiel C, Serrano L. Structure-energy-based predictions and network modelling of RASopathy and cancer missense mutations. Mol Syst Biol. PMID: 24803665", "BibTeX": "@article{24803665, title={Structure-energy-based predictions and network modelling of RASopathy and cancer missense mutations.}, author={Kiel C and Serrano L}, journal={Mol Syst Biol}}"}, "is_sup_mat_match": true}, {"pmid": 36293442, "pmcid": "PMC9604078", "title": "Rationale for Combining the BCL2 Inhibitor Venetoclax with the PI3K Inhibitor Bimiralisib in the Treatment of IDH2- and FLT3-Mutated Acute Myeloid Leukemia.", "journal": "Int J Mol Sci", "authors": ["Seipel K", "Br\u00fcgger Y", "Mandhair H", "Bacher U", "Pabst T"], "date": "2022-10-20T00:00:00Z", "year": 2022, "snippets": [{"_id": "36293442@45948", "snip_text": "ID Disease Status FLT3 TP53 Gene Variants Karyotype   HL-60 AML (M2) de novo wt null NRAS Q61LCDKN2A R80X hypotetraploid   ML-2 AML (M4) de novo wt wt KMT2A-AFDNKRAS A146T t(6;11)   MOLM-13 AML (M5) relapse ITD wt KMT2A-MLLT3 t(9;11)   MOLM-16 AML (M0) relapse wt V173M/C238S MLL V1368L hypotetraploid   OCI-AML3 AML (M4) de novo wt wt DNMT3A R882CNRAS Q61LNPM1 L287fs +1, +5, +8   PL-21 AML (M3) de novo ITD/P336L wt/P36fs KRAS A146V hypertetraploid   SKM-1 AML (M5) refractory wt R248Q/R248Q ASXL1 Y591TerKRAS K117N del(9q12)   OCI-Ly1 DLBCL relapse wt  R158H/C176G BCL2-IgH, PTEN del t(14;18)   ", "section": "table", "mentions": ["151|5|gene|ncbi_gene@4297|KMT2A", "313|3|disease|ncbi_mesh@D015470|AML", "336|6|gene|ncbi_gene@1788|DNMT3A", "530|7|disease||OCI-Ly1", "482|5|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|R248Q", "220|5|gene|ncbi_gene@4300|MLLT3", "190|3|disease|ncbi_mesh@D015470|AML", "182|7|cellline||MOLM-13", "418|5|variant|litvar@#3845#p.P36fsX&&&litvar@#3845#|P36fs", "123|4|disease|ncbi_mesh@C537366|ML-2", "382|5|disease|omim@614338|PL-21", "166|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "568|4|gene|ncbi_gene@596|BCL2", "409|5|variant|litvar@rs775677376##&&&litvar@#1788#&&&litvar@CA1556119#rs775677376##|P336L", "304|8|disease||OCI-AML3", "578|4|gene|ncbi_gene@5728|PTEN", "538|5|disease||DLBCL", "556|5|variant|litvar@#596#p.R158H&&&litvar@#596#|R158H", "18|4|gene|ncbi_gene@2322|FLT3", "388|3|disease|ncbi_mesh@D015470|AML", "101|4|variant|litvar@#4893#p.R80X&&&litvar@#4893#|R80X", "453|9|cellline||SKM-1 AML", "488|5|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|R248Q", "264|5|variant|litvar@rs876660754##&&&litvar@#7157#&&&litvar@CA10577579#rs876660754##|V173M", "23|4|gene|ncbi_gene@7157|TP53", "562|5|variant|litvar@#596#c.176C>G&&&litvar@#596#|C176G", "429|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "573|3|gene|ncbi_gene@3492|IgH", "128|3|disease|ncbi_mesh@D015470|AML", "214|5|gene|ncbi_gene@4297|KMT2A", "85|4|gene|ncbi_gene@4893|NRAS", "512|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "362|6|variant|litvar@#1788#p.L287fsX&&&litvar@#1788#|L287fs", "60|3|disease|ncbi_mesh@D015470|AML", "494|5|gene|ncbi_gene@171023|ASXL1", "280|6|variant|litvar@rs782465551##&&&litvar@#4297#&&&litvar@CA6303788#rs782465551##|V1368L", "424|4|gene|ncbi_gene@3845|KRAS", "276|3|gene|ncbi_gene@4297|MLL", "244|3|disease|ncbi_mesh@D015470|AML", "236|7|cellline||MOLM-16", "270|5|variant|litvar@rs730882005##&&&litvar@#7157#|C238S", "54|5|cellline||HL-60"], "figure_id": "ijms-23-12587-t001", "text_hl": "ID Disease Status FLT3 TP53 Gene Variants Karyotype   HL-60 AML (M2) de novo wt null NRAS Q61LCDKN2A R80X hypotetraploid   ML-2 AML (M4) de novo wt wt KMT2A-AFDNKRAS <m>A146T</m> t(6;11)   MOLM-13 AML (M5) relapse ITD wt KMT2A-MLLT3 t(9;11)   MOLM-16 AML (M0) relapse wt V173M/C238S MLL V1368L hypotetraploid   OCI-AML3 AML (M4) de novo wt wt DNMT3A R882CNRAS Q61LNPM1 L287fs +1, +5, +8   PL-21 AML (M3) de novo ITD/P336L wt/P36fs KRAS A146V hypertetraploid   SKM-1 AML (M5) refractory wt R248Q/R248Q ASXL1 Y591TerKRAS K117N del(9q12)   OCI-Ly1 DLBCL relapse wt  R158H/C176G BCL2-IgH, PTEN del t(14;18)   "}], "citations": {"NLM": "Seipel K, Br\u00fcgger Y, Mandhair H, Bacher U, Pabst T. Rationale for Combining the BCL2 Inhibitor Venetoclax with the PI3K Inhibitor Bimiralisib in the Treatment of IDH2- and FLT3-Mutated Acute Myeloid Leukemia. Int J Mol Sci. PMID: 36293442", "BibTeX": "@article{36293442, title={Rationale for Combining the BCL2 Inhibitor Venetoclax with the PI3K Inhibitor Bimiralisib in the Treatment of IDH2- and FLT3-Mutated Acute Myeloid Leukemia.}, author={Seipel K and Br\u00fcgger Y and Mandhair H and Bacher U and Pabst T}, journal={Int J Mol Sci}}"}, "is_sup_mat_match": false}, {"pmid": 37258666, "pmcid": "PMC10322706", "title": "Pan-KRAS inhibitor disables oncogenic signalling and tumour growth", "journal": "Nature", "authors": ["Kim D", "Herdeis L", "Rudolph D", "Zhao Y", "B\u00f6ttcher J", "Vides A", "Ayala-Santos CI", "Pourfarjam Y", "Cuevas-Navarro A", "Xue JY", "Mantoulidis A", "Br\u00f6ker J", "Wunberg T", "Schaaf O", "Popow J", "Wolkerstorfer B", "Kropatsch KG", "Qu R", "de Stanchina E", "Sang B", "Li C", "McConnell DB", "Kraut N", "Lito P"], "date": "2023-05-31T00:00:00Z", "year": 2023, "snippets": [{"_id": "37258666@19220", "snip_text": "Twenty-four cell lines had KRAS mutations (G12C: n = 4, G12D: n = 5, G12V: n = 4, G12S: n = 1, G12R: n = 2, G13D: n = 3, Q61X: n = 2, K117N: n = 1, A146T: n = 2).", "section": "other", "mentions": ["108|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "121|4|variant|litvar@rs121913240##&&&litvar@#3845#|Q61X", "148|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "43|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "82|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "95|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "134|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "27|4|gene|ncbi_gene@3845|KRAS", "56|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "69|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V"], "text_hl": "Twenty-four cell lines had KRAS mutations (G12C: n = 4, G12D: n = 5, G12V: n = 4, G12S: n = 1, G12R: n = 2, G13D: n = 3, Q61X: n = 2, K117N: n = 1, <m>A146T</m>: n = 2)."}], "citations": {"NLM": "Kim D, Herdeis L, Rudolph D, Zhao Y, B\u00f6ttcher J, Vides A, Ayala-Santos CI, Pourfarjam Y, Cuevas-Navarro A, Xue JY, Mantoulidis A, Br\u00f6ker J, Wunberg T, Schaaf O, Popow J, Wolkerstorfer B, Kropatsch KG, Qu R, de Stanchina E, Sang B, Li C, McConnell DB, Kraut N, Lito P. Pan-KRAS inhibitor disables oncogenic signalling and tumour growth Nature. PMID: 37258666", "BibTeX": "@article{37258666, title={Pan-KRAS inhibitor disables oncogenic signalling and tumour growth}, author={Kim D and Herdeis L and Rudolph D and Zhao Y and B\u00f6ttcher J and Vides A and Ayala-Santos CI and Pourfarjam Y and Cuevas-Navarro A and Xue JY and Mantoulidis A and Br\u00f6ker J and Wunberg T and Schaaf O and Popow J and Wolkerstorfer B and Kropatsch KG and Qu R and de Stanchina E and Sang B and Li C and McConnell DB and Kraut N and Lito P}, journal={Nature}}"}, "is_sup_mat_match": false}, {"pmid": 25186134, "pmcid": "PMC4161839", "title": "Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia.", "journal": "BMC Infect Dis", "authors": ["Dymova MA", "Cherednichenko AG", "Alkhovik OI", "Khrapov EA", "Petrenko TI", "Filipenko ML"], "date": "2014-09-03T00:00:00Z", "year": 2014, "snippets": [{"_id": "25186134@21400", "snip_text": "No rpoB katG gidB pncA gyr A gyrB rpsL rrs tlyA   6 S531L, S540R S315T E92D A-11G S95T No mutation K43R 1401 A   G L11L   9 S531L, S540R S315T E92D I5T D94A, S95T No mutation K43R 1401 A   G, DelA 1473396 L11L   15 S531L, S540R S315T L10R T-7C D94N, S95T No mutation No mutation 1401 A   G, 685 G   A L11L   17 S531L, S540R S315T E92D 48InsG D94H, S95T No mutation K43R No mutation L11L   20 L511P, D516G, S540R S315T E92D L4W S95T No mutation No mutation No mutation L11L   21 S531L, S540R S315T E92D Y99STOP A90V, S95T No mutation K43R 1401 A   G L11L   37 S531L, S540R S315T E92D T76P D94A, S95T No mutation K43R No mutation L11L   38 S531L, S540R S315T E92D L120P D94E, S95T No mutation K43R 1401 A   G L11L   48 D516V, S540R S315T L10R T76P A90V, S95T No mutation No mutation 1401 A   G N/A   78 S531L, S540R S315T E92D A28D D94G, S95T No mutation K43R No mutation N/A   87 S531L, S540R S315T E92D D12A D94G, S95T No mutation K43R No mutation N/A   94 S531L S315T E92D V139A S91P, S95T No mutation K43R 1401 A   G N/A   96 H513L S315T N/A No mutation D94N, S95T No mutation No mutation No mutation N/A   128 S531L S315T E92D Del G pos256, S179V N/A No mutation K88R 1401 A   G L11L   133* S531L S315T E92D N/A D94G, S95T No mutation K43R 1401 A   G N/A   145 L533P, S540R S315T E92D Del C pos 428 D94G, S95T No mutation K43R No mutation L11L   158 S531L S315T E92D No mutation S95T No mutation K43R 1401 A   G N/A   169 S531L, S540R S315T E92D A-11G D94Y, S95T No mutation K43R No mutation L11L   171 S531L S315T E92D No mutation S95T No mutation K43R No mutation L11L   235 S531L S315T E92D V7G A90V, S95T No mutation K43R No mutation L11L   236* S531L, S540R S315T E92D N/A D94G, S95T No mutation K43R 1401 A   G L11L   238 S531L S315T I81I, E92D V45G, I31S D94G, S95T No mutation K43R 1401 A   G L11L   275 S531L S315T E92D No mutation D94A, S95T No mutation K43R 1401 A   G L11L   276 S531L S315T N/A No mutation S95T No mutation No mutation 1401 A   G N/A   285 S531L S315T E92D L172P D94A, S95T No mutation K43R 1401 A   G L11L   287 S531L S315T N/A I31S S91P, S95T No mutation K43R 1401 A   G N/A   300 S531L, S540R S315T E92D, R102P I31S A90V, S95T No mutation K43R 1401 A   G N/A   309 S531L, S540R S315T N/A A146T A90V, S95T No mutation K43R 1401 A   G N/A   1084 S531L, S540R S315T N/A D8N D94N, S95T No mutation K43R 1401 A   G N/A   4548 S531L S315T E92D Del A pos 353 D94G, S95T No mutation K43R 1401 A   G N/A   ", "section": "table", "mentions": ["1182|4|variant|litvar@#888164#p.L11L&&&litvar@#888164#|L11L", "820|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "2018|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "491|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "1641|4|variant|litvar@#888164#p.L11L&&&litvar@#888164#|L11L", "59|5|variant|litvar@#888164#p.S540R&&&litvar@#888164#|S540R", "1922|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "2051|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "124|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "1900|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "1743|4|variant|litvar@#888164#p.I81I&&&litvar@#888164#|I81I", "1359|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "65|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "853|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "908|4|variant|litvar@#888164#p.D94G&&&litvar@#888164#|D94G", "1215|4|variant|litvar@#888164#p.D94G&&&litvar@#888164#|D94G", "205|4|variant|litvar@#888164#p.L11L&&&litvar@#888164#|L11L", "1506|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "752|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "1194|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "578|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "1221|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "427|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "1399|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "2235|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "82|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "2134|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "1827|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "406|5|variant|litvar@#888164#p.S540R&&&litvar@#888164#|S540R", "2410|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "239|4|variant|litvar@#888164#c.-7T>C&&&litvar@#888164#|T-7C", "418|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "611|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "1815|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "234|4|variant|litvar@#888164#p.L10R&&&litvar@#888164#|L10R", "2387|4|variant|litvar@#888164#p.D94G&&&litvar@#888164#|D94G", "244|4|variant|litvar@#888164#p.D94N&&&litvar@#888164#|D94N", "1425|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "1264|5|variant|litvar@#888164#p.L533P&&&litvar@#888164#|L533P", "131|5|variant|litvar@#888164#p.S540R&&&litvar@#888164#|S540R", "115|4|variant|litvar@#888164#p.L11L&&&litvar@#888164#|L11L", "510|4|variant|litvar@#888164#p.A90V&&&litvar@#888164#|A90V", "1113|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "1552|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "914|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "969|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "175|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "801|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "1704|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "1681|4|variant|litvar@#888164#p.D94G&&&litvar@#888164#|D94G", "502|7|variant|litvar@#888164#p.Y99X&&&litvar@#888164#|Y99STOP", "736|4|variant|litvar@#888164#p.L10R&&&litvar@#888164#|L10R", "1984|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "1461|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "1449|5|variant|litvar@#888164#c.-11A>G&&&litvar@#888164#|A-11G", "516|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "1353|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "365|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "559|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "963|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "980|4|variant|litvar@#888164#p.S91P&&&litvar@#888164#|S91P", "1028|5|variant|litvar@#888164#p.H513L&&&litvar@#888164#|H513L", "651|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "668|4|variant|litvar@#888164#p.D94E&&&litvar@#888164#|D94E", "1271|5|variant|litvar@#888164#p.S540R&&&litvar@#888164#|S540R", "301|4|variant|litvar@#888164#p.L11L&&&litvar@#888164#|L11L", "549|4|variant|litvar@#888164#p.L11L&&&litvar@#888164#|L11L", "2174|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "808|5|variant|litvar@#888164#p.S540R&&&litvar@#888164#|S540R", "825|4|variant|litvar@#888164#p.A28D&&&litvar@#888164#|A28D", "2229|4|variant|litvar@#888164#p.A90V&&&litvar@#888164#|A90V", "1495|4|variant|litvar@#888164#p.L11L&&&litvar@#888164#|L11L", "1592|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "1731|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "2213|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "1580|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "2001|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "674|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "707|4|variant|litvar@#888164#p.L11L&&&litvar@#888164#|L11L", "330|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "1624|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "1166|4|variant|litvar@#888164#p.K88R&&&litvar@#888164#|K88R", "717|5|variant|litvar@#888164#p.D516V&&&litvar@#888164#|D516V", "1144|5|variant|litvar@#888164#p.S179V&&&litvar@#888164#|S179V", "566|5|variant|litvar@#888164#p.S540R&&&litvar@#888164#|S540R", "583|4|variant|litvar@#888164#p.T76P&&&litvar@#888164#|T76P", "1771|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "2223|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "836|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "2089|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "152|4|variant|litvar@#888164#p.D94A&&&litvar@#888164#|D94A", "1512|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "2122|5|variant|litvar@#888164#p.S540R&&&litvar@#888164#|S540R", "1804|4|variant|litvar@#888164#p.L11L&&&litvar@#888164#|L11L", "76|5|variant|litvar@#888164#c.-11A>G&&&litvar@#888164#|A-11G", "2279|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "2128|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "324|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "228|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "594|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "2329|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "1535|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "2306|4|variant|litvar@#888164#p.D94N&&&litvar@#888164#|D94N", "724|5|variant|litvar@#888164#p.S540R&&&litvar@#888164#|S540R", "741|4|variant|litvar@#888164#p.T76P&&&litvar@#888164#|T76P", "412|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "158|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "1788|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "423|3|variant|litvar@#888164#p.L4W&&&litvar@#888164#|L4W", "1821|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "1687|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "1325|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "250|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "137|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "99|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "2146|4|variant|litvar@#888164#p.I31S&&&litvar@#888164#|I31S", "1978|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "1995|4|variant|litvar@#888164#p.D94A&&&litvar@#888164#|D94A", "3|4|gene|ncbi_gene@888164|rpoB", "1666|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "1844|4|variant|litvar@#888164#p.D94A&&&litvar@#888164#|D94A", "2286|5|variant|litvar@#888164#p.S540R&&&litvar@#888164#|S540R", "1444|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "1238|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "1720|4|variant|litvar@#888164#p.L11L&&&litvar@#888164#|L11L", "1569|4|variant|litvar@#888164#p.L11L&&&litvar@#888164#|L11L", "348|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "974|5|variant|litvar@#888164#p.V139A&&&litvar@#888164#|V139A", "830|4|variant|litvar@#888164#p.D94G&&&litvar@#888164#|D94G", "1601|4|variant|litvar@#888164#p.A90V&&&litvar@#888164#|A90V", "662|5|variant|litvar@#888164#p.L120P&&&litvar@#888164#|L120P", "1867|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "478|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "1277|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "2356|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "2157|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "1989|5|variant|litvar@#888164#p.L172P&&&litvar@#888164#|L172P", "52|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "2061|4|variant|litvar@#888164#p.I31S&&&litvar@#888164#|I31S", "2368|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "318|5|variant|litvar@#888164#p.S540R&&&litvar@#888164#|S540R", "1034|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "1749|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "1478|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "468|4|variant|litvar@#888164#p.L11L&&&litvar@#888164#|L11L", "1382|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "2292|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "588|4|variant|litvar@#888164#p.D94A&&&litvar@#888164#|D94A", "814|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "2045|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "879|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "572|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "1754|4|variant|litvar@#888164#p.V45G&&&litvar@#888164#|V45G", "1586|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "497|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "1894|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "2072|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "2393|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "1760|4|variant|litvar@#888164#p.I31S&&&litvar@#888164#|I31S", "1119|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "148|3|variant|litvar@#888164#p.I5T&&&litvar@#888164#|I5T", "215|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "342|4|variant|litvar@#888164#p.D94H&&&litvar@#888164#|D94H", "71|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "2207|5|variant|litvar@#888164#p.S540R&&&litvar@#888164#|S540R", "746|4|variant|litvar@#888164#p.A90V&&&litvar@#888164#|A90V", "691|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "638|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "2252|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "886|5|variant|litvar@#888164#p.S540R&&&litvar@#888164#|S540R", "903|4|variant|litvar@#888164#p.D12A&&&litvar@#888164#|D12A", "898|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "2312|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "2151|4|variant|litvar@#888164#p.A90V&&&litvar@#888164#|A90V", "730|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "1518|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "1302|4|variant|litvar@#888164#p.D94G&&&litvar@#888164#|D94G", "1206|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "628|4|variant|litvar@#888164#p.L11L&&&litvar@#888164#|L11L", "1432|5|variant|litvar@#888164#p.S540R&&&litvar@#888164#|S540R", "2140|5|variant|litvar@#888164#p.R102P&&&litvar@#888164#|R102P", "1653|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "1308|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "931|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "986|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "1438|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "1455|4|variant|litvar@#888164#p.D94Y&&&litvar@#888164#|D94Y", "222|5|variant|litvar@#888164#p.S540R&&&litvar@#888164#|S540R", "143|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "392|5|variant|litvar@#888164#p.L511P&&&litvar@#888164#|L511P", "892|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "1125|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "657|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "957|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "1607|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "2200|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "2066|4|variant|litvar@#888164#p.S91P&&&litvar@#888164#|S91P", "645|5|variant|litvar@#888164#p.S540R&&&litvar@#888164#|S540R", "1200|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "1850|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "1056|4|variant|litvar@#888164#p.D94N&&&litvar@#888164#|D94N", "1737|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "533|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "382|4|variant|litvar@#888164#p.L11L&&&litvar@#888164#|L11L", "1597|3|variant|litvar@#888164#p.V7G&&&litvar@#888164#|V7G", "2362|5|variant|litvar@#888164#p.S315T&&&litvar@#888164#|S315T", "1062|4|variant|litvar@#888164#p.S95T&&&litvar@#888164#|S95T", "1672|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "1972|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "2034|4|variant|litvar@#888164#p.L11L&&&litvar@#888164#|L11L", "1883|4|variant|litvar@#888164#p.L11L&&&litvar@#888164#|L11L", "1660|5|variant|litvar@#888164#p.S540R&&&litvar@#888164#|S540R", "311|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "1365|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "1003|4|variant|litvar@#888164#p.K43R&&&litvar@#888164#|K43R", "1342|4|variant|litvar@#888164#p.L11L&&&litvar@#888164#|L11L", "485|5|variant|litvar@#888164#p.S540R&&&litvar@#888164#|S540R", "2115|5|variant|litvar@#888164#p.S531L&&&litvar@#888164#|S531L", "1283|4|variant|litvar@#888164#p.E92D&&&litvar@#888164#|E92D", "1765|4|variant|litvar@#888164#p.D94G&&&litvar@#888164#|D94G", "399|5|variant|litvar@#888164#p.D516G&&&litvar@#888164#|D516G"], "figure_id": "Tab3", "text_hl": "No rpoB katG gidB pncA gyr A gyrB rpsL rrs tlyA   6 S531L, S540R S315T E92D A-11G S95T No mutation K43R 1401 A   G L11L   9 S531L, S540R S315T E92D I5T D94A, S95T No mutation K43R 1401 A   G, DelA 1473396 L11L   15 S531L, S540R S315T L10R T-7C D94N, S95T No mutation No mutation 1401 A   G, 685 G   A L11L   17 S531L, S540R S315T E92D 48InsG D94H, S95T No mutation K43R No mutation L11L   20 L511P, D516G, S540R S315T E92D L4W S95T No mutation No mutation No mutation L11L   21 S531L, S540R S315T E92D Y99STOP A90V, S95T No mutation K43R 1401 A   G L11L   37 S531L, S540R S315T E92D T76P D94A, S95T No mutation K43R No mutation L11L   38 S531L, S540R S315T E92D L120P D94E, S95T No mutation K43R 1401 A   G L11L   48 D516V, S540R S315T L10R T76P A90V, S95T No mutation No mutation 1401 A   G N/A   78 S531L, S540R S315T E92D A28D D94G, S95T No mutation K43R No mutation N/A   87 S531L, S540R S315T E92D D12A D94G, S95T No mutation K43R No mutation N/A   94 S531L S315T E92D V139A S91P, S95T No mutation K43R 1401 A   G N/A   96 H513L S315T N/A No mutation D94N, S95T No mutation No mutation No mutation N/A   128 S531L S315T E92D Del G pos256, S179V N/A No mutation K88R 1401 A   G L11L   133* S531L S315T E92D N/A D94G, S95T No mutation K43R 1401 A   G N/A   145 L533P, S540R S315T E92D Del C pos 428 D94G, S95T No mutation K43R No mutation L11L   158 S531L S315T E92D No mutation S95T No mutation K43R 1401 A   G N/A   169 S531L, S540R S315T E92D A-11G D94Y, S95T No mutation K43R No mutation L11L   171 S531L S315T E92D No mutation S95T No mutation K43R No mutation L11L   235 S531L S315T E92D V7G A90V, S95T No mutation K43R No mutation L11L   236* S531L, S540R S315T E92D N/A D94G, S95T No mutation K43R 1401 A   G L11L   238 S531L S315T I81I, E92D V45G, I31S D94G, S95T No mutation K43R 1401 A   G L11L   275 S531L S315T E92D No mutation D94A, S95T No mutation K43R 1401 A   G L11L   276 S531L S315T N/A No mutation S95T No mutation No mutation 1401 A   G N/A   285 S531L S315T E92D L172P D94A, S95T No mutation K43R 1401 A   G L11L   287 S531L S315T N/A I31S S91P, S95T No mutation K43R 1401 A   G N/A   300 S531L, S540R S315T E92D, R102P I31S A90V, S95T No mutation K43R 1401 A   G N/A   309 S531L, S540R S315T N/A <m>A146T</m> A90V, S95T No mutation K43R 1401 A   G N/A   1084 S531L, S540R S315T N/A D8N D94N, S95T No mutation K43R 1401 A   G N/A   4548 S531L S315T E92D Del A pos 353 D94G, S95T No mutation K43R 1401 A   G N/A   "}], "citations": {"NLM": "Dymova MA, Cherednichenko AG, Alkhovik OI, Khrapov EA, Petrenko TI, Filipenko ML. Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia. BMC Infect Dis. PMID: 25186134", "BibTeX": "@article{25186134, title={Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia.}, author={Dymova MA and Cherednichenko AG and Alkhovik OI and Khrapov EA and Petrenko TI and Filipenko ML}, journal={BMC Infect Dis}}"}, "is_sup_mat_match": false}, {"pmid": 34064352, "pmcid": "PMC8147792", "title": "Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors.", "journal": "Pharmaceutics", "authors": ["Indini A", "Rijavec E", "Ghidini M", "Cortellini A", "Grossi F"], "date": "2021-05-04T00:00:00Z", "year": 2021, "snippets": [{"_id": "34064352@21434", "snip_text": "KRAS mutations occur in approximately 44% of metastatic CRC (mCRC), with the majority being observed in codons 12 and 13 of exon 2 (80% are G12D, G12V, G12C, G12A, and G13D), and less frequently in codon 61 of exon 3 (5% are Q61H, Q61L, and Q61R) and codon 146 of exon 4 (2% are A146T and A146V).", "section": "other", "mentions": ["168|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "152|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "158|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "231|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "279|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "225|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "0|4|gene|ncbi_gene@3845|KRAS", "61|4|disease|ncbi_mesh@D015179|mCRC", "45|14|disease|ncbi_mesh@D015179|metastatic CRC", "241|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "289|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "140|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "146|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V"], "text_hl": "KRAS mutations occur in approximately 44% of metastatic CRC (mCRC), with the majority being observed in codons 12 and 13 of exon 2 (80% are G12D, G12V, G12C, G12A, and G13D), and less frequently in codon 61 of exon 3 (5% are Q61H, Q61L, and Q61R) and codon 146 of exon 4 (2% are <m>A146T</m> and A146V)."}], "citations": {"NLM": "Indini A, Rijavec E, Ghidini M, Cortellini A, Grossi F. Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors. Pharmaceutics. PMID: 34064352", "BibTeX": "@article{34064352, title={Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors.}, author={Indini A and Rijavec E and Ghidini M and Cortellini A and Grossi F}, journal={Pharmaceutics}}"}, "is_sup_mat_match": false}, {"pmid": 30921324, "pmcid": "PMC6438456", "title": "Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers.", "journal": "PLoS Comput Biol", "authors": ["Nussinov R", "Jang H", "Tsai CJ", "Cheng F"], "date": "2019-03-28T00:00:00Z", "year": 2019, "snippets": [{"_id": "30921324@80448", "snip_text": "Two (K117N and A146T) resemble drivers, one (L19F) presented weakened phenotype, and one (R164Q) resembled wild-type K-Ras.", "section": "other", "mentions": ["90|5|variant|litvar@rs372793780##&&&litvar@#3845#&&&litvar@CA135580#rs372793780##|R164Q", "15|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "5|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "45|4|variant|litvar@rs121913538##&&&litvar@#3845#&&&litvar@CA210356#rs121913538##|L19F", "117|5|gene|ncbi_gene@3845|K-Ras"], "text_hl": "Two (K117N and A146T) resemble drivers, one (L19F) presented weakened phenotype, and one (R164Q) resembled wild-type K-Ras."}], "citations": {"NLM": "Nussinov R, Jang H, Tsai CJ, Cheng F. Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers. PLoS Comput Biol. PMID: 30921324", "BibTeX": "@article{30921324, title={Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers.}, author={Nussinov R and Jang H and Tsai CJ and Cheng F}, journal={PLoS Comput Biol}}"}, "is_sup_mat_match": false}, {"pmid": 36950276, "pmcid": "PMC10026147", "title": "Direct GDP-KRASG12C inhibitors and mechanisms of resistance: the tip of the iceberg", "journal": "Ther Adv Med Oncol", "authors": ["Rosen JC", "Sacher A", "Tsao MS"], "date": "2023-03-16T00:00:00Z", "year": 2023, "snippets": [{"_id": "36950276@42958", "snip_text": "Indeed, mutations in residues that impact GTP hydrolysis and nucleotide binding like G13D, A59S, K117N, and A146P were less resistant to G12Ci compared to mutations which prevent drug binding like G12R or Y96C.", "section": "introduction", "mentions": ["61|10|chemical|ncbi_mesh@D009711|nucleotide", "85|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "197|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "97|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "91|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA354836#rs121913528##|A59S", "205|4|variant|litvar@rs587781991##&&&litvar@#7157#&&&litvar@CA160#rs587781991##|Y96C", "137|5|chemical||G12Ci", "108|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "42|3|chemical|ncbi_mesh@D006160|GTP"], "text_hl": "Indeed, mutations in residues that impact GTP hydrolysis and nucleotide binding like G13D, A59S, K117N, and A146P were less resistant to G12Ci compared to mutations which prevent drug binding like G12R or Y96C."}], "citations": {"NLM": "Rosen JC, Sacher A, Tsao MS. Direct GDP-KRASG12C inhibitors and mechanisms of resistance: the tip of the iceberg Ther Adv Med Oncol. PMID: 36950276", "BibTeX": "@article{36950276, title={Direct GDP-KRASG12C inhibitors and mechanisms of resistance: the tip of the iceberg}, author={Rosen JC and Sacher A and Tsao MS}, journal={Ther Adv Med Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 37754227, "pmcid": "PMC10529370", "title": "HSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia", "journal": "Curr Issues Mol Biol", "authors": ["Seipel K", "Kohler S", "Bacher U", "Pabst T"], "date": "2023-08-23T00:00:00Z", "year": 2023, "snippets": [{"_id": "37754227@39647", "snip_text": "ID\tDisease\tStatus\tFLT3\tTP53\tGene Variants\tKaryotype\t \tML-2\tAML (M4)\tde novo\twt\twt\tKMT2A-AFDNKRAS A146T\tt(6;11)\t \tMOLM-13\tAML (M5)\trelapse\tITD\twt\tKMT2A-MLLT3\tt(9;11)\t \tMOLM-16\tAML (M0)\trelapse\twt\tV173M/C238S\tMLL V1368L\thypotetraploid\t \tOCI-AML3\tAML (M4)\tde novo\twt\twt\tDNMT3A R882CNRAS Q61LNPM1 L287fs\t+1, +5, +8\t \tPL-21\tAML (M3)\tde novo\tITD/P336L\twt/P36fs\tKRAS A146V\thypertetraploid\t \tSKM-1\tAML (M5)\trefractory\twt\tR248Q/R248Q\tASXL1 Y591*KRAS K117N\tdel(9q12)\t \t", "section": "table", "mentions": ["23|4|gene|ncbi_gene@7157|TP53", "360|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "201|5|variant|litvar@rs730882005##&&&litvar@#7157#|C238S", "267|6|gene|ncbi_gene@1788|DNMT3A", "195|5|variant|litvar@rs876660754##&&&litvar@#7157#&&&litvar@CA10577579#rs876660754##|V173M", "349|5|variant|litvar@#3845#p.P36fsX&&&litvar@#3845#|P36fs", "413|5|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|R248Q", "293|6|variant|litvar@#1788#p.L287fsX&&&litvar@#1788#|L287fs", "441|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "425|5|gene|ncbi_gene@171023|ASXL1", "340|5|variant|litvar@rs775677376##&&&litvar@#1788#&&&litvar@CA1556119#rs775677376##|P336L", "97|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "211|6|variant|litvar@rs782465551##&&&litvar@#4297#&&&litvar@CA6303788#rs782465551##|V1368L", "207|3|gene|ncbi_gene@4297|MLL", "355|4|gene|ncbi_gene@3845|KRAS", "18|4|gene|ncbi_gene@2322|FLT3", "419|5|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|R248Q", "436|4|gene|ncbi_gene@3845|KRAS"], "figure_id": "cimb-45-00443-t001", "text_hl": "ID\tDisease\tStatus\tFLT3\tTP53\tGene Variants\tKaryotype\t \tML-2\tAML (M4)\tde novo\twt\twt\tKMT2A-AFDNKRAS <m>A146T</m>\tt(6;11)\t \tMOLM-13\tAML (M5)\trelapse\tITD\twt\tKMT2A-MLLT3\tt(9;11)\t \tMOLM-16\tAML (M0)\trelapse\twt\tV173M/C238S\tMLL V1368L\thypotetraploid\t \tOCI-AML3\tAML (M4)\tde novo\twt\twt\tDNMT3A R882CNRAS Q61LNPM1 L287fs\t+1, +5, +8\t \tPL-21\tAML (M3)\tde novo\tITD/P336L\twt/P36fs\tKRAS A146V\thypertetraploid\t \tSKM-1\tAML (M5)\trefractory\twt\tR248Q/R248Q\tASXL1 Y591*KRAS K117N\tdel(9q12)\t \t"}], "citations": {"NLM": "Seipel K, Kohler S, Bacher U, Pabst T. HSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia Curr Issues Mol Biol. PMID: 37754227", "BibTeX": "@article{37754227, title={HSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia}, author={Seipel K and Kohler S and Bacher U and Pabst T}, journal={Curr Issues Mol Biol}}"}, "is_sup_mat_match": false}, {"pmid": 29163853, "pmcid": "PMC5685774", "title": "Mechanisms of resistance to irreversible epidermal growth factor receptor tyrosine kinase inhibitors and therapeutic strategies in non-small cell lung cancer.", "journal": "Oncotarget", "authors": ["Xu J", "Wang J", "Zhang S"], "date": "2017-09-22T00:00:00Z", "year": 2017, "snippets": [{"_id": "29163853@34115", "snip_text": "Furthermore, KRAS mutations (KRAS G12A/S, Q61H/K, A146T and G13D) were detected in plasma samples of CO-1686 or AZD9291 resistant patients with mutant T790M , which ranged from 5-14%.. The emergence of KRAS mutation (KRAS G12S) was also reported in mutant T790M biopsy tissue at relapse under AZD9291 by targeted sequencing and the mutant KRAS transduced cells (PC-9 or HCC827) were less sensitive to third-generation TKIs compared with WT KRAS transduced cells.", "section": "introduction", "mentions": ["202|4|gene|ncbi_gene@3845|KRAS", "339|4|gene|ncbi_gene@3845|KRAS", "370|6|cellline||HCC827", "293|7|chemical|ncbi_mesh@C000596361|AZD9291", "13|4|gene|ncbi_gene@3845|KRAS", "222|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "362|4|cellline||PC-9", "60|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "130|8|species|ncbi_taxonomy@9606|patients", "42|6|variant|litvar@rs17851045##&&&litvar@#3845#|Q61H/K", "50|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "101|7|chemical|ncbi_mesh@C000589977|CO-1686", "151|5|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|T790M", "34|6|variant|litvar@rs121913529##&&&litvar@#3845#|G12A/S", "29|4|gene|ncbi_gene@3845|KRAS", "440|4|gene|ncbi_gene@3845|KRAS", "217|4|gene|ncbi_gene@3845|KRAS", "112|7|chemical|ncbi_mesh@C000596361|AZD9291", "256|5|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|T790M"], "text_hl": "Furthermore, KRAS mutations (KRAS G12A/S, Q61H/K, <m>A146T</m> and G13D) were detected in plasma samples of CO-1686 or AZD9291 resistant patients with mutant T790M , which ranged from 5-14%.. The emergence of KRAS mutation (KRAS G12S) was also reported in mutant T790M biopsy tissue at relapse under AZD9291 by targeted sequencing and the mutant KRAS transduced cells (PC-9 or HCC827) were less sensitive to third-generation TKIs compared with WT KRAS transduced cells."}], "citations": {"NLM": "Xu J, Wang J, Zhang S. Mechanisms of resistance to irreversible epidermal growth factor receptor tyrosine kinase inhibitors and therapeutic strategies in non-small cell lung cancer. Oncotarget. PMID: 29163853", "BibTeX": "@article{29163853, title={Mechanisms of resistance to irreversible epidermal growth factor receptor tyrosine kinase inhibitors and therapeutic strategies in non-small cell lung cancer.}, author={Xu J and Wang J and Zhang S}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 37873284, "pmcid": "PMC10592899", "title": "Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium", "journal": "bioRxiv", "authors": ["Sheth AI", "Engel K", "Tolison H", "Althoff MJ", "Amaya ML", "Krug A", "Young T", "Pei S", "Patel SB", "Minhajuddin M", "Winters A", "Miller R", "Shelton I", "St-Germain J", "Ling T", "Jones C", "Raught B", "Gillen A", "Ransom M", "Staggs S", "Smith CA", "Pollyea DA", "Stevens BM", "Jordan CT"], "date": "2023-10-03T00:00:00Z", "year": 2023, "snippets": [{"_id": "37873284@106602", "snip_text": "Patient Sample Number\tSex\tAge\tDiagnosis\tKaryotyping\tMutations\t \tAML 1\tF\t73\tDe Novo AML\t45,XX,add(3)(q27),- 7,add(8)(q24),t(9;22)(q34;q11.2) /54,sl,+3,add(3)(q27),+7,+8,+10, +12,+13,+15,+20,+der(22)t(9;22) (q34;q11.2)\tN/A\t \tAML 2\tM\t21\tDe Novo AML\tinv(16) (p13.1q22)\tCKIT D816V\t \tAML 3\tM\t79\tPrior MDS, AML Relapse\t46,XY,t(6;9) (p21;q34)\tFLT3 ITD+ and FLT3 TKD mutation (D835); IDH2 R140Q;\t \tAML 4\tM\t52\tDe Novo AML\t45,XY,- 7/46,sl,+r(7)(p11q21)/46,sdl1, der(5)t(1;5) (q31;p14)/46,XY\tASXL1 c.4120_4121insT; DNMT3A c.885delG; Notch1 c.4746_4747insTGGGGA; NRAS c. 182A>G\t \tAML 5\tF\t49\tDe Novo AML\tNormal karyotype (46, XX)\tFLT3 ITD+, FLT3 D835\t \tAML 6\tNA\tNA\tDe Novo AML\tNA\tNA\t \tAML 7\tM\t47\tRelapse AML\t46,XY,del(7)(q21)/46,sl,del(5) (q31q35),add(12)(p13)/46,sl, add(12)(p13),del(17)(q21)/46, XY,del(9)(q22q32)\tIDH1 R132; CKIT D816V\t \tAML 8\tF\t49\tRelapse AML\tNormal karyotype (46, XX)\tFLT3 ITD+, FLT3 D835\t \tAML 9\tNA\t36\tRelapse AML\tNormal karyotype\tTET2.I1762V, ASXL1.L815P, CUX1.A448T, BCORL1.F111L, TP53.P33R\t \tAML 10\tNA\tNA\tNA\tclone 1: +8q, +3q, t(9;22); clone 2: clone 1 abnormalities AND +3, +10, +12 +13, +15 +20; clone 3: clone 2 abnormalities AND der (22); by FISH -7\tNA\t \tAML 11\tF\t74\tDe Novo AML\t46,XX\tFLT3 TKD (D835), NPM1+, TET2 c.4311_4318GAAAAAC, 41%, TET2.I1762V 24%, PTPN11.A72T 43%, ASXL1.L815P 100%, BCCORL1.F111L 100%, DNMT3AA.G354C 43%, CUX1.A448T 100%, NOTCH1.V2285I 41%, CBLC.P389S 38%.\t \tAML 12\tF\t65\tRelapse AML\t46,XX,add(14)(q22), 46,XX\tFLT3+, NPM1+, IDH1+\t \tAML 13\tF\t60\tDe Novo AML\t46,XX,t(9;11)(p21;q23)/47, sl,+21/47,sl,+8\tKRAS.G13D 23%, KRAS.A146T 6%, PTPN11.T52A 47%\t \tAML 14\tNA\tNA\tDe Novo AML\t45,X,-Y; t(9;11)(p22;q23)\tFLT3 ITD\t \tAML 15\tNA\tNA\tNA\t46,XX,inv(3)(q21q26)\tNA\t \tAML 16\tM\t52\tDe Novo AML\t46,XY,add(1)(p11),del(5)(q15q33),del(7)(q22q36),der(11)t(1;1 1)(p31;p12-14) , Loss of 5q31 and 7q31\tASXL1 c.4120_4121insT; DNMT3A c.885delG; Notch1 c.4746_4747insTGGGGA; NRAS c. 182A>G\t \tAML 17\tF\t77\tDe Novo AML\t46,XX\tNPM1: W288fs 45%, RUNX1: S469P 6%, TET2: V1232del 48%\t \tAML 18\tF\t80\tDe Novo AML\t47,XX,+8/47,XX,+11/44-45,XX,add(5)(p12),dic(5;12)(q10;q10) t(11;14)(q13;q32),dic(17;18)(q10;q10), add(20)(q11.2)[cp8]/44,XX,dic(5;12) (q10;q10),der(8)(11qter- >\tCBL M400R, SRSF2 P95H, TET2 Q916X and S1290X\t \t\t\t\t\t11q13::14q32- > 14q10::8p11.2- > 8qter),der(11)t(11;14)(q13;q32), dic(17;18)(q10;q10)/46,XX\t\t \tAML 19\tM\t63\tDe Novo AML\t46,XY\tFLT3 ITD+, NPM1+\t \tAML 20\tF\t64\tDe Novo AML\tNA\tNA\t \tAML 21\tM\t69\tCMML to AML\t46,XY\tNPM1.W288CFs*12 37%, ASXL1.G646Wfs*12 36%, NRAS.G12D 46%, STAG2.G46Rfs*41 11%, EZH2.Q533L 50%, EZH2.L149Q 49%, TET2.N1610Ifs*6 50%, TET2.Q1699* 50%\t \tAML 22\tF\tNA\tDe Novo AML\t46,XX,t(6;11)(q27;q23)/92,slx2\tKRAS.G12C 16%, PTPN11.E76L 7%\t \tAML 23\t\t\tRelapse AML\t46,XY\tNA\t \tAML 24\tNA\tNA\tNA\t Trisomy 8 in 37% of cells. Positive for IGH/CCND1 in 7.7% of cells, positive for trisomy 12 in 12.5% of cells, positive for trisomy 11 in 3.5% of cells, positive for a population with one copy of TP53 and three copies of centromere 17 comprising 3% of cells.\tNA\t \t", "section": "table", "mentions": ["875|4|gene|ncbi_gene@2322|FLT3", "1259|6|variant|litvar@#5781#p.I1762V&&&litvar@#5781#|I1762V", "1637|4|gene|ncbi_gene@2322|FLT3", "627|4|gene|ncbi_gene@2322|FLT3", "528|20|variant|litvar@#4851#c.4746_4747insTGGGGA&&&litvar@#4851#|c.4746_4747insTGGGGA", "991|4|gene|ncbi_gene@7157|TP53", "1956|5|variant|litvar@#4851#p.S469P&&&litvar@#4851#|S469P", "2189|4|variant|litvar@#2322#p.P95H&&&litvar@#2322#|P95H", "2210|6|variant|litvar@#2322#p.S1290X&&&litvar@#2322#|S1290X", "2759|5|gene|ncbi_gene@595|CCND1", "2176|5|variant|litvar@#2322#p.M400R&&&litvar@#2322#|M400R", "970|5|variant|litvar@#4851#p.A448T&&&litvar@#4851#|A448T", "521|6|gene|ncbi_gene@4851|Notch1", "1820|15|variant|litvar@#4851#c.4120_4121insT&&&litvar@#4851#|c.4120_4121insT", "1568|6|gene|ncbi_gene@5781|PTPN11", "886|4|gene|ncbi_gene@2322|FLT3", "558|6|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|182A>G", "2639|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "984|5|variant|litvar@rs1057519987##&&&litvar@#7157#|F111L", "1538|4|gene|ncbi_gene@3845|KRAS", "0|7|species|ncbi_taxonomy@9606|Patient", "1543|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1362|6|gene|ncbi_gene@4851|NOTCH1", "958|5|variant|litvar@#5781#p.L815P&&&litvar@#5781#|L815P", "1972|8|variant|litvar@#4851#p.V1232del&&&litvar@#4851#|V1232del", "1937|6|variant|litvar@#4851#p.W288fsX&&&litvar@#4851#|W288fs", "1862|20|variant|litvar@#4851#c.4746_4747insTGGGGA&&&litvar@#4851#|c.4746_4747insTGGGGA", "270|5|variant|litvar@rs121913507##&&&litvar@#3815#&&&litvar@CA123513#rs121913507##|D816V", "2755|3|gene|ncbi_gene@3492|IGH", "1294|5|variant|litvar@#5781#p.L815P&&&litvar@#5781#|L815P", "1278|4|variant|litvar@rs121918453##&&&litvar@#5781#&&&litvar@CA180706#rs121918453##|A72T", "2493|6|variant|litvar@#3845#p.G46RfsX&&&litvar@#3845#|G46Rfs", "2839|10|disease|ncbi_mesh@C538294|trisomy 11", "1892|6|variant|litvar@rs121912666##&&&litvar@#7157#&&&litvar@CA315#rs121912666##|182A>G", "1369|6|variant|litvar@rs61751489##&&&litvar@#4851#&&&litvar@CA161235#rs61751489##|V2285I", "1386|5|variant|litvar@#4851#p.P389S&&&litvar@#4851#|P389S", "2529|5|variant|litvar@#3845#p.L149Q&&&litvar@#3845#|L149Q", "2656|4|variant|litvar@#5781#p.E76L&&&litvar@#5781#|E76L", "1350|5|variant|litvar@#4851#p.A448T&&&litvar@#4851#|A448T", "2477|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1449|4|gene|ncbi_gene@2322|FLT3", "2634|4|gene|ncbi_gene@3845|KRAS", "335|4|gene|ncbi_gene@2322|FLT3", "818|5|variant|litvar@rs121913507##&&&litvar@#3815#&&&litvar@CA123513#rs121913507##|D816V", "996|4|variant|litvar@rs1042522##&&&litvar@#7157#&&&litvar@CA72#rs1042522##|P33R", "349|4|gene|ncbi_gene@2322|FLT3", "1314|5|variant|litvar@rs1057519987##&&&litvar@#7157#|F111L", "1844|9|variant|litvar@#4851#c.885delG&&&litvar@#4851#|c.885delG", "2200|5|variant|litvar@#2322#p.Q916X&&&litvar@#2322#|Q916X", "2796|10|disease|ncbi_mesh@C538299|trisomy 12", "944|6|variant|litvar@#5781#p.I1762V&&&litvar@#5781#|I1762V", "616|4|gene|ncbi_gene@2322|FLT3", "2513|5|variant|litvar@#3845#p.Q533L&&&litvar@#3845#|Q533L", "2456|7|variant|litvar@#2322#p.G646WfsX&&&litvar@#2322#|G646Wfs", "1558|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "486|15|variant|litvar@#4851#c.4120_4121insT&&&litvar@#4851#|c.4120_4121insT", "1575|4|variant|litvar@rs1060501198##&&&litvar@#7157#|T52A", "1334|5|variant|litvar@rs587781858##&&&litvar@#7157#&&&litvar@CA676#rs587781858##|G354C", "2911|4|gene|ncbi_gene@7157|TP53", "1271|6|gene|ncbi_gene@5781|PTPN11", "2649|6|gene|ncbi_gene@5781|PTPN11", "1553|4|gene|ncbi_gene@3845|KRAS", "1855|6|gene|ncbi_gene@4851|Notch1", "380|5|variant|litvar@#2322#p.R140Q&&&litvar@#2322#|R140Q", "2348|4|gene|ncbi_gene@2322|FLT3", "1200|4|gene|ncbi_gene@2322|FLT3", "510|9|variant|litvar@#4851#c.885delG&&&litvar@#4851#|c.885delG"], "figure_id": "T2", "text_hl": "Patient Sample Number\tSex\tAge\tDiagnosis\tKaryotyping\tMutations\t \tAML 1\tF\t73\tDe Novo AML\t45,XX,add(3)(q27),- 7,add(8)(q24),t(9;22)(q34;q11.2) /54,sl,+3,add(3)(q27),+7,+8,+10, +12,+13,+15,+20,+der(22)t(9;22) (q34;q11.2)\tN/A\t \tAML 2\tM\t21\tDe Novo AML\tinv(16) (p13.1q22)\tCKIT D816V\t \tAML 3\tM\t79\tPrior MDS, AML Relapse\t46,XY,t(6;9) (p21;q34)\tFLT3 ITD+ and FLT3 TKD mutation (D835); IDH2 R140Q;\t \tAML 4\tM\t52\tDe Novo AML\t45,XY,- 7/46,sl,+r(7)(p11q21)/46,sdl1, der(5)t(1;5) (q31;p14)/46,XY\tASXL1 c.4120_4121insT; DNMT3A c.885delG; Notch1 c.4746_4747insTGGGGA; NRAS c. 182A>G\t \tAML 5\tF\t49\tDe Novo AML\tNormal karyotype (46, XX)\tFLT3 ITD+, FLT3 D835\t \tAML 6\tNA\tNA\tDe Novo AML\tNA\tNA\t \tAML 7\tM\t47\tRelapse AML\t46,XY,del(7)(q21)/46,sl,del(5) (q31q35),add(12)(p13)/46,sl, add(12)(p13),del(17)(q21)/46, XY,del(9)(q22q32)\tIDH1 R132; CKIT D816V\t \tAML 8\tF\t49\tRelapse AML\tNormal karyotype (46, XX)\tFLT3 ITD+, FLT3 D835\t \tAML 9\tNA\t36\tRelapse AML\tNormal karyotype\tTET2.I1762V, ASXL1.L815P, CUX1.A448T, BCORL1.F111L, TP53.P33R\t \tAML 10\tNA\tNA\tNA\tclone 1: +8q, +3q, t(9;22); clone 2: clone 1 abnormalities AND +3, +10, +12 +13, +15 +20; clone 3: clone 2 abnormalities AND der (22); by FISH -7\tNA\t \tAML 11\tF\t74\tDe Novo AML\t46,XX\tFLT3 TKD (D835), NPM1+, TET2 c.4311_4318GAAAAAC, 41%, TET2.I1762V 24%, PTPN11.A72T 43%, ASXL1.L815P 100%, BCCORL1.F111L 100%, DNMT3AA.G354C 43%, CUX1.A448T 100%, NOTCH1.V2285I 41%, CBLC.P389S 38%.\t \tAML 12\tF\t65\tRelapse AML\t46,XX,add(14)(q22), 46,XX\tFLT3+, NPM1+, IDH1+\t \tAML 13\tF\t60\tDe Novo AML\t46,XX,t(9;11)(p21;q23)/47, sl,+21/47,sl,+8\tKRAS.G13D 23%, KRAS.A146T 6%, PTPN11.T52A 47%\t \tAML 14\tNA\tNA\tDe Novo AML\t45,X,-Y; t(9;11)(p22;q23)\tFLT3 ITD\t \tAML 15\tNA\tNA\tNA\t46,XX,inv(3)(q21q26)\tNA\t \tAML 16\tM\t52\tDe Novo AML\t46,XY,add(1)(p11),del(5)(q15q33),del(7)(q22q36),der(11)t(1;1 1)(p31;p12-14) , Loss of 5q31 and 7q31\tASXL1 c.4120_4121insT; DNMT3A c.885delG; Notch1 c.4746_4747insTGGGGA; NRAS c. 182A>G\t \tAML 17\tF\t77\tDe Novo AML\t46,XX\tNPM1: W288fs 45%, RUNX1: S469P 6%, TET2: V1232del 48%\t \tAML 18\tF\t80\tDe Novo AML\t47,XX,+8/47,XX,+11/44-45,XX,add(5)(p12),dic(5;12)(q10;q10) t(11;14)(q13;q32),dic(17;18)(q10;q10), add(20)(q11.2)[cp8]/44,XX,dic(5;12) (q10;q10),der(8)(11qter- >\tCBL M400R, SRSF2 P95H, TET2 Q916X and S1290X\t \t\t\t\t\t11q13::14q32- > 14q10::8p11.2- > 8qter),der(11)t(11;14)(q13;q32), dic(17;18)(q10;q10)/46,XX\t\t \tAML 19\tM\t63\tDe Novo AML\t46,XY\tFLT3 ITD+, NPM1+\t \tAML 20\tF\t64\tDe Novo AML\tNA\tNA\t \tAML 21\tM\t69\tCMML to AML\t46,XY\tNPM1.W288CFs*12 37%, ASXL1.G646Wfs*12 36%, NRAS.G12D 46%, STAG2.G46Rfs*41 11%, EZH2.Q533L 50%, EZH2.L149Q 49%, TET2.N1610Ifs*6 50%, TET2.Q1699* 50%\t \tAML 22\tF\tNA\tDe Novo AML\t46,XX,t(6;11)(q27;q23)/92,slx2\tKRAS.G12C 16%, PTPN11.E76L 7%\t \tAML 23\t\t\tRelapse AML\t46,XY\tNA\t \tAML 24\tNA\tNA\tNA\t Trisomy 8 in 37% of cells. Positive for IGH/CCND1 in 7.7% of cells, positive for trisomy 12 in 12.5% of cells, positive for trisomy 11 in 3.5% of cells, positive for a population with one copy of TP53 and three copies of centromere 17 comprising 3% of cells.\tNA\t \t"}], "citations": {"NLM": "Sheth AI, Engel K, Tolison H, Althoff MJ, Amaya ML, Krug A, Young T, Pei S, Patel SB, Minhajuddin M, Winters A, Miller R, Shelton I, St-Germain J, Ling T, Jones C, Raught B, Gillen A, Ransom M, Staggs S, Smith CA, Pollyea DA, Stevens BM, Jordan CT. Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium bioRxiv. PMID: 37873284", "BibTeX": "@article{37873284, title={Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium}, author={Sheth AI and Engel K and Tolison H and Althoff MJ and Amaya ML and Krug A and Young T and Pei S and Patel SB and Minhajuddin M and Winters A and Miller R and Shelton I and St-Germain J and Ling T and Jones C and Raught B and Gillen A and Ransom M and Staggs S and Smith CA and Pollyea DA and Stevens BM and Jordan CT}, journal={bioRxiv}}"}, "is_sup_mat_match": false}, {"pmid": 35273907, "pmcid": "PMC8902245", "title": "The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer.", "journal": "Front Oncol", "authors": ["Cai J", "Jiang H", "Li S", "Yan X", "Wang M", "Li N", "Zhu C", "Dong H", "Wang D", "Xu Y", "Xie H", "Wu S", "Lou J", "Zhao J", "Li Q"], "date": "2022-02-22T00:00:00Z", "year": 2022, "snippets": [{"_id": "35273907@32008", "snip_text": "Highest_Drug Highest_Level Gene and Variant_Classification Count   Afatinib LEVEL_1 EGFR : Missense_Mutation:p.G452A; EGFR : Missense_Mutation:p.L594Q; EGFR : Missense_Mutation:p.G452C; EGFR : Missense_Mutation:p.S501I; EGFR : Missense_Mutation:p.G452S 30   Alpelisib+Fulvestrant LEVEL_1 PIK3CA : Missense_Mutation:p.E545K; PIK3CA : Missense_Mutation:p.E542K; PIK3CA : Missense_Mutation:p.C420R;PIK3CA : Missense_Mutation:p.H1047R 17   Amivantamab,Mobocertinib LEVEL_1 EGFR : In_Frame_Ins:p.A500delinsASVD; EGFR : In_Frame_Ins:p.P505delinsPHG; EGFR : In_Frame_Ins:p.P505delinsPH;EGFR : In_Frame_Ins:p.N504delinsNPHVC; EGFR : In_Frame_Ins:p.D503delinsDNGP; EGFR : In_Frame_Ins:p.H506delinsPNPY;EGFR : In_Frame_Ins:p.D503delinsDN 16   Dabrafenib,Dabrafenib+Trametinib LEVEL_1 BRAF : Missense_Mutation:p.V600E 3   Enasidenib LEVEL_1 IDH2: Missense_Mutation:p.R10Q 1   Erlotinib,Erlotinib+Ramucirumab LEVEL_1 EGFR : In_Frame_Del:p.480_486del; EGFR : Missense_Mutation:p.L591R; EGFR : In_Frame_Del:p.479_483del; EGFR : In_Frame_Del:p.478_483del; EGFR : In_Frame_Del:p.479_484del; EGFR : In_Frame_Del:p.484_492del; EGFR : In_Frame_Del:p.479_481del; EGFR : In_Frame_Del:p.479_485del 228   Ivosidenib LEVEL_1 IDH1: Missense_Mutation:p.R132C 3   Olaparib LEVEL_1 ATM : Missense_Mutation:p.R2832H 1   Osimertinib LEVEL_1 EGFR : Missense_Mutation:p.T523M 26   Sotorasib LEVEL_1 KRAS : Missense_Mutation:p.G12C 18   Ado-Trastuzumab Emtansine,Trastuzumab Deruxtecan LEVEL_2 ERBB2 : In_Frame_Ins:p.E770delinsEAYVM;ERBB2:Missense_Mutation:p.S310F;ERBB2:In_Frame_Ins:p.V777delinsVGFP;ERBB2 : In_Frame_Ins:p.V777delinsVGSP;ERBB2:In_Frame_Ins:p.G776delinsVC;ERBB2:In_Frame_Ins:p.A771delinsAYVMA 24   Alpelisib+Fulvestrant LEVEL_2 PIK3CA : Missense_Mutation:p.M1043I; PIK3CA : Missense_Mutation:p.M1043V; PIK3CA : Missense_Mutation:p.V344G;PIK3CA : Missense_Mutation:p.R38C; PIK3CA : Missense_Mutation:p.G1049R; PIK3CA : Missense_Mutation:p.Q546H;PIK3CA : Missense_Mutation:p.C378F; PIK3CA : Missense_Mutation:p.C378R 8   Cobimetinib,Trametinib LEVEL_2 KRAS : Missense_Mutation:p.K117N; KRAS : Missense_Mutation:p.A146T; KRAS : Missense_Mutation:p.G13D; BRAF : Missense_Mutation:p.N581I; KRAS : Missense_Mutation:p.K117R; KRAS : Missense_Mutation:p.G12D; KRAS : Missense_Mutation:p.A59G; KRAS : Missense_Mutation:p.G12A; KRAS : Missense_Mutation:p.G12V; NRAS : Missense_Mutation:p.Q61L; BRAF : Missense_Mutation:p.G596R; BRAF : Missense_Mutation:p.K601E; MAP2K1:Missense_Mutation:p.P124S; NRAS : Missense_Mutation:p.Q61R 38   Afatinib LEVEL_3A EGFR : In_Frame_Del:p.442_443del; EGFR : In_Frame_Del:p.484_492del 4   AZD5363 LEVEL_3A AKT1 : Missense_Mutation:p.E17K 3   Debio1347,Infigratinib LEVEL_4 FGFR3 : Missense_Mutation:p.G375D 1   Everolimus,Temsirolimus LEVEL_4 MTOR : Missense_Mutation:p.C1483F 1   Lapatinib LEVEL_4 EGFR : Missense_Mutation:p.A244V 5   Palbociclib,Ribociclib LEVEL_4 CDKN2A : Nonsense_Mutation:p.E10X; CDKN2A:Nonsense_Mutation:p.S12X 6   ", "section": "table", "mentions": ["2169|4|gene|ncbi_gene@3845|KRAS", "1430|22|chemical|ncbi_mesh@C000614160|Trastuzumab Deruxtecan", "118|4|gene|ncbi_gene@1956|EGFR", "360|6|gene|ncbi_gene@5290|PIK3CA", "1856|6|gene|ncbi_gene@5290|PIK3CA", "2427|7|variant|litvar@rs121913364##&&&litvar@#673#&&&litvar@CA123645#rs121913364##|p.K601E", "2228|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "925|12|variant|litvar@#1956#p.480_486del&&&litvar@#1956#|p.480_486del", "1682|9|chemical|ncbi_mesh@C585539|Alpelisib", "766|7|chemical||LEVEL_1", "1225|7|variant|litvar@rs747458067##&&&litvar@#2475#&&&litvar@CA590955#rs747458067##|p.R132C", "1991|7|variant|litvar@rs536181987##&&&litvar@#2263#&&&litvar@CA5720768#rs536181987##|p.C378R", "1883|8|variant|litvar@rs121913277##&&&litvar@#5290#&&&litvar@CA16602520#rs121913277##|p.G1049R", "324|6|gene|ncbi_gene@5290|PIK3CA", "1955|7|variant|litvar@rs536181987##&&&litvar@#2263#|p.C378F", "2093|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "2261|6|variant|litvar@#3845#p.A59G&&&litvar@#3845#|p.A59G", "799|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "638|16|variant|litvar@#1956#p.DNGP503delins&&&litvar@#1956#|p.D503delinsDNGP", "973|4|gene|ncbi_gene@1956|EGFR", "2843|11|chemical|ncbi_mesh@C500026|Palbociclib", "2236|4|gene|ncbi_gene@3845|KRAS", "693|4|gene|ncbi_gene@1956|EGFR", "2461|7|variant|litvar@rs1057519732##&&&litvar@#5604#|p.P124S", "2750|4|gene|ncbi_gene@2475|MTOR", "1821|6|gene|ncbi_gene@5290|PIK3CA", "599|17|variant|litvar@#1956#p.NPHVC504delins&&&litvar@#1956#|p.N504delinsNPHVC", "2269|4|gene|ncbi_gene@3845|KRAS", "245|7|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126722#rs28929495##|p.G452S", "2393|7|variant|litvar@rs121913361##&&&litvar@#673#&&&litvar@CA16602422#rs121913361##|p.G596R", "395|6|gene|ncbi_gene@5290|PIK3CA", "2901|6|variant|litvar@rs121913382##&&&litvar@#1029#&&&litvar@CA16602755#rs121913382##|p.E10X", "854|6|variant|litvar@rs1292838154##&&&litvar@#472#|p.R10Q", "2302|4|gene|ncbi_gene@3845|KRAS", "1739|8|variant|litvar@rs121913283##&&&litvar@#5290#&&&litvar@CA183868#rs121913283##|p.M1043I", "897|7|chemical||LEVEL_1", "1606|5|gene|ncbi_gene@2064|ERBB2", "939|4|gene|ncbi_gene@1956|EGFR", "1311|4|gene|ncbi_gene@1956|EGFR", "489|16|variant|litvar@#1956#p.A,ASVD500delins&&&litvar@#1956#|p.A500delinsASVD", "315|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "885|11|chemical|ncbi_mesh@C543333|Ramucirumab", "2934|6|variant|litvar@rs141798398##&&&litvar@#1029#&&&litvar@CA190733105#rs141798398##|p.S12X", "1041|4|gene|ncbi_gene@1956|EGFR", "993|12|variant|litvar@#1956#p.479_483del&&&litvar@#1956#|p.479_483del", "1893|6|gene|ncbi_gene@5290|PIK3CA", "2507|8|chemical|ncbi_mesh@D000077716|Afatinib", "1625|14|variant|litvar@#2064#p.G,VC776delins&&&litvar@#2064#|p.G776delinsVC", "448|12|chemical|ncbi_mesh@C000720862|Mobocertinib", "2203|4|gene|ncbi_gene@3845|KRAS", "1813|7|variant|litvar@rs1057519941##&&&litvar@#5290#|p.V344G", "2294|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "2015|10|chemical|ncbi_mesh@C560077|Trametinib", "152|4|gene|ncbi_gene@1956|EGFR", "2909|6|gene|ncbi_gene@1029|CDKN2A", "579|4|gene|ncbi_gene@1956|EGFR", "1964|6|gene|ncbi_gene@5290|PIK3CA", "1404|3|chemical|ncbi_mesh@C110027|Ado", "2672|7|chemical||LEVEL_4", "1075|4|gene|ncbi_gene@1956|EGFR", "1692|11|chemical|ncbi_mesh@D000077267|Fulvestrant", "2327|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1027|12|variant|litvar@#1956#p.478_483del&&&litvar@#1956#|p.478_483del", "1278|8|variant|litvar@rs529296539##&&&litvar@#472#&&&litvar@CA157186#rs529296539##|p.R2832H", "2718|10|chemical|ncbi_mesh@D000068338|Everolimus", "84|4|gene|ncbi_gene@1956|EGFR", "1129|12|variant|litvar@#1956#p.479_481del&&&litvar@#1956#|p.479_481del", "676|16|variant|litvar@#1956#p.PNPY506delins&&&litvar@#1956#|p.H506delinsPNPY", "1928|6|gene|ncbi_gene@5290|PIK3CA", "186|4|gene|ncbi_gene@1956|EGFR", "1007|4|gene|ncbi_gene@1956|EGFR", "2680|5|gene|ncbi_gene@2261|FGFR3", "2706|7|variant|litvar@rs606231253##&&&litvar@#1956#&&&litvar@CA170941#rs606231253##|p.G375D", "1109|4|gene|ncbi_gene@1956|EGFR", "1061|12|variant|litvar@#1956#p.479_484del&&&litvar@#1956#|p.479_484del", "2160|7|variant|litvar@#3845#p.N581I&&&litvar@#3845#|p.N581I", "755|10|chemical|ncbi_mesh@C560077|Trametinib", "1776|8|variant|litvar@rs1057519936##&&&litvar@#5290#|p.M1043V", "774|4|gene|ncbi_gene@673|BRAF", "564|14|variant|litvar@#1956#p.PH505delins&&&litvar@#1956#|p.P505delinsPH", "2059|7|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.K117N", "422|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.H1047R", "436|11|chemical|ncbi_mesh@C000718215|Amivantamab", "618|4|gene|ncbi_gene@1956|EGFR", "2831|7|variant|litvar@rs149840192##&&&litvar@#1956#&&&litvar@CA16602664#rs149840192##|p.A244V", "1095|12|variant|litvar@#1956#p.484_492del&&&litvar@#1956#|p.484_492del", "865|9|chemical|ncbi_mesh@D000069347|Erlotinib", "2194|7|variant|litvar@rs587782329##&&&litvar@#7157#&&&litvar@CA391#rs587782329##|p.K117R", "1640|5|gene|ncbi_gene@2064|ERBB2", "220|4|gene|ncbi_gene@1956|EGFR", "1551|16|variant|litvar@#2064#p.VGFP777delins&&&litvar@#2064#|p.V777delinsVGFP", "2368|4|gene|ncbi_gene@673|BRAF", "1461|5|gene|ncbi_gene@2064|ERBB2", "1291|11|chemical|ncbi_mesh@C000596361|Osimertinib", "143|7|variant|litvar@rs121913444##&&&litvar@#1956#&&&litvar@CA176021#rs121913444##|p.L594Q", "527|15|variant|litvar@#1956#p.P,PHG505delins&&&litvar@#1956#|p.P505delinsPHG", "964|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L591R", "2525|4|gene|ncbi_gene@1956|EGFR", "1143|4|gene|ncbi_gene@1956|EGFR", "1336|7|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|p.T523M", "2788|17|chemical||Lapatinib LEVEL_4", "469|4|gene|ncbi_gene@1956|EGFR", "2003|11|chemical|ncbi_mesh@C574276|Cobimetinib", "2638|6|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|p.E17K", "2402|4|gene|ncbi_gene@673|BRAF", "387|7|variant|litvar@rs121913272##&&&litvar@#5290#&&&litvar@CA180900#rs121913272##|p.C420R", "2613|4|gene|ncbi_gene@207|AKT1", "1182|23|chemical||Ivosidenib LEVEL_1 IDH1", "1500|5|gene|ncbi_gene@2064|ERBB2", "1749|6|gene|ncbi_gene@5290|PIK3CA", "1920|7|variant|litvar@rs1057519940##&&&litvar@#5290#|p.Q546H", "1786|6|gene|ncbi_gene@5290|PIK3CA", "2068|4|gene|ncbi_gene@3845|KRAS", "351|7|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.E542K", "2360|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "177|7|variant|litvar@rs28929495##&&&litvar@#1956#&&&litvar@CA126719#rs28929495##|p.G452C", "2596|7|chemical|ncbi_mesh@C575618|AZD5363", "1392|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "258|9|chemical|ncbi_mesh@C585539|Alpelisib", "733|10|chemical|ncbi_mesh@C561627|Dabrafenib", "2127|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "2545|12|variant|litvar@#1956#p.442_443del&&&litvar@#1956#|p.442_443del", "1163|12|variant|litvar@#1956#p.479_485del&&&litvar@#1956#|p.479_485del", "1367|4|gene|ncbi_gene@3845|KRAS", "2102|4|gene|ncbi_gene@3845|KRAS", "2495|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Q61R", "109|7|variant|litvar@rs121913428##&&&litvar@#1956#&&&litvar@CA135775#rs121913428##|p.G452A", "2335|4|gene|ncbi_gene@4893|NRAS", "2729|12|chemical|ncbi_mesh@C401859|Temsirolimus", "1848|6|variant|litvar@rs749415085##&&&litvar@#5290#&&&litvar@CA2710497#rs749415085##|p.R38C", "875|9|chemical|ncbi_mesh@D000069347|Erlotinib", "211|7|variant|litvar@rs121913465##&&&litvar@#1956#&&&litvar@CA135840#rs121913465##|p.S501I", "2436|6|gene|ncbi_gene@5604|MAP2K1", "1303|7|chemical||LEVEL_1", "2855|10|chemical|ncbi_mesh@C000589651|Ribociclib", "656|4|gene|ncbi_gene@1956|EGFR", "268|11|chemical|ncbi_mesh@D000077267|Fulvestrant", "1524|7|variant|litvar@rs1057519816##&&&litvar@#2064#|p.S310F", "2135|4|gene|ncbi_gene@673|BRAF", "744|10|chemical|ncbi_mesh@C561627|Dabrafenib", "1408|21|chemical|ncbi_mesh@D000080044|Trastuzumab Emtansine", "1237|8|chemical|ncbi_mesh@C531550|Olaparib", "2470|4|gene|ncbi_gene@4893|NRAS", "905|4|gene|ncbi_gene@1956|EGFR", "288|6|gene|ncbi_gene@5290|PIK3CA", "1568|5|gene|ncbi_gene@2064|ERBB2", "1589|16|variant|litvar@#2064#p.VGSP777delins&&&litvar@#2064#|p.V777delinsVGSP", "2034|4|gene|ncbi_gene@3845|KRAS", "2579|12|variant|litvar@#1956#p.484_492del&&&litvar@#1956#|p.484_492del", "2775|8|variant|litvar@rs786205165##&&&litvar@#2475#&&&litvar@CA199563#rs786205165##|p.C1483F", "2806|4|gene|ncbi_gene@1956|EGFR", "507|4|gene|ncbi_gene@1956|EGFR", "461|7|chemical||LEVEL_1", "2559|4|gene|ncbi_gene@1956|EGFR", "1532|5|gene|ncbi_gene@2064|ERBB2", "544|4|gene|ncbi_gene@1956|EGFR"], "figure_id": "T4", "text_hl": "Highest_Drug Highest_Level Gene and Variant_Classification Count   Afatinib LEVEL_1 EGFR : Missense_Mutation:p.G452A; EGFR : Missense_Mutation:p.L594Q; EGFR : Missense_Mutation:p.G452C; EGFR : Missense_Mutation:p.S501I; EGFR : Missense_Mutation:p.G452S 30   Alpelisib+Fulvestrant LEVEL_1 PIK3CA : Missense_Mutation:p.E545K; PIK3CA : Missense_Mutation:p.E542K; PIK3CA : Missense_Mutation:p.C420R;PIK3CA : Missense_Mutation:p.H1047R 17   Amivantamab,Mobocertinib LEVEL_1 EGFR : In_Frame_Ins:p.A500delinsASVD; EGFR : In_Frame_Ins:p.P505delinsPHG; EGFR : In_Frame_Ins:p.P505delinsPH;EGFR : In_Frame_Ins:p.N504delinsNPHVC; EGFR : In_Frame_Ins:p.D503delinsDNGP; EGFR : In_Frame_Ins:p.H506delinsPNPY;EGFR : In_Frame_Ins:p.D503delinsDN 16   Dabrafenib,Dabrafenib+Trametinib LEVEL_1 BRAF : Missense_Mutation:p.V600E 3   Enasidenib LEVEL_1 IDH2: Missense_Mutation:p.R10Q 1   Erlotinib,Erlotinib+Ramucirumab LEVEL_1 EGFR : In_Frame_Del:p.480_486del; EGFR : Missense_Mutation:p.L591R; EGFR : In_Frame_Del:p.479_483del; EGFR : In_Frame_Del:p.478_483del; EGFR : In_Frame_Del:p.479_484del; EGFR : In_Frame_Del:p.484_492del; EGFR : In_Frame_Del:p.479_481del; EGFR : In_Frame_Del:p.479_485del 228   Ivosidenib LEVEL_1 IDH1: Missense_Mutation:p.R132C 3   Olaparib LEVEL_1 ATM : Missense_Mutation:p.R2832H 1   Osimertinib LEVEL_1 EGFR : Missense_Mutation:p.T523M 26   Sotorasib LEVEL_1 KRAS : Missense_Mutation:p.G12C 18   Ado-Trastuzumab Emtansine,Trastuzumab Deruxtecan LEVEL_2 ERBB2 : In_Frame_Ins:p.E770delinsEAYVM;ERBB2:Missense_Mutation:p.S310F;ERBB2:In_Frame_Ins:p.V777delinsVGFP;ERBB2 : In_Frame_Ins:p.V777delinsVGSP;ERBB2:In_Frame_Ins:p.G776delinsVC;ERBB2:In_Frame_Ins:p.A771delinsAYVMA 24   Alpelisib+Fulvestrant LEVEL_2 PIK3CA : Missense_Mutation:p.M1043I; PIK3CA : Missense_Mutation:p.M1043V; PIK3CA : Missense_Mutation:p.V344G;PIK3CA : Missense_Mutation:p.R38C; PIK3CA : Missense_Mutation:p.G1049R; PIK3CA : Missense_Mutation:p.Q546H;PIK3CA : Missense_Mutation:p.C378F; PIK3CA : Missense_Mutation:p.C378R 8   Cobimetinib,Trametinib LEVEL_2 KRAS : Missense_Mutation:p.K117N; KRAS : Missense_Mutation:p.A146T; KRAS : Missense_Mutation:p.G13D; BRAF : Missense_Mutation:p.N581I; KRAS : Missense_Mutation:p.K117R; KRAS : Missense_Mutation:p.G12D; KRAS : Missense_Mutation:p.A59G; KRAS : Missense_Mutation:p.G12A; KRAS : Missense_Mutation:p.G12V; NRAS : Missense_Mutation:p.Q61L; BRAF : Missense_Mutation:p.G596R; BRAF : Missense_Mutation:p.K601E; MAP2K1:Missense_Mutation:p.P124S; NRAS : Missense_Mutation:p.Q61R 38   Afatinib LEVEL_3A EGFR : In_Frame_Del:p.442_443del; EGFR : In_Frame_Del:p.484_492del 4   AZD5363 LEVEL_3A AKT1 : Missense_Mutation:p.E17K 3   Debio1347,Infigratinib LEVEL_4 FGFR3 : Missense_Mutation:p.G375D 1   Everolimus,Temsirolimus LEVEL_4 MTOR : Missense_Mutation:p.C1483F 1   Lapatinib LEVEL_4 EGFR : Missense_Mutation:p.A244V 5   Palbociclib,Ribociclib LEVEL_4 CDKN2A : Nonsense_Mutation:p.E10X; CDKN2A:Nonsense_Mutation:p.S12X 6   "}], "citations": {"NLM": "Cai J, Jiang H, Li S, Yan X, Wang M, Li N, Zhu C, Dong H, Wang D, Xu Y, Xie H, Wu S, Lou J, Zhao J, Li Q. The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer. Front Oncol. PMID: 35273907", "BibTeX": "@article{35273907, title={The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer.}, author={Cai J and Jiang H and Li S and Yan X and Wang M and Li N and Zhu C and Dong H and Wang D and Xu Y and Xie H and Wu S and Lou J and Zhao J and Li Q}, journal={Front Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 33365374, "pmcid": "PMC7749371", "title": "Genotyping data of routinely processed matched primary/metastatic tumor samples", "journal": "Data Brief", "authors": ["Kotoula V", "Chatzopoulos K", "Papadopoulou K", "Giannoulatou E", "Koliou GA", "Karavasilis V", "Pazarli E", "Pervana S", "Kafiri G", "Tsoulfas G", "Chrisafi S", "Sgouramali H", "Papakostas P", "Pectasides D", "Hytiroglou P", "Pentheroudakis G", "Fountzilas G"], "date": "2020-12-11T00:00:00Z", "year": 2020, "snippets": [], "citations": {"NLM": "Kotoula V, Chatzopoulos K, Papadopoulou K, Giannoulatou E, Koliou GA, Karavasilis V, Pazarli E, Pervana S, Kafiri G, Tsoulfas G, Chrisafi S, Sgouramali H, Papakostas P, Pectasides D, Hytiroglou P, Pentheroudakis G, Fountzilas G. Genotyping data of routinely processed matched primary/metastatic tumor samples Data Brief. PMID: 33365374", "BibTeX": "@article{33365374, title={Genotyping data of routinely processed matched primary/metastatic tumor samples}, author={Kotoula V and Chatzopoulos K and Papadopoulou K and Giannoulatou E and Koliou GA and Karavasilis V and Pazarli E and Pervana S and Kafiri G and Tsoulfas G and Chrisafi S and Sgouramali H and Papakostas P and Pectasides D and Hytiroglou P and Pentheroudakis G and Fountzilas G}, journal={Data Brief}}"}, "is_sup_mat_match": true}, {"pmid": 23165447, "pmcid": "PMC3588155", "title": "Use of multivariate analysis to suggest a new molecular classification of colorectal cancer", "journal": "J Pathol", "authors": ["Domingo E", "Ramamoorthy R", "Oukrif D", "Rosmarin D", "Presz M", "Wang H", "Pulker H", "Lockstone H", "Hveem T", "Cranston T", "Danielsen H", "Novelli M", "Davidson B", "Xu ZZ", "Molloy P", "Johnstone E", "Holmes C", "Midgley R", "Kerr D", "Sieber O", "Tomlinson I"], "date": "2013-02-01T00:00:00Z", "year": 2013, "snippets": [], "citations": {"NLM": "Domingo E, Ramamoorthy R, Oukrif D, Rosmarin D, Presz M, Wang H, Pulker H, Lockstone H, Hveem T, Cranston T, Danielsen H, Novelli M, Davidson B, Xu ZZ, Molloy P, Johnstone E, Holmes C, Midgley R, Kerr D, Sieber O, Tomlinson I. Use of multivariate analysis to suggest a new molecular classification of colorectal cancer J Pathol. PMID: 23165447", "BibTeX": "@article{23165447, title={Use of multivariate analysis to suggest a new molecular classification of colorectal cancer}, author={Domingo E and Ramamoorthy R and Oukrif D and Rosmarin D and Presz M and Wang H and Pulker H and Lockstone H and Hveem T and Cranston T and Danielsen H and Novelli M and Davidson B and Xu ZZ and Molloy P and Johnstone E and Holmes C and Midgley R and Kerr D and Sieber O and Tomlinson I}, journal={J Pathol}}"}, "is_sup_mat_match": true}, {"pmid": 36864254, "pmcid": "PMC10033412", "title": "Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer", "journal": "Nat Med", "authors": ["van de Haar J", "Ma X", "Ooft SN", "van der Helm PW", "Hoes LR", "Mainardi S", "Pinato DJ", "Sun K", "Salvatore L", "Tortora G", "Zurlo IV", "Leo S", "Giampieri R", "Berardi R", "Gelsomino F", "Merz V", "Mazzuca F", "Antonuzzo L", "Rosati G", "Stavraka C", "Ross P", "Rodriquenz MG", "Pavarana M", "Messina C", "Iveson T", "Zoratto F", "Thomas A", "Fenocchio E", "Ratti M", "Depetris I", "Cergnul M", "Morelli C", "Libertini M", "Parisi A", "De Tursi M", "Zanaletti N", "Garrone O", "Graham J", "Longarini R", "Gobba SM", "Petrillo A", "Tamburini E", "La Verde N", "Petrelli F", "Ricci V", "Wessels LFA", "Ghidini M", "Cortellini A", "Voest EE", "Valeri N"], "date": "2023-03-01T00:00:00Z", "year": 2023, "snippets": [], "citations": {"NLM": "van de Haar J, Ma X, Ooft SN, van der Helm PW, Hoes LR, Mainardi S, Pinato DJ, Sun K, Salvatore L, Tortora G, Zurlo IV, Leo S, Giampieri R, Berardi R, Gelsomino F, Merz V, Mazzuca F, Antonuzzo L, Rosati G, Stavraka C, Ross P, Rodriquenz MG, Pavarana M, Messina C, Iveson T, Zoratto F, Thomas A, Fenocchio E, Ratti M, Depetris I, Cergnul M, Morelli C, Libertini M, Parisi A, De Tursi M, Zanaletti N, Garrone O, Graham J, Longarini R, Gobba SM, Petrillo A, Tamburini E, La Verde N, Petrelli F, Ricci V, Wessels LFA, Ghidini M, Cortellini A, Voest EE, Valeri N. Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer Nat Med. PMID: 36864254", "BibTeX": "@article{36864254, title={Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer}, author={van de Haar J and Ma X and Ooft SN and van der Helm PW and Hoes LR and Mainardi S and Pinato DJ and Sun K and Salvatore L and Tortora G and Zurlo IV and Leo S and Giampieri R and Berardi R and Gelsomino F and Merz V and Mazzuca F and Antonuzzo L and Rosati G and Stavraka C and Ross P and Rodriquenz MG and Pavarana M and Messina C and Iveson T and Zoratto F and Thomas A and Fenocchio E and Ratti M and Depetris I and Cergnul M and Morelli C and Libertini M and Parisi A and De Tursi M and Zanaletti N and Garrone O and Graham J and Longarini R and Gobba SM and Petrillo A and Tamburini E and La Verde N and Petrelli F and Ricci V and Wessels LFA and Ghidini M and Cortellini A and Voest EE and Valeri N}, journal={Nat Med}}"}, "is_sup_mat_match": true}, {"pmid": 26203125, "pmcid": "PMC4527292", "title": "RASopathies: unraveling mechanisms with animal models.", "journal": "Dis Model Mech", "authors": ["Jindal GA", "Goyal Y", "Burdine RD", "Rauen KA", "Shvartsman SY"], "date": "2015-08-01T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Jindal GA, Goyal Y, Burdine RD, Rauen KA, Shvartsman SY. RASopathies: unraveling mechanisms with animal models. Dis Model Mech. PMID: 26203125", "BibTeX": "@article{26203125, title={RASopathies: unraveling mechanisms with animal models.}, author={Jindal GA and Goyal Y and Burdine RD and Rauen KA and Shvartsman SY}, journal={Dis Model Mech}}"}, "is_sup_mat_match": true}, {"pmid": 32242071, "pmcid": "PMC7118117", "title": "Single-cell analysis of a mutant library generated using CRISPR-guided deaminase in human melanoma cells.", "journal": "Commun Biol", "authors": ["Jun S", "Lim H", "Chun H", "Lee JH", "Bang D"], "date": "2020-04-02T00:00:00Z", "year": 2020, "snippets": [], "citations": {"NLM": "Jun S, Lim H, Chun H, Lee JH, Bang D. Single-cell analysis of a mutant library generated using CRISPR-guided deaminase in human melanoma cells. Commun Biol. PMID: 32242071", "BibTeX": "@article{32242071, title={Single-cell analysis of a mutant library generated using CRISPR-guided deaminase in human melanoma cells.}, author={Jun S and Lim H and Chun H and Lee JH and Bang D}, journal={Commun Biol}}"}, "is_sup_mat_match": true}, {"pmid": 30837471, "pmcid": "PMC6400950", "title": "The use of technical replication for detection of low-level somatic mutations in next-generation sequencing.", "journal": "Nat Commun", "authors": ["Kim J", "Kim D", "Lim JS", "Maeng JH", "Son H", "Kang HC", "Nam H", "Lee JH", "Kim S"], "date": "2019-03-05T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Kim J, Kim D, Lim JS, Maeng JH, Son H, Kang HC, Nam H, Lee JH, Kim S. The use of technical replication for detection of low-level somatic mutations in next-generation sequencing. Nat Commun. PMID: 30837471", "BibTeX": "@article{30837471, title={The use of technical replication for detection of low-level somatic mutations in next-generation sequencing.}, author={Kim J and Kim D and Lim JS and Maeng JH and Son H and Kang HC and Nam H and Lee JH and Kim S}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 27397505, "pmcid": "PMC4967469", "title": "A Landscape of Pharmacogenomic Interactions in Cancer.", "journal": "Cell", "authors": ["Iorio F", "Knijnenburg TA", "Vis DJ", "Bignell GR", "Menden MP", "Schubert M", "Aben N", "Gon\u00e7alves E", "Barthorpe S", "Lightfoot H", "Cokelaer T", "Greninger P", "van Dyk E", "Chang H", "de Silva H", "Heyn H", "Deng X", "Egan RK", "Liu Q", "Mironenko T", "Mitropoulos X", "Richardson L", "Wang J", "Zhang T", "Moran S", "Sayols S", "Soleimani M", "Tamborero D", "Lopez-Bigas N", "Ross-Macdonald P", "Esteller M", "Gray NS", "Haber DA", "Stratton MR", "Benes CH", "Wessels LFA", "Saez-Rodriguez J", "McDermott U", "Garnett MJ"], "date": "2016-07-28T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Iorio F, Knijnenburg TA, Vis DJ, Bignell GR, Menden MP, Schubert M, Aben N, Gon\u00e7alves E, Barthorpe S, Lightfoot H, Cokelaer T, Greninger P, van Dyk E, Chang H, de Silva H, Heyn H, Deng X, Egan RK, Liu Q, Mironenko T, Mitropoulos X, Richardson L, Wang J, Zhang T, Moran S, Sayols S, Soleimani M, Tamborero D, Lopez-Bigas N, Ross-Macdonald P, Esteller M, Gray NS, Haber DA, Stratton MR, Benes CH, Wessels LFA, Saez-Rodriguez J, McDermott U, Garnett MJ. A Landscape of Pharmacogenomic Interactions in Cancer. Cell. PMID: 27397505", "BibTeX": "@article{27397505, title={A Landscape of Pharmacogenomic Interactions in Cancer.}, author={Iorio F and Knijnenburg TA and Vis DJ and Bignell GR and Menden MP and Schubert M and Aben N and Gon\u00e7alves E and Barthorpe S and Lightfoot H and Cokelaer T and Greninger P and van Dyk E and Chang H and de Silva H and Heyn H and Deng X and Egan RK and Liu Q and Mironenko T and Mitropoulos X and Richardson L and Wang J and Zhang T and Moran S and Sayols S and Soleimani M and Tamborero D and Lopez-Bigas N and Ross-Macdonald P and Esteller M and Gray NS and Haber DA and Stratton MR and Benes CH and Wessels LFA and Saez-Rodriguez J and McDermott U and Garnett MJ}, journal={Cell}}"}, "is_sup_mat_match": true}, {"pmid": 35165384, "pmcid": "PMC9232935", "title": "Base editing sensor libraries for high-throughput engineering and functional analysis of cancer-associated single nucleotide variants.", "journal": "Nat Biotechnol", "authors": ["S\u00e1nchez-Rivera FJ", "Diaz BJ", "Kastenhuber ER", "Schmidt H", "Katti A", "Kennedy M", "Tem V", "Ho YJ", "Leibold J", "Paffenholz SV", "Barriga FM", "Chu K", "Goswami S", "Wuest AN", "Simon JM", "Tsanov KM", "Chakravarty D", "Zhang H", "Leslie CS", "Lowe SW", "Dow LE"], "date": "2022-06-01T00:00:00Z", "year": 2022, "snippets": [], "citations": {"NLM": "S\u00e1nchez-Rivera FJ, Diaz BJ, Kastenhuber ER, Schmidt H, Katti A, Kennedy M, Tem V, Ho YJ, Leibold J, Paffenholz SV, Barriga FM, Chu K, Goswami S, Wuest AN, Simon JM, Tsanov KM, Chakravarty D, Zhang H, Leslie CS, Lowe SW, Dow LE. Base editing sensor libraries for high-throughput engineering and functional analysis of cancer-associated single nucleotide variants. Nat Biotechnol. PMID: 35165384", "BibTeX": "@article{35165384, title={Base editing sensor libraries for high-throughput engineering and functional analysis of cancer-associated single nucleotide variants.}, author={S\u00e1nchez-Rivera FJ and Diaz BJ and Kastenhuber ER and Schmidt H and Katti A and Kennedy M and Tem V and Ho YJ and Leibold J and Paffenholz SV and Barriga FM and Chu K and Goswami S and Wuest AN and Simon JM and Tsanov KM and Chakravarty D and Zhang H and Leslie CS and Lowe SW and Dow LE}, journal={Nat Biotechnol}}"}, "is_sup_mat_match": true}, {"pmid": 34753780, "pmcid": "PMC9377769", "title": "The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA.", "journal": "Clin Cancer Res", "authors": ["Lee JK", "Hazar-Rethinam M", "Decker B", "Gjoerup O", "Madison RW", "Lieber DS", "Chung JH", "Schrock AB", "Creeden J", "Venstrom J", "Alexander B", "Oxnard GR"], "date": "2022-02-15T00:00:00Z", "year": 2022, "snippets": [], "citations": {"NLM": "Lee JK, Hazar-Rethinam M, Decker B, Gjoerup O, Madison RW, Lieber DS, Chung JH, Schrock AB, Creeden J, Venstrom J, Alexander B, Oxnard GR. The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA. Clin Cancer Res. PMID: 34753780", "BibTeX": "@article{34753780, title={The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA.}, author={Lee JK and Hazar-Rethinam M and Decker B and Gjoerup O and Madison RW and Lieber DS and Chung JH and Schrock AB and Creeden J and Venstrom J and Alexander B and Oxnard GR}, journal={Clin Cancer Res}}"}, "is_sup_mat_match": true}, {"pmid": 29570743, "pmcid": "PMC5865730", "title": "Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors.", "journal": "PLoS One", "authors": ["Pannuti A", "Filipovic A", "Hicks C", "Lefkowitz E", "Ptacek T", "Stebbing J", "Miele L"], "date": "2018-03-23T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Pannuti A, Filipovic A, Hicks C, Lefkowitz E, Ptacek T, Stebbing J, Miele L. Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors. PLoS One. PMID: 29570743", "BibTeX": "@article{29570743, title={Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors.}, author={Pannuti A and Filipovic A and Hicks C and Lefkowitz E and Ptacek T and Stebbing J and Miele L}, journal={PLoS One}}"}, "is_sup_mat_match": true}, {"pmid": 36751942, "pmcid": "PMC10070170", "title": "Dynamics of Age- versus Therapy-Related Clonal Hematopoiesis in Long-term Survivors of Pediatric Cancer", "journal": "Cancer Discov", "authors": ["Hagiwara K", "Natarajan S", "Wang Z", "Zubair H", "Mulder HL", "Dong L", "Plyler EM", "Thimmaiah P", "Ma X", "Ness KK", "Li Z", "Mulrooney DA", "Wilson CL", "Yasui Y", "Hudson MM", "Easton J", "Robison LL", "Zhang J"], "date": "2023-04-03T00:00:00Z", "year": 2023, "snippets": [], "citations": {"NLM": "Hagiwara K, Natarajan S, Wang Z, Zubair H, Mulder HL, Dong L, Plyler EM, Thimmaiah P, Ma X, Ness KK, Li Z, Mulrooney DA, Wilson CL, Yasui Y, Hudson MM, Easton J, Robison LL, Zhang J. Dynamics of Age- versus Therapy-Related Clonal Hematopoiesis in Long-term Survivors of Pediatric Cancer Cancer Discov. PMID: 36751942", "BibTeX": "@article{36751942, title={Dynamics of Age- versus Therapy-Related Clonal Hematopoiesis in Long-term Survivors of Pediatric Cancer}, author={Hagiwara K and Natarajan S and Wang Z and Zubair H and Mulder HL and Dong L and Plyler EM and Thimmaiah P and Ma X and Ness KK and Li Z and Mulrooney DA and Wilson CL and Yasui Y and Hudson MM and Easton J and Robison LL and Zhang J}, journal={Cancer Discov}}"}, "is_sup_mat_match": true}, {"pmid": 29988082, "pmcid": "PMC6485381", "title": "Prediction of acute myeloid leukaemia risk in healthy individuals.", "journal": "Nature", "authors": ["Abelson S", "Collord G", "Ng SWK", "Weissbrod O", "Mendelson Cohen N", "Niemeyer E", "Barda N", "Zuzarte PC", "Heisler L", "Sundaravadanam Y", "Luben R", "Hayat S", "Wang TT", "Zhao Z", "Cirlan I", "Pugh TJ", "Soave D", "Ng K", "Latimer C", "Hardy C", "Raine K", "Jones D", "Hoult D", "Britten A", "McPherson JD", "Johansson M", "Mbabaali F", "Eagles J", "Miller JK", "Pasternack D", "Timms L", "Krzyzanowski P", "Awadalla P", "Costa R", "Segal E", "Bratman SV", "Beer P", "Behjati S", "Martincorena I", "Wang JCY", "Bowles KM", "Quir\u00f3s JR", "Karakatsani A", "La Vecchia C", "Trichopoulou A", "Salamanca-Fern\u00e1ndez E", "Huerta JM", "Barricarte A", "Travis RC", "Tumino R", "Masala G", "Boeing H", "Panico S", "Kaaks R", "Kr\u00e4mer A", "Sieri S", "Riboli E", "Vineis P", "Foll M", "McKay J", "Polidoro S", "Sala N", "Khaw KT", "Vermeulen R", "Campbell PJ", "Papaemmanuil E", "Minden MD", "Tanay A", "Balicer RD", "Wareham NJ", "Gerstung M", "Dick JE", "Brennan P", "Vassiliou GS", "Shlush LI"], "date": "2018-07-01T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Abelson S, Collord G, Ng SWK, Weissbrod O, Mendelson Cohen N, Niemeyer E, Barda N, Zuzarte PC, Heisler L, Sundaravadanam Y, Luben R, Hayat S, Wang TT, Zhao Z, Cirlan I, Pugh TJ, Soave D, Ng K, Latimer C, Hardy C, Raine K, Jones D, Hoult D, Britten A, McPherson JD, Johansson M, Mbabaali F, Eagles J, Miller JK, Pasternack D, Timms L, Krzyzanowski P, Awadalla P, Costa R, Segal E, Bratman SV, Beer P, Behjati S, Martincorena I, Wang JCY, Bowles KM, Quir\u00f3s JR, Karakatsani A, La Vecchia C, Trichopoulou A, Salamanca-Fern\u00e1ndez E, Huerta JM, Barricarte A, Travis RC, Tumino R, Masala G, Boeing H, Panico S, Kaaks R, Kr\u00e4mer A, Sieri S, Riboli E, Vineis P, Foll M, McKay J, Polidoro S, Sala N, Khaw KT, Vermeulen R, Campbell PJ, Papaemmanuil E, Minden MD, Tanay A, Balicer RD, Wareham NJ, Gerstung M, Dick JE, Brennan P, Vassiliou GS, Shlush LI. Prediction of acute myeloid leukaemia risk in healthy individuals. Nature. PMID: 29988082", "BibTeX": "@article{29988082, title={Prediction of acute myeloid leukaemia risk in healthy individuals.}, author={Abelson S and Collord G and Ng SWK and Weissbrod O and Mendelson Cohen N and Niemeyer E and Barda N and Zuzarte PC and Heisler L and Sundaravadanam Y and Luben R and Hayat S and Wang TT and Zhao Z and Cirlan I and Pugh TJ and Soave D and Ng K and Latimer C and Hardy C and Raine K and Jones D and Hoult D and Britten A and McPherson JD and Johansson M and Mbabaali F and Eagles J and Miller JK and Pasternack D and Timms L and Krzyzanowski P and Awadalla P and Costa R and Segal E and Bratman SV and Beer P and Behjati S and Martincorena I and Wang JCY and Bowles KM and Quir\u00f3s JR and Karakatsani A and La Vecchia C and Trichopoulou A and Salamanca-Fern\u00e1ndez E and Huerta JM and Barricarte A and Travis RC and Tumino R and Masala G and Boeing H and Panico S and Kaaks R and Kr\u00e4mer A and Sieri S and Riboli E and Vineis P and Foll M and McKay J and Polidoro S and Sala N and Khaw KT and Vermeulen R and Campbell PJ and Papaemmanuil E and Minden MD and Tanay A and Balicer RD and Wareham NJ and Gerstung M and Dick JE and Brennan P and Vassiliou GS and Shlush LI}, journal={Nature}}"}, "is_sup_mat_match": true}, {"pmid": 29748584, "pmcid": "PMC5945620", "title": "The effects of mutational processes and selection on driver mutations across cancer types.", "journal": "Nat Commun", "authors": ["Temko D", "Tomlinson IPM", "Severini S", "Schuster-B\u00f6ckler B", "Graham TA"], "date": "2018-05-10T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Temko D, Tomlinson IPM, Severini S, Schuster-B\u00f6ckler B, Graham TA. The effects of mutational processes and selection on driver mutations across cancer types. Nat Commun. PMID: 29748584", "BibTeX": "@article{29748584, title={The effects of mutational processes and selection on driver mutations across cancer types.}, author={Temko D and Tomlinson IPM and Severini S and Schuster-B\u00f6ckler B and Graham TA}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 29340109, "pmcid": "PMC5762377", "title": "Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours.", "journal": "Oncotarget", "authors": ["Izquierdo E", "Yuan L", "George S", "Hubank M", "Jones C", "Proszek P", "Shipley J", "Gatz SA", "Stinson C", "Moore AS", "Clifford SC", "Hicks D", "Lindsey JC", "Hill RM", "Jacques TS", "Chalker J", "Thway K", "O'Connor S", "Marshall L", "Moreno L", "Pearson A", "Chesler L", "Walker BA", "De Castro DG"], "date": "2017-12-06T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Izquierdo E, Yuan L, George S, Hubank M, Jones C, Proszek P, Shipley J, Gatz SA, Stinson C, Moore AS, Clifford SC, Hicks D, Lindsey JC, Hill RM, Jacques TS, Chalker J, Thway K, O'Connor S, Marshall L, Moreno L, Pearson A, Chesler L, Walker BA, De Castro DG. Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours. Oncotarget. PMID: 29340109", "BibTeX": "@article{29340109, title={Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours.}, author={Izquierdo E and Yuan L and George S and Hubank M and Jones C and Proszek P and Shipley J and Gatz SA and Stinson C and Moore AS and Clifford SC and Hicks D and Lindsey JC and Hill RM and Jacques TS and Chalker J and Thway K and O'Connor S and Marshall L and Moreno L and Pearson A and Chesler L and Walker BA and De Castro DG}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 29760388, "pmcid": "PMC5951856", "title": "Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma.", "journal": "Nat Commun", "authors": ["North JP", "Golovato J", "Vaske CJ", "Sanborn JZ", "Nguyen A", "Wu W", "Goode B", "Stevers M", "McMullen K", "Perez White BE", "Collisson EA", "Bloomer M", "Solomon DA", "Benz SC", "Cho RJ"], "date": "2018-05-14T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "North JP, Golovato J, Vaske CJ, Sanborn JZ, Nguyen A, Wu W, Goode B, Stevers M, McMullen K, Perez White BE, Collisson EA, Bloomer M, Solomon DA, Benz SC, Cho RJ. Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma. Nat Commun. PMID: 29760388", "BibTeX": "@article{29760388, title={Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma.}, author={North JP and Golovato J and Vaske CJ and Sanborn JZ and Nguyen A and Wu W and Goode B and Stevers M and McMullen K and Perez White BE and Collisson EA and Bloomer M and Solomon DA and Benz SC and Cho RJ}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 31925297, "pmcid": "PMC6946677", "title": "Diversity spectrum analysis identifies mutation-specific effects of cancer driver genes.", "journal": "Commun Biol", "authors": ["Dong X", "Huang D", "Yi X", "Zhang S", "Wang Z", "Yan B", "Chung Sham P", "Chen K", "Jun Li M"], "date": "2020-01-07T00:00:00Z", "year": 2020, "snippets": [], "citations": {"NLM": "Dong X, Huang D, Yi X, Zhang S, Wang Z, Yan B, Chung Sham P, Chen K, Jun Li M. Diversity spectrum analysis identifies mutation-specific effects of cancer driver genes. Commun Biol. PMID: 31925297", "BibTeX": "@article{31925297, title={Diversity spectrum analysis identifies mutation-specific effects of cancer driver genes.}, author={Dong X and Huang D and Yi X and Zhang S and Wang Z and Yan B and Chung Sham P and Chen K and Jun Li M}, journal={Commun Biol}}"}, "is_sup_mat_match": true}, {"pmid": 27612425, "pmcid": "PMC5356579", "title": "The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy.", "journal": "Oncotarget", "authors": ["Ahn SM", "Ansari AA", "Kim J", "Kim D", "Chun SM", "Kim J", "Kim TW", "Park I", "Yu CS", "Jang SJ"], "date": "2016-10-18T00:00:00Z", "year": 2016, "snippets": [], "citations": {"NLM": "Ahn SM, Ansari AA, Kim J, Kim D, Chun SM, Kim J, Kim TW, Park I, Yu CS, Jang SJ. The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy. Oncotarget. PMID: 27612425", "BibTeX": "@article{27612425, title={The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy.}, author={Ahn SM and Ansari AA and Kim J and Kim D and Chun SM and Kim J and Kim TW and Park I and Yu CS and Jang SJ}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 26110843, "pmcid": "PMC4480953", "title": "Bioinformatics analysis of thousands of TCGA tumors to determine the involvement of epigenetic regulators in human cancer.", "journal": "BMC Genomics", "authors": ["Gnad F", "Doll S", "Manning G", "Arnott D", "Zhang Z"], "date": "2015-01-01T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Gnad F, Doll S, Manning G, Arnott D, Zhang Z. Bioinformatics analysis of thousands of TCGA tumors to determine the involvement of epigenetic regulators in human cancer. BMC Genomics. PMID: 26110843", "BibTeX": "@article{26110843, title={Bioinformatics analysis of thousands of TCGA tumors to determine the involvement of epigenetic regulators in human cancer.}, author={Gnad F and Doll S and Manning G and Arnott D and Zhang Z}, journal={BMC Genomics}}"}, "is_sup_mat_match": true}, {"pmid": 26090869, "pmcid": "PMC4695180", "title": "Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation.", "journal": "Oncotarget", "authors": ["Lionetti M", "Barbieri M", "Todoerti K", "Agnelli L", "Marzorati S", "Fabris S", "Ciceri G", "Galletti S", "Milesi G", "Manzoni M", "Mazzoni M", "Greco A", "Tonon G", "Musto P", "Baldini L", "Neri A"], "date": "2015-09-15T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Lionetti M, Barbieri M, Todoerti K, Agnelli L, Marzorati S, Fabris S, Ciceri G, Galletti S, Milesi G, Manzoni M, Mazzoni M, Greco A, Tonon G, Musto P, Baldini L, Neri A. Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation. Oncotarget. PMID: 26090869", "BibTeX": "@article{26090869, title={Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation.}, author={Lionetti M and Barbieri M and Todoerti K and Agnelli L and Marzorati S and Fabris S and Ciceri G and Galletti S and Milesi G and Manzoni M and Mazzoni M and Greco A and Tonon G and Musto P and Baldini L and Neri A}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 28157215, "pmcid": "PMC5386337", "title": "Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia.", "journal": "Blood Cancer J", "authors": ["Richter-Pecha\u0144ska P", "Kunz JB", "Hof J", "Zimmermann M", "Rausch T", "Bandapalli OR", "Orlova E", "Scapinello G", "Sagi JC", "Stanulla M", "Schrappe M", "Cario G", "Kirschner-Schwabe R", "Eckert C", "Benes V", "Korbel JO", "Muckenthaler MU", "Kulozik AE"], "date": "2017-02-03T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Richter-Pecha\u0144ska P, Kunz JB, Hof J, Zimmermann M, Rausch T, Bandapalli OR, Orlova E, Scapinello G, Sagi JC, Stanulla M, Schrappe M, Cario G, Kirschner-Schwabe R, Eckert C, Benes V, Korbel JO, Muckenthaler MU, Kulozik AE. Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia. Blood Cancer J. PMID: 28157215", "BibTeX": "@article{28157215, title={Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia.}, author={Richter-Pecha\u0144ska P and Kunz JB and Hof J and Zimmermann M and Rausch T and Bandapalli OR and Orlova E and Scapinello G and Sagi JC and Stanulla M and Schrappe M and Cario G and Kirschner-Schwabe R and Eckert C and Benes V and Korbel JO and Muckenthaler MU and Kulozik AE}, journal={Blood Cancer J}}"}, "is_sup_mat_match": true}, {"pmid": 29352306, "pmcid": "PMC5774843", "title": "Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR.", "journal": "PLoS One", "authors": ["Peraldo-Neia C", "Cavalloni G", "Fenocchio E", "Cagnazzo C", "Gammaitoni L", "Cereda S", "Nasti G", "Satolli MA", "Aprile G", "Reni M", "Avallone A", "Spadi R", "Venesio T", "Martin V", "Doglioni C", "Frattini M", "Aglietta M", "Leone F"], "date": "2018-01-19T00:00:00Z", "year": 2018, "snippets": [{"_id": "29352306@8800", "snip_text": "In our previous work we described 3 patients with BRAF V600E mutations, 2 with NRAS mutations (A146S and Q61R), and 2 with PIK3CA E545K mutations.", "section": "results", "mentions": ["79|4|gene|ncbi_gene@4893|NRAS", "105|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "36|8|species|ncbi_taxonomy@9606|patients", "123|6|gene|ncbi_gene@5290|PIK3CA", "130|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "50|4|gene|ncbi_gene@673|BRAF", "55|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "95|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146S"], "text_hl": "In our previous work we described 3 patients with BRAF V600E mutations, 2 with NRAS mutations (A146S and Q61R), and 2 with PIK3CA E545K mutations."}], "citations": {"NLM": "Peraldo-Neia C, Cavalloni G, Fenocchio E, Cagnazzo C, Gammaitoni L, Cereda S, Nasti G, Satolli MA, Aprile G, Reni M, Avallone A, Spadi R, Venesio T, Martin V, Doglioni C, Frattini M, Aglietta M, Leone F. Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR. PLoS One. PMID: 29352306", "BibTeX": "@article{29352306, title={Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR.}, author={Peraldo-Neia C and Cavalloni G and Fenocchio E and Cagnazzo C and Gammaitoni L and Cereda S and Nasti G and Satolli MA and Aprile G and Reni M and Avallone A and Spadi R and Venesio T and Martin V and Doglioni C and Frattini M and Aglietta M and Leone F}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 37700806, "pmcid": "PMC10494558", "title": "Targeting KRAS in pancreatic adenocarcinoma: Progress in demystifying the holy grail", "journal": "World J Clin Oncol", "authors": ["Elhariri A", "Alhaj A", "Ahn D", "Sonbol MB", "Bekaii-Saab T", "Wu C", "Rutenberg MS", "Stauffer J", "Starr J", "Majeed U", "Jones J", "Borad M", "Babiker H"], "date": "2023-08-24T00:00:00Z", "year": 2023, "snippets": [{"_id": "37700806@2400", "snip_text": "Others are A11T, A146T, A18V, G12A, G12I, G12L, G12S, G13C, G13D, G13H, G13P, G13R, L23V, Q61H, Q61K, Q61R.", "section": "figure_legend", "mentions": ["42|4|variant|litvar@rs121913530##&&&litvar@#3845#|G12L", "90|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "60|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "102|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "72|4|variant|litvar@rs112445441##&&&litvar@#3845#|G13P", "84|4|variant|litvar@#3845#p.L23V&&&litvar@#3845#|L23V", "54|4|variant|litvar@rs121913535##&&&litvar@#3845#&&&litvar@CA122542#rs121913535##|G13C", "24|4|variant|litvar@#3845#p.A18V&&&litvar@#3845#|A18V", "96|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "17|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "11|4|variant|litvar@#3845#c.11A>T&&&litvar@#3845#|A11T", "66|4|variant|litvar@rs112445441##&&&litvar@#3845#|G13H", "36|4|variant|litvar@rs121913530##&&&litvar@#3845#|G12I", "30|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "78|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "48|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S"], "figure_id": "F1", "text_hl": "Others are A11T, <m>A146T</m>, A18V, G12A, G12I, G12L, G12S, G13C, G13D, G13H, G13P, G13R, L23V, Q61H, Q61K, Q61R."}], "citations": {"NLM": "Elhariri A, Alhaj A, Ahn D, Sonbol MB, Bekaii-Saab T, Wu C, Rutenberg MS, Stauffer J, Starr J, Majeed U, Jones J, Borad M, Babiker H. Targeting KRAS in pancreatic adenocarcinoma: Progress in demystifying the holy grail World J Clin Oncol. PMID: 37700806", "BibTeX": "@article{37700806, title={Targeting KRAS in pancreatic adenocarcinoma: Progress in demystifying the holy grail}, author={Elhariri A and Alhaj A and Ahn D and Sonbol MB and Bekaii-Saab T and Wu C and Rutenberg MS and Stauffer J and Starr J and Majeed U and Jones J and Borad M and Babiker H}, journal={World J Clin Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 36900260, "pmcid": "PMC10001009", "title": "Predictive and Prognostic Value of Oncogene Mutations and Microsatellite Instability in Locally-Advanced Rectal Cancer Treated with Neoadjuvant Radiation-Based Therapy: A Systematic Review and Meta-Analysis", "journal": "Cancers (Basel)", "authors": ["De Mattia E", "Polesel J", "Mezzalira S", "Palazzari E", "Pollesel S", "Toffoli G", "Cecchin E"], "date": "2023-02-25T00:00:00Z", "year": 2023, "snippets": [{"_id": "36900260@17014", "snip_text": "Of note, El Otmani et al., in a subgroup analysis according to the specific codon mutations of KRAS, showed a significant association between mutations detected at codon 146 (i.e.  A146T and A146V) and the presence of both recurrence and distant metastases (p = 0.019).", "section": "results", "mentions": ["95|4|gene|ncbi_gene@3845|KRAS", "246|10|disease|ncbi_mesh@D009362|metastases", "181|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "191|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V"], "text_hl": "Of note, El Otmani et al., in a subgroup analysis according to the specific codon mutations of KRAS, showed a significant association between mutations detected at codon 146 (i.e.  <m>A146T</m> and A146V) and the presence of both recurrence and distant metastases (p = 0.019)."}], "citations": {"NLM": "De Mattia E, Polesel J, Mezzalira S, Palazzari E, Pollesel S, Toffoli G, Cecchin E. Predictive and Prognostic Value of Oncogene Mutations and Microsatellite Instability in Locally-Advanced Rectal Cancer Treated with Neoadjuvant Radiation-Based Therapy: A Systematic Review and Meta-Analysis Cancers (Basel). PMID: 36900260", "BibTeX": "@article{36900260, title={Predictive and Prognostic Value of Oncogene Mutations and Microsatellite Instability in Locally-Advanced Rectal Cancer Treated with Neoadjuvant Radiation-Based Therapy: A Systematic Review and Meta-Analysis}, author={De Mattia E and Polesel J and Mezzalira S and Palazzari E and Pollesel S and Toffoli G and Cecchin E}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 33328217, "pmcid": "PMC7611341", "title": "MNK Inhibition Sensitizes KRAS-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression.", "journal": "Cancer Discov", "authors": ["Knight JRP", "Alexandrou C", "Skalka GL", "Vlahov N", "Pennel K", "Officer L", "Teodosio A", "Kanellos G", "Gay DM", "May-Wilson S", "Smith EM", "Najumudeen AK", "Gilroy K", "Ridgway RA", "Flanagan DJ", "Smith RCL", "McDonald L", "MacKay C", "Cheasty A", "McArthur K", "Stanway E", "Leach JDG", "Jackstadt R", "Waldron JA", "Campbell AD", "Vlachogiannis G", "Valeri N", "Haigis KM", "Sonenberg N", "Proud CG", "Jones NP", "Swarbrick ME", "McKinnon HJ", "Faller WJ", "Le Quesne J", "Edwards J", "Willis AE", "Bushell M", "Sansom OJ"], "date": "2020-12-16T00:00:00Z", "year": 2020, "snippets": [{"_id": "33328217@9244", "snip_text": "In colorectal cancer KRASA146T can drive anti-EGFR resistance, but correlates with better survival than KRASG12D, and is less potent in cooperating with Apc loss in mouse models.", "section": "results", "mentions": ["3|17|disease|ncbi_mesh@D015179|colorectal cancer", "46|4|gene|ncbi_gene@13649|EGFR", "165|5|species|ncbi_taxonomy@10090|mouse", "21|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T", "153|3|gene|ncbi_gene@11789|Apc"], "text_hl": "In colorectal cancer KRASA146T can drive anti-EGFR resistance, but correlates with better survival than KRASG12D, and is less potent in cooperating with Apc loss in mouse models."}], "citations": {"NLM": "Knight JRP, Alexandrou C, Skalka GL, Vlahov N, Pennel K, Officer L, Teodosio A, Kanellos G, Gay DM, May-Wilson S, Smith EM, Najumudeen AK, Gilroy K, Ridgway RA, Flanagan DJ, Smith RCL, McDonald L, MacKay C, Cheasty A, McArthur K, Stanway E, Leach JDG, Jackstadt R, Waldron JA, Campbell AD, Vlachogiannis G, Valeri N, Haigis KM, Sonenberg N, Proud CG, Jones NP, Swarbrick ME, McKinnon HJ, Faller WJ, Le Quesne J, Edwards J, Willis AE, Bushell M, Sansom OJ. MNK Inhibition Sensitizes KRAS-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression. Cancer Discov. PMID: 33328217", "BibTeX": "@article{33328217, title={MNK Inhibition Sensitizes KRAS-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression.}, author={Knight JRP and Alexandrou C and Skalka GL and Vlahov N and Pennel K and Officer L and Teodosio A and Kanellos G and Gay DM and May-Wilson S and Smith EM and Najumudeen AK and Gilroy K and Ridgway RA and Flanagan DJ and Smith RCL and McDonald L and MacKay C and Cheasty A and McArthur K and Stanway E and Leach JDG and Jackstadt R and Waldron JA and Campbell AD and Vlachogiannis G and Valeri N and Haigis KM and Sonenberg N and Proud CG and Jones NP and Swarbrick ME and McKinnon HJ and Faller WJ and Le Quesne J and Edwards J and Willis AE and Bushell M and Sansom OJ}, journal={Cancer Discov}}"}, "is_sup_mat_match": false}, {"pmid": 37555357, "pmcid": "PMC10556276", "title": " DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell-rich histological mimics", "journal": "J Pathol Clin Res", "authors": ["Guimar\u00e3es LM", "Baumhoer D", "Andrei V", "Friedel D", "Koelsche C", "Gomez RS", "von Deimling A", "Gomes CC"], "date": "2023-11-01T00:00:00Z", "year": 2023, "snippets": [{"_id": "37555357@24584", "snip_text": "KRAS mutations (including the hot-spots p.G12A/D/V and p.G13D, and other variants p.K117N, p.A146P/T/V, p.Q61R/L, and p.A11Q) were reported in 64% of NOF of bone.", "section": "discussion", "mentions": ["55|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "118|6|variant|litvar@#3845#p.A11Q&&&litvar@#3845#|p.A11Q", "82|7|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.K117N", "91|7|variant|litvar@rs121913527##&&&litvar@#3845#|p.A146P", "40|8|variant|litvar@rs121913529##&&&litvar@#3845#|p.G12A/D", "0|4|gene|ncbi_gene@3845|KRAS", "104|6|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA261702#rs121913240##|p.Q61R", "150|11|disease|ncbi_mesh@D018214|NOF of bone"], "text_hl": "KRAS mutations (including the hot-spots p.G12A/D/V and p.G13D, and other variants p.K117N, p.A146P/T/V, p.Q61R/L, and p.A11Q) were reported in 64% of NOF of bone."}], "citations": {"NLM": "Guimar\u00e3es LM, Baumhoer D, Andrei V, Friedel D, Koelsche C, Gomez RS, von Deimling A, Gomes CC.  DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell-rich histological mimics J Pathol Clin Res. PMID: 37555357", "BibTeX": "@article{37555357, title={ DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell-rich histological mimics}, author={Guimar\u00e3es LM and Baumhoer D and Andrei V and Friedel D and Koelsche C and Gomez RS and von Deimling A and Gomes CC}, journal={J Pathol Clin Res}}"}, "is_sup_mat_match": false}, {"pmid": 37559590, "pmcid": "PMC10407719", "title": "Gastric metastasis from nodular malignant melanoma of the auricle with multigene aberrations: A rare case report and literature review", "journal": "Oncol Lett", "authors": ["Yuan YC", "Li Y", "Pan Y", "Gao B"], "date": "2023-07-13T00:00:00Z", "year": 2023, "snippets": [{"_id": "37559590@6365", "snip_text": "ARMS-PCR revealed the BRAF V600E mutation (Fig. 3), and no common NRAS (G12D, G12S, G13D, G13R, G12C, G12V, G12A, G13V, A59D, Q61R, Q61K, Q61L, Q61H, K117N, and A146T) mutations were found.", "section": "other", "mentions": ["27|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "108|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "102|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "120|4|variant|litvar@#4893#p.A59D&&&litvar@#4893#|A59D", "22|4|gene|ncbi_gene@673|BRAF", "161|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "72|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "114|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "132|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "84|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "150|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "144|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "126|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "66|4|gene|ncbi_gene@4893|NRAS", "78|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "96|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "90|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "138|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L"], "text_hl": "ARMS-PCR revealed the BRAF V600E mutation (Fig. 3), and no common NRAS (G12D, G12S, G13D, G13R, G12C, G12V, G12A, G13V, A59D, Q61R, Q61K, Q61L, Q61H, K117N, and <m>A146T</m>) mutations were found."}], "citations": {"NLM": "Yuan YC, Li Y, Pan Y, Gao B. Gastric metastasis from nodular malignant melanoma of the auricle with multigene aberrations: A rare case report and literature review Oncol Lett. PMID: 37559590", "BibTeX": "@article{37559590, title={Gastric metastasis from nodular malignant melanoma of the auricle with multigene aberrations: A rare case report and literature review}, author={Yuan YC and Li Y and Pan Y and Gao B}, journal={Oncol Lett}}"}, "is_sup_mat_match": false}, {"pmid": 29725370, "pmcid": "PMC5920233", "title": "Upregulation of c-mesenchymal epithelial transition expression and RAS mutations are associated with late lung metastasis and poor prognosis in colorectal carcinoma.", "journal": "Exp Ther Med", "authors": ["Liu J", "Zeng W", "Huang C", "Wang J", "Xu L", "Ma D"], "date": "2018-05-01T00:00:00Z", "year": 2018, "snippets": [{"_id": "29725370@12339", "snip_text": "Mapping correlations between molecular biomarkers demonstrated that 4 patients carried concurrent KRAS and NRAS mutations (combinations were p.G12D/p.G12D, p.G12D/p.A18T and p.A146T/p.Q61L), and in another 4 patients, KRAS and BRAF mutations (combinations were all p.G12D/p.V600E) were concomitantly observed.", "section": "results", "mentions": ["163|6|variant|litvar@rs121913248##&&&litvar@#4893#&&&litvar@CA16602497#rs121913248##|p.A18T", "174|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "182|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "70|8|species|ncbi_taxonomy@9606|patients", "265|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "208|8|species|ncbi_taxonomy@9606|patients", "156|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "148|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "272|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "141|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "98|4|gene|ncbi_gene@3845|KRAS", "218|4|gene|ncbi_gene@3845|KRAS", "227|4|gene|ncbi_gene@673|BRAF", "107|4|gene|ncbi_gene@4893|NRAS"], "text_hl": "Mapping correlations between molecular biomarkers demonstrated that 4 patients carried concurrent KRAS and NRAS mutations (combinations were p.G12D/p.G12D, p.G12D/p.A18T and <m>p.A146T</m>/p.Q61L), and in another 4 patients, KRAS and BRAF mutations (combinations were all p.G12D/p.V600E) were concomitantly observed."}], "citations": {"NLM": "Liu J, Zeng W, Huang C, Wang J, Xu L, Ma D. Upregulation of c-mesenchymal epithelial transition expression and RAS mutations are associated with late lung metastasis and poor prognosis in colorectal carcinoma. Exp Ther Med. PMID: 29725370", "BibTeX": "@article{29725370, title={Upregulation of c-mesenchymal epithelial transition expression and RAS mutations are associated with late lung metastasis and poor prognosis in colorectal carcinoma.}, author={Liu J and Zeng W and Huang C and Wang J and Xu L and Ma D}, journal={Exp Ther Med}}"}, "is_sup_mat_match": false}, {"pmid": 33672345, "pmcid": "PMC7927050", "title": "Germline and Somatic Whole-Exome Sequencing Identifies New Candidate Genes Involved in Familial Predisposition to Serrated Polyposis Syndrome.", "journal": "Cancers (Basel)", "authors": ["Soares de Lima Y", "Arnau-Collell C", "D\u00edaz-Gay M", "Bonjoch L", "Franch-Exp\u00f3sito S", "Mu\u00f1oz J", "Moreira L", "Oca\u00f1a T", "Cuatrecasas M", "Herrera-Pariente C", "Carballal S", "Moreno L", "D\u00edaz de Bustamante A", "Castells A", "Bujanda L", "Cubiella J", "Rodr\u00edguez-Alcalde D", "Balaguer F", "Castellv\u00ed-Bel S"], "date": "2021-02-23T00:00:00Z", "year": 2021, "snippets": [{"_id": "33672345@15438", "snip_text": "On the other hand, only one KRAS (A146T) variant of unknown significance (VUS) was identified in the somatic profile of one patient in family SPS.14 (Supplementary Table S4).", "section": "results", "mentions": ["124|7|species|ncbi_taxonomy@9606|patient", "28|4|gene|ncbi_gene@3845|KRAS", "34|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "142|6|disease|ncbi_mesh@D044483|SPS.14"], "text_hl": "On the other hand, only one KRAS (<m>A146T</m>) variant of unknown significance (VUS) was identified in the somatic profile of one patient in family SPS.14 (Supplementary Table S4)."}], "citations": {"NLM": "Soares de Lima Y, Arnau-Collell C, D\u00edaz-Gay M, Bonjoch L, Franch-Exp\u00f3sito S, Mu\u00f1oz J, Moreira L, Oca\u00f1a T, Cuatrecasas M, Herrera-Pariente C, Carballal S, Moreno L, D\u00edaz de Bustamante A, Castells A, Bujanda L, Cubiella J, Rodr\u00edguez-Alcalde D, Balaguer F, Castellv\u00ed-Bel S. Germline and Somatic Whole-Exome Sequencing Identifies New Candidate Genes Involved in Familial Predisposition to Serrated Polyposis Syndrome. Cancers (Basel). PMID: 33672345", "BibTeX": "@article{33672345, title={Germline and Somatic Whole-Exome Sequencing Identifies New Candidate Genes Involved in Familial Predisposition to Serrated Polyposis Syndrome.}, author={Soares de Lima Y and Arnau-Collell C and D\u00edaz-Gay M and Bonjoch L and Franch-Exp\u00f3sito S and Mu\u00f1oz J and Moreira L and Oca\u00f1a T and Cuatrecasas M and Herrera-Pariente C and Carballal S and Moreno L and D\u00edaz de Bustamante A and Castells A and Bujanda L and Cubiella J and Rodr\u00edguez-Alcalde D and Balaguer F and Castellv\u00ed-Bel S}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 26619011, "pmcid": "PMC4744099", "title": "Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.", "journal": "Nat Biotechnol", "authors": ["Chang MT", "Asthana S", "Gao SP", "Lee BH", "Chapman JS", "Kandoth C", "Gao J", "Socci ND", "Solit DB", "Olshen AB", "Schultz N", "Taylor BS"], "date": "2016-02-01T00:00:00Z", "year": 2016, "snippets": [{"_id": "26619011@25382", "snip_text": "Whereas activating KRAS A146T mutations arise predominantly in colorectal carcinomas (Supplementary Table 2), RAC1 A159V mutations are most common in head and neck cancers and were not present in any melanomas, despite the frequency of RAC1 P29S in this cancer type.", "section": "results", "mentions": ["200|9|disease|ncbi_mesh@D008545|melanomas", "254|6|disease|ncbi_mesh@D009369|cancer", "19|4|gene|ncbi_gene@3845|KRAS", "63|21|disease|ncbi_mesh@D015179|colorectal carcinomas", "236|4|gene|ncbi_gene@5879|RAC1", "110|4|gene|ncbi_gene@5879|RAC1", "150|21|disease|ncbi_mesh@D006258|head and neck cancers", "115|5|variant|litvar@rs753094370##&&&litvar@#4609#&&&litvar@CA4875290#rs753094370##|A159V", "24|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "241|4|variant|litvar@rs1057519874##&&&litvar@#5879#|P29S"], "text_hl": "Whereas activating KRAS <m>A146T</m> mutations arise predominantly in colorectal carcinomas (Supplementary Table 2), RAC1 A159V mutations are most common in head and neck cancers and were not present in any melanomas, despite the frequency of RAC1 P29S in this cancer type."}], "citations": {"NLM": "Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C, Gao J, Socci ND, Solit DB, Olshen AB, Schultz N, Taylor BS. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Nat Biotechnol. PMID: 26619011", "BibTeX": "@article{26619011, title={Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.}, author={Chang MT and Asthana S and Gao SP and Lee BH and Chapman JS and Kandoth C and Gao J and Socci ND and Solit DB and Olshen AB and Schultz N and Taylor BS}, journal={Nat Biotechnol}}"}, "is_sup_mat_match": false}, {"pmid": 25120700, "pmcid": "PMC4114707", "title": "Mutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinoma.", "journal": "Oncol Lett", "authors": ["Hou W", "Liu J", "Chen P", "Wang H", "Ye BC", "Qiang F"], "date": "2014-09-01T00:00:00Z", "year": 2014, "snippets": [{"_id": "25120700@17765", "snip_text": "Gene Mutation Forward primer sequence (5' to 3') Reverse primer sequence (5' to 3')   KRAS G12C, G12D, G13S, G13D, L19F, Q22K CTTAAGCGTCGATGGAGGAG CCCTGACATACTCCCAAGGA    A59T, Q61E, Q61R, Q61H GGTGCTTAGTGGCCATTTGT CCTAGGTTTCAATCCCAGCA    A146T TTGTGGACAGGTTTTGAAAGA AGAAACCAAAGCCAAAAGCA   NRAS G12S, G12V, G13R, G13V, A18T GCCCAAGGACTGTTGAAAAA CCGACAAGTGAGAGACAGGA    Q61K, Q61R, Q61H GGCAGAAATGGGCTTGAATA AGGTTAATATCCGCAAATGAC   HRAS G12S, G12V, G13R, G13D GTGGGTTTGCCCTTCAGAT TGGTGGATGTCCTCAAAAGA    Q61K, Q61R, Q61H TGGCTGTGTGAACTCCCC GTCAGTGAGTGCTGCTCCC   BRAF G464V, G466V, G469A, V471F CACTTGGTAGACGGGACTCG AGTTTATTGATGCGAACAGTGA    D594G, L597V, V600E AACTCTTCATAATGCTTGCTCTGA AGCCTCAATTCTTACCATCCA   PIK3CA R38G, Q75E, R108H GCCTAATCAAGTCAAACTATGGAA AAGCTTTATGGTTATTTGCATTTT    G118D ATGTTTGCTGCCTTTGCTCT ATAAGCAGTCCCTGCCTTCA    C378R TAAGGGGATTGTGGGCCTAT AATGGGGTCTTGCTTTGTTG    C420R CTCATGCTTGCTTTGGTTCA TTGGCATGCTCTTCAATCAC    P539R, E542K, E545K, E545G, Q546K GATTGGTTCTTTCCTGTCTCTG CCACAAATATCAATTTACAACCATTG    T1025A, M1043T, M1043I, H1047Y, H1047R, H1047L CATTTGCTCCAAACTGACCA CACCCCAAGCATTTTTCTTC   PIK3R1 G376R CAGACGGGACCTTTTTGGTA AACAAAATAGCTGACATGGAAACA    K459E, D464H GGCTTCTCTGACCCATTAACC CCCCACCTCATTCGTAAAAA    L570P GGAAGAGAAGCCACGCTTTA CCCAACCACTCGTTCAACTT   PTEN R130G, R130Q CCGTATAGCGTAAATTCCCAGA TCTCAGATCCAGGAAGAGGAA   R233X TGCTTGAGATCAAGATTGCAG GCCATAAGGCCTTTTCCTTC    ", "section": "table", "mentions": ["448|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "177|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA16602362#rs121913254##|Q61E", "587|5|variant|litvar@rs121913376##&&&litvar@#673#&&&litvar@CA281968#rs121913376##|V471F", "940|5|variant|litvar@rs121913285##&&&litvar@#5290#&&&litvar@CA16602696#rs121913285##|P539R", "1043|6|variant|litvar@rs121913283##&&&litvar@#5290#&&&litvar@CA183868#rs121913283##|M1043I", "1294|5|variant|litvar@rs121909224##&&&litvar@#5728#&&&litvar@CA16602437#rs121909224##|R130G", "301|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1239|5|variant|litvar@#5728#p.L570P&&&litvar@#5728#|L570P", "968|5|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123338#rs121913286##|Q546K", "647|5|variant|litvar@rs121913369##&&&litvar@#673#&&&litvar@CA123651#rs121913369##|L597V", "239|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "375|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "1354|5|variant|litvar@rs121909219##&&&litvar@#5728#&&&litvar@CA549#rs121909219##|R233X", "1067|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|H1047L", "1125|5|variant|litvar@rs1057519757##&&&litvar@#5295#|G376R", "1180|5|variant|litvar@#5295#p.K459E&&&litvar@#5295#|K459E", "709|6|gene|ncbi_gene@5290|PIK3CA", "91|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "109|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "1289|4|gene|ncbi_gene@5728|PTEN", "183|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "431|4|gene|ncbi_gene@3265|HRAS", "1035|6|variant|litvar@rs1057519937##&&&litvar@#5290#|M1043T", "716|4|variant|litvar@rs749415085##&&&litvar@#5290#|R38G", "307|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "1118|6|gene|ncbi_gene@5295|PIK3R1", "381|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "436|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "454|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "509|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "566|5|variant|litvar@rs121913348##&&&litvar@#673#&&&litvar@CA135076#rs121913348##|G464V", "640|5|variant|litvar@rs121913338##&&&litvar@#673#&&&litvar@CA123657#rs121913338##|D594G", "947|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "1059|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "1301|5|variant|litvar@rs121909229##&&&litvar@#5728#&&&litvar@CA437#rs121909229##|R130Q", "97|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "580|5|variant|litvar@rs121913355##&&&litvar@#673#&&&litvar@CA279970#rs121913355##|G469A", "515|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "290|4|gene|ncbi_gene@4893|NRAS", "787|5|variant|litvar@rs587777790##&&&litvar@#5290#&&&litvar@CA170883#rs587777790##|G118D", "115|4|variant|litvar@rs745476335##&&&litvar@#673#&&&litvar@CA4517047#rs745476335##|L19F", "189|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "654|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "961|5|variant|litvar@rs121913274##&&&litvar@#5290#&&&litvar@CA123336#rs121913274##|E545G", "728|5|variant|litvar@rs886042002##&&&litvar@#5290#&&&litvar@CA10602871#rs886042002##|R108H", "313|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "561|4|gene|ncbi_gene@673|BRAF", "1027|6|variant|litvar@rs397517202##&&&litvar@#5290#&&&litvar@CA136374#rs397517202##|T1025A", "1187|5|variant|litvar@rs121913348##&&&litvar@#673#|D464H", "838|5|variant|litvar@#5290#p.C378R&&&litvar@#5290#|C378R", "171|4|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|A59T", "954|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "295|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "103|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA16602674#rs121434595##|G13S", "722|4|variant|litvar@rs1285162474##&&&litvar@#174#|Q75E", "369|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "442|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "889|5|variant|litvar@rs121913272##&&&litvar@#5290#&&&litvar@CA180900#rs121913272##|C420R", "1051|6|variant|litvar@rs121913281##&&&litvar@#5290#&&&litvar@CA130471#rs121913281##|H1047Y", "121|4|variant|litvar@rs121917757##&&&litvar@#3265#&&&litvar@CA122553#rs121917757##|Q22K", "573|5|variant|litvar@rs121913351##&&&litvar@#673#&&&litvar@CA123647#rs121913351##|G466V", "503|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "319|4|variant|litvar@rs121913248##&&&litvar@#4893#&&&litvar@CA16602497#rs121913248##|A18T"], "figure_id": "tI-ol-08-03-1249", "text_hl": "Gene Mutation Forward primer sequence (5' to 3') Reverse primer sequence (5' to 3')   KRAS G12C, G12D, G13S, G13D, L19F, Q22K CTTAAGCGTCGATGGAGGAG CCCTGACATACTCCCAAGGA    A59T, Q61E, Q61R, Q61H GGTGCTTAGTGGCCATTTGT CCTAGGTTTCAATCCCAGCA    <m>A146T</m> TTGTGGACAGGTTTTGAAAGA AGAAACCAAAGCCAAAAGCA   NRAS G12S, G12V, G13R, G13V, A18T GCCCAAGGACTGTTGAAAAA CCGACAAGTGAGAGACAGGA    Q61K, Q61R, Q61H GGCAGAAATGGGCTTGAATA AGGTTAATATCCGCAAATGAC   HRAS G12S, G12V, G13R, G13D GTGGGTTTGCCCTTCAGAT TGGTGGATGTCCTCAAAAGA    Q61K, Q61R, Q61H TGGCTGTGTGAACTCCCC GTCAGTGAGTGCTGCTCCC   BRAF G464V, G466V, G469A, V471F CACTTGGTAGACGGGACTCG AGTTTATTGATGCGAACAGTGA    D594G, L597V, V600E AACTCTTCATAATGCTTGCTCTGA AGCCTCAATTCTTACCATCCA   PIK3CA R38G, Q75E, R108H GCCTAATCAAGTCAAACTATGGAA AAGCTTTATGGTTATTTGCATTTT    G118D ATGTTTGCTGCCTTTGCTCT ATAAGCAGTCCCTGCCTTCA    C378R TAAGGGGATTGTGGGCCTAT AATGGGGTCTTGCTTTGTTG    C420R CTCATGCTTGCTTTGGTTCA TTGGCATGCTCTTCAATCAC    P539R, E542K, E545K, E545G, Q546K GATTGGTTCTTTCCTGTCTCTG CCACAAATATCAATTTACAACCATTG    T1025A, M1043T, M1043I, H1047Y, H1047R, H1047L CATTTGCTCCAAACTGACCA CACCCCAAGCATTTTTCTTC   PIK3R1 G376R CAGACGGGACCTTTTTGGTA AACAAAATAGCTGACATGGAAACA    K459E, D464H GGCTTCTCTGACCCATTAACC CCCCACCTCATTCGTAAAAA    L570P GGAAGAGAAGCCACGCTTTA CCCAACCACTCGTTCAACTT   PTEN R130G, R130Q CCGTATAGCGTAAATTCCCAGA TCTCAGATCCAGGAAGAGGAA   R233X TGCTTGAGATCAAGATTGCAG GCCATAAGGCCTTTTCCTTC    "}], "citations": {"NLM": "Hou W, Liu J, Chen P, Wang H, Ye BC, Qiang F. Mutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinoma. Oncol Lett. PMID: 25120700", "BibTeX": "@article{25120700, title={Mutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinoma.}, author={Hou W and Liu J and Chen P and Wang H and Ye BC and Qiang F}, journal={Oncol Lett}}"}, "is_sup_mat_match": false}, {"pmid": 36044716, "pmcid": "PMC9489170", "title": "Durable Response to Nivolumab in a Patient With Hepatic Sarcomatoid Carcinoma: Evolutive Characterization of Genomic and Immunohistochemical PD-L1 Expression Findings.", "journal": "JCO Precis Oncol", "authors": ["Queiroz MM", "Munhoz RR", "Masotti C", "Souza LM", "Lima LGCA", "Asprino PF", "Begnami MDFS", "Camargo AA", "Bettoni F"], "date": "2022-08-01T00:00:00Z", "year": 2022, "snippets": [{"_id": "36044716@5586", "snip_text": "Next-generation sequencing revealed CD274 (PD-L1) and PDCD1LG2 (PD-L2) amplifications, CDKN2A/B loss, deletion of exons 2-7 of the CTNNB1 gene, and KRAS A146T, PIK3CA E542K, and FANCC A349fs*25 somatic mutations.", "section": "other", "mentions": ["43|5|gene|ncbi_gene@29126|PD-L1", "36|5|gene|ncbi_gene@29126|CD274", "54|8|gene|ncbi_gene@80380|PDCD1LG2", "167|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "153|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "131|6|gene|ncbi_gene@1499|CTNNB1", "184|6|variant|litvar@#2176#p.A349fsX&&&litvar@#2176#|A349fs", "64|5|gene|ncbi_gene@80380|PD-L2", "160|6|gene|ncbi_gene@5290|PIK3CA", "178|5|gene|ncbi_gene@2176|FANCC", "148|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "Next-generation sequencing revealed CD274 (PD-L1) and PDCD1LG2 (PD-L2) amplifications, CDKN2A/B loss, deletion of exons 2-7 of the CTNNB1 gene, and KRAS <m>A146T</m>, PIK3CA E542K, and FANCC A349fs*25 somatic mutations."}], "citations": {"NLM": "Queiroz MM, Munhoz RR, Masotti C, Souza LM, Lima LGCA, Asprino PF, Begnami MDFS, Camargo AA, Bettoni F. Durable Response to Nivolumab in a Patient With Hepatic Sarcomatoid Carcinoma: Evolutive Characterization of Genomic and Immunohistochemical PD-L1 Expression Findings. JCO Precis Oncol. PMID: 36044716", "BibTeX": "@article{36044716, title={Durable Response to Nivolumab in a Patient With Hepatic Sarcomatoid Carcinoma: Evolutive Characterization of Genomic and Immunohistochemical PD-L1 Expression Findings.}, author={Queiroz MM and Munhoz RR and Masotti C and Souza LM and Lima LGCA and Asprino PF and Begnami MDFS and Camargo AA and Bettoni F}, journal={JCO Precis Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 32428838, "pmcid": "PMC7232108", "title": "Tumor Location Is Associated With the Prevalence of Braf And Pik3ca Mutations in Patients with Wild-Type Ras Colorectal Cancer: A Prospective Multi-Center Cohort Study in Japan.", "journal": "Transl Oncol", "authors": ["Taniguchi H", "Uehara K", "Nakayama G", "Nakayama H", "Aiba T", "Hattori N", "Kataoka M", "Nakano Y", "Kawase Y", "Okochi O", "Matsuoka H", "Utsunomiya S", "Sakamoto E", "Mori Y", "Umeda S", "Shikano T", "Komori K", "Tajika M", "Kadowaki S", "Muro K", "Yatabe Y"], "date": "2020-07-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "32428838@8661", "snip_text": "We also used Genosearch  Mu-Pack , which detects mutations in KRAS codons 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H) and 146 (A146T, A146S, A146P, A146E, A146V, and A146G); NRAS codons 12 (G12A, G12D, G12C, G12S, G12R, and G12V), 13 (G13A, G13D, G13C, G13S, G13R, and G13V), and 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H); PIK3CA codons 542 (E542K), 545 (E545K), 546 (E546K), and 1047 (H1047R and H1047L); and BRAF V600 (V600E, V600K, V600D, and V600R).", "section": "methods", "mentions": ["127|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "208|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "448|5|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16021333#rs121913227##|V600R", "112|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "370|5|variant|litvar@#5290#p.E546K&&&litvar@#5290#|E546K", "259|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "155|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "62|4|gene|ncbi_gene@3845|KRAS", "190|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "241|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "296|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "269|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "357|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "214|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "344|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "196|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "90|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "302|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "423|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "134|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146S", "224|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "166|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146G", "247|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13C", "417|4|variant|litvar@rs121913227##&&&litvar@#673#|V600", "96|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "437|5|variant|litvar@rs121913377##&&&litvar@#673#&&&litvar@CA16602419#rs121913377##|V600D", "148|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146E", "284|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "388|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "412|4|gene|ncbi_gene@673|BRAF", "174|4|gene|ncbi_gene@4893|NRAS", "84|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "202|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "308|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "78|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "325|6|gene|ncbi_gene@5290|PIK3CA", "290|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "235|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602364#rs121434596##|G13A", "253|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA16602674#rs121434595##|G13S", "318|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "102|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "430|5|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16602420#rs121913227##|V600K", "141|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "399|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|H1047L"], "text_hl": "We also used Genosearch  Mu-Pack , which detects mutations in KRAS codons 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H) and 146 (<m>A146T</m>, A146S, A146P, A146E, A146V, and A146G); NRAS codons 12 (G12A, G12D, G12C, G12S, G12R, and G12V), 13 (G13A, G13D, G13C, G13S, G13R, and G13V), and 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H); PIK3CA codons 542 (E542K), 545 (E545K), 546 (E546K), and 1047 (H1047R and H1047L); and BRAF V600 (V600E, V600K, V600D, and V600R)."}], "citations": {"NLM": "Taniguchi H, Uehara K, Nakayama G, Nakayama H, Aiba T, Hattori N, Kataoka M, Nakano Y, Kawase Y, Okochi O, Matsuoka H, Utsunomiya S, Sakamoto E, Mori Y, Umeda S, Shikano T, Komori K, Tajika M, Kadowaki S, Muro K, Yatabe Y. Tumor Location Is Associated With the Prevalence of Braf And Pik3ca Mutations in Patients with Wild-Type Ras Colorectal Cancer: A Prospective Multi-Center Cohort Study in Japan. Transl Oncol. PMID: 32428838", "BibTeX": "@article{32428838, title={Tumor Location Is Associated With the Prevalence of Braf And Pik3ca Mutations in Patients with Wild-Type Ras Colorectal Cancer: A Prospective Multi-Center Cohort Study in Japan.}, author={Taniguchi H and Uehara K and Nakayama G and Nakayama H and Aiba T and Hattori N and Kataoka M and Nakano Y and Kawase Y and Okochi O and Matsuoka H and Utsunomiya S and Sakamoto E and Mori Y and Umeda S and Shikano T and Komori K and Tajika M and Kadowaki S and Muro K and Yatabe Y}, journal={Transl Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 35256486, "pmcid": "PMC7614788", "title": "FOCUS4 biomarker laboratories: from the benefits to the practical and logistical issues faced during 6 years of centralised testing", "journal": "J Clin Pathol", "authors": ["Richman SD", "Hemmings G", "Roberts H", "Gallop N", "Dodds R", "Wilkinson L", "Davis J", "White R", "Yates E", "Jasani B", "Brown L", "Maughan TS", "Butler R", "Quirke P", "Adams R"], "date": "2022-03-07T00:00:00Z", "year": 2022, "snippets": [{"_id": "35256486@17232", "snip_text": "Sample ID\tLeeds pyrosequencing (VAF)\tCardiff pyrosequencing (VAF)\tCardiff NGS (VAF)\t \tSample 4\tBRAF c.1799T>A (52%)\tBRAF c.1799T>A (50%)\tBRAF c.1799T>A (50%)TP53 c.844C>T (68%)\t \tSample 5\tKRAS c.35G>A (42%)PIK3CA c.1633G>A (51%)\tKRAS c.35G>A (55%)PIK3CA c.1633G>A (41%)\tKRAS c.35G>A (36%)PIK3CA c.1633G>A (50%)\t \tSample 6\tKRAS c.436G>A (72%)\tKRAS c.436G>A (100%)\tKRAS c.436G>A (72%)TP53 c.832C>T (66%)\t \t", "section": "table", "mentions": ["363|4|gene|ncbi_gene@3845|KRAS", "234|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "247|6|gene|ncbi_gene@5290|PIK3CA", "100|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "254|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G>A", "157|4|gene|ncbi_gene@7157|TP53", "95|4|gene|ncbi_gene@673|BRAF", "295|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G>A", "206|6|gene|ncbi_gene@5290|PIK3CA", "288|6|gene|ncbi_gene@5290|PIK3CA", "322|4|gene|ncbi_gene@3845|KRAS", "382|4|gene|ncbi_gene@7157|TP53", "121|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "347|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "116|4|gene|ncbi_gene@673|BRAF", "270|4|gene|ncbi_gene@3845|KRAS", "213|9|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G>A", "327|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "142|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "368|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "137|4|gene|ncbi_gene@673|BRAF", "188|4|gene|ncbi_gene@3845|KRAS", "193|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "275|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "162|8|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|c.844C>T", "229|4|gene|ncbi_gene@3845|KRAS", "387|8|variant|litvar@rs17849781##&&&litvar@#7157#|c.832C>T", "342|4|gene|ncbi_gene@3845|KRAS"], "figure_id": "T3", "text_hl": "Sample ID\tLeeds pyrosequencing (VAF)\tCardiff pyrosequencing (VAF)\tCardiff NGS (VAF)\t \tSample 4\tBRAF c.1799T>A (52%)\tBRAF c.1799T>A (50%)\tBRAF c.1799T>A (50%)TP53 c.844C>T (68%)\t \tSample 5\tKRAS c.35G>A (42%)PIK3CA c.1633G>A (51%)\tKRAS c.35G>A (55%)PIK3CA c.1633G>A (41%)\tKRAS c.35G>A (36%)PIK3CA c.1633G>A (50%)\t \tSample 6\tKRAS c.436G>A (72%)\tKRAS c.436G>A (100%)\tKRAS c.436G>A (72%)TP53 c.832C>T (66%)\t \t"}], "citations": {"NLM": "Richman SD, Hemmings G, Roberts H, Gallop N, Dodds R, Wilkinson L, Davis J, White R, Yates E, Jasani B, Brown L, Maughan TS, Butler R, Quirke P, Adams R. FOCUS4 biomarker laboratories: from the benefits to the practical and logistical issues faced during 6 years of centralised testing J Clin Pathol. PMID: 35256486", "BibTeX": "@article{35256486, title={FOCUS4 biomarker laboratories: from the benefits to the practical and logistical issues faced during 6 years of centralised testing}, author={Richman SD and Hemmings G and Roberts H and Gallop N and Dodds R and Wilkinson L and Davis J and White R and Yates E and Jasani B and Brown L and Maughan TS and Butler R and Quirke P and Adams R}, journal={J Clin Pathol}}"}, "is_sup_mat_match": false}, {"pmid": 37989729, "pmcid": "PMC10663560", "title": "Targetable lesions and proteomes predict therapy sensitivity through disease evolution in pediatric acute lymphoblastic leukemia", "journal": "Nat Commun", "authors": ["Lorentzian AC", "Rever J", "Ergin EK", "Guo M", "Akella NM", "Rolf N", "James Lim C", "Reid GSD", "Maxwell CA", "Lange PF"], "date": "2023-11-21T00:00:00Z", "year": 2023, "snippets": [{"_id": "37989729@6776", "snip_text": "At time of relapse of pediatric ALL, clonal evolution is frequently convergent, and includes the outgrowth of clones defined by a different mutational site within the same affected gene; for example, a relapse clone with KRAS.A146T replaces the diagnostic KRAS.G12D clone.", "section": "results", "mentions": ["261|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "226|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "At time of relapse of pediatric ALL, clonal evolution is frequently convergent, and includes the outgrowth of clones defined by a different mutational site within the same affected gene; for example, a relapse clone with KRAS.A146T replaces the diagnostic KRAS.G12D clone."}], "citations": {"NLM": "Lorentzian AC, Rever J, Ergin EK, Guo M, Akella NM, Rolf N, James Lim C, Reid GSD, Maxwell CA, Lange PF. Targetable lesions and proteomes predict therapy sensitivity through disease evolution in pediatric acute lymphoblastic leukemia Nat Commun. PMID: 37989729", "BibTeX": "@article{37989729, title={Targetable lesions and proteomes predict therapy sensitivity through disease evolution in pediatric acute lymphoblastic leukemia}, author={Lorentzian AC and Rever J and Ergin EK and Guo M and Akella NM and Rolf N and James Lim C and Reid GSD and Maxwell CA and Lange PF}, journal={Nat Commun}}"}, "is_sup_mat_match": false}, {"pmid": 21763698, "pmcid": "PMC4177034", "title": "Structural and Functional Impact of Cancer Related Missense Somatic Mutations", "journal": "J Mol Biol", "authors": ["Shi Z", "Moult J"], "date": "2011-10-21T00:00:00Z", "year": 2011, "snippets": [{"_id": "21763698@20479", "snip_text": "A146T, K117N and G13D in KRAS all appear to weaken GTP/GDP binding, and are also destabilizing to different degrees.", "section": "results", "mentions": ["51|3|chemical|ncbi_mesh@D006160|GTP", "25|4|gene|ncbi_gene@3845|KRAS", "55|3|chemical|ncbi_mesh@D006153|GDP", "7|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "0|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "17|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D"], "text_hl": "<m>A146T</m>, K117N and G13D in KRAS all appear to weaken GTP/GDP binding, and are also destabilizing to different degrees."}], "citations": {"NLM": "Shi Z, Moult J. Structural and Functional Impact of Cancer Related Missense Somatic Mutations J Mol Biol. PMID: 21763698", "BibTeX": "@article{21763698, title={Structural and Functional Impact of Cancer Related Missense Somatic Mutations}, author={Shi Z and Moult J}, journal={J Mol Biol}}"}, "is_sup_mat_match": false}, {"pmid": 30705875, "pmcid": "PMC6344461", "title": "Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic.", "journal": "Front Oncol", "authors": ["Ghatalia P", "Smith CH", "Winer A", "Gou J", "Kiedrowski LA", "Slifker M", "Saltzberg PD", "Bubes N", "Anari FM", "Kasireddy V", "Varshavsky A", "Liu Y", "Ross EA", "El-Deiry WS"], "date": "2019-01-17T00:00:00Z", "year": 2019, "snippets": [{"_id": "30705875@15237", "snip_text": "One patient post-cetuximab anti-EGFR therapy had five KRAS gene mutations (A146T*, G12V, G13D, G60R, K117N), 3 EGFR alterations (N493D, P373S, Y1172Y), 7 p53 mutations (A161T, C176R, Q354R*, R282W, p.Lys382fs, p.Ser2fs*, p.Val73fs), among others.", "section": "results", "mentions": ["183|5|variant|litvar@rs752142489##&&&litvar@#7157#&&&litvar@CA810#rs752142489##|Q354R", "176|5|variant|litvar@rs967461896##&&&litvar@#7157#|C176R", "210|8|variant|litvar@#7157#p.S2fsX&&&litvar@#7157#|p.Ser2fs", "89|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "75|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "17|9|chemical|ncbi_mesh@D000068818|cetuximab", "83|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "143|6|variant|litvar@#7157#p.Y1172Y&&&litvar@#7157#|Y1172Y", "32|4|gene|ncbi_gene@1956|EGFR", "169|5|variant|litvar@rs193920817##&&&litvar@#7157#&&&litvar@CA234#rs193920817##|A161T", "101|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "54|4|gene|ncbi_gene@3845|KRAS", "111|4|gene|ncbi_gene@1956|EGFR", "95|4|variant|litvar@rs104894359##&&&litvar@#3845#&&&litvar@CA273416#rs104894359##|G60R", "198|10|variant|litvar@#7157#p.K382fsX&&&litvar@#7157#|p.Lys382fs", "129|5|variant|litvar@rs180177040##&&&litvar@#673#&&&litvar@CA279976#rs180177040##|N493D", "154|3|gene|ncbi_gene@7157|p53", "4|7|species|ncbi_taxonomy@9606|patient", "136|5|variant|litvar@#7157#p.P373S&&&litvar@#7157#|P373S", "221|9|variant|litvar@rs730882018##&&&litvar@#7157#|p.Val73fs", "191|5|variant|litvar@rs28934574##&&&litvar@#7157#&&&litvar@CA454#rs28934574##|R282W"], "text_hl": "One patient post-cetuximab anti-EGFR therapy had five KRAS gene mutations (<m>A146T</m>*, G12V, G13D, G60R, K117N), 3 EGFR alterations (N493D, P373S, Y1172Y), 7 p53 mutations (A161T, C176R, Q354R*, R282W, p.Lys382fs, p.Ser2fs*, p.Val73fs), among others."}], "citations": {"NLM": "Ghatalia P, Smith CH, Winer A, Gou J, Kiedrowski LA, Slifker M, Saltzberg PD, Bubes N, Anari FM, Kasireddy V, Varshavsky A, Liu Y, Ross EA, El-Deiry WS. Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic. Front Oncol. PMID: 30705875", "BibTeX": "@article{30705875, title={Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic.}, author={Ghatalia P and Smith CH and Winer A and Gou J and Kiedrowski LA and Slifker M and Saltzberg PD and Bubes N and Anari FM and Kasireddy V and Varshavsky A and Liu Y and Ross EA and El-Deiry WS}, journal={Front Oncol}}"}, "is_sup_mat_match": false}, {"pmid": 29908105, "pmcid": "PMC6113428", "title": "Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer", "journal": "Cancer Sci", "authors": ["Osumi H", "Shinozaki E", "Mashima T", "Wakatsuki T", "Suenaga M", "Ichimura T", "Ogura M", "Ota Y", "Nakayama I", "Takahari D", "Chin K", "Miki Y", "Yamaguchi K"], "date": "2018-08-01T00:00:00Z", "year": 2018, "snippets": [{"_id": "29908105@10245", "snip_text": "KRAS codon 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H); KRAS codon 146 (A146T, A146S, A146P, A146E, A146V, and A146G); BRAF codon 600 (V600E); NRAS codon 12 (G12S, G12C, G12R, G12D, G12V, and G12A), codon 13 (G13S, G13C, G13R, G13D, G13V, and G13A), and codon 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H); and PIK3CA exon 9 codon 542 (E542K), codon 545 (E545K), codon 546 (E546K), and exon 20 codon 1047 (H1047R and H1047L) were analyzed using Luminex (xMAP) technology (GENOSEARCH Mu-PACK; MBL).", "section": "methods", "mentions": ["243|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602364#rs121434596##|G13A", "27|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "270|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "93|5|variant|litvar@rs1484032303##&&&litvar@#1956#|A146E", "215|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13C", "111|5|variant|litvar@rs1484032303##&&&litvar@#1956#|A146G", "0|4|gene|ncbi_gene@3845|KRAS", "119|4|gene|ncbi_gene@673|BRAF", "298|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "221|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "276|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "135|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "143|4|gene|ncbi_gene@4893|NRAS", "56|4|gene|ncbi_gene@3845|KRAS", "33|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "170|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "176|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "15|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "72|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "404|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|H1047R", "100|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "86|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "158|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "334|5|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|E542K", "209|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA16602674#rs121434595##|G13S", "39|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "264|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "282|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA16602443#rs121913240##|Q61P", "227|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "21|4|variant|litvar@rs121913238##&&&litvar@#3845#&&&litvar@CA16602770#rs121913238##|Q61E", "309|6|gene|ncbi_gene@5290|PIK3CA", "288|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "49|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "353|5|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|E545K", "372|5|variant|litvar@#5290#p.E546K&&&litvar@#5290#|E546K", "164|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "182|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "192|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "415|6|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|H1047L", "79|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146S", "233|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V"], "text_hl": "KRAS codon 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H); KRAS codon 146 (<m>A146T</m>, A146S, A146P, A146E, A146V, and A146G); BRAF codon 600 (V600E); NRAS codon 12 (G12S, G12C, G12R, G12D, G12V, and G12A), codon 13 (G13S, G13C, G13R, G13D, G13V, and G13A), and codon 61 (Q61K, Q61E, Q61L, Q61P, Q61R, and Q61H); and PIK3CA exon 9 codon 542 (E542K), codon 545 (E545K), codon 546 (E546K), and exon 20 codon 1047 (H1047R and H1047L) were analyzed using Luminex (xMAP) technology (GENOSEARCH Mu-PACK; MBL)."}], "citations": {"NLM": "Osumi H, Shinozaki E, Mashima T, Wakatsuki T, Suenaga M, Ichimura T, Ogura M, Ota Y, Nakayama I, Takahari D, Chin K, Miki Y, Yamaguchi K. Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer Cancer Sci. PMID: 29908105", "BibTeX": "@article{29908105, title={Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer}, author={Osumi H and Shinozaki E and Mashima T and Wakatsuki T and Suenaga M and Ichimura T and Ogura M and Ota Y and Nakayama I and Takahari D and Chin K and Miki Y and Yamaguchi K}, journal={Cancer Sci}}"}, "is_sup_mat_match": false}, {"pmid": 35069704, "pmcid": "PMC8766716", "title": "Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal Cancer.", "journal": "Front Genet", "authors": ["Stasik S", "Mende M", "Schuster C", "Mahler S", "Aust D", "Tannapfel A", "Reinacher-Schick A", "Baretton G", "Krippendorf C", "Bornh\u00e4user M", "Ehninger G", "Folprecht G", "Thiede C"], "date": "2022-01-05T00:00:00Z", "year": 2022, "snippets": [{"_id": "35069704@21504", "snip_text": "Patient characteristic TNM classification ctDNA marker Time to detection of recurrence [d]   Pat Gender Age (years) UICC pT pN M Gene HGVS p.HGVS Imaging ctDNA     Pat#1 Male 77 IV 4 2 1 KRAS c.35G > A p.Gly12Asp 764 647 117   Pat#2 Male 66 IV 4 2 1 KRAS c.35G > A p.Gly12Asp 962 962 0   Pat#3 Female 81 III 3 1 0 KRAS c.35G > T p.Gly12Val 903 752 151   Pat#4 Female 53 IV 3 0 1 KRAS c.35G > T p.Gly12Val 226 226 0   Pat#5 Female 62 II 4 0 0 KRAS c.34G > T p.Gly12Cys 305 n.d n.a   Pat#6 Female 72 IV 3 1 1 KRAS c.40G > A p.Val14Ile 163 109 54   Pat#7 Male 74 III 3 1 0 KRAS c.175G > A p.Ala59Thr 268 42 226   Pat#8 Male 63 III 3 1 0 KRAS c.436G > A p.Ala146Thr 228 116 112   Pat#9 Male 70 III 3 2 0 KRAS c.350A > G p.Lys117Arg 397 315 82   Pat#10 Male 54 IV 3 2 1 NRAS c.38G > A p.Gly13Asp 227 192 35   Pat#11 Male 50 IV 4 1 1 NRAS c.182A > G p.Gln61Arg 463 326 137   Pat#12 Male 54 IV 4 2 1 TP53 c.584T > C p.Ile195Thr 427 318 109   Pat#13 Male 77 IV 4 1 1 TP53 c.743G > A p.Arg248Gln 269 98 171   Pat#14 Male 70 IV 3 1 1 TP53 c.742C > T p.Arg248Trp 381 195 186   ", "section": "table", "mentions": ["250|4|gene|ncbi_gene@3845|KRAS", "457|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.Gly12Cys", "893|4|gene|ncbi_gene@7157|TP53", "379|4|gene|ncbi_gene@3845|KRAS", "586|10|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|p.Ala59Thr", "765|4|gene|ncbi_gene@4893|NRAS", "716|11|variant|litvar@rs587782329##&&&litvar@#7157#&&&litvar@CA391#rs587782329##|p.Lys117Arg", "705|10|variant|litvar@rs587782329##&&&litvar@#7157#&&&litvar@CA391#rs587782329##|c.350A > G", "898|10|variant|litvar@rs760043106##&&&litvar@#7157#&&&litvar@CA2232#rs760043106##|c.584T > C", "265|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.Gly12Asp", "329|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.Gly12Val", "522|10|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|p.Val14Ile", "394|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.Gly12Val", "187|4|gene|ncbi_gene@3845|KRAS", "909|11|variant|litvar@rs760043106##&&&litvar@#7157#&&&litvar@CA2232#rs760043106##|p.Ile195Thr", "447|9|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|c.34G > T", "512|9|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|c.40G > A", "319|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "959|4|gene|ncbi_gene@7157|TP53", "780|10|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.Gly13Asp", "844|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Gln61Arg", "202|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.Gly12Asp", "1024|4|gene|ncbi_gene@7157|TP53", "255|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "770|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "0|7|species|ncbi_taxonomy@9606|Patient", "384|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G > T", "964|10|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|c.743G > A", "975|11|variant|litvar@rs11540652##&&&litvar@#7157#&&&litvar@CA387#rs11540652##|p.Arg248Gln", "1029|10|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|c.742C > T", "570|4|gene|ncbi_gene@3845|KRAS", "634|4|gene|ncbi_gene@3845|KRAS", "192|9|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G > A", "650|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "575|10|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|c.175G > A", "639|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "1040|11|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|p.Arg248Trp", "442|4|gene|ncbi_gene@3845|KRAS", "828|4|gene|ncbi_gene@4893|NRAS", "700|4|gene|ncbi_gene@3845|KRAS", "314|4|gene|ncbi_gene@3845|KRAS", "507|4|gene|ncbi_gene@3845|KRAS", "833|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A > G"], "figure_id": "T1", "text_hl": "Patient characteristic TNM classification ctDNA marker Time to detection of recurrence [d]   Pat Gender Age (years) UICC pT pN M Gene HGVS p.HGVS Imaging ctDNA     Pat#1 Male 77 IV 4 2 1 KRAS c.35G > A p.Gly12Asp 764 647 117   Pat#2 Male 66 IV 4 2 1 KRAS c.35G > A p.Gly12Asp 962 962 0   Pat#3 Female 81 III 3 1 0 KRAS c.35G > T p.Gly12Val 903 752 151   Pat#4 Female 53 IV 3 0 1 KRAS c.35G > T p.Gly12Val 226 226 0   Pat#5 Female 62 II 4 0 0 KRAS c.34G > T p.Gly12Cys 305 n.d n.a   Pat#6 Female 72 IV 3 1 1 KRAS c.40G > A p.Val14Ile 163 109 54   Pat#7 Male 74 III 3 1 0 KRAS c.175G > A p.Ala59Thr 268 42 226   Pat#8 Male 63 III 3 1 0 KRAS c.436G > A <m>p.Ala146Thr</m> 228 116 112   Pat#9 Male 70 III 3 2 0 KRAS c.350A > G p.Lys117Arg 397 315 82   Pat#10 Male 54 IV 3 2 1 NRAS c.38G > A p.Gly13Asp 227 192 35   Pat#11 Male 50 IV 4 1 1 NRAS c.182A > G p.Gln61Arg 463 326 137   Pat#12 Male 54 IV 4 2 1 TP53 c.584T > C p.Ile195Thr 427 318 109   Pat#13 Male 77 IV 4 1 1 TP53 c.743G > A p.Arg248Gln 269 98 171   Pat#14 Male 70 IV 3 1 1 TP53 c.742C > T p.Arg248Trp 381 195 186   "}], "citations": {"NLM": "Stasik S, Mende M, Schuster C, Mahler S, Aust D, Tannapfel A, Reinacher-Schick A, Baretton G, Krippendorf C, Bornh\u00e4user M, Ehninger G, Folprecht G, Thiede C. Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal Cancer. Front Genet. PMID: 35069704", "BibTeX": "@article{35069704, title={Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal Cancer.}, author={Stasik S and Mende M and Schuster C and Mahler S and Aust D and Tannapfel A and Reinacher-Schick A and Baretton G and Krippendorf C and Bornh\u00e4user M and Ehninger G and Folprecht G and Thiede C}, journal={Front Genet}}"}, "is_sup_mat_match": false}, {"pmid": 32341551, "pmcid": "PMC7787056", "title": "The duality of human oncoproteins: drivers of cancer and congenital disorders", "journal": "Nat Rev Cancer", "authors": ["Castel P", "Rauen KA", "McCormick F"], "date": "2020-07-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "32341551@6194", "snip_text": "Furthermore, the signalling output of the KRAS-A146T mutant, the encoding allele of which is found only in gastrointestinal tumours, is strikingly different from that of the most common G12D variant, though still oncogenic.", "section": "other", "mentions": ["186|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "47|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "42|4|gene|ncbi_gene@3845|KRAS", "107|24|disease|ncbi_mesh@D005770|gastrointestinal tumours"], "text_hl": "Furthermore, the signalling output of the KRAS-<m>A146T</m> mutant, the encoding allele of which is found only in gastrointestinal tumours, is strikingly different from that of the most common G12D variant, though still oncogenic."}], "citations": {"NLM": "Castel P, Rauen KA, McCormick F. The duality of human oncoproteins: drivers of cancer and congenital disorders Nat Rev Cancer. PMID: 32341551", "BibTeX": "@article{32341551, title={The duality of human oncoproteins: drivers of cancer and congenital disorders}, author={Castel P and Rauen KA and McCormick F}, journal={Nat Rev Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 30150883, "pmcid": "PMC6103235", "title": "Quality and practical aspects of pathological and molecular diagnostics in metastatic colorectal cancer (mCRC).", "journal": "Contemp Oncol (Pozn)", "authors": ["Tysarowski A", "Nasierowska-Guttmejer A"], "date": "2018-01-01T00:00:00Z", "year": 2018, "snippets": [{"_id": "30150883@19031", "snip_text": "Gene Exon Codon Mutation name (protein level) Mutation name (nucleotide level)   KRAS  12 p.Gly12Asp c.35G > A   p.Gly12Val c.35G > T   p.Gly12Cys c.34G > T   p.Gly12Arg c.34G > C   p.Gly12Ser c.34G > A   p.Gly12Ala c.35G > C   2 13 p.Gly13Asp c.38G > A   p.Gly13Cys c.37G > T   p.Gly13Arg c.37G > C   p.Gly13Ser c.37G > A   p.Gly13Ala c.38G > C   p.Gly13Val c.38G > T   3 59 p.Ala59Thr c.175G > A   p.Ala59Glu c.176C > A   p.Ala59Gly c.176C > G   61 p.Gln61Lys c.181C > A   p.Gln61Lys c.180_181TC > AA   p.Gln61Leu c.182A > T   p.Gln61Arg c.182A > G   p.Gln61His c.183A > C   p.Gln61His c.183A > T   4 117 p.Lys117Asn c.351A > C   p.Lys117Asn c.351A > T   146 p.Ala146Thr c.436G > A   p.Ala146Pro c.436G > C   p.Ala146Val c.437C > T   NRAS 2 12 p.Gly12Cys c.34G > T   p.Gly12Ser c.34G > A   p.Gly12Ala c.35G > C   p.Gly12Asp c.35G > A   p.Gly12Val c.35G > T   13 p.Gly13Arg c.37G > C   p.Gly13Val c.38G > T   p.Gly13Asp c.38G > A   3 59 p.Ala59Thr c.175G > A   61 p.Gln61Lys c.181C > A   p.Gln61Leu c.182A > T   p.Gln61Arg c.182A > G   p.Gln61His c.183A > T   p.Gln61His c.183A > C   4 117 p.Lys117Asn c.351G > C   p.Lys117Asn c.351G > T   146 p.Ala146Thr c.436G > A   p.Ala146Val c.437C > T   BRAF 15 600 p.Val600Glu c.1799T > A   ", "section": "table", "mentions": ["746|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.Gly12Cys", "673|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "313|9|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA16602674#rs121434595##|c.37G > A", "723|10|variant|litvar@rs763725375##&&&litvar@#4292#|c.437C > T", "989|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Gln61Leu", "1182|10|variant|litvar@rs763725375##&&&litvar@#4292#|c.437C > T", "267|9|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA16602248#rs121434595##|c.37G > T", "838|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.Gly12Val", "976|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C > A", "182|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.Gly12Ser", "302|10|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA16602674#rs121434595##|p.Gly13Ser", "159|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.Gly12Arg", "359|9|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|c.38G > T", "769|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.Gly12Ser", "1116|11|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.Lys117Asn", "256|10|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|p.Gly13Cys", "113|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.Gly12Val", "233|10|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.Gly13Asp", "949|10|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|c.175G > A", "348|10|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|p.Gly13Val", "205|10|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|p.Gly12Ala", "325|10|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602364#rs121434596##|p.Gly13Ala", "607|11|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.Lys117Asn", "921|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "1024|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A > G", "898|9|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|c.38G > T", "376|10|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|p.Ala59Thr", "1145|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "1157|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "588|10|variant|litvar@rs121913255##&&&litvar@#4893#&&&litvar@CA16042285#rs121913255##|c.183A > T", "887|10|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|p.Gly13Val", "1195|4|gene|ncbi_gene@673|BRAF", "803|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > C", "698|10|variant|litvar@rs779123278##&&&litvar@#2956#|c.436G > C", "529|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Gln61Arg", "780|9|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA180753#rs121913250##|c.34G > A", "757|9|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|c.34G > T", "451|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Gln61Lys", "124|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA261525#rs121913237##|c.35G > T", "644|10|variant|litvar@rs770248150##&&&litvar@#3845#|c.351A > T", "736|4|gene|ncbi_gene@4893|NRAS", "101|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "910|10|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.Gly13Asp", "1048|10|variant|litvar@rs121913255##&&&litvar@#4893#&&&litvar@CA16042285#rs121913255##|c.183A > T", "632|11|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.Lys117Asn", "216|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > C", "826|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|c.35G > A", "1219|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T > A", "553|10|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Gln61His", "1091|11|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.Lys117Asn", "170|9|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|c.34G > C", "290|9|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|c.37G > C", "411|10|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|c.176C > A", "336|9|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602364#rs121434596##|c.38G > C", "815|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.Gly12Asp", "1170|11|variant|litvar@rs1057519725##&&&litvar@#3845#|p.Ala146Val", "792|10|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|p.Gly12Ala", "136|10|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.Gly12Cys", "475|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Gln61Lys", "540|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|c.182A > G", "90|10|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.Gly12Asp", "661|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "462|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|c.181C > A", "1072|10|variant|litvar@rs121913255##&&&litvar@#4893#|c.183A > C", "577|10|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Gln61His", "619|10|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|c.351A > C", "1013|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|p.Gln61Arg", "435|10|variant|litvar@rs1060500116##&&&litvar@#5728#|c.176C > G", "1207|11|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.Val600Glu", "1000|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|c.182A > T", "1128|10|variant|litvar@rs769554703##&&&litvar@#5395#&&&litvar@CA51542#rs769554703##|c.351G > T", "279|10|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|p.Gly13Arg", "486|16|variant|litvar@#4893#c.180_181TC>AA&&&litvar@#4893#|c.180_181TC > AA", "1037|10|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Gln61His", "875|9|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|c.37G > C", "564|10|variant|litvar@rs121913255##&&&litvar@#4893#|c.183A > C", "505|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Gln61Leu", "686|11|variant|litvar@rs121913527##&&&litvar@#3845#|p.Ala146Pro", "849|9|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA261525#rs121913237##|c.35G > T", "400|10|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|p.Ala59Glu", "1061|10|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Gln61His", "965|10|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Gln61Lys", "193|9|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA180753#rs121913250##|c.34G > A", "387|10|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|c.175G > A", "147|9|variant|litvar@rs121913250##&&&litvar@#4893#&&&litvar@CA297020#rs121913250##|c.34G > T", "864|10|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|p.Gly13Arg", "424|10|variant|litvar@rs763572530##&&&litvar@#1956#|p.Ala59Gly", "938|10|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|p.Ala59Thr", "516|10|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|c.182A > T", "244|9|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|c.38G > A", "1103|10|variant|litvar@rs114185660##&&&litvar@#5395#&&&litvar@CA13290#rs114185660##|c.351G > C", "711|11|variant|litvar@rs1057519725##&&&litvar@#3845#|p.Ala146Val"], "figure_id": "t0002", "text_hl": "Gene Exon Codon Mutation name (protein level) Mutation name (nucleotide level)   KRAS  12 p.Gly12Asp c.35G > A   p.Gly12Val c.35G > T   p.Gly12Cys c.34G > T   p.Gly12Arg c.34G > C   p.Gly12Ser c.34G > A   p.Gly12Ala c.35G > C   2 13 p.Gly13Asp c.38G > A   p.Gly13Cys c.37G > T   p.Gly13Arg c.37G > C   p.Gly13Ser c.37G > A   p.Gly13Ala c.38G > C   p.Gly13Val c.38G > T   3 59 p.Ala59Thr c.175G > A   p.Ala59Glu c.176C > A   p.Ala59Gly c.176C > G   61 p.Gln61Lys c.181C > A   p.Gln61Lys c.180_181TC > AA   p.Gln61Leu c.182A > T   p.Gln61Arg c.182A > G   p.Gln61His c.183A > C   p.Gln61His c.183A > T   4 117 p.Lys117Asn c.351A > C   p.Lys117Asn c.351A > T   146 <m>p.Ala146Thr</m> c.436G > A   p.Ala146Pro c.436G > C   p.Ala146Val c.437C > T   NRAS 2 12 p.Gly12Cys c.34G > T   p.Gly12Ser c.34G > A   p.Gly12Ala c.35G > C   p.Gly12Asp c.35G > A   p.Gly12Val c.35G > T   13 p.Gly13Arg c.37G > C   p.Gly13Val c.38G > T   p.Gly13Asp c.38G > A   3 59 p.Ala59Thr c.175G > A   61 p.Gln61Lys c.181C > A   p.Gln61Leu c.182A > T   p.Gln61Arg c.182A > G   p.Gln61His c.183A > T   p.Gln61His c.183A > C   4 117 p.Lys117Asn c.351G > C   p.Lys117Asn c.351G > T   146 <m>p.Ala146Thr</m> c.436G > A   p.Ala146Val c.437C > T   BRAF 15 600 p.Val600Glu c.1799T > A   "}], "citations": {"NLM": "Tysarowski A, Nasierowska-Guttmejer A. Quality and practical aspects of pathological and molecular diagnostics in metastatic colorectal cancer (mCRC). Contemp Oncol (Pozn). PMID: 30150883", "BibTeX": "@article{30150883, title={Quality and practical aspects of pathological and molecular diagnostics in metastatic colorectal cancer (mCRC).}, author={Tysarowski A and Nasierowska-Guttmejer A}, journal={Contemp Oncol (Pozn)}}"}, "is_sup_mat_match": false}, {"pmid": 35267442, "pmcid": "PMC8909363", "title": "Evaluation of the Clinical Utility of Genomic Profiling to Inform Selection of Clinical Trial Therapy in Salivary Gland Cancer", "journal": "Cancers (Basel)", "authors": ["Rack S", "Feeney L", "Hapuarachi B", "Adderley H", "Woodhouse L", "Betts G", "Burghel GJ", "Harrington KJ", "Metcalf R"], "date": "2022-02-23T00:00:00Z", "year": 2022, "snippets": [{"_id": "35267442@50643", "snip_text": "Patient\tSubtype\tVariant\tPatient\tSubtype\tVariant\t \tACC1\tACC\tTP53 c.832C > T p.(Pro278Ser) 17% reads\tACC16\tACC\tPIK3CA c.1633G > A p.(Glu545Lys) 11% reads\t \tACC3\tACC\tTP53 c.814G > T p.(Val272Leu) 4% reads\tACC19\tACC\tPIK3CA c.1258T > C p.(Cys420Arg) 18% reads;\t \tACC10\tACC\tTP53 c.328delC p.(Arg110ValfsTer13) 6% reads\tACC19\tACC\tPIK3CA c.1633G > A p.(Glu545Lys) 8% reads\t \tACC13\tACC\tTP53 c.1146delA p.(Lys382AsnfsTer40) 29% reads\tACINIC25\tACINIC\tPIK3CA c.3140A > G p.(His1047Arg) 23% reads\t \tACC14\tACC\tTP53 c.375G > A p.(Thr125Thr) 28% reads\tADENO32\tADENO\tPIK3CA c.1636C > A p.(Gln546Lys) 36.41% reads\t \tACC15\tACC\tTP53 c.584T > C p.(Ile195Thr) 7% reads\tExPleo35\tExPleo\tPIK3CA c.1633G > A p.(Glu545Lys) 39% reads\t \tACC18\tACC\tTP53 c.373A > G p.(Thr125Ala) 14% reads\tSDC44\tSDC\tPIK3CA c.1624G > A p.(Glu542Lys) 13% reads\t \tACC19\tACC\tPIK3CA c.1633G > A p.(Glu545Lys) 8% reads\tSDC45\tSDC\tPIK3CA c.1093G > A p.(Glu365Lys) 20% reads\t \tACC21\tACC\tTP53 c.329G > C p.(Arg110Pro) 50% reads\tSDC46\tSDC\tPIK3CA c.3140A > G p.(His1047Arg) 13% reads\t \tACC22\tACC\tTP53 c.824G > A p.(Cys275Tyr) 4% reads\tSDC47\tSDC\tPIK3CA c.1624G > A p.(Glu542Lys) 13% reads\t \tACC22\tACC\tTP53 c.467G > C p.(Arg156Pro) 8% read\tSDC49\tSDC\tPIK3CA c.3140A > G p.(His1047Arg) 10% reads\t \tACC24\tACC\tTP53 c.1010G > A p.(Arg337His) 13% reads\tSDC52\tSDC\tPIK3CA c.3140A > G p.(His1047Arg) 51% reads\t \tACINIC25\tACINIC\tTP53 c.742C > T p.(Arg248Trp) 4% reads\tACC1\tACC\tAKT1 c.49G > A p.(Glu17Lys) 4% reads\t \tACINIC26\tACINIC\tTP53 c.818G > T p.(Arg273Leu) 35% reads\tSDC54\tSDC\tAKT1 c.49G > A p.(Glu17Lys) 22% reads\t \tADENO27\tADENO\tTP53 c.794T > G p.(Leu265Arg) 37% reads\tSDC56\tSDC\tAKT1 c.49G > A p.(Glu17Lys) 19% reads\t \tADENO28\tADENO\tTP53 c.637C > T p.(Arg213Ter) 26% reads\tACC5\tACC\tPTEN c.829dup p.(Thr277AsnfsTer21) 9% reads\t \tADENO29\tADENO\tTP53 c.626_627delGA p.(Arg209LysfsTer6) 30% reads\tACC7\tACC\tPTEN c.750_765dup p.(Glu256TrpfsTer2) 52% reads\t \tADENO30\tADENO\tTP53 c.481G > A p.(Ala161Thr) 22% reads;\tACC12\tACC\tPTEN c.16A > T p.(Lys6Ter) 62% reads\t \tExPleo34\tExPleo\tTP53 c.686_687dupGT p.(Thr230ValfsTer18) 38% reads\tACC17\tACC\tPTEN c.686C > G p.(Ser229Ter) 12% reads\t \tExPleo35\tExPleo\tTP53 c.991C > T p.(Gln331Ter) 44% reads;\tADENO31\tADENO\tPTEN c.382A > C p.(Lys128Gln) 7% reads\t \tExPleo36\tExPleo\tTP53 c.750_754dupCATCC p.(Leu252ArgfsTer95) 20% reads\tMEC40\tMEC\tPTEN c.634 + 5G > T 42% reads\t \tExPleo37\tExPleo\tTP53 c.989T > G p.(Leu330Arg) 26% reads\tACC4\tACC\tEGFR c.2369C > T p.(Thr790Met) 31% reads\t \tMEC38\tMEC\tTP53 c.828delC p.(Cys277ValfsTer68) 7% reads\tExPleo36\tExPleo\tERBB2 c.2305G > C p.(Asp769His) 81% reads\t \tMEC39\tMEC\tTP53 c.733G > A p.(Gly245Ser) 15% reads\tSDC43\tSDC\tERBB2 c.929C > T p.(Ser310Phe) 34% reads\t \tMEC41\tMEC\tTP53 c.460_462delGGC p.(Gly154del) 60% reads\tSDC50\tSDC\tERBB2 c.2305G > C p.(Asp769His) 26% reads\t \tSDC42\tSDC\tTP53 c.839G > C p.(Arg280Thr) 14% reads\tACC11\tACC\tBRAF c.1397G > A p.(Gly466Glu) 27% reads\t \tSDC43\tSDC\tTP53 c.993 + 1G > T 41% reads\tSDC45\tSDC\tBRAF c.1780G > A p.(Asp594Asn) 20% reads;\t \tSDC45\tSDC\tTP53 c.374C > G p.(Thr125Arg) 22% reads\tADENO27\tADENO\tKRAS c.436G > A p.(Ala146Thr) 8% reads\t \tSDC48\tSDC\tTP53 c.841G > C p.(Asp281His) 39% reads.\tACC6\tACC\tCTNNB1 c.134C > T p.(Ser45Phe) 23% reads\t \tSDC50\tSDC\tTP53 c.377_380delACTC p.(Tyr126SerfsTer43) 18% reads\t\t\t\t \tSDC52\tSDC\tTP53 c.626_627delGA p.(Arg209LysfsTer6) 43% reads\t\t\t\t \tSDC53\tSDC\tTP53 c.919 + 1G > C 25% reads\t\t\t\t \tSDC54\tSDC\tTP53 c.650T > G p.(Val217Gly) 15% reads\t\t\t\t \tSDC55\tSDC\tTP53 c.452C > G p.(Pro151Arg) 21% reads\t\t\t\t \tSDC56\tSDC\tTP53 c.912delT p.(Lys305SerfsTer40) 17% reads\t\t\t\t \t", "section": "table", "mentions": ["168|10|variant|litvar@rs121912657##&&&litvar@#7157#&&&litvar@CA430#rs121912657##|c.814G > T", "3188|16|variant|litvar@#7157#c.377_380delACTC&&&litvar@#7157#|c.377_380delACTC", "1092|11|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|c.1624G > A", "323|6|gene|ncbi_gene@5290|PIK3CA", "670|11|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G > A", "882|11|variant|litvar@rs1064793732##&&&litvar@#5290#|c.1093G > A", "273|9|variant|litvar@rs587780066##&&&litvar@#7157#|c.328delC", "1085|6|gene|ncbi_gene@5290|PIK3CA", "2845|13|variant|litvar@rs121913351##&&&litvar@#673#&&&litvar@CA16602535#rs121913351##|p.(Gly466Glu)", "459|14|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.(His1047Arg)", "663|6|gene|ncbi_gene@5290|PIK3CA", "1569|10|variant|litvar@rs1335033900##&&&litvar@#5728#|c.794T > G", "1195|11|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A > G", "875|6|gene|ncbi_gene@5290|PIK3CA", "3029|4|gene|ncbi_gene@3845|KRAS", "2894|6|variant|litvar@#7157#c.1G>T&&&litvar@#7157#|1G > T", "2566|4|gene|ncbi_gene@7157|TP53", "116|11|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G > A", "1405|4|gene|ncbi_gene@207|AKT1", "1244|4|gene|ncbi_gene@7157|TP53", "1460|4|gene|ncbi_gene@7157|TP53", "109|6|gene|ncbi_gene@5290|PIK3CA", "3256|14|variant|litvar@rs1057517840##&&&litvar@#7157#|c.626_627delGA", "382|10|variant|litvar@#7157#c.1146delA&&&litvar@#7157#|c.1146delA", "1188|6|gene|ncbi_gene@5290|PIK3CA", "3421|10|variant|litvar@rs1057520000##&&&litvar@#7157#|c.452C > G", "2415|13|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|p.(Thr790Met)", "1373|13|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|p.(Arg248Trp)", "2530|13|variant|litvar@rs121913468##&&&litvar@#2064#&&&litvar@CA16602465#rs121913468##|p.(Asp769His)", "3361|4|gene|ncbi_gene@7157|TP53", "1629|12|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|p.(Glu17Lys)", "2072|10|variant|litvar@rs201598843##&&&litvar@#5295#&&&litvar@CA3290123#rs201598843##|c.686C > G", "2616|5|gene|ncbi_gene@2064|ERBB2", "1410|9|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|c.49G > A", "608|4|gene|ncbi_gene@7157|TP53", "2141|13|variant|litvar@rs1341708803##&&&litvar@#1956#|p.(Gln331Ter)", "2196|13|variant|litvar@rs202217100##&&&litvar@#1499#|p.(Lys128Gln)", "2730|11|variant|litvar@rs121913468##&&&litvar@#2064#&&&litvar@CA16602465#rs121913468##|c.2305G > C", "512|13|variant|litvar@rs55863639##&&&litvar@#7157#&&&litvar@CA144#rs55863639##|p.(Thr125Thr)", "2314|6|variant|litvar@rs780442292##&&&litvar@#7157#&&&litvar@CA2638#rs780442292##|5G > T", "330|11|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G > A", "1036|4|gene|ncbi_gene@7157|TP53", "987|11|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A > G", "2633|13|variant|litvar@rs1057519816##&&&litvar@#2064#|p.(Ser310Phe)", "935|10|variant|litvar@rs11540654##&&&litvar@#7157#&&&litvar@CA10580948#rs11540654##|c.329G > C", "1362|10|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|c.742C > T", "1249|11|variant|litvar@rs121912664##&&&litvar@#7157#&&&litvar@CA13#rs121912664##|c.1010G > A", "980|6|gene|ncbi_gene@5290|PIK3CA", "1956|9|variant|litvar@rs1211697061##&&&litvar@#2064#|c.16A > T", "1684|13|variant|litvar@rs397516436##&&&litvar@#7157#&&&litvar@CA301#rs397516436##|p.(Arg213Ter)", "59|4|gene|ncbi_gene@7157|TP53", "1156|13|variant|litvar@rs371524413##&&&litvar@#7157#|p.(Arg156Pro)", "1782|14|variant|litvar@rs1057517840##&&&litvar@#7157#|c.626_627delGA", "557|11|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123338#rs121913286##|c.1636C > A", "734|13|variant|litvar@rs951911536##&&&litvar@#367#|p.(Thr125Ala)", "1836|4|gene|ncbi_gene@5728|PTEN", "2828|4|gene|ncbi_gene@673|BRAF", "2451|4|gene|ncbi_gene@7157|TP53", "3085|10|variant|litvar@rs764146326##&&&litvar@#7157#|c.841G > C", "2938|13|variant|litvar@rs397516896##&&&litvar@#673#&&&litvar@CA135095#rs397516896##|p.(Asp594Asn)", "946|13|variant|litvar@rs11540654##&&&litvar@#7157#&&&litvar@CA10580948#rs11540654##|p.(Arg110Pro)", "1777|4|gene|ncbi_gene@7157|TP53", "2130|10|variant|litvar@rs1341708803##&&&litvar@#1956#|c.991C > T", "2975|4|gene|ncbi_gene@7157|TP53", "550|6|gene|ncbi_gene@5290|PIK3CA", "179|13|variant|litvar@rs121912657##&&&litvar@#7157#&&&litvar@CA430#rs121912657##|p.(Val272Leu)", "501|10|variant|litvar@rs55863639##&&&litvar@#7157#&&&litvar@CA144#rs55863639##|c.375G > A", "2690|13|variant||p.(Gly154del)", "2398|4|gene|ncbi_gene@1956|EGFR", "2237|4|gene|ncbi_gene@7157|TP53", "219|11|variant|litvar@rs121913272##&&&litvar@#5290#&&&litvar@CA180900#rs121913272##|c.1258T > C", "2783|10|variant|litvar@rs121912660##&&&litvar@#7157#&&&litvar@CA445#rs121912660##|c.839G > C", "2622|10|variant|litvar@rs1057519816##&&&litvar@#2064#|c.929C > T", "999|14|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.(His1047Arg)", "3251|4|gene|ncbi_gene@7157|TP53", "3045|13|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.(Ala146Thr)", "212|6|gene|ncbi_gene@5290|PIK3CA", "1515|9|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|c.49G > A", "830|11|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|c.1633G > A", "775|11|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|c.1624G > A", "1673|10|variant|litvar@rs397516436##&&&litvar@#7157#&&&litvar@CA301#rs397516436##|c.637C > T", "2582|13|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|p.(Gly245Ser)", "2456|9|variant|litvar@#7157#c.828delC&&&litvar@#7157#|c.828delC", "1104|13|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.(Glu542Lys)", "3096|13|variant|litvar@rs764146326##&&&litvar@#7157#|p.(Asp281His)", "1476|13|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA1530#rs28934576##|p.(Arg273Leu)", "2669|4|gene|ncbi_gene@7157|TP53", "682|13|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.(Glu545Lys)", "723|10|variant|litvar@rs879254249##&&&litvar@#7157#&&&litvar@CA10584591#rs879254249##|c.373A > G", "1525|12|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|p.(Glu17Lys)", "823|6|gene|ncbi_gene@5290|PIK3CA", "2881|4|gene|ncbi_gene@7157|TP53", "1564|4|gene|ncbi_gene@7157|TP53", "3476|9|variant|litvar@#7157#c.912delT&&&litvar@#7157#|c.912delT", "1420|12|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|p.(Glu17Lys)", "3377|13|variant|litvar@rs1060500117##&&&litvar@#5728#|p.(Val217Gly)", "1207|14|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.(His1047Arg)", "2011|14|variant|litvar@#7157#c.686_687dupGT&&&litvar@#7157#|c.686_687dupGT", "2083|13|variant|litvar@rs201598843##&&&litvar@#5295#|p.(Ser229Ter)", "2833|11|variant|litvar@rs121913351##&&&litvar@#673#&&&litvar@CA16602535#rs121913351##|c.1397G > A", "3432|13|variant|litvar@rs1057520000##&&&litvar@#7157#|p.(Pro151Arg)", "1510|4|gene|ncbi_gene@207|AKT1", "2794|13|variant|litvar@rs121912660##&&&litvar@#7157#&&&litvar@CA445#rs121912660##|p.(Arg280Thr)", "2674|15|variant|litvar@#7157#p.G460_462del&&&litvar@#7157#|c.460_462delGGC", "128|13|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.(Glu545Lys)", "2180|4|gene|ncbi_gene@5728|PTEN", "2354|10|variant|litvar@#7157#c.989T>G&&&litvar@#7157#|c.989T > G", "2006|4|gene|ncbi_gene@7157|TP53", "1900|4|gene|ncbi_gene@7157|TP53", "496|4|gene|ncbi_gene@7157|TP53", "3034|10|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G > A", "377|4|gene|ncbi_gene@7157|TP53", "1966|11|variant|litvar@rs1211697061##&&&litvar@#2064#|p.(Lys6Ter)", "2724|5|gene|ncbi_gene@2064|ERBB2", "2571|10|variant|litvar@rs28934575##&&&litvar@#7157#&&&litvar@CA367#rs28934575##|c.733G > A", "3471|4|gene|ncbi_gene@7157|TP53", "1465|10|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA1530#rs28934576##|c.818G > T", "440|6|gene|ncbi_gene@5290|PIK3CA", "1717|4|gene|ncbi_gene@5728|PTEN", "3130|6|gene|ncbi_gene@1499|CTNNB1", "2365|13|variant|litvar@#7157#p.L330R&&&litvar@#7157#|p.(Leu330Arg)", "3148|12|variant|litvar@rs121913409##&&&litvar@#1499#&&&litvar@CA127283#rs121913409##|p.(Ser45Phe)", "2403|11|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|c.2369C > T", "2301|4|gene|ncbi_gene@5728|PTEN", "1668|4|gene|ncbi_gene@7157|TP53", "2921|4|gene|ncbi_gene@673|BRAF", "2518|11|variant|litvar@rs121913468##&&&litvar@#2064#&&&litvar@CA16602465#rs121913468##|c.2305G > C", "1140|4|gene|ncbi_gene@7157|TP53", "1302|11|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A > G", "3366|10|variant|litvar@rs1060500117##&&&litvar@#5728#|c.650T > G", "2742|13|variant|litvar@rs121913468##&&&litvar@#2064#&&&litvar@CA16602465#rs121913468##|p.(Asp769His)", "3316|4|gene|ncbi_gene@7157|TP53", "342|13|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.(Glu545Lys)", "1295|6|gene|ncbi_gene@5290|PIK3CA", "163|4|gene|ncbi_gene@7157|TP53", "613|10|variant|litvar@rs760043106##&&&litvar@#7157#&&&litvar@CA2232#rs760043106##|c.584T > C", "2991|13|variant|litvar@rs786201057##&&&litvar@#7157#|p.(Thr125Arg)", "768|6|gene|ncbi_gene@5290|PIK3CA", "930|4|gene|ncbi_gene@7157|TP53", "1357|4|gene|ncbi_gene@7157|TP53", "1041|10|variant|litvar@rs863224451##&&&litvar@#7157#&&&litvar@CA337141#rs863224451##|c.824G > A", "2349|4|gene|ncbi_gene@7157|TP53", "1261|13|variant|litvar@rs121912664##&&&litvar@#7157#&&&litvar@CA13#rs121912664##|p.(Arg337His)", "894|13|variant|litvar@rs1064793732##&&&litvar@#5290#|p.(Glu365Lys)", "1722|8|variant|litvar@#5728#c.829dup&&&litvar@#5728#|c.829dup", "569|13|variant|litvar@rs121913286##&&&litvar@#5290#&&&litvar@CA123338#rs121913286##|p.(Gln546Lys)", "624|13|variant|litvar@rs760043106##&&&litvar@#7157#&&&litvar@CA2232#rs760043106##|p.(Ile195Thr)", "2185|10|variant|litvar@rs202217100##&&&litvar@#1499#&&&litvar@CA2330905#rs202217100##|c.382A > C", "64|10|variant|litvar@rs17849781##&&&litvar@#7157#|c.832C > T", "3080|4|gene|ncbi_gene@7157|TP53", "1905|10|variant|litvar@rs193920817##&&&litvar@#7157#&&&litvar@CA234#rs193920817##|c.481G > A", "2125|4|gene|ncbi_gene@7157|TP53", "2512|5|gene|ncbi_gene@2064|ERBB2", "1314|14|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.(His1047Arg)", "1951|4|gene|ncbi_gene@5728|PTEN", "1619|9|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|c.49G > A", "2926|11|variant|litvar@rs397516896##&&&litvar@#673#&&&litvar@CA135095#rs397516896##|c.1780G > A", "447|11|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|c.3140A > G", "2778|4|gene|ncbi_gene@7157|TP53", "1580|13|variant|litvar@rs1335033900##&&&litvar@#5728#|p.(Leu265Arg)", "2980|10|variant|litvar@rs786201057##&&&litvar@#7157#|c.374C > G", "231|13|variant|litvar@rs121913272##&&&litvar@#5290#&&&litvar@CA180900#rs121913272##|p.(Cys420Arg)", "3416|4|gene|ncbi_gene@7157|TP53", "1052|13|variant|litvar@rs863224451##&&&litvar@#7157#&&&litvar@CA337141#rs863224451##|p.(Cys275Tyr)", "268|4|gene|ncbi_gene@7157|TP53", "2242|17|variant|litvar@#7157#c.750_754dupCATCC&&&litvar@#7157#|c.750_754dupCATCC", "3137|10|variant|litvar@rs121913409##&&&litvar@#1499#&&&litvar@CA127283#rs121913409##|c.134C > T", "1145|10|variant|litvar@rs1301607353##&&&litvar@#3164#|c.467G > C", "3183|4|gene|ncbi_gene@7157|TP53", "787|13|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.(Glu542Lys)", "842|13|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.(Glu545Lys)", "1841|12|variant|litvar@#5728#c.750_765dup&&&litvar@#5728#|c.750_765dup", "2067|4|gene|ncbi_gene@5728|PTEN", "718|4|gene|ncbi_gene@7157|TP53", "3329|6|variant|litvar@#7157#c.1G>C&&&litvar@#7157#|1G > C", "75|13|variant|litvar@rs17849781##&&&litvar@#7157#|p.(Pro278Ser)", "1916|13|variant|litvar@rs193920817##&&&litvar@#7157#&&&litvar@CA234#rs193920817##|p.(Ala161Thr)", "1614|4|gene|ncbi_gene@207|AKT1"], "figure_id": "cancers-14-01133-t003", "text_hl": "Patient\tSubtype\tVariant\tPatient\tSubtype\tVariant\t \tACC1\tACC\tTP53 c.832C > T p.(Pro278Ser) 17% reads\tACC16\tACC\tPIK3CA c.1633G > A p.(Glu545Lys) 11% reads\t \tACC3\tACC\tTP53 c.814G > T p.(Val272Leu) 4% reads\tACC19\tACC\tPIK3CA c.1258T > C p.(Cys420Arg) 18% reads;\t \tACC10\tACC\tTP53 c.328delC p.(Arg110ValfsTer13) 6% reads\tACC19\tACC\tPIK3CA c.1633G > A p.(Glu545Lys) 8% reads\t \tACC13\tACC\tTP53 c.1146delA p.(Lys382AsnfsTer40) 29% reads\tACINIC25\tACINIC\tPIK3CA c.3140A > G p.(His1047Arg) 23% reads\t \tACC14\tACC\tTP53 c.375G > A p.(Thr125Thr) 28% reads\tADENO32\tADENO\tPIK3CA c.1636C > A p.(Gln546Lys) 36.41% reads\t \tACC15\tACC\tTP53 c.584T > C p.(Ile195Thr) 7% reads\tExPleo35\tExPleo\tPIK3CA c.1633G > A p.(Glu545Lys) 39% reads\t \tACC18\tACC\tTP53 c.373A > G p.(Thr125Ala) 14% reads\tSDC44\tSDC\tPIK3CA c.1624G > A p.(Glu542Lys) 13% reads\t \tACC19\tACC\tPIK3CA c.1633G > A p.(Glu545Lys) 8% reads\tSDC45\tSDC\tPIK3CA c.1093G > A p.(Glu365Lys) 20% reads\t \tACC21\tACC\tTP53 c.329G > C p.(Arg110Pro) 50% reads\tSDC46\tSDC\tPIK3CA c.3140A > G p.(His1047Arg) 13% reads\t \tACC22\tACC\tTP53 c.824G > A p.(Cys275Tyr) 4% reads\tSDC47\tSDC\tPIK3CA c.1624G > A p.(Glu542Lys) 13% reads\t \tACC22\tACC\tTP53 c.467G > C p.(Arg156Pro) 8% read\tSDC49\tSDC\tPIK3CA c.3140A > G p.(His1047Arg) 10% reads\t \tACC24\tACC\tTP53 c.1010G > A p.(Arg337His) 13% reads\tSDC52\tSDC\tPIK3CA c.3140A > G p.(His1047Arg) 51% reads\t \tACINIC25\tACINIC\tTP53 c.742C > T p.(Arg248Trp) 4% reads\tACC1\tACC\tAKT1 c.49G > A p.(Glu17Lys) 4% reads\t \tACINIC26\tACINIC\tTP53 c.818G > T p.(Arg273Leu) 35% reads\tSDC54\tSDC\tAKT1 c.49G > A p.(Glu17Lys) 22% reads\t \tADENO27\tADENO\tTP53 c.794T > G p.(Leu265Arg) 37% reads\tSDC56\tSDC\tAKT1 c.49G > A p.(Glu17Lys) 19% reads\t \tADENO28\tADENO\tTP53 c.637C > T p.(Arg213Ter) 26% reads\tACC5\tACC\tPTEN c.829dup p.(Thr277AsnfsTer21) 9% reads\t \tADENO29\tADENO\tTP53 c.626_627delGA p.(Arg209LysfsTer6) 30% reads\tACC7\tACC\tPTEN c.750_765dup p.(Glu256TrpfsTer2) 52% reads\t \tADENO30\tADENO\tTP53 c.481G > A p.(Ala161Thr) 22% reads;\tACC12\tACC\tPTEN c.16A > T p.(Lys6Ter) 62% reads\t \tExPleo34\tExPleo\tTP53 c.686_687dupGT p.(Thr230ValfsTer18) 38% reads\tACC17\tACC\tPTEN c.686C > G p.(Ser229Ter) 12% reads\t \tExPleo35\tExPleo\tTP53 c.991C > T p.(Gln331Ter) 44% reads;\tADENO31\tADENO\tPTEN c.382A > C p.(Lys128Gln) 7% reads\t \tExPleo36\tExPleo\tTP53 c.750_754dupCATCC p.(Leu252ArgfsTer95) 20% reads\tMEC40\tMEC\tPTEN c.634 + 5G > T 42% reads\t \tExPleo37\tExPleo\tTP53 c.989T > G p.(Leu330Arg) 26% reads\tACC4\tACC\tEGFR c.2369C > T p.(Thr790Met) 31% reads\t \tMEC38\tMEC\tTP53 c.828delC p.(Cys277ValfsTer68) 7% reads\tExPleo36\tExPleo\tERBB2 c.2305G > C p.(Asp769His) 81% reads\t \tMEC39\tMEC\tTP53 c.733G > A p.(Gly245Ser) 15% reads\tSDC43\tSDC\tERBB2 c.929C > T p.(Ser310Phe) 34% reads\t \tMEC41\tMEC\tTP53 c.460_462delGGC p.(Gly154del) 60% reads\tSDC50\tSDC\tERBB2 c.2305G > C p.(Asp769His) 26% reads\t \tSDC42\tSDC\tTP53 c.839G > C p.(Arg280Thr) 14% reads\tACC11\tACC\tBRAF c.1397G > A p.(Gly466Glu) 27% reads\t \tSDC43\tSDC\tTP53 c.993 + 1G > T 41% reads\tSDC45\tSDC\tBRAF c.1780G > A p.(Asp594Asn) 20% reads;\t \tSDC45\tSDC\tTP53 c.374C > G p.(Thr125Arg) 22% reads\tADENO27\tADENO\tKRAS c.436G > A p.(<m>Ala146Thr</m>) 8% reads\t \tSDC48\tSDC\tTP53 c.841G > C p.(Asp281His) 39% reads.\tACC6\tACC\tCTNNB1 c.134C > T p.(Ser45Phe) 23% reads\t \tSDC50\tSDC\tTP53 c.377_380delACTC p.(Tyr126SerfsTer43) 18% reads\t\t\t\t \tSDC52\tSDC\tTP53 c.626_627delGA p.(Arg209LysfsTer6) 43% reads\t\t\t\t \tSDC53\tSDC\tTP53 c.919 + 1G > C 25% reads\t\t\t\t \tSDC54\tSDC\tTP53 c.650T > G p.(Val217Gly) 15% reads\t\t\t\t \tSDC55\tSDC\tTP53 c.452C > G p.(Pro151Arg) 21% reads\t\t\t\t \tSDC56\tSDC\tTP53 c.912delT p.(Lys305SerfsTer40) 17% reads\t\t\t\t \t"}], "citations": {"NLM": "Rack S, Feeney L, Hapuarachi B, Adderley H, Woodhouse L, Betts G, Burghel GJ, Harrington KJ, Metcalf R. Evaluation of the Clinical Utility of Genomic Profiling to Inform Selection of Clinical Trial Therapy in Salivary Gland Cancer Cancers (Basel). PMID: 35267442", "BibTeX": "@article{35267442, title={Evaluation of the Clinical Utility of Genomic Profiling to Inform Selection of Clinical Trial Therapy in Salivary Gland Cancer}, author={Rack S and Feeney L and Hapuarachi B and Adderley H and Woodhouse L and Betts G and Burghel GJ and Harrington KJ and Metcalf R}, journal={Cancers (Basel)}}"}, "is_sup_mat_match": false}, {"pmid": 32376853, "pmcid": "PMC7483889", "title": "KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy.", "journal": "Mod Pathol", "authors": ["Favazza LA", "Parseghian CM", "Kaya C", "Nikiforova MN", "Roy S", "Wald AI", "Landau MS", "Proksell SS", "Dueker JM", "Johnston ER", "Brand RE", "Bahary N", "Gorantla VC", "Rhee JC", "Pingpank JF", "Choudry HA", "Lee K", "Paniccia A", "Ongchin MC", "Zureikat AH", "Bartlett DL", "Singhi AD"], "date": "2020-09-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "32376853@33745", "snip_text": "Case Age (years) Sex History of IBD Primary Colonic Origin Histologic Subtype Histologic Grade RAS Gene Amplification   (CN) Other Genomic Alterations* MMR Protein Status Anti-EGFR Treatment Follow-up (months)   1 49 M Yes (UC) Rectum Conventional Moderate KRAS (19)  Preserved Yes (panitumumab)** AWD (18)   2 45 M Yes (UC) Rectum Conventional Moderate KRAS (17)  Preserved No AWD (27)   3 73 M Yes (UC) Sigmoid Colon Conventional Moderate KRAS (10)  Preserved Yes (panitumumab)** AWD (57)   4 63 M Yes (UC) Sigmoid Colon Conventional Moderate KRAS (6)  Preserved Yes (panitumumab)** AWD (30)   5 38 F Yes (Crohn's) Cecum Signet Ring Cell Poor KRAS (13)  Preserved No DOD (5)   6 54 F Yes (UC) Sigmoid Colon Conventional Moderate KRAS (7)  Preserved N/A N/A   7 59 M No Cecum Micropapillary Moderate KRAS (14)  Preserved No DOD (6)   8 61 M No Cecum Mucinous Moderate KRAS (8) BRAF p.V600E Preserved No DOD (31)   9 60 F No Ascending Colon Mucinous Moderate KRAS (8)  Preserved Yes (panitumumab)** DOD (23)   10 26 M No Sigmoid Conventional Poor KRAS (7)  Preserved No AWD (15)   11 78 M No Rectum Conventional Moderate KRAS (6) KRAS p.G12V Preserved No DOD (7)   12 74 M No Rectum Conventional Moderate KRAS (7) KRAS p.G12R Preserved No DOD (21)   13 41 M Yes (Crohn's) Rectum Conventional Poor KRAS (12) KRAS p.G12D Preserved No DOD (2)   14 57 M Yes (Crohn's) Rectum Conventional Moderate KRAS (6) KRAS p.A146T Preserved No DOD (8)   15 53 M Yes (Crohn's) Rectum Conventional Moderate KRAS (6) KRAS p.G12D Preserved No DOD (15)   16 57 M No Rectum Conventional Moderate NRAS (16)  Preserved Yes (panitumumab)*** AWD (10)   17 52 M No Rectum Conventional Moderate NRAS (14)  Preserved N/A N/A   18 51 F No Rectum Conventional Poor NRAS (8) NRAS p.G12D Preserved No DOD (156)   19 72 M No Cecum Mucinous Moderate NRAS (7) KRAS p.G12R Preserved No DOD (11)   20 66 M No Cecum Mucinous Moderate NRAS (6) KRAS p.G12S Preserved No DOD (11)   21 67 F No Cecum Mucinous Poor HRAS (21) BRAF p.V600E MLH1/PMS2-deficient No DOD (31)   22 79 F No Cecum Mucinous Poor HRAS (19) BRAF p.V600E MLH1/PMS2-deficient No DOD (20)   ", "section": "table", "mentions": ["1214|4|gene|ncbi_gene@3845|KRAS", "1407|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "1135|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1297|4|gene|ncbi_gene@3845|KRAS", "1986|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "545|4|gene|ncbi_gene@3845|KRAS", "1734|4|gene|ncbi_gene@4893|NRAS", "1743|4|gene|ncbi_gene@4893|NRAS", "2017|95|disease|ncbi_mesh@D002430|DOD (31)   22 79 F No Cecum Mucinous Poor HRAS (19) BRAF p.V600E MLH1/PMS2-deficient No DOD (20", "1307|4|gene|ncbi_gene@3845|KRAS", "1829|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "1895|4|gene|ncbi_gene@4893|NRAS", "1904|4|gene|ncbi_gene@3845|KRAS", "257|4|gene|ncbi_gene@3845|KRAS", "1503|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "570|11|chemical|ncbi_mesh@D000077544|panitumumab", "959|4|gene|ncbi_gene@3845|KRAS", "984|11|chemical|ncbi_mesh@D000077544|panitumumab", "1219|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "1574|4|gene|ncbi_gene@4893|NRAS", "441|4|gene|ncbi_gene@3845|KRAS", "354|4|gene|ncbi_gene@3845|KRAS", "1263|7|disease|ncbi_mesh@D003424|Crohn's", "1047|4|gene|ncbi_gene@3845|KRAS", "1312|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1451|7|disease|ncbi_mesh@D003424|Crohn's", "1121|4|gene|ncbi_gene@3845|KRAS", "1130|4|gene|ncbi_gene@3845|KRAS", "1667|4|gene|ncbi_gene@4893|NRAS", "1355|7|disease|ncbi_mesh@D003424|Crohn's", "1748|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "32|3|disease|ncbi_mesh@D015212|IBD", "1600|11|chemical|ncbi_mesh@D000077544|panitumumab", "878|4|gene|ncbi_gene@673|BRAF", "1402|4|gene|ncbi_gene@3845|KRAS", "283|11|chemical|ncbi_mesh@D000077544|panitumumab", "1498|4|gene|ncbi_gene@3845|KRAS", "1909|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "731|4|gene|ncbi_gene@3845|KRAS", "883|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "176|4|gene|ncbi_gene@1956|EGFR", "1815|4|gene|ncbi_gene@4893|NRAS", "1824|4|gene|ncbi_gene@3845|KRAS", "1971|4|gene|ncbi_gene@3265|HRAS", "869|4|gene|ncbi_gene@3845|KRAS", "1393|4|gene|ncbi_gene@3845|KRAS", "645|4|gene|ncbi_gene@3845|KRAS", "467|11|chemical|ncbi_mesh@D000077544|panitumumab", "1489|4|gene|ncbi_gene@3845|KRAS", "801|4|gene|ncbi_gene@3845|KRAS", "608|7|disease|ncbi_mesh@D003424|Crohn's", "1981|4|gene|ncbi_gene@673|BRAF", "1205|4|gene|ncbi_gene@3845|KRAS"], "figure_id": "T2", "text_hl": "Case Age (years) Sex History of IBD Primary Colonic Origin Histologic Subtype Histologic Grade RAS Gene Amplification   (CN) Other Genomic Alterations* MMR Protein Status Anti-EGFR Treatment Follow-up (months)   1 49 M Yes (UC) Rectum Conventional Moderate KRAS (19)  Preserved Yes (panitumumab)** AWD (18)   2 45 M Yes (UC) Rectum Conventional Moderate KRAS (17)  Preserved No AWD (27)   3 73 M Yes (UC) Sigmoid Colon Conventional Moderate KRAS (10)  Preserved Yes (panitumumab)** AWD (57)   4 63 M Yes (UC) Sigmoid Colon Conventional Moderate KRAS (6)  Preserved Yes (panitumumab)** AWD (30)   5 38 F Yes (Crohn's) Cecum Signet Ring Cell Poor KRAS (13)  Preserved No DOD (5)   6 54 F Yes (UC) Sigmoid Colon Conventional Moderate KRAS (7)  Preserved N/A N/A   7 59 M No Cecum Micropapillary Moderate KRAS (14)  Preserved No DOD (6)   8 61 M No Cecum Mucinous Moderate KRAS (8) BRAF p.V600E Preserved No DOD (31)   9 60 F No Ascending Colon Mucinous Moderate KRAS (8)  Preserved Yes (panitumumab)** DOD (23)   10 26 M No Sigmoid Conventional Poor KRAS (7)  Preserved No AWD (15)   11 78 M No Rectum Conventional Moderate KRAS (6) KRAS p.G12V Preserved No DOD (7)   12 74 M No Rectum Conventional Moderate KRAS (7) KRAS p.G12R Preserved No DOD (21)   13 41 M Yes (Crohn's) Rectum Conventional Poor KRAS (12) KRAS p.G12D Preserved No DOD (2)   14 57 M Yes (Crohn's) Rectum Conventional Moderate KRAS (6) KRAS <m>p.A146T</m> Preserved No DOD (8)   15 53 M Yes (Crohn's) Rectum Conventional Moderate KRAS (6) KRAS p.G12D Preserved No DOD (15)   16 57 M No Rectum Conventional Moderate NRAS (16)  Preserved Yes (panitumumab)*** AWD (10)   17 52 M No Rectum Conventional Moderate NRAS (14)  Preserved N/A N/A   18 51 F No Rectum Conventional Poor NRAS (8) NRAS p.G12D Preserved No DOD (156)   19 72 M No Cecum Mucinous Moderate NRAS (7) KRAS p.G12R Preserved No DOD (11)   20 66 M No Cecum Mucinous Moderate NRAS (6) KRAS p.G12S Preserved No DOD (11)   21 67 F No Cecum Mucinous Poor HRAS (21) BRAF p.V600E MLH1/PMS2-deficient No DOD (31)   22 79 F No Cecum Mucinous Poor HRAS (19) BRAF p.V600E MLH1/PMS2-deficient No DOD (20)   "}], "citations": {"NLM": "Favazza LA, Parseghian CM, Kaya C, Nikiforova MN, Roy S, Wald AI, Landau MS, Proksell SS, Dueker JM, Johnston ER, Brand RE, Bahary N, Gorantla VC, Rhee JC, Pingpank JF, Choudry HA, Lee K, Paniccia A, Ongchin MC, Zureikat AH, Bartlett DL, Singhi AD. KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy. Mod Pathol. PMID: 32376853", "BibTeX": "@article{32376853, title={KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy.}, author={Favazza LA and Parseghian CM and Kaya C and Nikiforova MN and Roy S and Wald AI and Landau MS and Proksell SS and Dueker JM and Johnston ER and Brand RE and Bahary N and Gorantla VC and Rhee JC and Pingpank JF and Choudry HA and Lee K and Paniccia A and Ongchin MC and Zureikat AH and Bartlett DL and Singhi AD}, journal={Mod Pathol}}"}, "is_sup_mat_match": false}, {"pmid": 35709138, "pmcid": "PMC9202917", "title": "Genomic landscape of pathogenic mutation of APC, KRAS, TP53, PIK3CA, and MLH1 in Indonesian colorectal cancer.", "journal": "PLoS One", "authors": ["Marbun VMG", "Erlina L", "Lalisang TJM"], "date": "2022-06-16T00:00:00Z", "year": 2022, "snippets": [{"_id": "35709138@10452", "snip_text": "The most frequently occurred SNVs are T20 = in 4 subjects, A146T, and P34L in 3 subjects (Table 5).", "section": "results", "mentions": ["70|4|variant|litvar@rs104894366##&&&litvar@#3845#&&&litvar@CA235301#rs104894366##|P34L", "59|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "The most frequently occurred SNVs are T20 = in 4 subjects, <m>A146T</m>, and P34L in 3 subjects (Table 5)."}], "citations": {"NLM": "Marbun VMG, Erlina L, Lalisang TJM. Genomic landscape of pathogenic mutation of APC, KRAS, TP53, PIK3CA, and MLH1 in Indonesian colorectal cancer. PLoS One. PMID: 35709138", "BibTeX": "@article{35709138, title={Genomic landscape of pathogenic mutation of APC, KRAS, TP53, PIK3CA, and MLH1 in Indonesian colorectal cancer.}, author={Marbun VMG and Erlina L and Lalisang TJM}, journal={PLoS One}}"}, "is_sup_mat_match": false}, {"pmid": 19467855, "pmcid": "PMC2743116", "title": "The RASopathies: Developmental syndromes of Ras/MAPK pathway dysregulation", "journal": "Curr Opin Genet Dev", "authors": ["Tidyman WE", "Rauen KA"], "date": "2009-06-01T00:00:00Z", "year": 2009, "snippets": [{"_id": "19467855@11753", "snip_text": "In addition, less frequently observed mutations, such as K117R and A146T may result in an atypical phenotype.", "section": "other", "mentions": ["57|5|variant|litvar@#5594#p.K117R&&&litvar@#5594#|K117R", "67|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "In addition, less frequently observed mutations, such as K117R and <m>A146T</m> may result in an atypical phenotype."}], "citations": {"NLM": "Tidyman WE, Rauen KA. The RASopathies: Developmental syndromes of Ras/MAPK pathway dysregulation Curr Opin Genet Dev. PMID: 19467855", "BibTeX": "@article{19467855, title={The RASopathies: Developmental syndromes of Ras/MAPK pathway dysregulation}, author={Tidyman WE and Rauen KA}, journal={Curr Opin Genet Dev}}"}, "is_sup_mat_match": false}, {"pmid": 36202073, "pmcid": "PMC10273900", "title": "Prevalence of Molecular Alterations in a Swiss Cohort of 512 Colorectal Carcinoma Patients by Targeted Next-Generation Sequencing Analysis in Routine Diagnostics", "journal": "Pathobiology", "authors": ["Haefliger S", "Marston K", "Alborelli I", "Stauffer EJ", "Gugger M", "Jermann PM", "Hoeller S", "Tornillo L", "Terracciano LM", "Bihl M", "Matter MS"], "date": "2022-10-06T00:00:00Z", "year": 2022, "snippets": [{"_id": "36202073@31454", "snip_text": "Gene\tAlteration\tAlterations, N\tAlterations in primary tumor\tAlterations in metastasis\t \tKRAS\tp.A146T/V\t10 (5/5)\t7 (3/4)\t3 (2/1)\t \t\tp.A59E/G\t3 (1/2)\t2 (1/1)\t1 (0/1)\t \t\tp.G12A/C/D/F/R/S/V\t160 (15/16/61/2/2/14/50)\t126 (11/12/52/2/2/8/39)\t34 (4/4/9/0/0/6/11)\t \t\tp.G13D\t56\t51\t5\t \t\tp.K117N/R\t4 (3/1)\t4(3/1)\t0\t \t\tp.Q61H/K/R\t11 (9/1/1)\t9 (7/1/1)\t2 (2/0/0)\t \t\tp.L19F\t1\t1\t0\t \t\tp.V14I\t1\t1\t0\t \t\tp.G10_A11dup\t1\t1\t0\t \t\t \tBRAF\tp.D594G/N/V\t6 (3/2/1)\t6 (3/2/1)\t0\t \t\tp.E586K\t1\t1\t0\t \t\tp.G466V\t1\t0\t1\t \t\tp.G469A/E/R\t6 (1/3/2)\t4 (1/2/1)\t2 (0/1/1)\t \t\tp.N581S/I\t2\t2 (1/1)\t0\t \t\tp.V600E/K\t52 (51/1)\t46 (45/1)\t6 (6/0)\t \t\tp.T599A\t1\t1\t0\t \t\t \tNRAS\tp.A59T\t1\t0\t0\t \t\tp.G12A/C/D\t7 (1/2/4)\t5 (1/2/2)\t2 (0/0/2)\t \t\tp.G13V\t1\t1\t0\t \t\tp.Q61H/K/R\t8 (2/3/3)\t8 (2/3/3)\t0\t \t\tp.S65N\t1\t1\t0\t \t\t \tPIK3CA\tp.A1020T\t1\t0\t1\t \t\tp.E542A/K\t12 (1/11)\t10 (0/10)\t2 (1/1)\t \t\tp.E545G/K/Q\t31 (2/28/1)\t25 (1/24/0)\t6 (1/4/1)\t \t\tp.E547K\t1\t1\t0\t \t\tp.G460S\t1\t1\t0\t \t\tp.G1049R\t1\t1\t0\t \t\tp.H1047L/R/Y\t12 (2/9/1)\t10 (2/7/1)\t2 (0/2/0)\t \t\tp.I391M\t9\t7\t2\t \t\tp.M1043I\t1\t1\t0\t \t\tp.Q546H/K/L/P/R\t8 (1/3/1/2/1)\t7 (1/3/1/1/1)\t1 (0/0/0/1/0)\t \t\tp.R88Q\t1\t1\t0\t \t\tp.V344G\t1\t1\t0\t \t\tp.Y1021C\t1\t0\t1\t \t\t \tERBB2\tp.V762L\t1\t1\t0\t \t\tp.L755S\t1\t1\t0\t \t\tp.V747L\t1\t1\t0\t \t\tp.T862A\t1\t1\t0\t \t\tp.L841F/V\t2 (1/1)\t2 (1/1)\t0\t \t\tp.V842I\t2\t2\t0\t \t\t \tCTNNB1\tp.S45P\t1\t1\t0\t \t\tp.D32N\t1\t1\t0\t \t\tp.I35S\t2\t2\t0\t \t\tp.S45F\t1\t1\t0\t \t\t \tAKT1\tp.E17L\t1\t0\t1\t \t\tp.E17K\t6\t5\t1\t \t\t \tMAP2K1\tp.Q56R\t1\t1\t0\t \t\t \tIDH2\tp.R172K\t1\t1\t0\t \t", "section": "table", "mentions": ["466|7|variant|litvar@rs121913351##&&&litvar@#673#&&&litvar@CA123647#rs121913351##|p.G466V", "1092|8|variant|litvar@rs121913288##&&&litvar@#5290#&&&litvar@CA16602699#rs121913288##|p.Y1021C", "258|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "1118|7|variant|litvar@rs121913471##&&&litvar@#2064#&&&litvar@CA135387#rs121913471##|p.V762L", "483|9|variant|litvar@rs121913355##&&&litvar@#673#|p.G469A/E", "613|4|gene|ncbi_gene@4893|NRAS", "1314|6|variant|litvar@#207#p.E17L&&&litvar@#207#|p.E17L", "880|7|variant|litvar@rs1060503127##&&&litvar@#5395#|p.G460S", "407|4|gene|ncbi_gene@673|BRAF", "1291|6|variant|litvar@rs121913409##&&&litvar@#1499#&&&litvar@CA127283#rs121913409##|p.S45F", "1259|6|variant|litvar@rs28931588##&&&litvar@#1499#&&&litvar@CA16602681#rs28931588##|p.D32N", "169|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "1236|6|gene|ncbi_gene@1499|CTNNB1", "553|9|variant|litvar@rs113488022##&&&litvar@#673#|p.V600E/K", "998|9|variant|litvar@rs121913286##&&&litvar@#5290#|p.Q546H/K", "773|9|variant|litvar@rs121913273##&&&litvar@#5290#|p.E542A/K", "1112|5|gene|ncbi_gene@2064|ERBB2", "814|9|variant|litvar@rs104886003##&&&litvar@#5290#|p.E545G/K", "694|8|variant|litvar@rs17851045##&&&litvar@#3845#|p.Q61H/K", "1169|7|variant|litvar@rs777679881##&&&litvar@#2066#&&&litvar@CA2087704#rs777679881##|p.T862A", "351|6|variant|litvar@rs745476335##&&&litvar@#673#&&&litvar@CA4517047#rs745476335##|p.L19F", "963|7|variant|litvar@rs2230461##&&&litvar@#5290#&&&litvar@CA161490#rs2230461##|p.I391M", "1186|9|variant|litvar@rs1236342555##&&&litvar@#2956#|p.L841F/V", "449|7|variant|litvar@rs121913340##&&&litvar@#673#&&&litvar@CA135092#rs121913340##|p.E586K", "678|6|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|p.G13V", "1152|7|variant|litvar@rs121913471##&&&litvar@#2064#&&&litvar@CA135387#rs121913471##|p.V747L", "863|7|variant|litvar@rs756706958##&&&litvar@#673#&&&litvar@CA168086237#rs756706958##|p.E547K", "1330|6|variant|litvar@rs121434592##&&&litvar@#207#&&&litvar@CA123660#rs121434592##|p.E17K", "915|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123328#rs121913279##|p.H1047L", "1059|6|variant|litvar@rs121913287##&&&litvar@#5290#&&&litvar@CA16602516#rs121913287##|p.R88Q", "1275|6|variant|litvar@#673#p.I35S&&&litvar@#673#|p.I35S", "618|6|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|p.A59T", "1348|6|gene|ncbi_gene@5604|MAP2K1", "389|6|variant|litvar@rs730881775##&&&litvar@#4436#|A11dup", "412|9|variant|litvar@rs121913338##&&&litvar@#673#|p.D594G/N", "131|8|variant|litvar@rs730880965##&&&litvar@#4893#|p.A59E/G", "276|7|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|p.K117N", "1217|7|variant|litvar@rs1057519738##&&&litvar@#2064#|p.V842I", "1243|6|variant|litvar@rs121913407##&&&litvar@#1499#&&&litvar@CA127285#rs121913407##|p.S45P", "897|8|variant|litvar@rs121913277##&&&litvar@#5290#&&&litvar@CA16602520#rs121913277##|p.G1049R", "1075|7|variant|litvar@rs1057519941##&&&litvar@#5290#|p.V344G", "1309|4|gene|ncbi_gene@207|AKT1", "1373|4|gene|ncbi_gene@3418|IDH2", "88|4|gene|ncbi_gene@3845|KRAS", "755|8|variant|litvar@rs1456190774##&&&litvar@#324#|p.A1020T", "306|8|variant|litvar@rs17851045##&&&litvar@#3845#|p.Q61H/K", "980|8|variant|litvar@rs121913283##&&&litvar@#5290#&&&litvar@CA183868#rs121913283##|p.M1043I", "1135|7|variant|litvar@rs121913470##&&&litvar@#2064#&&&litvar@CA16602502#rs121913470##|p.L755S", "367|6|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|p.V14I", "1378|7|variant|litvar@rs121913503##&&&litvar@#3418#&&&litvar@CA16602462#rs121913503##|p.R172K", "594|7|variant|litvar@rs761780458##&&&litvar@#324#&&&litvar@CA32951#rs761780458##|p.T599A", "95|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "528|9|variant|litvar@rs121913370##&&&litvar@#673#|p.N581S/I", "636|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A", "730|6|variant|litvar@rs763784377##&&&litvar@#5728#&&&litvar@CA60479#rs763784377##|p.S65N", "748|6|gene|ncbi_gene@5290|PIK3CA", "1355|6|variant|litvar@rs1286309175##&&&litvar@#4851#|p.Q56R"], "figure_id": "T2", "text_hl": "Gene\tAlteration\tAlterations, N\tAlterations in primary tumor\tAlterations in metastasis\t \tKRAS\t<m>p.A146T</m>/V\t10 (5/5)\t7 (3/4)\t3 (2/1)\t \t\tp.A59E/G\t3 (1/2)\t2 (1/1)\t1 (0/1)\t \t\tp.G12A/C/D/F/R/S/V\t160 (15/16/61/2/2/14/50)\t126 (11/12/52/2/2/8/39)\t34 (4/4/9/0/0/6/11)\t \t\tp.G13D\t56\t51\t5\t \t\tp.K117N/R\t4 (3/1)\t4(3/1)\t0\t \t\tp.Q61H/K/R\t11 (9/1/1)\t9 (7/1/1)\t2 (2/0/0)\t \t\tp.L19F\t1\t1\t0\t \t\tp.V14I\t1\t1\t0\t \t\tp.G10_A11dup\t1\t1\t0\t \t\t \tBRAF\tp.D594G/N/V\t6 (3/2/1)\t6 (3/2/1)\t0\t \t\tp.E586K\t1\t1\t0\t \t\tp.G466V\t1\t0\t1\t \t\tp.G469A/E/R\t6 (1/3/2)\t4 (1/2/1)\t2 (0/1/1)\t \t\tp.N581S/I\t2\t2 (1/1)\t0\t \t\tp.V600E/K\t52 (51/1)\t46 (45/1)\t6 (6/0)\t \t\tp.T599A\t1\t1\t0\t \t\t \tNRAS\tp.A59T\t1\t0\t0\t \t\tp.G12A/C/D\t7 (1/2/4)\t5 (1/2/2)\t2 (0/0/2)\t \t\tp.G13V\t1\t1\t0\t \t\tp.Q61H/K/R\t8 (2/3/3)\t8 (2/3/3)\t0\t \t\tp.S65N\t1\t1\t0\t \t\t \tPIK3CA\tp.A1020T\t1\t0\t1\t \t\tp.E542A/K\t12 (1/11)\t10 (0/10)\t2 (1/1)\t \t\tp.E545G/K/Q\t31 (2/28/1)\t25 (1/24/0)\t6 (1/4/1)\t \t\tp.E547K\t1\t1\t0\t \t\tp.G460S\t1\t1\t0\t \t\tp.G1049R\t1\t1\t0\t \t\tp.H1047L/R/Y\t12 (2/9/1)\t10 (2/7/1)\t2 (0/2/0)\t \t\tp.I391M\t9\t7\t2\t \t\tp.M1043I\t1\t1\t0\t \t\tp.Q546H/K/L/P/R\t8 (1/3/1/2/1)\t7 (1/3/1/1/1)\t1 (0/0/0/1/0)\t \t\tp.R88Q\t1\t1\t0\t \t\tp.V344G\t1\t1\t0\t \t\tp.Y1021C\t1\t0\t1\t \t\t \tERBB2\tp.V762L\t1\t1\t0\t \t\tp.L755S\t1\t1\t0\t \t\tp.V747L\t1\t1\t0\t \t\tp.T862A\t1\t1\t0\t \t\tp.L841F/V\t2 (1/1)\t2 (1/1)\t0\t \t\tp.V842I\t2\t2\t0\t \t\t \tCTNNB1\tp.S45P\t1\t1\t0\t \t\tp.D32N\t1\t1\t0\t \t\tp.I35S\t2\t2\t0\t \t\tp.S45F\t1\t1\t0\t \t\t \tAKT1\tp.E17L\t1\t0\t1\t \t\tp.E17K\t6\t5\t1\t \t\t \tMAP2K1\tp.Q56R\t1\t1\t0\t \t\t \tIDH2\tp.R172K\t1\t1\t0\t \t"}], "citations": {"NLM": "Haefliger S, Marston K, Alborelli I, Stauffer EJ, Gugger M, Jermann PM, Hoeller S, Tornillo L, Terracciano LM, Bihl M, Matter MS. Prevalence of Molecular Alterations in a Swiss Cohort of 512 Colorectal Carcinoma Patients by Targeted Next-Generation Sequencing Analysis in Routine Diagnostics Pathobiology. PMID: 36202073", "BibTeX": "@article{36202073, title={Prevalence of Molecular Alterations in a Swiss Cohort of 512 Colorectal Carcinoma Patients by Targeted Next-Generation Sequencing Analysis in Routine Diagnostics}, author={Haefliger S and Marston K and Alborelli I and Stauffer EJ and Gugger M and Jermann PM and Hoeller S and Tornillo L and Terracciano LM and Bihl M and Matter MS}, journal={Pathobiology}}"}, "is_sup_mat_match": false}, {"pmid": 32187889, "pmcid": "PMC7495839", "title": "GTP hydrolysis is modulated by Arg34 in the RASopathy-associated KRASP34R", "journal": "Birth Defects Res", "authors": ["Bera AK", "Lu J", "Lu C", "Li L", "Gondi S", "Yan W", "Nelson A", "Zhang G", "Westover KD"], "date": "2020-06-01T00:00:00Z", "year": 2020, "snippets": [{"_id": "32187889@24103", "snip_text": "(a) KRASA146T exemplifies rapid nucleotide exchange mutants where RAS activity is elevated by increased efficiency of nucleotide exchange.", "section": "figure_legend", "mentions": ["4|9|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|KRASA146T"], "figure_id": "F1", "text_hl": "(a) KRASA146T exemplifies rapid nucleotide exchange mutants where RAS activity is elevated by increased efficiency of nucleotide exchange."}], "citations": {"NLM": "Bera AK, Lu J, Lu C, Li L, Gondi S, Yan W, Nelson A, Zhang G, Westover KD. GTP hydrolysis is modulated by Arg34 in the RASopathy-associated KRASP34R Birth Defects Res. PMID: 32187889", "BibTeX": "@article{32187889, title={GTP hydrolysis is modulated by Arg34 in the RASopathy-associated KRASP34R}, author={Bera AK and Lu J and Lu C and Li L and Gondi S and Yan W and Nelson A and Zhang G and Westover KD}, journal={Birth Defects Res}}"}, "is_sup_mat_match": false}, {"pmid": 27737491, "pmcid": "PMC5477980", "title": "Mutation Location on the RAS Oncogene Affects Pathologic Features and Survival After Resection of Colorectal Liver Metastases", "journal": "Cancer", "authors": ["Frankel TL", "Vakiani E", "Nathan H", "DeMatteo RP", "Kingham TP", "Allen PJ", "Jarnagin WR", "Kemeny NE", "Solit DB", "D'Angelica MI"], "date": "2017-02-15T00:00:00Z", "year": 2017, "snippets": [{"_id": "27737491@8818", "snip_text": "The location of mutation in the K/NRAS gene was most often in exon 2 (codon 12 or 13, including G12D, G12S, G12V, G13C, G13D; 81.6% of RAS mutations), followed by exon 3 (codon 61, including Q61R and Q61H; 10% of RAS mutations), and exon 4 (codon 146, including A146T; 8.5% of RAS mutations) (Table 2).", "section": "results", "mentions": ["262|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "34|4|gene|ncbi_gene@4893|NRAS", "108|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "114|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13C", "102|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "191|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "200|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "120|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "96|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D"], "text_hl": "The location of mutation in the K/NRAS gene was most often in exon 2 (codon 12 or 13, including G12D, G12S, G12V, G13C, G13D; 81.6% of RAS mutations), followed by exon 3 (codon 61, including Q61R and Q61H; 10% of RAS mutations), and exon 4 (codon 146, including <m>A146T</m>; 8.5% of RAS mutations) (Table 2)."}], "citations": {"NLM": "Frankel TL, Vakiani E, Nathan H, DeMatteo RP, Kingham TP, Allen PJ, Jarnagin WR, Kemeny NE, Solit DB, D'Angelica MI. Mutation Location on the RAS Oncogene Affects Pathologic Features and Survival After Resection of Colorectal Liver Metastases Cancer. PMID: 27737491", "BibTeX": "@article{27737491, title={Mutation Location on the RAS Oncogene Affects Pathologic Features and Survival After Resection of Colorectal Liver Metastases}, author={Frankel TL and Vakiani E and Nathan H and DeMatteo RP and Kingham TP and Allen PJ and Jarnagin WR and Kemeny NE and Solit DB and D'Angelica MI}, journal={Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 37207265, "pmcid": "PMC10189839", "title": "Beyond Structural Bioinformatics for Genomics with Dynamics Characterization of an Expanded KRAS Mutational Landscape", "journal": "bioRxiv", "authors": ["Ratnasinghe BD", "Haque N", "Wagenknecht JB", "Jensen DR", "Esparza GV", "Leverence EN", "De Assuncao TM", "Mathison AJ", "Lomberk G", "Smith BC", "Volkman BF", "Urrutia R", "Zimmermann MT"], "date": "2023-04-28T00:00:00Z", "year": 2023, "snippets": [{"_id": "37207265@25664", "snip_text": "Also, mutants with high sum of square residuals (SSR) in both GDP and GTP simulations, such as N26I, Q61L, and A146T, overly favor the SOS1 binding conformation regardless of the nucleotide-bound state.", "section": "results", "mentions": ["95|4|variant|litvar@rs794727277##|N26I", "70|3|chemical|ncbi_mesh@D006160|GTP", "62|3|chemical|ncbi_mesh@D006153|GDP", "111|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "179|10|chemical|ncbi_mesh@D009711|nucleotide", "101|4|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|Q61L", "135|4|gene|ncbi_gene@6654|SOS1"], "text_hl": "Also, mutants with high sum of square residuals (SSR) in both GDP and GTP simulations, such as N26I, Q61L, and <m>A146T</m>, overly favor the SOS1 binding conformation regardless of the nucleotide-bound state."}], "citations": {"NLM": "Ratnasinghe BD, Haque N, Wagenknecht JB, Jensen DR, Esparza GV, Leverence EN, De Assuncao TM, Mathison AJ, Lomberk G, Smith BC, Volkman BF, Urrutia R, Zimmermann MT. Beyond Structural Bioinformatics for Genomics with Dynamics Characterization of an Expanded KRAS Mutational Landscape bioRxiv. PMID: 37207265", "BibTeX": "@article{37207265, title={Beyond Structural Bioinformatics for Genomics with Dynamics Characterization of an Expanded KRAS Mutational Landscape}, author={Ratnasinghe BD and Haque N and Wagenknecht JB and Jensen DR and Esparza GV and Leverence EN and De Assuncao TM and Mathison AJ and Lomberk G and Smith BC and Volkman BF and Urrutia R and Zimmermann MT}, journal={bioRxiv}}"}, "is_sup_mat_match": false}, {"pmid": 28353383, "pmcid": "PMC7888553", "title": "SP174, NRAS Q61R Mutant-Specific Antibody, Cross-Reacts With KRAS Q61R Mutant Protein in Colorectal Carcinoma", "journal": "Arch Pathol Lab Med", "authors": ["Lasota J", "Kowalik A", "Felisiak-Golabek A", "Inaguma S", "Wang ZF", "Pi\u0119ciak L", "Zi\u0119ba S", "P\u0119ksa R", "Kopczynski J", "Oko\u0144 K", "Waloszczyk P", "Gozdz S", "Biernat W", "Miettinen M"], "date": "2017-04-01T00:00:00Z", "year": 2017, "snippets": [{"_id": "28353383@13902", "snip_text": "\tGenotype\t\t \tIHC SP174\tKRAS\tNRAS\tKRAS and NRAS\tTotal No. of Tumors\t \t\t\t\t \t\tG12A (n = 2)\tG13D\tQ61R\tQ61H (n = 4)\tA146T (n = 4)\tQ61H (n = 1)\tQ61R\tWildtype\tMutation status unknown\t\t \t\tG12C (n = 6)\t\t\tQ61L (n = 3)\tA146V (n = 1)\tQ61K (n = 1)\t\t\t \t\tG12D (n = 13)\t\t\t\t\t\t\t\t\t \t\tG12S (n = 1)\t\t\t\t\t\t\t\t\t\t \t\tG12V (n = 8)\t\t\t\t\t\t\t\t\t\t \tNegative\t30\t3\t0\t7\t5\t2\t0\t62\t1064\t1173\t \tPositive\t0\t0\t4\t0\t0\t0\t8\t  0\t   0\t 12\t \t\t\t\t\t\t\t\t\t\t\t1185\t \t", "section": "table", "mentions": ["23|4|gene|ncbi_gene@3845|KRAS", "208|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "290|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "138|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "28|4|gene|ncbi_gene@4893|NRAS", "93|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "240|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "33|4|gene|ncbi_gene@3845|KRAS", "88|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "265|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "42|4|gene|ncbi_gene@4893|NRAS", "125|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "180|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "98|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "222|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "111|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "17|5|gene|ncbi_gene@53829|SP174", "195|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "75|4|variant|litvar@rs121913237##&&&litvar@#4893#&&&litvar@CA280928#rs121913237##|G12A"], "figure_id": "T1", "text_hl": "\tGenotype\t\t \tIHC SP174\tKRAS\tNRAS\tKRAS and NRAS\tTotal No. of Tumors\t \t\t\t\t \t\tG12A (n = 2)\tG13D\tQ61R\tQ61H (n = 4)\t<m>A146T</m> (n = 4)\tQ61H (n = 1)\tQ61R\tWildtype\tMutation status unknown\t\t \t\tG12C (n = 6)\t\t\tQ61L (n = 3)\tA146V (n = 1)\tQ61K (n = 1)\t\t\t \t\tG12D (n = 13)\t\t\t\t\t\t\t\t\t \t\tG12S (n = 1)\t\t\t\t\t\t\t\t\t\t \t\tG12V (n = 8)\t\t\t\t\t\t\t\t\t\t \tNegative\t30\t3\t0\t7\t5\t2\t0\t62\t1064\t1173\t \tPositive\t0\t0\t4\t0\t0\t0\t8\t  0\t   0\t 12\t \t\t\t\t\t\t\t\t\t\t\t1185\t \t"}], "citations": {"NLM": "Lasota J, Kowalik A, Felisiak-Golabek A, Inaguma S, Wang ZF, Pi\u0119ciak L, Zi\u0119ba S, P\u0119ksa R, Kopczynski J, Oko\u0144 K, Waloszczyk P, Gozdz S, Biernat W, Miettinen M. SP174, NRAS Q61R Mutant-Specific Antibody, Cross-Reacts With KRAS Q61R Mutant Protein in Colorectal Carcinoma Arch Pathol Lab Med. PMID: 28353383", "BibTeX": "@article{28353383, title={SP174, NRAS Q61R Mutant-Specific Antibody, Cross-Reacts With KRAS Q61R Mutant Protein in Colorectal Carcinoma}, author={Lasota J and Kowalik A and Felisiak-Golabek A and Inaguma S and Wang ZF and Pi\u0119ciak L and Zi\u0119ba S and P\u0119ksa R and Kopczynski J and Oko\u0144 K and Waloszczyk P and Gozdz S and Biernat W and Miettinen M}, journal={Arch Pathol Lab Med}}"}, "is_sup_mat_match": false}, {"pmid": 27872090, "pmcid": "PMC5243866", "title": "Mutational landscape of pediatric acute lymphoblastic leukemia", "journal": "Cancer Res", "authors": ["Ding LW", "Sun QY", "Tan KT", "Chien W", "Mayakonda A", "Yeoh AEJ", "Kawamata N", "Nagata Y", "Xiao JF", "Loh XY", "Lin DC", "Garg M", "Jiang YY", "Xu L", "Lim SL", "Liu LZ", "Madan V", "Sanada M", "Fern\u00e1ndez LT", "Hema Preethi SS", "Lill M", "Kantarjian HM", "Kornblau SM", "Miyano S", "Liang DC", "Ogawa S", "Shih LY", "Yang H", "Koeffler HP"], "date": "2017-01-15T00:00:00Z", "year": 2017, "snippets": [{"_id": "27872090@10775", "snip_text": "Besides the well know hotspot mutations [G12 (NRAS, n=21; KRAS, n=12), G13 (NRAS, n= 15; KRAS, n=11) and Q61 (NRAS, n=16; KRAS n=1)], novel mutational sites were also identified for KRAS: A146T/P (n=4), K117N/T (n=4) and V14I (n=1) (Fig. 2A).", "section": "results", "mentions": ["182|4|gene|ncbi_gene@3845|KRAS", "89|4|gene|ncbi_gene@3845|KRAS", "221|4|variant|litvar@rs104894365##&&&litvar@#3845#&&&litvar@CA156358#rs104894365##|V14I", "76|4|gene|ncbi_gene@4893|NRAS", "71|3|variant|litvar@rs112445441##&&&litvar@#3845#|G13", "46|4|gene|ncbi_gene@4893|NRAS", "110|4|gene|ncbi_gene@4893|NRAS", "203|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "122|4|gene|ncbi_gene@3845|KRAS", "58|4|gene|ncbi_gene@3845|KRAS", "188|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T"], "text_hl": "Besides the well know hotspot mutations [G12 (NRAS, n=21; KRAS, n=12), G13 (NRAS, n= 15; KRAS, n=11) and Q61 (NRAS, n=16; KRAS n=1)], novel mutational sites were also identified for KRAS: <m>A146T</m>/P (n=4), K117N/T (n=4) and V14I (n=1) (Fig. 2A)."}], "citations": {"NLM": "Ding LW, Sun QY, Tan KT, Chien W, Mayakonda A, Yeoh AEJ, Kawamata N, Nagata Y, Xiao JF, Loh XY, Lin DC, Garg M, Jiang YY, Xu L, Lim SL, Liu LZ, Madan V, Sanada M, Fern\u00e1ndez LT, Hema Preethi SS, Lill M, Kantarjian HM, Kornblau SM, Miyano S, Liang DC, Ogawa S, Shih LY, Yang H, Koeffler HP. Mutational landscape of pediatric acute lymphoblastic leukemia Cancer Res. PMID: 27872090", "BibTeX": "@article{27872090, title={Mutational landscape of pediatric acute lymphoblastic leukemia}, author={Ding LW and Sun QY and Tan KT and Chien W and Mayakonda A and Yeoh AEJ and Kawamata N and Nagata Y and Xiao JF and Loh XY and Lin DC and Garg M and Jiang YY and Xu L and Lim SL and Liu LZ and Madan V and Sanada M and Fern\u00e1ndez LT and Hema Preethi SS and Lill M and Kantarjian HM and Kornblau SM and Miyano S and Liang DC and Ogawa S and Shih LY and Yang H and Koeffler HP}, journal={Cancer Res}}"}, "is_sup_mat_match": false}, {"pmid": 26968814, "pmcid": "PMC5008380", "title": "Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technology.", "journal": "Oncotarget", "authors": ["Ibarrola-Villava M", "Fleitas T", "Llorca-Carde\u00f1osa MJ", "Mongort C", "Alonso E", "Navarro S", "Burgues O", "Vivancos A", "Cejalvo JM", "Perez-Fidalgo JA", "Rosell\u00f3 S", "Ribas G", "Cervantes A"], "date": "2016-04-19T00:00:00Z", "year": 2016, "snippets": [{"_id": "26968814@12527", "snip_text": "Mutations in five of the samples found by NGS were not detected by Sequenom (KRAS p.G12C 10.8%, p.Q61K 47.1% and p.A146T 11.6%, and p.Q61L 13.7% and BRAF p.V600E 12.3%; percentages represent the frequency of mutant alleles).", "section": "results", "mentions": ["154|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "149|4|gene|ncbi_gene@673|BRAF", "96|6|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|p.Q61K", "82|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "132|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "77|4|gene|ncbi_gene@3845|KRAS", "113|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T"], "text_hl": "Mutations in five of the samples found by NGS were not detected by Sequenom (KRAS p.G12C 10.8%, p.Q61K 47.1% and <m>p.A146T</m> 11.6%, and p.Q61L 13.7% and BRAF p.V600E 12.3%; percentages represent the frequency of mutant alleles)."}], "citations": {"NLM": "Ibarrola-Villava M, Fleitas T, Llorca-Carde\u00f1osa MJ, Mongort C, Alonso E, Navarro S, Burgues O, Vivancos A, Cejalvo JM, Perez-Fidalgo JA, Rosell\u00f3 S, Ribas G, Cervantes A. Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technology. Oncotarget. PMID: 26968814", "BibTeX": "@article{26968814, title={Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technology.}, author={Ibarrola-Villava M and Fleitas T and Llorca-Carde\u00f1osa MJ and Mongort C and Alonso E and Navarro S and Burgues O and Vivancos A and Cejalvo JM and Perez-Fidalgo JA and Rosell\u00f3 S and Ribas G and Cervantes A}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 36293374, "pmcid": "PMC9604085", "title": "Assessing and Evaluating the Scope and Constraints of Idylla Molecular Assays by Using Different Source Materials in Routine Diagnostic Settings", "journal": "Int J Mol Sci", "authors": ["Boppudi SM", "Scheil-Bertram S", "Faust E", "Annamneedi A", "Fisseler-Eckhoff A"], "date": "2022-10-19T00:00:00Z", "year": 2022, "snippets": [{"_id": "36293374@52675", "section": "table", "mentions": ["4373|4|gene|ncbi_gene@673|BRAF", "1853|4|gene|ncbi_gene@3845|KRAS", "4194|4|gene|ncbi_gene@673|BRAF", "3293|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|p.G12C", "4364|4|gene|ncbi_gene@4893|NRAS", "605|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "940|4|gene|ncbi_gene@4893|NRAS", "4185|4|gene|ncbi_gene@4893|NRAS", "1248|4|gene|ncbi_gene@4893|NRAS", "1891|4|gene|ncbi_gene@3845|KRAS", "4654|4|gene|ncbi_gene@4893|NRAS", "3089|4|gene|ncbi_gene@1956|EGFR", "2140|4|gene|ncbi_gene@673|BRAF", "974|4|gene|ncbi_gene@673|BRAF", "4310|4|gene|ncbi_gene@3845|KRAS", "969|4|gene|ncbi_gene@4893|NRAS", "1195|4|gene|ncbi_gene@673|BRAF", "3196|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "2842|4|gene|ncbi_gene@673|BRAF", "3269|4|gene|ncbi_gene@3845|KRAS", "4628|4|gene|ncbi_gene@3845|KRAS", "4532|4|gene|ncbi_gene@1956|EGFR", "2269|4|gene|ncbi_gene@673|BRAF", "2053|4|gene|ncbi_gene@673|BRAF", "4100|4|gene|ncbi_gene@673|BRAF", "1621|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1012|4|gene|ncbi_gene@673|BRAF", "3614|4|gene|ncbi_gene@3845|KRAS", "649|7|variant|litvar@rs121913465##&&&litvar@#1956#&&&litvar@CA135840#rs121913465##|p.S768I", "3013|7|variant|litvar@#1956#p.G721S&&&litvar@#1956#|p.G721S", "1862|11|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.Ala146Thr", "2935|4|gene|ncbi_gene@4893|NRAS", "888|4|gene|ncbi_gene@1956|EGFR", "4560|4|gene|ncbi_gene@673|BRAF", "3982|4|gene|ncbi_gene@3845|KRAS", "2150|7|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16602420#rs121913227##|p.V600K", "3129|4|gene|ncbi_gene@1956|EGFR", "4382|4|gene|ncbi_gene@4893|NRAS", "398|4|gene|ncbi_gene@1956|EGFR", "1041|4|gene|ncbi_gene@4893|NRAS", "1958|4|gene|ncbi_gene@3845|KRAS", "1773|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "3799|4|gene|ncbi_gene@3845|KRAS", "2248|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "852|4|gene|ncbi_gene@1956|EGFR", "1656|4|gene|ncbi_gene@3845|KRAS", "4323|4|gene|ncbi_gene@3845|KRAS", "2175|4|gene|ncbi_gene@673|BRAF", "674|4|gene|ncbi_gene@1956|EGFR", "1046|4|gene|ncbi_gene@673|BRAF", "1987|4|gene|ncbi_gene@3845|KRAS", "638|4|gene|ncbi_gene@1956|EGFR", "3002|4|gene|ncbi_gene@1956|EGFR", "2424|4|gene|ncbi_gene@673|BRAF", "1469|4|gene|ncbi_gene@4893|NRAS", "524|4|gene|ncbi_gene@1956|EGFR", "1345|4|gene|ncbi_gene@4893|NRAS", "712|4|gene|ncbi_gene@1956|EGFR", "3186|4|gene|ncbi_gene@1956|EGFR", "1190|4|gene|ncbi_gene@4893|NRAS", "557|4|gene|ncbi_gene@1956|EGFR", "3531|4|gene|ncbi_gene@1956|EGFR", "3315|4|gene|ncbi_gene@3845|KRAS", "2912|4|gene|ncbi_gene@4893|NRAS", "3839|4|gene|ncbi_gene@1956|EGFR", "2434|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "4480|18|variant|litvar@#1956#p.A,EGFR746,750del&&&litvar@#1956#|p.E746_A750delEGFR", "3215|4|gene|ncbi_gene@1956|EGFR", "2366|4|gene|ncbi_gene@673|BRAF", "870|7|variant|litvar@#1956#c.751delT&&&litvar@#1956#|T751del", "2063|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "2940|4|gene|ncbi_gene@673|BRAF", "3278|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "797|4|gene|ncbi_gene@1956|EGFR", "1022|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "3032|4|gene|ncbi_gene@1956|EGFR", "2238|4|gene|ncbi_gene@673|BRAF", "3808|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "4538|4|gene|ncbi_gene@673|BRAF", "4387|4|gene|ncbi_gene@673|BRAF", "3955|4|gene|ncbi_gene@3845|KRAS", "1546|4|gene|ncbi_gene@3845|KRAS", "3965|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "2083|4|gene|ncbi_gene@673|BRAF", "1450|4|gene|ncbi_gene@673|BRAF", "1289|4|gene|ncbi_gene@4893|NRAS", "2455|4|gene|ncbi_gene@673|BRAF", "4208|4|gene|ncbi_gene@4893|NRAS", "440|4|gene|ncbi_gene@1956|EGFR", "2345|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "1386|4|gene|ncbi_gene@4893|NRAS", "4452|4|gene|ncbi_gene@1956|EGFR", "3100|17|variant|litvar@#1956#p.S746,752delins&&&litvar@#1956#|p.E746_S752delins", "1690|4|gene|ncbi_gene@3845|KRAS", "3503|4|gene|ncbi_gene@1956|EGFR", "1969|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|p.G12R", "2856|4|gene|ncbi_gene@673|BRAF", "4463|7|variant|litvar@rs121434569##&&&litvar@#1956#&&&litvar@CA90928#rs121434569##|p.T790M", "2921|4|gene|ncbi_gene@673|BRAF", "722|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "4114|4|gene|ncbi_gene@673|BRAF", "3417|4|gene|ncbi_gene@673|BRAF", "1797|4|gene|ncbi_gene@3845|KRAS", "951|6|variant|litvar@#4893#c.49delA&&&litvar@#4893#|49delA", "595|4|gene|ncbi_gene@1956|EGFR", "1573|4|gene|ncbi_gene@3845|KRAS", "4638|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "2335|4|gene|ncbi_gene@673|BRAF", "1294|4|gene|ncbi_gene@673|BRAF", "4213|4|gene|ncbi_gene@673|BRAF", "1763|4|gene|ncbi_gene@3845|KRAS", "4544|4|gene|ncbi_gene@3845|KRAS", "3388|4|gene|ncbi_gene@673|BRAF", "1391|4|gene|ncbi_gene@673|BRAF", "1460|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "3852|4|gene|ncbi_gene@1956|EGFR", "478|4|gene|ncbi_gene@1956|EGFR", "4348|4|gene|ncbi_gene@1956|EGFR", "408|15|variant|litvar@#1956#p.S747,7522del&&&litvar@#1956#|p.L747_S7522del", "1666|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "1612|4|gene|ncbi_gene@3845|KRAS", "488|7|variant|litvar@#1956#p.A755G&&&litvar@#1956#|p.A755G", "4504|7|variant|litvar@rs121434568##&&&litvar@#1956#&&&litvar@CA126713#rs121434568##|p.L858R", "1149|4|gene|ncbi_gene@4893|NRAS", "4339|4|gene|ncbi_gene@1956|EGFR", "4555|4|gene|ncbi_gene@4893|NRAS", "3398|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "1489|4|gene|ncbi_gene@4893|NRAS", "1494|4|gene|ncbi_gene@673|BRAF", "755|4|gene|ncbi_gene@1956|EGFR"], "figure_id": "ijms-23-12515-t001", "snip_text": "Case No. #\tYear of Tissue Prepared\tTumor Cells (%)\tCancer Type\tPrevious Result\tVAF %\tAlternate Method (s)\tIdylla Cartridge Used\tInput Material (s) in Cartridge\tgDNA Input-FFPE Scratched Slide\tgDNA Input-HE Scratched Slide\t \t\t\t\t\t\t\t\t\t\tDNA Conc. (ng/muL)\tDNA Quality Score *\tDNA Input in the Cartridge-microL\tDNA Conc. (ng/muL)\tDNA Quality Score *\tDNA Input in the Cartridge-microL\t \t1\t2019\t90%\tNSCLC\tEGFR-Ex19:p.L747_S7522del\t38.9%\tNGS; Pyro\tEGFR\tFFPE; gDNA\t26.4\t1\t10\t34.7\t2\t15\t \tEGFR-Ex19:p.A755G\t39.4%\t \t2\t2020\t30-40%\tNSCLC\tEGFR-Ex20:p.T790M\t8.4%\tNGS; Pyro\tEGFR\tFFPE; gDNA\t24.1\t1\t10\t23.2\t3\t25\t \tEGFR-Ex21:p.L858R\t29.7%\t \t3\t2020\t70%\tNSCLC\tEGFR-Ex 20:p.S768I \t31.6%\tNGS; Pyro\tEGFR\tFFPE; gDNA\t54.2\t1\t15\t70.5\t3\t20\t \tEGFR-Ex21:p.L858R\t14.8%\t \t4\t2012\t50%\tNSCLC\tEGFR-Ex 19: p.E746_T753>V\t51.5%\tNGS; Pyro\tEGFR\tFFPE; gDNA\t31.6\t2\t20\t29.1\t3\t20\t \t5\t2021\t75%\tNSCLC\tEGFR-Ex19: p.L747_T751del\t34.4%\tNGS\tEGFR\tFFPE; gDNA\t143.5\t1\t10\t52\t2\t15\t \t6\t2020\t80%\tCRC\tNRAS-Ex2-c:49delA\t28.40%\tNGS\tNRAS/BRAF\tFFPE; gDNA\t91.3\t1\t10\t38.2\t2\t20\t \tBRAF-Ex15:p.V600E\t41.70%\tNGS\tNRAS/BRAF\tFFPE; gDNA\t10\t20\t \tMSI High (5/10 System Unstable)\t\tNGS; FA\tMSI\tFFPE; gDNA\t10\t20\t \t7\t2019\t80%\tCRC\tNRAS-Ex 3:p.Q61LBRAF-WT\t22.10%\tNGS; Pyro\tNRAS/BRAF\tFFPE; gDNA\t139\t1\t12\t21.3\t3\t20\t \t8\t2019\t100%\tPTC\tNRAS-Ex 3:p.Q61RBRAF-WT\t34.20%\tNGS; Pyro\tNRAS/BRAF\tFFPE; gDNA\t36\t2\t20\t88.8\t2\t15\t \t9\t2019\t80%\tCRC\tNRAS-Ex 3:p.Q61RBRAF-WT\t20.20%\tNGS; Pyro\tNRAS/BRAF\tFFPE; gDNA\t12.4\t4\t25\t24.5\t4\t25\t \t10\t2020\t95%\tMelanoma\tBRAF-Ex15:p.V600E, NRAS-WT\t14.40%\tPyro\tNRAS/BRAF\tFFPE; gDNA\t275\t1\t5\t35.3\t4\t25\t \t11\t2004\t70%\tCRC\tKRAS-Ex2:p.G12D\t14.1%\tPyro\tKRAS\tFFPE; gDNA\t196.1\t1\t12\t50.9\t1\t15\t \tKRAS-Ex2:p.G12V\t2.1%\t \t12\t2019\t30-40%\tNSCLC\tKRAS-Ex 2:p.G12A \t26.1%\tNGS; Pyro\tKRAS\tFFPE; gDNA\t101.1\t1\t10\t33.5\t1\t15\t \t13\t2019\t80%\tOesophageal Carcinoma\tKRAS-Ex 2:p.G13D\t55.94%\tNGS; Pyro\tKRAS\tFFPE; gDNA\t86.5\t1\t10\t64.7\t3\t25\t \t14\t2018\t65%\tNSCLC\tKRAS-Ex4:p.Ala146Thr\t63.86%\tNGS; Pyro\tKRAS\tFFPE; gDNA\t295.1\t1\t5\t9.7\t2\t25\t \t15\t2022\t60%\tPancreatic cancer\tKRAS- Ex 2:p.G12R\t9.50%\tPyro\tKRAS\tFFPE; gDNA\t59.6\t1\t12\t167.2\t1\t10\t \t16\t2021\t90%\tThyroid cancer\tBRAF-Ex15:p.V600E\t19.70%\tPyro\tBRAF\tFFPE; gDNA\t10\t1\t15\t13.2\t1\t10\t \t17\t2018\t75%\tMelanoma\tBRAF-Ex15:p.V600K\t32.90%\tNGS; Pyro\tBRAF\tFFPE; gDNA\t259\t1\t8\t96.2\t1\t10\t \t18\t2021\t50%\tThyroid cancer\tBRAF-Ex15:p.V600E \t36.70%\tPyro\tBRAF\tFFPE; gDNA\t113.9\t1\t10\t38.5\t3\t25\t \t19\t2021\t90%\tThyroid cancer\tBRAF-Ex15:p.V600E \t24.10%\tPyro\tBRAF\tFFPE; gDNA\t95\t1\t10\t118.1\t2\t15\t \t20\t2022\t50%\tMelanoma\tBRAF-Ex15:p.V600E \t44.70%\tPyro\tBRAF\tFFPE; gDNA\t45.3\t2\t15\t43.8\t2\t20\t \t21\t2020\t80%\tCRC\tMSI High (3/10 System unstable)\t\tFA\tMSI\tFFPE; gDNA\t190\t1\t8\t8.9\t1\t15\t \t22\t2010\t80%\tCRC\tMSS\t\tFA\tMSI\tFFPE; gDNA\t141\t1\t10\t5.35\t1\t15\t \t23\t2021\t70%\tCRC\tMSI High (7/10 System unstable)\t\tFA\tMSI\tFFPE; gDNA\t132\t1\t10\t125.3\t2\t10\t \t24\t2020\t90%\tCRC\tMSI High (8/10 System unstable)\t\tNGS; FA\tMSI\tFFPE; gDNA\t322\t1\t8\t140.5\t1\t10\t \t25\t2017\t30%\tMelanoma\tBRAF-WT\t\tPyro\tBRAF\tFFPE-HE\tN/A\tN/A\tN/A\tN/A\tN/A\tN/A\t \t26\t2021\t60% \tCRC\tNRAS-WT; BRAF-WT\t\tPyro\tNRAS-BRAF\tFFPE; gDNA-HE\tN/A\tN/A\tN/A\t11.5\t1\t10\t \t27\t2021\t70%\tNSCLC \tEGFR-Ex18: p.G721S \t5.80%\tNGS\tEGFR\tFFPE-HE\tN/A\tN/A\tN/A\tN/A\tN/A\tN/A\t \t28\t2020\t90%\tNSCLC\tEGFR-Ex19: p.E746_S752delins\t57.20%\tNGS\tEGFR\tFFPE-HE\tN/A\tN/A\tN/A\tN/A\tN/A\tN/A\t \t29\t2021\t80%\tNSCLC\tEGFR-Ex21:p.L858R\t14.80%\tNGS\tEGFR\tgDNA-FFPE\t5.5\t1\t15\tN/A\tN/A\tN/A\t \t30\t2022\t80%\tCRC\tKRAS-Ex2:p.G12DKRAS-Ex2:p.G12C\t25.8%1.43%\tNGS\tKRAS\tFFPE-HE + FFPE\tN/A\tN/A\tN/A\tN/A\tN/A\tN/A\t \t31\t2021\t20%\tThyroid cancer\tBRAF-Ex15:p.V600E\t6.90%\tPyro\tBRAF\tgDNA-HE\tN/A\tN/A\tN/A\t6.7\t4\t10-25 microL\t \t32\t2021\t60%\tcholangiocellular carcinoma\tEGFR-Ex19:PV742I\t46.70%\tNGS\tEGFR\tCytological fluid; gDNA\t20 microL Cytofluid material input in the cartridge\t \tKRAS\t20-500 microL Cytofluid material input in the cartridge and gDNA prepared from FFPE-cytoblock with 30 microL input and gDNA prepared from Cytofluid material with 40 microL input\t \tKRAS:Ex2:G12D\t3.10%\t \t33\t2021\t30%\tNSCLC\tEGFR-WT\t\tNGS\tEGFR\tCytofluid pleural effusion\t20 microL Cytofluid material input in the cartridge\t \t34\t2022\t10%\tIPMN\tKRAS-Ex2: G12D\t26.50%\tPyro\tKRAS\tpleural effusion fluid; gDNA\tgDNA prepared from Cytopleural effusion-with 40 microL input\t \t35\t2015\t70%\tMelanoma\tBRAF-WT\t\tPyro\tBRAF\tFFPE\tN/A\t \t36\t2011\t20%\tCRC\tMSS\t\tFA\tMSI\tFFPE\tN/A\t \t37\t2018\t50%\tCRC\tNRAS-WT; BRAF-WT\t\tPyro\tNRAS-BRAF\tFFPE\tN/A\t \t38\t2022\t\tOesophageal Carcinoma\tMSS\t\tFA\tMSI\tFFPE-HE + PAS\tN/A\t \t39\t2021\t90%\tNSCLC\tKRAS-WT\t\tNGS\tKRAS\tFFPE\tN/A\t \tEGFR-WT\t\tEGFR\tFFPE\tN/A\t \tNRAS-WT; BRAF-WT\t\tNRAS-BRAF\tFFPE\tN/A\t \t40\tN/A\t\tCP-Positive Control (Reference Standard)\tEGFR-Ex20: p.T790MEGFR-Ex19:p.E746_A750delEGFR-Ex21:p.L858R\t7.46%7.12%8.42%\tNGS\tEGFR; BRAF; KRAS; MSI; NRAS-BRAF\tgDNA\t6.25 ng/microL-10 microL direct input in each cartridge\t \tKRAS-Ex 2:p.G13D\t20.89%\t \tNRAS-WTBRAF-WTMSI-High\t\t \t", "text_hl": "Case No. #\tYear of Tissue Prepared\tTumor Cells (%)\tCancer Type\tPrevious Result\tVAF %\tAlternate Method (s)\tIdylla Cartridge Used\tInput Material (s) in Cartridge\tgDNA Input-FFPE Scratched Slide\tgDNA Input-HE Scratched Slide\t \t\t\t\t\t\t\t\t\t\tDNA Conc. (ng/muL)\tDNA Quality Score *\tDNA Input in the Cartridge-microL\tDNA Conc. (ng/muL)\tDNA Quality Score *\tDNA Input in the Cartridge-microL\t \t1\t2019\t90%\tNSCLC\tEGFR-Ex19:p.L747_S7522del\t38.9%\tNGS; Pyro\tEGFR\tFFPE; gDNA\t26.4\t1\t10\t34.7\t2\t15\t \tEGFR-Ex19:p.A755G\t39.4%\t \t2\t2020\t30-40%\tNSCLC\tEGFR-Ex20:p.T790M\t8.4%\tNGS; Pyro\tEGFR\tFFPE; gDNA\t24.1\t1\t10\t23.2\t3\t25\t \tEGFR-Ex21:p.L858R\t29.7%\t \t3\t2020\t70%\tNSCLC\tEGFR-Ex 20:p.S768I \t31.6%\tNGS; Pyro\tEGFR\tFFPE; gDNA\t54.2\t1\t15\t70.5\t3\t20\t \tEGFR-Ex21:p.L858R\t14.8%\t \t4\t2012\t50%\tNSCLC\tEGFR-Ex 19: p.E746_T753>V\t51.5%\tNGS; Pyro\tEGFR\tFFPE; gDNA\t31.6\t2\t20\t29.1\t3\t20\t \t5\t2021\t75%\tNSCLC\tEGFR-Ex19: p.L747_T751del\t34.4%\tNGS\tEGFR\tFFPE; gDNA\t143.5\t1\t10\t52\t2\t15\t \t6\t2020\t80%\tCRC\tNRAS-Ex2-c:49delA\t28.40%\tNGS\tNRAS/BRAF\tFFPE; gDNA\t91.3\t1\t10\t38.2\t2\t20\t \tBRAF-Ex15:p.V600E\t41.70%\tNGS\tNRAS/BRAF\tFFPE; gDNA\t10\t20\t \tMSI High (5/10 System Unstable)\t\tNGS; FA\tMSI\tFFPE; gDNA\t10\t20\t \t7\t2019\t80%\tCRC\tNRAS-Ex 3:p.Q61LBRAF-WT\t22.10%\tNGS; Pyro\tNRAS/BRAF\tFFPE; gDNA\t139\t1\t12\t21.3\t3\t20\t \t8\t2019\t100%\tPTC\tNRAS-Ex 3:p.Q61RBRAF-WT\t34.20%\tNGS; Pyro\tNRAS/BRAF\tFFPE; gDNA\t36\t2\t20\t88.8\t2\t15\t \t9\t2019\t80%\tCRC\tNRAS-Ex 3:p.Q61RBRAF-WT\t20.20%\tNGS; Pyro\tNRAS/BRAF\tFFPE; gDNA\t12.4\t4\t25\t24.5\t4\t25\t \t10\t2020\t95%\tMelanoma\tBRAF-Ex15:p.V600E, NRAS-WT\t14.40%\tPyro\tNRAS/BRAF\tFFPE; gDNA\t275\t1\t5\t35.3\t4\t25\t \t11\t2004\t70%\tCRC\tKRAS-Ex2:p.G12D\t14.1%\tPyro\tKRAS\tFFPE; gDNA\t196.1\t1\t12\t50.9\t1\t15\t \tKRAS-Ex2:p.G12V\t2.1%\t \t12\t2019\t30-40%\tNSCLC\tKRAS-Ex 2:p.G12A \t26.1%\tNGS; Pyro\tKRAS\tFFPE; gDNA\t101.1\t1\t10\t33.5\t1\t15\t \t13\t2019\t80%\tOesophageal Carcinoma\tKRAS-Ex 2:p.G13D\t55.94%\tNGS; Pyro\tKRAS\tFFPE; gDNA\t86.5\t1\t10\t64.7\t3\t25\t \t14\t2018\t65%\tNSCLC\tKRAS-Ex4:p.Ala146Thr\t63.86%\tNGS; Pyro\tKRAS\tFFPE; gDNA\t295.1\t1\t5\t9.7\t2\t25\t \t15\t2022\t60%\tPancreatic cancer\tKRAS- Ex 2:p.G12R\t9.50%\tPyro\tKRAS\tFFPE; gDNA\t59.6\t1\t12\t167.2\t1\t10\t \t16\t2021\t90%\tThyroid cancer\tBRAF-Ex15:p.V600E\t19.70%\tPyro\tBRAF\tFFPE; gDNA\t10\t1\t15\t13.2\t1\t10\t \t17\t2018\t75%\tMelanoma\tBRAF-Ex15:p.V600K\t32.90%\tNGS; Pyro\tBRAF\tFFPE; gDNA\t259\t1\t8\t96.2\t1\t10\t \t18\t2021\t50%\tThyroid cancer\tBRAF-Ex15:p.V600E \t36.70%\tPyro\tBRAF\tFFPE; gDNA\t113.9\t1\t10\t38.5\t3\t25\t \t19\t2021\t90%\tThyroid cancer\tBRAF-Ex15:p.V600E \t24.10%\tPyro\tBRAF\tFFPE; gDNA\t95\t1\t10\t118.1\t2\t15\t \t20\t2022\t50%\tMelanoma\tBRAF-Ex15:p.V600E \t44.70%\tPyro\tBRAF\tFFPE; gDNA\t45.3\t2\t15\t43.8\t2\t20\t \t21\t2020\t80%\tCRC\tMSI High (3/10 System unstable)\t\tFA\tMSI\tFFPE; gDNA\t190\t1\t8\t8.9\t1\t15\t \t22\t2010\t80%\tCRC\tMSS\t\tFA\tMSI\tFFPE; gDNA\t141\t1\t10\t5.35\t1\t15\t \t23\t2021\t70%\tCRC\tMSI High (7/10 System unstable)\t\tFA\tMSI\tFFPE; gDNA\t132\t1\t10\t125.3\t2\t10\t \t24\t2020\t90%\tCRC\tMSI High (8/10 System unstable)\t\tNGS; FA\tMSI\tFFPE; gDNA\t322\t1\t8\t140.5\t1\t10\t \t25\t2017\t30%\tMelanoma\tBRAF-WT\t\tPyro\tBRAF\tFFPE-HE\tN/A\tN/A\tN/A\tN/A\tN/A\tN/A\t \t26\t2021\t60% \tCRC\tNRAS-WT; BRAF-WT\t\tPyro\tNRAS-BRAF\tFFPE; gDNA-HE\tN/A\tN/A\tN/A\t11.5\t1\t10\t \t27\t2021\t70%\tNSCLC \tEGFR-Ex18: p.G721S \t5.80%\tNGS\tEGFR\tFFPE-HE\tN/A\tN/A\tN/A\tN/A\tN/A\tN/A\t \t28\t2020\t90%\tNSCLC\tEGFR-Ex19: p.E746_S752delins\t57.20%\tNGS\tEGFR\tFFPE-HE\tN/A\tN/A\tN/A\tN/A\tN/A\tN/A\t \t29\t2021\t80%\tNSCLC\tEGFR-Ex21:p.L858R\t14.80%\tNGS\tEGFR\tgDNA-FFPE\t5.5\t1\t15\tN/A\tN/A\tN/A\t \t30\t2022\t80%\tCRC\tKRAS-Ex2:p.G12DKRAS-Ex2:p.G12C\t25.8%1.43%\tNGS\tKRAS\tFFPE-HE + FFPE\tN/A\tN/A\tN/A\tN/A\tN/A\tN/A\t \t31\t2021\t20%\tThyroid cancer\tBRAF-Ex15:p.V600E\t6.90%\tPyro\tBRAF\tgDNA-HE\tN/A\tN/A\tN/A\t6.7\t4\t10-25 microL\t \t32\t2021\t60%\tcholangiocellular carcinoma\tEGFR-Ex19:PV742I\t46.70%\tNGS\tEGFR\tCytological fluid; gDNA\t20 microL Cytofluid material input in the cartridge\t \tKRAS\t20-500 microL Cytofluid material input in the cartridge and gDNA prepared from FFPE-cytoblock with 30 microL input and gDNA prepared from Cytofluid material with 40 microL input\t \tKRAS:Ex2:G12D\t3.10%\t \t33\t2021\t30%\tNSCLC\tEGFR-WT\t\tNGS\tEGFR\tCytofluid pleural effusion\t20 microL Cytofluid material input in the cartridge\t \t34\t2022\t10%\tIPMN\tKRAS-Ex2: G12D\t26.50%\tPyro\tKRAS\tpleural effusion fluid; gDNA\tgDNA prepared from Cytopleural effusion-with 40 microL input\t \t35\t2015\t70%\tMelanoma\tBRAF-WT\t\tPyro\tBRAF\tFFPE\tN/A\t \t36\t2011\t20%\tCRC\tMSS\t\tFA\tMSI\tFFPE\tN/A\t \t37\t2018\t50%\tCRC\tNRAS-WT; BRAF-WT\t\tPyro\tNRAS-BRAF\tFFPE\tN/A\t \t38\t2022\t\tOesophageal Carcinoma\tMSS\t\tFA\tMSI\tFFPE-HE + PAS\tN/A\t \t39\t2021\t90%\tNSCLC\tKRAS-WT\t\tNGS\tKRAS\tFFPE\tN/A\t \tEGFR-WT\t\tEGFR\tFFPE\tN/A\t \tNRAS-WT; BRAF-WT\t\tNRAS-BRAF\tFFPE\tN/A\t \t40\tN/A\t\tCP-Positive Control (Reference Standard)\tEGFR-Ex20: p.T790MEGFR-Ex19:p.E746_A750delEGFR-Ex21:p.L858R\t7.46%7.12%8.42%\tNGS\tEGFR; BRAF; KRAS; MSI; NRAS-BRAF\tgDNA\t6.25 ng/microL-10 microL direct input in each cartridge\t \tKRAS-Ex 2:p.G13D\t20.89%\t \tNRAS-WTBRAF-WTMSI-High\t\t \t"}], "citations": {"NLM": "Boppudi SM, Scheil-Bertram S, Faust E, Annamneedi A, Fisseler-Eckhoff A. Assessing and Evaluating the Scope and Constraints of Idylla Molecular Assays by Using Different Source Materials in Routine Diagnostic Settings Int J Mol Sci. PMID: 36293374", "BibTeX": "@article{36293374, title={Assessing and Evaluating the Scope and Constraints of Idylla Molecular Assays by Using Different Source Materials in Routine Diagnostic Settings}, author={Boppudi SM and Scheil-Bertram S and Faust E and Annamneedi A and Fisseler-Eckhoff A}, journal={Int J Mol Sci}}"}, "is_sup_mat_match": false}, {"pmid": 27283768, "pmcid": "PMC5129933", "title": "Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance.", "journal": "Oncotarget", "authors": ["M\u00f3dos O", "Reis H", "Niedworok C", "R\u00fcbben H", "Szendr\u00f6i A", "Sz\u00e1sz MA", "T\u00edm\u00e1r J", "Baghy K", "Kovalszky I", "Golabek T", "Chlosta P", "Okon K", "Peyronnet B", "Mathieu R", "Shariat SF", "Holl\u00f3si P", "Nyir\u00e1dy P", "Szarvas T"], "date": "2016-06-28T00:00:00Z", "year": 2016, "snippets": [{"_id": "27283768@5972", "snip_text": "Gene Exon Codon Spot change Amino change  Gene Exon   KRAS 2 12 c.35G>A p.G12D GGT --> GAT Gly --> Asp 1/22    2 12 c.35G>T p.G12V GGT --> GTT Gly --> Val 1/22    2 13     0/22    3 59     0/22    3 61 c.182A>T p.Q61L CAA --> CTA Gln --> Leu 1/22    4 146 c.437C>T p.A146V GCA --> GTA Ala --> Val 2/22    4 146 c.436G>A p.A146T GCA --> ACA Ala --> Thr 1/22           6/22   NRAS 2 12, 13     0/22    3 59     0/22    3 61 c.183A>T p.Q61H CAA --> CTA Gln --> His 1/22    4 146     0/22           1/22   BRAF 15 600 c.1799T>A p.V600E GTG --> GAG Val --> Glu 4/22   EGFR 18 719     0/22    19 744-750     0/22    20 768, 790     0/22    21 858-861     0/22           0/22   PIK3CA 9 542, 545     0/22    20 1047     0/22           0/22   ", "section": "table", "mentions": ["524|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "202|8|variant|litvar@rs121913240##&&&litvar@#3845#&&&litvar@CA210876#rs121913240##|c.182A>T", "422|8|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|c.183A>T", "431|6|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|p.Q61H", "265|7|variant|litvar@rs1057519725##&&&litvar@#3845#|p.A146V", "320|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "563|4|gene|ncbi_gene@1956|EGFR", "211|6|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|p.Q61L", "116|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|c.35G>T", "124|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "502|4|gene|ncbi_gene@673|BRAF", "54|4|gene|ncbi_gene@3845|KRAS", "311|8|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|c.436G>A", "64|7|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|c.35G>A", "72|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "256|8|variant|litvar@rs1057519725##&&&litvar@#3845#|c.437C>T", "514|9|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|c.1799T>A", "671|6|gene|ncbi_gene@5290|PIK3CA"], "figure_id": "T1", "text_hl": "Gene Exon Codon Spot change Amino change  Gene Exon   KRAS 2 12 c.35G>A p.G12D GGT --> GAT Gly --> Asp 1/22    2 12 c.35G>T p.G12V GGT --> GTT Gly --> Val 1/22    2 13     0/22    3 59     0/22    3 61 c.182A>T p.Q61L CAA --> CTA Gln --> Leu 1/22    4 146 c.437C>T p.A146V GCA --> GTA Ala --> Val 2/22    4 146 c.436G>A <m>p.A146T</m> GCA --> ACA Ala --> Thr 1/22           6/22   NRAS 2 12, 13     0/22    3 59     0/22    3 61 c.183A>T p.Q61H CAA --> CTA Gln --> His 1/22    4 146     0/22           1/22   BRAF 15 600 c.1799T>A p.V600E GTG --> GAG Val --> Glu 4/22   EGFR 18 719     0/22    19 744-750     0/22    20 768, 790     0/22    21 858-861     0/22           0/22   PIK3CA 9 542, 545     0/22    20 1047     0/22           0/22   "}], "citations": {"NLM": "M\u00f3dos O, Reis H, Niedworok C, R\u00fcbben H, Szendr\u00f6i A, Sz\u00e1sz MA, T\u00edm\u00e1r J, Baghy K, Kovalszky I, Golabek T, Chlosta P, Okon K, Peyronnet B, Mathieu R, Shariat SF, Holl\u00f3si P, Nyir\u00e1dy P, Szarvas T. Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance. Oncotarget. PMID: 27283768", "BibTeX": "@article{27283768, title={Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance.}, author={M\u00f3dos O and Reis H and Niedworok C and R\u00fcbben H and Szendr\u00f6i A and Sz\u00e1sz MA and T\u00edm\u00e1r J and Baghy K and Kovalszky I and Golabek T and Chlosta P and Okon K and Peyronnet B and Mathieu R and Shariat SF and Holl\u00f3si P and Nyir\u00e1dy P and Szarvas T}, journal={Oncotarget}}"}, "is_sup_mat_match": false}, {"pmid": 28761742, "pmcid": "PMC5519811", "title": "Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate.", "journal": "ESMO Open", "authors": ["Ree AH", "Russnes HG", "Heinrich D", "Dueland S", "Boye K", "Nygaard V", "Silwal-Pandit L", "\u00d8strup O", "Hovig E", "Nygaard V", "R\u00f8dland EA", "Nakken S", "\u00d8ien JT", "Johansen C", "Bergheim IR", "Skarpeteig V", "Sathermugathevan M", "Sauer T", "Lund-Iversen M", "Beiske K", "Nasser S", "Julsrud L", "Reisse CH", "Ruud EA", "Fl\u00f8renes VA", "Hagene KT", "Aas E", "Lur\u00e5s H", "Johnsen-Soriano S", "Geitvik GA", "Lingj\u00e6rde OC", "B\u00f8rresen-Dale AL", "M\u00e6landsmo GM", "Flatmark K"], "date": "2017-05-02T00:00:00Z", "year": 2017, "snippets": [{"_id": "28761742@18016", "snip_text": "Sex Age Primary tumour site Histological diagnosis Sampling site(s) Adverse event Gene mutation(s)   Male 43 Parotid gland Neuroendocrine carcinoma Lung None None detected   Male 69 Liver Hepatocellular carcinoma Liver transplant None None detected   Female 59 Pancreas Adenocarcinoma Liver None KRAS p.G12D   Male 62 Pancreas Adenocarcinoma Liver None KRAS p.G12D, TP53 p.R306X   Female 66 Pancreas Not determined Liver None KRAS p.G12D, GNAS p.R201H   Female 46 Right colon Adenocarcinoma Liver None KRAS p.G12D, SMAD4 p.R361C, TP53 p.C176F   Male 54 Right colon Adenocarcinoma Liver None KRAS p.G12D, PIK3CA p.E545K, SMAD4 p.G419R   Male 62 Right colon Adenocarcinoma Liver None KRAS p.G12D, SMAD4 p.Y353C, APC p.Q1444X, TP53 p.T102fs   Male 52 Left colon Adenocarcinoma Liver None KRAS p.G12V, PIK3CA p.E545Q   Male 59 Left colon Adenocarcinoma Liver None TP53 p.R273H, TP53 p.L350fs   Male 65 Left colon Mucinous adenocarcinoma Lung None KRAS p.A146T, PIK3CA p.H1047R   Female 68 Left colon Adenocarcinoma Liver transplant None KRAS p.G12A, APC p.Q1291fs   Male 70 Left colon Adenocarcinoma Liver None KRAS p.G13D, APC p.E1306X, APC p.K889fs, TP53 p.R248W   Male 54 Rectum Adenocarcinoma Lung None KRAS p.G12S, APC p.E1317X, TP53 p.R175G   Male 61 Rectum Adenocarcinoma Lung Pneumo-thorax KRAS p.G12S, APC p.Q1378X, FBXW7 p.R505C   Male 61 Rectum Mucinous adenocarcinoma Lung None BRAF p.V600E, SMAD4 p.W524C, TP53 p.R306X   Male 68 Rectum Adenocarcinoma Lung None KRAS p.G12D, PIK3CA p.E542K   Male 63 Kidney Clear cell renal cell carcinoma Thoracic wall None VHL p.L158P   Male 65 Kidney Renal Xp11.2 translocation carcinoma Liver None None detected   Male 61 Urinary bladder Urothelial carcinoma Inguinal lymph node and peritoneum None None detected   Female 48 Ovary Small-cell sarcoma* Peritoneum None KRAS p.T58I, PIK3CA p.H1047Y, ERBB2 p.V842I, CTNNB1 p.G34R, TP53 p.R306X*   Male 65 Prostate Adenocarcinoma Axillary lymph node None TP53 p.D184fs   ", "section": "table", "mentions": ["1935|4|disease|ncbi_mesh@D012804|node", "1719|4|disease|ncbi_mesh@D012804|node", "261|23|disease|ncbi_mesh@D000230|Pancreas Adenocarcinoma", "1950|8|variant|litvar@#7157#p.D184fsX&&&litvar@#7157#|p.D184fs", "1220|8|variant|litvar@rs1211642532##&&&litvar@#324#|p.E1317X", "1400|5|gene|ncbi_gene@4089|SMAD4", "444|7|variant|litvar@rs121913495##&&&litvar@#2778#&&&litvar@CA126069#rs121913495##|p.R201H", "439|4|gene|ncbi_gene@2778|GNAS", "1475|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "964|8|variant|litvar@rs121913279##&&&litvar@#5290#&&&litvar@CA123326#rs121913279##|p.H1047R", "1622|9|disease|ncbi_mesh@D009369|carcinoma", "620|5|gene|ncbi_gene@4089|SMAD4", "957|6|gene|ncbi_gene@5290|PIK3CA", "507|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1832|8|variant|litvar@rs121913281##&&&litvar@#5290#&&&litvar@CA130471#rs121913281##|p.H1047Y", "701|7|variant|litvar@rs377767346##&&&litvar@#4089#|p.Y353C", "1812|4|gene|ncbi_gene@3845|KRAS", "1896|23|disease|ncbi_mesh@D000230|Prostate Adenocarcinoma", "16|6|disease|ncbi_mesh@D009369|tumour", "371|7|variant|litvar@rs121913344##&&&litvar@#7157#&&&litvar@CA495#rs121913344##|p.R306X", "604|6|gene|ncbi_gene@5290|PIK3CA", "1857|6|gene|ncbi_gene@1499|CTNNB1", "1230|4|gene|ncbi_gene@7157|TP53", "1588|19|disease|ncbi_mesh@D007674|Kidney Renal Xp11.2", "1386|4|gene|ncbi_gene@673|BRAF", "695|5|gene|ncbi_gene@4089|SMAD4", "785|4|gene|ncbi_gene@3845|KRAS", "301|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1033|4|gene|ncbi_gene@3845|KRAS", "1460|4|disease|ncbi_mesh@D008171|Lung", "470|20|disease|ncbi_mesh@D003110|colon Adenocarcinoma", "318|23|disease|ncbi_mesh@D000230|Pancreas Adenocarcinoma", "1842|5|gene|ncbi_gene@2064|ERBB2", "1391|7|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|p.V600E", "1675|28|disease|ncbi_mesh@D001749|bladder Urothelial carcinoma", "710|3|gene|ncbi_gene@324|APC", "148|4|disease|ncbi_mesh@D008171|Lung", "879|8|variant|litvar@rs1131691008##&&&litvar@#7157#|p.L350fs", "828|20|disease|ncbi_mesh@D003110|colon Adenocarcinoma", "1203|4|gene|ncbi_gene@3845|KRAS", "1107|4|gene|ncbi_gene@3845|KRAS", "1307|3|gene|ncbi_gene@324|APC", "933|4|disease|ncbi_mesh@D008171|Lung", "714|8|variant|litvar@rs1060503288##&&&litvar@#324#|p.Q1444X", "123|24|disease|ncbi_mesh@D018278|Neuroendocrine carcinoma", "1415|4|gene|ncbi_gene@7157|TP53", "798|6|gene|ncbi_gene@5290|PIK3CA", "1120|3|gene|ncbi_gene@324|APC", "1153|7|variant|litvar@rs121912651##&&&litvar@#7157#&&&litvar@CA382#rs121912651##|p.R248W", "790|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|p.G12V", "1311|8|variant|litvar@rs121913329##&&&litvar@#324#&&&litvar@CA16030382#rs121913329##|p.Q1378X", "358|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "650|20|disease|ncbi_mesh@D003110|colon Adenocarcinoma", "502|4|gene|ncbi_gene@3845|KRAS", "874|4|gene|ncbi_gene@7157|TP53", "1299|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "1420|7|variant|litvar@rs121913344##&&&litvar@#7157#&&&litvar@CA495#rs121913344##|p.R306X", "1134|3|gene|ncbi_gene@324|APC", "1864|6|variant|litvar@rs121913399##&&&litvar@#1499#&&&litvar@CA16602685#rs121913399##|p.G34R", "626|7|variant|litvar@rs1486841342##&&&litvar@#3717#|p.G419R", "903|29|disease|ncbi_mesh@D003110|colon Mucinous adenocarcinoma", "943|4|gene|ncbi_gene@3845|KRAS", "1208|6|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|p.G12S", "1112|6|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|p.G13D", "990|20|disease|ncbi_mesh@D003110|colon Adenocarcinoma", "729|8|variant|litvar@#7157#p.T102fsX&&&litvar@#7157#|p.T102fs", "1138|8|variant|litvar@#324#p.K889fsX&&&litvar@#324#|p.K889fs", "530|4|gene|ncbi_gene@7157|TP53", "1848|7|variant|litvar@rs1057519738##&&&litvar@#2064#|p.V842I", "559|20|disease|ncbi_mesh@D003110|colon Adenocarcinoma", "948|7|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|p.A146T", "366|4|gene|ncbi_gene@7157|TP53", "1275|4|disease|ncbi_mesh@D008171|Lung", "1490|7|variant|litvar@rs121913273##&&&litvar@#5290#&&&litvar@CA333572#rs121913273##|p.E542K", "591|4|gene|ncbi_gene@3845|KRAS", "1124|8|variant|litvar@rs121913462##&&&litvar@#324#&&&litvar@CA16029925#rs121913462##|p.E1306X", "535|7|variant|litvar@rs786202962##&&&litvar@#7157#|p.C176F", "1872|4|gene|ncbi_gene@7157|TP53", "1945|4|gene|ncbi_gene@7157|TP53", "724|4|gene|ncbi_gene@7157|TP53", "753|20|disease|ncbi_mesh@D003110|colon Adenocarcinoma", "515|5|gene|ncbi_gene@4089|SMAD4", "1376|4|disease|ncbi_mesh@D008171|Lung", "1877|7|variant|litvar@rs121913344##&&&litvar@#7157#&&&litvar@CA495#rs121913344##|p.R306X", "426|4|gene|ncbi_gene@3845|KRAS", "353|4|gene|ncbi_gene@3845|KRAS", "1294|4|gene|ncbi_gene@3845|KRAS", "1075|20|disease|ncbi_mesh@D003110|colon Adenocarcinoma", "1825|6|gene|ncbi_gene@5290|PIK3CA", "1193|4|disease|ncbi_mesh@D008171|Lung", "687|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1235|7|variant|litvar@rs138729528##&&&litvar@#7157#&&&litvar@CA16603066#rs138729528##|p.R175G", "1050|9|variant|litvar@#324#p.Q1291fsX&&&litvar@#324#|p.Q1291fs", "611|7|variant|litvar@rs104886003##&&&litvar@#5290#&&&litvar@CA123334#rs104886003##|p.E545K", "1327|7|variant|litvar@rs1303357004##&&&litvar@#6714#|p.R505C", "1216|3|gene|ncbi_gene@324|APC", "1570|7|variant|litvar@rs121913346##&&&litvar@#7428#&&&litvar@CA20399#rs121913346##|p.L158P", "431|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "521|7|variant|litvar@rs80338963##&&&litvar@#4089#&&&litvar@CA128095#rs80338963##|p.R361C", "1148|4|gene|ncbi_gene@7157|TP53", "1817|6|variant|litvar@rs104894364##&&&litvar@#3845#&&&litvar@CA256480#rs104894364##|p.T58I", "596|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|p.G12D", "1046|3|gene|ncbi_gene@324|APC", "1515|31|disease|ncbi_mesh@D002292|Clear cell renal cell carcinoma", "1776|18|disease|ncbi_mesh@D018228|Small-cell sarcoma", "860|4|gene|ncbi_gene@7157|TP53", "1470|4|gene|ncbi_gene@3845|KRAS", "188|24|disease|ncbi_mesh@D006528|Hepatocellular carcinoma", "1406|7|variant|litvar@#4089#p.W524C&&&litvar@#4089#|p.W524C", "805|7|variant|litvar@rs104886003##&&&litvar@#5290#|p.E545Q", "1038|6|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|p.G12A", "1483|6|gene|ncbi_gene@5290|PIK3CA", "296|4|gene|ncbi_gene@3845|KRAS", "865|7|variant|litvar@rs28934576##&&&litvar@#7157#&&&litvar@CA434#rs28934576##|p.R273H", "1566|3|gene|ncbi_gene@7428|VHL", "682|4|gene|ncbi_gene@3845|KRAS"], "figure_id": "T2", "text_hl": "Sex Age Primary tumour site Histological diagnosis Sampling site(s) Adverse event Gene mutation(s)   Male 43 Parotid gland Neuroendocrine carcinoma Lung None None detected   Male 69 Liver Hepatocellular carcinoma Liver transplant None None detected   Female 59 Pancreas Adenocarcinoma Liver None KRAS p.G12D   Male 62 Pancreas Adenocarcinoma Liver None KRAS p.G12D, TP53 p.R306X   Female 66 Pancreas Not determined Liver None KRAS p.G12D, GNAS p.R201H   Female 46 Right colon Adenocarcinoma Liver None KRAS p.G12D, SMAD4 p.R361C, TP53 p.C176F   Male 54 Right colon Adenocarcinoma Liver None KRAS p.G12D, PIK3CA p.E545K, SMAD4 p.G419R   Male 62 Right colon Adenocarcinoma Liver None KRAS p.G12D, SMAD4 p.Y353C, APC p.Q1444X, TP53 p.T102fs   Male 52 Left colon Adenocarcinoma Liver None KRAS p.G12V, PIK3CA p.E545Q   Male 59 Left colon Adenocarcinoma Liver None TP53 p.R273H, TP53 p.L350fs   Male 65 Left colon Mucinous adenocarcinoma Lung None KRAS <m>p.A146T</m>, PIK3CA p.H1047R   Female 68 Left colon Adenocarcinoma Liver transplant None KRAS p.G12A, APC p.Q1291fs   Male 70 Left colon Adenocarcinoma Liver None KRAS p.G13D, APC p.E1306X, APC p.K889fs, TP53 p.R248W   Male 54 Rectum Adenocarcinoma Lung None KRAS p.G12S, APC p.E1317X, TP53 p.R175G   Male 61 Rectum Adenocarcinoma Lung Pneumo-thorax KRAS p.G12S, APC p.Q1378X, FBXW7 p.R505C   Male 61 Rectum Mucinous adenocarcinoma Lung None BRAF p.V600E, SMAD4 p.W524C, TP53 p.R306X   Male 68 Rectum Adenocarcinoma Lung None KRAS p.G12D, PIK3CA p.E542K   Male 63 Kidney Clear cell renal cell carcinoma Thoracic wall None VHL p.L158P   Male 65 Kidney Renal Xp11.2 translocation carcinoma Liver None None detected   Male 61 Urinary bladder Urothelial carcinoma Inguinal lymph node and peritoneum None None detected   Female 48 Ovary Small-cell sarcoma* Peritoneum None KRAS p.T58I, PIK3CA p.H1047Y, ERBB2 p.V842I, CTNNB1 p.G34R, TP53 p.R306X*   Male 65 Prostate Adenocarcinoma Axillary lymph node None TP53 p.D184fs   "}], "citations": {"NLM": "Ree AH, Russnes HG, Heinrich D, Dueland S, Boye K, Nygaard V, Silwal-Pandit L, \u00d8strup O, Hovig E, Nygaard V, R\u00f8dland EA, Nakken S, \u00d8ien JT, Johansen C, Bergheim IR, Skarpeteig V, Sathermugathevan M, Sauer T, Lund-Iversen M, Beiske K, Nasser S, Julsrud L, Reisse CH, Ruud EA, Fl\u00f8renes VA, Hagene KT, Aas E, Lur\u00e5s H, Johnsen-Soriano S, Geitvik GA, Lingj\u00e6rde OC, B\u00f8rresen-Dale AL, M\u00e6landsmo GM, Flatmark K. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate. ESMO Open. PMID: 28761742", "BibTeX": "@article{28761742, title={Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate.}, author={Ree AH and Russnes HG and Heinrich D and Dueland S and Boye K and Nygaard V and Silwal-Pandit L and \u00d8strup O and Hovig E and Nygaard V and R\u00f8dland EA and Nakken S and \u00d8ien JT and Johansen C and Bergheim IR and Skarpeteig V and Sathermugathevan M and Sauer T and Lund-Iversen M and Beiske K and Nasser S and Julsrud L and Reisse CH and Ruud EA and Fl\u00f8renes VA and Hagene KT and Aas E and Lur\u00e5s H and Johnsen-Soriano S and Geitvik GA and Lingj\u00e6rde OC and B\u00f8rresen-Dale AL and M\u00e6landsmo GM and Flatmark K}, journal={ESMO Open}}"}, "is_sup_mat_match": false}, {"pmid": 27312529, "pmcid": "PMC4970882", "title": "Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer", "journal": "Cancer Res", "authors": ["Oddo D", "Sennott EM", "Barault L", "Valtorta E", "Arena S", "Cassingena A", "Filiciotto G", "Marzolla G", "Elez E", "van Geel RM", "Bartolini A", "Crisafulli G", "Boscaro V", "Godfrey JT", "Buscarino M", "Cancelliere C", "Linnebacher M", "Corti G", "Truini M", "Siravegna G", "Grasselli J", "Gallicchio M", "Bernards R", "Schellens JH", "Tabernero J", "Engelman JA", "Sartore-Bianchi A", "Bardelli A", "Siena S", "Corcoran RB", "Di Nicolantonio F"], "date": "2016-08-01T00:00:00Z", "year": 2016, "snippets": [{"_id": "27312529@15673", "snip_text": "Acquired KRAS mutations affecting exons 2 and 4 (G12D, G13D and A146T/V) were found in five different cell line models resistant to doublet BRAFi+EGFRi or triplet E+C+A.", "section": "results", "mentions": ["49|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "146|5|chemical||EGFRi", "9|4|gene|ncbi_gene@3845|KRAS", "64|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "140|5|chemical||BRAFi", "55|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D"], "text_hl": "Acquired KRAS mutations affecting exons 2 and 4 (G12D, G13D and <m>A146T</m>/V) were found in five different cell line models resistant to doublet BRAFi+EGFRi or triplet E+C+A."}], "citations": {"NLM": "Oddo D, Sennott EM, Barault L, Valtorta E, Arena S, Cassingena A, Filiciotto G, Marzolla G, Elez E, van Geel RM, Bartolini A, Crisafulli G, Boscaro V, Godfrey JT, Buscarino M, Cancelliere C, Linnebacher M, Corti G, Truini M, Siravegna G, Grasselli J, Gallicchio M, Bernards R, Schellens JH, Tabernero J, Engelman JA, Sartore-Bianchi A, Bardelli A, Siena S, Corcoran RB, Di Nicolantonio F. Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer Cancer Res. PMID: 27312529", "BibTeX": "@article{27312529, title={Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer}, author={Oddo D and Sennott EM and Barault L and Valtorta E and Arena S and Cassingena A and Filiciotto G and Marzolla G and Elez E and van Geel RM and Bartolini A and Crisafulli G and Boscaro V and Godfrey JT and Buscarino M and Cancelliere C and Linnebacher M and Corti G and Truini M and Siravegna G and Grasselli J and Gallicchio M and Bernards R and Schellens JH and Tabernero J and Engelman JA and Sartore-Bianchi A and Bardelli A and Siena S and Corcoran RB and Di Nicolantonio F}, journal={Cancer Res}}"}, "is_sup_mat_match": false}, {"pmid": 27082517, "pmcid": "PMC5429592", "title": "Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center", "journal": "Pediatr Blood Cancer", "authors": ["Ortiz MV", "Kobos R", "Walsh M", "Slotkin EK", "Roberts S", "Berger MF", "Hameed M", "Solit D", "Ladanyi M", "Shukla N", "Kentsis A"], "date": "2016-08-01T00:00:00Z", "year": 2016, "snippets": [{"_id": "27082517@14542", "snip_text": "For example, a patient with refractory neuroblastoma and activating somatic KRAS A146T mutation was considered for potential therapy with either RAF or MEK kinase inhibitors.", "section": "results", "mentions": ["152|3|gene|ncbi_gene@5609|MEK", "145|3|gene|ncbi_gene@22882|RAF", "15|7|species|ncbi_taxonomy@9606|patient", "39|13|disease|ncbi_mesh@D009447|neuroblastoma", "81|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "76|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "For example, a patient with refractory neuroblastoma and activating somatic KRAS <m>A146T</m> mutation was considered for potential therapy with either RAF or MEK kinase inhibitors."}], "citations": {"NLM": "Ortiz MV, Kobos R, Walsh M, Slotkin EK, Roberts S, Berger MF, Hameed M, Solit D, Ladanyi M, Shukla N, Kentsis A. Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center Pediatr Blood Cancer. PMID: 27082517", "BibTeX": "@article{27082517, title={Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center}, author={Ortiz MV and Kobos R and Walsh M and Slotkin EK and Roberts S and Berger MF and Hameed M and Solit D and Ladanyi M and Shukla N and Kentsis A}, journal={Pediatr Blood Cancer}}"}, "is_sup_mat_match": false}, {"pmid": 34026331, "pmcid": "PMC8115557", "title": "PPARgamma induces PD-L1 expression in MSS+ colorectal cancer cells.", "journal": "Oncoimmunology", "authors": ["Gutting T", "Hauber V", "Pahl J", "Klapproth K", "Wu W", "Dobrota I", "Herweck F", "Reichling J", "Helm L", "Schroeder T", "Li B", "Weidner P", "Zhan T", "Eckardt M", "Betge J", "Belle S", "Sticht C", "Gaiser T", "Boutros M", "Ebert MPA", "Cerwenka A", "Burgermeister E"], "date": "2021-05-05T00:00:00Z", "year": 2021, "snippets": [{"_id": "34026331@19007", "snip_text": "We therefore selected four patients with MSS+ CRC based on the tumor's KRAS gene mutation (wt/A146T, n = 2; G12D/C, n = 2) (Table S2), and who had been well characterized in our hospital with regard to their clinical performance and tumor genetics.", "section": "results", "mentions": ["108|6|variant|litvar@rs121913530##&&&litvar@#3845#|G12D/C", "63|5|disease|ncbi_mesh@D009369|tumor", "46|3|disease|ncbi_mesh@D015179|CRC", "233|5|disease|ncbi_mesh@D009369|tumor", "27|8|species|ncbi_taxonomy@9606|patients", "94|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "41|3|disease|ncbi_mesh@D013132|MSS", "71|4|gene|ncbi_gene@3845|KRAS"], "text_hl": "We therefore selected four patients with MSS+ CRC based on the tumor's KRAS gene mutation (wt/<m>A146T</m>, n = 2; G12D/C, n = 2) (Table S2), and who had been well characterized in our hospital with regard to their clinical performance and tumor genetics."}], "citations": {"NLM": "Gutting T, Hauber V, Pahl J, Klapproth K, Wu W, Dobrota I, Herweck F, Reichling J, Helm L, Schroeder T, Li B, Weidner P, Zhan T, Eckardt M, Betge J, Belle S, Sticht C, Gaiser T, Boutros M, Ebert MPA, Cerwenka A, Burgermeister E. PPARgamma induces PD-L1 expression in MSS+ colorectal cancer cells. Oncoimmunology. PMID: 34026331", "BibTeX": "@article{34026331, title={PPARgamma induces PD-L1 expression in MSS+ colorectal cancer cells.}, author={Gutting T and Hauber V and Pahl J and Klapproth K and Wu W and Dobrota I and Herweck F and Reichling J and Helm L and Schroeder T and Li B and Weidner P and Zhan T and Eckardt M and Betge J and Belle S and Sticht C and Gaiser T and Boutros M and Ebert MPA and Cerwenka A and Burgermeister E}, journal={Oncoimmunology}}"}, "is_sup_mat_match": false}, {"pmid": 33240421, "pmcid": "PMC7681220", "title": "KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy and clinical evaluation.", "journal": "Oncol Lett", "authors": ["Lastraioli E", "Antonuzzo L", "Fantechi B", "Di Cerbo L", "Di Costanzo A", "Lavacchi D", "Armenio M", "Arcangeli A", "Castiglione F", "Messerini L", "Di Costanzo F"], "date": "2021-01-01T00:00:00Z", "year": 2021, "snippets": [{"_id": "33240421@31027", "snip_text": "RAS status No. of patients (%)   Wild-type KRAS 6 (19.35)   Mutated KRAS 25 (80.65)     Exon 2 codon 12 19 (76.00)       G12A 4       G12C 3       G12D 10       G12V 2     Exon 2 codon 13 5 (20.00)       G13D 4       G13V 1     Exon 3 codon 59 0 (0.00)     Exon 3 codon 61 0 (0.00)     Exon 4 codon 117 0 (0.00)     Exon 4 codon 146 1 (4.00)       A146P 1   Wild-type NRAS 30 (96.77)   Mutated NRAS 1 (3.23)     Exon 2 codon 12 1 (100.00)       G12D 1     Exon 2 codon 13 0 (0.00)     Exon 3 codon 59 0 (0.00)     Exon 3 codon 61 0 (0.00)     Exon 4 codon 117 0 (0.00)     Exon 4 codon 146 0 (0.00)     Undefined 0 (0.00)   ", "section": "table", "mentions": ["161|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "134|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "18|8|species|ncbi_taxonomy@9606|patients", "217|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA135573#rs112445441##|G13V", "121|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "368|4|gene|ncbi_gene@4893|NRAS", "147|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "348|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "204|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "445|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "394|4|gene|ncbi_gene@4893|NRAS", "68|4|gene|ncbi_gene@3845|KRAS", "43|4|gene|ncbi_gene@3845|KRAS"], "figure_id": "tII-ol-0-0-12276", "text_hl": "RAS status No. of patients (%)   Wild-type KRAS 6 (19.35)   Mutated KRAS 25 (80.65)     Exon 2 codon 12 19 (76.00)       G12A 4       G12C 3       G12D 10       G12V 2     Exon 2 codon 13 5 (20.00)       G13D 4       G13V 1     Exon 3 codon 59 0 (0.00)     Exon 3 codon 61 0 (0.00)     Exon 4 codon 117 0 (0.00)     Exon 4 codon 146 1 (4.00)       A146P 1   Wild-type NRAS 30 (96.77)   Mutated NRAS 1 (3.23)     Exon 2 codon 12 1 (100.00)       G12D 1     Exon 2 codon 13 0 (0.00)     Exon 3 codon 59 0 (0.00)     Exon 3 codon 61 0 (0.00)     Exon 4 codon 117 0 (0.00)     Exon 4 codon 146 0 (0.00)     Undefined 0 (0.00)   "}], "citations": {"NLM": "Lastraioli E, Antonuzzo L, Fantechi B, Di Cerbo L, Di Costanzo A, Lavacchi D, Armenio M, Arcangeli A, Castiglione F, Messerini L, Di Costanzo F. KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy and clinical evaluation. Oncol Lett. PMID: 33240421", "BibTeX": "@article{33240421, title={KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy and clinical evaluation.}, author={Lastraioli E and Antonuzzo L and Fantechi B and Di Cerbo L and Di Costanzo A and Lavacchi D and Armenio M and Arcangeli A and Castiglione F and Messerini L and Di Costanzo F}, journal={Oncol Lett}}"}, "is_sup_mat_match": false}, {"pmid": 27916952, "pmcid": "PMC5187815", "title": "High Intra- and Inter-Tumoral Heterogeneity of RAS Mutations in Colorectal Cancer.", "journal": "Int J Mol Sci", "authors": ["Jeantet M", "Tougeron D", "Tachon G", "Cortes U", "Archambaut C", "Fromont G", "Karayan-Tapon L"], "date": "2016-12-01T00:00:00Z", "year": 2016, "snippets": [{"_id": "27916952@29875", "snip_text": "Heterogeneity Patients pTNM %TC KRAS Other Genes   Intra-tumoral heterogeneity 4 ITS 70 WT BRAF:V600E (PLLM)   pT1 30 WT WT   pT2 90 WT BRAF:V600E (MUT)   9 ITS 70 G12S (PLLM)/Q61R (PLLM) NRAS:Q61R (MUT)   pT1 95 WT NRAS:Q61R (MUT)   pT2 70 WT NRAS:Q61R (MUT)   pT3 25 WT NRAS:Q61R (MUT)   18 ITS 80 G12R (MUT) WT   pT1 30 G12R (MUT) NRAS : K117N (PLLM)   pT2 35 G12R (MUT) WT   pT3 20 G12R (MUT) WT   Intra-tumoral and Inter-tumoral heterogeneity 2 ITS 80 WT NRAS: A59T (PLLM)   pT2 15 WT WT   pT3 20 G13D (MUT) WT   N 5 WT WT   7 ITS 60 G12S (PLLM) FA (NRAS61 et KRAS146)   pT1 70 G12D (MUT)/Q61L (PLLM) NRAS:Q61K (MUT)   pT2 25 G12S (MUT) NRAS:Q61K (MUT)   pT3 40 Q61L (PLLM) NRAS:Q61K (MUT)   N 25 WT NRAS:Q61K (MUT)   12 ITS 40 G12D (PLLM)/A146T (MUT) WT   pT2 15 A146T (MUT) WT   pT3 20 Q61H(PLLM)/A146T (MUT) FA (BRAF)   M 25 WT FA(NRAS59)   Inter-tumoral heterogeneity only 14 ITS 30 G12V (MUT) WT   pT1 5 G12V (PLLM) WT   pT2 40 G12V (MUT) WT   pT3 5 G12V (PLLM) WT   N 5 WT WT   Mutation without heterogeneity 8 ITS 30 G12V (MUT) WT   pT1 60 G12V (MUT) WT   pT2 75 G12V (MUT) WT   pT3 60 G12V (MUT) WT   N 80 G12V (MUT) WT   11 ITS 5 G12D (PLLM) WT   pT2 5 G12D (MUT) WT   pT3 5 G12D (PLLM) WT   N 5 G12D (MUT) WT   13 ITS 70 G12V (MUT) WT   pT1 70 G12V (MUT) WT   pT2 10 G12V (MUT) WT   pT3 15 G12V (MUT) WT   15 ITS 40 G12D (MUT) WT   pT1 60 G12D (MUT) WT   pT2 15 G12D (MUT) WT   pT3 20 G12D (MUT) WT   N 40 G12D (MUT) WT   16 ITS 40 G12V (MUT) WT   pT1 80 G12V (MUT) WT   pT2 40 G12V (MUT) WT   pT3 10 G12V (MUT) WT   17 ITS 30 G12V (MUT) WT   pT1 30 G12V (MUT) WT   pT2 20 G12V (MUT) WT   pT3 10 G12V (MUT) WT   N 20 G12V (MUT) WT   ", "section": "table", "mentions": ["539|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "466|4|variant|litvar@rs730880965##&&&litvar@#4893#&&&litvar@CA297023#rs730880965##|A59T", "820|4|gene|ncbi_gene@673|BRAF", "1416|1|chemical|ncbi_mesh@D009584|N", "164|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "1114|1|chemical|ncbi_mesh@D009584|N", "545|4|disease||PLLM", "600|4|disease||PLLM", "1206|1|chemical|ncbi_mesh@D009584|N", "14|8|species|ncbi_taxonomy@9606|Patients", "710|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "348|4|disease||PLLM", "1119|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "91|4|gene|ncbi_gene@673|BRAF", "1588|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "472|4|disease||PLLM", "1542|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "193|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "32|4|gene|ncbi_gene@3845|KRAS", "188|4|gene|ncbi_gene@4893|NRAS", "798|4|disease||PLLM", "341|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "647|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "1611|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1189|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "23|4|disease|ncbi_mesh@D008207|pTNM", "611|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "684|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "739|4|disease||PLLM", "244|4|gene|ncbi_gene@4893|NRAS", "221|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "914|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1195|4|disease||PLLM", "1493|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1144|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "277|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "460|4|gene|ncbi_gene@4893|NRAS", "1098|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "502|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "141|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "769|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "103|4|disease||PLLM", "1236|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "667|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "966|4|disease||PLLM", "300|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "631|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "136|4|gene|ncbi_gene@673|BRAF", "673|4|disease||PLLM", "96|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "733|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1632|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1210|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "705|4|gene|ncbi_gene@4893|NRAS", "182|4|disease||PLLM", "804|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "334|4|gene|ncbi_gene@4893|NRAS", "977|1|chemical|ncbi_mesh@D009584|N", "793|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "642|4|gene|ncbi_gene@4893|NRAS", "745|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "1400|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "679|4|gene|ncbi_gene@4893|NRAS", "1377|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "583|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1354|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "1565|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1331|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "216|4|gene|ncbi_gene@4893|NRAS", "386|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "170|4|disease||PLLM", "1029|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "363|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "606|4|gene|ncbi_gene@4893|NRAS", "960|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "249|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "1075|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1447|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1052|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1167|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "323|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "1305|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1516|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1282|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "920|4|disease||PLLM", "594|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "1259|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "272|4|gene|ncbi_gene@4893|NRAS", "938|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1470|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "176|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "892|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "1150|4|disease||PLLM", "1421|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D"], "figure_id": "ijms-17-02015-t002", "text_hl": "Heterogeneity Patients pTNM %TC KRAS Other Genes   Intra-tumoral heterogeneity 4 ITS 70 WT BRAF:V600E (PLLM)   pT1 30 WT WT   pT2 90 WT BRAF:V600E (MUT)   9 ITS 70 G12S (PLLM)/Q61R (PLLM) NRAS:Q61R (MUT)   pT1 95 WT NRAS:Q61R (MUT)   pT2 70 WT NRAS:Q61R (MUT)   pT3 25 WT NRAS:Q61R (MUT)   18 ITS 80 G12R (MUT) WT   pT1 30 G12R (MUT) NRAS : K117N (PLLM)   pT2 35 G12R (MUT) WT   pT3 20 G12R (MUT) WT   Intra-tumoral and Inter-tumoral heterogeneity 2 ITS 80 WT NRAS: A59T (PLLM)   pT2 15 WT WT   pT3 20 G13D (MUT) WT   N 5 WT WT   7 ITS 60 G12S (PLLM) FA (NRAS61 et KRAS146)   pT1 70 G12D (MUT)/Q61L (PLLM) NRAS:Q61K (MUT)   pT2 25 G12S (MUT) NRAS:Q61K (MUT)   pT3 40 Q61L (PLLM) NRAS:Q61K (MUT)   N 25 WT NRAS:Q61K (MUT)   12 ITS 40 G12D (PLLM)/<m>A146T</m> (MUT) WT   pT2 15 <m>A146T</m> (MUT) WT   pT3 20 Q61H(PLLM)/<m>A146T</m> (MUT) FA (BRAF)   M 25 WT FA(NRAS59)   Inter-tumoral heterogeneity only 14 ITS 30 G12V (MUT) WT   pT1 5 G12V (PLLM) WT   pT2 40 G12V (MUT) WT   pT3 5 G12V (PLLM) WT   N 5 WT WT   Mutation without heterogeneity 8 ITS 30 G12V (MUT) WT   pT1 60 G12V (MUT) WT   pT2 75 G12V (MUT) WT   pT3 60 G12V (MUT) WT   N 80 G12V (MUT) WT   11 ITS 5 G12D (PLLM) WT   pT2 5 G12D (MUT) WT   pT3 5 G12D (PLLM) WT   N 5 G12D (MUT) WT   13 ITS 70 G12V (MUT) WT   pT1 70 G12V (MUT) WT   pT2 10 G12V (MUT) WT   pT3 15 G12V (MUT) WT   15 ITS 40 G12D (MUT) WT   pT1 60 G12D (MUT) WT   pT2 15 G12D (MUT) WT   pT3 20 G12D (MUT) WT   N 40 G12D (MUT) WT   16 ITS 40 G12V (MUT) WT   pT1 80 G12V (MUT) WT   pT2 40 G12V (MUT) WT   pT3 10 G12V (MUT) WT   17 ITS 30 G12V (MUT) WT   pT1 30 G12V (MUT) WT   pT2 20 G12V (MUT) WT   pT3 10 G12V (MUT) WT   N 20 G12V (MUT) WT   "}], "citations": {"NLM": "Jeantet M, Tougeron D, Tachon G, Cortes U, Archambaut C, Fromont G, Karayan-Tapon L. High Intra- and Inter-Tumoral Heterogeneity of RAS Mutations in Colorectal Cancer. Int J Mol Sci. PMID: 27916952", "BibTeX": "@article{27916952, title={High Intra- and Inter-Tumoral Heterogeneity of RAS Mutations in Colorectal Cancer.}, author={Jeantet M and Tougeron D and Tachon G and Cortes U and Archambaut C and Fromont G and Karayan-Tapon L}, journal={Int J Mol Sci}}"}, "is_sup_mat_match": false}, {"pmid": 32170146, "pmcid": "PMC7070091", "title": "Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation.", "journal": "Sci Rep", "authors": ["Del Carmen S", "Corchete LA", "Gervas R", "Rodriguez A", "Garcia M", "\u00c1lcazar JA", "Garc\u00eda J", "Bengoechea O", "Mu\u00f1oz-Bellvis L", "Sayagu\u00e9s JM", "Abad M"], "date": "2020-03-13T00:00:00Z", "year": 2020, "snippets": [{"_id": "32170146@48420", "snip_text": "A multiplex allele-specific PCR-based assay was used for this purpose that assesses 44 mutations in KRAS codons 12, 13, 59, 61, 117 and 146 (G12A, G12C, G12D, G12R, G12S, G12V, G13D, A59E, A59G, A59T, Q61K (C > A), Q61K (C > AA), Q61L, Q61R, Q61H(A > T), Q61H(A > C), K117N(A > C), K117(A > T), A146P, A146V, and A146T), NRAS codons 12, 13, 59, 61, 117 and 146 (G12D, G12C, G12S, G12A, G12V, G13D, G13R, G13V, A59T, Q61K, Q61R, Q61L, Q61H(A > C), Q61H(A > T), K117N(G > C), K117N(G > T), A146T and A146V) and BRAF codon 600 (V600E(T > A), V600E(G > AA), V600D, V600K and V600R).", "section": "methods", "mentions": ["295|5|variant|litvar@rs121913527##&&&litvar@#3845#|A146P", "230|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "386|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "545|6|variant|litvar@#673#|G > AA", "571|5|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16021333#rs121913227##|V600R", "539|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "404|4|variant|litvar@rs121434596##&&&litvar@#4893#&&&litvar@CA16602363#rs121434596##|G13V", "452|5|variant|litvar@#4893#|A > T", "525|5|variant|litvar@rs113488022##&&&litvar@#673#&&&litvar@CA123643#rs113488022##|V600E", "171|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122540#rs121913529##|G12V", "189|4|variant|litvar@rs781085650##&&&litvar@#673#&&&litvar@CA4517046#rs781085650##|A59G", "287|5|variant|litvar@#4893#|A > T", "368|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "480|5|variant|litvar@#673#|G > T", "498|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "466|5|variant|litvar@#673#|G > C", "410|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "531|5|variant|litvar@#673#|T > A", "428|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA16602361#rs11554290##|Q61L", "439|5|variant|litvar@#4893#|A > C", "260|5|variant|litvar@#4893#|A > C", "447|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "554|5|variant|litvar@rs121913377##&&&litvar@#673#&&&litvar@CA16602419#rs121913377##|V600D", "392|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "153|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "274|5|variant|litvar@#4893#|A > C", "236|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "374|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "247|5|variant|litvar@#4893#|A > T", "255|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "302|5|variant|litvar@rs1057519725##&&&litvar@#3845#|A146V", "159|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122531#rs121913530##|G12R", "177|4|variant|litvar@rs112445441##&&&litvar@#3845#&&&litvar@CA122534#rs112445441##|G13D", "434|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "242|4|variant|litvar@rs17851045##&&&litvar@#3845#&&&litvar@CA135552#rs17851045##|Q61H", "195|4|variant|litvar@rs121913528##&&&litvar@#3845#&&&litvar@CA122536#rs121913528##|A59T", "398|4|variant|litvar@rs121434595##&&&litvar@#4893#&&&litvar@CA151261#rs121434595##|G13R", "100|4|gene|ncbi_gene@3845|KRAS", "147|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA122528#rs121913530##|G12C", "416|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "201|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "313|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "460|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "380|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "221|5|variant|litvar@#3845#|C > A", "509|4|gene|ncbi_gene@673|BRAF", "141|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA135567#rs121913529##|G12A", "422|4|variant|litvar@rs11554290##&&&litvar@#4893#&&&litvar@CA123618#rs11554290##|Q61R", "215|4|variant|litvar@rs121913254##&&&litvar@#4893#&&&litvar@CA151263#rs121913254##|Q61K", "488|5|variant|litvar@rs121913527##&&&litvar@#3845#&&&litvar@CA245262#rs121913527##|A146T", "561|5|variant|litvar@rs121913227##&&&litvar@#673#&&&litvar@CA16602420#rs121913227##|V600K", "183|4|variant|litvar@rs763572530##&&&litvar@#1956#&&&litvar@CA4265148#rs763572530##|A59E", "474|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N", "321|4|gene|ncbi_gene@4893|NRAS", "362|4|variant|litvar@rs121913529##&&&litvar@#3845#&&&litvar@CA122538#rs121913529##|G12D", "165|4|variant|litvar@rs121913530##&&&litvar@#3845#&&&litvar@CA135565#rs121913530##|G12S", "268|5|variant|litvar@rs770248150##&&&litvar@#3845#&&&litvar@CA6486888#rs770248150##|K117N"], "text_hl": "A multiplex allele-specific PCR-based assay was used for this purpose that assesses 44 mutations in KRAS codons 12, 13, 59, 61, 117 and 146 (G12A, G12C, G12D, G12R, G12S, G12V, G13D, A59E, A59G, A59T, Q61K (C > A), Q61K (C > AA), Q61L, Q61R, Q61H(A > T), Q61H(A > C), K117N(A > C), K117(A > T), A146P, A146V, and <m>A146T</m>), NRAS codons 12, 13, 59, 61, 117 and 146 (G12D, G12C, G12S, G12A, G12V, G13D, G13R, G13V, A59T, Q61K, Q61R, Q61L, Q61H(A > C), Q61H(A > T), K117N(G > C), K117N(G > T), <m>A146T</m> and A146V) and BRAF codon 600 (V600E(T > A), V600E(G > AA), V600D, V600K and V600R)."}], "citations": {"NLM": "Del Carmen S, Corchete LA, Gervas R, Rodriguez A, Garcia M, \u00c1lcazar JA, Garc\u00eda J, Bengoechea O, Mu\u00f1oz-Bellvis L, Sayagu\u00e9s JM, Abad M. Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation. Sci Rep. PMID: 32170146", "BibTeX": "@article{32170146, title={Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation.}, author={Del Carmen S and Corchete LA and Gervas R and Rodriguez A and Garcia M and \u00c1lcazar JA and Garc\u00eda J and Bengoechea O and Mu\u00f1oz-Bellvis L and Sayagu\u00e9s JM and Abad M}, journal={Sci Rep}}"}, "is_sup_mat_match": false}, {"pmid": 35617825, "pmcid": "PMC9130225", "title": "Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q.", "journal": "EBioMedicine", "authors": ["Adema V", "Palomo L", "Walter W", "Mallo M", "Hutter S", "La Framboise T", "Arenillas L", "Meggendorfer M", "Radivoyevitch T", "Xicoy B", "Pellagatti A", "Haferlach C", "Boultwood J", "Kern W", "Visconte V", "Sekeres M", "Barnard J", "Haferlach T", "Sol\u00e9 F", "Maciejewski JP"], "date": "2022-06-01T00:00:00Z", "year": 2022, "snippets": [], "citations": {"NLM": "Adema V, Palomo L, Walter W, Mallo M, Hutter S, La Framboise T, Arenillas L, Meggendorfer M, Radivoyevitch T, Xicoy B, Pellagatti A, Haferlach C, Boultwood J, Kern W, Visconte V, Sekeres M, Barnard J, Haferlach T, Sol\u00e9 F, Maciejewski JP. Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q. EBioMedicine. PMID: 35617825", "BibTeX": "@article{35617825, title={Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q.}, author={Adema V and Palomo L and Walter W and Mallo M and Hutter S and La Framboise T and Arenillas L and Meggendorfer M and Radivoyevitch T and Xicoy B and Pellagatti A and Haferlach C and Boultwood J and Kern W and Visconte V and Sekeres M and Barnard J and Haferlach T and Sol\u00e9 F and Maciejewski JP}, journal={EBioMedicine}}"}, "is_sup_mat_match": true}, {"pmid": 32686686, "pmcid": "PMC7371703", "title": "Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival.", "journal": "Nat Commun", "authors": ["Zaidi SH", "Harrison TA", "Phipps AI", "Steinfelder R", "Trinh QM", "Qu C", "Banbury BL", "Georgeson P", "Grasso CS", "Giannakis M", "Adams JB", "Alwers E", "Amitay EL", "Barfield RT", "Berndt SI", "Borozan I", "Brenner H", "Brezina S", "Buchanan DD", "Cao Y", "Chan AT", "Chang-Claude J", "Connolly CM", "Drew DA", "Farris AB 3rd", "Figueiredo JC", "French AJ", "Fuchs CS", "Garraway LA", "Gruber S", "Guinter MA", "Hamilton SR", "Harlid S", "Heisler LE", "Hidaka A", "Hopper JL", "Huang WY", "Huyghe JR", "Jenkins MA", "Krzyzanowski PM", "Lemire M", "Lin Y", "Luo X", "Mardis ER", "McPherson JD", "Miller JK", "Moreno V", "Mu XJ", "Nishihara R", "Papadopoulos N", "Pasternack D", "Quist MJ", "Rafikova A", "Reid EEG", "Shinbrot E", "Shirts BH", "Stein LD", "Teney CD", "Timms L", "Um CY", "Van Guelpen B", "Van Tassel M", "Wang X", "Wheeler DA", "Yung CK", "Hsu L", "Ogino S", "Gsur A", "Newcomb PA", "Gallinger S", "Hoffmeister M", "Campbell PT", "Thibodeau SN", "Sun W", "Hudson TJ", "Peters U"], "date": "2020-07-20T00:00:00Z", "year": 2020, "snippets": [], "citations": {"NLM": "Zaidi SH, Harrison TA, Phipps AI, Steinfelder R, Trinh QM, Qu C, Banbury BL, Georgeson P, Grasso CS, Giannakis M, Adams JB, Alwers E, Amitay EL, Barfield RT, Berndt SI, Borozan I, Brenner H, Brezina S, Buchanan DD, Cao Y, Chan AT, Chang-Claude J, Connolly CM, Drew DA, Farris AB 3rd, Figueiredo JC, French AJ, Fuchs CS, Garraway LA, Gruber S, Guinter MA, Hamilton SR, Harlid S, Heisler LE, Hidaka A, Hopper JL, Huang WY, Huyghe JR, Jenkins MA, Krzyzanowski PM, Lemire M, Lin Y, Luo X, Mardis ER, McPherson JD, Miller JK, Moreno V, Mu XJ, Nishihara R, Papadopoulos N, Pasternack D, Quist MJ, Rafikova A, Reid EEG, Shinbrot E, Shirts BH, Stein LD, Teney CD, Timms L, Um CY, Van Guelpen B, Van Tassel M, Wang X, Wheeler DA, Yung CK, Hsu L, Ogino S, Gsur A, Newcomb PA, Gallinger S, Hoffmeister M, Campbell PT, Thibodeau SN, Sun W, Hudson TJ, Peters U. Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival. Nat Commun. PMID: 32686686", "BibTeX": "@article{32686686, title={Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival.}, author={Zaidi SH and Harrison TA and Phipps AI and Steinfelder R and Trinh QM and Qu C and Banbury BL and Georgeson P and Grasso CS and Giannakis M and Adams JB and Alwers E and Amitay EL and Barfield RT and Berndt SI and Borozan I and Brenner H and Brezina S and Buchanan DD and Cao Y and Chan AT and Chang-Claude J and Connolly CM and Drew DA and Farris AB 3rd and Figueiredo JC and French AJ and Fuchs CS and Garraway LA and Gruber S and Guinter MA and Hamilton SR and Harlid S and Heisler LE and Hidaka A and Hopper JL and Huang WY and Huyghe JR and Jenkins MA and Krzyzanowski PM and Lemire M and Lin Y and Luo X and Mardis ER and McPherson JD and Miller JK and Moreno V and Mu XJ and Nishihara R and Papadopoulos N and Pasternack D and Quist MJ and Rafikova A and Reid EEG and Shinbrot E and Shirts BH and Stein LD and Teney CD and Timms L and Um CY and Van Guelpen B and Van Tassel M and Wang X and Wheeler DA and Yung CK and Hsu L and Ogino S and Gsur A and Newcomb PA and Gallinger S and Hoffmeister M and Campbell PT and Thibodeau SN and Sun W and Hudson TJ and Peters U}, journal={Nat Commun}}"}, "is_sup_mat_match": true}, {"pmid": 26366557, "pmcid": "PMC4569137", "title": "Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers.", "journal": "PLoS One", "authors": ["D'Haene N", "Le Mercier M", "De N\u00e8ve N", "Blanchard O", "Delaunoy M", "El Housni H", "Dessars B", "Heimann P", "Remmelink M", "Demetter P", "Tejpar S", "Salmon I"], "date": "2015-09-14T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "D'Haene N, Le Mercier M, De N\u00e8ve N, Blanchard O, Delaunoy M, El Housni H, Dessars B, Heimann P, Remmelink M, Demetter P, Tejpar S, Salmon I. Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers. PLoS One. PMID: 26366557", "BibTeX": "@article{26366557, title={Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers.}, author={D'Haene N and Le Mercier M and De N\u00e8ve N and Blanchard O and Delaunoy M and El Housni H and Dessars B and Heimann P and Remmelink M and Demetter P and Tejpar S and Salmon I}, journal={PLoS One}}"}, "is_sup_mat_match": true}, {"pmid": 28420421, "pmcid": "PMC5395719", "title": "Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.", "journal": "Genome Med", "authors": ["Chalmers ZR", "Connelly CF", "Fabrizio D", "Gay L", "Ali SM", "Ennis R", "Schrock A", "Campbell B", "Shlien A", "Chmielecki J", "Huang F", "He Y", "Sun J", "Tabori U", "Kennedy M", "Lieber DS", "Roels S", "White J", "Otto GA", "Ross JS", "Garraway L", "Miller VA", "Stephens PJ", "Frampton GM"], "date": "2017-04-19T00:00:00Z", "year": 2017, "snippets": [], "citations": {"NLM": "Chalmers ZR, Connelly CF, Fabrizio D, Gay L, Ali SM, Ennis R, Schrock A, Campbell B, Shlien A, Chmielecki J, Huang F, He Y, Sun J, Tabori U, Kennedy M, Lieber DS, Roels S, White J, Otto GA, Ross JS, Garraway L, Miller VA, Stephens PJ, Frampton GM. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. PMID: 28420421", "BibTeX": "@article{28420421, title={Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.}, author={Chalmers ZR and Connelly CF and Fabrizio D and Gay L and Ali SM and Ennis R and Schrock A and Campbell B and Shlien A and Chmielecki J and Huang F and He Y and Sun J and Tabori U and Kennedy M and Lieber DS and Roels S and White J and Otto GA and Ross JS and Garraway L and Miller VA and Stephens PJ and Frampton GM}, journal={Genome Med}}"}, "is_sup_mat_match": true}, {"pmid": 29575536, "pmcid": "PMC5951744", "title": "Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers", "journal": "Genes Chromosomes Cancer", "authors": ["Wolff RK", "Hoffman MD", "Wolff EC", "Herrick JS", "Sakoda LC", "Samowitz WS", "Slattery ML"], "date": "2018-07-01T00:00:00Z", "year": 2018, "snippets": [], "citations": {"NLM": "Wolff RK, Hoffman MD, Wolff EC, Herrick JS, Sakoda LC, Samowitz WS, Slattery ML. Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers Genes Chromosomes Cancer. PMID: 29575536", "BibTeX": "@article{29575536, title={Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers}, author={Wolff RK and Hoffman MD and Wolff EC and Herrick JS and Sakoda LC and Samowitz WS and Slattery ML}, journal={Genes Chromosomes Cancer}}"}, "is_sup_mat_match": true}, {"pmid": 31034466, "pmcid": "PMC6508748", "title": "Finding driver mutations in cancer: Elucidating the role of background mutational processes", "journal": "PLoS Comput Biol", "authors": ["Brown AL", "Li M", "Goncearenco A", "Panchenko AR"], "date": "2019-04-29T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Brown AL, Li M, Goncearenco A, Panchenko AR. Finding driver mutations in cancer: Elucidating the role of background mutational processes PLoS Comput Biol. PMID: 31034466", "BibTeX": "@article{31034466, title={Finding driver mutations in cancer: Elucidating the role of background mutational processes}, author={Brown AL and Li M and Goncearenco A and Panchenko AR}, journal={PLoS Comput Biol}}"}, "is_sup_mat_match": true}, {"pmid": 26109429, "pmcid": "PMC4673155", "title": "Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels", "journal": "Oncotarget", "authors": ["Lim B", "Mun J", "Kim JH", "Kim CW", "Roh SA", "Cho DH", "Kim YS", "Kim SY", "Kim JC"], "date": "2015-09-08T00:00:00Z", "year": 2015, "snippets": [], "citations": {"NLM": "Lim B, Mun J, Kim JH, Kim CW, Roh SA, Cho DH, Kim YS, Kim SY, Kim JC. Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels Oncotarget. PMID: 26109429", "BibTeX": "@article{26109429, title={Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels}, author={Lim B and Mun J and Kim JH and Kim CW and Roh SA and Cho DH and Kim YS and Kim SY and Kim JC}, journal={Oncotarget}}"}, "is_sup_mat_match": true}, {"pmid": 31337866, "pmcid": "PMC6756116", "title": "Rare, functional, somatic variants in gene families linked to cancer genes: GPCR signaling as a paradigm.", "journal": "Oncogene", "authors": ["Raimondi F", "Inoue A", "Kadji FMN", "Shuai N", "Gonzalez JC", "Singh G", "de la Vega AA", "Sotillo R", "Fischer B", "Aoki J", "Gutkind JS", "Russell RB"], "date": "2019-09-01T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Raimondi F, Inoue A, Kadji FMN, Shuai N, Gonzalez JC, Singh G, de la Vega AA, Sotillo R, Fischer B, Aoki J, Gutkind JS, Russell RB. Rare, functional, somatic variants in gene families linked to cancer genes: GPCR signaling as a paradigm. Oncogene. PMID: 31337866", "BibTeX": "@article{31337866, title={Rare, functional, somatic variants in gene families linked to cancer genes: GPCR signaling as a paradigm.}, author={Raimondi F and Inoue A and Kadji FMN and Shuai N and Gonzalez JC and Singh G and de la Vega AA and Sotillo R and Fischer B and Aoki J and Gutkind JS and Russell RB}, journal={Oncogene}}"}, "is_sup_mat_match": true}, {"pmid": 31254442, "pmcid": "PMC6670011", "title": "Detection of mutational patterns in cell-free DNA of colorectal cancer by custom amplicon sequencing.", "journal": "Mol Oncol", "authors": ["Herrmann S", "Zhan T", "Betge J", "Rauscher B", "Belle S", "Gutting T", "Schulte N", "Jesenofsky R", "H\u00e4rtel N", "Gaiser T", "Hofheinz RD", "Ebert MP", "Boutros M"], "date": "2019-08-01T00:00:00Z", "year": 2019, "snippets": [], "citations": {"NLM": "Herrmann S, Zhan T, Betge J, Rauscher B, Belle S, Gutting T, Schulte N, Jesenofsky R, H\u00e4rtel N, Gaiser T, Hofheinz RD, Ebert MP, Boutros M. Detection of mutational patterns in cell-free DNA of colorectal cancer by custom amplicon sequencing. Mol Oncol. PMID: 31254442", "BibTeX": "@article{31254442, title={Detection of mutational patterns in cell-free DNA of colorectal cancer by custom amplicon sequencing.}, author={Herrmann S and Zhan T and Betge J and Rauscher B and Belle S and Gutting T and Schulte N and Jesenofsky R and H\u00e4rtel N and Gaiser T and Hofheinz RD and Ebert MP and Boutros M}, journal={Mol Oncol}}"}, "is_sup_mat_match": true}, {"pmid": 31953485, "pmcid": "PMC6969060", "title": "Latency and interval therapy affect the evolution in metastatic colorectal cancer.", "journal": "Sci Rep", "authors": ["Nikbakht H", "Jessa S", "Sukhai MA", "Arseneault M", "Zhang T", "Letourneau L", "Thomas M", "Bourgey M", "Roehrl MHA", "Eveleigh R", "Chen EX", "Krzyzanowska M", "Moore MJ", "Giesler A", "Yu C", "Bedard PL", "Kamel-Reid S", "Majewski J", "Siu LL", "Riazalhosseini Y", "Graham DM"], "date": "2020-01-17T00:00:00Z", "year": 2020, "snippets": [], "citations": {"NLM": "Nikbakht H, Jessa S, Sukhai MA, Arseneault M, Zhang T, Letourneau L, Thomas M, Bourgey M, Roehrl MHA, Eveleigh R, Chen EX, Krzyzanowska M, Moore MJ, Giesler A, Yu C, Bedard PL, Kamel-Reid S, Majewski J, Siu LL, Riazalhosseini Y, Graham DM. Latency and interval therapy affect the evolution in metastatic colorectal cancer. Sci Rep. PMID: 31953485", "BibTeX": "@article{31953485, title={Latency and interval therapy affect the evolution in metastatic colorectal cancer.}, author={Nikbakht H and Jessa S and Sukhai MA and Arseneault M and Zhang T and Letourneau L and Thomas M and Bourgey M and Roehrl MHA and Eveleigh R and Chen EX and Krzyzanowska M and Moore MJ and Giesler A and Yu C and Bedard PL and Kamel-Reid S and Majewski J and Siu LL and Riazalhosseini Y and Graham DM}, journal={Sci Rep}}"}, "is_sup_mat_match": true}]